A2463_36@402@403@deletion@2@1577024@1577362@1@chr1:1577024-1577362@8.11@89@33@0.371@CNVR17.1@CDK11B_10, CDK11B_9@0@0@0@:cyclin-dependent kinase 11B@:protein serine/threonine kinase activity;protein tyrosine kinase activity;protein phosphorylation;protein kinase activity;cell division;transferase activity, transferring phosphorus-containing groups;ATP binding@NA
A2463_36@422@425@deletion@4@1634916@1635783@1@chr1:1634916-1635783@8.31@139@71@0.511@CNVR17.1@CDK11A_18, CDK11A_17, CDK11A_16, CDK11A_15@0@0@0@:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A@:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division@NA
A2463_36@428@432@duplication@5@1637082@1640572@1@chr1:1637082-1640572@6.44@142@215@1.51@CNVR17.1@CDK11A_12, CDK11A_11, CDK11A_10, CDK11A_9, CDK11A_8@0@0@0@:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A@:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division@NA
A2463_36@434@440@deletion@7@1643704@1666274@1@chr1:1643704-1666274@25.2@554@301@0.543@CNVR17.1@CDK11A_6, CDK11A_5, CDK11A_4, CDK11A_3, CDK11A_2, SLC35E2_6, SLC35E2_5@0@0@0@:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A:solute carrier family 35, member E2@:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division:integral to membrane;membrane@NA
A2463_36@1817@1818@duplication@2@12941676@12943215@1@chr1:12941676-12943215@4.91@395@529@1.34@CNVR72.3, CNVR72.4, CNVR72.12, CNVR72.13@PRAMEF4_3, PRAMEF4_2@0@0@0@:PRAME family member 4@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_36@1825@1833@duplication@9@12998506@13219581@1@chr1:12998506-13219581@19.6@413@649@1.57@CNVR73.2@PRAMEF6_4, PRAMEF6_3, PRAMEF6_2, PRAMEF22_1, PRAMEF22_2, PRAMEF22_3, WI2-3308P17.2_1, WI2-2994D6.2_2, WI2-2994D6.2_1@0@0@0@:PRAME family member 6;PRAME family member 23;PRAME family member 9/15-like;PRAME family member 5:PRAME family member 22:PRAME family member@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_36@1855@1855@duplication@1@13521974@13522259@1@chr1:13521974-13522259@5.54@9@46@5.11@NA@PRAMEF21_2@0@0@0@:PRAME family member 21;PRAME family member 20@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_36@2170@2187@duplication@18@17248515@17275019@1@chr1:17248515-17275019@46.8@1070@1640@1.53@CNVR94.4, CNVR94.5@CROCC_1, CROCC_2, CROCC_3, CROCC_4, CROCC_5, CROCC_6, CROCC_7, CROCC_8, CROCC_9, CROCC_10, CROCC_11, CROCC_12, CROCC_13, CROCC_14, CROCC_15, CROCC_16, CROCC_17, CROCC_18@0@0@0@:ciliary rootlet coiled-coil, rootletin@:centriole;centrosome organization;centrosome;kinesin binding;actin cytoskeleton;cytoplasm;protein binding;vesicle-mediated transport;structural molecule activity;ciliary rootlet;protein localization;plasma membrane;cell cycle;cell projection organization;membrane@NA
A2463_36@3194@3198@deletion@5@24287949@24301567@1@chr1:24287949-24301567@15.6@74@2@0.027@NA@PNRC2_3, SRSF10_6, SRSF10_5, SRSF10_4, SRSF10_3@0@0@0@:proline-rich nuclear receptor coactivator 2;proline-rich nuclear receptor coactivator 2-like:serine/arginine-rich splicing factor 10-like;serine/arginine-rich splicing factor 10@:protein binding;deadenylation-independent decapping of nuclear-transcribed mRNA;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;nucleus;regulation of transcription, DNA-dependent;transcription, DNA-dependent;cytoplasmic mRNA processing body:nucleoplasm;RNA splicing, via transesterification reactions;nuclear speck;RS domain binding;RNA binding;nucleus;mRNA splice site selection;unfolded protein binding;assembly of spliceosomal tri-snRNP;negative regulation of mRNA splicing, via spliceosome;regulation of transcription, DNA-dependent;nucleotide binding;cytoplasm;mRNA export from nucleus;protein binding;cytoplasmic transport;mRNA splicing, via spliceosome;nucleic acid binding@NA
A2463_36@3334@3334@deletion@1@25611065@25611250@1@chr1:25611065-25611250@5.42@158@89@0.563@CNVR116.1, CNVR116.2@RHD_2@0@0@0@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
A2463_36@3357@3357@duplication@1@25735175@25735360@1@chr1:25735175-25735360@5.76@125@203@1.62@CNVR117.1@RHCE_2@0@0@0@:Rh blood group, CcEe antigens@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@: BLOOD GROUP--RHESUS SYSTEM E POLYPEPTIDE; RHE; RHESUS BLOOD GROUP, CcEe ANTIGENS; RHCE
A2463_36@9365@9374@duplication@10@104202983@104234232@1@chr1:104202983-104234232@35.6@338@702@2.08@CNVR266.3, CNVR266.1, CNVR266.15@AMY1A_7, AMY1A_8, AMY1A_9, AMY1A_10, AMY1A_11, AMY1B_11, AMY1B_10, AMY1B_9, AMY1B_8, AMY1B_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
A2463_36@9385@9386@deletion@2@104297122@104297436@1@chr1:104297122-104297436@82.4@447@4@0.00895@CNVR266.3, CNVR266.5@AMY1C_6, AMY1C_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
A2463_36@9460@9460@duplication@1@109007811@109008046@1@chr1:109007811-109008046@5.59@82@144@1.76@CNVR294.4@NBPF6_13@0@0@0@:neuroblastoma breakpoint family, member 6@:cytoplasm@NA
A2463_36@9766@9773@deletion@8@110230497@110235917@1@chr1:110230497-110235917@56.6@266@2@0.00752@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_1, GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
A2463_36@10788@10793@deletion@6@144220788@144340398@1@chr1:144220788-144340398@11@112@41@0.366@CNVR334.4@RP3-377D14.1_87, RP3-377D14.1_88, RP3-377D14.1_89, RP3-377D14.1_90, RP3-377D14.1_91, AL592284.1_1@0@0@0@:uncharacterized LOC730256;uncharacterized LOC101060698;uncharacterized LOC642441@NA@NA
A2463_36@10862@10864@deletion@3@145295424@145297691@1@chr1:145295424-145297691@17.3@568@342@0.602@CNVR341.2, CNVR341.3, CNVR341.4@NBPF10_2, NBPF10_3, NBPF10_4@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family, member 10@:protein binding;calcium ion binding@NA
A2463_36@10890@10896@duplication@7@145325953@145330855@1@chr1:145325953-145330855@40.5@146@470@3.22@CNVR341.2, CNVR341.3@NBPF10_30, NBPF10_31, NBPF10_32, NBPF10_33, NBPF10_34, NBPF10_35, NBPF10_36@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family, member 10@NA@NA
A2463_36@10934@10942@duplication@9@145360556@145366999@1@chr1:145360556-145366999@14.2@119@238@2@CNVR341.2, CNVR341.3@NBPF10_74, NBPF10_75, NBPF10_76, NBPF10_77, NBPF10_78, NBPF10_79, NBPF10_80, NBPF10_81, NBPF10_82@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family, member 10@NA@NA
A2463_36@11161@11162@duplication@2@146248917@146250999@1@chr1:146248917-146250999@6.18@74@135@1.82@NA@NBPF12_4, NBPF12_3@0@0@0@:neuroblastoma breakpoint family member 21-like@NA@NA
A2463_36@11169@11173@deletion@5@146400092@146405926@1@chr1:146400092-146405926@20.1@128@23@0.18@NA@NBPF12_9, NBPF12_10, NBPF12_11, NBPF12_12, NBPF12_13@0@0@0@:neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family member 14-like;neuroblastoma breakpoint family, member 12@:cytoplasm@NA
A2463_36@11341@11342@deletion@2@148008574@148009516@1@chr1:148008574-148009516@6.93@609@404@0.663@CNVR346.2, CNVR346.4@NBPF14_17, NBPF14_16@0@0@0@:neuroblastoma breakpoint family, member 14@:cytoplasm@NA
A2463_36@11500@11500@deletion@1@149459426@149459549@1@chr1:149459426-149459549@4.54@71@34@0.479@CNVR350.1, CNVR350.5@FAM72C_1@0@0@0@:family with sequence similarity 72, member C@NA@NA
A2463_36@14053@14055@duplication@3@161565346@161596192@1@chr1:161565346-161596192@15.1@380@594@1.56@CNVR383.1@FCGR2C_1, FCGR3B_5, FCGR3B_4@0@0@0@:Fc fragment of IgG, low affinity IIIa, receptor (CD16a):Fc fragment of IgG, low affinity IIb, receptor (CD32):Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene):Fc fragment of IgG, low affinity IIIb, receptor (CD16b)@:IgG binding;protein binding;regulation of immune response;extracellular region;integral to membrane;immune response;plasma membrane;external side of plasma membrane:IgG binding;protein binding;signal transduction;regulation of immune response;integral to membrane;immune response;plasma membrane;virus-host interaction:IgG binding;protein binding;extracellular region;immune response;plasma membrane;anchored to membrane@: MALARIA, SUSCEPTIBILITY TO; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
A2463_36@16029@16040@duplication@12@196744018@196801129@1@chr1:196744018-196801129@25.9@2359@3141@1.33@CNVR459.1@CFHR3_1, CFHR3_2, CFHR3_3, CFHR3_4, CFHR3_5, CFHR3_6, CFHR1_1, CFHR1_2, CFHR1_3, CFHR1_4, CFHR1_5, CFHR1_6@0@0@0@:complement factor H-related 3:complement factor H-related 1:complement factor H-related 2@:extracellular space:extracellular space;complement activation:extracellular region@NA
A2463_36@19777@19778@duplication@2@248801589@248814185@1@chr1:248801589-248814185@8.42@380@545@1.43@NA@OR2T35_1, OR2T27_1@0@0@0@:olfactory receptor, family 2, subfamily T, member 35:olfactory receptor, family 2, subfamily T, member 27@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_36@24822@24822@deletion@1@87178420@87178483@2@chr2:87178420-87178483@6.48@31@1@0.0323@NA@RGPD1_2@0@0@0@:RANBP2-like and GRIP domain containing 1@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_36@24847@24851@duplication@5@88047674@88071883@2@chr2:88047674-88071883@6.31@101@164@1.62@NA@PLGLB2_1, PLGLB2_2, PLGLB2_3, RGPD2_23, RGPD2_22@0@0@0@:plasminogen-like B1;plasminogen-like B2:RANBP2-like and GRIP domain containing 2@:extracellular region:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_36@24862@24863@duplication@2@88094928@88095367@2@chr2:88094928-88095367@7.1@33@85@2.58@NA@RGPD2_11, RGPD2_10@0@0@0@:RANBP2-like and GRIP domain containing 2@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_36@25350@25351@deletion@2@97818242@97820478@2@chr2:97818242-97820478@34.5@169@1@0.00592@CNVR886.2@ANKRD36_14, ANKRD36_15@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_36@25369@25370@deletion@2@97854825@97855027@2@chr2:97854825-97855027@33.7@165@3@0.0182@CNVR886.2, CNVR886.3@ANKRD36_33, ANKRD36_34@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_36@25375@25386@duplication@12@97860464@97870000@2@chr2:97860464-97870000@47.1@2080@2980@1.43@CNVR886.1@ANKRD36_39, ANKRD36_40, ANKRD36_41, ANKRD36_42, ANKRD36_43, ANKRD36_44, ANKRD36_45, ANKRD36_46, ANKRD36_47, ANKRD36_48, ANKRD36_49, ANKRD36_50@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_36@25391@25404@duplication@14@97875419@97899608@2@chr2:97875419-97899608@75@2223@3430@1.54@NA@ANKRD36_55, ANKRD36_56, ANKRD36_57, ANKRD36_58, ANKRD36_59, ANKRD36_60, ANKRD36_61, ANKRD36_62, ANKRD36_63, ANKRD36_64, ANKRD36_65, ANKRD36_66, ANKRD36_67, ANKRD36_68@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_36@25407@25411@duplication@5@97910895@97915904@2@chr2:97910895-97915904@7.2@342@491@1.44@CNVR887.1@ANKRD36_71, ANKRD36_72, ANKRD36_73, ANKRD36_74, ANKRD36_75@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_36@26021@26024@duplication@4@108479139@108486433@2@chr2:108479139-108486433@17@397@630@1.59@NA@RGPD4_16, RGPD4_17, RGPD4_18, RGPD4_19@0@0@0@:RANBP2-like and GRIP domain containing 4@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_36@26082@26083@duplication@2@109271532@109276220@2@chr2:109271532-109276220@4.94@102@162@1.59@NA@LIMS1_1, LIMS1_2@0@0@0@:LIM and senescent cell antigen-like domains 1@:negative regulation of transcription, DNA-dependent;cell aging;perinuclear region of cytoplasm;cellular response to transforming growth factor beta stimulus;cytosol;protein binding;focal adhesion;plasma membrane;zinc ion binding;cell junction assembly@NA
A2463_36@27163@27163@deletion@1@130843388@130843568@2@chr2:130843388-130843568@9.29@44@1@0.0227@NA@POTEF_13@0@0@0@:POTE ankyrin domain family, member F@:cell cortex;protein binding;ATP binding@NA
A2463_36@27172@27172@deletion@1@130869569@130869674@2@chr2:130869569-130869674@6.65@71@26@0.366@NA@POTEF_4@0@0@0@:POTE ankyrin domain family, member F@:cell cortex;protein binding;ATP binding@NA
A2463_36@27180@27180@deletion@1@130898732@130898869@2@chr2:130898732-130898869@13.7@108@25@0.231@NA@CCDC74B_4@0@0@0@:coiled-coil domain containing 74A;coiled-coil domain containing 74B@NA@NA
A2463_36@27243@27251@duplication@9@131231952@131256794@2@chr2:131231952-131256794@8.33@229@334@1.46@NA@POTEI_13, POTEI_12, POTEI_11, POTEI_10, POTEI_9, POTEI_8, POTEI_7, POTEI_6, POTEI_5@0@0@0@:POTE ankyrin domain family, member I@:protein binding;ATP binding@NA
A2463_36@27996@27997@duplication@2@152463121@152464122@2@chr2:152463121-152464122@19@116@304@2.62@CNVR1026.1@NEB_84, NEB_83@0@0@0@:nebulin@:Z disc;muscle filament sliding;oxidation-reduction process;contractile fiber part;actin cytoskeleton;regulation of actin filament length;structural constituent of muscle;cytosol;actin binding;protein binding;myofibril;somatic muscle development;muscle organ development@: NEMALINE MYOPATHY 2; NEM2
A2463_36@33397@33401@duplication@5@233244897@233246077@2@chr2:233244897-233246077@9.17@336@475@1.41@NA@ALPP_6, ALPP_7, ALPP_8, ALPP_9, ALPP_10@0@0@0@:alkaline phosphatase, placental@:phosphatase activity;catalytic activity;integral to membrane;plasma membrane;metabolic process;cell surface;anchored to membrane;alkaline phosphatase activity;metal ion binding@NA
A2463_36@33408@33410@deletion@3@233272978@233273548@2@chr2:233272978-233273548@13.2@109@33@0.303@NA@ALPPL2_6, ALPPL2_7, ALPPL2_8@0@0@0@:alkaline phosphatase, placental-like 2@:phosphatase activity;catalytic activity;phosphorylation;plasma membrane;metabolic process;membrane;anchored to membrane;alkaline phosphatase activity;metal ion binding@NA
A2463_36@39892@39894@deletion@3@75786030@75790887@3@chr3:75786030-75790887@53@285@3@0.0105@CNVR1432.5, CNVR1432.9, CNVR1432.4@ZNF717_5, ZNF717_4, ZNF717_3@0@0@0@:zinc finger protein 717;zinc finger protein 717-like@:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_36@46667@46675@deletion@9@9174900@9237700@4@chr4:9174900-9237700@22.5@134@20@0.149@NA@FAM90A26P_4, FAM90A26P_5, FAM90A26P_6, FAM90A26P_7, USP17L13_1, USP17L10_1, USP17L11_1, USP17L12_1, USP17L13_2, USP17L15_1@0@0@0@:ubiquitin specific peptidase 17-like family member 10:ubiquitin specific peptidase 17-like family member 13:ubiquitin specific peptidase 17-like family member 11:ubiquitin specific peptidase 17-like family member 12:ubiquitin specific peptidase 17-like family member 15@:zinc ion binding;nucleic acid binding:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
A2463_36@48556@48561@deletion@6@69403344@69434202@4@chr4:69403344-69434202@108@610@33@0.0541@CNVR1953.1@UGT2B17_6, UGT2B17_5, UGT2B17_4, UGT2B17_3, UGT2B17_2, UGT2B17_1@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B17@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;membrane@: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
A2463_36@48592@48597@deletion@6@70146220@70160527@4@chr4:70146220-70160527@7.16@915@647@0.707@CNVR1957.2, CNVR1957.1@UGT2B28_1, UGT2B28_2, UGT2B28_3, UGT2B28_4, UGT2B28_5, UGT2B28_6@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B28@:carbohydrate binding;transferase activity, transferring hexosyl groups;endoplasmic reticulum;glucuronosyltransferase activity;carbohydrate metabolic process;xenobiotic metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process@NA
A2463_36@53051@53051@duplication@1@186382204@186382313@4@chr4:186382204-186382313@5.41@157@241@1.54@NA@CCDC110_5@0@0@0@:coiled-coil domain containing 110@:intracellular membrane-bounded organelle;Golgi apparatus;nucleolus;plasma membrane;nucleus;cytoplasm@NA
A2463_36@53306@53308@duplication@3@741710@748674@5@chr5:741710-748674@7.13@184@275@1.49@CNVR2280.3@ZDHHC11B_7, ZDHHC11B_6, ZDHHC11B_5@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
A2463_36@55190@55190@deletion@1@54960522@54960691@5@chr5:54960522-54960691@5.48@124@66@0.532@NA@SLC38A9_8@0@0@0@:solute carrier family 38, member 9@:amino acid transport;integral to membrane;sodium ion transport@NA
A2463_36@55787@55789@deletion@3@68868273@68874935@5@chr5:68868273-68874935@5.45@70@31@0.443@CNVR2494.7, CNVR2494.46@GTF2H2C_8, GTF2H2C_9, GTF2H2C_10@0@0@0@:general transcription factor IIH, polypeptide 2C;general transcription factor IIH, polypeptide 2D@:regulation of transcription, DNA-dependent;nucleotide-excision repair;DNA repair;core TFIIH complex;protein binding;nucleus;transcription, DNA-dependent;zinc ion binding@NA
A2463_36@55835@55835@deletion@1@70338009@70338111@5@chr5:70338009-70338111@5.91@27@0@0@CNVR2494.41, CNVR2494.14, CNVR2494.20, CNVR2494.62, CNVR2494.8@GTF2H2_14@0@0@0@:general transcription factor IIH, polypeptide 2, 44kDa@:nucleoplasm;nucleotide-excision repair, DNA damage removal;transcription from RNA polymerase I promoter;DNA repair;RNA polymerase II carboxy-terminal domain kinase activity;nucleus;viral reproduction;translation;gene expression;transcription elongation from RNA polymerase I promoter;response to UV;holo TFIIH complex;protein kinase activity;nucleotide-excision repair;transcription from RNA polymerase II promoter;transcription-coupled nucleotide-excision repair;transcription, DNA-dependent;zinc ion binding;transcription elongation from RNA polymerase II promoter;termination of RNA polymerase I transcription;sequence-specific DNA binding transcription factor activity;G-protein coupled receptor internalization;DNA-dependent ATPase activity;protein N-terminus binding;transcription initiation from RNA polymerase I promoter;7-methylguanosine mRNA capping;transcription initiation from RNA polymerase II promoter;protein phosphorylation;translation factor activity, nucleic acid binding;regulation of transcription, DNA-dependent;core TFIIH complex;protein binding;positive regulation of viral transcription;nucleic acid binding@NA
A2463_36@55837@55837@deletion@1@70343834@70343940@5@chr5:70343834-70343940@9.42@43@0@0@CNVR2494.41, CNVR2494.14, CNVR2494.20, CNVR2494.62, CNVR2494.8@GTF2H2_12@0@0@0@:general transcription factor IIH, polypeptide 2, 44kDa@:nucleoplasm;nucleotide-excision repair, DNA damage removal;transcription from RNA polymerase I promoter;DNA repair;RNA polymerase II carboxy-terminal domain kinase activity;nucleus;viral reproduction;translation;gene expression;transcription elongation from RNA polymerase I promoter;response to UV;holo TFIIH complex;protein kinase activity;nucleotide-excision repair;transcription from RNA polymerase II promoter;transcription-coupled nucleotide-excision repair;transcription, DNA-dependent;zinc ion binding;transcription elongation from RNA polymerase II promoter;termination of RNA polymerase I transcription;sequence-specific DNA binding transcription factor activity;G-protein coupled receptor internalization;DNA-dependent ATPase activity;protein N-terminus binding;transcription initiation from RNA polymerase I promoter;7-methylguanosine mRNA capping;transcription initiation from RNA polymerase II promoter;protein phosphorylation;translation factor activity, nucleic acid binding;regulation of transcription, DNA-dependent;core TFIIH complex;protein binding;positive regulation of viral transcription;nucleic acid binding@NA
A2463_36@55840@55844@deletion@5@70351180@70357135@5@chr5:70351180-70357135@13.1@158@66@0.418@CNVR2494.41, CNVR2494.14, CNVR2494.20, CNVR2494.62, CNVR2494.8@GTF2H2_9, GTF2H2_8, GTF2H2_7, GTF2H2_6, GTF2H2_5@0@0@0@:general transcription factor IIH, polypeptide 2, 44kDa@:nucleoplasm;nucleotide-excision repair, DNA damage removal;transcription from RNA polymerase I promoter;DNA repair;RNA polymerase II carboxy-terminal domain kinase activity;nucleus;viral reproduction;translation;gene expression;transcription elongation from RNA polymerase I promoter;response to UV;holo TFIIH complex;protein kinase activity;nucleotide-excision repair;transcription from RNA polymerase II promoter;transcription-coupled nucleotide-excision repair;transcription, DNA-dependent;zinc ion binding;transcription elongation from RNA polymerase II promoter;termination of RNA polymerase I transcription;sequence-specific DNA binding transcription factor activity;G-protein coupled receptor internalization;DNA-dependent ATPase activity;protein N-terminus binding;transcription initiation from RNA polymerase I promoter;7-methylguanosine mRNA capping;transcription initiation from RNA polymerase II promoter;protein phosphorylation;translation factor activity, nucleic acid binding;regulation of transcription, DNA-dependent;core TFIIH complex;protein binding;positive regulation of viral transcription;nucleic acid binding@NA
A2463_36@59065@59065@deletion@1@140557617@140560021@5@chr5:140557617-140560021@14.5@2686@1533@0.571@CNVR2624.1@PCDHB8_1@0@0@0@:protocadherin beta 8@:integral to membrane;homophilic cell adhesion;plasma membrane;membrane;calcium ion binding@NA
A2463_36@60876@60879@duplication@4@175388055@175394270@5@chr5:175388055-175394270@6.33@90@149@1.66@NA@THOC3_5, THOC3_4, THOC3_3, THOC3_2@0@0@0@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
A2463_36@60900@60901@duplication@2@175540804@175541052@5@chr5:175540804-175541052@9.43@157@263@1.68@NA@FAM153B_19, FAM153B_20@0@0@0@:uncharacterized LOC100507387;family with sequence similarity 153, member B@NA@NA
A2463_36@61269@61269@deletion@1@177166602@177166671@5@chr5:177166602-177166671@6.73@35@3@0.0857@NA@FAM153A_8@0@0@0@:family with sequence similarity 153, member A@NA@NA
A2463_36@61641@61645@deletion@5@180376905@180429785@5@chr5:180376905-180429785@17.8@802@495@0.617@CNVR2719.1@BTNL8_8, BTNL3_1, BTNL3_2, BTNL3_3, BTNL3_4@0@0@0@:butyrophilin-like 8:butyrophilin-like 3@:protein binding;integral to membrane:protein binding;integral to membrane;molecular_function;cellular_component;biological_process@NA
A2463_36@62724@62724@duplication@1@26368794@26369140@6@chr6:26368794-26369140@4.6@138@209@1.51@NA@BTN3A2_4@0@0@0@:butyrophilin, subfamily 3, member A2@:protein binding;integral to membrane;biological_process@NA
A2463_36@62738@62738@deletion@1@26406138@26406484@6@chr6:26406138-26406484@5.23@61@25@0.41@NA@BTN3A1_3@0@0@0@:butyrophilin, subfamily 3, member A1@:protein binding;integral to membrane;lipid metabolic process@NA
A2463_36@63730@63730@deletion@1@31963497@31963571@6@chr6:31963497-31963571@7.08@135@66@0.489@CNVR2843.6, CNVR2843.3@C4A_25@0@0@0@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
A2463_36@63734@63735@duplication@2@31964607@31965088@6@chr6:31964607-31965088@7.86@24@81@3.38@CNVR2843.6, CNVR2843.3@C4A_29, C4A_30@0@0@0@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
A2463_36@63768@63776@duplication@9@31994761@31997115@6@chr6:31994761-31997115@36.4@751@1217@1.62@CNVR2843.6, CNVR2843.5@C4B_20, C4B_21, C4B_22, C4B_23, C4B_24, C4B_25, C4B_26, C4B_27, C4B_28@0@0@0@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
A2463_36@63797@63798@duplication@2@32008184@32008548@6@chr6:32008184-32008548@5.26@389@531@1.37@CNVR2843.6, CNVR2843.5@CYP21A2_8, CYP21A2_9@0@0@0@:cytochrome P450, family 21, subfamily A, polypeptide 2@:oxidation-reduction process;electron carrier activity;response to antibiotic;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;steroid 21-monooxygenase activity;C21-steroid hormone biosynthetic process;heme binding;mineralocorticoid biosynthetic process;progesterone metabolic process;monooxygenase activity;cellular response to peptide hormone stimulus;iron ion binding@: ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY
A2463_36@63810@63811@duplication@2@32011785@32012493@6@chr6:32011785-32012493@5.55@59@112@1.9@CNVR2843.6, CNVR2843.5@TNXB_3, TNXB_2@0@0@0@:tenascin-X-like;tenascin XB@:integrin binding;extracellular matrix;cell-cell adhesion;elastic fiber assembly;collagen fibril organization;fibrillar collagen;actin cytoskeleton organization;extracellular space;heparin binding;proteinaceous extracellular matrix;fatty acid metabolic process;regulation of JUN kinase activity;receptor binding;intracellular;cell-matrix adhesion;extracellular matrix organization;lipid metabolic process;protein binding;signal transduction;extracellular region;collagen binding;cell adhesion;triglyceride metabolic process;fibril organization;collagen metabolic process@: EHLERS-DANLOS-LIKE SYNDROME DUE TO TENASCIN-X DEFICIENCY; EHLERS-DANLOS SYNDROME, TYPE III
A2463_36@63953@63957@duplication@5@32485517@32489951@6@chr6:32485517-32489951@22.7@209@408@1.95@CNVR2845.21, CNVR2845.25, CNVR2845.30@HLA-DRB5_6, HLA-DRB5_5, HLA-DRB5_4, HLA-DRB5_3, HLA-DRB5_2@0@0@0@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
A2463_36@63959@63960@duplication@2@32546869@32548047@6@chr6:32546869-32548047@5.18@149@220@1.48@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.5, CNVR2845.4@HLA-DRB1_6, HLA-DRB1_5@0@0@0@:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1@:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
A2463_36@66018@66021@duplication@4@49437891@49440571@6@chr6:49437891-49440571@8.27@468@643@1.37@NA@CENPQ_2, CENPQ_3, CENPQ_4, CENPQ_5@0@0@0@:centromere protein Q@:nucleoplasm;mitotic cell cycle;cytosol;chromosome, centromeric region;mitotic prometaphase;M phase of mitotic cell cycle;nucleosome assembly;CenH3-containing nucleosome assembly at centromere@NA
A2463_36@70816@70819@duplication@4@161054786@161061880@6@chr6:161054786-161061880@35.5@207@611@2.95@CNVR3133.1@LPA_9, LPA_8, LPA_7, LPA_6@0@0@0@:lipoprotein, Lp(a)@:blood circulation;endopeptidase inhibitor activity;catalytic activity;lipoprotein metabolic process;proteolysis;heparin binding;receptor-mediated endocytosis;fibronectin binding;small molecule metabolic process;apolipoprotein binding;lipid metabolic process;negative regulation of endopeptidase activity;extracellular region;plasma lipoprotein particle;lipid transport;serine-type endopeptidase activity@: APOLIPOPROTEIN(a); LPA
A2463_36@71030@71030@deletion@1@167790035@167790192@6@chr6:167790035-167790192@7.34@48@9@0.188@NA@TCP10_5@0@0@0@:t-complex 10@:cytosol@NA
A2463_36@71744@71746@duplication@3@5939916@5940563@7@chr7:5939916-5940563@5.29@326@440@1.35@NA@CCZ1_2, CCZ1_3, CCZ1_4@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
A2463_36@71753@71762@duplication@10@5958499@5977532@7@chr7:5958499-5977532@13.7@637@882@1.38@NA@CCZ1_11, CCZ1_12, CCZ1_13, CCZ1_14, CCZ1_15, RSPH10B_20, RSPH10B_19, RSPH10B_18, RSPH10B_17, RSPH10B_16@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae):radial spoke head 10 homolog B (Chlamydomonas)@:lysosomal membrane@NA
A2463_36@71776@71776@deletion@1@6006495@6006747@7@chr7:6006495-6006747@5.37@135@74@0.548@NA@RSPH10B_2@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
A2463_36@71776@71778@duplication@2@6006495@6017388@7@chr7:6006495-6017388@-5.92@436@511@1.17@NA@RSPH10B_2, PMS2_15, PMS2_14@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas):PMS2 postmeiotic segregation increased 2 (S. cerevisiae)@:response to drug;DNA binding;MutSalpha complex binding;ATP binding;mismatch repair;DNA repair;mismatched DNA binding;ATPase activity;nucleus;mismatch repair complex;reciprocal meiotic recombination;ATP catabolic process;single-stranded DNA binding;response to DNA damage stimulus;single base insertion or deletion binding;protein binding;somatic hypermutation of immunoglobulin genes;somatic recombination of immunoglobulin gene segments;MutLalpha complex;endonuclease activity@: COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 4; HNPCC4; MISMATCH REPAIR CANCER SYNDROME
A2463_36@71939@71944@deletion@6@6836200@6844686@7@chr7:6836200-6844686@33.7@251@66@0.263@NA@RSPH10B2_19, RSPH10B2_20, CCZ1B_15, CCZ1B_14, CCZ1B_13, CCZ1B_12@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
A2463_36@74566@74568@deletion@3@74159098@74160750@7@chr7:74159098-74160750@5.8@247@155@0.628@NA@GTF2I_21, GTF2I_22, GTF2I_23@0@0@0@:general transcription factor IIi@:neuronal cell body;transcription initiation from RNA polymerase II promoter;mitogen-activated protein kinase binding;negative regulation of angiogenesis;DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;cytoplasm;transcription from RNA polymerase II promoter;protein binding;signal transduction;nucleus;cell projection;reduction of cytosolic calcium ion concentration@NA
A2463_36@74573@74574@deletion@2@74166423@74167509@7@chr7:74166423-74167509@19.8@188@68@0.362@NA@GTF2I_28, GTF2I_29@0@0@0@:general transcription factor IIi@:neuronal cell body;transcription initiation from RNA polymerase II promoter;mitogen-activated protein kinase binding;negative regulation of angiogenesis;DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;cytoplasm;transcription from RNA polymerase II promoter;protein binding;signal transduction;nucleus;cell projection;reduction of cytosolic calcium ion concentration@NA
A2463_36@74597@74598@deletion@2@74225431@74227349@7@chr7:74225431-74227349@11.9@63@5@0.0794@NA@GTF2IRD2_10, GTF2IRD2_9@0@0@0@:GTF2I repeat domain containing 2@:nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_36@74662@74664@duplication@3@75054358@75055735@7@chr7:75054358-75055735@9.27@123@215@1.75@NA@POM121C_10, POM121C_9, POM121C_8@0@0@0@:POM121 transmembrane nucleoporin C@:nuclear membrane;protein binding;protein transport;endoplasmic reticulum membrane;nuclear pore;mRNA transport@NA
A2463_36@74781@74783@duplication@3@76121471@76129837@7@chr7:76121471-76129837@6.19@76@133@1.75@CNVR3462.1@DTX2_6, DTX2_7, DTX2_8@0@0@0@:deltex homolog 2 (Drosophila)@:ligase activity;cytoplasm;nuclear membrane;Notch signaling pathway;protein binding;nucleus;zinc ion binding;protein ubiquitination@NA
A2463_36@76244@76245@duplication@2@99910764@99912373@7@chr7:99910764-99912373@6.75@80@144@1.8@CNVR3508.2, CNVR3508.1@SPDYE3_5, SPDYE3_6@0@0@0@:speedy homolog E3 (Xenopus laevis)@NA@NA
A2463_36@76741@76752@duplication@12@102158094@102212968@7@chr7:102158094-102212968@13.9@637@909@1.43@CNVR3518.1@RASA4B_1, SPDYE2_2, SPDYE2_3, SPDYE2_4, SPDYE2_5, SPDYE2_6, SPDYE2_7, SPDYE2_8, POLR2J3_4, POLR2J3_3, POLR2J3_2, POLR2J3_1@0@0@0@:RAS p21 protein activator 4B:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:speedy homolog E2 (Xenopus laevis)@:phospholipid binding;intracellular;GTPase activator activity;cytosol;signal transduction;protein binding;plasma membrane;regulation of small GTPase mediated signal transduction;metal ion binding;intracellular signal transduction:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
A2463_36@76765@76779@duplication@15@102235753@102279646@7@chr7:102235753-102279646@9.51@426@591@1.39@CNVR3518.1@RASA4_11, RASA4_10, RASA4_9, RASA4_8, RASA4_7, RASA4_6, RASA4_5, RASA4_4, RASA4_3, RASA4_2, UPK3BL_7, RASA4_1, UPK3BL_6, UPK3BL_6, UPK3BL_5, UPK3BL_5, UPK3BL_4, UPK3BL_4@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4:uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity:integral to membrane:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
A2463_36@76792@76793@deletion@2@102309363@102312048@7@chr7:102309363-102312048@13.9@68@3@0.0441@CNVR3518.1@POLR2J2_2, POLR2J2_2, POLR2J2_1, POLR2J2_1@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
A2463_36@79287@79287@deletion@1@143400089@143400710@7@chr7:143400089-143400710@5.13@43@13@0.302@CNVR3594.2, CNVR3594.1@FAM115C_2@0@0@0@:family with sequence similarity 115, member C;protein FAM115C-like@NA@NA
A2463_36@79309@79309@deletion@1@143880598@143882930@7@chr7:143880598-143882930@20.2@397@155@0.39@CNVR3598.4, CNVR3598.3@CTAGE4_1@0@0@0@:CTAGE family, member 4@:integral to membrane;nucleotide binding;cellular_component;biological_process@NA
A2463_36@79313@79313@duplication@1@143964011@143966343@7@chr7:143964011-143966343@8@309@478@1.55@CNVR3598.4@CTAGE8_1@0@0@0@:Rho guanine nucleotide exchange factor (GEF) 35:CTAGE family, member 6, pseudogene;CTAGE family, member 15, pseudogene@:integral to membrane@NA
A2463_36@80364@80377@duplication@14@7217760@7343904@8@chr8:7217760-7343904@76.4@1016@1977@1.95@CNVR3771.8, CNVR3771.10, CNVR3771.4@ZNF705G_5, ZNF705G_4, DEFB4B_2, DEFB4B_1, DEFB103B_2, DEFB103B_1, SPAG11B_3, SPAG11B_2, SPAG11B_1, DEFB104B_2, DEFB104B_1, DEFB106B_2, DEFB106B_1@0@0@0@:zinc finger protein 705G:defensin, beta 4B;defensin, beta 4A:defensin, beta 103B;defensin, beta 103A:sperm associated antigen 11B:defensin, beta 104A;defensin, beta 104B:defensin, beta 106B;defensin, beta 106A@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response:extracellular region;defense response to bacterium;Golgi lumen;positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria;defense response;innate immune response:spermatogenesis;defense response to bacterium;extracellular region;molecular_function;defense response:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium@NA
A2463_36@80382@80411@duplication@30@7366604@7808269@8@chr8:7366604-7808269@132@1184@2616@2.21@CNVR3772.4, CNVR3772.6@DEFB107B_2, RP11-1118M6.1_1, RP11-1118M6.1_2, RP11-1118M6.1_3, RP11-1118M6.1_4, AC084121.16_4, AC084121.16_3, AC084121.16_2, AC084121.16_1, DEFB107A_2, DEFB107A_1, DEFB105A_3, DEFB105A_1, DEFB106A_1, DEFB106A_2, DEFB104A_1, DEFB104A_2, SPAG11A_1, SPAG11A_2, SPAG11A_3, DEFB103A_1, DEFB103A_2, DEFB4A_1, DEFB4A_2, ZNF705B_3, ZNF705B_4, ZNF705B_5@0@0@0@:defensin, beta 107B;defensin, beta 107A:uncharacterized LOC100133251:uncharacterized LOC100133251:defensin, beta 107B;defensin, beta 107A:defensin, beta 105B;defensin, beta 105A:defensin, beta 106B;defensin, beta 106A:defensin, beta 104A;defensin, beta 104B:sperm associated antigen 11A;sperm associated antigen 11B:defensin, beta 103B;defensin, beta 103A:defensin, beta 4B;defensin, beta 4A:zinc finger protein 705B@:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response:extracellular region;defense response to bacterium;Golgi lumen;positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria;defense response;innate immune response:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response:intracellular;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_36@80564@80586@duplication@23@11970084@12423650@8@chr8:11970084-12423650@202@3026@7375@2.44@CNVR3786.4@ZNF705D_6, USP17L2_1, FAM86B1_8, FAM86B1_7, FAM86B1_6, FAM86B1_5, FAM86B1_4, FAM86B1_3, FAM86B1_2, FAM86B1_1, DEFB130_2, DEFB130_1, FAM86B2_8, FAM86B2_7, FAM86B2_6, FAM86B2_5, FAM86B2_4, FAM86B2_3, FAM86B2_2, FAM86B2_1, AC130352.1_5, AC130352.1_6, AC130352.1_7@0@0@0@:zinc finger protein 705D:ubiquitin specific peptidase 17-like family member 1, pseudogene;ubiquitin specific peptidase 17-like family member 2;ubiquitin specific peptidase 17-like family member 4;ubiquitin specific peptidase 17-like family member 7;ubiquitin specific peptidase 17-like family member 8;ubiquitin specific peptidase 17-like family member 3:family with sequence similarity 86, member B2;family with sequence similarity 86, member B1:defensin, beta 130-like;defensin, beta 130:family with sequence similarity 86, member B2@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:protein deubiquitination;ubiquitin-specific protease activity;mitotic cell cycle G1/S transition checkpoint;nucleus;G2/M transition checkpoint;apoptotic process;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:extracellular region;defense response to bacterium;defense response@NA
A2463_36@83673@83673@deletion@1@86573700@86575726@8@chr8:86573700-86575726@5.4@433@278@0.642@CNVR3955.1@REXO1L1_1@0@0@0@:exonuclease GOR-like;REX1, RNA exonuclease 1 homolog (S. cerevisiae)-like 1@:intracellular;nucleus;exonuclease activity;nucleic acid binding;cytoplasm@NA
A2463_36@88271@88272@duplication@2@35810437@35810679@9@chr9:35810437-35810679@4.93@161@233@1.45@NA@SPAG8_5, SPAG8_4@0@0@0@:sperm associated antigen 8@:microtubule binding;acrosomal vesicle;cytoplasm;positive regulation of protein binding;protein binding;nucleus;molecular_function;membrane;biological_process;positive regulation of transcription from RNA polymerase II promoter@NA
A2463_36@88526@88529@duplication@4@40701711@40716325@9@chr9:40701711-40716325@21.7@1145@1805@1.58@NA@SPATA31A3_2, SPATA31A3_3, SPATA31A3_4, FAM74A3_1@0@0@0@:SPATA31 subfamily A, member 3@:integral to membrane@NA
A2463_36@88536@88536@deletion@1@41321261@41324995@9@chr9:41321261-41324995@4.94@27@3@0.111@CNVR4278.2@SPATA31A4_4@0@0@0@:SPATA31 subfamily A, member 4@:integral to membrane@NA
A2463_36@88586@88587@duplication@2@43629264@43630701@9@chr9:43629264-43630701@5.1@205@289@1.41@NA@SPATA31A6_2, SPATA31A6_1@0@0@0@:SPATA31 subfamily A, member 6@:integral to membrane@NA
A2463_36@88596@88596@deletion@1@43828079@43828221@9@chr9:43828079-43828221@11.3@71@11@0.155@CNVR4294.1@CNTNAP3B_9@0@0@0@:contactin associated protein-like 3B;contactin associated protein-like 3@:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
A2463_36@88613@88613@duplication@1@44401891@44402255@9@chr9:44401891-44402255@9.66@156@285@1.83@CNVR4297.3@BX088651.1_1@0@0@0@NA@NA@NA
A2463_36@88620@88622@duplication@3@45727245@45733965@9@chr9:45727245-45733965@13.1@192@334@1.74@CNVR4305.1@FAM27A_1, AL953889.1_2, AL953889.1_1, FAM27A_2, FAM27E2_1@0@0@0@NA@NA@NA
A2463_36@88620@88624@deletion@2@45727245@46390900@9@chr9:45727245-46390900@-23.6@235@347@1.48@NA@FAM27A_1, AL953889.1_2, AL953889.1_1, FAM27A_2, FAM27E2_1, FAM27E1_1, FAM27D1_1@0@0@0@:family with sequence similarity 27, member E3:protein FAM27E2-like;protein FAM27D1-like@NA@NA
A2463_36@88631@88633@duplication@3@65503517@65508193@9@chr9:65503517-65508193@25.1@329@628@1.91@CNVR4312.5@SPATA31A7_4, SPATA31A7_3, SPATA31A7_2@0@0@0@:SPATA31 subfamily A, member 7@:integral to membrane@NA
A2463_36@88635@88642@duplication@8@67785914@67934829@9@chr9:67785914-67934829@13.4@205@339@1.65@NA@FAM27E3_2, FAM27B_2, FAM27B_1, BX649567.1_1, ANKRD20A1_1, ANKRD20A1_2, ANKRD20A1_3, ANKRD20A1_4@0@0@0@:family with sequence similarity 27, member E3:ankyrin repeat domain 20 family, member A1@:protein binding;plasma membrane@NA
A2463_36@88635@88644@deletion@2@67785914@67938658@9@chr9:67785914-67938658@-29.5@405@456@1.13@NA@FAM27E3_2, FAM27B_2, FAM27B_1, BX649567.1_1, ANKRD20A1_1, ANKRD20A1_2, ANKRD20A1_3, ANKRD20A1_4, ANKRD20A1_5, ANKRD20A1_6@0@0@0@:family with sequence similarity 27, member E3:ankyrin repeat domain 20 family, member A1@:protein binding;plasma membrane@NA
A2463_36@88652@88656@deletion@5@67966594@67985922@9@chr9:67966594-67985922@32.1@849@482@0.568@NA@ANKRD20A1_14, ANKRD20A1_15, RP11-195B21.3_3, RP11-195B21.3_4, RP11-195B21.3_5@0@0@0@:ankyrin repeat domain 20 family, member A1:coiled-coil domain-containing protein 29-like;uncharacterized LOC644249@:protein binding;plasma membrane@NA
A2463_36@88670@88690@duplication@21@69252846@69424176@9@chr9:69252846-69424176@83.2@1380@2431@1.76@NA@BX255923.1_1, CBWD6_4, CBWD6_3, CBWD6_2, CBWD6_1, CR769776.1_1, ANKRD20A4_1, ANKRD20A4_2, ANKRD20A4_3, ANKRD20A4_4, ANKRD20A4_5, ANKRD20A4_6, ANKRD20A4_7, ANKRD20A4_8, ANKRD20A4_9, ANKRD20A4_10, ANKRD20A4_11, ANKRD20A4_12, ANKRD20A4_13, ANKRD20A4_14, ANKRD20A4_15@0@0@0@:COBW domain containing 6:ankyrin repeat domain 20 family, member A4@:ATP binding:protein binding@NA
A2463_36@93657@93664@duplication@8@139089172@139103298@9@chr9:139089172-139103298@33.8@1041@1568@1.51@NA@LHX3_6, LHX3_5, LHX3_4, LHX3_3, LHX3_2, LHX3_1, QSOX2_12, QSOX2_11@0@0@0@:LIM homeobox 3:quiescin Q6 sulfhydryl oxidase 2@:cell differentiation;negative regulation of apoptotic process;inner ear development;sequence-specific DNA binding;DNA binding;sequence-specific DNA binding transcription factor activity;placenta development;spinal cord association neuron differentiation;transcription factor complex;ventral spinal cord interneuron specification;nucleus;medial motor column neuron differentiation;organ morphogenesis;positive regulation of transcription from RNA polymerase II promoter;spinal cord motor neuron cell fate specification;pituitary gland development;dorsal/ventral pattern formation;protein binding transcription factor activity;intracellular;regulation of transcription, DNA-dependent;protein binding;positive regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;motor neuron axon guidance:nuclear membrane;oxidation-reduction process;thiol oxidase activity;extracellular region;integral to membrane;plasma membrane;cell redox homeostasis@: PITUITARY HORMONE DEFICIENCY, COMBINED, 3; CPHD3
A2463_36@95376@95381@duplication@6@17949551@18065159@10@chr10:17949551-18065159@12.2@82@178@2.17@NA@MRC1L1_28, MRC1L1_29, MRC1L1_30, TMEM236_1, TMEM236_2, TMEM236_3@0@0@0@:macrophage mannose receptor 1-like:transmembrane protein 236;transmembrane protein 236-like@:carbohydrate binding:integral to membrane@NA
A2463_36@95410@95411@deletion@2@18196464@18198276@10@chr10:18196464-18198276@6.92@120@64@0.533@NA@MRC1_28, MRC1_29@0@0@0@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
A2463_36@96242@96242@deletion@1@37478396@37478485@10@chr10:37478396-37478485@6.49@131@66@0.504@CNVR4692.1, CNVR4692.2@ANKRD30A_25@0@0@0@:ankyrin repeat domain 30A@:protein binding;nucleus;DNA binding;regulation of transcription, DNA-dependent;sequence-specific DNA binding transcription factor activity@NA
A2463_36@96454@96461@duplication@8@46312644@46342795@10@chr10:46312644-46342795@22.5@223@478@2.14@NA@FAM25E_1, AGAP4_7, AGAP4_6, AGAP4_5, AGAP4_4, AGAP4_3, AGAP4_2, AGAP4_1@0@0@0@:ArfGAP with GTPase domain, ankyrin repeat and PH domain 4;arf-GAP with GTPase, ANK repeat and PH domain-containing protein 5-like@:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity@NA
A2463_36@96468@96470@duplication@3@46605764@46611811@10@chr10:46605764-46611811@5.86@40@87@2.17@CNVR4712.3@PTPN20A_4, PTPN20A_3, PTPN20A_2@0@0@0@:protein tyrosine phosphatase, non-receptor type 20B;protein tyrosine phosphatase, non-receptor type 20A@:phosphatase activity;protein tyrosine phosphatase activity;microtubule;nucleus;dephosphorylation;protein dephosphorylation;microtubule organizing center@NA
A2463_36@96482@96482@deletion@1@47158838@47158896@10@chr10:47158838-47158896@9.34@43@0@0@CNVR4712.9, CNVR4712.2, CNVR4712.4, CNVR4712.6, CNVR4712.5@ANXA8L1_12@0@0@0@:annexin A8-like 1;annexin A8@:calcium-dependent phospholipid binding;calcium ion binding@NA
A2463_36@96536@96563@duplication@28@47894573@47948853@10@chr10:47894573-47948853@134@674@1810@2.69@CNVR4715.2@FAM21B_2, FAM21B_3, FAM21B_4, FAM21B_5, FAM21B_6, FAM21B_7, FAM21B_8, FAM21B_9, FAM21B_10, FAM21B_11, FAM21B_12, FAM21B_13, FAM21B_14, FAM21B_15, FAM21B_16, FAM21B_17, FAM21B_18, FAM21B_19, FAM21B_20, FAM21B_21, FAM21B_22, FAM21B_23, FAM21B_24, FAM21B_25, FAM21B_26, FAM21B_27, FAM21B_28, FAM21B_29@0@0@0@:family with sequence similarity 21, member B@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_36@96576@96579@deletion@4@48029221@48049021@10@chr10:48029221-48049021@7.16@132@68@0.515@CNVR4715.2@ASAH2C_6, ASAH2C_5, ASAH2C_4, ASAH2C_3@0@0@0@@:ceramidase activity;sphingolipid metabolic process@NA
A2463_36@96620@96623@duplication@4@48771316@48795444@10@chr10:48771316-48795444@15.5@82@231@2.82@CNVR4716.10, CNVR4716.3@PTPN20B_6, PTPN20B_5, PTPN20B_4, PTPN20B_3@0@0@0@:protein tyrosine phosphatase, non-receptor type 20B;protein tyrosine phosphatase, non-receptor type 20A@:phosphatase activity;protein tyrosine phosphatase activity;microtubule;nucleus;dephosphorylation;protein dephosphorylation;microtubule organizing center@NA
A2463_36@96631@96633@deletion@3@49376639@49381136@10@chr10:49376639-49381136@12.1@91@25@0.275@CNVR4717.2@FRMPD2_27, FRMPD2_26, FRMPD2_25@0@0@0@:FERM and PDZ domain containing 2@:basolateral plasma membrane;transferase activity, transferring phosphorus-containing groups;cytoplasm;tight junction;protein binding;cytoskeleton;1-phosphatidylinositol binding;tight junction assembly@NA
A2463_36@96850@96852@deletion@3@51246188@51374428@10@chr10:51246188-51374428@12.7@139@51@0.367@NA@AGAP8_1, TIMM23B_1, TIMM23B_2@0@0@0@:ArfGAP with GTPase domain, ankyrin repeat and PH domain 8:translocase of inner mitochondrial membrane 23 homolog B (yeast)@:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process@NA
A2463_36@96900@96923@deletion@24@51847036@51892705@10@chr10:51847036-51892705@154@913@113@0.124@CNVR4734.2@FAM21A_8, FAM21A_9, FAM21A_10, FAM21A_11, FAM21A_12, FAM21A_13, FAM21A_14, FAM21A_15, FAM21A_16, FAM21A_17, FAM21A_18, FAM21A_19, FAM21A_20, FAM21A_21, FAM21A_22, FAM21A_23, FAM21A_24, FAM21A_25, FAM21A_26, FAM21A_27, FAM21A_28, FAM21A_29, FAM21A_30, FAM21A_31@0@0@0@:family with sequence similarity 21, member B;family with sequence similarity 21, member A@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_36@96932@96939@duplication@8@51965743@51994312@10@chr10:51965743-51994312@18.6@130@276@2.12@NA@ASAH2_12, ASAH2_11, ASAH2_10, ASAH2_9, ASAH2_8, ASAH2_7, ASAH2_6, ASAH2_5@0@0@0@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
A2463_36@98344@98348@duplication@5@81463367@81470520@10@chr10:81463367-81470520@12.9@143@263@1.84@CNVR4815.2, CNVR4815.4@FAM22B_1, FAM22B_2, FAM22B_3, FAM22B_4, FAM22B_5@0@0@0@NA@NA@NA
A2463_36@98350@98350@duplication@1@81471457@81472241@10@chr10:81471457-81472241@13.5@421@733@1.74@CNVR4815.2, CNVR4815.4@FAM22B_7@0@0@0@NA@NA@NA
A2463_36@98350@98357@deletion@7@81471457@81610362@10@chr10:81471457-81610362@11.6@567@739@1.3@CNVR4815.2@FAM22B_7, FAM22E_1, FAM22E_2, FAM22E_3, FAM22E_4, FAM22E_5, FAM22E_6, FAM22E_7@0@0@0@NA@NA@NA
A2463_36@103289@103290@duplication@2@5270599@5271034@11@chr11:5270599-5271034@5@90@145@1.61@NA@HBG1_2, HBG1_1@0@0@0@:hemoglobin, gamma A@:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex@NA
A2463_36@103342@103342@deletion@1@5798891@5799864@11@chr11:5798891-5799864@7.91@258@142@0.55@CNVR5049.1@OR52N5_1@0@0@0@:tripartite motif containing 5:olfactory receptor, family 52, subfamily N, member 5@:defense response to virus;Golgi apparatus;intracellular;protein trimerization;ligase activity;cytoplasm;protein binding;nucleus;protein homodimerization activity;identical protein binding;zinc ion binding;cytoplasmic mRNA processing body;protein ubiquitination;virus-host interaction:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_36@106046@106048@deletion@3@55370918@55419315@11@chr11:55370918-55419315@131@725@5@0.0069@CNVR5179.1@OR4C11_1, OR4P4_1, OR4S2_1@0@0@0@:olfactory receptor, family 4, subfamily C, member 11:olfactory receptor, family 4, subfamily P, member 4:olfactory receptor, family 4, subfamily S, member 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_36@110120@110125@duplication@6@89608779@89773130@11@chr11:89608779-89773130@9.98@485@683@1.41@NA@TRIM64B_1, TRIM49C_3, TRIM49C_4, TRIM49C_5, TRIM49C_6, TRIM49C_7@0@0@0@:tripartite motif containing 64;tripartite motif containing 64C;tripartite motif containing 64B:tripartite motif containing 49D, pseudogene;tripartite motif containing 49-like 1;tripartite motif containing 49C;tripartite motif-containing protein 49-like protein 1-like@:protein binding;intracellular;zinc ion binding:protein binding;intracellular;DNA binding;zinc ion binding@NA
A2463_36@112992@113009@deletion@18@134153632@134214349@11@chr11:134153632-134214349@61.6@1234@652@0.528@NA@GLB1L3_6, GLB1L3_7, GLB1L3_8, GLB1L3_9, GLB1L3_10, GLB1L3_11, GLB1L3_12, GLB1L3_13, GLB1L3_14, GLB1L3_15, GLB1L3_16, GLB1L3_17, GLB1L3_18, GLB1L3_19, GLB1L3_20, GLB1L2_1, GLB1L2_2, GLB1L2_3@0@0@0@:galactosidase, beta 1-like 3:galactosidase, beta 1-like 2@:cation binding;beta-galactosidase activity;hydrolase activity, hydrolyzing O-glycosyl compounds;beta-galactosidase complex;carbohydrate metabolic process:cation binding;extracellular region;beta-galactosidase activity;hydrolase activity, hydrolyzing O-glycosyl compounds;beta-galactosidase complex;carbohydrate metabolic process@NA
A2463_36@114080@114080@duplication@1@7945547@7945808@12@chr12:7945547-7945808@6@93@161@1.73@NA@NANOG_2@0@0@0@:NECAP endocytosis associated 1:Nanog homeobox@:coated pit;protein binding;endocytosis;protein transport;clathrin vesicle coat;plasma membrane;membrane:cell differentiation;regulation of cell differentiation;somatic stem cell maintenance;sequence-specific DNA binding;transcription corepressor activity;embryo development;DNA binding;sequence-specific DNA binding transcription factor activity;nucleus;positive regulation of transcription from RNA polymerase II promoter;regulation of gene expression;regulation of transcription, DNA-dependent;cell proliferation;endodermal cell fate specification;nucleolus;transcription, DNA-dependent@NA
A2463_36@114136@114139@deletion@4@8374419@8377428@12@chr12:8374419-8377428@22.1@1722@1063@0.617@CNVR5422.3, CNVR5422.5, CNVR5422.6, CNVR5422.1@FAM90A1_7, FAM90A1_6, FAM90A1_5, FAM90A1_4@0@0@0@:family with sequence similarity 90, member A1@:zinc ion binding;nucleic acid binding@NA
A2463_36@114483@114483@deletion@1@11243900@11244828@12@chr12:11243900-11244828@58.2@334@0@0@CNVR5434.1@TAS2R43_1@0@0@0@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):taste receptor, type 2, member 14:taste receptor, type 2, member 43@:extracellular space;visual perception:bitter taste receptor activity;taste receptor activity;integral to membrane;sensory perception of taste;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of bitter taste:G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;motile cilium;taste receptor activity;bitter taste receptor activity;integral to membrane;sensory perception of taste;detection of chemical stimulus involved in sensory perception of bitter taste;cilium membrane@NA
A2463_36@114493@114496@deletion@4@11506042@11508487@12@chr12:11506042-11508487@19.5@448@239@0.533@CNVR5435.2, CNVR5435.1@PRB1_4, PRB1_3, PRB1_2, PRB1_1@0@0@0@:proline-rich protein BstNI subfamily 1@NA@NA
A2463_36@117169@117172@duplication@4@52865206@52867521@12@chr12:52865206-52867521@7.26@816@1071@1.31@NA@KRT6C_4, KRT6C_3, KRT6C_2, KRT6C_1@0@0@0@:keratin 6C@:intermediate filament;structural molecule activity;keratin filament;cytoskeleton organization@NA
A2463_36@127333@127337@duplication@5@19553418@19563541@14@chr14:19553418-19563541@28.3@868@1376@1.59@CNVR6072.1@POTEG_1, POTEG_2, POTEG_3, POTEG_4, POTEG_5@0@0@0@:POTE ankyrin domain family, member G@:protein binding@NA
A2463_36@127348@127352@deletion@5@20010104@20020220@14@chr14:20010104-20020220@6.31@296@195@0.659@CNVR6072.6, CNVR6072.12@POTEM_5, POTEM_4, POTEM_3, POTEM_2, POTEM_1@0@0@0@:POTE ankyrin domain family, member M@:protein binding@NA
A2463_36@127348@127358@duplication@6@20010104@20404761@14@chr14:20010104-20404761@3.22@3247@4225@1.3@CNVR6072.12, CNVR6072.4@POTEM_5, POTEM_4, POTEM_3, POTEM_2, POTEM_1, OR4Q3_1, OR4M1_1, OR4N2_1, OR4K2_1, OR4K5_1, OR4K1_1@0@0@0@:POTE ankyrin domain family, member M:olfactory receptor, family 4, subfamily N, member 2:olfactory receptor, family 4, subfamily Q, member 3:olfactory receptor, family 4, subfamily M, member 1:olfactory receptor, family 4, subfamily K, member 2:olfactory receptor, family 4, subfamily K, member 5:olfactory receptor, family 4, subfamily K, member 1@:protein binding:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_36@133409@133414@deletion@6@106373070@106380248@14@chr14:106373070-106380248@8.25@233@139@0.597@CNVR6294.27, CNVR6294.36, CNVR6294.48, CNVR6294.25, CNVR6294.57, CNVR6294.29@IGHD2-8_1, IGHD1-7_1, IGHD6-6_1, IGHD5-5_1, IGHD4-4_1, IGHD3-3_1@0@0@0@NA@NA@NA
A2463_36@133426@133426@deletion@1@106478111@106478411@14@chr14:106478111-106478411@6.84@86@35@0.407@CNVR6294.36, CNVR6294.48, CNVR6294.12, CNVR6294.24@IGHV4-4_2@0@0@0@@:protein binding@NA
A2463_36@133458@133462@deletion@5@106791006@106816026@14@chr14:106791006-106816026@38.1@422@145@0.344@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.53@IGHV3-30_2, IGHV3-30_1, IGHV4-31_2, IGHV4-31_1, IGHV3-33_2@0@0@0@@:protein binding:protein binding:protein binding@NA
A2463_36@133470@133473@duplication@4@106877620@106926644@14@chr14:106877620-106926644@8.6@420@579@1.38@CNVR6294.26, CNVR6294.56, CNVR6294.18@IGHV4-39_2, IGHV4-39_1, IGHV3-43_2, IGHV3-43_1@0@0@0@@:protein binding:protein binding@NA
A2463_36@133509@133520@duplication@12@20739498@21051328@15@chr15:20739498-21051328@36.2@744@1346@1.81@NA@GOLGA6L6_8, GOLGA6L6_7, GOLGA6L6_6, GOLGA6L6_5, GOLGA6L6_4, GOLGA6L6_3, GOLGA6L6_2, GOLGA6L6_1, AC012414.1_1, POTEB_11, POTEB_10, POTEB_9@0@0@0@:putative transmembrane protein FLJ36131-like;putative transmembrane protein ENSP00000320207-like;golgin A6 family-like 6:POTE ankyrin domain family member B-like@:protein binding@NA
A2463_36@133523@133525@deletion@3@21059387@21063546@15@chr15:21059387-21063546@5.82@32@4@0.125@NA@POTEB_6, POTEB_5, POTEB_4@0@0@0@:POTE ankyrin domain family member B-like@:protein binding@NA
A2463_36@133535@133535@duplication@1@22070541@22070610@15@chr15:22070541-22070610@5.68@80@142@1.78@NA@POTEB_6@0@0@0@:POTE ankyrin domain family member B-like@:protein binding@NA
A2463_36@133622@133622@deletion@1@23259497@23259543@15@chr15:23259497-23259543@5.42@43@12@0.279@CNVR6300.4@GOLGA8I_6@0@0@0@:golgin A8 family, member I@:Golgi cisterna membrane@NA
A2463_36@133636@133641@deletion@6@23406272@23411062@15@chr15:23406272-23411062@41.5@625@266@0.426@CNVR6300.8@RP11-467N20.5_8, RP11-467N20.5_7, RP11-467N20.5_6, RP11-467N20.5_5, RP11-467N20.5_4, RP11-467N20.5_3@0@0@0@:putative golgin subfamily A member 6-like protein 6-like@NA@NA
A2463_36@133659@133662@deletion@4@23609491@23610281@15@chr15:23609491-23610281@44.8@414@123@0.297@NA@GOLGA8S_16, GOLGA8S_17, GOLGA8S_18, GOLGA8S_19@0@0@0@@:Golgi apparatus@NA
A2463_36@133869@133870@deletion@2@28629294@28629596@15@chr15:28629294-28629596@6.83@31@0@0@CNVR6329.4@GOLGA8F_9, GOLGA8F_10@0@0@0@@:Golgi apparatus@NA
A2463_36@133887@133887@deletion@1@28771402@28771657@15@chr15:28771402-28771657@6.46@29@0@0@CNVR6330.3@GOLGA8G_12@0@0@0@:golgin A8 family, member G;golgin A8 family, member F@:Golgi apparatus@NA
A2463_36@133977@133982@duplication@6@30379779@30382483@15@chr15:30379779-30382483@8.46@291@415@1.43@NA@GOLGA8J_8, GOLGA8J_9, GOLGA8J_10, GOLGA8J_11, GOLGA8J_12, GOLGA8J_13@0@0@0@:golgin A8 family, member J@:Golgi apparatus@NA
A2463_36@134004@134007@duplication@4@30436983@30437770@15@chr15:30436983-30437770@6.02@222@311@1.4@NA@GOLGA8T_16, GOLGA8T_17, GOLGA8T_18, GOLGA8T_19@0@0@0@:golgin A8 family, member J;golgin A8 family, member K@:Golgi apparatus@NA
A2463_36@134036@134039@deletion@4@30845996@30848215@15@chr15:30845996-30848215@14.5@86@14@0.163@NA@GOLGA8Q_2, GOLGA8Q_3, GOLGA8Q_4, GOLGA8Q_5@0@0@0@@:Golgi apparatus@NA
A2463_36@134047@134054@deletion@8@30851427@30896376@15@chr15:30851427-30896376@21.5@145@32@0.221@CNVR6339.2, CNVR6339.3, CNVR6339.1@GOLGA8Q_13, GOLGA8Q_14, GOLGA8Q_15, GOLGA8Q_16, GOLGA8Q_17, GOLGA8Q_18, GOLGA8Q_19, GOLGA8H_1@0@0@0@:golgin A8 family, member H@:Golgi apparatus:Golgi apparatus@NA
A2463_36@134158@134177@duplication@20@32684984@32695395@15@chr15:32684984-32695395@39.8@880@1341@1.52@NA@GOLGA8K_19, GOLGA8K_18, GOLGA8K_17, GOLGA8K_16, GOLGA8K_15, GOLGA8K_14, GOLGA8K_13, GOLGA8K_12, GOLGA8K_11, GOLGA8K_10, GOLGA8K_9, GOLGA8K_8, GOLGA8K_7, GOLGA8K_6, GOLGA8K_5, GOLGA8K_4, GOLGA8K_3, GOLGA8K_2, AC139426.2_1, GOLGA8K_1@0@0@0@:golgin A8 family, member J@:Golgi apparatus@NA
A2463_36@134180@134181@deletion@2@32737820@32738099@15@chr15:32737820-32738099@6.11@27@0@0@CNVR6346.1@GOLGA8O_17, GOLGA8O_16@0@0@0@:golgin A8 family, member O@:Golgi apparatus@NA
A2463_36@134189@134191@deletion@3@32743115@32743539@15@chr15:32743115-32743539@16.9@86@6@0.0698@CNVR6346.1@GOLGA8O_8, GOLGA8O_7, GOLGA8O_6@0@0@0@:golgin A8 family, member O@:Golgi apparatus@NA
A2463_36@134203@134214@duplication@12@32889954@32895667@15@chr15:32889954-32895667@14.1@187@324@1.73@NA@GOLGA8N_6, GOLGA8N_7, GOLGA8N_8, GOLGA8N_9, GOLGA8N_10, GOLGA8N_11, GOLGA8N_12, GOLGA8N_13, GOLGA8N_14, GOLGA8N_15, GOLGA8N_16, GOLGA8N_17@0@0@0@:golgin A8 family, member R@:Golgi apparatus@NA
A2463_36@134431@134432@duplication@2@34673613@34674057@15@chr15:34673613-34674057@7.95@172@274@1.59@CNVR6351.4, CNVR6351.3@GOLGA8A_24, GOLGA8A_23@0@0@0@:golgin A8 family, member A@:Golgi cisterna membrane;Golgi apparatus@NA
A2463_36@134447@134448@deletion@2@34819834@34820278@15@chr15:34819834-34820278@5.42@124@68@0.548@CNVR6351.3@GOLGA8B_25, GOLGA8B_24@0@0@0@:golgin A8 family, member A:golgin A8 family, member A;golgin A8 family, member B@:Golgi cisterna membrane;Golgi apparatus:Golgi cisterna membrane;Golgi apparatus@NA
A2463_36@134457@134460@duplication@4@34823677@34825163@15@chr15:34823677-34825163@7.83@78@144@1.85@CNVR6351.3@GOLGA8B_15, GOLGA8B_14, GOLGA8B_13, GOLGA8B_12@0@0@0@:golgin A8 family, member A:golgin A8 family, member A;golgin A8 family, member B@:Golgi cisterna membrane;Golgi apparatus:Golgi cisterna membrane;Golgi apparatus@NA
A2463_36@138284@138286@deletion@3@72954594@72956852@15@chr15:72954594-72956852@31.7@192@24@0.125@CNVR6443.1@GOLGA6B_11, GOLGA6B_12, GOLGA6B_13@0@0@0@:golgin A6 family, member B@:Golgi apparatus@NA
A2463_36@138413@138415@duplication@3@74363466@74363997@15@chr15:74363466-74363997@12@33@117@3.55@CNVR6448.1@GOLGA6A_17, GOLGA6A_16, GOLGA6A_15@0@0@0@:golgin A6 family, member C;golgin A6 family, member A;golgin A6 family, member D;golgin A6 family, member B@:Golgi apparatus@NA
A2463_36@138636@138637@deletion@2@75557464@75557765@15@chr15:75557464-75557765@8.73@192@104@0.542@CNVR6452.1@GOLGA6C_8, GOLGA6C_9@0@0@0@:golgin A6 family, member C@:Golgi apparatus@NA
A2463_36@138639@138644@duplication@6@75558447@75562083@15@chr15:75558447-75562083@7.69@60@121@2.02@CNVR6452.1@GOLGA6C_11, GOLGA6C_12, GOLGA6C_13, GOLGA6C_14, GOLGA6C_15, GOLGA6C_16@0@0@0@:golgin A6 family, member C@:Golgi apparatus@NA
A2463_36@140476@140484@deletion@9@64382@68068@16@chr16:64382-68068@31.5@443@208@0.47@CNVR6565.1@WASH4P_10, WASH4P_9, WASH4P_8, WASH4P_7, WASH4P_6, WASH4P_5, WASH4P_4, WASH4P_3, WASH4P_2@0@0@0@@:intracellular membrane-bounded organelle;endosomal transport;recycling endosome;early endosome;Arp2/3 complex-mediated actin nucleation;actin binding;alpha-tubulin binding;retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;recycling endosome membrane@NA
A2463_36@142668@142671@duplication@4@14965479@14969279@16@chr16:14965479-14969279@8.02@277@396@1.43@NA@NOMO1_17, NOMO1_18, NOMO1_19, NOMO1_20@0@0@0@:NODAL modulator 1;nodal modulator 1-like@:carbohydrate binding;integral to membrane;carboxypeptidase activity;molecular_function;cellular_component;biological_process@NA
A2463_36@142673@142674@duplication@2@14970522@14972691@16@chr16:14970522-14972691@5.77@222@317@1.43@NA@NOMO1_22, NOMO1_23@0@0@0@:NODAL modulator 1;nodal modulator 1-like@:carbohydrate binding;integral to membrane;carboxypeptidase activity;molecular_function;cellular_component;biological_process@NA
A2463_36@142690@142690@deletion@1@15045473@15045882@16@chr16:15045473-15045882@6.93@199@109@0.548@NA@NPIP_8@0@0@0@:nuclear pore complex-interacting protein-like;nuclear pore complex interacting protein;nuclear pore complex-interacting protein-like 1-like@:nuclear membrane;protein transport;nuclear pore;mRNA transport@NA
A2463_36@142750@142757@duplication@8@15457517@15472151@16@chr16:15457517-15472151@17.2@447@742@1.66@CNVR6649.1@PKD1P1_8, PKD1P1_7, PKD1P1_6, PKD1P1_5, PKD1P1_4, PKD1P1_3, PKD1P1_2, PKD1P1_1@0@0@0@:NPIP-like protein 1-like;nuclear pore complex-interacting protein-like 1-like@NA@NA
A2463_36@142905@142924@duplication@20@16313412@16360988@16@chr16:16313412-16360988@21.2@772@1089@1.41@NA@ABCC6_4, ABCC6_3, ABCC6_2, ABCC6_1, NOMO3_1, NOMO3_2, NOMO3_3, NOMO3_4, NOMO3_5, NOMO3_6, NOMO3_7, NOMO3_8, NOMO3_9, NOMO3_10, NOMO3_11, NOMO3_12, NOMO3_13, NOMO3_14, NOMO3_15, NOMO3_16@0@0@0@:ATP-binding cassette, sub-family C (CFTR/MRP), member 6:NODAL modulator 3@:ATPase activity, coupled to transmembrane movement of substances;transport;transporter activity;lateral plasma membrane;response to drug;ATP binding;transmembrane transport;integral to membrane;ATPase activity;plasma membrane;ATP catabolic process;apical plasma membrane;nucleoside-triphosphatase activity;nucleotide binding;visual perception;membrane:carbohydrate binding;integral to membrane;carboxypeptidase activity@: PSEUDOXANTHOMA ELASTICUM; PXE; PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE; ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 2; GACI2
A2463_36@143482@143483@duplication@2@21763691@21764445@16@chr16:21763691-21764445@5.17@109@171@1.57@CNVR6668.5, CNVR6668.2, CNVR6668.7@OTOA_25, OTOA_26@0@0@0@:otoancorin@:proteinaceous extracellular matrix;apical plasma membrane;sensory perception of sound;anchored to membrane@: DEAFNESS, AUTOSOMAL RECESSIVE 22; DFNB22
A2463_36@144047@144052@duplication@6@28467746@28478223@16@chr16:28467746-28478223@8.92@141@238@1.69@NA@NPIPL1_7, NPIPL1_6, NPIPL1_5, NPIPL1_4, NPIPL1_3, NPIPL1_2@0@0@0@:ceroid-lipofuscinosis, neuronal 3@:membrane:negative regulation of apoptotic process;late endosome;mitochondrion;galactosylceramide metabolic process;neuromuscular process controlling balance;neuron projection;lysosomal lumen pH elevation;integral to endoplasmic reticulum membrane;cell death;plasma membrane;nucleus;lysosomal lumen acidification;negative regulation of catalytic activity;negative regulation of macroautophagy;unfolded protein binding;neurotransmitter metabolic process;endoplasmic reticulum;vesicle transport along microtubule;protein catabolic process;autophagic vacuole;early endosome;trans-Golgi network;cellular membrane organization;ceramide metabolic process;glucosylceramide metabolic process;negative regulation of neuron apoptotic process;membrane;globoside metabolic process;membrane raft;synaptic vesicle;vacuolar transport;protein processing;Golgi membrane;caveola;protein folding;ionotropic glutamate receptor signaling pathway;cytosolic calcium ion homeostasis;Golgi stack;integral to membrane;receptor-mediated endocytosis;arginine transport;lysosome;negative regulation of proteolysis;Golgi apparatus;lysosome organization;associative learning;sphingomyelin metabolic process;macroautophagy;lysosomal membrane;amyloid precursor protein catabolic process;cytoplasm;autophagic vacuole fusion;protein binding;regulation of action potential;cellular amino acid metabolic process@: CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3
A2463_36@144104@144104@duplication@1@28659457@28659638@16@chr16:28659457-28659638@6.82@16@65@4.06@NA@A-575C2.4_2@0@0@0@:nuclear pore complex-interacting protein-like 2-like;putative NPIP-like protein LOC613037-like@NA@NA
A2463_36@144130@144134@duplication@5@28763890@28777810@16@chr16:28763890-28777810@7.58@92@162@1.76@NA@A-575C2.4_1, A-575C2.4_2, A-575C2.4_3, A-575C2.4_4, A-575C2.4_5@0@0@0@NA@NA@NA
A2463_36@144262@144265@duplication@4@29057332@29062028@16@chr16:29057332-29062028@6.49@200@290@1.45@NA@CTB-134H23.2_3, CTB-134H23.2_4, CTB-134H23.2_5, CTB-134H23.2_6@0@0@0@NA@NA@NA
A2463_36@145014@145014@deletion@1@32266213@32266224@16@chr16:32266213-32266224@5@92@46@0.5@CNVR6701.6, CNVR6701.2@TP53TG3D_2@0@0@0@:TP53 target 3B;TP53 target 3;TP53-target gene 3 protein-like;TP53 target 3C@:nucleus;cytoplasm@NA
A2463_36@147111@147124@deletion@14@70162863@70190782@16@chr16:70162863-70190782@40.6@1855@1154@0.622@CNVR6764.1, CNVR6764.3@PDPR_6, PDPR_7, PDPR_8, PDPR_9, PDPR_10, PDPR_11, PDPR_12, PDPR_13, PDPR_14, PDPR_15, PDPR_16, PDPR_17, PDPR_18, PDPR_19@0@0@0@:pyruvate dehydrogenase phosphatase regulatory subunit@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix@NA
A2463_36@147420@147421@deletion@2@72092154@72093087@16@chr16:72092154-72093087@21.5@101@0@0@CNVR6769.1, CNVR6769.2@HP_5, HP_6@0@0@0@:thioredoxin-like 4B:haptoglobin:haptoglobin-related protein@:mitosis;mRNA processing;RNA splicing;spliceosomal complex;cell redox homeostasis:cellular iron ion homeostasis;negative regulation of oxidoreductase activity;catalytic activity;negative regulation of hydrogen peroxide catabolic process;positive regulation of cell death;haptoglobin-hemoglobin complex;extracellular space;proteolysis;response to hydrogen peroxide;extracellular region;hemoglobin binding;defense response;serine-type endopeptidase activity:spherical high-density lipoprotein particle;proteolysis;extracellular region;hemoglobin binding;catalytic activity;serine-type endopeptidase activity@: ANHAPTOGLOBINEMIA; AHP
A2463_36@147496@147502@deletion@7@74411873@74425978@16@chr16:74411873-74425978@25.3@1761@1169@0.664@CNVR6778.2, CNVR6778.4@NPIPL2_1, NPIPL2_2, NPIPL2_3, NPIPL2_4, NPIPL2_5, NPIPL2_6, NPIPL2_7@0@0@0@@:extracellular region@NA
A2463_36@147512@147515@deletion@4@74447478@74455168@16@chr16:74447478-74455168@7.71@283@176@0.622@CNVR6778.2, CNVR6778.3@CLEC18B_4, CLEC18B_3, CLEC18B_2, CLEC18B_1@0@0@0@:C-type lectin domain family 18, member B@:carbohydrate binding;protein binding;extracellular region@NA
A2463_36@151558@151559@deletion@2@16667280@16675333@17@chr17:16667280-16675333@6.81@240@146@0.608@NA@CCDC144A_15, CCDC144A_15, CCDC144A_16, CCDC144A_16@0@0@0@:coiled-coil domain containing 144A@NA@NA
A2463_36@151875@151876@duplication@2@18380170@18387280@17@chr17:18380170-18387280@7.08@103@176@1.71@CNVR7014.1@LGALS9C_1, LGALS9C_2@0@0@0@:lectin, galactoside-binding, soluble, 9C@:carbohydrate binding@NA
A2463_36@151886@151886@duplication@1@18429609@18430117@17@chr17:18429609-18430117@4.75@113@177@1.57@NA@FAM106A_1@0@0@0@:protein FAM106B-like@NA@NA
A2463_36@152122@152125@duplication@4@20353287@20355705@17@chr17:20353287-20355705@7.64@123@200@1.63@CNVR7021.1, CNVR7021.3@LGALS9B_11, LGALS9B_10, LGALS9B_9, LGALS9B_8@0@0@0@:lectin, galactoside-binding, soluble, 9B@:carbohydrate binding@NA
A2463_36@152131@152132@deletion@2@20363666@20370783@17@chr17:20363666-20370783@4.87@69@32@0.464@CNVR7021.1, CNVR7021.3@LGALS9B_2, LGALS9B_1@0@0@0@:lectin, galactoside-binding, soluble, 9B@:carbohydrate binding@NA
A2463_36@152212@152212@deletion@1@25965290@25965380@17@chr17:25965290-25965380@4.74@21@0@0@CNVR7045.1, CNVR7045.2@LGALS9_2@0@0@0@:lectin, galactoside-binding, soluble, 9@:carbohydrate binding;positive regulation of I-kappaB kinase/NF-kappaB cascade;signal transduction;extracellular region;galactose binding;signal transducer activity;cytoplasm@NA
A2463_36@153368@153373@duplication@6@34497250@34500806@17@chr17:34497250-34500806@11.9@261@403@1.54@CNVR7077.1, CNVR7077.3, CNVR7077.11, CNVR7077.16@TBC1D3B_9, TBC1D3B_8, TBC1D3B_7, TBC1D3B_6, TBC1D3B_5, TBC1D3B_4@0@0@0@:TBC1 domain family, member 3B@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_36@153376@153394@deletion@19@34522686@34590454@17@chr17:34522686-34590454@17.8@120@29@0.242@CNVR7077.1, CNVR7077.13, CNVR7077.19@CCL3L3_3, CCL3L3_2, CCL3L3_1, CCL4L1_1, CCL4L1_2, CCL4L1_3, TBC1D3C_14, TBC1D3C_13, TBC1D3C_12, TBC1D3C_11, TBC1D3C_10, TBC1D3C_9, TBC1D3C_8, TBC1D3C_7, TBC1D3C_6, TBC1D3C_5, TBC1D3C_4, TBC1D3C_3, TBC1D3C_2@0@0@0@:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1:TBC1 domain family, member 3C;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3H-like;TBC1 domain family, member 3H@:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_36@153376@153400@duplication@6@34522686@34641537@17@chr17:34522686-34641537@-13.2@293@293@1@CNVR7077.1, CNVR7077.19, CNVR7077.2@CCL3L3_3, CCL3L3_2, CCL3L3_1, CCL4L1_1, CCL4L1_2, CCL4L1_3, TBC1D3C_14, TBC1D3C_13, TBC1D3C_12, TBC1D3C_11, TBC1D3C_10, TBC1D3C_9, TBC1D3C_8, TBC1D3C_7, TBC1D3C_6, TBC1D3C_5, TBC1D3C_4, TBC1D3C_3, TBC1D3C_2, CCL3L1_3, CCL3L1_2, CCL3L1_1, CCL4L2_1, CCL4L2_2, CCL4L2_3@0@0@0@:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1:TBC1 domain family, member 3C;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3H-like;TBC1 domain family, member 3H:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
A2463_36@153414@153414@deletion@1@34797487@34798054@17@chr17:34797487-34798054@21@104@2@0.0192@CNVR7078.2, CNVR7078.3@TBC1D3G_14@0@0@0@:TBC1 domain family member 3H-like;TBC1 domain family, member 3H:TBC1 domain family, member 3;TBC1 domain family, member 3G;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like;TBC1 domain family, member 3H@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_36@155581@155611@deletion@31@44248222@44632790@17@chr17:44248222-44632790@160@3669@1790@0.488@CNVR7114.2@KANSL1_2, LRRC37A_1, LRRC37A_2, LRRC37A_3, LRRC37A_4, LRRC37A_5, LRRC37A_6, LRRC37A_7, LRRC37A_8, LRRC37A_9, LRRC37A_10, LRRC37A_11, LRRC37A_12, LRRC37A_13, LRRC37A_14, ARL17B_4, ARL17B_3, ARL17B_2, LRRC37A2_2, LRRC37A2_3, LRRC37A2_4, LRRC37A2_5, LRRC37A2_6, LRRC37A2_7, LRRC37A2_8, LRRC37A2_9, LRRC37A2_10, LRRC37A2_11, LRRC37A2_12, LRRC37A2_13, LRRC37A2_14@0@0@0@:KAT8 regulatory NSL complex subunit 1:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:histone acetyltransferase activity (H4-K8 specific);histone acetyltransferase activity (H4-K16 specific);histone acetyltransferase activity (H4-K5 specific);histone acetyltransferase complex;histone H4-K5 acetylation;MLL1 complex;histone H4-K16 acetylation;protein binding;histone H4-K8 acetylation;nucleus:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
A2463_36@160721@160721@deletion@1@10911185@10911226@18@chr18:10911185-10911226@4.8@90@46@0.511@NA@PIEZO2_4@0@0@0@:piezo-type mechanosensitive ion channel component 2@:ion channel activity;regulation of membrane potential;mechanically-gated ion channel activity;integral to membrane;cation transport;cation channel activity@NA
A2463_36@162017@162018@deletion@2@44542732@44550298@18@chr18:44542732-44550298@88.8@513@13@0.0253@CNVR7319.1, CNVR7319.2@TCEB3CL2_1, TCEB3CL_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2:transcription elongation factor B polypeptide 3C-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_36@162017@162019@duplication@1@44542732@44556213@18@chr18:44542732-44556213@-87.8@3051@3538@1.16@CNVR7319.1, CNVR7319.2@TCEB3CL2_1, TCEB3CL_1, TCEB3C_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2:transcription elongation factor B polypeptide 3C-like:transcription elongation factor B polypeptide 3C (elongin A3);RNA polymerase II transcription factor SIII subunit A3-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_36@164951@164951@deletion@1@7032325@7032905@19@chr19:7032325-7032905@5.45@37@8@0.216@CNVR7517.1@MBD3L5_2@0@0@0@:methyl-CpG binding domain protein 3-like 5@NA@NA
A2463_36@170099@170099@deletion@1@40380120@40380711@19@chr19:40380120-40380711@16.1@77@1@0.013@CNVR7639.2@FCGBP_23@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_36@170107@170107@duplication@1@40395805@40396396@19@chr19:40395805-40396396@6.78@245@375@1.53@CNVR7639.2, CNVR7639.3@FCGBP_15@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_36@170109@170112@deletion@4@40399240@40406060@19@chr19:40399240-40406060@6.88@105@51@0.486@CNVR7639.2@FCGBP_13, FCGBP_12, FCGBP_11, FCGBP_10@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_36@170366@170373@deletion@8@41356153@41386533@19@chr19:41356153-41386533@22.2@462@250@0.541@CNVR7642.1@CYP2A6_1, CYP2A7_9, CYP2A7_8, CYP2A7_7, CYP2A7_6, CYP2A7_5, CYP2A7_4, CYP2A7_3@0@0@0@:cytochrome P450, family 2, subfamily A, polypeptide 6:cytochrome P450, family 2, subfamily A, polypeptide 7@:coumarin 7-hydroxylase activity;steroid metabolic process;oxidation-reduction process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;endoplasmic reticulum membrane;drug metabolic process;electron carrier activity;small molecule metabolic process;exogenous drug catabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;enzyme binding;heme binding;xenobiotic metabolic process;iron ion binding;coumarin catabolic process;coumarin metabolic process:oxidation-reduction process;electron carrier activity;aromatase activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;oxygen binding;heme binding;monooxygenase activity;endoplasmic reticulum membrane;iron ion binding@: CYTOCHROME P450, SUBFAMILY IIA, POLYPEPTIDE 6; CYP2A6
A2463_36@170399@170399@deletion@1@41627863@41628038@19@chr19:41627863-41628038@5.36@59@23@0.39@CNVR7644.1@CYP2F1_6@0@0@0@:cytochrome P450, family 2, subfamily F, polypeptide 1@:trichloroethylene metabolic process;oxidation-reduction process;aromatase activity;response to toxin;oxygen binding;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;endoplasmic reticulum membrane;naphthalene metabolic process;intracellular membrane-bounded organelle;electron carrier activity;small molecule metabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;heme binding;xenobiotic metabolic process;monooxygenase activity;iron ion binding@NA
A2463_36@172134@172136@deletion@3@49557549@49558632@19@chr19:49557549-49558632@11.7@144@61@0.424@CNVR7684.1@CGB7_5, CGB7_4, CGB7_3@0@0@0@:chorionic gonadotropin, beta polypeptide 7@:small molecule metabolic process;hormone activity;female gamete generation;cell-cell signaling;signal transduction;extracellular region;apoptotic process;cellular nitrogen compound metabolic process;peptide hormone processing@NA
A2463_36@172991@172993@deletion@3@52147033@52149313@19@chr19:52147033-52149313@6.45@149@84@0.564@CNVR7702.1@SIGLEC14_5, SIGLEC14_4, SIGLEC14_3@0@0@0@:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 14@:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion;plasma membrane@NA
A2463_36@173298@173298@deletion@1@54726151@54726434@19@chr19:54726151-54726434@6.59@31@1@0.0323@CNVR7721.3, CNVR7721.4@LILRB3_3@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
A2463_36@173336@173341@duplication@6@54801928@54804173@19@chr19:54801928-54804173@7.68@347@475@1.37@CNVR7722.1@LILRA3_6, LILRA3_5, LILRA3_4, LILRA3_3, LILRA3_2, LILRA3_1@0@0@0@:leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3@:antigen binding;signal transduction;protein binding;extracellular region;plasma membrane;receptor activity;defense response@NA
A2463_36@173456@173457@deletion@2@55237520@55239376@19@chr19:55237520-55239376@5.02@22@0@0@NA@KIR3DL3_3, KIR3DL3_4@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:integral to membrane;plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane@NA
A2463_36@173459@173477@duplication@19@55246721@55295265@19@chr19:55246721-55295265@71@1242@2061@1.66@CNVR7725.2, CNVR7725.1@KIR3DL3_6, KIR3DL3_7, KIR3DL3_8, KIR2DL3_1, KIR2DL3_2, KIR2DL3_3, KIR2DL3_4, KIR2DL3_5, KIR2DL3_6, KIR2DL3_7, KIR2DL3_8, KIR2DL1_1, KIR2DL1_2, KIR2DL1_3, KIR2DL1_4, KIR2DL1_5, KIR2DL1_6, KIR2DL1_7, KIR2DL1_8@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:integral to membrane;plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane@NA
A2463_36@173479@173482@deletion@4@55315347@55320338@19@chr19:55315347-55320338@11@72@16@0.222@CNVR7725.1, CNVR7725.3@KIR2DL4_2, KIR2DL4_3, KIR2DL4_4, KIR2DL4_5@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane@NA
A2463_36@173500@173503@deletion@4@55359207@55362710@19@chr19:55359207-55362710@18.6@85@0@0@CNVR7725.1, CNVR7725.6, CNVR7725.5, CNVR7725.10@KIR2DS4_7, KIR2DS4_8, KIR3DL2_1, KIR3DL2_2@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2-like@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane@NA
A2463_36@175735@175737@duplication@3@26054407@26063616@20@chr20:26054407-26063616@7.73@187@286@1.53@CNVR7823.4, CNVR7823.3, CNVR7823.5@FAM182A_3, FAM182A_4, FAM182A_5@0@0@0@NA@NA@NA
A2463_36@180976@180976@deletion@1@16287255@16287885@22@chr22:16287255-16287885@9.73@349@189@0.542@CNVR8071.2, CNVR8071.3, CNVR8071.9@POTEH_1@0@0@0@:POTE ankyrin domain family, member H@:protein binding@NA
A2463_36@181131@181133@deletion@3@18734088@18739404@22@chr22:18734088-18739404@5.08@47@17@0.362@CNVR8087.5, CNVR8087.2, CNVR8087.11@AC008132.1_6, AC008132.1_7, AC008132.1_8@0@0@0@NA@NA@NA
A2463_36@181417@181420@deletion@4@20366369@20367356@22@chr22:20366369-20367356@6.65@31@1@0.0323@CNVR8094.9, CNVR8094.4, CNVR8094.3@GGTLC3_5, GGTLC3_4, GGTLC3_3, GGTLC3_2@0@0@0@@:leukotriene biosynthetic process;glutathione metabolic process;gamma-glutamyltransferase activity;anchored to external side of plasma membrane@NA
A2463_36@181429@181430@duplication@2@20706373@20710986@22@chr22:20706373-20710986@4.93@191@275@1.44@CNVR8095.6, CNVR8095.5, CNVR8095.3@FAM230A_7, FAM230A_8@0@0@0@:putative uncharacterized protein ENSP00000383309-like:ubiquitin specific peptidase 41@:transferase activity, transferring phosphorus-containing groups:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
A2463_36@181622@181622@deletion@1@21480538@21481925@22@chr22:21480538-21481925@4.54@118@66@0.559@CNVR8100.6, CNVR8100.12@POM121L7_1@0@0@0@:putative POM121-like protein 1-like@NA@NA
A2463_36@181624@181631@duplication@8@21562879@21570956@22@chr22:21562879-21570956@12.5@237@371@1.57@CNVR8100.4, CNVR8100.10, CNVR8100.7@GGT2_14, GGT2_13, GGT2_12, GGT2_11, GGT2_10, GGT2_9, GGT2_8, GGT2_7@0@0@0@:gamma-glutamyltransferase 2;gamma-glutamyltranspeptidase 2-like@:hydrolase activity;small molecule metabolic process;leukotriene biosynthetic process;anchored to external side of plasma membrane;glutathione biosynthetic process;xenobiotic metabolic process;integral to membrane;glutathione metabolic process;plasma membrane;gamma-glutamyltransferase activity;cellular_component@NA
A2463_36@181806@181807@duplication@2@23243157@23247205@22@chr22:23243157-23247205@15@185@348@1.88@CNVR8103.2, CNVR8103.1, CNVR8103.6, CNVR8103.11, CNVR8103.35@IGLC2_1, IGLJ3_1@0@0@0@@:protein binding@NA
A2463_36@181849@181850@duplication@2@23651612@23652620@22@chr22:23651612-23652620@5.71@104@167@1.61@CNVR8107.2@BCR_17, BCR_18@0@0@0@:breakpoint cluster region@:phospholipid binding;protein autophosphorylation;protein tyrosine kinase activity;GTPase activator activity;neuromuscular process controlling balance;ATP binding;actin cytoskeleton organization;negative regulation of cell migration;plasma membrane;inner ear morphogenesis;positive regulation of Rac GTPase activity;positive regulation of phagocytosis;regulation of small GTPase mediated signal transduction;response to lipopolysaccharide;intracellular signal transduction;Rac GTPase activator activity;regulation of cell cycle;platelet-derived growth factor receptor signaling pathway;protein serine/threonine kinase activity;intracellular;small GTPase mediated signal transduction;regulation of Rho protein signal transduction;protein phosphorylation;negative regulation of inflammatory response;enzyme binding;Rho guanyl-nucleotide exchange factor activity;cytoplasm;cytosol;protein binding;signal transduction;brain development;kinase activity;negative regulation of neutrophil degranulation@: LEUKEMIA, CHRONIC MYELOID; CML
A2463_36@181948@181949@duplication@2@24324820@24325235@22@chr22:24324820-24325235@5.68@18@57@3.17@CNVR8114.6, CNVR8114.13, CNVR8114.8, CNVR8114.14@GSTT2_3, GSTT2_4@0@0@0@@:protein binding;glutathione transferase activity;nucleus;cytoplasm@NA
A2463_36@184143@184145@duplication@3@42522577@42523636@22@chr22:42522577-42523636@11.1@369@547@1.48@CNVR8168.1, CNVR8168.3@CYP2D6_9, CYP2D6_8, CYP2D6_7@0@0@0@:cytochrome P450, family 2, subfamily D, polypeptide 6@:oxidation-reduction process;mitochondrion;alkaloid catabolic process;aromatase activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;drug catabolic process;endoplasmic reticulum membrane;response to organic substance;oxidative demethylation;endoplasmic reticulum;alkaloid metabolic process;negative regulation of binding;heme binding;xenobiotic metabolic process;dopamine metabolic process;steroid metabolic process;isoquinoline alkaloid metabolic process;arachidonic acid monooxygenase activity;arachidonic acid metabolic process;steroid 21-monooxygenase activity;negative regulation of cellular organofluorine metabolic process;oxidoreductase activity;monoterpenoid metabolic process;heterocycle metabolic process;drug binding;drug metabolic process;electron carrier activity;small molecule metabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;monooxygenase activity;iron ion binding;coumarin metabolic process@: DRUG METABOLISM, POOR, CYP2D6-RELATED
A2463_36@184151@184152@duplication@2@42526615@42536467@22@chr22:42526615-42536467@4.99@209@298@1.43@CNVR8168.1, CNVR8168.3, CNVR8168.4@CYP2D6_1, CYP2D7P1_5@0@0@0@:cytochrome P450, family 2, subfamily D, polypeptide 6@:oxidation-reduction process;mitochondrion;alkaloid catabolic process;aromatase activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;drug catabolic process;endoplasmic reticulum membrane;response to organic substance;oxidative demethylation;endoplasmic reticulum;alkaloid metabolic process;negative regulation of binding;heme binding;xenobiotic metabolic process;dopamine metabolic process;steroid metabolic process;isoquinoline alkaloid metabolic process;arachidonic acid monooxygenase activity;arachidonic acid metabolic process;steroid 21-monooxygenase activity;negative regulation of cellular organofluorine metabolic process;oxidoreductase activity;monoterpenoid metabolic process;heterocycle metabolic process;drug binding;drug metabolic process;electron carrier activity;small molecule metabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;monooxygenase activity;iron ion binding;coumarin metabolic process:oxidation-reduction process;electron carrier activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;monooxygenase activity;iron ion binding;heme binding@: DRUG METABOLISM, POOR, CYP2D6-RELATED
A2463_35@7@7@duplication@1@138531@139309@1@chr1:138531-139309@9.85@540@789@1.46@CNVR1.2@AL627309.1_1@0@0@0@NA@NA@NA
A2463_35@423@427@deletion@5@1635264@1636464@1@chr1:1635264-1636464@7.41@166@95@0.572@CNVR17.1@CDK11A_17, CDK11A_16, CDK11A_15, CDK11A_14, CDK11A_13@0@0@0@:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A@:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division@NA
A2463_35@434@439@deletion@6@1643704@1663962@1@chr1:1643704-1663962@26.1@407@198@0.486@CNVR17.1@CDK11A_6, CDK11A_5, CDK11A_4, CDK11A_3, CDK11A_2, SLC35E2_6@0@0@0@:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A:solute carrier family 35, member E2@:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division:integral to membrane;membrane@NA
A2463_35@1833@1835@deletion@3@13219001@13330992@1@chr1:13219001-13330992@6.74@59@20@0.339@NA@WI2-2994D6.2_1, PRAMEF3_3, PRAMEF3_2@0@0@0@:PRAME family member:PRAME family member 3@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_35@1854@1855@duplication@2@13497571@13522259@1@chr1:13497571-13522259@8.21@58@122@2.1@NA@PRAMEF16_3, PRAMEF21_2@0@0@0@:PRAME family member 16:PRAME family member 21;PRAME family member 20@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_35@2170@2188@duplication@19@17248515@17275421@1@chr1:17248515-17275421@37.9@876@1311@1.5@CNVR94.4, CNVR94.5@CROCC_1, CROCC_2, CROCC_3, CROCC_4, CROCC_5, CROCC_6, CROCC_7, CROCC_8, CROCC_9, CROCC_10, CROCC_11, CROCC_12, CROCC_13, CROCC_14, CROCC_15, CROCC_16, CROCC_17, CROCC_18, CROCC_19@0@0@0@:ciliary rootlet coiled-coil, rootletin@:centriole;centrosome organization;centrosome;kinesin binding;actin cytoskeleton;cytoplasm;protein binding;vesicle-mediated transport;structural molecule activity;ciliary rootlet;protein localization;plasma membrane;cell cycle;cell projection organization;membrane@NA
A2463_35@2792@2792@deletion@1@21809637@21809879@1@chr1:21809637-21809879@5.93@69@29@0.42@CNVR107.2, CNVR107.1@NBPF3_15@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 3@:cytoplasm@NA
A2463_35@3194@3198@deletion@5@24287949@24301567@1@chr1:24287949-24301567@14@65@1@0.0154@NA@PNRC2_3, SRSF10_6, SRSF10_5, SRSF10_4, SRSF10_3@0@0@0@:proline-rich nuclear receptor coactivator 2;proline-rich nuclear receptor coactivator 2-like:serine/arginine-rich splicing factor 10-like;serine/arginine-rich splicing factor 10@:protein binding;deadenylation-independent decapping of nuclear-transcribed mRNA;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;nucleus;regulation of transcription, DNA-dependent;transcription, DNA-dependent;cytoplasmic mRNA processing body:nucleoplasm;RNA splicing, via transesterification reactions;nuclear speck;RS domain binding;RNA binding;nucleus;mRNA splice site selection;unfolded protein binding;assembly of spliceosomal tri-snRNP;negative regulation of mRNA splicing, via spliceosome;regulation of transcription, DNA-dependent;nucleotide binding;cytoplasm;mRNA export from nucleus;protein binding;cytoplasmic transport;mRNA splicing, via spliceosome;nucleic acid binding@NA
A2463_35@9354@9358@deletion@5@104163174@104166843@1@chr1:104163174-104166843@14.5@422@249@0.59@CNVR266.3, CNVR266.1@AMY2A_5, AMY2A_6, AMY2A_7, AMY2A_8, AMY2A_9@0@0@0@:amylase, alpha 2A (pancreatic)@:chloride ion binding;cation binding;small molecule metabolic process;carbohydrate metabolic process;catalytic activity;extracellular space;polysaccharide digestion;extracellular region;carbohydrate catabolic process;alpha-amylase activity;calcium ion binding@NA
A2463_35@9373@9386@deletion@14@104233917@104297436@1@chr1:104233917-104297436@66.4@477@88@0.184@CNVR266.3, CNVR266.5@AMY1B_8, AMY1B_7, AMY1B_6, AMY1B_5, AMY1B_4, AMY1B_3, AMY1B_2, AMY1C_1, AMY1C_2, AMY1C_3, AMY1C_4, AMY1C_5, AMY1C_6, AMY1C_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
A2463_35@9449@9461@duplication@13@108993225@109010287@1@chr1:108993225-109010287@15.5@222@368@1.66@CNVR294.4@NBPF6_2, NBPF6_3, NBPF6_4, NBPF6_5, NBPF6_6, NBPF6_7, NBPF6_8, NBPF6_9, NBPF6_10, NBPF6_11, NBPF6_12, NBPF6_13, NBPF6_14@0@0@0@:neuroblastoma breakpoint family, member 6@:cytoplasm@NA
A2463_35@9766@9773@deletion@8@110230497@110235917@1@chr1:110230497-110235917@58.5@277@5@0.0181@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_1, GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
A2463_35@10788@10795@deletion@8@144220788@144520832@1@chr1:144220788-144520832@14.6@150@58@0.387@NA@RP3-377D14.1_87, RP3-377D14.1_88, RP3-377D14.1_89, RP3-377D14.1_90, RP3-377D14.1_91, AL592284.1_1, PPIAL4B_1, AL592284.1_2@0@0@0@:uncharacterized LOC730256;uncharacterized LOC101060698;uncharacterized LOC642441:peptidylprolyl isomerase A (cyclophilin A)-like 4C;peptidyl-prolyl cis-trans isomerase A-like 4A/B/C-like;peptidylprolyl isomerase A (cyclophilin A)-like 4B;peptidylprolyl isomerase A (cyclophilin A)-like 4A@:protein folding;peptidyl-prolyl cis-trans isomerase activity;cytoplasm@NA
A2463_35@10799@10799@deletion@1@144815937@144816008@1@chr1:144815937-144816008@5.96@56@20@0.357@CNVR338.4, CNVR338.2, CNVR338.5, CNVR338.1@NBPF9_4@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 24@NA@NA
A2463_35@10890@10896@duplication@7@145325953@145330855@1@chr1:145325953-145330855@17.3@115@249@2.17@CNVR341.2, CNVR341.3@NBPF10_30, NBPF10_31, NBPF10_32, NBPF10_33, NBPF10_34, NBPF10_35, NBPF10_36@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family, member 10@NA@NA
A2463_35@11127@11162@duplication@36@146215076@146250999@1@chr1:146215076-146250999@28@441@719@1.63@NA@NBPF12_38, NBPF12_37, NBPF12_36, NBPF12_35, NBPF12_34, NBPF12_33, NBPF12_32, NBPF12_31, NBPF12_30, NBPF12_29, NBPF12_28, NBPF12_27, NBPF12_26, NBPF12_25, NBPF12_24, NBPF12_23, NBPF12_22, NBPF12_21, NBPF12_20, NBPF12_19, NBPF12_18, NBPF12_17, NBPF12_16, NBPF12_15, NBPF12_14, NBPF12_13, NBPF12_12, NBPF12_11, NBPF12_10, NBPF12_9, NBPF12_8, NBPF12_7, NBPF12_6, NBPF12_5, NBPF12_4, NBPF12_3@0@0@0@:neuroblastoma breakpoint family member 21-like@NA@NA
A2463_35@11164@11164@duplication@1@146253039@146253110@1@chr1:146253039-146253110@4.62@12@43@3.58@NA@NBPF12_1@0@0@0@:neuroblastoma breakpoint family member 21-like@NA@NA
A2463_35@11169@11184@deletion@16@146400092@146420191@1@chr1:146400092-146420191@34@355@137@0.386@NA@NBPF12_9, NBPF12_10, NBPF12_11, NBPF12_12, NBPF12_13, NBPF12_14, NBPF12_15, NBPF12_16, NBPF12_17, NBPF12_18, NBPF12_19, NBPF12_20, NBPF12_21, NBPF12_22, NBPF12_23, NBPF12_24@0@0@0@:neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family member 14-like;neuroblastoma breakpoint family, member 12@:cytoplasm@NA
A2463_35@11336@11351@duplication@16@148004549@148016460@1@chr1:148004549-148016460@45.2@1287@1966@1.53@CNVR346.2, CNVR346.4@NBPF14_22, NBPF14_21, NBPF14_20, NBPF14_19, NBPF14_18, NBPF14_17, NBPF14_16, NBPF14_15, NBPF14_14, NBPF14_13, NBPF14_12, NBPF14_11, NBPF14_10, NBPF14_9, NBPF14_8, NBPF14_7@0@0@0@:neuroblastoma breakpoint family, member 14@:cytoplasm@NA
A2463_35@11354@11357@duplication@4@148022928@148025848@1@chr1:148022928-148025848@7.49@325@452@1.39@CNVR346.2, CNVR346.4@NBPF14_4, NBPF14_3, NBPF14_2, NBPF14_1@0@0@0@:neuroblastoma breakpoint family, member 14@:cytoplasm@NA
A2463_35@12117@12118@duplication@2@152573209@152586574@1@chr1:152573209-152586574@6.09@112@178@1.59@CNVR358.1@LCE3C_1, LCE3B_1@0@0@0@:late cornified envelope 3C:late cornified envelope 3B@:keratinization:keratinization@NA
A2463_35@14053@14053@duplication@1@161565346@161565521@1@chr1:161565346-161565521@8.44@134@230@1.72@CNVR383.1@FCGR2C_1@0@0@0@:Fc fragment of IgG, low affinity IIIa, receptor (CD16a):Fc fragment of IgG, low affinity IIb, receptor (CD32):Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene)@:IgG binding;protein binding;regulation of immune response;extracellular region;integral to membrane;immune response;plasma membrane;external side of plasma membrane:IgG binding;protein binding;signal transduction;regulation of immune response;integral to membrane;immune response;plasma membrane;virus-host interaction@: MALARIA, SUSCEPTIBILITY TO; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
A2463_35@16034@16034@deletion@1@196762448@196762643@1@chr1:196762448-196762643@5.49@212@130@0.613@CNVR459.1@CFHR3_6@0@0@0@:complement factor H-related 3@:extracellular space@NA
A2463_35@24830@24831@deletion@2@87201197@87201636@2@chr2:87201197-87201636@9.13@214@118@0.551@NA@RGPD1_10, RGPD1_11@0@0@0@:RANBP2-like and GRIP domain containing 1@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_35@24851@24863@duplication@13@88071689@88095367@2@chr2:88071689-88095367@24.8@314@538@1.71@NA@RGPD2_22, RGPD2_21, RGPD2_20, RGPD2_19, RGPD2_18, RGPD2_17, RGPD2_16, RGPD2_15, RGPD2_14, RGPD2_13, RGPD2_12, RGPD2_11, RGPD2_10@0@0@0@:RANBP2-like and GRIP domain containing 2@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_35@25350@25351@deletion@2@97818242@97820478@2@chr2:97818242-97820478@5.13@147@88@0.599@CNVR886.2@ANKRD36_14, ANKRD36_15@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_35@25369@25370@deletion@2@97854825@97855027@2@chr2:97854825-97855027@30.1@141@1@0.00709@CNVR886.2, CNVR886.3@ANKRD36_33, ANKRD36_34@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_35@27163@27163@deletion@1@130843388@130843568@2@chr2:130843388-130843568@8.11@37@0@0@NA@POTEF_13@0@0@0@:POTE ankyrin domain family, member F@:cell cortex;protein binding;ATP binding@NA
A2463_35@27171@27172@deletion@2@130868117@130869674@2@chr2:130868117-130869674@11.6@84@21@0.25@NA@POTEF_5, POTEF_4@0@0@0@:POTE ankyrin domain family, member F@:cell cortex;protein binding;ATP binding@NA
A2463_35@27243@27250@duplication@8@131231952@131254195@2@chr2:131231952-131254195@7.89@192@287@1.49@NA@POTEI_13, POTEI_12, POTEI_11, POTEI_10, POTEI_9, POTEI_8, POTEI_7, POTEI_6@0@0@0@:POTE ankyrin domain family, member I@:protein binding;ATP binding@NA
A2463_35@27279@27282@deletion@4@131381638@131390229@2@chr2:131381638-131390229@7.81@160@87@0.544@NA@POTEJ_6, POTEJ_7, POTEJ_8, POTEJ_9@0@0@0@:POTE ankyrin domain family, member J@:protein binding;ATP binding@NA
A2463_35@27288@27288@deletion@1@131414123@131415450@2@chr2:131414123-131415450@6.04@603@404@0.67@NA@POTEJ_15@0@0@0@:POTE ankyrin domain family, member J@:protein binding;ATP binding@NA
A2463_35@27995@27996@duplication@2@152461075@152463227@2@chr2:152461075-152463227@8.05@78@149@1.91@CNVR1026.1@NEB_85, NEB_84@0@0@0@:nebulin@:Z disc;muscle filament sliding;oxidation-reduction process;contractile fiber part;actin cytoskeleton;regulation of actin filament length;structural constituent of muscle;cytosol;actin binding;protein binding;myofibril;somatic muscle development;muscle organ development@: NEMALINE MYOPATHY 2; NEM2
A2463_35@39892@39894@deletion@3@75786030@75790887@3@chr3:75786030-75790887@9.03@209@119@0.569@CNVR1432.5, CNVR1432.9, CNVR1432.4@ZNF717_5, ZNF717_4, ZNF717_3@0@0@0@:zinc finger protein 717;zinc finger protein 717-like@:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_35@45459@45460@duplication@2@195505175@195518368@3@chr3:195505175-195518368@11@2025@2782@1.37@CNVR1704.1@MUC4_3, MUC4_2@0@0@0@:mucin 4, cell surface associated@:ErbB-2 class receptor binding;Golgi lumen;cell-matrix adhesion;post-translational protein modification;extracellular matrix structural constituent;protein binding;O-glycan processing;cellular protein metabolic process;proteinaceous extracellular matrix;integral to plasma membrane;membrane;extracellular matrix constituent, lubricant activity;biological_process@NA
A2463_35@46667@46675@deletion@9@9174900@9237700@4@chr4:9174900-9237700@22.2@125@16@0.128@NA@FAM90A26P_4, FAM90A26P_5, FAM90A26P_6, FAM90A26P_7, USP17L13_1, USP17L10_1, USP17L11_1, USP17L12_1, USP17L13_2, USP17L15_1@0@0@0@:ubiquitin specific peptidase 17-like family member 10:ubiquitin specific peptidase 17-like family member 13:ubiquitin specific peptidase 17-like family member 11:ubiquitin specific peptidase 17-like family member 12:ubiquitin specific peptidase 17-like family member 15@:zinc ion binding;nucleic acid binding:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
A2463_35@48594@48597@deletion@4@70152471@70160527@4@chr4:70152471-70160527@11.2@349@213@0.61@CNVR1957.2, CNVR1957.1@UGT2B28_3, UGT2B28_4, UGT2B28_5, UGT2B28_6@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B28@:carbohydrate binding;transferase activity, transferring hexosyl groups;endoplasmic reticulum;glucuronosyltransferase activity;carbohydrate metabolic process;xenobiotic metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process@NA
A2463_35@48972@48973@duplication@2@75482007@75484724@4@chr4:75482007-75484724@6.67@30@78@2.6@NA@AREGB_2, AREGB_3@0@0@0@:amphiregulin;amphiregulin B@:growth factor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;cell proliferation;epidermal growth factor receptor signaling pathway;extracellular space;protein binding;integral to membrane;cytokine activity;cell surface;positive regulation of DNA replication@NA
A2463_35@53309@53312@deletion@4@751249@767067@5@chr5:751249-767067@5.52@126@72@0.571@CNVR2280.3@ZDHHC11B_4, ZDHHC11B_3, ZDHHC11B_2, ZDHHC11B_1@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
A2463_35@54849@54849@duplication@1@42629141@42629205@5@chr5:42629141-42629205@5.87@110@177@1.61@CNVR2445.1@GHR_3@0@0@0@:growth hormone receptor@:neuronal cell body;mitochondrion;proline-rich region binding;JAK-STAT cascade;growth factor binding;nucleus;succinate metabolic process;positive regulation of JAK-STAT cascade;JAK-STAT cascade involved in growth hormone signaling pathway;response to morphine;activation of MAPK activity;peptide hormone binding;response to estradiol stimulus;2-oxoglutarate metabolic process;valine metabolic process;response to cytokine stimulus;hormone-mediated signaling pathway;response to food;SH2 domain binding;oxaloacetate metabolic process;growth hormone receptor signaling pathway;allantoin metabolic process;integral to membrane;response to hormone stimulus;cartilage development involved in endochondral bone morphogenesis;positive regulation of peptidyl-tyrosine phosphorylation;receptor internalization;cytoplasm;cellular response to hormone stimulus;extracellular region;growth hormone receptor complex;positive regulation of tyrosine phosphorylation of Stat5 protein;regulation of multicellular organism growth;growth hormone receptor activity;positive regulation of tyrosine phosphorylation of Stat3 protein;response to peptide hormone stimulus;fatty acid metabolic process;creatinine metabolic process;plasma membrane;positive regulation of multicellular organism growth;receptor complex;protein phosphatase binding;protein kinase binding;creatine metabolic process;response to interleukin-1;response to cycloheximide;extracellular space;positive regulation of cell differentiation;activation of Janus kinase activity;taurine metabolic process;cellular response to insulin stimulus;integral to plasma membrane;protein homodimerization activity;negative regulation of neuron death;citrate metabolic process;endocytosis;isoleucine metabolic process;activation of JAK2 kinase activity;extrinsic to membrane;response to glucocorticoid stimulus;protein binding;insulin-like growth factor receptor signaling pathway;multicellular organismal metabolic process;cell surface@: HYPERCHOLESTEROLEMIA, FAMILIAL; LARON SYNDROME; SHORT STATURE, IDIOPATHIC, AUTOSOMAL
A2463_35@55190@55190@deletion@1@54960522@54960691@5@chr5:54960522-54960691@6.79@102@48@0.471@NA@SLC38A9_8@0@0@0@:solute carrier family 38, member 9@:amino acid transport;integral to membrane;sodium ion transport@NA
A2463_35@55773@55775@duplication@3@68800073@68809936@5@chr5:68800073-68809936@23.5@873@1299@1.49@NA@OCLN_2, OCLN_3, OCLN_4@0@0@0@:occludin@:S-adenosylmethionine metabolic process;cell-cell junction organization;cellular component disassembly involved in execution phase of apoptosis;response to testosterone stimulus;tight junction;integral to membrane;cell junction;plasma membrane;apoptotic process;thiopurine S-methyltransferase activity;S-adenosylhomocysteine metabolic process;apical plasma membrane;protein complex assembly;cytosol;cell-cell junction;protein binding;structural molecule activity;response to organic cyclic compound;apicolateral plasma membrane@: BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA;
A2463_35@55785@55787@duplication@3@68863555@68868377@5@chr5:68863555-68868377@9.69@119@210@1.76@CNVR2494.7, CNVR2494.46@GTF2H2C_6, GTF2H2C_7, GTF2H2C_8@0@0@0@:general transcription factor IIH, polypeptide 2C;general transcription factor IIH, polypeptide 2D@:regulation of transcription, DNA-dependent;nucleotide-excision repair;DNA repair;core TFIIH complex;protein binding;nucleus;transcription, DNA-dependent;zinc ion binding@NA
A2463_35@55806@55806@duplication@1@69372349@69372398@5@chr5:69372349-69372398@4.71@107@165@1.54@CNVR2494.48, CNVR2494.39, CNVR2494.15, CNVR2494.18, CNVR2494.26, CNVR2494.43, CNVR2494.52, CNVR2494.28, CNVR2494.2, CNVR2494.36@SMN2_8@0@0@0@:survival of motor neuron 2, centromeric;survival of motor neuron 1, telomeric@:nucleoplasm;ncRNA metabolic process;Cajal body;RNA metabolic process;spliceosomal complex;cytoplasm;cytosol;protein binding;cell death;spliceosomal complex assembly;RNA binding;mRNA processing;nucleus;gene expression;spliceosomal snRNP assembly@: SPINAL MUSCULAR ATROPHY, TYPE II; SMA2; SPINAL MUSCULAR ATROPHY, TYPE I; SMA1; SPINAL MUSCULAR ATROPHY, TYPE IV; SMA4; SPINAL MUSCULAR ATROPHY, TYPE III; SMA3
A2463_35@55840@55842@deletion@3@70351180@70355997@5@chr5:70351180-70355997@5.35@87@45@0.517@CNVR2494.41, CNVR2494.14, CNVR2494.20, CNVR2494.62, CNVR2494.8@GTF2H2_9, GTF2H2_8, GTF2H2_7@0@0@0@:general transcription factor IIH, polypeptide 2, 44kDa@:nucleoplasm;nucleotide-excision repair, DNA damage removal;transcription from RNA polymerase I promoter;DNA repair;RNA polymerase II carboxy-terminal domain kinase activity;nucleus;viral reproduction;translation;gene expression;transcription elongation from RNA polymerase I promoter;response to UV;holo TFIIH complex;protein kinase activity;nucleotide-excision repair;transcription from RNA polymerase II promoter;transcription-coupled nucleotide-excision repair;transcription, DNA-dependent;zinc ion binding;transcription elongation from RNA polymerase II promoter;termination of RNA polymerase I transcription;sequence-specific DNA binding transcription factor activity;G-protein coupled receptor internalization;DNA-dependent ATPase activity;protein N-terminus binding;transcription initiation from RNA polymerase I promoter;7-methylguanosine mRNA capping;transcription initiation from RNA polymerase II promoter;protein phosphorylation;translation factor activity, nucleic acid binding;regulation of transcription, DNA-dependent;core TFIIH complex;protein binding;positive regulation of viral transcription;nucleic acid binding@NA
A2463_35@59065@59065@deletion@1@140557617@140560021@5@chr5:140557617-140560021@32.7@2337@1141@0.488@CNVR2624.1@PCDHB8_1@0@0@0@:protocadherin beta 8@:integral to membrane;homophilic cell adhesion;plasma membrane;membrane;calcium ion binding@NA
A2463_35@60876@60878@duplication@3@175388055@175392158@5@chr5:175388055-175392158@5.46@43@85@1.98@NA@THOC3_5, THOC3_4, THOC3_3@0@0@0@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
A2463_35@61261@61267@duplication@7@177156487@177164113@5@chr5:177156487-177164113@10.8@321@461@1.44@NA@FAM153A_16, FAM153A_15, FAM153A_14, FAM153A_13, FAM153A_12, FAM153A_11, FAM153A_10@0@0@0@:family with sequence similarity 153, member A@NA@NA
A2463_35@61271@61275@duplication@5@177168258@177175644@5@chr5:177168258-177175644@6.5@107@170@1.59@NA@FAM153A_6, FAM153A_5, FAM153A_4, FAM153A_3, FAM153A_2@0@0@0@:family with sequence similarity 153, member A@NA@NA
A2463_35@61638@61645@deletion@8@180375356@180429785@5@chr5:180375356-180429785@21@779@482@0.619@CNVR2719.1@BTNL8_5, BTNL8_6, BTNL8_7, BTNL8_8, BTNL3_1, BTNL3_2, BTNL3_3, BTNL3_4@0@0@0@:butyrophilin-like 8:butyrophilin-like 3@:protein binding;integral to membrane:protein binding;integral to membrane;molecular_function;cellular_component;biological_process@NA
A2463_35@63730@63730@deletion@1@31963497@31963571@6@chr6:31963497-31963571@7.06@111@53@0.477@CNVR2843.6, CNVR2843.3@C4A_25@0@0@0@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
A2463_35@63734@63735@duplication@2@31964607@31965088@6@chr6:31964607-31965088@5.18@20@56@2.8@CNVR2843.6, CNVR2843.3@C4A_29, C4A_30@0@0@0@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
A2463_35@63768@63776@duplication@9@31994761@31997115@6@chr6:31994761-31997115@34.5@606@982@1.62@CNVR2843.6, CNVR2843.5@C4B_20, C4B_21, C4B_22, C4B_23, C4B_24, C4B_25, C4B_26, C4B_27, C4B_28@0@0@0@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
A2463_35@63953@63958@duplication@6@32485517@32498001@6@chr6:32485517-32498001@30.5@291@560@1.92@CNVR2845.21, CNVR2845.25, CNVR2845.30, CNVR2845.43, CNVR2845.6@HLA-DRB5_6, HLA-DRB5_5, HLA-DRB5_4, HLA-DRB5_3, HLA-DRB5_2, HLA-DRB5_1@0@0@0@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
A2463_35@64602@64603@duplication@2@35754776@35755787@6@chr6:35754776-35755787@5.16@312@423@1.36@CNVR2861.1@CLPSL1_2, CLPSL1_3@0@0@0@:colipase-like 1@:extracellular region;enzyme activator activity;digestion;lipid catabolic process@NA
A2463_35@66018@66021@duplication@4@49437891@49440571@6@chr6:49437891-49440571@10.5@404@571@1.41@NA@CENPQ_2, CENPQ_3, CENPQ_4, CENPQ_5@0@0@0@:centromere protein Q@:nucleoplasm;mitotic cell cycle;cytosol;chromosome, centromeric region;mitotic prometaphase;M phase of mitotic cell cycle;nucleosome assembly;CenH3-containing nucleosome assembly at centromere@NA
A2463_35@70816@70817@duplication@2@161054786@161056336@6@chr6:161054786-161056336@27@176@427@2.43@CNVR3133.1@LPA_9, LPA_8@0@0@0@:lipoprotein, Lp(a)@:blood circulation;endopeptidase inhibitor activity;catalytic activity;lipoprotein metabolic process;proteolysis;heparin binding;receptor-mediated endocytosis;fibronectin binding;small molecule metabolic process;apolipoprotein binding;lipid metabolic process;negative regulation of endopeptidase activity;extracellular region;plasma lipoprotein particle;lipid transport;serine-type endopeptidase activity@: APOLIPOPROTEIN(a); LPA
A2463_35@71744@71745@duplication@2@5939916@5940197@7@chr7:5939916-5940197@5.87@172@250@1.45@NA@CCZ1_2, CCZ1_3@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
A2463_35@71754@71760@duplication@7@5959481@5972506@7@chr7:5959481-5972506@15.1@468@676@1.44@NA@CCZ1_12, CCZ1_13, CCZ1_14, CCZ1_15, RSPH10B_20, RSPH10B_19, RSPH10B_18@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae):radial spoke head 10 homolog B (Chlamydomonas)@:lysosomal membrane@NA
A2463_35@71939@71944@deletion@6@6836200@6844686@7@chr7:6836200-6844686@36@207@31@0.15@NA@RSPH10B2_19, RSPH10B2_20, CCZ1B_15, CCZ1B_14, CCZ1B_13, CCZ1B_12@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
A2463_35@73242@73242@deletion@1@38279626@38279767@7@chr7:38279626-38279767@5.18@42@13@0.31@NA@TRGC2_4@0@0@0@@:protein binding@NA
A2463_35@74573@74576@deletion@4@74166423@74169869@7@chr7:74166423-74169869@16.4@197@89@0.452@NA@GTF2I_28, GTF2I_29, GTF2I_30, GTF2I_31@0@0@0@:general transcription factor IIi@:neuronal cell body;transcription initiation from RNA polymerase II promoter;mitogen-activated protein kinase binding;negative regulation of angiogenesis;DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;cytoplasm;transcription from RNA polymerase II promoter;protein binding;signal transduction;nucleus;cell projection;reduction of cytosolic calcium ion concentration@NA
A2463_35@74597@74598@deletion@2@74225431@74227349@7@chr7:74225431-74227349@8.12@43@4@0.093@NA@GTF2IRD2_10, GTF2IRD2_9@0@0@0@:GTF2I repeat domain containing 2@:nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_35@76427@76432@deletion@6@100331793@100336236@7@chr7:100331793-100336236@54@250@1@0.004@CNVR3509.1@ZAN_1, ZAN_2, ZAN_3, ZAN_4, ZAN_5, ZAN_6@0@0@0@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
A2463_35@76792@76793@deletion@2@102309363@102312048@7@chr7:102309363-102312048@14.3@68@2@0.0294@CNVR3518.1@POLR2J2_2, POLR2J2_2, POLR2J2_1, POLR2J2_1@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
A2463_35@79310@79310@duplication@1@143884023@143885476@7@chr7:143884023-143885476@5.1@193@278@1.44@CNVR3598.4, CNVR3598.3, CNVR3598.7@ARHGEF35_2@0@0@0@:Rho guanine nucleotide exchange factor (GEF) 35@NA@NA
A2463_35@80367@80386@duplication@20@7272484@7399402@8@chr8:7272484-7399402@86.9@590@1407@2.38@CNVR3771.8, CNVR3771.10, CNVR3771.4@DEFB4B_2, DEFB4B_1, DEFB103B_2, DEFB103B_1, SPAG11B_3, SPAG11B_2, SPAG11B_1, DEFB104B_2, DEFB104B_1, DEFB106B_2, DEFB106B_1, DEFB105B_1, DEFB105B_2, DEFB105B_3, DEFB107B_1, DEFB107B_2, RP11-1118M6.1_1, RP11-1118M6.1_2, RP11-1118M6.1_3, RP11-1118M6.1_4@0@0@0@:defensin, beta 4B;defensin, beta 4A:defensin, beta 103B;defensin, beta 103A:sperm associated antigen 11B:defensin, beta 104A;defensin, beta 104B:defensin, beta 106B;defensin, beta 106A:defensin, beta 105B;defensin, beta 105A:defensin, beta 107B;defensin, beta 107A:uncharacterized LOC100133251@:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response:extracellular region;defense response to bacterium;Golgi lumen;positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria;defense response;innate immune response:spermatogenesis;defense response to bacterium;extracellular region;molecular_function;defense response:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium@NA
A2463_35@80392@80399@duplication@8@7673082@7698716@8@chr8:7673082-7698716@48.5@319@737@2.31@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@DEFB107A_1, DEFB105A_3, DEFB105A_2, DEFB105A_1, DEFB106A_1, DEFB106A_2, DEFB104A_1, DEFB104A_2@0@0@0@:defensin, beta 107B;defensin, beta 107A:defensin, beta 105B;defensin, beta 105A:defensin, beta 106B;defensin, beta 106A:defensin, beta 104A;defensin, beta 104B@:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium@NA
A2463_35@80402@80402@deletion@1@7718169@7718245@8@chr8:7718169-7718245@6.76@32@1@0.0312@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@SPAG11A_3@0@0@0@:sperm associated antigen 11A;sperm associated antigen 11B@:extracellular region;defense response@NA
A2463_35@80402@80412@duplication@10@7718169@7809913@8@chr8:7718169-7809913@76.3@494@1231@2.49@CNVR3772.4, CNVR3772.6, CNVR3772.10, CNVR3772.13@SPAG11A_3, SPAG11A_4, DEFB103A_1, DEFB103A_2, DEFB4A_1, DEFB4A_2, ZNF705B_2, ZNF705B_3, ZNF705B_4, ZNF705B_5, ZNF705B_6@0@0@0@:sperm associated antigen 11A;sperm associated antigen 11B:defensin, beta 103B;defensin, beta 103A:defensin, beta 4B;defensin, beta 4A:zinc finger protein 705B@:extracellular region;defense response:extracellular region;defense response to bacterium;Golgi lumen;positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria;defense response;innate immune response:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response:intracellular;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_35@80564@80586@duplication@23@11970084@12423650@8@chr8:11970084-12423650@199@2380@5271@2.21@CNVR3786.4@ZNF705D_6, USP17L2_1, FAM86B1_8, FAM86B1_7, FAM86B1_6, FAM86B1_5, FAM86B1_4, FAM86B1_3, FAM86B1_2, FAM86B1_1, DEFB130_2, DEFB130_1, FAM86B2_8, FAM86B2_7, FAM86B2_6, FAM86B2_5, FAM86B2_4, FAM86B2_3, FAM86B2_2, FAM86B2_1, AC130352.1_5, AC130352.1_6, AC130352.1_7@0@0@0@:zinc finger protein 705D:ubiquitin specific peptidase 17-like family member 1, pseudogene;ubiquitin specific peptidase 17-like family member 2;ubiquitin specific peptidase 17-like family member 4;ubiquitin specific peptidase 17-like family member 7;ubiquitin specific peptidase 17-like family member 8;ubiquitin specific peptidase 17-like family member 3:family with sequence similarity 86, member B2;family with sequence similarity 86, member B1:defensin, beta 130-like;defensin, beta 130:family with sequence similarity 86, member B2@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:protein deubiquitination;ubiquitin-specific protease activity;mitotic cell cycle G1/S transition checkpoint;nucleus;G2/M transition checkpoint;apoptotic process;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:extracellular region;defense response to bacterium;defense response@NA
A2463_35@83673@83673@deletion@1@86573700@86575726@8@chr8:86573700-86575726@61.1@350@12@0.0343@CNVR3955.1@REXO1L1_1@0@0@0@:exonuclease GOR-like;REX1, RNA exonuclease 1 homolog (S. cerevisiae)-like 1@:intracellular;nucleus;exonuclease activity;nucleic acid binding;cytoplasm@NA
A2463_35@84160@84162@duplication@3@98787966@98827629@8@chr8:98787966-98827629@5.77@234@324@1.38@NA@LAPTM4B_1, LAPTM4B_2, LAPTM4B_3@0@0@0@:lysosomal protein transmembrane 4 beta@:protein binding;endomembrane system;transport;integral to membrane@NA
A2463_35@88529@88529@duplication@1@40715850@40716325@9@chr9:40715850-40716325@6.23@327@463@1.42@NA@FAM74A3_1@0@0@0@NA@NA@NA
A2463_35@88534@88534@duplication@1@41306194@41306209@9@chr9:41306194-41306209@4.81@44@85@1.93@CNVR4278.2@FAM74A2_2@0@0@0@@:integral to membrane@NA
A2463_35@88544@88558@deletion@15@42368416@42410483@9@chr9:42368416-42410483@15@223@106@0.475@NA@ANKRD20A2_1, ANKRD20A2_2, ANKRD20A2_3, ANKRD20A2_4, ANKRD20A2_5, ANKRD20A2_6, ANKRD20A2_7, ANKRD20A2_8, ANKRD20A2_9, ANKRD20A2_10, ANKRD20A2_11, ANKRD20A2_12, ANKRD20A2_13, ANKRD20A2_14, ANKRD20A2_15, RP11-146D12.2_1@0@0@0@:ankyrin repeat domain 20 family, member A2@:protein binding@NA
A2463_35@88595@88597@deletion@3@43822519@43844315@9@chr9:43822519-43844315@16.5@237@113@0.477@CNVR4294.1@CNTNAP3B_8, CNTNAP3B_9, CNTNAP3B_10@0@0@0@:contactin associated protein-like 3B;contactin associated protein-like 3@:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
A2463_35@88600@88601@deletion@2@43861004@43876145@9@chr9:43861004-43876145@8.08@137@69@0.504@NA@CNTNAP3B_13, CNTNAP3B_14@0@0@0@:contactin associated protein-like 3B;contactin associated protein-like 3@:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
A2463_35@88610@88610@deletion@1@43915827@43915897@9@chr9:43915827-43915897@5.2@64@28@0.438@NA@CNTNAP3B_23@0@0@0@:contactin associated protein-like 3B;contactin associated protein-like 3@:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
A2463_35@88613@88613@duplication@1@44401891@44402255@9@chr9:44401891-44402255@6.14@127@201@1.58@CNVR4297.3@BX088651.1_1@0@0@0@NA@NA@NA
A2463_35@88620@88622@duplication@3@45727245@45733965@9@chr9:45727245-45733965@14.2@141@271@1.92@CNVR4305.1@FAM27A_1, AL953889.1_2, AL953889.1_1, FAM27A_2, FAM27E2_1@0@0@0@NA@NA@NA
A2463_35@88620@88624@deletion@2@45727245@46390900@9@chr9:45727245-46390900@-25.5@178@278@1.56@NA@FAM27A_1, AL953889.1_2, AL953889.1_1, FAM27A_2, FAM27E2_1, FAM27E1_1, FAM27D1_1@0@0@0@:family with sequence similarity 27, member E3:protein FAM27E2-like;protein FAM27D1-like@NA@NA
A2463_35@88631@88633@duplication@3@65503517@65508193@9@chr9:65503517-65508193@27.1@248@503@2.03@CNVR4312.5@SPATA31A7_4, SPATA31A7_3, SPATA31A7_2@0@0@0@:SPATA31 subfamily A, member 7@:integral to membrane@NA
A2463_35@88644@88644@deletion@1@67938604@67938658@9@chr9:67938604-67938658@10.1@145@64@0.441@NA@ANKRD20A1_6@0@0@0@:ankyrin repeat domain 20 family, member A1@:protein binding;plasma membrane@NA
A2463_35@88670@88670@duplication@1@69252846@69253282@9@chr9:69252846-69253282@6.18@111@181@1.63@NA@BX255923.1_1@0@0@0@:COBW domain containing 6@:ATP binding@NA
A2463_35@88676@88690@duplication@15@69382094@69424176@9@chr9:69382094-69424176@81.1@852@1679@1.97@NA@ANKRD20A4_1, ANKRD20A4_2, ANKRD20A4_3, ANKRD20A4_4, ANKRD20A4_5, ANKRD20A4_6, ANKRD20A4_7, ANKRD20A4_8, ANKRD20A4_9, ANKRD20A4_10, ANKRD20A4_11, ANKRD20A4_12, ANKRD20A4_13, ANKRD20A4_14, ANKRD20A4_15@0@0@0@:ankyrin repeat domain 20 family, member A4@:protein binding@NA
A2463_35@90056@90056@deletion@1@99700647@99701431@9@chr9:99700647-99701431@5.22@151@88@0.583@CNVR4411.1@FAM22G_7@0@0@0@:family with sequence similarity 22, member G@NA@NA
A2463_35@91242@91246@duplication@5@117085415@117087432@9@chr9:117085415-117087432@63.8@381@1027@2.7@CNVR4448.1@ORM1_1, ORM1_2, ORM1_3, ORM1_4, ORM1_5@0@0@0@:orosomucoid 1@:protein binding;extracellular space;regulation of immune system process;transport;inflammatory response;extracellular region;acute-phase response@NA
A2463_35@91248@91252@deletion@5@117092186@117094209@9@chr9:117092186-117094209@12.2@259@142@0.548@CNVR4448.1@ORM2_1, ORM2_2, ORM2_3, ORM2_4, ORM2_5@0@0@0@:orosomucoid 2@:extracellular space;regulation of immune system process;transport;acute-phase response@NA
A2463_35@91254@91274@deletion@21@117099335@117143613@9@chr9:117099335-117143613@73.6@1151@562@0.488@NA@AKNA_22, AKNA_21, AKNA_20, AKNA_19, AKNA_18, AKNA_17, AKNA_16, AKNA_15, AKNA_14, AKNA_13, AKNA_12, AKNA_11, AKNA_10, AKNA_9, AKNA_8, AKNA_7, AKNA_6, AKNA_5, AKNA_4, AKNA_3, AKNA_2@0@0@0@:AT-hook transcription factor@:nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_35@95376@95381@duplication@6@17949551@18065159@10@chr10:17949551-18065159@16.4@70@188@2.69@NA@MRC1L1_28, MRC1L1_29, MRC1L1_30, TMEM236_1, TMEM236_2, TMEM236_3@0@0@0@:macrophage mannose receptor 1-like:transmembrane protein 236;transmembrane protein 236-like@:carbohydrate binding:integral to membrane@NA
A2463_35@95410@95411@deletion@2@18196464@18198276@10@chr10:18196464-18198276@20.9@98@1@0.0102@NA@MRC1_28, MRC1_29@0@0@0@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
A2463_35@96439@96439@deletion@1@46254764@46254849@10@chr10:46254764-46254849@5.55@57@22@0.386@NA@FAM21C_17@0@0@0@:family with sequence similarity 21, member C@:endosome;protein binding;plasma membrane;retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_35@96454@96458@duplication@5@46312644@46329564@10@chr10:46312644-46329564@19.4@172@364@2.12@NA@FAM25E_1, AGAP4_7, AGAP4_6, AGAP4_5, AGAP4_4@0@0@0@:ArfGAP with GTPase domain, ankyrin repeat and PH domain 4;arf-GAP with GTPase, ANK repeat and PH domain-containing protein 5-like@:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity@NA
A2463_35@96540@96564@duplication@25@47903160@48001973@10@chr10:47903160-48001973@128@524@1483@2.83@CNVR4715.2@FAM21B_6, FAM21B_7, FAM21B_8, FAM21B_9, FAM21B_10, FAM21B_11, FAM21B_12, FAM21B_13, FAM21B_14, FAM21B_15, FAM21B_16, FAM21B_17, FAM21B_18, FAM21B_19, FAM21B_20, FAM21B_21, FAM21B_22, FAM21B_23, FAM21B_24, FAM21B_25, FAM21B_26, FAM21B_27, FAM21B_28, FAM21B_29, ASAH2C_18@0@0@0@:family with sequence similarity 21, member B@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome:ceramidase activity;sphingolipid metabolic process@NA
A2463_35@96573@96581@duplication@9@48025301@48055018@10@chr10:48025301-48055018@7.91@327@452@1.38@CNVR4715.2@ASAH2C_9, ASAH2C_8, ASAH2C_7, ASAH2C_6, ASAH2C_5, ASAH2C_4, ASAH2C_3, ASAH2C_2, ASAH2C_1@0@0@0@@:ceramidase activity;sphingolipid metabolic process@NA
A2463_35@96620@96620@duplication@1@48771316@48771405@10@chr10:48771316-48771405@5.55@61@112@1.84@CNVR4716.10, CNVR4716.3@PTPN20B_6@0@0@0@:protein tyrosine phosphatase, non-receptor type 20B;protein tyrosine phosphatase, non-receptor type 20A@:phosphatase activity;protein tyrosine phosphatase activity;microtubule;nucleus;dephosphorylation;protein dephosphorylation;microtubule organizing center@NA
A2463_35@96631@96634@deletion@4@49376639@49382998@10@chr10:49376639-49382998@8.66@70@22@0.314@CNVR4717.2@FRMPD2_27, FRMPD2_26, FRMPD2_25, FRMPD2_24@0@0@0@:FERM and PDZ domain containing 2@:basolateral plasma membrane;transferase activity, transferring phosphorus-containing groups;cytoplasm;tight junction;protein binding;cytoskeleton;1-phosphatidylinositol binding;tight junction assembly@NA
A2463_35@96844@96852@deletion@9@51224991@51374428@10@chr10:51224991-51374428@15.1@313@169@0.54@NA@AGAP8_7, AGAP8_6, AGAP8_5, AGAP8_4, AGAP8_3, AGAP8_2, AGAP8_1, TIMM23B_1, TIMM23B_2@0@0@0@:ArfGAP with GTPase domain, ankyrin repeat and PH domain 8:translocase of inner mitochondrial membrane 23 homolog B (yeast)@:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process@NA
A2463_35@96883@96884@duplication@2@51620325@51623214@10@chr10:51620325-51623214@5.68@200@286@1.43@NA@TIMM23_2, TIMM23_1@0@0@0@:translocase of inner mitochondrial membrane 23 homolog B (yeast):translocase of inner mitochondrial membrane 23 homolog B (yeast);translocase of inner mitochondrial membrane 23 homolog (yeast)@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process:mitochondrion;mitochondrial inner membrane;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;mitochondrial intermembrane space;integral to mitochondrial inner membrane;intracellular protein transport;protein binding;integral to membrane;cellular protein metabolic process;protein targeting to mitochondrion@NA
A2463_35@96900@96939@deletion@40@51847036@51994312@10@chr10:51847036-51994312@146@863@128@0.148@NA@FAM21A_8, FAM21A_9, FAM21A_10, FAM21A_11, FAM21A_12, FAM21A_13, FAM21A_14, FAM21A_15, FAM21A_16, FAM21A_17, FAM21A_18, FAM21A_19, FAM21A_20, FAM21A_21, FAM21A_22, FAM21A_23, FAM21A_24, FAM21A_25, FAM21A_26, FAM21A_27, FAM21A_28, FAM21A_29, FAM21A_30, FAM21A_31, ASAH2_20, ASAH2_19, ASAH2_18, ASAH2_17, ASAH2_16, ASAH2_15, ASAH2_14, ASAH2_13, ASAH2_12, ASAH2_11, ASAH2_10, ASAH2_9, ASAH2_8, ASAH2_7, ASAH2_6, ASAH2_5@0@0@0@:family with sequence similarity 21, member B;family with sequence similarity 21, member A:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
A2463_35@98349@98349@deletion@1@81471007@81471122@10@chr10:81471007-81471122@6.7@147@79@0.537@CNVR4815.2, CNVR4815.4@FAM22B_6@0@0@0@NA@NA@NA
A2463_35@98352@98357@duplication@6@81603930@81610362@10@chr10:81603930-81610362@35.5@114@377@3.31@NA@FAM22E_2, FAM22E_3, FAM22E_4, FAM22E_5, FAM22E_6, FAM22E_7@0@0@0@NA@NA@NA
A2463_35@98599@98600@deletion@2@88992361@88993346@10@chr10:88992361-88993346@6.9@50@13@0.26@CNVR4840.3, CNVR4840.5, CNVR4840.6@FAM22A_5, FAM22A_6@0@0@0@:family with sequence similarity 22, member A@NA@NA
A2463_35@103269@103269@duplication@1@4976003@4976943@11@chr11:4976003-4976943@7.93@327@480@1.47@CNVR5040.1@OR51A2_1@0@0@0@:matrix metallopeptidase 26:olfactory receptor, family 51, subfamily A, member 2@:metallopeptidase activity;extracellular matrix;proteolysis;proteinaceous extracellular matrix;collagen catabolic process;metalloendopeptidase activity;zinc ion binding;metabolic process:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_35@114136@114139@deletion@4@8374419@8377428@12@chr12:8374419-8377428@25@1516@926@0.611@CNVR5422.3, CNVR5422.5, CNVR5422.6, CNVR5422.1@FAM90A1_7, FAM90A1_6, FAM90A1_5, FAM90A1_4@0@0@0@:family with sequence similarity 90, member A1@:zinc ion binding;nucleic acid binding@NA
A2463_35@114483@114483@deletion@1@11243900@11244828@12@chr12:11243900-11244828@54.7@288@4@0.0139@CNVR5434.1@TAS2R43_1@0@0@0@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):taste receptor, type 2, member 14:taste receptor, type 2, member 43@:extracellular space;visual perception:bitter taste receptor activity;taste receptor activity;integral to membrane;sensory perception of taste;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of bitter taste:G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;motile cilium;taste receptor activity;bitter taste receptor activity;integral to membrane;sensory perception of taste;detection of chemical stimulus involved in sensory perception of bitter taste;cilium membrane@NA
A2463_35@127333@127337@duplication@5@19553418@19563541@14@chr14:19553418-19563541@37.6@723@1191@1.65@CNVR6072.1@POTEG_1, POTEG_2, POTEG_3, POTEG_4, POTEG_5@0@0@0@:POTE ankyrin domain family, member G@:protein binding@NA
A2463_35@131037@131037@duplication@1@74041613@74042217@14@chr14:74041613-74042217@4.79@83@135@1.63@CNVR6188.1, CNVR6188.6@ACOT2_3@0@0@0@:acyl-CoA thioesterase 2@:acyl-CoA metabolic process;mitochondrion;very long-chain fatty acid metabolic process;thiolester hydrolase activity;acyl-CoA hydrolase activity;palmitoyl-CoA hydrolase activity;long-chain fatty acid metabolic process;carboxylesterase activity;receptor binding@NA
A2463_35@132549@132550@deletion@2@99182530@99183611@14@chr14:99182530-99183611@10.1@166@82@0.494@NA@C14orf177_3, C14orf177_4@0@0@0@:chromosome 14 open reading frame 177@NA@NA
A2463_35@133409@133414@deletion@6@106373070@106380248@14@chr14:106373070-106380248@9.41@190@106@0.558@CNVR6294.27, CNVR6294.36, CNVR6294.48, CNVR6294.25, CNVR6294.57, CNVR6294.29@IGHD2-8_1, IGHD1-7_1, IGHD6-6_1, IGHD5-5_1, IGHD4-4_1, IGHD3-3_1@0@0@0@NA@NA@NA
A2463_35@133432@133435@deletion@4@106539080@106552729@14@chr14:106539080-106552729@25.5@116@0@0@CNVR6294.36, CNVR6294.48, CNVR6294.24, CNVR6294.10, CNVR6294.34@IGHV1-8_2, IGHV1-8_1, IGHV3-9_2, IGHV3-9_1@0@0@0@@:protein binding:protein binding@NA
A2463_35@133458@133459@deletion@2@106791006@106791456@14@chr14:106791006-106791456@9.07@202@108@0.535@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.53@IGHV3-30_2, IGHV3-30_1@0@0@0@@:protein binding@NA
A2463_35@133470@133471@duplication@2@106877620@106878076@14@chr14:106877620-106878076@5.61@173@250@1.45@CNVR6294.26, CNVR6294.56, CNVR6294.2, CNVR6294.18@IGHV4-39_2, IGHV4-39_1@0@0@0@@:protein binding@NA
A2463_35@133491@133492@duplication@2@107095127@107095561@14@chr14:107095127-107095561@7.33@89@156@1.75@CNVR6294.56, CNVR6294.16, CNVR6294.91@IGHV4-61_2, IGHV4-61_1@0@0@0@@:protein binding@NA
A2463_35@133541@133542@deletion@2@22368577@22383423@15@chr15:22368577-22383423@9.28@801@541@0.675@CNVR6297.4, CNVR6297.17, CNVR6297.2@OR4M2_1, OR4N4_1@0@0@0@:olfactory receptor, family 4, subfamily M, member 2:olfactory receptor, family 4, subfamily N, member 4@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_35@133622@133623@deletion@2@23259497@23259716@15@chr15:23259497-23259716@6.98@60@20@0.333@CNVR6300.4@GOLGA8I_6, GOLGA8I_7@0@0@0@:golgin A8 family, member I@:Golgi cisterna membrane@NA
A2463_35@133654@133662@deletion@9@23605876@23610281@15@chr15:23605876-23610281@29.2@544@285@0.524@CNVR6301.3@GOLGA8S_11, GOLGA8S_12, GOLGA8S_13, GOLGA8S_14, GOLGA8S_15, GOLGA8S_16, GOLGA8S_17, GOLGA8S_18, GOLGA8S_19@0@0@0@@:Golgi apparatus@NA
A2463_35@133869@133870@deletion@2@28629294@28629596@15@chr15:28629294-28629596@7.2@32@0@0@CNVR6329.4@GOLGA8F_9, GOLGA8F_10@0@0@0@@:Golgi apparatus@NA
A2463_35@134012@134012@duplication@1@30665182@30665348@15@chr15:30665182-30665348@4.85@48@91@1.9@CNVR6337.1@CHRFAM7A_6@0@0@0@:CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:transport;integral to membrane;ion transport;postsynaptic membrane;membrane;extracellular ligand-gated ion channel activity@NA
A2463_35@134036@134039@duplication@4@30845996@30848215@15@chr15:30845996-30848215@6.32@78@135@1.73@NA@GOLGA8Q_2, GOLGA8Q_3, GOLGA8Q_4, GOLGA8Q_5@0@0@0@@:Golgi apparatus@NA
A2463_35@134153@134153@deletion@1@32449810@32449976@15@chr15:32449810-32449976@5.18@25@1@0.04@CNVR6345.2, CNVR6345.1@CHRNA7_6@0@0@0@:cholinergic receptor, nicotinic, alpha 7 (neuronal);CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:cellular calcium ion homeostasis;transport;beta-amyloid binding;calcium ion transport;acetylcholine receptor activity;ion transport;acetylcholine-activated cation-selective channel activity;integral to membrane;chloride channel regulator activity;cell junction;plasma membrane;positive regulation of cell proliferation;protein homodimerization activity;acetylcholine-gated channel complex;response to chemical stimulus;activation of MAPK activity;negative regulation of tumor necrosis factor production;response to hypoxia;response to nicotine;acetylcholine binding;positive regulation of angiogenesis;signal transduction;memory;toxin binding;synaptic transmission;postsynaptic membrane;membrane;cognition;extracellular ligand-gated ion channel activity@NA
A2463_35@134158@134177@duplication@20@32684984@32695395@15@chr15:32684984-32695395@24.9@695@1004@1.44@NA@GOLGA8K_19, GOLGA8K_18, GOLGA8K_17, GOLGA8K_16, GOLGA8K_15, GOLGA8K_14, GOLGA8K_13, GOLGA8K_12, GOLGA8K_11, GOLGA8K_10, GOLGA8K_9, GOLGA8K_8, GOLGA8K_7, GOLGA8K_6, GOLGA8K_5, GOLGA8K_4, GOLGA8K_3, GOLGA8K_2, AC139426.2_1, GOLGA8K_1@0@0@0@:golgin A8 family, member J@:Golgi apparatus@NA
A2463_35@134189@134190@deletion@2@32743115@32743403@15@chr15:32743115-32743403@12.3@61@4@0.0656@CNVR6346.1@GOLGA8O_8, GOLGA8O_7@0@0@0@:golgin A8 family, member O@:Golgi apparatus@NA
A2463_35@135048@135055@duplication@8@41857225@41863316@15@chr15:41857225-41863316@15.4@329@499@1.52@NA@TYRO3_6, TYRO3_7, TYRO3_8, TYRO3_9, TYRO3_10, TYRO3_11, TYRO3_12, TYRO3_13@0@0@0@:TYRO3 protein tyrosine kinase@:protein tyrosine kinase activity;platelet aggregation;negative regulation of toll-like receptor signaling pathway;ATP binding;vagina development;substrate adhesion-dependent cell spreading;nucleus;negative regulation of lymphocyte activation;endoplasmic reticulum membrane;phosphatidylinositol 3-kinase cascade;nuclear envelope;platelet activation;protein kinase activity;protein kinase B signaling cascade;neuron homeostasis;negative regulation of neuron apoptotic process;negative regulation of innate immune response;protein autophosphorylation;transmembrane receptor protein tyrosine kinase activity;apoptotic cell clearance;transferase activity, transferring phosphorus-containing groups;spermatogenesis;forebrain cell migration;integral to membrane;integral to plasma membrane;ovulation cycle;natural killer cell differentiation;phosphatidylinositol 3-kinase binding;negative regulation of inflammatory response;protein phosphorylation;receptor signaling protein tyrosine kinase activity;protein heterodimerization activity;secretion by cell;protein binding;signal transduction;cell adhesion;signal transduction by phosphorylation@NA
A2463_35@135058@135061@duplication@4@41865201@41870474@15@chr15:41865201-41870474@20.3@239@427@1.79@NA@TYRO3_16, TYRO3_17, TYRO3_18, TYRO3_19@0@0@0@:TYRO3 protein tyrosine kinase@:protein tyrosine kinase activity;platelet aggregation;negative regulation of toll-like receptor signaling pathway;ATP binding;vagina development;substrate adhesion-dependent cell spreading;nucleus;negative regulation of lymphocyte activation;endoplasmic reticulum membrane;phosphatidylinositol 3-kinase cascade;nuclear envelope;platelet activation;protein kinase activity;protein kinase B signaling cascade;neuron homeostasis;negative regulation of neuron apoptotic process;negative regulation of innate immune response;protein autophosphorylation;transmembrane receptor protein tyrosine kinase activity;apoptotic cell clearance;transferase activity, transferring phosphorus-containing groups;spermatogenesis;forebrain cell migration;integral to membrane;integral to plasma membrane;ovulation cycle;natural killer cell differentiation;phosphatidylinositol 3-kinase binding;negative regulation of inflammatory response;protein phosphorylation;receptor signaling protein tyrosine kinase activity;protein heterodimerization activity;secretion by cell;protein binding;signal transduction;cell adhesion;signal transduction by phosphorylation@NA
A2463_35@135680@135681@duplication@2@43873201@43873586@15@chr15:43873201-43873586@9.55@440@617@1.4@CNVR6365.1@PPIP5K1_10, PPIP5K1_9@0@0@0@:diphosphoinositol pentakisphosphate kinase 1@:inositol hexakisphosphate 3-kinase activity;inositol hexakisphosphate 1-kinase activity;inositol metabolic process;diphosphoinositol-pentakisphosphate kinase activity;ATP binding;acid phosphatase activity;cytoplasm;cytosol;inositol hexakisphosphate 5-kinase activity;nucleus;kinase activity;inositol-1,3,4,5,6-pentakisphosphate kinase activity@NA
A2463_35@138417@138422@duplication@6@74365084@74368326@15@chr15:74365084-74368326@11.8@283@427@1.51@CNVR6448.1@GOLGA6A_13, GOLGA6A_12, GOLGA6A_11, GOLGA6A_10, GOLGA6A_9, GOLGA6A_8@0@0@0@:golgin A6 family, member C;golgin A6 family, member A;golgin A6 family, member D;golgin A6 family, member B@:Golgi apparatus@NA
A2463_35@138661@138662@deletion@2@75586071@75586359@15@chr15:75586071-75586359@5.43@126@72@0.571@CNVR6452.1@GOLGA6D_15, GOLGA6D_16@0@0@0@:golgin A6 family, member D@:Golgi apparatus@NA
A2463_35@139295@139295@duplication@1@82933940@82933999@15@chr15:82933940-82933999@5.49@4@39@9.75@CNVR6477.6@RP13-996F3.5_7@0@0@0@NA@NA@NA
A2463_35@139302@139308@duplication@7@83011416@83015609@15@chr15:83011416-83015609@9.71@38@104@2.74@CNVR6477.6, CNVR6477.2@RP13-996F3.4_9, RP13-996F3.4_8, RP13-996F3.4_7, RP13-996F3.4_6, RP13-996F3.4_5, RP13-996F3.4_4, RP13-996F3.4_3@0@0@0@NA@NA@NA
A2463_35@140476@140478@deletion@3@64382@65633@16@chr16:64382-65633@13.4@74@9@0.122@CNVR6565.1@WASH4P_10, WASH4P_9, WASH4P_8@0@0@0@@:intracellular membrane-bounded organelle;endosomal transport;recycling endosome;early endosome;Arp2/3 complex-mediated actin nucleation;actin binding;alpha-tubulin binding;retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;recycling endosome membrane@NA
A2463_35@141416@141416@deletion@1@2152063@2152257@16@chr16:2152063-2152257@11.7@87@21@0.241@CNVR6597.1@PKD1_26@0@0@0@:polycystin-1-like;polycystic kidney disease 1 (autosomal dominant)@:peptidyl-serine phosphorylation;kidney development;placenta blood vessel development;JAK-STAT cascade;metanephric distal tubule morphogenesis;homophilic cell adhesion;nucleus;metanephric ascending thin limb development;skin development;protein export from nucleus;lung epithelium development;spinal cord development;cilium;in utero embryonic development;detection of mechanical stimulus;heart development;cation channel activity;membrane;protein domain specific binding;motile primary cilium;carbohydrate binding;anatomical structure morphogenesis;mesonephric tubule development;basolateral plasma membrane;protein kinase binding;digestive tract development;calcium ion transport;calcium-independent cell-matrix adhesion;integral to membrane;embryonic placenta development;metanephric proximal tubule development;cell cycle arrest;integral to plasma membrane;branching morphogenesis of a tube;genitalia development;positive regulation of transcription from RNA polymerase II promoter;neuropeptide signaling pathway;mesonephric duct development;cell-matrix adhesion;cytoplasmic sequestering of transcription factor;cytoplasm;positive regulation of protein binding;protein binding;metanephric collecting duct development;positive regulation of cyclin-dependent protein kinase activity involved in G1/S;ion channel binding;polycystin complex;neural tube development;cartilage condensation;cartilage development@: POLYCYSTIC KIDNEY DISEASE 1; PKD1
A2463_35@141425@141425@deletion@1@2156807@2156949@16@chr16:2156807-2156949@7.89@77@27@0.351@CNVR6597.1@PKD1_17@0@0@0@:polycystin-1-like;polycystic kidney disease 1 (autosomal dominant)@:peptidyl-serine phosphorylation;kidney development;placenta blood vessel development;JAK-STAT cascade;metanephric distal tubule morphogenesis;homophilic cell adhesion;nucleus;metanephric ascending thin limb development;skin development;protein export from nucleus;lung epithelium development;spinal cord development;cilium;in utero embryonic development;detection of mechanical stimulus;heart development;cation channel activity;membrane;protein domain specific binding;motile primary cilium;carbohydrate binding;anatomical structure morphogenesis;mesonephric tubule development;basolateral plasma membrane;protein kinase binding;digestive tract development;calcium ion transport;calcium-independent cell-matrix adhesion;integral to membrane;embryonic placenta development;metanephric proximal tubule development;cell cycle arrest;integral to plasma membrane;branching morphogenesis of a tube;genitalia development;positive regulation of transcription from RNA polymerase II promoter;neuropeptide signaling pathway;mesonephric duct development;cell-matrix adhesion;cytoplasmic sequestering of transcription factor;cytoplasm;positive regulation of protein binding;protein binding;metanephric collecting duct development;positive regulation of cyclin-dependent protein kinase activity involved in G1/S;ion channel binding;polycystin complex;neural tube development;cartilage condensation;cartilage development@: POLYCYSTIC KIDNEY DISEASE 1; PKD1
A2463_35@142670@142674@duplication@5@14968894@14972691@16@chr16:14968894-14972691@21.2@499@761@1.53@NA@NOMO1_19, NOMO1_20, NOMO1_21, NOMO1_22, NOMO1_23@0@0@0@:NODAL modulator 1;nodal modulator 1-like@:carbohydrate binding;integral to membrane;carboxypeptidase activity;molecular_function;cellular_component;biological_process@NA
A2463_35@142750@142753@duplication@4@15457517@15460617@16@chr16:15457517-15460617@19.6@270@518@1.92@CNVR6649.1@PKD1P1_8, PKD1P1_7, PKD1P1_6, PKD1P1_5@0@0@0@:NPIP-like protein 1-like;nuclear pore complex-interacting protein-like 1-like@NA@NA
A2463_35@142927@142928@deletion@2@16367547@16367932@16@chr16:16367547-16367932@15.4@89@12@0.135@NA@NOMO3_19, NOMO3_20@0@0@0@:NODAL modulator 3@:carbohydrate binding;integral to membrane;carboxypeptidase activity@NA
A2463_35@142971@142971@deletion@1@18414875@18414981@16@chr16:18414875-18414981@10.3@47@0@0@CNVR6658.1@RP11-1212A22.2_7@0@0@0@NA@NA@NA
A2463_35@144130@144131@duplication@2@28763890@28769404@16@chr16:28763890-28769404@8.13@68@134@1.97@NA@A-575C2.4_1, A-575C2.4_2@0@0@0@NA@NA@NA
A2463_35@147109@147127@deletion@19@70161164@70211383@16@chr16:70161164-70211383@49.5@1777@1093@0.615@CNVR6764.1, CNVR6764.3@PDPR_4, PDPR_5, PDPR_6, PDPR_7, PDPR_8, PDPR_9, PDPR_10, PDPR_11, PDPR_12, PDPR_13, PDPR_14, PDPR_15, PDPR_16, PDPR_17, PDPR_18, PDPR_19, CLEC18C_1, CLEC18C_2, CLEC18C_3@0@0@0@:pyruvate dehydrogenase phosphatase regulatory subunit:C-type lectin domain family 18, member C@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix:carbohydrate binding;protein binding;extracellular region@NA
A2463_35@147497@147502@deletion@6@74415415@74425978@16@chr16:74415415-74425978@22.4@1353@895@0.661@CNVR6778.2, CNVR6778.4@NPIPL2_2, NPIPL2_3, NPIPL2_4, NPIPL2_5, NPIPL2_6, NPIPL2_7@0@0@0@@:extracellular region@NA
A2463_35@151879@151886@deletion@8@18392256@18430117@17@chr17:18392256-18430117@15.8@341@192@0.563@NA@LGALS9C_5, LGALS9C_6, LGALS9C_7, LGALS9C_8, LGALS9C_9, LGALS9C_10, LGALS9C_11, FAM106A_1@0@0@0@:lectin, galactoside-binding, soluble, 9C:protein FAM106B-like@:carbohydrate binding@NA
A2463_35@152122@152127@duplication@6@20353287@20356920@17@chr17:20353287-20356920@7.67@129@205@1.59@CNVR7021.1, CNVR7021.3@LGALS9B_11, LGALS9B_10, LGALS9B_9, LGALS9B_8, LGALS9B_7, LGALS9B_6@0@0@0@:lectin, galactoside-binding, soluble, 9B@:carbohydrate binding@NA
A2463_35@153366@153372@duplication@7@34495989@34500284@17@chr17:34495989-34500284@7.17@217@314@1.45@CNVR7077.1, CNVR7077.3, CNVR7077.11, CNVR7077.16@TBC1D3B_11, TBC1D3B_10, TBC1D3B_9, TBC1D3B_8, TBC1D3B_7, TBC1D3B_6, TBC1D3B_5@0@0@0@:TBC1 domain family, member 3B@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_35@153376@153381@deletion@6@34522686@34539971@17@chr17:34522686-34539971@9.64@44@0@0@CNVR7077.1, CNVR7077.3, CNVR7077.6@CCL3L3_3, CCL3L3_2, CCL3L3_1, CCL4L1_1, CCL4L1_2, CCL4L1_3@0@0@0@:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
A2463_35@153389@153394@deletion@6@34587259@34590454@17@chr17:34587259-34590454@6.47@32@2@0.0625@CNVR7077.1, CNVR7077.13, CNVR7077.19, CNVR7077.10, CNVR7077.2@TBC1D3C_7, TBC1D3C_6, TBC1D3C_5, TBC1D3C_4, TBC1D3C_3, TBC1D3C_2@0@0@0@:TBC1 domain family, member 3C;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3H-like;TBC1 domain family, member 3H@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_35@153414@153414@deletion@1@34797487@34798054@17@chr17:34797487-34798054@18.7@86@0@0@CNVR7078.2, CNVR7078.3@TBC1D3G_14@0@0@0@:TBC1 domain family member 3H-like;TBC1 domain family, member 3H:TBC1 domain family, member 3;TBC1 domain family, member 3G;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like;TBC1 domain family, member 3H@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_35@154346@154346@duplication@1@39421631@39422112@17@chr17:39421631-39422112@9.94@59@142@2.41@CNVR7096.1@KRTAP9-6_1@0@0@0@:keratin associated protein 9-6@:keratin filament@NA
A2463_35@155581@155582@deletion@2@44248222@44375108@17@chr17:44248222-44375108@16.4@604@358@0.593@CNVR7114.3, CNVR7114.2, CNVR7114.10@KANSL1_2, LRRC37A_1@0@0@0@:KAT8 regulatory NSL complex subunit 1:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:histone acetyltransferase activity (H4-K8 specific);histone acetyltransferase activity (H4-K16 specific);histone acetyltransferase activity (H4-K5 specific);histone acetyltransferase complex;histone H4-K5 acetylation;MLL1 complex;histone H4-K16 acetylation;protein binding;histone H4-K8 acetylation;nucleus:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
A2463_35@155584@155590@duplication@7@44380005@44409347@17@chr17:44380005-44409347@25@301@540@1.79@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A_3, LRRC37A_4, LRRC37A_5, LRRC37A_6, LRRC37A_7, LRRC37A_8, LRRC37A_9@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
A2463_35@155584@155591@deletion@1@44380005@44410022@17@chr17:44380005-44410022@-45@419@585@1.4@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A_3, LRRC37A_4, LRRC37A_5, LRRC37A_6, LRRC37A_7, LRRC37A_8, LRRC37A_9, LRRC37A_10@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
A2463_35@155593@155600@duplication@8@44414663@44594799@17@chr17:44414663-44594799@73.9@195@825@4.23@CNVR7114.2, CNVR7114.1@LRRC37A_12, LRRC37A_13, LRRC37A_14, ARL17B_4, ARL17B_3, ARL17B_2, LRRC37A2_2, LRRC37A2_3@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
A2463_35@155608@155608@duplication@1@44627782@44627885@17@chr17:44627782-44627885@6.01@48@99@2.06@CNVR7114.2, CNVR7114.5, CNVR7114.4, CNVR7114.6@LRRC37A2_11@0@0@0@:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
A2463_35@155610@155613@deletion@4@44632519@44634996@17@chr17:44632519-44634996@36.4@314@85@0.271@CNVR7114.2, CNVR7114.5, CNVR7114.4@LRRC37A2_13, LRRC37A2_14, LRRC37A2_15, ARL17A_4@0@0@0@:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
A2463_35@162017@162018@duplication@2@44542732@44550298@18@chr18:44542732-44550298@44.4@407@940@2.31@CNVR7319.1, CNVR7319.2@TCEB3CL2_1, TCEB3CL_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2:transcription elongation factor B polypeptide 3C-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_35@162017@162019@deletion@1@44542732@44556213@18@chr18:44542732-44556213@-42.1@2616@2378@0.909@CNVR7319.1, CNVR7319.2@TCEB3CL2_1, TCEB3CL_1, TCEB3C_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2:transcription elongation factor B polypeptide 3C-like:transcription elongation factor B polypeptide 3C (elongin A3);RNA polymerase II transcription factor SIII subunit A3-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_35@164951@164951@deletion@1@7032325@7032905@19@chr19:7032325-7032905@6.37@35@4@0.114@CNVR7517.1@MBD3L5_2@0@0@0@:methyl-CpG binding domain protein 3-like 5@NA@NA
A2463_35@170099@170100@deletion@2@40380120@40382826@19@chr19:40380120-40382826@30.6@141@0@0@CNVR7639.2@FCGBP_23, FCGBP_22@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_35@170107@170108@duplication@2@40395805@40398510@19@chr19:40395805-40398510@10.2@317@471@1.49@CNVR7639.2, CNVR7639.3@FCGBP_15, FCGBP_14@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_35@170107@170112@deletion@4@40395805@40406060@19@chr19:40395805-40406060@-20.8@404@494@1.22@CNVR7639.2, CNVR7639.3@FCGBP_15, FCGBP_14, FCGBP_13, FCGBP_12, FCGBP_11, FCGBP_10@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_35@172987@172987@duplication@1@52133087@52133469@19@chr19:52133087-52133469@6.63@38@90@2.37@CNVR7702.1@SIGLEC5_2, SIGLEC5_2@0@0@0@:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 5@:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion@NA
A2463_35@172990@172995@deletion@6@52146791@52150012@19@chr19:52146791-52150012@13.4@197@98@0.497@CNVR7702.1@SIGLEC14_6, SIGLEC14_5, SIGLEC14_4, SIGLEC14_3, SIGLEC14_2, SIGLEC14_1, SIGLEC5_1@0@0@0@:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 14@:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion;plasma membrane@NA
A2463_35@173336@173341@duplication@6@54801928@54804173@19@chr19:54801928-54804173@6.25@294@400@1.36@CNVR7722.1@LILRA3_6, LILRA3_5, LILRA3_4, LILRA3_3, LILRA3_2, LILRA3_1@0@0@0@:leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3@:antigen binding;signal transduction;protein binding;extracellular region;plasma membrane;receptor activity;defense response@NA
A2463_35@173483@173498@duplication@16@55325146@55354373@19@chr19:55325146-55354373@17.4@874@1183@1.35@CNVR7725.1, CNVR7725.6@KIR2DL4_6, KIR2DL4_7, KIR3DL1_1, KIR3DL1_2, KIR3DL1_3, KIR3DL1_4, KIR3DL1_5, KIR3DL1_6, KIR3DL1_7, KIR3DL1_8, KIR3DL1_9, KIR2DS4_1, KIR2DS4_2, KIR2DS4_3, KIR2DS4_4, KIR2DS4_5@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane@NA
A2463_35@173500@173503@deletion@4@55359207@55362710@19@chr19:55359207-55362710@15.2@69@0@0@CNVR7725.1, CNVR7725.6, CNVR7725.5, CNVR7725.10@KIR2DS4_7, KIR2DS4_8, KIR3DL2_1, KIR3DL2_2@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2-like@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane@NA
A2463_35@173902@173903@deletion@2@56658282@56662350@19@chr19:56658282-56662350@5.02@64@29@0.453@NA@ZNF444_3, AC024580.1_2@0@0@0@:zinc finger protein 444@:intracellular;DNA binding;regulation of transcription, DNA-dependent;sequence-specific DNA binding transcription factor activity;viral reproduction;nucleus;transcription, DNA-dependent;zinc ion binding@NA
A2463_35@175736@175737@duplication@2@26061801@26063616@20@chr20:26061801-26063616@5.35@144@212@1.47@CNVR7823.4, CNVR7823.3, CNVR7823.5, CNVR7823.1@FAM182A_4, FAM182A_5@0@0@0@NA@NA@NA
A2463_35@180976@180976@deletion@1@16287255@16287885@22@chr22:16287255-16287885@10.1@249@133@0.534@CNVR8071.2, CNVR8071.3, CNVR8071.9@POTEH_1@0@0@0@:POTE ankyrin domain family, member H@:protein binding@NA
A2463_35@181417@181420@deletion@4@20366369@20367356@22@chr22:20366369-20367356@6.23@31@2@0.0645@CNVR8094.9, CNVR8094.4, CNVR8094.3@GGTLC3_5, GGTLC3_4, GGTLC3_3, GGTLC3_2@0@0@0@@:leukotriene biosynthetic process;glutathione metabolic process;gamma-glutamyltransferase activity;anchored to external side of plasma membrane@NA
A2463_35@181487@181489@duplication@3@21065630@21067085@22@chr22:21065630-21067085@6.28@130@198@1.52@CNVR8099.6, CNVR8099.2@PI4KA_51, PI4KA_50, PI4KA_49@0@0@0@:phosphatidylinositol 4-kinase, catalytic, alpha@:phospholipid metabolic process;1-phosphatidylinositol 4-kinase activity;small molecule metabolic process;phosphatidylinositol phosphorylation;binding;transferase activity, transferring phosphorus-containing groups;phosphotransferase activity, alcohol group as acceptor;ATP binding;Golgi-associated vesicle;phosphatidylinositol biosynthetic process;cytosol;protein binding;signal transduction;synaptic transmission;kinase activity;phosphatidylinositol-mediated signaling@NA
A2463_35@181806@181807@duplication@2@23243157@23247205@22@chr22:23243157-23247205@13.2@160@291@1.82@CNVR8103.2, CNVR8103.1, CNVR8103.6, CNVR8103.11, CNVR8103.35@IGLC2_1, IGLJ3_1@0@0@0@@:protein binding@NA
A2463_18@6@6@duplication@1@69092@70008@1@chr1:69092-70008@13.7@98@230@2.35@CNVR1.1, CNVR1.2@OR4F5_1@0@0@0@:olfactory receptor, family 4, subfamily F, member 5@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_18@400@408@duplication@9@1575639@1581245@1@chr1:1575639-1581245@10.9@555@759@1.37@CNVR17.1@CDK11B_12, CDK11B_11, CDK11B_10, CDK11B_9, CDK11B_8, CDK11B_7, CDK11B_6, CDK11B_5, CDK11B_4@0@0@0@:cyclin-dependent kinase 11B@:protein serine/threonine kinase activity;protein tyrosine kinase activity;protein phosphorylation;protein kinase activity;cell division;transferase activity, transferring phosphorus-containing groups;ATP binding@NA
A2463_18@418@418@duplication@1@1607504@1607638@1@chr1:1607504-1607638@7.44@62@128@2.06@CNVR17.1@SLC35E2B_4@0@0@0@:solute carrier family 35, member E2B@:integral to membrane;membrane;transmembrane transport@NA
A2463_18@428@434@deletion@7@1637082@1643839@1@chr1:1637082-1643839@14.4@158@67@0.424@CNVR17.1@CDK11A_12, CDK11A_11, CDK11A_10, CDK11A_9, CDK11A_8, CDK11A_7, CDK11A_6@0@0@0@:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A@:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division@NA
A2463_18@1809@1809@duplication@1@12884801@12885361@1@chr1:12884801-12885361@6.96@287@422@1.47@CNVR72.3, CNVR72.10, CNVR72.11, CNVR72.4@PRAMEF11_4@0@0@0@:PRAME family member 11@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_18@1835@1839@duplication@5@13330415@13368733@1@chr1:13330415-13368733@9.54@57@130@2.28@CNVR74.8, CNVR74.4@PRAMEF3_2, PRAMEF3_1, PRAMEF5_2, PRAMEF5_3, PRAMEF5_4@0@0@0@:PRAME family member 3:PRAME family member 5@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_18@1849@1849@deletion@1@13474690@13475262@1@chr1:13474690-13475262@4.67@79@40@0.506@CNVR74.8, CNVR74.12@PRAMEF18_3@0@0@0@:PRAME family member 18@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_18@1853@1864@duplication@12@13495968@13696098@1@chr1:13495968-13696098@14.1@260@409@1.57@NA@PRAMEF16_2, PRAMEF16_3, PRAMEF21_2, PRAMEF21_3, PRAMEF21_4, PRAMEF15_2, PRAMEF15_3, PRAMEF15_4, PRAMEF14_4, PRAMEF14_3, PRAMEF14_2, PRAMEF19_3@0@0@0@:PRAME family member 16:PRAME family member 21;PRAME family member 20:PRAME family member 9/15-like;PRAME family member 15;PRAME family member 9:PRAME family member 14:PRAME family member 19@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_18@3194@3198@deletion@5@24287949@24301567@1@chr1:24287949-24301567@15.5@72@1@0.0139@NA@PNRC2_3, SRSF10_6, SRSF10_5, SRSF10_4, SRSF10_3@0@0@0@:proline-rich nuclear receptor coactivator 2;proline-rich nuclear receptor coactivator 2-like:serine/arginine-rich splicing factor 10-like;serine/arginine-rich splicing factor 10@:protein binding;deadenylation-independent decapping of nuclear-transcribed mRNA;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;nucleus;regulation of transcription, DNA-dependent;transcription, DNA-dependent;cytoplasmic mRNA processing body:nucleoplasm;RNA splicing, via transesterification reactions;nuclear speck;RS domain binding;RNA binding;nucleus;mRNA splice site selection;unfolded protein binding;assembly of spliceosomal tri-snRNP;negative regulation of mRNA splicing, via spliceosome;regulation of transcription, DNA-dependent;nucleotide binding;cytoplasm;mRNA export from nucleus;protein binding;cytoplasmic transport;mRNA splicing, via spliceosome;nucleic acid binding@NA
A2463_18@3334@3334@deletion@1@25611065@25611250@1@chr1:25611065-25611250@7.7@162@84@0.519@CNVR116.1, CNVR116.2@RHD_2@0@0@0@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
A2463_18@3357@3357@duplication@1@25735175@25735360@1@chr1:25735175-25735360@6.54@126@205@1.63@CNVR117.1@RHCE_2@0@0@0@:Rh blood group, CcEe antigens@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@: BLOOD GROUP--RHESUS SYSTEM E POLYPEPTIDE; RHE; RHESUS BLOOD GROUP, CcEe ANTIGENS; RHCE
A2463_18@9353@9353@deletion@1@104162177@104162406@1@chr1:104162177-104162406@6.45@269@163@0.606@CNVR266.3, CNVR266.1@AMY2A_4@0@0@0@:amylase, alpha 2A (pancreatic)@:chloride ion binding;cation binding;small molecule metabolic process;carbohydrate metabolic process;catalytic activity;extracellular space;polysaccharide digestion;extracellular region;carbohydrate catabolic process;alpha-amylase activity;calcium ion binding@NA
A2463_18@9365@9374@duplication@10@104202983@104234232@1@chr1:104202983-104234232@65.7@342@942@2.75@CNVR266.3, CNVR266.1, CNVR266.15@AMY1A_7, AMY1A_8, AMY1A_9, AMY1A_10, AMY1A_11, AMY1B_11, AMY1B_10, AMY1B_9, AMY1B_8, AMY1B_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
A2463_18@9385@9386@deletion@2@104297122@104297436@1@chr1:104297122-104297436@27.8@439@188@0.428@CNVR266.3, CNVR266.5@AMY1C_6, AMY1C_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
A2463_18@9449@9449@duplication@1@108993225@108993401@1@chr1:108993225-108993401@4.9@38@79@2.08@CNVR294.4, CNVR294.2@NBPF6_2@0@0@0@:neuroblastoma breakpoint family, member 6@:cytoplasm@NA
A2463_18@9766@9773@deletion@8@110230497@110235917@1@chr1:110230497-110235917@53.6@259@8@0.0309@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_1, GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
A2463_18@10793@10795@deletion@3@144339779@144520832@1@chr1:144339779-144520832@18.1@98@9@0.0918@NA@AL592284.1_1, PPIAL4B_1, AL592284.1_2@0@0@0@:uncharacterized LOC730256;uncharacterized LOC101060698;uncharacterized LOC642441:peptidylprolyl isomerase A (cyclophilin A)-like 4C;peptidyl-prolyl cis-trans isomerase A-like 4A/B/C-like;peptidylprolyl isomerase A (cyclophilin A)-like 4B;peptidylprolyl isomerase A (cyclophilin A)-like 4A@:protein folding;peptidyl-prolyl cis-trans isomerase activity;cytoplasm@NA
A2463_18@10799@10799@deletion@1@144815937@144816008@1@chr1:144815937-144816008@5.31@67@29@0.433@CNVR338.4, CNVR338.2, CNVR338.5, CNVR338.1@NBPF9_4@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 24@NA@NA
A2463_18@11127@11127@duplication@1@146215076@146215318@1@chr1:146215076-146215318@4.98@139@209@1.5@NA@NBPF12_38@0@0@0@:neuroblastoma breakpoint family member 21-like@NA@NA
A2463_18@11161@11163@duplication@3@146248917@146252574@1@chr1:146248917-146252574@10.6@175@286@1.63@NA@NBPF12_4, NBPF12_3, NBPF12_2@0@0@0@:neuroblastoma breakpoint family member 21-like@NA@NA
A2463_18@11168@11173@deletion@6@146399556@146405926@1@chr1:146399556-146405926@28.1@221@65@0.294@NA@NBPF12_8, NBPF12_9, NBPF12_10, NBPF12_11, NBPF12_12, NBPF12_13@0@0@0@:neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family member 14-like;neuroblastoma breakpoint family, member 12@:cytoplasm@NA
A2463_18@11176@11176@deletion@1@146409947@146410048@1@chr1:146409947-146410048@6.41@29@0@0@NA@NBPF12_16@0@0@0@:neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family member 14-like;neuroblastoma breakpoint family, member 12@:cytoplasm@NA
A2463_18@11242@11242@deletion@1@146465879@146466121@1@chr1:146465879-146466121@18.4@179@53@0.296@CNVR344.2@NBPF12_82@0@0@0@:neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family member 14-like;neuroblastoma breakpoint family, member 12@:cytoplasm@NA
A2463_18@11335@11357@duplication@23@147954851@148025848@1@chr1:147954851-148025848@63.9@2347@3497@1.49@CNVR346.2, CNVR346.3, CNVR346.4@PPIAL4A_1, NBPF14_22, NBPF14_21, NBPF14_20, NBPF14_19, NBPF14_18, NBPF14_17, NBPF14_16, NBPF14_15, NBPF14_14, NBPF14_13, NBPF14_12, NBPF14_11, NBPF14_10, NBPF14_9, NBPF14_8, NBPF14_7, NBPF14_6, NBPF14_5, NBPF14_4, NBPF14_3, NBPF14_2, NBPF14_1@0@0@0@:peptidylprolyl isomerase A (cyclophilin A)-like 4C;peptidyl-prolyl cis-trans isomerase A-like 4A/B/C-like;peptidylprolyl isomerase A (cyclophilin A)-like 4B;peptidylprolyl isomerase A (cyclophilin A)-like 4A:neuroblastoma breakpoint family, member 14@:protein folding;peptidyl-prolyl cis-trans isomerase activity;cytoplasm:cytoplasm@NA
A2463_18@16029@16040@deletion@12@196744018@196801129@1@chr1:196744018-196801129@35.5@2366@1573@0.665@CNVR459.1@CFHR3_1, CFHR3_2, CFHR3_3, CFHR3_4, CFHR3_5, CFHR3_6, CFHR1_1, CFHR1_2, CFHR1_3, CFHR1_4, CFHR1_5, CFHR1_6@0@0@0@:complement factor H-related 3:complement factor H-related 1:complement factor H-related 2@:extracellular space:extracellular space;complement activation:extracellular region@NA
A2463_18@17294@17297@duplication@4@207737210@207741387@1@chr1:207737210-207741387@19.2@496@771@1.55@CNVR485.1, CNVR485.2@CR1_22, CR1_23, CR1_24, CR1_25@0@0@0@:complement component (3b/4b) receptor 1 (Knops blood group)@:complement component C4b receptor activity;complement activation, classical pathway;negative regulation of complement activation, alternative pathway;innate immune response;negative regulation of serine-type endopeptidase activity;complement component C3b binding;negative regulation of complement activation, classical pathway;plasma membrane;integral to plasma membrane;complement component C3b receptor activity;complement component C4b binding;cell surface;regulation of complement activation;positive regulation of serine-type endopeptidase activity@: MALARIA, SUSCEPTIBILITY TO; KNOPS BLOOD GROUP SYSTEM; KN
A2463_18@19778@19778@duplication@1@248813233@248814185@1@chr1:248813233-248814185@5.69@209@306@1.46@NA@OR2T27_1@0@0@0@:olfactory receptor, family 2, subfamily T, member 27@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_18@24822@24822@deletion@1@87178420@87178483@2@chr2:87178420-87178483@6.57@31@1@0.0323@NA@RGPD1_2@0@0@0@:RANBP2-like and GRIP domain containing 1@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_18@24862@24863@duplication@2@88094928@88095367@2@chr2:88094928-88095367@5.73@39@84@2.15@NA@RGPD2_11, RGPD2_10@0@0@0@:RANBP2-like and GRIP domain containing 2@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_18@25137@25138@deletion@2@96697782@96698107@2@chr2:96697782-96698107@7.76@146@77@0.527@NA@GPAT2_4, GPAT2_3@0@0@0@:glycerol-3-phosphate acyltransferase 2, mitochondrial@:glycerol-3-phosphate O-acyltransferase activity;mitochondrion;phospholipid metabolic process;triglyceride biosynthetic process;glycerophospholipid biosynthetic process;small molecule metabolic process;transferase activity, transferring acyl groups;mitochondrial outer membrane;phosphatidic acid biosynthetic process;integral to membrane;glycerol-3-phosphate metabolic process;CDP-diacylglycerol biosynthetic process;membrane;metabolic process;phospholipid biosynthetic process@NA
A2463_18@25369@25370@deletion@2@97854825@97855027@2@chr2:97854825-97855027@33.7@160@2@0.0125@CNVR886.2, CNVR886.3@ANKRD36_33, ANKRD36_34@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_18@25375@25386@duplication@12@97860464@97870000@2@chr2:97860464-97870000@36.6@2118@2887@1.36@CNVR886.1@ANKRD36_39, ANKRD36_40, ANKRD36_41, ANKRD36_42, ANKRD36_43, ANKRD36_44, ANKRD36_45, ANKRD36_46, ANKRD36_47, ANKRD36_48, ANKRD36_49, ANKRD36_50@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_18@25391@25411@duplication@21@97875419@97915904@2@chr2:97875419-97915904@55.7@2729@3808@1.4@NA@ANKRD36_55, ANKRD36_56, ANKRD36_57, ANKRD36_58, ANKRD36_59, ANKRD36_60, ANKRD36_61, ANKRD36_62, ANKRD36_63, ANKRD36_64, ANKRD36_65, ANKRD36_66, ANKRD36_67, ANKRD36_68, ANKRD36_69, ANKRD36_70, ANKRD36_71, ANKRD36_72, ANKRD36_73, ANKRD36_74, ANKRD36_75@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_18@26412@26426@deletion@15@113127756@113161752@2@chr2:113127756-113161752@105@1843@688@0.373@NA@RGPD8_23, RGPD8_22, RGPD8_21, RGPD8_20, RGPD8_19, RGPD8_18, RGPD8_17, RGPD8_16, RGPD8_15, RGPD8_14, RGPD8_13, RGPD8_12, RGPD8_11, RGPD8_10, RGPD8_9@0@0@0@:RANBP2-like and GRIP domain containing 8@:protein binding;intracellular;intracellular transport;nuclear pore;protein targeting to Golgi;Ran GTPase binding;biological_process@NA
A2463_18@27279@27279@deletion@1@131381638@131381707@2@chr2:131381638-131381707@7.45@139@70@0.504@NA@POTEJ_6@0@0@0@:POTE ankyrin domain family, member J@:protein binding;ATP binding@NA
A2463_18@27342@27342@deletion@1@132289238@132289375@2@chr2:132289238-132289375@6.64@96@44@0.458@NA@CCDC74A_4@0@0@0@:coiled-coil domain containing 74A@NA@NA
A2463_18@34945@34945@deletion@1@10091059@10091189@3@chr3:10091059-10091189@17@203@72@0.355@NA@FANCD2_17@0@0@0@:Fanconi anemia, complementation group D2@:nucleoplasm;synapsis;binding;response to DNA damage stimulus;gamete generation;DNA repair;condensed chromosome;protein binding;response to gamma radiation@: FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2
A2463_18@39892@39894@duplication@3@75786030@75790887@3@chr3:75786030-75790887@10.4@284@416@1.46@CNVR1432.5, CNVR1432.9, CNVR1432.4@ZNF717_5, ZNF717_4, ZNF717_3@0@0@0@:zinc finger protein 717;zinc finger protein 717-like@:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_18@46667@46675@deletion@9@9174900@9237700@4@chr4:9174900-9237700@24@131@14@0.107@NA@FAM90A26P_4, FAM90A26P_5, FAM90A26P_6, FAM90A26P_7, USP17L13_1, USP17L10_1, USP17L11_1, USP17L12_1, USP17L13_2, USP17L15_1@0@0@0@:ubiquitin specific peptidase 17-like family member 10:ubiquitin specific peptidase 17-like family member 13:ubiquitin specific peptidase 17-like family member 11:ubiquitin specific peptidase 17-like family member 12:ubiquitin specific peptidase 17-like family member 15@:zinc ion binding;nucleic acid binding:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
A2463_18@48556@48561@deletion@6@69403344@69434202@4@chr4:69403344-69434202@124@618@4@0.00647@CNVR1953.1@UGT2B17_6, UGT2B17_5, UGT2B17_4, UGT2B17_3, UGT2B17_2, UGT2B17_1@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B17@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;membrane@: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
A2463_18@48596@48596@duplication@1@70156311@70156529@4@chr4:70156311-70156529@5.57@125@196@1.57@CNVR1957.2, CNVR1957.1@UGT2B28_5@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B28@:carbohydrate binding;transferase activity, transferring hexosyl groups;endoplasmic reticulum;glucuronosyltransferase activity;carbohydrate metabolic process;xenobiotic metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process@NA
A2463_18@48972@48974@deletion@3@75482007@75486006@4@chr4:75482007-75486006@7.61@102@48@0.471@NA@AREGB_2, AREGB_3, AREGB_4@0@0@0@:amphiregulin;amphiregulin B@:growth factor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;cell proliferation;epidermal growth factor receptor signaling pathway;extracellular space;protein binding;integral to membrane;cytokine activity;cell surface;positive regulation of DNA replication@NA
A2463_18@55835@55835@deletion@1@70338009@70338111@5@chr5:70338009-70338111@6.08@27@0@0@CNVR2494.41, CNVR2494.14, CNVR2494.20, CNVR2494.62, CNVR2494.8@GTF2H2_14@0@0@0@:general transcription factor IIH, polypeptide 2, 44kDa@:nucleoplasm;nucleotide-excision repair, DNA damage removal;transcription from RNA polymerase I promoter;DNA repair;RNA polymerase II carboxy-terminal domain kinase activity;nucleus;viral reproduction;translation;gene expression;transcription elongation from RNA polymerase I promoter;response to UV;holo TFIIH complex;protein kinase activity;nucleotide-excision repair;transcription from RNA polymerase II promoter;transcription-coupled nucleotide-excision repair;transcription, DNA-dependent;zinc ion binding;transcription elongation from RNA polymerase II promoter;termination of RNA polymerase I transcription;sequence-specific DNA binding transcription factor activity;G-protein coupled receptor internalization;DNA-dependent ATPase activity;protein N-terminus binding;transcription initiation from RNA polymerase I promoter;7-methylguanosine mRNA capping;transcription initiation from RNA polymerase II promoter;protein phosphorylation;translation factor activity, nucleic acid binding;regulation of transcription, DNA-dependent;core TFIIH complex;protein binding;positive regulation of viral transcription;nucleic acid binding@NA
A2463_18@55837@55837@deletion@1@70343834@70343940@5@chr5:70343834-70343940@9.26@44@1@0.0227@CNVR2494.41, CNVR2494.14, CNVR2494.20, CNVR2494.62, CNVR2494.8@GTF2H2_12@0@0@0@:general transcription factor IIH, polypeptide 2, 44kDa@:nucleoplasm;nucleotide-excision repair, DNA damage removal;transcription from RNA polymerase I promoter;DNA repair;RNA polymerase II carboxy-terminal domain kinase activity;nucleus;viral reproduction;translation;gene expression;transcription elongation from RNA polymerase I promoter;response to UV;holo TFIIH complex;protein kinase activity;nucleotide-excision repair;transcription from RNA polymerase II promoter;transcription-coupled nucleotide-excision repair;transcription, DNA-dependent;zinc ion binding;transcription elongation from RNA polymerase II promoter;termination of RNA polymerase I transcription;sequence-specific DNA binding transcription factor activity;G-protein coupled receptor internalization;DNA-dependent ATPase activity;protein N-terminus binding;transcription initiation from RNA polymerase I promoter;7-methylguanosine mRNA capping;transcription initiation from RNA polymerase II promoter;protein phosphorylation;translation factor activity, nucleic acid binding;regulation of transcription, DNA-dependent;core TFIIH complex;protein binding;positive regulation of viral transcription;nucleic acid binding@NA
A2463_18@57357@57371@duplication@15@110427988@110446977@5@chr5:110427988-110446977@92.6@3790@5532@1.46@NA@WDR36_1, WDR36_2, WDR36_3, WDR36_4, WDR36_5, WDR36_6, WDR36_7, WDR36_8, WDR36_9, WDR36_10, WDR36_11, WDR36_12, WDR36_13, WDR36_14, WDR36_15@0@0@0@:WD repeat domain 36@:small-subunit processome;response to stimulus;protein binding;visual perception;nucleolus;molecular_function;rRNA processing;cellular_component;biological_process@: GLAUCOMA 1, OPEN ANGLE, G; GLC1G
A2463_18@59064@59065@duplication@2@140552418@140560021@5@chr5:140552418-140560021@56.8@4047@8476@2.09@CNVR2624.1@PCDHB7_1, PCDHB8_1@0@0@0@:protocadherin beta 7:protocadherin beta 8@:integral to membrane;calcium-dependent cell-cell adhesion;homophilic cell adhesion;plasma membrane;membrane;calcium ion binding:integral to membrane;homophilic cell adhesion;plasma membrane;membrane;calcium ion binding@NA
A2463_18@59488@59488@deletion@1@147553798@147553933@5@chr5:147553798-147553933@7.85@35@0@0@CNVR2637.2, CNVR2637.1@SPINK14_3@0@0@0@:serine peptidase inhibitor, Kazal type 14 (putative)@:serine-type endopeptidase inhibitor activity;protein binding;extracellular region@NA
A2463_18@60883@60885@duplication@3@175516523@175520277@5@chr5:175516523-175520277@5.48@104@166@1.6@NA@FAM153B_2, FAM153B_3, FAM153B_4@0@0@0@:uncharacterized LOC100507387;family with sequence similarity 153, member B@NA@NA
A2463_18@61638@61641@deletion@4@180375356@180377544@5@chr5:180375356-180377544@20.8@507@271@0.535@CNVR2719.1@BTNL8_5, BTNL8_6, BTNL8_7, BTNL8_8@0@0@0@:butyrophilin-like 8@:protein binding;integral to membrane@NA
A2463_18@63291@63292@deletion@2@31324466@31324935@6@chr6:31324466-31324935@9.42@241@136@0.564@CNVR2841.12, CNVR2841.14, CNVR2841.8@HLA-B_2, HLA-B_1@0@0@0@:major histocompatibility complex, class I, B@:MHC class I protein complex;regulation of immune response;regulation of interleukin-12 production;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;regulation of T cell anergy;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;receptor binding;early endosome membrane;virus-host interaction;regulation of interleukin-6 production;regulation of dendritic cell differentiation;phagocytic vesicle membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;MHC class I receptor activity;membrane@: SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO; SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1; SPDA1
A2463_18@63725@63733@duplication@9@31962023@31964377@6@chr6:31962023-31964377@90.4@1205@2354@1.95@CNVR2843.6, CNVR2843.3@C4A_20, C4A_21, C4A_22, C4A_23, C4A_24, C4A_25, C4A_26, C4A_27, C4A_28@0@0@0@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
A2463_18@63747@63748@duplication@2@31973946@31974881@6@chr6:31973946-31974881@17.9@210@394@1.88@CNVR2843.6, CNVR2843.3@AL645922.1_2, AL645922.1_1@0@0@0@NA@NA@NA
A2463_18@63768@63776@deletion@9@31994761@31997115@6@chr6:31994761-31997115@46.5@783@395@0.504@CNVR2843.6, CNVR2843.5@C4B_20, C4B_21, C4B_22, C4B_23, C4B_24, C4B_25, C4B_26, C4B_27, C4B_28@0@0@0@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
A2463_18@63768@63778@duplication@2@31994761@31997825@6@chr6:31994761-31997825@-77.1@1007@740@0.735@CNVR2843.6, CNVR2843.5@C4B_20, C4B_21, C4B_22, C4B_23, C4B_24, C4B_25, C4B_26, C4B_27, C4B_28, C4B_29, C4B_30@0@0@0@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
A2463_18@63798@63799@duplication@2@32008446@32008911@6@chr6:32008446-32008911@7.89@378@529@1.4@CNVR2843.6, CNVR2843.5@CYP21A2_9, CYP21A2_10@0@0@0@:cytochrome P450, family 21, subfamily A, polypeptide 2@:oxidation-reduction process;electron carrier activity;response to antibiotic;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;steroid 21-monooxygenase activity;C21-steroid hormone biosynthetic process;heme binding;mineralocorticoid biosynthetic process;progesterone metabolic process;monooxygenase activity;cellular response to peptide hormone stimulus;iron ion binding@: ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY
A2463_18@63811@63812@duplication@2@32012159@32012996@6@chr6:32012159-32012996@7.29@232@349@1.5@CNVR2843.6, CNVR2843.5@TNXB_2, TNXB_1@0@0@0@:tenascin-X-like;tenascin XB@:integrin binding;extracellular matrix;cell-cell adhesion;elastic fiber assembly;collagen fibril organization;fibrillar collagen;actin cytoskeleton organization;extracellular space;heparin binding;proteinaceous extracellular matrix;fatty acid metabolic process;regulation of JUN kinase activity;receptor binding;intracellular;cell-matrix adhesion;extracellular matrix organization;lipid metabolic process;protein binding;signal transduction;extracellular region;collagen binding;cell adhesion;triglyceride metabolic process;fibril organization;collagen metabolic process@: EHLERS-DANLOS-LIKE SYNDROME DUE TO TENASCIN-X DEFICIENCY; EHLERS-DANLOS SYNDROME, TYPE III
A2463_18@63953@63954@deletion@2@32485517@32485854@6@chr6:32485517-32485854@5.68@40@10@0.25@CNVR2845.21, CNVR2845.25, CNVR2845.30@HLA-DRB5_6, HLA-DRB5_5@0@0@0@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
A2463_18@63956@63958@duplication@3@32487148@32498001@6@chr6:32487148-32498001@16.7@302@503@1.67@CNVR2845.21, CNVR2845.25, CNVR2845.30, CNVR2845.43, CNVR2845.6@HLA-DRB5_3, HLA-DRB5_2, HLA-DRB5_1@0@0@0@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
A2463_18@63956@63960@deletion@2@32487148@32548047@6@chr6:32487148-32548047@-18.1@453@536@1.18@CNVR2845.21, CNVR2845.25, CNVR2845.24@HLA-DRB5_3, HLA-DRB5_2, HLA-DRB5_1, HLA-DRB1_6, HLA-DRB1_5@0@0@0@:major histocompatibility complex, class II, DR beta 5:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
A2463_18@63966@63968@deletion@3@32609088@32610541@6@chr6:32609088-32610541@26.5@681@371@0.545@CNVR2845.21, CNVR2845.25, CNVR2845.37, CNVR2845.27, CNVR2845.22, CNVR2845.39, CNVR2845.20@HLA-DQA1_2, HLA-DQA1_3, HLA-DQA1_4@0@0@0@:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
A2463_18@70816@70816@deletion@1@161054786@161054944@6@chr6:161054786-161054944@5.06@145@84@0.579@CNVR3133.1@LPA_9@0@0@0@:lipoprotein, Lp(a)@:blood circulation;endopeptidase inhibitor activity;catalytic activity;lipoprotein metabolic process;proteolysis;heparin binding;receptor-mediated endocytosis;fibronectin binding;small molecule metabolic process;apolipoprotein binding;lipid metabolic process;negative regulation of endopeptidase activity;extracellular region;plasma lipoprotein particle;lipid transport;serine-type endopeptidase activity@: APOLIPOPROTEIN(a); LPA
A2463_18@71028@71031@deletion@4@167787840@167791580@6@chr6:167787840-167791580@15.4@274@147@0.536@NA@TCP10_7, TCP10_6, TCP10_5, TCP10_4@0@0@0@:t-complex 10@:cytosol@NA
A2463_18@71756@71759@deletion@4@5963467@5968025@7@chr7:5963467-5968025@9.56@471@306@0.65@NA@CCZ1_14, CCZ1_15, RSPH10B_20, RSPH10B_19@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae):radial spoke head 10 homolog B (Chlamydomonas)@:lysosomal membrane@NA
A2463_18@71923@71934@duplication@12@6798716@6821107@7@chr7:6798716-6821107@8.59@327@452@1.38@NA@RSPH10B2_3, RSPH10B2_4, RSPH10B2_5, RSPH10B2_6, RSPH10B2_7, RSPH10B2_8, RSPH10B2_9, RSPH10B2_10, RSPH10B2_11, RSPH10B2_12, RSPH10B2_13, RSPH10B2_14@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
A2463_18@71939@71945@duplication@7@6836200@6845668@7@chr7:6836200-6845668@21.9@286@502@1.76@NA@RSPH10B2_19, RSPH10B2_20, CCZ1B_15, CCZ1B_14, CCZ1B_13, CCZ1B_12, CCZ1B_11@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
A2463_18@72491@72492@deletion@2@22532185@22533455@7@chr7:22532185-22533455@19.4@507@250@0.493@NA@STEAP1B_4, STEAP1B_3@0@0@0@:STEAP family member 1B@:integral to membrane@NA
A2463_18@73242@73242@deletion@1@38279626@38279767@7@chr7:38279626-38279767@5.42@50@17@0.34@NA@TRGC2_4@0@0@0@@:protein binding@NA
A2463_18@74245@74246@deletion@2@66648114@66660324@7@chr7:66648114-66660324@12.9@177@77@0.435@NA@TYW1_14, TYW1_15@0@0@0@:tRNA-yW synthesizing protein 1 homolog (S. cerevisiae);tRNA-yW synthesizing protein 1 homolog B (S. cerevisiae)@:tRNA processing;4 iron, 4 sulfur cluster binding;iron-sulfur cluster binding;oxidoreductase activity;FMN binding;iron ion binding;catalytic activity@NA
A2463_18@74567@74568@duplication@2@74160223@74160750@7@chr7:74160223-74160750@5.98@87@145@1.67@NA@GTF2I_22, GTF2I_23@0@0@0@:general transcription factor IIi@:neuronal cell body;transcription initiation from RNA polymerase II promoter;mitogen-activated protein kinase binding;negative regulation of angiogenesis;DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;cytoplasm;transcription from RNA polymerase II promoter;protein binding;signal transduction;nucleus;cell projection;reduction of cytosolic calcium ion concentration@NA
A2463_18@74581@74582@duplication@2@74191614@74193503@7@chr7:74191614-74193503@8.05@183@280@1.53@NA@NCF1_2, NCF1_3@0@0@0@:neutrophil cytosolic factor 1@:inflammatory response;antigen processing and presentation of peptide antigen via MHC class I;phagosome maturation;NADPH oxidase complex;neutrophil mediated killing of gram-positive bacterium;cell communication;interaction with host;leukotriene metabolic process;response to yeast;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;respiratory burst;GTPase activity;negative regulation of smooth muscle contraction;GTP catabolic process;cytosol;defense response to fungus;defense response to bacterium;antigen processing and presentation of exogenous peptide antigen via MHC class I;leukocyte mediated cytotoxicity;neutrophil mediated killing of fungus;phosphatidylinositol binding;defense response to Gram-positive bacterium;GTP binding;respiratory burst involved in defense response;superoxide-generating NADPH oxidase activity;hydrogen peroxide biosynthetic process;protein targeting to membrane;electron carrier activity;superoxide metabolic process;innate immune response;phagolysosome;cytoplasm;cell proliferation;superoxide anion generation;protein binding;SH3 domain binding;cellular defense response;response to bacterium@: GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE,
A2463_18@74781@74783@duplication@3@76121471@76129837@7@chr7:76121471-76129837@7.47@76@140@1.84@CNVR3462.1@DTX2_6, DTX2_7, DTX2_8@0@0@0@:deltex homolog 2 (Drosophila)@:ligase activity;cytoplasm;nuclear membrane;Notch signaling pathway;protein binding;nucleus;zinc ion binding;protein ubiquitination@NA
A2463_18@76243@76244@deletion@2@99909374@99910981@7@chr7:99909374-99910981@5.06@101@55@0.545@CNVR3508.2, CNVR3508.1@SPDYE3_4, SPDYE3_5@0@0@0@:speedy homolog E3 (Xenopus laevis)@NA@NA
A2463_18@76718@76727@deletion@10@102114809@102134416@7@chr7:102114809-102134416@9.37@226@134@0.593@CNVR3518.1@POLR2J_3, POLR2J_2, POLR2J_1, RASA4B_21, RASA4B_20, RASA4B_19, RASA4B_18, RASA4B_17, RASA4B_16, RASA4B_15@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J, 13.3kDa:RAS p21 protein activator 4B@:nucleoplasm;DNA binding;DNA repair;protein dimerization activity;nucleus;viral reproduction;gene expression;transcription initiation from RNA polymerase II promoter;7-methylguanosine mRNA capping;protein phosphorylation;LRR domain binding;protein kinase activity;DNA-directed RNA polymerase II, core complex;nucleotide-excision repair;transcription from RNA polymerase II promoter;DNA-directed RNA polymerase activity;protein binding;transcription-coupled nucleotide-excision repair;RNA splicing;mRNA splicing, via spliceosome;transcription, DNA-dependent;transcription elongation from RNA polymerase II promoter;positive regulation of viral transcription:phospholipid binding;intracellular;GTPase activator activity;cytosol;signal transduction;protein binding;plasma membrane;regulation of small GTPase mediated signal transduction;metal ion binding;intracellular signal transduction@NA
A2463_18@76765@76767@duplication@3@102235753@102236576@7@chr7:102235753-102236576@7.05@72@132@1.83@CNVR3518.1@RASA4_11, RASA4_10, RASA4_9@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity@NA
A2463_18@76792@76793@deletion@2@102309363@102312048@7@chr7:102309363-102312048@6.2@67@28@0.418@CNVR3518.1@POLR2J2_2, POLR2J2_2, POLR2J2_1, POLR2J2_1@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
A2463_18@79309@79309@duplication@1@143880598@143882930@7@chr7:143880598-143882930@9.84@404@613@1.52@CNVR3598.4, CNVR3598.3@CTAGE4_1@0@0@0@:CTAGE family, member 4@:integral to membrane;nucleotide binding;cellular_component;biological_process@NA
A2463_18@79315@79318@duplication@4@144059764@144064448@7@chr7:144059764-144064448@10.1@995@1363@1.37@CNVR3598.4, CNVR3598.5, CNVR3598.11@ARHGEF5_2, ARHGEF5_3, ARHGEF5_4, ARHGEF5_5@0@0@0@:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
A2463_18@79321@79322@duplication@2@144069393@144069850@7@chr7:144069393-144069850@6.83@89@157@1.76@CNVR3598.4, CNVR3598.5, CNVR3598.11@ARHGEF5_8, ARHGEF5_9@0@0@0@:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
A2463_18@80368@80368@duplication@1@7274293@7274349@8@chr8:7274293-7274349@5.86@10@49@4.9@CNVR3771.8, CNVR3771.10, CNVR3771.4@DEFB4B_1@0@0@0@:defensin, beta 4B;defensin, beta 4A@:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response@NA
A2463_18@80371@80410@deletion@40@7308236@7807650@8@chr8:7308236-7807650@78.4@1765@971@0.55@CNVR3772.4, CNVR3772.6@SPAG11B_3, SPAG11B_2, SPAG11B_1, DEFB104B_2, DEFB104B_1, DEFB106B_2, DEFB105B_1, DEFB105B_3, DEFB107B_1, DEFB107B_2, RP11-1118M6.1_1, RP11-1118M6.1_2, RP11-1118M6.1_3, RP11-1118M6.1_4, AC084121.16_4, AC084121.16_3, AC084121.16_2, AC084121.16_1, DEFB107A_2, DEFB107A_1, DEFB105A_3, DEFB105A_1, DEFB106A_2, DEFB104A_1, DEFB104A_2, SPAG11A_1, SPAG11A_2, SPAG11A_3, DEFB103A_1, DEFB103A_2, DEFB4A_1, DEFB4A_2, ZNF705B_3, ZNF705B_4@0@0@0@:sperm associated antigen 11B:defensin, beta 104A;defensin, beta 104B:defensin, beta 106B;defensin, beta 106A:defensin, beta 105B;defensin, beta 105A:defensin, beta 107B;defensin, beta 107A:uncharacterized LOC100133251:uncharacterized LOC100133251:defensin, beta 107B;defensin, beta 107A:defensin, beta 105B;defensin, beta 105A:defensin, beta 106B;defensin, beta 106A:defensin, beta 104A;defensin, beta 104B:sperm associated antigen 11A;sperm associated antigen 11B:defensin, beta 103B;defensin, beta 103A:defensin, beta 4B;defensin, beta 4A:zinc finger protein 705B@:spermatogenesis;defense response to bacterium;extracellular region;molecular_function;defense response:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response:extracellular region;defense response to bacterium;Golgi lumen;positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria;defense response;innate immune response:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response:intracellular;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_18@80564@80567@deletion@4@11970084@12043034@8@chr8:11970084-12043034@206@1895@95@0.0501@CNVR3785.8, CNVR3785.5, CNVR3785.2, CNVR3785.3@ZNF705D_6, USP17L2_1, FAM86B1_8, FAM86B1_7@0@0@0@:zinc finger protein 705D:ubiquitin specific peptidase 17-like family member 1, pseudogene;ubiquitin specific peptidase 17-like family member 2;ubiquitin specific peptidase 17-like family member 4;ubiquitin specific peptidase 17-like family member 7;ubiquitin specific peptidase 17-like family member 8;ubiquitin specific peptidase 17-like family member 3:family with sequence similarity 86, member B2;family with sequence similarity 86, member B1@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:protein deubiquitination;ubiquitin-specific protease activity;mitotic cell cycle G1/S transition checkpoint;nucleus;G2/M transition checkpoint;apoptotic process;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
A2463_18@80576@80579@deletion@4@12283399@12286623@8@chr8:12283399-12286623@16.9@136@42@0.309@CNVR3786.4, CNVR3786.16@FAM86B2_8, FAM86B2_7, FAM86B2_6, FAM86B2_5@0@0@0@:family with sequence similarity 86, member B2@NA@NA
A2463_18@80584@80586@deletion@3@12338341@12423650@8@chr8:12338341-12423650@16@439@247@0.563@CNVR3786.4, CNVR3786.16@AC130352.1_5, AC130352.1_6, AC130352.1_7@0@0@0@NA@NA@NA
A2463_18@86358@86359@deletion@2@145486843@145487390@8@chr8:145486843-145487390@5.06@23@0@0@NA@BOP1_13, BOP1_12@0@0@0@:block of proliferation 1@:nucleoplasm;regulation of cell cycle;ribonucleoprotein complex;maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);ribosome biogenesis;cell proliferation;protein binding;PeBoW complex;nucleus;rRNA processing@NA
A2463_18@88498@88498@deletion@1@39103742@39103911@9@chr9:39103742-39103911@4.9@82@41@0.5@NA@CNTNAP3_16@0@0@0@:contactin associated protein-like 3@:binding;signal transduction;protein binding;integral to membrane;extracellular region;cell adhesion;plasma membrane;cell recognition;receptor binding@NA
A2463_18@88528@88528@duplication@1@40702653@40706387@9@chr9:40702653-40706387@4.54@665@886@1.33@NA@SPATA31A3_4@0@0@0@:SPATA31 subfamily A, member 3@:integral to membrane@NA
A2463_18@88536@88539@deletion@4@41321261@41327364@9@chr9:41321261-41327364@6.64@36@4@0.111@CNVR4278.2@SPATA31A4_4, SPATA31A4_3, SPATA31A4_2, SPATA31A4_1@0@0@0@:SPATA31 subfamily A, member 4@:integral to membrane@NA
A2463_18@88593@88594@deletion@2@43816638@43818184@9@chr9:43816638-43818184@6.72@334@215@0.644@CNVR4294.1@CNTNAP3B_6, CNTNAP3B_7@0@0@0@:contactin associated protein-like 3B;contactin associated protein-like 3@:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
A2463_18@88601@88602@deletion@2@43875990@43885072@9@chr9:43875990-43885072@5.94@115@62@0.539@NA@CNTNAP3B_14, CNTNAP3B_15@0@0@0@:contactin associated protein-like 3B;contactin associated protein-like 3@:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
A2463_18@88631@88633@duplication@3@65503517@65508193@9@chr9:65503517-65508193@35.7@347@734@2.12@CNVR4312.5@SPATA31A7_4, SPATA31A7_3, SPATA31A7_2@0@0@0@:SPATA31 subfamily A, member 7@:integral to membrane@NA
A2463_18@88639@88643@deletion@5@67926874@67936012@9@chr9:67926874-67936012@21.2@156@43@0.276@NA@ANKRD20A1_1, ANKRD20A1_2, ANKRD20A1_3, ANKRD20A1_4, ANKRD20A1_5@0@0@0@:ankyrin repeat domain 20 family, member A1@:protein binding;plasma membrane@NA
A2463_18@88670@88670@deletion@1@69252846@69253282@9@chr9:69252846-69253282@27.8@149@8@0.0537@NA@BX255923.1_1@0@0@0@:COBW domain containing 6@:ATP binding@NA
A2463_18@88676@88678@deletion@3@69382094@69386055@9@chr9:69382094-69386055@13.8@75@8@0.107@NA@ANKRD20A4_1, ANKRD20A4_2, ANKRD20A4_3@0@0@0@:ankyrin repeat domain 20 family, member A4@:protein binding@NA
A2463_18@88681@88690@deletion@10@69393823@69424176@9@chr9:69393823-69424176@64.5@935@376@0.402@NA@ANKRD20A4_6, ANKRD20A4_7, ANKRD20A4_8, ANKRD20A4_9, ANKRD20A4_10, ANKRD20A4_11, ANKRD20A4_12, ANKRD20A4_13, ANKRD20A4_14, ANKRD20A4_15@0@0@0@:ankyrin repeat domain 20 family, member A4@:protein binding@NA
A2463_18@90516@90516@deletion@1@107571748@107571845@9@chr9:107571748-107571845@4.87@148@87@0.588@NA@ABCA1_30@0@0@0@:ATP-binding cassette, sub-family A (ABC1), member 1@:phagocytosis, engulfment;intracellular cholesterol transport;ATP binding;lipoprotein metabolic process;negative regulation of cholesterol storage;platelet dense granule organization;ATPase activity;plasma membrane;reverse cholesterol transport;cholesterol efflux;endosomal transport;cellular response to lipopolysaccharide;apolipoprotein A-I binding;phospholipid transporter activity;phospholipid homeostasis;apolipoprotein A-I receptor activity;phagocytic vesicle;lipoprotein biosynthetic process;lipid metabolic process;protein lipidation;apolipoprotein A-I-mediated signaling pathway;phospholipid translocation;interleukin-1 beta secretion;peptide secretion;positive regulation of cholesterol efflux;response to laminar fluid shear stress;syntaxin binding;high-density lipoprotein particle assembly;phospholipid binding;cholesterol binding;membrane raft;phospholipid efflux;cholesterol homeostasis;anion transmembrane transporter activity;response to low-density lipoprotein particle stimulus;cholesterol transporter activity;cholesterol metabolic process;integral to plasma membrane;positive regulation of cAMP biosynthetic process;negative regulation of macrophage derived foam cell differentiation;regulation of Cdc42 protein signal transduction;intracellular membrane-bounded organelle;endocytic vesicle;cellular response to retinoic acid;apolipoprotein binding;small molecule metabolic process;nucleoside-triphosphatase activity;Golgi apparatus;lysosome organization;G-protein coupled receptor signaling pathway;cellular lipid metabolic process;nucleotide binding;small GTPase binding;protein binding;anion transport@: ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 1; ABCA1; HYPOALPHALIPOPROTEINEMIA, PRIMARY; TANGIER DISEASE; TGD
A2463_18@95359@95359@deletion@1@17905545@17905692@10@chr10:17905545-17905692@4.58@51@21@0.412@NA@MRC1L1_11@0@0@0@:macrophage mannose receptor 1-like@:carbohydrate binding@NA
A2463_18@95380@95393@duplication@14@18060293@18152611@10@chr10:18060293-18152611@12.9@216@343@1.59@NA@TMEM236_2, TMEM236_3, TMEM236_4, MRC1_1, MRC1_2, MRC1_3, MRC1_4, MRC1_5, MRC1_6, MRC1_7, MRC1_8, MRC1_9, MRC1_10, MRC1_11@0@0@0@:transmembrane protein 236;transmembrane protein 236-like:mannose receptor, C type 1;macrophage mannose receptor 1-like@:integral to membrane:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
A2463_18@96482@96482@deletion@1@47158838@47158896@10@chr10:47158838-47158896@9.01@42@1@0.0238@CNVR4712.9, CNVR4712.2, CNVR4712.4, CNVR4712.6, CNVR4712.5@ANXA8L1_12@0@0@0@:annexin A8-like 1;annexin A8@:calcium-dependent phospholipid binding;calcium ion binding@NA
A2463_18@96536@96549@duplication@14@47894573@47915964@10@chr10:47894573-47915964@15.4@317@482@1.52@CNVR4715.2@FAM21B_2, FAM21B_3, FAM21B_4, FAM21B_5, FAM21B_6, FAM21B_7, FAM21B_8, FAM21B_9, FAM21B_10, FAM21B_11, FAM21B_12, FAM21B_13, FAM21B_14, FAM21B_15@0@0@0@:family with sequence similarity 21, member B@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_18@96558@96563@duplication@6@47941963@47948853@10@chr10:47941963-47948853@11.4@277@414@1.49@CNVR4715.2, CNVR4715.1@FAM21B_24, FAM21B_25, FAM21B_26, FAM21B_27, FAM21B_28, FAM21B_29@0@0@0@:family with sequence similarity 21, member B@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_18@96565@96565@deletion@1@48003969@48004056@10@chr10:48003969-48004056@21.4@104@2@0.0192@CNVR4715.2@ASAH2C_17@0@0@0@@:ceramidase activity;sphingolipid metabolic process@NA
A2463_18@96572@96581@deletion@10@48020451@48055018@10@chr10:48020451-48055018@76.2@412@40@0.0971@CNVR4715.2@ASAH2C_10, ASAH2C_9, ASAH2C_8, ASAH2C_7, ASAH2C_6, ASAH2C_5, ASAH2C_4, ASAH2C_3, ASAH2C_2, ASAH2C_1@0@0@0@@:ceramidase activity;sphingolipid metabolic process@NA
A2463_18@96620@96624@duplication@5@48771316@48798739@10@chr10:48771316-48798739@7.07@149@230@1.54@CNVR4716.10, CNVR4716.3@PTPN20B_6, PTPN20B_5, PTPN20B_4, PTPN20B_3, PTPN20B_2@0@0@0@:protein tyrosine phosphatase, non-receptor type 20B;protein tyrosine phosphatase, non-receptor type 20A@:phosphatase activity;protein tyrosine phosphatase activity;microtubule;nucleus;dephosphorylation;protein dephosphorylation;microtubule organizing center@NA
A2463_18@96629@96630@duplication@2@49365366@49371714@10@chr10:49365366-49371714@4.97@179@256@1.43@CNVR4717.2@FRMPD2_29, FRMPD2_28@0@0@0@:FERM and PDZ domain containing 2@:basolateral plasma membrane;transferase activity, transferring phosphorus-containing groups;cytoplasm;tight junction;protein binding;cytoskeleton;1-phosphatidylinositol binding;tight junction assembly@NA
A2463_18@96859@96861@deletion@3@51469924@51480527@10@chr10:51469924-51480527@6.98@170@99@0.582@CNVR4729.1@AGAP7_5, AGAP7_4, AGAP7_3@0@0@0@:translocase of inner mitochondrial membrane 23 homolog B (yeast):ArfGAP with GTPase domain, ankyrin repeat and PH domain 7@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity@NA
A2463_18@96896@96907@deletion@12@51838436@51855538@10@chr10:51838436-51855538@14.8@188@88@0.468@NA@FAM21A_4, FAM21A_5, FAM21A_6, FAM21A_7, FAM21A_8, FAM21A_9, FAM21A_10, FAM21A_11, FAM21A_12, FAM21A_13, FAM21A_14, FAM21A_15@0@0@0@:family with sequence similarity 21, member B;family with sequence similarity 21, member A@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_18@96922@96923@deletion@2@51890662@51892705@10@chr10:51890662-51892705@11.8@206@103@0.5@CNVR4734.2@FAM21A_30, FAM21A_31@0@0@0@:family with sequence similarity 21, member B;family with sequence similarity 21, member A@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_18@96932@96937@duplication@6@51965743@51978390@10@chr10:51965743-51978390@51.6@107@479@4.48@NA@ASAH2_12, ASAH2_11, ASAH2_10, ASAH2_9, ASAH2_8, ASAH2_7@0@0@0@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
A2463_18@96952@96952@deletion@1@52504963@52505034@10@chr10:52504963-52505034@5.13@24@1@0.0417@NA@ASAH2B_3@0@0@0@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2B@NA@NA
A2463_18@98355@98357@deletion@3@81608270@81610362@10@chr10:81608270-81610362@8.83@133@68@0.511@NA@FAM22E_5, FAM22E_6, FAM22E_7@0@0@0@NA@NA@NA
A2463_18@99033@99035@deletion@3@95092979@95095803@10@chr10:95092979-95095803@12.2@197@98@0.497@NA@MYOF_43, MYOF_42, MYOF_41@0@0@0@:myoferlin@:cytoplasmic vesicle membrane;blood circulation;phospholipid binding;nuclear envelope;intracellular membrane-bounded organelle;plasma membrane repair;regulation of vascular endothelial growth factor receptor signaling pathway;cellular response to heat;caveola;cytoplasmic vesicle;nuclear membrane;protein binding;integral to membrane;plasma membrane;muscle contraction@NA
A2463_18@101608@101613@duplication@6@124344788@124352111@10@chr10:124344788-124352111@8.43@599@792@1.32@CNVR4912.4, CNVR4912.3, CNVR4912.2@DMBT1_15, DMBT1_16, DMBT1_17, DMBT1_18, DMBT1_19, DMBT1_20@0@0@0@:deleted in malignant brain tumors 1@:defense response to virus;calcium-dependent protein binding;pattern recognition receptor signaling pathway;blastocyst development;response to estrogen stimulus;tissue regeneration;proteinaceous extracellular matrix;protein transport;Gram-negative bacterial cell surface binding;positive regulation of epithelial cell differentiation;virus-host interaction;epithelial cell differentiation;induction of bacterial agglutination;phagocytic vesicle membrane;intracellular;Gram-positive bacterial cell surface binding;zymogen binding;innate immune response;cytoplasm;extrinsic to membrane;protein binding;zymogen granule membrane;extracellular region;scavenger receptor activity;pattern recognition receptor activity;inner cell mass cell proliferation;membrane@: GLIOMA SUSCEPTIBILITY 1; GLM1
A2463_18@103139@103139@deletion@1@3239175@3240043@11@chr11:3239175-3240043@8.43@133@62@0.466@CNVR5028.1@MRGPRG_1@0@0@0@:MAS-related GPR, member G@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway@NA
A2463_18@103620@103620@deletion@1@7817522@7818489@11@chr11:7817522-7818489@18.5@338@145@0.429@CNVR5059.1@OR5P2_1@0@0@0@:olfactory receptor, family 5, subfamily P, member 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_18@104444@104444@duplication@1@18288436@18288525@11@chr11:18288436-18288525@10.9@83@183@2.2@NA@SAA1_2@0@0@0@:serum amyloid A1@:regulation of protein secretion;platelet activation;neutrophil chemotaxis;negative regulation of inflammatory response;positive regulation of cytokine secretion;macrophage chemotaxis;positive regulation of cell adhesion;positive regulation of interleukin-1 secretion;extracellular region;lymphocyte chemotaxis;high-density lipoprotein particle;elevation of cytosolic calcium ion concentration;acute-phase response;G-protein coupled receptor binding@NA
A2463_18@106038@106041@deletion@4@55032377@55036814@11@chr11:55032377-55036814@22.3@750@438@0.584@CNVR5178.5@TRIM48_2, TRIM48_3, TRIM48_4, TRIM48_5@0@0@0@:tripartite motif containing 48@:protein binding;intracellular;zinc ion binding@NA
A2463_18@106046@106048@duplication@3@55370918@55419315@11@chr11:55370918-55419315@14.8@730@1033@1.42@CNVR5179.1@OR4C11_1, OR4P4_1, OR4S2_1@0@0@0@:olfactory receptor, family 4, subfamily C, member 11:olfactory receptor, family 4, subfamily P, member 4:olfactory receptor, family 4, subfamily S, member 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_18@106571@106578@deletion@8@60971038@60978907@11@chr11:60971038-60978907@16.3@152@56@0.368@CNVR5194.1@PGA3_1, PGA3_2, PGA3_3, PGA3_4, PGA3_5, PGA3_6, PGA3_7, PGA3_8@0@0@0@:pepsinogen 3, group I (pepsinogen A)@:proteolysis;extracellular region;digestion;aspartic-type endopeptidase activity@NA
A2463_18@110109@110109@duplication@1@89531299@89531797@11@chr11:89531299-89531797@10.4@230@381@1.66@NA@TRIM49_8@0@0@0@:tripartite motif containing 49@:protein binding;intracellular;DNA binding;zinc ion binding@NA
A2463_18@110120@110121@deletion@2@89608779@89768790@11@chr11:89608779-89768790@17.8@411@216@0.526@NA@TRIM64B_1, TRIM49C_3@0@0@0@:tripartite motif containing 64;tripartite motif containing 64C;tripartite motif containing 64B:tripartite motif containing 49D, pseudogene;tripartite motif containing 49-like 1;tripartite motif containing 49C;tripartite motif-containing protein 49-like protein 1-like@:protein binding;intracellular;zinc ion binding:protein binding;intracellular;DNA binding;zinc ion binding@NA
A2463_18@110126@110126@deletion@1@89774220@89774718@11@chr11:89774220-89774718@10.3@239@123@0.515@NA@TRIM49C_8@0@0@0@:tripartite motif containing 49D, pseudogene;tripartite motif containing 49-like 1;tripartite motif containing 49C;tripartite motif-containing protein 49-like protein 1-like@:protein binding;intracellular;DNA binding;zinc ion binding@NA
A2463_18@114080@114080@deletion@1@7945547@7945808@12@chr12:7945547-7945808@7.14@96@42@0.438@NA@NANOG_2@0@0@0@:NECAP endocytosis associated 1:Nanog homeobox@:coated pit;protein binding;endocytosis;protein transport;clathrin vesicle coat;plasma membrane;membrane:cell differentiation;regulation of cell differentiation;somatic stem cell maintenance;sequence-specific DNA binding;transcription corepressor activity;embryo development;DNA binding;sequence-specific DNA binding transcription factor activity;nucleus;positive regulation of transcription from RNA polymerase II promoter;regulation of gene expression;regulation of transcription, DNA-dependent;cell proliferation;endodermal cell fate specification;nucleolus;transcription, DNA-dependent@NA
A2463_18@114136@114139@deletion@4@8374419@8377428@12@chr12:8374419-8377428@13.5@1724@1201@0.697@CNVR5422.3, CNVR5422.5, CNVR5422.6, CNVR5422.1@FAM90A1_7, FAM90A1_6, FAM90A1_5, FAM90A1_4@0@0@0@:family with sequence similarity 90, member A1@:zinc ion binding;nucleic acid binding@NA
A2463_18@114483@114483@deletion@1@11243900@11244828@12@chr12:11243900-11244828@61@325@0@0@CNVR5434.1@TAS2R43_1@0@0@0@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):taste receptor, type 2, member 14:taste receptor, type 2, member 43@:extracellular space;visual perception:bitter taste receptor activity;taste receptor activity;integral to membrane;sensory perception of taste;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of bitter taste:G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;motile cilium;taste receptor activity;bitter taste receptor activity;integral to membrane;sensory perception of taste;detection of chemical stimulus involved in sensory perception of bitter taste;cilium membrane@NA
A2463_18@127336@127337@deletion@2@19561995@19563541@14@chr14:19561995-19563541@17.4@115@22@0.191@CNVR6072.1@POTEG_4, POTEG_5@0@0@0@:POTE ankyrin domain family, member G@:protein binding@NA
A2463_18@127354@127358@deletion@5@20248483@20404761@14@chr14:20248483-20404761@21.5@2596@1778@0.685@CNVR6072.12, CNVR6072.4, CNVR6072.5@OR4M1_1, OR4N2_1, OR4K2_1, OR4K5_1, OR4K1_1@0@0@0@:olfactory receptor, family 4, subfamily N, member 2:olfactory receptor, family 4, subfamily M, member 1:olfactory receptor, family 4, subfamily K, member 2:olfactory receptor, family 4, subfamily K, member 5:olfactory receptor, family 4, subfamily K, member 1@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_18@133426@133427@duplication@2@106478111@106478539@14@chr14:106478111-106478539@6.69@150@231@1.54@CNVR6294.36, CNVR6294.48, CNVR6294.12, CNVR6294.24@IGHV4-4_2, IGHV4-4_1@0@0@0@@:protein binding@NA
A2463_18@133462@133462@duplication@1@106815723@106816026@14@chr14:106815723-106816026@5.35@104@167@1.61@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.56, CNVR6294.51@IGHV3-33_2@0@0@0@@:protein binding@NA
A2463_18@133470@133471@duplication@2@106877620@106878076@14@chr14:106877620-106878076@6.1@221@315@1.43@CNVR6294.26, CNVR6294.56, CNVR6294.2, CNVR6294.18@IGHV4-39_2, IGHV4-39_1@0@0@0@@:protein binding@NA
A2463_18@133523@133525@deletion@3@21059387@21063546@15@chr15:21059387-21063546@6.23@32@3@0.0938@NA@POTEB_6, POTEB_5, POTEB_4@0@0@0@:POTE ankyrin domain family member B-like@:protein binding@NA
A2463_18@133541@133542@deletion@2@22368577@22383423@15@chr15:22368577-22383423@23.8@967@547@0.566@CNVR6297.4, CNVR6297.17, CNVR6297.2@OR4M2_1, OR4N4_1@0@0@0@:olfactory receptor, family 4, subfamily M, member 2:olfactory receptor, family 4, subfamily N, member 4@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_18@133552@133552@duplication@1@22742397@22743598@15@chr15:22742397-22743598@24.5@1000@1830@1.83@CNVR6298.5@GOLGA6L1_8@0@0@0@:golgin A6 family-like 1;putative transmembrane protein FLJ36131-like;putative transmembrane protein ENSP00000320207-like;putative golgin subfamily A member 6-like@NA@NA
A2463_18@133636@133641@deletion@6@23406272@23411062@15@chr15:23406272-23411062@72.7@637@129@0.203@CNVR6300.8@RP11-467N20.5_8, RP11-467N20.5_7, RP11-467N20.5_6, RP11-467N20.5_5, RP11-467N20.5_4, RP11-467N20.5_3@0@0@0@:putative golgin subfamily A member 6-like protein 6-like@NA@NA
A2463_18@133869@133870@deletion@2@28629294@28629596@15@chr15:28629294-28629596@6.34@30@1@0.0333@CNVR6329.4@GOLGA8F_9, GOLGA8F_10@0@0@0@@:Golgi apparatus@NA
A2463_18@133978@133979@duplication@2@30380944@30381243@15@chr15:30380944-30381243@6.77@110@181@1.65@NA@GOLGA8J_9, GOLGA8J_10@0@0@0@:golgin A8 family, member J@:Golgi apparatus@NA
A2463_18@134006@134007@duplication@2@30437356@30437770@15@chr15:30437356-30437770@5.96@74@128@1.73@NA@GOLGA8T_18, GOLGA8T_19@0@0@0@:golgin A8 family, member J;golgin A8 family, member K@:Golgi apparatus@NA
A2463_18@134012@134015@deletion@4@30665182@30675554@15@chr15:30665182-30675554@7.57@108@51@0.472@CNVR6337.1@CHRFAM7A_6, CHRFAM7A_5, CHRFAM7A_4, CHRFAM7A_3@0@0@0@:CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:transport;integral to membrane;ion transport;postsynaptic membrane;membrane;extracellular ligand-gated ion channel activity@NA
A2463_18@134036@134054@deletion@19@30845996@30896376@15@chr15:30845996-30896376@53.6@463@159@0.343@CNVR6339.2, CNVR6339.3, CNVR6339.1@GOLGA8Q_2, GOLGA8Q_3, GOLGA8Q_4, GOLGA8Q_5, GOLGA8Q_6, GOLGA8Q_7, GOLGA8Q_8, GOLGA8Q_9, GOLGA8Q_10, GOLGA8Q_11, GOLGA8Q_12, GOLGA8Q_13, GOLGA8Q_14, GOLGA8Q_15, GOLGA8Q_16, GOLGA8Q_17, GOLGA8Q_18, GOLGA8Q_19, GOLGA8H_1@0@0@0@:golgin A8 family, member H@:Golgi apparatus:Golgi apparatus@NA
A2463_18@134158@134193@deletion@36@32684984@32744772@15@chr15:32684984-32744772@106@1260@546@0.433@CNVR6346.1@GOLGA8K_19, GOLGA8K_18, GOLGA8K_17, GOLGA8K_16, GOLGA8K_15, GOLGA8K_14, GOLGA8K_13, GOLGA8K_12, GOLGA8K_11, GOLGA8K_10, GOLGA8K_9, GOLGA8K_8, GOLGA8K_7, GOLGA8K_6, GOLGA8K_5, GOLGA8K_4, GOLGA8K_3, GOLGA8K_2, AC139426.2_1, GOLGA8K_1, GOLGA8O_19, GOLGA8O_18, GOLGA8O_17, GOLGA8O_16, GOLGA8O_15, GOLGA8O_14, GOLGA8O_13, GOLGA8O_12, GOLGA8O_11, GOLGA8O_10, GOLGA8O_9, GOLGA8O_8, GOLGA8O_7, GOLGA8O_6, GOLGA8O_5, GOLGA8O_4@0@0@0@:golgin A8 family, member J:golgin A8 family, member O@:Golgi apparatus:Golgi apparatus@NA
A2463_18@138505@138505@duplication@1@74836279@74836829@15@chr15:74836279-74836829@5.61@226@328@1.45@NA@ARID3B_2@0@0@0@:AT rich interactive domain 3B (BRIGHT-like)@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;biological_process@NA
A2463_18@139296@139299@duplication@4@82934267@82936608@15@chr15:82934267-82936608@7.24@128@206@1.61@CNVR6477.6, CNVR6477.7@RP13-996F3.5_6, RP13-996F3.5_5, RP13-996F3.5_4, RP13-996F3.5_3@0@0@0@NA@NA@NA
A2463_18@139473@139479@deletion@7@84850735@84909534@15@chr15:84850735-84909534@14.3@295@166@0.563@CNVR6486.2@RP11-182J1.16_3, GOLGA6L4_1, GOLGA6L4_2, GOLGA6L4_3, GOLGA6L4_4, GOLGA6L4_5, GOLGA6L4_6@0@0@0@:uncharacterized LOC100505679@:Golgi apparatus@NA
A2463_18@140476@140480@duplication@5@64382@66738@16@chr16:64382-66738@10.4@109@201@1.84@CNVR6565.1@WASH4P_10, WASH4P_9, WASH4P_8, WASH4P_7, WASH4P_6@0@0@0@@:intracellular membrane-bounded organelle;endosomal transport;recycling endosome;early endosome;Arp2/3 complex-mediated actin nucleation;actin binding;alpha-tubulin binding;retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;recycling endosome membrane@NA
A2463_18@142927@142928@duplication@2@16367547@16367932@16@chr16:16367547-16367932@6.48@102@168@1.65@NA@NOMO3_19, NOMO3_20@0@0@0@:NODAL modulator 3@:carbohydrate binding;integral to membrane;carboxypeptidase activity@NA
A2463_18@142971@142971@duplication@1@18414875@18414981@16@chr16:18414875-18414981@5.7@58@110@1.9@CNVR6658.1@RP11-1212A22.2_7@0@0@0@NA@NA@NA
A2463_18@144262@144265@duplication@4@29057332@29062028@16@chr16:29057332-29062028@9.51@201@311@1.55@NA@CTB-134H23.2_3, CTB-134H23.2_4, CTB-134H23.2_5, CTB-134H23.2_6@0@0@0@NA@NA@NA
A2463_18@144286@144290@deletion@5@29466720@29469445@16@chr16:29466720-29469445@10.2@46@0@0@CNVR6690.2, CNVR6690.3, CNVR6690.4@SLX1B_2, SLX1B_3, SLX1B_4, SLX1B_5, SLX1B_6@0@0@0@:structure-specific endonuclease subunit SLX1-like;SLX1 structure-specific endonuclease subunit homolog B (S. cerevisiae);SLX1 structure-specific endonuclease subunit homolog A (S. cerevisiae):sulfotransferase family, cytosolic, 1A, phenol-preferring, member 4;sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3;sulfotransferase 1A3/1A4-like@:Slx1-Slx4 complex;5'-flap endonuclease activity;DNA repair;protein binding;DNA double-strand break processing involved in repair via single-strand annealing;double-strand break repair via homologous recombination;metal ion binding;crossover junction endodeoxyribonuclease activity:steroid metabolic process;small molecule metabolic process;sulfation;aryl sulfotransferase activity;cytoplasm;catecholamine metabolic process;cytosol;endoplasmic reticulum unfolded protein response;xenobiotic metabolic process;sulfotransferase activity;activation of signaling protein activity involved in unfolded protein response;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process@NA
A2463_18@144501@144502@duplication@2@30208296@30208678@16@chr16:30208296-30208678@5.25@37@79@2.14@CNVR6694.1, CNVR6694.2, CNVR6694.3@SLX1A_4, SLX1A_5@0@0@0@:structure-specific endonuclease subunit SLX1-like;SLX1 structure-specific endonuclease subunit homolog B (S. cerevisiae);SLX1 structure-specific endonuclease subunit homolog A (S. cerevisiae):sulfotransferase family, cytosolic, 1A, phenol-preferring, member 4;sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3;sulfotransferase 1A3/1A4-like@:Slx1-Slx4 complex;5'-flap endonuclease activity;DNA repair;protein binding;DNA double-strand break processing involved in repair via single-strand annealing;double-strand break repair via homologous recombination;metal ion binding;crossover junction endodeoxyribonuclease activity:steroid metabolic process;small molecule metabolic process;sulfation;aryl sulfotransferase activity;cytoplasm;catecholamine metabolic process;cytosol;endoplasmic reticulum unfolded protein response;xenobiotic metabolic process;sulfotransferase activity;activation of signaling protein activity involved in unfolded protein response;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process@NA
A2463_18@145023@145035@duplication@13@46615642@46655271@16@chr16:46615642-46655271@42.3@1613@2299@1.43@NA@SHCBP1_13, SHCBP1_12, SHCBP1_11, SHCBP1_10, SHCBP1_9, SHCBP1_8, SHCBP1_7, SHCBP1_6, SHCBP1_5, SHCBP1_4, SHCBP1_3, SHCBP1_2, SHCBP1_1@0@0@0@:SHC SH2-domain binding protein 1@:protein binding;SH2 domain binding@NA
A2463_18@147091@147091@duplication@1@69988238@69988476@16@chr16:69988238-69988476@5.14@74@127@1.72@CNVR6762.3, CNVR6762.1@CLEC18A_3@0@0@0@:C-type lectin domain family 18, member A@:carbohydrate binding;protein binding;extracellular region@NA
A2463_18@147126@147126@duplication@1@70208851@70208941@16@chr16:70208851-70208941@5.9@55@108@1.96@CNVR6764.1@CLEC18C_2@0@0@0@:C-type lectin domain family 18, member C@:carbohydrate binding;protein binding;extracellular region@NA
A2463_18@148452@148453@deletion@2@89006604@89017768@16@chr16:89006604-89017768@6.97@537@348@0.648@NA@RP11-830F9.6_1, RP11-830F9.6_2@0@0@0@:core-binding factor, runt domain, alpha subunit 2; translocated to, 3@:nucleoplasm;intracellular;granulocyte differentiation;regulation of transcription, DNA-dependent;sequence-specific DNA binding transcription factor activity;Golgi membrane;cell proliferation;chromatin binding;protein binding;nucleolus;transcription, DNA-dependent;zinc ion binding;positive regulation of transcription from RNA polymerase II promoter@NA
A2463_18@151404@151404@deletion@1@15468848@15469578@17@chr17:15468848-15469578@6.34@440@283@0.643@NA@CDRT1_1@0@0@0@:CMT1A duplicated region transcript 1@:protein binding;molecular_function;cellular_component;biological_process@NA
A2463_18@151415@151415@deletion@1@15517148@15517347@17@chr17:15517148-15517347@8.83@110@45@0.409@NA@CDRT1_3, TRIM16_9@0@0@0@:CMT1A duplicated region transcript 1@:protein binding;molecular_function;cellular_component;biological_process:protein binding;intracellular;zinc ion binding;cytoplasm@NA
A2463_18@151877@151886@duplication@10@18389249@18430117@17@chr17:18389249-18430117@28.7@506@813@1.61@NA@LGALS9C_3, LGALS9C_4, LGALS9C_5, LGALS9C_6, LGALS9C_7, LGALS9C_8, LGALS9C_9, LGALS9C_10, LGALS9C_11, FAM106A_1@0@0@0@:lectin, galactoside-binding, soluble, 9C:protein FAM106B-like@:carbohydrate binding@NA
A2463_18@151958@151959@deletion@2@18996506@18997166@17@chr17:18996506-18997166@68.6@350@3@0.00857@CNVR7018.4, CNVR7018.2, CNVR7018.6@AC007952.5_1, AC007952.5_2@0@0@0@NA@NA@NA
A2463_18@152122@152129@deletion@8@20353287@20359984@17@chr17:20353287-20359984@21.5@182@62@0.341@CNVR7021.1, CNVR7021.3@LGALS9B_11, LGALS9B_10, LGALS9B_9, LGALS9B_8, LGALS9B_7, LGALS9B_6, LGALS9B_5, LGALS9B_4@0@0@0@:lectin, galactoside-binding, soluble, 9B@:carbohydrate binding@NA
A2463_18@153363@153368@deletion@6@34493376@34497369@17@chr17:34493376-34497369@19.8@117@18@0.154@CNVR7077.1, CNVR7077.3, CNVR7077.11, CNVR7077.16@TBC1D3B_14, TBC1D3B_13, TBC1D3B_12, TBC1D3B_11, TBC1D3B_10, TBC1D3B_9@0@0@0@:TBC1 domain family, member 3B@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_18@153372@153372@deletion@1@34500205@34500284@17@chr17:34500205-34500284@8.33@44@4@0.0909@CNVR7077.1, CNVR7077.3, CNVR7077.11, CNVR7077.16@TBC1D3B_5@0@0@0@:TBC1 domain family, member 3B@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_18@153376@153381@duplication@6@34522686@34539971@17@chr17:34522686-34539971@11.7@49@134@2.73@CNVR7077.1, CNVR7077.3, CNVR7077.6@CCL3L3_3, CCL3L3_2, CCL3L3_1, CCL4L1_1, CCL4L1_2, CCL4L1_3@0@0@0@:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
A2463_18@153393@153394@duplication@2@34590136@34590454@17@chr17:34590136-34590454@6.12@28@74@2.64@CNVR7077.1, CNVR7077.13, CNVR7077.19, CNVR7077.10, CNVR7077.2@TBC1D3C_3, TBC1D3C_2@0@0@0@:TBC1 domain family, member 3C;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3H-like;TBC1 domain family, member 3H@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_18@153414@153414@duplication@1@34797487@34798054@17@chr17:34797487-34798054@10.3@101@204@2.02@CNVR7078.2, CNVR7078.3@TBC1D3G_14@0@0@0@:TBC1 domain family member 3H-like;TBC1 domain family, member 3H:TBC1 domain family, member 3;TBC1 domain family, member 3G;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like;TBC1 domain family, member 3H@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_18@153643@153643@deletion@1@36342585@36342632@17@chr17:36342585-36342632@7.63@34@0@0@CNVR7083.3@TBC1D3_12@0@0@0@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
A2463_18@154328@154329@duplication@2@39240460@39254336@17@chr17:39240460-39254336@6.61@262@371@1.42@NA@KRTAP4-7_1, KRTAP4-8_1@0@0@0@:keratin associated protein 4-7:keratin associated protein 4-8@:keratin filament:keratin filament@NA
A2463_18@154738@154743@duplication@6@40704953@40706956@17@chr17:40704953-40706956@16.6@387@589@1.52@NA@HSD17B1_1, HSD17B1_2, HSD17B1_3, HSD17B1_4, HSD17B1_5, HSD17B1_6@0@0@0@:hydroxysteroid (17-beta) dehydrogenase 1@:steroid metabolic process;oxidation-reduction process;testosterone 17-beta-dehydrogenase (NAD+) activity;cellular response to metal ion;bone development;steroid biosynthetic process;catalytic activity;testosterone biosynthetic process;oxidoreductase activity;metabolic process;estrogen metabolic process;small molecule metabolic process;nucleotide binding;cytoplasm;cytosol;estrogen biosynthetic process;estradiol 17-beta-dehydrogenase activity@NA
A2463_18@155584@155590@duplication@7@44380005@44409347@17@chr17:44380005-44409347@28.2@404@745@1.84@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A_3, LRRC37A_4, LRRC37A_5, LRRC37A_6, LRRC37A_7, LRRC37A_8, LRRC37A_9@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
A2463_18@155593@155600@duplication@8@44414663@44594799@17@chr17:44414663-44594799@31.5@301@598@1.99@CNVR7114.2, CNVR7114.1@LRRC37A_12, LRRC37A_13, LRRC37A_14, ARL17B_4, ARL17B_3, ARL17B_2, LRRC37A2_2, LRRC37A2_3@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
A2463_18@156882@156882@duplication@1@57676737@57676844@17@chr17:57676737-57676844@6.46@150@236@1.57@NA@DHX40_14@0@0@0@:DEAH (Asp-Glu-Ala-His) box polypeptide 40@:transport;helicase activity;intracellular;ATP-dependent helicase activity;nucleic acid binding;ATP binding@NA
A2463_18@162016@162018@deletion@3@44497286@44550298@18@chr18:44497286-44550298@103@599@42@0.0701@NA@PIAS2_1, TCEB3CL2_1, TCEB3CL_1@0@0@0@:protein inhibitor of activated STAT, 2:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2:transcription elongation factor B polypeptide 3C-like@:nuclear body;nuclear speck;DNA binding;negative regulation of androgen receptor signaling pathway;transcription coactivator activity;protein sumoylation;PML body;nucleus;androgen receptor signaling pathway;androgen receptor binding;ubiquitin protein ligase binding;positive regulation of transcription from RNA polymerase II promoter;SUMO ligase activity;regulation of transcription from RNA polymerase II promoter;regulation of osteoblast differentiation;positive regulation of transcription, DNA-dependent;protein binding;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_18@162016@162019@duplication@1@44497286@44556213@18@chr18:44497286-44556213@-105@3145@3405@1.08@NA@PIAS2_1, TCEB3CL2_1, TCEB3CL_1, TCEB3C_1@0@0@0@:protein inhibitor of activated STAT, 2:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2:transcription elongation factor B polypeptide 3C-like:transcription elongation factor B polypeptide 3C (elongin A3);RNA polymerase II transcription factor SIII subunit A3-like@:nuclear body;nuclear speck;DNA binding;negative regulation of androgen receptor signaling pathway;transcription coactivator activity;protein sumoylation;PML body;nucleus;androgen receptor signaling pathway;androgen receptor binding;ubiquitin protein ligase binding;positive regulation of transcription from RNA polymerase II promoter;SUMO ligase activity;regulation of transcription from RNA polymerase II promoter;regulation of osteoblast differentiation;positive regulation of transcription, DNA-dependent;protein binding;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_18@164276@164280@duplication@5@4219589@4229614@19@chr19:4219589-4229614@23.8@214@419@1.96@NA@ANKRD24_19, ANKRD24_20, ANKRD24_21, ANKRD24_22, EBI3_1@0@0@0@:ankyrin repeat domain 24:Epstein-Barr virus induced 3@:protein binding:T-helper 1 type immune response;interleukin-27 receptor binding;positive regulation of interferon-gamma biosynthetic process;cytokine receptor activity;extracellular space;protein binding;humoral immune response;positive regulation of alpha-beta T cell proliferation;cytokine activity;plasma membrane;cytokine-mediated signaling pathway@NA
A2463_18@164950@164955@duplication@6@7030624@7051633@19@chr19:7030624-7051633@23.8@210@433@2.06@CNVR7517.1@MBD3L5_1, MBD3L5_2, MBD3L4_2, MBD3L4_1, MBD3L2_1, MBD3L2_2@0@0@0@:methyl-CpG binding domain protein 3-like 5:methyl-CpG binding domain protein 3-like 4:methyl-CpG-binding domain protein 3-like 2-like;methyl-CpG binding domain protein 3-like 2@:regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_18@167047@167047@deletion@1@14877791@14877921@19@chr19:14877791-14877921@5.07@78@38@0.487@NA@EMR2_6@0@0@0@:egf-like module containing, mucin-like, hormone receptor-like 2@:transmembrane signaling receptor activity;inflammatory response;G-protein coupled receptor activity;ruffle membrane;integral to membrane;plasma membrane;cell surface receptor signaling pathway;neuropeptide signaling pathway;granulocyte chemotaxis;cell migration;leading edge membrane;G-protein coupled receptor signaling pathway;protein binding;cell adhesion;membrane;calcium ion binding;chondroitin sulfate binding@NA
A2463_18@168441@168442@deletion@2@22939008@22939580@19@chr19:22939008-22939580@13.5@307@165@0.537@NA@ZNF99_8, ZNF99_7@0@0@0@:zinc finger protein 99@:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_18@168952@168952@deletion@1@35862263@35863302@19@chr19:35862263-35863302@21.1@123@13@0.106@CNVR7627.1@GPR42_2@0@0@0@@:integral to membrane;G-protein coupled receptor activity;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
A2463_18@170096@170099@deletion@4@40373946@40380711@19@chr19:40373946-40380711@25.5@387@189@0.488@CNVR7639.2@FCGBP_26, FCGBP_25, FCGBP_24, FCGBP_23@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_18@170821@170826@deletion@6@43702150@43763287@19@chr19:43702150-43763287@16.6@515@310@0.602@CNVR7658.5, CNVR7658.1@PSG4_3, PSG4_2, PSG4_1, PSG9_6, PSG9_5, PSG9_4@0@0@0@:pregnancy specific beta-1-glycoprotein 4:pregnancy specific beta-1-glycoprotein 9@:protein binding;extracellular region;female pregnancy;defense response:protein binding;extracellular region;female pregnancy;defense response@NA
A2463_18@172987@172987@deletion@1@52133087@52133469@19@chr19:52133087-52133469@8.89@43@2@0.0465@CNVR7702.1@SIGLEC5_2, SIGLEC5_2@0@0@0@:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 5@:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion@NA
A2463_18@173295@173298@deletion@4@54724399@54726434@19@chr19:54724399-54726434@12.9@143@59@0.413@CNVR7721.3, CNVR7721.4@LILRB3_6, LILRB3_5, LILRB3_4, LILRB3_3@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
A2463_18@173336@173342@duplication@7@54801928@54818834@19@chr19:54801928-54818834@9.94@394@548@1.39@CNVR7722.1@LILRA3_6, LILRA3_5, LILRA3_4, LILRA3_3, LILRA3_2, LILRA3_1, LILRA5_7@0@0@0@:leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5@:antigen binding;signal transduction;protein binding;extracellular region;plasma membrane;receptor activity;defense response:protein binding;extracellular region;integral to membrane;innate immune response@NA
A2463_18@173464@173470@duplication@7@55253427@55281336@19@chr19:55253427-55281336@20.4@625@923@1.48@CNVR7725.2, CNVR7725.1@KIR2DL3_3, KIR2DL3_4, KIR2DL3_5, KIR2DL3_6, KIR2DL3_7, KIR2DL3_8, KIR2DL1_1@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane@NA
A2463_18@173479@173504@duplication@26@55315347@55363737@19@chr19:55315347-55363737@80.2@1281@2114@1.65@CNVR7725.1, CNVR7725.6@KIR2DL4_2, KIR2DL4_3, KIR2DL4_4, KIR2DL4_5, KIR2DL4_6, KIR2DL4_7, KIR3DL1_1, KIR3DL1_2, KIR3DL1_3, KIR3DL1_4, KIR3DL1_5, KIR3DL1_6, KIR3DL1_7, KIR3DL1_8, KIR3DL1_9, KIR2DS4_1, KIR2DS4_2, KIR2DS4_3, KIR2DS4_4, KIR2DS4_5, KIR2DS4_6, KIR2DS4_7, KIR2DS4_8, KIR3DL2_1, KIR3DL2_2, KIR3DL2_3@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2-like@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane@NA
A2463_18@174394@174395@deletion@2@1558985@1569278@20@chr20:1558985-1569278@6.59@197@119@0.604@CNVR7763.1@RP4-576H24.4_2, SIRPB1_2, RP4-576H24.4_1@0@0@0@:signal-regulatory protein beta 1;signal-regulatory protein beta-1-like;signal-regulatory protein beta-1 isoform 3-like@:protein binding:protein binding;signal transduction;integral to membrane;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway@NA
A2463_18@174403@174403@duplication@1@1895746@1896101@20@chr20:1895746-1896101@5.02@149@223@1.5@CNVR7764.2@SIRPA_2@0@0@0@:signal-regulatory protein alpha@:blood coagulation;protein binding;integral to membrane;SH3 domain binding;cell adhesion;plasma membrane;membrane;leukocyte migration@NA
A2463_18@175736@175737@duplication@2@26061801@26063616@20@chr20:26061801-26063616@5.1@189@267@1.41@CNVR7823.4, CNVR7823.3, CNVR7823.5, CNVR7823.1@FAM182A_4, FAM182A_5@0@0@0@NA@NA@NA
A2463_18@181131@181131@duplication@1@18734088@18734148@22@chr22:18734088-18734148@4.74@28@65@2.32@CNVR8087.5, CNVR8087.2, CNVR8087.11@AC008132.1_6@0@0@0@NA@NA@NA
A2463_18@181134@181134@duplication@1@18834446@18835833@22@chr22:18834446-18835833@6.73@252@373@1.48@CNVR8087.2, CNVR8087.7, CNVR8087.12, CNVR8087.10@AC008132.13_1@0@0@0@NA@NA@NA
A2463_18@181484@181484@deletion@1@21063585@21063667@22@chr22:21063585-21063667@4.64@37@11@0.297@CNVR8099.6, CNVR8099.2@PI4KA_54@0@0@0@:phosphatidylinositol 4-kinase, catalytic, alpha@:phospholipid metabolic process;1-phosphatidylinositol 4-kinase activity;small molecule metabolic process;phosphatidylinositol phosphorylation;binding;transferase activity, transferring phosphorus-containing groups;phosphotransferase activity, alcohol group as acceptor;ATP binding;Golgi-associated vesicle;phosphatidylinositol biosynthetic process;cytosol;protein binding;signal transduction;synaptic transmission;kinase activity;phosphatidylinositol-mediated signaling@NA
A2463_18@181487@181489@deletion@3@21065630@21067085@22@chr22:21065630-21067085@11.7@172@84@0.488@CNVR8099.6, CNVR8099.2@PI4KA_51, PI4KA_50, PI4KA_49@0@0@0@:phosphatidylinositol 4-kinase, catalytic, alpha@:phospholipid metabolic process;1-phosphatidylinositol 4-kinase activity;small molecule metabolic process;phosphatidylinositol phosphorylation;binding;transferase activity, transferring phosphorus-containing groups;phosphotransferase activity, alcohol group as acceptor;ATP binding;Golgi-associated vesicle;phosphatidylinositol biosynthetic process;cytosol;protein binding;signal transduction;synaptic transmission;kinase activity;phosphatidylinositol-mediated signaling@NA
A2463_18@181806@181807@deletion@2@23243157@23247205@22@chr22:23243157-23247205@6.4@195@117@0.6@CNVR8103.2, CNVR8103.1, CNVR8103.6, CNVR8103.11, CNVR8103.35@IGLC2_1, IGLJ3_1@0@0@0@@:protein binding@NA
A2463_02@425@443@deletion@19@1635663@1670996@1@chr1:1635663-1670996@48.9@795@404@0.508@CNVR17.1@CDK11A_15, CDK11A_14, CDK11A_13, CDK11A_12, CDK11A_11, CDK11A_10, CDK11A_9, CDK11A_8, CDK11A_7, CDK11A_6, CDK11A_5, CDK11A_4, CDK11A_3, CDK11A_2, SLC35E2_6, SLC35E2_5, SLC35E2_4, SLC35E2_3, SLC35E2_2@0@0@0@:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A:solute carrier family 35, member E2@:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division:integral to membrane;membrane@NA
A2463_02@1806@1807@deletion@2@12853378@12854642@1@chr1:12853378-12854642@6.63@428@288@0.673@CNVR72.3, CNVR72.10@PRAMEF1_2, PRAMEF1_3@0@0@0@:PRAME family member 1@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_02@1809@1811@deletion@3@12884801@12888523@1@chr1:12884801-12888523@33.7@573@258@0.45@CNVR72.3, CNVR72.10, CNVR72.11, CNVR72.4@PRAMEF11_4, PRAMEF11_3, PRAMEF11_2@0@0@0@:PRAME family member 11@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_02@1816@1824@deletion@9@12939366@12980233@1@chr1:12939366-12980233@40.1@1010@570@0.564@CNVR72.3, CNVR72.4, CNVR72.2@PRAMEF4_4, PRAMEF4_3, PRAMEF4_2, PRAMEF10_4, PRAMEF10_3, PRAMEF10_2, PRAMEF7_2, PRAMEF7_3, PRAMEF7_4@0@0@0@:PRAME family member 4:PRAME family member 10:PRAME family member 7@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_02@1835@1839@deletion@5@13330415@13368733@1@chr1:13330415-13368733@8.72@44@3@0.0682@CNVR74.8, CNVR74.4@PRAMEF3_2, PRAMEF3_1, PRAMEF5_2, PRAMEF5_3, PRAMEF5_4@0@0@0@:PRAME family member 3:PRAME family member 5@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_02@1853@1855@duplication@3@13495968@13522259@1@chr1:13495968-13522259@8.57@49@113@2.31@NA@PRAMEF16_2, PRAMEF16_3, PRAMEF21_2@0@0@0@:PRAME family member 16:PRAME family member 21;PRAME family member 20@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_02@1869@1870@deletion@2@13718405@13743098@1@chr1:13718405-13743098@13.9@108@30@0.278@NA@PRAMEF17_3, PRAMEF20_2@0@0@0@:PRAME family member 17:PRAME family member 21;PRAME family member 20@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_02@3333@3342@deletion@10@25599040@25655415@1@chr1:25599040-25655415@156@801@45@0.0562@CNVR116.1, CNVR116.2@RHD_1, RHD_2, RHD_3, RHD_4, RHD_5, RHD_6, RHD_7, RHD_8, RHD_9, RHD_10@0@0@0@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
A2463_02@3357@3357@duplication@1@25735175@25735360@1@chr1:25735175-25735360@4.76@92@147@1.6@CNVR117.1@RHCE_2@0@0@0@:Rh blood group, CcEe antigens@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@: BLOOD GROUP--RHESUS SYSTEM E POLYPEPTIDE; RHE; RHESUS BLOOD GROUP, CcEe ANTIGENS; RHCE
A2463_02@8507@8508@deletion@2@89476588@89477710@1@chr1:89476588-89477710@71.6@365@4@0.011@CNVR244.1@GBP3_8, GBP3_7@0@0@0@:guanylate binding protein 3@:defense response to virus;GTP binding;GTPase activity;membrane;cytoplasm@NA
A2463_02@9354@9374@deletion@21@104163174@104234232@1@chr1:104163174-104234232@36.7@607@311@0.512@CNVR266.3, CNVR266.1@AMY2A_5, AMY2A_6, AMY2A_7, AMY2A_8, AMY2A_9, AMY2A_10, AMY1A_2, AMY1A_3, AMY1A_4, AMY1A_5, AMY1A_6, AMY1A_7, AMY1A_8, AMY1A_9, AMY1A_10, AMY1A_11, AMY1B_11, AMY1B_10, AMY1B_9, AMY1B_8, AMY1B_7@0@0@0@:amylase, alpha 2A (pancreatic):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:chloride ion binding;cation binding;small molecule metabolic process;carbohydrate metabolic process;catalytic activity;extracellular space;polysaccharide digestion;extracellular region;carbohydrate catabolic process;alpha-amylase activity;calcium ion binding:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
A2463_02@9766@9773@deletion@8@110230497@110235917@1@chr1:110230497-110235917@52.8@251@5@0.0199@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_1, GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
A2463_02@10788@10788@duplication@1@144220788@144220959@1@chr1:144220788-144220959@8.67@57@131@2.3@CNVR333.1, CNVR333.3@RP3-377D14.1_87@0@0@0@NA@NA@NA
A2463_02@10793@10793@deletion@1@144339779@144340398@1@chr1:144339779-144340398@4.57@23@2@0.087@CNVR334.4, CNVR334.2@AL592284.1_1@0@0@0@:uncharacterized LOC730256;uncharacterized LOC101060698;uncharacterized LOC642441@NA@NA
A2463_02@10890@10893@deletion@4@145325953@145328432@1@chr1:145325953-145328432@9.35@47@3@0.0638@CNVR341.2, CNVR341.3@NBPF10_30, NBPF10_31, NBPF10_32, NBPF10_33@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family, member 10@NA@NA
A2463_02@11143@11157@deletion@15@146227744@146244717@1@chr1:146227744-146244717@13.2@61@1@0.0164@NA@NBPF12_22, NBPF12_21, NBPF12_20, NBPF12_19, NBPF12_18, NBPF12_17, NBPF12_16, NBPF12_15, NBPF12_14, NBPF12_13, NBPF12_12, NBPF12_11, NBPF12_10, NBPF12_9, NBPF12_8@0@0@0@:neuroblastoma breakpoint family member 21-like@NA@NA
A2463_02@11161@11164@deletion@4@146248917@146253110@1@chr1:146248917-146253110@14.8@144@56@0.389@NA@NBPF12_4, NBPF12_3, NBPF12_2, NBPF12_1@0@0@0@:neuroblastoma breakpoint family member 21-like@NA@NA
A2463_02@11169@11173@duplication@5@146400092@146405926@1@chr1:146400092-146405926@11.7@94@191@2.03@NA@NBPF12_9, NBPF12_10, NBPF12_11, NBPF12_12, NBPF12_13@0@0@0@:neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family member 14-like;neuroblastoma breakpoint family, member 12@:cytoplasm@NA
A2463_02@11353@11355@deletion@3@148021578@148023669@1@chr1:148021578-148023669@11.1@219@115@0.525@CNVR346.2, CNVR346.4@NBPF14_5, NBPF14_4, NBPF14_3@0@0@0@:neuroblastoma breakpoint family, member 14@:cytoplasm@NA
A2463_02@12117@12118@deletion@2@152573209@152586574@1@chr1:152573209-152586574@23.9@111@0@0@CNVR358.1@LCE3C_1, LCE3B_1@0@0@0@:late cornified envelope 3C:late cornified envelope 3B@:keratinization:keratinization@NA
A2463_02@14046@14053@duplication@8@161487766@161565521@1@chr1:161487766-161565521@20.8@1187@1641@1.38@CNVR383.3, CNVR383.1@FCGR2A_7, HSPA6_1, FCGR3A_5, FCGR3A_4, FCGR3A_3, FCGR3A_2, FCGR3A_1, FCGR2C_1@0@0@0@:Fc fragment of IgG, low affinity IIa, receptor (CD32):heat shock 70kDa protein 6 (HSP70B'):Fc fragment of IgG, low affinity IIIa, receptor (CD16a):Fc fragment of IgG, low affinity IIb, receptor (CD32):Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene)@:IgG binding;protein binding;integral to membrane;plasma membrane:signalosome;cell morphogenesis;response to unfolded protein;ATP binding:IgG binding;protein binding;regulation of immune response;extracellular region;integral to membrane;immune response;plasma membrane;external side of plasma membrane:IgG binding;protein binding;signal transduction;regulation of immune response;integral to membrane;immune response;plasma membrane;virus-host interaction@: MALARIA, SUSCEPTIBILITY TO; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
A2463_02@16026@16026@duplication@1@196712583@196712758@1@chr1:196712583-196712758@5.04@238@339@1.42@CNVR459.1@CFH_20@0@0@0@:complement factor H@:complement activation, alternative pathway;extracellular space;complement activation;extracellular region;regulation of complement activation;innate immune response@: HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1; AHUS1; MACULAR DEGENERATION, AGE-RELATED, 4; ARMD4; COMPLEMENT FACTOR H DEFICIENCY; CFHD; BASAL LAMINAR DRUSEN
A2463_02@16038@16038@deletion@1@196797201@196797376@1@chr1:196797201-196797376@9.29@124@52@0.419@CNVR459.1@CFHR1_4@0@0@0@:complement factor H-related 1:complement factor H-related 2@:extracellular space;complement activation:extracellular region@NA
A2463_02@19774@19778@deletion@5@248737103@248814185@1@chr1:248737103-248814185@27.5@927@547@0.59@CNVR600.1@OR2T34_1, OR2T10_1, OR2T11_1, OR2T35_1, OR2T27_1@0@0@0@:olfactory receptor, family 2, subfamily T, member 34:olfactory receptor, family 2, subfamily T, member 10:olfactory receptor, family 2, subfamily T, member 11:olfactory receptor, family 2, subfamily T, member 35:olfactory receptor, family 2, subfamily T, member 27@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_02@24822@24822@duplication@1@87178420@87178483@2@chr2:87178420-87178483@6.77@20@68@3.4@NA@RGPD1_2@0@0@0@:RANBP2-like and GRIP domain containing 1@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_02@24851@24851@deletion@1@88071689@88071883@2@chr2:88071689-88071883@5.37@36@8@0.222@NA@RGPD2_22@0@0@0@:RANBP2-like and GRIP domain containing 2@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_02@24862@24871@deletion@10@88094928@88118142@2@chr2:88094928-88118142@14.3@103@24@0.233@NA@RGPD2_11, RGPD2_10, RGPD2_9, RGPD2_8, RGPD2_7, RGPD2_6, RGPD2_5, RGPD2_4, RGPD2_3, RGPD2_2@0@0@0@:RANBP2-like and GRIP domain containing 2@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_02@25004@25005@duplication@2@90192949@90193424@2@chr2:90192949-90193424@6.83@176@265@1.51@CNVR867.10, CNVR867.5, CNVR867.3, CNVR867.9, CNVR867.15@IGKV1D-13_1, IGKV1D-13_2@0@0@0@@:protein binding@NA
A2463_02@25089@25091@deletion@3@96259773@96262180@2@chr2:96259773-96262180@18.9@343@169@0.493@NA@TRIM43_2, TRIM43_3, TRIM43_4@0@0@0@:tripartite motif containing 43B;tripartite motif containing 43@:protein binding;intracellular;zinc ion binding@NA
A2463_02@25369@25370@duplication@2@97854825@97855027@2@chr2:97854825-97855027@21.9@106@287@2.71@CNVR886.2, CNVR886.3@ANKRD36_33, ANKRD36_34@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_02@25383@25386@deletion@4@97867940@97870000@2@chr2:97867940-97870000@20.6@584@335@0.574@CNVR886.1@ANKRD36_47, ANKRD36_48, ANKRD36_49, ANKRD36_50@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_02@26008@26011@deletion@4@108454714@108460186@2@chr2:108454714-108460186@12@121@43@0.355@NA@RGPD4_3, RGPD4_4, RGPD4_5, RGPD4_6@0@0@0@:RANBP2-like and GRIP domain containing 4@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_02@26021@26021@deletion@1@108479139@108479317@2@chr2:108479139-108479317@4.83@145@85@0.586@NA@RGPD4_16@0@0@0@:RANBP2-like and GRIP domain containing 4@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_02@27163@27163@deletion@1@130843388@130843568@2@chr2:130843388-130843568@8.85@40@0@0@NA@POTEF_13@0@0@0@:POTE ankyrin domain family, member F@:cell cortex;protein binding;ATP binding@NA
A2463_02@27171@27173@deletion@3@130868117@130872627@2@chr2:130868117-130872627@10.5@112@44@0.393@NA@POTEF_5, POTEF_4, POTEF_3@0@0@0@:POTE ankyrin domain family, member F@:cell cortex;protein binding;ATP binding@NA
A2463_02@27279@27288@deletion@10@131381638@131415450@2@chr2:131381638-131415450@16.2@834@533@0.639@NA@POTEJ_6, POTEJ_7, POTEJ_8, POTEJ_9, POTEJ_10, POTEJ_11, POTEJ_12, POTEJ_13, POTEJ_14, POTEJ_15@0@0@0@:POTE ankyrin domain family, member J@:protein binding;ATP binding@NA
A2463_02@27318@27319@duplication@2@131984397@131985954@2@chr2:131984397-131985954@4.97@197@277@1.41@NA@POTEE_4, POTEE_5@0@0@0@:pleckstrin homology domain containing, family B (evectins) member 2:POTE ankyrin domain family, member E@:phospholipid binding;protein binding;recycling endosome membrane:protein binding;ATP binding@NA
A2463_02@27996@27997@duplication@2@152463121@152464122@2@chr2:152463121-152464122@6.83@88@155@1.76@CNVR1026.1@NEB_84, NEB_83@0@0@0@:nebulin@:Z disc;muscle filament sliding;oxidation-reduction process;contractile fiber part;actin cytoskeleton;regulation of actin filament length;structural constituent of muscle;cytosol;actin binding;protein binding;myofibril;somatic muscle development;muscle organ development@: NEMALINE MYOPATHY 2; NEM2
A2463_02@39892@39894@deletion@3@75786030@75790887@3@chr3:75786030-75790887@9.91@206@113@0.549@CNVR1432.5, CNVR1432.9, CNVR1432.4@ZNF717_5, ZNF717_4, ZNF717_3@0@0@0@:zinc finger protein 717;zinc finger protein 717-like@:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_02@41721@41722@deletion@2@126142169@126142487@3@chr3:126142169-126142487@6.28@62@23@0.371@NA@CCDC37_12, CCDC37_13@0@0@0@:coiled-coil domain containing 37@:pathogenesis;extracellular region@NA
A2463_02@46667@46675@deletion@9@9174900@9237700@4@chr4:9174900-9237700@24.1@124@9@0.0726@NA@FAM90A26P_4, FAM90A26P_5, FAM90A26P_6, FAM90A26P_7, USP17L13_1, USP17L10_1, USP17L11_1, USP17L12_1, USP17L13_2, USP17L15_1@0@0@0@:ubiquitin specific peptidase 17-like family member 10:ubiquitin specific peptidase 17-like family member 13:ubiquitin specific peptidase 17-like family member 11:ubiquitin specific peptidase 17-like family member 12:ubiquitin specific peptidase 17-like family member 15@:zinc ion binding;nucleic acid binding:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
A2463_02@46677@46677@deletion@1@9250357@9251948@4@chr4:9250357-9251948@10.9@292@154@0.527@NA@USP17L18_1@0@0@0@:ubiquitin specific peptidase 17-like family member 18@:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
A2463_02@48556@48561@deletion@6@69403344@69434202@4@chr4:69403344-69434202@84.6@483@51@0.106@CNVR1953.1@UGT2B17_6, UGT2B17_5, UGT2B17_4, UGT2B17_3, UGT2B17_2, UGT2B17_1@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B17@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;membrane@: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
A2463_02@48592@48597@deletion@6@70146220@70160527@4@chr4:70146220-70160527@13.3@660@432@0.655@CNVR1957.2, CNVR1957.1@UGT2B28_1, UGT2B28_2, UGT2B28_3, UGT2B28_4, UGT2B28_5, UGT2B28_6@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B28@:carbohydrate binding;transferase activity, transferring hexosyl groups;endoplasmic reticulum;glucuronosyltransferase activity;carbohydrate metabolic process;xenobiotic metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process@NA
A2463_02@55835@55837@deletion@3@70338009@70343940@5@chr5:70338009-70343940@11.7@103@37@0.359@CNVR2494.41, CNVR2494.14, CNVR2494.20, CNVR2494.62, CNVR2494.8@GTF2H2_14, GTF2H2_13, GTF2H2_12@0@0@0@:general transcription factor IIH, polypeptide 2, 44kDa@:nucleoplasm;nucleotide-excision repair, DNA damage removal;transcription from RNA polymerase I promoter;DNA repair;RNA polymerase II carboxy-terminal domain kinase activity;nucleus;viral reproduction;translation;gene expression;transcription elongation from RNA polymerase I promoter;response to UV;holo TFIIH complex;protein kinase activity;nucleotide-excision repair;transcription from RNA polymerase II promoter;transcription-coupled nucleotide-excision repair;transcription, DNA-dependent;zinc ion binding;transcription elongation from RNA polymerase II promoter;termination of RNA polymerase I transcription;sequence-specific DNA binding transcription factor activity;G-protein coupled receptor internalization;DNA-dependent ATPase activity;protein N-terminus binding;transcription initiation from RNA polymerase I promoter;7-methylguanosine mRNA capping;transcription initiation from RNA polymerase II promoter;protein phosphorylation;translation factor activity, nucleic acid binding;regulation of transcription, DNA-dependent;core TFIIH complex;protein binding;positive regulation of viral transcription;nucleic acid binding@NA
A2463_02@59046@59047@deletion@2@140228082@140238021@5@chr5:140228082-140238021@23.4@1521@904@0.594@CNVR2622.1@PCDHA9_1, PCDHA10_1@0@0@0@:protocadherin alpha 1:protocadherin alpha 2:protocadherin alpha 3:protocadherin alpha 4:protocadherin alpha 5:protocadherin alpha 6:protocadherin alpha 7:protocadherin alpha 8:protocadherin alpha 9:protocadherin alpha 10@:extracellular region;cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:integral to membrane;cell adhesion;homophilic cell adhesion;plasma membrane;integral to plasma membrane;membrane;nervous system development;calcium ion binding:cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:extracellular region;cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:integral to membrane;homophilic cell adhesion;plasma membrane;membrane;calcium ion binding:extracellular region;cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development@NA
A2463_02@59065@59065@deletion@1@140557617@140560021@5@chr5:140557617-140560021@23.3@2107@1106@0.525@CNVR2624.1@PCDHB8_1@0@0@0@:protocadherin beta 8@:integral to membrane;homophilic cell adhesion;plasma membrane;membrane;calcium ion binding@NA
A2463_02@59488@59488@deletion@1@147553798@147553933@5@chr5:147553798-147553933@6.64@30@0@0@CNVR2637.2, CNVR2637.1@SPINK14_3@0@0@0@:serine peptidase inhibitor, Kazal type 14 (putative)@:serine-type endopeptidase inhibitor activity;protein binding;extracellular region@NA
A2463_02@60882@60887@deletion@6@175487236@175523903@5@chr5:175487236-175523903@13.8@125@41@0.328@NA@RP11-826N14.2_2, FAM153B_3, FAM153B_4, FAM153B_5, FAM153B_6@0@0@0@:uncharacterized LOC100507387;family with sequence similarity 153, member B@NA@NA
A2463_02@61454@61455@duplication@2@179071801@179078353@5@chr5:179071801-179078353@5.3@153@226@1.48@NA@C5orf60_1, AC136604.1_1@0@0@0@:chromosome 5 open reading frame 60@:integral to membrane@NA
A2463_02@61640@61647@deletion@8@180376240@180431443@5@chr5:180376240-180431443@29.4@716@394@0.55@CNVR2719.1@BTNL8_7, BTNL8_8, BTNL3_1, BTNL3_2, BTNL3_3, BTNL3_4, BTNL3_5, BTNL3_6@0@0@0@:butyrophilin-like 8:butyrophilin-like 3@:protein binding;integral to membrane:protein binding;integral to membrane;molecular_function;cellular_component;biological_process@NA
A2463_02@63773@63777@duplication@5@31996235@31997575@6@chr6:31996235-31997575@6.85@579@759@1.31@CNVR2843.6, CNVR2843.5@C4B_25, C4B_26, C4B_27, C4B_28, C4B_29@0@0@0@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
A2463_02@63953@63955@deletion@3@32485517@32486443@6@chr6:32485517-32486443@5.92@35@6@0.171@CNVR2845.21, CNVR2845.25, CNVR2845.30@HLA-DRB5_6, HLA-DRB5_5, HLA-DRB5_4@0@0@0@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
A2463_02@65214@65215@deletion@2@42023270@42023752@6@chr6:42023270-42023752@5.06@84@43@0.512@NA@TAF8_3, TAF8_4@0@0@0@:TAF8 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 43kDa@:cell differentiation;protein heterodimerization activity;transcription factor TFIID complex;perinuclear region of cytoplasm;maintenance of protein location in nucleus;protein binding;positive regulation of transcription, DNA-dependent;regulation of fat cell differentiation;nucleus;transcription, DNA-dependent;inner cell mass cell proliferation@NA
A2463_02@70808@70817@deletion@10@161032595@161056336@6@chr6:161032595-161056336@21.9@236@91@0.386@CNVR3133.1@LPA_17, LPA_16, LPA_15, LPA_14, LPA_13, LPA_12, LPA_11, LPA_10, LPA_9, LPA_8@0@0@0@:lipoprotein, Lp(a)@:blood circulation;endopeptidase inhibitor activity;catalytic activity;lipoprotein metabolic process;proteolysis;heparin binding;receptor-mediated endocytosis;fibronectin binding;small molecule metabolic process;apolipoprotein binding;lipid metabolic process;negative regulation of endopeptidase activity;extracellular region;plasma lipoprotein particle;lipid transport;serine-type endopeptidase activity@: APOLIPOPROTEIN(a); LPA
A2463_02@71011@71011@duplication@1@167590486@167590622@6@chr6:167590486-167590622@4.74@76@126@1.66@NA@TCP10L2_4@0@0@0@:t-complex 10;t-complex 10-like 2@NA@NA
A2463_02@71030@71032@deletion@3@167790035@167794824@6@chr6:167790035-167794824@16.2@130@38@0.292@NA@TCP10_5, TCP10_4, TCP10_3@0@0@0@:t-complex 10@:cytosol@NA
A2463_02@71746@71758@duplication@13@5940487@5966179@7@chr7:5940487-5966179@33.8@893@1341@1.5@NA@CCZ1_4, CCZ1_5, CCZ1_6, CCZ1_7, CCZ1_8, CCZ1_9, CCZ1_10, CCZ1_11, CCZ1_12, CCZ1_13, CCZ1_14, CCZ1_15, RSPH10B_20@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae):radial spoke head 10 homolog B (Chlamydomonas)@:lysosomal membrane@NA
A2463_02@71772@71776@duplication@5@5998625@6006747@7@chr7:5998625-6006747@8.64@153@248@1.62@NA@RSPH10B_6, RSPH10B_5, RSPH10B_4, RSPH10B_3, RSPH10B_2@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
A2463_02@71922@71927@deletion@6@6797310@6806508@7@chr7:6797310-6806508@18.7@272@125@0.46@NA@RSPH10B2_2, RSPH10B2_3, RSPH10B2_4, RSPH10B2_5, RSPH10B2_6, RSPH10B2_7@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
A2463_02@71939@71953@deletion@15@6836200@6864179@7@chr7:6836200-6864179@60.3@1067@548@0.514@NA@RSPH10B2_19, RSPH10B2_20, CCZ1B_15, CCZ1B_14, CCZ1B_13, CCZ1B_12, CCZ1B_11, CCZ1B_10, CCZ1B_9, CCZ1B_8, CCZ1B_7, CCZ1B_6, CCZ1B_5, CCZ1B_4, CCZ1B_3@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
A2463_02@73260@73263@duplication@4@38388957@38393784@7@chr7:38388957-38393784@9.67@211@325@1.54@CNVR3354.3, CNVR3354.1@TRGV5_2, TRGV5_1, TRGV4_2, TRGV4_1@0@0@0@@:protein binding:protein binding@NA
A2463_02@74573@74573@duplication@1@74166423@74166502@7@chr7:74166423-74166502@6.86@66@129@1.95@NA@GTF2I_28@0@0@0@:general transcription factor IIi@:neuronal cell body;transcription initiation from RNA polymerase II promoter;mitogen-activated protein kinase binding;negative regulation of angiogenesis;DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;cytoplasm;transcription from RNA polymerase II promoter;protein binding;signal transduction;nucleus;cell projection;reduction of cytosolic calcium ion concentration@NA
A2463_02@74597@74598@duplication@2@74225431@74227349@7@chr7:74225431-74227349@9.42@45@115@2.56@NA@GTF2IRD2_10, GTF2IRD2_9@0@0@0@:GTF2I repeat domain containing 2@:nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_02@74634@74635@deletion@2@74550812@74552657@7@chr7:74550812-74552657@6.04@121@64@0.529@NA@GTF2IRD2B_10, GTF2IRD2B_11@0@0@0@:GTF2I repeat domain containing 2B@:nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_02@76779@76793@deletion@15@102279571@102312048@7@chr7:102279571-102312048@17.5@170@61@0.359@CNVR3518.1@UPK3BL_4, UPK3BL_4, UPK3BL_3, UPK3BL_3, UPK3BL_2, UPK3BL_2, UPK3BL_1, UPK3BL_1, SPDYE2L_2, SPDYE2L_3, SPDYE2L_4, SPDYE2L_5, SPDYE2L_6, SPDYE2L_7, SPDYE2L_8, POLR2J2_4, POLR2J2_4, POLR2J2_3, POLR2J2_3, POLR2J2_2, POLR2J2_2, POLR2J2_1, POLR2J2_1@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4:uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J2:WBSCR19-like protein 3;speedy homolog E6 (Xenopus laevis)@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity:integral to membrane:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
A2463_02@77407@77407@deletion@1@111958238@111958328@7@chr7:111958238-111958328@6.11@72@30@0.417@NA@ZNF277_5@0@0@0@:zinc finger protein 277@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;sequence-specific DNA binding transcription factor activity;nucleic acid binding@NA
A2463_02@79287@79288@duplication@2@143400089@143417767@7@chr7:143400089-143417767@8.3@113@193@1.71@CNVR3594.2, CNVR3594.1@FAM115C_2, FAM115C_3@0@0@0@:family with sequence similarity 115, member C;protein FAM115C-like@NA@NA
A2463_02@80364@80366@deletion@3@7217760@7220468@8@chr8:7217760-7220468@5.86@333@221@0.664@CNVR3771.8, CNVR3771.10, CNVR3771.4@ZNF705G_5, ZNF705G_4, ZNF705G_3@0@0@0@:zinc finger protein 705G@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_02@80387@80388@duplication@2@7636684@7637611@8@chr8:7636684-7637611@5.08@14@49@3.5@CNVR3772.4, CNVR3772.6, CNVR3772.2, CNVR3772.8, CNVR3772.10@AC084121.16_4, AC084121.16_3@0@0@0@:uncharacterized LOC100133251@NA@NA
A2463_02@80565@80565@duplication@1@11994678@11996269@8@chr8:11994678-11996269@5.42@1137@1521@1.34@CNVR3785.8, CNVR3785.5, CNVR3785.6, CNVR3785.2, CNVR3785.1, CNVR3785.3@USP17L2_1@0@0@0@:ubiquitin specific peptidase 17-like family member 1, pseudogene;ubiquitin specific peptidase 17-like family member 2;ubiquitin specific peptidase 17-like family member 4;ubiquitin specific peptidase 17-like family member 7;ubiquitin specific peptidase 17-like family member 8;ubiquitin specific peptidase 17-like family member 3@:protein deubiquitination;ubiquitin-specific protease activity;mitotic cell cycle G1/S transition checkpoint;nucleus;G2/M transition checkpoint;apoptotic process;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
A2463_02@88596@88596@deletion@1@43828079@43828221@9@chr9:43828079-43828221@7.63@50@10@0.2@CNVR4294.1@CNTNAP3B_9@0@0@0@:contactin associated protein-like 3B;contactin associated protein-like 3@:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
A2463_02@88610@88611@deletion@2@43915827@43920370@9@chr9:43915827-43920370@8.41@71@22@0.31@NA@CNTNAP3B_23, CNTNAP3B_24@0@0@0@:contactin associated protein-like 3B;contactin associated protein-like 3@:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
A2463_02@88620@88622@duplication@3@45727245@45733965@9@chr9:45727245-45733965@10.3@149@254@1.7@CNVR4305.1@FAM27A_1, AL953889.1_2, AL953889.1_1, FAM27A_2, FAM27E2_1@0@0@0@NA@NA@NA
A2463_02@88631@88632@duplication@2@65503517@65507567@9@chr9:65503517-65507567@12.3@201@341@1.7@CNVR4312.5@SPATA31A7_4, SPATA31A7_3@0@0@0@:SPATA31 subfamily A, member 7@:integral to membrane@NA
A2463_02@88643@88643@deletion@1@67935876@67936012@9@chr9:67935876-67936012@5.68@25@0@0@NA@ANKRD20A1_5@0@0@0@:ankyrin repeat domain 20 family, member A1@:protein binding;plasma membrane@NA
A2463_02@88647@88657@deletion@11@67951933@67987998@9@chr9:67951933-67987998@31.5@838@507@0.605@NA@ANKRD20A1_9, ANKRD20A1_10, ANKRD20A1_11, ANKRD20A1_12, ANKRD20A1_13, ANKRD20A1_14, ANKRD20A1_15, RP11-195B21.3_3, RP11-195B21.3_4, RP11-195B21.3_5, RP11-195B21.3_6@0@0@0@:ankyrin repeat domain 20 family, member A1:coiled-coil domain-containing protein 29-like;uncharacterized LOC644249@:protein binding;plasma membrane@NA
A2463_02@88681@88690@duplication@10@69393823@69424176@9@chr9:69393823-69424176@39.6@674@1181@1.75@NA@ANKRD20A4_6, ANKRD20A4_7, ANKRD20A4_8, ANKRD20A4_9, ANKRD20A4_10, ANKRD20A4_11, ANKRD20A4_12, ANKRD20A4_13, ANKRD20A4_14, ANKRD20A4_15@0@0@0@:ankyrin repeat domain 20 family, member A4@:protein binding@NA
A2463_02@91242@91246@duplication@5@117085415@117087432@9@chr9:117085415-117087432@27.1@338@635@1.88@CNVR4448.1@ORM1_1, ORM1_2, ORM1_3, ORM1_4, ORM1_5@0@0@0@:orosomucoid 1@:protein binding;extracellular space;regulation of immune system process;transport;inflammatory response;extracellular region;acute-phase response@NA
A2463_02@91249@91249@deletion@1@117092715@117092856@9@chr9:117092715-117092856@11.8@146@57@0.39@CNVR4448.1@ORM2_2@0@0@0@:orosomucoid 2@:extracellular space;regulation of immune system process;transport;acute-phase response@NA
A2463_02@95350@95352@duplication@3@17865074@17875838@10@chr10:17865074-17875838@7.05@117@190@1.62@NA@MRC1L1_2, MRC1L1_3, MRC1L1_4@0@0@0@:macrophage mannose receptor 1-like@:carbohydrate binding@NA
A2463_02@95384@95386@deletion@3@18112045@18122792@10@chr10:18112045-18122792@11.3@71@14@0.197@NA@MRC1_2, MRC1_3, MRC1_4@0@0@0@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
A2463_02@96467@96470@deletion@4@46587345@46611811@10@chr10:46587345-46611811@8.57@44@4@0.0909@CNVR4712.3@PTPN20A_5, PTPN20A_4, PTPN20A_3, PTPN20A_2@0@0@0@:protein tyrosine phosphatase, non-receptor type 20B;protein tyrosine phosphatase, non-receptor type 20A@:phosphatase activity;protein tyrosine phosphatase activity;microtubule;nucleus;dephosphorylation;protein dephosphorylation;microtubule organizing center@NA
A2463_02@96480@96481@duplication@2@46998882@47087911@10@chr10:46998882-47087911@5.63@640@844@1.32@CNVR4712.9, CNVR4712.2, CNVR4712.7, CNVR4712.4@GPRIN2_1, PPYR1_3@0@0@0@:G protein regulated inducer of neurite outgrowth 2:pancreatic polypeptide receptor 1;neuropeptide Y receptor type 4-like@:blood circulation;peptide YY receptor activity;peptide binding;pancreatic polypeptide receptor activity;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;integral to membrane;digestion;plasma membrane;integral to plasma membrane;feeding behavior@NA
A2463_02@96499@96499@deletion@1@47207813@47207846@10@chr10:47207813-47207846@6.06@45@12@0.267@CNVR4712.9@AGAP10_6@0@0@0@:ArfGAP with GTPase domain, ankyrin repeat and PH domain 9@:phospholipid binding;protein binding;ARF GTPase activator activity;GTP binding;GTPase activity;zinc ion binding;regulation of ARF GTPase activity@NA
A2463_02@96538@96577@deletion@40@47899952@48033105@10@chr10:47899952-48033105@113@980@331@0.338@CNVR4715.2@FAM21B_4, FAM21B_5, FAM21B_6, FAM21B_7, FAM21B_8, FAM21B_9, FAM21B_10, FAM21B_11, FAM21B_12, FAM21B_13, FAM21B_14, FAM21B_15, FAM21B_16, FAM21B_17, FAM21B_18, FAM21B_19, FAM21B_20, FAM21B_21, FAM21B_22, FAM21B_23, FAM21B_24, FAM21B_25, FAM21B_26, FAM21B_27, FAM21B_28, FAM21B_29, ASAH2C_18, ASAH2C_17, ASAH2C_16, ASAH2C_15, ASAH2C_14, ASAH2C_13, ASAH2C_12, ASAH2C_11, ASAH2C_10, ASAH2C_9, ASAH2C_8, ASAH2C_7, ASAH2C_6, ASAH2C_5@0@0@0@:family with sequence similarity 21, member B@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome:ceramidase activity;sphingolipid metabolic process@NA
A2463_02@96620@96620@deletion@1@48771316@48771405@10@chr10:48771316-48771405@13.3@63@1@0.0159@CNVR4716.10, CNVR4716.3@PTPN20B_6@0@0@0@:protein tyrosine phosphatase, non-receptor type 20B;protein tyrosine phosphatase, non-receptor type 20A@:phosphatase activity;protein tyrosine phosphatase activity;microtubule;nucleus;dephosphorylation;protein dephosphorylation;microtubule organizing center@NA
A2463_02@96898@96922@duplication@25@51843833@51890838@10@chr10:51843833-51890838@29.4@655@996@1.52@CNVR4734.2@FAM21A_6, FAM21A_7, FAM21A_8, FAM21A_9, FAM21A_10, FAM21A_11, FAM21A_12, FAM21A_13, FAM21A_14, FAM21A_15, FAM21A_16, FAM21A_17, FAM21A_18, FAM21A_19, FAM21A_20, FAM21A_21, FAM21A_22, FAM21A_23, FAM21A_24, FAM21A_25, FAM21A_26, FAM21A_27, FAM21A_28, FAM21A_29, FAM21A_30@0@0@0@:family with sequence similarity 21, member B;family with sequence similarity 21, member A@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_02@96932@96937@duplication@6@51965743@51978390@10@chr10:51965743-51978390@13.3@75@173@2.31@NA@ASAH2_12, ASAH2_11, ASAH2_10, ASAH2_9, ASAH2_8, ASAH2_7@0@0@0@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
A2463_02@96952@96952@duplication@1@52504963@52505034@10@chr10:52504963-52505034@5.06@17@53@3.12@NA@ASAH2B_3@0@0@0@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2B@NA@NA
A2463_02@98348@98350@duplication@3@81470139@81472241@10@chr10:81470139-81472241@5.8@477@637@1.34@CNVR4815.2, CNVR4815.4@FAM22B_5, FAM22B_6, FAM22B_7@0@0@0@NA@NA@NA
A2463_02@98353@98357@deletion@5@81606587@81610362@10@chr10:81606587-81610362@18.3@105@13@0.124@NA@FAM22E_3, FAM22E_4, FAM22E_5, FAM22E_6, FAM22E_7@0@0@0@NA@NA@NA
A2463_02@98599@98599@deletion@1@88992361@88992742@10@chr10:88992361-88992742@5.73@39@9@0.231@CNVR4840.3, CNVR4840.5, CNVR4840.6@FAM22A_5@0@0@0@:family with sequence similarity 22, member A@NA@NA
A2463_02@101622@101622@deletion@1@124361314@124361636@10@chr10:124361314-124361636@8.92@45@3@0.0667@CNVR4912.1@DMBT1_29@0@0@0@:deleted in malignant brain tumors 1@:defense response to virus;calcium-dependent protein binding;pattern recognition receptor signaling pathway;blastocyst development;response to estrogen stimulus;tissue regeneration;proteinaceous extracellular matrix;protein transport;Gram-negative bacterial cell surface binding;positive regulation of epithelial cell differentiation;virus-host interaction;epithelial cell differentiation;induction of bacterial agglutination;phagocytic vesicle membrane;intracellular;Gram-positive bacterial cell surface binding;zymogen binding;innate immune response;cytoplasm;extrinsic to membrane;protein binding;zymogen granule membrane;extracellular region;scavenger receptor activity;pattern recognition receptor activity;inner cell mass cell proliferation;membrane@: GLIOMA SUSCEPTIBILITY 1; GLM1
A2463_02@103289@103290@deletion@2@5270599@5271034@11@chr11:5270599-5271034@14.3@79@8@0.101@NA@HBG1_2, HBG1_1@0@0@0@:hemoglobin, gamma A@:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex@NA
A2463_02@106571@106578@deletion@8@60971038@60978907@11@chr11:60971038-60978907@15.1@109@28@0.257@CNVR5194.1@PGA3_1, PGA3_2, PGA3_3, PGA3_4, PGA3_5, PGA3_6, PGA3_7, PGA3_8@0@0@0@:pepsinogen 3, group I (pepsinogen A)@:proteolysis;extracellular region;digestion;aspartic-type endopeptidase activity@NA
A2463_02@114424@114429@deletion@6@10583717@10588585@12@chr12:10583717-10588585@27.4@659@373@0.566@CNVR5430.1@KLRC2_6, KLRC2_5, KLRC2_4, KLRC2_3, NKG2-E_3, KLRC2_2, NKG2-E_2, KLRC2_1, NKG2-E_1@0@0@0@:killer cell lectin-like receptor subfamily C, member 2@:carbohydrate binding:transmembrane signaling receptor activity;carbohydrate binding;protein binding;signal transduction;cellular defense response;integral to plasma membrane@NA
A2463_02@114483@114483@duplication@1@11243900@11244828@12@chr12:11243900-11244828@15.5@233@447@1.92@CNVR5434.1@TAS2R43_1@0@0@0@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):taste receptor, type 2, member 14:taste receptor, type 2, member 43@:extracellular space;visual perception:bitter taste receptor activity;taste receptor activity;integral to membrane;sensory perception of taste;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of bitter taste:G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;motile cilium;taste receptor activity;bitter taste receptor activity;integral to membrane;sensory perception of taste;detection of chemical stimulus involved in sensory perception of bitter taste;cilium membrane@NA
A2463_02@124178@124178@deletion@1@24468279@24468340@13@chr13:24468279-24468340@5.85@35@6@0.171@NA@C1QTNF9B_2@0@0@0@:C1q and tumor necrosis factor related protein 9B@:collagen;protein binding@NA
A2463_02@127333@127336@deletion@4@19553418@19562100@14@chr14:19553418-19562100@11.8@635@426@0.671@CNVR6072.1@POTEG_1, POTEG_2, POTEG_3, POTEG_4@0@0@0@:POTE ankyrin domain family, member G@:protein binding@NA
A2463_02@127339@127340@deletion@2@19571349@19573144@14@chr14:19571349-19573144@13.4@218@103@0.472@CNVR6072.1@POTEG_7, POTEG_8@0@0@0@:POTE ankyrin domain family, member G@:protein binding@NA
A2463_02@127352@127352@duplication@1@20019701@20020220@14@chr14:20019701-20020220@4.44@171@246@1.44@CNVR6072.6, CNVR6072.12@POTEM_1@0@0@0@:POTE ankyrin domain family, member M@:protein binding@NA
A2463_02@130410@130412@duplication@3@65016717@65019579@14@chr14:65016717-65019579@8.9@175@273@1.56@CNVR6172.1@PPP1R36_1, PPP1R36_2, PPP1R36_3@0@0@0@:protein phosphatase 1, regulatory subunit 36@:phosphatase binding;protein phosphatase inhibitor activity;negative regulation of phosphatase activity@NA
A2463_02@133317@133320@duplication@4@105933045@105936552@14@chr14:105933045-105936552@7.15@179@264@1.47@NA@MTA1_18, MTA1_19, MTA1_20, MTA1_21@0@0@0@:metastasis associated 1@:intracellular membrane-bounded organelle;endoplasmic reticulum;sequence-specific DNA binding;enzyme binding;DNA binding;regulation of transcription, DNA-dependent;sequence-specific DNA binding transcription factor activity;cytoplasm;NuRD complex;protein binding;chromatin binding;signal transduction;secretory granule organization;nucleus;zinc ion binding@NA
A2463_02@133349@133351@duplication@3@106090814@106091716@14@chr14:106090814-106091716@10@324@477@1.47@CNVR6294.46, CNVR6294.20, CNVR6294.54, CNVR6294.43, CNVR6294.50, CNVR6294.61@IGHG4_4, IGHG4_3, IGHG4_2@0@0@0@@:antigen binding;protein binding;complement activation;extracellular region;immune response;membrane;complement activation, classical pathway;innate immune response@NA
A2463_02@133426@133426@deletion@1@106478111@106478411@14@chr14:106478111-106478411@5.45@62@25@0.403@CNVR6294.36, CNVR6294.48, CNVR6294.12, CNVR6294.24@IGHV4-4_2@0@0@0@@:protein binding@NA
A2463_02@133432@133435@duplication@4@106539080@106552729@14@chr14:106539080-106552729@7.07@103@170@1.65@CNVR6294.36, CNVR6294.48, CNVR6294.24, CNVR6294.10, CNVR6294.34@IGHV1-8_2, IGHV1-8_1, IGHV3-9_2, IGHV3-9_1@0@0@0@@:protein binding:protein binding@NA
A2463_02@133460@133463@duplication@4@106805210@106816173@14@chr14:106805210-106816173@15.1@130@264@2.03@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.41@IGHV4-31_2, IGHV4-31_1, IGHV3-33_2, IGHV3-33_1@0@0@0@@:protein binding:protein binding@NA
A2463_02@133552@133552@duplication@1@22742397@22743598@15@chr15:22742397-22743598@4.76@756@1010@1.34@CNVR6298.5@GOLGA6L1_8@0@0@0@:golgin A6 family-like 1;putative transmembrane protein FLJ36131-like;putative transmembrane protein ENSP00000320207-like;putative golgin subfamily A member 6-like@NA@NA
A2463_02@133636@133641@deletion@6@23406272@23411062@15@chr15:23406272-23411062@7.05@501@342@0.683@CNVR6300.8@RP11-467N20.5_8, RP11-467N20.5_7, RP11-467N20.5_6, RP11-467N20.5_5, RP11-467N20.5_4, RP11-467N20.5_3@0@0@0@:putative golgin subfamily A member 6-like protein 6-like@NA@NA
A2463_02@133869@133870@deletion@2@28629294@28629596@15@chr15:28629294-28629596@5.56@25@0@0@CNVR6329.4@GOLGA8F_9, GOLGA8F_10@0@0@0@@:Golgi apparatus@NA
A2463_02@134036@134040@deletion@5@30845996@30848525@15@chr15:30845996-30848525@13.8@81@13@0.16@NA@GOLGA8Q_2, GOLGA8Q_3, GOLGA8Q_4, GOLGA8Q_5, GOLGA8Q_6@0@0@0@@:Golgi apparatus@NA
A2463_02@134044@134054@deletion@11@30850148@30896376@15@chr15:30850148-30896376@28.2@152@16@0.105@CNVR6339.2, CNVR6339.3, CNVR6339.1@GOLGA8Q_10, GOLGA8Q_11, GOLGA8Q_12, GOLGA8Q_13, GOLGA8Q_14, GOLGA8Q_15, GOLGA8Q_16, GOLGA8Q_17, GOLGA8Q_18, GOLGA8Q_19, GOLGA8H_1@0@0@0@:golgin A8 family, member H@:Golgi apparatus:Golgi apparatus@NA
A2463_02@134158@134162@duplication@5@32684984@32686434@15@chr15:32684984-32686434@16.3@163@303@1.86@NA@GOLGA8K_19, GOLGA8K_18, GOLGA8K_17, GOLGA8K_16, GOLGA8K_15@0@0@0@:golgin A8 family, member J@:Golgi apparatus@NA
A2463_02@134174@134177@duplication@4@32692604@32695395@15@chr15:32692604-32695395@9.79@73@151@2.07@NA@GOLGA8K_3, GOLGA8K_2, AC139426.2_1, GOLGA8K_1@0@0@0@:golgin A8 family, member J@:Golgi apparatus@NA
A2463_02@134180@134190@deletion@11@32737820@32743403@15@chr15:32737820-32743403@8.09@186@112@0.602@CNVR6346.1@GOLGA8O_17, GOLGA8O_16, GOLGA8O_15, GOLGA8O_14, GOLGA8O_13, GOLGA8O_12, GOLGA8O_11, GOLGA8O_10, GOLGA8O_9, GOLGA8O_8, GOLGA8O_7@0@0@0@:golgin A8 family, member O@:Golgi apparatus@NA
A2463_02@135680@135681@deletion@2@43873201@43873586@15@chr15:43873201-43873586@13.5@429@248@0.578@CNVR6365.1@PPIP5K1_10, PPIP5K1_9@0@0@0@:diphosphoinositol pentakisphosphate kinase 1@:inositol hexakisphosphate 3-kinase activity;inositol hexakisphosphate 1-kinase activity;inositol metabolic process;diphosphoinositol-pentakisphosphate kinase activity;ATP binding;acid phosphatase activity;cytoplasm;cytosol;inositol hexakisphosphate 5-kinase activity;nucleus;kinase activity;inositol-1,3,4,5,6-pentakisphosphate kinase activity@NA
A2463_02@138284@138287@duplication@4@72954594@72957376@15@chr15:72954594-72957376@14.9@148@279@1.89@CNVR6443.1@GOLGA6B_11, GOLGA6B_12, GOLGA6B_13, GOLGA6B_14@0@0@0@:golgin A6 family, member B@:Golgi apparatus@NA
A2463_02@138416@138416@deletion@1@74364560@74364650@15@chr15:74364560-74364650@4.83@111@61@0.55@CNVR6448.1@GOLGA6A_14@0@0@0@:golgin A6 family, member C;golgin A6 family, member A;golgin A6 family, member D;golgin A6 family, member B@:Golgi apparatus@NA
A2463_02@138421@138422@deletion@2@74368025@74368326@15@chr15:74368025-74368326@5.88@112@59@0.527@CNVR6448.1@GOLGA6A_9, GOLGA6A_8@0@0@0@:golgin A6 family, member C;golgin A6 family, member A;golgin A6 family, member D;golgin A6 family, member B@:Golgi apparatus@NA
A2463_02@138632@138637@duplication@6@75555690@75557765@15@chr15:75555690-75557765@7.37@266@372@1.4@CNVR6452.1@GOLGA6C_4, GOLGA6C_5, GOLGA6C_6, GOLGA6C_7, GOLGA6C_8, GOLGA6C_9@0@0@0@:golgin A6 family, member C@:Golgi apparatus@NA
A2463_02@143607@143607@deletion@1@22544948@22547706@16@chr16:22544948-22547706@7.91@357@214@0.599@CNVR6669.2@NPIPL3_7@0@0@0@:nuclear pore complex interacting protein pseudogene;nuclear pore complex interacting protein related gene;nuclear pore complex interacting protein-like@:integral to membrane@NA
A2463_02@144288@144290@deletion@3@29468954@29469445@16@chr16:29468954-29469445@7.48@34@0@0@CNVR6690.2, CNVR6690.3, CNVR6690.4@SLX1B_4, SLX1B_5, SLX1B_6@0@0@0@:structure-specific endonuclease subunit SLX1-like;SLX1 structure-specific endonuclease subunit homolog B (S. cerevisiae);SLX1 structure-specific endonuclease subunit homolog A (S. cerevisiae):sulfotransferase family, cytosolic, 1A, phenol-preferring, member 4;sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3;sulfotransferase 1A3/1A4-like@:Slx1-Slx4 complex;5'-flap endonuclease activity;DNA repair;protein binding;DNA double-strand break processing involved in repair via single-strand annealing;double-strand break repair via homologous recombination;metal ion binding;crossover junction endodeoxyribonuclease activity:steroid metabolic process;small molecule metabolic process;sulfation;aryl sulfotransferase activity;cytoplasm;catecholamine metabolic process;cytosol;endoplasmic reticulum unfolded protein response;xenobiotic metabolic process;sulfotransferase activity;activation of signaling protein activity involved in unfolded protein response;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process@NA
A2463_02@144303@144303@duplication@1@29495011@29497154@16@chr16:29495011-29497154@4.76@74@124@1.68@CNVR6690.2, CNVR6690.4@NPIPL3_3@0@0@0@NA@NA@NA
A2463_02@147125@147125@deletion@1@70208183@70208305@16@chr16:70208183-70208305@4.9@23@1@0.0435@CNVR6764.1@CLEC18C_1@0@0@0@:C-type lectin domain family 18, member C@:carbohydrate binding;protein binding;extracellular region@NA
A2463_02@147421@147421@deletion@1@72093014@72093087@16@chr16:72093014-72093087@5.36@64@27@0.422@CNVR6769.1, CNVR6769.2@HP_6@0@0@0@:thioredoxin-like 4B:haptoglobin:haptoglobin-related protein@:mitosis;mRNA processing;RNA splicing;spliceosomal complex;cell redox homeostasis:cellular iron ion homeostasis;negative regulation of oxidoreductase activity;catalytic activity;negative regulation of hydrogen peroxide catabolic process;positive regulation of cell death;haptoglobin-hemoglobin complex;extracellular space;proteolysis;response to hydrogen peroxide;extracellular region;hemoglobin binding;defense response;serine-type endopeptidase activity:spherical high-density lipoprotein particle;proteolysis;extracellular region;hemoglobin binding;catalytic activity;serine-type endopeptidase activity@: ANHAPTOGLOBINEMIA; AHP
A2463_02@147513@147515@duplication@3@74451958@74455168@16@chr16:74451958-74455168@9.13@123@213@1.73@CNVR6778.2, CNVR6778.3@CLEC18B_3, CLEC18B_2, CLEC18B_1@0@0@0@:C-type lectin domain family 18, member B@:carbohydrate binding;protein binding;extracellular region@NA
A2463_02@152122@152129@deletion@8@20353287@20359984@17@chr17:20353287-20359984@15.8@138@49@0.355@CNVR7021.1, CNVR7021.3@LGALS9B_11, LGALS9B_10, LGALS9B_9, LGALS9B_8, LGALS9B_7, LGALS9B_6, LGALS9B_5, LGALS9B_4@0@0@0@:lectin, galactoside-binding, soluble, 9B@:carbohydrate binding@NA
A2463_02@153380@153382@deletion@3@34539179@34581968@17@chr17:34539179-34581968@7.61@37@2@0.0541@CNVR7077.1, CNVR7077.13, CNVR7077.19@CCL4L1_2, CCL4L1_3, TBC1D3C_14@0@0@0@:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1:TBC1 domain family, member 3C;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3H-like;TBC1 domain family, member 3H@:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_02@153394@153394@deletion@1@34590384@34590454@17@chr17:34590384-34590454@4.69@21@0@0@CNVR7077.1, CNVR7077.13, CNVR7077.19, CNVR7077.10, CNVR7077.2@TBC1D3C_2@0@0@0@:TBC1 domain family, member 3C;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3H-like;TBC1 domain family, member 3H@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_02@153414@153414@deletion@1@34797487@34798054@17@chr17:34797487-34798054@18@84@0@0@CNVR7078.2, CNVR7078.3@TBC1D3G_14@0@0@0@:TBC1 domain family member 3H-like;TBC1 domain family, member 3H:TBC1 domain family, member 3;TBC1 domain family, member 3G;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like;TBC1 domain family, member 3H@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_02@153643@153643@duplication@1@36342585@36342632@17@chr17:36342585-36342632@6.07@24@68@2.83@CNVR7083.3@TBC1D3_12@0@0@0@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
A2463_02@154346@154346@deletion@1@39421631@39422112@17@chr17:39421631-39422112@5.78@53@18@0.34@CNVR7096.1@KRTAP9-6_1@0@0@0@:keratin associated protein 9-6@:keratin filament@NA
A2463_02@155584@155588@deletion@5@44380005@44400393@17@chr17:44380005-44400393@10.2@94@34@0.362@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A_3, LRRC37A_4, LRRC37A_5, LRRC37A_6, LRRC37A_7@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
A2463_02@155592@155600@deletion@9@44412912@44594799@17@chr17:44412912-44594799@38.6@218@28@0.128@CNVR7114.2, CNVR7114.1@LRRC37A_11, LRRC37A_12, LRRC37A_13, LRRC37A_14, ARL17B_4, ARL17B_3, ARL17B_2, LRRC37A2_2, LRRC37A2_3@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
A2463_02@157443@157445@deletion@3@61950196@61950974@17@chr17:61950196-61950974@5.23@167@102@0.611@NA@CSH2_3, CSH2_2, CSH2_1@0@0@0@:chorionic somatomammotropin hormone 2@:JAK-STAT cascade involved in growth hormone signaling pathway;signal transduction;female pregnancy;hormone activity;extracellular region;metal ion binding@NA
A2463_02@157452@157454@duplication@3@61973092@61973871@17@chr17:61973092-61973871@8.76@55@124@2.25@NA@CSH1_3, CSH1_2, CSH1_1@0@0@0@:chorionic somatomammotropin hormone 1 (placental lactogen);chorionic somatomammotropin hormone-like 1@:JAK-STAT cascade involved in growth hormone signaling pathway;signal transduction;hormone activity;extracellular region;female pregnancy;metal ion binding@NA
A2463_02@160150@160153@duplication@4@47391@49557@18@chr18:47391-49557@6.79@571@754@1.32@CNVR7228.2@RP11-683L23.1_4, RP11-683L23.1_3, RP11-683L23.1_2, RP11-683L23.1_1@0@0@0@@:GTPase activity;protein complex;GTP catabolic process;cytoplasm;microtubule cytoskeleton;protein polymerization;microtubule-based movement;structural molecule activity;microtubule;GTP binding;plasma membrane@NA
A2463_02@162017@162018@deletion@2@44542732@44550298@18@chr18:44542732-44550298@84.7@440@6@0.0136@CNVR7319.1, CNVR7319.2@TCEB3CL2_1, TCEB3CL_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2:transcription elongation factor B polypeptide 3C-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_02@162017@162019@duplication@1@44542732@44556213@18@chr18:44542732-44556213@-59@2237@3399@1.52@CNVR7319.1, CNVR7319.2@TCEB3CL2_1, TCEB3CL_1, TCEB3C_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2:transcription elongation factor B polypeptide 3C-like:transcription elongation factor B polypeptide 3C (elongin A3);RNA polymerase II transcription factor SIII subunit A3-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_02@164950@164955@deletion@6@7030624@7051633@19@chr19:7030624-7051633@10.6@167@86@0.515@CNVR7517.1@MBD3L5_1, MBD3L5_2, MBD3L4_2, MBD3L4_1, MBD3L2_1, MBD3L2_2@0@0@0@:methyl-CpG binding domain protein 3-like 5:methyl-CpG binding domain protein 3-like 4:methyl-CpG-binding domain protein 3-like 2-like;methyl-CpG binding domain protein 3-like 2@:regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_02@167457@167460@duplication@4@17014513@17017927@19@chr19:17014513-17017927@5.88@155@226@1.46@NA@CPAMD8_33, CPAMD8_32, CPAMD8_31, CPAMD8_30@0@0@0@:C3 and PZP-like, alpha-2-macroglobulin domain containing 8@:serine-type endopeptidase inhibitor activity;protein binding;extracellular space;extracellular region;endopeptidase inhibitor activity;plasma membrane@NA
A2463_02@168952@168952@deletion@1@35862263@35863302@19@chr19:35862263-35863302@11.2@103@32@0.311@CNVR7627.1@GPR42_2@0@0@0@@:integral to membrane;G-protein coupled receptor activity;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
A2463_02@170096@170101@deletion@6@40373946@40384167@19@chr19:40373946-40384167@53.5@387@94@0.243@CNVR7639.2@FCGBP_26, FCGBP_25, FCGBP_24, FCGBP_23, FCGBP_22, FCGBP_21@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_02@170104@170112@duplication@9@40389653@40406060@19@chr19:40389653-40406060@32.1@642@1015@1.58@CNVR7639.2, CNVR7639.3@FCGBP_18, FCGBP_17, FCGBP_16, FCGBP_15, FCGBP_14, FCGBP_13, FCGBP_12, FCGBP_11, FCGBP_10@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_02@173336@173341@deletion@6@54801928@54804173@19@chr19:54801928-54804173@60.6@289@5@0.0173@CNVR7722.1@LILRA3_6, LILRA3_5, LILRA3_4, LILRA3_3, LILRA3_2, LILRA3_1@0@0@0@:leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3@:antigen binding;signal transduction;protein binding;extracellular region;plasma membrane;receptor activity;defense response@NA
A2463_02@173486@173501@deletion@16@55328990@55359398@19@chr19:55328990-55359398@15.7@768@512@0.667@CNVR7725.1, CNVR7725.6@KIR3DL1_2, KIR3DL1_3, KIR3DL1_4, KIR3DL1_5, KIR3DL1_6, KIR3DL1_7, KIR3DL1_8, KIR3DL1_9, KIR2DS4_1, KIR2DS4_2, KIR2DS4_3, KIR2DS4_4, KIR2DS4_5, KIR2DS4_6, KIR2DS4_7, KIR2DS4_8@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
A2463_02@180807@180807@duplication@1@47612392@47613088@21@chr21:47612392-47613088@5.16@137@208@1.52@NA@AP001468.1_3, AP001468.1_2@0@0@0@:lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase):uncharacterized LOC101060037@:steroid metabolic process;lanosterol synthase activity;small molecule metabolic process;lipid particle;cholesterol biosynthetic process;endoplasmic reticulum membrane;catalytic activity;intramolecular transferase activity:protein binding@NA
A2463_02@181129@181134@deletion@6@18727044@18835833@22@chr22:18727044-18835833@31.7@252@60@0.238@CNVR8087.5, CNVR8087.2, CNVR8087.7@AC008132.1_4, AC008132.1_5, AC008132.1_6, AC008132.1_7, AC008132.1_8, AC008132.13_1@0@0@0@NA@NA@NA
A2463_02@181628@181633@deletion@6@21567355@21576503@22@chr22:21567355-21576503@18.1@136@37@0.272@CNVR8100.4, CNVR8100.10, CNVR8100.7@GGT2_10, GGT2_9, GGT2_8, GGT2_7, GGT2_6, GGT2_5@0@0@0@:gamma-glutamyltransferase 2;gamma-glutamyltranspeptidase 2-like@:hydrolase activity;small molecule metabolic process;leukotriene biosynthetic process;anchored to external side of plasma membrane;glutathione biosynthetic process;xenobiotic metabolic process;integral to membrane;glutathione metabolic process;plasma membrane;gamma-glutamyltransferase activity;cellular_component@NA
A2463_02@181806@181807@deletion@2@23243157@23247205@22@chr22:23243157-23247205@20.1@156@44@0.282@CNVR8103.2, CNVR8103.1, CNVR8103.6, CNVR8103.11, CNVR8103.35@IGLC2_1, IGLJ3_1@0@0@0@@:protein binding@NA
A2463_02@181850@181850@deletion@1@23652512@23652620@22@chr22:23652512-23652620@5.28@42@12@0.286@CNVR8107.2, CNVR8107.3@BCR_18@0@0@0@:breakpoint cluster region@:phospholipid binding;protein autophosphorylation;protein tyrosine kinase activity;GTPase activator activity;neuromuscular process controlling balance;ATP binding;actin cytoskeleton organization;negative regulation of cell migration;plasma membrane;inner ear morphogenesis;positive regulation of Rac GTPase activity;positive regulation of phagocytosis;regulation of small GTPase mediated signal transduction;response to lipopolysaccharide;intracellular signal transduction;Rac GTPase activator activity;regulation of cell cycle;platelet-derived growth factor receptor signaling pathway;protein serine/threonine kinase activity;intracellular;small GTPase mediated signal transduction;regulation of Rho protein signal transduction;protein phosphorylation;negative regulation of inflammatory response;enzyme binding;Rho guanyl-nucleotide exchange factor activity;cytoplasm;cytosol;protein binding;signal transduction;brain development;kinase activity;negative regulation of neutrophil degranulation@: LEUKEMIA, CHRONIC MYELOID; CML
A2463_02@181936@181938@duplication@3@24300473@24302568@22@chr22:24300473-24302568@7.22@37@89@2.41@CNVR8114.6, CNVR8114.12, CNVR8114.13, CNVR8114.8@GSTT2B_4, GSTT2B_3, GSTT2B_2@0@0@0@:glutathione S-transferase theta 2B (gene/pseudogene);glutathione S-transferase theta 2@:protein binding;glutathione transferase activity;nucleus;transferase activity;cytoplasm@NA
A2463_02@181949@181950@duplication@2@24325063@24325797@22@chr22:24325063-24325797@5@11@45@4.09@CNVR8114.6, CNVR8114.13, CNVR8114.8, CNVR8114.14@GSTT2_4, GSTT2_5@0@0@0@@:protein binding;glutathione transferase activity;nucleus;cytoplasm@NA
A2463_02@184165@184167@duplication@3@42908917@42910785@22@chr22:42908917-42910785@5.52@162@234@1.44@CNVR8171.2, CNVR8171.3@RRP7A_7, RRP7A_6, RRP7A_5@0@0@0@:ribosomal RNA processing 7 homolog A (S. cerevisiae)@:RNA binding;nucleotide binding@NA
A2463_01@438@438@duplication@1@1654148@1654257@1@chr1:1654148-1654257@4.67@99@157@1.59@CNVR17.1@CDK11A_2@0@0@0@:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A@:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division@NA
A2463_01@1807@1816@duplication@10@12854065@12939926@1@chr1:12854065-12939926@22.9@2296@3069@1.34@CNVR72.3, CNVR72.10, CNVR72.4, CNVR72.12@PRAMEF1_3, PRAMEF1_4, PRAMEF11_4, PRAMEF11_3, PRAMEF11_2, HNRNPCL1_2, PRAMEF2_2, PRAMEF2_3, PRAMEF2_4, PRAMEF4_4@0@0@0@:PRAME family member 1:PRAME family member 11:heterogeneous nuclear ribonucleoprotein C-like 1-like;heterogeneous nuclear ribonucleoprotein C-like;heterogeneous nuclear ribonucleoprotein C-like 1:PRAME family member 2:PRAME family member 4@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:ribonucleoprotein complex;RNA binding;nucleus;nucleotide binding;nucleic acid binding:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_01@1820@1824@duplication@5@12954418@12980233@1@chr1:12954418-12980233@11.3@351@514@1.46@CNVR72.3, CNVR72.4, CNVR72.2@PRAMEF10_3, PRAMEF10_2, PRAMEF7_2, PRAMEF7_3, PRAMEF7_4@0@0@0@:PRAME family member 10:PRAME family member 7@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_01@1835@1838@deletion@4@13330415@13366425@1@chr1:13330415-13366425@6.23@45@12@0.267@CNVR74.8, CNVR74.4@PRAMEF3_2, PRAMEF3_1, PRAMEF5_2, PRAMEF5_3@0@0@0@:PRAME family member 3:PRAME family member 5@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_01@1853@1861@deletion@9@13495968@13669463@1@chr1:13495968-13669463@14.3@132@45@0.341@NA@PRAMEF16_2, PRAMEF16_3, PRAMEF21_2, PRAMEF21_3, PRAMEF21_4, PRAMEF15_2, PRAMEF15_3, PRAMEF15_4, PRAMEF14_4@0@0@0@:PRAME family member 16:PRAME family member 21;PRAME family member 20:PRAME family member 9/15-like;PRAME family member 15;PRAME family member 9:PRAME family member 14@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_01@1869@1869@duplication@1@13718405@13718962@1@chr1:13718405-13718962@5.6@50@100@2@CNVR76.2@PRAMEF17_3@0@0@0@:PRAME family member 17@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_01@2170@2189@duplication@20@17248515@17277617@1@chr1:17248515-17277617@53@935@1501@1.61@CNVR94.4, CNVR94.5@CROCC_1, CROCC_2, CROCC_3, CROCC_4, CROCC_5, CROCC_6, CROCC_7, CROCC_8, CROCC_9, CROCC_10, CROCC_11, CROCC_12, CROCC_13, CROCC_14, CROCC_15, CROCC_16, CROCC_17, CROCC_18, CROCC_19, CROCC_20@0@0@0@:ciliary rootlet coiled-coil, rootletin@:centriole;centrosome organization;centrosome;kinesin binding;actin cytoskeleton;cytoplasm;protein binding;vesicle-mediated transport;structural molecule activity;ciliary rootlet;protein localization;plasma membrane;cell cycle;cell projection organization;membrane@NA
A2463_01@3333@3342@duplication@10@25599040@25655415@1@chr1:25599040-25655415@73.9@741@1513@2.04@CNVR116.1, CNVR116.2@RHD_1, RHD_2, RHD_3, RHD_4, RHD_5, RHD_6, RHD_7, RHD_8, RHD_9, RHD_10@0@0@0@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
A2463_01@3357@3357@deletion@1@25735175@25735360@1@chr1:25735175-25735360@23.5@113@0@0@CNVR117.1@RHCE_2@0@0@0@:Rh blood group, CcEe antigens@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@: BLOOD GROUP--RHESUS SYSTEM E POLYPEPTIDE; RHE; RHESUS BLOOD GROUP, CcEe ANTIGENS; RHCE
A2463_01@3357@3358@duplication@1@25735175@25747277@1@chr1:25735175-25747277@-16.7@173@122@0.705@CNVR117.1@RHCE_2, RHCE_1@0@0@0@:Rh blood group, CcEe antigens@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@: BLOOD GROUP--RHESUS SYSTEM E POLYPEPTIDE; RHE; RHESUS BLOOD GROUP, CcEe ANTIGENS; RHCE
A2463_01@5149@5149@deletion@1@39987049@39987242@1@chr1:39987049-39987242@4.99@22@0@0@NA@BMP8A_4@0@0@0@:bone morphogenetic protein 8a@:cell differentiation;growth factor activity;extracellular space;growth;cytokine activity;cartilage development;ossification@NA
A2463_01@8507@8508@duplication@2@89476588@89477710@1@chr1:89476588-89477710@10.4@330@498@1.51@CNVR244.1@GBP3_8, GBP3_7@0@0@0@:guanylate binding protein 3@:defense response to virus;GTP binding;GTPase activity;membrane;cytoplasm@NA
A2463_01@9366@9374@duplication@9@104203200@104234232@1@chr1:104203200-104234232@12.2@170@290@1.71@CNVR266.3, CNVR266.1, CNVR266.15@AMY1A_8, AMY1A_9, AMY1A_10, AMY1A_11, AMY1B_11, AMY1B_10, AMY1B_9, AMY1B_8, AMY1B_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
A2463_01@9449@9450@deletion@2@108993225@108994911@1@chr1:108993225-108994911@7.28@39@4@0.103@CNVR294.4, CNVR294.2@NBPF6_2, NBPF6_3@0@0@0@:neuroblastoma breakpoint family, member 6@:cytoplasm@NA
A2463_01@9766@9773@deletion@8@110230497@110235917@1@chr1:110230497-110235917@47.1@224@4@0.0179@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_1, GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
A2463_01@10793@10793@duplication@1@144339779@144340398@1@chr1:144339779-144340398@5.1@20@57@2.85@CNVR334.4, CNVR334.2@AL592284.1_1@0@0@0@:uncharacterized LOC730256;uncharacterized LOC101060698;uncharacterized LOC642441@NA@NA
A2463_01@10890@10895@deletion@6@145325953@145330074@1@chr1:145325953-145330074@13.6@97@25@0.258@CNVR341.2, CNVR341.3@NBPF10_30, NBPF10_31, NBPF10_32, NBPF10_33, NBPF10_34, NBPF10_35@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family, member 10@NA@NA
A2463_01@11080@11080@deletion@1@145756418@145756613@1@chr1:145756418-145756613@5.19@26@2@0.0769@NA@PDZK1_6@0@0@0@:PDZ domain containing 1@:PDZ domain binding;transport;transporter activity;cytoplasm;cell proliferation;protein binding;positive regulation of ion transmembrane transport;scavenger receptor binding;brush border membrane;establishment of protein localization to plasma membrane;carnitine transport;drug transport@NA
A2463_01@11143@11157@deletion@15@146227744@146244717@1@chr1:146227744-146244717@11.7@60@5@0.0833@NA@NBPF12_22, NBPF12_21, NBPF12_20, NBPF12_19, NBPF12_18, NBPF12_17, NBPF12_16, NBPF12_15, NBPF12_14, NBPF12_13, NBPF12_12, NBPF12_11, NBPF12_10, NBPF12_9, NBPF12_8@0@0@0@:neuroblastoma breakpoint family member 21-like@NA@NA
A2463_01@11162@11162@deletion@1@146250791@146250999@1@chr1:146250791-146250999@12.1@59@2@0.0339@NA@NBPF12_3@0@0@0@:neuroblastoma breakpoint family member 21-like@NA@NA
A2463_01@11170@11170@duplication@1@146401672@146401880@1@chr1:146401672-146401880@9.43@60@145@2.42@NA@NBPF12_10@0@0@0@:neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family member 14-like;neuroblastoma breakpoint family, member 12@:cytoplasm@NA
A2463_01@11336@11343@duplication@8@148004549@148010164@1@chr1:148004549-148010164@20.5@815@1221@1.5@CNVR346.2, CNVR346.4@NBPF14_22, NBPF14_21, NBPF14_20, NBPF14_19, NBPF14_18, NBPF14_17, NBPF14_16, NBPF14_15@0@0@0@:neuroblastoma breakpoint family, member 14@:cytoplasm@NA
A2463_01@11479@11479@deletion@1@148591202@148591373@1@chr1:148591202-148591373@4.68@22@1@0.0455@CNVR348.1, CNVR348.4@NBPF15_17@0@0@0@:neuroblastoma breakpoint family, member 15@:cytoplasm@NA
A2463_01@16036@16039@duplication@4@196794608@196799812@1@chr1:196794608-196799812@13.2@670@936@1.4@CNVR459.1@CFHR1_2, CFHR1_3, CFHR1_4, CFHR1_5@0@0@0@:complement factor H-related 1:complement factor H-related 2@:extracellular space;complement activation:extracellular region@NA
A2463_01@17286@17287@deletion@2@207718654@207719023@1@chr1:207718654-207719023@8.72@40@0@0@CNVR485.1@CR1_14, CR1_15@0@0@0@:complement component (3b/4b) receptor 1 (Knops blood group)@:complement component C4b receptor activity;complement activation, classical pathway;negative regulation of complement activation, alternative pathway;innate immune response;negative regulation of serine-type endopeptidase activity;complement component C3b binding;negative regulation of complement activation, classical pathway;plasma membrane;integral to plasma membrane;complement component C3b receptor activity;complement component C4b binding;cell surface;regulation of complement activation;positive regulation of serine-type endopeptidase activity@: MALARIA, SUSCEPTIBILITY TO; KNOPS BLOOD GROUP SYSTEM; KN
A2463_01@24839@24840@duplication@2@87211878@87214922@2@chr2:87211878-87214922@5.29@179@266@1.49@NA@RGPD1_19, RGPD1_20@0@0@0@:RANBP2-like and GRIP domain containing 1@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_01@24853@24863@deletion@11@88081644@88095367@2@chr2:88081644-88095367@13.9@263@138@0.525@NA@RGPD2_20, RGPD2_19, RGPD2_18, RGPD2_17, RGPD2_16, RGPD2_15, RGPD2_14, RGPD2_13, RGPD2_12, RGPD2_11, RGPD2_10@0@0@0@:RANBP2-like and GRIP domain containing 2@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_01@24982@25015@duplication@34@89975705@90260248@2@chr2:89975705-90260248@101@2855@4264@1.49@CNVR867.10, CNVR867.5@IGKV2D-30_1, IGKV2D-30_2, IGKV2D-29_1, IGKV2D-29_2, IGKV2D-28_1, IGKV2D-28_2, IGKV2D-26_1, IGKV2D-26_2, IGKV2D-24_1, IGKV2D-24_2, IGKV6D-21_1, IGKV6D-21_2, IGKV3D-20_1, IGKV3D-20_2, IGKV6D-41_1, IGKV6D-41_2, IGKV1D-17_1, IGKV1D-17_2, IGKV1D-16_1, IGKV1D-16_2, IGKV3D-15_1, IGKV3D-15_2, IGKV1D-13_1, IGKV1D-13_2, IGKV1D-12_1, IGKV1D-12_2, IGKV3D-11_1, IGKV3D-11_2, IGKV1D-42_1, IGKV1D-42_2, IGKV1D-43_1, IGKV1D-43_2, IGKV1D-8_1, IGKV1D-8_2@0@0@0@@:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding@NA
A2463_01@25369@25370@deletion@2@97854825@97855027@2@chr2:97854825-97855027@28.4@134@1@0.00746@CNVR886.2, CNVR886.3@ANKRD36_33, ANKRD36_34@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_01@26008@26011@deletion@4@108454714@108460186@2@chr2:108454714-108460186@9.89@121@50@0.413@NA@RGPD4_3, RGPD4_4, RGPD4_5, RGPD4_6@0@0@0@:RANBP2-like and GRIP domain containing 4@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_01@26021@26021@deletion@1@108479139@108479317@2@chr2:108479139-108479317@5.23@145@82@0.566@NA@RGPD4_16@0@0@0@:RANBP2-like and GRIP domain containing 4@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_01@26414@26414@deletion@1@113138402@113138540@2@chr2:113138402-113138540@8.42@59@13@0.22@NA@RGPD8_21@0@0@0@:RANBP2-like and GRIP domain containing 8@:protein binding;intracellular;intracellular transport;nuclear pore;protein targeting to Golgi;Ran GTPase binding;biological_process@NA
A2463_01@27162@27166@duplication@5@130834655@130851081@2@chr2:130834655-130851081@11.3@89@184@2.07@NA@POTEF_14, POTEF_13, POTEF_12, POTEF_11, POTEF_10@0@0@0@:POTE ankyrin domain family, member F@:cell cortex;protein binding;ATP binding@NA
A2463_01@27171@27174@duplication@4@130868117@130872901@2@chr2:130868117-130872901@8.16@184@281@1.53@NA@POTEF_5, POTEF_4, POTEF_3, POTEF_2@0@0@0@:POTE ankyrin domain family, member F@:cell cortex;protein binding;ATP binding@NA
A2463_01@27181@27181@duplication@1@130899707@130899954@2@chr2:130899707-130899954@4.86@79@133@1.68@NA@CCDC74B_3@0@0@0@:coiled-coil domain containing 74A;coiled-coil domain containing 74B@NA@NA
A2463_01@27208@27211@duplication@4@130951360@130955933@2@chr2:130951360-130955933@7.71@261@371@1.42@NA@TUBA3E_4, TUBA3E_3, TUBA3E_2, TUBA3E_1@0@0@0@:tubulin, alpha 3e@:GTPase activity;structural constituent of cytoskeleton;protein complex;GTP catabolic process;cytoplasm;microtubule cytoskeleton;protein polymerization;microtubule-based movement;structural molecule activity;cytoplasmic microtubule;GTP binding;microtubule;microtubule cytoskeleton organization;protein domain specific binding@NA
A2463_01@27326@27327@deletion@2@132010100@132010672@2@chr2:132010100-132010672@8.37@131@63@0.481@NA@POTEE_12, POTEE_13@0@0@0@:pleckstrin homology domain containing, family B (evectins) member 2:POTE ankyrin domain family, member E@:phospholipid binding;protein binding;recycling endosome membrane:protein binding;ATP binding@NA
A2463_01@38063@38067@duplication@5@49847412@49848524@3@chr3:49847412-49848524@7.04@202@292@1.45@NA@UBA7_14, UBA7_13, UBA7_12, UBA7_11, UBA7_10@0@0@0@:microRNA 5193;ubiquitin-like modifier activating enzyme 7@:negative regulation of type I interferon production;catalytic activity;small protein activating enzyme activity;ligase activity;ATP binding;innate immune response;cytosol;cellular protein modification process;ISG15 activating enzyme activity;modification-dependent protein catabolic process;ISG15-protein conjugation;cytokine-mediated signaling pathway;protein ubiquitination@NA
A2463_01@39892@39894@duplication@3@75786030@75790887@3@chr3:75786030-75790887@24.3@220@493@2.24@CNVR1432.5, CNVR1432.9, CNVR1432.4@ZNF717_5, ZNF717_4, ZNF717_3@0@0@0@:zinc finger protein 717;zinc finger protein 717-like@:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_01@45434@45438@duplication@5@195451552@195475935@3@chr3:195451552-195475935@9.48@679@913@1.34@CNVR1703.1, CNVR1703.2, CNVR1703.5, CNVR1703.3@MUC20_2, MUC20_3, MUC20_4, MUC4_25, MUC4_24@0@0@0@:mucin 20, cell surface associated:mucin 4, cell surface associated@:microvillus membrane;apical plasma membrane;activation of MAPK activity;Golgi lumen;post-translational protein modification;protein binding;O-glycan processing;hepatocyte growth factor receptor signaling pathway;cellular protein metabolic process;extracellular region;protein homooligomerization;basal plasma membrane:ErbB-2 class receptor binding;Golgi lumen;cell-matrix adhesion;post-translational protein modification;extracellular matrix structural constituent;protein binding;O-glycan processing;cellular protein metabolic process;proteinaceous extracellular matrix;integral to plasma membrane;membrane;extracellular matrix constituent, lubricant activity;biological_process@NA
A2463_01@46667@46675@deletion@9@9174900@9237700@4@chr4:9174900-9237700@19.7@121@21@0.174@NA@FAM90A26P_4, FAM90A26P_5, FAM90A26P_6, FAM90A26P_7, USP17L13_1, USP17L10_1, USP17L11_1, USP17L12_1, USP17L13_2, USP17L15_1@0@0@0@:ubiquitin specific peptidase 17-like family member 10:ubiquitin specific peptidase 17-like family member 13:ubiquitin specific peptidase 17-like family member 11:ubiquitin specific peptidase 17-like family member 12:ubiquitin specific peptidase 17-like family member 15@:zinc ion binding;nucleic acid binding:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
A2463_01@46677@46677@duplication@1@9250357@9251948@4@chr4:9250357-9251948@9.41@300@480@1.6@NA@USP17L18_1@0@0@0@:ubiquitin specific peptidase 17-like family member 18@:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
A2463_01@47649@47649@duplication@1@42088100@42088143@4@chr4:42088100-42088143@5.66@23@66@2.87@NA@SLC30A9_18@0@0@0@:solute carrier family 30 (zinc transporter), member 9@:cation transmembrane transporter activity;zinc ion transport;cation transport;sequence-specific DNA binding transcription factor activity;nucleotide binding;nucleotide-excision repair;transmembrane transport;chromatin binding;ligand-dependent nuclear receptor binding;integral to membrane;nucleus;cytoskeleton;transcription, DNA-dependent;ligand-dependent nuclear receptor transcription coactivator activity;positive regulation of transcription from RNA polymerase II promoter@NA
A2463_01@48556@48561@duplication@6@69403344@69434202@4@chr4:69403344-69434202@30.8@435@787@1.81@CNVR1953.1@UGT2B17_6, UGT2B17_5, UGT2B17_4, UGT2B17_3, UGT2B17_2, UGT2B17_1@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B17@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;membrane@: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
A2463_01@48595@48597@duplication@3@70155384@70160527@4@chr4:70155384-70160527@11.7@240@379@1.58@CNVR1957.2, CNVR1957.1@UGT2B28_4, UGT2B28_5, UGT2B28_6@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B28@:carbohydrate binding;transferase activity, transferring hexosyl groups;endoplasmic reticulum;glucuronosyltransferase activity;carbohydrate metabolic process;xenobiotic metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process@NA
A2463_01@48973@48974@duplication@2@75484524@75486006@4@chr4:75484524-75486006@5.19@56@101@1.8@NA@AREGB_3, AREGB_4@0@0@0@:amphiregulin;amphiregulin B@:growth factor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;cell proliferation;epidermal growth factor receptor signaling pathway;extracellular space;protein binding;integral to membrane;cytokine activity;cell surface;positive regulation of DNA replication@NA
A2463_01@53303@53312@duplication@10@716924@767067@5@chr5:716924-767067@29.2@476@790@1.66@CNVR2280.3@ZDHHC11B_10, ZDHHC11B_9, ZDHHC11B_8, ZDHHC11B_7, ZDHHC11B_6, ZDHHC11B_5, ZDHHC11B_4, ZDHHC11B_3, ZDHHC11B_2, ZDHHC11B_1@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
A2463_01@53319@53322@duplication@4@837481@847730@5@chr5:837481-847730@6.55@274@378@1.38@CNVR2280.3, CNVR2280.8@ZDHHC11_6, ZDHHC11_5, ZDHHC11_4, ZDHHC11_3@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
A2463_01@59488@59489@duplication@2@147553798@147554961@5@chr5:147553798-147554961@13.5@137@265@1.93@CNVR2637.1@SPINK14_3, SPINK14_4@0@0@0@:serine peptidase inhibitor, Kazal type 14 (putative)@:serine-type endopeptidase inhibitor activity;protein binding;extracellular region@NA
A2463_01@60795@60798@deletion@4@172195766@172197955@5@chr5:172195766-172197955@5.77@279@181@0.649@NA@DUSP1_4, DUSP1_3, DUSP1_2, DUSP1_1@0@0@0@:dual specificity phosphatase 1@:nucleoplasm;response to oxidative stress;response to light stimulus;response to testosterone stimulus;protein dephosphorylation;protein tyrosine/serine/threonine phosphatase activity;nucleus;endoderm formation;response to organic substance;intracellular signal transduction;phosphatase activity;response to calcium ion;protein tyrosine phosphatase activity;non-membrane spanning protein tyrosine phosphatase activity;response to cAMP;response to retinoic acid;response to estradiol stimulus;protein tyrosine/threonine phosphatase activity;cellular response to hormone stimulus;protein binding;inactivation of MAPK activity;response to glucocorticoid stimulus;response to hydrogen peroxide;MAP kinase tyrosine/serine/threonine phosphatase activity;dephosphorylation;regulation of apoptotic process;cell cycle;positive regulation of apoptotic process@NA
A2463_01@60885@60886@duplication@2@175520199@175520771@5@chr5:175520199-175520771@14@71@201@2.83@NA@FAM153B_4, FAM153B_5@0@0@0@:uncharacterized LOC100507387;family with sequence similarity 153, member B@NA@NA
A2463_01@61262@61264@deletion@3@177158571@177161405@5@chr5:177158571-177161405@5.69@27@1@0.037@NA@FAM153A_15, FAM153A_14, FAM153A_13@0@0@0@:family with sequence similarity 153, member A@NA@NA
A2463_01@61267@61267@deletion@1@177164044@177164113@5@chr5:177164044-177164113@7.58@44@6@0.136@NA@FAM153A_10@0@0@0@:family with sequence similarity 153, member A@NA@NA
A2463_01@61273@61273@deletion@1@177171890@177171968@5@chr5:177171890-177171968@5.96@71@29@0.408@NA@FAM153A_4@0@0@0@:family with sequence similarity 153, member A@NA@NA
A2463_01@63730@63730@duplication@1@31963497@31963571@6@chr6:31963497-31963571@5.05@104@167@1.61@CNVR2843.6, CNVR2843.3@C4A_25@0@0@0@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
A2463_01@63768@63768@duplication@1@31994761@31994899@6@chr6:31994761-31994899@5.76@76@136@1.79@CNVR2843.6, CNVR2843.5@C4B_20@0@0@0@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
A2463_01@63800@63803@deletion@4@32009127@32010139@6@chr6:32009127-32010139@6.2@182@107@0.588@CNVR2843.6, CNVR2843.5@TNXB_13, TNXB_12, TNXB_11, TNXB_10@0@0@0@:cytochrome P450, family 21, subfamily A, polypeptide 2:tenascin-X-like;tenascin XB@:oxidation-reduction process;electron carrier activity;response to antibiotic;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;steroid 21-monooxygenase activity;C21-steroid hormone biosynthetic process;heme binding;mineralocorticoid biosynthetic process;progesterone metabolic process;monooxygenase activity;cellular response to peptide hormone stimulus;iron ion binding:integrin binding;extracellular matrix;cell-cell adhesion;elastic fiber assembly;collagen fibril organization;fibrillar collagen;actin cytoskeleton organization;extracellular space;heparin binding;proteinaceous extracellular matrix;fatty acid metabolic process;regulation of JUN kinase activity;receptor binding;intracellular;cell-matrix adhesion;extracellular matrix organization;lipid metabolic process;protein binding;signal transduction;extracellular region;collagen binding;cell adhesion;triglyceride metabolic process;fibril organization;collagen metabolic process@: ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY: EHLERS-DANLOS-LIKE SYNDROME DUE TO TENASCIN-X DEFICIENCY; EHLERS-DANLOS SYNDROME, TYPE III
A2463_01@63953@63955@deletion@3@32485517@32486443@6@chr6:32485517-32486443@8.15@51@10@0.196@CNVR2845.21, CNVR2845.25, CNVR2845.30@HLA-DRB5_6, HLA-DRB5_5, HLA-DRB5_4@0@0@0@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
A2463_01@63966@63968@deletion@3@32609088@32610541@6@chr6:32609088-32610541@16.2@541@318@0.588@CNVR2845.21, CNVR2845.25, CNVR2845.37, CNVR2845.27, CNVR2845.22, CNVR2845.39, CNVR2845.20@HLA-DQA1_2, HLA-DQA1_3, HLA-DQA1_4@0@0@0@:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
A2463_01@70816@70819@deletion@4@161054786@161061880@6@chr6:161054786-161061880@19.3@177@54@0.305@CNVR3133.1@LPA_9, LPA_8, LPA_7, LPA_6@0@0@0@:lipoprotein, Lp(a)@:blood circulation;endopeptidase inhibitor activity;catalytic activity;lipoprotein metabolic process;proteolysis;heparin binding;receptor-mediated endocytosis;fibronectin binding;small molecule metabolic process;apolipoprotein binding;lipid metabolic process;negative regulation of endopeptidase activity;extracellular region;plasma lipoprotein particle;lipid transport;serine-type endopeptidase activity@: APOLIPOPROTEIN(a); LPA
A2463_01@71028@71032@duplication@5@167787840@167794824@6@chr6:167787840-167794824@12.9@238@379@1.59@NA@TCP10_7, TCP10_6, TCP10_5, TCP10_4, TCP10_3@0@0@0@:t-complex 10@:cytosol@NA
A2463_01@71763@71765@deletion@3@5978354@5983621@7@chr7:5978354-5983621@6.5@176@104@0.591@NA@RSPH10B_15, RSPH10B_14, RSPH10B_13@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
A2463_01@71776@71776@deletion@1@6006495@6006747@7@chr7:6006495-6006747@21.8@106@1@0.00943@NA@RSPH10B_2@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
A2463_01@71922@71922@duplication@1@6797310@6797562@7@chr7:6797310-6797562@6.11@190@291@1.53@NA@RSPH10B2_2@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
A2463_01@71936@71944@duplication@9@6826510@6844686@7@chr7:6826510-6844686@10.5@258@384@1.49@NA@RSPH10B2_16, RSPH10B2_17, RSPH10B2_18, RSPH10B2_19, RSPH10B2_20, CCZ1B_15, CCZ1B_14, CCZ1B_13, CCZ1B_12@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
A2463_01@73260@73263@duplication@4@38388957@38393784@7@chr7:38388957-38393784@15.9@203@364@1.79@CNVR3354.3, CNVR3354.1@TRGV5_2, TRGV5_1, TRGV4_2, TRGV4_1@0@0@0@@:protein binding:protein binding@NA
A2463_01@74597@74598@duplication@2@74225431@74227349@7@chr7:74225431-74227349@5.05@45@87@1.93@NA@GTF2IRD2_10, GTF2IRD2_9@0@0@0@:GTF2I repeat domain containing 2@:nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_01@76779@76793@deletion@15@102279571@102312048@7@chr7:102279571-102312048@18.7@197@71@0.36@CNVR3518.1@UPK3BL_4, UPK3BL_4, UPK3BL_3, UPK3BL_3, UPK3BL_2, UPK3BL_2, UPK3BL_1, UPK3BL_1, SPDYE2L_2, SPDYE2L_3, SPDYE2L_4, SPDYE2L_5, SPDYE2L_6, SPDYE2L_7, SPDYE2L_8, POLR2J2_4, POLR2J2_4, POLR2J2_3, POLR2J2_3, POLR2J2_2, POLR2J2_2, POLR2J2_1, POLR2J2_1@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4:uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J2:WBSCR19-like protein 3;speedy homolog E6 (Xenopus laevis)@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity:integral to membrane:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
A2463_01@77093@77102@deletion@10@105893464@105925330@7@chr7:105893464-105925330@38.4@752@394@0.524@NA@NAMPT_10, NAMPT_9, NAMPT_8, NAMPT_7, NAMPT_6, NAMPT_5, NAMPT_4, NAMPT_3, NAMPT_2, NAMPT_1@0@0@0@:nicotinamide phosphoribosyltransferase@:nicotinate phosphoribosyltransferase activity;small molecule metabolic process;positive regulation of nitric-oxide synthase biosynthetic process;NAD metabolic process;cytoplasm;cell-cell signaling;NAD biosynthetic process;cytosol;signal transduction;cytokine activity;positive regulation of cell proliferation;water-soluble vitamin metabolic process;nicotinate-nucleotide diphosphorylase (carboxylating) activity;nicotinamide metabolic process;vitamin metabolic process;nicotinamide phosphoribosyltransferase activity@NA
A2463_01@79309@79310@deletion@2@143880598@143885476@7@chr7:143880598-143885476@28.9@539@239@0.443@CNVR3598.4, CNVR3598.3@CTAGE4_1, ARHGEF35_2@0@0@0@:CTAGE family, member 4:Rho guanine nucleotide exchange factor (GEF) 35@:integral to membrane;nucleotide binding;cellular_component;biological_process@NA
A2463_01@80141@80142@deletion@2@116087@142298@8@chr8:116087-142298@13.2@80@13@0.162@CNVR3684.8, CNVR3684.5@OR4F21_1, RP11-585F1.10_2@0@0@0@:olfactory receptor, family 4, subfamily F, member 21:F-box only protein 25-like;putative uncharacterized protein C20orf69-like@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_01@80362@80363@duplication@2@7215499@7217223@8@chr8:7215499-7217223@19.3@619@1038@1.68@CNVR3771.8, CNVR3771.10, CNVR3771.4@ZNF705G_7, ZNF705G_6@0@0@0@:zinc finger protein 705G@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_01@80366@80366@duplication@1@7220458@7220468@8@chr8:7220458-7220468@5.27@92@153@1.66@CNVR3771.8, CNVR3771.10, CNVR3771.4@ZNF705G_3@0@0@0@:zinc finger protein 705G@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_01@80376@80381@duplication@6@7340127@7353525@8@chr8:7340127-7353525@11.8@123@226@1.84@CNVR3771.8, CNVR3771.10, CNVR3771.4, CNVR3771.6@DEFB106B_2, DEFB106B_1, DEFB105B_1, DEFB105B_2, DEFB105B_3, DEFB107B_1@0@0@0@:defensin, beta 106B;defensin, beta 106A:defensin, beta 105B;defensin, beta 105A:defensin, beta 107B;defensin, beta 107A@:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium@NA
A2463_01@80394@80397@deletion@4@7680905@7686475@8@chr8:7680905-7686475@7.2@184@107@0.582@CNVR3772.4, CNVR3772.6, CNVR3772.2, CNVR3772.8, CNVR3772.10@DEFB105A_2, DEFB105A_1, DEFB106A_1, DEFB106A_2@0@0@0@:defensin, beta 105B;defensin, beta 105A:defensin, beta 106B;defensin, beta 106A@:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium@NA
A2463_01@80402@80403@duplication@2@7718169@7721057@8@chr8:7718169-7721057@9.44@168@273@1.62@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@SPAG11A_3, SPAG11A_4@0@0@0@:sperm associated antigen 11A;sperm associated antigen 11B@:extracellular region;defense response@NA
A2463_01@80576@80579@deletion@4@12283399@12286623@8@chr8:12283399-12286623@20.2@104@8@0.0769@CNVR3786.4, CNVR3786.16@FAM86B2_8, FAM86B2_7, FAM86B2_6, FAM86B2_5@0@0@0@:family with sequence similarity 86, member B2@NA@NA
A2463_01@80584@80584@deletion@1@12338341@12338444@8@chr8:12338341-12338444@20@116@11@0.0948@CNVR3786.4, CNVR3786.16@AC130352.1_5@0@0@0@NA@NA@NA
A2463_01@81715@81718@duplication@4@29924294@29940465@8@chr8:29924294-29940465@6.17@259@364@1.41@NA@TMEM66_4, TMEM66_3, TMEM66_2, TMEM66_1@0@0@0@:transmembrane protein 66@:protein binding;integral to endoplasmic reticulum membrane;store-operated calcium channel activity;regulation of store-operated calcium entry@NA
A2463_01@83673@83673@duplication@1@86573700@86575726@8@chr8:86573700-86575726@6.16@345@498@1.44@CNVR3955.1@REXO1L1_1@0@0@0@:exonuclease GOR-like;REX1, RNA exonuclease 1 homolog (S. cerevisiae)-like 1@:intracellular;nucleus;exonuclease activity;nucleic acid binding;cytoplasm@NA
A2463_01@86646@86646@deletion@1@178817@178969@9@chr9:178817-178969@14@65@0@0@CNVR4135.1@CBWD1_1@0@0@0@:COBW domain containing 1;COBW domain-containing protein 1-like;COBW domain containing 5@:ATP binding@NA
A2463_01@88558@88558@deletion@1@42409510@42410483@9@chr9:42409510-42410483@16.4@88@6@0.0682@NA@ANKRD20A2_15, RP11-146D12.2_1@0@0@0@:ankyrin repeat domain 20 family, member A2@:protein binding@NA
A2463_01@88596@88596@deletion@1@43828079@43828221@9@chr9:43828079-43828221@9.79@53@5@0.0943@CNVR4294.1@CNTNAP3B_9@0@0@0@:contactin associated protein-like 3B;contactin associated protein-like 3@:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
A2463_01@88609@88610@deletion@2@43915361@43915897@9@chr9:43915361-43915897@5.76@88@43@0.489@NA@CNTNAP3B_22, CNTNAP3B_23@0@0@0@:contactin associated protein-like 3B;contactin associated protein-like 3@:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
A2463_01@88620@88622@duplication@3@45727245@45733965@9@chr9:45727245-45733965@7.48@159@248@1.56@CNVR4305.1@FAM27A_1, AL953889.1_2, AL953889.1_1, FAM27A_2, FAM27E2_1@0@0@0@NA@NA@NA
A2463_01@88639@88641@deletion@3@67926874@67930837@9@chr9:67926874-67930837@11.6@55@2@0.0364@NA@ANKRD20A1_1, ANKRD20A1_2, ANKRD20A1_3@0@0@0@:ankyrin repeat domain 20 family, member A1@:protein binding;plasma membrane@NA
A2463_01@88644@88644@deletion@1@67938604@67938658@9@chr9:67938604-67938658@11.9@134@47@0.351@NA@ANKRD20A1_6@0@0@0@:ankyrin repeat domain 20 family, member A1@:protein binding;plasma membrane@NA
A2463_01@88647@88656@duplication@10@67951933@67985922@9@chr9:67951933-67985922@20.4@834@1175@1.41@NA@ANKRD20A1_9, ANKRD20A1_10, ANKRD20A1_11, ANKRD20A1_12, ANKRD20A1_13, ANKRD20A1_14, ANKRD20A1_15, RP11-195B21.3_3, RP11-195B21.3_4, RP11-195B21.3_5@0@0@0@:ankyrin repeat domain 20 family, member A1:coiled-coil domain-containing protein 29-like;uncharacterized LOC644249@:protein binding;plasma membrane@NA
A2463_01@88675@88690@duplication@16@69380012@69424176@9@chr9:69380012-69424176@25.3@972@1404@1.44@NA@CR769776.1_1, ANKRD20A4_1, ANKRD20A4_2, ANKRD20A4_3, ANKRD20A4_4, ANKRD20A4_5, ANKRD20A4_6, ANKRD20A4_7, ANKRD20A4_8, ANKRD20A4_9, ANKRD20A4_10, ANKRD20A4_11, ANKRD20A4_12, ANKRD20A4_13, ANKRD20A4_14, ANKRD20A4_15@0@0@0@:ankyrin repeat domain 20 family, member A4@:protein binding@NA
A2463_01@88722@88724@duplication@3@70912497@70914009@9@chr9:70912497-70914009@7.18@181@271@1.5@NA@CBWD3_12, CBWD3_13, CBWD3_14@0@0@0@:COBW domain-containing protein 5-like;COBW domain-containing protein 1-like;COBW domain containing 3@:ATP binding@NA
A2463_01@95352@95357@deletion@6@17875675@17898362@10@chr10:17875675-17898362@20.6@130@24@0.185@NA@MRC1L1_4, MRC1L1_5, MRC1L1_6, MRC1L1_7, MRC1L1_8, MRC1L1_9@0@0@0@:macrophage mannose receptor 1-like@:carbohydrate binding@NA
A2463_01@95386@95391@duplication@6@18122629@18145281@10@chr10:18122629-18145281@12.6@102@203@1.99@NA@MRC1_4, MRC1_5, MRC1_6, MRC1_7, MRC1_8, MRC1_9@0@0@0@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
A2463_01@96434@96435@deletion@2@46248037@46248685@10@chr10:46248037-46248685@13.8@91@19@0.209@NA@FAM21C_12, FAM21C_13@0@0@0@:family with sequence similarity 21, member C@:endosome;protein binding;plasma membrane;retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_01@96444@96444@deletion@1@46272722@46272873@10@chr10:46272722-46272873@4.67@85@43@0.506@CNVR4711.1@FAM21C_22@0@0@0@:family with sequence similarity 21, member C@:endosome;protein binding;plasma membrane;retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_01@96543@96564@deletion@22@47908065@48001973@10@chr10:47908065-48001973@80.9@533@116@0.218@CNVR4715.2@FAM21B_9, FAM21B_10, FAM21B_11, FAM21B_12, FAM21B_13, FAM21B_14, FAM21B_15, FAM21B_16, FAM21B_17, FAM21B_18, FAM21B_19, FAM21B_20, FAM21B_21, FAM21B_22, FAM21B_23, FAM21B_24, FAM21B_25, FAM21B_26, FAM21B_27, FAM21B_28, FAM21B_29, ASAH2C_18@0@0@0@:family with sequence similarity 21, member B@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome:ceramidase activity;sphingolipid metabolic process@NA
A2463_01@96624@96624@deletion@1@48798646@48798739@10@chr10:48798646-48798739@4.74@48@18@0.375@CNVR4716.10, CNVR4716.3@PTPN20B_2@0@0@0@:protein tyrosine phosphatase, non-receptor type 20B;protein tyrosine phosphatase, non-receptor type 20A@:phosphatase activity;protein tyrosine phosphatase activity;microtubule;nucleus;dephosphorylation;protein dephosphorylation;microtubule organizing center@NA
A2463_01@96631@96633@duplication@3@49376639@49381136@10@chr10:49376639-49381136@15.5@59@173@2.93@CNVR4717.2@FRMPD2_27, FRMPD2_26, FRMPD2_25@0@0@0@:FERM and PDZ domain containing 2@:basolateral plasma membrane;transferase activity, transferring phosphorus-containing groups;cytoplasm;tight junction;protein binding;cytoskeleton;1-phosphatidylinositol binding;tight junction assembly@NA
A2463_01@96844@96844@duplication@1@51224991@51226465@10@chr10:51224991-51226465@8.06@178@295@1.66@CNVR4727.1@AGAP8_7@0@0@0@:ArfGAP with GTPase domain, ankyrin repeat and PH domain 8@:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity@NA
A2463_01@96900@96923@duplication@24@51847036@51892705@10@chr10:51847036-51892705@31.4@731@1111@1.52@CNVR4734.2@FAM21A_8, FAM21A_9, FAM21A_10, FAM21A_11, FAM21A_12, FAM21A_13, FAM21A_14, FAM21A_15, FAM21A_16, FAM21A_17, FAM21A_18, FAM21A_19, FAM21A_20, FAM21A_21, FAM21A_22, FAM21A_23, FAM21A_24, FAM21A_25, FAM21A_26, FAM21A_27, FAM21A_28, FAM21A_29, FAM21A_30, FAM21A_31@0@0@0@:family with sequence similarity 21, member B;family with sequence similarity 21, member A@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_01@96932@96937@deletion@6@51965743@51978390@10@chr10:51965743-51978390@11.9@97@32@0.33@NA@ASAH2_12, ASAH2_11, ASAH2_10, ASAH2_9, ASAH2_8, ASAH2_7@0@0@0@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
A2463_01@98355@98357@deletion@3@81608270@81610362@10@chr10:81608270-81610362@8.69@93@38@0.409@NA@FAM22E_5, FAM22E_6, FAM22E_7@0@0@0@NA@NA@NA
A2463_01@98595@98602@deletion@8@88985589@89118188@10@chr10:88985589-89118188@51.7@532@180@0.338@CNVR4840.3@FAM22A_1, FAM22A_2, FAM22A_3, FAM22A_4, FAM22A_5, FAM22A_6, FAM22A_7, FAM22D_1@0@0@0@:family with sequence similarity 22, member A:family with sequence similarity 22, member D@NA@NA
A2463_01@101608@101615@deletion@8@124344788@124354044@10@chr10:124344788-124354044@14.6@544@336@0.618@CNVR4912.4, CNVR4912.3, CNVR4912.2@DMBT1_15, DMBT1_16, DMBT1_17, DMBT1_18, DMBT1_19, DMBT1_20, DMBT1_21, DMBT1_22@0@0@0@:deleted in malignant brain tumors 1@:defense response to virus;calcium-dependent protein binding;pattern recognition receptor signaling pathway;blastocyst development;response to estrogen stimulus;tissue regeneration;proteinaceous extracellular matrix;protein transport;Gram-negative bacterial cell surface binding;positive regulation of epithelial cell differentiation;virus-host interaction;epithelial cell differentiation;induction of bacterial agglutination;phagocytic vesicle membrane;intracellular;Gram-positive bacterial cell surface binding;zymogen binding;innate immune response;cytoplasm;extrinsic to membrane;protein binding;zymogen granule membrane;extracellular region;scavenger receptor activity;pattern recognition receptor activity;inner cell mass cell proliferation;membrane@: GLIOMA SUSCEPTIBILITY 1; GLM1
A2463_01@102590@102591@deletion@2@694760@695846@11@chr11:694760-695846@7.97@68@20@0.294@NA@DEAF1_1, TMEM80_1@0@0@0@:deformed epidermal autoregulatory factor 1 (Drosophila):EPS8-like 2:transmembrane protein 80@:anatomical structure morphogenesis;embryonic skeletal system development;germ cell development;regulation of transcription from RNA polymerase II promoter;DNA binding;neural tube closure;cytoplasm;transcription from RNA polymerase II promoter;double-stranded DNA binding;protein binding;extracellular region;transcription factor complex;nucleus;zinc ion binding;regulation of mammary gland epithelial cell proliferation:protein binding;plasma membrane;cytoplasm:integral to membrane@NA
A2463_01@103269@103269@deletion@1@4976003@4976943@11@chr11:4976003-4976943@50.4@286@5@0.0175@CNVR5040.1@OR51A2_1@0@0@0@:matrix metallopeptidase 26:olfactory receptor, family 51, subfamily A, member 2@:metallopeptidase activity;extracellular matrix;proteolysis;proteinaceous extracellular matrix;collagen catabolic process;metalloendopeptidase activity;zinc ion binding;metabolic process:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_01@103289@103291@duplication@3@5270599@5274635@11@chr11:5270599-5274635@5.43@221@310@1.4@NA@HBG1_2, HBG1_1, HBG2_8@0@0@0@:hemoglobin, gamma A:hemoglobin, gamma G@:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex@: CYANOSIS, TRANSIENT NEONATAL; TNCY
A2463_01@103342@103342@duplication@1@5798891@5799864@11@chr11:5798891-5799864@4.91@199@290@1.46@CNVR5049.1@OR52N5_1@0@0@0@:tripartite motif containing 5:olfactory receptor, family 52, subfamily N, member 5@:defense response to virus;Golgi apparatus;intracellular;protein trimerization;ligase activity;cytoplasm;protein binding;nucleus;protein homodimerization activity;identical protein binding;zinc ion binding;cytoplasmic mRNA processing body;protein ubiquitination;virus-host interaction:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_01@104933@104933@deletion@1@32125912@32126018@11@chr11:32125912-32126018@4.71@70@33@0.471@NA@RCN1_6@0@0@0@:uncharacterized LOC440034;reticulocalbin 1, EF-hand calcium binding domain@:protein binding;endoplasmic reticulum;in utero embryonic development;endoplasmic reticulum lumen;calcium ion binding;camera-type eye development@NA
A2463_01@110121@110125@deletion@5@89768381@89773130@11@chr11:89768381-89773130@7.08@224@136@0.607@NA@TRIM49C_3, TRIM49C_4, TRIM49C_5, TRIM49C_6, TRIM49C_7@0@0@0@:tripartite motif containing 49D, pseudogene;tripartite motif containing 49-like 1;tripartite motif containing 49C;tripartite motif-containing protein 49-like protein 1-like@:protein binding;intracellular;DNA binding;zinc ion binding@NA
A2463_01@113033@113033@deletion@1@176050@176602@12@chr12:176050-176602@6.31@194@110@0.567@CNVR5380.1, CNVR5380.4, CNVR5380.3@IQSEC3_1@0@0@0@:IQ motif and Sec7 domain 3;IQ motif and SEC7 domain-containing protein 3-like@:phospholipid binding;inhibitory synapse;intracellular;ARF guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;protein binding;cell junction;nucleus;regulation of ARF protein signal transduction;postsynaptic membrane@NA
A2463_01@114136@114139@deletion@4@8374419@8377428@12@chr12:8374419-8377428@19@1415@861@0.608@CNVR5422.3, CNVR5422.5, CNVR5422.6, CNVR5422.1@FAM90A1_7, FAM90A1_6, FAM90A1_5, FAM90A1_4@0@0@0@:family with sequence similarity 90, member A1@:zinc ion binding;nucleic acid binding@NA
A2463_01@127333@127337@deletion@5@19553418@19563541@14@chr14:19553418-19563541@54.3@715@258@0.361@CNVR6072.1@POTEG_1, POTEG_2, POTEG_3, POTEG_4, POTEG_5@0@0@0@:POTE ankyrin domain family, member G@:protein binding@NA
A2463_01@127340@127341@deletion@2@19573101@19574352@14@chr14:19573101-19574352@5.26@180@109@0.606@CNVR6072.1@POTEG_8, POTEG_9@0@0@0@:POTE ankyrin domain family, member G@:protein binding@NA
A2463_01@127348@127352@duplication@5@20010104@20020220@14@chr14:20010104-20020220@24.8@240@504@2.1@CNVR6072.6, CNVR6072.12@POTEM_5, POTEM_4, POTEM_3, POTEM_2, POTEM_1@0@0@0@:POTE ankyrin domain family, member M@:protein binding@NA
A2463_01@131032@131033@duplication@2@74004127@74008399@14@chr14:74004127-74008399@16.1@203@379@1.87@CNVR6188.1, CNVR6188.4@ACOT1_1, ACOT1_2@0@0@0@:HEAT repeat containing 4:acyl-CoA thioesterase 1@:protein binding;binding:hydrolase activity;mitochondrion;acyl-CoA metabolic process;very long-chain fatty acid metabolic process;thiolester hydrolase activity;acyl-CoA hydrolase activity;cytosol;palmitoyl-CoA hydrolase activity;long-chain fatty acid metabolic process;carboxylesterase activity@NA
A2463_01@133450@133451@duplication@2@106725202@106725654@14@chr14:106725202-106725654@10.3@164@281@1.71@CNVR6294.48, CNVR6294.24, CNVR6294.40, CNVR6294.38, CNVR6294.17, CNVR6294.23@IGHV3-23_2, IGHV3-23_1@0@0@0@@:protein binding@NA
A2463_01@133460@133462@deletion@3@106805210@106816026@14@chr14:106805210-106816026@18@139@37@0.266@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.41@IGHV4-31_2, IGHV4-31_1, IGHV3-33_2@0@0@0@@:protein binding:protein binding@NA
A2463_01@133472@133473@duplication@2@106926189@106926644@14@chr14:106926189-106926644@11.5@160@282@1.76@CNVR6294.56, CNVR6294.1@IGHV3-43_2, IGHV3-43_1@0@0@0@@:protein binding@NA
A2463_01@133497@133500@deletion@4@107169932@107179262@14@chr14:107169932-107179262@5.67@309@205@0.663@CNVR6294.56, CNVR6294.6, CNVR6294.92, CNVR6294.93@IGHV1-69_2, IGHV1-69_1, IGHV2-70_2, IGHV2-70_1@0@0@0@@:protein binding:protein binding@NA
A2463_01@133520@133528@duplication@9@21051163@21071610@15@chr15:21051163-21071610@15.9@282@456@1.62@NA@POTEB_9, POTEB_8, POTEB_7, POTEB_6, POTEB_5, POTEB_4, POTEB_3, POTEB_2, POTEB_1@0@0@0@:POTE ankyrin domain family member B-like@:protein binding@NA
A2463_01@133642@133647@deletion@6@23412149@23602766@15@chr15:23412149-23602766@9.22@97@38@0.392@CNVR6300.8@RP11-467N20.5_2, RP11-467N20.5_1, GOLGA8S_1, GOLGA8S_2, GOLGA8S_3, GOLGA8S_4@0@0@0@:putative golgin subfamily A member 6-like protein 6-like@:Golgi apparatus@NA
A2463_01@133654@133658@deletion@5@23605876@23608916@15@chr15:23605876-23608916@8.09@200@115@0.575@CNVR6301.3@GOLGA8S_11, GOLGA8S_12, GOLGA8S_13, GOLGA8S_14, GOLGA8S_15@0@0@0@@:Golgi apparatus@NA
A2463_01@133869@133870@deletion@2@28629294@28629596@15@chr15:28629294-28629596@5.7@28@2@0.0714@CNVR6329.4@GOLGA8F_9, GOLGA8F_10@0@0@0@@:Golgi apparatus@NA
A2463_01@133887@133887@deletion@1@28771402@28771657@15@chr15:28771402-28771657@4.9@22@0@0@CNVR6330.3@GOLGA8G_12@0@0@0@:golgin A8 family, member G;golgin A8 family, member F@:Golgi apparatus@NA
A2463_01@134023@134030@deletion@8@30699479@30702470@15@chr15:30699479-30702470@14.4@193@84@0.435@NA@GOLGA8R_12, GOLGA8R_11, GOLGA8R_10, GOLGA8R_9, GOLGA8R_8, GOLGA8R_7, GOLGA8R_6, GOLGA8R_5@0@0@0@@:Golgi apparatus@NA
A2463_01@134036@134054@duplication@19@30845996@30896376@15@chr15:30845996-30896376@53.2@338@757@2.24@CNVR6339.2, CNVR6339.3, CNVR6339.1@GOLGA8Q_2, GOLGA8Q_3, GOLGA8Q_4, GOLGA8Q_5, GOLGA8Q_6, GOLGA8Q_7, GOLGA8Q_8, GOLGA8Q_9, GOLGA8Q_10, GOLGA8Q_11, GOLGA8Q_12, GOLGA8Q_13, GOLGA8Q_14, GOLGA8Q_15, GOLGA8Q_16, GOLGA8Q_17, GOLGA8Q_18, GOLGA8Q_19, GOLGA8H_1@0@0@0@:golgin A8 family, member H@:Golgi apparatus:Golgi apparatus@NA
A2463_01@134158@134161@deletion@4@32684984@32685771@15@chr15:32684984-32685771@15.2@159@64@0.403@NA@GOLGA8K_19, GOLGA8K_18, GOLGA8K_17, GOLGA8K_16@0@0@0@:golgin A8 family, member J@:Golgi apparatus@NA
A2463_01@134173@134196@deletion@24@32692342@32747737@15@chr15:32692342-32747737@34.1@374@158@0.422@CNVR6346.1@GOLGA8K_4, GOLGA8K_3, GOLGA8K_2, AC139426.2_1, GOLGA8K_1, GOLGA8O_19, GOLGA8O_18, GOLGA8O_17, GOLGA8O_16, GOLGA8O_15, GOLGA8O_14, GOLGA8O_13, GOLGA8O_12, GOLGA8O_11, GOLGA8O_10, GOLGA8O_9, GOLGA8O_8, GOLGA8O_7, GOLGA8O_6, GOLGA8O_5, GOLGA8O_4, GOLGA8O_3, GOLGA8O_2, GOLGA8O_1@0@0@0@:golgin A8 family, member J:golgin A8 family, member O@:Golgi apparatus:Golgi apparatus@NA
A2463_01@135680@135737@duplication@58@43873201@43940259@15@chr15:43873201-43940259@123@4636@6742@1.45@CNVR6365.1@PPIP5K1_10, PPIP5K1_9, PPIP5K1_8, PPIP5K1_7, PPIP5K1_6, PPIP5K1_5, PPIP5K1_4, PPIP5K1_3, CKMT1B_2, CKMT1B_3, CKMT1B_4, CKMT1B_5, CKMT1B_6, CKMT1B_7, CKMT1B_8, CKMT1B_9, CKMT1B_10, STRC_29, STRC_28, STRC_27, STRC_26, STRC_25, STRC_24, STRC_23, STRC_22, STRC_21, STRC_20, STRC_19, STRC_18, STRC_17, STRC_16, STRC_15, STRC_14, STRC_13, STRC_12, STRC_11, STRC_10, STRC_9, STRC_8, STRC_7, STRC_6, STRC_5, STRC_4, STRC_3, STRC_2, STRC_1, CATSPER2_13, CATSPER2_12, CATSPER2_11, CATSPER2_10, CATSPER2_9, CATSPER2_8, CATSPER2_7, CATSPER2_6, CATSPER2_5, CATSPER2_4, CATSPER2_3, CATSPER2_2@0@0@0@:diphosphoinositol pentakisphosphate kinase 1:creatine kinase, mitochondrial 1A;creatine kinase, mitochondrial 1B:stereocilin:cation channel, sperm associated 2@:inositol hexakisphosphate 3-kinase activity;inositol hexakisphosphate 1-kinase activity;inositol metabolic process;diphosphoinositol-pentakisphosphate kinase activity;ATP binding;acid phosphatase activity;cytoplasm;cytosol;inositol hexakisphosphate 5-kinase activity;nucleus;kinase activity;inositol-1,3,4,5,6-pentakisphosphate kinase activity:mitochondrion;small molecule metabolic process;mitochondrial inner membrane;creatine metabolic process;creatine kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;kinase activity;cellular nitrogen compound metabolic process:detection of mechanical stimulus involved in sensory perception of sound;stereocilium bundle tip;stereocilium;cell surface;kinocilium;auditory receptor cell stereocilium organization:cell differentiation;CatSper complex;ion transport;transmembrane transport;voltage-gated ion channel activity;flagellar membrane;spermatogenesis;integral to membrane;multicellular organismal development;fertilization;sperm motility;ion channel activity;ciliary or flagellar motility;calcium channel activity;cilium;protein binding;microtubule-based flagellum;membrane@: DEAFNESS, AUTOSOMAL RECESSIVE 16; DFNB16; DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY: DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY
A2463_01@142651@142651@deletion@1@14858861@14859270@16@chr16:14858861-14859270@6.75@72@27@0.375@CNVR6644.1@RP11-719K4.2_8@0@0@0@:nuclear pore complex-interacting protein-like 1-like@NA@NA
A2463_01@142917@142928@deletion@12@16346291@16367932@16@chr16:16346291-16367932@18.9@498@291@0.584@NA@NOMO3_9, NOMO3_10, NOMO3_11, NOMO3_12, NOMO3_13, NOMO3_14, NOMO3_15, NOMO3_16, NOMO3_17, NOMO3_18, NOMO3_19, NOMO3_20@0@0@0@:NODAL modulator 3@:carbohydrate binding;integral to membrane;carboxypeptidase activity@NA
A2463_01@142999@143007@duplication@9@18535812@18553583@16@chr16:18535812-18553583@13.6@419@604@1.44@NA@NOMO2_17, NOMO2_16, NOMO2_15, NOMO2_14, NOMO2_13, NOMO2_12, NOMO2_11, NOMO2_10, NOMO2_9@0@0@0@:NODAL modulator 2@:carbohydrate binding;protein binding;integral to membrane;carboxypeptidase activity;endoplasmic reticulum membrane@NA
A2463_01@143481@143483@deletion@3@21763257@21764445@16@chr16:21763257-21764445@6.62@90@42@0.467@CNVR6668.5, CNVR6668.2, CNVR6668.7@OTOA_24, OTOA_25, OTOA_26@0@0@0@:otoancorin@:proteinaceous extracellular matrix;apical plasma membrane;sensory perception of sound;anchored to membrane@: DEAFNESS, AUTOSOMAL RECESSIVE 22; DFNB22
A2463_01@143512@143513@duplication@2@22019624@22087020@16@chr16:22019624-22087020@5.94@208@302@1.45@NA@C16orf52_1, C16orf52_2@0@0@0@:chromosome 16 open reading frame 52;uncharacterized LOC101060634@:membrane@NA
A2463_01@144038@144039@duplication@2@28403074@28403463@16@chr16:28403074-28403463@6.32@74@133@1.8@CNVR6684.2@EIF3CL_10, EIF3CL_9@0@0@0@:eukaryotic translation initiation factor 3, subunit C-like@:protein binding;eukaryotic translation initiation factor 3 complex;translational initiation;translation initiation factor activity@NA
A2463_01@144047@144052@deletion@6@28467746@28478223@16@chr16:28467746-28478223@20.5@113@13@0.115@NA@NPIPL1_7, NPIPL1_6, NPIPL1_5, NPIPL1_4, NPIPL1_3, NPIPL1_2@0@0@0@:ceroid-lipofuscinosis, neuronal 3@:membrane:negative regulation of apoptotic process;late endosome;mitochondrion;galactosylceramide metabolic process;neuromuscular process controlling balance;neuron projection;lysosomal lumen pH elevation;integral to endoplasmic reticulum membrane;cell death;plasma membrane;nucleus;lysosomal lumen acidification;negative regulation of catalytic activity;negative regulation of macroautophagy;unfolded protein binding;neurotransmitter metabolic process;endoplasmic reticulum;vesicle transport along microtubule;protein catabolic process;autophagic vacuole;early endosome;trans-Golgi network;cellular membrane organization;ceramide metabolic process;glucosylceramide metabolic process;negative regulation of neuron apoptotic process;membrane;globoside metabolic process;membrane raft;synaptic vesicle;vacuolar transport;protein processing;Golgi membrane;caveola;protein folding;ionotropic glutamate receptor signaling pathway;cytosolic calcium ion homeostasis;Golgi stack;integral to membrane;receptor-mediated endocytosis;arginine transport;lysosome;negative regulation of proteolysis;Golgi apparatus;lysosome organization;associative learning;sphingomyelin metabolic process;macroautophagy;lysosomal membrane;amyloid precursor protein catabolic process;cytoplasm;autophagic vacuole fusion;protein binding;regulation of action potential;cellular amino acid metabolic process@: CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3
A2463_01@144095@144097@deletion@3@28607105@28617557@16@chr16:28607105-28617557@9.77@210@111@0.529@CNVR6685.1@SULT1A2_2, SULT1A1_10, SULT1A1_9@0@0@0@:sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2:sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1@:steroid metabolic process;small molecule metabolic process;sulfation;aryl sulfotransferase activity;catecholamine metabolic process;cytosol;xenobiotic metabolic process;phenol-containing compound metabolic process;sulfotransferase activity;amine biosynthetic process;flavonol 3-sulfotransferase activity;3'-phosphoadenosine 5'-phosphosulfate metabolic process:small molecule metabolic process;sulfation;aryl sulfotransferase activity;amine metabolic process;catecholamine metabolic process;xenobiotic metabolic process;cytosol;steroid sulfotransferase activity;integral to membrane;sulfotransferase activity;flavonol 3-sulfotransferase activity;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process;estrogen metabolic process@NA
A2463_01@144118@144134@deletion@17@28734770@28777810@16@chr16:28734770-28777810@15.6@182@75@0.412@CNVR6686.3, CNVR6686.2@EIF3C_10, EIF3C_11, EIF3C_12, EIF3C_13, EIF3C_14, EIF3C_15, EIF3C_16, EIF3C_17, EIF3C_18, EIF3C_19, EIF3C_20, EIF3C_21, A-575C2.4_1, A-575C2.4_2, A-575C2.4_3, A-575C2.4_4, A-575C2.4_5@0@0@0@:eukaryotic translation initiation factor 3, subunit C@:cytosol;protein binding;eukaryotic translation initiation factor 3 complex;translational initiation;cellular protein metabolic process;binding;gene expression;translation;translation initiation factor activity@NA
A2463_01@144286@144290@deletion@5@29466720@29469445@16@chr16:29466720-29469445@8.27@37@0@0@CNVR6690.2, CNVR6690.3, CNVR6690.4@SLX1B_2, SLX1B_3, SLX1B_4, SLX1B_5, SLX1B_6@0@0@0@:structure-specific endonuclease subunit SLX1-like;SLX1 structure-specific endonuclease subunit homolog B (S. cerevisiae);SLX1 structure-specific endonuclease subunit homolog A (S. cerevisiae):sulfotransferase family, cytosolic, 1A, phenol-preferring, member 4;sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3;sulfotransferase 1A3/1A4-like@:Slx1-Slx4 complex;5'-flap endonuclease activity;DNA repair;protein binding;DNA double-strand break processing involved in repair via single-strand annealing;double-strand break repair via homologous recombination;metal ion binding;crossover junction endodeoxyribonuclease activity:steroid metabolic process;small molecule metabolic process;sulfation;aryl sulfotransferase activity;cytoplasm;catecholamine metabolic process;cytosol;endoplasmic reticulum unfolded protein response;xenobiotic metabolic process;sulfotransferase activity;activation of signaling protein activity involved in unfolded protein response;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process@NA
A2463_01@146569@146569@deletion@1@67465153@67465416@16@chr16:67465153-67465416@5.55@48@15@0.312@NA@HSD11B2_1@0@0@0@:hydroxysteroid (11-beta) dehydrogenase 2@:response to drug;11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity;oxidoreductase activity;NAD binding;metabolic process;glucocorticoid metabolic process;intracellular membrane-bounded organelle;regulation of blood volume by renal aldosterone;endoplasmic reticulum;response to hypoxia;nucleotide binding;response to stress;cytoplasm;response to glucocorticoid stimulus;female pregnancy;response to insulin stimulus;steroid binding;response to steroid hormone stimulus;response to food;glucocorticoid biosynthetic process@: APPARENT MINERALOCORTICOID EXCESS; AME
A2463_01@151956@151959@duplication@4@18945121@18997166@17@chr17:18945121-18997166@31.7@271@663@2.45@CNVR7018.4, CNVR7018.2, CNVR7018.6@GRAP_2, GRAP_1, AC007952.5_1, AC007952.5_2@0@0@0@:GRB2-related adaptor protein@:SH3/SH2 adaptor activity;cytosol;protein binding;Ras protein signal transduction;cytoplasm;cell-cell signaling@NA
A2463_01@153376@153381@deletion@6@34522686@34539971@17@chr17:34522686-34539971@7.95@39@2@0.0513@CNVR7077.1, CNVR7077.3, CNVR7077.6@CCL3L3_3, CCL3L3_2, CCL3L3_1, CCL4L1_1, CCL4L1_2, CCL4L1_3@0@0@0@:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
A2463_01@153650@153660@duplication@11@36351930@36398302@17@chr17:36351930-36398302@165@1414@3511@2.48@CNVR7083.3@RP11-1407O15.2_12, RP11-1407O15.2_11, RP11-1407O15.2_10, RP11-1407O15.2_9, RP11-1407O15.2_8, RP11-1407O15.2_7, RP11-1407O15.2_6, RP11-1407O15.2_5, RP11-1407O15.2_4, RP11-1407O15.2_3, RP11-1407O15.2_2@0@0@0@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
A2463_01@154346@154346@deletion@1@39421631@39422112@17@chr17:39421631-39422112@5.86@58@21@0.362@CNVR7096.1@KRTAP9-6_1@0@0@0@:keratin associated protein 9-6@:keratin filament@NA
A2463_01@155584@155590@duplication@7@44380005@44409347@17@chr17:44380005-44409347@27.3@310@612@1.97@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A_3, LRRC37A_4, LRRC37A_5, LRRC37A_6, LRRC37A_7, LRRC37A_8, LRRC37A_9@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
A2463_01@155593@155600@duplication@8@44414663@44594799@17@chr17:44414663-44594799@27.4@199@449@2.26@CNVR7114.2, CNVR7114.1@LRRC37A_12, LRRC37A_13, LRRC37A_14, ARL17B_4, ARL17B_3, ARL17B_2, LRRC37A2_2, LRRC37A2_3@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
A2463_01@162017@162019@deletion@3@44542732@44556213@18@chr18:44542732-44556213@131@2525@454@0.18@CNVR7319.1, CNVR7319.2@TCEB3CL2_1, TCEB3CL_1, TCEB3C_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2:transcription elongation factor B polypeptide 3C-like:transcription elongation factor B polypeptide 3C (elongin A3);RNA polymerase II transcription factor SIII subunit A3-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_01@164951@164951@deletion@1@7032325@7032905@19@chr19:7032325-7032905@5.34@30@4@0.133@CNVR7517.1@MBD3L5_2@0@0@0@:methyl-CpG binding domain protein 3-like 5@NA@NA
A2463_01@168645@168646@duplication@2@33486933@33490611@19@chr19:33486933-33490611@5.84@352@486@1.38@CNVR7617.1@RHPN2_11, RHPN2_10@0@0@0@:rhophilin, Rho GTPase binding protein 2@:signal transduction;protein binding;intracellular;perinuclear region of cytoplasm@NA
A2463_01@170098@170100@deletion@3@40376632@40382826@19@chr19:40376632-40382826@28.8@252@84@0.333@CNVR7639.2@FCGBP_24, FCGBP_23, FCGBP_22@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_01@170821@170826@deletion@6@43702150@43763287@19@chr19:43702150-43763287@8.82@408@263@0.645@CNVR7658.5, CNVR7658.1@PSG4_3, PSG4_2, PSG4_1, PSG9_6, PSG9_5, PSG9_4@0@0@0@:pregnancy specific beta-1-glycoprotein 4:pregnancy specific beta-1-glycoprotein 9@:protein binding;extracellular region;female pregnancy;defense response:protein binding;extracellular region;female pregnancy;defense response@NA
A2463_01@172987@172988@deletion@2@52133087@52133588@19@chr19:52133087-52133588@7.19@37@3@0.0811@CNVR7702.1@SIGLEC5_2, SIGLEC5_2, SIGLEC5_1@0@0@0@:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 5@:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion@NA
A2463_01@173300@173308@duplication@9@54726816@54746600@19@chr19:54726816-54746600@24.9@679@1012@1.49@CNVR7721.3, CNVR7721.4, CNVR7721.1@LILRB3_1, LILRA6_8, LILRA6_7, LILRA6_6, LILRA6_5, LILRA6_4, LILRA6_3, LILRA6_2, LILRA6_1@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
A2463_01@173400@173400@deletion@1@55020246@55020295@19@chr19:55020246-55020295@6.3@28@0@0@NA@LAIR2_4@0@0@0@:leukocyte-associated immunoglobulin-like receptor 2@:extracellular region@NA
A2463_01@173456@173504@duplication@49@55237520@55363737@19@chr19:55237520-55363737@145@1932@3360@1.74@CNVR7725.1@KIR3DL3_3, KIR3DL3_4, KIR3DL3_5, KIR3DL3_6, KIR3DL3_7, KIR3DL3_8, KIR2DL3_1, KIR2DL3_2, KIR2DL3_3, KIR2DL3_4, KIR2DL3_5, KIR2DL3_6, KIR2DL3_7, KIR2DL3_8, KIR2DL1_1, KIR2DL1_2, KIR2DL1_3, KIR2DL1_4, KIR2DL1_5, KIR2DL1_6, KIR2DL1_7, KIR2DL1_8, KIR2DL4_1, KIR2DL4_2, KIR2DL4_3, KIR2DL4_4, KIR2DL4_5, KIR2DL4_6, KIR2DL4_7, KIR3DL1_1, KIR3DL1_2, KIR3DL1_3, KIR3DL1_4, KIR3DL1_5, KIR3DL1_6, KIR3DL1_7, KIR3DL1_8, KIR3DL1_9, KIR2DS4_1, KIR2DS4_2, KIR2DS4_3, KIR2DS4_4, KIR2DS4_5, KIR2DS4_6, KIR2DS4_7, KIR2DS4_8, KIR3DL2_1, KIR3DL2_2, KIR3DL2_3@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2-like@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:integral to membrane;plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane:regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane@NA
A2463_01@179011@179021@duplication@11@14982551@15013887@21@chr21:14982551-15013887@34.3@205@509@2.48@CNVR7952.1@POTED_1, POTED_2, POTED_3, POTED_4, POTED_5, POTED_6, POTED_7, POTED_8, POTED_9, POTED_10, POTED_11@0@0@0@:POTE ankyrin domain family, member B;POTE ankyrin domain family, member C;POTE ankyrin domain family, member D@:protein binding;plasma membrane@NA
A2463_01@180976@180976@duplication@1@16287255@16287885@22@chr22:16287255-16287885@20.1@253@577@2.28@CNVR8071.2, CNVR8071.3, CNVR8071.9@POTEH_1@0@0@0@:POTE ankyrin domain family, member H@:protein binding@NA
A2463_01@181126@181133@duplication@8@18721541@18739404@22@chr22:18721541-18739404@11.7@58@143@2.47@CNVR8087.5, CNVR8087.2, CNVR8087.11@AC008132.1_1, AC008132.1_2, AC008132.1_3, AC008132.1_4, AC008132.1_5, AC008132.1_6, AC008132.1_7, AC008132.1_8@0@0@0@NA@NA@NA
A2463_01@181484@181489@duplication@6@21063585@21067085@22@chr22:21063585-21067085@8.15@369@506@1.37@CNVR8099.6, CNVR8099.2@PI4KA_54, PI4KA_53, PI4KA_52, PI4KA_51, PI4KA_50, PI4KA_49@0@0@0@:phosphatidylinositol 4-kinase, catalytic, alpha@:phospholipid metabolic process;1-phosphatidylinositol 4-kinase activity;small molecule metabolic process;phosphatidylinositol phosphorylation;binding;transferase activity, transferring phosphorus-containing groups;phosphotransferase activity, alcohol group as acceptor;ATP binding;Golgi-associated vesicle;phosphatidylinositol biosynthetic process;cytosol;protein binding;signal transduction;synaptic transmission;kinase activity;phosphatidylinositol-mediated signaling@NA
A2463_01@181624@181633@duplication@10@21562879@21576503@22@chr22:21562879-21576503@14@216@352@1.63@CNVR8100.4, CNVR8100.10, CNVR8100.7@GGT2_14, GGT2_13, GGT2_12, GGT2_11, GGT2_10, GGT2_9, GGT2_8, GGT2_7, GGT2_6, GGT2_5@0@0@0@:gamma-glutamyltransferase 2;gamma-glutamyltranspeptidase 2-like@:hydrolase activity;small molecule metabolic process;leukotriene biosynthetic process;anchored to external side of plasma membrane;glutathione biosynthetic process;xenobiotic metabolic process;integral to membrane;glutathione metabolic process;plasma membrane;gamma-glutamyltransferase activity;cellular_component@NA
A2463_01@181805@181806@deletion@2@23241695@23243475@22@chr22:23241695-23243475@6.67@128@67@0.523@CNVR8103.2, CNVR8103.1, CNVR8103.6, CNVR8103.11@IGLJ2_1, IGLC2_1@0@0@0@@:protein binding@NA
A2463_01@181850@181850@deletion@1@23652512@23652620@22@chr22:23652512-23652620@7.37@48@9@0.188@CNVR8107.2, CNVR8107.3@BCR_18@0@0@0@:breakpoint cluster region@:phospholipid binding;protein autophosphorylation;protein tyrosine kinase activity;GTPase activator activity;neuromuscular process controlling balance;ATP binding;actin cytoskeleton organization;negative regulation of cell migration;plasma membrane;inner ear morphogenesis;positive regulation of Rac GTPase activity;positive regulation of phagocytosis;regulation of small GTPase mediated signal transduction;response to lipopolysaccharide;intracellular signal transduction;Rac GTPase activator activity;regulation of cell cycle;platelet-derived growth factor receptor signaling pathway;protein serine/threonine kinase activity;intracellular;small GTPase mediated signal transduction;regulation of Rho protein signal transduction;protein phosphorylation;negative regulation of inflammatory response;enzyme binding;Rho guanyl-nucleotide exchange factor activity;cytoplasm;cytosol;protein binding;signal transduction;brain development;kinase activity;negative regulation of neutrophil degranulation@: LEUKEMIA, CHRONIC MYELOID; CML
A2463_01@182490@182491@duplication@2@30163389@30165708@22@chr22:30163389-30165708@8.96@144@241@1.67@NA@UQCR10_1, UQCR10_2@0@0@0@:ubiquinol-cytochrome c reductase, complex III subunit X@:mitochondrion;small molecule metabolic process;ubiquinol-cytochrome-c reductase activity;mitochondrial inner membrane;mitochondrial electron transport, ubiquinol to cytochrome c;respiratory electron transport chain;mitochondrial envelope;respiratory chain@NA
A2463_01@184165@184177@duplication@13@42908917@42952594@22@chr22:42908917-42952594@8.73@394@539@1.37@CNVR8171.2, CNVR8171.3@RRP7A_7, RRP7A_6, RRP7A_5, RRP7A_4, RRP7A_3, RRP7A_2, RRP7A_1, SERHL2_1, SERHL2_2, SERHL2_3, SERHL2_4, SERHL2_5, SERHL2_6@0@0@0@:ribosomal RNA processing 7 homolog A (S. cerevisiae):serine hydrolase-like 2@:RNA binding;nucleotide binding:hydrolase activity;mitochondrion;peroxisome;cytoplasmic membrane-bounded vesicle;molecular_function;cellular_component;perinuclear region of cytoplasm;biological_process@NA
A2463_11@6@6@deletion@1@69092@70008@1@chr1:69092-70008@21.6@101@0@0@CNVR1.1, CNVR1.2@OR4F5_1@0@0@0@:olfactory receptor, family 4, subfamily F, member 5@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_11@431@434@duplication@4@1640234@1643839@1@chr1:1640234-1643839@6.96@51@106@2.08@CNVR17.1@CDK11A_9, CDK11A_8, CDK11A_7, CDK11A_6@0@0@0@:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A@:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division@NA
A2463_11@438@438@duplication@1@1654148@1654257@1@chr1:1654148-1654257@5.85@126@199@1.58@CNVR17.1@CDK11A_2@0@0@0@:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A@:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division@NA
A2463_11@1808@1809@duplication@2@12855588@12885361@1@chr1:12855588-12885361@5.66@535@709@1.33@CNVR72.3, CNVR72.10@PRAMEF1_4, PRAMEF11_4@0@0@0@:PRAME family member 1:PRAME family member 11@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_11@1812@1814@duplication@3@12907262@12920126@1@chr1:12907262-12920126@15@882@1247@1.41@CNVR72.3, CNVR72.4, CNVR72.7, CNVR72.12@HNRNPCL1_2, PRAMEF2_2, PRAMEF2_3@0@0@0@:heterogeneous nuclear ribonucleoprotein C-like 1-like;heterogeneous nuclear ribonucleoprotein C-like;heterogeneous nuclear ribonucleoprotein C-like 1:PRAME family member 2@:ribonucleoprotein complex;RNA binding;nucleus;nucleotide binding;nucleic acid binding:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_11@1829@1838@deletion@10@13036223@13366425@1@chr1:13036223-13366425@24.9@394@191@0.485@NA@PRAMEF22_2, PRAMEF22_3, WI2-3308P17.2_1, WI2-2994D6.2_2, WI2-2994D6.2_1, PRAMEF3_3, PRAMEF3_2, PRAMEF3_1, PRAMEF5_2, PRAMEF5_3@0@0@0@:PRAME family member 6;PRAME family member 23;PRAME family member 9/15-like;PRAME family member 5:PRAME family member 22:PRAME family member:PRAME family member 3:PRAME family member 5@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_11@1853@1855@deletion@3@13495968@13522259@1@chr1:13495968-13522259@14.3@72@4@0.0556@NA@PRAMEF16_2, PRAMEF16_3, PRAMEF21_2@0@0@0@:PRAME family member 16:PRAME family member 21;PRAME family member 20@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_11@3194@3198@deletion@5@24287949@24301567@1@chr1:24287949-24301567@14.2@66@1@0.0152@NA@PNRC2_3, SRSF10_6, SRSF10_5, SRSF10_4, SRSF10_3@0@0@0@:proline-rich nuclear receptor coactivator 2;proline-rich nuclear receptor coactivator 2-like:serine/arginine-rich splicing factor 10-like;serine/arginine-rich splicing factor 10@:protein binding;deadenylation-independent decapping of nuclear-transcribed mRNA;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;nucleus;regulation of transcription, DNA-dependent;transcription, DNA-dependent;cytoplasmic mRNA processing body:nucleoplasm;RNA splicing, via transesterification reactions;nuclear speck;RS domain binding;RNA binding;nucleus;mRNA splice site selection;unfolded protein binding;assembly of spliceosomal tri-snRNP;negative regulation of mRNA splicing, via spliceosome;regulation of transcription, DNA-dependent;nucleotide binding;cytoplasm;mRNA export from nucleus;protein binding;cytoplasmic transport;mRNA splicing, via spliceosome;nucleic acid binding@NA
A2463_11@9766@9773@deletion@8@110230497@110235917@1@chr1:110230497-110235917@68.3@324@5@0.0154@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_1, GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
A2463_11@10788@10788@deletion@1@144220788@144220959@1@chr1:144220788-144220959@17.5@83@1@0.012@CNVR333.1, CNVR333.3@RP3-377D14.1_87@0@0@0@NA@NA@NA
A2463_11@10799@10799@deletion@1@144815937@144816008@1@chr1:144815937-144816008@8.12@64@18@0.281@CNVR338.4, CNVR338.2, CNVR338.5, CNVR338.1@NBPF9_4@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 24@NA@NA
A2463_11@10890@10896@deletion@7@145325953@145330855@1@chr1:145325953-145330855@26.3@153@23@0.15@CNVR341.2, CNVR341.3@NBPF10_30, NBPF10_31, NBPF10_32, NBPF10_33, NBPF10_34, NBPF10_35, NBPF10_36@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family, member 10@NA@NA
A2463_11@11079@11080@deletion@2@145753956@145756613@1@chr1:145753956-145756613@6.43@32@2@0.0625@NA@PDZK1_5, PDZK1_6@0@0@0@:PDZ domain containing 1@:PDZ domain binding;transport;transporter activity;cytoplasm;cell proliferation;protein binding;positive regulation of ion transmembrane transport;scavenger receptor binding;brush border membrane;establishment of protein localization to plasma membrane;carnitine transport;drug transport@NA
A2463_11@11149@11157@deletion@9@146232495@146244717@1@chr1:146232495-146244717@9.95@55@7@0.127@NA@NBPF12_16, NBPF12_15, NBPF12_14, NBPF12_13, NBPF12_12, NBPF12_11, NBPF12_10, NBPF12_9, NBPF12_8@0@0@0@:neuroblastoma breakpoint family member 21-like@NA@NA
A2463_11@11341@11350@deletion@10@148008574@148015797@1@chr1:148008574-148015797@104@1137@367@0.323@CNVR346.2, CNVR346.4@NBPF14_17, NBPF14_16, NBPF14_15, NBPF14_14, NBPF14_13, NBPF14_12, NBPF14_11, NBPF14_10, NBPF14_9, NBPF14_8@0@0@0@:neuroblastoma breakpoint family, member 14@:cytoplasm@NA
A2463_11@12117@12118@deletion@2@152573209@152586574@1@chr1:152573209-152586574@32.4@151@0@0@CNVR358.1@LCE3C_1, LCE3B_1@0@0@0@:late cornified envelope 3C:late cornified envelope 3B@:keratinization:keratinization@NA
A2463_11@16030@16034@deletion@5@196748293@196762643@1@chr1:196748293-196762643@37.6@1041@615@0.591@CNVR459.1@CFHR3_2, CFHR3_3, CFHR3_4, CFHR3_5, CFHR3_6@0@0@0@:complement factor H-related 3@:extracellular space@NA
A2463_11@16049@16049@duplication@1@196884087@196884268@1@chr1:196884087-196884268@5.06@173@253@1.46@CNVR459.2@CFHR4_9@0@0@0@:complement factor H-related 2:complement factor H-related 4@:extracellular region:extracellular region;lipid transporter activity;lipid transport@NA
A2463_11@17286@17287@deletion@2@207718654@207719023@1@chr1:207718654-207719023@10.4@47@0@0@CNVR485.1@CR1_14, CR1_15@0@0@0@:complement component (3b/4b) receptor 1 (Knops blood group)@:complement component C4b receptor activity;complement activation, classical pathway;negative regulation of complement activation, alternative pathway;innate immune response;negative regulation of serine-type endopeptidase activity;complement component C3b binding;negative regulation of complement activation, classical pathway;plasma membrane;integral to plasma membrane;complement component C3b receptor activity;complement component C4b binding;cell surface;regulation of complement activation;positive regulation of serine-type endopeptidase activity@: MALARIA, SUSCEPTIBILITY TO; KNOPS BLOOD GROUP SYSTEM; KN
A2463_11@24822@24822@deletion@1@87178420@87178483@2@chr2:87178420-87178483@5.08@23@0@0@NA@RGPD1_2@0@0@0@:RANBP2-like and GRIP domain containing 1@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_11@24856@24863@deletion@8@88091510@88095367@2@chr2:88091510-88095367@11.2@52@1@0.0192@NA@RGPD2_17, RGPD2_16, RGPD2_15, RGPD2_14, RGPD2_13, RGPD2_12, RGPD2_11, RGPD2_10@0@0@0@:RANBP2-like and GRIP domain containing 2@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_11@24979@25015@duplication@37@89923730@90260248@2@chr2:89923730-90260248@109@3472@5057@1.46@CNVR867.10@IGKV1D-37_2, IGKV1D-33_1, IGKV1D-33_2, IGKV2D-30_1, IGKV2D-30_2, IGKV2D-29_1, IGKV2D-29_2, IGKV2D-28_1, IGKV2D-28_2, IGKV2D-26_1, IGKV2D-26_2, IGKV2D-24_1, IGKV2D-24_2, IGKV6D-21_1, IGKV6D-21_2, IGKV3D-20_1, IGKV3D-20_2, IGKV6D-41_1, IGKV6D-41_2, IGKV1D-17_1, IGKV1D-17_2, IGKV1D-16_1, IGKV1D-16_2, IGKV3D-15_1, IGKV3D-15_2, IGKV1D-13_1, IGKV1D-13_2, IGKV1D-12_1, IGKV1D-12_2, IGKV3D-11_1, IGKV3D-11_2, IGKV1D-42_1, IGKV1D-42_2, IGKV1D-43_1, IGKV1D-43_2, IGKV1D-8_1, IGKV1D-8_2@0@0@0@@:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding@NA
A2463_11@25369@25370@deletion@2@97854825@97855027@2@chr2:97854825-97855027@32.5@159@5@0.0314@CNVR886.2, CNVR886.3@ANKRD36_33, ANKRD36_34@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_11@26088@26088@deletion@1@109293063@109293154@2@chr2:109293063-109293154@6.3@92@43@0.467@NA@LIMS1_7@0@0@0@:LIM and senescent cell antigen-like domains 1@:negative regulation of transcription, DNA-dependent;cell aging;perinuclear region of cytoplasm;cellular response to transforming growth factor beta stimulus;cytosol;protein binding;focal adhesion;plasma membrane;zinc ion binding;cell junction assembly@NA
A2463_11@27208@27208@duplication@1@130951360@130952039@2@chr2:130951360-130952039@5.4@165@246@1.49@NA@TUBA3E_4@0@0@0@:tubulin, alpha 3e@:GTPase activity;structural constituent of cytoskeleton;protein complex;GTP catabolic process;cytoplasm;microtubule cytoskeleton;protein polymerization;microtubule-based movement;structural molecule activity;cytoplasmic microtubule;GTP binding;microtubule;microtubule cytoskeleton organization;protein domain specific binding@NA
A2463_11@27326@27326@deletion@1@132010100@132010143@2@chr2:132010100-132010143@4.74@23@1@0.0435@NA@POTEE_12@0@0@0@:pleckstrin homology domain containing, family B (evectins) member 2:POTE ankyrin domain family, member E@:phospholipid binding;protein binding;recycling endosome membrane:protein binding;ATP binding@NA
A2463_11@27333@27334@deletion@2@132236882@132238322@2@chr2:132236882-132238322@18@236@98@0.415@NA@TUBA3D_3, TUBA3D_4@0@0@0@:microRNA 4784;mitotic spindle organizing protein 2A:tubulin, alpha 3c;tubulin, alpha 3d@:gamma-tubulin ring complex;centrosome;spindle:microtubule-based process;structural constituent of cytoskeleton;protein folding;protein polymerization;cytoplasmic microtubule;GTP binding;microtubule cytoskeleton organization;GTPase activity;GTP catabolic process;protein complex;cytoplasm;microtubule cytoskeleton;protein binding;'de novo' posttranslational protein folding;cellular protein metabolic process;microtubule-based movement;structural molecule activity;microtubule;protein domain specific binding@NA
A2463_11@27341@27343@deletion@3@132288153@132290354@2@chr2:132288153-132290354@19.5@215@84@0.391@NA@CCDC74A_3, CCDC74A_4, CCDC74A_5@0@0@0@:coiled-coil domain containing 74A@NA@NA
A2463_11@27995@27997@deletion@3@152461075@152464122@2@chr2:152461075-152464122@24.6@132@12@0.0909@CNVR1026.1@NEB_85, NEB_84, NEB_83@0@0@0@:nebulin@:Z disc;muscle filament sliding;oxidation-reduction process;contractile fiber part;actin cytoskeleton;regulation of actin filament length;structural constituent of muscle;cytosol;actin binding;protein binding;myofibril;somatic muscle development;muscle organ development@: NEMALINE MYOPATHY 2; NEM2
A2463_11@39893@39894@deletion@2@75790428@75790887@3@chr3:75790428-75790887@4.9@25@2@0.08@CNVR1432.5, CNVR1432.9, CNVR1432.4@ZNF717_4, ZNF717_3@0@0@0@:zinc finger protein 717;zinc finger protein 717-like@:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_11@45459@45460@duplication@2@195505175@195518368@3@chr3:195505175-195518368@6.03@2414@3128@1.3@CNVR1704.1@MUC4_3, MUC4_2@0@0@0@:mucin 4, cell surface associated@:ErbB-2 class receptor binding;Golgi lumen;cell-matrix adhesion;post-translational protein modification;extracellular matrix structural constituent;protein binding;O-glycan processing;cellular protein metabolic process;proteinaceous extracellular matrix;integral to plasma membrane;membrane;extracellular matrix constituent, lubricant activity;biological_process@NA
A2463_11@46667@46671@deletion@5@9174900@9213975@4@chr4:9174900-9213975@18.2@120@25@0.208@NA@FAM90A26P_4, FAM90A26P_5, FAM90A26P_6, FAM90A26P_7, USP17L13_1, USP17L10_1@0@0@0@:ubiquitin specific peptidase 17-like family member 10:ubiquitin specific peptidase 17-like family member 13@:zinc ion binding;nucleic acid binding:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
A2463_11@48556@48561@duplication@6@69403344@69434202@4@chr4:69403344-69434202@60.2@556@1160@2.09@CNVR1953.1@UGT2B17_6, UGT2B17_5, UGT2B17_4, UGT2B17_3, UGT2B17_2, UGT2B17_1@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B17@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;membrane@: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
A2463_11@48968@48970@deletion@3@75314765@75318354@4@chr4:75314765-75318354@7.13@106@51@0.481@NA@AREG_3, AREG_4, AREG_5@0@0@0@:amphiregulin;amphiregulin B@:growth factor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;cell proliferation;epidermal growth factor receptor signaling pathway;extracellular space;protein binding;integral to membrane;cytokine activity;cell surface;positive regulation of DNA replication@NA
A2463_11@48972@48973@duplication@2@75482007@75484724@4@chr4:75482007-75484724@7.28@41@95@2.32@NA@AREGB_2, AREGB_3@0@0@0@:amphiregulin;amphiregulin B@:growth factor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;cell proliferation;epidermal growth factor receptor signaling pathway;extracellular space;protein binding;integral to membrane;cytokine activity;cell surface;positive regulation of DNA replication@NA
A2463_11@53051@53051@duplication@1@186382204@186382313@4@chr4:186382204-186382313@7.43@154@248@1.61@NA@CCDC110_5@0@0@0@:coiled-coil domain containing 110@:intracellular membrane-bounded organelle;Golgi apparatus;nucleolus;plasma membrane;nucleus;cytoplasm@NA
A2463_11@53303@53306@duplication@4@716924@741743@5@chr5:716924-741743@14.9@323@498@1.54@CNVR2280.3@ZDHHC11B_10, ZDHHC11B_9, ZDHHC11B_8, ZDHHC11B_7@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
A2463_11@53311@53312@duplication@2@756082@767067@5@chr5:756082-767067@5.16@119@183@1.54@CNVR2280.3@ZDHHC11B_2, ZDHHC11B_1@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
A2463_11@55806@55806@duplication@1@69372349@69372398@5@chr5:69372349-69372398@8.39@119@210@1.76@CNVR2494.48, CNVR2494.39, CNVR2494.15, CNVR2494.18, CNVR2494.26, CNVR2494.43, CNVR2494.52, CNVR2494.28, CNVR2494.2, CNVR2494.36@SMN2_8@0@0@0@:survival of motor neuron 2, centromeric;survival of motor neuron 1, telomeric@:nucleoplasm;ncRNA metabolic process;Cajal body;RNA metabolic process;spliceosomal complex;cytoplasm;cytosol;protein binding;cell death;spliceosomal complex assembly;RNA binding;mRNA processing;nucleus;gene expression;spliceosomal snRNP assembly@: SPINAL MUSCULAR ATROPHY, TYPE II; SMA2; SPINAL MUSCULAR ATROPHY, TYPE I; SMA1; SPINAL MUSCULAR ATROPHY, TYPE IV; SMA4; SPINAL MUSCULAR ATROPHY, TYPE III; SMA3
A2463_11@55835@55837@duplication@3@70338009@70343940@5@chr5:70338009-70343940@8.11@137@220@1.61@CNVR2494.41, CNVR2494.14, CNVR2494.20, CNVR2494.62, CNVR2494.8@GTF2H2_14, GTF2H2_13, GTF2H2_12@0@0@0@:general transcription factor IIH, polypeptide 2, 44kDa@:nucleoplasm;nucleotide-excision repair, DNA damage removal;transcription from RNA polymerase I promoter;DNA repair;RNA polymerase II carboxy-terminal domain kinase activity;nucleus;viral reproduction;translation;gene expression;transcription elongation from RNA polymerase I promoter;response to UV;holo TFIIH complex;protein kinase activity;nucleotide-excision repair;transcription from RNA polymerase II promoter;transcription-coupled nucleotide-excision repair;transcription, DNA-dependent;zinc ion binding;transcription elongation from RNA polymerase II promoter;termination of RNA polymerase I transcription;sequence-specific DNA binding transcription factor activity;G-protein coupled receptor internalization;DNA-dependent ATPase activity;protein N-terminus binding;transcription initiation from RNA polymerase I promoter;7-methylguanosine mRNA capping;transcription initiation from RNA polymerase II promoter;protein phosphorylation;translation factor activity, nucleic acid binding;regulation of transcription, DNA-dependent;core TFIIH complex;protein binding;positive regulation of viral transcription;nucleic acid binding@NA
A2463_11@59044@59045@deletion@2@140213970@140223300@5@chr5:140213970-140223300@22.8@2159@1354@0.627@CNVR2621.1@PCDHA7_1, PCDHA8_1@0@0@0@:protocadherin alpha 1:protocadherin alpha 2:protocadherin alpha 3:protocadherin alpha 4:protocadherin alpha 5:protocadherin alpha 6:protocadherin alpha 7:protocadherin alpha 8@:extracellular region;cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:integral to membrane;cell adhesion;homophilic cell adhesion;plasma membrane;integral to plasma membrane;membrane;nervous system development;calcium ion binding:cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:extracellular region;cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development@NA
A2463_11@59065@59065@duplication@1@140557617@140560021@5@chr5:140557617-140560021@8.8@2706@3705@1.37@CNVR2624.1@PCDHB8_1@0@0@0@:protocadherin beta 8@:integral to membrane;homophilic cell adhesion;plasma membrane;membrane;calcium ion binding@NA
A2463_11@59488@59488@duplication@1@147553798@147553933@5@chr5:147553798-147553933@4.59@31@67@2.16@CNVR2637.2, CNVR2637.1@SPINK14_3@0@0@0@:serine peptidase inhibitor, Kazal type 14 (putative)@:serine-type endopeptidase inhibitor activity;protein binding;extracellular region@NA
A2463_11@60875@60887@duplication@13@175386973@175523903@5@chr5:175386973-175523903@13.7@470@663@1.41@NA@THOC3_6, THOC3_5, THOC3_4, THOC3_3, THOC3_2, THOC3_1, RP11-826N14.2_3, RP11-826N14.2_2, FAM153B_3, FAM153B_4, FAM153B_5, FAM153B_6@0@0@0@:THO complex 3:uncharacterized LOC100507387;family with sequence similarity 153, member B@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
A2463_11@61262@61264@deletion@3@177158571@177161405@5@chr5:177158571-177161405@5.28@31@5@0.161@NA@FAM153A_15, FAM153A_14, FAM153A_13@0@0@0@:family with sequence similarity 153, member A@NA@NA
A2463_11@61267@61267@deletion@1@177164044@177164113@5@chr5:177164044-177164113@9.57@50@4@0.08@NA@FAM153A_10@0@0@0@:family with sequence similarity 153, member A@NA@NA
A2463_11@61273@61273@deletion@1@177171890@177171968@5@chr5:177171890-177171968@5.37@81@39@0.481@NA@FAM153A_4@0@0@0@:family with sequence similarity 153, member A@NA@NA
A2463_11@63725@63725@deletion@1@31962023@31962161@6@chr6:31962023-31962161@7@102@47@0.461@CNVR2843.6, CNVR2843.3@C4A_20@0@0@0@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
A2463_11@63768@63768@duplication@1@31994761@31994899@6@chr6:31994761-31994899@5.96@90@153@1.7@CNVR2843.6, CNVR2843.5@C4B_20@0@0@0@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
A2463_11@63800@63805@deletion@6@32009127@32010608@6@chr6:32009127-32010608@39.3@428@173@0.404@CNVR2843.6, CNVR2843.5@TNXB_13, TNXB_12, TNXB_11, TNXB_10, TNXB_9, TNXB_8@0@0@0@:cytochrome P450, family 21, subfamily A, polypeptide 2:tenascin-X-like;tenascin XB@:oxidation-reduction process;electron carrier activity;response to antibiotic;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;steroid 21-monooxygenase activity;C21-steroid hormone biosynthetic process;heme binding;mineralocorticoid biosynthetic process;progesterone metabolic process;monooxygenase activity;cellular response to peptide hormone stimulus;iron ion binding:integrin binding;extracellular matrix;cell-cell adhesion;elastic fiber assembly;collagen fibril organization;fibrillar collagen;actin cytoskeleton organization;extracellular space;heparin binding;proteinaceous extracellular matrix;fatty acid metabolic process;regulation of JUN kinase activity;receptor binding;intracellular;cell-matrix adhesion;extracellular matrix organization;lipid metabolic process;protein binding;signal transduction;extracellular region;collagen binding;cell adhesion;triglyceride metabolic process;fibril organization;collagen metabolic process@: ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY: EHLERS-DANLOS-LIKE SYNDROME DUE TO TENASCIN-X DEFICIENCY; EHLERS-DANLOS SYNDROME, TYPE III
A2463_11@63810@63810@deletion@1@32011785@32011906@6@chr6:32011785-32011906@4.97@54@22@0.407@CNVR2843.6, CNVR2843.5@TNXB_3@0@0@0@:tenascin-X-like;tenascin XB@:integrin binding;extracellular matrix;cell-cell adhesion;elastic fiber assembly;collagen fibril organization;fibrillar collagen;actin cytoskeleton organization;extracellular space;heparin binding;proteinaceous extracellular matrix;fatty acid metabolic process;regulation of JUN kinase activity;receptor binding;intracellular;cell-matrix adhesion;extracellular matrix organization;lipid metabolic process;protein binding;signal transduction;extracellular region;collagen binding;cell adhesion;triglyceride metabolic process;fibril organization;collagen metabolic process@: EHLERS-DANLOS-LIKE SYNDROME DUE TO TENASCIN-X DEFICIENCY; EHLERS-DANLOS SYNDROME, TYPE III
A2463_11@63952@63956@deletion@5@32411534@32487428@6@chr6:32411534-32487428@10.9@174@90@0.517@CNVR2845.21, CNVR2845.25@HLA-DRA_4, HLA-DRB5_6, HLA-DRB5_5, HLA-DRB5_4, HLA-DRB5_3@0@0@0@:major histocompatibility complex, class II, DR alpha:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;lysosome;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@: HEPATITIS B VIRUS, SUSCEPTIBILITY TO
A2463_11@63965@63967@deletion@3@32605237@32610030@6@chr6:32605237-32610030@26.8@549@274@0.499@CNVR2845.21, CNVR2845.25, CNVR2845.37, CNVR2845.63, CNVR2845.27, CNVR2845.22, CNVR2845.39, CNVR2845.20@HLA-DQA1_1, HLA-DQA1_2, HLA-DQA1_3@0@0@0@:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
A2463_11@70816@70817@deletion@2@161054786@161056336@6@chr6:161054786-161056336@22@218@73@0.335@CNVR3133.1@LPA_9, LPA_8@0@0@0@:lipoprotein, Lp(a)@:blood circulation;endopeptidase inhibitor activity;catalytic activity;lipoprotein metabolic process;proteolysis;heparin binding;receptor-mediated endocytosis;fibronectin binding;small molecule metabolic process;apolipoprotein binding;lipid metabolic process;negative regulation of endopeptidase activity;extracellular region;plasma lipoprotein particle;lipid transport;serine-type endopeptidase activity@: APOLIPOPROTEIN(a); LPA
A2463_11@71030@71030@deletion@1@167790035@167790192@6@chr6:167790035-167790192@7.93@50@9@0.18@NA@TCP10_5@0@0@0@:t-complex 10@:cytosol@NA
A2463_11@71744@71751@duplication@8@5939916@5951553@7@chr7:5939916-5951553@10.6@861@1127@1.31@NA@CCZ1_2, CCZ1_3, CCZ1_4, CCZ1_5, CCZ1_6, CCZ1_7, CCZ1_8, CCZ1_9@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
A2463_11@71777@71778@duplication@2@6013031@6017388@7@chr7:6013031-6017388@7.56@284@410@1.44@NA@PMS2_15, PMS2_14@0@0@0@:PMS2 postmeiotic segregation increased 2 (S. cerevisiae)@:response to drug;DNA binding;MutSalpha complex binding;ATP binding;mismatch repair;DNA repair;mismatched DNA binding;ATPase activity;nucleus;mismatch repair complex;reciprocal meiotic recombination;ATP catabolic process;single-stranded DNA binding;response to DNA damage stimulus;single base insertion or deletion binding;protein binding;somatic hypermutation of immunoglobulin genes;somatic recombination of immunoglobulin gene segments;MutLalpha complex;endonuclease activity@: COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 4; HNPCC4; MISMATCH REPAIR CANCER SYNDROME
A2463_11@71939@71944@deletion@6@6836200@6844686@7@chr7:6836200-6844686@24.1@244@93@0.381@NA@RSPH10B2_19, RSPH10B2_20, CCZ1B_15, CCZ1B_14, CCZ1B_13, CCZ1B_12@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
A2463_11@74781@74783@deletion@3@76121471@76129837@7@chr7:76121471-76129837@5.92@78@37@0.474@CNVR3462.1@DTX2_6, DTX2_7, DTX2_8@0@0@0@:deltex homolog 2 (Drosophila)@:ligase activity;cytoplasm;nuclear membrane;Notch signaling pathway;protein binding;nucleus;zinc ion binding;protein ubiquitination@NA
A2463_11@76427@76432@duplication@6@100331793@100336236@7@chr7:100331793-100336236@18.1@300@488@1.63@CNVR3509.1@ZAN_1, ZAN_2, ZAN_3, ZAN_4, ZAN_5, ZAN_6@0@0@0@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
A2463_11@76765@76771@deletion@7@102235753@102246434@7@chr7:102235753-102246434@15.3@162@62@0.383@CNVR3518.1@RASA4_11, RASA4_10, RASA4_9, RASA4_8, RASA4_7, RASA4_6, RASA4_5@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity@NA
A2463_11@76779@76793@deletion@15@102279571@102312048@7@chr7:102279571-102312048@22.8@243@91@0.374@CNVR3518.1@UPK3BL_4, UPK3BL_4, UPK3BL_3, UPK3BL_3, UPK3BL_2, UPK3BL_2, UPK3BL_1, UPK3BL_1, SPDYE2L_2, SPDYE2L_3, SPDYE2L_4, SPDYE2L_5, SPDYE2L_6, SPDYE2L_7, SPDYE2L_8, POLR2J2_4, POLR2J2_4, POLR2J2_3, POLR2J2_3, POLR2J2_2, POLR2J2_2, POLR2J2_1, POLR2J2_1@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4:uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J2:WBSCR19-like protein 3;speedy homolog E6 (Xenopus laevis)@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity:integral to membrane:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
A2463_11@77096@77102@deletion@7@105903839@105925330@7@chr7:105903839-105925330@12.4@649@431@0.664@NA@NAMPT_7, NAMPT_6, NAMPT_5, NAMPT_4, NAMPT_3, NAMPT_2, NAMPT_1@0@0@0@:nicotinamide phosphoribosyltransferase@:nicotinate phosphoribosyltransferase activity;small molecule metabolic process;positive regulation of nitric-oxide synthase biosynthetic process;NAD metabolic process;cytoplasm;cell-cell signaling;NAD biosynthetic process;cytosol;signal transduction;cytokine activity;positive regulation of cell proliferation;water-soluble vitamin metabolic process;nicotinate-nucleotide diphosphorylase (carboxylating) activity;nicotinamide metabolic process;vitamin metabolic process;nicotinamide phosphoribosyltransferase activity@NA
A2463_11@79309@79324@deletion@16@143880598@144071982@7@chr7:143880598-144071982@112@2863@1648@0.576@CNVR3598.4@CTAGE4_1, ARHGEF35_2, OR2A42_1, OR2A7_1, CTAGE8_1, OR2A1_1, ARHGEF5_2, ARHGEF5_3, ARHGEF5_4, ARHGEF5_5, ARHGEF5_6, ARHGEF5_7, ARHGEF5_8, ARHGEF5_9, ARHGEF5_10, ARHGEF5_11@0@0@0@:CTAGE family, member 4:Rho guanine nucleotide exchange factor (GEF) 35:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1:olfactory receptor, family 2, subfamily A, member 7:CTAGE family, member 6, pseudogene;CTAGE family, member 15, pseudogene:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:integral to membrane;nucleotide binding;cellular_component;biological_process:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
A2463_11@80358@80358@deletion@1@6873513@6873621@8@chr8:6873513-6873621@19.2@98@5@0.051@CNVR3769.1@DEFA3_3@0@0@0@:defensin, alpha 1B;defensin, alpha 1:defensin, alpha 3, neutrophil-specific;defensin, alpha 1B;defensin, alpha 1@:defense response to virus;extracellular matrix;immune response;Golgi lumen;azurophil granule lumen;killing of cells of other organism;innate immune response;chemotaxis;extracellular space;extracellular region;defense response to bacterium;defense response to fungus;defense response:defense response to virus;Golgi lumen;azurophil granule lumen;killing of cells of other organism;innate immune response;extracellular space;defense response to bacterium;defense response to fungus;extracellular region;defense response@NA
A2463_11@80367@80386@duplication@20@7272484@7399402@8@chr8:7272484-7399402@27.6@722@1079@1.49@CNVR3771.8, CNVR3771.10, CNVR3771.4@DEFB4B_2, DEFB4B_1, DEFB103B_2, DEFB103B_1, SPAG11B_3, SPAG11B_2, SPAG11B_1, DEFB104B_2, DEFB104B_1, DEFB106B_2, DEFB106B_1, DEFB105B_1, DEFB105B_2, DEFB105B_3, DEFB107B_1, DEFB107B_2, RP11-1118M6.1_1, RP11-1118M6.1_2, RP11-1118M6.1_3, RP11-1118M6.1_4@0@0@0@:defensin, beta 4B;defensin, beta 4A:defensin, beta 103B;defensin, beta 103A:sperm associated antigen 11B:defensin, beta 104A;defensin, beta 104B:defensin, beta 106B;defensin, beta 106A:defensin, beta 105B;defensin, beta 105A:defensin, beta 107B;defensin, beta 107A:uncharacterized LOC100133251@:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response:extracellular region;defense response to bacterium;Golgi lumen;positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria;defense response;innate immune response:spermatogenesis;defense response to bacterium;extracellular region;molecular_function;defense response:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium@NA
A2463_11@80392@80410@duplication@19@7673082@7807650@8@chr8:7673082-7807650@23.7@938@1319@1.41@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@DEFB107A_1, DEFB105A_3, DEFB105A_2, DEFB105A_1, DEFB106A_1, DEFB106A_2, DEFB104A_1, DEFB104A_2, SPAG11A_1, SPAG11A_2, SPAG11A_3, SPAG11A_4, DEFB103A_1, DEFB103A_2, DEFB4A_1, DEFB4A_2, ZNF705B_3, ZNF705B_4@0@0@0@:defensin, beta 107B;defensin, beta 107A:defensin, beta 105B;defensin, beta 105A:defensin, beta 106B;defensin, beta 106A:defensin, beta 104A;defensin, beta 104B:sperm associated antigen 11A;sperm associated antigen 11B:defensin, beta 103B;defensin, beta 103A:defensin, beta 4B;defensin, beta 4A:zinc finger protein 705B@:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response:extracellular region;defense response to bacterium;Golgi lumen;positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria;defense response;innate immune response:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response:intracellular;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_11@80566@80572@duplication@7@12041116@12049350@8@chr8:12041116-12049350@12.3@408@582@1.43@CNVR3785.5, CNVR3785.3@FAM86B1_8, FAM86B1_7, FAM86B1_6, FAM86B1_5, FAM86B1_4, FAM86B1_3, FAM86B1_2@0@0@0@:family with sequence similarity 86, member B2;family with sequence similarity 86, member B1@NA@NA
A2463_11@81713@81716@duplication@4@29921405@29927575@8@chr8:29921405-29927575@8.11@453@613@1.35@NA@TMEM66_6, TMEM66_5, TMEM66_4, TMEM66_3@0@0@0@:transmembrane protein 66@:protein binding;integral to endoplasmic reticulum membrane;store-operated calcium channel activity;regulation of store-operated calcium entry@NA
A2463_11@86646@86646@deletion@1@178817@178969@9@chr9:178817-178969@17.2@80@0@0@CNVR4135.1@CBWD1_1@0@0@0@:COBW domain containing 1;COBW domain-containing protein 1-like;COBW domain containing 5@:ATP binding@NA
A2463_11@88558@88558@deletion@1@42409510@42410483@9@chr9:42409510-42410483@7.05@104@48@0.462@NA@ANKRD20A2_15, RP11-146D12.2_1@0@0@0@:ankyrin repeat domain 20 family, member A2@:protein binding@NA
A2463_11@88639@88641@deletion@3@67926874@67930837@9@chr9:67926874-67930837@11.3@60@6@0.1@NA@ANKRD20A1_1, ANKRD20A1_2, ANKRD20A1_3@0@0@0@:ankyrin repeat domain 20 family, member A1@:protein binding;plasma membrane@NA
A2463_11@88643@88643@duplication@1@67935876@67936012@9@chr9:67935876-67936012@5.83@31@75@2.42@NA@ANKRD20A1_5@0@0@0@:ankyrin repeat domain 20 family, member A1@:protein binding;plasma membrane@NA
A2463_11@88645@88657@duplication@13@67945207@67987998@9@chr9:67945207-67987998@34@1161@1720@1.48@NA@ANKRD20A1_7, ANKRD20A1_8, ANKRD20A1_9, ANKRD20A1_10, ANKRD20A1_11, ANKRD20A1_12, ANKRD20A1_13, ANKRD20A1_14, ANKRD20A1_15, RP11-195B21.3_3, RP11-195B21.3_4, RP11-195B21.3_5, RP11-195B21.3_6@0@0@0@:ankyrin repeat domain 20 family, member A1:coiled-coil domain-containing protein 29-like;uncharacterized LOC644249@:protein binding;plasma membrane@NA
A2463_11@88706@88708@duplication@3@70484376@70490068@9@chr9:70484376-70490068@6.83@176@263@1.49@NA@CBWD5_3, CBWD5_2, CBWD5_1@0@0@0@:COBW domain-containing protein 5-like;COBW domain containing 7;COBW domain containing 5@:ATP binding@NA
A2463_11@93194@93194@duplication@1@135946375@135947151@9@chr9:135946375-135947151@5.02@259@364@1.41@CNVR4502.1@CEL_11@0@0@0@:carboxyl ester lipase (bile salt-stimulated lipase)@:intestinal lipid catabolic process;pancreatic juice secretion;catalytic activity;extracellular space;heparin binding;sterol esterase activity;carboxylesterase activity;metabolic process;ceramide catabolic process;hydrolase activity;small molecule metabolic process;acylglycerol lipase activity;lipid metabolic process;cytoplasm;protein esterification;cytosol;retinyl-palmitate esterase activity;fatty acid catabolic process;extracellular region;triglyceride lipase activity;lipid digestion;triglyceride metabolic process;cholesterol catabolic process;intestinal cholesterol absorption@: MATURITY-ONSET DIABETES OF THE YOUNG; MODY; MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 8, WITH EXOCRINE DYSFUNCTION;
A2463_11@95347@95352@duplication@6@17818029@17875838@10@chr10:17818029-17875838@11.3@143@248@1.73@NA@TMEM236_3, TMEM236_4, MRC1L1_1, MRC1L1_2, MRC1L1_3, MRC1L1_4@0@0@0@:transmembrane protein 236;transmembrane protein 236-like:macrophage mannose receptor 1-like@:integral to membrane:carbohydrate binding@NA
A2463_11@95384@95386@deletion@3@18112045@18122792@10@chr10:18112045-18122792@16.9@111@23@0.207@NA@MRC1_2, MRC1_3, MRC1_4@0@0@0@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
A2463_11@96444@96444@deletion@1@46272722@46272873@10@chr10:46272722-46272873@7.85@102@44@0.431@CNVR4711.1@FAM21C_22@0@0@0@:family with sequence similarity 21, member C@:endosome;protein binding;plasma membrane;retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_11@96455@96455@duplication@1@46321364@46322838@10@chr10:46321364-46322838@9.05@185@304@1.64@NA@AGAP4_7@0@0@0@:ArfGAP with GTPase domain, ankyrin repeat and PH domain 4;arf-GAP with GTPase, ANK repeat and PH domain-containing protein 5-like@:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity@NA
A2463_11@96505@96514@duplication@10@47658500@47674056@10@chr10:47658500-47674056@9.67@950@1226@1.29@CNVR4713.1@ANTXRL_1, ANTXRL_2, ANTXRL_3, ANTXRL_4, ANTXRL_5, ANTXRL_6, ANTXRL_7, ANTXRL_8, ANTXRL_9, ANTXRL_10@0@0@0@@:protein binding;integral to membrane;receptor activity;metal ion binding@NA
A2463_11@96541@96546@deletion@6@47906679@47911108@10@chr10:47906679-47911108@12.3@148@66@0.446@CNVR4715.2@FAM21B_7, FAM21B_8, FAM21B_9, FAM21B_10, FAM21B_11, FAM21B_12@0@0@0@:family with sequence similarity 21, member B@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_11@96548@96563@deletion@16@47913577@47948853@10@chr10:47913577-47948853@87.8@455@35@0.0769@CNVR4715.2, CNVR4715.1@FAM21B_14, FAM21B_15, FAM21B_16, FAM21B_17, FAM21B_18, FAM21B_19, FAM21B_20, FAM21B_21, FAM21B_22, FAM21B_23, FAM21B_24, FAM21B_25, FAM21B_26, FAM21B_27, FAM21B_28, FAM21B_29@0@0@0@:family with sequence similarity 21, member B@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_11@96572@96577@duplication@6@48020451@48033105@10@chr10:48020451-48033105@9.01@327@458@1.4@CNVR4715.2@ASAH2C_10, ASAH2C_9, ASAH2C_8, ASAH2C_7, ASAH2C_6, ASAH2C_5@0@0@0@@:ceramidase activity;sphingolipid metabolic process@NA
A2463_11@96620@96620@duplication@1@48771316@48771405@10@chr10:48771316-48771405@4.98@80@133@1.66@CNVR4716.10, CNVR4716.3@PTPN20B_6@0@0@0@:protein tyrosine phosphatase, non-receptor type 20B;protein tyrosine phosphatase, non-receptor type 20A@:phosphatase activity;protein tyrosine phosphatase activity;microtubule;nucleus;dephosphorylation;protein dephosphorylation;microtubule organizing center@NA
A2463_11@96844@96844@deletion@1@51224991@51226465@10@chr10:51224991-51226465@9.98@198@99@0.5@CNVR4727.1@AGAP8_7@0@0@0@:ArfGAP with GTPase domain, ankyrin repeat and PH domain 8@:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity@NA
A2463_11@96851@96852@deletion@2@51371542@51374428@10@chr10:51371542-51374428@14.1@120@34@0.283@NA@TIMM23B_1, TIMM23B_2@0@0@0@:translocase of inner mitochondrial membrane 23 homolog B (yeast)@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process@NA
A2463_11@96859@96862@duplication@4@51469924@51483242@10@chr10:51469924-51483242@7.61@217@314@1.45@CNVR4729.1@AGAP7_5, AGAP7_4, AGAP7_3, AGAP7_2@0@0@0@:translocase of inner mitochondrial membrane 23 homolog B (yeast):ArfGAP with GTPase domain, ankyrin repeat and PH domain 7@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity@NA
A2463_11@96883@96884@duplication@2@51620325@51623214@10@chr10:51620325-51623214@11.1@239@380@1.59@NA@TIMM23_2, TIMM23_1@0@0@0@:translocase of inner mitochondrial membrane 23 homolog B (yeast):translocase of inner mitochondrial membrane 23 homolog B (yeast);translocase of inner mitochondrial membrane 23 homolog (yeast)@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process:mitochondrion;mitochondrial inner membrane;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;mitochondrial intermembrane space;integral to mitochondrial inner membrane;intracellular protein transport;protein binding;integral to membrane;cellular protein metabolic process;protein targeting to mitochondrion@NA
A2463_11@96907@96907@deletion@1@51855360@51855538@10@chr10:51855360-51855538@6.66@31@1@0.0323@NA@FAM21A_15@0@0@0@:family with sequence similarity 21, member B;family with sequence similarity 21, member A@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_11@96907@96921@duplication@14@51855360@51889799@10@chr10:51855360-51889799@15.8@532@760@1.43@CNVR4734.2@FAM21A_15, FAM21A_16, FAM21A_17, FAM21A_18, FAM21A_19, FAM21A_20, FAM21A_21, FAM21A_22, FAM21A_23, FAM21A_24, FAM21A_25, FAM21A_26, FAM21A_27, FAM21A_28, FAM21A_29@0@0@0@:family with sequence similarity 21, member B;family with sequence similarity 21, member A@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_11@96932@96937@deletion@6@51965743@51978390@10@chr10:51965743-51978390@17.2@123@33@0.268@NA@ASAH2_12, ASAH2_11, ASAH2_10, ASAH2_9, ASAH2_8, ASAH2_7@0@0@0@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
A2463_11@98350@98350@duplication@1@81471457@81472241@10@chr10:81471457-81472241@13.4@381@623@1.64@CNVR4815.2, CNVR4815.4@FAM22B_7@0@0@0@NA@NA@NA
A2463_11@98350@98357@deletion@7@81471457@81610362@10@chr10:81471457-81610362@8.02@535@628@1.17@CNVR4815.2@FAM22B_7, FAM22E_1, FAM22E_2, FAM22E_3, FAM22E_4, FAM22E_5, FAM22E_6, FAM22E_7@0@0@0@NA@NA@NA
A2463_11@98595@98596@deletion@2@88985589@88988719@10@chr10:88985589-88988719@8.02@90@37@0.411@CNVR4840.3, CNVR4840.5@FAM22A_1, FAM22A_2@0@0@0@:family with sequence similarity 22, member A@NA@NA
A2463_11@98603@98606@duplication@4@89120239@89124960@10@chr10:89120239-89124960@7.19@83@148@1.78@CNVR4840.3@FAM22D_2, FAM22D_3, FAM22D_4, FAM22D_5@0@0@0@:family with sequence similarity 22, member D@NA@NA
A2463_11@100439@100479@duplication@41@105151952@105218508@10@chr10:105151952-105218508@110@3634@5242@1.44@NA@USMG5_4, USMG5_3, PDCD11_2, PDCD11_3, PDCD11_4, PDCD11_5, PDCD11_6, PDCD11_7, PDCD11_8, PDCD11_9, PDCD11_10, PDCD11_11, PDCD11_12, PDCD11_13, PDCD11_14, PDCD11_15, PDCD11_16, PDCD11_17, PDCD11_18, PDCD11_19, PDCD11_20, PDCD11_21, PDCD11_22, PDCD11_23, PDCD11_24, PDCD11_25, PDCD11_26, PDCD11_27, PDCD11_28, PDCD11_29, PDCD11_30, PDCD11_31, PDCD11_32, PDCD11_33, PDCD11_34, PDCD11_35, PDCD11_36, CALHM2_4, CALHM2_3, CALHM1_2, CALHM1_1@0@0@0@:up-regulated during skeletal muscle growth 5 homolog (mouse):programmed cell death 11:calcium homeostasis modulator 2:calcium homeostasis modulator 1@:mitochondrion;integral to membrane;mitochondrial inner membrane;mitochondrial proton-transporting ATP synthase complex:intracellular;cytosol;protein binding;mRNA processing;nucleolus;RNA binding;nucleus;transcription factor binding;rRNA processing;RNA processing:integral to membrane:integral to membrane;calcium channel activity;plasma membrane;endoplasmic reticulum membrane;identical protein binding@NA
A2463_11@101608@101615@deletion@8@124344788@124354044@10@chr10:124344788-124354044@36.2@695@361@0.519@CNVR4912.4, CNVR4912.3, CNVR4912.2@DMBT1_15, DMBT1_16, DMBT1_17, DMBT1_18, DMBT1_19, DMBT1_20, DMBT1_21, DMBT1_22@0@0@0@:deleted in malignant brain tumors 1@:defense response to virus;calcium-dependent protein binding;pattern recognition receptor signaling pathway;blastocyst development;response to estrogen stimulus;tissue regeneration;proteinaceous extracellular matrix;protein transport;Gram-negative bacterial cell surface binding;positive regulation of epithelial cell differentiation;virus-host interaction;epithelial cell differentiation;induction of bacterial agglutination;phagocytic vesicle membrane;intracellular;Gram-positive bacterial cell surface binding;zymogen binding;innate immune response;cytoplasm;extrinsic to membrane;protein binding;zymogen granule membrane;extracellular region;scavenger receptor activity;pattern recognition receptor activity;inner cell mass cell proliferation;membrane@: GLIOMA SUSCEPTIBILITY 1; GLM1
A2463_11@110110@110114@duplication@5@89532885@89537637@11@chr11:89532885-89537637@19.7@364@596@1.64@NA@TRIM49_7, TRIM49_6, TRIM49_5, TRIM49_4, TRIM49_3@0@0@0@:tripartite motif containing 49@:protein binding;intracellular;DNA binding;zinc ion binding@NA
A2463_11@110120@110125@deletion@6@89608779@89773130@11@chr11:89608779-89773130@69.2@460@70@0.152@NA@TRIM64B_1, TRIM49C_3, TRIM49C_4, TRIM49C_5, TRIM49C_6, TRIM49C_7@0@0@0@:tripartite motif containing 64;tripartite motif containing 64C;tripartite motif containing 64B:tripartite motif containing 49D, pseudogene;tripartite motif containing 49-like 1;tripartite motif containing 49C;tripartite motif-containing protein 49-like protein 1-like@:protein binding;intracellular;zinc ion binding:protein binding;intracellular;DNA binding;zinc ion binding@NA
A2463_11@114136@114138@deletion@3@8374419@8376811@12@chr12:8374419-8376811@13.6@1516@1007@0.664@CNVR5422.3, CNVR5422.5, CNVR5422.6, CNVR5422.1@FAM90A1_7, FAM90A1_6, FAM90A1_5@0@0@0@:family with sequence similarity 90, member A1@:zinc ion binding;nucleic acid binding@NA
A2463_11@127333@127333@deletion@1@19553418@19553937@14@chr14:19553418-19553937@7.56@590@380@0.644@CNVR6072.1@POTEG_1@0@0@0@:POTE ankyrin domain family, member G@:protein binding@NA
A2463_11@127336@127338@deletion@3@19561995@19566082@14@chr14:19561995-19566082@20.7@418@209@0.5@CNVR6072.1@POTEG_4, POTEG_5, POTEG_6@0@0@0@:POTE ankyrin domain family, member G@:protein binding@NA
A2463_11@127348@127352@duplication@5@20010104@20020220@14@chr14:20010104-20020220@18.9@268@465@1.74@CNVR6072.6, CNVR6072.12@POTEM_5, POTEM_4, POTEM_3, POTEM_2, POTEM_1@0@0@0@:POTE ankyrin domain family, member M@:protein binding@NA
A2463_11@133349@133352@deletion@4@106090814@106092403@14@chr14:106090814-106092403@9.77@527@344@0.653@CNVR6294.46, CNVR6294.20, CNVR6294.54, CNVR6294.43, CNVR6294.50, CNVR6294.61@IGHG4_4, IGHG4_3, IGHG4_2, IGHG4_1@0@0@0@@:antigen binding;protein binding;complement activation;extracellular region;immune response;membrane;complement activation, classical pathway;innate immune response@NA
A2463_11@133432@133435@deletion@4@106539080@106552729@14@chr14:106539080-106552729@33.6@160@4@0.025@CNVR6294.36, CNVR6294.48, CNVR6294.24, CNVR6294.10, CNVR6294.34@IGHV1-8_2, IGHV1-8_1, IGHV3-9_2, IGHV3-9_1@0@0@0@@:protein binding:protein binding@NA
A2463_11@133450@133451@duplication@2@106725202@106725654@14@chr14:106725202-106725654@11.3@190@315@1.66@CNVR6294.48, CNVR6294.24, CNVR6294.40, CNVR6294.38, CNVR6294.17, CNVR6294.23@IGHV3-23_2, IGHV3-23_1@0@0@0@@:protein binding@NA
A2463_11@133458@133459@duplication@2@106791006@106791456@14@chr14:106791006-106791456@8.53@231@350@1.52@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.53@IGHV3-30_2, IGHV3-30_1@0@0@0@@:protein binding@NA
A2463_11@133462@133463@deletion@2@106815723@106816173@14@chr14:106815723-106816173@10.9@103@34@0.33@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.56, CNVR6294.51@IGHV3-33_2, IGHV3-33_1@0@0@0@@:protein binding@NA
A2463_11@133532@133537@duplication@6@22062317@22074702@15@chr15:22062317-22074702@7.89@191@284@1.49@NA@POTEB_9, POTEB_8, POTEB_7, POTEB_6, POTEB_5, POTEB_4@0@0@0@:POTE ankyrin domain family member B-like@:protein binding@NA
A2463_11@133632@133633@deletion@2@23264766@23265045@15@chr15:23264766-23265045@16.7@102@17@0.167@CNVR6300.4@GOLGA8I_16, GOLGA8I_17@0@0@0@:golgin A8 family, member I@:Golgi cisterna membrane@NA
A2463_11@133638@133641@duplication@4@23409198@23411062@15@chr15:23409198-23411062@11.2@147@250@1.7@CNVR6300.8@RP11-467N20.5_6, RP11-467N20.5_5, RP11-467N20.5_4, RP11-467N20.5_3@0@0@0@:putative golgin subfamily A member 6-like protein 6-like@NA@NA
A2463_11@133670@133670@deletion@1@23690458@23690585@15@chr15:23690458-23690585@5.62@31@4@0.129@NA@GOLGA6L2_2@0@0@0@:golgin A6 family-like 2@NA@NA
A2463_11@133869@133870@deletion@2@28629294@28629596@15@chr15:28629294-28629596@10.3@47@0@0@CNVR6329.4@GOLGA8F_9, GOLGA8F_10@0@0@0@@:Golgi apparatus@NA
A2463_11@133901@133902@duplication@2@28947612@28947891@15@chr15:28947612-28947891@13.7@231@388@1.68@NA@GOLGA8M_17, GOLGA8M_16@0@0@0@:golgin A8 family, member M@:Golgi apparatus@NA
A2463_11@134012@134015@duplication@4@30665182@30675554@15@chr15:30665182-30675554@7.64@104@177@1.7@CNVR6337.1@CHRFAM7A_6, CHRFAM7A_5, CHRFAM7A_4, CHRFAM7A_3@0@0@0@:CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:transport;integral to membrane;ion transport;postsynaptic membrane;membrane;extracellular ligand-gated ion channel activity@NA
A2463_11@134036@134054@duplication@19@30845996@30896376@15@chr15:30845996-30896376@46.4@446@839@1.88@CNVR6339.2, CNVR6339.3, CNVR6339.1@GOLGA8Q_2, GOLGA8Q_3, GOLGA8Q_4, GOLGA8Q_5, GOLGA8Q_6, GOLGA8Q_7, GOLGA8Q_8, GOLGA8Q_9, GOLGA8Q_10, GOLGA8Q_11, GOLGA8Q_12, GOLGA8Q_13, GOLGA8Q_14, GOLGA8Q_15, GOLGA8Q_16, GOLGA8Q_17, GOLGA8Q_18, GOLGA8Q_19, GOLGA8H_1@0@0@0@:golgin A8 family, member H@:Golgi apparatus:Golgi apparatus@NA
A2463_11@134153@134153@deletion@1@32449810@32449976@15@chr15:32449810-32449976@6.54@29@0@0@CNVR6345.2, CNVR6345.1@CHRNA7_6@0@0@0@:cholinergic receptor, nicotinic, alpha 7 (neuronal);CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:cellular calcium ion homeostasis;transport;beta-amyloid binding;calcium ion transport;acetylcholine receptor activity;ion transport;acetylcholine-activated cation-selective channel activity;integral to membrane;chloride channel regulator activity;cell junction;plasma membrane;positive regulation of cell proliferation;protein homodimerization activity;acetylcholine-gated channel complex;response to chemical stimulus;activation of MAPK activity;negative regulation of tumor necrosis factor production;response to hypoxia;response to nicotine;acetylcholine binding;positive regulation of angiogenesis;signal transduction;memory;toxin binding;synaptic transmission;postsynaptic membrane;membrane;cognition;extracellular ligand-gated ion channel activity@NA
A2463_11@134163@134164@duplication@2@32686867@32688232@15@chr15:32686867-32688232@6.74@107@175@1.64@NA@GOLGA8K_14, GOLGA8K_13@0@0@0@:golgin A8 family, member J@:Golgi apparatus@NA
A2463_11@134167@134171@duplication@5@32689405@32691186@15@chr15:32689405-32691186@13.4@353@523@1.48@NA@GOLGA8K_10, GOLGA8K_9, GOLGA8K_8, GOLGA8K_7, GOLGA8K_6@0@0@0@:golgin A8 family, member J@:Golgi apparatus@NA
A2463_11@134180@134181@duplication@2@32737820@32738099@15@chr15:32737820-32738099@8.78@24@83@3.46@CNVR6346.1@GOLGA8O_17, GOLGA8O_16@0@0@0@:golgin A8 family, member O@:Golgi apparatus@NA
A2463_11@134189@134191@duplication@3@32743115@32743539@15@chr15:32743115-32743539@7.05@75@136@1.81@CNVR6346.1@GOLGA8O_8, GOLGA8O_7, GOLGA8O_6@0@0@0@:golgin A8 family, member O@:Golgi apparatus@NA
A2463_11@135680@135737@duplication@58@43873201@43940259@15@chr15:43873201-43940259@140@5560@7961@1.43@CNVR6365.1@PPIP5K1_10, PPIP5K1_9, PPIP5K1_8, PPIP5K1_7, PPIP5K1_6, PPIP5K1_5, PPIP5K1_4, PPIP5K1_3, CKMT1B_2, CKMT1B_3, CKMT1B_4, CKMT1B_5, CKMT1B_6, CKMT1B_7, CKMT1B_8, CKMT1B_9, CKMT1B_10, STRC_29, STRC_28, STRC_27, STRC_26, STRC_25, STRC_24, STRC_23, STRC_22, STRC_21, STRC_20, STRC_19, STRC_18, STRC_17, STRC_16, STRC_15, STRC_14, STRC_13, STRC_12, STRC_11, STRC_10, STRC_9, STRC_8, STRC_7, STRC_6, STRC_5, STRC_4, STRC_3, STRC_2, STRC_1, CATSPER2_13, CATSPER2_12, CATSPER2_11, CATSPER2_10, CATSPER2_9, CATSPER2_8, CATSPER2_7, CATSPER2_6, CATSPER2_5, CATSPER2_4, CATSPER2_3, CATSPER2_2@0@0@0@:diphosphoinositol pentakisphosphate kinase 1:creatine kinase, mitochondrial 1A;creatine kinase, mitochondrial 1B:stereocilin:cation channel, sperm associated 2@:inositol hexakisphosphate 3-kinase activity;inositol hexakisphosphate 1-kinase activity;inositol metabolic process;diphosphoinositol-pentakisphosphate kinase activity;ATP binding;acid phosphatase activity;cytoplasm;cytosol;inositol hexakisphosphate 5-kinase activity;nucleus;kinase activity;inositol-1,3,4,5,6-pentakisphosphate kinase activity:mitochondrion;small molecule metabolic process;mitochondrial inner membrane;creatine metabolic process;creatine kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;kinase activity;cellular nitrogen compound metabolic process:detection of mechanical stimulus involved in sensory perception of sound;stereocilium bundle tip;stereocilium;cell surface;kinocilium;auditory receptor cell stereocilium organization:cell differentiation;CatSper complex;ion transport;transmembrane transport;voltage-gated ion channel activity;flagellar membrane;spermatogenesis;integral to membrane;multicellular organismal development;fertilization;sperm motility;ion channel activity;ciliary or flagellar motility;calcium channel activity;cilium;protein binding;microtubule-based flagellum;membrane@: DEAFNESS, AUTOSOMAL RECESSIVE 16; DFNB16; DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY: DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY
A2463_11@138284@138285@duplication@2@72954594@72955446@15@chr15:72954594-72955446@5.63@138@210@1.52@CNVR6443.1@GOLGA6B_11, GOLGA6B_12@0@0@0@:golgin A6 family, member B@:Golgi apparatus@NA
A2463_11@138660@138663@duplication@4@75585415@75586602@15@chr15:75585415-75586602@8.37@213@316@1.48@CNVR6452.1@GOLGA6D_14, GOLGA6D_15, GOLGA6D_16, GOLGA6D_17@0@0@0@:golgin A6 family, member D@:Golgi apparatus@NA
A2463_11@139305@139308@duplication@4@83013228@83015609@15@chr15:83013228-83015609@7.08@39@91@2.33@CNVR6477.6, CNVR6477.2@RP13-996F3.4_6, RP13-996F3.4_5, RP13-996F3.4_4, RP13-996F3.4_3@0@0@0@NA@NA@NA
A2463_11@139473@139482@deletion@10@84850735@84911344@15@chr15:84850735-84911344@41.6@441@170@0.385@CNVR6486.2@RP11-182J1.16_3, GOLGA6L4_1, GOLGA6L4_2, GOLGA6L4_3, GOLGA6L4_4, GOLGA6L4_5, GOLGA6L4_6, GOLGA6L4_7, GOLGA6L4_8, GOLGA6L4_9@0@0@0@:uncharacterized LOC100505679@:Golgi apparatus@NA
A2463_11@142651@142651@deletion@1@14858861@14859270@16@chr16:14858861-14859270@11.4@90@24@0.267@CNVR6644.1@RP11-719K4.2_8@0@0@0@:nuclear pore complex-interacting protein-like 1-like@NA@NA
A2463_11@142654@142658@duplication@5@14935220@14946439@16@chr16:14935220-14946439@6.6@150@230@1.53@NA@NOMO1_3, NOMO1_4, NOMO1_5, NOMO1_6, NOMO1_7@0@0@0@:NODAL modulator 1;nodal modulator 1-like@:carbohydrate binding;integral to membrane;carboxypeptidase activity;molecular_function;cellular_component;biological_process@NA
A2463_11@142750@142750@duplication@1@15457517@15457926@16@chr16:15457517-15457926@10.3@282@448@1.59@CNVR6649.1@PKD1P1_8@0@0@0@:NPIP-like protein 1-like;nuclear pore complex-interacting protein-like 1-like@NA@NA
A2463_11@142910@142928@deletion@19@16330759@16367932@16@chr16:16330759-16367932@83.9@638@172@0.27@NA@NOMO3_2, NOMO3_3, NOMO3_4, NOMO3_5, NOMO3_6, NOMO3_7, NOMO3_8, NOMO3_9, NOMO3_10, NOMO3_11, NOMO3_12, NOMO3_13, NOMO3_14, NOMO3_15, NOMO3_16, NOMO3_17, NOMO3_18, NOMO3_19, NOMO3_20@0@0@0@:NODAL modulator 3@:carbohydrate binding;integral to membrane;carboxypeptidase activity@NA
A2463_11@142950@142952@duplication@3@16481257@16484731@16@chr16:16481257-16484731@9.94@70@150@2.14@CNVR6654.1@RP11-467M13.1_3, RP11-467M13.1_4, RP11-467M13.1_5@0@0@0@NA@NA@NA
A2463_11@142971@142973@deletion@3@18414875@18418355@16@chr16:18414875-18418355@13.8@64@1@0.0156@CNVR6658.1@RP11-1212A22.2_7, RP11-1212A22.2_6, RP11-1212A22.2_5@0@0@0@NA@NA@NA
A2463_11@143000@143012@duplication@13@18538860@18562861@16@chr16:18538860-18562861@22.2@658@955@1.45@NA@NOMO2_16, NOMO2_15, NOMO2_14, NOMO2_13, NOMO2_12, NOMO2_11, NOMO2_10, NOMO2_9, NOMO2_8, NOMO2_7, NOMO2_6, NOMO2_5, NOMO2_4@0@0@0@:NODAL modulator 2@:carbohydrate binding;protein binding;integral to membrane;carboxypeptidase activity;endoplasmic reticulum membrane@NA
A2463_11@147113@147126@duplication@14@70165206@70208941@16@chr16:70165206-70208941@21.3@1513@1998@1.32@CNVR6764.1, CNVR6764.3@PDPR_8, PDPR_9, PDPR_10, PDPR_11, PDPR_12, PDPR_13, PDPR_14, PDPR_15, PDPR_16, PDPR_17, PDPR_18, PDPR_19, CLEC18C_1, CLEC18C_2@0@0@0@:pyruvate dehydrogenase phosphatase regulatory subunit:C-type lectin domain family 18, member C@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix:carbohydrate binding;protein binding;extracellular region@NA
A2463_11@147509@147515@duplication@7@74446053@74455168@16@chr16:74446053-74455168@9.17@573@762@1.33@CNVR6778.2, CNVR6778.3@CLEC18B_7, CLEC18B_6, CLEC18B_5, CLEC18B_4, CLEC18B_3, CLEC18B_2, CLEC18B_1@0@0@0@:C-type lectin domain family 18, member B@:carbohydrate binding;protein binding;extracellular region@NA
A2463_11@150032@150033@deletion@2@7011156@7011876@17@chr17:7011156-7011876@4.98@98@54@0.551@NA@ASGR2_5, ASGR2_4@0@0@0@:asialoglycoprotein receptor 2@:carbohydrate binding;regulation of protein stability;glycoprotein metabolic process;protein binding;integral to membrane;asialoglycoprotein receptor activity;bone mineralization;lipid homeostasis;cell surface receptor signaling pathway@NA
A2463_11@151958@151959@duplication@2@18996506@18997166@17@chr17:18996506-18997166@17.4@306@523@1.71@CNVR7018.4, CNVR7018.2, CNVR7018.6@AC007952.5_1, AC007952.5_2@0@0@0@NA@NA@NA
A2463_11@153376@153394@deletion@19@34522686@34590454@17@chr17:34522686-34590454@22.5@142@29@0.204@CNVR7077.1, CNVR7077.13, CNVR7077.19@CCL3L3_3, CCL3L3_2, CCL3L3_1, CCL4L1_1, CCL4L1_2, CCL4L1_3, TBC1D3C_14, TBC1D3C_13, TBC1D3C_12, TBC1D3C_11, TBC1D3C_10, TBC1D3C_9, TBC1D3C_8, TBC1D3C_7, TBC1D3C_6, TBC1D3C_5, TBC1D3C_4, TBC1D3C_3, TBC1D3C_2@0@0@0@:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1:TBC1 domain family, member 3C;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3H-like;TBC1 domain family, member 3H@:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_11@153650@153659@duplication@10@36351930@36375177@17@chr17:36351930-36375177@28.7@1589@2168@1.36@CNVR7083.3@RP11-1407O15.2_12, RP11-1407O15.2_11, RP11-1407O15.2_10, RP11-1407O15.2_9, RP11-1407O15.2_8, RP11-1407O15.2_7, RP11-1407O15.2_6, RP11-1407O15.2_5, RP11-1407O15.2_4, RP11-1407O15.2_3@0@0@0@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
A2463_11@155584@155590@deletion@7@44380005@44409347@17@chr17:44380005-44409347@18.2@381@209@0.549@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A_3, LRRC37A_4, LRRC37A_5, LRRC37A_6, LRRC37A_7, LRRC37A_8, LRRC37A_9@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
A2463_11@155592@155595@deletion@4@44412912@44415089@17@chr17:44412912-44415089@22.2@103@1@0.00971@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A_11, LRRC37A_12, LRRC37A_13, LRRC37A_14@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
A2463_11@155600@155607@duplication@8@44594729@44627209@17@chr17:44594729-44627209@8.28@1301@1706@1.31@CNVR7114.2, CNVR7114.5@LRRC37A2_3, LRRC37A2_4, LRRC37A2_5, LRRC37A2_6, LRRC37A2_7, LRRC37A2_8, LRRC37A2_9, LRRC37A2_10@0@0@0@:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
A2463_11@155610@155613@duplication@4@44632519@44634996@17@chr17:44632519-44634996@14@333@514@1.54@CNVR7114.2, CNVR7114.5, CNVR7114.4@LRRC37A2_13, LRRC37A2_14, LRRC37A2_15, ARL17A_4@0@0@0@:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
A2463_11@160721@160721@duplication@1@10911185@10911226@18@chr18:10911185-10911226@8.14@95@176@1.85@NA@PIEZO2_4@0@0@0@:piezo-type mechanosensitive ion channel component 2@:ion channel activity;regulation of membrane potential;mechanically-gated ion channel activity;integral to membrane;cation transport;cation channel activity@NA
A2463_11@162017@162018@deletion@2@44542732@44550298@18@chr18:44542732-44550298@68@472@70@0.148@CNVR7319.1, CNVR7319.2@TCEB3CL2_1, TCEB3CL_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2:transcription elongation factor B polypeptide 3C-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_11@164951@164951@deletion@1@7032325@7032905@19@chr19:7032325-7032905@6.15@37@6@0.162@CNVR7517.1@MBD3L5_2@0@0@0@:methyl-CpG binding domain protein 3-like 5@NA@NA
A2463_11@170093@170093@deletion@1@40367299@40367914@19@chr19:40367299-40367914@5.04@24@1@0.0417@CNVR7639.2@FCGBP_29@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_11@170098@170100@deletion@3@40376632@40382826@19@chr19:40376632-40382826@37.9@326@107@0.328@CNVR7639.2@FCGBP_24, FCGBP_23, FCGBP_22@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_11@170107@170108@duplication@2@40395805@40398510@19@chr19:40395805-40398510@12.2@364@545@1.5@CNVR7639.2, CNVR7639.3@FCGBP_15, FCGBP_14@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_11@170107@170112@deletion@4@40395805@40406060@19@chr19:40395805-40406060@-21.1@460@568@1.23@CNVR7639.2, CNVR7639.3@FCGBP_15, FCGBP_14, FCGBP_13, FCGBP_12, FCGBP_11, FCGBP_10@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_11@170399@170399@deletion@1@41627863@41628038@19@chr19:41627863-41628038@5.61@55@20@0.364@CNVR7644.1@CYP2F1_6@0@0@0@:cytochrome P450, family 2, subfamily F, polypeptide 1@:trichloroethylene metabolic process;oxidation-reduction process;aromatase activity;response to toxin;oxygen binding;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;endoplasmic reticulum membrane;naphthalene metabolic process;intracellular membrane-bounded organelle;electron carrier activity;small molecule metabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;heme binding;xenobiotic metabolic process;monooxygenase activity;iron ion binding@NA
A2463_11@170821@170826@deletion@6@43702150@43763287@19@chr19:43702150-43763287@13.3@497@312@0.628@CNVR7658.5, CNVR7658.1@PSG4_3, PSG4_2, PSG4_1, PSG9_6, PSG9_5, PSG9_4@0@0@0@:pregnancy specific beta-1-glycoprotein 4:pregnancy specific beta-1-glycoprotein 9@:protein binding;extracellular region;female pregnancy;defense response:protein binding;extracellular region;female pregnancy;defense response@NA
A2463_11@173457@173460@duplication@4@55239078@55247339@19@chr19:55239078-55247339@10.9@113@207@1.83@CNVR7725.2@KIR3DL3_4, KIR3DL3_5, KIR3DL3_6, KIR3DL3_7@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:integral to membrane;plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane@NA
A2463_11@173464@173469@duplication@6@55253427@55263971@19@chr19:55253427-55263971@22.3@483@752@1.56@CNVR7725.2, CNVR7725.1@KIR2DL3_3, KIR2DL3_4, KIR2DL3_5, KIR2DL3_6, KIR2DL3_7, KIR2DL3_8@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity@NA
A2463_11@173484@173496@duplication@13@55325298@55349330@19@chr19:55325298-55349330@20.7@917@1267@1.38@CNVR7725.1, CNVR7725.6@KIR2DL4_7, KIR3DL1_1, KIR3DL1_2, KIR3DL1_3, KIR3DL1_4, KIR3DL1_5, KIR3DL1_6, KIR3DL1_7, KIR3DL1_8, KIR3DL1_9, KIR2DS4_1, KIR2DS4_2, KIR2DS4_3@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane@NA
A2463_11@173500@173501@deletion@2@55359207@55359398@19@chr19:55359207-55359398@9.63@43@0@0@CNVR7725.1, CNVR7725.6, CNVR7725.5, CNVR7725.10@KIR2DS4_7, KIR2DS4_8@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
A2463_11@174394@174394@deletion@1@1558985@1559340@20@chr20:1558985-1559340@5.07@183@111@0.607@CNVR7763.1, CNVR7763.2@RP4-576H24.4_2, SIRPB1_2@0@0@0@:signal-regulatory protein beta 1;signal-regulatory protein beta-1-like;signal-regulatory protein beta-1 isoform 3-like@:protein binding:protein binding;signal transduction;integral to membrane;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway@NA
A2463_11@179011@179021@duplication@11@14982551@15013887@21@chr21:14982551-15013887@41.2@255@608@2.38@CNVR7952.1@POTED_1, POTED_2, POTED_3, POTED_4, POTED_5, POTED_6, POTED_7, POTED_8, POTED_9, POTED_10, POTED_11@0@0@0@:POTE ankyrin domain family, member B;POTE ankyrin domain family, member C;POTE ankyrin domain family, member D@:protein binding;plasma membrane@NA
A2463_11@181127@181133@duplication@7@18723546@18739404@22@chr22:18723546-18739404@12.5@73@166@2.27@CNVR8087.5, CNVR8087.2, CNVR8087.11@AC008132.1_2, AC008132.1_3, AC008132.1_4, AC008132.1_5, AC008132.1_6, AC008132.1_7, AC008132.1_8@0@0@0@NA@NA@NA
A2463_11@181417@181420@deletion@4@20366369@20367356@22@chr22:20366369-20367356@7.75@36@1@0.0278@CNVR8094.9, CNVR8094.4, CNVR8094.3@GGTLC3_5, GGTLC3_4, GGTLC3_3, GGTLC3_2@0@0@0@@:leukotriene biosynthetic process;glutathione metabolic process;gamma-glutamyltransferase activity;anchored to external side of plasma membrane@NA
A2463_11@181487@181489@duplication@3@21065630@21067085@22@chr22:21065630-21067085@7.19@153@233@1.52@CNVR8099.6, CNVR8099.2@PI4KA_51, PI4KA_50, PI4KA_49@0@0@0@:phosphatidylinositol 4-kinase, catalytic, alpha@:phospholipid metabolic process;1-phosphatidylinositol 4-kinase activity;small molecule metabolic process;phosphatidylinositol phosphorylation;binding;transferase activity, transferring phosphorus-containing groups;phosphotransferase activity, alcohol group as acceptor;ATP binding;Golgi-associated vesicle;phosphatidylinositol biosynthetic process;cytosol;protein binding;signal transduction;synaptic transmission;kinase activity;phosphatidylinositol-mediated signaling@NA
A2463_11@181624@181633@duplication@10@21562879@21576503@22@chr22:21562879-21576503@34.5@265@554@2.09@CNVR8100.4, CNVR8100.10, CNVR8100.7@GGT2_14, GGT2_13, GGT2_12, GGT2_11, GGT2_10, GGT2_9, GGT2_8, GGT2_7, GGT2_6, GGT2_5@0@0@0@:gamma-glutamyltransferase 2;gamma-glutamyltranspeptidase 2-like@:hydrolase activity;small molecule metabolic process;leukotriene biosynthetic process;anchored to external side of plasma membrane;glutathione biosynthetic process;xenobiotic metabolic process;integral to membrane;glutathione metabolic process;plasma membrane;gamma-glutamyltransferase activity;cellular_component@NA
A2463_11@181806@181806@deletion@1@23243157@23243475@22@chr22:23243157-23243475@5.42@108@57@0.528@CNVR8103.2, CNVR8103.1, CNVR8103.6, CNVR8103.11@IGLC2_1@0@0@0@@:protein binding@NA
A2463_11@181951@181955@duplication@5@24376424@24384231@22@chr22:24376424-24384231@11.3@134@233@1.74@CNVR8114.13, CNVR8114.1, CNVR8114.7@GSTT1_5, GSTT1_4, GSTT1_3, GSTT1_2, GSTT1_1@0@0@0@:glutathione S-transferase theta 1@:glutathione peroxidase activity;response to drug;transferase activity;cytosol;protein binding;glutathione transferase activity;glutathione metabolic process;response to organic cyclic compound@NA
A2463_11@183263@183264@deletion@2@37524137@37528508@22@chr22:37524137-37528508@10.5@172@85@0.494@NA@IL2RB_10, IL2RB_9@0@0@0@:interleukin 2 receptor, beta@:negative regulation of apoptotic process;external side of plasma membrane;protein complex assembly;protein binding;signal transduction;interleukin-2 receptor activity;interleukin-2-mediated signaling pathway;plasma membrane;integral to plasma membrane;interleukin-2 binding;cytokine-mediated signaling pathway;virus-host interaction@NA
A2463_34@428@432@deletion@5@1637082@1640572@1@chr1:1637082-1640572@9.98@156@78@0.5@CNVR17.1@CDK11A_12, CDK11A_11, CDK11A_10, CDK11A_9, CDK11A_8@0@0@0@:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A@:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division@NA
A2463_34@1821@1826@duplication@6@12955393@13001395@1@chr1:12955393-13001395@8.39@549@783@1.43@CNVR72.3, CNVR72.4, CNVR72.2@PRAMEF10_2, PRAMEF7_2, PRAMEF7_3, PRAMEF7_4, PRAMEF6_4, PRAMEF6_3@0@0@0@:PRAME family member 10:PRAME family member 7:PRAME family member 6;PRAME family member 23;PRAME family member 9/15-like;PRAME family member 5@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_34@3333@3339@duplication@7@25599040@25633220@1@chr1:25599040-25633220@11.7@1288@1864@1.45@CNVR116.1, CNVR116.2@RHD_1, RHD_2, RHD_3, RHD_4, RHD_5, RHD_6, RHD_7@0@0@0@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
A2463_34@6008@6015@duplication@8@45797696@45798996@1@chr1:45797696-45798996@7@1692@2220@1.31@NA@MUTYH_11, MUTYH_10, MUTYH_9, MUTYH_8, MUTYH_7, MUTYH_6, MUTYH_5, MUTYH_4@0@0@0@:mutY homolog (E. coli)@:nucleoplasm;mitochondrion;depurination;catalytic activity;MutSalpha complex binding;mismatch repair;DNA repair;nucleus;hydrolase activity;4 iron, 4 sulfur cluster binding;base-excision repair;protein binding;base-excision repair, AP site formation;hydrolase activity, acting on glycosyl bonds;endonuclease activity;metal ion binding@: GASTRIC CANCER; FAMILIAL ADENOMATOUS POLYPOSIS, 2; FAP2
A2463_34@8377@8385@deletion@9@86824471@86848879@1@chr1:86824471-86848879@9.76@1423@906@0.637@NA@ODF2L_13, ODF2L_12, ODF2L_11, ODF2L_10, ODF2L_9, ODF2L_8, ODF2L_7, ODF2L_6, ODF2L_5@0@0@0@:outer dense fiber of sperm tails 2-like@:centrosome;nucleotide binding@NA
A2463_34@8601@8604@deletion@4@91727799@91733412@1@chr1:91727799-91733412@6.57@844@520@0.616@NA@HFM1_38, HFM1_37, HFM1_36, HFM1_35@0@0@0@:HFM1, ATP-dependent DNA helicase homolog (S. cerevisiae)@:hydrolase activity;helicase activity;DNA binding;ATP-dependent helicase activity;nucleic acid binding;ATP binding@NA
A2463_34@9365@9368@duplication@4@104202983@104205633@1@chr1:104202983-104205633@10.4@440@765@1.74@CNVR266.3, CNVR266.1@AMY1A_7, AMY1A_8, AMY1A_9, AMY1A_10@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
A2463_34@9766@9773@duplication@8@110230497@110235917@1@chr1:110230497-110235917@28.9@237@667@2.81@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_1, GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
A2463_34@10793@10793@deletion@1@144339779@144340398@1@chr1:144339779-144340398@4.68@23@0@0@CNVR334.4, CNVR334.2@AL592284.1_1@0@0@0@:uncharacterized LOC730256;uncharacterized LOC101060698;uncharacterized LOC642441@NA@NA
A2463_34@10867@10872@duplication@6@145301721@145310063@1@chr1:145301721-145310063@6.39@1062@1375@1.29@CNVR341.2, CNVR341.3@NBPF10_7, NBPF10_8, NBPF10_9, NBPF10_10, NBPF10_11, NBPF10_12@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family, member 10@:protein binding;calcium ion binding@NA
A2463_34@10889@10896@duplication@8@145325236@145330855@1@chr1:145325236-145330855@8.97@273@446@1.63@CNVR341.2, CNVR341.3@NBPF10_29, NBPF10_30, NBPF10_31, NBPF10_32, NBPF10_33, NBPF10_34, NBPF10_35, NBPF10_36@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family, member 10@NA@NA
A2463_34@10920@10942@duplication@23@145349564@145366999@1@chr1:145349564-145366999@12.7@342@528@1.54@CNVR341.2, CNVR341.3@NBPF10_60, NBPF10_61, NBPF10_62, NBPF10_63, NBPF10_64, NBPF10_65, NBPF10_66, NBPF10_67, NBPF10_68, NBPF10_69, NBPF10_70, NBPF10_71, NBPF10_72, NBPF10_73, NBPF10_74, NBPF10_75, NBPF10_76, NBPF10_77, NBPF10_78, NBPF10_79, NBPF10_80, NBPF10_81, NBPF10_82@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family, member 10@NA@NA
A2463_34@11169@11170@deletion@2@146400092@146401880@1@chr1:146400092-146401880@9.48@78@13@0.167@NA@NBPF12_9, NBPF12_10@0@0@0@:neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family member 14-like;neuroblastoma breakpoint family, member 12@:cytoplasm@NA
A2463_34@11345@11346@deletion@2@148011681@148012675@1@chr1:148011681-148012675@4.91@328@171@0.521@CNVR346.2, CNVR346.4@NBPF14_13, NBPF14_12@0@0@0@:neuroblastoma breakpoint family, member 14@:cytoplasm@NA
A2463_34@11500@11500@deletion@1@149459426@149459549@1@chr1:149459426-149459549@7.9@51@2@0.0392@CNVR350.1, CNVR350.5@FAM72C_1@0@0@0@:family with sequence similarity 72, member C@NA@NA
A2463_34@16038@16038@deletion@1@196797201@196797376@1@chr1:196797201-196797376@5.25@178@66@0.371@CNVR459.1@CFHR1_4@0@0@0@:complement factor H-related 1:complement factor H-related 2@:extracellular space;complement activation:extracellular region@NA
A2463_34@17286@17287@deletion@2@207718654@207719023@1@chr1:207718654-207719023@4.98@27@1@0.037@CNVR485.1@CR1_14, CR1_15@0@0@0@:complement component (3b/4b) receptor 1 (Knops blood group)@:complement component C4b receptor activity;complement activation, classical pathway;negative regulation of complement activation, alternative pathway;innate immune response;negative regulation of serine-type endopeptidase activity;complement component C3b binding;negative regulation of complement activation, classical pathway;plasma membrane;integral to plasma membrane;complement component C3b receptor activity;complement component C4b binding;cell surface;regulation of complement activation;positive regulation of serine-type endopeptidase activity@: MALARIA, SUSCEPTIBILITY TO; KNOPS BLOOD GROUP SYSTEM; KN
A2463_34@24856@24863@deletion@8@88091510@88095367@2@chr2:88091510-88095367@10.9@54@0@0@NA@RGPD2_17, RGPD2_16, RGPD2_15, RGPD2_14, RGPD2_13, RGPD2_12, RGPD2_11, RGPD2_10@0@0@0@:RANBP2-like and GRIP domain containing 2@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_34@24942@24954@duplication@13@89292350@89417308@2@chr2:89292350-89417308@10.3@1922@2435@1.27@CNVR866.7, CNVR866.10, CNVR866.11@IGKV1-8_1, IGKV1-9_2, IGKV1-9_1, IGKV3-11_2, IGKV3-11_1, IGKV1-12_2, IGKV1-12_1, IGKV3-15_2, IGKV3-15_1, IGKV1-16_2, IGKV1-16_1, IGKV1-17_2, IGKV1-17_1@0@0@0@@:protein binding:protein binding:regulation of immune response;complement activation;immune response;complement activation, classical pathway;innate immune response;antigen binding;protein binding;extracellular region;plasma membrane:protein binding:protein binding:protein binding:protein binding@NA
A2463_34@25369@25370@deletion@2@97854825@97855027@2@chr2:97854825-97855027@6.03@34@3@0.0882@CNVR886.2, CNVR886.3@ANKRD36_33, ANKRD36_34@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_34@27171@27181@duplication@11@130868117@130899954@2@chr2:130868117-130899954@10.2@1115@1483@1.33@NA@POTEF_5, POTEF_4, POTEF_3, POTEF_2, POTEF_1, CCDC74B_8, CCDC74B_7, CCDC74B_6, CCDC74B_5, CCDC74B_4, CCDC74B_3@0@0@0@:POTE ankyrin domain family, member F:coiled-coil domain containing 74A;coiled-coil domain containing 74B@:cell cortex;protein binding;ATP binding@NA
A2463_34@27207@27211@duplication@5@130949405@130955933@2@chr2:130949405-130955933@5.69@447@607@1.36@NA@TUBA3E_5, TUBA3E_4, TUBA3E_3, TUBA3E_2, TUBA3E_1@0@0@0@:tubulin, alpha 3e@:GTPase activity;structural constituent of cytoskeleton;protein complex;GTP catabolic process;cytoplasm;microtubule cytoskeleton;protein polymerization;microtubule-based movement;structural molecule activity;cytoplasmic microtubule;GTP binding;microtubule;microtubule cytoskeleton organization;protein domain specific binding@NA
A2463_34@33406@33420@duplication@15@233272305@233322577@2@chr2:233272305-233322577@10.9@836@1115@1.33@NA@ALPPL2_4, ALPPL2_5, ALPPL2_6, ALPPL2_7, ALPPL2_8, ALPPL2_9, ALPPL2_10, ALPPL2_11, ALPI_1, ALPI_2, ALPI_3, ALPI_4, ALPI_5, ALPI_6, ALPI_7@0@0@0@:alkaline phosphatase, placental-like 2:alkaline phosphatase, intestinal@:phosphatase activity;catalytic activity;phosphorylation;plasma membrane;metabolic process;membrane;anchored to membrane;alkaline phosphatase activity;metal ion binding:phosphatase activity;catalytic activity;phosphorylation;integral to membrane;plasma membrane;alkaline phosphatase activity;metabolic process;membrane;anchored to membrane;metal ion binding@NA
A2463_34@37554@37583@duplication@30@48619757@48626903@3@chr3:48619757-48626903@16.4@4753@6001@1.26@NA@COL7A1_46, COL7A1_45, COL7A1_44, COL7A1_43, COL7A1_42, COL7A1_41, COL7A1_40, COL7A1_39, COL7A1_38, COL7A1_37, COL7A1_36, COL7A1_35, COL7A1_34, COL7A1_33, COL7A1_32, COL7A1_31, COL7A1_30, COL7A1_29, COL7A1_28, COL7A1_27, COL7A1_26, COL7A1_25, COL7A1_24, COL7A1_23, COL7A1_22, COL7A1_21, COL7A1_20, COL7A1_19, COL7A1_18, COL7A1_17@0@0@0@:collagen, type VII, alpha 1@:extracellular matrix;extracellular matrix organization;endoplasmic reticulum lumen;serine-type endopeptidase inhibitor activity;protein binding;extracellular region;cell adhesion;basement membrane;collagen type VII;epidermis development@: NAIL DISORDER, NONSYNDROMIC CONGENITAL, 8; NDNC8; EPIDERMOLYSIS BULLOSA DYSTROPHICA, PRETIBIAL; EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL DOMINANT; DDEB; EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE; RDEB; EPIDERMOLYSIS BULLOSA WITH CONGENITAL LOCALIZED ABSENCE OF SKIN AND; EPIDERMOLYSIS BULLOSA PRURIGINOSA; TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN; TBDN
A2463_34@37739@37744@duplication@6@49053022@49054106@3@chr3:49053022-49054106@6.99@304@448@1.47@NA@DALRD3_12, DALRD3_11, DALRD3_10, DALRD3_9, DALRD3_8, DALRD3_7@0@0@0@:WD repeat domain 6:DALR anticodon binding domain containing 3@:insulin receptor substrate binding;signalosome;negative regulation of cell proliferation;protein complex;cytoplasm;protein binding;cell cycle arrest;negative regulation of autophagy:arginyl-tRNA aminoacylation;arginine-tRNA ligase activity;aminoacyl-tRNA ligase activity;nucleotide binding;tRNA aminoacylation for protein translation;ATP binding;cytoplasm@NA
A2463_34@39893@39894@deletion@2@75790428@75790887@3@chr3:75790428-75790887@9.44@54@2@0.037@CNVR1432.5, CNVR1432.9, CNVR1432.4@ZNF717_4, ZNF717_3@0@0@0@:zinc finger protein 717;zinc finger protein 717-like@:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_34@53303@53312@deletion@10@716924@767067@5@chr5:716924-767067@27.1@576@249@0.432@CNVR2280.3@ZDHHC11B_10, ZDHHC11B_9, ZDHHC11B_8, ZDHHC11B_7, ZDHHC11B_6, ZDHHC11B_5, ZDHHC11B_4, ZDHHC11B_3, ZDHHC11B_2, ZDHHC11B_1@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
A2463_34@61266@61271@deletion@6@177163581@177168333@5@chr5:177163581-177168333@15.2@300@156@0.52@NA@FAM153A_11, FAM153A_10, FAM153A_9, FAM153A_8, FAM153A_7, FAM153A_6@0@0@0@:family with sequence similarity 153, member A@NA@NA
A2463_34@61281@61287@duplication@7@177462154@177473452@5@chr5:177462154-177473452@11.4@359@562@1.57@NA@FAM153C_4, FAM153C_5, FAM153C_6, FAM153C_7, FAM153C_8, FAM153C_9@0@0@0@NA@NA@NA
A2463_34@61638@61646@duplication@9@180375356@180430876@5@chr5:180375356-180430876@10.7@1100@1532@1.39@CNVR2719.1@BTNL8_5, BTNL8_6, BTNL8_7, BTNL8_8, BTNL3_1, BTNL3_2, BTNL3_3, BTNL3_4, BTNL3_5@0@0@0@:butyrophilin-like 8:butyrophilin-like 3@:protein binding;integral to membrane:protein binding;integral to membrane;molecular_function;cellular_component;biological_process@NA
A2463_34@63801@63808@duplication@8@32009549@32011333@6@chr6:32009549-32011333@8.84@464@656@1.41@CNVR2843.6, CNVR2843.5@TNXB_12, TNXB_11, TNXB_10, TNXB_9, TNXB_8, TNXB_7, TNXB_6, TNXB_5@0@0@0@:tenascin-X-like;tenascin XB@:integrin binding;extracellular matrix;cell-cell adhesion;elastic fiber assembly;collagen fibril organization;fibrillar collagen;actin cytoskeleton organization;extracellular space;heparin binding;proteinaceous extracellular matrix;fatty acid metabolic process;regulation of JUN kinase activity;receptor binding;intracellular;cell-matrix adhesion;extracellular matrix organization;lipid metabolic process;protein binding;signal transduction;extracellular region;collagen binding;cell adhesion;triglyceride metabolic process;fibril organization;collagen metabolic process@: EHLERS-DANLOS-LIKE SYNDROME DUE TO TENASCIN-X DEFICIENCY; EHLERS-DANLOS SYNDROME, TYPE III
A2463_34@64093@64112@duplication@20@33141479@33146903@6@chr6:33141479-33146903@10.8@2093@2652@1.27@NA@COL11A2_33, COL11A2_32, COL11A2_31, COL11A2_30, COL11A2_29, COL11A2_28, COL11A2_27, COL11A2_26, COL11A2_25, COL11A2_24, COL11A2_23, COL11A2_22, COL11A2_21, COL11A2_20, COL11A2_19, COL11A2_18, COL11A2_17, COL11A2_16, COL11A2_15, COL11A2_14@0@0@0@:collagen, type XI, alpha 2@:collagen fibril organization;tissue homeostasis;palate development;extracellular matrix structural constituent conferring tensile strength;receptor binding;ossification;collagen type XI;skeletal system morphogenesis;soft palate development;protein binding, bridging;sensory perception of sound;extracellular matrix organization;endoplasmic reticulum lumen;collagen;extracellular matrix structural constituent;signal transduction;extracellular region;cartilage development;chondrocyte differentiation;skeletal system development@: OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA; OSMED; DEAFNESS, AUTOSOMAL DOMINANT 13; DFNA13; FIBROCHONDROGENESIS 2; FBCG2; DEAFNESS, AUTOSOMAL RECESSIVE 53; DFNB53; WEISSENBACHER-ZWEYMULLER SYNDROME; WZS; STICKLER SYNDROME, TYPE III; STL3
A2463_34@68873@68877@deletion@5@123833449@123869757@6@chr6:123833449-123869757@6.69@639@399@0.624@NA@TRDN_7, TRDN_6, TRDN_5, TRDN_4, TRDN_3@0@0@0@:triadin@:protein binding, bridging;junctional sarcoplasmic reticulum membrane;cytoplasm;release of sequestered calcium ion into cytosol by sarcoplasmic reticulum;integral to membrane;sarcoplasmic reticulum;ion channel binding;voltage-gated calcium channel complex;heart contraction;plasma membrane;negative regulation of ryanodine-sensitive calcium-release channel activity;sarcoplasmic reticulum lumen;membrane;muscle contraction;receptor binding@NA
A2463_34@70816@70817@duplication@2@161054786@161056336@6@chr6:161054786-161056336@7.61@317@635@2@CNVR3133.1@LPA_9, LPA_8@0@0@0@:lipoprotein, Lp(a)@:blood circulation;endopeptidase inhibitor activity;catalytic activity;lipoprotein metabolic process;proteolysis;heparin binding;receptor-mediated endocytosis;fibronectin binding;small molecule metabolic process;apolipoprotein binding;lipid metabolic process;negative regulation of endopeptidase activity;extracellular region;plasma lipoprotein particle;lipid transport;serine-type endopeptidase activity@: APOLIPOPROTEIN(a); LPA
A2463_34@71015@71015@deletion@1@167595214@167595404@6@chr6:167595214-167595404@4.51@87@30@0.345@NA@TCP10L2_8@0@0@0@:t-complex 10;t-complex 10-like 2@NA@NA
A2463_34@71754@71763@deletion@10@5959481@5978460@7@chr7:5959481-5978460@16.2@667@431@0.646@NA@CCZ1_12, CCZ1_13, CCZ1_14, CCZ1_15, RSPH10B_20, RSPH10B_19, RSPH10B_18, RSPH10B_17, RSPH10B_16, RSPH10B_15@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae):radial spoke head 10 homolog B (Chlamydomonas)@:lysosomal membrane@NA
A2463_34@71776@71776@deletion@1@6006495@6006747@7@chr7:6006495-6006747@14.3@112@1@0.00893@NA@RSPH10B_2@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
A2463_34@71936@71944@duplication@9@6826510@6844686@7@chr7:6826510-6844686@14.4@408@701@1.72@NA@RSPH10B2_16, RSPH10B2_17, RSPH10B2_18, RSPH10B2_19, RSPH10B2_20, CCZ1B_15, CCZ1B_14, CCZ1B_13, CCZ1B_12@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
A2463_34@73258@73263@duplication@6@38369945@38393784@7@chr7:38369945-38393784@7.53@515@734@1.43@NA@TRGV8_2, TRGV8_1, TRGV5_2, TRGV5_1, TRGV4_2, TRGV4_1@0@0@0@@:protein binding:protein binding:protein binding@NA
A2463_34@74663@74664@deletion@2@75054919@75055735@7@chr7:75054919-75055735@9.42@102@29@0.284@NA@POM121C_9, POM121C_8@0@0@0@:POM121 transmembrane nucleoporin C@:nuclear membrane;protein binding;protein transport;endoplasmic reticulum membrane;nuclear pore;mRNA transport@NA
A2463_34@76427@76432@duplication@6@100331793@100336236@7@chr7:100331793-100336236@10.5@411@666@1.62@CNVR3509.1@ZAN_1, ZAN_2, ZAN_3, ZAN_4, ZAN_5, ZAN_6@0@0@0@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
A2463_34@76726@76733@duplication@8@102133564@102137411@7@chr7:102133564-102137411@6.97@154@258@1.68@CNVR3518.1@RASA4B_16, RASA4B_15, RASA4B_14, RASA4B_13, RASA4B_12, RASA4B_11, RASA4B_10, RASA4B_9@0@0@0@:RAS p21 protein activator 4B@:phospholipid binding;intracellular;GTPase activator activity;cytosol;signal transduction;protein binding;plasma membrane;regulation of small GTPase mediated signal transduction;metal ion binding;intracellular signal transduction@NA
A2463_34@79309@79326@duplication@18@143880598@144074283@7@chr7:143880598-144074283@30.8@3797@6334@1.67@CNVR3598.4@CTAGE4_1, ARHGEF35_2, OR2A42_1, OR2A7_1, CTAGE8_1, OR2A1_1, ARHGEF5_2, ARHGEF5_3, ARHGEF5_4, ARHGEF5_5, ARHGEF5_6, ARHGEF5_7, ARHGEF5_8, ARHGEF5_9, ARHGEF5_10, ARHGEF5_11, ARHGEF5_12, ARHGEF5_13@0@0@0@:CTAGE family, member 4:Rho guanine nucleotide exchange factor (GEF) 35:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1:olfactory receptor, family 2, subfamily A, member 7:CTAGE family, member 6, pseudogene;CTAGE family, member 15, pseudogene:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:integral to membrane;nucleotide binding;cellular_component;biological_process:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
A2463_34@80141@80143@deletion@3@116087@150533@8@chr8:116087-150533@11.2@71@7@0.0986@CNVR3684.5, CNVR3684.11@OR4F21_1, RP11-585F1.10_2, RP11-585F1.10_1@0@0@0@:olfactory receptor, family 4, subfamily F, member 21:F-box only protein 25-like;putative uncharacterized protein C20orf69-like@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_34@80371@80382@deletion@12@7308236@7366745@8@chr8:7308236-7366745@26.2@660@251@0.38@CNVR3771.8, CNVR3771.10, CNVR3771.4@SPAG11B_3, SPAG11B_2, SPAG11B_1, DEFB104B_2, DEFB104B_1, DEFB106B_2, DEFB106B_1, DEFB105B_1, DEFB105B_2, DEFB105B_3, DEFB107B_1, DEFB107B_2@0@0@0@:sperm associated antigen 11B:defensin, beta 104A;defensin, beta 104B:defensin, beta 106B;defensin, beta 106A:defensin, beta 105B;defensin, beta 105A:defensin, beta 107B;defensin, beta 107A@:spermatogenesis;defense response to bacterium;extracellular region;molecular_function;defense response:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium@NA
A2463_34@80388@80394@deletion@7@7637545@7680945@8@chr8:7637545-7680945@9.88@237@108@0.456@CNVR3772.4, CNVR3772.6, CNVR3772.2, CNVR3772.8, CNVR3772.10@AC084121.16_3, AC084121.16_2, AC084121.16_1, DEFB107A_2, DEFB107A_1, DEFB105A_3, DEFB105A_2@0@0@0@:uncharacterized LOC100133251:defensin, beta 107B;defensin, beta 107A:defensin, beta 105B;defensin, beta 105A@:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium@NA
A2463_34@80406@80412@deletion@7@7752236@7809913@8@chr8:7752236-7809913@38.3@495@89@0.18@CNVR3772.4, CNVR3772.6, CNVR3772.10, CNVR3772.13@DEFB4A_1, DEFB4A_2, ZNF705B_2, ZNF705B_3, ZNF705B_4, ZNF705B_5, ZNF705B_6@0@0@0@:defensin, beta 4B;defensin, beta 4A:zinc finger protein 705B@:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response:intracellular;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_34@80564@80572@deletion@9@11970084@12049350@8@chr8:11970084-12049350@43.9@2541@1206@0.475@CNVR3785.8, CNVR3785.5, CNVR3785.2, CNVR3785.3@ZNF705D_6, USP17L2_1, FAM86B1_8, FAM86B1_7, FAM86B1_6, FAM86B1_5, FAM86B1_4, FAM86B1_3, FAM86B1_2@0@0@0@:zinc finger protein 705D:ubiquitin specific peptidase 17-like family member 1, pseudogene;ubiquitin specific peptidase 17-like family member 2;ubiquitin specific peptidase 17-like family member 4;ubiquitin specific peptidase 17-like family member 7;ubiquitin specific peptidase 17-like family member 8;ubiquitin specific peptidase 17-like family member 3:family with sequence similarity 86, member B2;family with sequence similarity 86, member B1@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:protein deubiquitination;ubiquitin-specific protease activity;mitotic cell cycle G1/S transition checkpoint;nucleus;G2/M transition checkpoint;apoptotic process;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
A2463_34@80576@80579@deletion@4@12283399@12286623@8@chr8:12283399-12286623@15.7@171@39@0.228@CNVR3786.4, CNVR3786.16@FAM86B2_8, FAM86B2_7, FAM86B2_6, FAM86B2_5@0@0@0@:family with sequence similarity 86, member B2@NA@NA
A2463_34@88584@88588@duplication@5@43624656@43685379@9@chr9:43624656-43685379@8.68@1837@2718@1.48@NA@SPATA31A6_4, SPATA31A6_3, SPATA31A6_2, SPATA31A6_1, CNTNAP3B_1@0@0@0@:SPATA31 subfamily A, member 6:contactin associated protein-like 3B;contactin associated protein-like 3@:integral to membrane:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
A2463_34@88596@88611@duplication@16@43828079@43920370@9@chr9:43828079-43920370@15@565@834@1.48@NA@CNTNAP3B_9, CNTNAP3B_10, CNTNAP3B_11, CNTNAP3B_12, CNTNAP3B_13, CNTNAP3B_14, CNTNAP3B_15, CNTNAP3B_16, CNTNAP3B_17, CNTNAP3B_18, CNTNAP3B_19, CNTNAP3B_20, CNTNAP3B_21, CNTNAP3B_22, CNTNAP3B_23, CNTNAP3B_24@0@0@0@:contactin associated protein-like 3B;contactin associated protein-like 3@:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
A2463_34@88652@88656@deletion@5@67966594@67985922@9@chr9:67966594-67985922@17.2@715@343@0.48@NA@ANKRD20A1_14, ANKRD20A1_15, RP11-195B21.3_3, RP11-195B21.3_4, RP11-195B21.3_5@0@0@0@:ankyrin repeat domain 20 family, member A1:coiled-coil domain-containing protein 29-like;uncharacterized LOC644249@:protein binding;plasma membrane@NA
A2463_34@88675@88678@deletion@4@69380012@69386055@9@chr9:69380012-69386055@14.6@91@8@0.0879@NA@CR769776.1_1, ANKRD20A4_1, ANKRD20A4_2, ANKRD20A4_3@0@0@0@:ankyrin repeat domain 20 family, member A4@:protein binding@NA
A2463_34@88681@88683@deletion@3@69393823@69403204@9@chr9:69393823-69403204@10.2@137@44@0.321@NA@ANKRD20A4_6, ANKRD20A4_7, ANKRD20A4_8@0@0@0@:ankyrin repeat domain 20 family, member A4@:protein binding@NA
A2463_34@93347@93347@deletion@1@136419480@136419815@9@chr9:136419480-136419815@7.32@40@0@0@NA@ADAMTSL2_10@0@0@0@:ADAMTS-like protein 2-like;ADAMTS-like 2@:peptidase activity;protein binding;extracellular matrix;proteinaceous extracellular matrix;negative regulation of transforming growth factor beta receptor signaling pathway;metalloendopeptidase activity;zinc ion binding@: GELEOPHYSIC DYSPLASIA 1; GPHYSD1
A2463_34@95389@95393@deletion@5@18138509@18152611@10@chr10:18138509-18152611@8.87@54@6@0.111@NA@MRC1_7, MRC1_8, MRC1_9, MRC1_10, MRC1_11@0@0@0@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
A2463_34@95800@95802@deletion@3@27311488@27317874@10@chr10:27311488-27317874@5.89@781@463@0.593@NA@ANKRD26_29, ANKRD26_28, ANKRD26_27@0@0@0@:ankyrin repeat domain 26@:regulation of feeding behavior;centrosome;transferase activity;cofactor binding;negative regulation of multicellular organism growth;regulation of fatty acid metabolic process;actin filament;protein binding;negative regulation of organ growth@NA
A2463_34@96558@96558@deletion@1@47941963@47942084@10@chr10:47941963-47942084@6.75@58@8@0.138@CNVR4715.2, CNVR4715.1@FAM21B_24@0@0@0@:family with sequence similarity 21, member B@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_34@96572@96581@duplication@10@48020451@48055018@10@chr10:48020451-48055018@8.53@382@576@1.51@CNVR4715.2@ASAH2C_10, ASAH2C_9, ASAH2C_8, ASAH2C_7, ASAH2C_6, ASAH2C_5, ASAH2C_4, ASAH2C_3, ASAH2C_2, ASAH2C_1@0@0@0@@:ceramidase activity;sphingolipid metabolic process@NA
A2463_34@96631@96633@deletion@3@49376639@49381136@10@chr10:49376639-49381136@12.2@123@34@0.276@CNVR4717.2@FRMPD2_27, FRMPD2_26, FRMPD2_25@0@0@0@:FERM and PDZ domain containing 2@:basolateral plasma membrane;transferase activity, transferring phosphorus-containing groups;cytoplasm;tight junction;protein binding;cytoskeleton;1-phosphatidylinositol binding;tight junction assembly@NA
A2463_34@96907@96907@deletion@1@51855360@51855538@10@chr10:51855360-51855538@5.14@26@0@0@NA@FAM21A_15@0@0@0@:family with sequence similarity 21, member B;family with sequence similarity 21, member A@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_34@96932@96937@deletion@6@51965743@51978390@10@chr10:51965743-51978390@21.9@161@30@0.186@NA@ASAH2_12, ASAH2_11, ASAH2_10, ASAH2_9, ASAH2_8, ASAH2_7@0@0@0@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
A2463_34@101609@101615@duplication@7@124345577@124354044@10@chr10:124345577-124354044@6.56@741@976@1.32@CNVR4912.4, CNVR4912.3, CNVR4912.2@DMBT1_16, DMBT1_17, DMBT1_18, DMBT1_19, DMBT1_20, DMBT1_21, DMBT1_22@0@0@0@:deleted in malignant brain tumors 1@:defense response to virus;calcium-dependent protein binding;pattern recognition receptor signaling pathway;blastocyst development;response to estrogen stimulus;tissue regeneration;proteinaceous extracellular matrix;protein transport;Gram-negative bacterial cell surface binding;positive regulation of epithelial cell differentiation;virus-host interaction;epithelial cell differentiation;induction of bacterial agglutination;phagocytic vesicle membrane;intracellular;Gram-positive bacterial cell surface binding;zymogen binding;innate immune response;cytoplasm;extrinsic to membrane;protein binding;zymogen granule membrane;extracellular region;scavenger receptor activity;pattern recognition receptor activity;inner cell mass cell proliferation;membrane@: GLIOMA SUSCEPTIBILITY 1; GLM1
A2463_34@103289@103290@deletion@2@5270599@5271034@11@chr11:5270599-5271034@8.84@99@18@0.182@NA@HBG1_2, HBG1_1@0@0@0@:hemoglobin, gamma A@:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex@NA
A2463_34@106571@106579@duplication@9@60971038@60980174@11@chr11:60971038-60980174@10.4@238@424@1.78@CNVR5194.1@PGA3_1, PGA3_2, PGA3_3, PGA3_4, PGA3_5, PGA3_6, PGA3_7, PGA3_8, PGA3_9@0@0@0@:pepsinogen 3, group I (pepsinogen A)@:proteolysis;extracellular region;digestion;aspartic-type endopeptidase activity@NA
A2463_34@110121@110125@deletion@5@89768381@89773130@11@chr11:89768381-89773130@6.64@266@166@0.624@NA@TRIM49C_3, TRIM49C_4, TRIM49C_5, TRIM49C_6, TRIM49C_7@0@0@0@:tripartite motif containing 49D, pseudogene;tripartite motif containing 49-like 1;tripartite motif containing 49C;tripartite motif-containing protein 49-like protein 1-like@:protein binding;intracellular;DNA binding;zinc ion binding@NA
A2463_34@112333@112337@duplication@5@123847404@123909708@11@chr11:123847404-123909708@6.17@1479@1996@1.35@NA@OR10S1_1, OR10G4_1, OR10G9_1, OR10G8_1, OR10G7_1@0@0@0@:olfactory receptor, family 10, subfamily S, member 1:olfactory receptor, family 10, subfamily G, member 4:olfactory receptor, family 10, subfamily G, member 9:olfactory receptor, family 10, subfamily G, member 8:olfactory receptor, family 10, subfamily G, member 7@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_34@114468@114469@duplication@2@11034835@11035297@12@chr12:11034835-11035297@7.02@188@377@2.01@NA@PRH1_4, PRH1_3@0@0@0@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):proline-rich protein HaeIII subfamily 1@:extracellular space;visual perception:protein binding;extracellular space@NA
A2463_34@120003@120012@deletion@10@88519024@88533341@12@chr12:88519024-88533341@10.6@1862@1252@0.672@NA@CEP290_13, CEP290_12, CEP290_11, CEP290_10, CEP290_9, CEP290_8, CEP290_7, CEP290_6, CEP290_5, CEP290_4@0@0@0@:centrosomal protein 290kDa@:pronephros development;mitotic cell cycle;retina development in camera-type eye;TCTN-B9D complex;otic vesicle formation;protein transport;nucleus;cilium assembly;photoreceptor connecting cilium;hindbrain development;centrosome;microtubule basal body;cytoplasm;G2/M transition of mitotic cell cycle;cytosol;protein binding;positive regulation of transcription, DNA-dependent;eye photoreceptor cell development;gamma-tubulin complex;cilium morphogenesis;cell surface@: LEBER CONGENITAL AMAUROSIS 10; LCA10; MECKEL SYNDROME, TYPE 4; MKS4; SENIOR-LOKEN SYNDROME 6; SLSN6; JOUBERT SYNDROME 5; JBTS5; BARDET-BIEDL SYNDROME; BBS
A2463_34@133407@133414@duplication@8@106370357@106380248@14@chr14:106370357-106380248@9.89@336@509@1.51@CNVR6294.27, CNVR6294.36, CNVR6294.48, CNVR6294.25, CNVR6294.57, CNVR6294.29@IGHD3-10_1, IGHD3-9_1, IGHD2-8_1, IGHD1-7_1, IGHD6-6_1, IGHD5-5_1, IGHD4-4_1, IGHD3-3_1@0@0@0@NA@NA@NA
A2463_34@133422@133455@duplication@34@106452672@106758092@14@chr14:106452672-106758092@24.4@4717@6085@1.29@CNVR6294.48, CNVR6294.24, CNVR6294.40@IGHV1-2_2, IGHV1-2_1, IGHV1-3_2, IGHV1-3_1, IGHV4-4_2, IGHV4-4_1, IGHV2-5_2, IGHV2-5_1, IGHV3-7_2, IGHV3-7_1, IGHV1-8_2, IGHV1-8_1, IGHV3-9_2, IGHV3-9_1, IGHV3-11_2, IGHV3-11_1, IGHV3-13_2, IGHV3-13_1, IGHV3-15_2, IGHV3-15_1, IGHV3-16_2, IGHV3-16_1, IGHV1-18_2, IGHV1-18_1, IGHV3-20_2, IGHV3-20_1, IGHV3-21_2, IGHV3-21_1, IGHV3-23_2, IGHV3-23_1, IGHV1-24_2, IGHV1-24_1, IGHV2-26_2, IGHV2-26_1@0@0@0@@:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding@NA
A2463_34@133460@133463@duplication@4@106805210@106816173@14@chr14:106805210-106816173@11.6@262@541@2.06@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.41@IGHV4-31_2, IGHV4-31_1, IGHV3-33_2, IGHV3-33_1@0@0@0@@:protein binding:protein binding@NA
A2463_34@133509@133509@deletion@1@20739498@20740969@15@chr15:20739498-20740969@5.28@519@215@0.414@CNVR6296.13@GOLGA6L6_8@0@0@0@:putative transmembrane protein FLJ36131-like;putative transmembrane protein ENSP00000320207-like;golgin A6 family-like 6@NA@NA
A2463_34@133520@133525@deletion@6@21051163@21063546@15@chr15:21051163-21063546@7.03@245@102@0.416@NA@POTEB_9, POTEB_8, POTEB_7, POTEB_6, POTEB_5, POTEB_4@0@0@0@:POTE ankyrin domain family member B-like@:protein binding@NA
A2463_34@133617@133661@duplication@45@23255341@23610021@15@chr15:23255341-23610021@63.3@3256@5177@1.59@CNVR6300.8@GOLGA8I_1, GOLGA8I_2, GOLGA8I_3, GOLGA8I_4, GOLGA8I_5, GOLGA8I_6, GOLGA8I_7, GOLGA8I_8, GOLGA8I_9, GOLGA8I_10, GOLGA8I_11, GOLGA8I_12, GOLGA8I_13, GOLGA8I_14, GOLGA8I_15, GOLGA8I_16, GOLGA8I_17, GOLGA8I_18, GOLGA8I_19, RP11-467N20.5_8, RP11-467N20.5_7, RP11-467N20.5_6, RP11-467N20.5_5, RP11-467N20.5_4, RP11-467N20.5_3, RP11-467N20.5_2, RP11-467N20.5_1, GOLGA8S_1, GOLGA8S_2, GOLGA8S_3, GOLGA8S_4, GOLGA8S_5, GOLGA8S_6, GOLGA8S_7, GOLGA8S_8, GOLGA8S_9, GOLGA8S_10, GOLGA8S_11, GOLGA8S_12, GOLGA8S_13, GOLGA8S_14, GOLGA8S_15, GOLGA8S_16, GOLGA8S_17, GOLGA8S_18@0@0@0@:golgin A8 family, member I:putative golgin subfamily A member 6-like protein 6-like@:Golgi cisterna membrane:Golgi apparatus@NA
A2463_34@133869@133870@deletion@2@28629294@28629596@15@chr15:28629294-28629596@8.12@40@0@0@CNVR6329.4@GOLGA8F_9, GOLGA8F_10@0@0@0@@:Golgi apparatus@NA
A2463_34@133907@133917@duplication@11@28951263@28957469@15@chr15:28951263-28957469@8.66@995@1252@1.26@CNVR6331.1@GOLGA8M_11, GOLGA8M_10, GOLGA8M_9, GOLGA8M_8, GOLGA8M_7, GOLGA8M_6, GOLGA8M_5, GOLGA8M_4, GOLGA8M_3, GOLGA8M_2, GOLGA8M_1@0@0@0@:golgin A8 family, member M@:Golgi apparatus@NA
A2463_34@133976@134012@duplication@37@30379599@30665348@15@chr15:30379599-30665348@27@1853@2554@1.38@CNVR6337.1@GOLGA8J_7, GOLGA8J_8, GOLGA8J_9, GOLGA8J_10, GOLGA8J_11, GOLGA8J_12, GOLGA8J_13, GOLGA8J_14, GOLGA8J_15, GOLGA8J_16, GOLGA8J_17, GOLGA8J_18, GOLGA8J_19, GOLGA8T_1, GOLGA8T_2, GOLGA8T_3, GOLGA8T_4, GOLGA8T_5, GOLGA8T_6, GOLGA8T_7, GOLGA8T_8, GOLGA8T_9, GOLGA8T_10, GOLGA8T_11, GOLGA8T_12, GOLGA8T_13, GOLGA8T_14, GOLGA8T_15, GOLGA8T_16, GOLGA8T_17, GOLGA8T_18, GOLGA8T_19, CHRFAM7A_10, CHRFAM7A_9, CHRFAM7A_8, CHRFAM7A_7, CHRFAM7A_6@0@0@0@:golgin A8 family, member J:golgin A8 family, member J;golgin A8 family, member K:CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:Golgi apparatus:Golgi apparatus:transport;integral to membrane;ion transport;postsynaptic membrane;membrane;extracellular ligand-gated ion channel activity@NA
A2463_34@134035@134068@duplication@34@30844282@30905398@15@chr15:30844282-30905398@44.2@2099@3086@1.47@CNVR6339.2, CNVR6339.3, CNVR6339.1@GOLGA8Q_1, GOLGA8Q_2, GOLGA8Q_3, GOLGA8Q_4, GOLGA8Q_5, GOLGA8Q_6, GOLGA8Q_7, GOLGA8Q_8, GOLGA8Q_9, GOLGA8Q_10, GOLGA8Q_11, GOLGA8Q_12, GOLGA8Q_13, GOLGA8Q_14, GOLGA8Q_15, GOLGA8Q_16, GOLGA8Q_17, GOLGA8Q_18, GOLGA8Q_19, GOLGA8H_1, GOLGA8H_2, GOLGA8H_3, GOLGA8H_4, GOLGA8H_5, GOLGA8H_6, GOLGA8H_7, GOLGA8H_8, GOLGA8H_9, GOLGA8H_10, GOLGA8H_11, GOLGA8H_12, GOLGA8H_13, GOLGA8H_14, GOLGA8H_15@0@0@0@:golgin A8 family, member H@:Golgi apparatus:Golgi apparatus@NA
A2463_34@134158@134166@duplication@9@32684984@32689208@15@chr15:32684984-32689208@8.91@454@647@1.43@NA@GOLGA8K_19, GOLGA8K_18, GOLGA8K_17, GOLGA8K_16, GOLGA8K_15, GOLGA8K_14, GOLGA8K_13, GOLGA8K_12, GOLGA8K_11@0@0@0@:golgin A8 family, member J@:Golgi apparatus@NA
A2463_34@134174@134181@duplication@8@32692604@32738099@15@chr15:32692604-32738099@12.2@129@270@2.09@CNVR6346.1@GOLGA8K_3, GOLGA8K_2, AC139426.2_1, GOLGA8K_1, GOLGA8O_19, GOLGA8O_18, GOLGA8O_17, GOLGA8O_16@0@0@0@:golgin A8 family, member J:golgin A8 family, member O@:Golgi apparatus:Golgi apparatus@NA
A2463_34@134189@134191@duplication@3@32743115@32743539@15@chr15:32743115-32743539@10.1@88@230@2.61@CNVR6346.1@GOLGA8O_8, GOLGA8O_7, GOLGA8O_6@0@0@0@:golgin A8 family, member O@:Golgi apparatus@NA
A2463_34@134204@134205@deletion@2@32890090@32890378@15@chr15:32890090-32890378@9.02@99@29@0.293@NA@GOLGA8N_7, GOLGA8N_8@0@0@0@:golgin A8 family, member R@:Golgi apparatus@NA
A2463_34@134440@134449@duplication@10@34677250@34820490@15@chr15:34677250-34820490@19.1@367@731@1.99@CNVR6351.3@GOLGA8A_15, GOLGA8A_14, GOLGA8A_13, GOLGA8A_12, GOLGA8A_11, GOLGA8A_10, GOLGA8A_9, GOLGA8B_25, GOLGA8B_24, GOLGA8B_23@0@0@0@:golgin A8 family, member A:golgin A8 family, member A;golgin A8 family, member B@:Golgi cisterna membrane;Golgi apparatus:Golgi cisterna membrane;Golgi apparatus@NA
A2463_34@134457@134460@deletion@4@34823677@34825163@15@chr15:34823677-34825163@16@90@2@0.0222@CNVR6351.3@GOLGA8B_15, GOLGA8B_14, GOLGA8B_13, GOLGA8B_12@0@0@0@:golgin A8 family, member A:golgin A8 family, member A;golgin A8 family, member B@:Golgi cisterna membrane;Golgi apparatus:Golgi cisterna membrane;Golgi apparatus@NA
A2463_34@135699@135713@duplication@15@43892395@43903513@15@chr15:43892395-43903513@28.3@2581@3866@1.5@CNVR6365.1@STRC_27, STRC_26, STRC_25, STRC_24, STRC_23, STRC_22, STRC_21, STRC_20, STRC_19, STRC_18, STRC_17, STRC_16, STRC_15, STRC_14, STRC_13@0@0@0@:diphosphoinositol pentakisphosphate kinase 1:stereocilin@:inositol hexakisphosphate 3-kinase activity;inositol hexakisphosphate 1-kinase activity;inositol metabolic process;diphosphoinositol-pentakisphosphate kinase activity;ATP binding;acid phosphatase activity;cytoplasm;cytosol;inositol hexakisphosphate 5-kinase activity;nucleus;kinase activity;inositol-1,3,4,5,6-pentakisphosphate kinase activity:detection of mechanical stimulus involved in sensory perception of sound;stereocilium bundle tip;stereocilium;cell surface;kinocilium;auditory receptor cell stereocilium organization@: DEAFNESS, AUTOSOMAL RECESSIVE 16; DFNB16; DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY
A2463_34@138284@138286@deletion@3@72954594@72956852@15@chr15:72954594-72956852@10.6@120@31@0.258@CNVR6443.1@GOLGA6B_11, GOLGA6B_12, GOLGA6B_13@0@0@0@:golgin A6 family, member B@:Golgi apparatus@NA
A2463_34@138288@138291@duplication@4@72957938@72958683@15@chr15:72957938-72958683@7.33@299@477@1.6@CNVR6443.1@GOLGA6B_15, GOLGA6B_16, GOLGA6B_17, GOLGA6B_18@0@0@0@:golgin A6 family, member B@:Golgi apparatus@NA
A2463_34@138412@138422@duplication@11@74363252@74368326@15@chr15:74363252-74368326@17.1@783@1343@1.72@CNVR6448.1@GOLGA6A_18, GOLGA6A_17, GOLGA6A_16, GOLGA6A_15, GOLGA6A_14, GOLGA6A_13, GOLGA6A_12, GOLGA6A_11, GOLGA6A_10, GOLGA6A_9, GOLGA6A_8@0@0@0@:golgin A6 family, member C;golgin A6 family, member A;golgin A6 family, member D;golgin A6 family, member B@:Golgi apparatus@NA
A2463_34@138633@138638@duplication@6@75555990@75558045@15@chr15:75555990-75558045@10.3@446@698@1.57@CNVR6452.1@GOLGA6C_5, GOLGA6C_6, GOLGA6C_7, GOLGA6C_8, GOLGA6C_9, GOLGA6C_10@0@0@0@:golgin A6 family, member C@:Golgi apparatus@NA
A2463_34@138650@138671@duplication@22@75579971@75632219@15@chr15:75579971-75632219@22.1@1178@1745@1.48@NA@GOLGA6D_4, GOLGA6D_5, GOLGA6D_6, GOLGA6D_7, GOLGA6D_8, GOLGA6D_9, GOLGA6D_10, GOLGA6D_11, GOLGA6D_12, GOLGA6D_13, GOLGA6D_14, GOLGA6D_15, GOLGA6D_16, GOLGA6D_17, GOLGA6D_18, COMMD4_2, COMMD4_3, COMMD4_4, COMMD4_5, COMMD4_6, COMMD4_7@0@0@0@:golgin A6 family, member D:COMM domain containing 4@:Golgi apparatus:protein binding;cytoplasm@NA
A2463_34@139473@139482@duplication@10@84850735@84911344@15@chr15:84850735-84911344@16@579@1110@1.92@CNVR6486.2@RP11-182J1.16_3, GOLGA6L4_1, GOLGA6L4_2, GOLGA6L4_3, GOLGA6L4_4, GOLGA6L4_5, GOLGA6L4_6, GOLGA6L4_7, GOLGA6L4_8, GOLGA6L4_9@0@0@0@:uncharacterized LOC100505679@:Golgi apparatus@NA
A2463_34@140476@140485@duplication@10@64382@68789@16@chr16:64382-68789@24.3@580@1047@1.81@CNVR6565.1@WASH4P_10, WASH4P_9, WASH4P_8, WASH4P_7, WASH4P_6, WASH4P_5, WASH4P_4, WASH4P_3, WASH4P_2, WASH4P_1@0@0@0@@:intracellular membrane-bounded organelle;endosomal transport;recycling endosome;early endosome;Arp2/3 complex-mediated actin nucleation;actin binding;alpha-tubulin binding;retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;recycling endosome membrane@NA
A2463_34@140808@140813@duplication@6@774912@776085@16@chr16:774912-776085@6.54@654@900@1.38@NA@CCDC78_7, CCDC78_6, CCDC78_5, CCDC78_4, CCDC78_3, CCDC78_2@0@0@0@:mesothelin:coiled-coil domain containing 78@:pancreas development;Golgi apparatus;protein binding;extracellular space;cell adhesion;plasma membrane;membrane;cell surface;anchored to membrane:sarcoplasmic reticulum;skeletal muscle contraction;sarcolemma;perinuclear region of cytoplasm;cytoplasm@NA
A2463_34@140964@140971@duplication@8@1291436@1308377@16@chr16:1291436-1308377@7.54@519@712@1.37@CNVR6591.1@TPSAB1_4, TPSAB1_5, TPSAB1_6, TPSD1_1, TPSD1_2, TPSD1_3, TPSD1_4, TPSD1_5@0@0@0@:tryptase alpha/beta 1:tryptase delta 1@:serine-type peptidase activity;extracellular matrix;extracellular matrix organization;catalytic activity;extracellular matrix disassembly;proteolysis;extracellular space;protein binding;extracellular region;defense response;serine-type endopeptidase activity:serine-type peptidase activity;proteolysis;extracellular region;catalytic activity;serine-type endopeptidase activity@NA
A2463_34@142683@142690@duplication@8@15031301@15045882@16@chr16:15031301-15045882@7.18@239@362@1.51@CNVR6645.2@NPIP_1, NPIP_2, NPIP_3, NPIP_4, NPIP_5, NPIP_6, NPIP_7, NPIP_8@0@0@0@:nuclear pore complex-interacting protein-like;nuclear pore complex interacting protein;nuclear pore complex-interacting protein-like 1-like@:nuclear membrane;protein transport;nuclear pore;mRNA transport@NA
A2463_34@142906@142928@duplication@23@16313680@16367932@16@chr16:16313680-16367932@20.5@1078@1521@1.41@NA@ABCC6_3, ABCC6_2, ABCC6_1, NOMO3_1, NOMO3_2, NOMO3_3, NOMO3_4, NOMO3_5, NOMO3_6, NOMO3_7, NOMO3_8, NOMO3_9, NOMO3_10, NOMO3_11, NOMO3_12, NOMO3_13, NOMO3_14, NOMO3_15, NOMO3_16, NOMO3_17, NOMO3_18, NOMO3_19, NOMO3_20@0@0@0@:ATP-binding cassette, sub-family C (CFTR/MRP), member 6:NODAL modulator 3@:ATPase activity, coupled to transmembrane movement of substances;transport;transporter activity;lateral plasma membrane;response to drug;ATP binding;transmembrane transport;integral to membrane;ATPase activity;plasma membrane;ATP catabolic process;apical plasma membrane;nucleoside-triphosphatase activity;nucleotide binding;visual perception;membrane:carbohydrate binding;integral to membrane;carboxypeptidase activity@: PSEUDOXANTHOMA ELASTICUM; PXE; PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE; ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 2; GACI2
A2463_34@142952@142952@deletion@1@16484625@16484731@16@chr16:16484625-16484731@7.85@50@2@0.04@CNVR6654.1@RP11-467M13.1_5@0@0@0@NA@NA@NA
A2463_34@144089@144103@duplication@15@28603350@28649801@16@chr16:28603350-28649801@30.3@1590@2549@1.6@NA@SULT1A2_8, SULT1A2_7, SULT1A2_6, SULT1A2_5, SULT1A2_4, SULT1A2_3, SULT1A2_2, SULT1A1_10, SULT1A1_9, SULT1A1_8, SULT1A1_7, SULT1A1_6, SULT1A1_5, SULT1A1_4, A-575C2.4_1@0@0@0@:sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2:sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1:nuclear pore complex-interacting protein-like 2-like;putative NPIP-like protein LOC613037-like@:steroid metabolic process;small molecule metabolic process;sulfation;aryl sulfotransferase activity;catecholamine metabolic process;cytosol;xenobiotic metabolic process;phenol-containing compound metabolic process;sulfotransferase activity;amine biosynthetic process;flavonol 3-sulfotransferase activity;3'-phosphoadenosine 5'-phosphosulfate metabolic process:small molecule metabolic process;sulfation;aryl sulfotransferase activity;amine metabolic process;catecholamine metabolic process;xenobiotic metabolic process;cytosol;steroid sulfotransferase activity;integral to membrane;sulfotransferase activity;flavonol 3-sulfotransferase activity;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process;estrogen metabolic process@NA
A2463_34@144252@144257@duplication@6@28997457@29000910@16@chr16:28997457-29000910@6.35@250@362@1.45@NA@LAT_5, LAT_6, LAT_7, LAT_8, LAT_9, LAT_10@0@0@0@:linker for activation of T cells@:T cell activation;inflammatory response;membrane raft;immune response;protein kinase binding;Ras protein signal transduction;blood coagulation;integral to membrane;plasma membrane;integrin-mediated signaling pathway;gene expression;intracellular signal transduction;SH3/SH2 adaptor activity;regulation of T cell activation;signalosome;platelet activation;calcium-mediated signaling;immunological synapse;protein binding;signal transduction;T cell receptor signaling pathway;mast cell degranulation;membrane@NA
A2463_34@144288@144305@duplication@18@29468954@29498743@16@chr16:29468954-29498743@15.9@245@464@1.89@CNVR6690.2, CNVR6690.3, CNVR6690.4@SLX1B_4, SLX1B_5, SLX1B_6, SULT1A4_3, SULT1A4_4, SULT1A4_5, SULT1A4_6, SULT1A4_7, SULT1A4_8, SULT1A4_9, RP11-345J4.3_5, RP11-345J4.3_4, RP11-345J4.3_3, RP11-345J4.3_2, RP11-345J4.3_1, NPIPL3_3, NPIPL3_2, NPIPL3_1@0@0@0@:structure-specific endonuclease subunit SLX1-like;SLX1 structure-specific endonuclease subunit homolog B (S. cerevisiae);SLX1 structure-specific endonuclease subunit homolog A (S. cerevisiae):sulfotransferase family, cytosolic, 1A, phenol-preferring, member 4;sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3;sulfotransferase 1A3/1A4-like@:Slx1-Slx4 complex;5'-flap endonuclease activity;DNA repair;protein binding;DNA double-strand break processing involved in repair via single-strand annealing;double-strand break repair via homologous recombination;metal ion binding;crossover junction endodeoxyribonuclease activity:steroid metabolic process;small molecule metabolic process;sulfation;aryl sulfotransferase activity;cytoplasm;catecholamine metabolic process;cytosol;endoplasmic reticulum unfolded protein response;xenobiotic metabolic process;sulfotransferase activity;activation of signaling protein activity involved in unfolded protein response;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process@NA
A2463_34@144501@144503@deletion@3@30208296@30208787@16@chr16:30208296-30208787@9.6@52@1@0.0192@CNVR6694.1, CNVR6694.2, CNVR6694.3@SLX1A_4, SLX1A_5, SLX1A_6@0@0@0@:structure-specific endonuclease subunit SLX1-like;SLX1 structure-specific endonuclease subunit homolog B (S. cerevisiae);SLX1 structure-specific endonuclease subunit homolog A (S. cerevisiae):sulfotransferase family, cytosolic, 1A, phenol-preferring, member 4;sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3;sulfotransferase 1A3/1A4-like@:Slx1-Slx4 complex;5'-flap endonuclease activity;DNA repair;protein binding;DNA double-strand break processing involved in repair via single-strand annealing;double-strand break repair via homologous recombination;metal ion binding;crossover junction endodeoxyribonuclease activity:steroid metabolic process;small molecule metabolic process;sulfation;aryl sulfotransferase activity;cytoplasm;catecholamine metabolic process;cytosol;endoplasmic reticulum unfolded protein response;xenobiotic metabolic process;sulfotransferase activity;activation of signaling protein activity involved in unfolded protein response;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process@NA
A2463_34@145012@145014@duplication@3@32063312@32266224@16@chr16:32063312-32266224@6.73@460@728@1.58@CNVR6701.6@AC142381.1_1, TP53TG3D_1@0@0@0@:TP53 target 3B;TP53 target 3;TP53-target gene 3 protein-like;TP53 target 3C@:protein binding:nucleus;cytoplasm@NA
A2463_34@147101@147101@deletion@1@70010292@70010635@16@chr16:70010292-70010635@5.5@209@77@0.368@CNVR6762.3, CNVR6762.2@RP11-419C5.2_7@0@0@0@NA@NA@NA
A2463_34@147417@147424@duplication@8@72090061@72107876@16@chr16:72090061-72107876@9.68@1081@1385@1.28@CNVR6769.1@HP_2, HP_3, HP_4, HP_5, HP_6, HP_7, HPR_1, HPR_2@0@0@0@:thioredoxin-like 4B:haptoglobin:haptoglobin-related protein@:mitosis;mRNA processing;RNA splicing;spliceosomal complex;cell redox homeostasis:cellular iron ion homeostasis;negative regulation of oxidoreductase activity;catalytic activity;negative regulation of hydrogen peroxide catabolic process;positive regulation of cell death;haptoglobin-hemoglobin complex;extracellular space;proteolysis;response to hydrogen peroxide;extracellular region;hemoglobin binding;defense response;serine-type endopeptidase activity:spherical high-density lipoprotein particle;proteolysis;extracellular region;hemoglobin binding;catalytic activity;serine-type endopeptidase activity@: ANHAPTOGLOBINEMIA; AHP
A2463_34@147616@147628@duplication@13@75238060@75258086@16@chr16:75238060-75258086@10.5@316@467@1.48@NA@CTRB2_7, CTRB2_6, CTRB2_5, CTRB2_4, CTRB2_3, CTRB2_2, CTRB2_1, CTRB1_1, CTRB1_2, CTRB1_3, CTRB1_4, CTRB1_5, CTRB1_6@0@0@0@:chymotrypsinogen B2:chymotrypsinogen B1@:extracellular space;proteolysis;extracellular region;digestion;extracellular matrix organization;catalytic activity;serine-type endopeptidase activity;extracellular matrix disassembly:extracellular space;proteolysis;extracellular region;digestion;extracellular matrix organization;catalytic activity;serine-type endopeptidase activity;extracellular matrix disassembly@NA
A2463_34@151956@151959@duplication@4@18945121@18997166@17@chr17:18945121-18997166@7.3@535@924@1.73@CNVR7018.4, CNVR7018.2, CNVR7018.6@GRAP_2, GRAP_1, AC007952.5_1, AC007952.5_2@0@0@0@:GRB2-related adaptor protein@:SH3/SH2 adaptor activity;cytosol;protein binding;Ras protein signal transduction;cytoplasm;cell-cell signaling@NA
A2463_34@152122@152129@deletion@8@20353287@20359984@17@chr17:20353287-20359984@15.1@174@66@0.379@CNVR7021.1, CNVR7021.3@LGALS9B_11, LGALS9B_10, LGALS9B_9, LGALS9B_8, LGALS9B_7, LGALS9B_6, LGALS9B_5, LGALS9B_4@0@0@0@:lectin, galactoside-binding, soluble, 9B@:carbohydrate binding@NA
A2463_34@153414@153414@deletion@1@34797487@34798054@17@chr17:34797487-34798054@9.81@74@4@0.0541@CNVR7078.2, CNVR7078.3@TBC1D3G_14@0@0@0@:TBC1 domain family member 3H-like;TBC1 domain family, member 3H:TBC1 domain family, member 3;TBC1 domain family, member 3G;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like;TBC1 domain family, member 3H@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_34@153627@153648@duplication@22@36287671@36346847@17@chr17:36287671-36346847@12.2@364@559@1.54@NA@TBC1D3F_5, TBC1D3F_6, TBC1D3F_7, TBC1D3F_8, TBC1D3F_9, TBC1D3F_10, TBC1D3F_11, TBC1D3F_12, TBC1D3F_13, TBC1D3F_14, TBC1D3_18, TBC1D3_17, TBC1D3_16, TBC1D3_15, TBC1D3_14, TBC1D3_13, TBC1D3_12, TBC1D3_11, TBC1D3_10, TBC1D3_9, TBC1D3_8, TBC1D3_7@0@0@0@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family member 3G-like:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
A2463_34@155583@155600@deletion@18@44377161@44594799@17@chr17:44377161-44594799@79.3@1225@328@0.268@CNVR7114.2, CNVR7114.1@LRRC37A_2, LRRC37A_3, LRRC37A_4, LRRC37A_5, LRRC37A_6, LRRC37A_7, LRRC37A_8, LRRC37A_9, LRRC37A_10, LRRC37A_11, LRRC37A_12, LRRC37A_13, LRRC37A_14, ARL17B_4, ARL17B_3, ARL17B_2, LRRC37A2_2, LRRC37A2_3@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
A2463_34@158669@158679@duplication@11@73831491@73836410@17@chr17:73831491-73836410@8.01@1393@1815@1.3@NA@UNC13D_20, UNC13D_19, UNC13D_18, UNC13D_17, UNC13D_16, UNC13D_15, UNC13D_14, UNC13D_13, UNC13D_12, UNC13D_11, UNC13D_10@0@0@0@:unc-13 homolog D (C. elegans)@:germinal center formation;defense response to virus;exocytic vesicle;late endosome;phagocytosis;regulation of mast cell degranulation;recycling endosome;natural killer cell degranulation;granuloma formation;protein binding;membrane;lysosome;positive regulation of exocytosis@: HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 3; FHL3
A2463_34@162017@162018@deletion@2@44542732@44550298@18@chr18:44542732-44550298@28.1@317@21@0.0662@CNVR7319.1, CNVR7319.2@TCEB3CL2_1, TCEB3CL_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2:transcription elongation factor B polypeptide 3C-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_34@166378@166378@duplication@1@12504112@12504237@19@chr19:12504112-12504237@4.64@40@121@3.02@CNVR7541.1@CTD-3105H18.16_2, ZNF799_2@0@0@0@:zinc finger protein 799@:intracellular;regulation of transcription, DNA-dependent;nucleic acid binding:nucleus;intracellular;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:intracellular;regulation of transcription, DNA-dependent;nucleic acid binding@NA
A2463_34@166448@166454@duplication@7@12800031@12802268@19@chr19:12800031-12802268@7.18@466@654@1.4@NA@FBXW9_10, FBXW9_9, FBXW9_8, FBXW9_7, FBXW9_6, FBXW9_5, FBXW9_4@0@0@0@:F-box and WD repeat domain containing 9@:protein binding@NA
A2463_34@166916@166920@duplication@5@14508471@14512572@19@chr19:14508471-14512572@7.33@178@282@1.58@NA@CD97_7, CD97_8, CD97_9, CD97_10, CD97_11@0@0@0@:CD97 molecule@:transmembrane signaling receptor activity;neuropeptide signaling pathway;inflammatory response;immune response;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;protein binding;extracellular space;integral to membrane;cell adhesion;plasma membrane;integral to plasma membrane;membrane;calcium ion binding;cell surface receptor signaling pathway;cellular component movement@NA
A2463_34@167243@167244@deletion@2@15784341@15789215@19@chr19:15784341-15789215@6.11@32@2@0.0625@CNVR7553.1@CYP4F12_2, CYP4F12_3@0@0@0@:cytochrome P450, family 4, subfamily F, polypeptide 12@:pressure natriuresis;negative regulation of blood coagulation;oxidation-reduction process;very long-chain fatty acid metabolic process;arachidonic acid metabolic process;aromatase activity;sodium ion homeostasis;renal water homeostasis;arachidonic acid epoxygenase activity;integral to membrane;leukotriene B4 catabolic process;endoplasmic reticulum membrane;epoxygenase P450 pathway;electron carrier activity;intracellular membrane-bounded organelle;drug metabolic process;alkane 1-monooxygenase activity;small molecule metabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;apical plasma membrane;heme binding;vitamin E metabolic process;cytoplasm;vitamin-K-epoxide reductase (warfarin-sensitive) activity;xenobiotic metabolic process;vitamin K biosynthetic process;leukotriene-B4 20-monooxygenase activity;long-chain fatty acid metabolic process;iron ion binding@NA
A2463_34@168952@168952@duplication@1@35862263@35863302@19@chr19:35862263-35863302@5.22@245@593@2.42@CNVR7627.1@GPR42_2@0@0@0@@:integral to membrane;G-protein coupled receptor activity;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
A2463_34@168993@168996@duplication@4@36037575@36038349@19@chr19:36037575-36038349@5.7@333@490@1.47@NA@TMEM147_4, TMEM147_5, TMEM147_6, TMEM147_7@0@0@0@:transmembrane protein 147@:integral to membrane;endoplasmic reticulum membrane@NA
A2463_34@169509@169517@duplication@9@38795016@38799968@19@chr19:38795016-38799968@7.26@501@677@1.35@NA@C19orf33_2, CTB-102L5.4_4, C19orf33_3, CTB-102L5.4_5, CTB-102L5.4_6, C19orf33_4, YIF1B_8, YIF1B_7, YIF1B_6, YIF1B_5, YIF1B_4, YIF1B_3@0@0@0@:chromosome 19 open reading frame 33:Yip1 interacting factor homolog B (S. cerevisiae)@:serine-type endopeptidase inhibitor activity:nucleus;biological_process:integral to membrane;membrane@NA
A2463_34@170095@170103@duplication@9@40370196@40386783@19@chr19:40370196-40386783@20.3@608@1201@1.98@CNVR7639.2@FCGBP_27, FCGBP_26, FCGBP_25, FCGBP_24, FCGBP_23, FCGBP_22, FCGBP_21, FCGBP_20, FCGBP_19@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_34@170110@170113@duplication@4@40400251@40408135@19@chr19:40400251-40408135@6.04@207@316@1.53@CNVR7639.2@FCGBP_12, FCGBP_11, FCGBP_10, FCGBP_9@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_34@172119@172136@duplication@18@49526144@49558632@19@chr19:49526144-49558632@12.5@1038@1378@1.33@CNVR7684.1@CGB_3, CTB-60B18.6_3, CTB-60B18.6_2, CGB_2, CGB_1, CGB2_1, CGB2_2, CGB2_3, CGB1_3, CGB1_2, CGB1_1, CGB5_1, CGB5_2, CGB5_3, CGB8_3, CGB8_2, CGB8_1, CGB7_5, CGB7_4, CGB7_3@0@0@0@:chorionic gonadotropin, beta polypeptide 8;chorionic gonadotropin, beta polypeptide;chorionic gonadotropin, beta polypeptide 5:chorionic gonadotropin, beta polypeptide 1;chorionic gonadotropin, beta polypeptide 2:chorionic gonadotropin, beta polypeptide 1:chorionic gonadotropin, beta polypeptide 8;chorionic gonadotropin, beta polypeptide;chorionic gonadotropin, beta polypeptide 5:chorionic gonadotropin, beta polypeptide 8;chorionic gonadotropin, beta polypeptide;chorionic gonadotropin, beta polypeptide 5:chorionic gonadotropin, beta polypeptide 7@:hormone activity;small molecule metabolic process;female gamete generation;cell-cell signaling;signal transduction;extracellular region;apoptotic process;cellular nitrogen compound metabolic process;peptide hormone processing:hormone activity;extracellular region:hormone activity;extracellular region:hormone activity;extracellular region:hormone activity;small molecule metabolic process;female gamete generation;cell-cell signaling;signal transduction;extracellular region;apoptotic process;cellular nitrogen compound metabolic process;peptide hormone processing:hormone activity;small molecule metabolic process;female gamete generation;cell-cell signaling;signal transduction;extracellular region;apoptotic process;cellular nitrogen compound metabolic process;peptide hormone processing:small molecule metabolic process;hormone activity;female gamete generation;cell-cell signaling;signal transduction;extracellular region;apoptotic process;cellular nitrogen compound metabolic process;peptide hormone processing@NA
A2463_34@173298@173305@duplication@8@54726151@54745754@19@chr19:54726151-54745754@10.3@764@1099@1.44@CNVR7721.3, CNVR7721.4, CNVR7721.1@LILRB3_3, LILRB3_2, LILRB3_1, LILRA6_8, LILRA6_7, LILRA6_6, LILRA6_5, LILRA6_4@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
A2463_34@173459@173477@duplication@19@55246721@55295265@19@chr19:55246721-55295265@18.9@1886@2606@1.38@CNVR7725.2, CNVR7725.1@KIR3DL3_6, KIR3DL3_7, KIR3DL3_8, KIR2DL3_1, KIR2DL3_2, KIR2DL3_3, KIR2DL3_4, KIR2DL3_5, KIR2DL3_6, KIR2DL3_7, KIR2DL3_8, KIR2DL1_1, KIR2DL1_2, KIR2DL1_3, KIR2DL1_4, KIR2DL1_5, KIR2DL1_6, KIR2DL1_7, KIR2DL1_8@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:integral to membrane;plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane@NA
A2463_34@173482@173482@deletion@1@55320289@55320338@19@chr19:55320289-55320338@5.33@27@0@0@CNVR7725.1, CNVR7725.3@KIR2DL4_5@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane@NA
A2463_34@173500@173503@deletion@4@55359207@55362710@19@chr19:55359207-55362710@22.2@118@1@0.00847@CNVR7725.1, CNVR7725.6, CNVR7725.5, CNVR7725.10@KIR2DS4_7, KIR2DS4_8, KIR3DL2_1, KIR3DL2_2@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2-like@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane@NA
A2463_34@174540@174555@duplication@16@2840886@2845300@20@chr20:2840886-2845300@10.1@1114@1460@1.31@NA@VPS16_4, VPS16_5, VPS16_6, VPS16_7, VPS16_8, VPS16_9, VPS16_10, VPS16_11, VPS16_12, VPS16_13, VPS16_14, VPS16_15, VPS16_16, VPS16_17, VPS16_18, VPS16_19@0@0@0@:vacuolar protein sorting 16 homolog (S. cerevisiae):protein tyrosine phosphatase, receptor type, A@:endosome;neuronal cell body;axon;late endosome;HOPS complex;late endosome membrane;lysosomal membrane;recycling endosome;early endosome;cytoplasm;intracellular protein transport;actin binding;protein binding;actin filament;actin filament binding:phosphatase activity;protein tyrosine phosphatase activity;protein phosphorylation;protein dephosphorylation;axon guidance;insulin receptor signaling pathway;plasma membrane;dephosphorylation;integral to plasma membrane;transmembrane receptor protein tyrosine phosphatase activity;peptidyl-tyrosine dephosphorylation@NA
A2463_34@181129@181133@deletion@5@18727044@18739404@22@chr22:18727044-18739404@6.25@62@23@0.371@CNVR8087.5, CNVR8087.2, CNVR8087.11@AC008132.1_4, AC008132.1_5, AC008132.1_6, AC008132.1_7, AC008132.1_8@0@0@0@NA@NA@NA
A2463_34@181938@181938@deletion@1@24302482@24302568@22@chr22:24302482-24302568@5.37@27@0@0@CNVR8114.6, CNVR8114.12, CNVR8114.13, CNVR8114.8@GSTT2B_2@0@0@0@:glutathione S-transferase theta 2B (gene/pseudogene);glutathione S-transferase theta 2@:protein binding;glutathione transferase activity;nucleus;transferase activity;cytoplasm@NA
A2463_34@181951@181955@duplication@5@24376424@24384231@22@chr22:24376424-24384231@12.1@183@361@1.97@CNVR8114.13, CNVR8114.1, CNVR8114.7@GSTT1_5, GSTT1_4, GSTT1_3, GSTT1_2, GSTT1_1@0@0@0@:glutathione S-transferase theta 1@:glutathione peroxidase activity;response to drug;transferase activity;cytosol;protein binding;glutathione transferase activity;glutathione metabolic process;response to organic cyclic compound@NA
A2463_33@428@434@deletion@7@1637082@1643839@1@chr1:1637082-1643839@6.85@59@20@0.339@CNVR17.1@CDK11A_12, CDK11A_11, CDK11A_10, CDK11A_9, CDK11A_8, CDK11A_7, CDK11A_6@0@0@0@:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A@:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division@NA
A2463_33@1831@1838@deletion@8@13052727@13366425@1@chr1:13052727-13366425@10.2@119@48@0.403@NA@WI2-3308P17.2_1, WI2-2994D6.2_2, WI2-2994D6.2_1, PRAMEF3_3, PRAMEF3_2, PRAMEF3_1, PRAMEF5_2, PRAMEF5_3@0@0@0@:PRAME family member 6;PRAME family member 23;PRAME family member 9/15-like;PRAME family member 5:PRAME family member:PRAME family member 3:PRAME family member 5@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_33@2289@2298@duplication@10@17594333@17607291@1@chr1:17594333-17607291@11.2@349@513@1.47@NA@PADI3_6, PADI3_7, PADI3_8, PADI3_9, PADI3_10, PADI3_11, PADI3_12, PADI3_13, PADI3_14, PADI3_15@0@0@0@:peptidyl arginine deiminase, type III@:protein-arginine deiminase activity;nucleus;peptidyl-citrulline biosynthetic process from peptidyl-arginine;calcium ion binding;cytoplasm@NA
A2463_33@3194@3198@deletion@5@24287949@24301567@1@chr1:24287949-24301567@8.18@37@0@0@NA@PNRC2_3, SRSF10_6, SRSF10_5, SRSF10_4, SRSF10_3@0@0@0@:proline-rich nuclear receptor coactivator 2;proline-rich nuclear receptor coactivator 2-like:serine/arginine-rich splicing factor 10-like;serine/arginine-rich splicing factor 10@:protein binding;deadenylation-independent decapping of nuclear-transcribed mRNA;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;nucleus;regulation of transcription, DNA-dependent;transcription, DNA-dependent;cytoplasmic mRNA processing body:nucleoplasm;RNA splicing, via transesterification reactions;nuclear speck;RS domain binding;RNA binding;nucleus;mRNA splice site selection;unfolded protein binding;assembly of spliceosomal tri-snRNP;negative regulation of mRNA splicing, via spliceosome;regulation of transcription, DNA-dependent;nucleotide binding;cytoplasm;mRNA export from nucleus;protein binding;cytoplasmic transport;mRNA splicing, via spliceosome;nucleic acid binding@NA
A2463_33@3342@3342@deletion@1@25655390@25655415@1@chr1:25655390-25655415@5.49@52@16@0.308@CNVR116.1@RHD_10@0@0@0@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
A2463_33@5194@5194@deletion@1@40229385@40229463@1@chr1:40229385-40229463@5.33@28@2@0.0714@NA@BMP8B_5@0@0@0@:peptidylprolyl isomerase E (cyclophilin E):bone morphogenetic protein 8b@:regulation of transcription, DNA-dependent;nucleotide binding;catalytic step 2 spliceosome;protein folding;protein binding;protein peptidyl-prolyl isomerization;peptidyl-prolyl cis-trans isomerase activity;cyclosporin A binding;RNA binding;mRNA splicing, via spliceosome;nucleus;nucleic acid binding:cell differentiation;growth factor activity;extracellular space;growth;extracellular region;cytokine activity;cartilage development;skeletal system development;ossification@NA
A2463_33@9352@9386@deletion@35@104161534@104297436@1@chr1:104161534-104297436@36.7@581@284@0.489@CNVR266.3, CNVR266.5@AMY2A_3, AMY2A_4, AMY2A_5, AMY2A_6, AMY2A_7, AMY2A_8, AMY2A_9, AMY2A_10, AMY1A_2, AMY1A_3, AMY1A_4, AMY1A_5, AMY1A_6, AMY1A_7, AMY1A_8, AMY1A_9, AMY1A_10, AMY1A_11, AMY1B_11, AMY1B_10, AMY1B_9, AMY1B_8, AMY1B_7, AMY1B_6, AMY1B_5, AMY1B_4, AMY1B_3, AMY1B_2, AMY1C_1, AMY1C_2, AMY1C_3, AMY1C_4, AMY1C_5, AMY1C_6, AMY1C_7@0@0@0@:amylase, alpha 2A (pancreatic):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:chloride ion binding;cation binding;small molecule metabolic process;carbohydrate metabolic process;catalytic activity;extracellular space;polysaccharide digestion;extracellular region;carbohydrate catabolic process;alpha-amylase activity;calcium ion binding:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
A2463_33@9766@9775@deletion@10@110230497@110255315@1@chr1:110230497-110255315@29.7@193@38@0.197@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_1, GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8, GSTM5_1, GSTM5_2@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1:glutathione S-transferase mu 5@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process:xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process;glutathione metabolic process;endoplasmic reticulum membrane@NA
A2463_33@10692@10692@deletion@1@120927138@120927417@1@chr1:120927138-120927417@4.63@79@36@0.456@CNVR320.1@FCGR1B_5@0@0@0@:Fc fragment of IgG, high affinity Ib, receptor (CD64);Fc fragment of IgG, high affinity Ic, receptor (CD64), pseudogene@:IgG binding;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;antigen processing and presentation of peptide antigen via MHC class I;immune response;immunoglobulin receptor activity;clathrin-coated endocytic vesicle membrane;protein binding;interferon-gamma-mediated signaling pathway;integral to membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I;plasma membrane;Fc receptor signaling pathway;cytokine-mediated signaling pathway;early endosome membrane@NA
A2463_33@10788@10793@deletion@6@144220788@144340398@1@chr1:144220788-144340398@16.3@82@2@0.0244@CNVR334.4@RP3-377D14.1_87, RP3-377D14.1_88, RP3-377D14.1_89, RP3-377D14.1_90, RP3-377D14.1_91, AL592284.1_1@0@0@0@:uncharacterized LOC730256;uncharacterized LOC101060698;uncharacterized LOC642441@NA@NA
A2463_33@10796@10798@deletion@3@144811749@144814894@1@chr1:144811749-144814894@9.67@167@79@0.473@CNVR338.4, CNVR338.2, CNVR338.5, CNVR338.1@NBPF9_1, NBPF9_2, NBPF9_3@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 24@NA@NA
A2463_33@10856@10867@deletion@12@145248858@145301822@1@chr1:145248858-145301822@16.8@2064@1402@0.679@CNVR341.2, CNVR341.1@NOTCH2NL_3, RP11-458D21.5_2, NOTCH2NL_4, RP11-458D21.5_3, NOTCH2NL_5, RP11-458D21.5_4, NOTCH2NL_6, RP11-458D21.5_5, NBPF10_1, NBPF10_2, NBPF10_3, NBPF10_4, NBPF10_5, NBPF10_6, NBPF10_7@0@0@0@:notch 2 N-terminal like:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family, member 10@:multicellular organismal development;cell differentiation;protein binding;Notch signaling pathway;extracellular region;calcium ion binding;cytoplasm:protein binding;calcium ion binding@NA
A2463_33@10887@10887@deletion@1@145323655@145323705@1@chr1:145323655-145323705@6.49@411@227@0.552@CNVR341.2, CNVR341.3@NBPF10_27@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family, member 10@NA@NA
A2463_33@11132@11136@duplication@5@146219128@146222344@1@chr1:146219128-146222344@7.08@5@52@10.4@NA@NBPF12_33, NBPF12_32, NBPF12_31, NBPF12_30, NBPF12_29@0@0@0@:neuroblastoma breakpoint family member 21-like@NA@NA
A2463_33@11149@11157@duplication@9@146232495@146244717@1@chr1:146232495-146244717@8.8@15@78@5.2@NA@NBPF12_16, NBPF12_15, NBPF12_14, NBPF12_13, NBPF12_12, NBPF12_11, NBPF12_10, NBPF12_9, NBPF12_8@0@0@0@:neuroblastoma breakpoint family member 21-like@NA@NA
A2463_33@11165@11168@deletion@4@146395343@146399627@1@chr1:146395343-146399627@6.02@235@148@0.63@NA@NBPF12_5, NBPF12_6, NBPF12_7, NBPF12_8@0@0@0@:neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family member 14-like;neuroblastoma breakpoint family, member 12@:cytoplasm@NA
A2463_33@11175@11184@deletion@10@146407959@146420191@1@chr1:146407959-146420191@8.38@157@77@0.49@NA@NBPF12_15, NBPF12_16, NBPF12_17, NBPF12_18, NBPF12_19, NBPF12_20, NBPF12_21, NBPF12_22, NBPF12_23, NBPF12_24@0@0@0@:neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family member 14-like;neuroblastoma breakpoint family, member 12@:cytoplasm@NA
A2463_33@11242@11242@deletion@1@146465879@146466121@1@chr1:146465879-146466121@5.29@89@39@0.438@CNVR344.2@NBPF12_82@0@0@0@:neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family member 14-like;neuroblastoma breakpoint family, member 12@:cytoplasm@NA
A2463_33@11335@11336@deletion@2@147954851@148004791@1@chr1:147954851-148004791@5.97@110@51@0.464@CNVR346.2, CNVR346.3, CNVR346.1, CNVR346.4@PPIAL4A_1, NBPF14_22@0@0@0@:peptidylprolyl isomerase A (cyclophilin A)-like 4C;peptidyl-prolyl cis-trans isomerase A-like 4A/B/C-like;peptidylprolyl isomerase A (cyclophilin A)-like 4B;peptidylprolyl isomerase A (cyclophilin A)-like 4A:neuroblastoma breakpoint family, member 14@:protein folding;peptidyl-prolyl cis-trans isomerase activity;cytoplasm:cytoplasm@NA
A2463_33@11349@11357@deletion@9@148014855@148025848@1@chr1:148014855-148025848@16@472@277@0.587@CNVR346.2, CNVR346.4@NBPF14_9, NBPF14_8, NBPF14_7, NBPF14_6, NBPF14_5, NBPF14_4, NBPF14_3, NBPF14_2, NBPF14_1@0@0@0@:neuroblastoma breakpoint family, member 14@:cytoplasm@NA
A2463_33@12117@12118@deletion@2@152573209@152586574@1@chr1:152573209-152586574@17@83@1@0.012@CNVR358.1@LCE3C_1, LCE3B_1@0@0@0@:late cornified envelope 3C:late cornified envelope 3B@:keratinization:keratinization@NA
A2463_33@16029@16040@deletion@12@196744018@196801129@1@chr1:196744018-196801129@41.2@1221@663@0.543@CNVR459.1@CFHR3_1, CFHR3_2, CFHR3_3, CFHR3_4, CFHR3_5, CFHR3_6, CFHR1_1, CFHR1_2, CFHR1_3, CFHR1_4, CFHR1_5, CFHR1_6@0@0@0@:complement factor H-related 3:complement factor H-related 1:complement factor H-related 2@:extracellular space:extracellular space;complement activation:extracellular region@NA
A2463_33@22191@22194@duplication@4@38956699@38972329@2@chr2:38956699-38972329@8.38@164@264@1.61@CNVR759.1@GALM_5, GALM_6, GALM_7, SRSF7_8@0@0@0@:galactose mutarotase (aldose 1-epimerase):serine/arginine-rich splicing factor 7@:isomerase activity;carbohydrate binding;aldose 1-epimerase activity;hexose metabolic process;carbohydrate metabolic process;catalytic activity;cytoplasm:nucleoplasm;negative regulation of mRNA splicing, via spliceosome;mRNA 3'-end processing;termination of RNA polymerase II transcription;nucleotide binding;transcription from RNA polymerase II promoter;protein binding;mRNA export from nucleus;RNA binding;mRNA processing;nucleus;RNA splicing;mRNA splicing, via spliceosome;gene expression;zinc ion binding;nucleic acid binding@NA
A2463_33@24992@24993@deletion@2@90060445@90060995@2@chr2:90060445-90060995@7.16@116@55@0.474@CNVR867.10, CNVR867.1, CNVR867.6, CNVR867.5, CNVR867.12@IGKV6D-21_1, IGKV6D-21_2@0@0@0@@:protein binding@NA
A2463_33@25004@25009@deletion@6@90192949@90212253@2@chr2:90192949-90212253@9.01@284@171@0.602@CNVR867.10, CNVR867.3, CNVR867.9, CNVR867.2@IGKV1D-13_1, IGKV1D-13_2, IGKV1D-12_1, IGKV1D-12_2, IGKV3D-11_1, IGKV3D-11_2@0@0@0@@:protein binding:protein binding:protein binding@NA
A2463_33@25115@25116@deletion@2@96652500@96652954@2@chr2:96652500-96652954@7.16@46@9@0.196@NA@ANKRD36C_3, ANKRD36C_2@0@0@0@:ankyrin repeat domain-containing protein 36A-like@:ion channel inhibitor activity;protein binding@NA
A2463_33@25369@25370@deletion@2@97854825@97855027@2@chr2:97854825-97855027@18.1@89@2@0.0225@CNVR886.2, CNVR886.3@ANKRD36_33, ANKRD36_34@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_33@26304@26316@deletion@13@112539947@112561416@2@chr2:112539947-112561416@17@550@347@0.631@CNVR928.1@ANAPC1_43, ANAPC1_42, ANAPC1_41, ANAPC1_40, ANAPC1_39, ANAPC1_38, ANAPC1_37, ANAPC1_36, ANAPC1_35, ANAPC1_34, ANAPC1_33, ANAPC1_32, ANAPC1_31@0@0@0@:anaphase-promoting complex subunit 1-like;anaphase promoting complex subunit 1@:nucleoplasm;regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle;anaphase-promoting complex;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle spindle assembly checkpoint;cytosol;protein K11-linked ubiquitination;protein binding;mitosis;nucleus;cell cycle checkpoint;cell division;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle@NA
A2463_33@27271@27288@deletion@18@131356216@131415450@2@chr2:131356216-131415450@21.2@725@416@0.574@NA@CFC1_3, CFC1_2, CFC1_1, POTEJ_1, POTEJ_2, POTEJ_3, POTEJ_4, POTEJ_5, POTEJ_6, POTEJ_7, POTEJ_8, POTEJ_9, POTEJ_10, POTEJ_11, POTEJ_12, POTEJ_13, POTEJ_14, POTEJ_15@0@0@0@:cripto, FRL-1, cryptic family 1:POTE ankyrin domain family, member J@:gastrulation;nodal signaling pathway;protein binding;extracellular region;nodal binding;plasma membrane;molecular_function;determination of left/right symmetry;cellular_component;anchored to membrane:protein binding;ATP binding@: TRANSPOSITION OF THE GREAT ARTERIES, DEXTRO-LOOPED 2; DTGA2; CONOTRUNCAL HEART MALFORMATIONS; CTHM; HETEROTAXY, VISCERAL, 2, AUTOSOMAL; HTX2
A2463_33@48556@48561@duplication@6@69403344@69434202@4@chr4:69403344-69434202@21.8@208@484@2.33@CNVR1953.1@UGT2B17_6, UGT2B17_5, UGT2B17_4, UGT2B17_3, UGT2B17_2, UGT2B17_1@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B17@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;membrane@: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
A2463_33@53302@53312@duplication@11@677866@767067@5@chr5:677866-767067@13.4@309@478@1.55@CNVR2280.3@TPPP_2, ZDHHC11B_10, ZDHHC11B_9, ZDHHC11B_8, ZDHHC11B_7, ZDHHC11B_6, ZDHHC11B_5, ZDHHC11B_4, ZDHHC11B_3, ZDHHC11B_2, ZDHHC11B_1@0@0@0@:tubulin polymerization promoting protein:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:microtubule binding;microtubule polymerization;perinuclear region of cytoplasm;cytoplasm;positive regulation of protein complex assembly;protein binding;microtubule bundle formation;focal adhesion;microtubule;nucleus;plasma membrane;tubulin binding;calcium ion binding;positive regulation of protein polymerization:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
A2463_33@55493@55494@duplication@2@64020212@64024006@5@chr5:64020212-64024006@5.09@153@232@1.52@NA@SREK1IP1_5, SREK1IP1_4@0@0@0@:SREK1-interacting protein 1@:mRNA processing;RNA splicing;zinc ion binding;nucleic acid binding@NA
A2463_33@55777@55783@deletion@7@68840732@68862452@5@chr5:68840732-68862452@6.86@279@185@0.663@CNVR2494.7, CNVR2494.46@OCLN_6, OCLN_7, OCLN_8, OCLN_9, GTF2H2C_2, GTF2H2C_3, GTF2H2C_4@0@0@0@:occludin:general transcription factor IIH, polypeptide 2C;general transcription factor IIH, polypeptide 2D@:S-adenosylmethionine metabolic process;cell-cell junction organization;cellular component disassembly involved in execution phase of apoptosis;response to testosterone stimulus;tight junction;integral to membrane;cell junction;plasma membrane;apoptotic process;thiopurine S-methyltransferase activity;S-adenosylhomocysteine metabolic process;apical plasma membrane;protein complex assembly;cytosol;cell-cell junction;protein binding;structural molecule activity;response to organic cyclic compound;apicolateral plasma membrane:regulation of transcription, DNA-dependent;nucleotide-excision repair;DNA repair;core TFIIH complex;protein binding;nucleus;transcription, DNA-dependent;zinc ion binding@: BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA;
A2463_33@59065@59065@deletion@1@140557617@140560021@5@chr5:140557617-140560021@7.66@1172@658@0.561@CNVR2624.1@PCDHB8_1@0@0@0@:protocadherin beta 8@:integral to membrane;homophilic cell adhesion;plasma membrane;membrane;calcium ion binding@NA
A2463_33@61267@61267@deletion@1@177164044@177164113@5@chr5:177164044-177164113@5.37@24@0@0@NA@FAM153A_10@0@0@0@:family with sequence similarity 153, member A@NA@NA
A2463_33@61638@61644@deletion@7@180375356@180424488@5@chr5:180375356-180424488@12@387@221@0.571@CNVR2719.1@BTNL8_5, BTNL8_6, BTNL8_7, BTNL8_8, BTNL3_1, BTNL3_2, BTNL3_3@0@0@0@:butyrophilin-like 8:butyrophilin-like 3@:protein binding;integral to membrane:protein binding;integral to membrane;molecular_function;cellular_component;biological_process@NA
A2463_33@63953@63958@duplication@6@32485517@32498001@6@chr6:32485517-32498001@15.8@153@300@1.96@CNVR2845.21, CNVR2845.25, CNVR2845.30, CNVR2845.43, CNVR2845.6@HLA-DRB5_6, HLA-DRB5_5, HLA-DRB5_4, HLA-DRB5_3, HLA-DRB5_2, HLA-DRB5_1@0@0@0@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
A2463_33@63953@63960@deletion@2@32485517@32548047@6@chr6:32485517-32548047@-25.5@249@343@1.38@CNVR2845.21, CNVR2845.25, CNVR2845.24@HLA-DRB5_6, HLA-DRB5_5, HLA-DRB5_4, HLA-DRB5_3, HLA-DRB5_2, HLA-DRB5_1, HLA-DRB1_6, HLA-DRB1_5@0@0@0@:major histocompatibility complex, class II, DR beta 5:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
A2463_33@64602@64603@duplication@2@35754776@35755787@6@chr6:35754776-35755787@6.98@199@320@1.61@CNVR2861.1@CLPSL1_2, CLPSL1_3@0@0@0@:colipase-like 1@:extracellular region;enzyme activator activity;digestion;lipid catabolic process@NA
A2463_33@71010@71011@deletion@2@167587242@167590622@6@chr6:167587242-167590622@7.38@96@39@0.406@NA@TCP10L2_3, TCP10L2_4@0@0@0@:t-complex 10;t-complex 10-like 2@NA@NA
A2463_33@71776@71779@duplication@4@6006495@6018327@7@chr7:6006495-6018327@18.2@356@635@1.78@NA@RSPH10B_2, PMS2_15, PMS2_14, PMS2_13@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas):PMS2 postmeiotic segregation increased 2 (S. cerevisiae)@:response to drug;DNA binding;MutSalpha complex binding;ATP binding;mismatch repair;DNA repair;mismatched DNA binding;ATPase activity;nucleus;mismatch repair complex;reciprocal meiotic recombination;ATP catabolic process;single-stranded DNA binding;response to DNA damage stimulus;single base insertion or deletion binding;protein binding;somatic hypermutation of immunoglobulin genes;somatic recombination of immunoglobulin gene segments;MutLalpha complex;endonuclease activity@: COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 4; HNPCC4; MISMATCH REPAIR CANCER SYNDROME
A2463_33@71922@71946@deletion@25@6797310@6851694@7@chr7:6797310-6851694@65.3@493@115@0.233@NA@RSPH10B2_2, RSPH10B2_3, RSPH10B2_4, RSPH10B2_5, RSPH10B2_6, RSPH10B2_7, RSPH10B2_8, RSPH10B2_9, RSPH10B2_10, RSPH10B2_11, RSPH10B2_12, RSPH10B2_13, RSPH10B2_14, RSPH10B2_15, RSPH10B2_16, RSPH10B2_17, RSPH10B2_18, RSPH10B2_19, RSPH10B2_20, CCZ1B_15, CCZ1B_14, CCZ1B_13, CCZ1B_12, CCZ1B_11, CCZ1B_10@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
A2463_33@74573@74574@deletion@2@74166423@74167509@7@chr7:74166423-74167509@5.59@94@45@0.479@NA@GTF2I_28, GTF2I_29@0@0@0@:general transcription factor IIi@:neuronal cell body;transcription initiation from RNA polymerase II promoter;mitogen-activated protein kinase binding;negative regulation of angiogenesis;DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;cytoplasm;transcription from RNA polymerase II promoter;protein binding;signal transduction;nucleus;cell projection;reduction of cytosolic calcium ion concentration@NA
A2463_33@76427@76432@deletion@6@100331793@100336236@7@chr7:100331793-100336236@36.9@177@2@0.0113@CNVR3509.1@ZAN_1, ZAN_2, ZAN_3, ZAN_4, ZAN_5, ZAN_6@0@0@0@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
A2463_33@76737@76775@deletion@39@102147143@102257136@7@chr7:102147143-102257136@30.5@408@169@0.414@CNVR3518.1@RASA4B_5, RASA4B_4, RASA4B_3, RASA4B_2, RASA4B_1, SPDYE2_2, SPDYE2_3, SPDYE2_4, SPDYE2_5, SPDYE2_6, SPDYE2_7, SPDYE2_8, POLR2J3_4, POLR2J3_3, POLR2J3_2, POLR2J3_1, AC093668.1_3, AC093668.1_2, AC093668.1_1, RASA4_21, RASA4_20, RASA4_19, RASA4_18, RASA4_17, RASA4_16, RASA4_15, RASA4_14, RASA4_13, RASA4_12, RASA4_11, RASA4_10, RASA4_9, RASA4_8, RASA4_7, RASA4_6, RASA4_5, RASA4_4, RASA4_3, RASA4_2, UPK3BL_7, RASA4_1@0@0@0@:RAS p21 protein activator 4B:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:speedy homolog E2 (Xenopus laevis):RAS p21 protein activator 4B;RAS p21 protein activator 4@:phospholipid binding;intracellular;GTPase activator activity;cytosol;signal transduction;protein binding;plasma membrane;regulation of small GTPase mediated signal transduction;metal ion binding;intracellular signal transduction:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity@NA
A2463_33@76792@76795@deletion@4@102309363@102319303@7@chr7:102309363-102319303@8.15@169@92@0.544@CNVR3518.1@POLR2J2_2, POLR2J2_2, POLR2J2_1, POLR2J2_1, AC105052.1_3, AC105052.1_2, AC105052.1_1@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
A2463_33@79287@79288@deletion@2@143400089@143417767@7@chr7:143400089-143417767@8.11@63@16@0.254@CNVR3594.2, CNVR3594.1@FAM115C_2, FAM115C_3@0@0@0@:family with sequence similarity 115, member C;protein FAM115C-like@NA@NA
A2463_33@80366@80386@deletion@21@7220458@7399402@8@chr8:7220458-7399402@13.4@292@159@0.545@CNVR3771.8, CNVR3771.10, CNVR3771.4@DEFB4B_2, DEFB4B_1, DEFB103B_2, DEFB103B_1, SPAG11B_3, SPAG11B_2, SPAG11B_1, DEFB104B_2, DEFB104B_1, DEFB106B_2, DEFB106B_1, DEFB105B_1, DEFB105B_2, DEFB105B_3, DEFB107B_1, DEFB107B_2, RP11-1118M6.1_1, RP11-1118M6.1_2, RP11-1118M6.1_3, RP11-1118M6.1_4@0@0@0@:zinc finger protein 705G:defensin, beta 4B;defensin, beta 4A:defensin, beta 103B;defensin, beta 103A:sperm associated antigen 11B:defensin, beta 104A;defensin, beta 104B:defensin, beta 106B;defensin, beta 106A:defensin, beta 105B;defensin, beta 105A:defensin, beta 107B;defensin, beta 107A:uncharacterized LOC100133251@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response:extracellular region;defense response to bacterium;Golgi lumen;positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria;defense response;innate immune response:spermatogenesis;defense response to bacterium;extracellular region;molecular_function;defense response:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium@NA
A2463_33@80397@80398@deletion@2@7686328@7694064@8@chr8:7686328-7694064@5.96@49@14@0.286@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@DEFB106A_2, DEFB104A_1@0@0@0@:defensin, beta 106B;defensin, beta 106A:defensin, beta 104A;defensin, beta 104B@:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium@NA
A2463_33@80406@80411@deletion@6@7752236@7808269@8@chr8:7752236-7808269@12.7@155@67@0.432@CNVR3772.4, CNVR3772.6, CNVR3772.10, CNVR3772.13@DEFB4A_1, DEFB4A_2, ZNF705B_2, ZNF705B_3, ZNF705B_4, ZNF705B_5@0@0@0@:defensin, beta 4B;defensin, beta 4A:zinc finger protein 705B@:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response:intracellular;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_33@80566@80578@deletion@13@12041116@12286407@8@chr8:12041116-12286407@16.9@194@89@0.459@CNVR3786.4@FAM86B1_8, FAM86B1_7, FAM86B1_6, FAM86B1_5, FAM86B1_4, FAM86B1_3, FAM86B1_2, FAM86B1_1, DEFB130_2, DEFB130_1, FAM86B2_8, FAM86B2_7, FAM86B2_6@0@0@0@:family with sequence similarity 86, member B2;family with sequence similarity 86, member B1:defensin, beta 130-like;defensin, beta 130:family with sequence similarity 86, member B2@:extracellular region;defense response to bacterium;defense response@NA
A2463_33@80583@80584@deletion@2@12293758@12338444@8@chr8:12293758-12338444@9.65@77@18@0.234@CNVR3786.4, CNVR3786.16@FAM86B2_1, AC130352.1_5@0@0@0@:family with sequence similarity 86, member B2@NA@NA
A2463_33@83673@83673@duplication@1@86573700@86575726@8@chr8:86573700-86575726@7.56@199@361@1.81@CNVR3955.1@REXO1L1_1@0@0@0@:exonuclease GOR-like;REX1, RNA exonuclease 1 homolog (S. cerevisiae)-like 1@:intracellular;nucleus;exonuclease activity;nucleic acid binding;cytoplasm@NA
A2463_33@86632@86636@deletion@5@121468@135030@9@chr9:121468-135030@8.79@200@113@0.565@CNVR4135.1@CBWD1_15, CBWD1_14, CBWD1_13, CBWD1_12, CBWD1_11@0@0@0@:COBW domain containing 1;COBW domain-containing protein 1-like;COBW domain containing 5@:ATP binding@NA
A2463_33@86644@86646@deletion@3@173271@178969@9@chr9:173271-178969@5.73@114@60@0.526@CNVR4135.1@CBWD1_3, CBWD1_2, CBWD1_1@0@0@0@:COBW domain containing 1;COBW domain-containing protein 1-like;COBW domain containing 5@:ATP binding@NA
A2463_33@88528@88529@deletion@2@40702653@40716325@9@chr9:40702653-40716325@12@479@255@0.532@NA@SPATA31A3_4, FAM74A3_1@0@0@0@:SPATA31 subfamily A, member 3@:integral to membrane@NA
A2463_33@88534@88539@deletion@6@41306194@41327364@9@chr9:41306194-41327364@9.52@63@13@0.206@CNVR4278.2@FAM74A2_2, FAM74A2_1, SPATA31A4_4, SPATA31A4_3, SPATA31A4_2, SPATA31A4_1@0@0@0@:SPATA31 subfamily A, member 4@:integral to membrane:integral to membrane@NA
A2463_33@88639@88643@deletion@5@67926874@67936012@9@chr9:67926874-67936012@6.1@50@16@0.32@NA@ANKRD20A1_1, ANKRD20A1_2, ANKRD20A1_3, ANKRD20A1_4, ANKRD20A1_5@0@0@0@:ankyrin repeat domain 20 family, member A1@:protein binding;plasma membrane@NA
A2463_33@88676@88690@deletion@15@69382094@69424176@9@chr9:69382094-69424176@20.8@487@263@0.54@NA@ANKRD20A4_1, ANKRD20A4_2, ANKRD20A4_3, ANKRD20A4_4, ANKRD20A4_5, ANKRD20A4_6, ANKRD20A4_7, ANKRD20A4_8, ANKRD20A4_9, ANKRD20A4_10, ANKRD20A4_11, ANKRD20A4_12, ANKRD20A4_13, ANKRD20A4_14, ANKRD20A4_15@0@0@0@:ankyrin repeat domain 20 family, member A4@:protein binding@NA
A2463_33@88718@88728@deletion@11@70881137@70993277@9@chr9:70881137-70993277@13.3@280@154@0.55@NA@CBWD3_8, CBWD3_9, CBWD3_10, CBWD3_11, CBWD3_12, CBWD3_13, CBWD3_14, CBWD3_15, FOXD4L3_1, PGM5_1, PGM5_2@0@0@0@:COBW domain-containing protein 5-like;COBW domain-containing protein 1-like;COBW domain containing 3:forkhead box D4-like 3:phosphoglucomutase 5@:ATP binding:sequence-specific DNA binding;nucleus;regulation of transcription, DNA-dependent;sequence-specific DNA binding transcription factor activity:Z disc;intramolecular transferase activity, phosphotransferases;magnesium ion binding;stress fiber;focal adhesion;glucose metabolic process;intercalated disc;sarcolemma;internal side of plasma membrane;carbohydrate metabolic process;cell-cell adherens junction;cell-substrate junction;protein binding;dystrophin-associated glycoprotein complex;cell adhesion;structural molecule activity;costamere;spot adherens junction@NA
A2463_33@95410@95411@deletion@2@18196464@18198276@10@chr10:18196464-18198276@6.7@60@18@0.3@NA@MRC1_28, MRC1_29@0@0@0@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
A2463_33@96242@96243@deletion@2@37478396@37482020@10@chr10:37478396-37482020@14.1@132@41@0.311@CNVR4692.1, CNVR4692.2@ANKRD30A_25, ANKRD30A_26@0@0@0@:ankyrin repeat domain 30A@:protein binding;nucleus;DNA binding;regulation of transcription, DNA-dependent;sequence-specific DNA binding transcription factor activity@NA
A2463_33@96463@96470@duplication@8@46552470@46611811@10@chr10:46552470-46611811@9.83@36@108@3@CNVR4712.3@PTPN20A_9, PTPN20A_8, PTPN20A_7, PTPN20A_6, PTPN20A_5, PTPN20A_4, PTPN20A_3, PTPN20A_2@0@0@0@:protein tyrosine phosphatase, non-receptor type 20B;protein tyrosine phosphatase, non-receptor type 20A@:phosphatase activity;protein tyrosine phosphatase activity;microtubule;nucleus;dephosphorylation;protein dephosphorylation;microtubule organizing center@NA
A2463_33@96522@96531@deletion@10@47747113@47758904@10@chr10:47747113-47758904@9.06@105@45@0.429@CNVR4714.1@ANXA8L2_1, ANXA8L2_2, ANXA8L2_3, ANXA8L2_4, ANXA8L2_5, ANXA8L2_6, ANXA8L2_7, ANXA8L2_8, ANXA8L2_9, ANXA8L2_10@0@0@0@:annexin A8-like 2:uncharacterized LOC101060462;uncharacterized LOC100996760@:calcium-dependent phospholipid binding;calcium ion binding@NA
A2463_33@96540@96563@deletion@24@47903160@47948853@10@chr10:47903160-47948853@63.1@338@30@0.0888@CNVR4715.2, CNVR4715.1@FAM21B_6, FAM21B_7, FAM21B_8, FAM21B_9, FAM21B_10, FAM21B_11, FAM21B_12, FAM21B_13, FAM21B_14, FAM21B_15, FAM21B_16, FAM21B_17, FAM21B_18, FAM21B_19, FAM21B_20, FAM21B_21, FAM21B_22, FAM21B_23, FAM21B_24, FAM21B_25, FAM21B_26, FAM21B_27, FAM21B_28, FAM21B_29@0@0@0@:family with sequence similarity 21, member B@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_33@96620@96620@duplication@1@48771316@48771405@10@chr10:48771316-48771405@11@38@160@4.21@CNVR4716.10, CNVR4716.3@PTPN20B_6@0@0@0@:protein tyrosine phosphatase, non-receptor type 20B;protein tyrosine phosphatase, non-receptor type 20A@:phosphatase activity;protein tyrosine phosphatase activity;microtubule;nucleus;dephosphorylation;protein dephosphorylation;microtubule organizing center@NA
A2463_33@96844@96852@deletion@9@51224991@51374428@10@chr10:51224991-51374428@16.9@176@57@0.324@NA@AGAP8_7, AGAP8_6, AGAP8_5, AGAP8_4, AGAP8_3, AGAP8_2, AGAP8_1, TIMM23B_1, TIMM23B_2@0@0@0@:ArfGAP with GTPase domain, ankyrin repeat and PH domain 8:translocase of inner mitochondrial membrane 23 homolog B (yeast)@:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process@NA
A2463_33@96932@96937@deletion@6@51965743@51978390@10@chr10:51965743-51978390@13.8@78@10@0.128@NA@ASAH2_12, ASAH2_11, ASAH2_10, ASAH2_9, ASAH2_8, ASAH2_7@0@0@0@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
A2463_33@98355@98357@duplication@3@81608270@81610362@10@chr10:81608270-81610362@9.32@53@133@2.51@NA@FAM22E_5, FAM22E_6, FAM22E_7@0@0@0@NA@NA@NA
A2463_33@103289@103293@deletion@5@5270599@5275958@11@chr11:5270599-5275958@12.5@262@142@0.542@NA@HBG1_2, HBG1_1, HBG2_8, HBG2_7, HBG2_6@0@0@0@:hemoglobin, gamma A:hemoglobin, gamma G@:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex@: CYANOSIS, TRANSIENT NEONATAL; TNCY
A2463_33@103342@103342@deletion@1@5798891@5799864@11@chr11:5798891-5799864@26.1@143@0@0@CNVR5049.1@OR52N5_1@0@0@0@:tripartite motif containing 5:olfactory receptor, family 52, subfamily N, member 5@:defense response to virus;Golgi apparatus;intracellular;protein trimerization;ligase activity;cytoplasm;protein binding;nucleus;protein homodimerization activity;identical protein binding;zinc ion binding;cytoplasmic mRNA processing body;protein ubiquitination;virus-host interaction:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_33@109914@109916@deletion@3@82984691@82985035@11@chr11:82984691-82985035@8.22@241@135@0.56@NA@CCDC90B_7, CCDC90B_6, CCDC90B_5@0@0@0@:coiled-coil domain containing 90B@:mitochondrion;integral to membrane@NA
A2463_33@110121@110126@deletion@6@89768381@89774718@11@chr11:89768381-89774718@8.1@233@136@0.584@NA@TRIM49C_3, TRIM49C_4, TRIM49C_5, TRIM49C_6, TRIM49C_7, TRIM49C_8@0@0@0@:tripartite motif containing 49D, pseudogene;tripartite motif containing 49-like 1;tripartite motif containing 49C;tripartite motif-containing protein 49-like protein 1-like@:protein binding;intracellular;DNA binding;zinc ion binding@NA
A2463_33@110237@110238@deletion@2@93463037@93463314@11@chr11:93463037-93463314@5.21@126@69@0.548@NA@KIAA1731_28, KIAA1731_29@0@0@0@:KIAA1731:microRNA 1304;small nucleolar RNA, C/D box 5;small nucleolar RNA, H/ACA box 1;small nucleolar RNA, H/ACA box 18;small nucleolar RNA, H/ACA box 8;small nucleolar RNA, H/ACA box 40;small nucleolar RNA, H/ACA box 32;TATA box binding protein (TBP)-associated factor, RNA polymerase I, D, 41kDa@:centrosome;cytoskeleton;cytoplasm:protein binding;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_33@114080@114080@deletion@1@7945547@7945808@12@chr12:7945547-7945808@6.29@41@7@0.171@NA@NANOG_2@0@0@0@:NECAP endocytosis associated 1:Nanog homeobox@:coated pit;protein binding;endocytosis;protein transport;clathrin vesicle coat;plasma membrane;membrane:cell differentiation;regulation of cell differentiation;somatic stem cell maintenance;sequence-specific DNA binding;transcription corepressor activity;embryo development;DNA binding;sequence-specific DNA binding transcription factor activity;nucleus;positive regulation of transcription from RNA polymerase II promoter;regulation of gene expression;regulation of transcription, DNA-dependent;cell proliferation;endodermal cell fate specification;nucleolus;transcription, DNA-dependent@NA
A2463_33@114483@114483@deletion@1@11243900@11244828@12@chr12:11243900-11244828@34.5@207@0@0@CNVR5434.1@TAS2R43_1@0@0@0@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):taste receptor, type 2, member 14:taste receptor, type 2, member 43@:extracellular space;visual perception:bitter taste receptor activity;taste receptor activity;integral to membrane;sensory perception of taste;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of bitter taste:G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;motile cilium;taste receptor activity;bitter taste receptor activity;integral to membrane;sensory perception of taste;detection of chemical stimulus involved in sensory perception of bitter taste;cilium membrane@NA
A2463_33@114862@114875@duplication@14@19472956@19519043@12@chr12:19472956-19519043@9.26@1158@1492@1.29@NA@PLEKHA5_17, PLEKHA5_18, PLEKHA5_19, PLEKHA5_20, PLEKHA5_21, PLEKHA5_22, PLEKHA5_23, PLEKHA5_24, PLEKHA5_25, PLEKHA5_26, PLEKHA5_27, PLEKHA5_28, PLEKHA5_29, PLEKHA5_30@0@0@0@:pleckstrin homology domain containing, family A member 5@:phospholipid binding;protein binding;1-phosphatidylinositol binding;cellular_component;biological_process@NA
A2463_33@117170@117172@deletion@3@52865457@52867521@12@chr12:52865457-52867521@7.88@269@159@0.591@NA@KRT6C_3, KRT6C_2, KRT6C_1@0@0@0@:keratin 6C@:intermediate filament;structural molecule activity;keratin filament;cytoskeleton organization@NA
A2463_33@127333@127341@deletion@9@19553418@19574352@14@chr14:19553418-19574352@28.6@738@383@0.519@CNVR6072.1@POTEG_1, POTEG_2, POTEG_3, POTEG_4, POTEG_5, POTEG_6, POTEG_7, POTEG_8, POTEG_9@0@0@0@:POTE ankyrin domain family, member G@:protein binding@NA
A2463_33@127354@127358@deletion@5@20248483@20404761@14@chr14:20248483-20404761@14.2@1289@831@0.645@CNVR6072.12, CNVR6072.4, CNVR6072.5@OR4M1_1, OR4N2_1, OR4K2_1, OR4K5_1, OR4K1_1@0@0@0@:olfactory receptor, family 4, subfamily N, member 2:olfactory receptor, family 4, subfamily M, member 1:olfactory receptor, family 4, subfamily K, member 2:olfactory receptor, family 4, subfamily K, member 5:olfactory receptor, family 4, subfamily K, member 1@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_33@131033@131034@deletion@2@74008198@74010359@14@chr14:74008198-74010359@14.8@150@55@0.367@CNVR6188.1, CNVR6188.4@ACOT1_2, ACOT1_3@0@0@0@:HEAT repeat containing 4:acyl-CoA thioesterase 1@:protein binding;binding:hydrolase activity;mitochondrion;acyl-CoA metabolic process;very long-chain fatty acid metabolic process;thiolester hydrolase activity;acyl-CoA hydrolase activity;cytosol;palmitoyl-CoA hydrolase activity;long-chain fatty acid metabolic process;carboxylesterase activity@NA
A2463_33@133432@133435@deletion@4@106539080@106552729@14@chr14:106539080-106552729@16.1@76@1@0.0132@CNVR6294.36, CNVR6294.48, CNVR6294.24, CNVR6294.10, CNVR6294.34@IGHV1-8_2, IGHV1-8_1, IGHV3-9_2, IGHV3-9_1@0@0@0@@:protein binding:protein binding@NA
A2463_33@133509@133513@deletion@5@20739498@20743825@15@chr15:20739498-20743825@7.79@212@106@0.5@CNVR6296.13@GOLGA6L6_8, GOLGA6L6_7, GOLGA6L6_6, GOLGA6L6_5, GOLGA6L6_4@0@0@0@:putative transmembrane protein FLJ36131-like;putative transmembrane protein ENSP00000320207-like;golgin A6 family-like 6@NA@NA
A2463_33@133520@133528@deletion@9@21051163@21071610@15@chr15:21051163-21071610@9.18@149@68@0.456@NA@POTEB_9, POTEB_8, POTEB_7, POTEB_6, POTEB_5, POTEB_4, POTEB_3, POTEB_2, POTEB_1@0@0@0@:POTE ankyrin domain family member B-like@:protein binding@NA
A2463_33@133552@133552@deletion@1@22742397@22743598@15@chr15:22742397-22743598@8.52@409@205@0.501@CNVR6298.5@GOLGA6L1_8@0@0@0@:golgin A6 family-like 1;putative transmembrane protein FLJ36131-like;putative transmembrane protein ENSP00000320207-like;putative golgin subfamily A member 6-like@NA@NA
A2463_33@133869@133872@deletion@4@28629294@28630527@15@chr15:28629294-28630527@10.3@73@17@0.233@CNVR6329.4@GOLGA8F_9, GOLGA8F_10, GOLGA8F_11, GOLGA8F_12@0@0@0@@:Golgi apparatus@NA
A2463_33@134023@134078@deletion@56@30699479@30927833@15@chr15:30699479-30927833@98.9@1117@426@0.381@NA@GOLGA8R_12, GOLGA8R_11, GOLGA8R_10, GOLGA8R_9, GOLGA8R_8, GOLGA8R_7, GOLGA8R_6, GOLGA8R_5, GOLGA8R_4, GOLGA8R_3, GOLGA8R_2, GOLGA8R_1, GOLGA8Q_1, GOLGA8Q_2, GOLGA8Q_3, GOLGA8Q_4, GOLGA8Q_5, GOLGA8Q_6, GOLGA8Q_7, GOLGA8Q_8, GOLGA8Q_9, GOLGA8Q_10, GOLGA8Q_11, GOLGA8Q_12, GOLGA8Q_13, GOLGA8Q_14, GOLGA8Q_15, GOLGA8Q_16, GOLGA8Q_17, GOLGA8Q_18, GOLGA8Q_19, GOLGA8H_1, GOLGA8H_2, GOLGA8H_3, GOLGA8H_4, GOLGA8H_5, GOLGA8H_6, GOLGA8H_7, GOLGA8H_8, GOLGA8H_9, GOLGA8H_10, GOLGA8H_11, GOLGA8H_12, GOLGA8H_13, GOLGA8H_14, GOLGA8H_15, GOLGA8H_16, GOLGA8H_17, GOLGA8H_18, GOLGA8H_19, ARHGAP11B_1, ARHGAP11B_2, ARHGAP11B_3, ARHGAP11B_4, ARHGAP11B_5, ARHGAP11B_6@0@0@0@:golgin A8 family, member H:Rho GTPase activating protein 11B;OTU domain containing 7A pseudogene@:Golgi apparatus:Golgi apparatus:Golgi apparatus:cytosol;signal transduction;intracellular;small GTPase mediated signal transduction;GTPase activator activity;regulation of small GTPase mediated signal transduction@NA
A2463_33@134158@134177@deletion@20@32684984@32695395@15@chr15:32684984-32695395@25.7@368@177@0.481@NA@GOLGA8K_19, GOLGA8K_18, GOLGA8K_17, GOLGA8K_16, GOLGA8K_15, GOLGA8K_14, GOLGA8K_13, GOLGA8K_12, GOLGA8K_11, GOLGA8K_10, GOLGA8K_9, GOLGA8K_8, GOLGA8K_7, GOLGA8K_6, GOLGA8K_5, GOLGA8K_4, GOLGA8K_3, GOLGA8K_2, AC139426.2_1, GOLGA8K_1@0@0@0@:golgin A8 family, member J@:Golgi apparatus@NA
A2463_33@134189@134190@duplication@2@32743115@32743403@15@chr15:32743115-32743403@5.26@24@65@2.71@CNVR6346.1@GOLGA8O_8, GOLGA8O_7@0@0@0@:golgin A8 family, member O@:Golgi apparatus@NA
A2463_33@134198@134214@deletion@17@32885756@32895667@15@chr15:32885756-32895667@16.6@185@72@0.389@NA@GOLGA8N_1, GOLGA8N_2, GOLGA8N_3, GOLGA8N_4, GOLGA8N_5, GOLGA8N_6, GOLGA8N_7, GOLGA8N_8, GOLGA8N_9, GOLGA8N_10, GOLGA8N_11, GOLGA8N_12, GOLGA8N_13, GOLGA8N_14, GOLGA8N_15, GOLGA8N_16, GOLGA8N_17@0@0@0@:golgin A8 family, member R@:Golgi apparatus@NA
A2463_33@134431@134432@deletion@2@34673613@34674057@15@chr15:34673613-34674057@5.02@68@29@0.426@CNVR6351.4, CNVR6351.3@GOLGA8A_24, GOLGA8A_23@0@0@0@:golgin A8 family, member A@:Golgi cisterna membrane;Golgi apparatus@NA
A2463_33@134458@134460@deletion@3@34823850@34825163@15@chr15:34823850-34825163@6.45@29@0@0@CNVR6351.3@GOLGA8B_14, GOLGA8B_13, GOLGA8B_12@0@0@0@:golgin A8 family, member A:golgin A8 family, member A;golgin A8 family, member B@:Golgi cisterna membrane;Golgi apparatus:Golgi cisterna membrane;Golgi apparatus@NA
A2463_33@136923@136929@duplication@7@57730199@57754090@15@chr15:57730199-57754090@11.1@708@994@1.4@NA@CGNL1_2, CGNL1_3, CGNL1_4, CGNL1_5, CGNL1_6, CGNL1_7, CGNL1_8@0@0@0@:cingulin-like 1@:tight junction;motor activity;myosin complex;actin cytoskeleton;apical junction complex@: AROMATASE EXCESS SYNDROME; AEXS
A2463_33@138281@138286@deletion@6@72953606@72956852@15@chr15:72953606-72956852@22.5@173@45@0.26@CNVR6443.1@GOLGA6B_8, GOLGA6B_9, GOLGA6B_10, GOLGA6B_11, GOLGA6B_12, GOLGA6B_13@0@0@0@:golgin A6 family, member B@:Golgi apparatus@NA
A2463_33@138632@138660@deletion@29@75555690@75585505@15@chr15:75555690-75585505@16.8@326@178@0.546@CNVR6452.1@GOLGA6C_4, GOLGA6C_5, GOLGA6C_6, GOLGA6C_7, GOLGA6C_8, GOLGA6C_9, GOLGA6C_10, GOLGA6C_11, GOLGA6C_12, GOLGA6C_13, GOLGA6C_14, GOLGA6C_15, GOLGA6C_16, GOLGA6C_17, GOLGA6C_18, GOLGA6D_1, GOLGA6D_2, GOLGA6D_3, GOLGA6D_4, GOLGA6D_5, GOLGA6D_6, GOLGA6D_7, GOLGA6D_8, GOLGA6D_9, GOLGA6D_10, GOLGA6D_11, GOLGA6D_12, GOLGA6D_13, GOLGA6D_14@0@0@0@:golgin A6 family, member C:golgin A6 family, member D@:Golgi apparatus:Golgi apparatus@NA
A2463_33@139472@139482@deletion@11@84842761@84911344@15@chr15:84842761-84911344@21.4@234@86@0.368@CNVR6486.2@RP11-182J1.16_2, RP11-182J1.16_3, GOLGA6L4_1, GOLGA6L4_2, GOLGA6L4_3, GOLGA6L4_4, GOLGA6L4_5, GOLGA6L4_6, GOLGA6L4_7, GOLGA6L4_8, GOLGA6L4_9@0@0@0@:uncharacterized LOC100505679@:Golgi apparatus@NA
A2463_33@140476@140485@deletion@10@64382@68789@16@chr16:64382-68789@11.4@202@111@0.55@CNVR6565.1@WASH4P_10, WASH4P_9, WASH4P_8, WASH4P_7, WASH4P_6, WASH4P_5, WASH4P_4, WASH4P_3, WASH4P_2, WASH4P_1@0@0@0@@:intracellular membrane-bounded organelle;endosomal transport;recycling endosome;early endosome;Arp2/3 complex-mediated actin nucleation;actin binding;alpha-tubulin binding;retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;recycling endosome membrane@NA
A2463_33@144097@144102@duplication@6@28617378@28620176@16@chr16:28617378-28620176@12.6@273@434@1.59@CNVR6685.1, CNVR6685.2@SULT1A1_9, SULT1A1_8, SULT1A1_7, SULT1A1_6, SULT1A1_5, SULT1A1_4@0@0@0@:sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1@:small molecule metabolic process;sulfation;aryl sulfotransferase activity;amine metabolic process;catecholamine metabolic process;xenobiotic metabolic process;cytosol;steroid sulfotransferase activity;integral to membrane;sulfotransferase activity;flavonol 3-sulfotransferase activity;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process;estrogen metabolic process@NA
A2463_33@147420@147423@deletion@4@72092154@72097159@16@chr16:72092154-72097159@12.2@315@223@0.708@CNVR6769.1@HP_5, HP_6, HP_7, HPR_1@0@0@0@:thioredoxin-like 4B:haptoglobin:haptoglobin-related protein@:mitosis;mRNA processing;RNA splicing;spliceosomal complex;cell redox homeostasis:cellular iron ion homeostasis;negative regulation of oxidoreductase activity;catalytic activity;negative regulation of hydrogen peroxide catabolic process;positive regulation of cell death;haptoglobin-hemoglobin complex;extracellular space;proteolysis;response to hydrogen peroxide;extracellular region;hemoglobin binding;defense response;serine-type endopeptidase activity:spherical high-density lipoprotein particle;proteolysis;extracellular region;hemoglobin binding;catalytic activity;serine-type endopeptidase activity@: ANHAPTOGLOBINEMIA; AHP
A2463_33@151551@151555@deletion@5@16623832@16638957@17@chr17:16623832-16638957@5.83@355@227@0.639@NA@CCDC144A_8, CCDC144A_8, CCDC144A_9, CCDC144A_9, CCDC144A_10, CCDC144A_10, CCDC144A_11, CCDC144A_11, CCDC144A_12, CCDC144A_12@0@0@0@:coiled-coil domain containing 144A@NA@NA
A2463_33@151884@151886@deletion@3@18396012@18430117@17@chr17:18396012-18430117@8.21@102@41@0.402@NA@LGALS9C_10, LGALS9C_11, FAM106A_1@0@0@0@:lectin, galactoside-binding, soluble, 9C:protein FAM106B-like@:carbohydrate binding@NA
A2463_33@151958@151959@deletion@2@18996506@18997166@17@chr17:18996506-18997166@8.05@160@79@0.494@CNVR7018.4, CNVR7018.2, CNVR7018.6@AC007952.5_1, AC007952.5_2@0@0@0@NA@NA@NA
A2463_33@153364@153372@deletion@9@34494907@34500284@17@chr17:34494907-34500284@7.58@142@74@0.521@CNVR7077.1, CNVR7077.3, CNVR7077.11, CNVR7077.16@TBC1D3B_13, TBC1D3B_12, TBC1D3B_11, TBC1D3B_10, TBC1D3B_9, TBC1D3B_8, TBC1D3B_7, TBC1D3B_6, TBC1D3B_5@0@0@0@:TBC1 domain family, member 3B@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_33@155584@155590@deletion@7@44380005@44409347@17@chr17:44380005-44409347@22.1@222@72@0.324@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A_3, LRRC37A_4, LRRC37A_5, LRRC37A_6, LRRC37A_7, LRRC37A_8, LRRC37A_9@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
A2463_33@155592@155600@deletion@9@44412912@44594799@17@chr17:44412912-44594799@47.7@244@3@0.0123@CNVR7114.2, CNVR7114.1@LRRC37A_11, LRRC37A_12, LRRC37A_13, LRRC37A_14, ARL17B_4, ARL17B_3, ARL17B_2, LRRC37A2_2, LRRC37A2_3@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
A2463_33@155606@155608@deletion@3@44623622@44627885@17@chr17:44623622-44627885@8.05@603@418@0.693@CNVR7114.2, CNVR7114.5, CNVR7114.4, CNVR7114.6@LRRC37A2_9, LRRC37A2_10, LRRC37A2_11@0@0@0@:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
A2463_33@160150@160153@duplication@4@47391@49557@18@chr18:47391-49557@11.4@337@541@1.61@CNVR7228.2@RP11-683L23.1_4, RP11-683L23.1_3, RP11-683L23.1_2, RP11-683L23.1_1@0@0@0@@:GTPase activity;protein complex;GTP catabolic process;cytoplasm;microtubule cytoskeleton;protein polymerization;microtubule-based movement;structural molecule activity;microtubule;GTP binding;plasma membrane@NA
A2463_33@162017@162017@deletion@1@44542732@44544371@18@chr18:44542732-44544371@8.39@122@45@0.369@CNVR7319.1@TCEB3CL2_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_33@162017@162018@duplication@1@44542732@44550298@18@chr18:44542732-44550298@-5.1@253@331@1.31@CNVR7319.1, CNVR7319.2@TCEB3CL2_1, TCEB3CL_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2:transcription elongation factor B polypeptide 3C-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_33@162017@162019@deletion@1@44542732@44556213@18@chr18:44542732-44556213@44.9@1360@489@0.36@CNVR7319.1, CNVR7319.2@TCEB3CL2_1, TCEB3CL_1, TCEB3C_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2:transcription elongation factor B polypeptide 3C-like:transcription elongation factor B polypeptide 3C (elongin A3);RNA polymerase II transcription factor SIII subunit A3-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_33@164951@164955@deletion@5@7032325@7051633@19@chr19:7032325-7051633@9.1@98@37@0.378@CNVR7517.1@MBD3L5_2, MBD3L4_2, MBD3L4_1, MBD3L2_1, MBD3L2_2@0@0@0@:methyl-CpG binding domain protein 3-like 5:methyl-CpG binding domain protein 3-like 4:methyl-CpG-binding domain protein 3-like 2-like;methyl-CpG binding domain protein 3-like 2@:regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_33@170096@170100@deletion@5@40373946@40382826@19@chr19:40373946-40382826@23@254@93@0.366@CNVR7639.2@FCGBP_26, FCGBP_25, FCGBP_24, FCGBP_23, FCGBP_22@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_33@170107@170108@duplication@2@40395805@40398510@19@chr19:40395805-40398510@5.97@123@200@1.63@CNVR7639.2, CNVR7639.3@FCGBP_15, FCGBP_14@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_33@173459@173477@duplication@19@55246721@55295265@19@chr19:55246721-55295265@22.4@471@732@1.55@CNVR7725.2, CNVR7725.1@KIR3DL3_6, KIR3DL3_7, KIR3DL3_8, KIR2DL3_1, KIR2DL3_2, KIR2DL3_3, KIR2DL3_4, KIR2DL3_5, KIR2DL3_6, KIR2DL3_7, KIR2DL3_8, KIR2DL1_1, KIR2DL1_2, KIR2DL1_3, KIR2DL1_4, KIR2DL1_5, KIR2DL1_6, KIR2DL1_7, KIR2DL1_8@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:integral to membrane;plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane@NA
A2463_33@173842@173844@deletion@3@56273168@56283456@19@chr19:56273168-56283456@7.92@368@256@0.696@CNVR7734.1@RFPL4A_2, RFPL4A_3, CTD-2611O12.2_2@0@0@0@:ret finger protein-like 4A;ret finger protein-like 4A-like:ret finger protein-like 4A-like@:protein binding;zinc ion binding:protein binding;zinc ion binding@NA
A2463_33@174395@174395@duplication@1@1569207@1569278@20@chr20:1569207-1569278@4.44@7@39@5.57@CNVR7763.1@RP4-576H24.4_1@0@0@0@:signal-regulatory protein beta 1;signal-regulatory protein beta-1-like;signal-regulatory protein beta-1 isoform 3-like@:protein binding:protein binding;signal transduction;integral to membrane;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway@NA
A2463_33@175736@175737@deletion@2@26061801@26063616@20@chr20:26061801-26063616@15.4@76@2@0.0263@CNVR7823.4, CNVR7823.3, CNVR7823.5, CNVR7823.1@FAM182A_4, FAM182A_5@0@0@0@NA@NA@NA
A2463_33@178216@178216@deletion@1@57484577@57484634@20@chr20:57484577-57484634@4.69@115@58@0.504@NA@GNAS_9@0@0@0@:GNAS complex locus@:adenylate cyclase-activating dopamine receptor signaling pathway;protein secretion;intracellular transport;energy reserve metabolic process;transmembrane transport;embryonic hindlimb morphogenesis;intrinsic to membrane;adenylate cyclase activity;cAMP biosynthetic process;plasma membrane;water transport;dendrite;skin development;post-embryonic development;sensory perception of smell;cellular response to catecholamine stimulus;GTPase activity;GTP catabolic process;signal transducer activity;heterotrimeric G-protein complex;cytosol;genetic imprinting;embryonic cranial skeleton morphogenesis;regulation of insulin secretion;multicellular organism growth;ionotropic glutamate receptor binding;membrane;cellular response to glucagon stimulus;skeletal system development;mu-type opioid receptor binding;adenylate cyclase-activating G-protein coupled receptor signaling pathway;activation of adenylate cyclase activity;post-embryonic body morphogenesis;response to drug;guanyl nucleotide binding;blood coagulation;tissue homeostasis;extrinsic to internal side of plasma membrane;GTP binding;DNA methylation;cellular response to prostaglandin E stimulus;sensory perception of chemical stimulus;small molecule metabolic process;endochondral ossification;positive regulation of osteoclast differentiation;transport vesicle;G-protein coupled receptor signaling pathway;behavior;cytoplasm;G-protein beta/gamma-subunit complex binding;protein binding;signal transduction;female pregnancy;extracellular region;positive regulation of osteoblast differentiation;molecular_function;cartilage development;trans-Golgi network membrane;ruffle;metal ion binding@: PITUITARY ADENOMA, GROWTH HORMONE-SECRETING; OSSEOUS HETEROPLASIA, PROGRESSIVE; POH; PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A; MCCUNE-ALBRIGHT SYNDROME; MAS; PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C; COLORECTAL CANCER; CRC; GNAS COMPLEX LOCUS; GNAS; PSEUDOHYPOPARATHYROIDISM, TYPE IB; PHP1B; ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH
A2463_33@179011@179021@deletion@11@14982551@15013887@21@chr21:14982551-15013887@20.7@118@15@0.127@CNVR7952.1@POTED_1, POTED_2, POTED_3, POTED_4, POTED_5, POTED_6, POTED_7, POTED_8, POTED_9, POTED_10, POTED_11@0@0@0@:POTE ankyrin domain family, member B;POTE ankyrin domain family, member C;POTE ankyrin domain family, member D@:protein binding;plasma membrane@NA
A2463_33@180976@180977@deletion@2@16287255@16449804@22@chr22:16287255-16449804@13@348@171@0.491@CNVR8071.2, CNVR8071.3@POTEH_1, OR11H1_1@0@0@0@:POTE ankyrin domain family, member H:olfactory receptor, family 11, subfamily H, member 1;olfactory receptor, family 11, subfamily H, member 2@:protein binding:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_33@181134@181134@duplication@1@18834446@18835833@22@chr22:18834446-18835833@5.48@102@183@1.79@CNVR8087.2, CNVR8087.7, CNVR8087.12, CNVR8087.10@AC008132.13_1@0@0@0@NA@NA@NA
A2463_33@181417@181422@deletion@6@20366369@20461301@22@chr22:20366369-20461301@12.8@629@347@0.552@CNVR8094.9, CNVR8094.4, CNVR8094.10@GGTLC3_5, GGTLC3_4, GGTLC3_3, GGTLC3_2, GGTLC3_1, RIMBP3_1@0@0@0@:RIMS binding protein 3@:leukotriene biosynthetic process;glutathione metabolic process;gamma-glutamyltransferase activity;anchored to external side of plasma membrane:protein binding@NA
A2463_33@181623@181631@deletion@9@21562428@21570956@22@chr22:21562428-21570956@15.3@107@26@0.243@CNVR8100.4, CNVR8100.10, CNVR8100.7@GGT2_15, GGT2_14, GGT2_13, GGT2_12, GGT2_11, GGT2_10, GGT2_9, GGT2_8, GGT2_7@0@0@0@:gamma-glutamyltransferase 2;gamma-glutamyltranspeptidase 2-like@:hydrolase activity;small molecule metabolic process;leukotriene biosynthetic process;anchored to external side of plasma membrane;glutathione biosynthetic process;xenobiotic metabolic process;integral to membrane;glutathione metabolic process;plasma membrane;gamma-glutamyltransferase activity;cellular_component@NA
A2463_33@181764@181766@deletion@3@22985271@22989351@22@chr22:22985271-22989351@7.48@274@155@0.566@CNVR8103.5, CNVR8103.2, CNVR8103.13, CNVR8103.14@POM121L1P_1, GGTLC2_1, GGTLC2_2@0@0@0@:putative POM121-like protein 1-like:gamma-glutamyltransferase light chain 2@:leukotriene biosynthetic process;glutathione metabolic process;gamma-glutamyltransferase activity;anchored to external side of plasma membrane@NA
A2463_33@181807@181808@deletion@2@23247056@23248831@22@chr22:23247056-23248831@5.21@116@62@0.534@CNVR8103.2, CNVR8103.1, CNVR8103.6, CNVR8103.11@IGLJ3_1, IGLC3_1@0@0@0@@:protein binding@NA
A2463_16@6@7@deletion@2@69092@139309@1@chr1:69092-139309@22.5@642@376@0.586@CNVR1.2@OR4F5_1, AL627309.1_1@0@0@0@:olfactory receptor, family 4, subfamily F, member 5@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_16@1817@1818@duplication@2@12941676@12943215@1@chr1:12941676-12943215@5.3@323@439@1.36@CNVR72.3, CNVR72.4, CNVR72.12, CNVR72.13@PRAMEF4_3, PRAMEF4_2@0@0@0@:PRAME family member 4@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_16@1825@1830@deletion@6@12998506@13038381@1@chr1:12998506-13038381@11.1@152@71@0.467@CNVR72.3, CNVR72.4, CNVR72.9@PRAMEF6_4, PRAMEF6_3, PRAMEF6_2, PRAMEF22_1, PRAMEF22_2, PRAMEF22_3@0@0@0@:PRAME family member 6;PRAME family member 23;PRAME family member 9/15-like;PRAME family member 5:PRAME family member 22@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_16@1835@1838@duplication@4@13330415@13366425@1@chr1:13330415-13366425@8.62@39@102@2.62@CNVR74.8, CNVR74.4@PRAMEF3_2, PRAMEF3_1, PRAMEF5_2, PRAMEF5_3@0@0@0@:PRAME family member 3:PRAME family member 5@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_16@2182@2184@deletion@3@17266390@17272101@1@chr1:17266390-17272101@6.17@147@85@0.578@CNVR94.4, CNVR94.5@CROCC_13, CROCC_14, CROCC_15@0@0@0@:ciliary rootlet coiled-coil, rootletin@:centriole;centrosome organization;centrosome;kinesin binding;actin cytoskeleton;cytoplasm;protein binding;vesicle-mediated transport;structural molecule activity;ciliary rootlet;protein localization;plasma membrane;cell cycle;cell projection organization;membrane@NA
A2463_16@3194@3197@duplication@4@24287949@24298502@1@chr1:24287949-24298502@9.4@56@128@2.29@NA@PNRC2_3, SRSF10_6, SRSF10_5, SRSF10_4@0@0@0@:proline-rich nuclear receptor coactivator 2;proline-rich nuclear receptor coactivator 2-like:serine/arginine-rich splicing factor 10-like;serine/arginine-rich splicing factor 10@:protein binding;deadenylation-independent decapping of nuclear-transcribed mRNA;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;nucleus;regulation of transcription, DNA-dependent;transcription, DNA-dependent;cytoplasmic mRNA processing body:nucleoplasm;RNA splicing, via transesterification reactions;nuclear speck;RS domain binding;RNA binding;nucleus;mRNA splice site selection;unfolded protein binding;assembly of spliceosomal tri-snRNP;negative regulation of mRNA splicing, via spliceosome;regulation of transcription, DNA-dependent;nucleotide binding;cytoplasm;mRNA export from nucleus;protein binding;cytoplasmic transport;mRNA splicing, via spliceosome;nucleic acid binding@NA
A2463_16@3333@3342@deletion@10@25599040@25655415@1@chr1:25599040-25655415@151@783@51@0.0651@CNVR116.1, CNVR116.2@RHD_1, RHD_2, RHD_3, RHD_4, RHD_5, RHD_6, RHD_7, RHD_8, RHD_9, RHD_10@0@0@0@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
A2463_16@5149@5149@deletion@1@39987049@39987242@1@chr1:39987049-39987242@5.98@27@0@0@NA@BMP8A_4@0@0@0@:bone morphogenetic protein 8a@:cell differentiation;growth factor activity;extracellular space;growth;cytokine activity;cartilage development;ossification@NA
A2463_16@8507@8508@duplication@2@89476588@89477710@1@chr1:89476588-89477710@14.8@328@527@1.61@CNVR244.1@GBP3_8, GBP3_7@0@0@0@:guanylate binding protein 3@:defense response to virus;GTP binding;GTPase activity;membrane;cytoplasm@NA
A2463_16@9340@9358@duplication@19@104114226@104166843@1@chr1:104114226-104166843@225@2357@4932@2.09@CNVR266.8, CNVR266.3@AMY2B_3, AMY2B_4, AMY2B_5, AMY2B_6, AMY2B_7, AMY2B_8, AMY2B_9, AMY2B_10, AMY2B_11, AMY2B_12, AMY2A_1, AMY2A_2, AMY2A_3, AMY2A_4, AMY2A_5, AMY2A_6, AMY2A_7, AMY2A_8, AMY2A_9@0@0@0@:actin, gamma 1 pseudogene 4;amylase, alpha 2B (pancreatic):amylase, alpha 2A (pancreatic)@:extracellular region;cation binding;digestion;carbohydrate metabolic process;catalytic activity;alpha-amylase activity;metal ion binding:chloride ion binding;cation binding;small molecule metabolic process;carbohydrate metabolic process;catalytic activity;extracellular space;polysaccharide digestion;extracellular region;carbohydrate catabolic process;alpha-amylase activity;calcium ion binding@NA
A2463_16@9373@9374@deletion@2@104233917@104234232@1@chr1:104233917-104234232@16.8@80@2@0.025@CNVR266.3, CNVR266.5@AMY1B_8, AMY1B_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
A2463_16@9385@9386@duplication@2@104297122@104297436@1@chr1:104297122-104297436@43@342@870@2.54@CNVR266.3, CNVR266.5@AMY1C_6, AMY1C_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
A2463_16@9766@9773@duplication@8@110230497@110235917@1@chr1:110230497-110235917@44.8@193@533@2.76@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_1, GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
A2463_16@10793@10799@duplication@7@144339779@144816008@1@chr1:144339779-144816008@23.8@446@708@1.59@NA@AL592284.1_1, PPIAL4B_1, AL592284.1_2, NBPF9_1, NBPF9_2, NBPF9_3, NBPF9_4@0@0@0@:uncharacterized LOC730256;uncharacterized LOC101060698;uncharacterized LOC642441:peptidylprolyl isomerase A (cyclophilin A)-like 4C;peptidyl-prolyl cis-trans isomerase A-like 4A/B/C-like;peptidylprolyl isomerase A (cyclophilin A)-like 4B;peptidylprolyl isomerase A (cyclophilin A)-like 4A:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 24@:protein folding;peptidyl-prolyl cis-trans isomerase activity;cytoplasm@NA
A2463_16@10804@10805@duplication@2@144823814@144824756@1@chr1:144823814-144824756@6.53@76@135@1.78@CNVR338.2, CNVR338.5, CNVR338.1@NBPF9_9, NBPF9_10@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 24@NA@NA
A2463_16@10865@10865@duplication@1@145298156@145298366@1@chr1:145298156-145298366@5.45@210@307@1.46@CNVR341.2, CNVR341.3, CNVR341.4@NBPF10_5@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family, member 10@:protein binding;calcium ion binding@NA
A2463_16@11080@11080@deletion@1@145756418@145756613@1@chr1:145756418-145756613@5.66@27@1@0.037@NA@PDZK1_6@0@0@0@:PDZ domain containing 1@:PDZ domain binding;transport;transporter activity;cytoplasm;cell proliferation;protein binding;positive regulation of ion transmembrane transport;scavenger receptor binding;brush border membrane;establishment of protein localization to plasma membrane;carnitine transport;drug transport@NA
A2463_16@11127@11164@duplication@38@146215076@146253110@1@chr1:146215076-146253110@50.5@480@919@1.91@NA@NBPF12_38, NBPF12_37, NBPF12_36, NBPF12_35, NBPF12_34, NBPF12_33, NBPF12_32, NBPF12_31, NBPF12_30, NBPF12_29, NBPF12_28, NBPF12_27, NBPF12_26, NBPF12_25, NBPF12_24, NBPF12_23, NBPF12_22, NBPF12_21, NBPF12_20, NBPF12_19, NBPF12_18, NBPF12_17, NBPF12_16, NBPF12_15, NBPF12_14, NBPF12_13, NBPF12_12, NBPF12_11, NBPF12_10, NBPF12_9, NBPF12_8, NBPF12_7, NBPF12_6, NBPF12_5, NBPF12_4, NBPF12_3, NBPF12_2, NBPF12_1@0@0@0@:neuroblastoma breakpoint family member 21-like@NA@NA
A2463_16@11168@11184@deletion@17@146399556@146420191@1@chr1:146399556-146420191@40.7@481@202@0.42@NA@NBPF12_8, NBPF12_9, NBPF12_10, NBPF12_11, NBPF12_12, NBPF12_13, NBPF12_14, NBPF12_15, NBPF12_16, NBPF12_17, NBPF12_18, NBPF12_19, NBPF12_20, NBPF12_21, NBPF12_22, NBPF12_23, NBPF12_24@0@0@0@:neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family member 14-like;neuroblastoma breakpoint family, member 12@:cytoplasm@NA
A2463_16@11242@11242@deletion@1@146465879@146466121@1@chr1:146465879-146466121@4.7@147@87@0.592@CNVR344.2@NBPF12_82@0@0@0@:neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family member 14-like;neuroblastoma breakpoint family, member 12@:cytoplasm@NA
A2463_16@11336@11336@duplication@1@148004549@148004791@1@chr1:148004549-148004791@5.22@161@240@1.49@CNVR346.2, CNVR346.4@NBPF14_22@0@0@0@:neuroblastoma breakpoint family, member 14@:cytoplasm@NA
A2463_16@11341@11343@deletion@3@148008574@148010164@1@chr1:148008574-148010164@34.4@622@291@0.468@CNVR346.2, CNVR346.4@NBPF14_17, NBPF14_16, NBPF14_15@0@0@0@:neuroblastoma breakpoint family, member 14@:cytoplasm@NA
A2463_16@11345@11346@deletion@2@148011681@148012675@1@chr1:148011681-148012675@15.7@246@120@0.488@CNVR346.2, CNVR346.4@NBPF14_13, NBPF14_12@0@0@0@:neuroblastoma breakpoint family, member 14@:cytoplasm@NA
A2463_16@11351@11356@duplication@6@148016410@148024925@1@chr1:148016410-148024925@15.5@598@843@1.41@CNVR346.2, CNVR346.4@NBPF14_7, NBPF14_6, NBPF14_5, NBPF14_4, NBPF14_3, NBPF14_2@0@0@0@:neuroblastoma breakpoint family, member 14@:cytoplasm@NA
A2463_16@11508@11508@deletion@1@149762794@149763073@1@chr1:149762794-149763073@8.95@324@185@0.571@CNVR351.3, CNVR351.5@FCGR1A_6@0@0@0@:Fc fragment of IgG, high affinity Ib, receptor (CD64);Fc fragment of IgG, high affinity Ia, receptor (CD64):histone cluster 2, H2bf@:IgG receptor activity;phagocytosis, recognition;antibody-dependent cellular cytotoxicity;regulation of immune response;phagocytosis, engulfment;antigen processing and presentation of peptide antigen via MHC class I;immune response;clathrin-coated endocytic vesicle membrane;interferon-gamma-mediated signaling pathway;integral to membrane;Fc-gamma receptor signaling pathway;positive regulation of type III hypersensitivity;plasma membrane;receptor-mediated endocytosis;positive regulation of phagocytosis;cytokine-mediated signaling pathway;early endosome membrane;cell surface receptor signaling pathway;IgG binding;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;positive regulation of type IIa hypersensitivity;antigen processing and presentation of exogenous antigen;external side of plasma membrane;signal transduction;protein binding;defense response to bacterium;antigen processing and presentation of exogenous peptide antigen via MHC class I;receptor signaling protein activity;response to bacterium:sequence-specific DNA binding;intracellular;nucleus;protein heterodimerization activity;DNA binding;nucleosome assembly;nucleosome@NA
A2463_16@16029@16040@deletion@12@196744018@196801129@1@chr1:196744018-196801129@48@2054@1274@0.62@CNVR459.1@CFHR3_1, CFHR3_2, CFHR3_3, CFHR3_4, CFHR3_5, CFHR3_6, CFHR1_1, CFHR1_2, CFHR1_3, CFHR1_4, CFHR1_5, CFHR1_6@0@0@0@:complement factor H-related 3:complement factor H-related 1:complement factor H-related 2@:extracellular space:extracellular space;complement activation:extracellular region@NA
A2463_16@17278@17279@deletion@2@207700099@207700468@1@chr1:207700099-207700468@7.04@32@0@0@CNVR485.1@CR1_6, CR1_7@0@0@0@:complement component (3b/4b) receptor 1 (Knops blood group)@:complement component C4b receptor activity;complement activation, classical pathway;negative regulation of complement activation, alternative pathway;innate immune response;negative regulation of serine-type endopeptidase activity;complement component C3b binding;negative regulation of complement activation, classical pathway;plasma membrane;integral to plasma membrane;complement component C3b receptor activity;complement component C4b binding;cell surface;regulation of complement activation;positive regulation of serine-type endopeptidase activity@: MALARIA, SUSCEPTIBILITY TO; KNOPS BLOOD GROUP SYSTEM; KN
A2463_16@17286@17286@duplication@1@207718654@207718829@1@chr1:207718654-207718829@5.57@34@78@2.29@CNVR485.1@CR1_14@0@0@0@:complement component (3b/4b) receptor 1 (Knops blood group)@:complement component C4b receptor activity;complement activation, classical pathway;negative regulation of complement activation, alternative pathway;innate immune response;negative regulation of serine-type endopeptidase activity;complement component C3b binding;negative regulation of complement activation, classical pathway;plasma membrane;integral to plasma membrane;complement component C3b receptor activity;complement component C4b binding;cell surface;regulation of complement activation;positive regulation of serine-type endopeptidase activity@: MALARIA, SUSCEPTIBILITY TO; KNOPS BLOOD GROUP SYSTEM; KN
A2463_16@17294@17294@deletion@1@207737210@207737385@1@chr1:207737210-207737385@5.1@45@15@0.333@CNVR485.1, CNVR485.2@CR1_22@0@0@0@:complement component (3b/4b) receptor 1 (Knops blood group)@:complement component C4b receptor activity;complement activation, classical pathway;negative regulation of complement activation, alternative pathway;innate immune response;negative regulation of serine-type endopeptidase activity;complement component C3b binding;negative regulation of complement activation, classical pathway;plasma membrane;integral to plasma membrane;complement component C3b receptor activity;complement component C4b binding;cell surface;regulation of complement activation;positive regulation of serine-type endopeptidase activity@: MALARIA, SUSCEPTIBILITY TO; KNOPS BLOOD GROUP SYSTEM; KN
A2463_16@17624@17625@deletion@2@213003585@213009491@1@chr1:213003585-213009491@53.2@265@5@0.0189@CNVR498.1@C1orf227_3, C1orf227_2@0@0@0@:chromosome 1 open reading frame 227@NA@NA
A2463_16@18285@18285@deletion@1@226075487@226075732@1@chr1:226075487-226075732@7.02@116@56@0.483@NA@LEFTY1_2, RP4-559A3.7_6@0@0@0@:left-right determination factor 1@:growth factor activity;cell growth;transforming growth factor beta receptor signaling pathway;extracellular space;negative regulation of transcription from RNA polymerase II promoter;growth;transforming growth factor beta receptor binding;heart morphogenesis;cytokine activity;determination of left/right symmetry:oxidation-reduction process;oxidoreductase activity;proline biosynthetic process;pyrroline-5-carboxylate reductase activity;nucleotide binding@NA
A2463_16@19750@19750@duplication@1@248084321@248085258@1@chr1:248084321-248085258@4.61@82@134@1.63@NA@OR2T8_1@0@0@0@:olfactory receptor, family 2, subfamily T, member 8@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_16@24856@24863@deletion@8@88091510@88095367@2@chr2:88091510-88095367@8.21@38@1@0.0263@NA@RGPD2_17, RGPD2_16, RGPD2_15, RGPD2_14, RGPD2_13, RGPD2_12, RGPD2_11, RGPD2_10@0@0@0@:RANBP2-like and GRIP domain containing 2@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_16@25004@25007@deletion@4@90192949@90199190@2@chr2:90192949-90199190@9.66@360@226@0.628@CNVR867.10, CNVR867.5, CNVR867.3, CNVR867.9, CNVR867.15@IGKV1D-13_1, IGKV1D-13_2, IGKV1D-12_1, IGKV1D-12_2@0@0@0@@:protein binding:protein binding@NA
A2463_16@26412@26414@deletion@3@113127756@113138540@2@chr2:113127756-113138540@11.6@173@85@0.491@NA@RGPD8_23, RGPD8_22, RGPD8_21@0@0@0@:RANBP2-like and GRIP domain containing 8@:protein binding;intracellular;intracellular transport;nuclear pore;protein targeting to Golgi;Ran GTPase binding;biological_process@NA
A2463_16@27163@27166@duplication@4@130843388@130851081@2@chr2:130843388-130851081@7.9@87@158@1.82@NA@POTEF_13, POTEF_12, POTEF_11, POTEF_10@0@0@0@:POTE ankyrin domain family, member F@:cell cortex;protein binding;ATP binding@NA
A2463_16@27172@27172@duplication@1@130869569@130869674@2@chr2:130869569-130869674@4.66@57@101@1.77@NA@POTEF_4@0@0@0@:POTE ankyrin domain family, member F@:cell cortex;protein binding;ATP binding@NA
A2463_16@27995@27997@deletion@3@152461075@152464122@2@chr2:152461075-152464122@20.7@114@12@0.105@CNVR1026.1@NEB_85, NEB_84, NEB_83@0@0@0@:nebulin@:Z disc;muscle filament sliding;oxidation-reduction process;contractile fiber part;actin cytoskeleton;regulation of actin filament length;structural constituent of muscle;cytosol;actin binding;protein binding;myofibril;somatic muscle development;muscle organ development@: NEMALINE MYOPATHY 2; NEM2
A2463_16@39892@39894@deletion@3@75786030@75790887@3@chr3:75786030-75790887@12.8@238@122@0.513@CNVR1432.5, CNVR1432.9, CNVR1432.4@ZNF717_5, ZNF717_4, ZNF717_3@0@0@0@:zinc finger protein 717;zinc finger protein 717-like@:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_16@43974@43974@deletion@1@169587422@169587595@3@chr3:169587422-169587595@4.62@76@38@0.5@NA@LRRC31_1@0@0@0@:leucine rich repeat containing 31@:protein binding@NA
A2463_16@45433@45439@duplication@7@195447880@195477983@3@chr3:195447880-195477983@27.4@814@1234@1.52@CNVR1703.1, CNVR1703.2, CNVR1703.5@MUC20_1, MUC20_2, MUC20_3, MUC20_4, MUC4_25, MUC4_24, MUC4_23@0@0@0@:mucin 20, cell surface associated:mucin 4, cell surface associated@:microvillus membrane;apical plasma membrane;activation of MAPK activity;Golgi lumen;post-translational protein modification;protein binding;O-glycan processing;hepatocyte growth factor receptor signaling pathway;cellular protein metabolic process;extracellular region;protein homooligomerization;basal plasma membrane:ErbB-2 class receptor binding;Golgi lumen;cell-matrix adhesion;post-translational protein modification;extracellular matrix structural constituent;protein binding;O-glycan processing;cellular protein metabolic process;proteinaceous extracellular matrix;integral to plasma membrane;membrane;extracellular matrix constituent, lubricant activity;biological_process@NA
A2463_16@46667@46675@deletion@9@9174900@9237700@4@chr4:9174900-9237700@19.6@121@22@0.182@NA@FAM90A26P_4, FAM90A26P_5, FAM90A26P_6, FAM90A26P_7, USP17L13_1, USP17L10_1, USP17L11_1, USP17L12_1, USP17L13_2, USP17L15_1@0@0@0@:ubiquitin specific peptidase 17-like family member 10:ubiquitin specific peptidase 17-like family member 13:ubiquitin specific peptidase 17-like family member 11:ubiquitin specific peptidase 17-like family member 12:ubiquitin specific peptidase 17-like family member 15@:zinc ion binding;nucleic acid binding:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
A2463_16@48592@48595@deletion@4@70146220@70155470@4@chr4:70146220-70155470@12.1@575@365@0.635@CNVR1957.2, CNVR1957.1@UGT2B28_1, UGT2B28_2, UGT2B28_3, UGT2B28_4@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B28@:carbohydrate binding;transferase activity, transferring hexosyl groups;endoplasmic reticulum;glucuronosyltransferase activity;carbohydrate metabolic process;xenobiotic metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process@NA
A2463_16@53306@53311@duplication@6@741710@756259@5@chr5:741710-756259@17.8@178@331@1.86@CNVR2280.3@ZDHHC11B_7, ZDHHC11B_6, ZDHHC11B_5, ZDHHC11B_4, ZDHHC11B_3, ZDHHC11B_2@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
A2463_16@53318@53322@deletion@5@833889@847730@5@chr5:833889-847730@19.6@351@182@0.519@CNVR2280.3, CNVR2280.8@ZDHHC11_7, ZDHHC11_6, ZDHHC11_5, ZDHHC11_4, ZDHHC11_3@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
A2463_16@59488@59488@deletion@1@147553798@147553933@5@chr5:147553798-147553933@5.94@27@0@0@CNVR2637.2, CNVR2637.1@SPINK14_3@0@0@0@:serine peptidase inhibitor, Kazal type 14 (putative)@:serine-type endopeptidase inhibitor activity;protein binding;extracellular region@NA
A2463_16@60884@60885@deletion@2@175517374@175520277@5@chr5:175517374-175520277@11.4@81@18@0.222@NA@FAM153B_3, FAM153B_4@0@0@0@:uncharacterized LOC100507387;family with sequence similarity 153, member B@NA@NA
A2463_16@61641@61643@duplication@3@180376905@180420160@5@chr5:180376905-180420160@7.03@457@629@1.38@CNVR2719.1@BTNL8_8, BTNL3_1, BTNL3_2@0@0@0@:butyrophilin-like 8:butyrophilin-like 3@:protein binding;integral to membrane:protein binding;integral to membrane;molecular_function;cellular_component;biological_process@NA
A2463_16@63283@63283@deletion@1@31238851@31239125@6@chr6:31238851-31239125@6.88@154@82@0.532@CNVR2838.1@HLA-C_3@0@0@0@:major histocompatibility complex, class I, C@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;membrane@: PSORIASIS SUSCEPTIBILITY 1; PSORS1
A2463_16@63290@63290@duplication@1@31323945@31324219@6@chr6:31323945-31324219@6.79@127@209@1.65@CNVR2841.12, CNVR2841.14, CNVR2841.8@HLA-B_3@0@0@0@:major histocompatibility complex, class I, B@:MHC class I protein complex;regulation of immune response;regulation of interleukin-12 production;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;regulation of T cell anergy;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;receptor binding;early endosome membrane;virus-host interaction;regulation of interleukin-6 production;regulation of dendritic cell differentiation;phagocytic vesicle membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;MHC class I receptor activity;membrane@: SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO; SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1; SPDA1
A2463_16@63731@63733@deletion@3@31963733@31964377@6@chr6:31963733-31964377@31.5@578@273@0.472@CNVR2843.6, CNVR2843.3@C4A_26, C4A_27, C4A_28@0@0@0@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
A2463_16@63774@63776@duplication@3@31996471@31997115@6@chr6:31996471-31997115@6.95@426@579@1.36@CNVR2843.6, CNVR2843.5@C4B_26, C4B_27, C4B_28@0@0@0@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
A2463_16@63953@63957@duplication@5@32485517@32489951@6@chr6:32485517-32489951@19.5@154@312@2.03@CNVR2845.21, CNVR2845.25, CNVR2845.30@HLA-DRB5_6, HLA-DRB5_5, HLA-DRB5_4, HLA-DRB5_3, HLA-DRB5_2@0@0@0@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
A2463_16@63966@63969@duplication@4@32609088@32628026@6@chr6:32609088-32628026@18.5@572@856@1.5@CNVR2845.21, CNVR2845.25, CNVR2845.27, CNVR2845.22, CNVR2845.39, CNVR2845.20@HLA-DQA1_2, HLA-DQA1_3, HLA-DQA1_4, HLA-DQB1_6@0@0@0@:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@NA
A2463_16@64603@64603@deletion@1@35755645@35755787@6@chr6:35755645-35755787@7.25@256@149@0.582@CNVR2861.1@CLPSL1_3@0@0@0@:colipase-like 1@:extracellular region;enzyme activator activity;digestion;lipid catabolic process@NA
A2463_16@70816@70817@duplication@2@161054786@161056336@6@chr6:161054786-161056336@13.3@179@321@1.79@CNVR3133.1@LPA_9, LPA_8@0@0@0@:lipoprotein, Lp(a)@:blood circulation;endopeptidase inhibitor activity;catalytic activity;lipoprotein metabolic process;proteolysis;heparin binding;receptor-mediated endocytosis;fibronectin binding;small molecule metabolic process;apolipoprotein binding;lipid metabolic process;negative regulation of endopeptidase activity;extracellular region;plasma lipoprotein particle;lipid transport;serine-type endopeptidase activity@: APOLIPOPROTEIN(a); LPA
A2463_16@71010@71012@deletion@3@167587242@167592030@6@chr6:167587242-167592030@22.9@337@155@0.46@NA@TCP10L2_3, TCP10L2_4, TCP10L2_5@0@0@0@:t-complex 10;t-complex 10-like 2@NA@NA
A2463_16@71030@71032@duplication@3@167790035@167794824@6@chr6:167790035-167794824@25.8@119@326@2.74@NA@TCP10_5, TCP10_4, TCP10_3@0@0@0@:t-complex 10@:cytosol@NA
A2463_16@71744@71751@deletion@8@5939916@5951553@7@chr7:5939916-5951553@107@818@200@0.244@NA@CCZ1_2, CCZ1_3, CCZ1_4, CCZ1_5, CCZ1_6, CCZ1_7, CCZ1_8, CCZ1_9@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
A2463_16@71756@71776@duplication@21@5963467@6006747@7@chr7:5963467-6006747@35.6@781@1209@1.55@NA@CCZ1_14, CCZ1_15, RSPH10B_20, RSPH10B_19, RSPH10B_18, RSPH10B_17, RSPH10B_16, RSPH10B_15, RSPH10B_14, RSPH10B_13, RSPH10B_12, RSPH10B_11, RSPH10B_10, RSPH10B_9, RSPH10B_8, RSPH10B_7, RSPH10B_6, RSPH10B_5, RSPH10B_4, RSPH10B_3, RSPH10B_2@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae):radial spoke head 10 homolog B (Chlamydomonas)@:lysosomal membrane@NA
A2463_16@71922@71934@deletion@13@6797310@6821107@7@chr7:6797310-6821107@30@473@232@0.49@NA@RSPH10B2_2, RSPH10B2_3, RSPH10B2_4, RSPH10B2_5, RSPH10B2_6, RSPH10B2_7, RSPH10B2_8, RSPH10B2_9, RSPH10B2_10, RSPH10B2_11, RSPH10B2_12, RSPH10B2_13, RSPH10B2_14@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
A2463_16@71936@71942@deletion@7@6826510@6840706@7@chr7:6826510-6840706@42.2@213@13@0.061@NA@RSPH10B2_16, RSPH10B2_17, RSPH10B2_18, RSPH10B2_19, RSPH10B2_20, CCZ1B_15, CCZ1B_14@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
A2463_16@71948@71955@duplication@8@6854396@6865828@7@chr7:6854396-6865828@30.7@828@1280@1.55@NA@CCZ1B_8, CCZ1B_7, CCZ1B_6, CCZ1B_5, CCZ1B_4, CCZ1B_3, CCZ1B_2, CCZ1B_1@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
A2463_16@73242@73242@duplication@1@38279626@38279767@7@chr7:38279626-38279767@5.61@42@89@2.12@NA@TRGC2_4@0@0@0@@:protein binding@NA
A2463_16@73248@73248@deletion@1@38299690@38299831@7@chr7:38299690-38299831@5.88@71@30@0.423@CNVR3353.1@TRGC1_3@0@0@0@:TCR gamma alternate reading frame protein@:protein binding@NA
A2463_16@73260@73263@duplication@4@38388957@38393784@7@chr7:38388957-38393784@11@205@325@1.59@CNVR3354.3, CNVR3354.1@TRGV5_2, TRGV5_1, TRGV4_2, TRGV4_1@0@0@0@@:protein binding:protein binding@NA
A2463_16@74565@74566@duplication@2@74157789@74159280@7@chr7:74157789-74159280@5.6@150@224@1.49@NA@GTF2I_20, GTF2I_21@0@0@0@:general transcription factor IIi@:neuronal cell body;transcription initiation from RNA polymerase II promoter;mitogen-activated protein kinase binding;negative regulation of angiogenesis;DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;cytoplasm;transcription from RNA polymerase II promoter;protein binding;signal transduction;nucleus;cell projection;reduction of cytosolic calcium ion concentration@NA
A2463_16@74597@74598@deletion@2@74225431@74227349@7@chr7:74225431-74227349@10.3@53@4@0.0755@NA@GTF2IRD2_10, GTF2IRD2_9@0@0@0@:GTF2I repeat domain containing 2@:nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_16@74775@74776@deletion@2@76063356@76069658@7@chr7:76063356-76069658@5.17@93@50@0.538@CNVR3462.1@ZP3_5, ZP3_6@0@0@0@:zona pellucida glycoprotein 3 (sperm receptor)@:negative regulation of transcription, DNA-dependent;manganese ion transmembrane transporter activity;intracellular protein transport;proteinaceous extracellular matrix;plasma membrane;positive regulation of acrosome reaction;outer acrosomal membrane;protein kinase C signaling cascade;manganese ion transmembrane transport;intracellular signal transduction;humoral immune response mediated by circulating immunoglobulin;negative regulation of binding of sperm to zona pellucida;positive regulation of inflammatory response;endoplasmic reticulum;signal transducer activity;perinuclear region of cytoplasm;secretory granule;positive regulation of transcription, DNA-dependent;positive regulation of ovarian follicle development;positive regulation of interferon-gamma production;carbohydrate binding;manganese ion transport;positive regulation of antral ovarian follicle growth;extracellular matrix;positive regulation of leukocyte migration;positive regulation of humoral immune response;extracellular space;blastocyst formation;integral to membrane;store-operated calcium channel activity;oocyte development;multivesicular body;phosphatidylinositol-mediated signaling;acrosomal vesicle;positive regulation of protein kinase B signaling cascade;Golgi apparatus;positive regulation of calcium ion import;positive regulation of protein kinase activity;positive regulation of acrosomal vesicle exocytosis;positive regulation of interleukin-4 production;cytoplasm;protein binding;binding of sperm to zona pellucida;positive regulation of phosphatidylinositol biosynthetic process;extracellular region;positive regulation of T cell proliferation;acrosin binding;positive regulation of type IV hypersensitivity;egg coat formation@NA
A2463_16@76751@76753@deletion@3@102210283@102214371@7@chr7:102210283-102214371@15.9@363@190@0.523@CNVR3518.1@POLR2J3_2, POLR2J3_1, AC093668.1_3, AC093668.1_2@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
A2463_16@76765@76766@deletion@2@102235753@102236231@7@chr7:102235753-102236231@7.76@48@9@0.188@CNVR3518.1@RASA4_11, RASA4_10@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity@NA
A2463_16@76792@76793@duplication@2@102309363@102312048@7@chr7:102309363-102312048@15.6@60@180@3@CNVR3518.1@POLR2J2_2, POLR2J2_2, POLR2J2_1, POLR2J2_1@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
A2463_16@79312@79314@duplication@3@143955790@144016150@7@chr7:143955790-144016150@13.2@713@997@1.4@CNVR3598.4@OR2A7_1, CTAGE8_1, OR2A1_1@0@0@0@:Rho guanine nucleotide exchange factor (GEF) 35:olfactory receptor, family 2, subfamily A, member 7:CTAGE family, member 6, pseudogene;CTAGE family, member 15, pseudogene:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_16@79319@79325@duplication@7@144068255@144072768@7@chr7:144068255-144072768@7.86@294@411@1.4@CNVR3598.4, CNVR3598.5, CNVR3598.11@ARHGEF5_6, ARHGEF5_7, ARHGEF5_8, ARHGEF5_9, ARHGEF5_10, ARHGEF5_11, ARHGEF5_12@0@0@0@:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
A2463_16@80141@80141@deletion@1@116087@117024@8@chr8:116087-117024@8.3@38@0@0@CNVR3684.8, CNVR3684.5@OR4F21_1@0@0@0@:olfactory receptor, family 4, subfamily F, member 21@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_16@80397@80398@deletion@2@7686328@7694064@8@chr8:7686328-7694064@9.05@108@46@0.426@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@DEFB106A_2, DEFB104A_1@0@0@0@:defensin, beta 106B;defensin, beta 106A:defensin, beta 104A;defensin, beta 104B@:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium@NA
A2463_16@80410@80411@duplication@2@7807556@7808269@8@chr8:7807556-7808269@7.9@141@228@1.62@CNVR3772.4, CNVR3772.6, CNVR3772.10, CNVR3772.13@ZNF705B_4, ZNF705B_5@0@0@0@:zinc finger protein 705B@:intracellular;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_16@80565@80567@deletion@3@11994678@12043034@8@chr8:11994678-12043034@39.4@1339@564@0.421@CNVR3785.8, CNVR3785.5, CNVR3785.2, CNVR3785.3@USP17L2_1, FAM86B1_8, FAM86B1_7@0@0@0@:ubiquitin specific peptidase 17-like family member 1, pseudogene;ubiquitin specific peptidase 17-like family member 2;ubiquitin specific peptidase 17-like family member 4;ubiquitin specific peptidase 17-like family member 7;ubiquitin specific peptidase 17-like family member 8;ubiquitin specific peptidase 17-like family member 3:family with sequence similarity 86, member B2;family with sequence similarity 86, member B1@:protein deubiquitination;ubiquitin-specific protease activity;mitotic cell cycle G1/S transition checkpoint;nucleus;G2/M transition checkpoint;apoptotic process;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
A2463_16@80576@80579@deletion@4@12283399@12286623@8@chr8:12283399-12286623@12.5@109@37@0.339@CNVR3786.4, CNVR3786.16@FAM86B2_8, FAM86B2_7, FAM86B2_6, FAM86B2_5@0@0@0@:family with sequence similarity 86, member B2@NA@NA
A2463_16@83673@83673@deletion@1@86573700@86575726@8@chr8:86573700-86575726@12.9@357@184@0.515@CNVR3955.1@REXO1L1_1@0@0@0@:exonuclease GOR-like;REX1, RNA exonuclease 1 homolog (S. cerevisiae)-like 1@:intracellular;nucleus;exonuclease activity;nucleic acid binding;cytoplasm@NA
A2463_16@86646@86646@deletion@1@178817@178969@9@chr9:178817-178969@7.95@64@18@0.281@CNVR4135.1@CBWD1_1@0@0@0@:COBW domain containing 1;COBW domain-containing protein 1-like;COBW domain containing 5@:ATP binding@NA
A2463_16@88490@88495@deletion@6@39073888@39088644@9@chr9:39073888-39088644@31.2@568@291@0.512@NA@CNTNAP3_24, CNTNAP3_23, CNTNAP3_22, CNTNAP3_21, CNTNAP3_20, CNTNAP3_19@0@0@0@:contactin associated protein-like 3@:binding;signal transduction;protein binding;integral to membrane;extracellular region;cell adhesion;plasma membrane;cell recognition;receptor binding@NA
A2463_16@88528@88529@deletion@2@40702653@40716325@9@chr9:40702653-40716325@5.92@895@634@0.708@NA@SPATA31A3_4, FAM74A3_1@0@0@0@:SPATA31 subfamily A, member 3@:integral to membrane@NA
A2463_16@88534@88534@deletion@1@41306194@41306209@9@chr9:41306194-41306209@11.8@54@0@0@CNVR4278.2@FAM74A2_2@0@0@0@@:integral to membrane@NA
A2463_16@88544@88545@deletion@2@42368416@42372039@9@chr9:42368416-42372039@12.3@121@40@0.331@NA@ANKRD20A2_1, ANKRD20A2_2@0@0@0@:ankyrin repeat domain 20 family, member A2@:protein binding@NA
A2463_16@88585@88585@deletion@1@43628635@43628694@9@chr9:43628635-43628694@4.97@34@8@0.235@NA@SPATA31A6_3@0@0@0@:SPATA31 subfamily A, member 6@:integral to membrane@NA
A2463_16@88593@88601@duplication@9@43816638@43876145@9@chr9:43816638-43876145@27.8@668@1022@1.53@NA@CNTNAP3B_6, CNTNAP3B_7, CNTNAP3B_8, CNTNAP3B_9, CNTNAP3B_10, CNTNAP3B_11, CNTNAP3B_12, CNTNAP3B_13, CNTNAP3B_14@0@0@0@:contactin associated protein-like 3B;contactin associated protein-like 3@:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
A2463_16@88620@88624@deletion@5@45727245@46390900@9@chr9:45727245-46390900@35.7@202@24@0.119@NA@FAM27A_1, AL953889.1_2, AL953889.1_1, FAM27A_2, FAM27E2_1, FAM27E1_1, FAM27D1_1@0@0@0@:family with sequence similarity 27, member E3:protein FAM27E2-like;protein FAM27D1-like@NA@NA
A2463_16@88631@88633@deletion@3@65503517@65508193@9@chr9:65503517-65508193@37.1@287@69@0.24@CNVR4312.5@SPATA31A7_4, SPATA31A7_3, SPATA31A7_2@0@0@0@:SPATA31 subfamily A, member 7@:integral to membrane@NA
A2463_16@88639@88643@duplication@5@67926874@67936012@9@chr9:67926874-67936012@18@118@259@2.19@NA@ANKRD20A1_1, ANKRD20A1_2, ANKRD20A1_3, ANKRD20A1_4, ANKRD20A1_5@0@0@0@:ankyrin repeat domain 20 family, member A1@:protein binding;plasma membrane@NA
A2463_16@88651@88652@duplication@2@67965006@67966773@9@chr9:67965006-67966773@5.62@39@83@2.13@NA@ANKRD20A1_13, ANKRD20A1_14@0@0@0@:ankyrin repeat domain 20 family, member A1@:protein binding;plasma membrane@NA
A2463_16@88655@88656@duplication@2@67984834@67985922@9@chr9:67984834-67985922@16.5@236@418@1.77@CNVR4321.1@RP11-195B21.3_4, RP11-195B21.3_5@0@0@0@:coiled-coil domain-containing protein 29-like;uncharacterized LOC644249@NA@NA
A2463_16@88661@88664@deletion@4@69206735@69229668@9@chr9:69206735-69229668@12.5@318@181@0.569@NA@CBWD6_13, CBWD6_12, CBWD6_11, CBWD6_10@0@0@0@:COBW domain containing 6@:ATP binding@NA
A2463_16@88669@88670@deletion@2@69247523@69253282@9@chr9:69247523-69253282@26.3@158@23@0.146@NA@CBWD6_5, BX255923.1_1@0@0@0@:COBW domain containing 6@:ATP binding@NA
A2463_16@88676@88690@deletion@15@69382094@69424176@9@chr9:69382094-69424176@68.6@967@418@0.432@NA@ANKRD20A4_1, ANKRD20A4_2, ANKRD20A4_3, ANKRD20A4_4, ANKRD20A4_5, ANKRD20A4_6, ANKRD20A4_7, ANKRD20A4_8, ANKRD20A4_9, ANKRD20A4_10, ANKRD20A4_11, ANKRD20A4_12, ANKRD20A4_13, ANKRD20A4_14, ANKRD20A4_15@0@0@0@:ankyrin repeat domain 20 family, member A4@:protein binding@NA
A2463_16@88720@88723@duplication@4@70889799@70912733@9@chr9:70889799-70912733@14.5@159@295@1.86@NA@CBWD3_10, CBWD3_11, CBWD3_12, CBWD3_13@0@0@0@:COBW domain-containing protein 5-like;COBW domain-containing protein 1-like;COBW domain containing 3@:ATP binding@NA
A2463_16@95350@95355@duplication@6@17865074@17891768@10@chr10:17865074-17891768@9.84@202@313@1.55@NA@MRC1L1_2, MRC1L1_3, MRC1L1_4, MRC1L1_5, MRC1L1_6, MRC1L1_7@0@0@0@:macrophage mannose receptor 1-like@:carbohydrate binding@NA
A2463_16@95377@95393@deletion@17@17951323@18152611@10@chr10:17951323-18152611@30.3@181@31@0.171@NA@MRC1L1_29, MRC1L1_30, TMEM236_1, TMEM236_2, TMEM236_3, TMEM236_4, MRC1_1, MRC1_2, MRC1_3, MRC1_4, MRC1_5, MRC1_6, MRC1_7, MRC1_8, MRC1_9, MRC1_10, MRC1_11@0@0@0@:macrophage mannose receptor 1-like:transmembrane protein 236;transmembrane protein 236-like:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding:integral to membrane:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
A2463_16@96439@96439@duplication@1@46254764@46254849@10@chr10:46254764-46254849@4.77@58@104@1.79@NA@FAM21C_17@0@0@0@:family with sequence similarity 21, member C@:endosome;protein binding;plasma membrane;retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_16@96454@96458@duplication@5@46312644@46329564@10@chr10:46312644-46329564@12@171@301@1.76@NA@FAM25E_1, AGAP4_7, AGAP4_6, AGAP4_5, AGAP4_4@0@0@0@:ArfGAP with GTPase domain, ankyrin repeat and PH domain 4;arf-GAP with GTPase, ANK repeat and PH domain-containing protein 5-like@:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity@NA
A2463_16@96468@96470@duplication@3@46605764@46611811@10@chr10:46605764-46611811@7.48@33@88@2.67@CNVR4712.3@PTPN20A_4, PTPN20A_3, PTPN20A_2@0@0@0@:protein tyrosine phosphatase, non-receptor type 20B;protein tyrosine phosphatase, non-receptor type 20A@:phosphatase activity;protein tyrosine phosphatase activity;microtubule;nucleus;dephosphorylation;protein dephosphorylation;microtubule organizing center@NA
A2463_16@96536@96563@deletion@28@47894573@47948853@10@chr10:47894573-47948853@120@610@38@0.0623@CNVR4715.2@FAM21B_2, FAM21B_3, FAM21B_4, FAM21B_5, FAM21B_6, FAM21B_7, FAM21B_8, FAM21B_9, FAM21B_10, FAM21B_11, FAM21B_12, FAM21B_13, FAM21B_14, FAM21B_15, FAM21B_16, FAM21B_17, FAM21B_18, FAM21B_19, FAM21B_20, FAM21B_21, FAM21B_22, FAM21B_23, FAM21B_24, FAM21B_25, FAM21B_26, FAM21B_27, FAM21B_28, FAM21B_29@0@0@0@:family with sequence similarity 21, member B@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_16@96620@96620@duplication@1@48771316@48771405@10@chr10:48771316-48771405@11.9@58@159@2.74@CNVR4716.10, CNVR4716.3@PTPN20B_6@0@0@0@:protein tyrosine phosphatase, non-receptor type 20B;protein tyrosine phosphatase, non-receptor type 20A@:phosphatase activity;protein tyrosine phosphatase activity;microtubule;nucleus;dephosphorylation;protein dephosphorylation;microtubule organizing center@NA
A2463_16@96631@96633@deletion@3@49376639@49381136@10@chr10:49376639-49381136@10.8@69@14@0.203@CNVR4717.2@FRMPD2_27, FRMPD2_26, FRMPD2_25@0@0@0@:FERM and PDZ domain containing 2@:basolateral plasma membrane;transferase activity, transferring phosphorus-containing groups;cytoplasm;tight junction;protein binding;cytoskeleton;1-phosphatidylinositol binding;tight junction assembly@NA
A2463_16@96849@96858@deletion@10@51243389@51466627@10@chr10:51243389-51466627@19.2@668@396@0.593@NA@AGAP8_2, AGAP8_1, TIMM23B_1, TIMM23B_2, TIMM23B_3, TIMM23B_4, TIMM23B_5, TIMM23B_6, AGAP7_7, AGAP7_6@0@0@0@:ArfGAP with GTPase domain, ankyrin repeat and PH domain 8:translocase of inner mitochondrial membrane 23 homolog B (yeast):ArfGAP with GTPase domain, ankyrin repeat and PH domain 7@:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity@NA
A2463_16@96898@96907@duplication@10@51843833@51855538@10@chr10:51843833-51855538@14.3@138@259@1.88@NA@FAM21A_6, FAM21A_7, FAM21A_8, FAM21A_9, FAM21A_10, FAM21A_11, FAM21A_12, FAM21A_13, FAM21A_14, FAM21A_15@0@0@0@:family with sequence similarity 21, member B;family with sequence similarity 21, member A@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_16@96910@96922@duplication@13@51863803@51890838@10@chr10:51863803-51890838@29.9@477@795@1.67@CNVR4734.2@FAM21A_18, FAM21A_19, FAM21A_20, FAM21A_21, FAM21A_22, FAM21A_23, FAM21A_24, FAM21A_25, FAM21A_26, FAM21A_27, FAM21A_28, FAM21A_29, FAM21A_30@0@0@0@:family with sequence similarity 21, member B;family with sequence similarity 21, member A@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_16@96932@96937@deletion@6@51965743@51978390@10@chr10:51965743-51978390@13.2@97@27@0.278@NA@ASAH2_12, ASAH2_11, ASAH2_10, ASAH2_9, ASAH2_8, ASAH2_7@0@0@0@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
A2463_16@98351@98357@deletion@7@81601498@81610362@10@chr10:81601498-81610362@28@131@1@0.00763@NA@FAM22E_1, FAM22E_2, FAM22E_3, FAM22E_4, FAM22E_5, FAM22E_6, FAM22E_7@0@0@0@NA@NA@NA
A2463_16@98595@98596@deletion@2@88985589@88988719@10@chr10:88985589-88988719@5.2@78@39@0.5@CNVR4840.3, CNVR4840.5@FAM22A_1, FAM22A_2@0@0@0@:family with sequence similarity 22, member A@NA@NA
A2463_16@98603@98606@duplication@4@89120239@89124960@10@chr10:89120239-89124960@11.2@71@160@2.25@CNVR4840.3@FAM22D_2, FAM22D_3, FAM22D_4, FAM22D_5@0@0@0@:family with sequence similarity 22, member D@NA@NA
A2463_16@102313@102335@duplication@23@135340901@135379033@10@chr10:135340901-135379033@45.3@1137@1684@1.48@CNVR4989.7, CNVR4989.11, CNVR4989.4@CYP2E1_3, AL161645.2_2, CYP2E1_4, AL161645.2_1, CYP2E1_5, CYP2E1_6, CYP2E1_7, CYP2E1_8, CYP2E1_9, CYP2E1_10, CYP2E1_11, SYCE1_13, SYCE1_12, SYCE1_11, SYCE1_10, SYCE1_9, SYCE1_8, SYCE1_7, SYCE1_6, SYCE1_5, SYCE1_4, SYCE1_3, SYCE1_2, SYCE1_1@0@0@0@:shadow of prion protein homolog (zebrafish):cytochrome P450, family 2, subfamily E, polypeptide 1:synaptonemal complex central element protein 1@:plasma membrane;membrane;anchored to membrane:steroid metabolic process;oxidation-reduction process;mitochondrion;response to drug;oxygen binding;Golgi membrane;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;response to organic nitrogen;oxidoreductase activity;endoplasmic reticulum membrane;heterocycle metabolic process;monoterpenoid metabolic process;response to ethanol;electron carrier activity;drug metabolic process;intracellular membrane-bounded organelle;small molecule metabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;endoplasmic reticulum;enzyme binding;heme binding;response to ozone;intrinsic to endoplasmic reticulum membrane;xenobiotic metabolic process;monooxygenase activity;triglyceride metabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NADH or NADPH as one donor, and incorporation of one atom of oxygen;iron ion binding:protein binding;synaptonemal complex;meiotic prophase I;cell division;central element@NA
A2463_16@102313@102336@deletion@1@135340901@135439108@10@chr10:135340901-135439108@-171@1212@1717@1.42@CNVR4989.7, CNVR4989.11, CNVR4989.4@CYP2E1_3, AL161645.2_2, CYP2E1_4, AL161645.2_1, CYP2E1_5, CYP2E1_6, CYP2E1_7, CYP2E1_8, CYP2E1_9, CYP2E1_10, CYP2E1_11, SYCE1_13, SYCE1_12, SYCE1_11, SYCE1_10, SYCE1_9, SYCE1_8, SYCE1_7, SYCE1_6, SYCE1_5, SYCE1_4, SYCE1_3, SYCE1_2, SYCE1_1, FRG2B_4@0@0@0@:shadow of prion protein homolog (zebrafish):cytochrome P450, family 2, subfamily E, polypeptide 1:synaptonemal complex central element protein 1:FSHD region gene 2 family, member B@:plasma membrane;membrane;anchored to membrane:steroid metabolic process;oxidation-reduction process;mitochondrion;response to drug;oxygen binding;Golgi membrane;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;response to organic nitrogen;oxidoreductase activity;endoplasmic reticulum membrane;heterocycle metabolic process;monoterpenoid metabolic process;response to ethanol;electron carrier activity;drug metabolic process;intracellular membrane-bounded organelle;small molecule metabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;endoplasmic reticulum;enzyme binding;heme binding;response to ozone;intrinsic to endoplasmic reticulum membrane;xenobiotic metabolic process;monooxygenase activity;triglyceride metabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NADH or NADPH as one donor, and incorporation of one atom of oxygen;iron ion binding:protein binding;synaptonemal complex;meiotic prophase I;cell division;central element:nucleus@NA
A2463_16@103289@103290@duplication@2@5270599@5271034@11@chr11:5270599-5271034@14.4@67@190@2.84@NA@HBG1_2, HBG1_1@0@0@0@:hemoglobin, gamma A@:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex@NA
A2463_16@103292@103292@deletion@1@5275523@5275744@11@chr11:5275523-5275744@4.89@264@168@0.636@NA@HBG2_7@0@0@0@:hemoglobin, gamma G@:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex@: CYANOSIS, TRANSIENT NEONATAL; TNCY
A2463_16@103342@103342@deletion@1@5798891@5799864@11@chr11:5798891-5799864@43.6@223@1@0.00448@CNVR5049.1@OR52N5_1@0@0@0@:tripartite motif containing 5:olfactory receptor, family 52, subfamily N, member 5@:defense response to virus;Golgi apparatus;intracellular;protein trimerization;ligase activity;cytoplasm;protein binding;nucleus;protein homodimerization activity;identical protein binding;zinc ion binding;cytoplasmic mRNA processing body;protein ubiquitination;virus-host interaction:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_16@104933@104933@deletion@1@32125912@32126018@11@chr11:32125912-32126018@4.54@74@37@0.5@NA@RCN1_6@0@0@0@:uncharacterized LOC440034;reticulocalbin 1, EF-hand calcium binding domain@:protein binding;endoplasmic reticulum;in utero embryonic development;endoplasmic reticulum lumen;calcium ion binding;camera-type eye development@NA
A2463_16@106046@106048@duplication@3@55370918@55419315@11@chr11:55370918-55419315@11.2@604@838@1.39@CNVR5179.1@OR4C11_1, OR4P4_1, OR4S2_1@0@0@0@:olfactory receptor, family 4, subfamily C, member 11:olfactory receptor, family 4, subfamily P, member 4:olfactory receptor, family 4, subfamily S, member 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_16@106572@106572@deletion@1@60971580@60971741@11@chr11:60971580-60971741@5.32@25@1@0.04@CNVR5194.1@PGA3_2@0@0@0@:pepsinogen 3, group I (pepsinogen A)@:proteolysis;extracellular region;digestion;aspartic-type endopeptidase activity@NA
A2463_16@114085@114085@deletion@1@7972079@7972179@12@chr12:7972079-7972179@10.7@115@41@0.357@NA@SLC2A14_14@0@0@0@:NECAP endocytosis associated 1:solute carrier family 2 (facilitated glucose transporter), member 14@:coated pit;protein binding;endocytosis;protein transport;clathrin vesicle coat;plasma membrane;membrane:multicellular organismal development;cell differentiation;substrate-specific transmembrane transporter activity;transport;folic acid binding;glucose transmembrane transporter activity;transmembrane transport;spermatogenesis;reduced folate carrier activity;integral to membrane;transmembrane transporter activity;membrane@NA
A2463_16@114098@114098@duplication@1@8077007@8077107@12@chr12:8077007-8077107@7.67@119@206@1.73@CNVR5421.1@SLC2A3_8@0@0@0@:NECAP endocytosis associated 1:solute carrier family 2 (facilitated glucose transporter), member 3@:coated pit;protein binding;endocytosis;protein transport;clathrin vesicle coat;plasma membrane;membrane:substrate-specific transmembrane transporter activity;transport;glucose transmembrane transporter activity;transmembrane transport;integral to membrane;transmembrane transporter activity;plasma membrane;hexose transport;glucose transport;small molecule metabolic process;folic acid binding;carbohydrate metabolic process;L-ascorbic acid metabolic process;reduced folate carrier activity;water-soluble vitamin metabolic process;vitamin metabolic process;membrane@NA
A2463_16@114135@114139@duplication@5@8329596@8377428@12@chr12:8329596-8377428@105@1704@4203@2.47@CNVR5422.3, CNVR5422.5, CNVR5422.7@ZNF705A_5, FAM90A1_7, FAM90A1_6, FAM90A1_5, FAM90A1_4@0@0@0@:zinc finger protein 705A;zinc finger protein 705E:family with sequence similarity 90, member A1@:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding:zinc ion binding;nucleic acid binding@NA
A2463_16@114483@114483@duplication@1@11243900@11244828@12@chr12:11243900-11244828@11@268@444@1.66@CNVR5434.1@TAS2R43_1@0@0@0@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):taste receptor, type 2, member 14:taste receptor, type 2, member 43@:extracellular space;visual perception:bitter taste receptor activity;taste receptor activity;integral to membrane;sensory perception of taste;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of bitter taste:G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;motile cilium;taste receptor activity;bitter taste receptor activity;integral to membrane;sensory perception of taste;detection of chemical stimulus involved in sensory perception of bitter taste;cilium membrane@NA
A2463_16@124100@124100@duplication@1@21742128@21742538@13@chr13:21742128-21742538@7.79@149@247@1.66@NA@SKA3_4@0@0@0@:spindle and kinetochore associated complex subunit 3@:spindle microtubule;chromosome segregation;cytoplasm;mitosis;protein binding;regulation of microtubule polymerization or depolymerization;cell division;condensed chromosome outer kinetochore@NA
A2463_16@127333@127333@deletion@1@19553418@19553937@14@chr14:19553418-19553937@4.83@523@353@0.675@CNVR6072.1@POTEG_1@0@0@0@:POTE ankyrin domain family, member G@:protein binding@NA
A2463_16@127336@127341@deletion@6@19561995@19574352@14@chr14:19561995-19574352@43@651@299@0.459@CNVR6072.1@POTEG_4, POTEG_5, POTEG_6, POTEG_7, POTEG_8, POTEG_9@0@0@0@:POTE ankyrin domain family, member G@:protein binding@NA
A2463_16@127348@127349@deletion@2@20010104@20011657@14@chr14:20010104-20011657@6.85@62@21@0.339@CNVR6072.6, CNVR6072.12@POTEM_5, POTEM_4@0@0@0@:POTE ankyrin domain family, member M@:protein binding@NA
A2463_16@127353@127358@deletion@6@20215588@20404761@14@chr14:20215588-20404761@27.8@2504@1670@0.667@CNVR6072.12, CNVR6072.4, CNVR6072.5@OR4Q3_1, OR4M1_1, OR4N2_1, OR4K2_1, OR4K5_1, OR4K1_1@0@0@0@:olfactory receptor, family 4, subfamily N, member 2:olfactory receptor, family 4, subfamily Q, member 3:olfactory receptor, family 4, subfamily M, member 1:olfactory receptor, family 4, subfamily K, member 2:olfactory receptor, family 4, subfamily K, member 5:olfactory receptor, family 4, subfamily K, member 1@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_16@131032@131034@duplication@3@74004127@74010359@14@chr14:74004127-74010359@29.8@342@657@1.92@CNVR6188.1, CNVR6188.4@ACOT1_1, ACOT1_2, ACOT1_3@0@0@0@:HEAT repeat containing 4:acyl-CoA thioesterase 1@:protein binding;binding:hydrolase activity;mitochondrion;acyl-CoA metabolic process;very long-chain fatty acid metabolic process;thiolester hydrolase activity;acyl-CoA hydrolase activity;cytosol;palmitoyl-CoA hydrolase activity;long-chain fatty acid metabolic process;carboxylesterase activity@NA
A2463_16@133432@133435@deletion@4@106539080@106552729@14@chr14:106539080-106552729@26.9@132@6@0.0455@CNVR6294.36, CNVR6294.48, CNVR6294.24, CNVR6294.10, CNVR6294.34@IGHV1-8_2, IGHV1-8_1, IGHV3-9_2, IGHV3-9_1@0@0@0@@:protein binding:protein binding@NA
A2463_16@133458@133462@deletion@5@106791006@106816026@14@chr14:106791006-106816026@19.4@360@191@0.531@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.53@IGHV3-30_2, IGHV3-30_1, IGHV4-31_2, IGHV4-31_1, IGHV3-33_2@0@0@0@@:protein binding:protein binding:protein binding@NA
A2463_16@133489@133489@duplication@1@107083241@107083557@14@chr14:107083241-107083557@4.9@108@169@1.56@CNVR6294.56, CNVR6294.16, CNVR6294.91@IGHV4-59_2@0@0@0@@:protein binding@NA
A2463_16@133491@133492@deletion@2@107095127@107095561@14@chr14:107095127-107095561@14.6@91@16@0.176@CNVR6294.56, CNVR6294.16, CNVR6294.91@IGHV4-61_2, IGHV4-61_1@0@0@0@@:protein binding@NA
A2463_16@133509@133514@duplication@6@20739498@20743964@15@chr15:20739498-20743964@21.3@420@717@1.71@CNVR6296.13@GOLGA6L6_8, GOLGA6L6_7, GOLGA6L6_6, GOLGA6L6_5, GOLGA6L6_4, GOLGA6L6_3@0@0@0@:putative transmembrane protein FLJ36131-like;putative transmembrane protein ENSP00000320207-like;golgin A6 family-like 6@NA@NA
A2463_16@133523@133528@duplication@6@21059387@21071610@15@chr15:21059387-21071610@10@91@174@1.91@NA@POTEB_6, POTEB_5, POTEB_4, POTEB_3, POTEB_2, POTEB_1@0@0@0@:POTE ankyrin domain family member B-like@:protein binding@NA
A2463_16@133541@133542@duplication@2@22368577@22383423@15@chr15:22368577-22383423@12.2@787@1111@1.41@CNVR6297.4, CNVR6297.17, CNVR6297.2@OR4M2_1, OR4N4_1@0@0@0@:olfactory receptor, family 4, subfamily M, member 2:olfactory receptor, family 4, subfamily N, member 4@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_16@133640@133642@deletion@3@23410831@23412276@15@chr15:23410831-23412276@7.61@127@65@0.512@CNVR6300.8@RP11-467N20.5_4, RP11-467N20.5_3, RP11-467N20.5_2@0@0@0@:putative golgin subfamily A member 6-like protein 6-like@NA@NA
A2463_16@133655@133658@duplication@4@23606369@23608916@15@chr15:23606369-23608916@11.5@132@240@1.82@CNVR6301.3@GOLGA8S_12, GOLGA8S_13, GOLGA8S_14, GOLGA8S_15@0@0@0@@:Golgi apparatus@NA
A2463_16@133869@133870@duplication@2@28629294@28629596@15@chr15:28629294-28629596@16@28@137@4.89@CNVR6329.4@GOLGA8F_9, GOLGA8F_10@0@0@0@@:Golgi apparatus@NA
A2463_16@133872@133875@deletion@4@28630272@28632839@15@chr15:28630272-28632839@6.79@156@88@0.564@CNVR6329.4@GOLGA8F_12, GOLGA8F_13, GOLGA8F_14, GOLGA8F_15@0@0@0@@:Golgi apparatus@NA
A2463_16@133979@133981@deletion@3@30381137@30382159@15@chr15:30381137-30382159@5.24@148@88@0.595@NA@GOLGA8J_10, GOLGA8J_11, GOLGA8J_12@0@0@0@:golgin A8 family, member J@:Golgi apparatus@NA
A2463_16@133996@134000@deletion@5@30431879@30434261@15@chr15:30431879-30434261@8.46@186@104@0.559@NA@GOLGA8T_8, GOLGA8T_9, GOLGA8T_10, GOLGA8T_11, GOLGA8T_12@0@0@0@:golgin A8 family, member J;golgin A8 family, member K@:Golgi apparatus@NA
A2463_16@134005@134006@deletion@2@30437163@30437510@15@chr15:30437163-30437510@6.98@77@32@0.416@NA@GOLGA8T_17, GOLGA8T_18@0@0@0@:golgin A8 family, member J;golgin A8 family, member K@:Golgi apparatus@NA
A2463_16@134010@134011@deletion@2@30663302@30664544@15@chr15:30663302-30664544@5.61@36@8@0.222@CNVR6337.1@CHRFAM7A_8, CHRFAM7A_7@0@0@0@:CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:transport;integral to membrane;ion transport;postsynaptic membrane;membrane;extracellular ligand-gated ion channel activity@NA
A2463_16@134036@134039@deletion@4@30845996@30848215@15@chr15:30845996-30848215@12.5@71@10@0.141@NA@GOLGA8Q_2, GOLGA8Q_3, GOLGA8Q_4, GOLGA8Q_5@0@0@0@@:Golgi apparatus@NA
A2463_16@134044@134054@deletion@11@30850148@30896376@15@chr15:30850148-30896376@26.6@148@18@0.122@CNVR6339.2, CNVR6339.3, CNVR6339.1@GOLGA8Q_10, GOLGA8Q_11, GOLGA8Q_12, GOLGA8Q_13, GOLGA8Q_14, GOLGA8Q_15, GOLGA8Q_16, GOLGA8Q_17, GOLGA8Q_18, GOLGA8Q_19, GOLGA8H_1@0@0@0@:golgin A8 family, member H@:Golgi apparatus:Golgi apparatus@NA
A2463_16@134180@134191@deletion@12@32737820@32743539@15@chr15:32737820-32743539@22.3@208@76@0.365@CNVR6346.1@GOLGA8O_17, GOLGA8O_16, GOLGA8O_15, GOLGA8O_14, GOLGA8O_13, GOLGA8O_12, GOLGA8O_11, GOLGA8O_10, GOLGA8O_9, GOLGA8O_8, GOLGA8O_7, GOLGA8O_6@0@0@0@:golgin A8 family, member O@:Golgi apparatus@NA
A2463_16@134204@134205@duplication@2@32890090@32890378@15@chr15:32890090-32890378@5.95@72@126@1.75@NA@GOLGA8N_7, GOLGA8N_8@0@0@0@:golgin A8 family, member R@:Golgi apparatus@NA
A2463_16@134457@134460@duplication@4@34823677@34825163@15@chr15:34823677-34825163@7.06@62@119@1.92@CNVR6351.3@GOLGA8B_15, GOLGA8B_14, GOLGA8B_13, GOLGA8B_12@0@0@0@:golgin A8 family, member A:golgin A8 family, member A;golgin A8 family, member B@:Golgi cisterna membrane;Golgi apparatus:Golgi cisterna membrane;Golgi apparatus@NA
A2463_16@135733@135733@deletion@1@43931842@43931996@15@chr15:43931842-43931996@7.55@205@113@0.551@CNVR6365.1@CATSPER2_6@0@0@0@:diphosphoinositol pentakisphosphate kinase 1:stereocilin:cation channel, sperm associated 2@:inositol hexakisphosphate 3-kinase activity;inositol hexakisphosphate 1-kinase activity;inositol metabolic process;diphosphoinositol-pentakisphosphate kinase activity;ATP binding;acid phosphatase activity;cytoplasm;cytosol;inositol hexakisphosphate 5-kinase activity;nucleus;kinase activity;inositol-1,3,4,5,6-pentakisphosphate kinase activity:detection of mechanical stimulus involved in sensory perception of sound;stereocilium bundle tip;stereocilium;cell surface;kinocilium;auditory receptor cell stereocilium organization:cell differentiation;CatSper complex;ion transport;transmembrane transport;voltage-gated ion channel activity;flagellar membrane;spermatogenesis;integral to membrane;multicellular organismal development;fertilization;sperm motility;ion channel activity;ciliary or flagellar motility;calcium channel activity;cilium;protein binding;microtubule-based flagellum;membrane@: DEAFNESS, AUTOSOMAL RECESSIVE 16; DFNB16; DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY: DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY
A2463_16@138281@138286@duplication@6@72953606@72956852@15@chr15:72953606-72956852@41.1@283@669@2.36@CNVR6443.1@GOLGA6B_8, GOLGA6B_9, GOLGA6B_10, GOLGA6B_11, GOLGA6B_12, GOLGA6B_13@0@0@0@:golgin A6 family, member B@:Golgi apparatus@NA
A2463_16@138417@138422@deletion@6@74365084@74368326@15@chr15:74365084-74368326@18.3@290@144@0.497@CNVR6448.1@GOLGA6A_13, GOLGA6A_12, GOLGA6A_11, GOLGA6A_10, GOLGA6A_9, GOLGA6A_8@0@0@0@:golgin A6 family, member C;golgin A6 family, member A;golgin A6 family, member D;golgin A6 family, member B@:Golgi apparatus@NA
A2463_16@139472@139479@deletion@8@84842761@84909534@15@chr15:84842761-84909534@18.9@287@136@0.474@CNVR6486.2@RP11-182J1.16_2, RP11-182J1.16_3, GOLGA6L4_1, GOLGA6L4_2, GOLGA6L4_3, GOLGA6L4_4, GOLGA6L4_5, GOLGA6L4_6@0@0@0@:uncharacterized LOC100505679@:Golgi apparatus@NA
A2463_16@140476@140478@deletion@3@64382@65633@16@chr16:64382-65633@16.8@83@4@0.0482@CNVR6565.1@WASH4P_10, WASH4P_9, WASH4P_8@0@0@0@@:intracellular membrane-bounded organelle;endosomal transport;recycling endosome;early endosome;Arp2/3 complex-mediated actin nucleation;actin binding;alpha-tubulin binding;retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;recycling endosome membrane@NA
A2463_16@141416@141416@deletion@1@2152063@2152257@16@chr16:2152063-2152257@9.33@99@36@0.364@CNVR6597.1@PKD1_26@0@0@0@:polycystin-1-like;polycystic kidney disease 1 (autosomal dominant)@:peptidyl-serine phosphorylation;kidney development;placenta blood vessel development;JAK-STAT cascade;metanephric distal tubule morphogenesis;homophilic cell adhesion;nucleus;metanephric ascending thin limb development;skin development;protein export from nucleus;lung epithelium development;spinal cord development;cilium;in utero embryonic development;detection of mechanical stimulus;heart development;cation channel activity;membrane;protein domain specific binding;motile primary cilium;carbohydrate binding;anatomical structure morphogenesis;mesonephric tubule development;basolateral plasma membrane;protein kinase binding;digestive tract development;calcium ion transport;calcium-independent cell-matrix adhesion;integral to membrane;embryonic placenta development;metanephric proximal tubule development;cell cycle arrest;integral to plasma membrane;branching morphogenesis of a tube;genitalia development;positive regulation of transcription from RNA polymerase II promoter;neuropeptide signaling pathway;mesonephric duct development;cell-matrix adhesion;cytoplasmic sequestering of transcription factor;cytoplasm;positive regulation of protein binding;protein binding;metanephric collecting duct development;positive regulation of cyclin-dependent protein kinase activity involved in G1/S;ion channel binding;polycystin complex;neural tube development;cartilage condensation;cartilage development@: POLYCYSTIC KIDNEY DISEASE 1; PKD1
A2463_16@141425@141425@deletion@1@2156807@2156949@16@chr16:2156807-2156949@5.82@84@39@0.464@CNVR6597.1@PKD1_17@0@0@0@:polycystin-1-like;polycystic kidney disease 1 (autosomal dominant)@:peptidyl-serine phosphorylation;kidney development;placenta blood vessel development;JAK-STAT cascade;metanephric distal tubule morphogenesis;homophilic cell adhesion;nucleus;metanephric ascending thin limb development;skin development;protein export from nucleus;lung epithelium development;spinal cord development;cilium;in utero embryonic development;detection of mechanical stimulus;heart development;cation channel activity;membrane;protein domain specific binding;motile primary cilium;carbohydrate binding;anatomical structure morphogenesis;mesonephric tubule development;basolateral plasma membrane;protein kinase binding;digestive tract development;calcium ion transport;calcium-independent cell-matrix adhesion;integral to membrane;embryonic placenta development;metanephric proximal tubule development;cell cycle arrest;integral to plasma membrane;branching morphogenesis of a tube;genitalia development;positive regulation of transcription from RNA polymerase II promoter;neuropeptide signaling pathway;mesonephric duct development;cell-matrix adhesion;cytoplasmic sequestering of transcription factor;cytoplasm;positive regulation of protein binding;protein binding;metanephric collecting duct development;positive regulation of cyclin-dependent protein kinase activity involved in G1/S;ion channel binding;polycystin complex;neural tube development;cartilage condensation;cartilage development@: POLYCYSTIC KIDNEY DISEASE 1; PKD1
A2463_16@141626@141626@duplication@1@2607705@2607964@16@chr16:2607705-2607964@6.35@100@170@1.7@CNVR6601.1@PDPK1_2@0@0@0@:3-phosphoinositide dependent protein kinase-1@:3-phosphoinositide-dependent protein kinase activity;nucleoplasm;fibroblast growth factor receptor signaling pathway;protein tyrosine kinase activity;negative regulation of transforming growth factor beta receptor signaling pathway;negative regulation of toll-like receptor signaling pathway;regulation of endothelial cell migration;focal adhesion assembly;ATP binding;insulin receptor signaling pathway;plasma membrane;intracellular signal transduction;positive regulation of establishment of protein localization to plasma membrane;platelet activation;protein kinase activity;regulation of mast cell degranulation;cytosol;epidermal growth factor receptor signaling pathway;hyperosmotic response;nerve growth factor receptor signaling pathway;type B pancreatic cell development;synaptic transmission;regulation of apoptotic process;transcription, DNA-dependent;protein autophosphorylation;regulation of I-kappaB kinase/NF-kappaB cascade;protein kinase binding;T cell costimulation;insulin receptor binding;transferase activity, transferring phosphorus-containing groups;actin cytoskeleton organization;blood coagulation;negative regulation of protein kinase activity;cellular response to insulin stimulus;focal adhesion;phosphatidylinositol-mediated signaling;negative regulation of cardiac muscle cell apoptotic process;protein serine/threonine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;cytoplasm;activation of protein kinase B activity;protein binding;T cell receptor signaling pathway;cytoplasmic membrane-bounded vesicle;peptidyl-threonine phosphorylation;kinase activity@NA
A2463_16@142651@142651@duplication@1@14858861@14859270@16@chr16:14858861-14859270@7.07@67@133@1.99@CNVR6644.1@RP11-719K4.2_8@0@0@0@:nuclear pore complex-interacting protein-like 1-like@NA@NA
A2463_16@142690@142690@deletion@1@15045473@15045882@16@chr16:15045473-15045882@9.64@172@82@0.477@NA@NPIP_8@0@0@0@:nuclear pore complex-interacting protein-like;nuclear pore complex interacting protein;nuclear pore complex-interacting protein-like 1-like@:nuclear membrane;protein transport;nuclear pore;mRNA transport@NA
A2463_16@142749@142750@deletion@2@15224945@15457926@16@chr16:15224945-15457926@21.6@401@186@0.464@NA@NPIPP1_1, PKD1P1_8@0@0@0@:pyridoxal-dependent decarboxylase domain containing 1;pyridoxal-dependent decarboxylase domain-containing protein 1-like:nuclear pore complex-interacting protein-like:NPIP-like protein 1-like;nuclear pore complex-interacting protein-like 1-like@:carboxylic acid metabolic process;pyridoxal phosphate binding;carboxy-lyase activity:neuropeptide signaling pathway;integral to membrane;plasma membrane;membrane@NA
A2463_16@143267@143267@duplication@1@20491896@20492022@16@chr16:20491896-20492022@4.8@46@89@1.93@NA@ACSM2A_11@0@0@0@:acyl-CoA synthetase medium-chain family member 2A@:mitochondrion;butyrate-CoA ligase activity;catalytic activity;ATP binding;glucose homeostasis;medium-chain fatty-acyl-CoA metabolic process;fatty acid metabolic process;triglyceride homeostasis;metabolic process;mitochondrial matrix;metal ion binding@NA
A2463_16@144020@144020@duplication@1@28353929@28354509@16@chr16:28353929-28354509@5.5@284@404@1.42@NA@A-575C2.4_7@0@0@0@:uncharacterized LOC728741@NA@NA
A2463_16@144047@144052@duplication@6@28467746@28478223@16@chr16:28467746-28478223@14.6@116@244@2.1@NA@NPIPL1_7, NPIPL1_6, NPIPL1_5, NPIPL1_4, NPIPL1_3, NPIPL1_2@0@0@0@:ceroid-lipofuscinosis, neuronal 3@:membrane:negative regulation of apoptotic process;late endosome;mitochondrion;galactosylceramide metabolic process;neuromuscular process controlling balance;neuron projection;lysosomal lumen pH elevation;integral to endoplasmic reticulum membrane;cell death;plasma membrane;nucleus;lysosomal lumen acidification;negative regulation of catalytic activity;negative regulation of macroautophagy;unfolded protein binding;neurotransmitter metabolic process;endoplasmic reticulum;vesicle transport along microtubule;protein catabolic process;autophagic vacuole;early endosome;trans-Golgi network;cellular membrane organization;ceramide metabolic process;glucosylceramide metabolic process;negative regulation of neuron apoptotic process;membrane;globoside metabolic process;membrane raft;synaptic vesicle;vacuolar transport;protein processing;Golgi membrane;caveola;protein folding;ionotropic glutamate receptor signaling pathway;cytosolic calcium ion homeostasis;Golgi stack;integral to membrane;receptor-mediated endocytosis;arginine transport;lysosome;negative regulation of proteolysis;Golgi apparatus;lysosome organization;associative learning;sphingomyelin metabolic process;macroautophagy;lysosomal membrane;amyloid precursor protein catabolic process;cytoplasm;autophagic vacuole fusion;protein binding;regulation of action potential;cellular amino acid metabolic process@: CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3
A2463_16@144047@144053@deletion@1@28467746@28481759@16@chr16:28467746-28481759@-22.8@211@291@1.38@NA@NPIPL1_7, NPIPL1_6, NPIPL1_5, NPIPL1_4, NPIPL1_3, NPIPL1_2, NPIPL1_1@0@0@0@:ceroid-lipofuscinosis, neuronal 3@:membrane:negative regulation of apoptotic process;late endosome;mitochondrion;galactosylceramide metabolic process;neuromuscular process controlling balance;neuron projection;lysosomal lumen pH elevation;integral to endoplasmic reticulum membrane;cell death;plasma membrane;nucleus;lysosomal lumen acidification;negative regulation of catalytic activity;negative regulation of macroautophagy;unfolded protein binding;neurotransmitter metabolic process;endoplasmic reticulum;vesicle transport along microtubule;protein catabolic process;autophagic vacuole;early endosome;trans-Golgi network;cellular membrane organization;ceramide metabolic process;glucosylceramide metabolic process;negative regulation of neuron apoptotic process;membrane;globoside metabolic process;membrane raft;synaptic vesicle;vacuolar transport;protein processing;Golgi membrane;caveola;protein folding;ionotropic glutamate receptor signaling pathway;cytosolic calcium ion homeostasis;Golgi stack;integral to membrane;receptor-mediated endocytosis;arginine transport;lysosome;negative regulation of proteolysis;Golgi apparatus;lysosome organization;associative learning;sphingomyelin metabolic process;macroautophagy;lysosomal membrane;amyloid precursor protein catabolic process;cytoplasm;autophagic vacuole fusion;protein binding;regulation of action potential;cellular amino acid metabolic process@: CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3
A2463_16@144095@144101@duplication@7@28607105@28619924@16@chr16:28607105-28619924@30.2@448@772@1.72@CNVR6685.1@SULT1A2_2, SULT1A1_10, SULT1A1_9, SULT1A1_8, SULT1A1_7, SULT1A1_6, SULT1A1_5@0@0@0@:sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2:sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1@:steroid metabolic process;small molecule metabolic process;sulfation;aryl sulfotransferase activity;catecholamine metabolic process;cytosol;xenobiotic metabolic process;phenol-containing compound metabolic process;sulfotransferase activity;amine biosynthetic process;flavonol 3-sulfotransferase activity;3'-phosphoadenosine 5'-phosphosulfate metabolic process:small molecule metabolic process;sulfation;aryl sulfotransferase activity;amine metabolic process;catecholamine metabolic process;xenobiotic metabolic process;cytosol;steroid sulfotransferase activity;integral to membrane;sulfotransferase activity;flavonol 3-sulfotransferase activity;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process;estrogen metabolic process@NA
A2463_16@144286@144301@duplication@16@29466720@29478872@16@chr16:29466720-29478872@9.54@40@106@2.65@CNVR6690.2, CNVR6690.3, CNVR6690.4@SLX1B_2, SLX1B_3, SLX1B_4, SLX1B_5, SLX1B_6, SULT1A4_3, SULT1A4_4, SULT1A4_5, SULT1A4_6, SULT1A4_7, SULT1A4_8, SULT1A4_9, RP11-345J4.3_5, RP11-345J4.3_4, RP11-345J4.3_3, RP11-345J4.3_2@0@0@0@:structure-specific endonuclease subunit SLX1-like;SLX1 structure-specific endonuclease subunit homolog B (S. cerevisiae);SLX1 structure-specific endonuclease subunit homolog A (S. cerevisiae):sulfotransferase family, cytosolic, 1A, phenol-preferring, member 4;sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3;sulfotransferase 1A3/1A4-like@:Slx1-Slx4 complex;5'-flap endonuclease activity;DNA repair;protein binding;DNA double-strand break processing involved in repair via single-strand annealing;double-strand break repair via homologous recombination;metal ion binding;crossover junction endodeoxyribonuclease activity:steroid metabolic process;small molecule metabolic process;sulfation;aryl sulfotransferase activity;cytoplasm;catecholamine metabolic process;cytosol;endoplasmic reticulum unfolded protein response;xenobiotic metabolic process;sulfotransferase activity;activation of signaling protein activity involved in unfolded protein response;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process@NA
A2463_16@145554@145560@duplication@7@55844430@55855433@16@chr16:55844430-55855433@13@1138@1506@1.32@CNVR6731.1@CES1_11, CES1_10, CES1_9, CES1_8, CES1_7, CES1_6, CES1_5@0@0@0@:carboxylesterase 1;liver carboxylesterase 1-like@:hydrolase activity;methyl salicylate esterase activity;response to toxin;methylumbelliferyl-acetate deacetylase activity;endoplasmic reticulum lumen;retinyl-palmitate esterase activity;methyl jasmonate esterase activity;metabolic process;carboxylesterase activity;methyl indole-3-acetate esterase activity@: CARBOXYLESTERASE 1; CES1
A2463_16@147109@147112@duplication@4@70161164@70164447@16@chr16:70161164-70164447@9.68@352@503@1.43@CNVR6764.1, CNVR6764.3@PDPR_4, PDPR_5, PDPR_6, PDPR_7@0@0@0@:pyruvate dehydrogenase phosphatase regulatory subunit@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix@NA
A2463_16@147114@147124@duplication@11@70166055@70190782@16@chr16:70166055-70190782@31.2@1172@1688@1.44@CNVR6764.1, CNVR6764.3@PDPR_9, PDPR_10, PDPR_11, PDPR_12, PDPR_13, PDPR_14, PDPR_15, PDPR_16, PDPR_17, PDPR_18, PDPR_19@0@0@0@:pyruvate dehydrogenase phosphatase regulatory subunit@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix@NA
A2463_16@147127@147127@duplication@1@70211145@70211383@16@chr16:70211145-70211383@5.46@101@165@1.63@CNVR6764.1@CLEC18C_3@0@0@0@:C-type lectin domain family 18, member C@:carbohydrate binding;protein binding;extracellular region@NA
A2463_16@147496@147512@duplication@17@74411873@74447574@16@chr16:74411873-74447574@45@2231@3184@1.43@CNVR6778.2, CNVR6778.4@NPIPL2_1, NPIPL2_2, NPIPL2_3, NPIPL2_4, NPIPL2_5, NPIPL2_6, NPIPL2_7, CLEC18B_13, CLEC18B_12, CLEC18B_11, CLEC18B_10, CLEC18B_9, CLEC18B_8, CLEC18B_7, CLEC18B_6, CLEC18B_5, CLEC18B_4@0@0@0@:C-type lectin domain family 18, member B@:extracellular region:carbohydrate binding;protein binding;extracellular region@NA
A2463_16@149228@149228@deletion@1@3513855@3514266@17@chr17:3513855-3514266@5.46@69@30@0.435@NA@SHPK_7@0@0@0@:sedoheptulokinase;transient receptor potential cation channel, subfamily V, member 1:sedoheptulokinase@:cellular response to interleukin-4;transport;regulation of inflammatory response;calmodulin binding;ion transport;phosphotransferase activity, alcohol group as acceptor;phosphorylation;ATP binding;thermoception;cellular response to interleukin-13;integral to membrane;cell junction;regulation of macrophage activation;integral to plasma membrane;cell surface receptor signaling pathway;ion channel activity;chemosensory behavior;cellular response to lipopolysaccharide;calcium channel activity;sedoheptulokinase activity;carbohydrate metabolic process;cytoplasm;pentose-phosphate shunt, non-oxidative branch;dendritic spine membrane;protein binding;postsynaptic membrane:cellular response to interleukin-4;regulation of inflammatory response;cellular response to lipopolysaccharide;sedoheptulokinase activity;carbohydrate metabolic process;phosphotransferase activity, alcohol group as acceptor;ATP binding;cytoplasm;phosphorylation;pentose-phosphate shunt, non-oxidative branch;cellular response to interleukin-13;regulation of macrophage activation@NA
A2463_16@151875@151883@duplication@9@18380170@18395859@17@chr17:18380170-18395859@11.5@329@478@1.45@CNVR7014.1@LGALS9C_1, LGALS9C_2, LGALS9C_3, LGALS9C_4, LGALS9C_5, LGALS9C_6, LGALS9C_7, LGALS9C_8, LGALS9C_9@0@0@0@:lectin, galactoside-binding, soluble, 9C@:carbohydrate binding@NA
A2463_16@153363@153370@duplication@8@34493376@34499323@17@chr17:34493376-34499323@10.1@221@340@1.54@CNVR7077.1, CNVR7077.3, CNVR7077.11, CNVR7077.16@TBC1D3B_14, TBC1D3B_13, TBC1D3B_12, TBC1D3B_11, TBC1D3B_10, TBC1D3B_9, TBC1D3B_8, TBC1D3B_7@0@0@0@:TBC1 domain family, member 3B@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_16@153376@153381@deletion@6@34522686@34539971@17@chr17:34522686-34539971@10.2@46@0@0@CNVR7077.1, CNVR7077.3, CNVR7077.6@CCL3L3_3, CCL3L3_2, CCL3L3_1, CCL4L1_1, CCL4L1_2, CCL4L1_3@0@0@0@:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
A2463_16@153389@153394@deletion@6@34587259@34590454@17@chr17:34587259-34590454@6.91@33@1@0.0303@CNVR7077.1, CNVR7077.13, CNVR7077.19, CNVR7077.10, CNVR7077.2@TBC1D3C_7, TBC1D3C_6, TBC1D3C_5, TBC1D3C_4, TBC1D3C_3, TBC1D3C_2@0@0@0@:TBC1 domain family, member 3C;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3H-like;TBC1 domain family, member 3H@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_16@153389@153400@duplication@6@34587259@34641537@17@chr17:34587259-34641537@1.93@172@231@1.34@CNVR7077.1, CNVR7077.19, CNVR7077.2, CNVR7077.14@TBC1D3C_7, TBC1D3C_6, TBC1D3C_5, TBC1D3C_4, TBC1D3C_3, TBC1D3C_2, CCL3L1_3, CCL3L1_2, CCL3L1_1, CCL4L2_1, CCL4L2_2, CCL4L2_3@0@0@0@:TBC1 domain family, member 3C;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3H-like;TBC1 domain family, member 3H:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
A2463_16@153414@153414@deletion@1@34797487@34798054@17@chr17:34797487-34798054@18.7@91@2@0.022@CNVR7078.2, CNVR7078.3@TBC1D3G_14@0@0@0@:TBC1 domain family member 3H-like;TBC1 domain family, member 3H:TBC1 domain family, member 3;TBC1 domain family, member 3G;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like;TBC1 domain family, member 3H@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_16@153643@153643@duplication@1@36342585@36342632@17@chr17:36342585-36342632@5.89@27@71@2.63@CNVR7083.3@TBC1D3_12@0@0@0@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
A2463_16@155592@155600@deletion@9@44412912@44594799@17@chr17:44412912-44594799@40.6@230@30@0.13@CNVR7114.2, CNVR7114.1@LRRC37A_11, LRRC37A_12, LRRC37A_13, LRRC37A_14, ARL17B_4, ARL17B_3, ARL17B_2, LRRC37A2_2, LRRC37A2_3@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
A2463_16@155609@155612@duplication@4@44630767@44632945@17@chr17:44630767-44632945@8.29@639@850@1.33@CNVR7114.2, CNVR7114.5, CNVR7114.4@LRRC37A2_12, LRRC37A2_13, LRRC37A2_14, LRRC37A2_15@0@0@0@:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
A2463_16@156877@156878@deletion@2@57656834@57657240@17@chr17:57656834-57657240@14@66@1@0.0152@NA@DHX40_9, DHX40_10@0@0@0@:DEAH (Asp-Glu-Ala-His) box polypeptide 40@:transport;helicase activity;intracellular;ATP-dependent helicase activity;nucleic acid binding;ATP binding@NA
A2463_16@162017@162018@deletion@2@44542732@44550298@18@chr18:44542732-44550298@88.7@468@7@0.015@CNVR7319.1, CNVR7319.2@TCEB3CL2_1, TCEB3CL_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2:transcription elongation factor B polypeptide 3C-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_16@162017@162019@duplication@1@44542732@44556213@18@chr18:44542732-44556213@-67@2591@3777@1.46@CNVR7319.1, CNVR7319.2@TCEB3CL2_1, TCEB3CL_1, TCEB3C_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2:transcription elongation factor B polypeptide 3C-like:transcription elongation factor B polypeptide 3C (elongin A3);RNA polymerase II transcription factor SIII subunit A3-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_16@164951@164953@deletion@3@7032325@7040155@19@chr19:7032325-7040155@9.47@58@11@0.19@CNVR7517.1@MBD3L5_2, MBD3L4_2, MBD3L4_1@0@0@0@:methyl-CpG binding domain protein 3-like 5:methyl-CpG binding domain protein 3-like 4@:regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_16@167610@167619@duplication@10@17443740@17450075@19@chr19:17443740-17450075@22.2@484@743@1.54@CNVR7562.1@ANO8_5, ANO8_4, ANO8_3, ANO8_2, ANO8_1, GTPBP3_1, GTPBP3_2, GTPBP3_3, GTPBP3_4, GTPBP3_5@0@0@0@:anoctamin 8:GTP binding protein 3 (mitochondrial)@:chloride channel activity;chloride channel complex;intracellular:mitochondrion;GTP binding;GTPase activity;metal ion binding;tRNA modification@: DEAFNESS, AMINOGLYCOSIDE-INDUCED
A2463_16@168952@168952@deletion@1@35862263@35863302@19@chr19:35862263-35863302@13.5@101@23@0.228@CNVR7627.1@GPR42_2@0@0@0@@:integral to membrane;G-protein coupled receptor activity;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
A2463_16@170096@170100@deletion@5@40373946@40382826@19@chr19:40373946-40382826@43.1@387@131@0.339@CNVR7639.2@FCGBP_26, FCGBP_25, FCGBP_24, FCGBP_23, FCGBP_22@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_16@170104@170109@duplication@6@40389653@40399855@19@chr19:40389653-40399855@25.3@642@981@1.53@CNVR7639.2, CNVR7639.3@FCGBP_18, FCGBP_17, FCGBP_16, FCGBP_15, FCGBP_14, FCGBP_13@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_16@170821@170826@deletion@6@43702150@43763287@19@chr19:43702150-43763287@19.2@424@235@0.554@CNVR7658.5, CNVR7658.1@PSG4_3, PSG4_2, PSG4_1, PSG9_6, PSG9_5, PSG9_4@0@0@0@:pregnancy specific beta-1-glycoprotein 4:pregnancy specific beta-1-glycoprotein 9@:protein binding;extracellular region;female pregnancy;defense response:protein binding;extracellular region;female pregnancy;defense response@NA
A2463_16@173336@173341@duplication@6@54801928@54804173@19@chr19:54801928-54804173@8.03@290@406@1.4@CNVR7722.1@LILRA3_6, LILRA3_5, LILRA3_4, LILRA3_3, LILRA3_2, LILRA3_1@0@0@0@:leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3@:antigen binding;signal transduction;protein binding;extracellular region;plasma membrane;receptor activity;defense response@NA
A2463_16@173466@173477@deletion@12@55258788@55295265@19@chr19:55258788-55295265@12.5@682@461@0.676@CNVR7725.2, CNVR7725.1@KIR2DL3_5, KIR2DL3_6, KIR2DL3_7, KIR2DL3_8, KIR2DL1_1, KIR2DL1_2, KIR2DL1_3, KIR2DL1_4, KIR2DL1_5, KIR2DL1_6, KIR2DL1_7, KIR2DL1_8@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane@NA
A2463_16@173482@173486@duplication@5@55320289@55329024@19@chr19:55320289-55329024@8.16@107@181@1.69@CNVR7725.1, CNVR7725.3@KIR2DL4_5, KIR2DL4_6, KIR2DL4_7, KIR3DL1_1, KIR3DL1_2@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane@NA
A2463_16@173500@173503@duplication@4@55359207@55362710@19@chr19:55359207-55362710@9.13@61@130@2.13@CNVR7725.1, CNVR7725.6, CNVR7725.5, CNVR7725.10@KIR2DS4_7, KIR2DS4_8, KIR3DL2_1, KIR3DL2_2@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2-like@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane@NA
A2463_16@174403@174403@deletion@1@1895746@1896101@20@chr20:1895746-1896101@5.12@126@70@0.556@CNVR7764.2@SIRPA_2@0@0@0@:signal-regulatory protein alpha@:blood coagulation;protein binding;integral to membrane;SH3 domain binding;cell adhesion;plasma membrane;membrane;leukocyte migration@NA
A2463_16@178998@178999@duplication@2@10942712@10943020@21@chr21:10942712-10943020@6.33@367@503@1.37@CNVR7947.10, CNVR7947.6, CNVR7947.11@TPTE_13, TPTE_12@0@0@0@:transmembrane phosphatase with tensin homology@:phosphatase activity;ion channel activity;protein tyrosine phosphatase activity;ion transport;protein dephosphorylation;transmembrane transport;protein binding;signal transduction;integral to membrane;protein tyrosine/serine/threonine phosphatase activity;dephosphorylation;membrane;peptidyl-tyrosine dephosphorylation@NA
A2463_16@179011@179021@deletion@11@14982551@15013887@21@chr21:14982551-15013887@36.3@232@45@0.194@CNVR7952.1@POTED_1, POTED_2, POTED_3, POTED_4, POTED_5, POTED_6, POTED_7, POTED_8, POTED_9, POTED_10, POTED_11@0@0@0@:POTE ankyrin domain family, member B;POTE ankyrin domain family, member C;POTE ankyrin domain family, member D@:protein binding;plasma membrane@NA
A2463_16@180968@180976@deletion@9@16266930@16287885@22@chr22:16266930-16287885@45.3@1154@645@0.559@CNVR8071.2, CNVR8071.3@POTEH_9, POTEH_8, POTEH_7, POTEH_6, POTEH_5, POTEH_4, POTEH_3, POTEH_2, POTEH_1@0@0@0@:POTE ankyrin domain family, member H@:protein binding@NA
A2463_16@180979@180979@duplication@1@17264510@17265299@22@chr22:17264510-17265299@7.05@65@129@1.98@NA@XKR3_4@0@0@0@:XK, Kell blood group complex subunit-related family, member 3@:integral to membrane;plasma membrane@NA
A2463_16@181133@181133@duplication@1@18739383@18739404@22@chr22:18739383-18739404@5.78@10@49@4.9@CNVR8087.5, CNVR8087.2, CNVR8087.11@AC008132.1_8@0@0@0@NA@NA@NA
A2463_16@181133@181134@deletion@1@18739383@18835833@22@chr22:18739383-18835833@-2.2@220@165@0.75@CNVR8087.5, CNVR8087.2, CNVR8087.7@AC008132.1_8, AC008132.13_1@0@0@0@NA@NA@NA
A2463_16@181417@181420@duplication@4@20366369@20367356@22@chr22:20366369-20367356@10.5@22@90@4.09@CNVR8094.9, CNVR8094.4, CNVR8094.3@GGTLC3_5, GGTLC3_4, GGTLC3_3, GGTLC3_2@0@0@0@@:leukotriene biosynthetic process;glutathione metabolic process;gamma-glutamyltransferase activity;anchored to external side of plasma membrane@NA
A2463_16@181487@181489@duplication@3@21065630@21067085@22@chr22:21065630-21067085@5.26@130@192@1.48@CNVR8099.6, CNVR8099.2@PI4KA_51, PI4KA_50, PI4KA_49@0@0@0@:phosphatidylinositol 4-kinase, catalytic, alpha@:phospholipid metabolic process;1-phosphatidylinositol 4-kinase activity;small molecule metabolic process;phosphatidylinositol phosphorylation;binding;transferase activity, transferring phosphorus-containing groups;phosphotransferase activity, alcohol group as acceptor;ATP binding;Golgi-associated vesicle;phosphatidylinositol biosynthetic process;cytosol;protein binding;signal transduction;synaptic transmission;kinase activity;phosphatidylinositol-mediated signaling@NA
A2463_16@181638@181638@duplication@1@21900347@21905265@22@chr22:21900347-21905265@5.63@6@42@7@CNVR8101.1, CNVR8101.2@RIMBP3C_1, UBE2L3_1@0@0@0@:RIMS binding protein 3C:ubiquitin-conjugating enzyme E2L 3@:protein binding:cellular response to glucocorticoid stimulus;ubiquitin ligase complex;regulation of S phase of mitotic cell cycle;ATP binding;protein K11-linked ubiquitination;transcription coactivator activity;cellular protein modification process;cellular response to steroid hormone stimulus;protein transport;nucleus;ubiquitin protein ligase binding;ubiquitin-protein ligase activity;enzyme binding;regulation of transcription, DNA-dependent;ubiquitin-dependent protein catabolic process;cytoplasm;cell proliferation;protein binding;transcription, DNA-dependent;acid-amino acid ligase activity;protein polyubiquitination;protein ubiquitination@NA
A2463_16@181806@181808@duplication@3@23243157@23248831@22@chr22:23243157-23248831@25.7@319@591@1.85@CNVR8103.2, CNVR8103.1, CNVR8103.6, CNVR8103.11@IGLC2_1, IGLJ3_1, IGLC3_1@0@0@0@@:protein binding:protein binding@NA
A2463_14@6@7@deletion@2@69092@139309@1@chr1:69092-139309@21.3@468@234@0.5@CNVR1.2@OR4F5_1, AL627309.1_1@0@0@0@:olfactory receptor, family 4, subfamily F, member 5@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_14@1829@1829@deletion@1@13036223@13036800@1@chr1:13036223-13036800@7.63@61@17@0.279@CNVR72.3, CNVR72.14@PRAMEF22_2@0@0@0@:PRAME family member 6;PRAME family member 23;PRAME family member 9/15-like;PRAME family member 5:PRAME family member 22@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_14@1846@1854@deletion@9@13448051@13498128@1@chr1:13448051-13498128@8.97@111@52@0.468@CNVR74.8@PRAMEF13_4, PRAMEF13_3, PRAMEF13_2, PRAMEF18_3, PRAMEF18_2, PRAMEF18_1, PRAMEF16_1, PRAMEF16_2, PRAMEF16_3@0@0@0@:PRAME family member 13:PRAME family member 18:PRAME family member 16@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_14@2167@2167@deletion@1@16865562@16866070@1@chr1:16865562-16866070@4.64@41@14@0.341@CNVR93.3, CNVR93.6, CNVR93.10@AL355149.2_1@0@0@0@:UPF0627 protein ENSP00000364708@NA@NA
A2463_14@5196@5197@deletion@2@40235375@40240128@1@chr1:40235375-40240128@6.67@152@81@0.533@NA@OXCT2_1, BMP8B_3@0@0@0@:bone morphogenetic protein 8b:3-oxoacid CoA transferase 2@:cell differentiation;growth factor activity;extracellular space;growth;extracellular region;cytokine activity;cartilage development;skeletal system development;ossification:mitochondrion;microtubule-based flagellum;CoA-transferase activity;ketone body catabolic process;3-oxoacid CoA-transferase activity;metabolic process@NA
A2463_14@9340@9347@deletion@8@104114226@104120230@1@chr1:104114226-104120230@11.4@1120@785@0.701@CNVR266.8, CNVR266.10@AMY2B_3, AMY2B_4, AMY2B_5, AMY2B_6, AMY2B_7, AMY2B_8, AMY2B_9, AMY2B_10@0@0@0@:actin, gamma 1 pseudogene 4;amylase, alpha 2B (pancreatic)@:extracellular region;cation binding;digestion;carbohydrate metabolic process;catalytic activity;alpha-amylase activity;metal ion binding@NA
A2463_14@9350@9358@deletion@9@104160064@104166843@1@chr1:104160064-104166843@22.1@659@389@0.59@CNVR266.3, CNVR266.1@AMY2A_1, AMY2A_2, AMY2A_3, AMY2A_4, AMY2A_5, AMY2A_6, AMY2A_7, AMY2A_8, AMY2A_9@0@0@0@:amylase, alpha 2A (pancreatic)@:chloride ion binding;cation binding;small molecule metabolic process;carbohydrate metabolic process;catalytic activity;extracellular space;polysaccharide digestion;extracellular region;carbohydrate catabolic process;alpha-amylase activity;calcium ion binding@NA
A2463_14@9373@9374@duplication@2@104233917@104234232@1@chr1:104233917-104234232@5.97@42@89@2.12@CNVR266.3, CNVR266.5@AMY1B_8, AMY1B_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
A2463_14@9385@9386@deletion@2@104297122@104297436@1@chr1:104297122-104297436@12.6@352@194@0.551@CNVR266.3, CNVR266.5@AMY1C_6, AMY1C_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
A2463_14@9449@9450@deletion@2@108993225@108994911@1@chr1:108993225-108994911@6.42@42@9@0.214@CNVR294.4, CNVR294.2@NBPF6_2, NBPF6_3@0@0@0@:neuroblastoma breakpoint family, member 6@:cytoplasm@NA
A2463_14@10799@10799@deletion@1@144815937@144816008@1@chr1:144815937-144816008@10.1@56@6@0.107@CNVR338.4, CNVR338.2, CNVR338.5, CNVR338.1@NBPF9_4@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 24@NA@NA
A2463_14@10890@10893@deletion@4@145325953@145328432@1@chr1:145325953-145328432@12@54@0@0@CNVR341.2, CNVR341.3@NBPF10_30, NBPF10_31, NBPF10_32, NBPF10_33@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family, member 10@NA@NA
A2463_14@11149@11157@deletion@9@146232495@146244717@1@chr1:146232495-146244717@9.01@40@0@0@NA@NBPF12_16, NBPF12_15, NBPF12_14, NBPF12_13, NBPF12_12, NBPF12_11, NBPF12_10, NBPF12_9, NBPF12_8@0@0@0@:neuroblastoma breakpoint family member 21-like@NA@NA
A2463_14@11169@11170@deletion@2@146400092@146401880@1@chr1:146400092-146401880@10.2@49@2@0.0408@NA@NBPF12_9, NBPF12_10@0@0@0@:neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family member 14-like;neuroblastoma breakpoint family, member 12@:cytoplasm@NA
A2463_14@11341@11346@deletion@6@148008574@148012675@1@chr1:148008574-148012675@34.9@803@444@0.553@CNVR346.2, CNVR346.4@NBPF14_17, NBPF14_16, NBPF14_15, NBPF14_14, NBPF14_13, NBPF14_12@0@0@0@:neuroblastoma breakpoint family, member 14@:cytoplasm@NA
A2463_14@16030@16040@duplication@11@196748293@196801129@1@chr1:196748293-196801129@19.3@1542@2048@1.33@CNVR459.1@CFHR3_2, CFHR3_3, CFHR3_4, CFHR3_5, CFHR3_6, CFHR1_1, CFHR1_2, CFHR1_3, CFHR1_4, CFHR1_5, CFHR1_6@0@0@0@:complement factor H-related 3:complement factor H-related 1:complement factor H-related 2@:extracellular space:extracellular space;complement activation:extracellular region@NA
A2463_14@19775@19776@duplication@2@248756132@248790429@1@chr1:248756132-248790429@8.84@341@496@1.45@CNVR600.1@OR2T10_1, OR2T11_1@0@0@0@:olfactory receptor, family 2, subfamily T, member 10:olfactory receptor, family 2, subfamily T, member 11@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_14@20473@20474@duplication@2@17922880@17927213@2@chr2:17922880-17927213@6.1@154@232@1.51@NA@SMC6_4, SMC6_3@0@0@0@:structural maintenance of chromosomes 6@:Smc5-Smc6 complex;intracellular;telomere maintenance via recombination;cellular senescence;ATP binding;DNA repair;chromosome, telomeric region;protein binding;PML body@NA
A2463_14@24822@24822@deletion@1@87178420@87178483@2@chr2:87178420-87178483@5.89@26@0@0@NA@RGPD1_2@0@0@0@:RANBP2-like and GRIP domain containing 1@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_14@24862@24871@duplication@10@88094928@88118142@2@chr2:88094928-88118142@8.41@123@208@1.69@NA@RGPD2_11, RGPD2_10, RGPD2_9, RGPD2_8, RGPD2_7, RGPD2_6, RGPD2_5, RGPD2_4, RGPD2_3, RGPD2_2@0@0@0@:RANBP2-like and GRIP domain containing 2@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_14@25369@25370@deletion@2@97854825@97855027@2@chr2:97854825-97855027@21.9@103@1@0.00971@CNVR886.2, CNVR886.3@ANKRD36_33, ANKRD36_34@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_14@25390@25393@duplication@4@97873672@97877311@2@chr2:97873672-97877311@10.2@465@652@1.4@CNVR886.1@ANKRD36_54, ANKRD36_55, ANKRD36_56, ANKRD36_57@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_14@26305@26305@deletion@1@112541475@112541541@2@chr2:112541475-112541541@8.23@47@6@0.128@CNVR928.1@ANAPC1_42@0@0@0@:anaphase-promoting complex subunit 1-like;anaphase promoting complex subunit 1@:nucleoplasm;regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle;anaphase-promoting complex;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle spindle assembly checkpoint;cytosol;protein K11-linked ubiquitination;protein binding;mitosis;nucleus;cell cycle checkpoint;cell division;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle@NA
A2463_14@26310@26310@deletion@1@112551656@112551708@2@chr2:112551656-112551708@6.53@99@45@0.455@CNVR928.1@ANAPC1_37@0@0@0@:anaphase-promoting complex subunit 1-like;anaphase promoting complex subunit 1@:nucleoplasm;regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle;anaphase-promoting complex;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle spindle assembly checkpoint;cytosol;protein K11-linked ubiquitination;protein binding;mitosis;nucleus;cell cycle checkpoint;cell division;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle@NA
A2463_14@26579@26583@deletion@5@114251335@114258060@2@chr2:114251335-114258060@7.07@724@507@0.7@CNVR933.1@CBWD2_12, CBWD2_13, CBWD2_14, CBWD2_15, FOXD4L1_1@0@0@0@:COBW domain containing 2;COBW domain containing 1;COBW domain-containing protein 1-like:forkhead box D4-like 1@:ATP binding:positive regulation of BMP signaling pathway;positive regulation of kidney development;axon extension involved in axon guidance;lateral line nerve glial cell development;DNA binding, bending;sequence-specific DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;regulation of sequence-specific DNA binding transcription factor activity;transcription factor complex;nucleus;dichotomous subdivision of terminal units involved in ureteric bud branching;sympathetic nervous system development;melanocyte differentiation;enteric nervous system development;positive regulation of transcription from RNA polymerase II promoter;regulation of transcription, DNA-dependent;neural crest cell migration;peripheral nervous system development;double-stranded DNA binding;RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity;iridophore differentiation;transcription factor binding;cartilage development;pattern specification process@NA
A2463_14@27229@27229@deletion@1@131116971@131117065@2@chr2:131116971-131117065@5.45@49@16@0.327@NA@PTPN18_4@0@0@0@:protein tyrosine phosphatase, non-receptor type 18 (brain-derived)@:phosphatase activity;protein binding;protein tyrosine phosphatase activity;non-membrane spanning protein tyrosine phosphatase activity;nucleus;dephosphorylation;protein dephosphorylation;cytoplasm@NA
A2463_14@27243@27250@deletion@8@131231952@131254195@2@chr2:131231952-131254195@8.95@117@53@0.453@NA@POTEI_13, POTEI_12, POTEI_11, POTEI_10, POTEI_9, POTEI_8, POTEI_7, POTEI_6@0@0@0@:POTE ankyrin domain family, member I@:protein binding;ATP binding@NA
A2463_14@27326@27327@deletion@2@132010100@132010672@2@chr2:132010100-132010672@6.1@118@64@0.542@NA@POTEE_12, POTEE_13@0@0@0@:pleckstrin homology domain containing, family B (evectins) member 2:POTE ankyrin domain family, member E@:phospholipid binding;protein binding;recycling endosome membrane:protein binding;ATP binding@NA
A2463_14@27995@27997@deletion@3@152461075@152464122@2@chr2:152461075-152464122@15.6@76@3@0.0395@CNVR1026.1@NEB_85, NEB_84, NEB_83@0@0@0@:nebulin@:Z disc;muscle filament sliding;oxidation-reduction process;contractile fiber part;actin cytoskeleton;regulation of actin filament length;structural constituent of muscle;cytosol;actin binding;protein binding;myofibril;somatic muscle development;muscle organ development@: NEMALINE MYOPATHY 2; NEM2
A2463_14@39892@39892@duplication@1@75786030@75788496@3@chr3:75786030-75788496@7.65@106@194@1.83@CNVR1432.5, CNVR1432.9, CNVR1432.4@ZNF717_5@0@0@0@:zinc finger protein 717;zinc finger protein 717-like@:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_14@48560@48561@duplication@2@69431291@69434202@4@chr4:69431291-69434202@5.8@183@265@1.45@CNVR1953.1@UGT2B17_2, UGT2B17_1@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B17@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;membrane@: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
A2463_14@48972@48974@deletion@3@75482007@75486006@4@chr4:75482007-75486006@5.54@78@38@0.487@NA@AREGB_2, AREGB_3, AREGB_4@0@0@0@:amphiregulin;amphiregulin B@:growth factor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;cell proliferation;epidermal growth factor receptor signaling pathway;extracellular space;protein binding;integral to membrane;cytokine activity;cell surface;positive regulation of DNA replication@NA
A2463_14@55835@55838@deletion@4@70338009@70344676@5@chr5:70338009-70344676@8.09@131@73@0.557@CNVR2494.41, CNVR2494.14, CNVR2494.20, CNVR2494.62, CNVR2494.8@GTF2H2_14, GTF2H2_13, GTF2H2_12, GTF2H2_11@0@0@0@:general transcription factor IIH, polypeptide 2, 44kDa@:nucleoplasm;nucleotide-excision repair, DNA damage removal;transcription from RNA polymerase I promoter;DNA repair;RNA polymerase II carboxy-terminal domain kinase activity;nucleus;viral reproduction;translation;gene expression;transcription elongation from RNA polymerase I promoter;response to UV;holo TFIIH complex;protein kinase activity;nucleotide-excision repair;transcription from RNA polymerase II promoter;transcription-coupled nucleotide-excision repair;transcription, DNA-dependent;zinc ion binding;transcription elongation from RNA polymerase II promoter;termination of RNA polymerase I transcription;sequence-specific DNA binding transcription factor activity;G-protein coupled receptor internalization;DNA-dependent ATPase activity;protein N-terminus binding;transcription initiation from RNA polymerase I promoter;7-methylguanosine mRNA capping;transcription initiation from RNA polymerase II promoter;protein phosphorylation;translation factor activity, nucleic acid binding;regulation of transcription, DNA-dependent;core TFIIH complex;protein binding;positive regulation of viral transcription;nucleic acid binding@NA
A2463_14@61266@61274@deletion@9@177163581@177174794@5@chr5:177163581-177174794@17.4@258@135@0.523@NA@FAM153A_11, FAM153A_10, FAM153A_9, FAM153A_8, FAM153A_7, FAM153A_6, FAM153A_5, FAM153A_4, FAM153A_3@0@0@0@:family with sequence similarity 153, member A@NA@NA
A2463_14@63725@63733@duplication@9@31962023@31964377@6@chr6:31962023-31964377@20.6@854@1248@1.46@CNVR2843.6, CNVR2843.3@C4A_20, C4A_21, C4A_22, C4A_23, C4A_24, C4A_25, C4A_26, C4A_27, C4A_28@0@0@0@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
A2463_14@63769@63776@deletion@8@31995014@31997115@6@chr6:31995014-31997115@29.4@485@224@0.462@CNVR2843.6, CNVR2843.5@C4B_21, C4B_22, C4B_23, C4B_24, C4B_25, C4B_26, C4B_27, C4B_28@0@0@0@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
A2463_14@63793@63795@duplication@3@32007134@32007612@6@chr6:32007134-32007612@7.93@441@602@1.37@CNVR2843.6, CNVR2843.5@CYP21A2_4, CYP21A2_5, CYP21A2_6@0@0@0@:cytochrome P450, family 21, subfamily A, polypeptide 2@:oxidation-reduction process;electron carrier activity;response to antibiotic;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;steroid 21-monooxygenase activity;C21-steroid hormone biosynthetic process;heme binding;mineralocorticoid biosynthetic process;progesterone metabolic process;monooxygenase activity;cellular response to peptide hormone stimulus;iron ion binding@: ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY
A2463_14@63953@63957@duplication@5@32485517@32489951@6@chr6:32485517-32489951@10.4@159@259@1.63@CNVR2845.21, CNVR2845.25, CNVR2845.30@HLA-DRB5_6, HLA-DRB5_5, HLA-DRB5_4, HLA-DRB5_3, HLA-DRB5_2@0@0@0@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
A2463_14@70816@70817@deletion@2@161054786@161056336@6@chr6:161054786-161056336@11.1@121@46@0.38@CNVR3133.1@LPA_9, LPA_8@0@0@0@:lipoprotein, Lp(a)@:blood circulation;endopeptidase inhibitor activity;catalytic activity;lipoprotein metabolic process;proteolysis;heparin binding;receptor-mediated endocytosis;fibronectin binding;small molecule metabolic process;apolipoprotein binding;lipid metabolic process;negative regulation of endopeptidase activity;extracellular region;plasma lipoprotein particle;lipid transport;serine-type endopeptidase activity@: APOLIPOPROTEIN(a); LPA
A2463_14@71028@71030@deletion@3@167787840@167790192@6@chr6:167787840-167790192@8.94@130@67@0.515@NA@TCP10_7, TCP10_6, TCP10_5@0@0@0@:t-complex 10@:cytosol@NA
A2463_14@71776@71776@duplication@1@6006495@6006747@7@chr7:6006495-6006747@7.38@93@174@1.87@NA@RSPH10B_2@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
A2463_14@71778@71779@deletion@2@6017220@6018327@7@chr7:6017220-6018327@7.36@335@210@0.627@NA@PMS2_14, PMS2_13@0@0@0@:PMS2 postmeiotic segregation increased 2 (S. cerevisiae)@:response to drug;DNA binding;MutSalpha complex binding;ATP binding;mismatch repair;DNA repair;mismatched DNA binding;ATPase activity;nucleus;mismatch repair complex;reciprocal meiotic recombination;ATP catabolic process;single-stranded DNA binding;response to DNA damage stimulus;single base insertion or deletion binding;protein binding;somatic hypermutation of immunoglobulin genes;somatic recombination of immunoglobulin gene segments;MutLalpha complex;endonuclease activity@: COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 4; HNPCC4; MISMATCH REPAIR CANCER SYNDROME
A2463_14@71922@71922@deletion@1@6797310@6797562@7@chr7:6797310-6797562@7@169@89@0.527@NA@RSPH10B2_2@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
A2463_14@71936@71940@deletion@5@6826510@6838174@7@chr7:6826510-6838174@13.7@94@22@0.234@NA@RSPH10B2_16, RSPH10B2_17, RSPH10B2_18, RSPH10B2_19, RSPH10B2_20@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
A2463_14@74246@74246@deletion@1@66660158@66660324@7@chr7:66660158-66660324@6.12@67@26@0.388@NA@TYW1_15@0@0@0@:tRNA-yW synthesizing protein 1 homolog (S. cerevisiae);tRNA-yW synthesizing protein 1 homolog B (S. cerevisiae)@:tRNA processing;4 iron, 4 sulfur cluster binding;iron-sulfur cluster binding;oxidoreductase activity;FMN binding;iron ion binding;catalytic activity@NA
A2463_14@74568@74574@deletion@7@74160677@74167509@7@chr7:74160677-74167509@13.5@140@56@0.4@NA@GTF2I_23, GTF2I_24, GTF2I_25, GTF2I_26, GTF2I_27, GTF2I_28, GTF2I_29@0@0@0@:general transcription factor IIi@:neuronal cell body;transcription initiation from RNA polymerase II promoter;mitogen-activated protein kinase binding;negative regulation of angiogenesis;DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;cytoplasm;transcription from RNA polymerase II promoter;protein binding;signal transduction;nucleus;cell projection;reduction of cytosolic calcium ion concentration@NA
A2463_14@74664@74664@deletion@1@75055645@75055735@7@chr7:75055645-75055735@6.38@30@1@0.0333@NA@POM121C_8@0@0@0@:POM121 transmembrane nucleoporin C@:nuclear membrane;protein binding;protein transport;endoplasmic reticulum membrane;nuclear pore;mRNA transport@NA
A2463_14@76737@76737@deletion@1@102147143@102147271@7@chr7:102147143-102147271@6.41@41@8@0.195@CNVR3518.1@RASA4B_5@0@0@0@:RAS p21 protein activator 4B@:phospholipid binding;intracellular;GTPase activator activity;cytosol;signal transduction;protein binding;plasma membrane;regulation of small GTPase mediated signal transduction;metal ion binding;intracellular signal transduction@NA
A2463_14@76792@76793@deletion@2@102309363@102312048@7@chr7:102309363-102312048@11.3@97@32@0.33@CNVR3518.1@POLR2J2_2, POLR2J2_2, POLR2J2_1, POLR2J2_1@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
A2463_14@79287@79289@deletion@3@143400089@143418471@7@chr7:143400089-143418471@5.57@82@41@0.5@CNVR3594.2, CNVR3594.1@FAM115C_2, FAM115C_3, FAM115C_4@0@0@0@:family with sequence similarity 115, member C;protein FAM115C-like@NA@NA
A2463_14@79309@79316@deletion@8@143880598@144063505@7@chr7:143880598-144063505@53.9@1545@886@0.573@CNVR3598.4@CTAGE4_1, ARHGEF35_2, OR2A42_1, OR2A7_1, CTAGE8_1, OR2A1_1, ARHGEF5_2, ARHGEF5_3@0@0@0@:CTAGE family, member 4:Rho guanine nucleotide exchange factor (GEF) 35:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1:olfactory receptor, family 2, subfamily A, member 7:CTAGE family, member 6, pseudogene;CTAGE family, member 15, pseudogene:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:integral to membrane;nucleotide binding;cellular_component;biological_process:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
A2463_14@79319@79322@deletion@4@144068255@144069850@7@chr7:144068255-144069850@12.1@175@80@0.457@CNVR3598.4, CNVR3598.5, CNVR3598.11@ARHGEF5_6, ARHGEF5_7, ARHGEF5_8, ARHGEF5_9@0@0@0@:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
A2463_14@80358@80358@deletion@1@6873513@6873621@8@chr8:6873513-6873621@8.8@74@21@0.284@CNVR3769.1@DEFA3_3@0@0@0@:defensin, alpha 1B;defensin, alpha 1:defensin, alpha 3, neutrophil-specific;defensin, alpha 1B;defensin, alpha 1@:defense response to virus;extracellular matrix;immune response;Golgi lumen;azurophil granule lumen;killing of cells of other organism;innate immune response;chemotaxis;extracellular space;extracellular region;defense response to bacterium;defense response to fungus;defense response:defense response to virus;Golgi lumen;azurophil granule lumen;killing of cells of other organism;innate immune response;extracellular space;defense response to bacterium;defense response to fungus;extracellular region;defense response@NA
A2463_14@80362@80366@duplication@5@7215499@7220468@8@chr8:7215499-7220468@12.1@857@1180@1.38@CNVR3771.8, CNVR3771.10, CNVR3771.4@ZNF705G_7, ZNF705G_6, ZNF705G_5, ZNF705G_4, ZNF705G_3@0@0@0@:zinc finger protein 705G@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_14@80409@80411@deletion@3@7806652@7808269@8@chr8:7806652-7808269@14.3@75@7@0.0933@CNVR3772.4, CNVR3772.6, CNVR3772.10, CNVR3772.13@ZNF705B_3, ZNF705B_4, ZNF705B_5@0@0@0@:zinc finger protein 705B@:intracellular;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_14@80564@80564@deletion@1@11970084@11970667@8@chr8:11970084-11970667@15.4@72@0@0@CNVR3785.8, CNVR3785.5@ZNF705D_6@0@0@0@:zinc finger protein 705D@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_14@80564@80565@duplication@1@11970084@11996269@8@chr8:11970084-11996269@-10@943@1171@1.24@CNVR3785.8, CNVR3785.5, CNVR3785.6@ZNF705D_6, USP17L2_1@0@0@0@:zinc finger protein 705D:ubiquitin specific peptidase 17-like family member 1, pseudogene;ubiquitin specific peptidase 17-like family member 2;ubiquitin specific peptidase 17-like family member 4;ubiquitin specific peptidase 17-like family member 7;ubiquitin specific peptidase 17-like family member 8;ubiquitin specific peptidase 17-like family member 3@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:protein deubiquitination;ubiquitin-specific protease activity;mitotic cell cycle G1/S transition checkpoint;nucleus;G2/M transition checkpoint;apoptotic process;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
A2463_14@80576@80578@deletion@3@12283399@12286407@8@chr8:12283399-12286407@6.64@34@3@0.0882@CNVR3786.4, CNVR3786.16@FAM86B2_8, FAM86B2_7, FAM86B2_6@0@0@0@:family with sequence similarity 86, member B2@NA@NA
A2463_14@83673@83673@duplication@1@86573700@86575726@8@chr8:86573700-86575726@5.69@277@403@1.45@CNVR3955.1@REXO1L1_1@0@0@0@:exonuclease GOR-like;REX1, RNA exonuclease 1 homolog (S. cerevisiae)-like 1@:intracellular;nucleus;exonuclease activity;nucleic acid binding;cytoplasm@NA
A2463_14@85066@85080@duplication@15@121500400@121587465@8@chr8:121500400-121587465@41.5@1491@2144@1.44@NA@MTBP_12, MTBP_13, MTBP_14, MTBP_15, MTBP_16, MTBP_17, MTBP_18, MTBP_19, MTBP_20, MTBP_21, MTBP_22, SNTB1_8, SNTB1_7, SNTB1_6, SNTB1_5@0@0@0@:Mdm2, transformed 3T3 cell double minute 2, p53 binding protein (mouse) binding protein, 104kDa:syntrophin, beta 1 (dystrophin-associated protein A1, 59kDa, basic component 1)@:protein binding;negative regulation of cell proliferation;cell cycle arrest;traversing start control point of mitotic cell cycle:PDZ domain binding;phospholipid binding;calmodulin binding;sarcolemma;protein complex;cytoplasm;actin binding;dystrophin-associated glycoprotein complex;protein binding;synapse;cell junction;cytoskeleton;muscle contraction@NA
A2463_14@88493@88497@duplication@5@39085734@39102712@9@chr9:39085734-39102712@6.14@369@495@1.34@NA@CNTNAP3_21, CNTNAP3_20, CNTNAP3_19, CNTNAP3_18, CNTNAP3_17@0@0@0@:contactin associated protein-like 3@:binding;signal transduction;protein binding;integral to membrane;extracellular region;cell adhesion;plasma membrane;cell recognition;receptor binding@NA
A2463_14@88529@88529@duplication@1@40715850@40716325@9@chr9:40715850-40716325@8.96@295@473@1.6@NA@FAM74A3_1@0@0@0@NA@NA@NA
A2463_14@88584@88590@deletion@7@43624656@43737520@9@chr9:43624656-43737520@36.6@1529@769@0.503@NA@SPATA31A6_4, SPATA31A6_3, SPATA31A6_2, SPATA31A6_1, CNTNAP3B_1, CNTNAP3B_2, CNTNAP3B_3@0@0@0@:SPATA31 subfamily A, member 6:contactin associated protein-like 3B;contactin associated protein-like 3@:integral to membrane:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
A2463_14@88593@88604@deletion@12@43816638@43891712@9@chr9:43816638-43891712@48@715@340@0.476@NA@CNTNAP3B_6, CNTNAP3B_7, CNTNAP3B_8, CNTNAP3B_9, CNTNAP3B_10, CNTNAP3B_11, CNTNAP3B_12, CNTNAP3B_13, CNTNAP3B_14, CNTNAP3B_15, CNTNAP3B_16, CNTNAP3B_17@0@0@0@:contactin associated protein-like 3B;contactin associated protein-like 3@:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
A2463_14@88622@88622@duplication@1@45733589@45733965@9@chr9:45733589-45733965@6.11@45@99@2.2@CNVR4305.1, CNVR4305.7@FAM27E2_1@0@0@0@NA@NA@NA
A2463_14@88631@88633@duplication@3@65503517@65508193@9@chr9:65503517-65508193@5.52@132@200@1.52@CNVR4312.5@SPATA31A7_4, SPATA31A7_3, SPATA31A7_2@0@0@0@:SPATA31 subfamily A, member 7@:integral to membrane@NA
A2463_14@88644@88644@duplication@1@67938604@67938658@9@chr9:67938604-67938658@10.2@213@374@1.76@NA@ANKRD20A1_6@0@0@0@:ankyrin repeat domain 20 family, member A1@:protein binding;plasma membrane@NA
A2463_14@88652@88656@deletion@5@67966594@67985922@9@chr9:67966594-67985922@7.57@779@542@0.696@NA@ANKRD20A1_14, ANKRD20A1_15, RP11-195B21.3_3, RP11-195B21.3_4, RP11-195B21.3_5@0@0@0@:ankyrin repeat domain 20 family, member A1:coiled-coil domain-containing protein 29-like;uncharacterized LOC644249@:protein binding;plasma membrane@NA
A2463_14@88681@88690@duplication@10@69393823@69424176@9@chr9:69393823-69424176@21.6@552@863@1.56@NA@ANKRD20A4_6, ANKRD20A4_7, ANKRD20A4_8, ANKRD20A4_9, ANKRD20A4_10, ANKRD20A4_11, ANKRD20A4_12, ANKRD20A4_13, ANKRD20A4_14, ANKRD20A4_15@0@0@0@:ankyrin repeat domain 20 family, member A4@:protein binding@NA
A2463_14@88722@88723@deletion@2@70912497@70912733@9@chr9:70912497-70912733@7.24@92@40@0.435@NA@CBWD3_12, CBWD3_13@0@0@0@:COBW domain-containing protein 5-like;COBW domain-containing protein 1-like;COBW domain containing 3@:ATP binding@NA
A2463_14@95355@95386@deletion@32@17891584@18122792@10@chr10:17891584-18122792@25.6@224@77@0.344@NA@MRC1L1_7, MRC1L1_8, MRC1L1_9, MRC1L1_10, MRC1L1_11, MRC1L1_12, MRC1L1_13, MRC1L1_14, MRC1L1_15, MRC1L1_16, MRC1L1_17, MRC1L1_18, MRC1L1_19, MRC1L1_20, MRC1L1_21, MRC1L1_22, MRC1L1_23, MRC1L1_24, MRC1L1_25, MRC1L1_26, MRC1L1_27, MRC1L1_28, MRC1L1_29, MRC1L1_30, TMEM236_1, TMEM236_2, TMEM236_3, TMEM236_4, MRC1_1, MRC1_2, MRC1_3, MRC1_4@0@0@0@:macrophage mannose receptor 1-like:transmembrane protein 236;transmembrane protein 236-like:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding:integral to membrane:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
A2463_14@96466@96470@deletion@5@46584433@46611811@10@chr10:46584433-46611811@10.7@57@6@0.105@CNVR4712.3@PTPN20A_6, PTPN20A_5, PTPN20A_4, PTPN20A_3, PTPN20A_2@0@0@0@:protein tyrosine phosphatase, non-receptor type 20B;protein tyrosine phosphatase, non-receptor type 20A@:phosphatase activity;protein tyrosine phosphatase activity;microtubule;nucleus;dephosphorylation;protein dephosphorylation;microtubule organizing center@NA
A2463_14@96512@96520@duplication@9@47669068@47684552@10@chr10:47669068-47684552@7.16@479@630@1.32@CNVR4713.1@ANTXRL_8, ANTXRL_9, ANTXRL_10, ANTXRL_11, ANTXRL_12, ANTXRL_13, ANTXRL_14, ANTXRL_15, ANTXRL_16@0@0@0@@:protein binding;integral to membrane;receptor activity;metal ion binding@NA
A2463_14@96620@96620@deletion@1@48771316@48771405@10@chr10:48771316-48771405@14.3@67@0@0@CNVR4716.10, CNVR4716.3@PTPN20B_6@0@0@0@:protein tyrosine phosphatase, non-receptor type 20B;protein tyrosine phosphatase, non-receptor type 20A@:phosphatase activity;protein tyrosine phosphatase activity;microtubule;nucleus;dephosphorylation;protein dephosphorylation;microtubule organizing center@NA
A2463_14@96631@96633@duplication@3@49376639@49381136@10@chr10:49376639-49381136@5.27@72@121@1.68@CNVR4717.2@FRMPD2_27, FRMPD2_26, FRMPD2_25@0@0@0@:FERM and PDZ domain containing 2@:basolateral plasma membrane;transferase activity, transferring phosphorus-containing groups;cytoplasm;tight junction;protein binding;cytoskeleton;1-phosphatidylinositol binding;tight junction assembly@NA
A2463_14@96923@96939@deletion@17@51892567@51994312@10@chr10:51892567-51994312@21.9@187@62@0.332@NA@FAM21A_31, ASAH2_20, ASAH2_19, ASAH2_18, ASAH2_17, ASAH2_16, ASAH2_15, ASAH2_14, ASAH2_13, ASAH2_12, ASAH2_11, ASAH2_10, ASAH2_9, ASAH2_8, ASAH2_7, ASAH2_6, ASAH2_5@0@0@0@:family with sequence similarity 21, member B;family with sequence similarity 21, member A:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
A2463_14@98005@98005@duplication@1@75436478@75436528@10@chr10:75436478-75436528@4.77@35@75@2.14@CNVR4799.1@AGAP5_7@0@0@0@:ankyrin repeat and GTPase domain Arf GTPase activating protein 11;ArfGAP with GTPase domain, ankyrin repeat and PH domain 5;ArfGAP with GTPase domain, ankyrin repeat and PH domain 10;arf-GAP with GTPase, ANK repeat and PH domain-containing protein 5-like@:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity@NA
A2463_14@98350@98350@deletion@1@81471457@81472241@10@chr10:81471457-81472241@14.4@168@56@0.333@CNVR4815.2, CNVR4815.4@FAM22B_7@0@0@0@NA@NA@NA
A2463_14@98355@98357@duplication@3@81608270@81610362@10@chr10:81608270-81610362@9.18@86@173@2.01@NA@FAM22E_5, FAM22E_6, FAM22E_7@0@0@0@NA@NA@NA
A2463_14@101620@101622@deletion@3@124359581@124361636@10@chr10:124359581-124361636@8.75@55@11@0.2@CNVR4912.1@DMBT1_27, DMBT1_28, DMBT1_29@0@0@0@:deleted in malignant brain tumors 1@:defense response to virus;calcium-dependent protein binding;pattern recognition receptor signaling pathway;blastocyst development;response to estrogen stimulus;tissue regeneration;proteinaceous extracellular matrix;protein transport;Gram-negative bacterial cell surface binding;positive regulation of epithelial cell differentiation;virus-host interaction;epithelial cell differentiation;induction of bacterial agglutination;phagocytic vesicle membrane;intracellular;Gram-positive bacterial cell surface binding;zymogen binding;innate immune response;cytoplasm;extrinsic to membrane;protein binding;zymogen granule membrane;extracellular region;scavenger receptor activity;pattern recognition receptor activity;inner cell mass cell proliferation;membrane@: GLIOMA SUSCEPTIBILITY 1; GLM1
A2463_14@103289@103289@deletion@1@5270599@5270820@11@chr11:5270599-5270820@5.31@58@23@0.397@NA@HBG1_2@0@0@0@:hemoglobin, gamma A@:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex@NA
A2463_14@104572@104572@deletion@1@18955364@18956331@11@chr11:18955364-18956331@4.33@180@111@0.617@CNVR5091.2, CNVR5091.1@MRGPRX1_1@0@0@0@:MAS-related GPR, member X1@:integral to membrane;G-protein coupled receptor activity;plasma membrane;acute-phase response;G-protein coupled receptor signaling pathway@NA
A2463_14@106047@106048@deletion@2@55405835@55419315@11@chr11:55405835-55419315@5.94@417@275@0.659@CNVR5179.1@OR4P4_1, OR4S2_1@0@0@0@:olfactory receptor, family 4, subfamily P, member 4:olfactory receptor, family 4, subfamily S, member 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_14@114136@114139@deletion@4@8374419@8377428@12@chr12:8374419-8377428@20.8@1172@685@0.584@CNVR5422.3, CNVR5422.5, CNVR5422.6, CNVR5422.1@FAM90A1_7, FAM90A1_6, FAM90A1_5, FAM90A1_4@0@0@0@:family with sequence similarity 90, member A1@:zinc ion binding;nucleic acid binding@NA
A2463_14@117094@117094@deletion@1@52681381@52681505@12@chr12:52681381-52681505@5.23@74@34@0.459@CNVR5534.1@KRT81_6@0@0@0@:keratin 86:keratin 86:keratin 81@:intermediate filament;structural molecule activity;keratin filament;cytoskeleton organization:intermediate filament;structural molecule activity;keratin filament;cytoskeleton organization:protein binding;structural molecule activity;keratin filament@: MONILETHRIX: MONILETHRIX: MONILETHRIX
A2463_14@127335@127339@duplication@5@19558992@19571418@14@chr14:19558992-19571418@15.3@442@659@1.49@CNVR6072.1@POTEG_3, POTEG_4, POTEG_5, POTEG_6, POTEG_7@0@0@0@:POTE ankyrin domain family, member G@:protein binding@NA
A2463_14@127346@127352@duplication@7@20002226@20020220@14@chr14:20002226-20020220@26.3@338@611@1.81@CNVR6072.6, CNVR6072.12@POTEM_7, POTEM_6, POTEM_5, POTEM_4, POTEM_3, POTEM_2, POTEM_1@0@0@0@:POTE ankyrin domain family, member M@:protein binding@NA
A2463_14@133345@133346@deletion@2@106066404@106067141@14@chr14:106066404-106067141@5.49@210@132@0.629@CNVR6294.46, CNVR6294.20, CNVR6294.60, CNVR6294.54@IGHE_4, IGHE_3@0@0@0@@:antigen binding;protein binding;immune response@NA
A2463_14@133409@133414@deletion@6@106373070@106380248@14@chr14:106373070-106380248@15.2@161@65@0.404@CNVR6294.27, CNVR6294.36, CNVR6294.48, CNVR6294.25, CNVR6294.57, CNVR6294.29@IGHD2-8_1, IGHD1-7_1, IGHD6-6_1, IGHD5-5_1, IGHD4-4_1, IGHD3-3_1@0@0@0@NA@NA@NA
A2463_14@133432@133435@deletion@4@106539080@106552729@14@chr14:106539080-106552729@31.2@145@1@0.0069@CNVR6294.36, CNVR6294.48, CNVR6294.24, CNVR6294.10, CNVR6294.34@IGHV1-8_2, IGHV1-8_1, IGHV3-9_2, IGHV3-9_1@0@0@0@@:protein binding:protein binding@NA
A2463_14@133460@133462@duplication@3@106805210@106816026@14@chr14:106805210-106816026@5.29@131@196@1.5@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.41@IGHV4-31_2, IGHV4-31_1, IGHV3-33_2@0@0@0@@:protein binding:protein binding@NA
A2463_14@133489@133491@deletion@3@107083241@107095433@14@chr14:107083241-107095433@7.68@167@92@0.551@CNVR6294.56, CNVR6294.16, CNVR6294.91, CNVR6294.30@IGHV4-59_2, IGHV4-59_1, IGHV4-61_2@0@0@0@@:protein binding:protein binding@NA
A2463_14@133542@133542@deletion@1@22382474@22383423@15@chr15:22382474-22383423@8.65@365@207@0.567@CNVR6297.4, CNVR6297.17, CNVR6297.2@OR4N4_1@0@0@0@:olfactory receptor, family 4, subfamily N, member 4@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_14@133646@133662@deletion@17@23602444@23610281@15@chr15:23602444-23610281@25.5@549@313@0.57@CNVR6301.3@GOLGA8S_3, GOLGA8S_4, GOLGA8S_5, GOLGA8S_6, GOLGA8S_7, GOLGA8S_8, GOLGA8S_9, GOLGA8S_10, GOLGA8S_11, GOLGA8S_12, GOLGA8S_13, GOLGA8S_14, GOLGA8S_15, GOLGA8S_16, GOLGA8S_17, GOLGA8S_18, GOLGA8S_19@0@0@0@@:Golgi apparatus@NA
A2463_14@133906@133912@deletion@7@28950630@28953319@15@chr15:28950630-28953319@15.1@389@226@0.581@CNVR6331.1@GOLGA8M_12, GOLGA8M_11, GOLGA8M_10, GOLGA8M_9, GOLGA8M_8, GOLGA8M_7, GOLGA8M_6@0@0@0@:golgin A8 family, member M@:Golgi apparatus@NA
A2463_14@134162@134165@deletion@4@32686347@32688744@15@chr15:32686347-32688744@6.24@97@50@0.515@NA@GOLGA8K_15, GOLGA8K_14, GOLGA8K_13, GOLGA8K_12@0@0@0@:golgin A8 family, member J@:Golgi apparatus@NA
A2463_14@135681@135681@duplication@1@43873426@43873586@15@chr15:43873426-43873586@6.36@238@359@1.51@CNVR6365.1@PPIP5K1_9@0@0@0@:diphosphoinositol pentakisphosphate kinase 1@:inositol hexakisphosphate 3-kinase activity;inositol hexakisphosphate 1-kinase activity;inositol metabolic process;diphosphoinositol-pentakisphosphate kinase activity;ATP binding;acid phosphatase activity;cytoplasm;cytosol;inositol hexakisphosphate 5-kinase activity;nucleus;kinase activity;inositol-1,3,4,5,6-pentakisphosphate kinase activity@NA
A2463_14@135714@135721@deletion@8@43903698@43906674@15@chr15:43903698-43906674@7.91@37@1@0.027@CNVR6365.1@STRC_12, STRC_11, STRC_10, STRC_9, STRC_8, STRC_7, STRC_6, STRC_5@0@0@0@:diphosphoinositol pentakisphosphate kinase 1:stereocilin@:inositol hexakisphosphate 3-kinase activity;inositol hexakisphosphate 1-kinase activity;inositol metabolic process;diphosphoinositol-pentakisphosphate kinase activity;ATP binding;acid phosphatase activity;cytoplasm;cytosol;inositol hexakisphosphate 5-kinase activity;nucleus;kinase activity;inositol-1,3,4,5,6-pentakisphosphate kinase activity:detection of mechanical stimulus involved in sensory perception of sound;stereocilium bundle tip;stereocilium;cell surface;kinocilium;auditory receptor cell stereocilium organization@: DEAFNESS, AUTOSOMAL RECESSIVE 16; DFNB16; DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY
A2463_14@138281@138289@deletion@9@72953606@72958226@15@chr15:72953606-72958226@35.1@328@113@0.345@CNVR6443.1@GOLGA6B_8, GOLGA6B_9, GOLGA6B_10, GOLGA6B_11, GOLGA6B_12, GOLGA6B_13, GOLGA6B_14, GOLGA6B_15, GOLGA6B_16@0@0@0@:golgin A6 family, member B@:Golgi apparatus@NA
A2463_14@140476@140483@deletion@8@64382@67750@16@chr16:64382-67750@22.8@225@83@0.369@CNVR6565.1@WASH4P_10, WASH4P_9, WASH4P_8, WASH4P_7, WASH4P_6, WASH4P_5, WASH4P_4, WASH4P_3@0@0@0@@:intracellular membrane-bounded organelle;endosomal transport;recycling endosome;early endosome;Arp2/3 complex-mediated actin nucleation;actin binding;alpha-tubulin binding;retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;recycling endosome membrane@NA
A2463_14@142690@142690@deletion@1@15045473@15045882@16@chr16:15045473-15045882@5.32@99@50@0.505@NA@NPIP_8@0@0@0@:nuclear pore complex-interacting protein-like;nuclear pore complex interacting protein;nuclear pore complex-interacting protein-like 1-like@:nuclear membrane;protein transport;nuclear pore;mRNA transport@NA
A2463_14@143477@143477@deletion@1@21742159@21742251@16@chr16:21742159-21742251@8.19@52@9@0.173@CNVR6668.5, CNVR6668.2, CNVR6668.7@OTOA_20@0@0@0@:otoancorin@:proteinaceous extracellular matrix;apical plasma membrane;sensory perception of sound;anchored to membrane@: DEAFNESS, AUTOSOMAL RECESSIVE 22; DFNB22
A2463_14@143482@143488@deletion@7@21763691@21849065@16@chr16:21763691-21849065@16.3@238@113@0.475@CNVR6668.5, CNVR6668.2, CNVR6668.7@OTOA_25, OTOA_26, OTOA_27, OTOA_28, NPIPL3_9, NPIPL3_8, NPIPL3_7@0@0@0@:otoancorin:nuclear pore complex interacting protein-like 3;nuclear pore complex interacting protein-like;nuclear pore complex-interacting protein-like 3-like@:proteinaceous extracellular matrix;apical plasma membrane;sensory perception of sound;anchored to membrane@: DEAFNESS, AUTOSOMAL RECESSIVE 22; DFNB22
A2463_14@143493@143493@deletion@1@21858735@21858862@16@chr16:21858735-21858862@4.98@71@33@0.465@CNVR6668.5, CNVR6668.7@NPIPL3_2@0@0@0@:nuclear pore complex interacting protein-like 3;nuclear pore complex interacting protein-like;nuclear pore complex-interacting protein-like 3-like@NA@NA
A2463_14@144038@144039@deletion@2@28403074@28403463@16@chr16:28403074-28403463@10.4@48@1@0.0208@CNVR6684.2@EIF3CL_10, EIF3CL_9@0@0@0@:eukaryotic translation initiation factor 3, subunit C-like@:protein binding;eukaryotic translation initiation factor 3 complex;translational initiation;translation initiation factor activity@NA
A2463_14@144047@144052@duplication@6@28467746@28478223@16@chr16:28467746-28478223@7.91@133@219@1.65@NA@NPIPL1_7, NPIPL1_6, NPIPL1_5, NPIPL1_4, NPIPL1_3, NPIPL1_2@0@0@0@:ceroid-lipofuscinosis, neuronal 3@:membrane:negative regulation of apoptotic process;late endosome;mitochondrion;galactosylceramide metabolic process;neuromuscular process controlling balance;neuron projection;lysosomal lumen pH elevation;integral to endoplasmic reticulum membrane;cell death;plasma membrane;nucleus;lysosomal lumen acidification;negative regulation of catalytic activity;negative regulation of macroautophagy;unfolded protein binding;neurotransmitter metabolic process;endoplasmic reticulum;vesicle transport along microtubule;protein catabolic process;autophagic vacuole;early endosome;trans-Golgi network;cellular membrane organization;ceramide metabolic process;glucosylceramide metabolic process;negative regulation of neuron apoptotic process;membrane;globoside metabolic process;membrane raft;synaptic vesicle;vacuolar transport;protein processing;Golgi membrane;caveola;protein folding;ionotropic glutamate receptor signaling pathway;cytosolic calcium ion homeostasis;Golgi stack;integral to membrane;receptor-mediated endocytosis;arginine transport;lysosome;negative regulation of proteolysis;Golgi apparatus;lysosome organization;associative learning;sphingomyelin metabolic process;macroautophagy;lysosomal membrane;amyloid precursor protein catabolic process;cytoplasm;autophagic vacuole fusion;protein binding;regulation of action potential;cellular amino acid metabolic process@: CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3
A2463_14@144096@144102@deletion@7@28617143@28620176@16@chr16:28617143-28620176@10.4@465@302@0.649@CNVR6685.1, CNVR6685.2@SULT1A1_10, SULT1A1_9, SULT1A1_8, SULT1A1_7, SULT1A1_6, SULT1A1_5, SULT1A1_4@0@0@0@:sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1@:small molecule metabolic process;sulfation;aryl sulfotransferase activity;amine metabolic process;catecholamine metabolic process;xenobiotic metabolic process;cytosol;steroid sulfotransferase activity;integral to membrane;sulfotransferase activity;flavonol 3-sulfotransferase activity;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process;estrogen metabolic process@NA
A2463_14@145013@145013@deletion@1@32264676@32265036@16@chr16:32264676-32265036@5.75@174@99@0.569@CNVR6701.6, CNVR6701.2@TP53TG3D_1@0@0@0@:TP53 target 3B;TP53 target 3;TP53-target gene 3 protein-like;TP53 target 3C@:nucleus;cytoplasm@NA
A2463_14@147101@147101@duplication@1@70010292@70010635@16@chr16:70010292-70010635@5.67@118@192@1.63@CNVR6762.3, CNVR6762.2@RP11-419C5.2_7@0@0@0@NA@NA@NA
A2463_14@147423@147423@deletion@1@72097156@72097159@16@chr16:72097156-72097159@8.72@57@11@0.193@CNVR6769.1@HPR_1@0@0@0@:thioredoxin-like 4B:haptoglobin-related protein@:mitosis;mRNA processing;RNA splicing;spliceosomal complex;cell redox homeostasis:spherical high-density lipoprotein particle;proteolysis;extracellular region;hemoglobin binding;catalytic activity;serine-type endopeptidase activity@NA
A2463_14@147505@147510@deletion@6@74443751@74446778@16@chr16:74443751-74446778@8.8@297@187@0.63@CNVR6778.2, CNVR6778.3, CNVR6778.5@CLEC18B_11, CLEC18B_10, CLEC18B_9, CLEC18B_8, CLEC18B_7, CLEC18B_6@0@0@0@:C-type lectin domain family 18, member B@:carbohydrate binding;protein binding;extracellular region@NA
A2463_14@147833@147833@deletion@1@81272515@81272577@16@chr16:81272515-81272577@6.97@97@42@0.433@NA@BCMO1_1@0@0@0@:beta-carotene 15,15'-monooxygenase 1@:steroid metabolic process;small molecule metabolic process;retinoid metabolic process;retinal metabolic process;vitamin A biosynthetic process;cytosol;retinol metabolic process;monooxygenase activity;beta-carotene 15,15'-monooxygenase activity;metal ion binding@: HYPERCAROTENEMIA AND VITAMIN A DEFICIENCY, AUTOSOMAL DOMINANT
A2463_14@151415@151415@deletion@1@15517148@15517347@17@chr17:15517148-15517347@8.24@68@19@0.279@NA@CDRT1_3, TRIM16_9@0@0@0@:CMT1A duplicated region transcript 1@:protein binding;molecular_function;cellular_component;biological_process:protein binding;intracellular;zinc ion binding;cytoplasm@NA
A2463_14@153378@153394@deletion@17@34523998@34590454@17@chr17:34523998-34590454@18.5@91@6@0.0659@CNVR7077.1, CNVR7077.13, CNVR7077.19@CCL3L3_1, CCL4L1_1, CCL4L1_2, CCL4L1_3, TBC1D3C_14, TBC1D3C_13, TBC1D3C_12, TBC1D3C_11, TBC1D3C_10, TBC1D3C_9, TBC1D3C_8, TBC1D3C_7, TBC1D3C_6, TBC1D3C_5, TBC1D3C_4, TBC1D3C_3, TBC1D3C_2@0@0@0@:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1:TBC1 domain family, member 3C;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3H-like;TBC1 domain family, member 3H@:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_14@153414@153414@deletion@1@34797487@34798054@17@chr17:34797487-34798054@8.13@38@1@0.0263@CNVR7078.2, CNVR7078.3@TBC1D3G_14@0@0@0@:TBC1 domain family member 3H-like;TBC1 domain family, member 3H:TBC1 domain family, member 3;TBC1 domain family, member 3G;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like;TBC1 domain family, member 3H@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_14@155585@155590@duplication@6@44382876@44409347@17@chr17:44382876-44409347@18.7@319@540@1.69@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A_4, LRRC37A_5, LRRC37A_6, LRRC37A_7, LRRC37A_8, LRRC37A_9@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
A2463_14@155593@155609@duplication@17@44414663@44630815@17@chr17:44414663-44630815@52.1@1737@2676@1.54@CNVR7114.2, CNVR7114.1@LRRC37A_12, LRRC37A_13, LRRC37A_14, ARL17B_4, ARL17B_3, ARL17B_2, LRRC37A2_2, LRRC37A2_3, LRRC37A2_4, LRRC37A2_5, LRRC37A2_6, LRRC37A2_7, LRRC37A2_8, LRRC37A2_9, LRRC37A2_10, LRRC37A2_11, LRRC37A2_12@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
A2463_14@155593@155611@deletion@2@44414663@44632790@17@chr17:44414663-44632790@-104@1904@2773@1.46@CNVR7114.2, CNVR7114.1@LRRC37A_12, LRRC37A_13, LRRC37A_14, ARL17B_4, ARL17B_3, ARL17B_2, LRRC37A2_2, LRRC37A2_3, LRRC37A2_4, LRRC37A2_5, LRRC37A2_6, LRRC37A2_7, LRRC37A2_8, LRRC37A2_9, LRRC37A2_10, LRRC37A2_11, LRRC37A2_12, LRRC37A2_13, LRRC37A2_14@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
A2463_14@162017@162018@deletion@2@44542732@44550298@18@chr18:44542732-44550298@62.9@328@3@0.00915@CNVR7319.1, CNVR7319.2@TCEB3CL2_1, TCEB3CL_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2:transcription elongation factor B polypeptide 3C-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_14@164951@164956@deletion@6@7032325@7056914@19@chr19:7032325-7056914@13.2@218@109@0.5@CNVR7517.1@MBD3L5_2, MBD3L4_2, MBD3L4_1, MBD3L2_1, MBD3L2_2, MBD3L3_2@0@0@0@:methyl-CpG binding domain protein 3-like 5:methyl-CpG binding domain protein 3-like 4:methyl-CpG-binding domain protein 3-like 2-like;methyl-CpG binding domain protein 3-like 2:methyl-CpG binding domain protein 3-like 3@:regulation of transcription, DNA-dependent;transcription, DNA-dependent:regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_14@167243@167244@duplication@2@15784341@15789215@19@chr19:15784341-15789215@5.62@11@47@4.27@CNVR7553.1@CYP4F12_2, CYP4F12_3@0@0@0@:cytochrome P450, family 4, subfamily F, polypeptide 12@:pressure natriuresis;negative regulation of blood coagulation;oxidation-reduction process;very long-chain fatty acid metabolic process;arachidonic acid metabolic process;aromatase activity;sodium ion homeostasis;renal water homeostasis;arachidonic acid epoxygenase activity;integral to membrane;leukotriene B4 catabolic process;endoplasmic reticulum membrane;epoxygenase P450 pathway;electron carrier activity;intracellular membrane-bounded organelle;drug metabolic process;alkane 1-monooxygenase activity;small molecule metabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;apical plasma membrane;heme binding;vitamin E metabolic process;cytoplasm;vitamin-K-epoxide reductase (warfarin-sensitive) activity;xenobiotic metabolic process;vitamin K biosynthetic process;leukotriene-B4 20-monooxygenase activity;long-chain fatty acid metabolic process;iron ion binding@NA
A2463_14@169783@169783@deletion@1@39281330@39281530@19@chr19:39281330-39281530@5.88@92@43@0.467@NA@LGALS7B_3@0@0@0@:lectin, galactoside-binding, soluble, 7;lectin, galactoside-binding, soluble, 7B@:carbohydrate binding;heterophilic cell-cell adhesion;extracellular space;nucleus;apoptotic process;cytoplasm@NA
A2463_14@170808@170812@deletion@5@43570710@43586721@19@chr19:43570710-43586721@19.3@369@190@0.515@CNVR7658.4, CNVR7658.5@PSG2_5, PSG2_4, PSG2_3, PSG2_2, PSG2_1@0@0@0@:pregnancy specific beta-1-glycoprotein 2@:protein binding;extracellular region;female pregnancy;cell migration;molecular_function;cellular_component@NA
A2463_14@173295@173298@deletion@4@54724399@54726434@19@chr19:54724399-54726434@6.42@88@42@0.477@CNVR7721.3, CNVR7721.4@LILRB3_6, LILRB3_5, LILRB3_4, LILRB3_3@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
A2463_14@173457@173469@deletion@13@55239078@55263971@19@chr19:55239078-55263971@71.5@356@19@0.0534@CNVR7725.2, CNVR7725.1@KIR3DL3_4, KIR3DL3_5, KIR3DL3_6, KIR3DL3_7, KIR3DL3_8, KIR2DL3_1, KIR2DL3_2, KIR2DL3_3, KIR2DL3_4, KIR2DL3_5, KIR2DL3_6, KIR2DL3_7, KIR2DL3_8@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:integral to membrane;plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity@NA
A2463_14@173473@173474@deletion@2@55286618@55290114@19@chr19:55286618-55290114@8.27@54@11@0.204@CNVR7725.2, CNVR7725.1@KIR2DL1_4, KIR2DL1_5@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane@NA
A2463_14@173479@173501@deletion@23@55315347@55359398@19@chr19:55315347-55359398@58.2@910@459@0.504@CNVR7725.1, CNVR7725.6@KIR2DL4_2, KIR2DL4_3, KIR2DL4_4, KIR2DL4_5, KIR2DL4_6, KIR2DL4_7, KIR3DL1_1, KIR3DL1_2, KIR3DL1_3, KIR3DL1_4, KIR3DL1_5, KIR3DL1_6, KIR3DL1_7, KIR3DL1_8, KIR3DL1_9, KIR2DS4_1, KIR2DS4_2, KIR2DS4_3, KIR2DS4_4, KIR2DS4_5, KIR2DS4_6, KIR2DS4_7, KIR2DS4_8@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane@NA
A2463_14@175736@175737@deletion@2@26061801@26063616@20@chr20:26061801-26063616@22.4@105@1@0.00952@CNVR7823.4, CNVR7823.3, CNVR7823.5, CNVR7823.1@FAM182A_4, FAM182A_5@0@0@0@NA@NA@NA
A2463_14@179020@179021@duplication@2@15011837@15013887@21@chr21:15011837-15013887@17.5@83@253@3.05@CNVR7952.1@POTED_10, POTED_11@0@0@0@:POTE ankyrin domain family, member B;POTE ankyrin domain family, member C;POTE ankyrin domain family, member D@:protein binding;plasma membrane@NA
A2463_14@180968@180970@duplication@3@16266930@16269943@22@chr22:16266930-16269943@8@240@366@1.52@CNVR8071.2, CNVR8071.3@POTEH_9, POTEH_8, POTEH_7@0@0@0@:POTE ankyrin domain family, member H@:protein binding@NA
A2463_14@180976@180976@duplication@1@16287255@16287885@22@chr22:16287255-16287885@5.54@195@292@1.5@CNVR8071.2, CNVR8071.3, CNVR8071.9@POTEH_1@0@0@0@:POTE ankyrin domain family, member H@:protein binding@NA
A2463_14@180979@180979@deletion@1@17264510@17265299@22@chr22:17264510-17265299@13.6@63@0@0@NA@XKR3_4@0@0@0@:XK, Kell blood group complex subunit-related family, member 3@:integral to membrane;plasma membrane@NA
A2463_14@181133@181134@deletion@2@18739383@18835833@22@chr22:18739383-18835833@12.1@122@41@0.336@CNVR8087.5, CNVR8087.2, CNVR8087.7@AC008132.1_8, AC008132.13_1@0@0@0@NA@NA@NA
A2463_14@181733@181734@deletion@2@22707290@22707781@22@chr22:22707290-22707781@7.64@61@18@0.295@CNVR8103.20, CNVR8103.5, CNVR8103.2, CNVR8103.12, CNVR8103.10, CNVR8103.9, CNVR8103.22@IGLV5-48_1, IGLV5-48_2@0@0@0@@:protein binding@NA
A2463_14@181806@181808@duplication@3@23243157@23248831@22@chr22:23243157-23248831@10.2@252@381@1.51@CNVR8103.2, CNVR8103.1, CNVR8103.6, CNVR8103.11@IGLC2_1, IGLJ3_1, IGLC3_1@0@0@0@@:protein binding:protein binding@NA
A2463_14@183631@183631@deletion@1@39357393@39357686@22@chr22:39357393-39357686@4.83@39@12@0.308@CNVR8164.1@APOBEC3A_4@0@0@0@:apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A;APOBEC3A and APOBEC3B deletion hybrid@:cytidine deamination;defense response to virus;negative regulation of viral genome replication;DNA cytosine deamination;clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine;catalytic activity;DNA demethylation;cytoplasm;innate immune response;cytidine deaminase activity;nucleus;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines;cellular response to xenobiotic stimulus;zinc ion binding;negative regulation of transposition@NA
A2463_13@5@7@duplication@3@54831@139309@1@chr1:54831-139309@12.2@769@1048@1.36@CNVR1.2@AL627309.2_2, OR4F5_1, AL627309.1_1@0@0@0@:olfactory receptor, family 4, subfamily F, member 5@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_13@397@399@duplication@3@1572771@1573952@1@chr1:1572771-1573952@8.08@186@279@1.5@CNVR17.1@CDK11B_15, CDK11B_14, CDK11B_13@0@0@0@:cyclin-dependent kinase 11B@:protein serine/threonine kinase activity;protein tyrosine kinase activity;protein phosphorylation;protein kinase activity;cell division;transferase activity, transferring phosphorus-containing groups;ATP binding@NA
A2463_13@405@406@deletion@2@1580488@1580858@1@chr1:1580488-1580858@6.65@294@185@0.629@CNVR17.1@CDK11B_7, CDK11B_6@0@0@0@:cyclin-dependent kinase 11B@:protein serine/threonine kinase activity;protein tyrosine kinase activity;protein phosphorylation;protein kinase activity;cell division;transferase activity, transferring phosphorus-containing groups;ATP binding@NA
A2463_13@418@418@duplication@1@1607504@1607638@1@chr1:1607504-1607638@4.73@67@113@1.69@CNVR17.1@SLC35E2B_4@0@0@0@:solute carrier family 35, member E2B@:integral to membrane;membrane;transmembrane transport@NA
A2463_13@422@422@deletion@1@1634916@1635063@1@chr1:1634916-1635063@7.29@42@6@0.143@CNVR17.1@CDK11A_18@0@0@0@:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A@:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division@NA
A2463_13@426@429@deletion@4@1635990@1639023@1@chr1:1635990-1639023@24.8@183@48@0.262@CNVR17.1@CDK11A_14, CDK11A_13, CDK11A_12, CDK11A_11@0@0@0@:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A@:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division@NA
A2463_13@434@434@duplication@1@1643704@1643839@1@chr1:1643704-1643839@12.9@11@97@8.82@CNVR17.1@CDK11A_6@0@0@0@:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A@:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division@NA
A2463_13@438@440@duplication@3@1654148@1666274@1@chr1:1654148-1666274@21.1@297@522@1.76@CNVR17.1@CDK11A_2, SLC35E2_6, SLC35E2_5@0@0@0@:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A:solute carrier family 35, member E2@:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division:integral to membrane;membrane@NA
A2463_13@1835@1838@duplication@4@13330415@13366425@1@chr1:13330415-13366425@9.14@54@122@2.26@CNVR74.8, CNVR74.4@PRAMEF3_2, PRAMEF3_1, PRAMEF5_2, PRAMEF5_3@0@0@0@:PRAME family member 3:PRAME family member 5@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_13@1861@1864@duplication@4@13668906@13696098@1@chr1:13668906-13696098@7.44@173@262@1.51@CNVR76.2, CNVR76.5@PRAMEF14_4, PRAMEF14_3, PRAMEF14_2, PRAMEF19_3@0@0@0@:PRAME family member 14:PRAME family member 19@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_13@1869@1869@deletion@1@13718405@13718962@1@chr1:13718405-13718962@4.77@67@32@0.478@CNVR76.2@PRAMEF17_3@0@0@0@:PRAME family member 17@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_13@2788@2792@duplication@5@21806545@21809879@1@chr1:21806545-21809879@8.64@299@424@1.42@CNVR107.2, CNVR107.1@NBPF3_11, NBPF3_12, NBPF3_13, NBPF3_14, NBPF3_15@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 3@:cytoplasm@NA
A2463_13@3333@3342@duplication@10@25599040@25655415@1@chr1:25599040-25655415@103@980@1943@1.98@CNVR116.1, CNVR116.2@RHD_1, RHD_2, RHD_3, RHD_4, RHD_5, RHD_6, RHD_7, RHD_8, RHD_9, RHD_10@0@0@0@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
A2463_13@8507@8508@duplication@2@89476588@89477710@1@chr1:89476588-89477710@15.7@417@650@1.56@CNVR244.1@GBP3_8, GBP3_7@0@0@0@:guanylate binding protein 3@:defense response to virus;GTP binding;GTPase activity;membrane;cytoplasm@NA
A2463_13@9365@9374@deletion@10@104202983@104234232@1@chr1:104202983-104234232@70.4@335@4@0.0119@CNVR266.3, CNVR266.1, CNVR266.15@AMY1A_7, AMY1A_8, AMY1A_9, AMY1A_10, AMY1A_11, AMY1B_11, AMY1B_10, AMY1B_9, AMY1B_8, AMY1B_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
A2463_13@9766@9773@duplication@8@110230497@110235917@1@chr1:110230497-110235917@41.1@309@648@2.1@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_1, GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
A2463_13@10793@10793@deletion@1@144339779@144340398@1@chr1:144339779-144340398@7.98@38@1@0.0263@CNVR334.4, CNVR334.2@AL592284.1_1@0@0@0@:uncharacterized LOC730256;uncharacterized LOC101060698;uncharacterized LOC642441@NA@NA
A2463_13@10795@10795@duplication@1@144520648@144520832@1@chr1:144520648-144520832@4.9@73@122@1.67@CNVR335.1, CNVR335.2@AL592284.1_2@0@0@0@:uncharacterized LOC730256;uncharacterized LOC101060698;uncharacterized LOC642441@NA@NA
A2463_13@10799@10799@duplication@1@144815937@144816008@1@chr1:144815937-144816008@8.2@69@140@2.03@CNVR338.4, CNVR338.2, CNVR338.5, CNVR338.1@NBPF9_4@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 24@NA@NA
A2463_13@10887@10887@duplication@1@145323655@145323705@1@chr1:145323655-145323705@9.21@777@1088@1.4@CNVR341.2, CNVR341.3@NBPF10_27@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family, member 10@NA@NA
A2463_13@11149@11157@deletion@9@146232495@146244717@1@chr1:146232495-146244717@8.62@56@12@0.214@NA@NBPF12_16, NBPF12_15, NBPF12_14, NBPF12_13, NBPF12_12, NBPF12_11, NBPF12_10, NBPF12_9, NBPF12_8@0@0@0@:neuroblastoma breakpoint family member 21-like@NA@NA
A2463_13@11169@11173@duplication@5@146400092@146405926@1@chr1:146400092-146405926@9.28@101@179@1.77@NA@NBPF12_9, NBPF12_10, NBPF12_11, NBPF12_12, NBPF12_13@0@0@0@:neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family member 14-like;neuroblastoma breakpoint family, member 12@:cytoplasm@NA
A2463_13@11236@11236@duplication@1@146461120@146461291@1@chr1:146461120-146461291@7.69@3@51@17@CNVR344.1, CNVR344.2@NBPF12_76@0@0@0@:neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family member 14-like;neuroblastoma breakpoint family, member 12@:cytoplasm@NA
A2463_13@11478@11483@deletion@6@148590554@148594640@1@chr1:148590554-148594640@14.4@194@87@0.448@CNVR348.1, CNVR348.4@NBPF15_16, NBPF15_17, NBPF15_18, NBPF15_19, NBPF15_20, NBPF15_21@0@0@0@:neuroblastoma breakpoint family, member 15@:cytoplasm@NA
A2463_13@11485@11498@duplication@14@148741691@148756684@1@chr1:148741691-148756684@25@78@249@3.19@CNVR349.2, CNVR349.3@NBPF16_3, NBPF16_4, NBPF16_5, NBPF16_6, NBPF16_7, NBPF16_8, NBPF16_9, NBPF16_10, NBPF16_11, NBPF16_12, NBPF16_13, NBPF16_14, NBPF16_15, NBPF16_16@0@0@0@:neuroblastoma breakpoint family, member 16@:cytoplasm@NA
A2463_13@12105@12105@deletion@1@152185553@152193966@1@chr1:152185553-152193966@17.6@3634@2264@0.623@CNVR355.2, CNVR355.1@HRNR_3@0@0@0@:hornerin@:phosphoribosylanthranilate isomerase activity;nucleoside-triphosphatase activity;cornified envelope;nucleoside triphosphate catabolic process;keratinization;calcium ion binding;tryptophan metabolic process@NA
A2463_13@16029@16032@duplication@4@196744018@196757528@1@chr1:196744018-196757528@11.1@821@1093@1.33@CNVR459.1@CFHR3_1, CFHR3_2, CFHR3_3, CFHR3_4@0@0@0@:complement factor H-related 3@:extracellular space@NA
A2463_13@16035@16040@duplication@6@196788976@196801129@1@chr1:196788976-196801129@13@1109@1463@1.32@CNVR459.1@CFHR1_1, CFHR1_2, CFHR1_3, CFHR1_4, CFHR1_5, CFHR1_6@0@0@0@:complement factor H-related 1:complement factor H-related 2@:extracellular space;complement activation:extracellular region@NA
A2463_13@16049@16049@duplication@1@196884087@196884268@1@chr1:196884087-196884268@4.59@177@252@1.42@CNVR459.2@CFHR4_9@0@0@0@:complement factor H-related 2:complement factor H-related 4@:extracellular region:extracellular region;lipid transporter activity;lipid transport@NA
A2463_13@19769@19770@deletion@2@248616100@248637608@1@chr1:248616100-248637608@21.5@925@533@0.576@CNVR597.2@OR2T2_1, OR2T3_1@0@0@0@:olfactory receptor, family 2, subfamily T, member 2:olfactory receptor, family 2, subfamily T, member 3@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_13@19777@19778@duplication@2@248801589@248814185@1@chr1:248801589-248814185@31.4@358@719@2.01@NA@OR2T35_1, OR2T27_1@0@0@0@:olfactory receptor, family 2, subfamily T, member 35:olfactory receptor, family 2, subfamily T, member 27@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_13@24856@24863@deletion@8@88091510@88095367@2@chr2:88091510-88095367@10.4@50@2@0.04@NA@RGPD2_17, RGPD2_16, RGPD2_15, RGPD2_14, RGPD2_13, RGPD2_12, RGPD2_11, RGPD2_10@0@0@0@:RANBP2-like and GRIP domain containing 2@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_13@24947@24948@duplication@2@89339722@89340195@2@chr2:89339722-89340195@6.96@292@414@1.42@CNVR866.7, CNVR866.6, CNVR866.10, CNVR866.9, CNVR866.11@IGKV1-12_2, IGKV1-12_1@0@0@0@@:protein binding@NA
A2463_13@25377@25378@duplication@2@97862331@97862525@2@chr2:97862331-97862525@5.6@306@415@1.36@CNVR886.1@ANKRD36_41, ANKRD36_42@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_13@26021@26024@deletion@4@108479139@108486433@2@chr2:108479139-108486433@7.12@392@260@0.663@NA@RGPD4_16, RGPD4_17, RGPD4_18, RGPD4_19@0@0@0@:RANBP2-like and GRIP domain containing 4@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_13@26414@26414@duplication@1@113138402@113138540@2@chr2:113138402-113138540@5.03@75@126@1.68@NA@RGPD8_21@0@0@0@:RANBP2-like and GRIP domain containing 8@:protein binding;intracellular;intracellular transport;nuclear pore;protein targeting to Golgi;Ran GTPase binding;biological_process@NA
A2463_13@26579@26583@deletion@5@114251335@114258060@2@chr2:114251335-114258060@21.6@1357@872@0.643@CNVR933.1@CBWD2_12, CBWD2_13, CBWD2_14, CBWD2_15, FOXD4L1_1@0@0@0@:COBW domain containing 2;COBW domain containing 1;COBW domain-containing protein 1-like:forkhead box D4-like 1@:ATP binding:positive regulation of BMP signaling pathway;positive regulation of kidney development;axon extension involved in axon guidance;lateral line nerve glial cell development;DNA binding, bending;sequence-specific DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;regulation of sequence-specific DNA binding transcription factor activity;transcription factor complex;nucleus;dichotomous subdivision of terminal units involved in ureteric bud branching;sympathetic nervous system development;melanocyte differentiation;enteric nervous system development;positive regulation of transcription from RNA polymerase II promoter;regulation of transcription, DNA-dependent;neural crest cell migration;peripheral nervous system development;double-stranded DNA binding;RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity;iridophore differentiation;transcription factor binding;cartilage development;pattern specification process@NA
A2463_13@27996@27997@deletion@2@152463121@152464122@2@chr2:152463121-152464122@20.1@102@6@0.0588@CNVR1026.1@NEB_84, NEB_83@0@0@0@:nebulin@:Z disc;muscle filament sliding;oxidation-reduction process;contractile fiber part;actin cytoskeleton;regulation of actin filament length;structural constituent of muscle;cytosol;actin binding;protein binding;myofibril;somatic muscle development;muscle organ development@: NEMALINE MYOPATHY 2; NEM2
A2463_13@33408@33412@duplication@5@233272978@233274158@2@chr2:233272978-233274158@14.2@125@240@1.92@NA@ALPPL2_6, ALPPL2_7, ALPPL2_8, ALPPL2_9, ALPPL2_10@0@0@0@:alkaline phosphatase, placental-like 2@:phosphatase activity;catalytic activity;phosphorylation;plasma membrane;metabolic process;membrane;anchored to membrane;alkaline phosphatase activity;metal ion binding@NA
A2463_13@39892@39892@duplication@1@75786030@75788496@3@chr3:75786030-75788496@5.96@221@320@1.45@CNVR1432.5, CNVR1432.9, CNVR1432.4@ZNF717_5@0@0@0@:zinc finger protein 717;zinc finger protein 717-like@:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_13@39892@39894@deletion@2@75786030@75790887@3@chr3:75786030-75790887@-12.9@254@320@1.26@CNVR1432.5, CNVR1432.9, CNVR1432.4@ZNF717_5, ZNF717_4, ZNF717_3@0@0@0@:zinc finger protein 717;zinc finger protein 717-like@:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_13@45437@45438@deletion@2@195474048@195475935@3@chr3:195474048-195475935@10.2@292@171@0.586@CNVR1703.1, CNVR1703.2, CNVR1703.5, CNVR1703.4@MUC4_25, MUC4_24@0@0@0@:mucin 4, cell surface associated@:ErbB-2 class receptor binding;Golgi lumen;cell-matrix adhesion;post-translational protein modification;extracellular matrix structural constituent;protein binding;O-glycan processing;cellular protein metabolic process;proteinaceous extracellular matrix;integral to plasma membrane;membrane;extracellular matrix constituent, lubricant activity;biological_process@NA
A2463_13@46667@46682@deletion@16@9174900@9274637@4@chr4:9174900-9274637@88.3@628@106@0.169@NA@FAM90A26P_4, FAM90A26P_5, FAM90A26P_6, FAM90A26P_7, USP17L13_1, USP17L10_1, USP17L11_1, USP17L12_1, USP17L13_2, USP17L15_1, USP17L17_1, USP17L18_1, USP17L19_1, USP17L20_1, USP17L21_1, USP17L22_1, USP17L23_1@0@0@0@:ubiquitin specific peptidase 17-like family member 10:ubiquitin specific peptidase 17-like family member 13:ubiquitin specific peptidase 17-like family member 11:ubiquitin specific peptidase 17-like family member 12:ubiquitin specific peptidase 17-like family member 15:ubiquitin specific peptidase 17-like family member 17:ubiquitin specific peptidase 17-like family member 18:ubiquitin specific peptidase 17-like family member 19:ubiquitin specific peptidase 17-like family member 20:ubiquitin specific peptidase 17-like family member 21:ubiquitin specific peptidase 17-like family member 22@:zinc ion binding;nucleic acid binding:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
A2463_13@48594@48596@duplication@3@70152471@70156529@4@chr4:70152471-70156529@9.41@327@466@1.43@CNVR1957.2, CNVR1957.1@UGT2B28_3, UGT2B28_4, UGT2B28_5@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B28@:carbohydrate binding;transferase activity, transferring hexosyl groups;endoplasmic reticulum;glucuronosyltransferase activity;carbohydrate metabolic process;xenobiotic metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process@NA
A2463_13@48973@48975@deletion@3@75484524@75488112@4@chr4:75484524-75488112@6.52@77@34@0.442@NA@AREGB_3, AREGB_4, AREGB_5@0@0@0@:amphiregulin;amphiregulin B@:growth factor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;cell proliferation;epidermal growth factor receptor signaling pathway;extracellular space;protein binding;integral to membrane;cytokine activity;cell surface;positive regulation of DNA replication@NA
A2463_13@51662@51666@deletion@5@144917453@144940440@4@chr4:144917453-144940440@37.1@793@420@0.53@CNVR2102.1@GYPB_5, GYPB_4, GYPB_3, GYPB_2, GYPB_1@0@0@0@:glycophorin B (MNS blood group)@:integral to membrane;plasma membrane;integral to plasma membrane@: BLOOD GROUP--Ss LOCUS; Ss
A2463_13@53065@53096@duplication@32@186508782@187093141@4@chr4:186508782-187093141@134@5928@8595@1.45@NA@SORBS2_22, SORBS2_21, SORBS2_19, SORBS2_18, SORBS2_17, SORBS2_15, SORBS2_14, SORBS2_13, SORBS2_11, SORBS2_10, SORBS2_8, SORBS2_7, SORBS2_6, TLR3_2, TLR3_3, TLR3_4, TLR3_5, FAM149A_4, FAM149A_5, FAM149A_6, FAM149A_7, FAM149A_8, FAM149A_9, FAM149A_10, FAM149A_11, FAM149A_12, FAM149A_13, FAM149A_14@0@0@0@:sorbin and SH3 domain containing 2:toll-like receptor 3:family with sequence similarity 149, member A@:Z disc;cytoskeletal adaptor activity;structural constituent of cytoskeleton;actin cytoskeleton;perinuclear region of cytoplasm;structural constituent of muscle;protein binding;nucleus;zinc ion binding;biological_process:transmembrane signaling receptor activity;double-stranded RNA binding;defense response to virus;positive regulation of type III interferon production;inflammatory response;pathogen-associated molecular pattern dependent induction by symbiont of host innate immune response;toll-like receptor 4 signaling pathway;positive regulation of tumor necrosis factor production;positive regulation of chemokine production;positive regulation of interleukin-12 production;positive regulation of NF-kappaB transcription factor activity;cellular response to mechanical stimulus;endoplasmic reticulum membrane;defense response;detection of virus;cellular response to drug;positive regulation of interferon-beta production;positive regulation of interferon-alpha biosynthetic process;MyD88-independent toll-like receptor signaling pathway;positive regulation of NF-kappaB import into nucleus;positive regulation of inflammatory response;response to virus;intracellular;positive regulation of interferon-gamma biosynthetic process;TRIF-dependent toll-like receptor signaling pathway;cellular response to interferon-beta;positive regulation of type I interferon production;I-kappaB kinase/NF-kappaB cascade;endosome membrane;positive regulation of interleukin-8 production;defense response to bacterium;negative regulation of osteoclast differentiation;hyperosmotic response;toll-like receptor signaling pathway;membrane;cellular response to interferon-gamma;response to exogenous dsRNA;positive regulation of chemokine biosynthetic process;male gonad development;Golgi membrane;positive regulation of I-kappaB kinase/NF-kappaB cascade;Toll signaling pathway;positive regulation of JNK cascade;integral to membrane;I-kappaB phosphorylation;receptor activity;integral to plasma membrane;positive regulation of transcription from RNA polymerase II promoter;toll-like receptor 3 signaling pathway;positive regulation of interleukin-6 production;endolysosome membrane;microglial cell activation involved in immune response;positive regulation of interferon-beta biosynthetic process;cytoplasm;innate immune response;protein binding;positive regulation of toll-like receptor signaling pathway;signal transduction;positive regulation of protein phosphorylation;cellular response to exogenous dsRNA;activation of NF-kappaB-inducing kinase activity;cell surface;positive regulation of apoptotic process@: HERPES SIMPLEX ENCEPHALITIS, SUSCEPTIBILITY TO, 2
A2463_13@53166@53177@duplication@12@189012528@189065287@4@chr4:189012528-189065287@44.7@1086@1635@1.51@NA@TRIML2_7, TRIML2_6, TRIML2_5, TRIML2_4, TRIML2_3, TRIML2_2, TRIML2_1, TRIML1_1, TRIML1_2, TRIML1_3, TRIML1_4, TRIML1_5@0@0@0@:tripartite motif family-like 2:tripartite motif family-like 1@:protein binding;response to chemical stimulus;intracellular;response to retinoic acid;zinc ion binding;ligase activity;protein ubiquitination:multicellular organismal development;protein binding;zinc ion binding;ligase activity;protein ubiquitination@NA
A2463_13@53309@53311@deletion@3@751249@756259@5@chr5:751249-756259@5.7@44@13@0.295@CNVR2280.3@ZDHHC11B_4, ZDHHC11B_3, ZDHHC11B_2@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
A2463_13@53320@53320@deletion@1@840611@840765@5@chr5:840611-840765@6.16@145@81@0.559@CNVR2280.3, CNVR2280.8@ZDHHC11_5@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
A2463_13@55776@55777@duplication@2@68830522@68840946@5@chr5:68830522-68840946@7.97@191@291@1.52@CNVR2494.7, CNVR2494.4, CNVR2494.46@OCLN_5, OCLN_6@0@0@0@:occludin@:S-adenosylmethionine metabolic process;cell-cell junction organization;cellular component disassembly involved in execution phase of apoptosis;response to testosterone stimulus;tight junction;integral to membrane;cell junction;plasma membrane;apoptotic process;thiopurine S-methyltransferase activity;S-adenosylhomocysteine metabolic process;apical plasma membrane;protein complex assembly;cytosol;cell-cell junction;protein binding;structural molecule activity;response to organic cyclic compound;apicolateral plasma membrane@: BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA;
A2463_13@55835@55842@duplication@8@70338009@70355997@5@chr5:70338009-70355997@15.2@300@463@1.54@CNVR2494.41, CNVR2494.14, CNVR2494.20, CNVR2494.62, CNVR2494.8@GTF2H2_14, GTF2H2_13, GTF2H2_12, GTF2H2_11, GTF2H2_10, GTF2H2_9, GTF2H2_8, GTF2H2_7@0@0@0@:general transcription factor IIH, polypeptide 2, 44kDa@:nucleoplasm;nucleotide-excision repair, DNA damage removal;transcription from RNA polymerase I promoter;DNA repair;RNA polymerase II carboxy-terminal domain kinase activity;nucleus;viral reproduction;translation;gene expression;transcription elongation from RNA polymerase I promoter;response to UV;holo TFIIH complex;protein kinase activity;nucleotide-excision repair;transcription from RNA polymerase II promoter;transcription-coupled nucleotide-excision repair;transcription, DNA-dependent;zinc ion binding;transcription elongation from RNA polymerase II promoter;termination of RNA polymerase I transcription;sequence-specific DNA binding transcription factor activity;G-protein coupled receptor internalization;DNA-dependent ATPase activity;protein N-terminus binding;transcription initiation from RNA polymerase I promoter;7-methylguanosine mRNA capping;transcription initiation from RNA polymerase II promoter;protein phosphorylation;translation factor activity, nucleic acid binding;regulation of transcription, DNA-dependent;core TFIIH complex;protein binding;positive regulation of viral transcription;nucleic acid binding@NA
A2463_13@59065@59065@deletion@1@140557617@140560021@5@chr5:140557617-140560021@27.4@2720@1492@0.549@CNVR2624.1@PCDHB8_1@0@0@0@:protocadherin beta 8@:integral to membrane;homophilic cell adhesion;plasma membrane;membrane;calcium ion binding@NA
A2463_13@59488@59488@deletion@1@147553798@147553933@5@chr5:147553798-147553933@7@31@0@0@CNVR2637.2, CNVR2637.1@SPINK14_3@0@0@0@:serine peptidase inhibitor, Kazal type 14 (putative)@:serine-type endopeptidase inhibitor activity;protein binding;extracellular region@NA
A2463_13@61285@61285@deletion@1@177468695@177468764@5@chr5:177468695-177468764@5.61@103@54@0.524@NA@FAM153C_7@0@0@0@NA@NA@NA
A2463_13@63725@63725@deletion@1@31962023@31962161@6@chr6:31962023-31962161@7.52@104@47@0.452@CNVR2843.6, CNVR2843.3@C4A_20@0@0@0@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
A2463_13@63768@63773@duplication@6@31994761@31996309@6@chr6:31994761-31996309@12.9@229@370@1.62@CNVR2843.6, CNVR2843.5@C4B_20, C4B_21, C4B_22, C4B_23, C4B_24, C4B_25@0@0@0@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
A2463_13@63796@63805@duplication@10@32007783@32010608@6@chr6:32007783-32010608@33.8@1271@1823@1.43@CNVR2843.6, CNVR2843.5@CYP21A2_7, CYP21A2_8, CYP21A2_9, CYP21A2_10, TNXB_13, TNXB_12, TNXB_11, TNXB_10, TNXB_9, TNXB_8@0@0@0@:cytochrome P450, family 21, subfamily A, polypeptide 2:tenascin-X-like;tenascin XB@:oxidation-reduction process;electron carrier activity;response to antibiotic;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;steroid 21-monooxygenase activity;C21-steroid hormone biosynthetic process;heme binding;mineralocorticoid biosynthetic process;progesterone metabolic process;monooxygenase activity;cellular response to peptide hormone stimulus;iron ion binding:integrin binding;extracellular matrix;cell-cell adhesion;elastic fiber assembly;collagen fibril organization;fibrillar collagen;actin cytoskeleton organization;extracellular space;heparin binding;proteinaceous extracellular matrix;fatty acid metabolic process;regulation of JUN kinase activity;receptor binding;intracellular;cell-matrix adhesion;extracellular matrix organization;lipid metabolic process;protein binding;signal transduction;extracellular region;collagen binding;cell adhesion;triglyceride metabolic process;fibril organization;collagen metabolic process@: ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY: EHLERS-DANLOS-LIKE SYNDROME DUE TO TENASCIN-X DEFICIENCY; EHLERS-DANLOS SYNDROME, TYPE III
A2463_13@63953@63956@deletion@4@32485517@32487428@6@chr6:32485517-32487428@7.95@158@88@0.557@CNVR2845.21, CNVR2845.25, CNVR2845.30@HLA-DRB5_6, HLA-DRB5_5, HLA-DRB5_4, HLA-DRB5_3@0@0@0@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
A2463_13@63962@63962@duplication@1@32549335@32549615@6@chr6:32549335-32549615@4.66@223@311@1.39@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.5, CNVR2845.11, CNVR2845.54@HLA-DRB1_3@0@0@0@:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1@:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
A2463_13@64602@64606@deletion@5@35754776@35765065@6@chr6:35754776-35765065@18.5@547@320@0.585@CNVR2861.1@CLPSL1_2, CLPSL1_3, CLPS_3, CLPS_2, CLPS_1@0@0@0@:colipase-like 1:colipase, pancreatic@:extracellular region;enzyme activator activity;digestion;lipid catabolic process:steroid metabolic process;post-embryonic development;small molecule metabolic process;retinoid metabolic process;lipid metabolic process;extracellular region;enzyme activator activity;digestion;lipid catabolic process;lipid digestion;response to food@NA
A2463_13@70808@70808@duplication@1@161032595@161032753@6@chr6:161032595-161032753@9.1@100@187@1.87@CNVR3133.1@LPA_17@0@0@0@:lipoprotein, Lp(a)@:blood circulation;endopeptidase inhibitor activity;catalytic activity;lipoprotein metabolic process;proteolysis;heparin binding;receptor-mediated endocytosis;fibronectin binding;small molecule metabolic process;apolipoprotein binding;lipid metabolic process;negative regulation of endopeptidase activity;extracellular region;plasma lipoprotein particle;lipid transport;serine-type endopeptidase activity@: APOLIPOPROTEIN(a); LPA
A2463_13@70816@70816@deletion@1@161054786@161054944@6@chr6:161054786-161054944@4.62@146@88@0.603@CNVR3133.1@LPA_9@0@0@0@:lipoprotein, Lp(a)@:blood circulation;endopeptidase inhibitor activity;catalytic activity;lipoprotein metabolic process;proteolysis;heparin binding;receptor-mediated endocytosis;fibronectin binding;small molecule metabolic process;apolipoprotein binding;lipid metabolic process;negative regulation of endopeptidase activity;extracellular region;plasma lipoprotein particle;lipid transport;serine-type endopeptidase activity@: APOLIPOPROTEIN(a); LPA
A2463_13@71028@71030@duplication@3@167787840@167790192@6@chr6:167787840-167790192@8.59@181@277@1.53@NA@TCP10_7, TCP10_6, TCP10_5@0@0@0@:t-complex 10@:cytosol@NA
A2463_13@71748@71751@duplication@4@5942293@5951553@7@chr7:5942293-5951553@9.17@542@737@1.36@NA@CCZ1_6, CCZ1_7, CCZ1_8, CCZ1_9@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
A2463_13@71754@71756@deletion@3@5959481@5963593@7@chr7:5959481-5963593@12.3@176@83@0.472@NA@CCZ1_12, CCZ1_13, CCZ1_14@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
A2463_13@71922@71944@duplication@23@6797310@6844686@7@chr7:6797310-6844686@21.7@1038@1416@1.36@NA@RSPH10B2_2, RSPH10B2_3, RSPH10B2_4, RSPH10B2_5, RSPH10B2_6, RSPH10B2_7, RSPH10B2_8, RSPH10B2_9, RSPH10B2_10, RSPH10B2_11, RSPH10B2_12, RSPH10B2_13, RSPH10B2_14, RSPH10B2_15, RSPH10B2_16, RSPH10B2_17, RSPH10B2_18, RSPH10B2_19, RSPH10B2_20, CCZ1B_15, CCZ1B_14, CCZ1B_13, CCZ1B_12@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
A2463_13@73260@73263@duplication@4@38388957@38393784@7@chr7:38388957-38393784@10.6@227@348@1.53@CNVR3354.3, CNVR3354.1@TRGV5_2, TRGV5_1, TRGV4_2, TRGV4_1@0@0@0@@:protein binding:protein binding@NA
A2463_13@74565@74565@deletion@1@74157789@74157859@7@chr7:74157789-74157859@4.92@23@1@0.0435@NA@GTF2I_20@0@0@0@:general transcription factor IIi@:neuronal cell body;transcription initiation from RNA polymerase II promoter;mitogen-activated protein kinase binding;negative regulation of angiogenesis;DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;cytoplasm;transcription from RNA polymerase II promoter;protein binding;signal transduction;nucleus;cell projection;reduction of cytosolic calcium ion concentration@NA
A2463_13@74597@74598@deletion@2@74225431@74227349@7@chr7:74225431-74227349@8.87@49@6@0.122@NA@GTF2IRD2_10, GTF2IRD2_9@0@0@0@:GTF2I repeat domain containing 2@:nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_13@74663@74664@deletion@2@75054919@75055735@7@chr7:75054919-75055735@16.1@115@29@0.252@NA@POM121C_9, POM121C_8@0@0@0@:POM121 transmembrane nucleoporin C@:nuclear membrane;protein binding;protein transport;endoplasmic reticulum membrane;nuclear pore;mRNA transport@NA
A2463_13@76727@76737@duplication@11@102134273@102147271@7@chr7:102134273-102147271@25.7@182@391@2.15@CNVR3518.1@RASA4B_15, RASA4B_14, RASA4B_13, RASA4B_12, RASA4B_11, RASA4B_10, RASA4B_9, RASA4B_8, RASA4B_7, RASA4B_6, RASA4B_5@0@0@0@:RAS p21 protein activator 4B@:phospholipid binding;intracellular;GTPase activator activity;cytosol;signal transduction;protein binding;plasma membrane;regulation of small GTPase mediated signal transduction;metal ion binding;intracellular signal transduction@NA
A2463_13@76753@76753@duplication@1@102214326@102214371@7@chr7:102214326-102214371@5.8@3@39@13@CNVR3518.1@AC093668.1_3, AC093668.1_2@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
A2463_13@76784@76793@duplication@10@102293899@102312048@7@chr7:102293899-102312048@29.8@98@317@3.23@CNVR3518.1@SPDYE2L_3, SPDYE2L_4, SPDYE2L_5, SPDYE2L_6, SPDYE2L_7, SPDYE2L_8, POLR2J2_4, POLR2J2_4, POLR2J2_3, POLR2J2_3, POLR2J2_2, POLR2J2_2, POLR2J2_1, POLR2J2_1@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:polymerase (RNA) II (DNA directed) polypeptide J2:WBSCR19-like protein 3;speedy homolog E6 (Xenopus laevis)@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
A2463_13@79312@79325@deletion@14@143955790@144072768@7@chr7:143955790-144072768@38.7@2157@1442@0.669@CNVR3598.4@OR2A7_1, CTAGE8_1, OR2A1_1, ARHGEF5_2, ARHGEF5_3, ARHGEF5_4, ARHGEF5_5, ARHGEF5_6, ARHGEF5_7, ARHGEF5_8, ARHGEF5_9, ARHGEF5_10, ARHGEF5_11, ARHGEF5_12@0@0@0@:Rho guanine nucleotide exchange factor (GEF) 35:olfactory receptor, family 2, subfamily A, member 7:CTAGE family, member 6, pseudogene;CTAGE family, member 15, pseudogene:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
A2463_13@80141@80143@duplication@3@116087@150533@8@chr8:116087-150533@15@109@232@2.13@CNVR3684.5, CNVR3684.11@OR4F21_1, RP11-585F1.10_2, RP11-585F1.10_1@0@0@0@:olfactory receptor, family 4, subfamily F, member 21:F-box only protein 25-like;putative uncharacterized protein C20orf69-like@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_13@80366@80367@deletion@2@7220458@7272619@8@chr8:7220458-7272619@8.95@174@94@0.54@CNVR3771.8, CNVR3771.10, CNVR3771.4@ZNF705G_3, DEFB4B_2@0@0@0@:zinc finger protein 705G:defensin, beta 4B;defensin, beta 4A@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response@NA
A2463_13@80371@80382@deletion@12@7308236@7366745@8@chr8:7308236-7366745@41.8@507@213@0.42@CNVR3771.8, CNVR3771.10, CNVR3771.4@SPAG11B_3, SPAG11B_2, SPAG11B_1, DEFB104B_2, DEFB104B_1, DEFB106B_2, DEFB106B_1, DEFB105B_1, DEFB105B_2, DEFB105B_3, DEFB107B_1, DEFB107B_2@0@0@0@:sperm associated antigen 11B:defensin, beta 104A;defensin, beta 104B:defensin, beta 106B;defensin, beta 106A:defensin, beta 105B;defensin, beta 105A:defensin, beta 107B;defensin, beta 107A@:spermatogenesis;defense response to bacterium;extracellular region;molecular_function;defense response:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium@NA
A2463_13@80403@80412@deletion@10@7721024@7809913@8@chr8:7721024-7809913@70.1@553@140@0.253@CNVR3772.4, CNVR3772.6, CNVR3772.10, CNVR3772.13@SPAG11A_4, DEFB103A_1, DEFB103A_2, DEFB4A_1, DEFB4A_2, ZNF705B_2, ZNF705B_3, ZNF705B_4, ZNF705B_5, ZNF705B_6@0@0@0@:sperm associated antigen 11A;sperm associated antigen 11B:defensin, beta 103B;defensin, beta 103A:defensin, beta 4B;defensin, beta 4A:zinc finger protein 705B@:extracellular region;defense response:extracellular region;defense response to bacterium;Golgi lumen;positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria;defense response;innate immune response:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response:intracellular;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_13@80564@80572@deletion@9@11970084@12049350@8@chr8:11970084-12049350@112@2029@790@0.389@CNVR3785.8, CNVR3785.5, CNVR3785.2, CNVR3785.3@ZNF705D_6, USP17L2_1, FAM86B1_8, FAM86B1_7, FAM86B1_6, FAM86B1_5, FAM86B1_4, FAM86B1_3, FAM86B1_2@0@0@0@:zinc finger protein 705D:ubiquitin specific peptidase 17-like family member 1, pseudogene;ubiquitin specific peptidase 17-like family member 2;ubiquitin specific peptidase 17-like family member 4;ubiquitin specific peptidase 17-like family member 7;ubiquitin specific peptidase 17-like family member 8;ubiquitin specific peptidase 17-like family member 3:family with sequence similarity 86, member B2;family with sequence similarity 86, member B1@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:protein deubiquitination;ubiquitin-specific protease activity;mitotic cell cycle G1/S transition checkpoint;nucleus;G2/M transition checkpoint;apoptotic process;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
A2463_13@80579@80583@deletion@5@12286491@12293852@8@chr8:12286491-12293852@8.71@340@214@0.629@CNVR3786.4, CNVR3786.16@FAM86B2_5, FAM86B2_4, FAM86B2_3, FAM86B2_2, FAM86B2_1@0@0@0@:family with sequence similarity 86, member B2@NA@NA
A2463_13@83673@83673@deletion@1@86573700@86575726@8@chr8:86573700-86575726@7.73@435@276@0.634@CNVR3955.1@REXO1L1_1@0@0@0@:exonuclease GOR-like;REX1, RNA exonuclease 1 homolog (S. cerevisiae)-like 1@:intracellular;nucleus;exonuclease activity;nucleic acid binding;cytoplasm@NA
A2463_13@86336@86337@deletion@2@145317757@145318304@8@chr8:145317757-145318304@6.53@29@0@0@NA@KM-PA-2_11, KM-PA-2_10@0@0@0@@:protein binding;regulation of cell cycle;nucleus;rRNA processing@NA
A2463_13@86358@86359@duplication@2@145486843@145487390@8@chr8:145486843-145487390@7.41@21@70@3.33@NA@BOP1_13, BOP1_12@0@0@0@:block of proliferation 1@:nucleoplasm;regulation of cell cycle;ribonucleoprotein complex;maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);ribosome biogenesis;cell proliferation;protein binding;PeBoW complex;nucleus;rRNA processing@NA
A2463_13@86628@86630@deletion@3@34922@35519@9@chr9:34922-35519@13.8@112@34@0.304@CNVR4134.1@FAM138C_3, FAM138C_2, FAM138C_1@0@0@0@NA@NA@NA
A2463_13@86632@86635@duplication@4@121468@123454@9@chr9:121468-123454@7.08@333@456@1.37@CNVR4135.1@CBWD1_15, CBWD1_14, CBWD1_13, CBWD1_12@0@0@0@:COBW domain containing 1;COBW domain-containing protein 1-like;COBW domain containing 5@:ATP binding@NA
A2463_13@86646@86646@duplication@1@178817@178969@9@chr9:178817-178969@4.44@73@119@1.63@CNVR4135.1@CBWD1_1@0@0@0@:COBW domain containing 1;COBW domain-containing protein 1-like;COBW domain containing 5@:ATP binding@NA
A2463_13@88490@88517@duplication@28@39073888@39361806@9@chr9:39073888-39361806@122@2535@4055@1.6@NA@CNTNAP3_24, CNTNAP3_23, CNTNAP3_22, CNTNAP3_21, CNTNAP3_20, CNTNAP3_19, CNTNAP3_18, CNTNAP3_17, CNTNAP3_16, CNTNAP3_15, CNTNAP3_14, CNTNAP3_13, CNTNAP3_12, CNTNAP3_11, CNTNAP3_10, CNTNAP3_9, CNTNAP3_8, CNTNAP3_7, CNTNAP3_6, CNTNAP3_5, CNTNAP3_4, CNTNAP3_3, CNTNAP3_2, CNTNAP3_1, SPATA31A1_1, SPATA31A1_2, SPATA31A1_3, SPATA31A1_4@0@0@0@:contactin associated protein-like 3:SPATA31 subfamily A, member 1@:binding;signal transduction;protein binding;integral to membrane;extracellular region;cell adhesion;plasma membrane;cell recognition;receptor binding:integral to membrane@NA
A2463_13@88520@88520@deletion@1@39887007@39887066@9@chr9:39887007-39887066@4.74@62@28@0.452@NA@SPATA31A2_3@0@0@0@:SPATA31 subfamily A, member 2@:integral to membrane@NA
A2463_13@88531@88531@duplication@1@40784108@40784202@9@chr9:40784108-40784202@5.9@89@150@1.69@CNVR4274.1@ZNF658_4@0@0@0@:zinc finger protein 658@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_13@88544@88560@duplication@17@42368416@42419022@9@chr9:42368416-42419022@35.6@252@542@2.15@NA@ANKRD20A2_1, ANKRD20A2_2, ANKRD20A2_3, ANKRD20A2_4, ANKRD20A2_5, ANKRD20A2_6, ANKRD20A2_7, ANKRD20A2_8, ANKRD20A2_9, ANKRD20A2_10, ANKRD20A2_11, ANKRD20A2_12, ANKRD20A2_13, ANKRD20A2_14, ANKRD20A2_15, RP11-146D12.2_1, RP11-146D12.2_2@0@0@0@:ankyrin repeat domain 20 family, member A2@:protein binding@NA
A2463_13@88584@88585@duplication@2@43624656@43628694@9@chr9:43624656-43628694@16.9@1668@2376@1.42@NA@SPATA31A6_4, SPATA31A6_3@0@0@0@:SPATA31 subfamily A, member 6@:integral to membrane@NA
A2463_13@88594@88611@duplication@18@43818042@43920370@9@chr9:43818042-43920370@46.3@913@1433@1.57@NA@CNTNAP3B_7, CNTNAP3B_8, CNTNAP3B_9, CNTNAP3B_10, CNTNAP3B_11, CNTNAP3B_12, CNTNAP3B_13, CNTNAP3B_14, CNTNAP3B_15, CNTNAP3B_16, CNTNAP3B_17, CNTNAP3B_18, CNTNAP3B_19, CNTNAP3B_20, CNTNAP3B_21, CNTNAP3B_22, CNTNAP3B_23, CNTNAP3B_24@0@0@0@:contactin associated protein-like 3B;contactin associated protein-like 3@:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
A2463_13@88613@88613@deletion@1@44401891@44402255@9@chr9:44401891-44402255@4.89@160@97@0.606@CNVR4297.3@BX088651.1_1@0@0@0@NA@NA@NA
A2463_13@88621@88622@deletion@2@45727441@45733965@9@chr9:45727441-45733965@21.4@169@50@0.296@CNVR4305.1@AL953889.1_2, AL953889.1_1, FAM27A_2, FAM27E2_1@0@0@0@NA@NA@NA
A2463_13@88621@88624@duplication@2@45727441@46390900@9@chr9:45727441-46390900@-7.7@212@228@1.08@NA@AL953889.1_2, AL953889.1_1, FAM27A_2, FAM27E2_1, FAM27E1_1, FAM27D1_1@0@0@0@:family with sequence similarity 27, member E3:protein FAM27E2-like;protein FAM27D1-like@NA@NA
A2463_13@88631@88633@deletion@3@65503517@65508193@9@chr9:65503517-65508193@65.6@315@3@0.00952@CNVR4312.5@SPATA31A7_4, SPATA31A7_3, SPATA31A7_2@0@0@0@:SPATA31 subfamily A, member 7@:integral to membrane@NA
A2463_13@88640@88640@deletion@1@67930388@67930501@9@chr9:67930388-67930501@6.49@29@0@0@NA@ANKRD20A1_2@0@0@0@:ankyrin repeat domain 20 family, member A1@:protein binding;plasma membrane@NA
A2463_13@88642@88656@duplication@15@67934724@67985922@9@chr9:67934724-67985922@45.9@1457@2129@1.46@NA@ANKRD20A1_4, ANKRD20A1_5, ANKRD20A1_6, ANKRD20A1_7, ANKRD20A1_8, ANKRD20A1_9, ANKRD20A1_10, ANKRD20A1_11, ANKRD20A1_12, ANKRD20A1_13, ANKRD20A1_14, ANKRD20A1_15, RP11-195B21.3_3, RP11-195B21.3_4, RP11-195B21.3_5@0@0@0@:ankyrin repeat domain 20 family, member A1:coiled-coil domain-containing protein 29-like;uncharacterized LOC644249@:protein binding;plasma membrane@NA
A2463_13@88658@88690@duplication@33@69200360@69424176@9@chr9:69200360-69424176@128@2244@3742@1.67@NA@FOXD4L6_1, CBWD6_15, CBWD6_14, CBWD6_13, CBWD6_12, CBWD6_11, CBWD6_10, CBWD6_9, CBWD6_8, CBWD6_7, CBWD6_6, CBWD6_5, BX255923.1_1, CBWD6_4, CBWD6_3, CBWD6_2, CBWD6_1, CR769776.1_1, ANKRD20A4_1, ANKRD20A4_2, ANKRD20A4_3, ANKRD20A4_4, ANKRD20A4_5, ANKRD20A4_6, ANKRD20A4_7, ANKRD20A4_8, ANKRD20A4_9, ANKRD20A4_10, ANKRD20A4_11, ANKRD20A4_12, ANKRD20A4_13, ANKRD20A4_14, ANKRD20A4_15@0@0@0@:forkhead box D4-like 6;forkhead box protein D4-like 6-like:COBW domain containing 6:ankyrin repeat domain 20 family, member A4@:positive regulation of BMP signaling pathway;positive regulation of kidney development;axon extension involved in axon guidance;lateral line nerve glial cell development;DNA binding, bending;sequence-specific DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;regulation of sequence-specific DNA binding transcription factor activity;transcription factor complex;nucleus;dichotomous subdivision of terminal units involved in ureteric bud branching;sympathetic nervous system development;melanocyte differentiation;enteric nervous system development;positive regulation of transcription from RNA polymerase II promoter;regulation of transcription, DNA-dependent;neural crest cell migration;peripheral nervous system development;double-stranded DNA binding;RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity;iridophore differentiation;transcription factor binding;cartilage development;pattern specification process:ATP binding:protein binding@NA
A2463_13@88694@88694@duplication@1@70176734@70177983@9@chr9:70176734-70177983@29.5@350@779@2.23@NA@FOXD4L5_1@0@0@0@:forkhead box D4-like 5@:positive regulation of BMP signaling pathway;positive regulation of kidney development;axon extension involved in axon guidance;lateral line nerve glial cell development;DNA binding, bending;sequence-specific DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;regulation of sequence-specific DNA binding transcription factor activity;transcription factor complex;nucleus;dichotomous subdivision of terminal units involved in ureteric bud branching;sympathetic nervous system development;melanocyte differentiation;enteric nervous system development;positive regulation of transcription from RNA polymerase II promoter;regulation of transcription, DNA-dependent;neural crest cell migration;peripheral nervous system development;double-stranded DNA binding;RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity;iridophore differentiation;transcription factor binding;cartilage development;pattern specification process@NA
A2463_13@88706@88708@duplication@3@70484376@70490068@9@chr9:70484376-70490068@9.74@180@285@1.58@NA@CBWD5_3, CBWD5_2, CBWD5_1@0@0@0@:COBW domain-containing protein 5-like;COBW domain containing 7;COBW domain containing 5@:ATP binding@NA
A2463_13@95346@95355@duplication@10@17813309@17891768@10@chr10:17813309-17891768@25.4@281@505@1.8@NA@TMEM236_2, TMEM236_3, TMEM236_4, MRC1L1_1, MRC1L1_2, MRC1L1_3, MRC1L1_4, MRC1L1_5, MRC1L1_6, MRC1L1_7@0@0@0@:transmembrane protein 236;transmembrane protein 236-like:macrophage mannose receptor 1-like@:integral to membrane:carbohydrate binding@NA
A2463_13@95376@95377@duplication@2@17949551@17951363@10@chr10:17949551-17951363@9.32@74@149@2.01@NA@MRC1L1_28, MRC1L1_29@0@0@0@:macrophage mannose receptor 1-like@:carbohydrate binding@NA
A2463_13@95380@95393@deletion@14@18060293@18152611@10@chr10:18060293-18152611@47.4@227@7@0.0308@NA@TMEM236_2, TMEM236_3, TMEM236_4, MRC1_1, MRC1_2, MRC1_3, MRC1_4, MRC1_5, MRC1_6, MRC1_7, MRC1_8, MRC1_9, MRC1_10, MRC1_11@0@0@0@:transmembrane protein 236;transmembrane protein 236-like:mannose receptor, C type 1;macrophage mannose receptor 1-like@:integral to membrane:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
A2463_13@96434@96435@duplication@2@46248037@46248685@10@chr10:46248037-46248685@6.55@102@167@1.64@NA@FAM21C_12, FAM21C_13@0@0@0@:family with sequence similarity 21, member C@:endosome;protein binding;plasma membrane;retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_13@96454@96461@deletion@8@46312644@46342795@10@chr10:46312644-46342795@30.4@236@55@0.233@NA@FAM25E_1, AGAP4_7, AGAP4_6, AGAP4_5, AGAP4_4, AGAP4_3, AGAP4_2, AGAP4_1@0@0@0@:ArfGAP with GTPase domain, ankyrin repeat and PH domain 4;arf-GAP with GTPase, ANK repeat and PH domain-containing protein 5-like@:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity@NA
A2463_13@96510@96531@duplication@22@47668489@47758904@10@chr10:47668489-47758904@34.4@1117@1583@1.42@NA@ANTXRL_6, ANTXRL_7, ANTXRL_8, ANTXRL_9, ANTXRL_10, ANTXRL_11, ANTXRL_12, ANTXRL_13, ANTXRL_14, ANTXRL_15, ANTXRL_16, ANTXRL_17, ANXA8L2_1, ANXA8L2_2, ANXA8L2_3, ANXA8L2_4, ANXA8L2_5, ANXA8L2_6, ANXA8L2_7, ANXA8L2_8, ANXA8L2_9, ANXA8L2_10@0@0@0@:annexin A8-like 2:uncharacterized LOC101060462;uncharacterized LOC100996760@:protein binding;integral to membrane;receptor activity;metal ion binding:calcium-dependent phospholipid binding;calcium ion binding@NA
A2463_13@96548@96563@duplication@16@47913577@47948853@10@chr10:47913577-47948853@31.4@426@721@1.69@CNVR4715.2, CNVR4715.1@FAM21B_14, FAM21B_15, FAM21B_16, FAM21B_17, FAM21B_18, FAM21B_19, FAM21B_20, FAM21B_21, FAM21B_22, FAM21B_23, FAM21B_24, FAM21B_25, FAM21B_26, FAM21B_27, FAM21B_28, FAM21B_29@0@0@0@:family with sequence similarity 21, member B@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_13@96572@96579@duplication@8@48020451@48049021@10@chr10:48020451-48049021@14.6@352@523@1.49@CNVR4715.2@ASAH2C_10, ASAH2C_9, ASAH2C_8, ASAH2C_7, ASAH2C_6, ASAH2C_5, ASAH2C_4, ASAH2C_3@0@0@0@@:ceramidase activity;sphingolipid metabolic process@NA
A2463_13@96631@96633@deletion@3@49376639@49381136@10@chr10:49376639-49381136@12.4@76@14@0.184@CNVR4717.2@FRMPD2_27, FRMPD2_26, FRMPD2_25@0@0@0@:FERM and PDZ domain containing 2@:basolateral plasma membrane;transferase activity, transferring phosphorus-containing groups;cytoplasm;tight junction;protein binding;cytoskeleton;1-phosphatidylinositol binding;tight junction assembly@NA
A2463_13@96851@96857@duplication@7@51371542@51465939@10@chr10:51371542-51465939@20.4@664@1020@1.54@NA@TIMM23B_1, TIMM23B_2, TIMM23B_3, TIMM23B_4, TIMM23B_5, TIMM23B_6, AGAP7_7@0@0@0@:translocase of inner mitochondrial membrane 23 homolog B (yeast):ArfGAP with GTPase domain, ankyrin repeat and PH domain 7@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity@NA
A2463_13@96883@96883@deletion@1@51620325@51620382@10@chr10:51620325-51620382@11.5@173@78@0.451@NA@TIMM23_2@0@0@0@:translocase of inner mitochondrial membrane 23 homolog B (yeast):translocase of inner mitochondrial membrane 23 homolog B (yeast);translocase of inner mitochondrial membrane 23 homolog (yeast)@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process:mitochondrion;mitochondrial inner membrane;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;mitochondrial intermembrane space;integral to mitochondrial inner membrane;intracellular protein transport;protein binding;integral to membrane;cellular protein metabolic process;protein targeting to mitochondrion@NA
A2463_13@96932@96937@deletion@6@51965743@51978390@10@chr10:51965743-51978390@16.5@119@32@0.269@NA@ASAH2_12, ASAH2_11, ASAH2_10, ASAH2_9, ASAH2_8, ASAH2_7@0@0@0@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
A2463_13@98334@98335@deletion@2@81272407@81317341@10@chr10:81272407-81317341@9.45@443@281@0.634@NA@EIF5AL1_1, SFTPA2_6@0@0@0@:eukaryotic translation initiation factor 5A-like 1:surfactant protein A2@:ribosome binding;translation elongation factor activity;positive regulation of translational termination;mRNA transport;RNA binding;protein transport;translational frameshifting;endoplasmic reticulum membrane;peptidyl-lysine modification to hypusine;nuclear pore;positive regulation of translational elongation:collagen;respiratory gaseous exchange;carbohydrate binding;extracellular space;extracellular region@: PULMONARY FIBROSIS, IDIOPATHIC; IPF
A2463_13@98344@98344@deletion@1@81463367@81463747@10@chr10:81463367-81463747@9.73@44@0@0@CNVR4815.2@FAM22B_1@0@0@0@NA@NA@NA
A2463_13@98350@98350@deletion@1@81471457@81472241@10@chr10:81471457-81472241@23.7@395@164@0.415@CNVR4815.2, CNVR4815.4@FAM22B_7@0@0@0@NA@NA@NA
A2463_13@98350@98351@duplication@1@81471457@81601878@10@chr10:81471457-81601878@-38.7@418@224@0.536@CNVR4815.2@FAM22B_7, FAM22E_1@0@0@0@NA@NA@NA
A2463_13@98355@98356@deletion@2@81608270@81609243@10@chr10:81608270-81609243@4.96@30@6@0.2@NA@FAM22E_5, FAM22E_6@0@0@0@NA@NA@NA
A2463_13@98595@98595@duplication@1@88985589@88985969@10@chr10:88985589-88985969@16.5@20@136@6.8@CNVR4840.3, CNVR4840.5@FAM22A_1@0@0@0@:family with sequence similarity 22, member A@NA@NA
A2463_13@98602@98602@deletion@1@89118024@89118188@10@chr10:89118024-89118188@13.6@360@191@0.531@CNVR4840.3@FAM22D_1@0@0@0@:family with sequence similarity 22, member D@NA@NA
A2463_13@103268@103268@deletion@1@4967390@4968330@11@chr11:4967390-4968330@28.4@540@225@0.417@CNVR5040.1@OR51A4_1@0@0@0@:matrix metallopeptidase 26:olfactory receptor, family 51, subfamily A, member 4@:metallopeptidase activity;extracellular matrix;proteolysis;proteinaceous extracellular matrix;collagen catabolic process;metalloendopeptidase activity;zinc ion binding;metabolic process:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_13@103268@103269@duplication@1@4967390@4976943@11@chr11:4967390-4976943@-42.8@918@818@0.891@CNVR5040.1@OR51A4_1, OR51A2_1@0@0@0@:matrix metallopeptidase 26:olfactory receptor, family 51, subfamily A, member 4:olfactory receptor, family 51, subfamily A, member 2@:metallopeptidase activity;extracellular matrix;proteolysis;proteinaceous extracellular matrix;collagen catabolic process;metalloendopeptidase activity;zinc ion binding;metabolic process:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_13@103289@103290@deletion@2@5270599@5271034@11@chr11:5270599-5271034@20.3@94@0@0@NA@HBG1_2, HBG1_1@0@0@0@:hemoglobin, gamma A@:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex@NA
A2463_13@103342@103342@duplication@1@5798891@5799864@11@chr11:5798891-5799864@6.29@250@360@1.44@CNVR5049.1@OR52N5_1@0@0@0@:tripartite motif containing 5:olfactory receptor, family 52, subfamily N, member 5@:defense response to virus;Golgi apparatus;intracellular;protein trimerization;ligase activity;cytoplasm;protein binding;nucleus;protein homodimerization activity;identical protein binding;zinc ion binding;cytoplasmic mRNA processing body;protein ubiquitination;virus-host interaction:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_13@103346@103346@deletion@1@5877980@5878932@11@chr11:5877980-5878932@12.8@267@134@0.502@CNVR5050.1@OR52E8_1@0@0@0@:tripartite motif containing 5:olfactory receptor, family 52, subfamily E, member 8@:defense response to virus;Golgi apparatus;intracellular;protein trimerization;ligase activity;cytoplasm;protein binding;nucleus;protein homodimerization activity;identical protein binding;zinc ion binding;cytoplasmic mRNA processing body;protein ubiquitination;virus-host interaction:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_13@104444@104444@duplication@1@18288436@18288525@11@chr11:18288436-18288525@6.05@80@139@1.74@NA@SAA1_2@0@0@0@:serum amyloid A1@:regulation of protein secretion;platelet activation;neutrophil chemotaxis;negative regulation of inflammatory response;positive regulation of cytokine secretion;macrophage chemotaxis;positive regulation of cell adhesion;positive regulation of interleukin-1 secretion;extracellular region;lymphocyte chemotaxis;high-density lipoprotein particle;elevation of cytosolic calcium ion concentration;acute-phase response;G-protein coupled receptor binding@NA
A2463_13@106046@106048@duplication@3@55370918@55419315@11@chr11:55370918-55419315@16.7@700@998@1.43@CNVR5179.1@OR4C11_1, OR4P4_1, OR4S2_1@0@0@0@:olfactory receptor, family 4, subfamily C, member 11:olfactory receptor, family 4, subfamily P, member 4:olfactory receptor, family 4, subfamily S, member 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_13@110121@110122@duplication@2@89768381@89769151@11@chr11:89768381-89769151@5.51@190@274@1.44@NA@TRIM49C_3, TRIM49C_4@0@0@0@:tripartite motif containing 49D, pseudogene;tripartite motif containing 49-like 1;tripartite motif containing 49C;tripartite motif-containing protein 49-like protein 1-like@:protein binding;intracellular;DNA binding;zinc ion binding@NA
A2463_13@114138@114139@duplication@2@8376613@8377428@12@chr12:8376613-8377428@6.99@396@540@1.36@CNVR5422.3, CNVR5422.5, CNVR5422.6, CNVR5422.1@FAM90A1_5, FAM90A1_4@0@0@0@:family with sequence similarity 90, member A1@:zinc ion binding;nucleic acid binding@NA
A2463_13@114424@114429@deletion@6@10583717@10588585@12@chr12:10583717-10588585@29.9@890@529@0.594@CNVR5430.1@KLRC2_6, KLRC2_5, KLRC2_4, KLRC2_3, NKG2-E_3, KLRC2_2, NKG2-E_2, KLRC2_1, NKG2-E_1@0@0@0@:killer cell lectin-like receptor subfamily C, member 2@:carbohydrate binding:transmembrane signaling receptor activity;carbohydrate binding;protein binding;signal transduction;cellular defense response;integral to plasma membrane@NA
A2463_13@114483@114483@duplication@1@11243900@11244828@12@chr12:11243900-11244828@15.7@346@585@1.69@CNVR5434.1@TAS2R43_1@0@0@0@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):taste receptor, type 2, member 14:taste receptor, type 2, member 43@:extracellular space;visual perception:bitter taste receptor activity;taste receptor activity;integral to membrane;sensory perception of taste;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of bitter taste:G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;motile cilium;taste receptor activity;bitter taste receptor activity;integral to membrane;sensory perception of taste;detection of chemical stimulus involved in sensory perception of bitter taste;cilium membrane@NA
A2463_13@115535@115537@deletion@3@31247525@31249313@12@chr12:31247525-31249313@20.6@412@223@0.541@CNVR5483.1@DDX11_13, DDX11_14, DDX11_15@0@0@0@:DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11@:nucleoplasm;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;S phase of mitotic cell cycle;DNA binding;nucleobase-containing compound metabolic process;ATP binding;ATP-dependent DNA helicase activity;DNA helicase activity;midbody;RNA binding;DNA-dependent ATPase activity;nucleus;positive regulation of cell proliferation;virus-host interaction;nuclear chromatin;4 iron, 4 sulfur cluster binding;helicase activity;hydrolase activity, acting on acid anhydrides;DNA duplex unwinding;endoplasmic reticulum unfolded protein response;G2/M transition of mitotic cell cycle;protein binding;sister chromatid cohesion;activation of signaling protein activity involved in unfolded protein response;nucleolus;spindle pole;ATP-dependent helicase activity;metal ion binding;nucleic acid binding;mitotic sister chromatid segregation@: WARSAW BREAKAGE SYNDROME
A2463_13@115540@115540@deletion@1@31250820@31250931@12@chr12:31250820-31250931@6.19@130@70@0.538@CNVR5483.1@DDX11_18@0@0@0@:DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11@:nucleoplasm;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;S phase of mitotic cell cycle;DNA binding;nucleobase-containing compound metabolic process;ATP binding;ATP-dependent DNA helicase activity;DNA helicase activity;midbody;RNA binding;DNA-dependent ATPase activity;nucleus;positive regulation of cell proliferation;virus-host interaction;nuclear chromatin;4 iron, 4 sulfur cluster binding;helicase activity;hydrolase activity, acting on acid anhydrides;DNA duplex unwinding;endoplasmic reticulum unfolded protein response;G2/M transition of mitotic cell cycle;protein binding;sister chromatid cohesion;activation of signaling protein activity involved in unfolded protein response;nucleolus;spindle pole;ATP-dependent helicase activity;metal ion binding;nucleic acid binding;mitotic sister chromatid segregation@: WARSAW BREAKAGE SYNDROME
A2463_13@127333@127335@deletion@3@19553418@19559164@14@chr14:19553418-19559164@40.8@722@366@0.507@CNVR6072.1@POTEG_1, POTEG_2, POTEG_3@0@0@0@:POTE ankyrin domain family, member G@:protein binding@NA
A2463_13@127337@127338@duplication@2@19563405@19566082@14@chr14:19563405-19566082@8.52@386@546@1.41@CNVR6072.1@POTEG_5, POTEG_6@0@0@0@:POTE ankyrin domain family, member G@:protein binding@NA
A2463_13@131032@131034@deletion@3@74004127@74010359@14@chr14:74004127-74010359@75.3@484@80@0.165@CNVR6188.1, CNVR6188.4@ACOT1_1, ACOT1_2, ACOT1_3@0@0@0@:HEAT repeat containing 4:acyl-CoA thioesterase 1@:protein binding;binding:hydrolase activity;mitochondrion;acyl-CoA metabolic process;very long-chain fatty acid metabolic process;thiolester hydrolase activity;acyl-CoA hydrolase activity;cytosol;palmitoyl-CoA hydrolase activity;long-chain fatty acid metabolic process;carboxylesterase activity@NA
A2463_13@133352@133352@deletion@1@106092110@106092403@14@chr14:106092110-106092403@5.05@142@83@0.585@CNVR6294.46, CNVR6294.20, CNVR6294.54, CNVR6294.43, CNVR6294.50, CNVR6294.61@IGHG4_1@0@0@0@@:antigen binding;protein binding;complement activation;extracellular region;immune response;membrane;complement activation, classical pathway;innate immune response@NA
A2463_13@133425@133426@duplication@2@106471637@106478411@14@chr14:106471637-106478411@7.52@163@250@1.53@CNVR6294.36, CNVR6294.48, CNVR6294.12, CNVR6294.24@IGHV1-3_1, IGHV4-4_2@0@0@0@@:protein binding:protein binding@NA
A2463_13@133460@133461@duplication@2@106805210@106805644@14@chr14:106805210-106805644@6.22@61@115@1.89@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.41@IGHV4-31_2, IGHV4-31_1@0@0@0@@:protein binding@NA
A2463_13@133491@133492@deletion@2@107095127@107095561@14@chr14:107095127-107095561@17.1@101@15@0.149@CNVR6294.56, CNVR6294.16, CNVR6294.91@IGHV4-61_2, IGHV4-61_1@0@0@0@@:protein binding@NA
A2463_13@133552@133552@duplication@1@22742397@22743598@15@chr15:22742397-22743598@13.8@961@1415@1.47@CNVR6298.5@GOLGA6L1_8@0@0@0@:golgin A6 family-like 1;putative transmembrane protein FLJ36131-like;putative transmembrane protein ENSP00000320207-like;putative golgin subfamily A member 6-like@NA@NA
A2463_13@133869@133873@duplication@5@28629294@28630863@15@chr15:28629294-28630863@21.2@146@312@2.14@CNVR6329.4@GOLGA8F_9, GOLGA8F_10, GOLGA8F_11, GOLGA8F_12, GOLGA8F_13@0@0@0@@:Golgi apparatus@NA
A2463_13@133884@133887@deletion@4@28769090@28771657@15@chr15:28769090-28771657@7.03@58@19@0.328@CNVR6330.3@GOLGA8G_15, GOLGA8G_14, GOLGA8G_13, GOLGA8G_12@0@0@0@:golgin A8 family, member G;golgin A8 family, member F@:Golgi apparatus@NA
A2463_13@133902@133903@deletion@2@28947792@28948556@15@chr15:28947792-28948556@7.36@150@80@0.533@NA@GOLGA8M_16, GOLGA8M_15@0@0@0@:golgin A8 family, member M@:Golgi apparatus@NA
A2463_13@133910@133912@deletion@3@28952895@28953319@15@chr15:28952895-28953319@9.96@471@303@0.643@CNVR6331.1@GOLGA8M_8, GOLGA8M_7, GOLGA8M_6@0@0@0@:golgin A8 family, member M@:Golgi apparatus@NA
A2463_13@133977@133981@deletion@5@30379779@30382159@15@chr15:30379779-30382159@7.99@227@137@0.604@NA@GOLGA8J_8, GOLGA8J_9, GOLGA8J_10, GOLGA8J_11, GOLGA8J_12@0@0@0@:golgin A8 family, member J@:Golgi apparatus@NA
A2463_13@134004@134006@deletion@3@30436983@30437510@15@chr15:30436983-30437510@11.8@169@82@0.485@NA@GOLGA8T_16, GOLGA8T_17, GOLGA8T_18@0@0@0@:golgin A8 family, member J;golgin A8 family, member K@:Golgi apparatus@NA
A2463_13@134036@134040@duplication@5@30845996@30848525@15@chr15:30845996-30848525@13.4@101@209@2.07@NA@GOLGA8Q_2, GOLGA8Q_3, GOLGA8Q_4, GOLGA8Q_5, GOLGA8Q_6@0@0@0@@:Golgi apparatus@NA
A2463_13@134064@134070@duplication@7@30902506@30906253@15@chr15:30902506-30906253@10@284@413@1.45@CNVR6339.2, CNVR6339.3@GOLGA8H_11, GOLGA8H_12, GOLGA8H_13, GOLGA8H_14, GOLGA8H_15, GOLGA8H_16, GOLGA8H_17@0@0@0@:golgin A8 family, member H@:Golgi apparatus@NA
A2463_13@134158@134158@deletion@1@32684984@32685158@15@chr15:32684984-32685158@10.3@54@5@0.0926@NA@GOLGA8K_19@0@0@0@:golgin A8 family, member J@:Golgi apparatus@NA
A2463_13@134160@134161@deletion@2@32685495@32685771@15@chr15:32685495-32685771@19.2@94@4@0.0426@NA@GOLGA8K_17, GOLGA8K_16@0@0@0@:golgin A8 family, member J@:Golgi apparatus@NA
A2463_13@134163@134171@duplication@9@32686867@32691186@15@chr15:32686867-32691186@30.5@534@860@1.61@NA@GOLGA8K_14, GOLGA8K_13, GOLGA8K_12, GOLGA8K_11, GOLGA8K_10, GOLGA8K_9, GOLGA8K_8, GOLGA8K_7, GOLGA8K_6@0@0@0@:golgin A8 family, member J@:Golgi apparatus@NA
A2463_13@134173@134177@deletion@5@32692342@32695395@15@chr15:32692342-32695395@17.3@122@31@0.254@NA@GOLGA8K_4, GOLGA8K_3, GOLGA8K_2, AC139426.2_1, GOLGA8K_1@0@0@0@:golgin A8 family, member J@:Golgi apparatus@NA
A2463_13@134180@134181@duplication@2@32737820@32738099@15@chr15:32737820-32738099@8.53@22@79@3.59@CNVR6346.1@GOLGA8O_17, GOLGA8O_16@0@0@0@:golgin A8 family, member O@:Golgi apparatus@NA
A2463_13@134189@134191@duplication@3@32743115@32743539@15@chr15:32743115-32743539@25@68@245@3.6@CNVR6346.1@GOLGA8O_8, GOLGA8O_7, GOLGA8O_6@0@0@0@:golgin A8 family, member O@:Golgi apparatus@NA
A2463_13@134198@134198@deletion@1@32885756@32885802@15@chr15:32885756-32885802@5.4@138@79@0.572@NA@GOLGA8N_1@0@0@0@:golgin A8 family, member R@:Golgi apparatus@NA
A2463_13@138281@138286@deletion@6@72953606@72956852@15@chr15:72953606-72956852@34.7@363@145@0.399@CNVR6443.1@GOLGA6B_8, GOLGA6B_9, GOLGA6B_10, GOLGA6B_11, GOLGA6B_12, GOLGA6B_13@0@0@0@:golgin A6 family, member B@:Golgi apparatus@NA
A2463_13@138415@138416@deletion@2@74363896@74364650@15@chr15:74363896-74364650@14.9@144@48@0.333@CNVR6448.1@GOLGA6A_15, GOLGA6A_14@0@0@0@:golgin A6 family, member C;golgin A6 family, member A;golgin A6 family, member D;golgin A6 family, member B@:Golgi apparatus@NA
A2463_13@138661@138662@duplication@2@75586071@75586359@15@chr15:75586071-75586359@5.76@149@220@1.48@CNVR6452.1@GOLGA6D_15, GOLGA6D_16@0@0@0@:golgin A6 family, member D@:Golgi apparatus@NA
A2463_13@142753@142753@duplication@1@15460511@15460617@16@chr16:15460511-15460617@7.6@44@104@2.36@CNVR6649.1@PKD1P1_5@0@0@0@:NPIP-like protein 1-like;nuclear pore complex-interacting protein-like 1-like@NA@NA
A2463_13@142910@142928@deletion@19@16330759@16367932@16@chr16:16330759-16367932@139@654@9@0.0138@NA@NOMO3_2, NOMO3_3, NOMO3_4, NOMO3_5, NOMO3_6, NOMO3_7, NOMO3_8, NOMO3_9, NOMO3_10, NOMO3_11, NOMO3_12, NOMO3_13, NOMO3_14, NOMO3_15, NOMO3_16, NOMO3_17, NOMO3_18, NOMO3_19, NOMO3_20@0@0@0@:NODAL modulator 3@:carbohydrate binding;integral to membrane;carboxypeptidase activity@NA
A2463_13@142971@142971@deletion@1@18414875@18414981@16@chr16:18414875-18414981@12.7@58@0@0@CNVR6658.1@RP11-1212A22.2_7@0@0@0@NA@NA@NA
A2463_13@143000@143014@duplication@15@18538860@18569113@16@chr16:18538860-18569113@55.7@723@1261@1.74@NA@NOMO2_16, NOMO2_15, NOMO2_14, NOMO2_13, NOMO2_12, NOMO2_11, NOMO2_10, NOMO2_9, NOMO2_8, NOMO2_7, NOMO2_6, NOMO2_5, NOMO2_4, NOMO2_3, NOMO2_2@0@0@0@:NODAL modulator 2@:carbohydrate binding;protein binding;integral to membrane;carboxypeptidase activity;endoplasmic reticulum membrane@NA
A2463_13@143443@143443@duplication@1@21413606@21415323@16@chr16:21413606-21415323@5.14@15@50@3.33@CNVR6668.3@NPIPL3_14, NPIPL3_13, NPIPL3_12, NPIPL3_11@0@0@0@@:integral to membrane;molecular_function;cellular_component;biological_process@NA
A2463_13@143477@143477@deletion@1@21742159@21742251@16@chr16:21742159-21742251@4.7@118@68@0.576@CNVR6668.5, CNVR6668.2, CNVR6668.7@OTOA_20@0@0@0@:otoancorin@:proteinaceous extracellular matrix;apical plasma membrane;sensory perception of sound;anchored to membrane@: DEAFNESS, AUTOSOMAL RECESSIVE 22; DFNB22
A2463_13@144020@144020@deletion@1@28353929@28354509@16@chr16:28353929-28354509@10.7@350@200@0.571@NA@A-575C2.4_7@0@0@0@:uncharacterized LOC728741@NA@NA
A2463_13@144047@144047@deletion@1@28467746@28468347@16@chr16:28467746-28468347@16.2@86@7@0.0814@NA@NPIPL1_7@0@0@0@NA@NA@NA
A2463_13@144096@144102@duplication@7@28617143@28620176@16@chr16:28617143-28620176@27.1@655@990@1.51@CNVR6685.1, CNVR6685.2@SULT1A1_10, SULT1A1_9, SULT1A1_8, SULT1A1_7, SULT1A1_6, SULT1A1_5, SULT1A1_4@0@0@0@:sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1@:small molecule metabolic process;sulfation;aryl sulfotransferase activity;amine metabolic process;catecholamine metabolic process;xenobiotic metabolic process;cytosol;steroid sulfotransferase activity;integral to membrane;sulfotransferase activity;flavonol 3-sulfotransferase activity;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process;estrogen metabolic process@NA
A2463_13@144262@144265@deletion@4@29057332@29062028@16@chr16:29057332-29062028@35@204@26@0.127@NA@CTB-134H23.2_3, CTB-134H23.2_4, CTB-134H23.2_5, CTB-134H23.2_6@0@0@0@NA@NA@NA
A2463_13@147101@147101@deletion@1@70010292@70010635@16@chr16:70010292-70010635@12.8@202@92@0.455@CNVR6762.3, CNVR6762.2@RP11-419C5.2_7@0@0@0@NA@NA@NA
A2463_13@147125@147126@duplication@2@70208183@70208941@16@chr16:70208183-70208941@6.53@88@149@1.69@CNVR6764.1@CLEC18C_1, CLEC18C_2@0@0@0@:C-type lectin domain family 18, member C@:carbohydrate binding;protein binding;extracellular region@NA
A2463_13@151876@151886@duplication@11@18387190@18430117@17@chr17:18387190-18430117@9.45@546@729@1.34@NA@LGALS9C_2, LGALS9C_3, LGALS9C_4, LGALS9C_5, LGALS9C_6, LGALS9C_7, LGALS9C_8, LGALS9C_9, LGALS9C_10, LGALS9C_11, FAM106A_1@0@0@0@:lectin, galactoside-binding, soluble, 9C:protein FAM106B-like@:carbohydrate binding@NA
A2463_13@153376@153382@deletion@7@34522686@34581968@17@chr17:34522686-34581968@13.5@72@8@0.111@CNVR7077.1, CNVR7077.13@CCL3L3_3, CCL3L3_2, CCL3L3_1, CCL4L1_1, CCL4L1_2, CCL4L1_3, TBC1D3C_14@0@0@0@:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1:TBC1 domain family, member 3C;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3H-like;TBC1 domain family, member 3H@:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_13@153414@153414@duplication@1@34797487@34798054@17@chr17:34797487-34798054@11.7@113@225@1.99@CNVR7078.2, CNVR7078.3@TBC1D3G_14@0@0@0@:TBC1 domain family member 3H-like;TBC1 domain family, member 3H:TBC1 domain family, member 3;TBC1 domain family, member 3G;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like;TBC1 domain family, member 3H@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_13@153627@153659@deletion@33@36287671@36375177@17@chr17:36287671-36375177@71@2055@1192@0.58@NA@TBC1D3F_5, TBC1D3F_6, TBC1D3F_7, TBC1D3F_8, TBC1D3F_9, TBC1D3F_10, TBC1D3F_11, TBC1D3F_12, TBC1D3F_13, TBC1D3F_14, TBC1D3_18, TBC1D3_17, TBC1D3_16, TBC1D3_15, TBC1D3_14, TBC1D3_13, TBC1D3_12, TBC1D3_11, TBC1D3_10, TBC1D3_9, TBC1D3_8, TBC1D3_7, TBC1D3_6, RP11-1407O15.2_12, RP11-1407O15.2_11, RP11-1407O15.2_10, RP11-1407O15.2_9, RP11-1407O15.2_8, RP11-1407O15.2_7, RP11-1407O15.2_6, RP11-1407O15.2_5, RP11-1407O15.2_4, RP11-1407O15.2_3@0@0@0@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family member 3G-like:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
A2463_13@154328@154329@deletion@2@39240460@39254336@17@chr17:39240460-39254336@5.25@256@167@0.652@NA@KRTAP4-7_1, KRTAP4-8_1@0@0@0@:keratin associated protein 4-7:keratin associated protein 4-8@:keratin filament:keratin filament@NA
A2463_13@154346@154346@deletion@1@39421631@39422112@17@chr17:39421631-39422112@7.38@71@25@0.352@CNVR7096.1@KRTAP9-6_1@0@0@0@:keratin associated protein 9-6@:keratin filament@NA
A2463_13@155583@155590@duplication@8@44377161@44409347@17@chr17:44377161-44409347@29.7@401@719@1.79@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A_2, LRRC37A_3, LRRC37A_4, LRRC37A_5, LRRC37A_6, LRRC37A_7, LRRC37A_8, LRRC37A_9@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
A2463_13@155592@155600@duplication@9@44412912@44594799@17@chr17:44412912-44594799@47.1@314@705@2.25@CNVR7114.2, CNVR7114.1@LRRC37A_11, LRRC37A_12, LRRC37A_13, LRRC37A_14, ARL17B_4, ARL17B_3, ARL17B_2, LRRC37A2_2, LRRC37A2_3@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
A2463_13@155610@155611@deletion@2@44632519@44632790@17@chr17:44632519-44632790@9.54@308@185@0.601@CNVR7114.2, CNVR7114.5, CNVR7114.4@LRRC37A2_13, LRRC37A2_14@0@0@0@:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
A2463_13@156877@156878@deletion@2@57656834@57657240@17@chr17:57656834-57657240@4.91@83@43@0.518@NA@DHX40_9, DHX40_10@0@0@0@:DEAH (Asp-Glu-Ala-His) box polypeptide 40@:transport;helicase activity;intracellular;ATP-dependent helicase activity;nucleic acid binding;ATP binding@NA
A2463_13@160953@160953@deletion@1@14808551@14808578@18@chr18:14808551-14808578@5.93@89@43@0.483@CNVR7273.1@ANKRD30B_25@0@0@0@:ankyrin repeat domain 30B@:protein binding;molecular_function;cellular_component;biological_process@NA
A2463_13@162017@162017@deletion@1@44542732@44544371@18@chr18:44542732-44544371@36.5@181@3@0.0166@CNVR7319.1@TCEB3CL2_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_13@164950@164955@duplication@6@7030624@7051633@19@chr19:7030624-7051633@14.5@212@356@1.68@CNVR7517.1@MBD3L5_1, MBD3L5_2, MBD3L4_2, MBD3L4_1, MBD3L2_1, MBD3L2_2@0@0@0@:methyl-CpG binding domain protein 3-like 5:methyl-CpG binding domain protein 3-like 4:methyl-CpG-binding domain protein 3-like 2-like;methyl-CpG binding domain protein 3-like 2@:regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_13@168952@168952@duplication@1@35862263@35863302@19@chr19:35862263-35863302@6.55@114@187@1.64@CNVR7627.1@GPR42_2@0@0@0@@:integral to membrane;G-protein coupled receptor activity;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
A2463_13@170099@170100@duplication@2@40380120@40382826@19@chr19:40380120-40382826@10.7@145@248@1.71@CNVR7639.2@FCGBP_23, FCGBP_22@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_13@170109@170111@duplication@3@40399240@40402471@19@chr19:40399240-40402471@5.82@61@111@1.82@CNVR7639.2, CNVR7639.3@FCGBP_13, FCGBP_12, FCGBP_11@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_13@170398@170399@deletion@2@41627364@41628038@19@chr19:41627364-41628038@12.7@99@28@0.283@CNVR7644.1@CYP2F1_5, CYP2F1_6@0@0@0@:cytochrome P450, family 2, subfamily F, polypeptide 1@:trichloroethylene metabolic process;oxidation-reduction process;aromatase activity;response to toxin;oxygen binding;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;endoplasmic reticulum membrane;naphthalene metabolic process;intracellular membrane-bounded organelle;electron carrier activity;small molecule metabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;heme binding;xenobiotic metabolic process;monooxygenase activity;iron ion binding@NA
A2463_13@170821@170826@deletion@6@43702150@43763287@19@chr19:43702150-43763287@24.4@498@270@0.542@CNVR7658.5, CNVR7658.1@PSG4_3, PSG4_2, PSG4_1, PSG9_6, PSG9_5, PSG9_4@0@0@0@:pregnancy specific beta-1-glycoprotein 4:pregnancy specific beta-1-glycoprotein 9@:protein binding;extracellular region;female pregnancy;defense response:protein binding;extracellular region;female pregnancy;defense response@NA
A2463_13@172565@172566@deletion@2@50463395@50464192@19@chr19:50463395-50464192@5.86@237@151@0.637@NA@SIGLEC11_3, SIGLEC11_2@0@0@0@:sialic acid binding Ig-like lectin 11@:carbohydrate binding;protein binding;integral to membrane;cell adhesion@NA
A2463_13@172989@172994@deletion@6@52146609@52149893@19@chr19:52146609-52149893@17@250@125@0.5@CNVR7702.1@SIGLEC14_7, SIGLEC14_6, SIGLEC14_5, SIGLEC14_4, SIGLEC14_3, SIGLEC14_2@0@0@0@:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 14@:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion;plasma membrane@NA
A2463_13@173306@173308@deletion@3@54745903@54746600@19@chr19:54745903-54746600@11.6@315@183@0.581@CNVR7721.3, CNVR7721.6@LILRA6_3, LILRA6_2, LILRA6_1@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
A2463_13@173459@173465@deletion@7@55246721@55255536@19@chr19:55246721-55255536@53@391@102@0.261@CNVR7725.2, CNVR7725.4, CNVR7725.1@KIR3DL3_6, KIR3DL3_7, KIR3DL3_8, KIR2DL3_1, KIR2DL3_2, KIR2DL3_3, KIR2DL3_4@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:integral to membrane;plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity@NA
A2463_13@173491@173491@deletion@1@55340817@55340920@19@chr19:55340817-55340920@5.16@101@54@0.535@CNVR7725.1, CNVR7725.6@KIR3DL1_7@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
A2463_13@173500@173503@duplication@4@55359207@55362710@19@chr19:55359207-55362710@10@81@160@1.98@CNVR7725.1, CNVR7725.6, CNVR7725.5, CNVR7725.10@KIR2DS4_7, KIR2DS4_8, KIR3DL2_1, KIR3DL2_2@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2-like@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane@NA
A2463_13@174095@174100@duplication@6@58350392@58371508@19@chr19:58350392-58371508@28.3@1238@1824@1.47@NA@ZNF587B_2, ZNF587B_3, ZNF587B_4, ZNF587_1, ZNF587_2, CTD-2583A14.10_2, CTD-2583A14.10_3, ZNF587_3@0@0@0@:zinc finger protein 587B:zinc finger protein 814:zinc finger protein 587@:zinc ion binding:nucleus;intracellular;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding:intracellular;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_13@174394@174395@deletion@2@1558985@1569278@20@chr20:1558985-1569278@11@208@107@0.514@CNVR7763.1@RP4-576H24.4_2, SIRPB1_2, RP4-576H24.4_1@0@0@0@:signal-regulatory protein beta 1;signal-regulatory protein beta-1-like;signal-regulatory protein beta-1 isoform 3-like@:protein binding:protein binding;signal transduction;integral to membrane;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway@NA
A2463_13@175732@175732@duplication@1@25755498@25755948@20@chr20:25755498-25755948@8.03@171@272@1.59@CNVR7821.2, CNVR7821.4@FAM182B_3@0@0@0@:family with sequence similarity 27, member B;family with sequence similarity 27, member A;family with sequence similarity 27, member C;family with sequence similarity 182, member B@NA@NA
A2463_13@175736@175737@deletion@2@26061801@26063616@20@chr20:26061801-26063616@42@195@0@0@CNVR7823.4, CNVR7823.3, CNVR7823.5, CNVR7823.1@FAM182A_4, FAM182A_5@0@0@0@NA@NA@NA
A2463_13@179011@179021@deletion@11@14982551@15013887@21@chr21:14982551-15013887@47.5@277@41@0.148@CNVR7952.1@POTED_1, POTED_2, POTED_3, POTED_4, POTED_5, POTED_6, POTED_7, POTED_8, POTED_9, POTED_10, POTED_11@0@0@0@:POTE ankyrin domain family, member B;POTE ankyrin domain family, member C;POTE ankyrin domain family, member D@:protein binding;plasma membrane@NA
A2463_13@180966@180966@deletion@1@16157307@16157938@22@chr22:16157307-16157938@5.32@66@29@0.439@CNVR8071.2, CNVR8071.5@AP000525.1_1@0@0@0@:uncharacterized LOC101060615@NA@NA
A2463_13@180968@180970@duplication@3@16266930@16269943@22@chr22:16266930-16269943@5.5@364@486@1.34@CNVR8071.2, CNVR8071.3@POTEH_9, POTEH_8, POTEH_7@0@0@0@:POTE ankyrin domain family, member H@:protein binding@NA
A2463_13@180979@180979@deletion@1@17264510@17265299@22@chr22:17264510-17265299@17.5@82@1@0.0122@NA@XKR3_4@0@0@0@:XK, Kell blood group complex subunit-related family, member 3@:integral to membrane;plasma membrane@NA
A2463_13@181127@181132@duplication@6@18723546@18734647@22@chr22:18723546-18734647@6.64@60@113@1.88@CNVR8087.5, CNVR8087.2, CNVR8087.11@AC008132.1_2, AC008132.1_3, AC008132.1_4, AC008132.1_5, AC008132.1_6, AC008132.1_7@0@0@0@NA@NA@NA
A2463_13@181134@181134@duplication@1@18834446@18835833@22@chr22:18834446-18835833@5.21@234@330@1.41@CNVR8087.2, CNVR8087.7, CNVR8087.12, CNVR8087.10@AC008132.13_1@0@0@0@NA@NA@NA
A2463_13@181484@181484@deletion@1@21063585@21063667@22@chr22:21063585-21063667@6.69@38@5@0.132@CNVR8099.6, CNVR8099.2@PI4KA_54@0@0@0@:phosphatidylinositol 4-kinase, catalytic, alpha@:phospholipid metabolic process;1-phosphatidylinositol 4-kinase activity;small molecule metabolic process;phosphatidylinositol phosphorylation;binding;transferase activity, transferring phosphorus-containing groups;phosphotransferase activity, alcohol group as acceptor;ATP binding;Golgi-associated vesicle;phosphatidylinositol biosynthetic process;cytosol;protein binding;signal transduction;synaptic transmission;kinase activity;phosphatidylinositol-mediated signaling@NA
A2463_13@181487@181489@deletion@3@21065630@21067085@22@chr22:21065630-21067085@12.4@167@79@0.473@CNVR8099.6, CNVR8099.2@PI4KA_51, PI4KA_50, PI4KA_49@0@0@0@:phosphatidylinositol 4-kinase, catalytic, alpha@:phospholipid metabolic process;1-phosphatidylinositol 4-kinase activity;small molecule metabolic process;phosphatidylinositol phosphorylation;binding;transferase activity, transferring phosphorus-containing groups;phosphotransferase activity, alcohol group as acceptor;ATP binding;Golgi-associated vesicle;phosphatidylinositol biosynthetic process;cytosol;protein binding;signal transduction;synaptic transmission;kinase activity;phosphatidylinositol-mediated signaling@NA
A2463_13@181765@181765@duplication@1@22988817@22988991@22@chr22:22988817-22988991@8.32@51@118@2.31@CNVR8103.5, CNVR8103.2, CNVR8103.13@GGTLC2_1@0@0@0@:gamma-glutamyltransferase light chain 2@:leukotriene biosynthetic process;glutathione metabolic process;gamma-glutamyltransferase activity;anchored to external side of plasma membrane@NA
A2463_13@181805@181806@duplication@2@23241695@23243475@22@chr22:23241695-23243475@6.68@162@244@1.51@CNVR8103.2, CNVR8103.1, CNVR8103.6, CNVR8103.11@IGLJ2_1, IGLC2_1@0@0@0@@:protein binding@NA
A2463_13@183557@183558@deletion@2@38978355@38978922@22@chr22:38978355-38978922@7.27@137@73@0.533@NA@FAM227A_19, FAM227A_18@0@0@0@:family with sequence similarity 227, member A@NA@NA
A2463_13@183631@183631@deletion@1@39357393@39357686@22@chr22:39357393-39357686@7.25@70@25@0.357@CNVR8164.1@APOBEC3A_4@0@0@0@:apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A;APOBEC3A and APOBEC3B deletion hybrid@:cytidine deamination;defense response to virus;negative regulation of viral genome replication;DNA cytosine deamination;clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine;catalytic activity;DNA demethylation;cytoplasm;innate immune response;cytidine deaminase activity;nucleus;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines;cellular response to xenobiotic stimulus;zinc ion binding;negative regulation of transposition@NA
A2463_06@6@6@duplication@1@69092@70008@1@chr1:69092-70008@12.3@79@187@2.37@CNVR1.1, CNVR1.2@OR4F5_1@0@0@0@:olfactory receptor, family 4, subfamily F, member 5@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_06@389@393@duplication@5@1569582@1571843@1@chr1:1569582-1571843@6.27@55@105@1.91@CNVR17.1@MMP23B_7, MMP23B_8, CDK11B_21, CDK11B_20, CDK11B_19@0@0@0@:matrix metallopeptidase 23B:cyclin-dependent kinase 11B@:metallopeptidase activity;extracellular matrix;reproduction;intracellular;protein binding;proteolysis;integral to membrane;proteinaceous extracellular matrix;endoplasmic reticulum membrane;metalloendopeptidase activity;zinc ion binding:protein serine/threonine kinase activity;protein tyrosine kinase activity;protein phosphorylation;protein kinase activity;cell division;transferase activity, transferring phosphorus-containing groups;ATP binding@NA
A2463_06@426@432@deletion@7@1635990@1640572@1@chr1:1635990-1640572@13.1@182@89@0.489@CNVR17.1@CDK11A_14, CDK11A_13, CDK11A_12, CDK11A_11, CDK11A_10, CDK11A_9, CDK11A_8@0@0@0@:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A@:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division@NA
A2463_06@1833@1838@deletion@6@13219001@13366425@1@chr1:13219001-13366425@10.2@86@28@0.326@NA@WI2-2994D6.2_1, PRAMEF3_3, PRAMEF3_2, PRAMEF3_1, PRAMEF5_2, PRAMEF5_3@0@0@0@:PRAME family member:PRAME family member 3:PRAME family member 5@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_06@2972@2972@deletion@1@22338944@22338960@1@chr1:22338944-22338960@6.73@30@0@0@CNVR108.2, CNVR108.1@CELA3A_8@0@0@0@:chymotrypsin-like elastase family, member 3A@:proteolysis;digestion;cholesterol metabolic process;catalytic activity;serine-type endopeptidase activity@NA
A2463_06@3333@3342@deletion@10@25599040@25655415@1@chr1:25599040-25655415@110@650@101@0.155@CNVR116.1, CNVR116.2@RHD_1, RHD_2, RHD_3, RHD_4, RHD_5, RHD_6, RHD_7, RHD_8, RHD_9, RHD_10@0@0@0@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
A2463_06@3357@3357@deletion@1@25735175@25735360@1@chr1:25735175-25735360@5.81@108@56@0.519@CNVR117.1@RHCE_2@0@0@0@:Rh blood group, CcEe antigens@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@: BLOOD GROUP--RHESUS SYSTEM E POLYPEPTIDE; RHE; RHESUS BLOOD GROUP, CcEe ANTIGENS; RHCE
A2463_06@8507@8508@duplication@2@89476588@89477710@1@chr1:89476588-89477710@12.5@329@505@1.53@CNVR244.1@GBP3_8, GBP3_7@0@0@0@:guanylate binding protein 3@:defense response to virus;GTP binding;GTPase activity;membrane;cytoplasm@NA
A2463_06@9349@9351@duplication@3@104121934@104160722@1@chr1:104121934-104160722@6.45@382@515@1.35@CNVR266.8, CNVR266.3@AMY2B_12, AMY2A_1, AMY2A_2@0@0@0@:actin, gamma 1 pseudogene 4;amylase, alpha 2B (pancreatic):amylase, alpha 2A (pancreatic)@:extracellular region;cation binding;digestion;carbohydrate metabolic process;catalytic activity;alpha-amylase activity;metal ion binding:chloride ion binding;cation binding;small molecule metabolic process;carbohydrate metabolic process;catalytic activity;extracellular space;polysaccharide digestion;extracellular region;carbohydrate catabolic process;alpha-amylase activity;calcium ion binding@NA
A2463_06@9365@9374@deletion@10@104202983@104234232@1@chr1:104202983-104234232@27.4@265@96@0.362@CNVR266.3, CNVR266.1, CNVR266.15@AMY1A_7, AMY1A_8, AMY1A_9, AMY1A_10, AMY1A_11, AMY1B_11, AMY1B_10, AMY1B_9, AMY1B_8, AMY1B_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
A2463_06@9766@9773@duplication@8@110230497@110235917@1@chr1:110230497-110235917@25.5@230@440@1.91@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_1, GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
A2463_06@10893@10896@deletion@4@145328376@145330855@1@chr1:145328376-145330855@11.4@86@24@0.279@CNVR341.2, CNVR341.3@NBPF10_33, NBPF10_34, NBPF10_35, NBPF10_36@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family, member 10@NA@NA
A2463_06@11080@11080@deletion@1@145756418@145756613@1@chr1:145756418-145756613@4.78@21@0@0@NA@PDZK1_6@0@0@0@:PDZ domain containing 1@:PDZ domain binding;transport;transporter activity;cytoplasm;cell proliferation;protein binding;positive regulation of ion transmembrane transport;scavenger receptor binding;brush border membrane;establishment of protein localization to plasma membrane;carnitine transport;drug transport@NA
A2463_06@11127@11164@duplication@38@146215076@146253110@1@chr1:146215076-146253110@38@469@818@1.74@NA@NBPF12_38, NBPF12_37, NBPF12_36, NBPF12_35, NBPF12_34, NBPF12_33, NBPF12_32, NBPF12_31, NBPF12_30, NBPF12_29, NBPF12_28, NBPF12_27, NBPF12_26, NBPF12_25, NBPF12_24, NBPF12_23, NBPF12_22, NBPF12_21, NBPF12_20, NBPF12_19, NBPF12_18, NBPF12_17, NBPF12_16, NBPF12_15, NBPF12_14, NBPF12_13, NBPF12_12, NBPF12_11, NBPF12_10, NBPF12_9, NBPF12_8, NBPF12_7, NBPF12_6, NBPF12_5, NBPF12_4, NBPF12_3, NBPF12_2, NBPF12_1@0@0@0@:neuroblastoma breakpoint family member 21-like@NA@NA
A2463_06@11169@11176@deletion@8@146400092@146410048@1@chr1:146400092-146410048@23.9@253@96@0.379@NA@NBPF12_9, NBPF12_10, NBPF12_11, NBPF12_12, NBPF12_13, NBPF12_14, NBPF12_15, NBPF12_16@0@0@0@:neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family member 14-like;neuroblastoma breakpoint family, member 12@:cytoplasm@NA
A2463_06@11341@11351@duplication@11@148008574@148016460@1@chr1:148008574-148016460@54.5@986@1651@1.67@CNVR346.2, CNVR346.4@NBPF14_17, NBPF14_16, NBPF14_15, NBPF14_14, NBPF14_13, NBPF14_12, NBPF14_11, NBPF14_10, NBPF14_9, NBPF14_8, NBPF14_7@0@0@0@:neuroblastoma breakpoint family, member 14@:cytoplasm@NA
A2463_06@11464@11465@duplication@2@148341796@148342542@1@chr1:148341796-148342542@13.7@269@435@1.62@CNVR347.1, CNVR347.5@NBPF20_6, NBPF20_5@0@0@0@:uncharacterized LOC101060226;neuroblastoma breakpoint family member 14-like;neuroblastoma breakpoint family, member 12;neuroblastoma breakpoint family member 3-like;neuroblastoma breakpoint family, member 7@:cytoplasm@NA
A2463_06@11479@11483@deletion@5@148591202@148594640@1@chr1:148591202-148594640@9.95@139@65@0.468@CNVR348.1, CNVR348.4@NBPF15_17, NBPF15_18, NBPF15_19, NBPF15_20, NBPF15_21@0@0@0@:neuroblastoma breakpoint family, member 15@:cytoplasm@NA
A2463_06@11498@11498@duplication@1@148756442@148756684@1@chr1:148756442-148756684@9.72@34@106@3.12@CNVR349.2, CNVR349.3, CNVR349.4@NBPF16_16@0@0@0@:neuroblastoma breakpoint family, member 16@:cytoplasm@NA
A2463_06@11508@11508@deletion@1@149762794@149763073@1@chr1:149762794-149763073@5.38@282@180@0.638@CNVR351.3, CNVR351.5@FCGR1A_6@0@0@0@:Fc fragment of IgG, high affinity Ib, receptor (CD64);Fc fragment of IgG, high affinity Ia, receptor (CD64):histone cluster 2, H2bf@:IgG receptor activity;phagocytosis, recognition;antibody-dependent cellular cytotoxicity;regulation of immune response;phagocytosis, engulfment;antigen processing and presentation of peptide antigen via MHC class I;immune response;clathrin-coated endocytic vesicle membrane;interferon-gamma-mediated signaling pathway;integral to membrane;Fc-gamma receptor signaling pathway;positive regulation of type III hypersensitivity;plasma membrane;receptor-mediated endocytosis;positive regulation of phagocytosis;cytokine-mediated signaling pathway;early endosome membrane;cell surface receptor signaling pathway;IgG binding;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;positive regulation of type IIa hypersensitivity;antigen processing and presentation of exogenous antigen;external side of plasma membrane;signal transduction;protein binding;defense response to bacterium;antigen processing and presentation of exogenous peptide antigen via MHC class I;receptor signaling protein activity;response to bacterium:sequence-specific DNA binding;intracellular;nucleus;protein heterodimerization activity;DNA binding;nucleosome assembly;nucleosome@NA
A2463_06@12117@12118@deletion@2@152573209@152586574@1@chr1:152573209-152586574@20.3@96@2@0.0208@CNVR358.1@LCE3C_1, LCE3B_1@0@0@0@:late cornified envelope 3C:late cornified envelope 3B@:keratinization:keratinization@NA
A2463_06@14056@14062@duplication@7@161599569@161643019@1@chr1:161599569-161643019@8.24@304@427@1.4@CNVR383.1@FCGR3B_3, FCGR3B_2, FCGR3B_1, FCGR2B_1, FCGR2B_2, FCGR2B_3, FCGR2B_4@0@0@0@:Fc fragment of IgG, low affinity IIIa, receptor (CD16a):Fc fragment of IgG, low affinity IIb, receptor (CD32):Fc fragment of IgG, low affinity IIIb, receptor (CD16b)@:IgG binding;protein binding;regulation of immune response;extracellular region;integral to membrane;immune response;plasma membrane;external side of plasma membrane:IgG binding;protein binding;signal transduction;regulation of immune response;integral to membrane;immune response;plasma membrane;virus-host interaction:IgG binding;protein binding;extracellular region;immune response;plasma membrane;anchored to membrane@: MALARIA, SUSCEPTIBILITY TO; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
A2463_06@16029@16040@deletion@12@196744018@196801129@1@chr1:196744018-196801129@78.3@1663@902@0.542@CNVR459.1@CFHR3_1, CFHR3_2, CFHR3_3, CFHR3_4, CFHR3_5, CFHR3_6, CFHR1_1, CFHR1_2, CFHR1_3, CFHR1_4, CFHR1_5, CFHR1_6@0@0@0@:complement factor H-related 3:complement factor H-related 1:complement factor H-related 2@:extracellular space:extracellular space;complement activation:extracellular region@NA
A2463_06@24980@24981@deletion@2@89952882@89953355@2@chr2:89952882-89953355@6.67@34@3@0.0882@CNVR867.4, CNVR867.10@IGKV1D-33_1, IGKV1D-33_2@0@0@0@@:protein binding@NA
A2463_06@26008@26011@deletion@4@108454714@108460186@2@chr2:108454714-108460186@6.83@110@56@0.509@NA@RGPD4_3, RGPD4_4, RGPD4_5, RGPD4_6@0@0@0@:RANBP2-like and GRIP domain containing 4@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_06@26021@26021@deletion@1@108479139@108479317@2@chr2:108479139-108479317@4.92@133@77@0.579@NA@RGPD4_16@0@0@0@:RANBP2-like and GRIP domain containing 4@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_06@27996@27997@duplication@2@152463121@152464122@2@chr2:152463121-152464122@20.1@78@240@3.08@CNVR1026.1@NEB_84, NEB_83@0@0@0@:nebulin@:Z disc;muscle filament sliding;oxidation-reduction process;contractile fiber part;actin cytoskeleton;regulation of actin filament length;structural constituent of muscle;cytosol;actin binding;protein binding;myofibril;somatic muscle development;muscle organ development@: NEMALINE MYOPATHY 2; NEM2
A2463_06@39892@39894@deletion@3@75786030@75790887@3@chr3:75786030-75790887@6.84@201@124@0.617@CNVR1432.5, CNVR1432.9, CNVR1432.4@ZNF717_5, ZNF717_4, ZNF717_3@0@0@0@:zinc finger protein 717;zinc finger protein 717-like@:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_06@45438@45438@deletion@1@195475774@195475935@3@chr3:195475774-195475935@4.8@90@47@0.522@CNVR1703.1, CNVR1703.2, CNVR1703.5, CNVR1703.4@MUC4_24@0@0@0@:mucin 4, cell surface associated@:ErbB-2 class receptor binding;Golgi lumen;cell-matrix adhesion;post-translational protein modification;extracellular matrix structural constituent;protein binding;O-glycan processing;cellular protein metabolic process;proteinaceous extracellular matrix;integral to plasma membrane;membrane;extracellular matrix constituent, lubricant activity;biological_process@NA
A2463_06@46667@46671@deletion@5@9174900@9213975@4@chr4:9174900-9213975@12.6@66@6@0.0909@NA@FAM90A26P_4, FAM90A26P_5, FAM90A26P_6, FAM90A26P_7, USP17L13_1, USP17L10_1@0@0@0@:ubiquitin specific peptidase 17-like family member 10:ubiquitin specific peptidase 17-like family member 13@:zinc ion binding;nucleic acid binding:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
A2463_06@46677@46677@duplication@1@9250357@9251948@4@chr4:9250357-9251948@7.97@289@430@1.49@NA@USP17L18_1@0@0@0@:ubiquitin specific peptidase 17-like family member 18@:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
A2463_06@53303@53307@duplication@5@716924@745413@5@chr5:716924-745413@13.9@287@443@1.54@CNVR2280.3@ZDHHC11B_10, ZDHHC11B_9, ZDHHC11B_8, ZDHHC11B_7, ZDHHC11B_6@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
A2463_06@53311@53312@duplication@2@756082@767067@5@chr5:756082-767067@6.16@91@154@1.69@CNVR2280.3@ZDHHC11B_2, ZDHHC11B_1@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
A2463_06@53317@53321@duplication@5@825280@843839@5@chr5:825280-843839@5.94@331@443@1.34@CNVR2280.3, CNVR2280.8@ZDHHC11_8, ZDHHC11_7, ZDHHC11_6, ZDHHC11_5, ZDHHC11_4@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
A2463_06@59064@59065@duplication@2@140552418@140560021@5@chr5:140552418-140560021@27.3@3196@4875@1.53@CNVR2624.1@PCDHB7_1, PCDHB8_1@0@0@0@:protocadherin beta 7:protocadherin beta 8@:integral to membrane;calcium-dependent cell-cell adhesion;homophilic cell adhesion;plasma membrane;membrane;calcium ion binding:integral to membrane;homophilic cell adhesion;plasma membrane;membrane;calcium ion binding@NA
A2463_06@60884@60885@duplication@2@175517374@175520277@5@chr5:175517374-175520277@14.4@75@196@2.61@NA@FAM153B_3, FAM153B_4@0@0@0@:uncharacterized LOC100507387;family with sequence similarity 153, member B@NA@NA
A2463_06@61285@61285@deletion@1@177468695@177468764@5@chr5:177468695-177468764@12.3@74@11@0.149@NA@FAM153C_7@0@0@0@NA@NA@NA
A2463_06@63290@63292@duplication@3@31323945@31324935@6@chr6:31323945-31324935@14.1@289@451@1.56@CNVR2841.12, CNVR2841.14, CNVR2841.8@HLA-B_3, HLA-B_2, HLA-B_1@0@0@0@:major histocompatibility complex, class I, B@:MHC class I protein complex;regulation of immune response;regulation of interleukin-12 production;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;regulation of T cell anergy;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;receptor binding;early endosome membrane;virus-host interaction;regulation of interleukin-6 production;regulation of dendritic cell differentiation;phagocytic vesicle membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;MHC class I receptor activity;membrane@: SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO; SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1; SPDA1
A2463_06@63725@63748@duplication@24@31962023@31974881@6@chr6:31962023-31974881@84.7@1151@2091@1.82@CNVR2843.6, CNVR2843.3@C4A_20, C4A_21, C4A_22, C4A_23, C4A_24, C4A_25, C4A_26, C4A_27, C4A_28, C4A_29, C4A_30, C4A_31, C4A_32, C4A_33, C4A_34, C4A_35, C4A_36, C4A_37, C4A_38, C4A_39, C4A_40, C4A_41, AL645922.1_2, AL645922.1_1@0@0@0@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
A2463_06@63777@63778@duplication@2@31997344@31997825@6@chr6:31997344-31997825@13.2@164@299@1.82@CNVR2843.6, CNVR2843.5@C4B_29, C4B_30@0@0@0@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
A2463_06@63799@63799@duplication@1@32008647@32008911@6@chr6:32008647-32008911@5.69@164@246@1.5@CNVR2843.6, CNVR2843.5@CYP21A2_10@0@0@0@:cytochrome P450, family 21, subfamily A, polypeptide 2@:oxidation-reduction process;electron carrier activity;response to antibiotic;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;steroid 21-monooxygenase activity;C21-steroid hormone biosynthetic process;heme binding;mineralocorticoid biosynthetic process;progesterone metabolic process;monooxygenase activity;cellular response to peptide hormone stimulus;iron ion binding@: ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY
A2463_06@63810@63813@duplication@4@32011785@32083745@6@chr6:32011785-32083745@14@252@418@1.66@NA@TNXB_3, TNXB_2, TNXB_1, ATF6B_18@0@0@0@:tenascin-X-like;tenascin XB:activating transcription factor 6 beta@:integrin binding;extracellular matrix;cell-cell adhesion;elastic fiber assembly;collagen fibril organization;fibrillar collagen;actin cytoskeleton organization;extracellular space;heparin binding;proteinaceous extracellular matrix;fatty acid metabolic process;regulation of JUN kinase activity;receptor binding;intracellular;cell-matrix adhesion;extracellular matrix organization;lipid metabolic process;protein binding;signal transduction;extracellular region;collagen binding;cell adhesion;triglyceride metabolic process;fibril organization;collagen metabolic process:sequence-specific DNA binding;intracellular;regulation of transcription, DNA-dependent;sequence-specific DNA binding transcription factor activity;signal transduction;integral to membrane;nucleolus;protein dimerization activity;focal adhesion;response to unfolded protein;nucleus;transcription, DNA-dependent;endoplasmic reticulum membrane@: EHLERS-DANLOS-LIKE SYNDROME DUE TO TENASCIN-X DEFICIENCY; EHLERS-DANLOS SYNDROME, TYPE III
A2463_06@63953@63957@deletion@5@32485517@32489951@6@chr6:32485517-32489951@20.2@153@42@0.275@CNVR2845.21, CNVR2845.25, CNVR2845.30@HLA-DRB5_6, HLA-DRB5_5, HLA-DRB5_4, HLA-DRB5_3, HLA-DRB5_2@0@0@0@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
A2463_06@63964@63964@deletion@1@32557421@32557519@6@chr6:32557421-32557519@5.42@64@27@0.422@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.56, CNVR2845.34@HLA-DRB1_1@0@0@0@:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1@:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
A2463_06@63966@63967@duplication@2@32609088@32610030@6@chr6:32609088-32610030@10.1@390@561@1.44@CNVR2845.21, CNVR2845.25, CNVR2845.37, CNVR2845.27, CNVR2845.22, CNVR2845.39, CNVR2845.20@HLA-DQA1_2, HLA-DQA1_3@0@0@0@:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
A2463_06@70816@70817@duplication@2@161054786@161056336@6@chr6:161054786-161056336@15.8@167@326@1.95@CNVR3133.1@LPA_9, LPA_8@0@0@0@:lipoprotein, Lp(a)@:blood circulation;endopeptidase inhibitor activity;catalytic activity;lipoprotein metabolic process;proteolysis;heparin binding;receptor-mediated endocytosis;fibronectin binding;small molecule metabolic process;apolipoprotein binding;lipid metabolic process;negative regulation of endopeptidase activity;extracellular region;plasma lipoprotein particle;lipid transport;serine-type endopeptidase activity@: APOLIPOPROTEIN(a); LPA
A2463_06@71754@71757@duplication@4@5959481@5965318@7@chr7:5959481-5965318@11.3@190@308@1.62@NA@CCZ1_12, CCZ1_13, CCZ1_14, CCZ1_15@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae):radial spoke head 10 homolog B (Chlamydomonas)@:lysosomal membrane@NA
A2463_06@71762@71777@duplication@16@5977390@6013173@7@chr7:5977390-6013173@17.1@419@626@1.49@NA@RSPH10B_16, RSPH10B_15, RSPH10B_14, RSPH10B_13, RSPH10B_12, RSPH10B_11, RSPH10B_10, RSPH10B_9, RSPH10B_8, RSPH10B_7, RSPH10B_6, RSPH10B_5, RSPH10B_4, RSPH10B_3, RSPH10B_2, PMS2_15@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas):PMS2 postmeiotic segregation increased 2 (S. cerevisiae)@:response to drug;DNA binding;MutSalpha complex binding;ATP binding;mismatch repair;DNA repair;mismatched DNA binding;ATPase activity;nucleus;mismatch repair complex;reciprocal meiotic recombination;ATP catabolic process;single-stranded DNA binding;response to DNA damage stimulus;single base insertion or deletion binding;protein binding;somatic hypermutation of immunoglobulin genes;somatic recombination of immunoglobulin gene segments;MutLalpha complex;endonuclease activity@: COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 4; HNPCC4; MISMATCH REPAIR CANCER SYNDROME
A2463_06@71922@71922@deletion@1@6797310@6797562@7@chr7:6797310-6797562@7.38@176@96@0.545@NA@RSPH10B2_2@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
A2463_06@71932@71944@deletion@13@6819242@6844686@7@chr7:6819242-6844686@51.6@483@174@0.36@NA@RSPH10B2_12, RSPH10B2_13, RSPH10B2_14, RSPH10B2_15, RSPH10B2_16, RSPH10B2_17, RSPH10B2_18, RSPH10B2_19, RSPH10B2_20, CCZ1B_15, CCZ1B_14, CCZ1B_13, CCZ1B_12@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
A2463_06@73260@73263@duplication@4@38388957@38393784@7@chr7:38388957-38393784@17.6@188@349@1.86@CNVR3354.3, CNVR3354.1@TRGV5_2, TRGV5_1, TRGV4_2, TRGV4_1@0@0@0@@:protein binding:protein binding@NA
A2463_06@76792@76793@deletion@2@102309363@102312048@7@chr7:102309363-102312048@11.1@61@7@0.115@CNVR3518.1@POLR2J2_2, POLR2J2_2, POLR2J2_1, POLR2J2_1@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
A2463_06@79287@79287@deletion@1@143400089@143400710@7@chr7:143400089-143400710@4.78@32@7@0.219@CNVR3594.2, CNVR3594.1@FAM115C_2@0@0@0@:family with sequence similarity 115, member C;protein FAM115C-like@NA@NA
A2463_06@79310@79311@duplication@2@143884023@143929936@7@chr7:143884023-143929936@8.62@258@378@1.47@CNVR3598.4, CNVR3598.3, CNVR3598.7@ARHGEF35_2, OR2A42_1@0@0@0@:Rho guanine nucleotide exchange factor (GEF) 35:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_06@79313@79313@duplication@1@143964011@143966343@7@chr7:143964011-143966343@14.1@230@414@1.8@CNVR3598.4@CTAGE8_1@0@0@0@:Rho guanine nucleotide exchange factor (GEF) 35:CTAGE family, member 6, pseudogene;CTAGE family, member 15, pseudogene@:integral to membrane@NA
A2463_06@80141@80143@deletion@3@116087@150533@8@chr8:116087-150533@8.43@82@32@0.39@CNVR3684.5, CNVR3684.11@OR4F21_1, RP11-585F1.10_2, RP11-585F1.10_1@0@0@0@:olfactory receptor, family 4, subfamily F, member 21:F-box only protein 25-like;putative uncharacterized protein C20orf69-like@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_06@80362@80366@deletion@5@7215499@7220468@8@chr8:7215499-7220468@167@862@8@0.00928@CNVR3771.8, CNVR3771.10, CNVR3771.4@ZNF705G_7, ZNF705G_6, ZNF705G_5, ZNF705G_4, ZNF705G_3@0@0@0@:zinc finger protein 705G@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_06@80371@80377@duplication@7@7308236@7343904@8@chr8:7308236-7343904@29.2@389@697@1.79@CNVR3771.8, CNVR3771.10, CNVR3771.4@SPAG11B_3, SPAG11B_2, SPAG11B_1, DEFB104B_2, DEFB104B_1, DEFB106B_2, DEFB106B_1@0@0@0@:sperm associated antigen 11B:defensin, beta 104A;defensin, beta 104B:defensin, beta 106B;defensin, beta 106A@:spermatogenesis;defense response to bacterium;extracellular region;molecular_function;defense response:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium@NA
A2463_06@80384@80386@duplication@3@7398168@7399402@8@chr8:7398168-7399402@8.88@107@192@1.79@CNVR3771.8, CNVR3771.4, CNVR3771.2@RP11-1118M6.1_2, RP11-1118M6.1_3, RP11-1118M6.1_4@0@0@0@:uncharacterized LOC100133251@NA@NA
A2463_06@80392@80394@duplication@3@7673082@7680945@8@chr8:7673082-7680945@6.19@147@220@1.5@CNVR3772.4, CNVR3772.6, CNVR3772.2, CNVR3772.8, CNVR3772.10@DEFB107A_1, DEFB105A_3, DEFB105A_2@0@0@0@:defensin, beta 107B;defensin, beta 107A:defensin, beta 105B;defensin, beta 105A@:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium@NA
A2463_06@80402@80402@deletion@1@7718169@7718245@8@chr8:7718169-7718245@6.65@30@0@0@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@SPAG11A_3@0@0@0@:sperm associated antigen 11A;sperm associated antigen 11B@:extracellular region;defense response@NA
A2463_06@80402@80411@duplication@9@7718169@7808269@8@chr8:7718169-7808269@38.6@463@854@1.84@CNVR3772.4, CNVR3772.6, CNVR3772.10, CNVR3772.13@SPAG11A_3, SPAG11A_4, DEFB103A_1, DEFB103A_2, DEFB4A_1, DEFB4A_2, ZNF705B_2, ZNF705B_3, ZNF705B_4, ZNF705B_5@0@0@0@:sperm associated antigen 11A;sperm associated antigen 11B:defensin, beta 103B;defensin, beta 103A:defensin, beta 4B;defensin, beta 4A:zinc finger protein 705B@:extracellular region;defense response:extracellular region;defense response to bacterium;Golgi lumen;positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria;defense response;innate immune response:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response:intracellular;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_06@80564@80564@duplication@1@11970084@11970667@8@chr8:11970084-11970667@10.8@133@248@1.86@CNVR3785.8, CNVR3785.5@ZNF705D_6@0@0@0@:zinc finger protein 705D@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_06@80566@80586@duplication@21@12041116@12423650@8@chr8:12041116-12423650@52@1027@1612@1.57@CNVR3786.4@FAM86B1_8, FAM86B1_7, FAM86B1_6, FAM86B1_5, FAM86B1_4, FAM86B1_3, FAM86B1_2, FAM86B1_1, DEFB130_2, DEFB130_1, FAM86B2_8, FAM86B2_7, FAM86B2_6, FAM86B2_5, FAM86B2_4, FAM86B2_3, FAM86B2_2, FAM86B2_1, AC130352.1_5, AC130352.1_6, AC130352.1_7@0@0@0@:family with sequence similarity 86, member B2;family with sequence similarity 86, member B1:defensin, beta 130-like;defensin, beta 130:family with sequence similarity 86, member B2@:extracellular region;defense response to bacterium;defense response@NA
A2463_06@86646@86646@duplication@1@178817@178969@9@chr9:178817-178969@4.44@60@103@1.72@CNVR4135.1@CBWD1_1@0@0@0@:COBW domain containing 1;COBW domain-containing protein 1-like;COBW domain containing 5@:ATP binding@NA
A2463_06@87593@87604@duplication@12@27455132@27567118@9@chr9:27455132-27567118@48.5@1257@1896@1.51@NA@MOB3B_2, IFNK_1, C9orf72_11, C9orf72_10, C9orf72_9, C9orf72_8, C9orf72_7, C9orf72_6, C9orf72_5, C9orf72_4, C9orf72_3, C9orf72_2@0@0@0@:MOB kinase activator 3B:interferon, kappa:chromosome 9 open reading frame 72@:protein binding;metal ion binding:defense response to virus;negative regulation of cell proliferation;response to virus;regulation of transcription, DNA-dependent;interferon-alpha/beta receptor binding;extracellular space;positive regulation of innate immune response;extracellular region;natural killer cell activation;cytokine receptor binding;cytokine activity;cytokine-mediated signaling pathway;defense response:cell death;nucleus;cytoplasm@: FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS; FTDALS
A2463_06@88521@88521@deletion@1@39887323@39891057@9@chr9:39887323-39891057@20@199@61@0.307@NA@SPATA31A2_4@0@0@0@:SPATA31 subfamily A, member 2@:integral to membrane@NA
A2463_06@88544@88546@duplication@3@42368416@42372375@9@chr9:42368416-42372375@6.03@111@178@1.6@NA@ANKRD20A2_1, ANKRD20A2_2, ANKRD20A2_3@0@0@0@:ankyrin repeat domain 20 family, member A2@:protein binding@NA
A2463_06@88595@88600@duplication@6@43822519@43861206@9@chr9:43822519-43861206@12.6@370@541@1.46@CNVR4294.1@CNTNAP3B_8, CNTNAP3B_9, CNTNAP3B_10, CNTNAP3B_11, CNTNAP3B_12, CNTNAP3B_13@0@0@0@:contactin associated protein-like 3B;contactin associated protein-like 3@:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
A2463_06@88639@88641@deletion@3@67926874@67930837@9@chr9:67926874-67930837@10.8@49@0@0@NA@ANKRD20A1_1, ANKRD20A1_2, ANKRD20A1_3@0@0@0@:ankyrin repeat domain 20 family, member A1@:protein binding;plasma membrane@NA
A2463_06@88676@88678@deletion@3@69382094@69386055@9@chr9:69382094-69386055@8.67@42@2@0.0476@NA@ANKRD20A4_1, ANKRD20A4_2, ANKRD20A4_3@0@0@0@:ankyrin repeat domain 20 family, member A4@:protein binding@NA
A2463_06@88681@88690@deletion@10@69393823@69424176@9@chr9:69393823-69424176@21.8@616@380@0.617@NA@ANKRD20A4_6, ANKRD20A4_7, ANKRD20A4_8, ANKRD20A4_9, ANKRD20A4_10, ANKRD20A4_11, ANKRD20A4_12, ANKRD20A4_13, ANKRD20A4_14, ANKRD20A4_15@0@0@0@:ankyrin repeat domain 20 family, member A4@:protein binding@NA
A2463_06@88994@88994@deletion@1@77286706@77286817@9@chr9:77286706-77286817@5.33@58@23@0.397@NA@RORB_9@0@0@0@:RAR-related orphan receptor B@:nucleoplasm;steroid hormone mediated signaling pathway;sequence-specific DNA binding;melatonin receptor activity;sequence-specific DNA binding transcription factor activity;circadian rhythm;steroid hormone receptor activity;nucleus;gene expression;transcription initiation from RNA polymerase II promoter;intracellular receptor mediated signaling pathway;regulation of transcription, DNA-dependent;ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity;protein binding;brain development;positive regulation of transcription, DNA-dependent;eye photoreceptor cell development;visual perception;zinc ion binding@NA
A2463_06@95367@95382@deletion@16@17921734@18085490@10@chr10:17921734-18085490@12.9@97@28@0.289@NA@MRC1L1_19, MRC1L1_20, MRC1L1_21, MRC1L1_22, MRC1L1_23, MRC1L1_24, MRC1L1_25, MRC1L1_26, MRC1L1_27, MRC1L1_28, MRC1L1_29, MRC1L1_30, TMEM236_1, TMEM236_2, TMEM236_3, TMEM236_4@0@0@0@:macrophage mannose receptor 1-like:transmembrane protein 236;transmembrane protein 236-like@:carbohydrate binding:integral to membrane@NA
A2463_06@96454@96461@deletion@8@46312644@46342795@10@chr10:46312644-46342795@25.9@168@28@0.167@NA@FAM25E_1, AGAP4_7, AGAP4_6, AGAP4_5, AGAP4_4, AGAP4_3, AGAP4_2, AGAP4_1@0@0@0@:ArfGAP with GTPase domain, ankyrin repeat and PH domain 4;arf-GAP with GTPase, ANK repeat and PH domain-containing protein 5-like@:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity@NA
A2463_06@96468@96470@deletion@3@46605764@46611811@10@chr10:46605764-46611811@7.24@34@1@0.0294@CNVR4712.3@PTPN20A_4, PTPN20A_3, PTPN20A_2@0@0@0@:protein tyrosine phosphatase, non-receptor type 20B;protein tyrosine phosphatase, non-receptor type 20A@:phosphatase activity;protein tyrosine phosphatase activity;microtubule;nucleus;dephosphorylation;protein dephosphorylation;microtubule organizing center@NA
A2463_06@96543@96563@duplication@21@47908065@47948853@10@chr10:47908065-47948853@29.1@472@756@1.6@CNVR4715.2, CNVR4715.1@FAM21B_9, FAM21B_10, FAM21B_11, FAM21B_12, FAM21B_13, FAM21B_14, FAM21B_15, FAM21B_16, FAM21B_17, FAM21B_18, FAM21B_19, FAM21B_20, FAM21B_21, FAM21B_22, FAM21B_23, FAM21B_24, FAM21B_25, FAM21B_26, FAM21B_27, FAM21B_28, FAM21B_29@0@0@0@:family with sequence similarity 21, member B@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_06@96581@96581@duplication@1@48054984@48055018@10@chr10:48054984-48055018@4.51@31@67@2.16@CNVR4715.2@ASAH2C_1@0@0@0@@:ceramidase activity;sphingolipid metabolic process@NA
A2463_06@96620@96620@deletion@1@48771316@48771405@10@chr10:48771316-48771405@12.4@60@2@0.0333@CNVR4716.10, CNVR4716.3@PTPN20B_6@0@0@0@:protein tyrosine phosphatase, non-receptor type 20B;protein tyrosine phosphatase, non-receptor type 20A@:phosphatase activity;protein tyrosine phosphatase activity;microtubule;nucleus;dephosphorylation;protein dephosphorylation;microtubule organizing center@NA
A2463_06@96631@96633@duplication@3@49376639@49381136@10@chr10:49376639-49381136@13@59@152@2.58@CNVR4717.2@FRMPD2_27, FRMPD2_26, FRMPD2_25@0@0@0@:FERM and PDZ domain containing 2@:basolateral plasma membrane;transferase activity, transferring phosphorus-containing groups;cytoplasm;tight junction;protein binding;cytoskeleton;1-phosphatidylinositol binding;tight junction assembly@NA
A2463_06@96851@96860@duplication@10@51371542@51472652@10@chr10:51371542-51472652@12.8@638@884@1.39@NA@TIMM23B_1, TIMM23B_2, TIMM23B_3, TIMM23B_4, TIMM23B_5, TIMM23B_6, AGAP7_7, AGAP7_6, AGAP7_5, AGAP7_4@0@0@0@:translocase of inner mitochondrial membrane 23 homolog B (yeast):ArfGAP with GTPase domain, ankyrin repeat and PH domain 7@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity@NA
A2463_06@96906@96907@deletion@2@51854909@51855538@10@chr10:51854909-51855538@6.58@69@29@0.42@NA@FAM21A_14, FAM21A_15@0@0@0@:family with sequence similarity 21, member B;family with sequence similarity 21, member A@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_06@96920@96937@deletion@18@51887344@51978390@10@chr10:51887344-51978390@24.6@353@169@0.479@NA@FAM21A_28, FAM21A_29, FAM21A_30, FAM21A_31, ASAH2_20, ASAH2_19, ASAH2_18, ASAH2_17, ASAH2_16, ASAH2_15, ASAH2_14, ASAH2_13, ASAH2_12, ASAH2_11, ASAH2_10, ASAH2_9, ASAH2_8, ASAH2_7@0@0@0@:family with sequence similarity 21, member B;family with sequence similarity 21, member A:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
A2463_06@98344@98348@deletion@5@81463367@81470520@10@chr10:81463367-81470520@12@110@41@0.373@CNVR4815.2, CNVR4815.4@FAM22B_1, FAM22B_2, FAM22B_3, FAM22B_4, FAM22B_5@0@0@0@NA@NA@NA
A2463_06@98350@98350@deletion@1@81471457@81472241@10@chr10:81471457-81472241@42.9@326@52@0.16@CNVR4815.2, CNVR4815.4@FAM22B_7@0@0@0@NA@NA@NA
A2463_06@98350@98357@duplication@7@81471457@81610362@10@chr10:81471457-81610362@-27.3@411@334@0.813@CNVR4815.2@FAM22B_7, FAM22E_1, FAM22E_2, FAM22E_3, FAM22E_4, FAM22E_5, FAM22E_6, FAM22E_7@0@0@0@NA@NA@NA
A2463_06@101608@101611@duplication@4@124344788@124350210@10@chr10:124344788-124350210@6.78@250@350@1.4@CNVR4912.4, CNVR4912.3, CNVR4912.2@DMBT1_15, DMBT1_16, DMBT1_17, DMBT1_18@0@0@0@:deleted in malignant brain tumors 1@:defense response to virus;calcium-dependent protein binding;pattern recognition receptor signaling pathway;blastocyst development;response to estrogen stimulus;tissue regeneration;proteinaceous extracellular matrix;protein transport;Gram-negative bacterial cell surface binding;positive regulation of epithelial cell differentiation;virus-host interaction;epithelial cell differentiation;induction of bacterial agglutination;phagocytic vesicle membrane;intracellular;Gram-positive bacterial cell surface binding;zymogen binding;innate immune response;cytoplasm;extrinsic to membrane;protein binding;zymogen granule membrane;extracellular region;scavenger receptor activity;pattern recognition receptor activity;inner cell mass cell proliferation;membrane@: GLIOMA SUSCEPTIBILITY 1; GLM1
A2463_06@101622@101622@deletion@1@124361314@124361636@10@chr10:124361314-124361636@9.35@45@2@0.0444@CNVR4912.1@DMBT1_29@0@0@0@:deleted in malignant brain tumors 1@:defense response to virus;calcium-dependent protein binding;pattern recognition receptor signaling pathway;blastocyst development;response to estrogen stimulus;tissue regeneration;proteinaceous extracellular matrix;protein transport;Gram-negative bacterial cell surface binding;positive regulation of epithelial cell differentiation;virus-host interaction;epithelial cell differentiation;induction of bacterial agglutination;phagocytic vesicle membrane;intracellular;Gram-positive bacterial cell surface binding;zymogen binding;innate immune response;cytoplasm;extrinsic to membrane;protein binding;zymogen granule membrane;extracellular region;scavenger receptor activity;pattern recognition receptor activity;inner cell mass cell proliferation;membrane@: GLIOMA SUSCEPTIBILITY 1; GLM1
A2463_06@103269@103269@duplication@1@4976003@4976943@11@chr11:4976003-4976943@6.95@292@424@1.45@CNVR5040.1@OR51A2_1@0@0@0@:matrix metallopeptidase 26:olfactory receptor, family 51, subfamily A, member 2@:metallopeptidase activity;extracellular matrix;proteolysis;proteinaceous extracellular matrix;collagen catabolic process;metalloendopeptidase activity;zinc ion binding;metabolic process:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_06@106046@106048@duplication@3@55370918@55419315@11@chr11:55370918-55419315@8.35@554@744@1.34@CNVR5179.1@OR4C11_1, OR4P4_1, OR4S2_1@0@0@0@:olfactory receptor, family 4, subfamily C, member 11:olfactory receptor, family 4, subfamily P, member 4:olfactory receptor, family 4, subfamily S, member 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_06@108761@108792@duplication@32@68178905@68369437@11@chr11:68178905-68369437@102@2475@3720@1.5@NA@LRP5_11, LRP5_12, LRP5_13, LRP5_14, LRP5_15, LRP5_16, LRP5_17, LRP5_18, LRP5_19, LRP5_20, LRP5_21, LRP5_22, LRP5_23, PPP6R3_3, PPP6R3_4, PPP6R3_5, PPP6R3_6, PPP6R3_7, PPP6R3_8, PPP6R3_9, PPP6R3_10, PPP6R3_11, PPP6R3_12, PPP6R3_13, PPP6R3_14, PPP6R3_15, PPP6R3_16, PPP6R3_17, PPP6R3_18, PPP6R3_19, PPP6R3_20, PPP6R3_21@0@0@0@:low density lipoprotein receptor-related protein 5:protein phosphatase 6, regulatory subunit 3@:retinal blood vessel morphogenesis;positive regulation of mitosis;bone marrow development;bone remodeling;Wnt-protein binding;plasma membrane;positive regulation of mesenchymal cell proliferation;Wnt receptor signaling pathway;Wnt-activated receptor activity;endoplasmic reticulum;receptor complex;embryonic retina morphogenesis in camera-type eye;regulation of canonical Wnt receptor signaling pathway;bone morphogenesis;gastrulation with mouth forming second;coreceptor activity;canonical Wnt receptor signaling pathway;positive regulation of transcription, DNA-dependent;embryonic limb morphogenesis;positive regulation of fat cell differentiation;negative regulation of protein serine/threonine kinase activity;cholesterol homeostasis;anterior/posterior pattern specification;integral to membrane;positive regulation of cell proliferation;embryonic camera-type eye morphogenesis;Wnt receptor signaling pathway involved in dorsal/ventral axis specification;adipose tissue development;glucose catabolic process;retina morphogenesis in camera-type eye;positive regulation of transcription from RNA polymerase II promoter;negative regulation of osteoblast differentiation;endocytosis;branching involved in mammary gland duct morphogenesis;osteoblast development;regulation of insulin secretion involved in cellular response to glucose stimulus;protein binding;regulation of blood pressure:protein phosphatase binding;protein binding;binding;nucleus;regulation of phosphoprotein phosphatase activity;cytoplasm@: OSTEOPOROSIS; HYPEROSTOSIS CORTICALIS GENERALISATA, BENIGN FORM OF WORTH, WITH TORUS; BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 1; BMND1; OSTEOPETROSIS, AUTOSOMAL DOMINANT 1; OPTA1; VAN BUCHEM DISEASE, TYPE 2; EXUDATIVE VITREORETINOPATHY 4; EVR4; OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME; OPPG
A2463_06@126937@126938@duplication@2@111109122@111109934@13@chr13:111109122-111109934@5.57@216@305@1.41@NA@COL4A2-AS2_5, COL4A2_21, COL4A2-AS2_4@0@0@0@:collagen, type IV, alpha 2@:extracellular matrix;angiogenesis;negative regulation of angiogenesis;extracellular matrix organization;endoplasmic reticulum lumen;axon guidance;cellular response to transforming growth factor beta stimulus;extracellular matrix structural constituent;collagen;protein binding;extracellular region;basement membrane;collagen type IV;transcription, DNA-dependent@: HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO; ICH; PORENCEPHALY 2; POREN2
A2463_06@127334@127336@duplication@3@19558718@19562100@14@chr14:19558718-19562100@5.76@140@208@1.49@CNVR6072.1@POTEG_2, POTEG_3, POTEG_4@0@0@0@:POTE ankyrin domain family, member G@:protein binding@NA
A2463_06@127338@127344@duplication@7@19566013@19999451@14@chr14:19566013-19999451@43.5@522@987@1.89@CNVR6072.6, CNVR6072.12@POTEG_6, POTEG_7, POTEG_8, POTEG_9, POTEG_10, POTEM_10, POTEM_9@0@0@0@:POTE ankyrin domain family, member G:POTE ankyrin domain family, member M@:protein binding:protein binding@NA
A2463_06@127349@127352@deletion@4@20011552@20020220@14@chr14:20011552-20020220@9.88@153@72@0.471@CNVR6072.6, CNVR6072.12@POTEM_4, POTEM_3, POTEM_2, POTEM_1@0@0@0@:POTE ankyrin domain family, member M@:protein binding@NA
A2463_06@127349@127358@duplication@6@20011552@20404761@14@chr14:20011552-20404761@67.4@2322@3676@1.58@CNVR6072.12, CNVR6072.4@POTEM_4, POTEM_3, POTEM_2, POTEM_1, OR4Q3_1, OR4M1_1, OR4N2_1, OR4K2_1, OR4K5_1, OR4K1_1@0@0@0@:POTE ankyrin domain family, member M:olfactory receptor, family 4, subfamily N, member 2:olfactory receptor, family 4, subfamily Q, member 3:olfactory receptor, family 4, subfamily M, member 1:olfactory receptor, family 4, subfamily K, member 2:olfactory receptor, family 4, subfamily K, member 5:olfactory receptor, family 4, subfamily K, member 1@:protein binding:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_06@133432@133457@deletion@26@106539080@106780945@14@chr14:106539080-106780945@390@1874@30@0.016@CNVR6294.48, CNVR6294.24, CNVR6294.40@IGHV1-8_2, IGHV1-8_1, IGHV3-9_2, IGHV3-9_1, IGHV3-11_2, IGHV3-11_1, IGHV3-13_2, IGHV3-13_1, IGHV3-15_2, IGHV3-15_1, IGHV3-16_2, IGHV3-16_1, IGHV1-18_2, IGHV1-18_1, IGHV3-20_2, IGHV3-20_1, IGHV3-21_2, IGHV3-21_1, IGHV3-23_2, IGHV3-23_1, IGHV1-24_2, IGHV1-24_1, IGHV2-26_2, IGHV2-26_1, IGHV4-28_2, IGHV4-28_1@0@0@0@:uncharacterized LOC100653243;uncharacterized LOC642131@:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding@NA
A2463_06@133460@133463@duplication@4@106805210@106816173@14@chr14:106805210-106816173@18.8@135@294@2.18@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.41@IGHV4-31_2, IGHV4-31_1, IGHV3-33_2, IGHV3-33_1@0@0@0@@:protein binding:protein binding@NA
A2463_06@133491@133492@deletion@2@107095127@107095561@14@chr14:107095127-107095561@10.8@75@18@0.24@CNVR6294.56, CNVR6294.16, CNVR6294.91@IGHV4-61_2, IGHV4-61_1@0@0@0@@:protein binding@NA
A2463_06@133498@133500@deletion@3@107170323@107179262@14@chr14:107170323-107179262@6.48@127@69@0.543@CNVR6294.56, CNVR6294.6, CNVR6294.92, CNVR6294.93@IGHV1-69_1, IGHV2-70_2, IGHV2-70_1@0@0@0@@:protein binding:protein binding@NA
A2463_06@133532@133532@duplication@1@22062317@22062482@15@chr15:22062317-22062482@6.49@20@66@3.3@NA@POTEB_9@0@0@0@:POTE ankyrin domain family member B-like@:protein binding@NA
A2463_06@133541@133541@duplication@1@22368577@22369517@15@chr15:22368577-22369517@11@364@565@1.55@CNVR6297.9, CNVR6297.4, CNVR6297.17, CNVR6297.18@OR4M2_1@0@0@0@:olfactory receptor, family 4, subfamily M, member 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_06@133552@133552@deletion@1@22742397@22743598@15@chr15:22742397-22743598@5.05@740@512@0.692@CNVR6298.5@GOLGA6L1_8@0@0@0@:golgin A6 family-like 1;putative transmembrane protein FLJ36131-like;putative transmembrane protein ENSP00000320207-like;putative golgin subfamily A member 6-like@NA@NA
A2463_06@133622@133623@duplication@2@23259497@23259716@15@chr15:23259497-23259716@13.8@59@161@2.73@CNVR6300.4@GOLGA8I_6, GOLGA8I_7@0@0@0@:golgin A8 family, member I@:Golgi cisterna membrane@NA
A2463_06@133636@133641@duplication@6@23406272@23411062@15@chr15:23406272-23411062@14.5@451@673@1.49@CNVR6300.8@RP11-467N20.5_8, RP11-467N20.5_7, RP11-467N20.5_6, RP11-467N20.5_5, RP11-467N20.5_4, RP11-467N20.5_3@0@0@0@:putative golgin subfamily A member 6-like protein 6-like@NA@NA
A2463_06@133646@133656@deletion@11@23602444@23606939@15@chr15:23602444-23606939@27.1@358@163@0.455@CNVR6301.3@GOLGA8S_3, GOLGA8S_4, GOLGA8S_5, GOLGA8S_6, GOLGA8S_7, GOLGA8S_8, GOLGA8S_9, GOLGA8S_10, GOLGA8S_11, GOLGA8S_12, GOLGA8S_13@0@0@0@@:Golgi apparatus@NA
A2463_06@133826@133826@duplication@1@28467175@28467361@15@chr15:28467175-28467361@8.23@52@119@2.29@CNVR6328.1@HERC2_36@0@0@0@:putative HERC2-like protein 3-like;HECT and RLD domain containing E3 ubiquitin protein ligase 2@:mitochondrial inner membrane;protein ubiquitination involved in ubiquitin-dependent protein catabolic process;guanyl-nucleotide exchange factor activity;SUMO binding;DNA repair;intracellular protein transport;spermatogenesis;cellular protein modification process;nucleus;ubiquitin protein ligase binding;ubiquitin-protein ligase activity;centriole;intracellular;response to DNA damage stimulus;heme binding;cytoplasm;protein binding;zinc ion binding;protein ubiquitination;metal ion binding@: SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1; SHEP1
A2463_06@133869@133870@deletion@2@28629294@28629596@15@chr15:28629294-28629596@6.46@29@0@0@CNVR6329.4@GOLGA8F_9, GOLGA8F_10@0@0@0@@:Golgi apparatus@NA
A2463_06@134036@134039@duplication@4@30845996@30848215@15@chr15:30845996-30848215@10.4@62@140@2.26@NA@GOLGA8Q_2, GOLGA8Q_3, GOLGA8Q_4, GOLGA8Q_5@0@0@0@@:Golgi apparatus@NA
A2463_06@134160@134161@duplication@2@32685495@32685771@15@chr15:32685495-32685771@5.87@74@128@1.73@NA@GOLGA8K_17, GOLGA8K_16@0@0@0@:golgin A8 family, member J@:Golgi apparatus@NA
A2463_06@134163@134168@deletion@6@32686867@32689704@15@chr15:32686867-32689704@8.12@226@136@0.602@NA@GOLGA8K_14, GOLGA8K_13, GOLGA8K_12, GOLGA8K_11, GOLGA8K_10, GOLGA8K_9@0@0@0@:golgin A8 family, member J@:Golgi apparatus@NA
A2463_06@139295@139308@duplication@14@82933940@83015609@15@chr15:82933940-83015609@17.9@125@266@2.13@CNVR6477.6, CNVR6477.2, CNVR6477.3@RP13-996F3.5_7, RP13-996F3.5_6, RP13-996F3.5_5, RP13-996F3.5_4, RP13-996F3.5_3, RP13-996F3.5_2, RP13-996F3.5_1, RP13-996F3.4_9, RP13-996F3.4_8, RP13-996F3.4_7, RP13-996F3.4_6, RP13-996F3.4_5, RP13-996F3.4_4, RP13-996F3.4_3@0@0@0@NA@NA@NA
A2463_06@140476@140478@deletion@3@64382@65633@16@chr16:64382-65633@11.2@67@11@0.164@CNVR6565.1@WASH4P_10, WASH4P_9, WASH4P_8@0@0@0@@:intracellular membrane-bounded organelle;endosomal transport;recycling endosome;early endosome;Arp2/3 complex-mediated actin nucleation;actin binding;alpha-tubulin binding;retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;recycling endosome membrane@NA
A2463_06@141631@141631@deletion@1@2627427@2627501@16@chr16:2627427-2627501@9.35@90@31@0.344@CNVR6601.1@PDPK1_7@0@0@0@:3-phosphoinositide dependent protein kinase-1@:3-phosphoinositide-dependent protein kinase activity;nucleoplasm;fibroblast growth factor receptor signaling pathway;protein tyrosine kinase activity;negative regulation of transforming growth factor beta receptor signaling pathway;negative regulation of toll-like receptor signaling pathway;regulation of endothelial cell migration;focal adhesion assembly;ATP binding;insulin receptor signaling pathway;plasma membrane;intracellular signal transduction;positive regulation of establishment of protein localization to plasma membrane;platelet activation;protein kinase activity;regulation of mast cell degranulation;cytosol;epidermal growth factor receptor signaling pathway;hyperosmotic response;nerve growth factor receptor signaling pathway;type B pancreatic cell development;synaptic transmission;regulation of apoptotic process;transcription, DNA-dependent;protein autophosphorylation;regulation of I-kappaB kinase/NF-kappaB cascade;protein kinase binding;T cell costimulation;insulin receptor binding;transferase activity, transferring phosphorus-containing groups;actin cytoskeleton organization;blood coagulation;negative regulation of protein kinase activity;cellular response to insulin stimulus;focal adhesion;phosphatidylinositol-mediated signaling;negative regulation of cardiac muscle cell apoptotic process;protein serine/threonine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;cytoplasm;activation of protein kinase B activity;protein binding;T cell receptor signaling pathway;cytoplasmic membrane-bounded vesicle;peptidyl-threonine phosphorylation;kinase activity@NA
A2463_06@142750@142750@duplication@1@15457517@15457926@16@chr16:15457517-15457926@19.6@219@459@2.1@CNVR6649.1@PKD1P1_8@0@0@0@:NPIP-like protein 1-like;nuclear pore complex-interacting protein-like 1-like@NA@NA
A2463_06@143483@143488@deletion@6@21764349@21849065@16@chr16:21764349-21849065@27.4@329@140@0.426@CNVR6668.5, CNVR6668.2, CNVR6668.7@OTOA_26, OTOA_27, OTOA_28, NPIPL3_9, NPIPL3_8, NPIPL3_7@0@0@0@:otoancorin:nuclear pore complex interacting protein-like 3;nuclear pore complex interacting protein-like;nuclear pore complex-interacting protein-like 3-like@:proteinaceous extracellular matrix;apical plasma membrane;sensory perception of sound;anchored to membrane@: DEAFNESS, AUTOSOMAL RECESSIVE 22; DFNB22
A2463_06@143493@143493@duplication@1@21858735@21858862@16@chr16:21858735-21858862@6.07@102@168@1.65@CNVR6668.5, CNVR6668.7@NPIPL3_2@0@0@0@:nuclear pore complex interacting protein-like 3;nuclear pore complex interacting protein-like;nuclear pore complex-interacting protein-like 3-like@NA@NA
A2463_06@144047@144047@deletion@1@28467746@28468347@16@chr16:28467746-28468347@5.51@63@26@0.413@NA@NPIPL1_7@0@0@0@NA@NA@NA
A2463_06@144052@144052@duplication@1@28478042@28478223@16@chr16:28478042-28478223@7.05@41@97@2.37@NA@NPIPL1_2@0@0@0@:ceroid-lipofuscinosis, neuronal 3@:membrane:negative regulation of apoptotic process;late endosome;mitochondrion;galactosylceramide metabolic process;neuromuscular process controlling balance;neuron projection;lysosomal lumen pH elevation;integral to endoplasmic reticulum membrane;cell death;plasma membrane;nucleus;lysosomal lumen acidification;negative regulation of catalytic activity;negative regulation of macroautophagy;unfolded protein binding;neurotransmitter metabolic process;endoplasmic reticulum;vesicle transport along microtubule;protein catabolic process;autophagic vacuole;early endosome;trans-Golgi network;cellular membrane organization;ceramide metabolic process;glucosylceramide metabolic process;negative regulation of neuron apoptotic process;membrane;globoside metabolic process;membrane raft;synaptic vesicle;vacuolar transport;protein processing;Golgi membrane;caveola;protein folding;ionotropic glutamate receptor signaling pathway;cytosolic calcium ion homeostasis;Golgi stack;integral to membrane;receptor-mediated endocytosis;arginine transport;lysosome;negative regulation of proteolysis;Golgi apparatus;lysosome organization;associative learning;sphingomyelin metabolic process;macroautophagy;lysosomal membrane;amyloid precursor protein catabolic process;cytoplasm;autophagic vacuole fusion;protein binding;regulation of action potential;cellular amino acid metabolic process@: CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3
A2463_06@144118@144134@deletion@17@28734770@28777810@16@chr16:28734770-28777810@13.4@164@72@0.439@CNVR6686.3, CNVR6686.2@EIF3C_10, EIF3C_11, EIF3C_12, EIF3C_13, EIF3C_14, EIF3C_15, EIF3C_16, EIF3C_17, EIF3C_18, EIF3C_19, EIF3C_20, EIF3C_21, A-575C2.4_1, A-575C2.4_2, A-575C2.4_3, A-575C2.4_4, A-575C2.4_5@0@0@0@:eukaryotic translation initiation factor 3, subunit C@:cytosol;protein binding;eukaryotic translation initiation factor 3 complex;translational initiation;cellular protein metabolic process;binding;gene expression;translation;translation initiation factor activity@NA
A2463_06@147125@147127@duplication@3@70208183@70211383@16@chr16:70208183-70211383@6.68@166@246@1.48@CNVR6764.1@CLEC18C_1, CLEC18C_2, CLEC18C_3@0@0@0@:C-type lectin domain family 18, member C@:carbohydrate binding;protein binding;extracellular region@NA
A2463_06@147513@147515@deletion@3@74451958@74455168@16@chr16:74451958-74455168@12.2@113@41@0.363@CNVR6778.2, CNVR6778.3@CLEC18B_3, CLEC18B_2, CLEC18B_1@0@0@0@:C-type lectin domain family 18, member B@:carbohydrate binding;protein binding;extracellular region@NA
A2463_06@151404@151404@deletion@1@15468848@15469578@17@chr17:15468848-15469578@4.72@313@206@0.658@NA@CDRT1_1@0@0@0@:CMT1A duplicated region transcript 1@:protein binding;molecular_function;cellular_component;biological_process@NA
A2463_06@151413@151415@duplication@3@15516016@15517347@17@chr17:15516016-15517347@6.47@230@325@1.41@NA@CDRT1_5, TRIM16_11, CDRT1_4, TRIM16_10, CDRT1_3, TRIM16_9@0@0@0@:CMT1A duplicated region transcript 1@:protein binding;molecular_function;cellular_component;biological_process:protein binding;intracellular;zinc ion binding;cytoplasm@NA
A2463_06@151556@151561@duplication@6@16664740@16676947@17@chr17:16664740-16676947@31.5@825@1255@1.52@NA@CCDC144A_13, CCDC144A_13, CCDC144A_14, CCDC144A_14, CCDC144A_15, CCDC144A_15, CCDC144A_16, CCDC144A_16, CCDC144A_17, CCDC144A_18, CCDC144A_17@0@0@0@:coiled-coil domain containing 144A@NA@NA
A2463_06@151875@151886@deletion@12@18380170@18430117@17@chr17:18380170-18430117@91.7@467@31@0.0664@CNVR7014.1@LGALS9C_1, LGALS9C_2, LGALS9C_3, LGALS9C_4, LGALS9C_5, LGALS9C_6, LGALS9C_7, LGALS9C_8, LGALS9C_9, LGALS9C_10, LGALS9C_11, FAM106A_1@0@0@0@:lectin, galactoside-binding, soluble, 9C:protein FAM106B-like@:carbohydrate binding@NA
A2463_06@151959@151959@duplication@1@18996779@18997166@17@chr17:18996779-18997166@12@178@320@1.8@CNVR7018.4, CNVR7018.2, CNVR7018.6@AC007952.5_2@0@0@0@NA@NA@NA
A2463_06@152122@152129@duplication@8@20353287@20359984@17@chr17:20353287-20359984@9.91@141@234@1.66@CNVR7021.1, CNVR7021.3@LGALS9B_11, LGALS9B_10, LGALS9B_9, LGALS9B_8, LGALS9B_7, LGALS9B_6, LGALS9B_5, LGALS9B_4@0@0@0@:lectin, galactoside-binding, soluble, 9B@:carbohydrate binding@NA
A2463_06@153380@153391@duplication@12@34539179@34588329@17@chr17:34539179-34588329@14.7@61@163@2.67@CNVR7077.1, CNVR7077.13, CNVR7077.19@CCL4L1_2, CCL4L1_3, TBC1D3C_14, TBC1D3C_13, TBC1D3C_12, TBC1D3C_11, TBC1D3C_10, TBC1D3C_9, TBC1D3C_8, TBC1D3C_7, TBC1D3C_6, TBC1D3C_5@0@0@0@:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1:TBC1 domain family, member 3C;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3H-like;TBC1 domain family, member 3H@:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_06@153394@153394@deletion@1@34590384@34590454@17@chr17:34590384-34590454@5.07@23@0@0@CNVR7077.1, CNVR7077.13, CNVR7077.19, CNVR7077.10, CNVR7077.2@TBC1D3C_2@0@0@0@:TBC1 domain family, member 3C;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3H-like;TBC1 domain family, member 3H@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_06@154346@154346@deletion@1@39421631@39422112@17@chr17:39421631-39422112@6.3@52@16@0.308@CNVR7096.1@KRTAP9-6_1@0@0@0@:keratin associated protein 9-6@:keratin filament@NA
A2463_06@154366@154371@duplication@6@39535209@39538624@17@chr17:39535209-39538624@14.8@445@651@1.46@CNVR7098.1@KRT34_6, KRT34_5, KRT34_4, KRT34_3, KRT34_2, KRT34_1@0@0@0@:keratin 34;keratin, type I cuticular Ha4-like@:intermediate filament;structural molecule activity;epidermis development@NA
A2463_06@155587@155608@deletion@22@44399689@44627885@17@chr17:44399689-44627885@41.4@1508@967@0.641@CNVR7114.2, CNVR7114.1@LRRC37A_6, LRRC37A_7, LRRC37A_8, LRRC37A_9, LRRC37A_10, LRRC37A_11, LRRC37A_12, LRRC37A_13, LRRC37A_14, ARL17B_4, ARL17B_3, ARL17B_2, LRRC37A2_2, LRRC37A2_3, LRRC37A2_4, LRRC37A2_5, LRRC37A2_6, LRRC37A2_7, LRRC37A2_8, LRRC37A2_9, LRRC37A2_10, LRRC37A2_11@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
A2463_06@156877@156878@deletion@2@57656834@57657240@17@chr17:57656834-57657240@13.3@60@0@0@NA@DHX40_9, DHX40_10@0@0@0@:DEAH (Asp-Glu-Ala-His) box polypeptide 40@:transport;helicase activity;intracellular;ATP-dependent helicase activity;nucleic acid binding;ATP binding@NA
A2463_06@162018@162018@duplication@1@44548659@44550298@18@chr18:44548659-44550298@6.41@174@265@1.52@CNVR7319.1, CNVR7319.2@TCEB3CL_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_06@164951@164951@duplication@1@7032325@7032905@19@chr19:7032325-7032905@5.43@34@77@2.26@CNVR7517.1@MBD3L5_2@0@0@0@:methyl-CpG binding domain protein 3-like 5@NA@NA
A2463_06@166378@166378@duplication@1@12504112@12504237@19@chr19:12504112-12504237@5.68@14@52@3.71@CNVR7541.1@CTD-3105H18.16_2, ZNF799_2@0@0@0@:zinc finger protein 799@:intracellular;regulation of transcription, DNA-dependent;nucleic acid binding:nucleus;intracellular;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:intracellular;regulation of transcription, DNA-dependent;nucleic acid binding@NA
A2463_06@167047@167047@duplication@1@14877791@14877921@19@chr19:14877791-14877921@4.94@56@101@1.8@NA@EMR2_6@0@0@0@:egf-like module containing, mucin-like, hormone receptor-like 2@:transmembrane signaling receptor activity;inflammatory response;G-protein coupled receptor activity;ruffle membrane;integral to membrane;plasma membrane;cell surface receptor signaling pathway;neuropeptide signaling pathway;granulocyte chemotaxis;cell migration;leading edge membrane;G-protein coupled receptor signaling pathway;protein binding;cell adhesion;membrane;calcium ion binding;chondroitin sulfate binding@NA
A2463_06@167243@167244@duplication@2@15784341@15789215@19@chr19:15784341-15789215@7.02@2@44@22@CNVR7553.1@CYP4F12_2, CYP4F12_3@0@0@0@:cytochrome P450, family 4, subfamily F, polypeptide 12@:pressure natriuresis;negative regulation of blood coagulation;oxidation-reduction process;very long-chain fatty acid metabolic process;arachidonic acid metabolic process;aromatase activity;sodium ion homeostasis;renal water homeostasis;arachidonic acid epoxygenase activity;integral to membrane;leukotriene B4 catabolic process;endoplasmic reticulum membrane;epoxygenase P450 pathway;electron carrier activity;intracellular membrane-bounded organelle;drug metabolic process;alkane 1-monooxygenase activity;small molecule metabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;apical plasma membrane;heme binding;vitamin E metabolic process;cytoplasm;vitamin-K-epoxide reductase (warfarin-sensitive) activity;xenobiotic metabolic process;vitamin K biosynthetic process;leukotriene-B4 20-monooxygenase activity;long-chain fatty acid metabolic process;iron ion binding@NA
A2463_06@169778@169778@deletion@1@39262470@39262670@19@chr19:39262470-39262670@5.42@29@3@0.103@NA@LGALS7_3@0@0@0@:lectin, galactoside-binding, soluble, 7;lectin, galactoside-binding, soluble, 7B@:carbohydrate binding;heterophilic cell-cell adhesion;extracellular space;nucleus;apoptotic process;cytoplasm@NA
A2463_06@170099@170099@duplication@1@40380120@40380711@19@chr19:40380120-40380711@4.89@63@110@1.75@CNVR7639.2@FCGBP_23@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_06@173294@173298@deletion@5@54724026@54726434@19@chr19:54724026-54726434@7.16@112@57@0.509@CNVR7721.3, CNVR7721.4@LILRB3_7, LILRB3_6, LILRB3_5, LILRB3_4, LILRB3_3@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
A2463_06@173336@173341@duplication@6@54801928@54804173@19@chr19:54801928-54804173@7.56@258@363@1.41@CNVR7722.1@LILRA3_6, LILRA3_5, LILRA3_4, LILRA3_3, LILRA3_2, LILRA3_1@0@0@0@:leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3@:antigen binding;signal transduction;protein binding;extracellular region;plasma membrane;receptor activity;defense response@NA
A2463_06@173457@173469@deletion@13@55239078@55263971@19@chr19:55239078-55263971@121@594@24@0.0404@CNVR7725.2, CNVR7725.1@KIR3DL3_4, KIR3DL3_5, KIR3DL3_6, KIR3DL3_7, KIR3DL3_8, KIR2DL3_1, KIR2DL3_2, KIR2DL3_3, KIR2DL3_4, KIR2DL3_5, KIR2DL3_6, KIR2DL3_7, KIR2DL3_8@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:integral to membrane;plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity@NA
A2463_06@173473@173474@deletion@2@55286618@55290114@19@chr19:55286618-55290114@12.9@83@16@0.193@CNVR7725.2, CNVR7725.1@KIR2DL1_4, KIR2DL1_5@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane@NA
A2463_06@173479@173504@duplication@26@55315347@55363737@19@chr19:55315347-55363737@75.9@888@1572@1.77@CNVR7725.1, CNVR7725.6@KIR2DL4_2, KIR2DL4_3, KIR2DL4_4, KIR2DL4_5, KIR2DL4_6, KIR2DL4_7, KIR3DL1_1, KIR3DL1_2, KIR3DL1_3, KIR3DL1_4, KIR3DL1_5, KIR3DL1_6, KIR3DL1_7, KIR3DL1_8, KIR3DL1_9, KIR2DS4_1, KIR2DS4_2, KIR2DS4_3, KIR2DS4_4, KIR2DS4_5, KIR2DS4_6, KIR2DS4_7, KIR2DS4_8, KIR3DL2_1, KIR3DL2_2, KIR3DL2_3@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2-like@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane@NA
A2463_06@173844@173845@deletion@2@56283172@56284545@19@chr19:56283172-56284545@12.3@322@180@0.559@CNVR7734.1@CTD-2611O12.2_2, CTD-2611O12.2_3@0@0@0@:ret finger protein-like 4A-like@:protein binding;zinc ion binding@NA
A2463_06@174394@174395@deletion@2@1558985@1569278@20@chr20:1558985-1569278@5.47@142@84@0.592@CNVR7763.1@RP4-576H24.4_2, SIRPB1_2, RP4-576H24.4_1@0@0@0@:signal-regulatory protein beta 1;signal-regulatory protein beta-1-like;signal-regulatory protein beta-1 isoform 3-like@:protein binding:protein binding;signal transduction;integral to membrane;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway@NA
A2463_06@179011@179021@deletion@11@14982551@15013887@21@chr21:14982551-15013887@29@178@33@0.185@CNVR7952.1@POTED_1, POTED_2, POTED_3, POTED_4, POTED_5, POTED_6, POTED_7, POTED_8, POTED_9, POTED_10, POTED_11@0@0@0@:POTE ankyrin domain family, member B;POTE ankyrin domain family, member C;POTE ankyrin domain family, member D@:protein binding;plasma membrane@NA
A2463_06@180966@180970@deletion@5@16157307@16269943@22@chr22:16157307-16269943@15.3@337@178@0.528@CNVR8071.2, CNVR8071.5@AP000525.1_1, POTEH_10, POTEH_9, POTEH_8, POTEH_7@0@0@0@:uncharacterized LOC101060615:POTE ankyrin domain family, member H@:protein binding@NA
A2463_06@180972@180976@duplication@5@16277749@16287885@22@chr22:16277749-16287885@32.5@671@1170@1.74@CNVR8071.2, CNVR8071.3@POTEH_5, POTEH_4, POTEH_3, POTEH_2, POTEH_1@0@0@0@:POTE ankyrin domain family, member H@:protein binding@NA
A2463_06@181133@181133@duplication@1@18739383@18739404@22@chr22:18739383-18739404@4.4@13@43@3.31@CNVR8087.5, CNVR8087.2, CNVR8087.11@AC008132.1_8@0@0@0@NA@NA@NA
A2463_06@181133@181134@deletion@1@18739383@18835833@22@chr22:18739383-18835833@3.29@202@129@0.639@CNVR8087.5, CNVR8087.2, CNVR8087.7@AC008132.1_8, AC008132.13_1@0@0@0@NA@NA@NA
A2463_06@181487@181489@deletion@3@21065630@21067085@22@chr22:21065630-21067085@7.63@115@58@0.504@CNVR8099.6, CNVR8099.2@PI4KA_51, PI4KA_50, PI4KA_49@0@0@0@:phosphatidylinositol 4-kinase, catalytic, alpha@:phospholipid metabolic process;1-phosphatidylinositol 4-kinase activity;small molecule metabolic process;phosphatidylinositol phosphorylation;binding;transferase activity, transferring phosphorus-containing groups;phosphotransferase activity, alcohol group as acceptor;ATP binding;Golgi-associated vesicle;phosphatidylinositol biosynthetic process;cytosol;protein binding;signal transduction;synaptic transmission;kinase activity;phosphatidylinositol-mediated signaling@NA
A2463_06@183634@183638@deletion@5@39378460@39385615@22@chr22:39378460-39385615@8.49@209@122@0.584@CNVR8164.1@APOBEC3B_1, APOBEC3B_2, APOBEC3B_3, APOBEC3B_4, APOBEC3B_5@0@0@0@:apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B@:RNA binding;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines;negative regulation of transposition;catalytic activity;zinc ion binding@NA
A2463_15@7@7@deletion@1@138531@139309@1@chr1:138531-139309@13.9@432@243@0.562@CNVR1.2@AL627309.1_1@0@0@0@NA@NA@NA
A2463_15@426@432@deletion@7@1635990@1640572@1@chr1:1635990-1640572@14.3@157@67@0.427@CNVR17.1@CDK11A_14, CDK11A_13, CDK11A_12, CDK11A_11, CDK11A_10, CDK11A_9, CDK11A_8@0@0@0@:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A@:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division@NA
A2463_15@1825@1829@deletion@5@12998506@13036800@1@chr1:12998506-13036800@13.1@107@33@0.308@CNVR72.3, CNVR72.4, CNVR72.9@PRAMEF6_4, PRAMEF6_3, PRAMEF6_2, PRAMEF22_1, PRAMEF22_2@0@0@0@:PRAME family member 6;PRAME family member 23;PRAME family member 9/15-like;PRAME family member 5:PRAME family member 22@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_15@1832@1833@deletion@2@13216689@13219581@1@chr1:13216689-13219581@5.08@40@12@0.3@CNVR73.2, CNVR73.3@WI2-2994D6.2_2, WI2-2994D6.2_1@0@0@0@:PRAME family member@NA@NA
A2463_15@1835@1838@duplication@4@13330415@13366425@1@chr1:13330415-13366425@7.48@52@109@2.1@CNVR74.8, CNVR74.4@PRAMEF3_2, PRAMEF3_1, PRAMEF5_2, PRAMEF5_3@0@0@0@:PRAME family member 3:PRAME family member 5@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_15@1846@1846@deletion@1@13448051@13448608@1@chr1:13448051-13448608@5.26@36@9@0.25@CNVR74.8, CNVR74.4, CNVR74.10@PRAMEF13_4@0@0@0@:PRAME family member 13@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_15@1864@1864@deletion@1@13695526@13696098@1@chr1:13695526-13696098@5.42@56@22@0.393@CNVR76.2, CNVR76.5, CNVR76.6@PRAMEF19_3@0@0@0@:PRAME family member 19@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_15@2170@2188@duplication@19@17248515@17275421@1@chr1:17248515-17275421@28.3@794@1138@1.43@CNVR94.4, CNVR94.5@CROCC_1, CROCC_2, CROCC_3, CROCC_4, CROCC_5, CROCC_6, CROCC_7, CROCC_8, CROCC_9, CROCC_10, CROCC_11, CROCC_12, CROCC_13, CROCC_14, CROCC_15, CROCC_16, CROCC_17, CROCC_18, CROCC_19@0@0@0@:ciliary rootlet coiled-coil, rootletin@:centriole;centrosome organization;centrosome;kinesin binding;actin cytoskeleton;cytoplasm;protein binding;vesicle-mediated transport;structural molecule activity;ciliary rootlet;protein localization;plasma membrane;cell cycle;cell projection organization;membrane@NA
A2463_15@2972@2972@deletion@1@22338944@22338960@1@chr1:22338944-22338960@4.98@25@2@0.08@CNVR108.2, CNVR108.1@CELA3A_8@0@0@0@:chymotrypsin-like elastase family, member 3A@:proteolysis;digestion;cholesterol metabolic process;catalytic activity;serine-type endopeptidase activity@NA
A2463_15@3333@3342@deletion@10@25599040@25655415@1@chr1:25599040-25655415@139@761@83@0.109@CNVR116.1, CNVR116.2@RHD_1, RHD_2, RHD_3, RHD_4, RHD_5, RHD_6, RHD_7, RHD_8, RHD_9, RHD_10@0@0@0@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
A2463_15@3351@3351@deletion@1@25701841@25701919@1@chr1:25701841-25701919@6.06@149@85@0.57@CNVR117.1@RHCE_8@0@0@0@:Rh blood group, CcEe antigens@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@: BLOOD GROUP--RHESUS SYSTEM E POLYPEPTIDE; RHE; RHESUS BLOOD GROUP, CcEe ANTIGENS; RHCE
A2463_15@5149@5149@duplication@1@39987049@39987242@1@chr1:39987049-39987242@5.89@19@59@3.11@NA@BMP8A_4@0@0@0@:bone morphogenetic protein 8a@:cell differentiation;growth factor activity;extracellular space;growth;cytokine activity;cartilage development;ossification@NA
A2463_15@8507@8508@duplication@2@89476588@89477710@1@chr1:89476588-89477710@7.17@340@467@1.37@CNVR244.1@GBP3_8, GBP3_7@0@0@0@:guanylate binding protein 3@:defense response to virus;GTP binding;GTPase activity;membrane;cytoplasm@NA
A2463_15@9343@9374@deletion@32@104116331@104234232@1@chr1:104116331-104234232@60.6@1978@1242@0.628@CNVR266.3, CNVR266.1@AMY2B_6, AMY2B_7, AMY2B_8, AMY2B_9, AMY2B_10, AMY2B_11, AMY2B_12, AMY2A_1, AMY2A_2, AMY2A_3, AMY2A_4, AMY2A_5, AMY2A_6, AMY2A_7, AMY2A_8, AMY2A_9, AMY2A_10, AMY1A_2, AMY1A_3, AMY1A_4, AMY1A_5, AMY1A_6, AMY1A_7, AMY1A_8, AMY1A_9, AMY1A_10, AMY1A_11, AMY1B_11, AMY1B_10, AMY1B_9, AMY1B_8, AMY1B_7@0@0@0@:actin, gamma 1 pseudogene 4;amylase, alpha 2B (pancreatic):amylase, alpha 2A (pancreatic):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:extracellular region;cation binding;digestion;carbohydrate metabolic process;catalytic activity;alpha-amylase activity;metal ion binding:chloride ion binding;cation binding;small molecule metabolic process;carbohydrate metabolic process;catalytic activity;extracellular space;polysaccharide digestion;extracellular region;carbohydrate catabolic process;alpha-amylase activity;calcium ion binding:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
A2463_15@10868@10868@deletion@1@145302655@145302868@1@chr1:145302655-145302868@4.76@58@26@0.448@CNVR341.2, CNVR341.3, CNVR341.4@NBPF10_8@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family, member 10@:protein binding;calcium ion binding@NA
A2463_15@10890@10893@deletion@4@145325953@145328432@1@chr1:145325953-145328432@6.75@37@5@0.135@CNVR341.2, CNVR341.3@NBPF10_30, NBPF10_31, NBPF10_32, NBPF10_33@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family, member 10@NA@NA
A2463_15@11162@11162@duplication@1@146250791@146250999@1@chr1:146250791-146250999@6.98@68@129@1.9@NA@NBPF12_3@0@0@0@:neuroblastoma breakpoint family member 21-like@NA@NA
A2463_15@11169@11170@deletion@2@146400092@146401880@1@chr1:146400092-146401880@12.9@60@1@0.0167@NA@NBPF12_9, NBPF12_10@0@0@0@:neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family member 14-like;neuroblastoma breakpoint family, member 12@:cytoplasm@NA
A2463_15@11479@11479@deletion@1@148591202@148591373@1@chr1:148591202-148591373@5.24@23@0@0@CNVR348.1, CNVR348.4@NBPF15_17@0@0@0@:neuroblastoma breakpoint family, member 15@:cytoplasm@NA
A2463_15@12117@12118@deletion@2@152573209@152586574@1@chr1:152573209-152586574@27.5@126@0@0@CNVR358.1@LCE3C_1, LCE3B_1@0@0@0@:late cornified envelope 3C:late cornified envelope 3B@:keratinization:keratinization@NA
A2463_15@16031@16040@deletion@10@196748928@196801129@1@chr1:196748928-196801129@36.5@1215@756@0.622@CNVR459.1@CFHR3_3, CFHR3_4, CFHR3_5, CFHR3_6, CFHR1_1, CFHR1_2, CFHR1_3, CFHR1_4, CFHR1_5, CFHR1_6@0@0@0@:complement factor H-related 3:complement factor H-related 1:complement factor H-related 2@:extracellular space:extracellular space;complement activation:extracellular region@NA
A2463_15@17278@17278@duplication@1@207700099@207700274@1@chr1:207700099-207700274@5.57@22@61@2.77@CNVR485.1@CR1_6@0@0@0@:complement component (3b/4b) receptor 1 (Knops blood group)@:complement component C4b receptor activity;complement activation, classical pathway;negative regulation of complement activation, alternative pathway;innate immune response;negative regulation of serine-type endopeptidase activity;complement component C3b binding;negative regulation of complement activation, classical pathway;plasma membrane;integral to plasma membrane;complement component C3b receptor activity;complement component C4b binding;cell surface;regulation of complement activation;positive regulation of serine-type endopeptidase activity@: MALARIA, SUSCEPTIBILITY TO; KNOPS BLOOD GROUP SYSTEM; KN
A2463_15@17286@17287@deletion@2@207718654@207719023@1@chr1:207718654-207719023@7.39@33@0@0@CNVR485.1@CR1_14, CR1_15@0@0@0@:complement component (3b/4b) receptor 1 (Knops blood group)@:complement component C4b receptor activity;complement activation, classical pathway;negative regulation of complement activation, alternative pathway;innate immune response;negative regulation of serine-type endopeptidase activity;complement component C3b binding;negative regulation of complement activation, classical pathway;plasma membrane;integral to plasma membrane;complement component C3b receptor activity;complement component C4b binding;cell surface;regulation of complement activation;positive regulation of serine-type endopeptidase activity@: MALARIA, SUSCEPTIBILITY TO; KNOPS BLOOD GROUP SYSTEM; KN
A2463_15@24830@24837@deletion@8@87201197@87205054@2@chr2:87201197-87205054@16.4@218@99@0.454@NA@RGPD1_10, RGPD1_11, RGPD1_12, RGPD1_13, RGPD1_14, RGPD1_15, RGPD1_16, RGPD1_17@0@0@0@:RANBP2-like and GRIP domain containing 1@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_15@24862@24863@duplication@2@88094928@88095367@2@chr2:88094928-88095367@10@22@88@4@NA@RGPD2_11, RGPD2_10@0@0@0@:RANBP2-like and GRIP domain containing 2@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_15@25369@25370@deletion@2@97854825@97855027@2@chr2:97854825-97855027@24.4@111@0@0@CNVR886.2, CNVR886.3@ANKRD36_33, ANKRD36_34@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_15@25382@25386@duplication@5@97866191@97870000@2@chr2:97866191-97870000@6.54@646@832@1.29@CNVR886.1@ANKRD36_46, ANKRD36_47, ANKRD36_48, ANKRD36_49, ANKRD36_50@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_15@26426@26426@deletion@1@113161544@113161752@2@chr2:113161544-113161752@7.51@69@24@0.348@NA@RGPD8_9@0@0@0@:RANBP2-like and GRIP domain containing 8@:protein binding;intracellular;intracellular transport;nuclear pore;protein targeting to Golgi;Ran GTPase binding;biological_process@NA
A2463_15@26578@26583@deletion@6@114239755@114258060@2@chr2:114239755-114258060@27@928@545@0.587@CNVR933.1@CBWD2_11, CBWD2_12, CBWD2_13, CBWD2_14, CBWD2_15, FOXD4L1_1@0@0@0@:COBW domain containing 2;COBW domain containing 1;COBW domain-containing protein 1-like:forkhead box D4-like 1@:ATP binding:positive regulation of BMP signaling pathway;positive regulation of kidney development;axon extension involved in axon guidance;lateral line nerve glial cell development;DNA binding, bending;sequence-specific DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;regulation of sequence-specific DNA binding transcription factor activity;transcription factor complex;nucleus;dichotomous subdivision of terminal units involved in ureteric bud branching;sympathetic nervous system development;melanocyte differentiation;enteric nervous system development;positive regulation of transcription from RNA polymerase II promoter;regulation of transcription, DNA-dependent;neural crest cell migration;peripheral nervous system development;double-stranded DNA binding;RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity;iridophore differentiation;transcription factor binding;cartilage development;pattern specification process@NA
A2463_15@27180@27182@duplication@3@130898732@130900886@2@chr2:130898732-130900886@10.3@208@321@1.54@NA@CCDC74B_4, CCDC74B_3, CCDC74B_2@0@0@0@:coiled-coil domain containing 74A;coiled-coil domain containing 74B@NA@NA
A2463_15@27341@27342@deletion@2@132288153@132289375@2@chr2:132288153-132289375@14.9@125@41@0.328@NA@CCDC74A_3, CCDC74A_4@0@0@0@:coiled-coil domain containing 74A@NA@NA
A2463_15@27996@27997@duplication@2@152463121@152464122@2@chr2:152463121-152464122@8.2@68@135@1.99@CNVR1026.1@NEB_84, NEB_83@0@0@0@:nebulin@:Z disc;muscle filament sliding;oxidation-reduction process;contractile fiber part;actin cytoskeleton;regulation of actin filament length;structural constituent of muscle;cytosol;actin binding;protein binding;myofibril;somatic muscle development;muscle organ development@: NEMALINE MYOPATHY 2; NEM2
A2463_15@48556@48561@deletion@6@69403344@69434202@4@chr4:69403344-69434202@68.4@344@19@0.0552@CNVR1953.1@UGT2B17_6, UGT2B17_5, UGT2B17_4, UGT2B17_3, UGT2B17_2, UGT2B17_1@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B17@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;membrane@: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
A2463_15@55806@55806@duplication@1@69372349@69372398@5@chr5:69372349-69372398@5.1@108@167@1.55@CNVR2494.48, CNVR2494.39, CNVR2494.15, CNVR2494.18, CNVR2494.26, CNVR2494.43, CNVR2494.52, CNVR2494.28, CNVR2494.2, CNVR2494.36@SMN2_8@0@0@0@:survival of motor neuron 2, centromeric;survival of motor neuron 1, telomeric@:nucleoplasm;ncRNA metabolic process;Cajal body;RNA metabolic process;spliceosomal complex;cytoplasm;cytosol;protein binding;cell death;spliceosomal complex assembly;RNA binding;mRNA processing;nucleus;gene expression;spliceosomal snRNP assembly@: SPINAL MUSCULAR ATROPHY, TYPE II; SMA2; SPINAL MUSCULAR ATROPHY, TYPE I; SMA1; SPINAL MUSCULAR ATROPHY, TYPE IV; SMA4; SPINAL MUSCULAR ATROPHY, TYPE III; SMA3
A2463_15@55835@55837@deletion@3@70338009@70343940@5@chr5:70338009-70343940@11.2@100@36@0.36@CNVR2494.41, CNVR2494.14, CNVR2494.20, CNVR2494.62, CNVR2494.8@GTF2H2_14, GTF2H2_13, GTF2H2_12@0@0@0@:general transcription factor IIH, polypeptide 2, 44kDa@:nucleoplasm;nucleotide-excision repair, DNA damage removal;transcription from RNA polymerase I promoter;DNA repair;RNA polymerase II carboxy-terminal domain kinase activity;nucleus;viral reproduction;translation;gene expression;transcription elongation from RNA polymerase I promoter;response to UV;holo TFIIH complex;protein kinase activity;nucleotide-excision repair;transcription from RNA polymerase II promoter;transcription-coupled nucleotide-excision repair;transcription, DNA-dependent;zinc ion binding;transcription elongation from RNA polymerase II promoter;termination of RNA polymerase I transcription;sequence-specific DNA binding transcription factor activity;G-protein coupled receptor internalization;DNA-dependent ATPase activity;protein N-terminus binding;transcription initiation from RNA polymerase I promoter;7-methylguanosine mRNA capping;transcription initiation from RNA polymerase II promoter;protein phosphorylation;translation factor activity, nucleic acid binding;regulation of transcription, DNA-dependent;core TFIIH complex;protein binding;positive regulation of viral transcription;nucleic acid binding@NA
A2463_15@60884@60885@duplication@2@175517374@175520277@5@chr5:175517374-175520277@12.3@66@162@2.45@NA@FAM153B_3, FAM153B_4@0@0@0@:uncharacterized LOC100507387;family with sequence similarity 153, member B@NA@NA
A2463_15@61268@61268@deletion@1@177166115@177166138@5@chr5:177166115-177166138@5.38@77@37@0.481@NA@FAM153A_9@0@0@0@:family with sequence similarity 153, member A@NA@NA
A2463_15@61690@61696@deletion@7@292541@348841@6@chr6:292541-348841@11.8@434@277@0.638@CNVR2728.1@DUSP22_1, DUSP22_2, DUSP22_3, DUSP22_4, DUSP22_5, DUSP22_6, DUSP22_7@0@0@0@:dual specificity phosphatase 22;dual specificity protein phosphatase 22-like@:protein dephosphorylation;transforming growth factor beta receptor signaling pathway;positive regulation of JNK cascade;protein tyrosine/serine/threonine phosphatase activity;nucleus;apoptotic process;multicellular organismal development;phosphatase activity;protein tyrosine phosphatase activity;regulation of cell proliferation;cytoplasm;cell proliferation;inactivation of MAPK activity;protein binding;negative regulation of transcription from RNA polymerase II promoter;dephosphorylation@NA
A2463_15@63290@63292@duplication@3@31323945@31324935@6@chr6:31323945-31324935@7.65@293@407@1.39@CNVR2841.12, CNVR2841.14, CNVR2841.8@HLA-B_3, HLA-B_2, HLA-B_1@0@0@0@:major histocompatibility complex, class I, B@:MHC class I protein complex;regulation of immune response;regulation of interleukin-12 production;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;regulation of T cell anergy;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;receptor binding;early endosome membrane;virus-host interaction;regulation of interleukin-6 production;regulation of dendritic cell differentiation;phagocytic vesicle membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;MHC class I receptor activity;membrane@: SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO; SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1; SPDA1
A2463_15@63725@63748@duplication@24@31962023@31974881@6@chr6:31962023-31974881@69@1122@1880@1.68@CNVR2843.6, CNVR2843.3@C4A_20, C4A_21, C4A_22, C4A_23, C4A_24, C4A_25, C4A_26, C4A_27, C4A_28, C4A_29, C4A_30, C4A_31, C4A_32, C4A_33, C4A_34, C4A_35, C4A_36, C4A_37, C4A_38, C4A_39, C4A_40, C4A_41, AL645922.1_2, AL645922.1_1@0@0@0@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
A2463_15@63777@63777@duplication@1@31997344@31997575@6@chr6:31997344-31997575@5.63@124@191@1.54@CNVR2843.6, CNVR2843.5@C4B_29@0@0@0@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
A2463_15@63810@63812@duplication@3@32011785@32012996@6@chr6:32011785-32012996@10.3@218@342@1.57@CNVR2843.6, CNVR2843.5@TNXB_3, TNXB_2, TNXB_1@0@0@0@:tenascin-X-like;tenascin XB@:integrin binding;extracellular matrix;cell-cell adhesion;elastic fiber assembly;collagen fibril organization;fibrillar collagen;actin cytoskeleton organization;extracellular space;heparin binding;proteinaceous extracellular matrix;fatty acid metabolic process;regulation of JUN kinase activity;receptor binding;intracellular;cell-matrix adhesion;extracellular matrix organization;lipid metabolic process;protein binding;signal transduction;extracellular region;collagen binding;cell adhesion;triglyceride metabolic process;fibril organization;collagen metabolic process@: EHLERS-DANLOS-LIKE SYNDROME DUE TO TENASCIN-X DEFICIENCY; EHLERS-DANLOS SYNDROME, TYPE III
A2463_15@63953@63957@deletion@5@32485517@32489951@6@chr6:32485517-32489951@16.6@121@33@0.273@CNVR2845.21, CNVR2845.25, CNVR2845.30@HLA-DRB5_6, HLA-DRB5_5, HLA-DRB5_4, HLA-DRB5_3, HLA-DRB5_2@0@0@0@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
A2463_15@64602@64604@duplication@3@35754776@35763054@6@chr6:35754776-35763054@8.93@291@418@1.44@CNVR2861.1@CLPSL1_2, CLPSL1_3, CLPS_3@0@0@0@:colipase-like 1:colipase, pancreatic@:extracellular region;enzyme activator activity;digestion;lipid catabolic process:steroid metabolic process;post-embryonic development;small molecule metabolic process;retinoid metabolic process;lipid metabolic process;extracellular region;enzyme activator activity;digestion;lipid catabolic process;lipid digestion;response to food@NA
A2463_15@70816@70816@duplication@1@161054786@161054944@6@chr6:161054786-161054944@9.08@112@200@1.79@CNVR3133.1@LPA_9@0@0@0@:lipoprotein, Lp(a)@:blood circulation;endopeptidase inhibitor activity;catalytic activity;lipoprotein metabolic process;proteolysis;heparin binding;receptor-mediated endocytosis;fibronectin binding;small molecule metabolic process;apolipoprotein binding;lipid metabolic process;negative regulation of endopeptidase activity;extracellular region;plasma lipoprotein particle;lipid transport;serine-type endopeptidase activity@: APOLIPOPROTEIN(a); LPA
A2463_15@71011@71011@duplication@1@167590486@167590622@6@chr6:167590486-167590622@5.11@85@138@1.62@NA@TCP10L2_4@0@0@0@:t-complex 10;t-complex 10-like 2@NA@NA
A2463_15@71031@71032@deletion@2@167791444@167794824@6@chr6:167791444-167794824@10.9@92@29@0.315@NA@TCP10_4, TCP10_3@0@0@0@:t-complex 10@:cytosol@NA
A2463_15@71744@71745@duplication@2@5939916@5940197@7@chr7:5939916-5940197@5.99@123@188@1.53@NA@CCZ1_2, CCZ1_3@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
A2463_15@71778@71780@deletion@3@6017220@6022622@7@chr7:6017220-6022622@17.6@478@280@0.586@NA@PMS2_14, PMS2_13, PMS2_12@0@0@0@:PMS2 postmeiotic segregation increased 2 (S. cerevisiae)@:response to drug;DNA binding;MutSalpha complex binding;ATP binding;mismatch repair;DNA repair;mismatched DNA binding;ATPase activity;nucleus;mismatch repair complex;reciprocal meiotic recombination;ATP catabolic process;single-stranded DNA binding;response to DNA damage stimulus;single base insertion or deletion binding;protein binding;somatic hypermutation of immunoglobulin genes;somatic recombination of immunoglobulin gene segments;MutLalpha complex;endonuclease activity@: COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 4; HNPCC4; MISMATCH REPAIR CANCER SYNDROME
A2463_15@71936@71939@deletion@4@6826510@6836397@7@chr7:6826510-6836397@11.2@88@26@0.295@NA@RSPH10B2_16, RSPH10B2_17, RSPH10B2_18, RSPH10B2_19@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
A2463_15@73246@73250@deletion@5@38292982@38305279@7@chr7:38292982-38305279@5.93@340@230@0.676@CNVR3353.1@TRGJ2_1, TRGJP2_1, TRGC1_3, TRGC1_2, TRGC1_1@0@0@0@:TCR gamma alternate reading frame protein@:protein binding@NA
A2463_15@73260@73262@duplication@3@38388957@38393626@7@chr7:38388957-38393626@5.41@178@252@1.42@CNVR3354.3, CNVR3354.1@TRGV5_2, TRGV5_1, TRGV4_2@0@0@0@@:protein binding:protein binding@NA
A2463_15@74245@74246@deletion@2@66648114@66660324@7@chr7:66648114-66660324@10.9@104@38@0.365@NA@TYW1_14, TYW1_15@0@0@0@:tRNA-yW synthesizing protein 1 homolog (S. cerevisiae);tRNA-yW synthesizing protein 1 homolog B (S. cerevisiae)@:tRNA processing;4 iron, 4 sulfur cluster binding;iron-sulfur cluster binding;oxidoreductase activity;FMN binding;iron ion binding;catalytic activity@NA
A2463_15@74568@74579@deletion@12@74160677@74173168@7@chr7:74160677-74173168@15.4@286@158@0.552@NA@GTF2I_23, GTF2I_24, GTF2I_25, GTF2I_26, GTF2I_27, GTF2I_28, GTF2I_29, GTF2I_30, GTF2I_31, GTF2I_32, GTF2I_33, GTF2I_34@0@0@0@:general transcription factor IIi@:neuronal cell body;transcription initiation from RNA polymerase II promoter;mitogen-activated protein kinase binding;negative regulation of angiogenesis;DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;cytoplasm;transcription from RNA polymerase II promoter;protein binding;signal transduction;nucleus;cell projection;reduction of cytosolic calcium ion concentration@NA
A2463_15@76427@76432@duplication@6@100331793@100336236@7@chr7:100331793-100336236@10.6@221@333@1.51@CNVR3509.1@ZAN_1, ZAN_2, ZAN_3, ZAN_4, ZAN_5, ZAN_6@0@0@0@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
A2463_15@76751@76753@duplication@3@102210283@102214371@7@chr7:102210283-102214371@8.17@295@415@1.41@CNVR3518.1@POLR2J3_2, POLR2J3_1, AC093668.1_3, AC093668.1_2@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
A2463_15@76771@76779@duplication@9@102246306@102279646@7@chr7:102246306-102279646@8.8@242@352@1.45@CNVR3518.1@RASA4_5, RASA4_4, RASA4_3, RASA4_2, UPK3BL_7, RASA4_1, UPK3BL_6, UPK3BL_6, UPK3BL_5, UPK3BL_5, UPK3BL_4, UPK3BL_4@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4:uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity:integral to membrane:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
A2463_15@76792@76792@deletion@1@102309363@102309451@7@chr7:102309363-102309451@4.71@22@1@0.0455@CNVR3518.1@POLR2J2_2, POLR2J2_2@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
A2463_15@79287@79289@deletion@3@143400089@143418471@7@chr7:143400089-143418471@6.11@105@56@0.533@CNVR3594.2, CNVR3594.1@FAM115C_2, FAM115C_3, FAM115C_4@0@0@0@:family with sequence similarity 115, member C;protein FAM115C-like@NA@NA
A2463_15@79309@79309@deletion@1@143880598@143882930@7@chr7:143880598-143882930@27.4@322@113@0.351@CNVR3598.4, CNVR3598.3@CTAGE4_1@0@0@0@:CTAGE family, member 4@:integral to membrane;nucleotide binding;cellular_component;biological_process@NA
A2463_15@79312@79312@deletion@1@143955790@143956721@7@chr7:143955790-143956721@19.8@248@97@0.391@CNVR3598.4, CNVR3598.7, CNVR3598.6@OR2A7_1@0@0@0@:Rho guanine nucleotide exchange factor (GEF) 35:olfactory receptor, family 2, subfamily A, member 7@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_15@79314@79314@deletion@1@144015219@144016150@7@chr7:144015219-144016150@14@160@62@0.388@CNVR3598.4, CNVR3598.10@OR2A1_1@0@0@0@:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_15@79322@79322@deletion@1@144069777@144069850@7@chr7:144069777-144069850@5.46@59@24@0.407@CNVR3598.4, CNVR3598.5, CNVR3598.11@ARHGEF5_9@0@0@0@:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
A2463_15@80363@80366@deletion@4@7217142@7220468@8@chr8:7217142-7220468@9.18@424@278@0.656@CNVR3771.8, CNVR3771.10, CNVR3771.4@ZNF705G_6, ZNF705G_5, ZNF705G_4, ZNF705G_3@0@0@0@:zinc finger protein 705G@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_15@80371@80371@duplication@1@7308236@7308422@8@chr8:7308236-7308422@8.3@124@210@1.69@CNVR3771.8, CNVR3771.10, CNVR3771.4@SPAG11B_3@0@0@0@:sperm associated antigen 11B@:spermatogenesis;defense response to bacterium;extracellular region;molecular_function;defense response@NA
A2463_15@80403@80411@duplication@9@7721024@7808269@8@chr8:7721024-7808269@17.5@341@525@1.54@CNVR3772.4, CNVR3772.6, CNVR3772.10, CNVR3772.13@SPAG11A_4, DEFB103A_1, DEFB103A_2, DEFB4A_1, DEFB4A_2, ZNF705B_2, ZNF705B_3, ZNF705B_4, ZNF705B_5@0@0@0@:sperm associated antigen 11A;sperm associated antigen 11B:defensin, beta 103B;defensin, beta 103A:defensin, beta 4B;defensin, beta 4A:zinc finger protein 705B@:extracellular region;defense response:extracellular region;defense response to bacterium;Golgi lumen;positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria;defense response;innate immune response:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response:intracellular;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_15@80568@80572@duplication@5@12043862@12049350@8@chr8:12043862-12049350@10.5@184@290@1.58@CNVR3785.5, CNVR3785.3@FAM86B1_6, FAM86B1_5, FAM86B1_4, FAM86B1_3, FAM86B1_2@0@0@0@:family with sequence similarity 86, member B2;family with sequence similarity 86, member B1@NA@NA
A2463_15@80580@80586@duplication@7@12287860@12423650@8@chr8:12287860-12423650@7.58@531@700@1.32@CNVR3786.4, CNVR3786.16@FAM86B2_4, FAM86B2_3, FAM86B2_2, FAM86B2_1, AC130352.1_5, AC130352.1_6, AC130352.1_7@0@0@0@:family with sequence similarity 86, member B2@NA@NA
A2463_15@86629@86630@deletion@2@35061@35519@9@chr9:35061-35519@5.79@67@29@0.433@CNVR4134.1@FAM138C_2, FAM138C_1@0@0@0@NA@NA@NA
A2463_15@86646@86646@duplication@1@178817@178969@9@chr9:178817-178969@8.8@64@136@2.12@CNVR4135.1@CBWD1_1@0@0@0@:COBW domain containing 1;COBW domain-containing protein 1-like;COBW domain containing 5@:ATP binding@NA
A2463_15@88534@88539@deletion@6@41306194@41327364@9@chr9:41306194-41327364@11.8@82@21@0.256@CNVR4278.2@FAM74A2_2, FAM74A2_1, SPATA31A4_4, SPATA31A4_3, SPATA31A4_2, SPATA31A4_1@0@0@0@:SPATA31 subfamily A, member 4@:integral to membrane:integral to membrane@NA
A2463_15@88639@88642@deletion@4@67926874@67934829@9@chr9:67926874-67934829@9.99@71@19@0.268@NA@ANKRD20A1_1, ANKRD20A1_2, ANKRD20A1_3, ANKRD20A1_4@0@0@0@:ankyrin repeat domain 20 family, member A1@:protein binding;plasma membrane@NA
A2463_15@88644@88644@duplication@1@67938604@67938658@9@chr9:67938604-67938658@11.4@165@288@1.75@NA@ANKRD20A1_6@0@0@0@:ankyrin repeat domain 20 family, member A1@:protein binding;plasma membrane@NA
A2463_15@88647@88657@deletion@11@67951933@67987998@9@chr9:67951933-67987998@48.4@867@439@0.506@NA@ANKRD20A1_9, ANKRD20A1_10, ANKRD20A1_11, ANKRD20A1_12, ANKRD20A1_13, ANKRD20A1_14, ANKRD20A1_15, RP11-195B21.3_3, RP11-195B21.3_4, RP11-195B21.3_5, RP11-195B21.3_6@0@0@0@:ankyrin repeat domain 20 family, member A1:coiled-coil domain-containing protein 29-like;uncharacterized LOC644249@:protein binding;plasma membrane@NA
A2463_15@88687@88690@duplication@4@69416136@69424176@9@chr9:69416136-69424176@15.9@484@718@1.48@NA@ANKRD20A4_12, ANKRD20A4_13, ANKRD20A4_14, ANKRD20A4_15@0@0@0@:ankyrin repeat domain 20 family, member A4@:protein binding@NA
A2463_15@88718@88723@deletion@6@70881137@70912733@9@chr9:70881137-70912733@10.5@231@133@0.576@NA@CBWD3_8, CBWD3_9, CBWD3_10, CBWD3_11, CBWD3_12, CBWD3_13@0@0@0@:COBW domain-containing protein 5-like;COBW domain-containing protein 1-like;COBW domain containing 3@:ATP binding@NA
A2463_15@95386@95386@deletion@1@18122629@18122792@10@chr10:18122629-18122792@5.8@26@0@0@NA@MRC1_4@0@0@0@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
A2463_15@96435@96435@duplication@1@46248629@46248685@10@chr10:46248629-46248685@4.61@35@71@2.03@NA@FAM21C_13@0@0@0@:family with sequence similarity 21, member C@:endosome;protein binding;plasma membrane;retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_15@96466@96470@deletion@5@46584433@46611811@10@chr10:46584433-46611811@9.76@45@1@0.0222@CNVR4712.3@PTPN20A_6, PTPN20A_5, PTPN20A_4, PTPN20A_3, PTPN20A_2@0@0@0@:protein tyrosine phosphatase, non-receptor type 20B;protein tyrosine phosphatase, non-receptor type 20A@:phosphatase activity;protein tyrosine phosphatase activity;microtubule;nucleus;dephosphorylation;protein dephosphorylation;microtubule organizing center@NA
A2463_15@96548@96560@duplication@13@47913577@47943700@10@chr10:47913577-47943700@15.9@183@319@1.74@CNVR4715.2, CNVR4715.1@FAM21B_14, FAM21B_15, FAM21B_16, FAM21B_17, FAM21B_18, FAM21B_19, FAM21B_20, FAM21B_21, FAM21B_22, FAM21B_23, FAM21B_24, FAM21B_25, FAM21B_26@0@0@0@:family with sequence similarity 21, member B@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_15@96620@96620@deletion@1@48771316@48771405@10@chr10:48771316-48771405@10.8@55@4@0.0727@CNVR4716.10, CNVR4716.3@PTPN20B_6@0@0@0@:protein tyrosine phosphatase, non-receptor type 20B;protein tyrosine phosphatase, non-receptor type 20A@:phosphatase activity;protein tyrosine phosphatase activity;microtubule;nucleus;dephosphorylation;protein dephosphorylation;microtubule organizing center@NA
A2463_15@96631@96633@duplication@3@49376639@49381136@10@chr10:49376639-49381136@7.28@83@145@1.75@CNVR4717.2@FRMPD2_27, FRMPD2_26, FRMPD2_25@0@0@0@:FERM and PDZ domain containing 2@:basolateral plasma membrane;transferase activity, transferring phosphorus-containing groups;cytoplasm;tight junction;protein binding;cytoskeleton;1-phosphatidylinositol binding;tight junction assembly@NA
A2463_15@96918@96937@deletion@20@51885818@51978390@10@chr10:51885818-51978390@25.8@440@231@0.525@NA@FAM21A_26, FAM21A_27, FAM21A_28, FAM21A_29, FAM21A_30, FAM21A_31, ASAH2_20, ASAH2_19, ASAH2_18, ASAH2_17, ASAH2_16, ASAH2_15, ASAH2_14, ASAH2_13, ASAH2_12, ASAH2_11, ASAH2_10, ASAH2_9, ASAH2_8, ASAH2_7@0@0@0@:family with sequence similarity 21, member B;family with sequence similarity 21, member A:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
A2463_15@98344@98348@deletion@5@81463367@81470520@10@chr10:81463367-81470520@7.76@74@29@0.392@CNVR4815.2, CNVR4815.4@FAM22B_1, FAM22B_2, FAM22B_3, FAM22B_4, FAM22B_5@0@0@0@NA@NA@NA
A2463_15@98350@98350@deletion@1@81471457@81472241@10@chr10:81471457-81472241@30.4@232@50@0.216@CNVR4815.2, CNVR4815.4@FAM22B_7@0@0@0@NA@NA@NA
A2463_15@98350@98357@duplication@7@81471457@81610362@10@chr10:81471457-81610362@-14.5@329@322@0.979@CNVR4815.2@FAM22B_7, FAM22E_1, FAM22E_2, FAM22E_3, FAM22E_4, FAM22E_5, FAM22E_6, FAM22E_7@0@0@0@NA@NA@NA
A2463_15@98603@98606@deletion@4@89120239@89124960@10@chr10:89120239-89124960@6.71@57@19@0.333@CNVR4840.3@FAM22D_2, FAM22D_3, FAM22D_4, FAM22D_5@0@0@0@:family with sequence similarity 22, member D@NA@NA
A2463_15@101622@101622@deletion@1@124361314@124361636@10@chr10:124361314-124361636@5.38@27@2@0.0741@CNVR4912.1@DMBT1_29@0@0@0@:deleted in malignant brain tumors 1@:defense response to virus;calcium-dependent protein binding;pattern recognition receptor signaling pathway;blastocyst development;response to estrogen stimulus;tissue regeneration;proteinaceous extracellular matrix;protein transport;Gram-negative bacterial cell surface binding;positive regulation of epithelial cell differentiation;virus-host interaction;epithelial cell differentiation;induction of bacterial agglutination;phagocytic vesicle membrane;intracellular;Gram-positive bacterial cell surface binding;zymogen binding;innate immune response;cytoplasm;extrinsic to membrane;protein binding;zymogen granule membrane;extracellular region;scavenger receptor activity;pattern recognition receptor activity;inner cell mass cell proliferation;membrane@: GLIOMA SUSCEPTIBILITY 1; GLM1
A2463_15@110121@110124@deletion@4@89768381@89771883@11@chr11:89768381-89771883@6.31@163@97@0.595@NA@TRIM49C_3, TRIM49C_4, TRIM49C_5, TRIM49C_6@0@0@0@:tripartite motif containing 49D, pseudogene;tripartite motif containing 49-like 1;tripartite motif containing 49C;tripartite motif-containing protein 49-like protein 1-like@:protein binding;intracellular;DNA binding;zinc ion binding@NA
A2463_15@114080@114080@deletion@1@7945547@7945808@12@chr12:7945547-7945808@6.41@65@25@0.385@NA@NANOG_2@0@0@0@:NECAP endocytosis associated 1:Nanog homeobox@:coated pit;protein binding;endocytosis;protein transport;clathrin vesicle coat;plasma membrane;membrane:cell differentiation;regulation of cell differentiation;somatic stem cell maintenance;sequence-specific DNA binding;transcription corepressor activity;embryo development;DNA binding;sequence-specific DNA binding transcription factor activity;nucleus;positive regulation of transcription from RNA polymerase II promoter;regulation of gene expression;regulation of transcription, DNA-dependent;cell proliferation;endodermal cell fate specification;nucleolus;transcription, DNA-dependent@NA
A2463_15@114136@114139@deletion@4@8374419@8377428@12@chr12:8374419-8377428@27.8@1301@791@0.608@CNVR5422.3, CNVR5422.5, CNVR5422.6, CNVR5422.1@FAM90A1_7, FAM90A1_6, FAM90A1_5, FAM90A1_4@0@0@0@:family with sequence similarity 90, member A1@:zinc ion binding;nucleic acid binding@NA
A2463_15@114424@114430@deletion@7@10583717@10599261@12@chr12:10583717-10599261@28@729@431@0.591@CNVR5430.1@KLRC2_6, KLRC2_5, KLRC2_4, KLRC2_3, NKG2-E_3, KLRC2_2, NKG2-E_2, KLRC2_1, NKG2-E_1, KLRC1_8@0@0@0@:killer cell lectin-like receptor subfamily C, member 2:killer cell lectin-like receptor subfamily C, member 1@:carbohydrate binding:transmembrane signaling receptor activity;carbohydrate binding;protein binding;signal transduction;cellular defense response;integral to plasma membrane:transmembrane signaling receptor activity;carbohydrate binding;regulation of immune response;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway@NA
A2463_15@114493@114496@duplication@4@11506042@11508487@12@chr12:11506042-11508487@12@311@456@1.47@CNVR5435.2, CNVR5435.1@PRB1_4, PRB1_3, PRB1_2, PRB1_1@0@0@0@:proline-rich protein BstNI subfamily 1@NA@NA
A2463_15@127333@127336@deletion@4@19553418@19562100@14@chr14:19553418-19562100@21.5@493@277@0.562@CNVR6072.1@POTEG_1, POTEG_2, POTEG_3, POTEG_4@0@0@0@:POTE ankyrin domain family, member G@:protein binding@NA
A2463_15@127338@127340@duplication@3@19566013@19573144@14@chr14:19566013-19573144@17.2@463@696@1.5@CNVR6072.1@POTEG_6, POTEG_7, POTEG_8@0@0@0@:POTE ankyrin domain family, member G@:protein binding@NA
A2463_15@127344@127358@duplication@15@19999286@20404761@14@chr14:19999286-20404761@89.7@2471@3843@1.56@CNVR6072.12, CNVR6072.4@POTEM_9, POTEM_8, POTEM_7, POTEM_6, POTEM_5, POTEM_4, POTEM_3, POTEM_2, POTEM_1, OR4Q3_1, OR4M1_1, OR4N2_1, OR4K2_1, OR4K5_1, OR4K1_1@0@0@0@:POTE ankyrin domain family, member M:olfactory receptor, family 4, subfamily N, member 2:olfactory receptor, family 4, subfamily Q, member 3:olfactory receptor, family 4, subfamily M, member 1:olfactory receptor, family 4, subfamily K, member 2:olfactory receptor, family 4, subfamily K, member 5:olfactory receptor, family 4, subfamily K, member 1@:protein binding:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_15@133369@133370@deletion@2@106236631@106236862@14@chr14:106236631-106236862@5.8@36@7@0.194@CNVR6294.66, CNVR6294.68, CNVR6294.19, CNVR6294.35, CNVR6294.47@IGHG3_4, IGHG3_3@0@0@0@@:protein binding@NA
A2463_15@133432@133457@deletion@26@106539080@106780945@14@chr14:106539080-106780945@137@1731@772@0.446@CNVR6294.48, CNVR6294.24, CNVR6294.40@IGHV1-8_2, IGHV1-8_1, IGHV3-9_2, IGHV3-9_1, IGHV3-11_2, IGHV3-11_1, IGHV3-13_2, IGHV3-13_1, IGHV3-15_2, IGHV3-15_1, IGHV3-16_2, IGHV3-16_1, IGHV1-18_2, IGHV1-18_1, IGHV3-20_2, IGHV3-20_1, IGHV3-21_2, IGHV3-21_1, IGHV3-23_2, IGHV3-23_1, IGHV1-24_2, IGHV1-24_1, IGHV2-26_2, IGHV2-26_1, IGHV4-28_2, IGHV4-28_1@0@0@0@:uncharacterized LOC100653243;uncharacterized LOC642131@:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding@NA
A2463_15@133460@133462@duplication@3@106805210@106816026@14@chr14:106805210-106816026@16.5@131@267@2.04@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.41@IGHV4-31_2, IGHV4-31_1, IGHV3-33_2@0@0@0@@:protein binding:protein binding@NA
A2463_15@133491@133492@deletion@2@107095127@107095561@14@chr14:107095127-107095561@9.79@62@13@0.21@CNVR6294.56, CNVR6294.16, CNVR6294.91@IGHV4-61_2, IGHV4-61_1@0@0@0@@:protein binding@NA
A2463_15@133495@133498@deletion@4@107131034@107170367@14@chr14:107131034-107170367@6.42@262@169@0.645@CNVR6294.56, CNVR6294.16, CNVR6294.6, CNVR6294.92@IGHV3-66_2, IGHV3-66_1, IGHV1-69_2, IGHV1-69_1@0@0@0@@:protein binding:protein binding@NA
A2463_15@133523@133525@deletion@3@21059387@21063546@15@chr15:21059387-21063546@6.25@28@0@0@NA@POTEB_6, POTEB_5, POTEB_4@0@0@0@:POTE ankyrin domain family member B-like@:protein binding@NA
A2463_15@133541@133541@duplication@1@22368577@22369517@15@chr15:22368577-22369517@7.6@366@517@1.41@CNVR6297.9, CNVR6297.4, CNVR6297.17, CNVR6297.18@OR4M2_1@0@0@0@:olfactory receptor, family 4, subfamily M, member 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_15@133552@133552@deletion@1@22742397@22743598@15@chr15:22742397-22743598@13.2@652@396@0.607@CNVR6298.5@GOLGA6L1_8@0@0@0@:golgin A6 family-like 1;putative transmembrane protein FLJ36131-like;putative transmembrane protein ENSP00000320207-like;putative golgin subfamily A member 6-like@NA@NA
A2463_15@133622@133623@duplication@2@23259497@23259716@15@chr15:23259497-23259716@9.88@36@105@2.92@CNVR6300.4@GOLGA8I_6, GOLGA8I_7@0@0@0@:golgin A8 family, member I@:Golgi cisterna membrane@NA
A2463_15@133646@133654@deletion@9@23602444@23605962@15@chr15:23602444-23605962@14.2@219@111@0.507@CNVR6301.3@GOLGA8S_3, GOLGA8S_4, GOLGA8S_5, GOLGA8S_6, GOLGA8S_7, GOLGA8S_8, GOLGA8S_9, GOLGA8S_10, GOLGA8S_11@0@0@0@@:Golgi apparatus@NA
A2463_15@133659@133662@deletion@4@23609491@23610281@15@chr15:23609491-23610281@15.5@260@134@0.515@NA@GOLGA8S_16, GOLGA8S_17, GOLGA8S_18, GOLGA8S_19@0@0@0@@:Golgi apparatus@NA
A2463_15@133826@133826@duplication@1@28467175@28467361@15@chr15:28467175-28467361@4.92@61@106@1.74@CNVR6328.1@HERC2_36@0@0@0@:putative HERC2-like protein 3-like;HECT and RLD domain containing E3 ubiquitin protein ligase 2@:mitochondrial inner membrane;protein ubiquitination involved in ubiquitin-dependent protein catabolic process;guanyl-nucleotide exchange factor activity;SUMO binding;DNA repair;intracellular protein transport;spermatogenesis;cellular protein modification process;nucleus;ubiquitin protein ligase binding;ubiquitin-protein ligase activity;centriole;intracellular;response to DNA damage stimulus;heme binding;cytoplasm;protein binding;zinc ion binding;protein ubiquitination;metal ion binding@: SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1; SHEP1
A2463_15@133869@133870@duplication@2@28629294@28629596@15@chr15:28629294-28629596@8.35@49@111@2.27@CNVR6329.4@GOLGA8F_9, GOLGA8F_10@0@0@0@@:Golgi apparatus@NA
A2463_15@133906@133909@deletion@4@28950630@28951845@15@chr15:28950630-28951845@7.09@140@78@0.557@CNVR6331.1@GOLGA8M_12, GOLGA8M_11, GOLGA8M_10, GOLGA8M_9@0@0@0@:golgin A8 family, member M@:Golgi apparatus@NA
A2463_15@134023@134030@deletion@8@30699479@30702470@15@chr15:30699479-30702470@8.81@164@90@0.549@NA@GOLGA8R_12, GOLGA8R_11, GOLGA8R_10, GOLGA8R_9, GOLGA8R_8, GOLGA8R_7, GOLGA8R_6, GOLGA8R_5@0@0@0@@:Golgi apparatus@NA
A2463_15@134036@134039@duplication@4@30845996@30848215@15@chr15:30845996-30848215@16.7@67@187@2.79@NA@GOLGA8Q_2, GOLGA8Q_3, GOLGA8Q_4, GOLGA8Q_5@0@0@0@@:Golgi apparatus@NA
A2463_15@134044@134054@duplication@11@30850148@30896376@15@chr15:30850148-30896376@22.9@120@283@2.36@CNVR6339.2, CNVR6339.3, CNVR6339.1@GOLGA8Q_10, GOLGA8Q_11, GOLGA8Q_12, GOLGA8Q_13, GOLGA8Q_14, GOLGA8Q_15, GOLGA8Q_16, GOLGA8Q_17, GOLGA8Q_18, GOLGA8Q_19, GOLGA8H_1@0@0@0@:golgin A8 family, member H@:Golgi apparatus:Golgi apparatus@NA
A2463_15@134158@134181@deletion@24@32684984@32738099@15@chr15:32684984-32738099@50.7@528@214@0.405@CNVR6346.1@GOLGA8K_19, GOLGA8K_18, GOLGA8K_17, GOLGA8K_16, GOLGA8K_15, GOLGA8K_14, GOLGA8K_13, GOLGA8K_12, GOLGA8K_11, GOLGA8K_10, GOLGA8K_9, GOLGA8K_8, GOLGA8K_7, GOLGA8K_6, GOLGA8K_5, GOLGA8K_4, GOLGA8K_3, GOLGA8K_2, AC139426.2_1, GOLGA8K_1, GOLGA8O_19, GOLGA8O_18, GOLGA8O_17, GOLGA8O_16@0@0@0@:golgin A8 family, member J:golgin A8 family, member O@:Golgi apparatus:Golgi apparatus@NA
A2463_15@134203@134205@deletion@3@32889954@32890378@15@chr15:32889954-32890378@7.33@91@41@0.451@NA@GOLGA8N_6, GOLGA8N_7, GOLGA8N_8@0@0@0@:golgin A8 family, member R@:Golgi apparatus@NA
A2463_15@138282@138290@deletion@9@72953801@72958469@15@chr15:72953801-72958469@14.8@293@162@0.553@CNVR6443.1@GOLGA6B_9, GOLGA6B_10, GOLGA6B_11, GOLGA6B_12, GOLGA6B_13, GOLGA6B_14, GOLGA6B_15, GOLGA6B_16, GOLGA6B_17@0@0@0@:golgin A6 family, member B@:Golgi apparatus@NA
A2463_15@140476@140484@deletion@9@64382@68068@16@chr16:64382-68068@13.5@276@160@0.58@CNVR6565.1@WASH4P_10, WASH4P_9, WASH4P_8, WASH4P_7, WASH4P_6, WASH4P_5, WASH4P_4, WASH4P_3, WASH4P_2@0@0@0@@:intracellular membrane-bounded organelle;endosomal transport;recycling endosome;early endosome;Arp2/3 complex-mediated actin nucleation;actin binding;alpha-tubulin binding;retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;recycling endosome membrane@NA
A2463_15@141631@141631@deletion@1@2627427@2627501@16@chr16:2627427-2627501@10.6@79@21@0.266@CNVR6601.1@PDPK1_7@0@0@0@:3-phosphoinositide dependent protein kinase-1@:3-phosphoinositide-dependent protein kinase activity;nucleoplasm;fibroblast growth factor receptor signaling pathway;protein tyrosine kinase activity;negative regulation of transforming growth factor beta receptor signaling pathway;negative regulation of toll-like receptor signaling pathway;regulation of endothelial cell migration;focal adhesion assembly;ATP binding;insulin receptor signaling pathway;plasma membrane;intracellular signal transduction;positive regulation of establishment of protein localization to plasma membrane;platelet activation;protein kinase activity;regulation of mast cell degranulation;cytosol;epidermal growth factor receptor signaling pathway;hyperosmotic response;nerve growth factor receptor signaling pathway;type B pancreatic cell development;synaptic transmission;regulation of apoptotic process;transcription, DNA-dependent;protein autophosphorylation;regulation of I-kappaB kinase/NF-kappaB cascade;protein kinase binding;T cell costimulation;insulin receptor binding;transferase activity, transferring phosphorus-containing groups;actin cytoskeleton organization;blood coagulation;negative regulation of protein kinase activity;cellular response to insulin stimulus;focal adhesion;phosphatidylinositol-mediated signaling;negative regulation of cardiac muscle cell apoptotic process;protein serine/threonine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;cytoplasm;activation of protein kinase B activity;protein binding;T cell receptor signaling pathway;cytoplasmic membrane-bounded vesicle;peptidyl-threonine phosphorylation;kinase activity@NA
A2463_15@142690@142691@deletion@2@15045473@15069077@16@chr16:15045473-15069077@12@121@44@0.364@CNVR6646.1@NPIP_8, PDXDC1_1@0@0@0@:nuclear pore complex-interacting protein-like;nuclear pore complex interacting protein;nuclear pore complex-interacting protein-like 1-like:pyridoxal-dependent decarboxylase domain containing 1;pyridoxal-dependent decarboxylase domain-containing protein 1-like@:nuclear membrane;protein transport;nuclear pore;mRNA transport:carboxylic acid metabolic process;pyridoxal phosphate binding;carboxy-lyase activity@NA
A2463_15@142750@142750@duplication@1@15457517@15457926@16@chr16:15457517-15457926@10.5@190@313@1.65@CNVR6649.1@PKD1P1_8@0@0@0@:NPIP-like protein 1-like;nuclear pore complex-interacting protein-like 1-like@NA@NA
A2463_15@143477@143477@deletion@1@21742159@21742251@16@chr16:21742159-21742251@11.3@68@11@0.162@CNVR6668.5, CNVR6668.2, CNVR6668.7@OTOA_20@0@0@0@:otoancorin@:proteinaceous extracellular matrix;apical plasma membrane;sensory perception of sound;anchored to membrane@: DEAFNESS, AUTOSOMAL RECESSIVE 22; DFNB22
A2463_15@143482@143488@deletion@7@21763691@21849065@16@chr16:21763691-21849065@28@297@118@0.397@CNVR6668.5, CNVR6668.2, CNVR6668.7@OTOA_25, OTOA_26, OTOA_27, OTOA_28, NPIPL3_9, NPIPL3_8, NPIPL3_7@0@0@0@:otoancorin:nuclear pore complex interacting protein-like 3;nuclear pore complex interacting protein-like;nuclear pore complex-interacting protein-like 3-like@:proteinaceous extracellular matrix;apical plasma membrane;sensory perception of sound;anchored to membrane@: DEAFNESS, AUTOSOMAL RECESSIVE 22; DFNB22
A2463_15@147503@147509@deletion@7@74442905@74446144@16@chr16:74442905-74446144@15.2@317@179@0.565@CNVR6778.2, CNVR6778.3, CNVR6778.5@CLEC18B_13, CLEC18B_12, CLEC18B_11, CLEC18B_10, CLEC18B_9, CLEC18B_8, CLEC18B_7@0@0@0@:C-type lectin domain family 18, member B@:carbohydrate binding;protein binding;extracellular region@NA
A2463_15@147513@147515@deletion@3@74451958@74455168@16@chr16:74451958-74455168@9.31@86@32@0.372@CNVR6778.2, CNVR6778.3@CLEC18B_3, CLEC18B_2, CLEC18B_1@0@0@0@:C-type lectin domain family 18, member B@:carbohydrate binding;protein binding;extracellular region@NA
A2463_15@151959@151959@duplication@1@18996779@18997166@17@chr17:18996779-18997166@5.47@170@247@1.45@CNVR7018.4, CNVR7018.2, CNVR7018.6@AC007952.5_2@0@0@0@NA@NA@NA
A2463_15@153651@153652@deletion@2@36352423@36353765@17@chr17:36352423-36353765@6.11@140@81@0.579@CNVR7083.3@RP11-1407O15.2_11, RP11-1407O15.2_10@0@0@0@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
A2463_15@155584@155590@duplication@7@44380005@44409347@17@chr17:44380005-44409347@13@310@460@1.48@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A_3, LRRC37A_4, LRRC37A_5, LRRC37A_6, LRRC37A_7, LRRC37A_8, LRRC37A_9@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
A2463_15@155593@155604@duplication@12@44414663@44617613@17@chr17:44414663-44617613@61.3@439@985@2.24@CNVR7114.2, CNVR7114.1@LRRC37A_12, LRRC37A_13, LRRC37A_14, ARL17B_4, ARL17B_3, ARL17B_2, LRRC37A2_2, LRRC37A2_3, LRRC37A2_4, LRRC37A2_5, LRRC37A2_6, LRRC37A2_7@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
A2463_15@155607@155609@duplication@3@44625679@44630815@17@chr17:44625679-44630815@22.4@1189@1693@1.42@CNVR7114.2, CNVR7114.5, CNVR7114.4, CNVR7114.6@LRRC37A2_10, LRRC37A2_11, LRRC37A2_12@0@0@0@:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
A2463_15@155607@155612@deletion@3@44625679@44632945@17@chr17:44625679-44632945@-61.3@1408@1828@1.3@CNVR7114.2, CNVR7114.5, CNVR7114.4@LRRC37A2_10, LRRC37A2_11, LRRC37A2_12, LRRC37A2_13, LRRC37A2_14, LRRC37A2_15@0@0@0@:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
A2463_15@157080@157081@duplication@2@59480423@59481858@17@chr17:59480423-59481858@5.32@115@173@1.5@NA@TBX2_3, TBX2_4@0@0@0@:T-box 2@:mammary placode formation;embryonic digit morphogenesis;positive regulation of cardiac muscle cell proliferation;negative regulation of cardiac chamber formation;sequence-specific DNA binding;DNA binding;negative regulation of transcription, DNA-dependent;sequence-specific DNA binding transcription factor activity;aorta morphogenesis;outflow tract morphogenesis;transcription factor complex;regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation;nucleus;positive regulation of cell proliferation;embryonic camera-type eye morphogenesis;palate development;developmental growth involved in morphogenesis;atrioventricular canal development;endocardial cushion morphogenesis;regulation of transcription, DNA-dependent;outflow tract septum morphogenesis;cell aging;protein binding;negative regulation of transcription from RNA polymerase II promoter;pharynx development;heart morphogenesis;muscle cell fate determination;transcription, DNA-dependent;negative regulation of heart looping;cardiac muscle tissue development@NA
A2463_15@160925@160925@duplication@1@14534901@14535006@18@chr18:14534901-14535006@4.95@145@212@1.46@CNVR7269.1@POTEC_4@0@0@0@:POTE ankyrin domain family member B-like;POTE ankyrin domain family, member C@:protein binding@NA
A2463_15@162017@162017@deletion@1@44542732@44544371@18@chr18:44542732-44544371@8.78@196@107@0.546@CNVR7319.1@TCEB3CL2_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_15@162019@162019@deletion@1@44554574@44556213@18@chr18:44554574-44556213@28.5@1715@940@0.548@CNVR7319.1@TCEB3C_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C (elongin A3);RNA polymerase II transcription factor SIII subunit A3-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_15@164951@164951@duplication@1@7032325@7032905@19@chr19:7032325-7032905@8.29@22@78@3.55@CNVR7517.1@MBD3L5_2@0@0@0@:methyl-CpG binding domain protein 3-like 5@NA@NA
A2463_15@167243@167244@duplication@2@15784341@15789215@19@chr19:15784341-15789215@5.84@6@42@7@CNVR7553.1@CYP4F12_2, CYP4F12_3@0@0@0@:cytochrome P450, family 4, subfamily F, polypeptide 12@:pressure natriuresis;negative regulation of blood coagulation;oxidation-reduction process;very long-chain fatty acid metabolic process;arachidonic acid metabolic process;aromatase activity;sodium ion homeostasis;renal water homeostasis;arachidonic acid epoxygenase activity;integral to membrane;leukotriene B4 catabolic process;endoplasmic reticulum membrane;epoxygenase P450 pathway;electron carrier activity;intracellular membrane-bounded organelle;drug metabolic process;alkane 1-monooxygenase activity;small molecule metabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;apical plasma membrane;heme binding;vitamin E metabolic process;cytoplasm;vitamin-K-epoxide reductase (warfarin-sensitive) activity;xenobiotic metabolic process;vitamin K biosynthetic process;leukotriene-B4 20-monooxygenase activity;long-chain fatty acid metabolic process;iron ion binding@NA
A2463_15@170096@170100@duplication@5@40373946@40382826@19@chr19:40373946-40382826@33.2@330@625@1.89@CNVR7639.2@FCGBP_26, FCGBP_25, FCGBP_24, FCGBP_23, FCGBP_22@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_15@170104@170109@deletion@6@40389653@40399855@19@chr19:40389653-40399855@65.1@447@107@0.239@CNVR7639.2, CNVR7639.3@FCGBP_18, FCGBP_17, FCGBP_16, FCGBP_15, FCGBP_14, FCGBP_13@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_15@173295@173299@deletion@5@54724399@54726654@19@chr19:54724399-54726654@11.7@110@41@0.373@CNVR7721.3, CNVR7721.4@LILRB3_6, LILRB3_5, LILRB3_4, LILRB3_3, LILRB3_2@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
A2463_15@173456@173469@deletion@14@55237520@55263971@19@chr19:55237520-55263971@83.9@425@31@0.0729@CNVR7725.2, CNVR7725.1@KIR3DL3_3, KIR3DL3_4, KIR3DL3_5, KIR3DL3_6, KIR3DL3_7, KIR3DL3_8, KIR2DL3_1, KIR2DL3_2, KIR2DL3_3, KIR2DL3_4, KIR2DL3_5, KIR2DL3_6, KIR2DL3_7, KIR2DL3_8@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:integral to membrane;plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity@NA
A2463_15@173473@173501@deletion@29@55286618@55359398@19@chr19:55286618-55359398@50.8@992@559@0.564@CNVR7725.1@KIR2DL1_4, KIR2DL1_5, KIR2DL1_6, KIR2DL1_7, KIR2DL1_8, KIR2DL4_1, KIR2DL4_2, KIR2DL4_3, KIR2DL4_4, KIR2DL4_5, KIR2DL4_6, KIR2DL4_7, KIR3DL1_1, KIR3DL1_2, KIR3DL1_3, KIR3DL1_4, KIR3DL1_5, KIR3DL1_6, KIR3DL1_7, KIR3DL1_8, KIR3DL1_9, KIR2DS4_1, KIR2DS4_2, KIR2DS4_3, KIR2DS4_4, KIR2DS4_5, KIR2DS4_6, KIR2DS4_7, KIR2DS4_8@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane@NA
A2463_15@173844@173845@deletion@2@56283172@56284545@19@chr19:56283172-56284545@9.75@256@154@0.602@CNVR7734.1@CTD-2611O12.2_2, CTD-2611O12.2_3@0@0@0@:ret finger protein-like 4A-like@:protein binding;zinc ion binding@NA
A2463_15@180973@180976@duplication@4@16279196@16287885@22@chr22:16279196-16287885@25.1@607@964@1.59@CNVR8071.2, CNVR8071.3@POTEH_4, POTEH_3, POTEH_2, POTEH_1@0@0@0@:POTE ankyrin domain family, member H@:protein binding@NA
A2463_15@181133@181134@deletion@2@18739383@18835833@22@chr22:18739383-18835833@7.48@141@75@0.532@CNVR8087.5, CNVR8087.2, CNVR8087.7@AC008132.1_8, AC008132.13_1@0@0@0@NA@NA@NA
A2463_15@181487@181489@deletion@3@21065630@21067085@22@chr22:21065630-21067085@10.4@108@44@0.407@CNVR8099.6, CNVR8099.2@PI4KA_51, PI4KA_50, PI4KA_49@0@0@0@:phosphatidylinositol 4-kinase, catalytic, alpha@:phospholipid metabolic process;1-phosphatidylinositol 4-kinase activity;small molecule metabolic process;phosphatidylinositol phosphorylation;binding;transferase activity, transferring phosphorus-containing groups;phosphotransferase activity, alcohol group as acceptor;ATP binding;Golgi-associated vesicle;phosphatidylinositol biosynthetic process;cytosol;protein binding;signal transduction;synaptic transmission;kinase activity;phosphatidylinositol-mediated signaling@NA
A2463_15@181622@181631@deletion@10@21480538@21570956@22@chr22:21480538-21570956@8.78@235@142@0.604@CNVR8100.5, CNVR8100.4@POM121L7_1, GGT2_15, GGT2_14, GGT2_13, GGT2_12, GGT2_11, GGT2_10, GGT2_9, GGT2_8, GGT2_7@0@0@0@:putative POM121-like protein 1-like:gamma-glutamyltransferase 2;gamma-glutamyltranspeptidase 2-like@:hydrolase activity;small molecule metabolic process;leukotriene biosynthetic process;anchored to external side of plasma membrane;glutathione biosynthetic process;xenobiotic metabolic process;integral to membrane;glutathione metabolic process;plasma membrane;gamma-glutamyltransferase activity;cellular_component@NA
A2463_15@181806@181807@duplication@2@23243157@23247205@22@chr22:23243157-23247205@6.35@140@211@1.51@CNVR8103.2, CNVR8103.1, CNVR8103.6, CNVR8103.11, CNVR8103.35@IGLC2_1, IGLJ3_1@0@0@0@@:protein binding@NA
A2463_15@182140@182141@duplication@2@25747767@25750779@22@chr22:25747767-25750779@5.64@159@230@1.45@CNVR8120.1@LRP5L_6, LRP5L_5@0@0@0@:low density lipoprotein receptor-related protein 5-like@:Wnt-activated receptor activity;Wnt-protein binding;Wnt receptor signaling pathway involved in dorsal/ventral axis specification;canonical Wnt receptor signaling pathway@NA
A2463_15@183633@183641@deletion@9@39358501@39388450@22@chr22:39358501-39388450@19.9@329@172@0.523@CNVR8164.1@APOBEC3A_6, APOBEC3B_1, APOBEC3B_2, APOBEC3B_3, APOBEC3B_4, APOBEC3B_5, APOBEC3B_6, APOBEC3B_7, APOBEC3B_8@0@0@0@:apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A;APOBEC3A and APOBEC3B deletion hybrid:apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B@:cytidine deamination;defense response to virus;negative regulation of viral genome replication;DNA cytosine deamination;clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine;catalytic activity;DNA demethylation;cytoplasm;innate immune response;cytidine deaminase activity;nucleus;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines;cellular response to xenobiotic stimulus;zinc ion binding;negative regulation of transposition:RNA binding;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines;negative regulation of transposition;catalytic activity;zinc ion binding@NA
A2463_05@106@115@duplication@10@982201@985709@1@chr1:982201-985709@7.81@778@1057@1.36@NA@AGRN_19, AGRN_20, AGRN_21, AGRN_22, AGRN_23, AGRN_24, AGRN_25, AGRN_26, AGRN_27, AGRN_28@0@0@0@:agrin@:neuromuscular junction development;chondroitin sulfate metabolic process;basal lamina;structural constituent of cytoskeleton;glycosaminoglycan metabolic process;glycosaminoglycan biosynthetic process;laminin binding;synapse organization;lysosomal lumen;glycosaminoglycan catabolic process;clustering of voltage-gated sodium channels;positive regulation of neuron apoptotic process;plasma membrane;acetylcholine receptor regulator activity;Golgi lumen;neurotransmitter receptor metabolic process;synapse assembly;plasma membrane organization;regulation of synaptic growth at neuromuscular junction;receptor clustering;calcium ion binding;extracellular matrix;positive regulation of protein geranylgeranylation;G-protein coupled acetylcholine receptor signaling pathway;extracellular space;positive regulation of transcription from RNA polymerase II promoter;small molecule metabolic process;carbohydrate metabolic process;axon guidance;regulation of Rac GTPase activity;positive regulation of protein phosphorylation;signal transduction;protein binding;synapse;cell surface@: MYASTHENIA, LIMB-GIRDLE, FAMILIAL
A2463_05@3194@3198@duplication@5@24287949@24301567@1@chr1:24287949-24301567@6.77@58@128@2.21@NA@PNRC2_3, SRSF10_6, SRSF10_5, SRSF10_4, SRSF10_3@0@0@0@:proline-rich nuclear receptor coactivator 2;proline-rich nuclear receptor coactivator 2-like:serine/arginine-rich splicing factor 10-like;serine/arginine-rich splicing factor 10@:protein binding;deadenylation-independent decapping of nuclear-transcribed mRNA;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;nucleus;regulation of transcription, DNA-dependent;transcription, DNA-dependent;cytoplasmic mRNA processing body:nucleoplasm;RNA splicing, via transesterification reactions;nuclear speck;RS domain binding;RNA binding;nucleus;mRNA splice site selection;unfolded protein binding;assembly of spliceosomal tri-snRNP;negative regulation of mRNA splicing, via spliceosome;regulation of transcription, DNA-dependent;nucleotide binding;cytoplasm;mRNA export from nucleus;protein binding;cytoplasmic transport;mRNA splicing, via spliceosome;nucleic acid binding@NA
A2463_05@3357@3357@deletion@1@25735175@25735360@1@chr1:25735175-25735360@15.2@97@0@0@CNVR117.1@RHCE_2@0@0@0@:Rh blood group, CcEe antigens@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@: BLOOD GROUP--RHESUS SYSTEM E POLYPEPTIDE; RHE; RHESUS BLOOD GROUP, CcEe ANTIGENS; RHCE
A2463_05@8122@8128@deletion@7@79357210@79392776@1@chr1:79357210-79392776@7.54@770@486@0.631@NA@ELTD1_14, ELTD1_13, ELTD1_12, ELTD1_11, ELTD1_10, ELTD1_9, ELTD1_8@0@0@0@:EGF, latrophilin and seven transmembrane domain containing 1@:transmembrane signaling receptor activity;neuropeptide signaling pathway;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;protein binding;integral to membrane;protein dimerization activity;plasma membrane;membrane;calcium ion binding;cell surface receptor signaling pathway@NA
A2463_05@9365@9374@deletion@10@104202983@104234232@1@chr1:104202983-104234232@52@324@0@0@CNVR266.3, CNVR266.1, CNVR266.15@AMY1A_7, AMY1A_8, AMY1A_9, AMY1A_10, AMY1A_11, AMY1B_11, AMY1B_10, AMY1B_9, AMY1B_8, AMY1B_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
A2463_05@9766@9774@duplication@9@110230497@110254970@1@chr1:110230497-110254970@25.1@231@570@2.47@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_1, GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8, GSTM5_1@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1:glutathione S-transferase mu 5@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process:xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process;glutathione metabolic process;endoplasmic reticulum membrane@NA
A2463_05@10506@10509@deletion@4@118035770@118045592@1@chr1:118035770-118045592@6.15@486@286@0.588@NA@MAN1A2_9, MAN1A2_10, MAN1A2_11, MAN1A2_12@0@0@0@:mannosidase, alpha, class 1A, member 2@:respiratory gaseous exchange;Golgi apparatus;N-glycan processing;lung alveolus development;Golgi membrane;post-translational protein modification;glycoprotein metabolic process;mannosyl-oligosaccharide 1,2-alpha-mannosidase activity;cellular protein metabolic process;integral to membrane;nucleolus;protein N-linked glycosylation via asparagine;membrane;calcium ion binding@NA
A2463_05@10793@10795@duplication@3@144339779@144520832@1@chr1:144339779-144520832@7.09@76@178@2.34@NA@AL592284.1_1, PPIAL4B_1, AL592284.1_2@0@0@0@:uncharacterized LOC730256;uncharacterized LOC101060698;uncharacterized LOC642441:peptidylprolyl isomerase A (cyclophilin A)-like 4C;peptidyl-prolyl cis-trans isomerase A-like 4A/B/C-like;peptidylprolyl isomerase A (cyclophilin A)-like 4B;peptidylprolyl isomerase A (cyclophilin A)-like 4A@:protein folding;peptidyl-prolyl cis-trans isomerase activity;cytoplasm@NA
A2463_05@10799@10804@deletion@6@144815937@144823985@1@chr1:144815937-144823985@11.6@725@521@0.719@CNVR338.2, CNVR338.5, CNVR338.1@NBPF9_4, NBPF9_5, NBPF9_6, NBPF9_7, NBPF9_8, NBPF9_9@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 24@NA@NA
A2463_05@10893@10896@deletion@4@145328376@145330855@1@chr1:145328376-145330855@9.62@117@42@0.359@CNVR341.2, CNVR341.3@NBPF10_33, NBPF10_34, NBPF10_35, NBPF10_36@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family, member 10@NA@NA
A2463_05@11148@11157@duplication@10@146231724@146244717@1@chr1:146231724-146244717@10.4@49@184@3.76@NA@NBPF12_17, NBPF12_16, NBPF12_15, NBPF12_14, NBPF12_13, NBPF12_12, NBPF12_11, NBPF12_10, NBPF12_9, NBPF12_8@0@0@0@:neuroblastoma breakpoint family member 21-like@NA@NA
A2463_05@11162@11164@duplication@3@146250791@146253110@1@chr1:146250791-146253110@5.82@152@246@1.62@NA@NBPF12_3, NBPF12_2, NBPF12_1@0@0@0@:neuroblastoma breakpoint family member 21-like@NA@NA
A2463_05@11169@11184@deletion@16@146400092@146420191@1@chr1:146400092-146420191@31@410@134@0.327@NA@NBPF12_9, NBPF12_10, NBPF12_11, NBPF12_12, NBPF12_13, NBPF12_14, NBPF12_15, NBPF12_16, NBPF12_17, NBPF12_18, NBPF12_19, NBPF12_20, NBPF12_21, NBPF12_22, NBPF12_23, NBPF12_24@0@0@0@:neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family member 14-like;neuroblastoma breakpoint family, member 12@:cytoplasm@NA
A2463_05@11242@11242@deletion@1@146465879@146466121@1@chr1:146465879-146466121@4.35@148@63@0.426@CNVR344.2@NBPF12_82@0@0@0@:neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family member 14-like;neuroblastoma breakpoint family, member 12@:cytoplasm@NA
A2463_05@11477@11483@deletion@7@148589662@148594640@1@chr1:148589662-148594640@6.74@171@82@0.48@CNVR348.1, CNVR348.4@NBPF15_15, NBPF15_16, NBPF15_17, NBPF15_18, NBPF15_19, NBPF15_20, NBPF15_21@0@0@0@:neuroblastoma breakpoint family, member 15@:cytoplasm@NA
A2463_05@11485@11494@duplication@10@148741691@148753421@1@chr1:148741691-148753421@8.31@18@84@4.67@CNVR349.2, CNVR349.3@NBPF16_3, NBPF16_4, NBPF16_5, NBPF16_6, NBPF16_7, NBPF16_8, NBPF16_9, NBPF16_10, NBPF16_11, NBPF16_12@0@0@0@:neuroblastoma breakpoint family, member 16@:cytoplasm@NA
A2463_05@12117@12118@deletion@2@152573209@152586574@1@chr1:152573209-152586574@21.9@138@2@0.0145@CNVR358.1@LCE3C_1, LCE3B_1@0@0@0@:late cornified envelope 3C:late cornified envelope 3B@:keratinization:keratinization@NA
A2463_05@14051@14051@deletion@1@161518802@161518821@1@chr1:161518802-161518821@8.17@60@6@0.1@CNVR383.3, CNVR383.1@FCGR3A_2@0@0@0@:Fc fragment of IgG, low affinity IIIa, receptor (CD16a)@:IgG binding;protein binding;regulation of immune response;extracellular region;integral to membrane;immune response;plasma membrane;external side of plasma membrane@NA
A2463_05@14056@14062@duplication@7@161599569@161643019@1@chr1:161599569-161643019@10.4@378@656@1.74@CNVR383.1@FCGR3B_3, FCGR3B_2, FCGR3B_1, FCGR2B_1, FCGR2B_2, FCGR2B_3, FCGR2B_4@0@0@0@:Fc fragment of IgG, low affinity IIIa, receptor (CD16a):Fc fragment of IgG, low affinity IIb, receptor (CD32):Fc fragment of IgG, low affinity IIIb, receptor (CD16b)@:IgG binding;protein binding;regulation of immune response;extracellular region;integral to membrane;immune response;plasma membrane;external side of plasma membrane:IgG binding;protein binding;signal transduction;regulation of immune response;integral to membrane;immune response;plasma membrane;virus-host interaction:IgG binding;protein binding;extracellular region;immune response;plasma membrane;anchored to membrane@: MALARIA, SUSCEPTIBILITY TO; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
A2463_05@15741@15757@deletion@17@186036967@186062801@1@chr1:186036967-186062801@14.3@3928@2644@0.673@NA@HMCN1_50, HMCN1_51, HMCN1_52, HMCN1_53, HMCN1_54, HMCN1_55, HMCN1_56, HMCN1_57, HMCN1_58, HMCN1_59, HMCN1_60, HMCN1_61, HMCN1_62, HMCN1_63, HMCN1_64, HMCN1_65, HMCN1_66@0@0@0@:hemicentin 1@:extracellular matrix;cell cortex;response to stimulus;protein binding;extracellular region;visual perception;cell junction;basement membrane;membrane;calcium ion binding@: MACULAR DEGENERATION, AGE-RELATED, 1; ARMD1
A2463_05@16029@16040@deletion@12@196744018@196801129@1@chr1:196744018-196801129@40.4@2067@1024@0.495@CNVR459.1@CFHR3_1, CFHR3_2, CFHR3_3, CFHR3_4, CFHR3_5, CFHR3_6, CFHR1_1, CFHR1_2, CFHR1_3, CFHR1_4, CFHR1_5, CFHR1_6@0@0@0@:complement factor H-related 3:complement factor H-related 1:complement factor H-related 2@:extracellular space:extracellular space;complement activation:extracellular region@NA
A2463_05@16180@16195@deletion@16@198700747@198725310@1@chr1:198700747-198725310@20.6@3494@2250@0.644@NA@PTPRC_18, PTPRC_19, PTPRC_20, PTPRC_21, PTPRC_22, PTPRC_23, PTPRC_24, PTPRC_25, PTPRC_26, PTPRC_27, PTPRC_28, PTPRC_29, PTPRC_30, PTPRC_31, PTPRC_32, PTPRC_33@0@0@0@:protein tyrosine phosphatase, receptor type, C@:stem cell development;heterotypic cell-cell adhesion;negative regulation of protein autophosphorylation;response to gamma radiation;B cell proliferation;positive regulation of stem cell proliferation;activation of MAPK activity;regulation of humoral immune response mediated by circulating immunoglobulin;negative regulation of T cell mediated cytotoxicity;positive regulation of antigen receptor-mediated signaling pathway;positive regulation of B cell proliferation;regulation of S phase;protein dephosphorylation;integral to membrane;heparin binding;cell surface receptor signaling pathway;regulation of cell cycle;positive regulation of T cell mediated cytotoxicity;axon guidance;positive regulation of protein kinase activity;positive regulation of T cell mediated immunity;negative regulation of peptidyl-tyrosine phosphorylation;dephosphorylation;positive regulation of apoptotic process;defense response to virus;positive regulation of isotype switching to IgG isotypes;negative regulation of cytokine-mediated signaling pathway;T cell proliferation;bone marrow development;negative thymic T cell selection;B cell differentiation;positive thymic T cell selection;leukocyte cell-cell adhesion;plasma membrane;immunoglobulin biosynthetic process;heparan sulfate proteoglycan binding;positive regulation of T cell differentiation;B cell receptor signaling pathway;negative regulation of cell adhesion involved in substrate-bound cell migration;regulation of apoptotic process;transmembrane receptor protein tyrosine phosphatase activity;membrane raft;protein kinase binding;positive regulation of MAPK cascade;cell periphery;negative regulation of protein kinase activity;release of sequestered calcium ion into cytosol;focal adhesion;integral to plasma membrane;peptidyl-tyrosine dephosphorylation;hematopoietic progenitor cell differentiation;phosphatase activity;positive regulation of gamma-delta T cell differentiation;protein tyrosine phosphatase activity;regulation of B cell receptor signaling pathway;external side of plasma membrane;T cell differentiation;protein binding;T cell receptor signaling pathway;positive regulation of humoral immune response mediated by circulating immunoglobulin;positive regulation of alpha-beta T cell proliferation;regulation of B cell differentiation;positive regulation of T cell proliferation;positive regulation of hematopoietic stem cell migration;cell surface@: SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE,; MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO; MS
A2463_05@17286@17287@deletion@2@207718654@207719023@1@chr1:207718654-207719023@7.44@37@0@0@CNVR485.1@CR1_14, CR1_15@0@0@0@:complement component (3b/4b) receptor 1 (Knops blood group)@:complement component C4b receptor activity;complement activation, classical pathway;negative regulation of complement activation, alternative pathway;innate immune response;negative regulation of serine-type endopeptidase activity;complement component C3b binding;negative regulation of complement activation, classical pathway;plasma membrane;integral to plasma membrane;complement component C3b receptor activity;complement component C4b binding;cell surface;regulation of complement activation;positive regulation of serine-type endopeptidase activity@: MALARIA, SUSCEPTIBILITY TO; KNOPS BLOOD GROUP SYSTEM; KN
A2463_05@25358@25374@deletion@17@97833433@97858790@2@chr2:97833433-97858790@39.3@2099@1246@0.594@CNVR886.2@ANKRD36_22, ANKRD36_23, ANKRD36_24, ANKRD36_25, ANKRD36_26, ANKRD36_27, ANKRD36_28, ANKRD36_29, ANKRD36_30, ANKRD36_31, ANKRD36_32, ANKRD36_33, ANKRD36_34, ANKRD36_35, ANKRD36_36, ANKRD36_37, ANKRD36_38@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_05@25387@25390@deletion@4@97871678@97873743@2@chr2:97871678-97873743@6.91@526@307@0.584@CNVR886.1@ANKRD36_51, ANKRD36_52, ANKRD36_53, ANKRD36_54@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_05@27625@27631@deletion@7@141093185@141122352@2@chr2:141093185-141122352@9.9@925@560@0.605@NA@LRP1B_78, LRP1B_77, LRP1B_76, LRP1B_75, LRP1B_74, LRP1B_73, LRP1B_72@0@0@0@:low density lipoprotein receptor-related protein 1B@:low-density lipoprotein receptor activity;protein binding;integral to membrane;protein transport;receptor-mediated endocytosis;membrane;calcium ion binding@NA
A2463_05@28901@28920@deletion@20@169801116@169874635@2@chr2:169801116-169874635@15.7@2133@1415@0.663@NA@ABCB11_21, ABCB11_20, ABCB11_19, ABCB11_18, ABCB11_17, ABCB11_16, ABCB11_15, ABCB11_14, ABCB11_13, ABCB11_12, ABCB11_11, ABCB11_10, ABCB11_9, ABCB11_8, ABCB11_7, ABCB11_6, ABCB11_5, ABCB11_4, ABCB11_3, ABCB11_2@0@0@0@:ATP-binding cassette, sub-family B (MDR/TAP), member 11@:bile acid and bile salt transport;ATPase activity, coupled to transmembrane movement of substances;transport;transporter activity;apical part of cell;Golgi membrane;bile acid biosynthetic process;ATP binding;transmembrane transport;intercellular canaliculus;integral to membrane;ATPase activity;plasma membrane;integral to plasma membrane;canalicular bile acid transmembrane transporter activity;small molecule metabolic process;nucleoside-triphosphatase activity;apical plasma membrane;nucleotide binding;bile acid metabolic process;bile acid-exporting ATPase activity;canalicular bile acid transport;membrane;sodium-exporting ATPase activity, phosphorylative mechanism@: CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 2; PFIC2; CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC, 2; BRIC2
A2463_05@29746@29812@deletion@67@179476785@179536994@2@chr2:179476785-179536994@40.8@15218@10579@0.695@NA@TTN_216, TTN_215, TTN_214, TTN_213, TTN_212, TTN_211, TTN_210, TTN_209, TTN_208, TTN_207, TTN_206, TTN_205, TTN_204, TTN_203, TTN_202, TTN_201, TTN_200, TTN_199, TTN_198, TTN_197, TTN_196, TTN_195, TTN_194, TTN_193, TTN_192, TTN_191, TTN_190, TTN_189, TTN_188, TTN_187, TTN_186, TTN_185, TTN_184, TTN_183, TTN_182, TTN_181, TTN_180, TTN_179, TTN_178, TTN_177, TTN_176, TTN_175, TTN_174, TTN_173, TTN_172, TTN_171, TTN_170, TTN_169, TTN_168, TTN_167, TTN_166, TTN_165, TTN_164, TTN_163, TTN_162, TTN_161, TTN_160, TTN_159, TTN_158, TTN_157, TTN_156, TTN_155, TTN_154, TTN_153, TTN_152, TTN_151, TTN_150@0@0@0@:titin@:muscle alpha-actinin binding;condensed nuclear chromosome;platelet degranulation;skeletal muscle thin filament assembly;protein tyrosine kinase activity;forward locomotion;binding;regulation of catalytic activity;ATP binding;cardiac muscle tissue morphogenesis;nucleus;sarcomerogenesis;cardiac myofibril assembly;identical protein binding;cardiac muscle fiber development;somitogenesis;platelet activation;response to calcium ion;protein self-association;actinin binding;ankyrin binding;enzyme binding;protein kinase activity;in utero embryonic development;adult heart development;structural constituent of muscle;cytosol;heart morphogenesis;calcium ion binding;Z disc;muscle filament sliding;M band;calmodulin binding;cardiac muscle contraction;striated muscle contraction;transferase activity, transferring phosphorus-containing groups;A band;skeletal muscle myosin thick filament assembly;mitotic chromosome condensation;blood coagulation;striated muscle thin filament;sarcomere;regulation of protein kinase activity;protein serine/threonine kinase activity;Golgi apparatus;protein phosphorylation;protease binding;cytoplasm;protein binding;striated muscle cell development;actin filament binding;extracellular region;I band;telethonin binding;sarcomere organization;cardiac muscle hypertrophy;detection of muscle stretch;muscle contraction;nucleic acid binding@: MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2J; LGMD2J; MYOPATHY, EARLY-ONSET, WITH FATAL CARDIOMYOPATHY; TIBIAL MUSCULAR DYSTROPHY, TARDIVE; CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 9; CMH9; CARDIOMYOPATHY, DILATED, 1G; CMD1G; HEREDITARY MYOPATHY WITH EARLY RESPIRATORY FAILURE; HMERF
A2463_05@30198@30212@deletion@15@186620920@186697953@2@chr2:186620920-186697953@13.7@7872@5257@0.668@NA@FSIP2_9, FSIP2_10, FSIP2_11, FSIP2_12, FSIP2_13, FSIP2_14, FSIP2_15, FSIP2_16, FSIP2_17, FSIP2_18, FSIP2_19, FSIP2_20, FSIP2_21, FSIP2_22, FSIP2_23@0@0@0@:fibrous sheath interacting protein 2@:protein binding;mitochondrion;ribonucleoprotein complex;nucleic acid binding@NA
A2463_05@31822@31838@deletion@17@211444439@211481265@2@chr2:211444439-211481265@18.3@3270@2139@0.654@NA@CPS1_6, CPS1_7, CPS1_8, CPS1_9, CPS1_10, CPS1_11, CPS1_12, CPS1_13, CPS1_14, CPS1_15, CPS1_16, CPS1_17, CPS1_18, CPS1_19, CPS1_20, CPS1_21, CPS1_22@0@0@0@:carbamoyl-phosphate synthase 1, mitochondrial@:mitochondrion;nitrogen compound metabolic process;response to toxin;liver development;response to oleic acid;nitric oxide metabolic process;ATP binding;response to amino acid stimulus;cellular response to fibroblast growth factor stimulus;mitochondrial matrix;glycogen catabolic process;response to lipopolysaccharide;response to amine stimulus;positive regulation of vasodilation;citrulline biosynthetic process;response to zinc ion;response to cAMP;cellular response to cAMP;glutamate binding;response to glucagon stimulus;response to starvation;anion homeostasis;homocysteine metabolic process;nucleolus;cellular response to oleic acid;response to steroid hormone stimulus;response to acid;cellular nitrogen compound metabolic process;response to food;calcium ion binding;cellular response to glucagon stimulus;phospholipid binding;endopeptidase activity;urea cycle;mitochondrial inner membrane;response to drug;response to growth hormone stimulus;catalytic activity;D-alanine-D-alanine ligase activity;mitochondrial nucleoid;triglyceride catabolic process;midgut development;glutamine catabolic process;metabolic process;small molecule metabolic process;protein complex;carbamoyl-phosphate synthase (ammonia) activity;cytoplasm;protein binding;response to glucocorticoid stimulus;peptidoglycan biosynthetic process;response to dexamethasone stimulus;modified amino acid binding;hepatocyte differentiation;protein complex binding;carbamoyl phosphate biosynthetic process;metal ion binding@: CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO
A2463_05@35554@35561@deletion@8@17415964@17448018@3@chr3:17415964-17448018@9.59@742@466@0.628@NA@TBC1D5_13, TBC1D5_12, TBC1D5_11, TBC1D5_10, TBC1D5_9, TBC1D5_8, TBC1D5_7, TBC1D5_6@0@0@0@:TBC1 domain family, member 5@:Rab GTPase activator activity;protein binding;regulation of Rab GTPase activity;intracellular;retromer complex@NA
A2463_05@37507@37509@duplication@3@48608535@48609478@3@chr3:48608535-48609478@5.45@304@465@1.53@NA@COL7A1_93, COL7A1_92, COL7A1_91@0@0@0@:collagen, type VII, alpha 1@:extracellular matrix;extracellular matrix organization;endoplasmic reticulum lumen;serine-type endopeptidase inhibitor activity;protein binding;extracellular region;cell adhesion;basement membrane;collagen type VII;epidermis development@: NAIL DISORDER, NONSYNDROMIC CONGENITAL, 8; NDNC8; EPIDERMOLYSIS BULLOSA DYSTROPHICA, PRETIBIAL; EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL DOMINANT; DDEB; EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE; RDEB; EPIDERMOLYSIS BULLOSA WITH CONGENITAL LOCALIZED ABSENCE OF SKIN AND; EPIDERMOLYSIS BULLOSA PRURIGINOSA; TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN; TBDN
A2463_05@39892@39894@deletion@3@75786030@75790887@3@chr3:75786030-75790887@8.64@246@120@0.488@CNVR1432.5, CNVR1432.9, CNVR1432.4@ZNF717_5, ZNF717_4, ZNF717_3@0@0@0@:zinc finger protein 717;zinc finger protein 717-like@:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_05@41788@41804@duplication@17@126676260@126735527@3@chr3:126676260-126735527@13.8@941@1283@1.36@NA@CHCHD6_7, PLXNA1_1, PLXNA1_2, PLXNA1_3, PLXNA1_4, PLXNA1_5, PLXNA1_6, PLXNA1_7, PLXNA1_8, PLXNA1_9, PLXNA1_10, PLXNA1_11, PLXNA1_12, PLXNA1_13, PLXNA1_14, PLXNA1_15@0@0@0@:coiled-coil-helix-coiled-coil-helix domain containing 6:plexin A1@:protein binding;mitochondrion;mitochondrial inner membrane;cristae formation;response to DNA damage stimulus:multicellular organismal development;intracellular;axon guidance;cytoplasm;protein binding;signal transduction;semaphorin-plexin signaling pathway;dichotomous subdivision of terminal units involved in salivary gland branching;integral to membrane;semaphorin receptor activity;nucleus;plasma membrane;receptor activity;semaphorin receptor complex;membrane@NA
A2463_05@43802@43843@deletion@42@164697151@164783220@3@chr3:164697151-164783220@34.3@7940@5370@0.676@NA@SI_48, SI_47, SI_46, SI_45, SI_44, SI_43, SI_42, SI_41, SI_40, SI_39, SI_38, SI_37, SI_36, SI_35, SI_34, SI_33, SI_32, SI_31, SI_30, SI_29, SI_28, SI_27, SI_26, SI_25, SI_24, SI_23, SI_22, SI_21, SI_20, SI_19, SI_18, SI_17, SI_16, SI_15, SI_14, SI_13, SI_12, SI_11, SI_10, SI_9, SI_8, SI_7@0@0@0@:sucrase-isomaltase (alpha-glucosidase)@:carbohydrate binding;membrane raft;aging;catalytic activity;response to fructose stimulus;response to vitamin A;integral to membrane;polysaccharide digestion;alpha-glucosidase activity;plasma membrane;small molecule metabolic process;Golgi apparatus;apical plasma membrane;oligo-1,6-glucosidase activity;carbohydrate metabolic process;response to sucrose stimulus;response to starvation;brush border;sucrose alpha-glucosidase activity;response to glucocorticoid stimulus;response to insulin stimulus;hydrolase activity, hydrolyzing O-glycosyl compounds;membrane@: SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL; CSID
A2463_05@46667@46671@deletion@5@9174900@9213975@4@chr4:9174900-9213975@6.91@62@17@0.274@NA@FAM90A26P_4, FAM90A26P_5, FAM90A26P_6, FAM90A26P_7, USP17L13_1, USP17L10_1@0@0@0@:ubiquitin specific peptidase 17-like family member 10:ubiquitin specific peptidase 17-like family member 13@:zinc ion binding;nucleic acid binding:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
A2463_05@48556@48561@deletion@6@69403344@69434202@4@chr4:69403344-69434202@59@431@17@0.0394@CNVR1953.1@UGT2B17_6, UGT2B17_5, UGT2B17_4, UGT2B17_3, UGT2B17_2, UGT2B17_1@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B17@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;membrane@: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
A2463_05@48625@48642@deletion@18@70799931@70825797@4@chr4:70799931-70825797@12.8@2203@1503@0.682@NA@CSN1S1_3, CSN1S1_4, CSN1S1_5, CSN1S1_6, CSN1S1_7, CSN1S1_8, CSN1S1_9, CSN1S1_10, CSN1S1_11, CSN1S1_12, CSN1S1_13, CSN1S1_14, CSN1S1_15, CSN2_6, CSN2_5, CSN2_4, CSN2_3, CSN2_2@0@0@0@:casein alpha s1:casein beta@:extracellular region;transporter activity:enzyme inhibitor activity;transport;extracellular region;calcium ion transport;transporter activity;negative regulation of catalytic activity;calcium ion binding@NA
A2463_05@48659@48675@deletion@17@71027304@71115176@4@chr4:71027304-71115176@18.3@1875@1197@0.638@NA@C4orf40_4, ODAM_1, ODAM_2, ODAM_3, ODAM_4, ODAM_5, ODAM_6, ODAM_7, ODAM_8, ODAM_9, ODAM_10, FDCSP_2, FDCSP_3, FDCSP_4, CSN3_2, CSN3_3, CSN3_4@0@0@0@:chromosome 4 open reading frame 40:odontogenic, ameloblast asssociated:follicular dendritic cell secreted protein:casein kappa@:extracellular region:fibril;extracellular region;odontogenesis of dentin-containing tooth;biomineral tissue development:extracellular region:extracellular region;lactation@: AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA4; AI2A4
A2463_05@48769@48782@deletion@14@72319213@72433610@4@chr4:72319213-72433610@14.9@2564@1673@0.652@NA@SLC4A4_12, SLC4A4_13, SLC4A4_14, SLC4A4_15, SLC4A4_16, SLC4A4_17, SLC4A4_18, SLC4A4_19, SLC4A4_20, SLC4A4_21, SLC4A4_22, SLC4A4_23, SLC4A4_24, SLC4A4_25@0@0@0@:solute carrier family 4, sodium bicarbonate cotransporter, member 4@:transport;basolateral plasma membrane;transporter activity;ion transport;transmembrane transport;anion transmembrane transporter activity;integral to membrane;inorganic anion exchanger activity;plasma membrane;integral to plasma membrane;bicarbonate transport;protein binding;sodium:bicarbonate symporter activity;sodium ion transport;membrane;anion transport@: RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTAL
A2463_05@48972@48975@deletion@4@75482007@75488112@4@chr4:75482007-75488112@6.65@88@34@0.386@NA@AREGB_2, AREGB_3, AREGB_4, AREGB_5@0@0@0@:amphiregulin;amphiregulin B@:growth factor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;cell proliferation;epidermal growth factor receptor signaling pathway;extracellular space;protein binding;integral to membrane;cytokine activity;cell surface;positive regulation of DNA replication@NA
A2463_05@52810@52813@deletion@4@178882005@178911662@4@chr4:178882005-178911662@5.56@170@95@0.559@NA@RP11-389E17.1_3, RP11-389E17.1_4, RP11-389E17.1_5, RP11-389E17.1_6@0@0@0@NA@NA@NA
A2463_05@53308@53310@deletion@3@748520@755214@5@chr5:748520-755214@11.3@78@12@0.154@CNVR2280.3@ZDHHC11B_5, ZDHHC11B_4, ZDHHC11B_3@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
A2463_05@55037@55053@deletion@17@52351815@52376451@5@chr5:52351815-52376451@12.1@3595@2476@0.689@NA@ITGA2_9, ITGA2_10, ITGA2_11, ITGA2_12, ITGA2_13, ITGA2_14, ITGA2_15, ITGA2_16, ITGA2_17, ITGA2_18, ITGA2_19, ITGA2_20, ITGA2_21, ITGA2_22, ITGA2_23, ITGA2_24, ITGA2_25@0@0@0@:integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)@:basal part of cell;integrin complex;cell-matrix adhesion;external side of plasma membrane;axon guidance;protein binding;blood coagulation;collagen binding;cell adhesion;integrin-mediated signaling pathway;plasma membrane;organ morphogenesis;cell surface;virus-host interaction@NA
A2463_05@57336@57344@deletion@9@109940811@110003053@5@chr5:109940811-110003053@9.7@1247@805@0.646@NA@TMEM232_10, TMEM232_9, TMEM232_8, TMEM232_7, TMEM232_6, TMEM232_5, TMEM232_4, TMEM232_3, TMEM232_2@0@0@0@:transmembrane protein 232@:integral to membrane@NA
A2463_05@59454@59464@deletion@11@147449887@147480144@5@chr5:147449887-147480144@9.87@1983@1313@0.662@NA@SPINK5_3, SPINK5_4, SPINK5_5, SPINK5_6, SPINK5_7, SPINK5_8, SPINK5_9, SPINK5_10, SPINK5_11, SPINK5_12, SPINK5_13@0@0@0@:serine peptidase inhibitor, Kazal type 5@:negative regulation of immune response;negative regulation of angiogenesis;serine-type endopeptidase inhibitor activity;cell cortex;peptidase inhibitor activity;negative regulation of peptidase activity;epidermal cell differentiation;endoplasmic reticulum membrane;epithelial cell differentiation;negative regulation of proteolysis;regulation of T cell differentiation;endoplasmic reticulum;extracellular matrix organization;regulation of cell adhesion;cytoplasm;perinuclear region of cytoplasm;cytosol;protein binding;epidermal lamellar body;extracellular region;anagen;hair cell differentiation@: NETHERTON SYNDROME; NETH
A2463_05@59488@59490@deletion@3@147553798@147582717@5@chr5:147553798-147582717@7.1@192@114@0.594@NA@SPINK14_3, SPINK14_4, SPINK6_1@0@0@0@:serine peptidase inhibitor, Kazal type 14 (putative):serine peptidase inhibitor, Kazal type 6@:serine-type endopeptidase inhibitor activity;protein binding;extracellular region:serine-type endopeptidase inhibitor activity;protein binding;extracellular region@NA
A2463_05@61260@61273@deletion@14@177156025@177171968@5@chr5:177156025-177171968@20.4@556@335@0.603@NA@FAM153A_17, FAM153A_16, FAM153A_15, FAM153A_14, FAM153A_13, FAM153A_12, FAM153A_11, FAM153A_10, FAM153A_9, FAM153A_8, FAM153A_7, FAM153A_6, FAM153A_5, FAM153A_4@0@0@0@:family with sequence similarity 153, member A@NA@NA
A2463_05@63290@63292@duplication@3@31323945@31324935@6@chr6:31323945-31324935@5.43@368@557@1.51@CNVR2841.12, CNVR2841.14, CNVR2841.8@HLA-B_3, HLA-B_2, HLA-B_1@0@0@0@:major histocompatibility complex, class I, B@:MHC class I protein complex;regulation of immune response;regulation of interleukin-12 production;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;regulation of T cell anergy;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;receptor binding;early endosome membrane;virus-host interaction;regulation of interleukin-6 production;regulation of dendritic cell differentiation;phagocytic vesicle membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;MHC class I receptor activity;membrane@: SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO; SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1; SPDA1
A2463_05@63725@63748@duplication@24@31962023@31974881@6@chr6:31962023-31974881@41.6@1355@2970@2.19@CNVR2843.6, CNVR2843.3@C4A_20, C4A_21, C4A_22, C4A_23, C4A_24, C4A_25, C4A_26, C4A_27, C4A_28, C4A_29, C4A_30, C4A_31, C4A_32, C4A_33, C4A_34, C4A_35, C4A_36, C4A_37, C4A_38, C4A_39, C4A_40, C4A_41, AL645922.1_2, AL645922.1_1@0@0@0@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
A2463_05@63772@63778@duplication@7@31995846@31997825@6@chr6:31995846-31997825@16.4@771@1274@1.65@CNVR2843.6, CNVR2843.5@C4B_24, C4B_25, C4B_26, C4B_27, C4B_28, C4B_29, C4B_30@0@0@0@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
A2463_05@63798@63800@duplication@3@32008446@32009227@6@chr6:32008446-32009227@5.78@437@673@1.54@CNVR2843.6, CNVR2843.5@CYP21A2_9, CYP21A2_10, TNXB_13@0@0@0@:cytochrome P450, family 21, subfamily A, polypeptide 2:tenascin-X-like;tenascin XB@:oxidation-reduction process;electron carrier activity;response to antibiotic;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;steroid 21-monooxygenase activity;C21-steroid hormone biosynthetic process;heme binding;mineralocorticoid biosynthetic process;progesterone metabolic process;monooxygenase activity;cellular response to peptide hormone stimulus;iron ion binding:integrin binding;extracellular matrix;cell-cell adhesion;elastic fiber assembly;collagen fibril organization;fibrillar collagen;actin cytoskeleton organization;extracellular space;heparin binding;proteinaceous extracellular matrix;fatty acid metabolic process;regulation of JUN kinase activity;receptor binding;intracellular;cell-matrix adhesion;extracellular matrix organization;lipid metabolic process;protein binding;signal transduction;extracellular region;collagen binding;cell adhesion;triglyceride metabolic process;fibril organization;collagen metabolic process@: ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY: EHLERS-DANLOS-LIKE SYNDROME DUE TO TENASCIN-X DEFICIENCY; EHLERS-DANLOS SYNDROME, TYPE III
A2463_05@63809@63812@duplication@4@32011527@32012996@6@chr6:32011527-32012996@6.94@483@803@1.66@CNVR2843.6, CNVR2843.5@TNXB_4, TNXB_3, TNXB_2, TNXB_1@0@0@0@:tenascin-X-like;tenascin XB@:integrin binding;extracellular matrix;cell-cell adhesion;elastic fiber assembly;collagen fibril organization;fibrillar collagen;actin cytoskeleton organization;extracellular space;heparin binding;proteinaceous extracellular matrix;fatty acid metabolic process;regulation of JUN kinase activity;receptor binding;intracellular;cell-matrix adhesion;extracellular matrix organization;lipid metabolic process;protein binding;signal transduction;extracellular region;collagen binding;cell adhesion;triglyceride metabolic process;fibril organization;collagen metabolic process@: EHLERS-DANLOS-LIKE SYNDROME DUE TO TENASCIN-X DEFICIENCY; EHLERS-DANLOS SYNDROME, TYPE III
A2463_05@63953@63957@deletion@5@32485517@32489951@6@chr6:32485517-32489951@13.9@185@68@0.368@CNVR2845.21, CNVR2845.25, CNVR2845.30@HLA-DRB5_6, HLA-DRB5_5, HLA-DRB5_4, HLA-DRB5_3, HLA-DRB5_2@0@0@0@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
A2463_05@64314@64326@duplication@13@33638449@33648231@6@chr6:33638449-33648231@9.42@688@944@1.37@NA@ITPR3_20, ITPR3_21, ITPR3_22, ITPR3_23, ITPR3_24, ITPR3_25, ITPR3_26, ITPR3_27, ITPR3_28, ITPR3_29, ITPR3_30, ITPR3_31, ITPR3_32@0@0@0@:inositol 1,4,5-trisphosphate receptor, type 3@:neuronal cell body;nucleoplasm;fibroblast growth factor receptor signaling pathway;binding;energy reserve metabolic process;sensory perception of sweet taste;transmembrane transport;nucleus;plasma membrane;endoplasmic reticulum membrane;platelet dense tubular network membrane;inositol 1,3,4,5 tetrakisphosphate binding;ion channel activity;sensory perception of bitter taste;inositol hexakisphosphate binding;platelet activation;response to calcium ion;endoplasmic reticulum;activation of phospholipase C activity;calcium channel activity;regulation of insulin secretion;epidermal growth factor receptor signaling pathway;nucleolus;calcium ion transmembrane transport;nerve growth factor receptor signaling pathway;elevation of cytosolic calcium ion concentration;inositol 1,4,5 trisphosphate binding;membrane;nuclear outer membrane;intracellular ligand-gated calcium channel activity;calcium ion transport;apical part of cell;phosphatidylinositol binding;ion transport;sensory perception of umami taste;blood coagulation;protein heterooligomerization;inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity;integral to plasma membrane;small molecule metabolic process;myelin sheath;G-protein coupled receptor signaling pathway;inositol phosphate-mediated signaling;calcium ion transport into cytosol;cytoplasm;brush border;protein binding;signal transduction;protein homooligomerization@NA
A2463_05@66325@66329@deletion@5@54214515@54254723@6@chr6:54214515-54254723@7.98@556@318@0.572@NA@TINAG_7, TINAG_8, TINAG_9, TINAG_10, TINAG_11@0@0@0@:tubulointerstitial nephritis antigen@:cysteine-type peptidase activity;immune response;polysaccharide binding;nucleotide binding;Malpighian tubule morphogenesis;cysteine-type endopeptidase activity;proteolysis;scavenger receptor activity;cell adhesion;basement membrane@NA
A2463_05@66372@66379@deletion@8@55926448@55942371@6@chr6:55926448-55942371@9.45@709@432@0.609@NA@COL21A1_25, COL21A1_24, COL21A1_23, COL21A1_22, COL21A1_21, COL21A1_20, COL21A1_19, COL21A1_18@0@0@0@:collagen, type XXI, alpha 1@:collagen;protein binding;extracellular matrix;extracellular region;extracellular matrix organization;endoplasmic reticulum lumen@NA
A2463_05@68840@68856@deletion@17@123542633@123637640@6@chr6:123542633-123637640@16.2@1707@1089@0.638@NA@TRDN_40, TRDN_39, TRDN_38, TRDN_37, TRDN_36, TRDN_35, TRDN_34, TRDN_33, TRDN_32, TRDN_31, TRDN_30, TRDN_29, TRDN_28, TRDN_27, TRDN_26, TRDN_25, TRDN_24@0@0@0@:triadin@:protein binding, bridging;junctional sarcoplasmic reticulum membrane;cytoplasm;release of sequestered calcium ion into cytosol by sarcoplasmic reticulum;integral to membrane;sarcoplasmic reticulum;ion channel binding;voltage-gated calcium channel complex;heart contraction;plasma membrane;negative regulation of ryanodine-sensitive calcium-release channel activity;sarcoplasmic reticulum lumen;membrane;muscle contraction;receptor binding@NA
A2463_05@70816@70817@deletion@2@161054786@161056336@6@chr6:161054786-161056336@10.6@207@69@0.333@CNVR3133.1@LPA_9, LPA_8@0@0@0@:lipoprotein, Lp(a)@:blood circulation;endopeptidase inhibitor activity;catalytic activity;lipoprotein metabolic process;proteolysis;heparin binding;receptor-mediated endocytosis;fibronectin binding;small molecule metabolic process;apolipoprotein binding;lipid metabolic process;negative regulation of endopeptidase activity;extracellular region;plasma lipoprotein particle;lipid transport;serine-type endopeptidase activity@: APOLIPOPROTEIN(a); LPA
A2463_05@71010@71015@duplication@6@167587242@167595404@6@chr6:167587242-167595404@6.09@463@653@1.41@NA@TCP10L2_3, TCP10L2_4, TCP10L2_5, TCP10L2_6, TCP10L2_7, TCP10L2_8@0@0@0@:t-complex 10;t-complex 10-like 2@NA@NA
A2463_05@71028@71032@deletion@5@167787840@167794824@6@chr6:167787840-167794824@11.5@225@117@0.52@NA@TCP10_7, TCP10_6, TCP10_5, TCP10_4, TCP10_3@0@0@0@:t-complex 10@:cytosol@NA
A2463_05@71752@71776@duplication@25@5952475@6006747@7@chr7:5952475-6006747@24.2@1051@1636@1.56@NA@CCZ1_10, CCZ1_11, CCZ1_12, CCZ1_13, CCZ1_14, CCZ1_15, RSPH10B_20, RSPH10B_19, RSPH10B_18, RSPH10B_17, RSPH10B_16, RSPH10B_15, RSPH10B_14, RSPH10B_13, RSPH10B_12, RSPH10B_11, RSPH10B_10, RSPH10B_9, RSPH10B_8, RSPH10B_7, RSPH10B_6, RSPH10B_5, RSPH10B_4, RSPH10B_3, RSPH10B_2@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae):radial spoke head 10 homolog B (Chlamydomonas)@:lysosomal membrane@NA
A2463_05@71922@71944@deletion@23@6797310@6844686@7@chr7:6797310-6844686@74.2@863@254@0.294@NA@RSPH10B2_2, RSPH10B2_3, RSPH10B2_4, RSPH10B2_5, RSPH10B2_6, RSPH10B2_7, RSPH10B2_8, RSPH10B2_9, RSPH10B2_10, RSPH10B2_11, RSPH10B2_12, RSPH10B2_13, RSPH10B2_14, RSPH10B2_15, RSPH10B2_16, RSPH10B2_17, RSPH10B2_18, RSPH10B2_19, RSPH10B2_20, CCZ1B_15, CCZ1B_14, CCZ1B_13, CCZ1B_12@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
A2463_05@74663@74664@deletion@2@75054919@75055735@7@chr7:75054919-75055735@7.46@90@35@0.389@NA@POM121C_9, POM121C_8@0@0@0@:POM121 transmembrane nucleoporin C@:nuclear membrane;protein binding;protein transport;endoplasmic reticulum membrane;nuclear pore;mRNA transport@NA
A2463_05@74985@74996@deletion@12@81591211@81603868@7@chr7:81591211-81603868@8.97@1808@1223@0.676@NA@CACNA2D1_36, CACNA2D1_35, CACNA2D1_34, CACNA2D1_33, CACNA2D1_32, CACNA2D1_31, CACNA2D1_30, CACNA2D1_29, CACNA2D1_28, CACNA2D1_27, CACNA2D1_26, CACNA2D1_25@0@0@0@:calcium channel, voltage-dependent, alpha 2/delta subunit 1@:voltage-gated calcium channel activity;regulation of calcium ion transport;calcium ion transport;T-tubule;protein binding;sarcoplasmic reticulum;voltage-gated calcium channel complex;metal ion binding@NA
A2463_05@75081@75088@deletion@8@84636119@84670058@7@chr7:84636119-84670058@7.15@743@472@0.635@NA@SEMA3D_16, SEMA3D_15, SEMA3D_14, SEMA3D_13, SEMA3D_12, SEMA3D_11, SEMA3D_10, SEMA3D_9@0@0@0@:sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3D@:multicellular organismal development;cell differentiation;protein binding;extracellular region;receptor activity;membrane;nervous system development@NA
A2463_05@75556@75561@deletion@6@93098028@93125243@7@chr7:93098028-93125243@7.3@515@311@0.604@NA@CALCR_8, CALCR_7, CALCR_6, CALCR_5, CALCR_4, CALCR_3@0@0@0@:calcitonin receptor@:neuronal cell body;transmembrane signaling receptor activity;adenylate cyclase-activating G-protein coupled receptor signaling pathway;negative regulation of ossification;G-protein coupled receptor activity;calcitonin receptor activity;regulation of mRNA stability;osteoclast differentiation;neuron projection;integral to membrane;protein transport;adenylate cyclase-modulating G-protein coupled receptor signaling pathway;plasma membrane;receptor activity;integral to plasma membrane;positive regulation of cAMP biosynthetic process;microtubule-based flagellum part;cell surface receptor signaling pathway;acrosomal vesicle;axon;calcitonin binding;G-protein coupled receptor signaling pathway;receptor internalization;protein transporter activity;response to glucocorticoid stimulus;protein localization to plasma membrane;protein binding;elevation of cytosolic calcium ion concentration;membrane;positive regulation of adenylate cyclase activity@NA
A2463_05@76427@76434@duplication@8@100331793@100345264@7@chr7:100331793-100345264@12.7@393@642@1.63@CNVR3509.1@ZAN_1, ZAN_2, ZAN_3, ZAN_4, ZAN_5, ZAN_6, ZAN_7, ZAN_8@0@0@0@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
A2463_05@76792@76793@deletion@2@102309363@102312048@7@chr7:102309363-102312048@11@56@1@0.0179@CNVR3518.1@POLR2J2_2, POLR2J2_2, POLR2J2_1, POLR2J2_1@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
A2463_05@79309@79310@deletion@2@143880598@143885476@7@chr7:143880598-143885476@7.61@579@291@0.503@CNVR3598.4, CNVR3598.3@CTAGE4_1, ARHGEF35_2@0@0@0@:CTAGE family, member 4:Rho guanine nucleotide exchange factor (GEF) 35@:integral to membrane;nucleotide binding;cellular_component;biological_process@NA
A2463_05@79322@79322@deletion@1@144069777@144069850@7@chr7:144069777-144069850@4.65@69@22@0.319@CNVR3598.4, CNVR3598.5, CNVR3598.11@ARHGEF5_9@0@0@0@:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
A2463_05@80566@80573@duplication@8@12041116@12051579@8@chr8:12041116-12051579@8.76@414@625@1.51@CNVR3785.5, CNVR3785.3@FAM86B1_8, FAM86B1_7, FAM86B1_6, FAM86B1_5, FAM86B1_4, FAM86B1_3, FAM86B1_2, FAM86B1_1@0@0@0@:family with sequence similarity 86, member B2;family with sequence similarity 86, member B1@NA@NA
A2463_05@83673@83673@duplication@1@86573700@86575726@8@chr8:86573700-86575726@5.33@384@851@2.22@CNVR3955.1@REXO1L1_1@0@0@0@:exonuclease GOR-like;REX1, RNA exonuclease 1 homolog (S. cerevisiae)-like 1@:intracellular;nucleus;exonuclease activity;nucleic acid binding;cytoplasm@NA
A2463_05@86561@86571@duplication@11@145731232@145736547@8@chr8:145731232-145736547@8.42@976@1313@1.35@NA@GPT_6, GPT_7, GPT_8, GPT_9, GPT_10, GPT_11, MFSD3_1, MFSD3_2, MFSD3_3, MFSD3_4, MFSD3_5@0@0@0@:glutamic-pyruvate transaminase (alanine aminotransferase):major facilitator superfamily domain containing 3@:cellular amino acid biosynthetic process;L-alanine catabolic process;nitrogen compound metabolic process;small molecule metabolic process;pyridoxal phosphate binding;L-alanine:2-oxoglutarate aminotransferase activity;cytoplasm;cytosol;gluconeogenesis;biosynthetic process;cellular nitrogen compound metabolic process:integral to membrane;transmembrane transport@NA
A2463_05@86628@86630@deletion@3@34922@35519@9@chr9:34922-35519@10.4@96@22@0.229@CNVR4134.1@FAM138C_3, FAM138C_2, FAM138C_1@0@0@0@NA@NA@NA
A2463_05@87429@87440@deletion@12@20819796@20912953@9@chr9:20819796-20912953@9.69@1145@752@0.657@NA@FOCAD_14, FOCAD_15, FOCAD_16, FOCAD_17, FOCAD_18, FOCAD_19, FOCAD_20, FOCAD_21, FOCAD_22, FOCAD_23, FOCAD_24, FOCAD_25@0@0@0@:focadhesin@:protein binding;integral to membrane;binding;focal adhesion@NA
A2463_05@88521@88521@deletion@1@39887323@39891057@9@chr9:39887323-39891057@6.25@243@90@0.37@NA@SPATA31A2_4@0@0@0@:SPATA31 subfamily A, member 2@:integral to membrane@NA
A2463_05@88676@88690@deletion@15@69382094@69424176@9@chr9:69382094-69424176@25.4@1078@627@0.582@NA@ANKRD20A4_1, ANKRD20A4_2, ANKRD20A4_3, ANKRD20A4_4, ANKRD20A4_5, ANKRD20A4_6, ANKRD20A4_7, ANKRD20A4_8, ANKRD20A4_9, ANKRD20A4_10, ANKRD20A4_11, ANKRD20A4_12, ANKRD20A4_13, ANKRD20A4_14, ANKRD20A4_15@0@0@0@:ankyrin repeat domain 20 family, member A4@:protein binding@NA
A2463_05@92880@92883@duplication@4@133768816@133787275@9@chr9:133768816-133787275@6.3@232@355@1.53@NA@QRFP_1, FIBCD1_7, FIBCD1_6, FIBCD1_5@0@0@0@:pyroglutamylated RFamide peptide:fibrinogen C domain containing 1@:regulation of feeding behavior;neuropeptide signaling pathway;locomotory behavior;positive regulation of blood pressure;neuropeptide hormone activity;extracellular region;cellular_component;grooming behavior;orexigenic neuropeptide QRFP receptor binding:chitin binding;extracellular space;signal transduction;integral to membrane;membrane;metal ion binding;receptor binding@NA
A2463_05@93793@93817@duplication@25@139393352@139411837@9@chr9:139393352-139411837@12.8@2758@3560@1.29@NA@NOTCH1_33, NOTCH1_32, NOTCH1_31, NOTCH1_30, NOTCH1_29, NOTCH1_28, NOTCH1_27, NOTCH1_26, NOTCH1_25, NOTCH1_24, NOTCH1_23, NOTCH1_22, NOTCH1_21, NOTCH1_20, NOTCH1_19, NOTCH1_18, NOTCH1_17, NOTCH1_16, NOTCH1_15, NOTCH1_14, NOTCH1_13, NOTCH1_12, NOTCH1_11, NOTCH1_10, NOTCH1_9@0@0@0@:notch 1@:nucleoplasm;mesenchymal cell development;cell differentiation;sequence-specific DNA binding;regulation of epithelial cell proliferation;negative regulation of pro-B cell differentiation;response to muramyl dipeptide;negative regulation of transcription, DNA-dependent;coronary vein morphogenesis;tissue regeneration;collecting duct development;response to lipopolysaccharide;growth involved in heart morphogenesis;positive regulation of JAK-STAT cascade;cardiac right atrium morphogenesis;positive regulation of epithelial cell proliferation;enzyme binding;chromatin binding;negative regulation of glial cell proliferation;humoral immune response;membrane;prostate gland epithelium morphogenesis;positive regulation of cardiac muscle cell proliferation;negative regulation of ossification;neuron fate commitment;Golgi membrane;spermatogenesis;integral to membrane;cardiac left ventricle morphogenesis;negative regulation of neuron differentiation;Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation;receptor activity;negative regulation of anoikis;positive regulation of transcription from RNA polymerase II promoter;astrocyte differentiation;regulation of cell migration;vasculogenesis involved in coronary vascular morphogenesis;core promoter binding;somatic stem cell division;regulation of cardioblast proliferation;cytoplasm;neural tube development;positive regulation of astrocyte differentiation;regulation of extracellular matrix assembly;positive regulation of apoptotic process;negative regulation of apoptotic process;cell fate specification;immune response;liver development;epithelial to mesenchymal transition involved in endocardial cushion formation;axonogenesis;positive regulation of transcription from RNA polymerase II promoter in response to hypoxia;cardiac muscle tissue morphogenesis;endoplasmic reticulum membrane;hair follicle morphogenesis;keratinocyte differentiation;enzyme inhibitor activity;cardiac atrium morphogenesis;atrioventricular node development;negative regulation of cell differentiation;MAML1-RBP-Jkappa- ICN1 complex;cardiac vascular smooth muscle cell development;Notch receptor processing;negative regulation of photoreceptor cell differentiation;auditory receptor cell fate commitment;atrioventricular valve morphogenesis;negative regulation of BMP signaling pathway;negative regulation of canonical Wnt receptor signaling pathway;sequence-specific DNA binding transcription factor activity;positive regulation of keratinocyte differentiation;positive regulation of cell migration;interleukin-4 secretion;regulation of neurogenesis;regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation;ventricular trabecula myocardium morphogenesis;branching morphogenesis of a tube;foregut morphogenesis;cell fate commitment;heart trabecula morphogenesis;negative regulation of cell death;acrosomal vesicle;regulation of gene expression;transcription initiation from RNA polymerase II promoter;negative regulation of calcium ion-dependent exocytosis;negative regulation of neurogenesis;cardiac septum morphogenesis;endocardial cushion morphogenesis;negative regulation of myoblast differentiation;regulation of transcription from RNA polymerase II promoter;protein binding;regulation of somitogenesis;pericardium morphogenesis;glial cell differentiation;cell surface;arterial endothelial cell differentiation;left/right axis specification;aortic valve morphogenesis;pulmonary valve morphogenesis;cardiac right ventricle formation;secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development;negative regulation of cell-substrate adhesion;nucleus;positive regulation of neuroblast proliferation;sprouting angiogenesis;endocardium morphogenesis;in utero embryonic development;glomerular mesangial cell development;positive regulation of transcription, DNA-dependent;mitral valve formation;ventricular septum morphogenesis;oligodendrocyte differentiation;inflammatory response to antigenic stimulus;endoderm development;embryonic limb morphogenesis;neuronal stem cell maintenance;cardiac ventricle morphogenesis;lung development;epithelial to mesenchymal transition;cellular response to follicle-stimulating hormone stimulus;cell migration involved in endocardial cushion formation;determination of left/right symmetry;negative regulation of osteoblast differentiation;RNA polymerase II transcription factor binding transcription factor activity involved in positive regulation of transcription;regulation of transcription, DNA-dependent;compartment pattern specification;Notch signaling pathway;extracellular region;negative regulation of transcription from RNA polymerase II promoter;positive regulation of endothelial cell differentiation;embryonic hindlimb morphogenesis;chromatin DNA binding;venous endothelial cell differentiation;neuron differentiation;cardiac chamber formation;forebrain development;plasma membrane;endocardium development;negative regulation of catalytic activity;gene expression;positive regulation of transcription of Notch receptor target;cardiac muscle cell proliferation;endocardial cell differentiation;response to corticosteroid stimulus;distal tubule development;negative regulation of oligodendrocyte differentiation;organ regeneration;cell differentiation in spinal cord;anagen;heart development;negative regulation of myotube differentiation;calcium ion binding;Notch signaling involved in heart development;epidermis development;positive regulation of BMP signaling pathway;positive regulation of epithelial to mesenchymal transition;coronary artery morphogenesis;positive regulation of cell proliferation;multicellular organismal development;negative regulation of stem cell differentiation;cardiac epithelial to mesenchymal transition;regulation of epithelial cell proliferation involved in prostate gland development;regulation of developmental process;heart looping@: AORTIC VALVE DISEASE 1; AOVD1
A2463_05@94034@94047@duplication@14@139913631@139927683@9@chr9:139913631-139927683@9.77@798@1085@1.36@NA@ABCA2_11, ABCA2_10, ABCA2_9, ABCA2_8, ABCA2_7, ABCA2_6, ABCA2_5, ABCA2_4, ABCA2_3, ABCA2_2, ABCA2_1, FUT7_2, FUT7_1, C9orf139_2@0@0@0@:ATP-binding cassette, sub-family A (ABC1), member 2:chromosome 9 open reading frame 139:fucosyltransferase 7 (alpha (1,3) fucosyltransferase)@:ATPase activity, coupled to transmembrane movement of substances;transport;ATP-binding cassette (ABC) transporter complex;response to drug;ATP binding;microtubule organizing center;cholesterol homeostasis;integral to membrane;ATPase activity;ATP catabolic process;lysosome;endosome;nucleoside-triphosphatase activity;regulation of transcription from RNA polymerase II promoter;lysosomal membrane;regulation of intracellular cholesterol transport;nucleotide binding;lipid metabolic process;response to steroid hormone stimulus;cytoplasmic membrane-bounded vesicle:CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation;fucosylation;Golgi apparatus;leukocyte migration involved in immune response;Golgi cisterna membrane;alpha-(1->3)-fucosyltransferase activity;protein glycosylation;integral to membrane;fucosyltransferase activity;L-fucose catabolic process;membrane@NA
A2463_05@95367@95393@deletion@27@17921734@18152611@10@chr10:17921734-18152611@23.4@258@129@0.5@NA@MRC1L1_19, MRC1L1_20, MRC1L1_21, MRC1L1_22, MRC1L1_23, MRC1L1_24, MRC1L1_25, MRC1L1_26, MRC1L1_27, MRC1L1_28, MRC1L1_29, MRC1L1_30, TMEM236_1, TMEM236_2, TMEM236_3, TMEM236_4, MRC1_1, MRC1_2, MRC1_3, MRC1_4, MRC1_5, MRC1_6, MRC1_7, MRC1_8, MRC1_9, MRC1_10, MRC1_11@0@0@0@:macrophage mannose receptor 1-like:transmembrane protein 236;transmembrane protein 236-like:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding:integral to membrane:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
A2463_05@96466@96470@deletion@5@46584433@46611811@10@chr10:46584433-46611811@7.7@39@2@0.0513@CNVR4712.3@PTPN20A_6, PTPN20A_5, PTPN20A_4, PTPN20A_3, PTPN20A_2@0@0@0@:protein tyrosine phosphatase, non-receptor type 20B;protein tyrosine phosphatase, non-receptor type 20A@:phosphatase activity;protein tyrosine phosphatase activity;microtubule;nucleus;dephosphorylation;protein dephosphorylation;microtubule organizing center@NA
A2463_05@96564@96566@deletion@3@48001785@48007183@10@chr10:48001785-48007183@6.35@234@132@0.564@CNVR4715.2@ASAH2C_18, ASAH2C_17, ASAH2C_16@0@0@0@@:ceramidase activity;sphingolipid metabolic process@NA
A2463_05@96620@96624@deletion@5@48771316@48798739@10@chr10:48771316-48798739@10.9@114@39@0.342@CNVR4716.10, CNVR4716.3@PTPN20B_6, PTPN20B_5, PTPN20B_4, PTPN20B_3, PTPN20B_2@0@0@0@:protein tyrosine phosphatase, non-receptor type 20B;protein tyrosine phosphatase, non-receptor type 20A@:phosphatase activity;protein tyrosine phosphatase activity;microtubule;nucleus;dephosphorylation;protein dephosphorylation;microtubule organizing center@NA
A2463_05@96631@96634@duplication@4@49376639@49382998@10@chr10:49376639-49382998@10.3@87@221@2.54@CNVR4717.2@FRMPD2_27, FRMPD2_26, FRMPD2_25, FRMPD2_24@0@0@0@:FERM and PDZ domain containing 2@:basolateral plasma membrane;transferase activity, transferring phosphorus-containing groups;cytoplasm;tight junction;protein binding;cytoskeleton;1-phosphatidylinositol binding;tight junction assembly@NA
A2463_05@96932@96937@deletion@6@51965743@51978390@10@chr10:51965743-51978390@13.7@103@26@0.252@NA@ASAH2_12, ASAH2_11, ASAH2_10, ASAH2_9, ASAH2_8, ASAH2_7@0@0@0@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
A2463_05@98344@98350@deletion@7@81463367@81472241@10@chr10:81463367-81472241@17.1@665@382@0.574@CNVR4815.2, CNVR4815.4@FAM22B_1, FAM22B_2, FAM22B_3, FAM22B_4, FAM22B_5, FAM22B_6, FAM22B_7@0@0@0@NA@NA@NA
A2463_05@98355@98356@deletion@2@81608270@81609243@10@chr10:81608270-81609243@6.57@38@4@0.105@NA@FAM22E_5, FAM22E_6@0@0@0@NA@NA@NA
A2463_05@98680@98688@deletion@9@90512275@90534920@10@chr10:90512275-90534920@9.28@975@613@0.629@NA@LIPK_9, LIPN_1, LIPN_2, LIPN_3, LIPN_4, LIPN_5, LIPN_6, LIPN_7, LIPN_8@0@0@0@:lipase, family member K:lipase, family member N@:hydrolase activity, acting on ester bonds;extracellular region;lipid catabolic process;lipid metabolic process:hydrolase activity, acting on ester bonds;extracellular region;lipid catabolic process;lipid metabolic process@: ICHTHYOSIS, LAMELLAR, 4; LI4
A2463_05@101621@101622@deletion@2@124360508@124361636@10@chr10:124360508-124361636@9.9@78@16@0.205@CNVR4912.1@DMBT1_28, DMBT1_29@0@0@0@:deleted in malignant brain tumors 1@:defense response to virus;calcium-dependent protein binding;pattern recognition receptor signaling pathway;blastocyst development;response to estrogen stimulus;tissue regeneration;proteinaceous extracellular matrix;protein transport;Gram-negative bacterial cell surface binding;positive regulation of epithelial cell differentiation;virus-host interaction;epithelial cell differentiation;induction of bacterial agglutination;phagocytic vesicle membrane;intracellular;Gram-positive bacterial cell surface binding;zymogen binding;innate immune response;cytoplasm;extrinsic to membrane;protein binding;zymogen granule membrane;extracellular region;scavenger receptor activity;pattern recognition receptor activity;inner cell mass cell proliferation;membrane@: GLIOMA SUSCEPTIBILITY 1; GLM1
A2463_05@102404@102420@duplication@17@308194@375956@11@chr11:308194-375956@13.7@913@1271@1.39@NA@IFITM2_1, IFITM2_2, IFITM1_1, IFITM1_2, IFITM3_2, IFITM3_1, B4GALNT4_1, B4GALNT4_2, B4GALNT4_3, B4GALNT4_4, B4GALNT4_5, B4GALNT4_6, B4GALNT4_7, B4GALNT4_8, B4GALNT4_9, B4GALNT4_10, B4GALNT4_11@0@0@0@:interferon induced transmembrane protein 2:interferon induced transmembrane protein 1:interferon induced transmembrane protein 3:beta-1,4-N-acetyl-galactosaminyl transferase 4@:defense response to virus;response to interferon-alpha;negative regulation of viral genome replication;immune response;response to virus;response to biotic stimulus;negative regulation of viral entry into host cell;type I interferon-mediated signaling pathway;integral to membrane;response to interferon-gamma;plasma membrane;cytokine-mediated signaling pathway;response to interferon-beta:defense response to virus;response to interferon-alpha;negative regulation of cell proliferation;regulation of immune response;negative regulation of viral entry into host cell;negative regulation of cell migration;integral to membrane;plasma membrane;cytokine-mediated signaling pathway;ossification;cell surface receptor signaling pathway;negative regulation of viral genome replication;response to virus;response to biotic stimulus;type I interferon-mediated signaling pathway;protein binding;response to interferon-gamma;positive regulation of osteoblast differentiation;receptor signaling protein activity;response to interferon-beta:defense response to virus;response to interferon-alpha;negative regulation of viral genome replication;immune response;response to virus;negative regulation of viral transcription;response to biotic stimulus;late endosome membrane;negative regulation of viral entry into host cell;type I interferon-mediated signaling pathway;lysosomal membrane;integral to membrane;response to interferon-gamma;plasma membrane;cytokine-mediated signaling pathway;response to interferon-beta:transferase activity, transferring hexosyl groups;Golgi cisterna membrane;integral to membrane;acetylgalactosaminyltransferase activity;N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity@: INFLUENZA, SEVERE, SUSCEPTIBILITY TO
A2463_05@103289@103290@deletion@2@5270599@5271034@11@chr11:5270599-5271034@7.55@66@11@0.167@NA@HBG1_2, HBG1_1@0@0@0@:hemoglobin, gamma A@:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex@NA
A2463_05@104714@104719@deletion@6@22239793@22261230@11@chr11:22239793-22261230@6.85@1087@702@0.646@NA@ANO5_4, ANO5_5, ANO5_6, ANO5_7, ANO5_8, ANO5_9@0@0@0@:anoctamin 5@:chloride channel activity;chloride channel complex;endoplasmic reticulum membrane@: MIYOSHI MUSCULAR DYSTROPHY 3; MMD3; MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2L; LGMD2L; GNATHODIAPHYSEAL DYSPLASIA; GDD
A2463_05@106046@106048@deletion@3@55370918@55419315@11@chr11:55370918-55419315@8.01@614@336@0.547@CNVR5179.1@OR4C11_1, OR4P4_1, OR4S2_1@0@0@0@:olfactory receptor, family 4, subfamily C, member 11:olfactory receptor, family 4, subfamily P, member 4:olfactory receptor, family 4, subfamily S, member 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_05@106571@106578@duplication@8@60971038@60978907@11@chr11:60971038-60978907@8.91@147@274@1.86@CNVR5194.1@PGA3_1, PGA3_2, PGA3_3, PGA3_4, PGA3_5, PGA3_6, PGA3_7, PGA3_8@0@0@0@:pepsinogen 3, group I (pepsinogen A)@:proteolysis;extracellular region;digestion;aspartic-type endopeptidase activity@NA
A2463_05@108761@108793@duplication@33@68178905@68370960@11@chr11:68178905-68370960@52.3@2970@4469@1.5@NA@LRP5_11, LRP5_12, LRP5_13, LRP5_14, LRP5_15, LRP5_16, LRP5_17, LRP5_18, LRP5_19, LRP5_20, LRP5_21, LRP5_22, LRP5_23, PPP6R3_3, PPP6R3_4, PPP6R3_5, PPP6R3_6, PPP6R3_7, PPP6R3_8, PPP6R3_9, PPP6R3_10, PPP6R3_11, PPP6R3_12, PPP6R3_13, PPP6R3_14, PPP6R3_15, PPP6R3_16, PPP6R3_17, PPP6R3_18, PPP6R3_19, PPP6R3_20, PPP6R3_21, PPP6R3_22@0@0@0@:low density lipoprotein receptor-related protein 5:protein phosphatase 6, regulatory subunit 3@:retinal blood vessel morphogenesis;positive regulation of mitosis;bone marrow development;bone remodeling;Wnt-protein binding;plasma membrane;positive regulation of mesenchymal cell proliferation;Wnt receptor signaling pathway;Wnt-activated receptor activity;endoplasmic reticulum;receptor complex;embryonic retina morphogenesis in camera-type eye;regulation of canonical Wnt receptor signaling pathway;bone morphogenesis;gastrulation with mouth forming second;coreceptor activity;canonical Wnt receptor signaling pathway;positive regulation of transcription, DNA-dependent;embryonic limb morphogenesis;positive regulation of fat cell differentiation;negative regulation of protein serine/threonine kinase activity;cholesterol homeostasis;anterior/posterior pattern specification;integral to membrane;positive regulation of cell proliferation;embryonic camera-type eye morphogenesis;Wnt receptor signaling pathway involved in dorsal/ventral axis specification;adipose tissue development;glucose catabolic process;retina morphogenesis in camera-type eye;positive regulation of transcription from RNA polymerase II promoter;negative regulation of osteoblast differentiation;endocytosis;branching involved in mammary gland duct morphogenesis;osteoblast development;regulation of insulin secretion involved in cellular response to glucose stimulus;protein binding;regulation of blood pressure:protein phosphatase binding;protein binding;binding;nucleus;regulation of phosphoprotein phosphatase activity;cytoplasm@: OSTEOPOROSIS; HYPEROSTOSIS CORTICALIS GENERALISATA, BENIGN FORM OF WORTH, WITH TORUS; BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 1; BMND1; OSTEOPETROSIS, AUTOSOMAL DOMINANT 1; OPTA1; VAN BUCHEM DISEASE, TYPE 2; EXUDATIVE VITREORETINOPATHY 4; EVR4; OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME; OPPG
A2463_05@110686@110693@deletion@8@103090645@103107268@11@chr11:103090645-103107268@6.85@991@665@0.671@NA@DYNC2H1_56, DYNC2H1_57, DYNC2H1_58, DYNC2H1_59, DYNC2H1_60, DYNC2H1_61, DYNC2H1_62, DYNC2H1_63@0@0@0@:dynein, cytoplasmic 2, heavy chain 1@:microtubule motor activity;apical part of cell;protein processing;ATP binding;motor activity;forebrain development;ATPase activity;plasma membrane;cilium assembly;determination of left/right symmetry;cilium axoneme;antigen processing and presentation of exogenous peptide antigen via MHC class II;nucleoside-triphosphatase activity;dorsal/ventral pattern formation;Golgi apparatus;nucleotide binding;cytosol;dynein complex;microtubule-based movement;asymmetric protein localization;cilium morphogenesis;Golgi organization;microtubule;embryonic limb morphogenesis;motile primary cilium@: ASPHYXIATING THORACIC DYSTROPHY 3; ATD3; SHORT RIB-POLYDACTYLY SYNDROME, TYPE III
A2463_05@114424@114430@deletion@7@10583717@10599261@12@chr12:10583717-10599261@16.7@826@450@0.545@CNVR5430.1@KLRC2_6, KLRC2_5, KLRC2_4, KLRC2_3, NKG2-E_3, KLRC2_2, NKG2-E_2, KLRC2_1, NKG2-E_1, KLRC1_8@0@0@0@:killer cell lectin-like receptor subfamily C, member 2:killer cell lectin-like receptor subfamily C, member 1@:carbohydrate binding:transmembrane signaling receptor activity;carbohydrate binding;protein binding;signal transduction;cellular defense response;integral to plasma membrane:transmembrane signaling receptor activity;carbohydrate binding;regulation of immune response;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway@NA
A2463_05@114931@114939@deletion@9@21172183@21207570@12@chr12:21172183-21207570@10.8@1034@629@0.608@NA@SLCO1B7_2, SLCO1B7_3, SLCO1B7_4, SLCO1B7_5, SLCO1B7_6, SLCO1B7_7, SLCO1B7_8, SLCO1B7_9, SLCO1B7_10, RP11-125O5.2_1@0@0@0@:solute carrier organic anion transporter family, member 1B3:solute carrier organic anion transporter family, member 1B7 (non-functional)@:bile acid and bile salt transport;transport;basolateral plasma membrane;small molecule metabolic process;transporter activity;organic anion transport;cytoplasm;bile acid metabolic process;transmembrane transport;organic anion transmembrane transporter activity;sodium-independent organic anion transport;integral to membrane;plasma membrane;integral to plasma membrane;membrane:transport;integral to membrane;transporter activity;membrane;transmembrane transport:transport;integral to membrane;transmembrane transporter activity;transporter activity;plasma membrane;membrane;transmembrane transport:transport;transporter activity;membrane@: HYPERBILIRUBINEMIA, ROTOR TYPE; HBLRR
A2463_05@116120@116131@deletion@12@47168833@47186854@12@chr12:47168833-47186854@8.66@1014@676@0.667@NA@SLC38A4_13, SLC38A4_12, SLC38A4_11, SLC38A4_10, SLC38A4_9, SLC38A4_8, SLC38A4_7, SLC38A4_6, SLC38A4_5, SLC38A4_4, SLC38A4_3, SLC38A4_2@0@0@0@:solute carrier family 38, member 4@:amino acid transmembrane transporter activity;ion transport;transmembrane transport;amino acid transport;integral to membrane;sodium ion transport;plasma membrane;symporter activity;amino acid transmembrane transport@NA
A2463_05@119636@119650@deletion@15@78542623@78593311@12@chr12:78542623-78593311@10.7@1494@996@0.667@NA@NAV3_22, NAV3_23, NAV3_24, NAV3_25, NAV3_26, NAV3_27, NAV3_28, NAV3_29, NAV3_30, NAV3_31, NAV3_32, NAV3_33, NAV3_34, NAV3_35, NAV3_36@0@0@0@:neuron navigator 3@:protein binding;nuclear envelope;nucleoside-triphosphatase activity;nucleus;nucleotide binding;ATP binding;nuclear outer membrane@NA
A2463_05@119781@119786@deletion@6@80998839@81014155@12@chr12:80998839-81014155@8.33@911@577@0.633@NA@PTPRQ_32, PTPRQ_33, PTPRQ_34, PTPRQ_35, PTPRQ_36, PTPRQ_37@0@0@0@:protein tyrosine phosphatase, receptor type, Q@:phosphatase activity;protein binding;integral to membrane;regulation of fat cell differentiation;protein tyrosine phosphatase activity;inner ear morphogenesis;dephosphorylation;protein dephosphorylation@: DEAFNESS, AUTOSOMAL RECESSIVE 84; DFNB84
A2463_05@127333@127337@deletion@5@19553418@19563541@14@chr14:19553418-19563541@13.4@835@460@0.551@CNVR6072.1@POTEG_1, POTEG_2, POTEG_3, POTEG_4, POTEG_5@0@0@0@:POTE ankyrin domain family, member G@:protein binding@NA
A2463_05@131032@131034@duplication@3@74004127@74010359@14@chr14:74004127-74010359@10.9@375@707@1.89@CNVR6188.1, CNVR6188.4@ACOT1_1, ACOT1_2, ACOT1_3@0@0@0@:HEAT repeat containing 4:acyl-CoA thioesterase 1@:protein binding;binding:hydrolase activity;mitochondrion;acyl-CoA metabolic process;very long-chain fatty acid metabolic process;thiolester hydrolase activity;acyl-CoA hydrolase activity;cytosol;palmitoyl-CoA hydrolase activity;long-chain fatty acid metabolic process;carboxylesterase activity@NA
A2463_05@133349@133356@duplication@8@106090814@106111127@14@chr14:106090814-106111127@10.7@948@1418@1.5@CNVR6294.46, CNVR6294.20, CNVR6294.54, CNVR6294.43, CNVR6294.50@IGHG4_4, IGHG4_3, IGHG4_2, IGHG4_1, IGHG2_4, IGHG2_3, IGHG2_2, IGHG2_1@0@0@0@@:antigen binding;protein binding;complement activation;extracellular region;immune response;membrane;complement activation, classical pathway;innate immune response:antigen binding;protein binding;complement activation;extracellular region;immune response;membrane;complement activation, classical pathway;innate immune response@NA
A2463_05@133432@133457@deletion@26@106539080@106780945@14@chr14:106539080-106780945@84.5@2383@1127@0.473@CNVR6294.48, CNVR6294.24, CNVR6294.40@IGHV1-8_2, IGHV1-8_1, IGHV3-9_2, IGHV3-9_1, IGHV3-11_2, IGHV3-11_1, IGHV3-13_2, IGHV3-13_1, IGHV3-15_2, IGHV3-15_1, IGHV3-16_2, IGHV3-16_1, IGHV1-18_2, IGHV1-18_1, IGHV3-20_2, IGHV3-20_1, IGHV3-21_2, IGHV3-21_1, IGHV3-23_2, IGHV3-23_1, IGHV1-24_2, IGHV1-24_1, IGHV2-26_2, IGHV2-26_1, IGHV4-28_2, IGHV4-28_1@0@0@0@:uncharacterized LOC100653243;uncharacterized LOC642131@:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding@NA
A2463_05@133460@133463@duplication@4@106805210@106816173@14@chr14:106805210-106816173@6.59@189@342@1.81@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.41@IGHV4-31_2, IGHV4-31_1, IGHV3-33_2, IGHV3-33_1@0@0@0@@:protein binding:protein binding@NA
A2463_05@133491@133492@deletion@2@107095127@107095561@14@chr14:107095127-107095561@10.4@94@19@0.202@CNVR6294.56, CNVR6294.16, CNVR6294.91@IGHV4-61_2, IGHV4-61_1@0@0@0@@:protein binding@NA
A2463_05@133509@133516@duplication@8@20739498@20747023@15@chr15:20739498-20747023@9.22@464@727@1.57@CNVR6296.13@GOLGA6L6_8, GOLGA6L6_7, GOLGA6L6_6, GOLGA6L6_5, GOLGA6L6_4, GOLGA6L6_3, GOLGA6L6_2, GOLGA6L6_1@0@0@0@:putative transmembrane protein FLJ36131-like;putative transmembrane protein ENSP00000320207-like;golgin A6 family-like 6@NA@NA
A2463_05@133659@133661@deletion@3@23609491@23610021@15@chr15:23609491-23610021@11.2@265@118@0.445@NA@GOLGA8S_16, GOLGA8S_17, GOLGA8S_18@0@0@0@@:Golgi apparatus@NA
A2463_05@133826@133826@duplication@1@28467175@28467361@15@chr15:28467175-28467361@4.73@54@145@2.69@CNVR6328.1@HERC2_36@0@0@0@:putative HERC2-like protein 3-like;HECT and RLD domain containing E3 ubiquitin protein ligase 2@:mitochondrial inner membrane;protein ubiquitination involved in ubiquitin-dependent protein catabolic process;guanyl-nucleotide exchange factor activity;SUMO binding;DNA repair;intracellular protein transport;spermatogenesis;cellular protein modification process;nucleus;ubiquitin protein ligase binding;ubiquitin-protein ligase activity;centriole;intracellular;response to DNA damage stimulus;heme binding;cytoplasm;protein binding;zinc ion binding;protein ubiquitination;metal ion binding@: SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1; SHEP1
A2463_05@133869@133870@duplication@2@28629294@28629596@15@chr15:28629294-28629596@11.1@33@201@6.09@CNVR6329.4@GOLGA8F_9, GOLGA8F_10@0@0@0@@:Golgi apparatus@NA
A2463_05@134035@134054@duplication@20@30844282@30896376@15@chr15:30844282-30896376@28.3@450@857@1.9@CNVR6339.2, CNVR6339.3, CNVR6339.1@GOLGA8Q_1, GOLGA8Q_2, GOLGA8Q_3, GOLGA8Q_4, GOLGA8Q_5, GOLGA8Q_6, GOLGA8Q_7, GOLGA8Q_8, GOLGA8Q_9, GOLGA8Q_10, GOLGA8Q_11, GOLGA8Q_12, GOLGA8Q_13, GOLGA8Q_14, GOLGA8Q_15, GOLGA8Q_16, GOLGA8Q_17, GOLGA8Q_18, GOLGA8Q_19, GOLGA8H_1@0@0@0@:golgin A8 family, member H@:Golgi apparatus:Golgi apparatus@NA
A2463_05@134162@134181@deletion@20@32686347@32738099@15@chr15:32686347-32738099@47.5@612@243@0.397@CNVR6346.1@GOLGA8K_15, GOLGA8K_14, GOLGA8K_13, GOLGA8K_12, GOLGA8K_11, GOLGA8K_10, GOLGA8K_9, GOLGA8K_8, GOLGA8K_7, GOLGA8K_6, GOLGA8K_5, GOLGA8K_4, GOLGA8K_3, GOLGA8K_2, AC139426.2_1, GOLGA8K_1, GOLGA8O_19, GOLGA8O_18, GOLGA8O_17, GOLGA8O_16@0@0@0@:golgin A8 family, member J:golgin A8 family, member O@:Golgi apparatus:Golgi apparatus@NA
A2463_05@134189@134191@duplication@3@32743115@32743539@15@chr15:32743115-32743539@5.27@80@148@1.85@CNVR6346.1@GOLGA8O_8, GOLGA8O_7, GOLGA8O_6@0@0@0@:golgin A8 family, member O@:Golgi apparatus@NA
A2463_05@138281@138282@deletion@2@72953606@72953907@15@chr15:72953606-72953907@5.26@146@67@0.459@CNVR6443.1@GOLGA6B_8, GOLGA6B_9@0@0@0@:golgin A6 family, member B@:Golgi apparatus@NA
A2463_05@139295@139308@duplication@14@82933940@83015609@15@chr15:82933940-83015609@13.2@159@370@2.33@CNVR6477.6, CNVR6477.2, CNVR6477.3@RP13-996F3.5_7, RP13-996F3.5_6, RP13-996F3.5_5, RP13-996F3.5_4, RP13-996F3.5_3, RP13-996F3.5_2, RP13-996F3.5_1, RP13-996F3.4_9, RP13-996F3.4_8, RP13-996F3.4_7, RP13-996F3.4_6, RP13-996F3.4_5, RP13-996F3.4_4, RP13-996F3.4_3@0@0@0@NA@NA@NA
A2463_05@140476@140485@deletion@10@64382@68789@16@chr16:64382-68789@32.4@418@129@0.309@CNVR6565.1@WASH4P_10, WASH4P_9, WASH4P_8, WASH4P_7, WASH4P_6, WASH4P_5, WASH4P_4, WASH4P_3, WASH4P_2, WASH4P_1@0@0@0@@:intracellular membrane-bounded organelle;endosomal transport;recycling endosome;early endosome;Arp2/3 complex-mediated actin nucleation;actin binding;alpha-tubulin binding;retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;recycling endosome membrane@NA
A2463_05@140818@140825@duplication@8@778317@781702@16@chr16:778317-781702@8.42@405@586@1.45@NA@HAGHL_4, HAGHL_5, HAGHL_6, HAGHL_7, HAGHL_8, NARFL_11, NARFL_10, NARFL_9@0@0@0@:mesothelin:hydroxyacylglutathione hydrolase-like:nuclear prelamin A recognition factor-like@:pancreas development;Golgi apparatus;protein binding;extracellular space;cell adhesion;plasma membrane;membrane;cell surface;anchored to membrane:hydrolase activity;hydroxyacylglutathione hydrolase activity;zinc ion binding;glutathione biosynthetic process:oxygen homeostasis;4 iron, 4 sulfur cluster binding;iron-sulfur cluster assembly;response to hypoxia;regulation of transcription, DNA-dependent;metal ion binding;CIA complex@NA
A2463_05@143477@143488@deletion@12@21742159@21849065@16@chr16:21742159-21849065@31.4@684@323@0.472@CNVR6668.5, CNVR6668.2, CNVR6668.7@OTOA_20, OTOA_21, OTOA_22, OTOA_23, OTOA_24, OTOA_25, OTOA_26, OTOA_27, OTOA_28, NPIPL3_9, NPIPL3_8, NPIPL3_7@0@0@0@:otoancorin:nuclear pore complex interacting protein-like 3;nuclear pore complex interacting protein-like;nuclear pore complex-interacting protein-like 3-like@:proteinaceous extracellular matrix;apical plasma membrane;sensory perception of sound;anchored to membrane@: DEAFNESS, AUTOSOMAL RECESSIVE 22; DFNB22
A2463_05@147122@147127@duplication@6@70182368@70211383@16@chr16:70182368-70211383@10.4@549@818@1.49@CNVR6764.1@PDPR_17, PDPR_18, PDPR_19, CLEC18C_1, CLEC18C_2, CLEC18C_3@0@0@0@:pyruvate dehydrogenase phosphatase regulatory subunit:C-type lectin domain family 18, member C@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix:carbohydrate binding;protein binding;extracellular region@NA
A2463_05@147513@147514@deletion@2@74451958@74454490@16@chr16:74451958-74454490@9.8@78@8@0.103@CNVR6778.2, CNVR6778.3@CLEC18B_3, CLEC18B_2@0@0@0@:C-type lectin domain family 18, member B@:carbohydrate binding;protein binding;extracellular region@NA
A2463_05@152122@152130@duplication@9@20353287@20361697@17@chr17:20353287-20361697@14.1@258@455@1.76@CNVR7021.1, CNVR7021.3@LGALS9B_11, LGALS9B_10, LGALS9B_9, LGALS9B_8, LGALS9B_7, LGALS9B_6, LGALS9B_5, LGALS9B_4, LGALS9B_3@0@0@0@:lectin, galactoside-binding, soluble, 9B@:carbohydrate binding@NA
A2463_05@153363@153372@duplication@10@34493376@34500284@17@chr17:34493376-34500284@10.2@309@502@1.62@CNVR7077.1, CNVR7077.3, CNVR7077.11, CNVR7077.16@TBC1D3B_14, TBC1D3B_13, TBC1D3B_12, TBC1D3B_11, TBC1D3B_10, TBC1D3B_9, TBC1D3B_8, TBC1D3B_7, TBC1D3B_6, TBC1D3B_5@0@0@0@:TBC1 domain family, member 3B@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_05@153414@153414@deletion@1@34797487@34798054@17@chr17:34797487-34798054@11.1@63@0@0@CNVR7078.2, CNVR7078.3@TBC1D3G_14@0@0@0@:TBC1 domain family member 3H-like;TBC1 domain family, member 3H:TBC1 domain family, member 3;TBC1 domain family, member 3G;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like;TBC1 domain family, member 3H@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_05@154346@154346@deletion@1@39421631@39422112@17@chr17:39421631-39422112@5.78@73@19@0.26@CNVR7096.1@KRTAP9-6_1@0@0@0@:keratin associated protein 9-6@:keratin filament@NA
A2463_05@154365@154371@duplication@7@39534312@39538624@17@chr17:39534312-39538624@11@592@898@1.52@CNVR7098.1@KRT34_7, KRT34_6, KRT34_5, KRT34_4, KRT34_3, KRT34_2, KRT34_1@0@0@0@:keratin 34;keratin, type I cuticular Ha4-like@:intermediate filament;structural molecule activity;epidermis development@NA
A2463_05@155593@155600@duplication@8@44414663@44594799@17@chr17:44414663-44594799@24.2@350@1071@3.06@CNVR7114.2, CNVR7114.1@LRRC37A_12, LRRC37A_13, LRRC37A_14, ARL17B_4, ARL17B_3, ARL17B_2, LRRC37A2_2, LRRC37A2_3@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
A2463_05@155610@155612@deletion@3@44632519@44632945@17@chr17:44632519-44632945@11.7@296@111@0.375@CNVR7114.2, CNVR7114.5, CNVR7114.4@LRRC37A2_13, LRRC37A2_14, LRRC37A2_15@0@0@0@:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
A2463_05@159566@159574@duplication@9@79093737@79102349@17@chr17:79093737-79102349@7.31@649@872@1.34@CNVR7226.8@AATK_12, AATK_11, AATK_10, AATK_9, AATK_8, AATK_7, AATK_6, AATK_5, AATK_4@0@0@0@:apoptosis-associated tyrosine kinase@:mitochondrion;protein serine/threonine kinase activity;protein autophosphorylation;protein tyrosine kinase activity;protein phosphorylation;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;perinuclear region of cytoplasm;protein binding;integral to membrane;apoptotic process@NA
A2463_05@162017@162018@deletion@2@44542732@44550298@18@chr18:44542732-44550298@50.7@483@3@0.00621@CNVR7319.1, CNVR7319.2@TCEB3CL2_1, TCEB3CL_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2:transcription elongation factor B polypeptide 3C-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_05@162711@162719@deletion@9@61310396@61328450@18@chr18:61310396-61328450@7.56@714@462@0.647@NA@SERPINB4_3, SERPINB4_2, SERPINB3_8, SERPINB3_7, SERPINB3_6, SERPINB3_5, SERPINB3_4, SERPINB3_3, SERPINB3_2@0@0@0@:serpin peptidase inhibitor, clade B (ovalbumin), member 4:serpin peptidase inhibitor, clade B (ovalbumin), member 11 (gene/pseudogene):serpin peptidase inhibitor, clade B (ovalbumin), member 3@:serine-type endopeptidase inhibitor activity;negative regulation of endopeptidase activity;extracellular region;immune response;cytoplasm;regulation of proteolysis:serine-type endopeptidase inhibitor activity;negative regulation of endopeptidase activity;cytoplasm;regulation of proteolysis:serine-type endopeptidase inhibitor activity;negative regulation of endopeptidase activity;extracellular region;cytoplasm;regulation of proteolysis@NA
A2463_05@164950@164956@deletion@7@7030624@7056914@19@chr19:7030624-7056914@8.45@352@212@0.602@CNVR7517.1@MBD3L5_1, MBD3L5_2, MBD3L4_2, MBD3L4_1, MBD3L2_1, MBD3L2_2, MBD3L3_2@0@0@0@:methyl-CpG binding domain protein 3-like 5:methyl-CpG binding domain protein 3-like 4:methyl-CpG-binding domain protein 3-like 2-like;methyl-CpG binding domain protein 3-like 2:methyl-CpG binding domain protein 3-like 3@:regulation of transcription, DNA-dependent;transcription, DNA-dependent:regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_05@167243@167244@duplication@2@15784341@15789215@19@chr19:15784341-15789215@9.68@9@108@12@CNVR7553.1@CYP4F12_2, CYP4F12_3@0@0@0@:cytochrome P450, family 4, subfamily F, polypeptide 12@:pressure natriuresis;negative regulation of blood coagulation;oxidation-reduction process;very long-chain fatty acid metabolic process;arachidonic acid metabolic process;aromatase activity;sodium ion homeostasis;renal water homeostasis;arachidonic acid epoxygenase activity;integral to membrane;leukotriene B4 catabolic process;endoplasmic reticulum membrane;epoxygenase P450 pathway;electron carrier activity;intracellular membrane-bounded organelle;drug metabolic process;alkane 1-monooxygenase activity;small molecule metabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;apical plasma membrane;heme binding;vitamin E metabolic process;cytoplasm;vitamin-K-epoxide reductase (warfarin-sensitive) activity;xenobiotic metabolic process;vitamin K biosynthetic process;leukotriene-B4 20-monooxygenase activity;long-chain fatty acid metabolic process;iron ion binding@NA
A2463_05@170098@170100@deletion@3@40376632@40382826@19@chr19:40376632-40382826@23.2@267@86@0.322@CNVR7639.2@FCGBP_24, FCGBP_23, FCGBP_22@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_05@170104@170110@duplication@7@40389653@40400823@19@chr19:40389653-40400823@14@710@1172@1.65@CNVR7639.2, CNVR7639.3@FCGBP_18, FCGBP_17, FCGBP_16, FCGBP_15, FCGBP_14, FCGBP_13, FCGBP_12@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_05@172987@172987@deletion@1@52133087@52133469@19@chr19:52133087-52133469@4.71@31@4@0.129@CNVR7702.1@SIGLEC5_2, SIGLEC5_2@0@0@0@:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 5@:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion@NA
A2463_05@173295@173296@deletion@2@54724399@54725251@19@chr19:54724399-54725251@4.92@77@33@0.429@CNVR7721.3, CNVR7721.4@LILRB3_6, LILRB3_5@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
A2463_05@173336@173341@duplication@6@54801928@54804173@19@chr19:54801928-54804173@9.02@302@475@1.57@CNVR7722.1@LILRA3_6, LILRA3_5, LILRA3_4, LILRA3_3, LILRA3_2, LILRA3_1@0@0@0@:leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3@:antigen binding;signal transduction;protein binding;extracellular region;plasma membrane;receptor activity;defense response@NA
A2463_05@173457@173474@deletion@18@55239078@55290114@19@chr19:55239078-55290114@124@981@176@0.179@CNVR7725.2, CNVR7725.1@KIR3DL3_4, KIR3DL3_5, KIR3DL3_6, KIR3DL3_7, KIR3DL3_8, KIR2DL3_1, KIR2DL3_2, KIR2DL3_3, KIR2DL3_4, KIR2DL3_5, KIR2DL3_6, KIR2DL3_7, KIR2DL3_8, KIR2DL1_1, KIR2DL1_2, KIR2DL1_3, KIR2DL1_4, KIR2DL1_5@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:integral to membrane;plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane@NA
A2463_05@173478@173504@duplication@27@55315108@55363737@19@chr19:55315108-55363737@49.7@1119@1978@1.77@CNVR7725.1, CNVR7725.6@KIR2DL4_1, KIR2DL4_2, KIR2DL4_3, KIR2DL4_4, KIR2DL4_5, KIR2DL4_6, KIR2DL4_7, KIR3DL1_1, KIR3DL1_2, KIR3DL1_3, KIR3DL1_4, KIR3DL1_5, KIR3DL1_6, KIR3DL1_7, KIR3DL1_8, KIR3DL1_9, KIR2DS4_1, KIR2DS4_2, KIR2DS4_3, KIR2DS4_4, KIR2DS4_5, KIR2DS4_6, KIR2DS4_7, KIR2DS4_8, KIR3DL2_1, KIR3DL2_2, KIR3DL2_3@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2-like@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane@NA
A2463_05@180976@180976@duplication@1@16287255@16287885@22@chr22:16287255-16287885@5.39@324@737@2.27@CNVR8071.2, CNVR8071.3, CNVR8071.9@POTEH_1@0@0@0@:POTE ankyrin domain family, member H@:protein binding@NA
A2463_05@181133@181134@deletion@2@18739383@18835833@22@chr22:18739383-18835833@6.4@237@99@0.418@CNVR8087.5, CNVR8087.2, CNVR8087.7@AC008132.1_8, AC008132.13_1@0@0@0@NA@NA@NA
A2463_05@181417@181422@duplication@6@20366369@20461301@22@chr22:20366369-20461301@17.6@1073@2036@1.9@CNVR8094.9, CNVR8094.4, CNVR8094.10@GGTLC3_5, GGTLC3_4, GGTLC3_3, GGTLC3_2, GGTLC3_1, RIMBP3_1@0@0@0@:RIMS binding protein 3@:leukotriene biosynthetic process;glutathione metabolic process;gamma-glutamyltransferase activity;anchored to external side of plasma membrane:protein binding@NA
A2463_05@181487@181489@deletion@3@21065630@21067085@22@chr22:21065630-21067085@7.32@149@80@0.537@CNVR8099.6, CNVR8099.2@PI4KA_51, PI4KA_50, PI4KA_49@0@0@0@:phosphatidylinositol 4-kinase, catalytic, alpha@:phospholipid metabolic process;1-phosphatidylinositol 4-kinase activity;small molecule metabolic process;phosphatidylinositol phosphorylation;binding;transferase activity, transferring phosphorus-containing groups;phosphotransferase activity, alcohol group as acceptor;ATP binding;Golgi-associated vesicle;phosphatidylinositol biosynthetic process;cytosol;protein binding;signal transduction;synaptic transmission;kinase activity;phosphatidylinositol-mediated signaling@NA
A2463_05@181624@181634@duplication@11@21562879@21579843@22@chr22:21562879-21579843@21.9@281@603@2.15@CNVR8100.4, CNVR8100.10, CNVR8100.7@GGT2_14, GGT2_13, GGT2_12, GGT2_11, GGT2_10, GGT2_9, GGT2_8, GGT2_7, GGT2_6, GGT2_5, GGT2_4@0@0@0@:gamma-glutamyltransferase 2;gamma-glutamyltranspeptidase 2-like@:hydrolase activity;small molecule metabolic process;leukotriene biosynthetic process;anchored to external side of plasma membrane;glutathione biosynthetic process;xenobiotic metabolic process;integral to membrane;glutathione metabolic process;plasma membrane;gamma-glutamyltransferase activity;cellular_component@NA
A2463_05@181733@181734@deletion@2@22707290@22707781@22@chr22:22707290-22707781@6.01@82@27@0.329@CNVR8103.20, CNVR8103.5, CNVR8103.2, CNVR8103.12, CNVR8103.10, CNVR8103.9, CNVR8103.22@IGLV5-48_1, IGLV5-48_2@0@0@0@@:protein binding@NA
A2463_05@183631@183631@deletion@1@39357393@39357686@22@chr22:39357393-39357686@7.93@61@7@0.115@CNVR8164.1@APOBEC3A_4@0@0@0@:apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A;APOBEC3A and APOBEC3B deletion hybrid@:cytidine deamination;defense response to virus;negative regulation of viral genome replication;DNA cytosine deamination;clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine;catalytic activity;DNA demethylation;cytoplasm;innate immune response;cytidine deaminase activity;nucleus;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines;cellular response to xenobiotic stimulus;zinc ion binding;negative regulation of transposition@NA
A2463_04@6@7@deletion@2@69092@139309@1@chr1:69092-139309@27.3@611@327@0.535@CNVR1.2@OR4F5_1, AL627309.1_1@0@0@0@:olfactory receptor, family 4, subfamily F, member 5@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_04@438@438@duplication@1@1654148@1654257@1@chr1:1654148-1654257@5.68@100@161@1.61@CNVR17.1@CDK11A_2@0@0@0@:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A@:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division@NA
A2463_04@1820@1824@duplication@5@12954418@12980233@1@chr1:12954418-12980233@10.8@330@479@1.45@CNVR72.3, CNVR72.4, CNVR72.2@PRAMEF10_3, PRAMEF10_2, PRAMEF7_2, PRAMEF7_3, PRAMEF7_4@0@0@0@:PRAME family member 10:PRAME family member 7@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_04@3194@3198@deletion@5@24287949@24301567@1@chr1:24287949-24301567@10.4@48@1@0.0208@NA@PNRC2_3, SRSF10_6, SRSF10_5, SRSF10_4, SRSF10_3@0@0@0@:proline-rich nuclear receptor coactivator 2;proline-rich nuclear receptor coactivator 2-like:serine/arginine-rich splicing factor 10-like;serine/arginine-rich splicing factor 10@:protein binding;deadenylation-independent decapping of nuclear-transcribed mRNA;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;nucleus;regulation of transcription, DNA-dependent;transcription, DNA-dependent;cytoplasmic mRNA processing body:nucleoplasm;RNA splicing, via transesterification reactions;nuclear speck;RS domain binding;RNA binding;nucleus;mRNA splice site selection;unfolded protein binding;assembly of spliceosomal tri-snRNP;negative regulation of mRNA splicing, via spliceosome;regulation of transcription, DNA-dependent;nucleotide binding;cytoplasm;mRNA export from nucleus;protein binding;cytoplasmic transport;mRNA splicing, via spliceosome;nucleic acid binding@NA
A2463_04@5148@5149@deletion@2@39977429@39987242@1@chr1:39977429-39987242@7.5@58@17@0.293@NA@BMP8A_3, BMP8A_4@0@0@0@:bone morphogenetic protein 8a@:cell differentiation;growth factor activity;extracellular space;growth;cytokine activity;cartilage development;ossification@NA
A2463_04@9449@9451@deletion@3@108993225@108996017@1@chr1:108993225-108996017@8.8@41@1@0.0244@CNVR294.4, CNVR294.2@NBPF6_2, NBPF6_3, NBPF6_4@0@0@0@:neuroblastoma breakpoint family, member 6@:cytoplasm@NA
A2463_04@9766@9773@duplication@8@110230497@110235917@1@chr1:110230497-110235917@21.4@232@413@1.78@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_1, GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
A2463_04@10890@10893@deletion@4@145325953@145328432@1@chr1:145325953-145328432@11@51@1@0.0196@CNVR341.2, CNVR341.3@NBPF10_30, NBPF10_31, NBPF10_32, NBPF10_33@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family, member 10@NA@NA
A2463_04@11143@11163@deletion@21@146227744@146252574@1@chr1:146227744-146252574@23@302@145@0.48@NA@NBPF12_22, NBPF12_21, NBPF12_20, NBPF12_19, NBPF12_18, NBPF12_17, NBPF12_16, NBPF12_15, NBPF12_14, NBPF12_13, NBPF12_12, NBPF12_11, NBPF12_10, NBPF12_9, NBPF12_8, NBPF12_7, NBPF12_6, NBPF12_5, NBPF12_4, NBPF12_3, NBPF12_2@0@0@0@:neuroblastoma breakpoint family member 21-like@NA@NA
A2463_04@11169@11173@duplication@5@146400092@146405926@1@chr1:146400092-146405926@15.3@89@206@2.31@NA@NBPF12_9, NBPF12_10, NBPF12_11, NBPF12_12, NBPF12_13@0@0@0@:neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family member 14-like;neuroblastoma breakpoint family, member 12@:cytoplasm@NA
A2463_04@14056@14061@duplication@6@161599569@161641439@1@chr1:161599569-161641439@6.56@263@365@1.39@CNVR383.1@FCGR3B_3, FCGR3B_2, FCGR3B_1, FCGR2B_1, FCGR2B_2, FCGR2B_3@0@0@0@:Fc fragment of IgG, low affinity IIIa, receptor (CD16a):Fc fragment of IgG, low affinity IIb, receptor (CD32):Fc fragment of IgG, low affinity IIIb, receptor (CD16b)@:IgG binding;protein binding;regulation of immune response;extracellular region;integral to membrane;immune response;plasma membrane;external side of plasma membrane:IgG binding;protein binding;signal transduction;regulation of immune response;integral to membrane;immune response;plasma membrane;virus-host interaction:IgG binding;protein binding;extracellular region;immune response;plasma membrane;anchored to membrane@: MALARIA, SUSCEPTIBILITY TO; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
A2463_04@16029@16038@duplication@10@196744018@196797376@1@chr1:196744018-196797376@18@1426@1873@1.31@CNVR459.1@CFHR3_1, CFHR3_2, CFHR3_3, CFHR3_4, CFHR3_5, CFHR3_6, CFHR1_1, CFHR1_2, CFHR1_3, CFHR1_4@0@0@0@:complement factor H-related 3:complement factor H-related 1:complement factor H-related 2@:extracellular space:extracellular space;complement activation:extracellular region@NA
A2463_04@17285@17287@deletion@3@207715528@207719023@1@chr1:207715528-207719023@8.28@37@0@0@CNVR485.1@CR1_13, CR1_14, CR1_15@0@0@0@:complement component (3b/4b) receptor 1 (Knops blood group)@:complement component C4b receptor activity;complement activation, classical pathway;negative regulation of complement activation, alternative pathway;innate immune response;negative regulation of serine-type endopeptidase activity;complement component C3b binding;negative regulation of complement activation, classical pathway;plasma membrane;integral to plasma membrane;complement component C3b receptor activity;complement component C4b binding;cell surface;regulation of complement activation;positive regulation of serine-type endopeptidase activity@: MALARIA, SUSCEPTIBILITY TO; KNOPS BLOOD GROUP SYSTEM; KN
A2463_04@19774@19777@deletion@4@248737103@248802559@1@chr1:248737103-248802559@14@697@454@0.651@CNVR600.1@OR2T34_1, OR2T10_1, OR2T11_1, OR2T35_1@0@0@0@:olfactory receptor, family 2, subfamily T, member 34:olfactory receptor, family 2, subfamily T, member 10:olfactory receptor, family 2, subfamily T, member 11:olfactory receptor, family 2, subfamily T, member 35@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_04@22192@22194@duplication@3@38958878@38972329@2@chr2:38958878-38972329@6.4@169@248@1.47@CNVR759.1@GALM_6, GALM_7, SRSF7_8@0@0@0@:galactose mutarotase (aldose 1-epimerase):serine/arginine-rich splicing factor 7@:isomerase activity;carbohydrate binding;aldose 1-epimerase activity;hexose metabolic process;carbohydrate metabolic process;catalytic activity;cytoplasm:nucleoplasm;negative regulation of mRNA splicing, via spliceosome;mRNA 3'-end processing;termination of RNA polymerase II transcription;nucleotide binding;transcription from RNA polymerase II promoter;protein binding;mRNA export from nucleus;RNA binding;mRNA processing;nucleus;RNA splicing;mRNA splicing, via spliceosome;gene expression;zinc ion binding;nucleic acid binding@NA
A2463_04@25369@25370@deletion@2@97854825@97855027@2@chr2:97854825-97855027@26.3@123@2@0.0163@CNVR886.2, CNVR886.3@ANKRD36_33, ANKRD36_34@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_04@26305@26305@deletion@1@112541475@112541541@2@chr2:112541475-112541541@7.53@70@24@0.343@CNVR928.1@ANAPC1_42@0@0@0@:anaphase-promoting complex subunit 1-like;anaphase promoting complex subunit 1@:nucleoplasm;regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle;anaphase-promoting complex;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle spindle assembly checkpoint;cytosol;protein K11-linked ubiquitination;protein binding;mitosis;nucleus;cell cycle checkpoint;cell division;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle@NA
A2463_04@26310@26310@deletion@1@112551656@112551708@2@chr2:112551656-112551708@6.28@95@46@0.484@CNVR928.1@ANAPC1_37@0@0@0@:anaphase-promoting complex subunit 1-like;anaphase promoting complex subunit 1@:nucleoplasm;regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle;anaphase-promoting complex;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle spindle assembly checkpoint;cytosol;protein K11-linked ubiquitination;protein binding;mitosis;nucleus;cell cycle checkpoint;cell division;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle@NA
A2463_04@26579@26583@deletion@5@114251335@114258060@2@chr2:114251335-114258060@22.8@994@620@0.624@CNVR933.1@CBWD2_12, CBWD2_13, CBWD2_14, CBWD2_15, FOXD4L1_1@0@0@0@:COBW domain containing 2;COBW domain containing 1;COBW domain-containing protein 1-like:forkhead box D4-like 1@:ATP binding:positive regulation of BMP signaling pathway;positive regulation of kidney development;axon extension involved in axon guidance;lateral line nerve glial cell development;DNA binding, bending;sequence-specific DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;regulation of sequence-specific DNA binding transcription factor activity;transcription factor complex;nucleus;dichotomous subdivision of terminal units involved in ureteric bud branching;sympathetic nervous system development;melanocyte differentiation;enteric nervous system development;positive regulation of transcription from RNA polymerase II promoter;regulation of transcription, DNA-dependent;neural crest cell migration;peripheral nervous system development;double-stranded DNA binding;RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity;iridophore differentiation;transcription factor binding;cartilage development;pattern specification process@NA
A2463_04@27163@27163@deletion@1@130843388@130843568@2@chr2:130843388-130843568@6.5@29@0@0@NA@POTEF_13@0@0@0@:POTE ankyrin domain family, member F@:cell cortex;protein binding;ATP binding@NA
A2463_04@27171@27172@deletion@2@130868117@130869674@2@chr2:130868117-130869674@10.2@72@18@0.25@NA@POTEF_5, POTEF_4@0@0@0@:POTE ankyrin domain family, member F@:cell cortex;protein binding;ATP binding@NA
A2463_04@29624@29624@duplication@1@179296825@179296981@2@chr2:179296825-179296981@8.12@249@374@1.5@CNVR1065.1@PRKRA_8@0@0@0@:protein kinase, interferon-inducible double stranded RNA dependent activator@:double-stranded RNA binding;negative regulation of cell proliferation;immune response;pyridoxal phosphate binding;middle ear morphogenesis;production of siRNA involved in RNA interference;induction of apoptosis;protein homodimerization activity;skeletal system morphogenesis;response to virus;positive regulation of catalytic activity;protein phosphorylation;intracellular;response to stress;cytoplasm;perinuclear region of cytoplasm;outer ear morphogenesis;protein binding;enzyme activator activity;kinase activity@: DYSTONIA 16; DYT16
A2463_04@29630@29631@duplication@2@179314970@179315757@2@chr2:179314970-179315757@5.55@211@299@1.42@NA@PRKRA_2, PRKRA_1@0@0@0@:protein kinase, interferon-inducible double stranded RNA dependent activator@:double-stranded RNA binding;negative regulation of cell proliferation;immune response;pyridoxal phosphate binding;middle ear morphogenesis;production of siRNA involved in RNA interference;induction of apoptosis;protein homodimerization activity;skeletal system morphogenesis;response to virus;positive regulation of catalytic activity;protein phosphorylation;intracellular;response to stress;cytoplasm;perinuclear region of cytoplasm;outer ear morphogenesis;protein binding;enzyme activator activity;kinase activity@: DYSTONIA 16; DYT16
A2463_04@33408@33412@duplication@5@233272978@233274158@2@chr2:233272978-233274158@8.08@96@166@1.73@NA@ALPPL2_6, ALPPL2_7, ALPPL2_8, ALPPL2_9, ALPPL2_10@0@0@0@:alkaline phosphatase, placental-like 2@:phosphatase activity;catalytic activity;phosphorylation;plasma membrane;metabolic process;membrane;anchored to membrane;alkaline phosphatase activity;metal ion binding@NA
A2463_04@39892@39894@deletion@3@75786030@75790887@3@chr3:75786030-75790887@40.1@194@3@0.0155@CNVR1432.5, CNVR1432.9, CNVR1432.4@ZNF717_5, ZNF717_4, ZNF717_3@0@0@0@:zinc finger protein 717;zinc finger protein 717-like@:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_04@46667@46676@duplication@10@9174900@9247197@4@chr4:9174900-9247197@111@156@1034@6.63@NA@FAM90A26P_4, FAM90A26P_5, FAM90A26P_6, FAM90A26P_7, USP17L13_1, USP17L10_1, USP17L11_1, USP17L12_1, USP17L13_2, USP17L15_1, USP17L17_1@0@0@0@:ubiquitin specific peptidase 17-like family member 10:ubiquitin specific peptidase 17-like family member 13:ubiquitin specific peptidase 17-like family member 11:ubiquitin specific peptidase 17-like family member 12:ubiquitin specific peptidase 17-like family member 15:ubiquitin specific peptidase 17-like family member 17@:zinc ion binding;nucleic acid binding:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
A2463_04@46693@46693@duplication@1@9388004@9388098@4@chr4:9388004-9388098@10.5@26@100@3.85@CNVR1814.1, CNVR1814.2@RP11-1396O13.13_3@0@0@0@@:intracellular;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_04@48556@48561@deletion@6@69403344@69434202@4@chr4:69403344-69434202@82.9@409@13@0.0318@CNVR1953.1@UGT2B17_6, UGT2B17_5, UGT2B17_4, UGT2B17_3, UGT2B17_2, UGT2B17_1@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B17@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;membrane@: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
A2463_04@52397@52397@duplication@1@165890631@165891154@4@chr4:165890631-165891154@4.76@222@310@1.4@NA@TRIM61_3@0@0@0@:tripartite motif containing 61@:protein binding;intracellular;zinc ion binding@NA
A2463_04@53303@53317@duplication@15@716924@825366@5@chr5:716924-825366@25.9@702@1020@1.45@CNVR2280.3@ZDHHC11B_10, ZDHHC11B_9, ZDHHC11B_8, ZDHHC11B_7, ZDHHC11B_6, ZDHHC11B_5, ZDHHC11B_4, ZDHHC11B_3, ZDHHC11B_2, ZDHHC11B_1, ZDHHC11_12, ZDHHC11_11, ZDHHC11_10, ZDHHC11_9, ZDHHC11_8@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
A2463_04@53320@53320@duplication@1@840611@840765@5@chr5:840611-840765@5.5@109@172@1.58@CNVR2280.3, CNVR2280.8@ZDHHC11_5@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
A2463_04@55785@55788@duplication@4@68863555@68874629@5@chr5:68863555-68874629@10@104@191@1.84@CNVR2494.7, CNVR2494.46@GTF2H2C_6, GTF2H2C_7, GTF2H2C_8, GTF2H2C_9@0@0@0@:general transcription factor IIH, polypeptide 2C;general transcription factor IIH, polypeptide 2D@:regulation of transcription, DNA-dependent;nucleotide-excision repair;DNA repair;core TFIIH complex;protein binding;nucleus;transcription, DNA-dependent;zinc ion binding@NA
A2463_04@55790@55790@deletion@1@68875585@68875691@5@chr5:68875585-68875691@6.51@91@42@0.462@CNVR2494.7, CNVR2494.46@GTF2H2C_11@0@0@0@:general transcription factor IIH, polypeptide 2C;general transcription factor IIH, polypeptide 2D@:regulation of transcription, DNA-dependent;nucleotide-excision repair;DNA repair;core TFIIH complex;protein binding;nucleus;transcription, DNA-dependent;zinc ion binding@NA
A2463_04@60882@60885@duplication@4@175487236@175520277@5@chr5:175487236-175520277@5.89@91@148@1.63@NA@RP11-826N14.2_2, FAM153B_3, FAM153B_4@0@0@0@:uncharacterized LOC100507387;family with sequence similarity 153, member B@NA@NA
A2463_04@61261@61274@duplication@14@177156487@177174794@5@chr5:177156487-177174794@21.3@491@731@1.49@NA@FAM153A_16, FAM153A_15, FAM153A_14, FAM153A_13, FAM153A_12, FAM153A_11, FAM153A_10, FAM153A_9, FAM153A_8, FAM153A_7, FAM153A_6, FAM153A_5, FAM153A_4, FAM153A_3@0@0@0@:family with sequence similarity 153, member A@NA@NA
A2463_04@61640@61641@duplication@2@180376240@180377544@5@chr5:180376240-180377544@5.43@314@428@1.36@CNVR2719.1@BTNL8_7, BTNL8_8@0@0@0@:butyrophilin-like 8@:protein binding;integral to membrane@NA
A2463_04@63747@63748@deletion@2@31973946@31974881@6@chr6:31973946-31974881@6.71@146@82@0.562@CNVR2843.6, CNVR2843.3@AL645922.1_2, AL645922.1_1@0@0@0@NA@NA@NA
A2463_04@63768@63776@deletion@9@31994761@31997115@6@chr6:31994761-31997115@15.4@559@352@0.63@CNVR2843.6, CNVR2843.5@C4B_20, C4B_21, C4B_22, C4B_23, C4B_24, C4B_25, C4B_26, C4B_27, C4B_28@0@0@0@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
A2463_04@63956@63958@duplication@3@32487148@32498001@6@chr6:32487148-32498001@10@205@319@1.56@CNVR2845.21, CNVR2845.25, CNVR2845.30, CNVR2845.43, CNVR2845.6@HLA-DRB5_3, HLA-DRB5_2, HLA-DRB5_1@0@0@0@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
A2463_04@63956@63960@deletion@2@32487148@32548047@6@chr6:32487148-32548047@-13.9@320@336@1.05@CNVR2845.21, CNVR2845.25, CNVR2845.24@HLA-DRB5_3, HLA-DRB5_2, HLA-DRB5_1, HLA-DRB1_6, HLA-DRB1_5@0@0@0@:major histocompatibility complex, class II, DR beta 5:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
A2463_04@63966@63969@deletion@4@32609088@32628026@6@chr6:32609088-32628026@13.2@484@305@0.63@CNVR2845.21, CNVR2845.25, CNVR2845.27, CNVR2845.22, CNVR2845.39, CNVR2845.20@HLA-DQA1_2, HLA-DQA1_3, HLA-DQA1_4, HLA-DQB1_6@0@0@0@:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@NA
A2463_04@71013@71015@duplication@3@167592500@167595404@6@chr6:167592500-167595404@5.08@93@146@1.57@NA@TCP10L2_6, TCP10L2_7, TCP10L2_8@0@0@0@:t-complex 10;t-complex 10-like 2@NA@NA
A2463_04@71028@71032@deletion@5@167787840@167794824@6@chr6:167787840-167794824@16.2@201@93@0.463@NA@TCP10_7, TCP10_6, TCP10_5, TCP10_4, TCP10_3@0@0@0@:t-complex 10@:cytosol@NA
A2463_04@71758@71758@deletion@1@5966000@5966179@7@chr7:5966000-5966179@4.73@47@18@0.383@NA@RSPH10B_20@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
A2463_04@71772@71773@deletion@2@5998625@6000495@7@chr7:5998625-6000495@5.49@32@5@0.156@NA@RSPH10B_6, RSPH10B_5@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
A2463_04@73262@73263@deletion@2@38393317@38393784@7@chr7:38393317-38393784@5.55@87@44@0.506@CNVR3354.3, CNVR3354.1@TRGV4_2, TRGV4_1@0@0@0@@:protein binding@NA
A2463_04@74664@74664@deletion@1@75055645@75055735@7@chr7:75055645-75055735@8.83@40@0@0@NA@POM121C_8@0@0@0@:POM121 transmembrane nucleoporin C@:nuclear membrane;protein binding;protein transport;endoplasmic reticulum membrane;nuclear pore;mRNA transport@NA
A2463_04@74774@74775@duplication@2@76062788@76063472@7@chr7:76062788-76063472@6.08@51@99@1.94@CNVR3462.1@ZP3_4, ZP3_5@0@0@0@:zona pellucida glycoprotein 3 (sperm receptor)@:negative regulation of transcription, DNA-dependent;manganese ion transmembrane transporter activity;intracellular protein transport;proteinaceous extracellular matrix;plasma membrane;positive regulation of acrosome reaction;outer acrosomal membrane;protein kinase C signaling cascade;manganese ion transmembrane transport;intracellular signal transduction;humoral immune response mediated by circulating immunoglobulin;negative regulation of binding of sperm to zona pellucida;positive regulation of inflammatory response;endoplasmic reticulum;signal transducer activity;perinuclear region of cytoplasm;secretory granule;positive regulation of transcription, DNA-dependent;positive regulation of ovarian follicle development;positive regulation of interferon-gamma production;carbohydrate binding;manganese ion transport;positive regulation of antral ovarian follicle growth;extracellular matrix;positive regulation of leukocyte migration;positive regulation of humoral immune response;extracellular space;blastocyst formation;integral to membrane;store-operated calcium channel activity;oocyte development;multivesicular body;phosphatidylinositol-mediated signaling;acrosomal vesicle;positive regulation of protein kinase B signaling cascade;Golgi apparatus;positive regulation of calcium ion import;positive regulation of protein kinase activity;positive regulation of acrosomal vesicle exocytosis;positive regulation of interleukin-4 production;cytoplasm;protein binding;binding of sperm to zona pellucida;positive regulation of phosphatidylinositol biosynthetic process;extracellular region;positive regulation of T cell proliferation;acrosin binding;positive regulation of type IV hypersensitivity;egg coat formation@NA
A2463_04@76427@76432@duplication@6@100331793@100336236@7@chr7:100331793-100336236@12.6@229@358@1.56@CNVR3509.1@ZAN_1, ZAN_2, ZAN_3, ZAN_4, ZAN_5, ZAN_6@0@0@0@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
A2463_04@76726@76733@deletion@8@102133564@102137411@7@chr7:102133564-102137411@8.55@106@48@0.453@CNVR3518.1@RASA4B_16, RASA4B_15, RASA4B_14, RASA4B_13, RASA4B_12, RASA4B_11, RASA4B_10, RASA4B_9@0@0@0@:RAS p21 protein activator 4B@:phospholipid binding;intracellular;GTPase activator activity;cytosol;signal transduction;protein binding;plasma membrane;regulation of small GTPase mediated signal transduction;metal ion binding;intracellular signal transduction@NA
A2463_04@76779@76793@deletion@15@102279571@102312048@7@chr7:102279571-102312048@20.7@192@67@0.349@CNVR3518.1@UPK3BL_4, UPK3BL_4, UPK3BL_3, UPK3BL_3, UPK3BL_2, UPK3BL_2, UPK3BL_1, UPK3BL_1, SPDYE2L_2, SPDYE2L_3, SPDYE2L_4, SPDYE2L_5, SPDYE2L_6, SPDYE2L_7, SPDYE2L_8, POLR2J2_4, POLR2J2_4, POLR2J2_3, POLR2J2_3, POLR2J2_2, POLR2J2_2, POLR2J2_1, POLR2J2_1@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4:uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J2:WBSCR19-like protein 3;speedy homolog E6 (Xenopus laevis)@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity:integral to membrane:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
A2463_04@79315@79318@duplication@4@144059764@144064448@7@chr7:144059764-144064448@12.2@732@1035@1.41@CNVR3598.4, CNVR3598.5, CNVR3598.11@ARHGEF5_2, ARHGEF5_3, ARHGEF5_4, ARHGEF5_5@0@0@0@:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
A2463_04@80564@80567@deletion@4@11970084@12043034@8@chr8:11970084-12043034@49.5@1271@573@0.451@CNVR3785.8, CNVR3785.5, CNVR3785.2, CNVR3785.3@ZNF705D_6, USP17L2_1, FAM86B1_8, FAM86B1_7@0@0@0@:zinc finger protein 705D:ubiquitin specific peptidase 17-like family member 1, pseudogene;ubiquitin specific peptidase 17-like family member 2;ubiquitin specific peptidase 17-like family member 4;ubiquitin specific peptidase 17-like family member 7;ubiquitin specific peptidase 17-like family member 8;ubiquitin specific peptidase 17-like family member 3:family with sequence similarity 86, member B2;family with sequence similarity 86, member B1@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:protein deubiquitination;ubiquitin-specific protease activity;mitotic cell cycle G1/S transition checkpoint;nucleus;G2/M transition checkpoint;apoptotic process;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
A2463_04@80576@80580@deletion@5@12283399@12287960@8@chr8:12283399-12287960@17.1@169@65@0.385@CNVR3786.4, CNVR3786.16@FAM86B2_8, FAM86B2_7, FAM86B2_6, FAM86B2_5, FAM86B2_4@0@0@0@:family with sequence similarity 86, member B2@NA@NA
A2463_04@80738@80738@deletion@1@17581182@17581342@8@chr8:17581182-17581342@5.07@80@40@0.5@CNVR3804.1@MTUS1_4@0@0@0@:microtubule associated tumor suppressor 1@:oxidation-reduction process;mitochondrion;Golgi apparatus;microtubule organizing center;oxidoreductase activity;cellular response to peptide hormone stimulus;nucleus;plasma membrane;microtubule;transition metal ion binding;spindle@: HEPATOCELLULAR CARCINOMA
A2463_04@86631@86635@duplication@5@116801@123454@9@chr9:116801-123454@13.9@898@1202@1.34@CNVR4135.1@FOXD4_1, CBWD1_15, CBWD1_14, CBWD1_13, CBWD1_12@0@0@0@:forkhead box D4:COBW domain containing 1;COBW domain-containing protein 1-like;COBW domain containing 5@:positive regulation of BMP signaling pathway;positive regulation of kidney development;axon extension involved in axon guidance;lateral line nerve glial cell development;DNA binding, bending;sequence-specific DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;regulation of sequence-specific DNA binding transcription factor activity;transcription factor complex;nucleus;dichotomous subdivision of terminal units involved in ureteric bud branching;sympathetic nervous system development;melanocyte differentiation;enteric nervous system development;positive regulation of transcription from RNA polymerase II promoter;multicellular organismal development;regulation of transcription, DNA-dependent;neural crest cell migration;peripheral nervous system development;double-stranded DNA binding;RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity;iridophore differentiation;transcription factor binding;cartilage development;pattern specification process:ATP binding@NA
A2463_04@86646@86646@duplication@1@178817@178969@9@chr9:178817-178969@4.61@62@106@1.71@CNVR4135.1@CBWD1_1@0@0@0@:COBW domain containing 1;COBW domain-containing protein 1-like;COBW domain containing 5@:ATP binding@NA
A2463_04@88529@88529@deletion@1@40715850@40716325@9@chr9:40715850-40716325@6.33@319@203@0.636@NA@FAM74A3_1@0@0@0@NA@NA@NA
A2463_04@88534@88536@deletion@3@41306194@41324995@9@chr9:41306194-41324995@15.2@85@11@0.129@CNVR4278.2@FAM74A2_2, FAM74A2_1, SPATA31A4_4@0@0@0@:SPATA31 subfamily A, member 4@:integral to membrane:integral to membrane@NA
A2463_04@88584@88594@duplication@11@43624656@43818184@9@chr9:43624656-43818184@66.8@1945@3194@1.64@CNVR4294.1@SPATA31A6_4, SPATA31A6_3, SPATA31A6_2, SPATA31A6_1, CNTNAP3B_1, CNTNAP3B_2, CNTNAP3B_3, CNTNAP3B_4, CNTNAP3B_5, CNTNAP3B_6, CNTNAP3B_7@0@0@0@:SPATA31 subfamily A, member 6:contactin associated protein-like 3B;contactin associated protein-like 3@:integral to membrane:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
A2463_04@88596@88596@deletion@1@43828079@43828221@9@chr9:43828079-43828221@7.46@51@12@0.235@CNVR4294.1@CNTNAP3B_9@0@0@0@:contactin associated protein-like 3B;contactin associated protein-like 3@:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
A2463_04@88602@88602@duplication@1@43884946@43885072@9@chr9:43884946-43885072@4.72@60@104@1.73@NA@CNTNAP3B_15@0@0@0@:contactin associated protein-like 3B;contactin associated protein-like 3@:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
A2463_04@88610@88610@deletion@1@43915827@43915897@9@chr9:43915827-43915897@6.41@54@17@0.315@NA@CNTNAP3B_23@0@0@0@:contactin associated protein-like 3B;contactin associated protein-like 3@:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
A2463_04@88620@88622@duplication@3@45727245@45733965@9@chr9:45727245-45733965@17.5@140@288@2.06@CNVR4305.1@FAM27A_1, AL953889.1_2, AL953889.1_1, FAM27A_2, FAM27E2_1@0@0@0@NA@NA@NA
A2463_04@88620@88624@deletion@2@45727245@46390900@9@chr9:45727245-46390900@-30.8@180@295@1.64@NA@FAM27A_1, AL953889.1_2, AL953889.1_1, FAM27A_2, FAM27E2_1, FAM27E1_1, FAM27D1_1@0@0@0@:family with sequence similarity 27, member E3:protein FAM27E2-like;protein FAM27D1-like@NA@NA
A2463_04@88631@88633@deletion@3@65503517@65508193@9@chr9:65503517-65508193@29@247@77@0.312@CNVR4312.5@SPATA31A7_4, SPATA31A7_3, SPATA31A7_2@0@0@0@:SPATA31 subfamily A, member 7@:integral to membrane@NA
A2463_04@88639@88641@deletion@3@67926874@67930837@9@chr9:67926874-67930837@8.26@40@2@0.05@NA@ANKRD20A1_1, ANKRD20A1_2, ANKRD20A1_3@0@0@0@:ankyrin repeat domain 20 family, member A1@:protein binding;plasma membrane@NA
A2463_04@95367@95377@deletion@11@17921734@17951363@10@chr10:17921734-17951363@16.7@76@0@0@NA@MRC1L1_19, MRC1L1_20, MRC1L1_21, MRC1L1_22, MRC1L1_23, MRC1L1_24, MRC1L1_25, MRC1L1_26, MRC1L1_27, MRC1L1_28, MRC1L1_29@0@0@0@:macrophage mannose receptor 1-like@:carbohydrate binding@NA
A2463_04@95410@95410@duplication@1@18196464@18196627@10@chr10:18196464-18196627@6.12@18@60@3.33@NA@MRC1_28@0@0@0@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
A2463_04@96455@96455@duplication@1@46321364@46322838@10@chr10:46321364-46322838@7.16@138@222@1.61@NA@AGAP4_7@0@0@0@:ArfGAP with GTPase domain, ankyrin repeat and PH domain 4;arf-GAP with GTPase, ANK repeat and PH domain-containing protein 5-like@:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity@NA
A2463_04@96544@96563@duplication@20@47909171@47948853@10@chr10:47909171-47948853@16.9@488@698@1.43@CNVR4715.2, CNVR4715.1@FAM21B_10, FAM21B_11, FAM21B_12, FAM21B_13, FAM21B_14, FAM21B_15, FAM21B_16, FAM21B_17, FAM21B_18, FAM21B_19, FAM21B_20, FAM21B_21, FAM21B_22, FAM21B_23, FAM21B_24, FAM21B_25, FAM21B_26, FAM21B_27, FAM21B_28, FAM21B_29@0@0@0@:family with sequence similarity 21, member B@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_04@96631@96633@deletion@3@49376639@49381136@10@chr10:49376639-49381136@8.02@56@14@0.25@CNVR4717.2@FRMPD2_27, FRMPD2_26, FRMPD2_25@0@0@0@:FERM and PDZ domain containing 2@:basolateral plasma membrane;transferase activity, transferring phosphorus-containing groups;cytoplasm;tight junction;protein binding;cytoskeleton;1-phosphatidylinositol binding;tight junction assembly@NA
A2463_04@96844@96852@deletion@9@51224991@51374428@10@chr10:51224991-51374428@15.7@284@149@0.525@NA@AGAP8_7, AGAP8_6, AGAP8_5, AGAP8_4, AGAP8_3, AGAP8_2, AGAP8_1, TIMM23B_1, TIMM23B_2@0@0@0@:ArfGAP with GTPase domain, ankyrin repeat and PH domain 8:translocase of inner mitochondrial membrane 23 homolog B (yeast)@:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process@NA
A2463_04@96907@96907@deletion@1@51855360@51855538@10@chr10:51855360-51855538@5.7@26@0@0@NA@FAM21A_15@0@0@0@:family with sequence similarity 21, member B;family with sequence similarity 21, member A@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_04@98346@98350@deletion@5@81468456@81472241@10@chr10:81468456-81472241@7.98@493@335@0.68@CNVR4815.2, CNVR4815.4@FAM22B_3, FAM22B_4, FAM22B_5, FAM22B_6, FAM22B_7@0@0@0@NA@NA@NA
A2463_04@98346@98357@duplication@7@81468456@81610362@10@chr10:81468456-81610362@9.53@597@781@1.31@CNVR4815.2@FAM22B_3, FAM22B_4, FAM22B_5, FAM22B_6, FAM22B_7, FAM22E_1, FAM22E_2, FAM22E_3, FAM22E_4, FAM22E_5, FAM22E_6, FAM22E_7@0@0@0@NA@NA@NA
A2463_04@98599@98601@deletion@3@88992361@88994465@10@chr10:88992361-88994465@13.7@159@67@0.421@CNVR4840.3, CNVR4840.5, CNVR4840.6@FAM22A_5, FAM22A_6, FAM22A_7@0@0@0@:family with sequence similarity 22, member A@NA@NA
A2463_04@101622@101622@deletion@1@124361314@124361636@10@chr10:124361314-124361636@8.81@41@1@0.0244@CNVR4912.1@DMBT1_29@0@0@0@:deleted in malignant brain tumors 1@:defense response to virus;calcium-dependent protein binding;pattern recognition receptor signaling pathway;blastocyst development;response to estrogen stimulus;tissue regeneration;proteinaceous extracellular matrix;protein transport;Gram-negative bacterial cell surface binding;positive regulation of epithelial cell differentiation;virus-host interaction;epithelial cell differentiation;induction of bacterial agglutination;phagocytic vesicle membrane;intracellular;Gram-positive bacterial cell surface binding;zymogen binding;innate immune response;cytoplasm;extrinsic to membrane;protein binding;zymogen granule membrane;extracellular region;scavenger receptor activity;pattern recognition receptor activity;inner cell mass cell proliferation;membrane@: GLIOMA SUSCEPTIBILITY 1; GLM1
A2463_04@103269@103269@deletion@1@4976003@4976943@11@chr11:4976003-4976943@37.5@270@46@0.17@CNVR5040.1@OR51A2_1@0@0@0@:matrix metallopeptidase 26:olfactory receptor, family 51, subfamily A, member 2@:metallopeptidase activity;extracellular matrix;proteolysis;proteinaceous extracellular matrix;collagen catabolic process;metalloendopeptidase activity;zinc ion binding;metabolic process:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_04@103342@103342@deletion@1@5798891@5799864@11@chr11:5798891-5799864@39.6@194@2@0.0103@CNVR5049.1@OR52N5_1@0@0@0@:tripartite motif containing 5:olfactory receptor, family 52, subfamily N, member 5@:defense response to virus;Golgi apparatus;intracellular;protein trimerization;ligase activity;cytoplasm;protein binding;nucleus;protein homodimerization activity;identical protein binding;zinc ion binding;cytoplasmic mRNA processing body;protein ubiquitination;virus-host interaction:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_04@104444@104444@duplication@1@18288436@18288525@11@chr11:18288436-18288525@4.94@62@108@1.74@NA@SAA1_2@0@0@0@:serum amyloid A1@:regulation of protein secretion;platelet activation;neutrophil chemotaxis;negative regulation of inflammatory response;positive regulation of cytokine secretion;macrophage chemotaxis;positive regulation of cell adhesion;positive regulation of interleukin-1 secretion;extracellular region;lymphocyte chemotaxis;high-density lipoprotein particle;elevation of cytosolic calcium ion concentration;acute-phase response;G-protein coupled receptor binding@NA
A2463_04@106038@106041@deletion@4@55032377@55036814@11@chr11:55032377-55036814@33.1@587@287@0.489@CNVR5178.5@TRIM48_2, TRIM48_3, TRIM48_4, TRIM48_5@0@0@0@:tripartite motif containing 48@:protein binding;intracellular;zinc ion binding@NA
A2463_04@114483@114483@duplication@1@11243900@11244828@12@chr12:11243900-11244828@21.5@239@493@2.06@CNVR5434.1@TAS2R43_1@0@0@0@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):taste receptor, type 2, member 14:taste receptor, type 2, member 43@:extracellular space;visual perception:bitter taste receptor activity;taste receptor activity;integral to membrane;sensory perception of taste;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of bitter taste:G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;motile cilium;taste receptor activity;bitter taste receptor activity;integral to membrane;sensory perception of taste;detection of chemical stimulus involved in sensory perception of bitter taste;cilium membrane@NA
A2463_04@124178@124178@deletion@1@24468279@24468340@13@chr13:24468279-24468340@5.58@32@5@0.156@NA@C1QTNF9B_2@0@0@0@:C1q and tumor necrosis factor related protein 9B@:collagen;protein binding@NA
A2463_04@127335@127337@duplication@3@19558992@19563541@14@chr14:19558992-19563541@15.1@171@306@1.79@CNVR6072.1@POTEG_3, POTEG_4, POTEG_5@0@0@0@:POTE ankyrin domain family, member G@:protein binding@NA
A2463_04@127348@127358@duplication@11@20010104@20404761@14@chr14:20010104-20404761@56.3@2409@3430@1.42@CNVR6072.12, CNVR6072.4@POTEM_5, POTEM_4, POTEM_3, POTEM_2, POTEM_1, OR4Q3_1, OR4M1_1, OR4N2_1, OR4K2_1, OR4K5_1, OR4K1_1@0@0@0@:POTE ankyrin domain family, member M:olfactory receptor, family 4, subfamily N, member 2:olfactory receptor, family 4, subfamily Q, member 3:olfactory receptor, family 4, subfamily M, member 1:olfactory receptor, family 4, subfamily K, member 2:olfactory receptor, family 4, subfamily K, member 5:olfactory receptor, family 4, subfamily K, member 1@:protein binding:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_04@133491@133492@duplication@2@107095127@107095561@14@chr14:107095127-107095561@6.91@80@141@1.76@CNVR6294.56, CNVR6294.16, CNVR6294.91@IGHV4-61_2, IGHV4-61_1@0@0@0@@:protein binding@NA
A2463_04@133513@133514@deletion@2@20743733@20743964@15@chr15:20743733-20743964@5.62@59@24@0.407@CNVR6296.13@GOLGA6L6_4, GOLGA6L6_3@0@0@0@:putative transmembrane protein FLJ36131-like;putative transmembrane protein ENSP00000320207-like;golgin A6 family-like 6@NA@NA
A2463_04@133636@133642@duplication@7@23406272@23412276@15@chr15:23406272-23412276@32.6@519@896@1.73@CNVR6300.8@RP11-467N20.5_8, RP11-467N20.5_7, RP11-467N20.5_6, RP11-467N20.5_5, RP11-467N20.5_4, RP11-467N20.5_3, RP11-467N20.5_2@0@0@0@:putative golgin subfamily A member 6-like protein 6-like@NA@NA
A2463_04@133869@133870@deletion@2@28629294@28629596@15@chr15:28629294-28629596@6.74@30@0@0@CNVR6329.4@GOLGA8F_9, GOLGA8F_10@0@0@0@@:Golgi apparatus@NA
A2463_04@133996@134000@deletion@5@30431879@30434261@15@chr15:30431879-30434261@9.7@154@78@0.506@NA@GOLGA8T_8, GOLGA8T_9, GOLGA8T_10, GOLGA8T_11, GOLGA8T_12@0@0@0@:golgin A8 family, member J;golgin A8 family, member K@:Golgi apparatus@NA
A2463_04@134189@134194@duplication@6@32743115@32745013@15@chr15:32743115-32745013@9.73@146@237@1.62@CNVR6346.1@GOLGA8O_8, GOLGA8O_7, GOLGA8O_6, GOLGA8O_5, GOLGA8O_4, GOLGA8O_3@0@0@0@:golgin A8 family, member O@:Golgi apparatus@NA
A2463_04@135048@135061@duplication@14@41857225@41870474@15@chr15:41857225-41870474@12.8@598@808@1.35@NA@TYRO3_6, TYRO3_7, TYRO3_8, TYRO3_9, TYRO3_10, TYRO3_11, TYRO3_12, TYRO3_13, TYRO3_14, TYRO3_15, TYRO3_16, TYRO3_17, TYRO3_18, TYRO3_19@0@0@0@:TYRO3 protein tyrosine kinase@:protein tyrosine kinase activity;platelet aggregation;negative regulation of toll-like receptor signaling pathway;ATP binding;vagina development;substrate adhesion-dependent cell spreading;nucleus;negative regulation of lymphocyte activation;endoplasmic reticulum membrane;phosphatidylinositol 3-kinase cascade;nuclear envelope;platelet activation;protein kinase activity;protein kinase B signaling cascade;neuron homeostasis;negative regulation of neuron apoptotic process;negative regulation of innate immune response;protein autophosphorylation;transmembrane receptor protein tyrosine kinase activity;apoptotic cell clearance;transferase activity, transferring phosphorus-containing groups;spermatogenesis;forebrain cell migration;integral to membrane;integral to plasma membrane;ovulation cycle;natural killer cell differentiation;phosphatidylinositol 3-kinase binding;negative regulation of inflammatory response;protein phosphorylation;receptor signaling protein tyrosine kinase activity;protein heterodimerization activity;secretion by cell;protein binding;signal transduction;cell adhesion;signal transduction by phosphorylation@NA
A2463_04@138416@138416@duplication@1@74364560@74364650@15@chr15:74364560-74364650@6.42@103@171@1.66@CNVR6448.1@GOLGA6A_14@0@0@0@:golgin A6 family, member C;golgin A6 family, member A;golgin A6 family, member D;golgin A6 family, member B@:Golgi apparatus@NA
A2463_04@138421@138422@duplication@2@74368025@74368326@15@chr15:74368025-74368326@5.74@106@167@1.58@CNVR6448.1@GOLGA6A_9, GOLGA6A_8@0@0@0@:golgin A6 family, member C;golgin A6 family, member A;golgin A6 family, member D;golgin A6 family, member B@:Golgi apparatus@NA
A2463_04@139295@139295@duplication@1@82933940@82933999@15@chr15:82933940-82933999@4.92@1@31@31@CNVR6477.6@RP13-996F3.5_7@0@0@0@NA@NA@NA
A2463_04@140476@140483@duplication@8@64382@67750@16@chr16:64382-67750@9.38@299@424@1.42@CNVR6565.1@WASH4P_10, WASH4P_9, WASH4P_8, WASH4P_7, WASH4P_6, WASH4P_5, WASH4P_4, WASH4P_3@0@0@0@@:intracellular membrane-bounded organelle;endosomal transport;recycling endosome;early endosome;Arp2/3 complex-mediated actin nucleation;actin binding;alpha-tubulin binding;retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;recycling endosome membrane@NA
A2463_04@142925@142928@duplication@4@16363979@16367932@16@chr16:16363979-16367932@5.66@115@175@1.52@NA@NOMO3_17, NOMO3_18, NOMO3_19, NOMO3_20@0@0@0@:NODAL modulator 3@:carbohydrate binding;integral to membrane;carboxypeptidase activity@NA
A2463_04@144038@144039@deletion@2@28403074@28403463@16@chr16:28403074-28403463@13.9@63@0@0@CNVR6684.2@EIF3CL_10, EIF3CL_9@0@0@0@:eukaryotic translation initiation factor 3, subunit C-like@:protein binding;eukaryotic translation initiation factor 3 complex;translational initiation;translation initiation factor activity@NA
A2463_04@147420@147421@duplication@2@72092154@72093087@16@chr16:72092154-72093087@7.6@75@142@1.89@CNVR6769.1, CNVR6769.2@HP_5, HP_6@0@0@0@:thioredoxin-like 4B:haptoglobin:haptoglobin-related protein@:mitosis;mRNA processing;RNA splicing;spliceosomal complex;cell redox homeostasis:cellular iron ion homeostasis;negative regulation of oxidoreductase activity;catalytic activity;negative regulation of hydrogen peroxide catabolic process;positive regulation of cell death;haptoglobin-hemoglobin complex;extracellular space;proteolysis;response to hydrogen peroxide;extracellular region;hemoglobin binding;defense response;serine-type endopeptidase activity:spherical high-density lipoprotein particle;proteolysis;extracellular region;hemoglobin binding;catalytic activity;serine-type endopeptidase activity@: ANHAPTOGLOBINEMIA; AHP
A2463_04@147502@147507@duplication@6@74425290@74444932@16@chr16:74425290-74444932@11.3@896@1180@1.32@CNVR6778.2, CNVR6778.3@NPIPL2_7, CLEC18B_13, CLEC18B_12, CLEC18B_11, CLEC18B_10, CLEC18B_9@0@0@0@:C-type lectin domain family 18, member B@:extracellular region:carbohydrate binding;protein binding;extracellular region@NA
A2463_04@147513@147515@duplication@3@74451958@74455168@16@chr16:74451958-74455168@8.92@116@200@1.72@CNVR6778.2, CNVR6778.3@CLEC18B_3, CLEC18B_2, CLEC18B_1@0@0@0@:C-type lectin domain family 18, member B@:carbohydrate binding;protein binding;extracellular region@NA
A2463_04@152122@152129@deletion@8@20353287@20359984@17@chr17:20353287-20359984@16.5@135@44@0.326@CNVR7021.1, CNVR7021.3@LGALS9B_11, LGALS9B_10, LGALS9B_9, LGALS9B_8, LGALS9B_7, LGALS9B_6, LGALS9B_5, LGALS9B_4@0@0@0@:lectin, galactoside-binding, soluble, 9B@:carbohydrate binding@NA
A2463_04@153397@153400@deletion@4@34625572@34641537@17@chr17:34625572-34641537@22.3@109@5@0.0459@CNVR7077.1, CNVR7077.2, CNVR7077.12@CCL3L1_1, CCL4L2_1, CCL4L2_2, CCL4L2_3@0@0@0@:TBC1 domain family, member 3C;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3H-like;TBC1 domain family, member 3H:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
A2463_04@153414@153414@duplication@1@34797487@34798054@17@chr17:34797487-34798054@5.51@97@157@1.62@CNVR7078.2, CNVR7078.3@TBC1D3G_14@0@0@0@:TBC1 domain family member 3H-like;TBC1 domain family, member 3H:TBC1 domain family, member 3;TBC1 domain family, member 3G;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like;TBC1 domain family, member 3H@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_04@153421@153421@deletion@1@34803323@34803431@17@chr17:34803323-34803431@4.75@31@7@0.226@CNVR7078.2, CNVR7078.3@TBC1D3G_7@0@0@0@:TBC1 domain family member 3H-like;TBC1 domain family, member 3H:TBC1 domain family, member 3;TBC1 domain family, member 3G;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like;TBC1 domain family, member 3H@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_04@153627@153628@deletion@2@36287671@36288301@17@chr17:36287671-36288301@6.45@189@111@0.587@NA@TBC1D3F_5, TBC1D3F_6@0@0@0@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family member 3G-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_04@153650@153659@deletion@10@36351930@36375177@17@chr17:36351930-36375177@93.3@1256@544@0.433@CNVR7083.3@RP11-1407O15.2_12, RP11-1407O15.2_11, RP11-1407O15.2_10, RP11-1407O15.2_9, RP11-1407O15.2_8, RP11-1407O15.2_7, RP11-1407O15.2_6, RP11-1407O15.2_5, RP11-1407O15.2_4, RP11-1407O15.2_3@0@0@0@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
A2463_04@155592@155600@deletion@9@44412912@44594799@17@chr17:44412912-44594799@41.1@212@16@0.0755@CNVR7114.2, CNVR7114.1@LRRC37A_11, LRRC37A_12, LRRC37A_13, LRRC37A_14, ARL17B_4, ARL17B_3, ARL17B_2, LRRC37A2_2, LRRC37A2_3@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
A2463_04@162017@162018@duplication@2@44542732@44550298@18@chr18:44542732-44550298@26.3@374@672@1.8@CNVR7319.1, CNVR7319.2@TCEB3CL2_1, TCEB3CL_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2:transcription elongation factor B polypeptide 3C-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_04@163154@163159@duplication@6@497834@519423@19@chr19:497834-519423@10.6@216@329@1.52@CNVR7463.4@MADCAM1_2, MADCAM1_3, MADCAM1_4, MADCAM1_5, TPGS1_1, TPGS1_2@0@0@0@:mucosal vascular addressin cell adhesion molecule 1:tubulin polyglutamylase complex subunit 1@:regulation of immune response;aging;immune response;embryo development;positive regulation of leukocyte migration;protein binding;signal transduction;integral to membrane;cell adhesion;plasma membrane;membrane;keratinocyte differentiation;leukocyte migration:axon;multicellular organismal development;flagellar axoneme;centrosome;microtubule basal body;signal transduction;adult behavior;cAMP-dependent protein kinase regulator activity;microtubule;sperm axoneme assembly;dendrite;cilium axoneme@NA
A2463_04@164950@164951@deletion@2@7030624@7032905@19@chr19:7030624-7032905@6.91@39@6@0.154@CNVR7517.1@MBD3L5_1, MBD3L5_2@0@0@0@:methyl-CpG binding domain protein 3-like 5@NA@NA
A2463_04@168952@168952@deletion@1@35862263@35863302@19@chr19:35862263-35863302@15.3@94@15@0.16@CNVR7627.1@GPR42_2@0@0@0@@:integral to membrane;G-protein coupled receptor activity;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
A2463_04@170358@170362@deletion@5@41349702@41352956@19@chr19:41349702-41352956@12.2@324@191@0.59@CNVR7642.1@CYP2A6_9, CYP2A6_8, CYP2A6_7, CYP2A6_6, CYP2A6_5@0@0@0@:cytochrome P450, family 2, subfamily A, polypeptide 6@:coumarin 7-hydroxylase activity;steroid metabolic process;oxidation-reduction process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;endoplasmic reticulum membrane;drug metabolic process;electron carrier activity;small molecule metabolic process;exogenous drug catabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;enzyme binding;heme binding;xenobiotic metabolic process;iron ion binding;coumarin catabolic process;coumarin metabolic process@: CYTOCHROME P450, SUBFAMILY IIA, POLYPEPTIDE 6; CYP2A6
A2463_04@173294@173296@duplication@3@54724026@54725251@19@chr19:54724026-54725251@6.99@71@129@1.82@CNVR7721.3, CNVR7721.4@LILRB3_7, LILRB3_6, LILRB3_5@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
A2463_04@173298@173305@deletion@8@54726151@54745754@19@chr19:54726151-54745754@15.2@391@231@0.591@CNVR7721.3, CNVR7721.4, CNVR7721.1@LILRB3_3, LILRB3_2, LILRB3_1, LILRA6_8, LILRA6_7, LILRA6_6, LILRA6_5, LILRA6_4@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
A2463_04@173307@173308@duplication@2@54746372@54746600@19@chr19:54746372-54746600@5.42@38@80@2.11@CNVR7721.3, CNVR7721.6@LILRA6_2, LILRA6_1@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
A2463_04@173336@173339@duplication@4@54801928@54803753@19@chr19:54801928-54803753@9.55@224@337@1.5@CNVR7722.1@LILRA3_6, LILRA3_5, LILRA3_4, LILRA3_3@0@0@0@:leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3@:antigen binding;signal transduction;protein binding;extracellular region;plasma membrane;receptor activity;defense response@NA
A2463_04@173459@173467@deletion@9@55246721@55263205@19@chr19:55246721-55263205@43.4@438@171@0.39@CNVR7725.2, CNVR7725.4, CNVR7725.1@KIR3DL3_6, KIR3DL3_7, KIR3DL3_8, KIR2DL3_1, KIR2DL3_2, KIR2DL3_3, KIR2DL3_4, KIR2DL3_5, KIR2DL3_6@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:integral to membrane;plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity@NA
A2463_04@173482@173486@deletion@5@55320289@55329024@19@chr19:55320289-55329024@14.7@89@16@0.18@CNVR7725.1, CNVR7725.3@KIR2DL4_5, KIR2DL4_6, KIR2DL4_7, KIR3DL1_1, KIR3DL1_2@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane@NA
A2463_04@173488@173498@duplication@11@55331169@55354373@19@chr19:55331169-55354373@31@604@945@1.56@CNVR7725.1, CNVR7725.6@KIR3DL1_4, KIR3DL1_5, KIR3DL1_6, KIR3DL1_7, KIR3DL1_8, KIR3DL1_9, KIR2DS4_1, KIR2DS4_2, KIR2DS4_3, KIR2DS4_4, KIR2DS4_5@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
A2463_04@173500@173503@deletion@4@55359207@55362710@19@chr19:55359207-55362710@9.83@44@0@0@CNVR7725.1, CNVR7725.6, CNVR7725.5, CNVR7725.10@KIR2DS4_7, KIR2DS4_8, KIR3DL2_1, KIR3DL2_2@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2-like@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane@NA
A2463_04@180976@180976@duplication@1@16287255@16287885@22@chr22:16287255-16287885@11.1@222@365@1.64@CNVR8071.2, CNVR8071.3, CNVR8071.9@POTEH_1@0@0@0@:POTE ankyrin domain family, member H@:protein binding@NA
A2463_04@181132@181134@deletion@3@18734615@18835833@22@chr22:18734615-18835833@8.44@194@108@0.557@CNVR8087.5, CNVR8087.2, CNVR8087.7@AC008132.1_7, AC008132.1_8, AC008132.13_1@0@0@0@NA@NA@NA
A2463_04@181487@181488@duplication@2@21065630@21066899@22@chr22:21065630-21066899@5.23@85@136@1.6@CNVR8099.6, CNVR8099.2@PI4KA_51, PI4KA_50@0@0@0@:phosphatidylinositol 4-kinase, catalytic, alpha@:phospholipid metabolic process;1-phosphatidylinositol 4-kinase activity;small molecule metabolic process;phosphatidylinositol phosphorylation;binding;transferase activity, transferring phosphorus-containing groups;phosphotransferase activity, alcohol group as acceptor;ATP binding;Golgi-associated vesicle;phosphatidylinositol biosynthetic process;cytosol;protein binding;signal transduction;synaptic transmission;kinase activity;phosphatidylinositol-mediated signaling@NA
A2463_04@181629@181631@deletion@3@21568015@21570956@22@chr22:21568015-21570956@11.6@87@24@0.276@CNVR8100.4, CNVR8100.10, CNVR8100.7@GGT2_9, GGT2_8, GGT2_7@0@0@0@:gamma-glutamyltransferase 2;gamma-glutamyltranspeptidase 2-like@:hydrolase activity;small molecule metabolic process;leukotriene biosynthetic process;anchored to external side of plasma membrane;glutathione biosynthetic process;xenobiotic metabolic process;integral to membrane;glutathione metabolic process;plasma membrane;gamma-glutamyltransferase activity;cellular_component@NA
A2463_04@181806@181807@duplication@2@23243157@23247205@22@chr22:23243157-23247205@10.1@138@236@1.71@CNVR8103.2, CNVR8103.1, CNVR8103.6, CNVR8103.11, CNVR8103.35@IGLC2_1, IGLJ3_1@0@0@0@@:protein binding@NA
A2463_04@181850@181850@deletion@1@23652512@23652620@22@chr22:23652512-23652620@6.74@47@11@0.234@CNVR8107.2, CNVR8107.3@BCR_18@0@0@0@:breakpoint cluster region@:phospholipid binding;protein autophosphorylation;protein tyrosine kinase activity;GTPase activator activity;neuromuscular process controlling balance;ATP binding;actin cytoskeleton organization;negative regulation of cell migration;plasma membrane;inner ear morphogenesis;positive regulation of Rac GTPase activity;positive regulation of phagocytosis;regulation of small GTPase mediated signal transduction;response to lipopolysaccharide;intracellular signal transduction;Rac GTPase activator activity;regulation of cell cycle;platelet-derived growth factor receptor signaling pathway;protein serine/threonine kinase activity;intracellular;small GTPase mediated signal transduction;regulation of Rho protein signal transduction;protein phosphorylation;negative regulation of inflammatory response;enzyme binding;Rho guanyl-nucleotide exchange factor activity;cytoplasm;cytosol;protein binding;signal transduction;brain development;kinase activity;negative regulation of neutrophil degranulation@: LEUKEMIA, CHRONIC MYELOID; CML
A2463_04@181951@181955@duplication@5@24376424@24384231@22@chr22:24376424-24384231@7.42@108@177@1.64@CNVR8114.13, CNVR8114.1, CNVR8114.7@GSTT1_5, GSTT1_4, GSTT1_3, GSTT1_2, GSTT1_1@0@0@0@:glutathione S-transferase theta 1@:glutathione peroxidase activity;response to drug;transferase activity;cytosol;protein binding;glutathione transferase activity;glutathione metabolic process;response to organic cyclic compound@NA
A2463_04@183639@183639@duplication@1@39387338@39387631@22@chr22:39387338-39387631@4.86@73@122@1.67@CNVR8164.1@APOBEC3B_6@0@0@0@:apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B@:RNA binding;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines;negative regulation of transposition;catalytic activity;zinc ion binding@NA
A2463_17@6@7@deletion@2@69092@139309@1@chr1:69092-139309@27.6@640@330@0.516@CNVR1.2@OR4F5_1, AL627309.1_1@0@0@0@:olfactory receptor, family 4, subfamily F, member 5@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_17@428@434@deletion@7@1637082@1643839@1@chr1:1637082-1643839@20.2@130@26@0.2@CNVR17.1@CDK11A_12, CDK11A_11, CDK11A_10, CDK11A_9, CDK11A_8, CDK11A_7, CDK11A_6@0@0@0@:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A@:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division@NA
A2463_17@1835@1838@duplication@4@13330415@13366425@1@chr1:13330415-13366425@7.6@37@93@2.51@CNVR74.8, CNVR74.4@PRAMEF3_2, PRAMEF3_1, PRAMEF5_2, PRAMEF5_3@0@0@0@:PRAME family member 3:PRAME family member 5@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_17@1853@1854@deletion@2@13495968@13498128@1@chr1:13495968-13498128@9.4@44@1@0.0227@CNVR74.8@PRAMEF16_2, PRAMEF16_3@0@0@0@:PRAME family member 16@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_17@1868@1869@duplication@2@13716802@13718962@1@chr1:13716802-13718962@7.61@81@150@1.85@CNVR76.2@PRAMEF17_2, PRAMEF17_3@0@0@0@:PRAME family member 17@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_17@3333@3342@deletion@10@25599040@25655415@1@chr1:25599040-25655415@171@881@48@0.0545@CNVR116.1, CNVR116.2@RHD_1, RHD_2, RHD_3, RHD_4, RHD_5, RHD_6, RHD_7, RHD_8, RHD_9, RHD_10@0@0@0@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
A2463_17@5149@5149@deletion@1@39987049@39987242@1@chr1:39987049-39987242@4.81@23@1@0.0435@NA@BMP8A_4@0@0@0@:bone morphogenetic protein 8a@:cell differentiation;growth factor activity;extracellular space;growth;cytokine activity;cartilage development;ossification@NA
A2463_17@9340@9358@duplication@19@104114226@104166843@1@chr1:104114226-104166843@249@2176@4937@2.27@CNVR266.8, CNVR266.3@AMY2B_3, AMY2B_4, AMY2B_5, AMY2B_6, AMY2B_7, AMY2B_8, AMY2B_9, AMY2B_10, AMY2B_11, AMY2B_12, AMY2A_1, AMY2A_2, AMY2A_3, AMY2A_4, AMY2A_5, AMY2A_6, AMY2A_7, AMY2A_8, AMY2A_9@0@0@0@:actin, gamma 1 pseudogene 4;amylase, alpha 2B (pancreatic):amylase, alpha 2A (pancreatic)@:extracellular region;cation binding;digestion;carbohydrate metabolic process;catalytic activity;alpha-amylase activity;metal ion binding:chloride ion binding;cation binding;small molecule metabolic process;carbohydrate metabolic process;catalytic activity;extracellular space;polysaccharide digestion;extracellular region;carbohydrate catabolic process;alpha-amylase activity;calcium ion binding@NA
A2463_17@9373@9374@deletion@2@104233917@104234232@1@chr1:104233917-104234232@12.4@62@4@0.0645@CNVR266.3, CNVR266.5@AMY1B_8, AMY1B_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
A2463_17@9385@9386@duplication@2@104297122@104297436@1@chr1:104297122-104297436@43.1@331@849@2.56@CNVR266.3, CNVR266.5@AMY1C_6, AMY1C_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
A2463_17@9766@9773@duplication@8@110230497@110235917@1@chr1:110230497-110235917@25.5@259@485@1.87@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_1, GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
A2463_17@10793@10793@duplication@1@144339779@144340398@1@chr1:144339779-144340398@12.2@20@108@5.4@CNVR334.4, CNVR334.2@AL592284.1_1@0@0@0@:uncharacterized LOC730256;uncharacterized LOC101060698;uncharacterized LOC642441@NA@NA
A2463_17@10799@10799@duplication@1@144815937@144816008@1@chr1:144815937-144816008@5.41@61@112@1.84@CNVR338.4, CNVR338.2, CNVR338.5, CNVR338.1@NBPF9_4@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 24@NA@NA
A2463_17@10804@10805@duplication@2@144823814@144824756@1@chr1:144823814-144824756@5.89@75@130@1.73@CNVR338.2, CNVR338.5, CNVR338.1@NBPF9_9, NBPF9_10@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 24@NA@NA
A2463_17@11080@11080@deletion@1@145756418@145756613@1@chr1:145756418-145756613@5.61@27@1@0.037@NA@PDZK1_6@0@0@0@:PDZ domain containing 1@:PDZ domain binding;transport;transporter activity;cytoplasm;cell proliferation;protein binding;positive regulation of ion transmembrane transport;scavenger receptor binding;brush border membrane;establishment of protein localization to plasma membrane;carnitine transport;drug transport@NA
A2463_17@11127@11164@duplication@38@146215076@146253110@1@chr1:146215076-146253110@54.9@424@874@2.06@NA@NBPF12_38, NBPF12_37, NBPF12_36, NBPF12_35, NBPF12_34, NBPF12_33, NBPF12_32, NBPF12_31, NBPF12_30, NBPF12_29, NBPF12_28, NBPF12_27, NBPF12_26, NBPF12_25, NBPF12_24, NBPF12_23, NBPF12_22, NBPF12_21, NBPF12_20, NBPF12_19, NBPF12_18, NBPF12_17, NBPF12_16, NBPF12_15, NBPF12_14, NBPF12_13, NBPF12_12, NBPF12_11, NBPF12_10, NBPF12_9, NBPF12_8, NBPF12_7, NBPF12_6, NBPF12_5, NBPF12_4, NBPF12_3, NBPF12_2, NBPF12_1@0@0@0@:neuroblastoma breakpoint family member 21-like@NA@NA
A2463_17@11168@11184@deletion@17@146399556@146420191@1@chr1:146399556-146420191@45.9@486@188@0.387@NA@NBPF12_8, NBPF12_9, NBPF12_10, NBPF12_11, NBPF12_12, NBPF12_13, NBPF12_14, NBPF12_15, NBPF12_16, NBPF12_17, NBPF12_18, NBPF12_19, NBPF12_20, NBPF12_21, NBPF12_22, NBPF12_23, NBPF12_24@0@0@0@:neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family member 14-like;neuroblastoma breakpoint family, member 12@:cytoplasm@NA
A2463_17@11242@11242@deletion@1@146465879@146466121@1@chr1:146465879-146466121@9.55@156@72@0.462@CNVR344.2@NBPF12_82@0@0@0@:neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family member 14-like;neuroblastoma breakpoint family, member 12@:cytoplasm@NA
A2463_17@11341@11343@deletion@3@148008574@148010164@1@chr1:148008574-148010164@35@613@283@0.462@CNVR346.2, CNVR346.4@NBPF14_17, NBPF14_16, NBPF14_15@0@0@0@:neuroblastoma breakpoint family, member 14@:cytoplasm@NA
A2463_17@11345@11346@deletion@2@148011681@148012675@1@chr1:148011681-148012675@19.1@253@109@0.431@CNVR346.2, CNVR346.4@NBPF14_13, NBPF14_12@0@0@0@:neuroblastoma breakpoint family, member 14@:cytoplasm@NA
A2463_17@11353@11353@duplication@1@148021578@148021628@1@chr1:148021578-148021628@7.47@65@133@2.05@CNVR346.2, CNVR346.4@NBPF14_5@0@0@0@:neuroblastoma breakpoint family, member 14@:cytoplasm@NA
A2463_17@11508@11508@deletion@1@149762794@149763073@1@chr1:149762794-149763073@9.13@348@201@0.578@CNVR351.3, CNVR351.5@FCGR1A_6@0@0@0@:Fc fragment of IgG, high affinity Ib, receptor (CD64);Fc fragment of IgG, high affinity Ia, receptor (CD64):histone cluster 2, H2bf@:IgG receptor activity;phagocytosis, recognition;antibody-dependent cellular cytotoxicity;regulation of immune response;phagocytosis, engulfment;antigen processing and presentation of peptide antigen via MHC class I;immune response;clathrin-coated endocytic vesicle membrane;interferon-gamma-mediated signaling pathway;integral to membrane;Fc-gamma receptor signaling pathway;positive regulation of type III hypersensitivity;plasma membrane;receptor-mediated endocytosis;positive regulation of phagocytosis;cytokine-mediated signaling pathway;early endosome membrane;cell surface receptor signaling pathway;IgG binding;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;positive regulation of type IIa hypersensitivity;antigen processing and presentation of exogenous antigen;external side of plasma membrane;signal transduction;protein binding;defense response to bacterium;antigen processing and presentation of exogenous peptide antigen via MHC class I;receptor signaling protein activity;response to bacterium:sequence-specific DNA binding;intracellular;nucleus;protein heterodimerization activity;DNA binding;nucleosome assembly;nucleosome@NA
A2463_17@16029@16040@deletion@12@196744018@196801129@1@chr1:196744018-196801129@39.6@2109@1365@0.647@CNVR459.1@CFHR3_1, CFHR3_2, CFHR3_3, CFHR3_4, CFHR3_5, CFHR3_6, CFHR1_1, CFHR1_2, CFHR1_3, CFHR1_4, CFHR1_5, CFHR1_6@0@0@0@:complement factor H-related 3:complement factor H-related 1:complement factor H-related 2@:extracellular space:extracellular space;complement activation:extracellular region@NA
A2463_17@17278@17278@deletion@1@207700099@207700274@1@chr1:207700099-207700274@5.09@23@0@0@CNVR485.1@CR1_6@0@0@0@:complement component (3b/4b) receptor 1 (Knops blood group)@:complement component C4b receptor activity;complement activation, classical pathway;negative regulation of complement activation, alternative pathway;innate immune response;negative regulation of serine-type endopeptidase activity;complement component C3b binding;negative regulation of complement activation, classical pathway;plasma membrane;integral to plasma membrane;complement component C3b receptor activity;complement component C4b binding;cell surface;regulation of complement activation;positive regulation of serine-type endopeptidase activity@: MALARIA, SUSCEPTIBILITY TO; KNOPS BLOOD GROUP SYSTEM; KN
A2463_17@17294@17295@deletion@2@207737210@207737579@1@chr1:207737210-207737579@8.65@70@22@0.314@CNVR485.1, CNVR485.2@CR1_22, CR1_23@0@0@0@:complement component (3b/4b) receptor 1 (Knops blood group)@:complement component C4b receptor activity;complement activation, classical pathway;negative regulation of complement activation, alternative pathway;innate immune response;negative regulation of serine-type endopeptidase activity;complement component C3b binding;negative regulation of complement activation, classical pathway;plasma membrane;integral to plasma membrane;complement component C3b receptor activity;complement component C4b binding;cell surface;regulation of complement activation;positive regulation of serine-type endopeptidase activity@: MALARIA, SUSCEPTIBILITY TO; KNOPS BLOOD GROUP SYSTEM; KN
A2463_17@17624@17625@deletion@2@213003585@213009491@1@chr1:213003585-213009491@13.6@271@140@0.517@CNVR498.1@C1orf227_3, C1orf227_2@0@0@0@:chromosome 1 open reading frame 227@NA@NA
A2463_17@18285@18285@deletion@1@226075487@226075732@1@chr1:226075487-226075732@17.2@110@17@0.155@NA@LEFTY1_2, RP4-559A3.7_6@0@0@0@:left-right determination factor 1@:growth factor activity;cell growth;transforming growth factor beta receptor signaling pathway;extracellular space;negative regulation of transcription from RNA polymerase II promoter;growth;transforming growth factor beta receptor binding;heart morphogenesis;cytokine activity;determination of left/right symmetry:oxidation-reduction process;oxidoreductase activity;proline biosynthetic process;pyrroline-5-carboxylate reductase activity;nucleotide binding@NA
A2463_17@18296@18296@duplication@1@226127457@226127702@1@chr1:226127457-226127702@6.07@132@209@1.58@NA@LEFTY2_2@0@0@0@:left-right determination factor 2@:platelet degranulation;multicellular organismal development;growth factor activity;platelet activation;platelet alpha granule lumen;cell growth;transforming growth factor beta receptor signaling pathway;extracellular space;blood coagulation;growth;extracellular region;transforming growth factor beta receptor binding;cytokine activity@: LEFT-RIGHT DETERMINATION FACTOR 2; LEFTY2
A2463_17@19774@19778@deletion@5@248737103@248814185@1@chr1:248737103-248814185@24.6@898@542@0.604@CNVR600.1@OR2T34_1, OR2T10_1, OR2T11_1, OR2T35_1, OR2T27_1@0@0@0@:olfactory receptor, family 2, subfamily T, member 34:olfactory receptor, family 2, subfamily T, member 10:olfactory receptor, family 2, subfamily T, member 11:olfactory receptor, family 2, subfamily T, member 35:olfactory receptor, family 2, subfamily T, member 27@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_17@24957@24957@deletion@1@89459236@89459530@2@chr2:89459236-89459530@6.32@82@36@0.439@CNVR866.7, CNVR866.10, CNVR866.11, CNVR866.4, CNVR866.22@IGKV6-21_2@0@0@0@@:protein binding@NA
A2463_17@25116@25116@deletion@1@96652841@96652954@2@chr2:96652841-96652954@5.59@44@13@0.295@NA@ANKRD36C_2@0@0@0@:ankyrin repeat domain-containing protein 36A-like@:ion channel inhibitor activity;protein binding@NA
A2463_17@25137@25138@deletion@2@96697782@96698107@2@chr2:96697782-96698107@6.98@115@58@0.504@NA@GPAT2_4, GPAT2_3@0@0@0@:glycerol-3-phosphate acyltransferase 2, mitochondrial@:glycerol-3-phosphate O-acyltransferase activity;mitochondrion;phospholipid metabolic process;triglyceride biosynthetic process;glycerophospholipid biosynthetic process;small molecule metabolic process;transferase activity, transferring acyl groups;mitochondrial outer membrane;phosphatidic acid biosynthetic process;integral to membrane;glycerol-3-phosphate metabolic process;CDP-diacylglycerol biosynthetic process;membrane;metabolic process;phospholipid biosynthetic process@NA
A2463_17@25390@25392@deletion@3@97873672@97875609@2@chr2:97873672-97875609@10.3@356@220@0.618@CNVR886.1@ANKRD36_54, ANKRD36_55, ANKRD36_56@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_17@25396@25398@deletion@3@97879280@97881312@2@chr2:97879280-97881312@7.04@307@190@0.619@NA@ANKRD36_60, ANKRD36_61, ANKRD36_62@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_17@27163@27163@duplication@1@130843388@130843568@2@chr2:130843388-130843568@5.4@32@74@2.31@NA@POTEF_13@0@0@0@:POTE ankyrin domain family, member F@:cell cortex;protein binding;ATP binding@NA
A2463_17@27172@27172@duplication@1@130869569@130869674@2@chr2:130869569-130869674@7.63@54@119@2.2@NA@POTEF_4@0@0@0@:POTE ankyrin domain family, member F@:cell cortex;protein binding;ATP binding@NA
A2463_17@27996@27997@deletion@2@152463121@152464122@2@chr2:152463121-152464122@14.7@72@3@0.0417@CNVR1026.1@NEB_84, NEB_83@0@0@0@:nebulin@:Z disc;muscle filament sliding;oxidation-reduction process;contractile fiber part;actin cytoskeleton;regulation of actin filament length;structural constituent of muscle;cytosol;actin binding;protein binding;myofibril;somatic muscle development;muscle organ development@: NEMALINE MYOPATHY 2; NEM2
A2463_17@39892@39894@deletion@3@75786030@75790887@3@chr3:75786030-75790887@35.2@198@14@0.0707@CNVR1432.5, CNVR1432.9, CNVR1432.4@ZNF717_5, ZNF717_4, ZNF717_3@0@0@0@:zinc finger protein 717;zinc finger protein 717-like@:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_17@43974@43974@deletion@1@169587422@169587595@3@chr3:169587422-169587595@5.07@77@37@0.481@NA@LRRC31_1@0@0@0@:leucine rich repeat containing 31@:protein binding@NA
A2463_17@45437@45438@duplication@2@195474048@195475935@3@chr3:195474048-195475935@6.36@208@300@1.44@CNVR1703.1, CNVR1703.2, CNVR1703.5, CNVR1703.4@MUC4_25, MUC4_24@0@0@0@:mucin 4, cell surface associated@:ErbB-2 class receptor binding;Golgi lumen;cell-matrix adhesion;post-translational protein modification;extracellular matrix structural constituent;protein binding;O-glycan processing;cellular protein metabolic process;proteinaceous extracellular matrix;integral to plasma membrane;membrane;extracellular matrix constituent, lubricant activity;biological_process@NA
A2463_17@45459@45460@deletion@2@195505175@195518368@3@chr3:195505175-195518368@16.2@2008@1225@0.61@CNVR1704.1@MUC4_3, MUC4_2@0@0@0@:mucin 4, cell surface associated@:ErbB-2 class receptor binding;Golgi lumen;cell-matrix adhesion;post-translational protein modification;extracellular matrix structural constituent;protein binding;O-glycan processing;cellular protein metabolic process;proteinaceous extracellular matrix;integral to plasma membrane;membrane;extracellular matrix constituent, lubricant activity;biological_process@NA
A2463_17@46667@46675@deletion@9@9174900@9237700@4@chr4:9174900-9237700@21.6@134@24@0.179@NA@FAM90A26P_4, FAM90A26P_5, FAM90A26P_6, FAM90A26P_7, USP17L13_1, USP17L10_1, USP17L11_1, USP17L12_1, USP17L13_2, USP17L15_1@0@0@0@:ubiquitin specific peptidase 17-like family member 10:ubiquitin specific peptidase 17-like family member 13:ubiquitin specific peptidase 17-like family member 11:ubiquitin specific peptidase 17-like family member 12:ubiquitin specific peptidase 17-like family member 15@:zinc ion binding;nucleic acid binding:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
A2463_17@48556@48561@duplication@6@69403344@69434202@4@chr4:69403344-69434202@41.4@441@882@2@CNVR1953.1@UGT2B17_6, UGT2B17_5, UGT2B17_4, UGT2B17_3, UGT2B17_2, UGT2B17_1@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B17@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;membrane@: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
A2463_17@48592@48597@deletion@6@70146220@70160527@4@chr4:70146220-70160527@23.2@803@484@0.603@CNVR1957.2, CNVR1957.1@UGT2B28_1, UGT2B28_2, UGT2B28_3, UGT2B28_4, UGT2B28_5, UGT2B28_6@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B28@:carbohydrate binding;transferase activity, transferring hexosyl groups;endoplasmic reticulum;glucuronosyltransferase activity;carbohydrate metabolic process;xenobiotic metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process@NA
A2463_17@53306@53316@duplication@11@741710@822010@5@chr5:741710-822010@27.7@483@767@1.59@CNVR2280.3@ZDHHC11B_7, ZDHHC11B_6, ZDHHC11B_5, ZDHHC11B_4, ZDHHC11B_3, ZDHHC11B_2, ZDHHC11B_1, ZDHHC11_12, ZDHHC11_11, ZDHHC11_10, ZDHHC11_9@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
A2463_17@53318@53322@deletion@5@833889@847730@5@chr5:833889-847730@14.6@339@195@0.575@CNVR2280.3, CNVR2280.8@ZDHHC11_7, ZDHHC11_6, ZDHHC11_5, ZDHHC11_4, ZDHHC11_3@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
A2463_17@54849@54849@deletion@1@42629141@42629205@5@chr5:42629141-42629205@22.8@108@0@0@CNVR2445.1@GHR_3@0@0@0@:growth hormone receptor@:neuronal cell body;mitochondrion;proline-rich region binding;JAK-STAT cascade;growth factor binding;nucleus;succinate metabolic process;positive regulation of JAK-STAT cascade;JAK-STAT cascade involved in growth hormone signaling pathway;response to morphine;activation of MAPK activity;peptide hormone binding;response to estradiol stimulus;2-oxoglutarate metabolic process;valine metabolic process;response to cytokine stimulus;hormone-mediated signaling pathway;response to food;SH2 domain binding;oxaloacetate metabolic process;growth hormone receptor signaling pathway;allantoin metabolic process;integral to membrane;response to hormone stimulus;cartilage development involved in endochondral bone morphogenesis;positive regulation of peptidyl-tyrosine phosphorylation;receptor internalization;cytoplasm;cellular response to hormone stimulus;extracellular region;growth hormone receptor complex;positive regulation of tyrosine phosphorylation of Stat5 protein;regulation of multicellular organism growth;growth hormone receptor activity;positive regulation of tyrosine phosphorylation of Stat3 protein;response to peptide hormone stimulus;fatty acid metabolic process;creatinine metabolic process;plasma membrane;positive regulation of multicellular organism growth;receptor complex;protein phosphatase binding;protein kinase binding;creatine metabolic process;response to interleukin-1;response to cycloheximide;extracellular space;positive regulation of cell differentiation;activation of Janus kinase activity;taurine metabolic process;cellular response to insulin stimulus;integral to plasma membrane;protein homodimerization activity;negative regulation of neuron death;citrate metabolic process;endocytosis;isoleucine metabolic process;activation of JAK2 kinase activity;extrinsic to membrane;response to glucocorticoid stimulus;protein binding;insulin-like growth factor receptor signaling pathway;multicellular organismal metabolic process;cell surface@: HYPERCHOLESTEROLEMIA, FAMILIAL; LARON SYNDROME; SHORT STATURE, IDIOPATHIC, AUTOSOMAL
A2463_17@55817@55817@duplication@1@70247769@70247818@5@chr5:70247769-70247818@8.79@170@284@1.67@CNVR2494.41, CNVR2494.14, CNVR2494.30, CNVR2494.25, CNVR2494.20, CNVR2494.61, CNVR2494.22, CNVR2494.21, CNVR2494.62, CNVR2494.63@SMN1_8@0@0@0@:survival of motor neuron 2, centromeric;survival of motor neuron 1, telomeric@:nucleoplasm;ncRNA metabolic process;Cajal body;RNA metabolic process;spliceosomal complex;cytoplasm;cytosol;protein binding;cell death;spliceosomal complex assembly;RNA binding;mRNA processing;nucleus;gene expression;spliceosomal snRNP assembly@: SPINAL MUSCULAR ATROPHY, TYPE II; SMA2; SPINAL MUSCULAR ATROPHY, TYPE I; SMA1; SPINAL MUSCULAR ATROPHY, TYPE IV; SMA4; SPINAL MUSCULAR ATROPHY, TYPE III; SMA3
A2463_17@55835@55837@duplication@3@70338009@70343940@5@chr5:70338009-70343940@8.66@119@201@1.69@CNVR2494.41, CNVR2494.14, CNVR2494.20, CNVR2494.62, CNVR2494.8@GTF2H2_14, GTF2H2_13, GTF2H2_12@0@0@0@:general transcription factor IIH, polypeptide 2, 44kDa@:nucleoplasm;nucleotide-excision repair, DNA damage removal;transcription from RNA polymerase I promoter;DNA repair;RNA polymerase II carboxy-terminal domain kinase activity;nucleus;viral reproduction;translation;gene expression;transcription elongation from RNA polymerase I promoter;response to UV;holo TFIIH complex;protein kinase activity;nucleotide-excision repair;transcription from RNA polymerase II promoter;transcription-coupled nucleotide-excision repair;transcription, DNA-dependent;zinc ion binding;transcription elongation from RNA polymerase II promoter;termination of RNA polymerase I transcription;sequence-specific DNA binding transcription factor activity;G-protein coupled receptor internalization;DNA-dependent ATPase activity;protein N-terminus binding;transcription initiation from RNA polymerase I promoter;7-methylguanosine mRNA capping;transcription initiation from RNA polymerase II promoter;protein phosphorylation;translation factor activity, nucleic acid binding;regulation of transcription, DNA-dependent;core TFIIH complex;protein binding;positive regulation of viral transcription;nucleic acid binding@NA
A2463_17@59488@59488@deletion@1@147553798@147553933@5@chr5:147553798-147553933@4.97@22@0@0@CNVR2637.2, CNVR2637.1@SPINK14_3@0@0@0@:serine peptidase inhibitor, Kazal type 14 (putative)@:serine-type endopeptidase inhibitor activity;protein binding;extracellular region@NA
A2463_17@60881@60885@deletion@5@175477607@175520277@5@chr5:175477607-175520277@11@107@39@0.364@NA@RP11-826N14.2_3, RP11-826N14.2_2, FAM153B_3, FAM153B_4@0@0@0@:uncharacterized LOC100507387;family with sequence similarity 153, member B@NA@NA
A2463_17@63293@63297@deletion@5@31371411@31380208@6@chr6:31371411-31380208@12.6@299@171@0.572@CNVR2842.1@MICA_1, MICA_2, MICA_3, MICA_4, MICA_5@0@0@0@:MHC class I polypeptide-related sequence A@:MHC class I protein complex;protein binding;regulation of immune response;antigen processing and presentation;immune response;plasma membrane;membrane@: PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO; PSORIASIS SUSCEPTIBILITY 1; PSORS1
A2463_17@63734@63735@duplication@2@31964607@31965088@6@chr6:31964607-31965088@5.08@9@42@4.67@CNVR2843.6, CNVR2843.3@C4A_29, C4A_30@0@0@0@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
A2463_17@63768@63768@deletion@1@31994761@31994899@6@chr6:31994761-31994899@6.13@83@37@0.446@CNVR2843.6, CNVR2843.5@C4B_20@0@0@0@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
A2463_17@63953@63958@duplication@6@32485517@32498001@6@chr6:32485517-32498001@29.1@220@458@2.08@CNVR2845.21, CNVR2845.25, CNVR2845.30, CNVR2845.43, CNVR2845.6@HLA-DRB5_6, HLA-DRB5_5, HLA-DRB5_4, HLA-DRB5_3, HLA-DRB5_2, HLA-DRB5_1@0@0@0@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
A2463_17@64602@64606@deletion@5@35754776@35765065@6@chr6:35754776-35765065@9.44@451@293@0.65@CNVR2861.1@CLPSL1_2, CLPSL1_3, CLPS_3, CLPS_2, CLPS_1@0@0@0@:colipase-like 1:colipase, pancreatic@:extracellular region;enzyme activator activity;digestion;lipid catabolic process:steroid metabolic process;post-embryonic development;small molecule metabolic process;retinoid metabolic process;lipid metabolic process;extracellular region;enzyme activator activity;digestion;lipid catabolic process;lipid digestion;response to food@NA
A2463_17@66018@66021@duplication@4@49437891@49440571@6@chr6:49437891-49440571@13.1@396@582@1.47@NA@CENPQ_2, CENPQ_3, CENPQ_4, CENPQ_5@0@0@0@:centromere protein Q@:nucleoplasm;mitotic cell cycle;cytosol;chromosome, centromeric region;mitotic prometaphase;M phase of mitotic cell cycle;nucleosome assembly;CenH3-containing nucleosome assembly at centromere@NA
A2463_17@69212@69212@deletion@1@132021610@132022541@6@chr6:132021610-132022541@4.62@106@59@0.557@CNVR3068.1, CNVR3068.2@OR2A4_1@0@0@0@:ectonucleotide pyrophosphatase/phosphodiesterase 3:olfactory receptor, family 2, subfamily A, member 4@:nucleotide diphosphatase activity;immune response;phosphate-containing compound metabolic process;catalytic activity;phosphodiesterase I activity;integral to plasma membrane;metabolic process;hydrolase activity;nucleoside-triphosphate diphosphatase activity;nucleoside triphosphate catabolic process;polysaccharide binding;perinuclear region of cytoplasm;extracellular region;scavenger receptor activity;NADH pyrophosphatase activity;nucleic acid binding;metal ion binding:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_17@70816@70817@duplication@2@161054786@161056336@6@chr6:161054786-161056336@12.4@141@262@1.86@CNVR3133.1@LPA_9, LPA_8@0@0@0@:lipoprotein, Lp(a)@:blood circulation;endopeptidase inhibitor activity;catalytic activity;lipoprotein metabolic process;proteolysis;heparin binding;receptor-mediated endocytosis;fibronectin binding;small molecule metabolic process;apolipoprotein binding;lipid metabolic process;negative regulation of endopeptidase activity;extracellular region;plasma lipoprotein particle;lipid transport;serine-type endopeptidase activity@: APOLIPOPROTEIN(a); LPA
A2463_17@71010@71012@deletion@3@167587242@167592030@6@chr6:167587242-167592030@22.6@321@141@0.439@NA@TCP10L2_3, TCP10L2_4, TCP10L2_5@0@0@0@:t-complex 10;t-complex 10-like 2@NA@NA
A2463_17@71030@71032@duplication@3@167790035@167794824@6@chr6:167790035-167794824@22.3@121@306@2.53@NA@TCP10_5, TCP10_4, TCP10_3@0@0@0@:t-complex 10@:cytosol@NA
A2463_17@71744@71754@deletion@11@5939916@5959597@7@chr7:5939916-5959597@105@929@297@0.32@NA@CCZ1_2, CCZ1_3, CCZ1_4, CCZ1_5, CCZ1_6, CCZ1_7, CCZ1_8, CCZ1_9, CCZ1_10, CCZ1_11, CCZ1_12@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
A2463_17@71772@71776@duplication@5@5998625@6006747@7@chr7:5998625-6006747@14.6@130@267@2.05@NA@RSPH10B_6, RSPH10B_5, RSPH10B_4, RSPH10B_3, RSPH10B_2@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
A2463_17@71922@71923@deletion@2@6797310@6798790@7@chr7:6797310-6798790@11.2@221@108@0.489@NA@RSPH10B2_2, RSPH10B2_3@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
A2463_17@71949@71954@duplication@6@6859398@6864368@7@chr7:6859398-6864368@33.4@768@1237@1.61@NA@CCZ1B_7, CCZ1B_6, CCZ1B_5, CCZ1B_4, CCZ1B_3, CCZ1B_2@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
A2463_17@73250@73257@deletion@8@38304951@38357093@7@chr7:38304951-38357093@11.1@861@584@0.678@NA@TRGC1_1, TRGJ1_1, TRGJP_1, TRGJP1_1, TRGV11_1, TRGV10_1, TRGV9_2, TRGV9_1@0@0@0@:TCR gamma alternate reading frame protein@:protein binding:protein binding:protein binding@NA
A2463_17@74573@74573@deletion@1@74166423@74166502@7@chr7:74166423-74166502@4.69@74@36@0.486@NA@GTF2I_28@0@0@0@:general transcription factor IIi@:neuronal cell body;transcription initiation from RNA polymerase II promoter;mitogen-activated protein kinase binding;negative regulation of angiogenesis;DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;cytoplasm;transcription from RNA polymerase II promoter;protein binding;signal transduction;nucleus;cell projection;reduction of cytosolic calcium ion concentration@NA
A2463_17@74597@74598@deletion@2@74225431@74227349@7@chr7:74225431-74227349@9.77@47@2@0.0426@NA@GTF2IRD2_10, GTF2IRD2_9@0@0@0@:GTF2I repeat domain containing 2@:nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_17@74640@74640@deletion@1@74563501@74565103@7@chr7:74563501-74565103@12@416@228@0.548@NA@GTF2IRD2B_16@0@0@0@:GTF2I repeat domain containing 2B@:nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_17@76427@76432@duplication@6@100331793@100336236@7@chr7:100331793-100336236@13.3@256@398@1.55@CNVR3509.1@ZAN_1, ZAN_2, ZAN_3, ZAN_4, ZAN_5, ZAN_6@0@0@0@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
A2463_17@76792@76793@duplication@2@102309363@102312048@7@chr7:102309363-102312048@5.93@79@135@1.71@CNVR3518.1@POLR2J2_2, POLR2J2_2, POLR2J2_1, POLR2J2_1@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
A2463_17@79104@79118@deletion@15@142364235@142460871@7@chr7:142364235-142460871@15.9@1252@861@0.688@NA@TRBV24-1_1, TRBV24-1_2, TRBV25-1_1, TRBV25-1_2, TRBV27_1, TRBV27_2, TRBV28_1, TRBV28_2, TRBV29-1_1, TRBV29-1_2, PRSS1_1, PRSS1_2, PRSS1_3, PRSS1_4, PRSS1_5@0@0@0@:protease, serine, 1 (trypsin 1)@:protein binding:protein binding:protein binding:protein binding:protein binding:extracellular matrix organization;catalytic activity;extracellular matrix disassembly;proteolysis;extracellular space;extracellular region;digestion;metal ion binding;serine-type endopeptidase activity@: PANCREATITIS, HEREDITARY; PCTT
A2463_17@79287@79287@deletion@1@143400089@143400710@7@chr7:143400089-143400710@6.67@38@5@0.132@CNVR3594.2, CNVR3594.1@FAM115C_2@0@0@0@:family with sequence similarity 115, member C;protein FAM115C-like@NA@NA
A2463_17@79311@79311@deletion@1@143929005@143929936@7@chr7:143929005-143929936@7.52@72@25@0.347@CNVR3598.4, CNVR3598.7@OR2A42_1@0@0@0@:Rho guanine nucleotide exchange factor (GEF) 35:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_17@79311@79314@duplication@3@143929005@144016150@7@chr7:143929005-144016150@-0.673@736@926@1.26@CNVR3598.4@OR2A42_1, OR2A7_1, CTAGE8_1, OR2A1_1@0@0@0@:Rho guanine nucleotide exchange factor (GEF) 35:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1:olfactory receptor, family 2, subfamily A, member 7:CTAGE family, member 6, pseudogene;CTAGE family, member 15, pseudogene:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_17@80141@80141@deletion@1@116087@117024@8@chr8:116087-117024@7.88@39@2@0.0513@CNVR3684.8, CNVR3684.5@OR4F21_1@0@0@0@:olfactory receptor, family 4, subfamily F, member 21@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_17@80358@80358@duplication@1@6873513@6873621@8@chr8:6873513-6873621@5.42@74@129@1.74@CNVR3769.1@DEFA3_3@0@0@0@:defensin, alpha 1B;defensin, alpha 1:defensin, alpha 3, neutrophil-specific;defensin, alpha 1B;defensin, alpha 1@:defense response to virus;extracellular matrix;immune response;Golgi lumen;azurophil granule lumen;killing of cells of other organism;innate immune response;chemotaxis;extracellular space;extracellular region;defense response to bacterium;defense response to fungus;defense response:defense response to virus;Golgi lumen;azurophil granule lumen;killing of cells of other organism;innate immune response;extracellular space;defense response to bacterium;defense response to fungus;extracellular region;defense response@NA
A2463_17@80397@80398@deletion@2@7686328@7694064@8@chr8:7686328-7694064@6.88@93@43@0.462@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@DEFB106A_2, DEFB104A_1@0@0@0@:defensin, beta 106B;defensin, beta 106A:defensin, beta 104A;defensin, beta 104B@:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium@NA
A2463_17@80409@80412@deletion@4@7806652@7809913@8@chr8:7806652-7809913@15.4@103@22@0.214@CNVR3772.4, CNVR3772.6, CNVR3772.10, CNVR3772.13@ZNF705B_3, ZNF705B_4, ZNF705B_5, ZNF705B_6@0@0@0@:zinc finger protein 705B@:intracellular;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_17@80565@80565@duplication@1@11994678@11996269@8@chr8:11994678-11996269@4.57@1077@1422@1.32@CNVR3785.8, CNVR3785.5, CNVR3785.6, CNVR3785.2, CNVR3785.1, CNVR3785.3@USP17L2_1@0@0@0@:ubiquitin specific peptidase 17-like family member 1, pseudogene;ubiquitin specific peptidase 17-like family member 2;ubiquitin specific peptidase 17-like family member 4;ubiquitin specific peptidase 17-like family member 7;ubiquitin specific peptidase 17-like family member 8;ubiquitin specific peptidase 17-like family member 3@:protein deubiquitination;ubiquitin-specific protease activity;mitotic cell cycle G1/S transition checkpoint;nucleus;G2/M transition checkpoint;apoptotic process;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
A2463_17@80570@80572@deletion@3@12045582@12049350@8@chr8:12045582-12049350@11.8@72@12@0.167@CNVR3785.5, CNVR3785.3@FAM86B1_4, FAM86B1_3, FAM86B1_2@0@0@0@:family with sequence similarity 86, member B2;family with sequence similarity 86, member B1@NA@NA
A2463_17@80577@80578@deletion@2@12285167@12286407@8@chr8:12285167-12286407@13.4@67@4@0.0597@CNVR3786.4, CNVR3786.16@FAM86B2_7, FAM86B2_6@0@0@0@:family with sequence similarity 86, member B2@NA@NA
A2463_17@80582@80584@duplication@3@12291562@12338444@8@chr8:12291562-12338444@5.85@272@378@1.39@CNVR3786.4, CNVR3786.16@FAM86B2_2, FAM86B2_1, AC130352.1_5@0@0@0@:family with sequence similarity 86, member B2@NA@NA
A2463_17@88492@88495@deletion@4@39078688@39088644@9@chr9:39078688-39088644@21.6@429@228@0.531@NA@CNTNAP3_22, CNTNAP3_21, CNTNAP3_20, CNTNAP3_19@0@0@0@:contactin associated protein-like 3@:binding;signal transduction;protein binding;integral to membrane;extracellular region;cell adhesion;plasma membrane;cell recognition;receptor binding@NA
A2463_17@88534@88535@deletion@2@41306194@41311806@9@chr9:41306194-41311806@12.7@58@0@0@CNVR4278.2@FAM74A2_2, FAM74A2_1@0@0@0@@:integral to membrane@NA
A2463_17@88544@88549@deletion@6@42368416@42380206@9@chr9:42368416-42380206@16.4@147@44@0.299@NA@ANKRD20A2_1, ANKRD20A2_2, ANKRD20A2_3, ANKRD20A2_4, ANKRD20A2_5, ANKRD20A2_6@0@0@0@:ankyrin repeat domain 20 family, member A2@:protein binding@NA
A2463_17@88593@88604@duplication@12@43816638@43891712@9@chr9:43816638-43891712@17.6@809@1114@1.38@NA@CNTNAP3B_6, CNTNAP3B_7, CNTNAP3B_8, CNTNAP3B_9, CNTNAP3B_10, CNTNAP3B_11, CNTNAP3B_12, CNTNAP3B_13, CNTNAP3B_14, CNTNAP3B_15, CNTNAP3B_16, CNTNAP3B_17@0@0@0@:contactin associated protein-like 3B;contactin associated protein-like 3@:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
A2463_17@88621@88624@deletion@4@45727441@46390900@9@chr9:45727441-46390900@30.3@173@22@0.127@NA@AL953889.1_2, AL953889.1_1, FAM27A_2, FAM27E2_1, FAM27E1_1, FAM27D1_1@0@0@0@:family with sequence similarity 27, member E3:protein FAM27E2-like;protein FAM27D1-like@NA@NA
A2463_17@88631@88633@deletion@3@65503517@65508193@9@chr9:65503517-65508193@25@224@70@0.312@CNVR4312.5@SPATA31A7_4, SPATA31A7_3, SPATA31A7_2@0@0@0@:SPATA31 subfamily A, member 7@:integral to membrane@NA
A2463_17@88639@88641@duplication@3@67926874@67930837@9@chr9:67926874-67930837@17.9@29@150@5.17@NA@ANKRD20A1_1, ANKRD20A1_2, ANKRD20A1_3@0@0@0@:ankyrin repeat domain 20 family, member A1@:protein binding;plasma membrane@NA
A2463_17@88644@88647@deletion@4@67938604@67952016@9@chr9:67938604-67952016@8.42@355@226@0.637@NA@ANKRD20A1_6, ANKRD20A1_7, ANKRD20A1_8, ANKRD20A1_9@0@0@0@:ankyrin repeat domain 20 family, member A1@:protein binding;plasma membrane@NA
A2463_17@88661@88664@deletion@4@69206735@69229668@9@chr9:69206735-69229668@5.66@308@205@0.666@NA@CBWD6_13, CBWD6_12, CBWD6_11, CBWD6_10@0@0@0@:COBW domain containing 6@:ATP binding@NA
A2463_17@88670@88682@deletion@13@69252846@69400452@9@chr9:69252846-69400452@43.8@417@155@0.372@NA@BX255923.1_1, CBWD6_4, CBWD6_3, CBWD6_2, CBWD6_1, CR769776.1_1, ANKRD20A4_1, ANKRD20A4_2, ANKRD20A4_3, ANKRD20A4_4, ANKRD20A4_5, ANKRD20A4_6, ANKRD20A4_7@0@0@0@:COBW domain containing 6:ankyrin repeat domain 20 family, member A4@:ATP binding:protein binding@NA
A2463_17@88684@88690@deletion@7@69407157@69424176@9@chr9:69407157-69424176@34.3@572@256@0.448@NA@ANKRD20A4_9, ANKRD20A4_10, ANKRD20A4_11, ANKRD20A4_12, ANKRD20A4_13, ANKRD20A4_14, ANKRD20A4_15@0@0@0@:ankyrin repeat domain 20 family, member A4@:protein binding@NA
A2463_17@88705@88708@deletion@4@70483189@70490068@9@chr9:70483189-70490068@5.28@151@91@0.603@NA@CBWD5_4, CBWD5_3, CBWD5_2, CBWD5_1@0@0@0@:COBW domain-containing protein 5-like;COBW domain containing 7;COBW domain containing 5@:ATP binding@NA
A2463_17@88720@88723@duplication@4@70889799@70912733@9@chr9:70889799-70912733@18.2@144@304@2.11@NA@CBWD3_10, CBWD3_11, CBWD3_12, CBWD3_13@0@0@0@:COBW domain-containing protein 5-like;COBW domain-containing protein 1-like;COBW domain containing 3@:ATP binding@NA
A2463_17@95387@95393@deletion@7@18129623@18152611@10@chr10:18129623-18152611@8.3@56@13@0.232@NA@MRC1_5, MRC1_6, MRC1_7, MRC1_8, MRC1_9, MRC1_10, MRC1_11@0@0@0@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
A2463_17@95948@95950@deletion@3@29580773@29599117@10@chr10:29580773-29599117@5.71@108@59@0.546@NA@LYZL1_2, LYZL1_3, LYZL1_4@0@0@0@:lysozyme-like 1@:extracellular region;lysozyme activity;cell wall macromolecule catabolic process@NA
A2463_17@96529@96531@deletion@3@47756640@47758904@10@chr10:47756640-47758904@5.48@24@0@0@CNVR4714.1@ANXA8L2_8, ANXA8L2_9, ANXA8L2_10@0@0@0@:annexin A8-like 2:uncharacterized LOC101060462;uncharacterized LOC100996760@:calcium-dependent phospholipid binding;calcium ion binding@NA
A2463_17@96540@96563@deletion@24@47903160@47948853@10@chr10:47903160-47948853@89.9@552@99@0.179@CNVR4715.2, CNVR4715.1@FAM21B_6, FAM21B_7, FAM21B_8, FAM21B_9, FAM21B_10, FAM21B_11, FAM21B_12, FAM21B_13, FAM21B_14, FAM21B_15, FAM21B_16, FAM21B_17, FAM21B_18, FAM21B_19, FAM21B_20, FAM21B_21, FAM21B_22, FAM21B_23, FAM21B_24, FAM21B_25, FAM21B_26, FAM21B_27, FAM21B_28, FAM21B_29@0@0@0@:family with sequence similarity 21, member B@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_17@96631@96633@duplication@3@49376639@49381136@10@chr10:49376639-49381136@6.99@56@111@1.98@CNVR4717.2@FRMPD2_27, FRMPD2_26, FRMPD2_25@0@0@0@:FERM and PDZ domain containing 2@:basolateral plasma membrane;transferase activity, transferring phosphorus-containing groups;cytoplasm;tight junction;protein binding;cytoskeleton;1-phosphatidylinositol binding;tight junction assembly@NA
A2463_17@96857@96861@deletion@5@51464465@51480527@10@chr10:51464465-51480527@11.4@654@418@0.639@CNVR4729.1@AGAP7_7, AGAP7_6, AGAP7_5, AGAP7_4, AGAP7_3@0@0@0@:translocase of inner mitochondrial membrane 23 homolog B (yeast):ArfGAP with GTPase domain, ankyrin repeat and PH domain 7@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity@NA
A2463_17@96906@96923@duplication@18@51854909@51892705@10@chr10:51854909-51892705@22.3@669@972@1.45@CNVR4734.2@FAM21A_14, FAM21A_15, FAM21A_16, FAM21A_17, FAM21A_18, FAM21A_19, FAM21A_20, FAM21A_21, FAM21A_22, FAM21A_23, FAM21A_24, FAM21A_25, FAM21A_26, FAM21A_27, FAM21A_28, FAM21A_29, FAM21A_30, FAM21A_31@0@0@0@:family with sequence similarity 21, member B;family with sequence similarity 21, member A@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_17@96933@96937@deletion@5@51970584@51978390@10@chr10:51970584-51978390@10.4@94@36@0.383@NA@ASAH2_11, ASAH2_10, ASAH2_9, ASAH2_8, ASAH2_7@0@0@0@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
A2463_17@98355@98357@deletion@3@81608270@81610362@10@chr10:81608270-81610362@10.4@89@28@0.315@NA@FAM22E_5, FAM22E_6, FAM22E_7@0@0@0@NA@NA@NA
A2463_17@98595@98595@deletion@1@88985589@88985969@10@chr10:88985589-88985969@5.98@28@1@0.0357@CNVR4840.3, CNVR4840.5@FAM22A_1@0@0@0@:family with sequence similarity 22, member A@NA@NA
A2463_17@102314@102334@duplication@21@135341986@135373657@10@chr10:135341986-135373657@39.7@1022@1505@1.47@CNVR4989.7, CNVR4989.11, CNVR4989.4@CYP2E1_4, AL161645.2_1, CYP2E1_5, CYP2E1_6, CYP2E1_7, CYP2E1_8, CYP2E1_9, CYP2E1_10, CYP2E1_11, SYCE1_13, SYCE1_12, SYCE1_11, SYCE1_10, SYCE1_9, SYCE1_8, SYCE1_7, SYCE1_6, SYCE1_5, SYCE1_4, SYCE1_3, SYCE1_2@0@0@0@:shadow of prion protein homolog (zebrafish):cytochrome P450, family 2, subfamily E, polypeptide 1:synaptonemal complex central element protein 1@:plasma membrane;membrane;anchored to membrane:steroid metabolic process;oxidation-reduction process;mitochondrion;response to drug;oxygen binding;Golgi membrane;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;response to organic nitrogen;oxidoreductase activity;endoplasmic reticulum membrane;heterocycle metabolic process;monoterpenoid metabolic process;response to ethanol;electron carrier activity;drug metabolic process;intracellular membrane-bounded organelle;small molecule metabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;endoplasmic reticulum;enzyme binding;heme binding;response to ozone;intrinsic to endoplasmic reticulum membrane;xenobiotic metabolic process;monooxygenase activity;triglyceride metabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NADH or NADPH as one donor, and incorporation of one atom of oxygen;iron ion binding:protein binding;synaptonemal complex;meiotic prophase I;cell division;central element@NA
A2463_17@103139@103139@deletion@1@3239175@3240043@11@chr11:3239175-3240043@7.67@110@49@0.445@CNVR5028.1@MRGPRG_1@0@0@0@:MAS-related GPR, member G@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway@NA
A2463_17@103269@103269@duplication@1@4976003@4976943@11@chr11:4976003-4976943@5.17@306@428@1.4@CNVR5040.1@OR51A2_1@0@0@0@:matrix metallopeptidase 26:olfactory receptor, family 51, subfamily A, member 2@:metallopeptidase activity;extracellular matrix;proteolysis;proteinaceous extracellular matrix;collagen catabolic process;metalloendopeptidase activity;zinc ion binding;metabolic process:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_17@103289@103290@duplication@2@5270599@5271034@11@chr11:5270599-5271034@13.4@49@157@3.2@NA@HBG1_2, HBG1_1@0@0@0@:hemoglobin, gamma A@:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex@NA
A2463_17@103292@103293@deletion@2@5275523@5275958@11@chr11:5275523-5275958@11.8@271@139@0.513@NA@HBG2_7, HBG2_6@0@0@0@:hemoglobin, gamma G@:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex@: CYANOSIS, TRANSIENT NEONATAL; TNCY
A2463_17@106046@106048@duplication@3@55370918@55419315@11@chr11:55370918-55419315@11@585@812@1.39@CNVR5179.1@OR4C11_1, OR4P4_1, OR4S2_1@0@0@0@:olfactory receptor, family 4, subfamily C, member 11:olfactory receptor, family 4, subfamily P, member 4:olfactory receptor, family 4, subfamily S, member 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_17@106572@106572@deletion@1@60971580@60971741@11@chr11:60971580-60971741@5.89@26@0@0@CNVR5194.1@PGA3_2@0@0@0@:pepsinogen 3, group I (pepsinogen A)@:proteolysis;extracellular region;digestion;aspartic-type endopeptidase activity@NA
A2463_17@110121@110125@deletion@5@89768381@89773130@11@chr11:89768381-89773130@11.6@211@112@0.531@NA@TRIM49C_3, TRIM49C_4, TRIM49C_5, TRIM49C_6, TRIM49C_7@0@0@0@:tripartite motif containing 49D, pseudogene;tripartite motif containing 49-like 1;tripartite motif containing 49C;tripartite motif-containing protein 49-like protein 1-like@:protein binding;intracellular;DNA binding;zinc ion binding@NA
A2463_17@114136@114139@duplication@4@8374419@8377428@12@chr12:8374419-8377428@41.8@1260@2108@1.67@CNVR5422.3, CNVR5422.5, CNVR5422.6, CNVR5422.1@FAM90A1_7, FAM90A1_6, FAM90A1_5, FAM90A1_4@0@0@0@:family with sequence similarity 90, member A1@:zinc ion binding;nucleic acid binding@NA
A2463_17@114483@114483@duplication@1@11243900@11244828@12@chr12:11243900-11244828@9.1@320@492@1.54@CNVR5434.1@TAS2R43_1@0@0@0@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):taste receptor, type 2, member 14:taste receptor, type 2, member 43@:extracellular space;visual perception:bitter taste receptor activity;taste receptor activity;integral to membrane;sensory perception of taste;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of bitter taste:G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;motile cilium;taste receptor activity;bitter taste receptor activity;integral to membrane;sensory perception of taste;detection of chemical stimulus involved in sensory perception of bitter taste;cilium membrane@NA
A2463_17@124096@124101@duplication@6@21729833@21746643@13@chr13:21729833-21746643@20@778@1127@1.45@NA@SKA3_8, SKA3_7, SKA3_6, SKA3_5, SKA3_4, SKA3_3@0@0@0@:spindle and kinetochore associated complex subunit 3@:spindle microtubule;chromosome segregation;cytoplasm;mitosis;protein binding;regulation of microtubule polymerization or depolymerization;cell division;condensed chromosome outer kinetochore@NA
A2463_17@127332@127332@deletion@1@19377595@19378574@14@chr14:19377595-19378574@11@361@198@0.548@CNVR6072.1, CNVR6072.16@OR11H12_1@0@0@0@:olfactory receptor, family 11, subfamily H, member 12;olfactory receptor, family 11, subfamily H, member 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_17@127336@127349@deletion@14@19561995@20011657@14@chr14:19561995-20011657@50@809@391@0.483@CNVR6072.6, CNVR6072.12@POTEG_4, POTEG_5, POTEG_6, POTEG_7, POTEG_9, POTEG_10, POTEM_10, POTEM_9, POTEM_7, POTEM_6, POTEM_5, POTEM_4@0@0@0@:POTE ankyrin domain family, member G:POTE ankyrin domain family, member M@:protein binding:protein binding@NA
A2463_17@127353@127358@deletion@6@20215588@20404761@14@chr14:20215588-20404761@21.1@2333@1609@0.69@CNVR6072.12, CNVR6072.4, CNVR6072.5@OR4Q3_1, OR4M1_1, OR4N2_1, OR4K2_1, OR4K5_1, OR4K1_1@0@0@0@:olfactory receptor, family 4, subfamily N, member 2:olfactory receptor, family 4, subfamily Q, member 3:olfactory receptor, family 4, subfamily M, member 1:olfactory receptor, family 4, subfamily K, member 2:olfactory receptor, family 4, subfamily K, member 5:olfactory receptor, family 4, subfamily K, member 1@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_17@127735@127752@deletion@18@22409370@22521315@14@chr14:22409370-22521315@23.1@1377@920@0.668@NA@TRAV9-2_1, TRAV9-2_2, TRAV12-3_1, TRAV12-3_2, TRAV8-6_1, TRAV8-6_2, TRAV16_1, TRAV16_2, TRAV17_1, TRAV17_2, TRAV18_1, TRAV18_2, TRAV19_1, TRAV19_2, TRAV20_1, TRAV20_2, TRAV21_1, TRAV21_2@0@0@0@@:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding@NA
A2463_17@127756@127814@deletion@59@22554928@22958531@14@chr14:22554928-22958531@105@4390@2805@0.639@NA@TRAV23DV6_2, TRDV1_1, TRDV1_2, TRAV24_1, TRAV24_2, TRAV25_1, TRAV25_2, TRAV26-1_2, TRAV8-7_1, TRAV8-7_2, TRAV27_1, TRAV27_2, TRAV29DV5_1, TRAV29DV5_2, TRAV30_1, TRAV30_2, TRAV26-2_2, TRAV34_1, TRAV34_2, TRAV35_1, TRAV35_2, TRAV36DV7_1, TRAV36DV7_2, TRAV38-1_1, TRAV38-1_2, TRAV38-2DV8_1, TRAV38-2DV8_2, TRAV39_1, TRAV39_2, TRAV40_1, TRAV40_2, TRAV41_1, TRAV41_2, TRDV2_1, TRDV2_2, TRDJ1_1, TRDJ4_1, TRDJ2_1, TRDJ3_1, TRDC_1, TRDC_2, TRDC_3, TRDV3_2, TRAJ61_1, TRAJ59_1, TRAJ58_1, TRAJ57_1, TRAJ56_1, TRAJ54_1, TRAJ53_1, TRAJ52_1, TRAJ50_1, TRAJ49_1@0@0@0@@:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:integral to membrane:protein binding@NA
A2463_17@131032@131034@duplication@3@74004127@74010359@14@chr14:74004127-74010359@23.4@327@581@1.78@CNVR6188.1, CNVR6188.4@ACOT1_1, ACOT1_2, ACOT1_3@0@0@0@:HEAT repeat containing 4:acyl-CoA thioesterase 1@:protein binding;binding:hydrolase activity;mitochondrion;acyl-CoA metabolic process;very long-chain fatty acid metabolic process;thiolester hydrolase activity;acyl-CoA hydrolase activity;cytosol;palmitoyl-CoA hydrolase activity;long-chain fatty acid metabolic process;carboxylesterase activity@NA
A2463_17@133342@133352@duplication@11@106053275@106092403@14@chr14:106053275-106092403@84.2@1014@1898@1.87@CNVR6294.46, CNVR6294.20, CNVR6294.54, CNVR6294.43@IGHA2_3, IGHA2_2, IGHA2_1, IGHE_4, IGHE_3, IGHE_2, IGHE_1, IGHG4_4, IGHG4_3, IGHG4_2, IGHG4_1@0@0@0@@:protein binding:antigen binding;protein binding;immune response:antigen binding;protein binding;complement activation;extracellular region;immune response;membrane;complement activation, classical pathway;innate immune response@NA
A2463_17@133354@133356@duplication@3@106109961@106111127@14@chr14:106109961-106111127@19.6@293@511@1.74@CNVR6294.46, CNVR6294.20, CNVR6294.43, CNVR6294.50, CNVR6294.64@IGHG2_3, IGHG2_2, IGHG2_1@0@0@0@@:antigen binding;protein binding;complement activation;extracellular region;immune response;membrane;complement activation, classical pathway;innate immune response@NA
A2463_17@133366@133366@deletion@1@106235575@106235896@14@chr14:106235575-106235896@5.56@140@78@0.557@CNVR6294.46, CNVR6294.66, CNVR6294.68, CNVR6294.19, CNVR6294.35@IGHG3_7@0@0@0@@:protein binding@NA
A2463_17@133369@133370@deletion@2@106236631@106236862@14@chr14:106236631-106236862@6.58@48@13@0.271@CNVR6294.66, CNVR6294.68, CNVR6294.19, CNVR6294.35, CNVR6294.47@IGHG3_4, IGHG3_3@0@0@0@@:protein binding@NA
A2463_17@133432@133435@duplication@4@106539080@106552729@14@chr14:106539080-106552729@10.5@157@260@1.66@CNVR6294.36, CNVR6294.48, CNVR6294.24, CNVR6294.10, CNVR6294.34@IGHV1-8_2, IGHV1-8_1, IGHV3-9_2, IGHV3-9_1@0@0@0@@:protein binding:protein binding@NA
A2463_17@133462@133462@deletion@1@106815723@106816026@14@chr14:106815723-106816026@5.48@76@35@0.461@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.56, CNVR6294.51@IGHV3-33_2@0@0@0@@:protein binding@NA
A2463_17@133499@133500@deletion@2@107178821@107179262@14@chr14:107178821-107179262@4.93@104@57@0.548@CNVR6294.6, CNVR6294.92@IGHV2-70_2, IGHV2-70_1@0@0@0@@:protein binding@NA
A2463_17@133509@133512@deletion@4@20739498@20743636@15@chr15:20739498-20743636@8.85@318@186@0.585@CNVR6296.13@GOLGA6L6_8, GOLGA6L6_7, GOLGA6L6_6, GOLGA6L6_5@0@0@0@:putative transmembrane protein FLJ36131-like;putative transmembrane protein ENSP00000320207-like;golgin A6 family-like 6@NA@NA
A2463_17@133826@133826@duplication@1@28467175@28467361@15@chr15:28467175-28467361@9.01@51@125@2.45@CNVR6328.1@HERC2_36@0@0@0@:putative HERC2-like protein 3-like;HECT and RLD domain containing E3 ubiquitin protein ligase 2@:mitochondrial inner membrane;protein ubiquitination involved in ubiquitin-dependent protein catabolic process;guanyl-nucleotide exchange factor activity;SUMO binding;DNA repair;intracellular protein transport;spermatogenesis;cellular protein modification process;nucleus;ubiquitin protein ligase binding;ubiquitin-protein ligase activity;centriole;intracellular;response to DNA damage stimulus;heme binding;cytoplasm;protein binding;zinc ion binding;protein ubiquitination;metal ion binding@: SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1; SHEP1
A2463_17@133977@133982@deletion@6@30379779@30382483@15@chr15:30379779-30382483@8.37@199@115@0.578@NA@GOLGA8J_8, GOLGA8J_9, GOLGA8J_10, GOLGA8J_11, GOLGA8J_12, GOLGA8J_13@0@0@0@:golgin A8 family, member J@:Golgi apparatus@NA
A2463_17@134036@134036@duplication@1@30845996@30846114@15@chr15:30845996-30846114@5.47@38@83@2.18@NA@GOLGA8Q_2@0@0@0@@:Golgi apparatus@NA
A2463_17@134158@134161@deletion@4@32684984@32685771@15@chr15:32684984-32685771@21.7@150@36@0.24@NA@GOLGA8K_19, GOLGA8K_18, GOLGA8K_17, GOLGA8K_16@0@0@0@:golgin A8 family, member J@:Golgi apparatus@NA
A2463_17@134173@134190@deletion@18@32692342@32743403@15@chr15:32692342-32743403@40.7@283@69@0.244@CNVR6346.1@GOLGA8K_4, GOLGA8K_3, GOLGA8K_2, AC139426.2_1, GOLGA8K_1, GOLGA8O_19, GOLGA8O_18, GOLGA8O_17, GOLGA8O_16, GOLGA8O_15, GOLGA8O_14, GOLGA8O_13, GOLGA8O_12, GOLGA8O_11, GOLGA8O_10, GOLGA8O_9, GOLGA8O_8, GOLGA8O_7@0@0@0@:golgin A8 family, member J:golgin A8 family, member O@:Golgi apparatus:Golgi apparatus@NA
A2463_17@134204@134205@duplication@2@32890090@32890378@15@chr15:32890090-32890378@7.59@76@143@1.88@NA@GOLGA8N_7, GOLGA8N_8@0@0@0@:golgin A8 family, member R@:Golgi apparatus@NA
A2463_17@138281@138287@duplication@7@72953606@72957376@15@chr15:72953606-72957376@12.1@275@419@1.52@CNVR6443.1@GOLGA6B_8, GOLGA6B_9, GOLGA6B_10, GOLGA6B_11, GOLGA6B_12, GOLGA6B_13, GOLGA6B_14@0@0@0@:golgin A6 family, member B@:Golgi apparatus@NA
A2463_17@138421@138422@deletion@2@74368025@74368326@15@chr15:74368025-74368326@9.91@109@42@0.385@CNVR6448.1@GOLGA6A_9, GOLGA6A_8@0@0@0@:golgin A6 family, member C;golgin A6 family, member A;golgin A6 family, member D;golgin A6 family, member B@:Golgi apparatus@NA
A2463_17@139296@139299@duplication@4@82934267@82936608@15@chr15:82934267-82936608@7.7@96@173@1.8@CNVR6477.6, CNVR6477.7@RP13-996F3.5_6, RP13-996F3.5_5, RP13-996F3.5_4, RP13-996F3.5_3@0@0@0@NA@NA@NA
A2463_17@139305@139308@deletion@4@83013228@83015609@15@chr15:83013228-83015609@6.35@36@5@0.139@CNVR6477.6, CNVR6477.2@RP13-996F3.4_6, RP13-996F3.4_5, RP13-996F3.4_4, RP13-996F3.4_3@0@0@0@NA@NA@NA
A2463_17@139480@139482@deletion@3@84909802@84911344@15@chr15:84909802-84911344@7.99@122@59@0.484@CNVR6486.2@GOLGA6L4_7, GOLGA6L4_8, GOLGA6L4_9@0@0@0@@:Golgi apparatus@NA
A2463_17@140476@140478@deletion@3@64382@65633@16@chr16:64382-65633@13.6@83@14@0.169@CNVR6565.1@WASH4P_10, WASH4P_9, WASH4P_8@0@0@0@@:intracellular membrane-bounded organelle;endosomal transport;recycling endosome;early endosome;Arp2/3 complex-mediated actin nucleation;actin binding;alpha-tubulin binding;retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;recycling endosome membrane@NA
A2463_17@140482@140484@deletion@3@67292@68068@16@chr16:67292-68068@7.75@166@93@0.56@CNVR6565.1@WASH4P_4, WASH4P_3, WASH4P_2@0@0@0@@:intracellular membrane-bounded organelle;endosomal transport;recycling endosome;early endosome;Arp2/3 complex-mediated actin nucleation;actin binding;alpha-tubulin binding;retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;recycling endosome membrane@NA
A2463_17@142651@142651@duplication@1@14858861@14859270@16@chr16:14858861-14859270@10.3@67@158@2.36@CNVR6644.1@RP11-719K4.2_8@0@0@0@:nuclear pore complex-interacting protein-like 1-like@NA@NA
A2463_17@142676@142676@deletion@1@14975402@14975542@16@chr16:14975402-14975542@10.6@87@24@0.276@NA@NOMO1_25@0@0@0@:NODAL modulator 1;nodal modulator 1-like@:carbohydrate binding;integral to membrane;carboxypeptidase activity;molecular_function;cellular_component;biological_process@NA
A2463_17@142681@142706@deletion@26@14988856@15123913@16@chr16:14988856-15123913@90.4@1789@935@0.523@CNVR6646.1@NOMO1_30, NOMO1_31, NPIP_1, NPIP_2, NPIP_3, NPIP_4, NPIP_5, NPIP_6, NPIP_7, NPIP_8, PDXDC1_1, PDXDC1_2, PDXDC1_3, PDXDC1_4, PDXDC1_5, PDXDC1_6, PDXDC1_7, PDXDC1_8, PDXDC1_9, PDXDC1_10, PDXDC1_11, PDXDC1_12, PDXDC1_13, PDXDC1_14, PDXDC1_15, PDXDC1_16@0@0@0@:NODAL modulator 1;nodal modulator 1-like:nuclear pore complex-interacting protein-like;nuclear pore complex interacting protein;nuclear pore complex-interacting protein-like 1-like:pyridoxal-dependent decarboxylase domain containing 1;pyridoxal-dependent decarboxylase domain-containing protein 1-like@:carbohydrate binding;integral to membrane;carboxypeptidase activity;molecular_function;cellular_component;biological_process:nuclear membrane;protein transport;nuclear pore;mRNA transport:carboxylic acid metabolic process;pyridoxal phosphate binding;carboxy-lyase activity@NA
A2463_17@142749@142753@deletion@5@15224945@15460617@16@chr16:15224945-15460617@47.7@374@95@0.254@NA@NPIPP1_1, PKD1P1_8, PKD1P1_7, PKD1P1_6, PKD1P1_5@0@0@0@:pyridoxal-dependent decarboxylase domain containing 1;pyridoxal-dependent decarboxylase domain-containing protein 1-like:nuclear pore complex-interacting protein-like:NPIP-like protein 1-like;nuclear pore complex-interacting protein-like 1-like@:carboxylic acid metabolic process;pyridoxal phosphate binding;carboxy-lyase activity:neuropeptide signaling pathway;integral to membrane;plasma membrane;membrane@NA
A2463_17@142971@142971@duplication@1@18414875@18414981@16@chr16:18414875-18414981@6.64@38@91@2.39@CNVR6658.1@RP11-1212A22.2_7@0@0@0@NA@NA@NA
A2463_17@143488@143491@deletion@4@21847327@21854902@16@chr16:21847327-21854902@9.95@377@229@0.607@CNVR6668.5, CNVR6668.7@NPIPL3_7, NPIPL3_6, NPIPL3_5, NPIPL3_4@0@0@0@:nuclear pore complex interacting protein-like 3;nuclear pore complex interacting protein-like;nuclear pore complex-interacting protein-like 3-like@NA@NA
A2463_17@144052@144052@duplication@1@28478042@28478223@16@chr16:28478042-28478223@10.8@42@127@3.02@NA@NPIPL1_2@0@0@0@:ceroid-lipofuscinosis, neuronal 3@:membrane:negative regulation of apoptotic process;late endosome;mitochondrion;galactosylceramide metabolic process;neuromuscular process controlling balance;neuron projection;lysosomal lumen pH elevation;integral to endoplasmic reticulum membrane;cell death;plasma membrane;nucleus;lysosomal lumen acidification;negative regulation of catalytic activity;negative regulation of macroautophagy;unfolded protein binding;neurotransmitter metabolic process;endoplasmic reticulum;vesicle transport along microtubule;protein catabolic process;autophagic vacuole;early endosome;trans-Golgi network;cellular membrane organization;ceramide metabolic process;glucosylceramide metabolic process;negative regulation of neuron apoptotic process;membrane;globoside metabolic process;membrane raft;synaptic vesicle;vacuolar transport;protein processing;Golgi membrane;caveola;protein folding;ionotropic glutamate receptor signaling pathway;cytosolic calcium ion homeostasis;Golgi stack;integral to membrane;receptor-mediated endocytosis;arginine transport;lysosome;negative regulation of proteolysis;Golgi apparatus;lysosome organization;associative learning;sphingomyelin metabolic process;macroautophagy;lysosomal membrane;amyloid precursor protein catabolic process;cytoplasm;autophagic vacuole fusion;protein binding;regulation of action potential;cellular amino acid metabolic process@: CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3
A2463_17@144052@144053@deletion@1@28478042@28481759@16@chr16:28478042-28481759@-9.74@134@167@1.25@NA@NPIPL1_2, NPIPL1_1@0@0@0@:ceroid-lipofuscinosis, neuronal 3@:membrane:negative regulation of apoptotic process;late endosome;mitochondrion;galactosylceramide metabolic process;neuromuscular process controlling balance;neuron projection;lysosomal lumen pH elevation;integral to endoplasmic reticulum membrane;cell death;plasma membrane;nucleus;lysosomal lumen acidification;negative regulation of catalytic activity;negative regulation of macroautophagy;unfolded protein binding;neurotransmitter metabolic process;endoplasmic reticulum;vesicle transport along microtubule;protein catabolic process;autophagic vacuole;early endosome;trans-Golgi network;cellular membrane organization;ceramide metabolic process;glucosylceramide metabolic process;negative regulation of neuron apoptotic process;membrane;globoside metabolic process;membrane raft;synaptic vesicle;vacuolar transport;protein processing;Golgi membrane;caveola;protein folding;ionotropic glutamate receptor signaling pathway;cytosolic calcium ion homeostasis;Golgi stack;integral to membrane;receptor-mediated endocytosis;arginine transport;lysosome;negative regulation of proteolysis;Golgi apparatus;lysosome organization;associative learning;sphingomyelin metabolic process;macroautophagy;lysosomal membrane;amyloid precursor protein catabolic process;cytoplasm;autophagic vacuole fusion;protein binding;regulation of action potential;cellular amino acid metabolic process@: CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3
A2463_17@144095@144101@duplication@7@28607105@28619924@16@chr16:28607105-28619924@18.4@466@701@1.5@CNVR6685.1@SULT1A2_2, SULT1A1_10, SULT1A1_9, SULT1A1_8, SULT1A1_7, SULT1A1_6, SULT1A1_5@0@0@0@:sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2:sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1@:steroid metabolic process;small molecule metabolic process;sulfation;aryl sulfotransferase activity;catecholamine metabolic process;cytosol;xenobiotic metabolic process;phenol-containing compound metabolic process;sulfotransferase activity;amine biosynthetic process;flavonol 3-sulfotransferase activity;3'-phosphoadenosine 5'-phosphosulfate metabolic process:small molecule metabolic process;sulfation;aryl sulfotransferase activity;amine metabolic process;catecholamine metabolic process;xenobiotic metabolic process;cytosol;steroid sulfotransferase activity;integral to membrane;sulfotransferase activity;flavonol 3-sulfotransferase activity;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process;estrogen metabolic process@NA
A2463_17@145013@145013@deletion@1@32264676@32265036@16@chr16:32264676-32265036@7.82@235@132@0.562@CNVR6701.6, CNVR6701.2@TP53TG3D_1@0@0@0@:TP53 target 3B;TP53 target 3;TP53-target gene 3 protein-like;TP53 target 3C@:nucleus;cytoplasm@NA
A2463_17@145554@145556@duplication@3@55844430@55846955@16@chr16:55844430-55846955@6.84@577@765@1.33@CNVR6731.1@CES1_11, CES1_10, CES1_9@0@0@0@:carboxylesterase 1;liver carboxylesterase 1-like@:hydrolase activity;methyl salicylate esterase activity;response to toxin;methylumbelliferyl-acetate deacetylase activity;endoplasmic reticulum lumen;retinyl-palmitate esterase activity;methyl jasmonate esterase activity;metabolic process;carboxylesterase activity;methyl indole-3-acetate esterase activity@: CARBOXYLESTERASE 1; CES1
A2463_17@147423@147423@deletion@1@72097156@72097159@16@chr16:72097156-72097159@9.2@73@20@0.274@CNVR6769.1@HPR_1@0@0@0@:thioredoxin-like 4B:haptoglobin-related protein@:mitosis;mRNA processing;RNA splicing;spliceosomal complex;cell redox homeostasis:spherical high-density lipoprotein particle;proteolysis;extracellular region;hemoglobin binding;catalytic activity;serine-type endopeptidase activity@NA
A2463_17@147513@147513@deletion@1@74451958@74452196@16@chr16:74451958-74452196@12@63@5@0.0794@CNVR6778.2, CNVR6778.3@CLEC18B_3@0@0@0@:C-type lectin domain family 18, member B@:carbohydrate binding;protein binding;extracellular region@NA
A2463_17@148609@148623@deletion@15@89824986@89849510@16@chr16:89824986-89849510@72.2@1799@1004@0.558@NA@FANCA_30, FANCA_29, FANCA_28, FANCA_27, FANCA_26, FANCA_25, FANCA_24, FANCA_23, FANCA_22, FANCA_21, FANCA_20, FANCA_19, FANCA_18, FANCA_17, FANCA_16@0@0@0@:Fanconi anemia, complementation group A@:nucleoplasm;male gonad development;Fanconi anaemia nuclear complex;protein complex assembly;regulation of cell proliferation;cytoplasm;male meiosis;DNA repair;protein binding;female gonad development;nucleus@: FANCONI ANEMIA, COMPLEMENTATION GROUP A; FANCA
A2463_17@151422@151423@deletion@2@15539351@15546130@17@chr17:15539351-15546130@4.98@72@34@0.472@NA@TRIM16_3, TRIM16_8, TRIM16_2, TRIM16_7@0@0@0@:tripartite motif containing 16@:protein binding;intracellular;zinc ion binding;cytoplasm:histone H4 acetylation;response to growth hormone stimulus;NACHT domain binding;DNA binding;positive regulation of keratinocyte differentiation;response to organophosphorus;interleukin-1 binding;PML body;positive regulation of interleukin-1 beta secretion;intracellular;regulation of transcription, DNA-dependent;response to retinoic acid;cytoplasm;positive regulation of transcription, DNA-dependent;protein binding;positive regulation of retinoic acid receptor signaling pathway;histone H3 acetylation;zinc ion binding;nucleic acid binding@NA
A2463_17@153363@153370@duplication@8@34493376@34499323@17@chr17:34493376-34499323@7.92@208@305@1.47@CNVR7077.1, CNVR7077.3, CNVR7077.11, CNVR7077.16@TBC1D3B_14, TBC1D3B_13, TBC1D3B_12, TBC1D3B_11, TBC1D3B_10, TBC1D3B_9, TBC1D3B_8, TBC1D3B_7@0@0@0@:TBC1 domain family, member 3B@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_17@153376@153394@deletion@19@34522686@34590454@17@chr17:34522686-34590454@24.8@135@16@0.119@CNVR7077.1, CNVR7077.13, CNVR7077.19@CCL3L3_3, CCL3L3_2, CCL3L3_1, CCL4L1_1, CCL4L1_2, CCL4L1_3, TBC1D3C_14, TBC1D3C_13, TBC1D3C_12, TBC1D3C_11, TBC1D3C_10, TBC1D3C_9, TBC1D3C_8, TBC1D3C_7, TBC1D3C_6, TBC1D3C_5, TBC1D3C_4, TBC1D3C_3, TBC1D3C_2@0@0@0@:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1:TBC1 domain family, member 3C;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3H-like;TBC1 domain family, member 3H@:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_17@153414@153414@deletion@1@34797487@34798054@17@chr17:34797487-34798054@21.1@99@0@0@CNVR7078.2, CNVR7078.3@TBC1D3G_14@0@0@0@:TBC1 domain family member 3H-like;TBC1 domain family, member 3H:TBC1 domain family, member 3;TBC1 domain family, member 3G;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like;TBC1 domain family, member 3H@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_17@154346@154346@deletion@1@39421631@39422112@17@chr17:39421631-39422112@4.69@53@22@0.415@CNVR7096.1@KRTAP9-6_1@0@0@0@:keratin associated protein 9-6@:keratin filament@NA
A2463_17@155580@155582@duplication@3@44171927@44375108@17@chr17:44171927-44375108@7.86@716@955@1.33@CNVR7114.3, CNVR7114.2@KANSL1_3, KANSL1_2, LRRC37A_1@0@0@0@:KAT8 regulatory NSL complex subunit 1:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:histone acetyltransferase activity (H4-K8 specific);histone acetyltransferase activity (H4-K16 specific);histone acetyltransferase activity (H4-K5 specific);histone acetyltransferase complex;histone H4-K5 acetylation;MLL1 complex;histone H4-K16 acetylation;protein binding;histone H4-K8 acetylation;nucleus:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
A2463_17@155592@155595@deletion@4@44412912@44415089@17@chr17:44412912-44415089@14.1@65@1@0.0154@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A_11, LRRC37A_12, LRRC37A_13, LRRC37A_14@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
A2463_17@155599@155600@deletion@2@44590080@44594799@17@chr17:44590080-44594799@23.3@112@2@0.0179@CNVR7114.2, CNVR7114.5@LRRC37A2_2, LRRC37A2_3@0@0@0@:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
A2463_17@155604@155612@duplication@9@44617543@44632945@17@chr17:44617543-44632945@17.7@1612@2148@1.33@CNVR7114.2, CNVR7114.5, CNVR7114.4@LRRC37A2_7, LRRC37A2_8, LRRC37A2_9, LRRC37A2_10, LRRC37A2_11, LRRC37A2_12, LRRC37A2_13, LRRC37A2_14, LRRC37A2_15@0@0@0@:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
A2463_17@156877@156878@deletion@2@57656834@57657240@17@chr17:57656834-57657240@15.8@72@0@0@NA@DHX40_9, DHX40_10@0@0@0@:DEAH (Asp-Glu-Ala-His) box polypeptide 40@:transport;helicase activity;intracellular;ATP-dependent helicase activity;nucleic acid binding;ATP binding@NA
A2463_17@157453@157453@duplication@1@61973436@61973595@17@chr17:61973436-61973595@5.38@18@56@3.11@NA@CSH1_2@0@0@0@:chorionic somatomammotropin hormone 1 (placental lactogen);chorionic somatomammotropin hormone-like 1@:JAK-STAT cascade involved in growth hormone signaling pathway;signal transduction;hormone activity;extracellular region;female pregnancy;metal ion binding@NA
A2463_17@162017@162018@deletion@2@44542732@44550298@18@chr18:44542732-44550298@83.2@420@1@0.00238@CNVR7319.1, CNVR7319.2@TCEB3CL2_1, TCEB3CL_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2:transcription elongation factor B polypeptide 3C-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_17@162017@162019@duplication@1@44542732@44556213@18@chr18:44542732-44556213@-63.3@2389@3267@1.37@CNVR7319.1, CNVR7319.2@TCEB3CL2_1, TCEB3CL_1, TCEB3C_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2:transcription elongation factor B polypeptide 3C-like:transcription elongation factor B polypeptide 3C (elongin A3);RNA polymerase II transcription factor SIII subunit A3-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_17@166381@166382@deletion@2@12543192@12544011@19@chr19:12543192-12544011@6.65@194@115@0.593@CNVR7541.1@ZNF443_3, ZNF443_2@0@0@0@:zinc finger protein 443@:intracellular;regulation of transcription, DNA-dependent;nucleic acid binding:intracellular;DNA binding;regulation of transcription, DNA-dependent;response to stress;induction of apoptosis;nucleus;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:intracellular;regulation of transcription, DNA-dependent;nucleic acid binding@NA
A2463_17@167612@167620@duplication@9@17444232@17450408@19@chr19:17444232-17450408@12.5@368@529@1.44@CNVR7562.1@ANO8_3, ANO8_2, ANO8_1, GTPBP3_1, GTPBP3_2, GTPBP3_3, GTPBP3_4, GTPBP3_5, GTPBP3_6@0@0@0@:anoctamin 8:GTP binding protein 3 (mitochondrial)@:chloride channel activity;chloride channel complex;intracellular:mitochondrion;GTP binding;GTPase activity;metal ion binding;tRNA modification@: DEAFNESS, AMINOGLYCOSIDE-INDUCED
A2463_17@168952@168952@deletion@1@35862263@35863302@19@chr19:35862263-35863302@7.47@120@57@0.475@CNVR7627.1@GPR42_2@0@0@0@@:integral to membrane;G-protein coupled receptor activity;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
A2463_17@169783@169784@deletion@2@39281330@39282333@19@chr19:39281330-39282333@5.83@120@64@0.533@NA@LGALS7B_3, LGALS7B_4@0@0@0@:lectin, galactoside-binding, soluble, 7;lectin, galactoside-binding, soluble, 7B@:carbohydrate binding;heterophilic cell-cell adhesion;extracellular space;nucleus;apoptotic process;cytoplasm@NA
A2463_17@170358@170366@deletion@9@41349702@41356331@19@chr19:41349702-41356331@21.2@526@306@0.582@CNVR7642.1@CYP2A6_9, CYP2A6_8, CYP2A6_7, CYP2A6_6, CYP2A6_5, CYP2A6_4, CYP2A6_3, CYP2A6_2, CYP2A6_1@0@0@0@:cytochrome P450, family 2, subfamily A, polypeptide 6@:coumarin 7-hydroxylase activity;steroid metabolic process;oxidation-reduction process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;endoplasmic reticulum membrane;drug metabolic process;electron carrier activity;small molecule metabolic process;exogenous drug catabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;enzyme binding;heme binding;xenobiotic metabolic process;iron ion binding;coumarin catabolic process;coumarin metabolic process@: CYTOCHROME P450, SUBFAMILY IIA, POLYPEPTIDE 6; CYP2A6
A2463_17@173459@173474@deletion@16@55246721@55290114@19@chr19:55246721-55290114@144@797@89@0.112@CNVR7725.2, CNVR7725.1@KIR3DL3_6, KIR3DL3_7, KIR3DL3_8, KIR2DL3_1, KIR2DL3_2, KIR2DL3_3, KIR2DL3_4, KIR2DL3_5, KIR2DL3_6, KIR2DL3_7, KIR2DL3_8, KIR2DL1_1, KIR2DL1_2, KIR2DL1_3, KIR2DL1_4, KIR2DL1_5@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:integral to membrane;plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane@NA
A2463_17@173478@173504@duplication@27@55315108@55363737@19@chr19:55315108-55363737@47.3@1019@1549@1.52@CNVR7725.1, CNVR7725.6@KIR2DL4_1, KIR2DL4_2, KIR2DL4_3, KIR2DL4_4, KIR2DL4_5, KIR2DL4_6, KIR2DL4_7, KIR3DL1_1, KIR3DL1_2, KIR3DL1_3, KIR3DL1_4, KIR3DL1_5, KIR3DL1_6, KIR3DL1_7, KIR3DL1_8, KIR3DL1_9, KIR2DS4_1, KIR2DS4_2, KIR2DS4_3, KIR2DS4_4, KIR2DS4_5, KIR2DS4_6, KIR2DS4_7, KIR2DS4_8, KIR3DL2_1, KIR3DL2_2, KIR3DL2_3@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2-like@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane@NA
A2463_17@174403@174403@deletion@1@1895746@1896101@20@chr20:1895746-1896101@5.5@112@59@0.527@CNVR7764.2@SIRPA_2@0@0@0@:signal-regulatory protein alpha@:blood coagulation;protein binding;integral to membrane;SH3 domain binding;cell adhesion;plasma membrane;membrane;leukocyte migration@NA
A2463_17@175736@175737@deletion@2@26061801@26063616@20@chr20:26061801-26063616@4.77@152@93@0.612@CNVR7823.4, CNVR7823.3, CNVR7823.5, CNVR7823.1@FAM182A_4, FAM182A_5@0@0@0@NA@NA@NA
A2463_17@179020@179021@deletion@2@15011837@15013887@21@chr21:15011837-15013887@18.8@90@2@0.0222@CNVR7952.1@POTED_10, POTED_11@0@0@0@:POTE ankyrin domain family, member B;POTE ankyrin domain family, member C;POTE ankyrin domain family, member D@:protein binding;plasma membrane@NA
A2463_17@180968@180970@deletion@3@16266930@16269943@22@chr22:16266930-16269943@13.2@316@168@0.532@CNVR8071.2, CNVR8071.3@POTEH_9, POTEH_8, POTEH_7@0@0@0@:POTE ankyrin domain family, member H@:protein binding@NA
A2463_17@180976@180976@deletion@1@16287255@16287885@22@chr22:16287255-16287885@43.8@229@3@0.0131@CNVR8071.2, CNVR8071.3, CNVR8071.9@POTEH_1@0@0@0@:POTE ankyrin domain family, member H@:protein binding@NA
A2463_17@181129@181133@duplication@5@18727044@18739404@22@chr22:18727044-18739404@8.4@41@101@2.46@CNVR8087.5, CNVR8087.2, CNVR8087.11@AC008132.1_4, AC008132.1_5, AC008132.1_6, AC008132.1_7, AC008132.1_8@0@0@0@NA@NA@NA
A2463_17@181129@181134@deletion@1@18727044@18835833@22@chr22:18727044-18835833@-9.45@235@203@0.864@CNVR8087.5, CNVR8087.2, CNVR8087.7@AC008132.1_4, AC008132.1_5, AC008132.1_6, AC008132.1_7, AC008132.1_8, AC008132.13_1@0@0@0@NA@NA@NA
A2463_17@181417@181420@duplication@4@20366369@20367356@22@chr22:20366369-20367356@6.92@29@77@2.66@CNVR8094.9, CNVR8094.4, CNVR8094.3@GGTLC3_5, GGTLC3_4, GGTLC3_3, GGTLC3_2@0@0@0@@:leukotriene biosynthetic process;glutathione metabolic process;gamma-glutamyltransferase activity;anchored to external side of plasma membrane@NA
A2463_17@181624@181632@deletion@9@21562879@21576241@22@chr22:21562879-21576241@28.6@215@59@0.274@CNVR8100.4, CNVR8100.10, CNVR8100.7@GGT2_14, GGT2_13, GGT2_12, GGT2_11, GGT2_10, GGT2_9, GGT2_8, GGT2_7, GGT2_6@0@0@0@:gamma-glutamyltransferase 2;gamma-glutamyltranspeptidase 2-like@:hydrolase activity;small molecule metabolic process;leukotriene biosynthetic process;anchored to external side of plasma membrane;glutathione biosynthetic process;xenobiotic metabolic process;integral to membrane;glutathione metabolic process;plasma membrane;gamma-glutamyltransferase activity;cellular_component@NA
A2463_17@181634@181635@duplication@2@21579681@21743067@22@chr22:21579681-21743067@11.5@118@230@1.95@CNVR8100.4, CNVR8100.7, CNVR8100.16, CNVR8100.3@GGT2_4, RIMBP3B_1@0@0@0@:gamma-glutamyltransferase 2;gamma-glutamyltranspeptidase 2-like:RIMS binding protein 3B@:hydrolase activity;small molecule metabolic process;leukotriene biosynthetic process;anchored to external side of plasma membrane;glutathione biosynthetic process;xenobiotic metabolic process;integral to membrane;glutathione metabolic process;plasma membrane;gamma-glutamyltransferase activity;cellular_component:protein binding@NA
A2463_17@181951@181955@deletion@5@24376424@24384231@22@chr22:24376424-24384231@30.2@138@0@0@CNVR8114.13, CNVR8114.1, CNVR8114.7@GSTT1_5, GSTT1_4, GSTT1_3, GSTT1_2, GSTT1_1@0@0@0@:glutathione S-transferase theta 1@:glutathione peroxidase activity;response to drug;transferase activity;cytosol;protein binding;glutathione transferase activity;glutathione metabolic process;response to organic cyclic compound@NA
A2463_19@6@7@deletion@2@69092@139309@1@chr1:69092-139309@28.3@656@322@0.491@CNVR1.2@OR4F5_1, AL627309.1_1@0@0@0@:olfactory receptor, family 4, subfamily F, member 5@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_19@428@434@deletion@7@1637082@1643839@1@chr1:1637082-1643839@18.9@124@26@0.21@CNVR17.1@CDK11A_12, CDK11A_11, CDK11A_10, CDK11A_9, CDK11A_8, CDK11A_7, CDK11A_6@0@0@0@:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A@:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division@NA
A2463_19@1819@1824@duplication@6@12952748@12980233@1@chr1:12952748-12980233@18.7@457@709@1.55@CNVR72.3, CNVR72.4, CNVR72.2@PRAMEF10_4, PRAMEF10_3, PRAMEF10_2, PRAMEF7_2, PRAMEF7_3, PRAMEF7_4@0@0@0@:PRAME family member 10:PRAME family member 7@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_19@5149@5149@deletion@1@39987049@39987242@1@chr1:39987049-39987242@5.81@28@1@0.0357@NA@BMP8A_4@0@0@0@:bone morphogenetic protein 8a@:cell differentiation;growth factor activity;extracellular space;growth;cytokine activity;cartilage development;ossification@NA
A2463_19@9340@9358@duplication@19@104114226@104166843@1@chr1:104114226-104166843@155@2170@4001@1.84@CNVR266.8, CNVR266.3@AMY2B_3, AMY2B_4, AMY2B_5, AMY2B_6, AMY2B_7, AMY2B_8, AMY2B_9, AMY2B_10, AMY2B_11, AMY2B_12, AMY2A_1, AMY2A_2, AMY2A_3, AMY2A_4, AMY2A_5, AMY2A_6, AMY2A_7, AMY2A_8, AMY2A_9@0@0@0@:actin, gamma 1 pseudogene 4;amylase, alpha 2B (pancreatic):amylase, alpha 2A (pancreatic)@:extracellular region;cation binding;digestion;carbohydrate metabolic process;catalytic activity;alpha-amylase activity;metal ion binding:chloride ion binding;cation binding;small molecule metabolic process;carbohydrate metabolic process;catalytic activity;extracellular space;polysaccharide digestion;extracellular region;carbohydrate catabolic process;alpha-amylase activity;calcium ion binding@NA
A2463_19@9365@9374@deletion@10@104202983@104234232@1@chr1:104202983-104234232@20@226@94@0.416@CNVR266.3, CNVR266.1, CNVR266.15@AMY1A_7, AMY1A_8, AMY1A_9, AMY1A_10, AMY1A_11, AMY1B_11, AMY1B_10, AMY1B_9, AMY1B_8, AMY1B_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
A2463_19@9385@9386@duplication@2@104297122@104297436@1@chr1:104297122-104297436@34.1@323@731@2.26@CNVR266.3, CNVR266.5@AMY1C_6, AMY1C_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
A2463_19@9766@9773@duplication@8@110230497@110235917@1@chr1:110230497-110235917@28@255@493@1.93@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_1, GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
A2463_19@10793@10796@duplication@4@144339779@144811957@1@chr1:144339779-144811957@19.3@249@444@1.78@NA@AL592284.1_1, PPIAL4B_1, AL592284.1_2, NBPF9_1@0@0@0@:uncharacterized LOC730256;uncharacterized LOC101060698;uncharacterized LOC642441:peptidylprolyl isomerase A (cyclophilin A)-like 4C;peptidyl-prolyl cis-trans isomerase A-like 4A/B/C-like;peptidylprolyl isomerase A (cyclophilin A)-like 4B;peptidylprolyl isomerase A (cyclophilin A)-like 4A:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 24@:protein folding;peptidyl-prolyl cis-trans isomerase activity;cytoplasm@NA
A2463_19@10862@10862@deletion@1@145295424@145295525@1@chr1:145295424-145295525@6.31@72@29@0.403@CNVR341.2, CNVR341.3, CNVR341.4@NBPF10_2@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family, member 10@:protein binding;calcium ion binding@NA
A2463_19@10890@10893@duplication@4@145325953@145328432@1@chr1:145325953-145328432@8.41@63@132@2.1@CNVR341.2, CNVR341.3@NBPF10_30, NBPF10_31, NBPF10_32, NBPF10_33@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family, member 10@NA@NA
A2463_19@10926@10934@duplication@9@145354296@145360727@1@chr1:145354296-145360727@7.17@123@196@1.59@CNVR341.2, CNVR341.3@NBPF10_66, NBPF10_67, NBPF10_68, NBPF10_69, NBPF10_70, NBPF10_71, NBPF10_72, NBPF10_73, NBPF10_74@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family, member 10@NA@NA
A2463_19@11127@11157@duplication@31@146215076@146244717@1@chr1:146215076-146244717@34.2@168@434@2.58@NA@NBPF12_38, NBPF12_37, NBPF12_36, NBPF12_35, NBPF12_34, NBPF12_33, NBPF12_32, NBPF12_31, NBPF12_30, NBPF12_29, NBPF12_28, NBPF12_27, NBPF12_26, NBPF12_25, NBPF12_24, NBPF12_23, NBPF12_22, NBPF12_21, NBPF12_20, NBPF12_19, NBPF12_18, NBPF12_17, NBPF12_16, NBPF12_15, NBPF12_14, NBPF12_13, NBPF12_12, NBPF12_11, NBPF12_10, NBPF12_9, NBPF12_8@0@0@0@:neuroblastoma breakpoint family member 21-like@NA@NA
A2463_19@11161@11164@duplication@4@146248917@146253110@1@chr1:146248917-146253110@20.1@159@333@2.09@NA@NBPF12_4, NBPF12_3, NBPF12_2, NBPF12_1@0@0@0@:neuroblastoma breakpoint family member 21-like@NA@NA
A2463_19@11169@11184@deletion@16@146400092@146420191@1@chr1:146400092-146420191@37.9@390@142@0.364@NA@NBPF12_9, NBPF12_10, NBPF12_11, NBPF12_12, NBPF12_13, NBPF12_14, NBPF12_15, NBPF12_16, NBPF12_17, NBPF12_18, NBPF12_19, NBPF12_20, NBPF12_21, NBPF12_22, NBPF12_23, NBPF12_24@0@0@0@:neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family member 14-like;neuroblastoma breakpoint family, member 12@:cytoplasm@NA
A2463_19@11242@11242@deletion@1@146465879@146466121@1@chr1:146465879-146466121@5.82@158@89@0.563@CNVR344.2@NBPF12_82@0@0@0@:neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family member 14-like;neuroblastoma breakpoint family, member 12@:cytoplasm@NA
A2463_19@11341@11350@deletion@10@148008574@148015797@1@chr1:148008574-148015797@60.3@1077@523@0.486@CNVR346.2, CNVR346.4@NBPF14_17, NBPF14_16, NBPF14_15, NBPF14_14, NBPF14_13, NBPF14_12, NBPF14_11, NBPF14_10, NBPF14_9, NBPF14_8@0@0@0@:neuroblastoma breakpoint family, member 14@:cytoplasm@NA
A2463_19@11353@11354@duplication@2@148021578@148023132@1@chr1:148021578-148023132@7.15@237@343@1.45@CNVR346.2, CNVR346.4@NBPF14_5, NBPF14_4@0@0@0@:neuroblastoma breakpoint family, member 14@:cytoplasm@NA
A2463_19@14056@14056@deletion@1@161599569@161599825@1@chr1:161599569-161599825@4.76@57@24@0.421@CNVR383.1@FCGR3B_3@0@0@0@:Fc fragment of IgG, low affinity IIIa, receptor (CD16a):Fc fragment of IgG, low affinity IIb, receptor (CD32):Fc fragment of IgG, low affinity IIIb, receptor (CD16b)@:IgG binding;protein binding;regulation of immune response;extracellular region;integral to membrane;immune response;plasma membrane;external side of plasma membrane:IgG binding;protein binding;signal transduction;regulation of immune response;integral to membrane;immune response;plasma membrane;virus-host interaction:IgG binding;protein binding;extracellular region;immune response;plasma membrane;anchored to membrane@: MALARIA, SUSCEPTIBILITY TO; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
A2463_19@16029@16037@deletion@9@196744018@196796135@1@chr1:196744018-196796135@25.2@1539@1012@0.658@CNVR459.1@CFHR3_1, CFHR3_2, CFHR3_3, CFHR3_4, CFHR3_5, CFHR3_6, CFHR1_1, CFHR1_2, CFHR1_3@0@0@0@:complement factor H-related 3:complement factor H-related 1:complement factor H-related 2@:extracellular space:extracellular space;complement activation:extracellular region@NA
A2463_19@16039@16040@deletion@2@196799631@196801129@1@chr1:196799631-196801129@11.4@453@273@0.603@CNVR459.1@CFHR1_5, CFHR1_6@0@0@0@:complement factor H-related 1:complement factor H-related 2@:extracellular space;complement activation:extracellular region@NA
A2463_19@17624@17625@deletion@2@213003585@213009491@1@chr1:213003585-213009491@14@289@149@0.516@CNVR498.1@C1orf227_3, C1orf227_2@0@0@0@:chromosome 1 open reading frame 227@NA@NA
A2463_19@18285@18285@deletion@1@226075487@226075732@1@chr1:226075487-226075732@4.93@116@64@0.552@NA@LEFTY1_2, RP4-559A3.7_6@0@0@0@:left-right determination factor 1@:growth factor activity;cell growth;transforming growth factor beta receptor signaling pathway;extracellular space;negative regulation of transcription from RNA polymerase II promoter;growth;transforming growth factor beta receptor binding;heart morphogenesis;cytokine activity;determination of left/right symmetry:oxidation-reduction process;oxidoreductase activity;proline biosynthetic process;pyrroline-5-carboxylate reductase activity;nucleotide binding@NA
A2463_19@24822@24825@deletion@4@87178420@87185059@2@chr2:87178420-87185059@7.01@34@2@0.0588@NA@RGPD1_2, RGPD1_3, RGPD1_4, RGPD1_5@0@0@0@:RANBP2-like and GRIP domain containing 1@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_19@24862@24863@deletion@2@88094928@88095367@2@chr2:88094928-88095367@7.58@34@0@0@NA@RGPD2_11, RGPD2_10@0@0@0@:RANBP2-like and GRIP domain containing 2@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_19@24957@24957@deletion@1@89459236@89459530@2@chr2:89459236-89459530@6.64@83@35@0.422@CNVR866.7, CNVR866.10, CNVR866.11, CNVR866.4, CNVR866.22@IGKV6-21_2@0@0@0@@:protein binding@NA
A2463_19@25375@25386@deletion@12@97860464@97870000@2@chr2:97860464-97870000@26@1649@1102@0.668@CNVR886.1@ANKRD36_39, ANKRD36_40, ANKRD36_41, ANKRD36_42, ANKRD36_43, ANKRD36_44, ANKRD36_45, ANKRD36_46, ANKRD36_47, ANKRD36_48, ANKRD36_49, ANKRD36_50@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_19@25391@25396@deletion@6@97875419@97879351@2@chr2:97875419-97879351@12.4@528@332@0.629@CNVR886.1@ANKRD36_55, ANKRD36_56, ANKRD36_57, ANKRD36_58, ANKRD36_59, ANKRD36_60@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_19@25401@25411@deletion@11@97884788@97915904@2@chr2:97884788-97915904@8.49@819@578@0.706@NA@ANKRD36_65, ANKRD36_66, ANKRD36_67, ANKRD36_68, ANKRD36_69, ANKRD36_70, ANKRD36_71, ANKRD36_72, ANKRD36_73, ANKRD36_74, ANKRD36_75@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_19@27163@27163@duplication@1@130843388@130843568@2@chr2:130843388-130843568@6.32@37@88@2.38@NA@POTEF_13@0@0@0@:POTE ankyrin domain family, member F@:cell cortex;protein binding;ATP binding@NA
A2463_19@27987@27987@deletion@1@152450522@152450832@2@chr2:152450522-152450832@9@52@7@0.135@CNVR1026.1@NEB_93@0@0@0@:nebulin@:Z disc;muscle filament sliding;oxidation-reduction process;contractile fiber part;actin cytoskeleton;regulation of actin filament length;structural constituent of muscle;cytosol;actin binding;protein binding;myofibril;somatic muscle development;muscle organ development@: NEMALINE MYOPATHY 2; NEM2
A2463_19@27996@27997@deletion@2@152463121@152464122@2@chr2:152463121-152464122@15.3@81@6@0.0741@CNVR1026.1@NEB_84, NEB_83@0@0@0@:nebulin@:Z disc;muscle filament sliding;oxidation-reduction process;contractile fiber part;actin cytoskeleton;regulation of actin filament length;structural constituent of muscle;cytosol;actin binding;protein binding;myofibril;somatic muscle development;muscle organ development@: NEMALINE MYOPATHY 2; NEM2
A2463_19@39892@39894@deletion@3@75786030@75790887@3@chr3:75786030-75790887@5.23@212@137@0.646@CNVR1432.5, CNVR1432.9, CNVR1432.4@ZNF717_5, ZNF717_4, ZNF717_3@0@0@0@:zinc finger protein 717;zinc finger protein 717-like@:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_19@45434@45438@duplication@5@195451552@195475935@3@chr3:195451552-195475935@11.4@661@904@1.37@CNVR1703.1, CNVR1703.2, CNVR1703.5, CNVR1703.3@MUC20_2, MUC20_3, MUC20_4, MUC4_25, MUC4_24@0@0@0@:mucin 20, cell surface associated:mucin 4, cell surface associated@:microvillus membrane;apical plasma membrane;activation of MAPK activity;Golgi lumen;post-translational protein modification;protein binding;O-glycan processing;hepatocyte growth factor receptor signaling pathway;cellular protein metabolic process;extracellular region;protein homooligomerization;basal plasma membrane:ErbB-2 class receptor binding;Golgi lumen;cell-matrix adhesion;post-translational protein modification;extracellular matrix structural constituent;protein binding;O-glycan processing;cellular protein metabolic process;proteinaceous extracellular matrix;integral to plasma membrane;membrane;extracellular matrix constituent, lubricant activity;biological_process@NA
A2463_19@46667@46671@deletion@5@9174900@9213975@4@chr4:9174900-9213975@9.19@67@18@0.269@NA@FAM90A26P_4, FAM90A26P_5, FAM90A26P_6, FAM90A26P_7, USP17L13_1, USP17L10_1@0@0@0@:ubiquitin specific peptidase 17-like family member 10:ubiquitin specific peptidase 17-like family member 13@:zinc ion binding;nucleic acid binding:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
A2463_19@52397@52397@duplication@1@165890631@165891154@4@chr4:165890631-165891154@4.88@243@345@1.42@NA@TRIM61_3@0@0@0@:tripartite motif containing 61@:protein binding;intracellular;zinc ion binding@NA
A2463_19@53189@53189@duplication@1@190947540@190947616@4@chr4:190947540-190947616@7.35@75@146@1.95@CNVR2258.3@FRG2_3@0@0@0@:FSHD region gene 2-like;FSHD region gene 2@:nucleus@NA
A2463_19@53306@53317@duplication@12@741710@825366@5@chr5:741710-825366@25.9@545@835@1.53@CNVR2280.3@ZDHHC11B_7, ZDHHC11B_6, ZDHHC11B_5, ZDHHC11B_4, ZDHHC11B_3, ZDHHC11B_2, ZDHHC11B_1, ZDHHC11_12, ZDHHC11_11, ZDHHC11_10, ZDHHC11_9, ZDHHC11_8@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
A2463_19@55817@55817@duplication@1@70247769@70247818@5@chr5:70247769-70247818@6.55@177@275@1.55@CNVR2494.41, CNVR2494.14, CNVR2494.30, CNVR2494.25, CNVR2494.20, CNVR2494.61, CNVR2494.22, CNVR2494.21, CNVR2494.62, CNVR2494.63@SMN1_8@0@0@0@:survival of motor neuron 2, centromeric;survival of motor neuron 1, telomeric@:nucleoplasm;ncRNA metabolic process;Cajal body;RNA metabolic process;spliceosomal complex;cytoplasm;cytosol;protein binding;cell death;spliceosomal complex assembly;RNA binding;mRNA processing;nucleus;gene expression;spliceosomal snRNP assembly@: SPINAL MUSCULAR ATROPHY, TYPE II; SMA2; SPINAL MUSCULAR ATROPHY, TYPE I; SMA1; SPINAL MUSCULAR ATROPHY, TYPE IV; SMA4; SPINAL MUSCULAR ATROPHY, TYPE III; SMA3
A2463_19@59065@59065@duplication@1@140557617@140560021@5@chr5:140557617-140560021@20.6@2104@3530@1.68@CNVR2624.1@PCDHB8_1@0@0@0@:protocadherin beta 8@:integral to membrane;homophilic cell adhesion;plasma membrane;membrane;calcium ion binding@NA
A2463_19@60882@60885@deletion@4@175487236@175520277@5@chr5:175487236-175520277@11.7@87@22@0.253@NA@RP11-826N14.2_2, FAM153B_3, FAM153B_4@0@0@0@:uncharacterized LOC100507387;family with sequence similarity 153, member B@NA@NA
A2463_19@61266@61267@deletion@2@177163581@177164113@5@chr5:177163581-177164113@10.5@102@37@0.363@NA@FAM153A_11, FAM153A_10@0@0@0@:family with sequence similarity 153, member A@NA@NA
A2463_19@61269@61271@deletion@3@177166602@177168333@5@chr5:177166602-177168333@9.1@43@1@0.0233@NA@FAM153A_8, FAM153A_7, FAM153A_6@0@0@0@:family with sequence similarity 153, member A@NA@NA
A2463_19@62738@62738@deletion@1@26406138@26406484@6@chr6:26406138-26406484@7.95@49@8@0.163@NA@BTN3A1_3@0@0@0@:butyrophilin, subfamily 3, member A1@:protein binding;integral to membrane;lipid metabolic process@NA
A2463_19@63294@63297@deletion@4@31378321@31380208@6@chr6:31378321-31380208@15.6@273@139@0.509@CNVR2842.1@MICA_2, MICA_3, MICA_4, MICA_5@0@0@0@:MHC class I polypeptide-related sequence A@:MHC class I protein complex;protein binding;regulation of immune response;antigen processing and presentation;immune response;plasma membrane;membrane@: PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO; PSORIASIS SUSCEPTIBILITY 1; PSORS1
A2463_19@63731@63734@deletion@4@31963733@31964838@6@chr6:31963733-31964838@30.3@554@262@0.473@CNVR2843.6, CNVR2843.3@C4A_26, C4A_27, C4A_28, C4A_29@0@0@0@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
A2463_19@63768@63773@deletion@6@31994761@31996309@6@chr6:31994761-31996309@41@196@3@0.0153@CNVR2843.6, CNVR2843.5@C4B_20, C4B_21, C4B_22, C4B_23, C4B_24, C4B_25@0@0@0@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
A2463_19@63953@63955@deletion@3@32485517@32486443@6@chr6:32485517-32486443@6.38@43@10@0.233@CNVR2845.21, CNVR2845.25, CNVR2845.30@HLA-DRB5_6, HLA-DRB5_5, HLA-DRB5_4@0@0@0@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
A2463_19@64602@64606@deletion@5@35754776@35765065@6@chr6:35754776-35765065@9.11@484@314@0.649@CNVR2861.1@CLPSL1_2, CLPSL1_3, CLPS_3, CLPS_2, CLPS_1@0@0@0@:colipase-like 1:colipase, pancreatic@:extracellular region;enzyme activator activity;digestion;lipid catabolic process:steroid metabolic process;post-embryonic development;small molecule metabolic process;retinoid metabolic process;lipid metabolic process;extracellular region;enzyme activator activity;digestion;lipid catabolic process;lipid digestion;response to food@NA
A2463_19@66018@66021@duplication@4@49437891@49440571@6@chr6:49437891-49440571@16.8@430@654@1.52@NA@CENPQ_2, CENPQ_3, CENPQ_4, CENPQ_5@0@0@0@:centromere protein Q@:nucleoplasm;mitotic cell cycle;cytosol;chromosome, centromeric region;mitotic prometaphase;M phase of mitotic cell cycle;nucleosome assembly;CenH3-containing nucleosome assembly at centromere@NA
A2463_19@69212@69212@deletion@1@132021610@132022541@6@chr6:132021610-132022541@12.4@109@31@0.284@CNVR3068.1, CNVR3068.2@OR2A4_1@0@0@0@:ectonucleotide pyrophosphatase/phosphodiesterase 3:olfactory receptor, family 2, subfamily A, member 4@:nucleotide diphosphatase activity;immune response;phosphate-containing compound metabolic process;catalytic activity;phosphodiesterase I activity;integral to plasma membrane;metabolic process;hydrolase activity;nucleoside-triphosphate diphosphatase activity;nucleoside triphosphate catabolic process;polysaccharide binding;perinuclear region of cytoplasm;extracellular region;scavenger receptor activity;NADH pyrophosphatase activity;nucleic acid binding;metal ion binding:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_19@70816@70817@duplication@2@161054786@161056336@6@chr6:161054786-161056336@12.7@164@300@1.83@CNVR3133.1@LPA_9, LPA_8@0@0@0@:lipoprotein, Lp(a)@:blood circulation;endopeptidase inhibitor activity;catalytic activity;lipoprotein metabolic process;proteolysis;heparin binding;receptor-mediated endocytosis;fibronectin binding;small molecule metabolic process;apolipoprotein binding;lipid metabolic process;negative regulation of endopeptidase activity;extracellular region;plasma lipoprotein particle;lipid transport;serine-type endopeptidase activity@: APOLIPOPROTEIN(a); LPA
A2463_19@71010@71012@deletion@3@167587242@167592030@6@chr6:167587242-167592030@19.7@340@166@0.488@NA@TCP10L2_3, TCP10L2_4, TCP10L2_5@0@0@0@:t-complex 10;t-complex 10-like 2@NA@NA
A2463_19@71030@71032@duplication@3@167790035@167794824@6@chr6:167790035-167794824@27.8@129@364@2.82@NA@TCP10_5, TCP10_4, TCP10_3@0@0@0@:t-complex 10@:cytosol@NA
A2463_19@71744@71754@deletion@11@5939916@5959597@7@chr7:5939916-5959597@111@975@301@0.309@NA@CCZ1_2, CCZ1_3, CCZ1_4, CCZ1_5, CCZ1_6, CCZ1_7, CCZ1_8, CCZ1_9, CCZ1_10, CCZ1_11, CCZ1_12@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
A2463_19@71762@71765@duplication@4@5977390@5983621@7@chr7:5977390-5983621@5.88@182@263@1.45@NA@RSPH10B_16, RSPH10B_15, RSPH10B_14, RSPH10B_13@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
A2463_19@71926@71934@deletion@9@6805338@6821107@7@chr7:6805338-6821107@8.16@246@155@0.63@NA@RSPH10B2_6, RSPH10B2_7, RSPH10B2_8, RSPH10B2_9, RSPH10B2_10, RSPH10B2_11, RSPH10B2_12, RSPH10B2_13, RSPH10B2_14@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
A2463_19@71949@71954@duplication@6@6859398@6864368@7@chr7:6859398-6864368@38.8@815@1393@1.71@NA@CCZ1B_7, CCZ1B_6, CCZ1B_5, CCZ1B_4, CCZ1B_3, CCZ1B_2@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
A2463_19@73262@73263@duplication@2@38393317@38393784@7@chr7:38393317-38393784@5.47@112@177@1.58@CNVR3354.3, CNVR3354.1@TRGV4_2, TRGV4_1@0@0@0@@:protein binding@NA
A2463_19@74573@74573@deletion@1@74166423@74166502@7@chr7:74166423-74166502@14@68@2@0.0294@NA@GTF2I_28@0@0@0@:general transcription factor IIi@:neuronal cell body;transcription initiation from RNA polymerase II promoter;mitogen-activated protein kinase binding;negative regulation of angiogenesis;DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;cytoplasm;transcription from RNA polymerase II promoter;protein binding;signal transduction;nucleus;cell projection;reduction of cytosolic calcium ion concentration@NA
A2463_19@74595@74598@deletion@4@74221276@74227349@7@chr7:74221276-74227349@9.9@54@6@0.111@NA@GTF2IRD2_12, GTF2IRD2_11, GTF2IRD2_10, GTF2IRD2_9@0@0@0@:GTF2I repeat domain containing 2@:nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_19@74663@74664@duplication@2@75054919@75055735@7@chr7:75054919-75055735@7.52@90@160@1.78@NA@POM121C_9, POM121C_8@0@0@0@:POM121 transmembrane nucleoporin C@:nuclear membrane;protein binding;protein transport;endoplasmic reticulum membrane;nuclear pore;mRNA transport@NA
A2463_19@76428@76432@duplication@5@100333344@100336236@7@chr7:100333344-100336236@14.7@248@402@1.62@CNVR3509.1@ZAN_2, ZAN_3, ZAN_4, ZAN_5, ZAN_6@0@0@0@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
A2463_19@76743@76779@deletion@37@102194807@102279646@7@chr7:102194807-102279646@32.8@881@506@0.574@CNVR3518.1@SPDYE2_3, SPDYE2_4, SPDYE2_5, SPDYE2_6, SPDYE2_7, SPDYE2_8, POLR2J3_4, POLR2J3_3, POLR2J3_2, POLR2J3_1, AC093668.1_3, AC093668.1_2, AC093668.1_1, RASA4_21, RASA4_20, RASA4_19, RASA4_18, RASA4_17, RASA4_16, RASA4_15, RASA4_14, RASA4_13, RASA4_12, RASA4_11, RASA4_10, RASA4_9, RASA4_8, RASA4_7, RASA4_6, RASA4_5, RASA4_4, RASA4_3, RASA4_2, UPK3BL_7, RASA4_1, UPK3BL_6, UPK3BL_6, UPK3BL_5, UPK3BL_5, UPK3BL_4, UPK3BL_4@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:speedy homolog E2 (Xenopus laevis):RAS p21 protein activator 4B;RAS p21 protein activator 4:uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity:integral to membrane:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
A2463_19@79287@79288@deletion@2@143400089@143417767@7@chr7:143400089-143417767@11.5@110@39@0.355@CNVR3594.2, CNVR3594.1@FAM115C_2, FAM115C_3@0@0@0@:family with sequence similarity 115, member C;protein FAM115C-like@NA@NA
A2463_19@79309@79309@duplication@1@143880598@143882930@7@chr7:143880598-143882930@5.53@335@473@1.41@CNVR3598.4, CNVR3598.3@CTAGE4_1@0@0@0@:CTAGE family, member 4@:integral to membrane;nucleotide binding;cellular_component;biological_process@NA
A2463_19@79315@79319@deletion@5@144059764@144068414@7@chr7:144059764-144068414@13.5@813@505@0.621@CNVR3598.4, CNVR3598.5, CNVR3598.11@ARHGEF5_2, ARHGEF5_3, ARHGEF5_4, ARHGEF5_5, ARHGEF5_6@0@0@0@:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
A2463_19@79323@79323@deletion@1@144070289@144070377@7@chr7:144070289-144070377@11.6@53@0@0@CNVR3598.4, CNVR3598.5, CNVR3598.11@ARHGEF5_10@0@0@0@:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
A2463_19@80358@80358@duplication@1@6873513@6873621@8@chr8:6873513-6873621@8.32@75@154@2.05@CNVR3769.1@DEFA3_3@0@0@0@:defensin, alpha 1B;defensin, alpha 1:defensin, alpha 3, neutrophil-specific;defensin, alpha 1B;defensin, alpha 1@:defense response to virus;extracellular matrix;immune response;Golgi lumen;azurophil granule lumen;killing of cells of other organism;innate immune response;chemotaxis;extracellular space;extracellular region;defense response to bacterium;defense response to fungus;defense response:defense response to virus;Golgi lumen;azurophil granule lumen;killing of cells of other organism;innate immune response;extracellular space;defense response to bacterium;defense response to fungus;extracellular region;defense response@NA
A2463_19@80570@80572@deletion@3@12045582@12049350@8@chr8:12045582-12049350@16.9@94@10@0.106@CNVR3785.5, CNVR3785.3@FAM86B1_4, FAM86B1_3, FAM86B1_2@0@0@0@:family with sequence similarity 86, member B2;family with sequence similarity 86, member B1@NA@NA
A2463_19@80576@80579@deletion@4@12283399@12286623@8@chr8:12283399-12286623@16.6@94@12@0.128@CNVR3786.4, CNVR3786.16@FAM86B2_8, FAM86B2_7, FAM86B2_6, FAM86B2_5@0@0@0@:family with sequence similarity 86, member B2@NA@NA
A2463_19@80582@80584@duplication@3@12291562@12338444@8@chr8:12291562-12338444@8.27@308@447@1.45@CNVR3786.4, CNVR3786.16@FAM86B2_2, FAM86B2_1, AC130352.1_5@0@0@0@:family with sequence similarity 86, member B2@NA@NA
A2463_19@83673@83673@deletion@1@86573700@86575726@8@chr8:86573700-86575726@11.2@361@195@0.54@CNVR3955.1@REXO1L1_1@0@0@0@:exonuclease GOR-like;REX1, RNA exonuclease 1 homolog (S. cerevisiae)-like 1@:intracellular;nucleus;exonuclease activity;nucleic acid binding;cytoplasm@NA
A2463_19@86645@86646@deletion@2@175699@178969@9@chr9:175699-178969@15.8@162@65@0.401@CNVR4135.1@CBWD1_2, CBWD1_1@0@0@0@:COBW domain containing 1;COBW domain-containing protein 1-like;COBW domain containing 5@:ATP binding@NA
A2463_19@88492@88495@deletion@4@39078688@39088644@9@chr9:39078688-39088644@19.9@454@252@0.555@NA@CNTNAP3_22, CNTNAP3_21, CNTNAP3_20, CNTNAP3_19@0@0@0@:contactin associated protein-like 3@:binding;signal transduction;protein binding;integral to membrane;extracellular region;cell adhesion;plasma membrane;cell recognition;receptor binding@NA
A2463_19@88534@88536@deletion@3@41306194@41324995@9@chr9:41306194-41324995@6.15@94@47@0.5@CNVR4278.2@FAM74A2_2, FAM74A2_1, SPATA31A4_4@0@0@0@:SPATA31 subfamily A, member 4@:integral to membrane:integral to membrane@NA
A2463_19@88544@88558@deletion@15@42368416@42410483@9@chr9:42368416-42410483@13.3@248@128@0.516@NA@ANKRD20A2_1, ANKRD20A2_2, ANKRD20A2_3, ANKRD20A2_4, ANKRD20A2_5, ANKRD20A2_6, ANKRD20A2_7, ANKRD20A2_8, ANKRD20A2_9, ANKRD20A2_10, ANKRD20A2_11, ANKRD20A2_12, ANKRD20A2_13, ANKRD20A2_14, ANKRD20A2_15, RP11-146D12.2_1@0@0@0@:ankyrin repeat domain 20 family, member A2@:protein binding@NA
A2463_19@88585@88585@deletion@1@43628635@43628694@9@chr9:43628635-43628694@4.93@34@8@0.235@NA@SPATA31A6_3@0@0@0@:SPATA31 subfamily A, member 6@:integral to membrane@NA
A2463_19@88623@88624@deletion@2@46386623@46390900@9@chr9:46386623-46390900@8.86@46@4@0.087@CNVR4307.4, CNVR4307.3@FAM27E1_1, FAM27D1_1@0@0@0@:family with sequence similarity 27, member E3:protein FAM27E2-like;protein FAM27D1-like@NA@NA
A2463_19@88631@88633@deletion@3@65503517@65508193@9@chr9:65503517-65508193@29.9@246@67@0.272@CNVR4312.5@SPATA31A7_4, SPATA31A7_3, SPATA31A7_2@0@0@0@:SPATA31 subfamily A, member 7@:integral to membrane@NA
A2463_19@88639@88641@duplication@3@67926874@67930837@9@chr9:67926874-67930837@7.57@31@84@2.71@NA@ANKRD20A1_1, ANKRD20A1_2, ANKRD20A1_3@0@0@0@:ankyrin repeat domain 20 family, member A1@:protein binding;plasma membrane@NA
A2463_19@88644@88644@deletion@1@67938604@67938658@9@chr9:67938604-67938658@13.9@197@79@0.401@NA@ANKRD20A1_6@0@0@0@:ankyrin repeat domain 20 family, member A1@:protein binding;plasma membrane@NA
A2463_19@88651@88656@duplication@6@67965006@67985922@9@chr9:67965006-67985922@17.3@836@1161@1.39@NA@ANKRD20A1_13, ANKRD20A1_14, ANKRD20A1_15, RP11-195B21.3_3, RP11-195B21.3_4, RP11-195B21.3_5@0@0@0@:ankyrin repeat domain 20 family, member A1:coiled-coil domain-containing protein 29-like;uncharacterized LOC644249@:protein binding;plasma membrane@NA
A2463_19@88670@88670@deletion@1@69252846@69253282@9@chr9:69252846-69253282@6.85@143@74@0.517@NA@BX255923.1_1@0@0@0@:COBW domain containing 6@:ATP binding@NA
A2463_19@88681@88683@duplication@3@69393823@69403204@9@chr9:69393823-69403204@7.81@98@176@1.8@NA@ANKRD20A4_6, ANKRD20A4_7, ANKRD20A4_8@0@0@0@:ankyrin repeat domain 20 family, member A4@:protein binding@NA
A2463_19@88720@88723@duplication@4@70889799@70912733@9@chr9:70889799-70912733@12.3@140@254@1.81@NA@CBWD3_10, CBWD3_11, CBWD3_12, CBWD3_13@0@0@0@:COBW domain-containing protein 5-like;COBW domain-containing protein 1-like;COBW domain containing 3@:ATP binding@NA
A2463_19@91243@91244@deletion@2@117085944@117086368@9@chr9:117085944-117086368@6.94@317@196@0.618@CNVR4448.1@ORM1_2, ORM1_3@0@0@0@:orosomucoid 1@:protein binding;extracellular space;regulation of immune system process;transport;inflammatory response;extracellular region;acute-phase response@NA
A2463_19@95387@95394@deletion@8@18129623@18155690@10@chr10:18129623-18155690@8.19@70@24@0.343@NA@MRC1_5, MRC1_6, MRC1_7, MRC1_8, MRC1_9, MRC1_10, MRC1_11, MRC1_12@0@0@0@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
A2463_19@95947@95948@deletion@2@29578048@29580935@10@chr10:29578048-29580935@8.54@59@14@0.237@NA@LYZL1_1, LYZL1_2@0@0@0@:lysozyme-like 1@:extracellular region;lysozyme activity;cell wall macromolecule catabolic process@NA
A2463_19@96435@96435@deletion@1@46248629@46248685@10@chr10:46248629-46248685@8.75@44@3@0.0682@NA@FAM21C_13@0@0@0@:family with sequence similarity 21, member C@:endosome;protein binding;plasma membrane;retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_19@96529@96531@deletion@3@47756640@47758904@10@chr10:47756640-47758904@5.48@30@4@0.133@CNVR4714.1@ANXA8L2_8, ANXA8L2_9, ANXA8L2_10@0@0@0@:annexin A8-like 2:uncharacterized LOC101060462;uncharacterized LOC100996760@:calcium-dependent phospholipid binding;calcium ion binding@NA
A2463_19@96543@96563@deletion@21@47908065@47948853@10@chr10:47908065-47948853@106@610@83@0.136@CNVR4715.2, CNVR4715.1@FAM21B_9, FAM21B_10, FAM21B_11, FAM21B_12, FAM21B_13, FAM21B_14, FAM21B_15, FAM21B_16, FAM21B_17, FAM21B_18, FAM21B_19, FAM21B_20, FAM21B_21, FAM21B_22, FAM21B_23, FAM21B_24, FAM21B_25, FAM21B_26, FAM21B_27, FAM21B_28, FAM21B_29@0@0@0@:family with sequence similarity 21, member B@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_19@96620@96620@duplication@1@48771316@48771405@10@chr10:48771316-48771405@7.04@69@135@1.96@CNVR4716.10, CNVR4716.3@PTPN20B_6@0@0@0@:protein tyrosine phosphatase, non-receptor type 20B;protein tyrosine phosphatase, non-receptor type 20A@:phosphatase activity;protein tyrosine phosphatase activity;microtubule;nucleus;dephosphorylation;protein dephosphorylation;microtubule organizing center@NA
A2463_19@96905@96923@duplication@19@51853621@51892705@10@chr10:51853621-51892705@29.6@668@1029@1.54@CNVR4734.2@FAM21A_13, FAM21A_14, FAM21A_15, FAM21A_16, FAM21A_17, FAM21A_18, FAM21A_19, FAM21A_20, FAM21A_21, FAM21A_22, FAM21A_23, FAM21A_24, FAM21A_25, FAM21A_26, FAM21A_27, FAM21A_28, FAM21A_29, FAM21A_30, FAM21A_31@0@0@0@:family with sequence similarity 21, member B;family with sequence similarity 21, member A@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_19@96932@96937@deletion@6@51965743@51978390@10@chr10:51965743-51978390@11.1@90@29@0.322@NA@ASAH2_12, ASAH2_11, ASAH2_10, ASAH2_9, ASAH2_8, ASAH2_7@0@0@0@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
A2463_19@98350@98357@deletion@8@81471457@81610362@10@chr10:81471457-81610362@21.5@409@204@0.499@CNVR4815.2@FAM22B_7, FAM22E_1, FAM22E_2, FAM22E_3, FAM22E_4, FAM22E_5, FAM22E_6, FAM22E_7@0@0@0@NA@NA@NA
A2463_19@98595@98595@deletion@1@88985589@88985969@10@chr10:88985589-88985969@5.73@26@0@0@CNVR4840.3, CNVR4840.5@FAM22A_1@0@0@0@:family with sequence similarity 22, member A@NA@NA
A2463_19@98603@98606@deletion@4@89120239@89124960@10@chr10:89120239-89124960@14.2@71@4@0.0563@CNVR4840.3@FAM22D_2, FAM22D_3, FAM22D_4, FAM22D_5@0@0@0@:family with sequence similarity 22, member D@NA@NA
A2463_19@101605@101614@deletion@10@124341310@124353114@10@chr10:124341310-124353114@34@627@319@0.509@CNVR4912.4, CNVR4912.3, CNVR4912.2@DMBT1_12, DMBT1_13, DMBT1_14, DMBT1_15, DMBT1_16, DMBT1_17, DMBT1_18, DMBT1_19, DMBT1_20, DMBT1_21@0@0@0@:deleted in malignant brain tumors 1@:defense response to virus;calcium-dependent protein binding;pattern recognition receptor signaling pathway;blastocyst development;response to estrogen stimulus;tissue regeneration;proteinaceous extracellular matrix;protein transport;Gram-negative bacterial cell surface binding;positive regulation of epithelial cell differentiation;virus-host interaction;epithelial cell differentiation;induction of bacterial agglutination;phagocytic vesicle membrane;intracellular;Gram-positive bacterial cell surface binding;zymogen binding;innate immune response;cytoplasm;extrinsic to membrane;protein binding;zymogen granule membrane;extracellular region;scavenger receptor activity;pattern recognition receptor activity;inner cell mass cell proliferation;membrane@: GLIOMA SUSCEPTIBILITY 1; GLM1
A2463_19@102336@102336@deletion@1@135438604@135439108@10@chr10:135438604-135439108@14.5@67@0@0@CNVR4989.11, CNVR4989.4@FRG2B_4@0@0@0@:FSHD region gene 2 family, member B@:nucleus@NA
A2463_19@103139@103139@deletion@1@3239175@3240043@11@chr11:3239175-3240043@23.1@110@0@0@CNVR5028.1@MRGPRG_1@0@0@0@:MAS-related GPR, member G@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway@NA
A2463_19@103289@103290@duplication@2@5270599@5271034@11@chr11:5270599-5271034@16@50@183@3.66@NA@HBG1_2, HBG1_1@0@0@0@:hemoglobin, gamma A@:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex@NA
A2463_19@103292@103293@deletion@2@5275523@5275958@11@chr11:5275523-5275958@7.04@278@170@0.612@NA@HBG2_7, HBG2_6@0@0@0@:hemoglobin, gamma G@:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex@: CYANOSIS, TRANSIENT NEONATAL; TNCY
A2463_19@103342@103342@deletion@1@5798891@5799864@11@chr11:5798891-5799864@15.7@270@115@0.426@CNVR5049.1@OR52N5_1@0@0@0@:tripartite motif containing 5:olfactory receptor, family 52, subfamily N, member 5@:defense response to virus;Golgi apparatus;intracellular;protein trimerization;ligase activity;cytoplasm;protein binding;nucleus;protein homodimerization activity;identical protein binding;zinc ion binding;cytoplasmic mRNA processing body;protein ubiquitination;virus-host interaction:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_19@106046@106048@duplication@3@55370918@55419315@11@chr11:55370918-55419315@9.24@613@842@1.37@CNVR5179.1@OR4C11_1, OR4P4_1, OR4S2_1@0@0@0@:olfactory receptor, family 4, subfamily C, member 11:olfactory receptor, family 4, subfamily P, member 4:olfactory receptor, family 4, subfamily S, member 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_19@114136@114139@duplication@4@8374419@8377428@12@chr12:8374419-8377428@45.7@1260@2213@1.76@CNVR5422.3, CNVR5422.5, CNVR5422.6, CNVR5422.1@FAM90A1_7, FAM90A1_6, FAM90A1_5, FAM90A1_4@0@0@0@:family with sequence similarity 90, member A1@:zinc ion binding;nucleic acid binding@NA
A2463_19@114468@114469@deletion@2@11034835@11035297@12@chr12:11034835-11035297@5.19@116@65@0.56@NA@PRH1_4, PRH1_3@0@0@0@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):proline-rich protein HaeIII subfamily 1@:extracellular space;visual perception:protein binding;extracellular space@NA
A2463_19@114483@114483@duplication@1@11243900@11244828@12@chr12:11243900-11244828@9.5@308@483@1.57@CNVR5434.1@TAS2R43_1@0@0@0@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):taste receptor, type 2, member 14:taste receptor, type 2, member 43@:extracellular space;visual perception:bitter taste receptor activity;taste receptor activity;integral to membrane;sensory perception of taste;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of bitter taste:G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;motile cilium;taste receptor activity;bitter taste receptor activity;integral to membrane;sensory perception of taste;detection of chemical stimulus involved in sensory perception of bitter taste;cilium membrane@NA
A2463_19@115528@115528@deletion@1@31240873@31240917@12@chr12:31240873-31240917@5.21@52@19@0.365@CNVR5483.1@DDX11_6@0@0@0@:DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11@:nucleoplasm;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;S phase of mitotic cell cycle;DNA binding;nucleobase-containing compound metabolic process;ATP binding;ATP-dependent DNA helicase activity;DNA helicase activity;midbody;RNA binding;DNA-dependent ATPase activity;nucleus;positive regulation of cell proliferation;virus-host interaction;nuclear chromatin;4 iron, 4 sulfur cluster binding;helicase activity;hydrolase activity, acting on acid anhydrides;DNA duplex unwinding;endoplasmic reticulum unfolded protein response;G2/M transition of mitotic cell cycle;protein binding;sister chromatid cohesion;activation of signaling protein activity involved in unfolded protein response;nucleolus;spindle pole;ATP-dependent helicase activity;metal ion binding;nucleic acid binding;mitotic sister chromatid segregation@: WARSAW BREAKAGE SYNDROME
A2463_19@115535@115535@deletion@1@31247525@31247568@12@chr12:31247525-31247568@7.23@80@31@0.388@CNVR5483.1@DDX11_13@0@0@0@:DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11@:nucleoplasm;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;S phase of mitotic cell cycle;DNA binding;nucleobase-containing compound metabolic process;ATP binding;ATP-dependent DNA helicase activity;DNA helicase activity;midbody;RNA binding;DNA-dependent ATPase activity;nucleus;positive regulation of cell proliferation;virus-host interaction;nuclear chromatin;4 iron, 4 sulfur cluster binding;helicase activity;hydrolase activity, acting on acid anhydrides;DNA duplex unwinding;endoplasmic reticulum unfolded protein response;G2/M transition of mitotic cell cycle;protein binding;sister chromatid cohesion;activation of signaling protein activity involved in unfolded protein response;nucleolus;spindle pole;ATP-dependent helicase activity;metal ion binding;nucleic acid binding;mitotic sister chromatid segregation@: WARSAW BREAKAGE SYNDROME
A2463_19@124096@124101@duplication@6@21729833@21746643@13@chr13:21729833-21746643@27.3@829@1260@1.52@NA@SKA3_8, SKA3_7, SKA3_6, SKA3_5, SKA3_4, SKA3_3@0@0@0@:spindle and kinetochore associated complex subunit 3@:spindle microtubule;chromosome segregation;cytoplasm;mitosis;protein binding;regulation of microtubule polymerization or depolymerization;cell division;condensed chromosome outer kinetochore@NA
A2463_19@124177@124178@duplication@2@24465429@24468340@13@chr13:24465429-24468340@4.91@251@342@1.36@NA@C1QTNF9B_3, C1QTNF9B_2@0@0@0@:C1q and tumor necrosis factor related protein 9B@:collagen;protein binding@NA
A2463_19@127332@127338@deletion@7@19377595@19566082@14@chr14:19377595-19566082@50.4@1344@732@0.545@CNVR6072.1, CNVR6072.16@OR11H12_1, POTEG_1, POTEG_2, POTEG_3, POTEG_4, POTEG_5, POTEG_6@0@0@0@:olfactory receptor, family 11, subfamily H, member 12;olfactory receptor, family 11, subfamily H, member 2:POTE ankyrin domain family, member G@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:protein binding@NA
A2463_19@131032@131034@duplication@3@74004127@74010359@14@chr14:74004127-74010359@25.4@344@624@1.81@CNVR6188.1, CNVR6188.4@ACOT1_1, ACOT1_2, ACOT1_3@0@0@0@:HEAT repeat containing 4:acyl-CoA thioesterase 1@:protein binding;binding:hydrolase activity;mitochondrion;acyl-CoA metabolic process;very long-chain fatty acid metabolic process;thiolester hydrolase activity;acyl-CoA hydrolase activity;cytosol;palmitoyl-CoA hydrolase activity;long-chain fatty acid metabolic process;carboxylesterase activity@NA
A2463_19@133342@133342@duplication@1@106053275@106053668@14@chr14:106053275-106053668@5.89@62@117@1.89@CNVR6294.46@IGHA2_3@0@0@0@@:protein binding@NA
A2463_19@133345@133348@duplication@4@106066404@106068065@14@chr14:106066404-106068065@13.3@347@522@1.5@CNVR6294.46, CNVR6294.20, CNVR6294.54@IGHE_4, IGHE_3, IGHE_2, IGHE_1@0@0@0@@:antigen binding;protein binding;immune response@NA
A2463_19@133352@133352@duplication@1@106092110@106092403@14@chr14:106092110-106092403@5.69@101@167@1.65@CNVR6294.46, CNVR6294.20, CNVR6294.54, CNVR6294.43, CNVR6294.50, CNVR6294.61@IGHG4_1@0@0@0@@:antigen binding;protein binding;complement activation;extracellular region;immune response;membrane;complement activation, classical pathway;innate immune response@NA
A2463_19@133458@133463@deletion@6@106791006@106816173@14@chr14:106791006-106816173@27.4@365@167@0.458@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.53@IGHV3-30_2, IGHV3-30_1, IGHV4-31_2, IGHV4-31_1, IGHV3-33_2, IGHV3-33_1@0@0@0@@:protein binding:protein binding:protein binding@NA
A2463_19@133491@133492@deletion@2@107095127@107095561@14@chr14:107095127-107095561@10.4@78@21@0.269@CNVR6294.56, CNVR6294.16, CNVR6294.91@IGHV4-61_2, IGHV4-61_1@0@0@0@@:protein binding@NA
A2463_19@133497@133500@deletion@4@107169932@107179262@14@chr14:107169932-107179262@9.99@297@175@0.589@CNVR6294.56, CNVR6294.6, CNVR6294.92, CNVR6294.93@IGHV1-69_2, IGHV1-69_1, IGHV2-70_2, IGHV2-70_1@0@0@0@@:protein binding:protein binding@NA
A2463_19@133638@133642@deletion@5@23409198@23412276@15@chr15:23409198-23412276@6.14@170@102@0.6@CNVR6300.8@RP11-467N20.5_6, RP11-467N20.5_5, RP11-467N20.5_4, RP11-467N20.5_3, RP11-467N20.5_2@0@0@0@:putative golgin subfamily A member 6-like protein 6-like@NA@NA
A2463_19@133661@133661@deletion@1@23609867@23610021@15@chr15:23609867-23610021@5.73@38@8@0.211@NA@GOLGA8S_18@0@0@0@@:Golgi apparatus@NA
A2463_19@133816@133817@deletion@2@28447494@28451528@15@chr15:28447494-28451528@5.31@103@55@0.534@CNVR6328.1@HERC2_46, HERC2_45@0@0@0@:putative HERC2-like protein 3-like;HECT and RLD domain containing E3 ubiquitin protein ligase 2@:mitochondrial inner membrane;protein ubiquitination involved in ubiquitin-dependent protein catabolic process;guanyl-nucleotide exchange factor activity;SUMO binding;DNA repair;intracellular protein transport;spermatogenesis;cellular protein modification process;nucleus;ubiquitin protein ligase binding;ubiquitin-protein ligase activity;centriole;intracellular;response to DNA damage stimulus;heme binding;cytoplasm;protein binding;zinc ion binding;protein ubiquitination;metal ion binding@: SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1; SHEP1
A2463_19@133825@133826@duplication@2@28465599@28467361@15@chr15:28465599-28467361@5.27@125@189@1.51@CNVR6328.1@HERC2_37, HERC2_36@0@0@0@:putative HERC2-like protein 3-like;HECT and RLD domain containing E3 ubiquitin protein ligase 2@:mitochondrial inner membrane;protein ubiquitination involved in ubiquitin-dependent protein catabolic process;guanyl-nucleotide exchange factor activity;SUMO binding;DNA repair;intracellular protein transport;spermatogenesis;cellular protein modification process;nucleus;ubiquitin protein ligase binding;ubiquitin-protein ligase activity;centriole;intracellular;response to DNA damage stimulus;heme binding;cytoplasm;protein binding;zinc ion binding;protein ubiquitination;metal ion binding@: SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1; SHEP1
A2463_19@133869@133870@duplication@2@28629294@28629596@15@chr15:28629294-28629596@19.9@54@202@3.74@CNVR6329.4@GOLGA8F_9, GOLGA8F_10@0@0@0@@:Golgi apparatus@NA
A2463_19@134180@134190@deletion@11@32737820@32743403@15@chr15:32737820-32743403@17@170@65@0.382@CNVR6346.1@GOLGA8O_17, GOLGA8O_16, GOLGA8O_15, GOLGA8O_14, GOLGA8O_13, GOLGA8O_12, GOLGA8O_11, GOLGA8O_10, GOLGA8O_9, GOLGA8O_8, GOLGA8O_7@0@0@0@:golgin A8 family, member O@:Golgi apparatus@NA
A2463_19@138281@138286@duplication@6@72953606@72956852@15@chr15:72953606-72956852@20.9@258@477@1.85@CNVR6443.1@GOLGA6B_8, GOLGA6B_9, GOLGA6B_10, GOLGA6B_11, GOLGA6B_12, GOLGA6B_13@0@0@0@:golgin A6 family, member B@:Golgi apparatus@NA
A2463_19@138417@138422@deletion@6@74365084@74368326@15@chr15:74365084-74368326@22.4@265@109@0.411@CNVR6448.1@GOLGA6A_13, GOLGA6A_12, GOLGA6A_11, GOLGA6A_10, GOLGA6A_9, GOLGA6A_8@0@0@0@:golgin A6 family, member C;golgin A6 family, member A;golgin A6 family, member D;golgin A6 family, member B@:Golgi apparatus@NA
A2463_19@138642@138642@duplication@1@75561139@75561229@15@chr15:75561139-75561229@6.16@12@54@4.5@CNVR6452.1@GOLGA6C_14@0@0@0@:golgin A6 family, member C@:Golgi apparatus@NA
A2463_19@138660@138660@deletion@1@75585415@75585505@15@chr15:75585415-75585505@6.17@55@18@0.327@CNVR6452.1@GOLGA6D_14@0@0@0@:golgin A6 family, member D@:Golgi apparatus@NA
A2463_19@139296@139296@duplication@1@82934267@82935146@15@chr15:82934267-82935146@4.83@90@146@1.62@CNVR6477.6@RP13-996F3.5_6@0@0@0@NA@NA@NA
A2463_19@139305@139308@deletion@4@83013228@83015609@15@chr15:83013228-83015609@6.74@40@7@0.175@CNVR6477.6, CNVR6477.2@RP13-996F3.4_6, RP13-996F3.4_5, RP13-996F3.4_4, RP13-996F3.4_3@0@0@0@NA@NA@NA
A2463_19@140213@140213@duplication@1@94888359@94888393@15@chr15:94888359-94888393@9.29@157@273@1.74@CNVR6524.2, CNVR6524.1@MCTP2_7@0@0@0@:multiple C2 domains, transmembrane 2@:protein binding;integral to membrane;calcium-mediated signaling;calcium ion binding@NA
A2463_19@142651@142651@duplication@1@14858861@14859270@16@chr16:14858861-14859270@5.15@67@118@1.76@CNVR6644.1@RP11-719K4.2_8@0@0@0@:nuclear pore complex-interacting protein-like 1-like@NA@NA
A2463_19@142690@142690@deletion@1@15045473@15045882@16@chr16:15045473-15045882@10.3@168@76@0.452@NA@NPIP_8@0@0@0@:nuclear pore complex-interacting protein-like;nuclear pore complex interacting protein;nuclear pore complex-interacting protein-like 1-like@:nuclear membrane;protein transport;nuclear pore;mRNA transport@NA
A2463_19@142748@142751@deletion@4@15224493@15459321@16@chr16:15224493-15459321@30.3@423@170@0.402@NA@NPIPP1_2, NPIPP1_1, PKD1P1_8, PKD1P1_7@0@0@0@:pyridoxal-dependent decarboxylase domain containing 1;pyridoxal-dependent decarboxylase domain-containing protein 1-like:nuclear pore complex-interacting protein-like:NPIP-like protein 1-like;nuclear pore complex-interacting protein-like 1-like@:carboxylic acid metabolic process;pyridoxal phosphate binding;carboxy-lyase activity:neuropeptide signaling pathway;integral to membrane;plasma membrane;membrane@NA
A2463_19@142950@142952@deletion@3@16481257@16484731@16@chr16:16481257-16484731@5.38@63@27@0.429@CNVR6654.1@RP11-467M13.1_3, RP11-467M13.1_4, RP11-467M13.1_5@0@0@0@NA@NA@NA
A2463_19@142971@142971@duplication@1@18414875@18414981@16@chr16:18414875-18414981@7.8@40@102@2.55@CNVR6658.1@RP11-1212A22.2_7@0@0@0@NA@NA@NA
A2463_19@143488@143493@deletion@6@21847327@21858862@16@chr16:21847327-21858862@19.4@496@279@0.562@CNVR6668.5, CNVR6668.7@NPIPL3_7, NPIPL3_6, NPIPL3_5, NPIPL3_4, NPIPL3_3, NPIPL3_2@0@0@0@:nuclear pore complex interacting protein-like 3;nuclear pore complex interacting protein-like;nuclear pore complex-interacting protein-like 3-like@NA@NA
A2463_19@144052@144052@duplication@1@28478042@28478223@16@chr16:28478042-28478223@16.4@50@190@3.8@NA@NPIPL1_2@0@0@0@:ceroid-lipofuscinosis, neuronal 3@:membrane:negative regulation of apoptotic process;late endosome;mitochondrion;galactosylceramide metabolic process;neuromuscular process controlling balance;neuron projection;lysosomal lumen pH elevation;integral to endoplasmic reticulum membrane;cell death;plasma membrane;nucleus;lysosomal lumen acidification;negative regulation of catalytic activity;negative regulation of macroautophagy;unfolded protein binding;neurotransmitter metabolic process;endoplasmic reticulum;vesicle transport along microtubule;protein catabolic process;autophagic vacuole;early endosome;trans-Golgi network;cellular membrane organization;ceramide metabolic process;glucosylceramide metabolic process;negative regulation of neuron apoptotic process;membrane;globoside metabolic process;membrane raft;synaptic vesicle;vacuolar transport;protein processing;Golgi membrane;caveola;protein folding;ionotropic glutamate receptor signaling pathway;cytosolic calcium ion homeostasis;Golgi stack;integral to membrane;receptor-mediated endocytosis;arginine transport;lysosome;negative regulation of proteolysis;Golgi apparatus;lysosome organization;associative learning;sphingomyelin metabolic process;macroautophagy;lysosomal membrane;amyloid precursor protein catabolic process;cytoplasm;autophagic vacuole fusion;protein binding;regulation of action potential;cellular amino acid metabolic process@: CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3
A2463_19@144052@144053@deletion@1@28478042@28481759@16@chr16:28478042-28481759@-13.9@144@233@1.62@NA@NPIPL1_2, NPIPL1_1@0@0@0@:ceroid-lipofuscinosis, neuronal 3@:membrane:negative regulation of apoptotic process;late endosome;mitochondrion;galactosylceramide metabolic process;neuromuscular process controlling balance;neuron projection;lysosomal lumen pH elevation;integral to endoplasmic reticulum membrane;cell death;plasma membrane;nucleus;lysosomal lumen acidification;negative regulation of catalytic activity;negative regulation of macroautophagy;unfolded protein binding;neurotransmitter metabolic process;endoplasmic reticulum;vesicle transport along microtubule;protein catabolic process;autophagic vacuole;early endosome;trans-Golgi network;cellular membrane organization;ceramide metabolic process;glucosylceramide metabolic process;negative regulation of neuron apoptotic process;membrane;globoside metabolic process;membrane raft;synaptic vesicle;vacuolar transport;protein processing;Golgi membrane;caveola;protein folding;ionotropic glutamate receptor signaling pathway;cytosolic calcium ion homeostasis;Golgi stack;integral to membrane;receptor-mediated endocytosis;arginine transport;lysosome;negative regulation of proteolysis;Golgi apparatus;lysosome organization;associative learning;sphingomyelin metabolic process;macroautophagy;lysosomal membrane;amyloid precursor protein catabolic process;cytoplasm;autophagic vacuole fusion;protein binding;regulation of action potential;cellular amino acid metabolic process@: CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3
A2463_19@144095@144101@duplication@7@28607105@28619924@16@chr16:28607105-28619924@11.9@462@656@1.42@CNVR6685.1@SULT1A2_2, SULT1A1_10, SULT1A1_9, SULT1A1_8, SULT1A1_7, SULT1A1_6, SULT1A1_5@0@0@0@:sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2:sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1@:steroid metabolic process;small molecule metabolic process;sulfation;aryl sulfotransferase activity;catecholamine metabolic process;cytosol;xenobiotic metabolic process;phenol-containing compound metabolic process;sulfotransferase activity;amine biosynthetic process;flavonol 3-sulfotransferase activity;3'-phosphoadenosine 5'-phosphosulfate metabolic process:small molecule metabolic process;sulfation;aryl sulfotransferase activity;amine metabolic process;catecholamine metabolic process;xenobiotic metabolic process;cytosol;steroid sulfotransferase activity;integral to membrane;sulfotransferase activity;flavonol 3-sulfotransferase activity;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process;estrogen metabolic process@NA
A2463_19@144262@144265@duplication@4@29057332@29062028@16@chr16:29057332-29062028@13.1@153@281@1.84@NA@CTB-134H23.2_3, CTB-134H23.2_4, CTB-134H23.2_5, CTB-134H23.2_6@0@0@0@NA@NA@NA
A2463_19@144516@144520@duplication@5@30234351@30243168@16@chr16:30234351-30243168@7.92@11@62@5.64@CNVR6694.1, CNVR6694.2@NPIPL3_8, NPIPL3_7, NPIPL3_6, NPIPL3_5, NPIPL3_4@0@0@0@:nuclear pore complex interacting protein-like@:integral to membrane@NA
A2463_19@145013@145013@deletion@1@32264676@32265036@16@chr16:32264676-32265036@8.08@231@127@0.55@CNVR6701.6, CNVR6701.2@TP53TG3D_1@0@0@0@:TP53 target 3B;TP53 target 3;TP53-target gene 3 protein-like;TP53 target 3C@:nucleus;cytoplasm@NA
A2463_19@148609@148623@deletion@15@89824986@89849510@16@chr16:89824986-89849510@95.3@1889@966@0.511@NA@FANCA_30, FANCA_29, FANCA_28, FANCA_27, FANCA_26, FANCA_25, FANCA_24, FANCA_23, FANCA_22, FANCA_21, FANCA_20, FANCA_19, FANCA_18, FANCA_17, FANCA_16@0@0@0@:Fanconi anemia, complementation group A@:nucleoplasm;male gonad development;Fanconi anaemia nuclear complex;protein complex assembly;regulation of cell proliferation;cytoplasm;male meiosis;DNA repair;protein binding;female gonad development;nucleus@: FANCONI ANEMIA, COMPLEMENTATION GROUP A; FANCA
A2463_19@151959@151959@deletion@1@18996779@18997166@17@chr17:18996779-18997166@6.63@199@113@0.568@CNVR7018.4, CNVR7018.2, CNVR7018.6@AC007952.5_2@0@0@0@NA@NA@NA
A2463_19@152216@152216@duplication@1@25972341@25972375@17@chr17:25972341-25972375@5.14@48@94@1.96@CNVR7045.1, CNVR7045.2@LGALS9_6@0@0@0@:lectin, galactoside-binding, soluble, 9@:carbohydrate binding;positive regulation of I-kappaB kinase/NF-kappaB cascade;signal transduction;extracellular region;galactose binding;signal transducer activity;cytoplasm@NA
A2463_19@152991@152992@duplication@2@30354789@30357746@17@chr17:30354789-30357746@9.66@255@388@1.52@NA@LRRC37B_3, LRRC37B_4@0@0@0@:leucine rich repeat containing 37B@:protein binding;integral to membrane;cytoplasm@NA
A2463_19@153376@153394@deletion@19@34522686@34590454@17@chr17:34522686-34590454@24.9@126@9@0.0714@CNVR7077.1, CNVR7077.13, CNVR7077.19@CCL3L3_3, CCL3L3_2, CCL3L3_1, CCL4L1_1, CCL4L1_2, CCL4L1_3, TBC1D3C_14, TBC1D3C_13, TBC1D3C_12, TBC1D3C_11, TBC1D3C_10, TBC1D3C_9, TBC1D3C_8, TBC1D3C_7, TBC1D3C_6, TBC1D3C_5, TBC1D3C_4, TBC1D3C_3, TBC1D3C_2@0@0@0@:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1:TBC1 domain family, member 3C;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3H-like;TBC1 domain family, member 3H@:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_19@153414@153414@deletion@1@34797487@34798054@17@chr17:34797487-34798054@17.7@84@1@0.0119@CNVR7078.2, CNVR7078.3@TBC1D3G_14@0@0@0@:TBC1 domain family member 3H-like;TBC1 domain family, member 3H:TBC1 domain family, member 3;TBC1 domain family, member 3G;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like;TBC1 domain family, member 3H@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_19@153627@153628@deletion@2@36287671@36288301@17@chr17:36287671-36288301@4.96@220@137@0.623@NA@TBC1D3F_5, TBC1D3F_6@0@0@0@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family member 3G-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_19@154346@154346@deletion@1@39421631@39422112@17@chr17:39421631-39422112@6.14@59@21@0.356@CNVR7096.1@KRTAP9-6_1@0@0@0@:keratin associated protein 9-6@:keratin filament@NA
A2463_19@155584@155590@duplication@7@44380005@44409347@17@chr17:44380005-44409347@25@334@616@1.84@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A_3, LRRC37A_4, LRRC37A_5, LRRC37A_6, LRRC37A_7, LRRC37A_8, LRRC37A_9@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
A2463_19@155593@155600@duplication@8@44414663@44594799@17@chr17:44414663-44594799@36.6@319@683@2.14@CNVR7114.2, CNVR7114.1@LRRC37A_12, LRRC37A_13, LRRC37A_14, ARL17B_4, ARL17B_3, ARL17B_2, LRRC37A2_2, LRRC37A2_3@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
A2463_19@155608@155609@duplication@2@44627782@44630815@17@chr17:44627782-44630815@9.8@409@594@1.45@CNVR7114.2, CNVR7114.5, CNVR7114.4@LRRC37A2_11, LRRC37A2_12@0@0@0@:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
A2463_19@160152@160153@deletion@2@49130@49557@18@chr18:49130-49557@6.35@56@19@0.339@CNVR7228.2@RP11-683L23.1_2, RP11-683L23.1_1@0@0@0@@:GTPase activity;protein complex;GTP catabolic process;cytoplasm;microtubule cytoskeleton;protein polymerization;microtubule-based movement;structural molecule activity;microtubule;GTP binding;plasma membrane@NA
A2463_19@162017@162018@deletion@2@44542732@44550298@18@chr18:44542732-44550298@78.2@411@8@0.0195@CNVR7319.1, CNVR7319.2@TCEB3CL2_1, TCEB3CL_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2:transcription elongation factor B polypeptide 3C-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_19@162017@162019@duplication@1@44542732@44556213@18@chr18:44542732-44556213@-60.2@2427@3392@1.4@CNVR7319.1, CNVR7319.2@TCEB3CL2_1, TCEB3CL_1, TCEB3C_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2:transcription elongation factor B polypeptide 3C-like:transcription elongation factor B polypeptide 3C (elongin A3);RNA polymerase II transcription factor SIII subunit A3-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_19@164951@164951@deletion@1@7032325@7032905@19@chr19:7032325-7032905@5.63@27@1@0.037@CNVR7517.1@MBD3L5_2@0@0@0@:methyl-CpG binding domain protein 3-like 5@NA@NA
A2463_19@164953@164956@duplication@4@7040112@7056914@19@chr19:7040112-7056914@5.81@251@347@1.38@CNVR7517.1@MBD3L4_1, MBD3L2_1, MBD3L2_2, MBD3L3_2@0@0@0@:methyl-CpG binding domain protein 3-like 4:methyl-CpG-binding domain protein 3-like 2-like;methyl-CpG binding domain protein 3-like 2:methyl-CpG binding domain protein 3-like 3@:regulation of transcription, DNA-dependent;transcription, DNA-dependent:regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_19@166381@166382@deletion@2@12543192@12544011@19@chr19:12543192-12544011@8.31@200@112@0.56@CNVR7541.1@ZNF443_3, ZNF443_2@0@0@0@:zinc finger protein 443@:intracellular;regulation of transcription, DNA-dependent;nucleic acid binding:intracellular;DNA binding;regulation of transcription, DNA-dependent;response to stress;induction of apoptosis;nucleus;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:intracellular;regulation of transcription, DNA-dependent;nucleic acid binding@NA
A2463_19@167610@167620@duplication@11@17443740@17450408@19@chr19:17443740-17450408@17.1@507@737@1.45@CNVR7562.1@ANO8_5, ANO8_4, ANO8_3, ANO8_2, ANO8_1, GTPBP3_1, GTPBP3_2, GTPBP3_3, GTPBP3_4, GTPBP3_5, GTPBP3_6@0@0@0@:anoctamin 8:GTP binding protein 3 (mitochondrial)@:chloride channel activity;chloride channel complex;intracellular:mitochondrion;GTP binding;GTPase activity;metal ion binding;tRNA modification@: DEAFNESS, AMINOGLYCOSIDE-INDUCED
A2463_19@170097@170097@deletion@1@40376314@40376512@19@chr19:40376314-40376512@4.69@74@36@0.486@CNVR7639.2@FCGBP_25@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_19@170820@170826@deletion@7@43699148@43763287@19@chr19:43699148-43763287@28.5@560@295@0.527@CNVR7658.5, CNVR7658.1@PSG4_4, PSG4_3, PSG4_2, PSG4_1, PSG9_6, PSG9_5, PSG9_4@0@0@0@:pregnancy specific beta-1-glycoprotein 4:pregnancy specific beta-1-glycoprotein 9@:protein binding;extracellular region;female pregnancy;defense response:protein binding;extracellular region;female pregnancy;defense response@NA
A2463_19@173297@173300@deletion@4@54725701@54726848@19@chr19:54725701-54726848@6.77@77@33@0.429@CNVR7721.3, CNVR7721.4@LILRB3_4, LILRB3_3, LILRB3_2, LILRB3_1@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
A2463_19@173459@173477@deletion@19@55246721@55295265@19@chr19:55246721-55295265@182@858@8@0.00932@CNVR7725.2, CNVR7725.1@KIR3DL3_6, KIR3DL3_7, KIR3DL3_8, KIR2DL3_1, KIR2DL3_2, KIR2DL3_3, KIR2DL3_4, KIR2DL3_5, KIR2DL3_6, KIR2DL3_7, KIR2DL3_8, KIR2DL1_1, KIR2DL1_2, KIR2DL1_3, KIR2DL1_4, KIR2DL1_5, KIR2DL1_6, KIR2DL1_7, KIR2DL1_8@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:integral to membrane;plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane@NA
A2463_19@173479@173504@duplication@26@55315347@55363737@19@chr19:55315347-55363737@49.6@1015@1560@1.54@CNVR7725.1, CNVR7725.6@KIR2DL4_2, KIR2DL4_3, KIR2DL4_4, KIR2DL4_5, KIR2DL4_6, KIR2DL4_7, KIR3DL1_1, KIR3DL1_2, KIR3DL1_3, KIR3DL1_4, KIR3DL1_5, KIR3DL1_6, KIR3DL1_7, KIR3DL1_8, KIR3DL1_9, KIR2DS4_1, KIR2DS4_2, KIR2DS4_3, KIR2DS4_4, KIR2DS4_5, KIR2DS4_6, KIR2DS4_7, KIR2DS4_8, KIR3DL2_1, KIR3DL2_2, KIR3DL2_3@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2-like@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane@NA
A2463_19@174403@174403@deletion@1@1895746@1896101@20@chr20:1895746-1896101@4.77@112@62@0.554@CNVR7764.2@SIRPA_2@0@0@0@:signal-regulatory protein alpha@:blood coagulation;protein binding;integral to membrane;SH3 domain binding;cell adhesion;plasma membrane;membrane;leukocyte migration@NA
A2463_19@180967@180970@deletion@4@16258187@16269943@22@chr22:16258187-16269943@10.4@338@202@0.598@CNVR8071.2, CNVR8071.3@POTEH_10, POTEH_9, POTEH_8, POTEH_7@0@0@0@:POTE ankyrin domain family, member H@:protein binding@NA
A2463_19@181131@181133@duplication@3@18734088@18739404@22@chr22:18734088-18739404@8.08@26@82@3.15@CNVR8087.5, CNVR8087.2, CNVR8087.11@AC008132.1_6, AC008132.1_7, AC008132.1_8@0@0@0@NA@NA@NA
A2463_19@181131@181134@deletion@1@18734088@18835833@22@chr22:18734088-18835833@-9.21@223@197@0.883@CNVR8087.5, CNVR8087.2, CNVR8087.7@AC008132.1_6, AC008132.1_7, AC008132.1_8, AC008132.13_1@0@0@0@NA@NA@NA
A2463_19@181417@181420@duplication@4@20366369@20367356@22@chr22:20366369-20367356@6.55@33@79@2.39@CNVR8094.9, CNVR8094.4, CNVR8094.3@GGTLC3_5, GGTLC3_4, GGTLC3_3, GGTLC3_2@0@0@0@@:leukotriene biosynthetic process;glutathione metabolic process;gamma-glutamyltransferase activity;anchored to external side of plasma membrane@NA
A2463_19@181624@181634@deletion@11@21562879@21579843@22@chr22:21562879-21579843@21.1@235@97@0.413@CNVR8100.4, CNVR8100.10, CNVR8100.7@GGT2_14, GGT2_13, GGT2_12, GGT2_11, GGT2_10, GGT2_9, GGT2_8, GGT2_7, GGT2_6, GGT2_5, GGT2_4@0@0@0@:gamma-glutamyltransferase 2;gamma-glutamyltranspeptidase 2-like@:hydrolase activity;small molecule metabolic process;leukotriene biosynthetic process;anchored to external side of plasma membrane;glutathione biosynthetic process;xenobiotic metabolic process;integral to membrane;glutathione metabolic process;plasma membrane;gamma-glutamyltransferase activity;cellular_component@NA
A2463_19@181624@181635@duplication@1@21562879@21743067@22@chr22:21562879-21743067@-23.9@345@297@0.861@CNVR8100.4, CNVR8100.10, CNVR8100.7@GGT2_14, GGT2_13, GGT2_12, GGT2_11, GGT2_10, GGT2_9, GGT2_8, GGT2_7, GGT2_6, GGT2_5, GGT2_4, RIMBP3B_1@0@0@0@:gamma-glutamyltransferase 2;gamma-glutamyltranspeptidase 2-like:RIMS binding protein 3B@:hydrolase activity;small molecule metabolic process;leukotriene biosynthetic process;anchored to external side of plasma membrane;glutathione biosynthetic process;xenobiotic metabolic process;integral to membrane;glutathione metabolic process;plasma membrane;gamma-glutamyltransferase activity;cellular_component:protein binding@NA
A2463_21@6@7@deletion@2@69092@139309@1@chr1:69092-139309@27.5@754@426@0.565@CNVR1.2@OR4F5_1, AL627309.1_1@0@0@0@:olfactory receptor, family 4, subfamily F, member 5@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_21@1825@1829@deletion@5@12998506@13036800@1@chr1:12998506-13036800@10.9@159@73@0.459@CNVR72.3, CNVR72.4, CNVR72.9@PRAMEF6_4, PRAMEF6_3, PRAMEF6_2, PRAMEF22_1, PRAMEF22_2@0@0@0@:PRAME family member 6;PRAME family member 23;PRAME family member 9/15-like;PRAME family member 5:PRAME family member 22@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_21@1831@1839@duplication@9@13052727@13368733@1@chr1:13052727-13368733@28.5@267@534@2@NA@WI2-3308P17.2_1, WI2-2994D6.2_2, WI2-2994D6.2_1, PRAMEF3_3, PRAMEF3_2, PRAMEF3_1, PRAMEF5_2, PRAMEF5_3, PRAMEF5_4@0@0@0@:PRAME family member 6;PRAME family member 23;PRAME family member 9/15-like;PRAME family member 5:PRAME family member:PRAME family member 3:PRAME family member 5@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_21@2171@2188@deletion@18@17249159@17275421@1@chr1:17249159-17275421@24@992@633@0.638@CNVR94.4, CNVR94.5@CROCC_2, CROCC_3, CROCC_4, CROCC_5, CROCC_6, CROCC_7, CROCC_8, CROCC_9, CROCC_10, CROCC_11, CROCC_12, CROCC_13, CROCC_14, CROCC_15, CROCC_16, CROCC_17, CROCC_18, CROCC_19@0@0@0@:ciliary rootlet coiled-coil, rootletin@:centriole;centrosome organization;centrosome;kinesin binding;actin cytoskeleton;cytoplasm;protein binding;vesicle-mediated transport;structural molecule activity;ciliary rootlet;protein localization;plasma membrane;cell cycle;cell projection organization;membrane@NA
A2463_21@3194@3197@duplication@4@24287949@24298502@1@chr1:24287949-24298502@9.07@59@129@2.19@NA@PNRC2_3, SRSF10_6, SRSF10_5, SRSF10_4@0@0@0@:proline-rich nuclear receptor coactivator 2;proline-rich nuclear receptor coactivator 2-like:serine/arginine-rich splicing factor 10-like;serine/arginine-rich splicing factor 10@:protein binding;deadenylation-independent decapping of nuclear-transcribed mRNA;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;nucleus;regulation of transcription, DNA-dependent;transcription, DNA-dependent;cytoplasmic mRNA processing body:nucleoplasm;RNA splicing, via transesterification reactions;nuclear speck;RS domain binding;RNA binding;nucleus;mRNA splice site selection;unfolded protein binding;assembly of spliceosomal tri-snRNP;negative regulation of mRNA splicing, via spliceosome;regulation of transcription, DNA-dependent;nucleotide binding;cytoplasm;mRNA export from nucleus;protein binding;cytoplasmic transport;mRNA splicing, via spliceosome;nucleic acid binding@NA
A2463_21@3357@3357@deletion@1@25735175@25735360@1@chr1:25735175-25735360@4.57@113@63@0.558@CNVR117.1@RHCE_2@0@0@0@:Rh blood group, CcEe antigens@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@: BLOOD GROUP--RHESUS SYSTEM E POLYPEPTIDE; RHE; RHESUS BLOOD GROUP, CcEe ANTIGENS; RHCE
A2463_21@5147@5149@deletion@3@39976847@39987242@1@chr1:39976847-39987242@8.45@79@29@0.367@NA@BMP8A_2, BMP8A_3, BMP8A_4@0@0@0@:bone morphogenetic protein 8a@:cell differentiation;growth factor activity;extracellular space;growth;cytokine activity;cartilage development;ossification@NA
A2463_21@8507@8508@duplication@2@89476588@89477710@1@chr1:89476588-89477710@6.32@416@570@1.37@CNVR244.1@GBP3_8, GBP3_7@0@0@0@:guanylate binding protein 3@:defense response to virus;GTP binding;GTPase activity;membrane;cytoplasm@NA
A2463_21@9340@9358@duplication@19@104114226@104166843@1@chr1:104114226-104166843@191@2483@4873@1.96@CNVR266.8, CNVR266.3@AMY2B_3, AMY2B_4, AMY2B_5, AMY2B_6, AMY2B_7, AMY2B_8, AMY2B_9, AMY2B_10, AMY2B_11, AMY2B_12, AMY2A_1, AMY2A_2, AMY2A_3, AMY2A_4, AMY2A_5, AMY2A_6, AMY2A_7, AMY2A_8, AMY2A_9@0@0@0@:actin, gamma 1 pseudogene 4;amylase, alpha 2B (pancreatic):amylase, alpha 2A (pancreatic)@:extracellular region;cation binding;digestion;carbohydrate metabolic process;catalytic activity;alpha-amylase activity;metal ion binding:chloride ion binding;cation binding;small molecule metabolic process;carbohydrate metabolic process;catalytic activity;extracellular space;polysaccharide digestion;extracellular region;carbohydrate catabolic process;alpha-amylase activity;calcium ion binding@NA
A2463_21@9373@9374@deletion@2@104233917@104234232@1@chr1:104233917-104234232@18.7@86@0@0@CNVR266.3, CNVR266.5@AMY1B_8, AMY1B_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
A2463_21@9385@9386@duplication@2@104297122@104297436@1@chr1:104297122-104297436@51.4@361@1108@3.07@CNVR266.3, CNVR266.5@AMY1C_6, AMY1C_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
A2463_21@9436@9437@duplication@2@108769302@108771778@1@chr1:108769302-108771778@7.58@205@312@1.52@CNVR294.4@NBPF4_14, NBPF4_13@0@0@0@:neuroblastoma breakpoint family, member 4@:cytoplasm@NA
A2463_21@9449@9460@deletion@12@108993225@109008046@1@chr1:108993225-109008046@20@137@30@0.219@CNVR294.4, CNVR294.2@NBPF6_2, NBPF6_3, NBPF6_4, NBPF6_5, NBPF6_6, NBPF6_7, NBPF6_8, NBPF6_9, NBPF6_10, NBPF6_11, NBPF6_12, NBPF6_13@0@0@0@:neuroblastoma breakpoint family, member 6@:cytoplasm@NA
A2463_21@9766@9773@duplication@8@110230497@110235917@1@chr1:110230497-110235917@86.7@282@1032@3.66@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_1, GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
A2463_21@10788@10788@deletion@1@144220788@144220959@1@chr1:144220788-144220959@15.1@77@4@0.0519@CNVR333.1, CNVR333.3@RP3-377D14.1_87@0@0@0@NA@NA@NA
A2463_21@10793@10793@duplication@1@144339779@144340398@1@chr1:144339779-144340398@13.7@19@122@6.42@CNVR334.4, CNVR334.2@AL592284.1_1@0@0@0@:uncharacterized LOC730256;uncharacterized LOC101060698;uncharacterized LOC642441@NA@NA
A2463_21@10797@10799@duplication@3@144813743@144816008@1@chr1:144813743-144816008@7.21@231@332@1.44@CNVR338.4, CNVR338.2, CNVR338.5, CNVR338.1@NBPF9_2, NBPF9_3, NBPF9_4@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 24@NA@NA
A2463_21@10804@10805@duplication@2@144823814@144824756@1@chr1:144823814-144824756@6.22@82@141@1.72@CNVR338.2, CNVR338.5, CNVR338.1@NBPF9_9, NBPF9_10@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 24@NA@NA
A2463_21@10868@10868@duplication@1@145302655@145302868@1@chr1:145302655-145302868@10.4@81@181@2.23@CNVR341.2, CNVR341.3, CNVR341.4@NBPF10_8@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family, member 10@:protein binding;calcium ion binding@NA
A2463_21@10890@10896@deletion@7@145325953@145330855@1@chr1:145325953-145330855@23.2@143@26@0.182@CNVR341.2, CNVR341.3@NBPF10_30, NBPF10_31, NBPF10_32, NBPF10_33, NBPF10_34, NBPF10_35, NBPF10_36@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family, member 10@NA@NA
A2463_21@10934@10941@deletion@8@145360556@145366230@1@chr1:145360556-145366230@16.9@88@7@0.0795@CNVR341.2, CNVR341.3@NBPF10_74, NBPF10_75, NBPF10_76, NBPF10_77, NBPF10_78, NBPF10_79, NBPF10_80, NBPF10_81@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family, member 10@NA@NA
A2463_21@11080@11080@deletion@1@145756418@145756613@1@chr1:145756418-145756613@5.69@29@2@0.069@NA@PDZK1_6@0@0@0@:PDZ domain containing 1@:PDZ domain binding;transport;transporter activity;cytoplasm;cell proliferation;protein binding;positive regulation of ion transmembrane transport;scavenger receptor binding;brush border membrane;establishment of protein localization to plasma membrane;carnitine transport;drug transport@NA
A2463_21@11143@11148@duplication@6@146227744@146231774@1@chr1:146227744-146231774@12@29@116@4@NA@NBPF12_22, NBPF12_21, NBPF12_20, NBPF12_19, NBPF12_18, NBPF12_17@0@0@0@:neuroblastoma breakpoint family member 21-like@NA@NA
A2463_21@11162@11162@duplication@1@146250791@146250999@1@chr1:146250791-146250999@9.55@70@158@2.26@NA@NBPF12_3@0@0@0@:neuroblastoma breakpoint family member 21-like@NA@NA
A2463_21@11169@11170@deletion@2@146400092@146401880@1@chr1:146400092-146401880@16.2@84@6@0.0714@NA@NBPF12_9, NBPF12_10@0@0@0@:neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family member 14-like;neuroblastoma breakpoint family, member 12@:cytoplasm@NA
A2463_21@11341@11346@deletion@6@148008574@148012675@1@chr1:148008574-148012675@66.9@1138@508@0.446@CNVR346.2, CNVR346.4@NBPF14_17, NBPF14_16, NBPF14_15, NBPF14_14, NBPF14_13, NBPF14_12@0@0@0@:neuroblastoma breakpoint family, member 14@:cytoplasm@NA
A2463_21@11353@11354@duplication@2@148021578@148023132@1@chr1:148021578-148023132@12.4@250@405@1.62@CNVR346.2, CNVR346.4@NBPF14_5, NBPF14_4@0@0@0@:neuroblastoma breakpoint family, member 14@:cytoplasm@NA
A2463_21@12105@12105@deletion@1@152185553@152193966@1@chr1:152185553-152193966@7.15@3329@2249@0.676@CNVR355.2, CNVR355.1@HRNR_3@0@0@0@:hornerin@:phosphoribosylanthranilate isomerase activity;nucleoside-triphosphatase activity;cornified envelope;nucleoside triphosphate catabolic process;keratinization;calcium ion binding;tryptophan metabolic process@NA
A2463_21@12117@12118@duplication@2@152573209@152586574@1@chr1:152573209-152586574@20.4@141@334@2.37@CNVR358.1@LCE3C_1, LCE3B_1@0@0@0@:late cornified envelope 3C:late cornified envelope 3B@:keratinization:keratinization@NA
A2463_21@16029@16040@deletion@12@196744018@196801129@1@chr1:196744018-196801129@399@2120@43@0.0203@CNVR459.1@CFHR3_1, CFHR3_2, CFHR3_3, CFHR3_4, CFHR3_5, CFHR3_6, CFHR1_1, CFHR1_2, CFHR1_3, CFHR1_4, CFHR1_5, CFHR1_6@0@0@0@:complement factor H-related 3:complement factor H-related 1:complement factor H-related 2@:extracellular space:extracellular space;complement activation:extracellular region@NA
A2463_21@17278@17279@deletion@2@207700099@207700468@1@chr1:207700099-207700468@6.9@31@0@0@CNVR485.1@CR1_6, CR1_7@0@0@0@:complement component (3b/4b) receptor 1 (Knops blood group)@:complement component C4b receptor activity;complement activation, classical pathway;negative regulation of complement activation, alternative pathway;innate immune response;negative regulation of serine-type endopeptidase activity;complement component C3b binding;negative regulation of complement activation, classical pathway;plasma membrane;integral to plasma membrane;complement component C3b receptor activity;complement component C4b binding;cell surface;regulation of complement activation;positive regulation of serine-type endopeptidase activity@: MALARIA, SUSCEPTIBILITY TO; KNOPS BLOOD GROUP SYSTEM; KN
A2463_21@17286@17291@duplication@6@207718654@207726196@1@chr1:207718654-207726196@6.51@71@129@1.82@CNVR485.1@CR1_14, CR1_15, CR1_16, CR1_17, CR1_18, CR1_19@0@0@0@:complement component (3b/4b) receptor 1 (Knops blood group)@:complement component C4b receptor activity;complement activation, classical pathway;negative regulation of complement activation, alternative pathway;innate immune response;negative regulation of serine-type endopeptidase activity;complement component C3b binding;negative regulation of complement activation, classical pathway;plasma membrane;integral to plasma membrane;complement component C3b receptor activity;complement component C4b binding;cell surface;regulation of complement activation;positive regulation of serine-type endopeptidase activity@: MALARIA, SUSCEPTIBILITY TO; KNOPS BLOOD GROUP SYSTEM; KN
A2463_21@17294@17295@deletion@2@207737210@207737579@1@chr1:207737210-207737579@8.19@87@35@0.402@CNVR485.1, CNVR485.2@CR1_22, CR1_23@0@0@0@:complement component (3b/4b) receptor 1 (Knops blood group)@:complement component C4b receptor activity;complement activation, classical pathway;negative regulation of complement activation, alternative pathway;innate immune response;negative regulation of serine-type endopeptidase activity;complement component C3b binding;negative regulation of complement activation, classical pathway;plasma membrane;integral to plasma membrane;complement component C3b receptor activity;complement component C4b binding;cell surface;regulation of complement activation;positive regulation of serine-type endopeptidase activity@: MALARIA, SUSCEPTIBILITY TO; KNOPS BLOOD GROUP SYSTEM; KN
A2463_21@17624@17625@deletion@2@213003585@213009491@1@chr1:213003585-213009491@10.7@298@168@0.564@CNVR498.1@C1orf227_3, C1orf227_2@0@0@0@:chromosome 1 open reading frame 227@NA@NA
A2463_21@18285@18285@deletion@1@226075487@226075732@1@chr1:226075487-226075732@6.43@126@64@0.508@NA@LEFTY1_2, RP4-559A3.7_6@0@0@0@:left-right determination factor 1@:growth factor activity;cell growth;transforming growth factor beta receptor signaling pathway;extracellular space;negative regulation of transcription from RNA polymerase II promoter;growth;transforming growth factor beta receptor binding;heart morphogenesis;cytokine activity;determination of left/right symmetry:oxidation-reduction process;oxidoreductase activity;proline biosynthetic process;pyrroline-5-carboxylate reductase activity;nucleotide binding@NA
A2463_21@19773@19776@deletion@4@248721846@248790429@1@chr1:248721846-248790429@22.6@767@443@0.578@CNVR600.1@OR2T29_1, OR2T34_1, OR2T10_1, OR2T11_1@0@0@0@:olfactory receptor, family 2, subfamily T, member 29:olfactory receptor, family 2, subfamily T, member 34:olfactory receptor, family 2, subfamily T, member 10:olfactory receptor, family 2, subfamily T, member 11@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_21@19778@19778@deletion@1@248813233@248814185@1@chr1:248813233-248814185@11.9@184@78@0.424@NA@OR2T27_1@0@0@0@:olfactory receptor, family 2, subfamily T, member 27@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_21@24822@24837@duplication@16@87178420@87205054@2@chr2:87178420-87205054@12.2@310@463@1.49@NA@RGPD1_2, RGPD1_3, RGPD1_4, RGPD1_5, RGPD1_6, RGPD1_7, RGPD1_8, RGPD1_9, RGPD1_10, RGPD1_11, RGPD1_12, RGPD1_13, RGPD1_14, RGPD1_15, RGPD1_16, RGPD1_17@0@0@0@:RANBP2-like and GRIP domain containing 1@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_21@24856@24863@deletion@8@88091510@88095367@2@chr2:88091510-88095367@10.1@48@2@0.0417@NA@RGPD2_17, RGPD2_16, RGPD2_15, RGPD2_14, RGPD2_13, RGPD2_12, RGPD2_11, RGPD2_10@0@0@0@:RANBP2-like and GRIP domain containing 2@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_21@25135@25138@deletion@4@96696493@96698107@2@chr2:96696493-96698107@9.88@139@64@0.46@NA@GPAT2_6, GPAT2_5, GPAT2_4, GPAT2_3@0@0@0@:glycerol-3-phosphate acyltransferase 2, mitochondrial@:glycerol-3-phosphate O-acyltransferase activity;mitochondrion;phospholipid metabolic process;triglyceride biosynthetic process;glycerophospholipid biosynthetic process;small molecule metabolic process;transferase activity, transferring acyl groups;mitochondrial outer membrane;phosphatidic acid biosynthetic process;integral to membrane;glycerol-3-phosphate metabolic process;CDP-diacylglycerol biosynthetic process;membrane;metabolic process;phospholipid biosynthetic process@NA
A2463_21@25369@25370@duplication@2@97854825@97855027@2@chr2:97854825-97855027@5.73@143@215@1.5@CNVR886.2, CNVR886.3@ANKRD36_33, ANKRD36_34@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_21@25389@25390@deletion@2@97873549@97873743@2@chr2:97873549-97873743@6.09@357@231@0.647@CNVR886.1@ANKRD36_53, ANKRD36_54@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_21@26414@26414@deletion@1@113138402@113138540@2@chr2:113138402-113138540@9.07@75@21@0.28@NA@RGPD8_21@0@0@0@:RANBP2-like and GRIP domain containing 8@:protein binding;intracellular;intracellular transport;nuclear pore;protein targeting to Golgi;Ran GTPase binding;biological_process@NA
A2463_21@27255@27255@deletion@1@131266289@131266808@2@chr2:131266289-131266808@5.4@180@105@0.583@NA@POTEI_1@0@0@0@:POTE ankyrin domain family, member I@:protein binding;ATP binding@NA
A2463_21@27326@27326@duplication@1@132010100@132010143@2@chr2:132010100-132010143@6.66@18@65@3.61@NA@POTEE_12@0@0@0@:pleckstrin homology domain containing, family B (evectins) member 2:POTE ankyrin domain family, member E@:phospholipid binding;protein binding;recycling endosome membrane:protein binding;ATP binding@NA
A2463_21@27996@27997@deletion@2@152463121@152464122@2@chr2:152463121-152464122@21.8@108@3@0.0278@CNVR1026.1@NEB_84, NEB_83@0@0@0@:nebulin@:Z disc;muscle filament sliding;oxidation-reduction process;contractile fiber part;actin cytoskeleton;regulation of actin filament length;structural constituent of muscle;cytosol;actin binding;protein binding;myofibril;somatic muscle development;muscle organ development@: NEMALINE MYOPATHY 2; NEM2
A2463_21@39892@39894@deletion@3@75786030@75790887@3@chr3:75786030-75790887@42.1@219@4@0.0183@CNVR1432.5, CNVR1432.9, CNVR1432.4@ZNF717_5, ZNF717_4, ZNF717_3@0@0@0@:zinc finger protein 717;zinc finger protein 717-like@:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_21@45433@45438@duplication@6@195447880@195475935@3@chr3:195447880-195475935@19.5@789@1160@1.47@CNVR1703.1, CNVR1703.2, CNVR1703.5, CNVR1703.3@MUC20_1, MUC20_2, MUC20_3, MUC20_4, MUC4_25, MUC4_24@0@0@0@:mucin 20, cell surface associated:mucin 4, cell surface associated@:microvillus membrane;apical plasma membrane;activation of MAPK activity;Golgi lumen;post-translational protein modification;protein binding;O-glycan processing;hepatocyte growth factor receptor signaling pathway;cellular protein metabolic process;extracellular region;protein homooligomerization;basal plasma membrane:ErbB-2 class receptor binding;Golgi lumen;cell-matrix adhesion;post-translational protein modification;extracellular matrix structural constituent;protein binding;O-glycan processing;cellular protein metabolic process;proteinaceous extracellular matrix;integral to plasma membrane;membrane;extracellular matrix constituent, lubricant activity;biological_process@NA
A2463_21@45729@45729@deletion@1@264889@266419@4@chr4:264889-266419@7.36@300@176@0.587@NA@ZNF732_4@0@0@0@:zinc finger protein 732@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_21@46667@46675@deletion@9@9174900@9237700@4@chr4:9174900-9237700@18.7@124@26@0.21@NA@FAM90A26P_4, FAM90A26P_5, FAM90A26P_6, FAM90A26P_7, USP17L13_1, USP17L10_1, USP17L11_1, USP17L12_1, USP17L13_2, USP17L15_1@0@0@0@:ubiquitin specific peptidase 17-like family member 10:ubiquitin specific peptidase 17-like family member 13:ubiquitin specific peptidase 17-like family member 11:ubiquitin specific peptidase 17-like family member 12:ubiquitin specific peptidase 17-like family member 15@:zinc ion binding;nucleic acid binding:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
A2463_21@48556@48561@duplication@6@69403344@69434202@4@chr4:69403344-69434202@43.8@471@974@2.07@CNVR1953.1@UGT2B17_6, UGT2B17_5, UGT2B17_4, UGT2B17_3, UGT2B17_2, UGT2B17_1@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B17@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;membrane@: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
A2463_21@48592@48595@deletion@4@70146220@70155470@4@chr4:70146220-70155470@19.6@670@395@0.59@CNVR1957.2, CNVR1957.1@UGT2B28_1, UGT2B28_2, UGT2B28_3, UGT2B28_4@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B28@:carbohydrate binding;transferase activity, transferring hexosyl groups;endoplasmic reticulum;glucuronosyltransferase activity;carbohydrate metabolic process;xenobiotic metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process@NA
A2463_21@53307@53311@duplication@5@745299@756259@5@chr5:745299-756259@18.7@134@285@2.13@CNVR2280.3@ZDHHC11B_6, ZDHHC11B_5, ZDHHC11B_4, ZDHHC11B_3, ZDHHC11B_2@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
A2463_21@53318@53322@deletion@5@833889@847730@5@chr5:833889-847730@19.1@376@198@0.527@CNVR2280.3, CNVR2280.8@ZDHHC11_7, ZDHHC11_6, ZDHHC11_5, ZDHHC11_4, ZDHHC11_3@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
A2463_21@54849@54849@deletion@1@42629141@42629205@5@chr5:42629141-42629205@26.8@132@1@0.00758@CNVR2445.1@GHR_3@0@0@0@:growth hormone receptor@:neuronal cell body;mitochondrion;proline-rich region binding;JAK-STAT cascade;growth factor binding;nucleus;succinate metabolic process;positive regulation of JAK-STAT cascade;JAK-STAT cascade involved in growth hormone signaling pathway;response to morphine;activation of MAPK activity;peptide hormone binding;response to estradiol stimulus;2-oxoglutarate metabolic process;valine metabolic process;response to cytokine stimulus;hormone-mediated signaling pathway;response to food;SH2 domain binding;oxaloacetate metabolic process;growth hormone receptor signaling pathway;allantoin metabolic process;integral to membrane;response to hormone stimulus;cartilage development involved in endochondral bone morphogenesis;positive regulation of peptidyl-tyrosine phosphorylation;receptor internalization;cytoplasm;cellular response to hormone stimulus;extracellular region;growth hormone receptor complex;positive regulation of tyrosine phosphorylation of Stat5 protein;regulation of multicellular organism growth;growth hormone receptor activity;positive regulation of tyrosine phosphorylation of Stat3 protein;response to peptide hormone stimulus;fatty acid metabolic process;creatinine metabolic process;plasma membrane;positive regulation of multicellular organism growth;receptor complex;protein phosphatase binding;protein kinase binding;creatine metabolic process;response to interleukin-1;response to cycloheximide;extracellular space;positive regulation of cell differentiation;activation of Janus kinase activity;taurine metabolic process;cellular response to insulin stimulus;integral to plasma membrane;protein homodimerization activity;negative regulation of neuron death;citrate metabolic process;endocytosis;isoleucine metabolic process;activation of JAK2 kinase activity;extrinsic to membrane;response to glucocorticoid stimulus;protein binding;insulin-like growth factor receptor signaling pathway;multicellular organismal metabolic process;cell surface@: HYPERCHOLESTEROLEMIA, FAMILIAL; LARON SYNDROME; SHORT STATURE, IDIOPATHIC, AUTOSOMAL
A2463_21@55190@55190@duplication@1@54960522@54960691@5@chr5:54960522-54960691@6.08@108@180@1.67@NA@SLC38A9_8@0@0@0@:solute carrier family 38, member 9@:amino acid transport;integral to membrane;sodium ion transport@NA
A2463_21@55806@55806@duplication@1@69372349@69372398@5@chr5:69372349-69372398@8.03@123@218@1.77@CNVR2494.48, CNVR2494.39, CNVR2494.15, CNVR2494.18, CNVR2494.26, CNVR2494.43, CNVR2494.52, CNVR2494.28, CNVR2494.2, CNVR2494.36@SMN2_8@0@0@0@:survival of motor neuron 2, centromeric;survival of motor neuron 1, telomeric@:nucleoplasm;ncRNA metabolic process;Cajal body;RNA metabolic process;spliceosomal complex;cytoplasm;cytosol;protein binding;cell death;spliceosomal complex assembly;RNA binding;mRNA processing;nucleus;gene expression;spliceosomal snRNP assembly@: SPINAL MUSCULAR ATROPHY, TYPE II; SMA2; SPINAL MUSCULAR ATROPHY, TYPE I; SMA1; SPINAL MUSCULAR ATROPHY, TYPE IV; SMA4; SPINAL MUSCULAR ATROPHY, TYPE III; SMA3
A2463_21@55835@55837@duplication@3@70338009@70343940@5@chr5:70338009-70343940@12.1@123@231@1.88@CNVR2494.41, CNVR2494.14, CNVR2494.20, CNVR2494.62, CNVR2494.8@GTF2H2_14, GTF2H2_13, GTF2H2_12@0@0@0@:general transcription factor IIH, polypeptide 2, 44kDa@:nucleoplasm;nucleotide-excision repair, DNA damage removal;transcription from RNA polymerase I promoter;DNA repair;RNA polymerase II carboxy-terminal domain kinase activity;nucleus;viral reproduction;translation;gene expression;transcription elongation from RNA polymerase I promoter;response to UV;holo TFIIH complex;protein kinase activity;nucleotide-excision repair;transcription from RNA polymerase II promoter;transcription-coupled nucleotide-excision repair;transcription, DNA-dependent;zinc ion binding;transcription elongation from RNA polymerase II promoter;termination of RNA polymerase I transcription;sequence-specific DNA binding transcription factor activity;G-protein coupled receptor internalization;DNA-dependent ATPase activity;protein N-terminus binding;transcription initiation from RNA polymerase I promoter;7-methylguanosine mRNA capping;transcription initiation from RNA polymerase II promoter;protein phosphorylation;translation factor activity, nucleic acid binding;regulation of transcription, DNA-dependent;core TFIIH complex;protein binding;positive regulation of viral transcription;nucleic acid binding@NA
A2463_21@59488@59488@deletion@1@147553798@147553933@5@chr5:147553798-147553933@5.99@27@0@0@CNVR2637.2, CNVR2637.1@SPINK14_3@0@0@0@:serine peptidase inhibitor, Kazal type 14 (putative)@:serine-type endopeptidase inhibitor activity;protein binding;extracellular region@NA
A2463_21@60885@60885@deletion@1@175520199@175520277@5@chr5:175520199-175520277@12.5@92@20@0.217@NA@FAM153B_4@0@0@0@:uncharacterized LOC100507387;family with sequence similarity 153, member B@NA@NA
A2463_21@61638@61644@duplication@7@180375356@180424488@5@chr5:180375356-180424488@8.29@762@990@1.3@CNVR2719.1@BTNL8_5, BTNL8_6, BTNL8_7, BTNL8_8, BTNL3_1, BTNL3_2, BTNL3_3@0@0@0@:butyrophilin-like 8:butyrophilin-like 3@:protein binding;integral to membrane:protein binding;integral to membrane;molecular_function;cellular_component;biological_process@NA
A2463_21@61690@61697@deletion@8@292541@350868@6@chr6:292541-350868@25.3@728@424@0.582@CNVR2728.1@DUSP22_1, DUSP22_2, DUSP22_3, DUSP22_4, DUSP22_5, DUSP22_6, DUSP22_7, DUSP22_8@0@0@0@:dual specificity phosphatase 22;dual specificity protein phosphatase 22-like@:protein dephosphorylation;transforming growth factor beta receptor signaling pathway;positive regulation of JNK cascade;protein tyrosine/serine/threonine phosphatase activity;nucleus;apoptotic process;multicellular organismal development;phosphatase activity;protein tyrosine phosphatase activity;regulation of cell proliferation;cytoplasm;cell proliferation;inactivation of MAPK activity;protein binding;negative regulation of transcription from RNA polymerase II promoter;dephosphorylation@NA
A2463_21@63283@63284@deletion@2@31238851@31239645@6@chr6:31238851-31239645@9.58@342@204@0.596@CNVR2838.1@HLA-C_3, HLA-C_2@0@0@0@:major histocompatibility complex, class I, C@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;membrane@: PSORIASIS SUSCEPTIBILITY 1; PSORS1
A2463_21@63726@63726@deletion@1@31962276@31962484@6@chr6:31962276-31962484@7.74@235@130@0.553@CNVR2843.6, CNVR2843.3@C4A_21@0@0@0@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
A2463_21@63734@63735@duplication@2@31964607@31965088@6@chr6:31964607-31965088@13.3@19@112@5.89@CNVR2843.6, CNVR2843.3@C4A_29, C4A_30@0@0@0@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
A2463_21@63769@63775@duplication@7@31995014@31996838@6@chr6:31995014-31996838@14.6@379@570@1.5@CNVR2843.6, CNVR2843.5@C4B_21, C4B_22, C4B_23, C4B_24, C4B_25, C4B_26, C4B_27@0@0@0@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
A2463_21@63812@63812@deletion@1@32012784@32012996@6@chr6:32012784-32012996@6.17@216@126@0.583@CNVR2843.6, CNVR2843.5@TNXB_1@0@0@0@:tenascin-X-like;tenascin XB@:integrin binding;extracellular matrix;cell-cell adhesion;elastic fiber assembly;collagen fibril organization;fibrillar collagen;actin cytoskeleton organization;extracellular space;heparin binding;proteinaceous extracellular matrix;fatty acid metabolic process;regulation of JUN kinase activity;receptor binding;intracellular;cell-matrix adhesion;extracellular matrix organization;lipid metabolic process;protein binding;signal transduction;extracellular region;collagen binding;cell adhesion;triglyceride metabolic process;fibril organization;collagen metabolic process@: EHLERS-DANLOS-LIKE SYNDROME DUE TO TENASCIN-X DEFICIENCY; EHLERS-DANLOS SYNDROME, TYPE III
A2463_21@63953@63957@duplication@5@32485517@32489951@6@chr6:32485517-32489951@51.5@190@606@3.19@CNVR2845.21, CNVR2845.25, CNVR2845.30@HLA-DRB5_6, HLA-DRB5_5, HLA-DRB5_4, HLA-DRB5_3, HLA-DRB5_2@0@0@0@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
A2463_21@63965@63969@duplication@5@32605237@32628026@6@chr6:32605237-32628026@23.5@704@1078@1.53@CNVR2845.21, CNVR2845.25, CNVR2845.27, CNVR2845.22, CNVR2845.39, CNVR2845.20@HLA-DQA1_1, HLA-DQA1_2, HLA-DQA1_3, HLA-DQA1_4, HLA-DQB1_6@0@0@0@:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@NA
A2463_21@64603@64606@deletion@4@35755645@35765065@6@chr6:35755645-35765065@14@426@241@0.566@CNVR2861.1@CLPSL1_3, CLPS_3, CLPS_2, CLPS_1@0@0@0@:colipase-like 1:colipase, pancreatic@:extracellular region;enzyme activator activity;digestion;lipid catabolic process:steroid metabolic process;post-embryonic development;small molecule metabolic process;retinoid metabolic process;lipid metabolic process;extracellular region;enzyme activator activity;digestion;lipid catabolic process;lipid digestion;response to food@NA
A2463_21@71011@71015@deletion@5@167590486@167595404@6@chr6:167590486-167595404@14.1@416@241@0.579@NA@TCP10L2_4, TCP10L2_5, TCP10L2_6, TCP10L2_7, TCP10L2_8@0@0@0@:t-complex 10;t-complex 10-like 2@NA@NA
A2463_21@71028@71032@duplication@5@167787840@167794824@6@chr6:167787840-167794824@33.5@252@557@2.21@NA@TCP10_7, TCP10_6, TCP10_5, TCP10_4, TCP10_3@0@0@0@:t-complex 10@:cytosol@NA
A2463_21@71744@71753@deletion@10@5939916@5958531@7@chr7:5939916-5958531@110@973@291@0.299@NA@CCZ1_2, CCZ1_3, CCZ1_4, CCZ1_5, CCZ1_6, CCZ1_7, CCZ1_8, CCZ1_9, CCZ1_10, CCZ1_11@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
A2463_21@71755@71777@duplication@23@5963019@6013173@7@chr7:5963019-6013173@51.6@871@1453@1.67@NA@CCZ1_13, CCZ1_14, CCZ1_15, RSPH10B_20, RSPH10B_19, RSPH10B_18, RSPH10B_17, RSPH10B_16, RSPH10B_15, RSPH10B_14, RSPH10B_13, RSPH10B_12, RSPH10B_11, RSPH10B_10, RSPH10B_9, RSPH10B_8, RSPH10B_7, RSPH10B_6, RSPH10B_5, RSPH10B_4, RSPH10B_3, RSPH10B_2, PMS2_15@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae):radial spoke head 10 homolog B (Chlamydomonas):PMS2 postmeiotic segregation increased 2 (S. cerevisiae)@:lysosomal membrane:response to drug;DNA binding;MutSalpha complex binding;ATP binding;mismatch repair;DNA repair;mismatched DNA binding;ATPase activity;nucleus;mismatch repair complex;reciprocal meiotic recombination;ATP catabolic process;single-stranded DNA binding;response to DNA damage stimulus;single base insertion or deletion binding;protein binding;somatic hypermutation of immunoglobulin genes;somatic recombination of immunoglobulin gene segments;MutLalpha complex;endonuclease activity@: COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 4; HNPCC4; MISMATCH REPAIR CANCER SYNDROME
A2463_21@71922@71934@deletion@13@6797310@6821107@7@chr7:6797310-6821107@43.7@533@210@0.394@NA@RSPH10B2_2, RSPH10B2_3, RSPH10B2_4, RSPH10B2_5, RSPH10B2_6, RSPH10B2_7, RSPH10B2_8, RSPH10B2_9, RSPH10B2_10, RSPH10B2_11, RSPH10B2_12, RSPH10B2_13, RSPH10B2_14@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
A2463_21@71936@71942@deletion@7@6826510@6840706@7@chr7:6826510-6840706@43@228@19@0.0833@NA@RSPH10B2_16, RSPH10B2_17, RSPH10B2_18, RSPH10B2_19, RSPH10B2_20, CCZ1B_15, CCZ1B_14@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
A2463_21@71947@71955@duplication@9@6852608@6865828@7@chr7:6852608-6865828@42.9@1072@1717@1.6@NA@CCZ1B_9, CCZ1B_8, CCZ1B_7, CCZ1B_6, CCZ1B_5, CCZ1B_4, CCZ1B_3, CCZ1B_2, CCZ1B_1@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
A2463_21@74565@74566@duplication@2@74157789@74159280@7@chr7:74157789-74159280@11.2@168@295@1.76@NA@GTF2I_20, GTF2I_21@0@0@0@:general transcription factor IIi@:neuronal cell body;transcription initiation from RNA polymerase II promoter;mitogen-activated protein kinase binding;negative regulation of angiogenesis;DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;cytoplasm;transcription from RNA polymerase II promoter;protein binding;signal transduction;nucleus;cell projection;reduction of cytosolic calcium ion concentration@NA
A2463_21@74574@74579@duplication@6@74167427@74173168@7@chr7:74167427-74173168@14.1@241@395@1.64@NA@GTF2I_29, GTF2I_30, GTF2I_31, GTF2I_32, GTF2I_33, GTF2I_34@0@0@0@:general transcription factor IIi@:neuronal cell body;transcription initiation from RNA polymerase II promoter;mitogen-activated protein kinase binding;negative regulation of angiogenesis;DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;cytoplasm;transcription from RNA polymerase II promoter;protein binding;signal transduction;nucleus;cell projection;reduction of cytosolic calcium ion concentration@NA
A2463_21@74597@74598@deletion@2@74225431@74227349@7@chr7:74225431-74227349@9.86@51@4@0.0784@NA@GTF2IRD2_10, GTF2IRD2_9@0@0@0@:GTF2I repeat domain containing 2@:nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_21@74640@74640@deletion@1@74563501@74565103@7@chr7:74563501-74565103@8.95@492@292@0.593@NA@GTF2IRD2B_16@0@0@0@:GTF2I repeat domain containing 2B@:nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_21@74663@74664@deletion@2@75054919@75055735@7@chr7:75054919-75055735@10.4@98@37@0.378@NA@POM121C_9, POM121C_8@0@0@0@:POM121 transmembrane nucleoporin C@:nuclear membrane;protein binding;protein transport;endoplasmic reticulum membrane;nuclear pore;mRNA transport@NA
A2463_21@76717@76719@deletion@3@102114097@102116717@7@chr7:102114097-102116717@5.35@126@72@0.571@CNVR3518.1@POLR2J_4, POLR2J_3, POLR2J_2@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J, 13.3kDa@:nucleoplasm;DNA binding;DNA repair;protein dimerization activity;nucleus;viral reproduction;gene expression;transcription initiation from RNA polymerase II promoter;7-methylguanosine mRNA capping;protein phosphorylation;LRR domain binding;protein kinase activity;DNA-directed RNA polymerase II, core complex;nucleotide-excision repair;transcription from RNA polymerase II promoter;DNA-directed RNA polymerase activity;protein binding;transcription-coupled nucleotide-excision repair;RNA splicing;mRNA splicing, via spliceosome;transcription, DNA-dependent;transcription elongation from RNA polymerase II promoter;positive regulation of viral transcription@NA
A2463_21@76726@76741@deletion@16@102133564@102158157@7@chr7:102133564-102158157@12@189@96@0.508@CNVR3518.1@RASA4B_16, RASA4B_15, RASA4B_14, RASA4B_13, RASA4B_12, RASA4B_11, RASA4B_10, RASA4B_9, RASA4B_8, RASA4B_7, RASA4B_6, RASA4B_5, RASA4B_4, RASA4B_3, RASA4B_2, RASA4B_1@0@0@0@:RAS p21 protein activator 4B@:phospholipid binding;intracellular;GTPase activator activity;cytosol;signal transduction;protein binding;plasma membrane;regulation of small GTPase mediated signal transduction;metal ion binding;intracellular signal transduction@NA
A2463_21@76748@76792@deletion@45@102201564@102309451@7@chr7:102201564-102309451@24.8@842@526@0.625@CNVR3518.1@SPDYE2_8, POLR2J3_4, POLR2J3_3, POLR2J3_2, POLR2J3_1, AC093668.1_3, AC093668.1_2, AC093668.1_1, RASA4_21, RASA4_20, RASA4_19, RASA4_18, RASA4_17, RASA4_16, RASA4_15, RASA4_14, RASA4_13, RASA4_12, RASA4_11, RASA4_10, RASA4_9, RASA4_8, RASA4_7, RASA4_6, RASA4_5, RASA4_4, RASA4_3, RASA4_2, UPK3BL_7, RASA4_1, UPK3BL_6, UPK3BL_6, UPK3BL_5, UPK3BL_5, UPK3BL_4, UPK3BL_4, UPK3BL_3, UPK3BL_3, UPK3BL_2, UPK3BL_2, UPK3BL_1, UPK3BL_1, SPDYE2L_2, SPDYE2L_3, SPDYE2L_4, SPDYE2L_5, SPDYE2L_6, SPDYE2L_7, SPDYE2L_8, POLR2J2_4, POLR2J2_4, POLR2J2_3, POLR2J2_3, POLR2J2_2, POLR2J2_2@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:speedy homolog E2 (Xenopus laevis):RAS p21 protein activator 4B;RAS p21 protein activator 4:uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J2:WBSCR19-like protein 3;speedy homolog E6 (Xenopus laevis)@:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity:integral to membrane:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
A2463_21@79288@79288@duplication@1@143416777@143417767@7@chr7:143416777-143417767@5.88@89@153@1.72@CNVR3594.2, CNVR3594.1@FAM115C_3@0@0@0@:family with sequence similarity 115, member C;protein FAM115C-like@NA@NA
A2463_21@79309@79309@duplication@1@143880598@143882930@7@chr7:143880598-143882930@12.4@397@659@1.66@CNVR3598.4, CNVR3598.3@CTAGE4_1@0@0@0@:CTAGE family, member 4@:integral to membrane;nucleotide binding;cellular_component;biological_process@NA
A2463_21@79312@79312@duplication@1@143955790@143956721@7@chr7:143955790-143956721@7.99@310@473@1.53@CNVR3598.4, CNVR3598.7, CNVR3598.6@OR2A7_1@0@0@0@:Rho guanine nucleotide exchange factor (GEF) 35:olfactory receptor, family 2, subfamily A, member 7@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_21@79314@79324@duplication@11@144015219@144071982@7@chr7:144015219-144071982@36.3@1395@2209@1.58@CNVR3598.4, CNVR3598.5@OR2A1_1, ARHGEF5_2, ARHGEF5_3, ARHGEF5_4, ARHGEF5_5, ARHGEF5_6, ARHGEF5_7, ARHGEF5_8, ARHGEF5_9, ARHGEF5_10, ARHGEF5_11@0@0@0@:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
A2463_21@80141@80142@deletion@2@116087@142298@8@chr8:116087-142298@19.6@96@4@0.0417@CNVR3684.8, CNVR3684.5@OR4F21_1, RP11-585F1.10_2@0@0@0@:olfactory receptor, family 4, subfamily F, member 21:F-box only protein 25-like;putative uncharacterized protein C20orf69-like@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_21@80375@80379@duplication@5@7332534@7345699@8@chr8:7332534-7345699@6.69@152@227@1.49@CNVR3771.8, CNVR3771.10, CNVR3771.4@DEFB104B_1, DEFB106B_2, DEFB106B_1, DEFB105B_1, DEFB105B_2@0@0@0@:defensin, beta 104A;defensin, beta 104B:defensin, beta 106B;defensin, beta 106A:defensin, beta 105B;defensin, beta 105A@:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium@NA
A2463_21@80397@80398@deletion@2@7686328@7694064@8@chr8:7686328-7694064@6.06@118@63@0.534@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@DEFB106A_2, DEFB104A_1@0@0@0@:defensin, beta 106B;defensin, beta 106A:defensin, beta 104A;defensin, beta 104B@:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium@NA
A2463_21@80567@80567@deletion@1@12042886@12043034@8@chr8:12042886-12043034@6.33@53@16@0.302@CNVR3785.5, CNVR3785.3@FAM86B1_7@0@0@0@:family with sequence similarity 86, member B2;family with sequence similarity 86, member B1@NA@NA
A2463_21@80578@80579@deletion@2@12286143@12286623@8@chr8:12286143-12286623@11.6@67@8@0.119@CNVR3786.4, CNVR3786.16@FAM86B2_6, FAM86B2_5@0@0@0@:family with sequence similarity 86, member B2@NA@NA
A2463_21@85935@85936@duplication@2@143956651@143957294@8@chr8:143956651-143957294@6.93@221@327@1.48@NA@CYP11B1_7, CYP11B1_6@0@0@0@:glycosylphosphatidylinositol anchored molecule like:cytochrome P450, family 11, subfamily B, polypeptide 1@:negative regulation of cell proliferation;plasma membrane;apoptotic process;anchored to membrane;extrinsic to membrane;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest:cellular response to potassium ion;steroid metabolic process;oxidation-reduction process;mitochondrion;immune response;mitochondrial inner membrane;glucose homeostasis;steroid 11-beta-monooxygenase activity;electron carrier activity;small molecule metabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;C21-steroid hormone biosynthetic process;heme binding;cortisol biosynthetic process;response to stress;mineralocorticoid biosynthetic process;cellular response to hormone stimulus;xenobiotic metabolic process;aldosterone biosynthetic process;monooxygenase activity;iron ion binding;regulation of blood pressure;glucocorticoid biosynthetic process@: GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM; GRA; ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASE
A2463_21@85944@85944@deletion@1@143994224@143994301@8@chr8:143994224-143994301@7.92@120@54@0.45@NA@CYP11B2_7@0@0@0@:glycosylphosphatidylinositol anchored molecule like:cytochrome P450, family 11, subfamily B, polypeptide 2@:negative regulation of cell proliferation;plasma membrane;apoptotic process;anchored to membrane;extrinsic to membrane;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest:cellular response to potassium ion;steroid metabolic process;oxidation-reduction process;mitochondrion;mitochondrial inner membrane;sodium ion homeostasis;renal water homeostasis;steroid 11-beta-monooxygenase activity;electron carrier activity;small molecule metabolic process;regulation of blood volume by renal aldosterone;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;potassium ion homeostasis;C21-steroid hormone biosynthetic process;heme binding;cortisol biosynthetic process;xenobiotic metabolic process;cellular response to hormone stimulus;mineralocorticoid biosynthetic process;aldosterone biosynthetic process;iron ion binding;corticosterone 18-monooxygenase activity@: CORTICOSTERONE METHYLOXIDASE TYPE II DEFICIENCY; GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM; GRA; CORTICOSTERONE METHYLOXIDASE TYPE I DEFICIENCY
A2463_21@86628@86630@duplication@3@34922@35519@9@chr9:34922-35519@5.11@95@149@1.57@CNVR4134.1@FAM138C_3, FAM138C_2, FAM138C_1@0@0@0@NA@NA@NA
A2463_21@88492@88495@deletion@4@39078688@39088644@9@chr9:39078688-39088644@20.8@492@275@0.559@NA@CNTNAP3_22, CNTNAP3_21, CNTNAP3_20, CNTNAP3_19@0@0@0@:contactin associated protein-like 3@:binding;signal transduction;protein binding;integral to membrane;extracellular region;cell adhesion;plasma membrane;cell recognition;receptor binding@NA
A2463_21@88528@88529@deletion@2@40702653@40716325@9@chr9:40702653-40716325@5.6@1005@715@0.711@NA@SPATA31A3_4, FAM74A3_1@0@0@0@:SPATA31 subfamily A, member 3@:integral to membrane@NA
A2463_21@88534@88535@deletion@2@41306194@41311806@9@chr9:41306194-41311806@14.2@65@0@0@CNVR4278.2@FAM74A2_2, FAM74A2_1@0@0@0@@:integral to membrane@NA
A2463_21@88544@88549@deletion@6@42368416@42380206@9@chr9:42368416-42380206@18.3@152@39@0.257@NA@ANKRD20A2_1, ANKRD20A2_2, ANKRD20A2_3, ANKRD20A2_4, ANKRD20A2_5, ANKRD20A2_6@0@0@0@:ankyrin repeat domain 20 family, member A2@:protein binding@NA
A2463_21@88585@88585@deletion@1@43628635@43628694@9@chr9:43628635-43628694@5.35@38@9@0.237@NA@SPATA31A6_3@0@0@0@:SPATA31 subfamily A, member 6@:integral to membrane@NA
A2463_21@88593@88601@duplication@9@43816638@43876145@9@chr9:43816638-43876145@25.1@775@1153@1.49@NA@CNTNAP3B_6, CNTNAP3B_7, CNTNAP3B_8, CNTNAP3B_9, CNTNAP3B_10, CNTNAP3B_11, CNTNAP3B_12, CNTNAP3B_13, CNTNAP3B_14@0@0@0@:contactin associated protein-like 3B;contactin associated protein-like 3@:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
A2463_21@88604@88610@duplication@7@43891495@43915897@9@chr9:43891495-43915897@10.4@163@268@1.64@NA@CNTNAP3B_17, CNTNAP3B_18, CNTNAP3B_19, CNTNAP3B_20, CNTNAP3B_21, CNTNAP3B_22, CNTNAP3B_23@0@0@0@:contactin associated protein-like 3B;contactin associated protein-like 3@:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
A2463_21@88620@88624@deletion@5@45727245@46390900@9@chr9:45727245-46390900@34.2@218@39@0.179@NA@FAM27A_1, AL953889.1_2, AL953889.1_1, FAM27A_2, FAM27E2_1, FAM27E1_1, FAM27D1_1@0@0@0@:family with sequence similarity 27, member E3:protein FAM27E2-like;protein FAM27D1-like@NA@NA
A2463_21@88631@88633@deletion@3@65503517@65508193@9@chr9:65503517-65508193@34.5@301@86@0.286@CNVR4312.5@SPATA31A7_4, SPATA31A7_3, SPATA31A7_2@0@0@0@:SPATA31 subfamily A, member 7@:integral to membrane@NA
A2463_21@88639@88641@duplication@3@67926874@67930837@9@chr9:67926874-67930837@21@44@194@4.41@NA@ANKRD20A1_1, ANKRD20A1_2, ANKRD20A1_3@0@0@0@:ankyrin repeat domain 20 family, member A1@:protein binding;plasma membrane@NA
A2463_21@88655@88657@duplication@3@67984834@67987998@9@chr9:67984834-67987998@11.2@320@483@1.51@CNVR4321.1@RP11-195B21.3_4, RP11-195B21.3_5, RP11-195B21.3_6@0@0@0@:coiled-coil domain-containing protein 29-like;uncharacterized LOC644249@NA@NA
A2463_21@88661@88664@deletion@4@69206735@69229668@9@chr9:69206735-69229668@6.37@359@236@0.657@NA@CBWD6_13, CBWD6_12, CBWD6_11, CBWD6_10@0@0@0@:COBW domain containing 6@:ATP binding@NA
A2463_21@88670@88682@deletion@13@69252846@69400452@9@chr9:69252846-69400452@49.9@484@177@0.366@NA@BX255923.1_1, CBWD6_4, CBWD6_3, CBWD6_2, CBWD6_1, CR769776.1_1, ANKRD20A4_1, ANKRD20A4_2, ANKRD20A4_3, ANKRD20A4_4, ANKRD20A4_5, ANKRD20A4_6, ANKRD20A4_7@0@0@0@:COBW domain containing 6:ankyrin repeat domain 20 family, member A4@:ATP binding:protein binding@NA
A2463_21@88687@88690@deletion@4@69416136@69424176@9@chr9:69416136-69424176@39.4@649@273@0.421@NA@ANKRD20A4_12, ANKRD20A4_13, ANKRD20A4_14, ANKRD20A4_15@0@0@0@:ankyrin repeat domain 20 family, member A4@:protein binding@NA
A2463_21@88712@88714@duplication@3@70862530@70866572@9@chr9:70862530-70866572@6.04@56@105@1.88@NA@CBWD3_3, CBWD3_4, AL353608.1_1@0@0@0@:COBW domain-containing protein 5-like;COBW domain-containing protein 1-like;COBW domain containing 3@:ATP binding@NA
A2463_21@88720@88724@duplication@5@70889799@70914009@9@chr9:70889799-70914009@28.3@225@494@2.2@NA@CBWD3_10, CBWD3_11, CBWD3_12, CBWD3_13, CBWD3_14@0@0@0@:COBW domain-containing protein 5-like;COBW domain-containing protein 1-like;COBW domain containing 3@:ATP binding@NA
A2463_21@95377@95380@deletion@4@17951323@18060364@10@chr10:17951323-18060364@7.06@32@0@0@NA@MRC1L1_29, MRC1L1_30, TMEM236_1, TMEM236_2@0@0@0@:macrophage mannose receptor 1-like:transmembrane protein 236;transmembrane protein 236-like@:carbohydrate binding:integral to membrane@NA
A2463_21@95389@95393@deletion@5@18138509@18152611@10@chr10:18138509-18152611@7.31@34@1@0.0294@NA@MRC1_7, MRC1_8, MRC1_9, MRC1_10, MRC1_11@0@0@0@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
A2463_21@96540@96563@deletion@24@47903160@47948853@10@chr10:47903160-47948853@131@754@100@0.133@CNVR4715.2, CNVR4715.1@FAM21B_6, FAM21B_7, FAM21B_8, FAM21B_9, FAM21B_10, FAM21B_11, FAM21B_12, FAM21B_13, FAM21B_14, FAM21B_15, FAM21B_16, FAM21B_17, FAM21B_18, FAM21B_19, FAM21B_20, FAM21B_21, FAM21B_22, FAM21B_23, FAM21B_24, FAM21B_25, FAM21B_26, FAM21B_27, FAM21B_28, FAM21B_29@0@0@0@:family with sequence similarity 21, member B@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_21@96565@96565@duplication@1@48003969@48004056@10@chr10:48003969-48004056@5.85@85@148@1.74@CNVR4715.2@ASAH2C_17@0@0@0@@:ceramidase activity;sphingolipid metabolic process@NA
A2463_21@96631@96633@duplication@3@49376639@49381136@10@chr10:49376639-49381136@6.42@69@125@1.81@CNVR4717.2@FRMPD2_27, FRMPD2_26, FRMPD2_25@0@0@0@:FERM and PDZ domain containing 2@:basolateral plasma membrane;transferase activity, transferring phosphorus-containing groups;cytoplasm;tight junction;protein binding;cytoskeleton;1-phosphatidylinositol binding;tight junction assembly@NA
A2463_21@96896@96922@duplication@27@51838436@51890838@10@chr10:51838436-51890838@49.4@655@1159@1.77@NA@FAM21A_4, FAM21A_5, FAM21A_6, FAM21A_7, FAM21A_8, FAM21A_9, FAM21A_10, FAM21A_11, FAM21A_12, FAM21A_13, FAM21A_14, FAM21A_15, FAM21A_16, FAM21A_17, FAM21A_18, FAM21A_19, FAM21A_20, FAM21A_21, FAM21A_22, FAM21A_23, FAM21A_24, FAM21A_25, FAM21A_26, FAM21A_27, FAM21A_28, FAM21A_29, FAM21A_30@0@0@0@:family with sequence similarity 21, member B;family with sequence similarity 21, member A@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_21@96932@96937@deletion@6@51965743@51978390@10@chr10:51965743-51978390@17.7@126@33@0.262@NA@ASAH2_12, ASAH2_11, ASAH2_10, ASAH2_9, ASAH2_8, ASAH2_7@0@0@0@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
A2463_21@98005@98005@duplication@1@75436478@75436528@10@chr10:75436478-75436528@5.61@44@92@2.09@CNVR4799.1@AGAP5_7@0@0@0@:ankyrin repeat and GTPase domain Arf GTPase activating protein 11;ArfGAP with GTPase domain, ankyrin repeat and PH domain 5;ArfGAP with GTPase domain, ankyrin repeat and PH domain 10;arf-GAP with GTPase, ANK repeat and PH domain-containing protein 5-like@:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity@NA
A2463_21@98344@98350@duplication@7@81463367@81472241@10@chr10:81463367-81472241@15.7@637@947@1.49@CNVR4815.2, CNVR4815.4@FAM22B_1, FAM22B_2, FAM22B_3, FAM22B_4, FAM22B_5, FAM22B_6, FAM22B_7@0@0@0@NA@NA@NA
A2463_21@98344@98357@deletion@7@81463367@81610362@10@chr10:81463367-81610362@-16.6@789@948@1.2@CNVR4815.2@FAM22B_1, FAM22B_2, FAM22B_3, FAM22B_4, FAM22B_5, FAM22B_6, FAM22B_7, FAM22E_1, FAM22E_2, FAM22E_3, FAM22E_4, FAM22E_5, FAM22E_6, FAM22E_7@0@0@0@NA@NA@NA
A2463_21@98595@98596@deletion@2@88985589@88988719@10@chr10:88985589-88988719@7.53@89@38@0.427@CNVR4840.3, CNVR4840.5@FAM22A_1, FAM22A_2@0@0@0@:family with sequence similarity 22, member A@NA@NA
A2463_21@98603@98606@duplication@4@89120239@89124960@10@chr10:89120239-89124960@12.7@85@192@2.26@CNVR4840.3@FAM22D_2, FAM22D_3, FAM22D_4, FAM22D_5@0@0@0@:family with sequence similarity 22, member D@NA@NA
A2463_21@101608@101614@deletion@7@124344788@124353114@10@chr10:124344788-124353114@39.8@657@312@0.475@CNVR4912.4, CNVR4912.3, CNVR4912.2@DMBT1_15, DMBT1_16, DMBT1_17, DMBT1_18, DMBT1_19, DMBT1_20, DMBT1_21@0@0@0@:deleted in malignant brain tumors 1@:defense response to virus;calcium-dependent protein binding;pattern recognition receptor signaling pathway;blastocyst development;response to estrogen stimulus;tissue regeneration;proteinaceous extracellular matrix;protein transport;Gram-negative bacterial cell surface binding;positive regulation of epithelial cell differentiation;virus-host interaction;epithelial cell differentiation;induction of bacterial agglutination;phagocytic vesicle membrane;intracellular;Gram-positive bacterial cell surface binding;zymogen binding;innate immune response;cytoplasm;extrinsic to membrane;protein binding;zymogen granule membrane;extracellular region;scavenger receptor activity;pattern recognition receptor activity;inner cell mass cell proliferation;membrane@: GLIOMA SUSCEPTIBILITY 1; GLM1
A2463_21@102313@102334@duplication@22@135340901@135373657@10@chr10:135340901-135373657@42.8@1211@1769@1.46@CNVR4989.7, CNVR4989.11, CNVR4989.4@CYP2E1_3, AL161645.2_2, CYP2E1_4, AL161645.2_1, CYP2E1_5, CYP2E1_6, CYP2E1_7, CYP2E1_8, CYP2E1_9, CYP2E1_10, CYP2E1_11, SYCE1_13, SYCE1_12, SYCE1_11, SYCE1_10, SYCE1_9, SYCE1_8, SYCE1_7, SYCE1_6, SYCE1_5, SYCE1_4, SYCE1_3, SYCE1_2@0@0@0@:shadow of prion protein homolog (zebrafish):cytochrome P450, family 2, subfamily E, polypeptide 1:synaptonemal complex central element protein 1@:plasma membrane;membrane;anchored to membrane:steroid metabolic process;oxidation-reduction process;mitochondrion;response to drug;oxygen binding;Golgi membrane;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;response to organic nitrogen;oxidoreductase activity;endoplasmic reticulum membrane;heterocycle metabolic process;monoterpenoid metabolic process;response to ethanol;electron carrier activity;drug metabolic process;intracellular membrane-bounded organelle;small molecule metabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;endoplasmic reticulum;enzyme binding;heme binding;response to ozone;intrinsic to endoplasmic reticulum membrane;xenobiotic metabolic process;monooxygenase activity;triglyceride metabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NADH or NADPH as one donor, and incorporation of one atom of oxygen;iron ion binding:protein binding;synaptonemal complex;meiotic prophase I;cell division;central element@NA
A2463_21@103289@103290@duplication@2@5270599@5271034@11@chr11:5270599-5271034@15.4@68@206@3.03@NA@HBG1_2, HBG1_1@0@0@0@:hemoglobin, gamma A@:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex@NA
A2463_21@103342@103342@deletion@1@5798891@5799864@11@chr11:5798891-5799864@44.8@249@6@0.0241@CNVR5049.1@OR52N5_1@0@0@0@:tripartite motif containing 5:olfactory receptor, family 52, subfamily N, member 5@:defense response to virus;Golgi apparatus;intracellular;protein trimerization;ligase activity;cytoplasm;protein binding;nucleus;protein homodimerization activity;identical protein binding;zinc ion binding;cytoplasmic mRNA processing body;protein ubiquitination;virus-host interaction:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_21@106046@106048@duplication@3@55370918@55419315@11@chr11:55370918-55419315@11@644@897@1.39@CNVR5179.1@OR4C11_1, OR4P4_1, OR4S2_1@0@0@0@:olfactory receptor, family 4, subfamily C, member 11:olfactory receptor, family 4, subfamily P, member 4:olfactory receptor, family 4, subfamily S, member 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_21@106572@106572@deletion@1@60971580@60971741@11@chr11:60971580-60971741@6.35@29@0@0@CNVR5194.1@PGA3_2@0@0@0@:pepsinogen 3, group I (pepsinogen A)@:proteolysis;extracellular region;digestion;aspartic-type endopeptidase activity@NA
A2463_21@107319@107319@deletion@1@64004660@64004694@11@chr11:64004660-64004694@5.49@62@25@0.403@CNVR5198.1@VEGFB_5@0@0@0@:vascular endothelial growth factor B@:platelet degranulation;negative regulation of apoptotic process;negative regulation of gene expression;positive regulation of ERK1 and ERK2 cascade;vascular endothelial growth factor receptor 1 binding;growth factor activity;platelet activation;intracellular;platelet alpha granule lumen;vascular endothelial growth factor receptor signaling pathway;coronary vasculature development;positive chemotaxis;heart development;negative regulation of neuron apoptotic process;protein O-linked glycosylation;membrane;induction of positive chemotaxis;positive regulation of cell division;cardiac muscle contraction;response to drug;positive regulation of vascular wound healing;chemoattractant activity;blood coagulation;positive regulation of vascular endothelial growth factor receptor signaling pathway;extracellular space;heparin binding;protein homodimerization activity;positive regulation of protein kinase B signaling cascade;angiogenesis;positive regulation of peptidyl-tyrosine phosphorylation;protein heterodimerization activity;protein binding;extracellular region;positive regulation of endothelial cell proliferation;positive regulation of mast cell chemotaxis@NA
A2463_21@110120@110120@duplication@1@89608779@89609185@11@chr11:89608779-89609185@5.49@193@288@1.49@NA@TRIM64B_1@0@0@0@:tripartite motif containing 64;tripartite motif containing 64C;tripartite motif containing 64B@:protein binding;intracellular;zinc ion binding@NA
A2463_21@114085@114085@deletion@1@7972079@7972179@12@chr12:7972079-7972179@10.5@123@46@0.374@NA@SLC2A14_14@0@0@0@:NECAP endocytosis associated 1:solute carrier family 2 (facilitated glucose transporter), member 14@:coated pit;protein binding;endocytosis;protein transport;clathrin vesicle coat;plasma membrane;membrane:multicellular organismal development;cell differentiation;substrate-specific transmembrane transporter activity;transport;folic acid binding;glucose transmembrane transporter activity;transmembrane transport;spermatogenesis;reduced folate carrier activity;integral to membrane;transmembrane transporter activity;membrane@NA
A2463_21@114098@114098@duplication@1@8077007@8077107@12@chr12:8077007-8077107@6.18@133@214@1.61@CNVR5421.1@SLC2A3_8@0@0@0@:NECAP endocytosis associated 1:solute carrier family 2 (facilitated glucose transporter), member 3@:coated pit;protein binding;endocytosis;protein transport;clathrin vesicle coat;plasma membrane;membrane:substrate-specific transmembrane transporter activity;transport;glucose transmembrane transporter activity;transmembrane transport;integral to membrane;transmembrane transporter activity;plasma membrane;hexose transport;glucose transport;small molecule metabolic process;folic acid binding;carbohydrate metabolic process;L-ascorbic acid metabolic process;reduced folate carrier activity;water-soluble vitamin metabolic process;vitamin metabolic process;membrane@NA
A2463_21@114135@114139@duplication@5@8329596@8377428@12@chr12:8329596-8377428@94.8@1839@4408@2.4@CNVR5422.3, CNVR5422.5, CNVR5422.7@ZNF705A_5, FAM90A1_7, FAM90A1_6, FAM90A1_5, FAM90A1_4@0@0@0@:zinc finger protein 705A;zinc finger protein 705E:family with sequence similarity 90, member A1@:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding:zinc ion binding;nucleic acid binding@NA
A2463_21@114483@114483@duplication@1@11243900@11244828@12@chr12:11243900-11244828@16@294@561@1.91@CNVR5434.1@TAS2R43_1@0@0@0@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):taste receptor, type 2, member 14:taste receptor, type 2, member 43@:extracellular space;visual perception:bitter taste receptor activity;taste receptor activity;integral to membrane;sensory perception of taste;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of bitter taste:G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;motile cilium;taste receptor activity;bitter taste receptor activity;integral to membrane;sensory perception of taste;detection of chemical stimulus involved in sensory perception of bitter taste;cilium membrane@NA
A2463_21@127333@127336@deletion@4@19553418@19562100@14@chr14:19553418-19562100@11.4@755@512@0.678@CNVR6072.1@POTEG_1, POTEG_2, POTEG_3, POTEG_4@0@0@0@:POTE ankyrin domain family, member G@:protein binding@NA
A2463_21@127340@127340@deletion@1@19573101@19573144@14@chr14:19573101-19573144@4.93@185@111@0.6@CNVR6072.1@POTEG_8@0@0@0@:POTE ankyrin domain family, member G@:protein binding@NA
A2463_21@127349@127358@deletion@10@20011552@20404761@14@chr14:20011552-20404761@31.3@2987@1998@0.669@CNVR6072.12, CNVR6072.4@POTEM_4, POTEM_3, POTEM_2, POTEM_1, OR4Q3_1, OR4M1_1, OR4N2_1, OR4K2_1, OR4K5_1, OR4K1_1@0@0@0@:POTE ankyrin domain family, member M:olfactory receptor, family 4, subfamily N, member 2:olfactory receptor, family 4, subfamily Q, member 3:olfactory receptor, family 4, subfamily M, member 1:olfactory receptor, family 4, subfamily K, member 2:olfactory receptor, family 4, subfamily K, member 5:olfactory receptor, family 4, subfamily K, member 1@:protein binding:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_21@131032@131034@duplication@3@74004127@74010359@14@chr14:74004127-74010359@24.3@360@642@1.78@CNVR6188.1, CNVR6188.4@ACOT1_1, ACOT1_2, ACOT1_3@0@0@0@:HEAT repeat containing 4:acyl-CoA thioesterase 1@:protein binding;binding:hydrolase activity;mitochondrion;acyl-CoA metabolic process;very long-chain fatty acid metabolic process;thiolester hydrolase activity;acyl-CoA hydrolase activity;cytosol;palmitoyl-CoA hydrolase activity;long-chain fatty acid metabolic process;carboxylesterase activity@NA
A2463_21@133342@133352@duplication@11@106053275@106092403@14@chr14:106053275-106092403@35.9@1137@1682@1.48@CNVR6294.46, CNVR6294.20, CNVR6294.54, CNVR6294.43@IGHA2_3, IGHA2_2, IGHA2_1, IGHE_4, IGHE_3, IGHE_2, IGHE_1, IGHG4_4, IGHG4_3, IGHG4_2, IGHG4_1@0@0@0@@:protein binding:antigen binding;protein binding;immune response:antigen binding;protein binding;complement activation;extracellular region;immune response;membrane;complement activation, classical pathway;innate immune response@NA
A2463_21@133426@133426@deletion@1@106478111@106478411@14@chr14:106478111-106478411@6.24@78@33@0.423@CNVR6294.36, CNVR6294.48, CNVR6294.12, CNVR6294.24@IGHV4-4_2@0@0@0@@:protein binding@NA
A2463_21@133509@133514@duplication@6@20739498@20743964@15@chr15:20739498-20743964@15.2@463@699@1.51@CNVR6296.13@GOLGA6L6_8, GOLGA6L6_7, GOLGA6L6_6, GOLGA6L6_5, GOLGA6L6_4, GOLGA6L6_3@0@0@0@:putative transmembrane protein FLJ36131-like;putative transmembrane protein ENSP00000320207-like;golgin A6 family-like 6@NA@NA
A2463_21@133520@133528@duplication@9@21051163@21071610@15@chr15:21051163-21071610@16.1@312@497@1.59@NA@POTEB_9, POTEB_8, POTEB_7, POTEB_6, POTEB_5, POTEB_4, POTEB_3, POTEB_2, POTEB_1@0@0@0@:POTE ankyrin domain family member B-like@:protein binding@NA
A2463_21@133541@133542@duplication@2@22368577@22383423@15@chr15:22368577-22383423@11.3@873@1228@1.41@CNVR6297.4, CNVR6297.17, CNVR6297.2@OR4M2_1, OR4N4_1@0@0@0@:olfactory receptor, family 4, subfamily M, member 2:olfactory receptor, family 4, subfamily N, member 4@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_21@133622@133623@deletion@2@23259497@23259716@15@chr15:23259497-23259716@6.37@62@23@0.371@CNVR6300.4@GOLGA8I_6, GOLGA8I_7@0@0@0@:golgin A8 family, member I@:Golgi cisterna membrane@NA
A2463_21@133636@133641@duplication@6@23406272@23411062@15@chr15:23406272-23411062@23@554@931@1.68@CNVR6300.8@RP11-467N20.5_8, RP11-467N20.5_7, RP11-467N20.5_6, RP11-467N20.5_5, RP11-467N20.5_4, RP11-467N20.5_3@0@0@0@:putative golgin subfamily A member 6-like protein 6-like@NA@NA
A2463_21@133826@133826@duplication@1@28467175@28467361@15@chr15:28467175-28467361@9.14@60@141@2.35@CNVR6328.1@HERC2_36@0@0@0@:putative HERC2-like protein 3-like;HECT and RLD domain containing E3 ubiquitin protein ligase 2@:mitochondrial inner membrane;protein ubiquitination involved in ubiquitin-dependent protein catabolic process;guanyl-nucleotide exchange factor activity;SUMO binding;DNA repair;intracellular protein transport;spermatogenesis;cellular protein modification process;nucleus;ubiquitin protein ligase binding;ubiquitin-protein ligase activity;centriole;intracellular;response to DNA damage stimulus;heme binding;cytoplasm;protein binding;zinc ion binding;protein ubiquitination;metal ion binding@: SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1; SHEP1
A2463_21@133869@133870@deletion@2@28629294@28629596@15@chr15:28629294-28629596@7.67@35@0@0@CNVR6329.4@GOLGA8F_9, GOLGA8F_10@0@0@0@@:Golgi apparatus@NA
A2463_21@134023@134030@duplication@8@30699479@30702470@15@chr15:30699479-30702470@7.3@213@314@1.47@NA@GOLGA8R_12, GOLGA8R_11, GOLGA8R_10, GOLGA8R_9, GOLGA8R_8, GOLGA8R_7, GOLGA8R_6, GOLGA8R_5@0@0@0@@:Golgi apparatus@NA
A2463_21@134036@134039@deletion@4@30845996@30848215@15@chr15:30845996-30848215@15.6@82@8@0.0976@NA@GOLGA8Q_2, GOLGA8Q_3, GOLGA8Q_4, GOLGA8Q_5@0@0@0@@:Golgi apparatus@NA
A2463_21@134044@134054@deletion@11@30850148@30896376@15@chr15:30850148-30896376@28.3@167@26@0.156@CNVR6339.2, CNVR6339.3, CNVR6339.1@GOLGA8Q_10, GOLGA8Q_11, GOLGA8Q_12, GOLGA8Q_13, GOLGA8Q_14, GOLGA8Q_15, GOLGA8Q_16, GOLGA8Q_17, GOLGA8Q_18, GOLGA8Q_19, GOLGA8H_1@0@0@0@:golgin A8 family, member H@:Golgi apparatus:Golgi apparatus@NA
A2463_21@134180@134181@deletion@2@32737820@32738099@15@chr15:32737820-32738099@5.42@26@1@0.0385@CNVR6346.1@GOLGA8O_17, GOLGA8O_16@0@0@0@:golgin A8 family, member O@:Golgi apparatus@NA
A2463_21@134189@134191@deletion@3@32743115@32743539@15@chr15:32743115-32743539@13.1@73@9@0.123@CNVR6346.1@GOLGA8O_8, GOLGA8O_7, GOLGA8O_6@0@0@0@:golgin A8 family, member O@:Golgi apparatus@NA
A2463_21@134203@134205@duplication@3@32889954@32890378@15@chr15:32889954-32890378@19.9@101@270@2.67@NA@GOLGA8N_6, GOLGA8N_7, GOLGA8N_8@0@0@0@:golgin A8 family, member R@:Golgi apparatus@NA
A2463_21@134441@134448@duplication@8@34677456@34820278@15@chr15:34677456-34820278@8.9@208@314@1.51@CNVR6351.3@GOLGA8A_14, GOLGA8A_13, GOLGA8A_12, GOLGA8A_11, GOLGA8A_10, GOLGA8A_9, GOLGA8B_25, GOLGA8B_24@0@0@0@:golgin A8 family, member A:golgin A8 family, member A;golgin A8 family, member B@:Golgi cisterna membrane;Golgi apparatus:Golgi cisterna membrane;Golgi apparatus@NA
A2463_21@135733@135733@deletion@1@43931842@43931996@15@chr15:43931842-43931996@4.97@225@139@0.618@CNVR6365.1@CATSPER2_6@0@0@0@:diphosphoinositol pentakisphosphate kinase 1:stereocilin:cation channel, sperm associated 2@:inositol hexakisphosphate 3-kinase activity;inositol hexakisphosphate 1-kinase activity;inositol metabolic process;diphosphoinositol-pentakisphosphate kinase activity;ATP binding;acid phosphatase activity;cytoplasm;cytosol;inositol hexakisphosphate 5-kinase activity;nucleus;kinase activity;inositol-1,3,4,5,6-pentakisphosphate kinase activity:detection of mechanical stimulus involved in sensory perception of sound;stereocilium bundle tip;stereocilium;cell surface;kinocilium;auditory receptor cell stereocilium organization:cell differentiation;CatSper complex;ion transport;transmembrane transport;voltage-gated ion channel activity;flagellar membrane;spermatogenesis;integral to membrane;multicellular organismal development;fertilization;sperm motility;ion channel activity;ciliary or flagellar motility;calcium channel activity;cilium;protein binding;microtubule-based flagellum;membrane@: DEAFNESS, AUTOSOMAL RECESSIVE 16; DFNB16; DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY: DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY
A2463_21@138281@138288@duplication@8@72953606@72958039@15@chr15:72953606-72958039@41.4@336@748@2.23@CNVR6443.1@GOLGA6B_8, GOLGA6B_9, GOLGA6B_10, GOLGA6B_11, GOLGA6B_12, GOLGA6B_13, GOLGA6B_14, GOLGA6B_15@0@0@0@:golgin A6 family, member B@:Golgi apparatus@NA
A2463_21@138421@138422@deletion@2@74368025@74368326@15@chr15:74368025-74368326@5.4@128@72@0.562@CNVR6448.1@GOLGA6A_9, GOLGA6A_8@0@0@0@:golgin A6 family, member C;golgin A6 family, member A;golgin A6 family, member D;golgin A6 family, member B@:Golgi apparatus@NA
A2463_21@139305@139308@deletion@4@83013228@83015609@15@chr15:83013228-83015609@8.1@42@4@0.0952@CNVR6477.6, CNVR6477.2@RP13-996F3.4_6, RP13-996F3.4_5, RP13-996F3.4_4, RP13-996F3.4_3@0@0@0@NA@NA@NA
A2463_21@142643@142651@duplication@9@14819741@14859270@16@chr16:14819741-14859270@15.2@90@223@2.48@CNVR6644.1@RP11-719K4.1_8, RP11-719K4.2_1, RP11-719K4.2_2, RP11-719K4.2_3, RP11-719K4.2_4, RP11-719K4.2_5, RP11-719K4.2_6, RP11-719K4.2_7, RP11-719K4.2_8@0@0@0@:nuclear pore complex-interacting protein-like 1-like:nuclear pore complex-interacting protein-like 1-like@NA@NA
A2463_21@142676@142676@deletion@1@14975402@14975542@16@chr16:14975402-14975542@11.7@99@27@0.273@NA@NOMO1_25@0@0@0@:NODAL modulator 1;nodal modulator 1-like@:carbohydrate binding;integral to membrane;carboxypeptidase activity;molecular_function;cellular_component;biological_process@NA
A2463_21@142681@142706@deletion@26@14988856@15123913@16@chr16:14988856-15123913@103@1955@984@0.503@CNVR6646.1@NOMO1_30, NOMO1_31, NPIP_1, NPIP_2, NPIP_3, NPIP_4, NPIP_5, NPIP_6, NPIP_7, NPIP_8, PDXDC1_1, PDXDC1_2, PDXDC1_3, PDXDC1_4, PDXDC1_5, PDXDC1_6, PDXDC1_7, PDXDC1_8, PDXDC1_9, PDXDC1_10, PDXDC1_11, PDXDC1_12, PDXDC1_13, PDXDC1_14, PDXDC1_15, PDXDC1_16@0@0@0@:NODAL modulator 1;nodal modulator 1-like:nuclear pore complex-interacting protein-like;nuclear pore complex interacting protein;nuclear pore complex-interacting protein-like 1-like:pyridoxal-dependent decarboxylase domain containing 1;pyridoxal-dependent decarboxylase domain-containing protein 1-like@:carbohydrate binding;integral to membrane;carboxypeptidase activity;molecular_function;cellular_component;biological_process:nuclear membrane;protein transport;nuclear pore;mRNA transport:carboxylic acid metabolic process;pyridoxal phosphate binding;carboxy-lyase activity@NA
A2463_21@142749@142750@deletion@2@15224945@15457926@16@chr16:15224945-15457926@55.5@421@82@0.195@NA@NPIPP1_1, PKD1P1_8@0@0@0@:pyridoxal-dependent decarboxylase domain containing 1;pyridoxal-dependent decarboxylase domain-containing protein 1-like:nuclear pore complex-interacting protein-like:NPIP-like protein 1-like;nuclear pore complex-interacting protein-like 1-like@:carboxylic acid metabolic process;pyridoxal phosphate binding;carboxy-lyase activity:neuropeptide signaling pathway;integral to membrane;plasma membrane;membrane@NA
A2463_21@142920@142928@duplication@9@16355360@16367932@16@chr16:16355360-16367932@9.72@356@501@1.41@NA@NOMO3_12, NOMO3_13, NOMO3_14, NOMO3_15, NOMO3_16, NOMO3_17, NOMO3_18, NOMO3_19, NOMO3_20@0@0@0@:NODAL modulator 3@:carbohydrate binding;integral to membrane;carboxypeptidase activity@NA
A2463_21@143493@143493@duplication@1@21858735@21858862@16@chr16:21858735-21858862@6.89@122@206@1.69@CNVR6668.5, CNVR6668.7@NPIPL3_2@0@0@0@:nuclear pore complex interacting protein-like 3;nuclear pore complex interacting protein-like;nuclear pore complex-interacting protein-like 3-like@NA@NA
A2463_21@144038@144052@duplication@15@28403074@28478223@16@chr16:28403074-28478223@17.3@207@379@1.83@NA@EIF3CL_10, EIF3CL_9, EIF3CL_8, EIF3CL_7, EIF3CL_6, EIF3CL_5, EIF3CL_4, EIF3CL_3, EIF3CL_2, NPIPL1_7, NPIPL1_6, NPIPL1_5, NPIPL1_4, NPIPL1_3, NPIPL1_2@0@0@0@:eukaryotic translation initiation factor 3, subunit C-like:ceroid-lipofuscinosis, neuronal 3@:protein binding;eukaryotic translation initiation factor 3 complex;translational initiation;translation initiation factor activity:membrane:negative regulation of apoptotic process;late endosome;mitochondrion;galactosylceramide metabolic process;neuromuscular process controlling balance;neuron projection;lysosomal lumen pH elevation;integral to endoplasmic reticulum membrane;cell death;plasma membrane;nucleus;lysosomal lumen acidification;negative regulation of catalytic activity;negative regulation of macroautophagy;unfolded protein binding;neurotransmitter metabolic process;endoplasmic reticulum;vesicle transport along microtubule;protein catabolic process;autophagic vacuole;early endosome;trans-Golgi network;cellular membrane organization;ceramide metabolic process;glucosylceramide metabolic process;negative regulation of neuron apoptotic process;membrane;globoside metabolic process;membrane raft;synaptic vesicle;vacuolar transport;protein processing;Golgi membrane;caveola;protein folding;ionotropic glutamate receptor signaling pathway;cytosolic calcium ion homeostasis;Golgi stack;integral to membrane;receptor-mediated endocytosis;arginine transport;lysosome;negative regulation of proteolysis;Golgi apparatus;lysosome organization;associative learning;sphingomyelin metabolic process;macroautophagy;lysosomal membrane;amyloid precursor protein catabolic process;cytoplasm;autophagic vacuole fusion;protein binding;regulation of action potential;cellular amino acid metabolic process@: CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3
A2463_21@144038@144053@deletion@1@28403074@28481759@16@chr16:28403074-28481759@-33@305@427@1.4@NA@EIF3CL_10, EIF3CL_9, EIF3CL_8, EIF3CL_7, EIF3CL_6, EIF3CL_5, EIF3CL_4, EIF3CL_3, EIF3CL_2, NPIPL1_7, NPIPL1_6, NPIPL1_5, NPIPL1_4, NPIPL1_3, NPIPL1_2, NPIPL1_1@0@0@0@:eukaryotic translation initiation factor 3, subunit C-like:ceroid-lipofuscinosis, neuronal 3@:protein binding;eukaryotic translation initiation factor 3 complex;translational initiation;translation initiation factor activity:membrane:negative regulation of apoptotic process;late endosome;mitochondrion;galactosylceramide metabolic process;neuromuscular process controlling balance;neuron projection;lysosomal lumen pH elevation;integral to endoplasmic reticulum membrane;cell death;plasma membrane;nucleus;lysosomal lumen acidification;negative regulation of catalytic activity;negative regulation of macroautophagy;unfolded protein binding;neurotransmitter metabolic process;endoplasmic reticulum;vesicle transport along microtubule;protein catabolic process;autophagic vacuole;early endosome;trans-Golgi network;cellular membrane organization;ceramide metabolic process;glucosylceramide metabolic process;negative regulation of neuron apoptotic process;membrane;globoside metabolic process;membrane raft;synaptic vesicle;vacuolar transport;protein processing;Golgi membrane;caveola;protein folding;ionotropic glutamate receptor signaling pathway;cytosolic calcium ion homeostasis;Golgi stack;integral to membrane;receptor-mediated endocytosis;arginine transport;lysosome;negative regulation of proteolysis;Golgi apparatus;lysosome organization;associative learning;sphingomyelin metabolic process;macroautophagy;lysosomal membrane;amyloid precursor protein catabolic process;cytoplasm;autophagic vacuole fusion;protein binding;regulation of action potential;cellular amino acid metabolic process@: CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3
A2463_21@144095@144101@duplication@7@28607105@28619924@16@chr16:28607105-28619924@31.2@504@872@1.73@CNVR6685.1@SULT1A2_2, SULT1A1_10, SULT1A1_9, SULT1A1_8, SULT1A1_7, SULT1A1_6, SULT1A1_5@0@0@0@:sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2:sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1@:steroid metabolic process;small molecule metabolic process;sulfation;aryl sulfotransferase activity;catecholamine metabolic process;cytosol;xenobiotic metabolic process;phenol-containing compound metabolic process;sulfotransferase activity;amine biosynthetic process;flavonol 3-sulfotransferase activity;3'-phosphoadenosine 5'-phosphosulfate metabolic process:small molecule metabolic process;sulfation;aryl sulfotransferase activity;amine metabolic process;catecholamine metabolic process;xenobiotic metabolic process;cytosol;steroid sulfotransferase activity;integral to membrane;sulfotransferase activity;flavonol 3-sulfotransferase activity;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process;estrogen metabolic process@NA
A2463_21@144130@144131@duplication@2@28763890@28769404@16@chr16:28763890-28769404@5.11@77@127@1.65@NA@A-575C2.4_1, A-575C2.4_2@0@0@0@NA@NA@NA
A2463_21@144264@144265@duplication@2@29061824@29062028@16@chr16:29061824-29062028@6.92@146@229@1.57@NA@CTB-134H23.2_5, CTB-134H23.2_6@0@0@0@NA@NA@NA
A2463_21@144286@144301@duplication@16@29466720@29478872@16@chr16:29466720-29478872@18.5@49@175@3.57@CNVR6690.2, CNVR6690.3, CNVR6690.4@SLX1B_2, SLX1B_3, SLX1B_4, SLX1B_5, SLX1B_6, SULT1A4_3, SULT1A4_4, SULT1A4_5, SULT1A4_6, SULT1A4_7, SULT1A4_8, SULT1A4_9, RP11-345J4.3_5, RP11-345J4.3_4, RP11-345J4.3_3, RP11-345J4.3_2@0@0@0@:structure-specific endonuclease subunit SLX1-like;SLX1 structure-specific endonuclease subunit homolog B (S. cerevisiae);SLX1 structure-specific endonuclease subunit homolog A (S. cerevisiae):sulfotransferase family, cytosolic, 1A, phenol-preferring, member 4;sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3;sulfotransferase 1A3/1A4-like@:Slx1-Slx4 complex;5'-flap endonuclease activity;DNA repair;protein binding;DNA double-strand break processing involved in repair via single-strand annealing;double-strand break repair via homologous recombination;metal ion binding;crossover junction endodeoxyribonuclease activity:steroid metabolic process;small molecule metabolic process;sulfation;aryl sulfotransferase activity;cytoplasm;catecholamine metabolic process;cytosol;endoplasmic reticulum unfolded protein response;xenobiotic metabolic process;sulfotransferase activity;activation of signaling protein activity involved in unfolded protein response;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process@NA
A2463_21@144499@144503@deletion@5@30206062@30208787@16@chr16:30206062-30208787@8.8@132@66@0.5@CNVR6694.1, CNVR6694.2, CNVR6694.3@SLX1A_2, SLX1A_3, SLX1A_4, SLX1A_5, SLX1A_6@0@0@0@:structure-specific endonuclease subunit SLX1-like;SLX1 structure-specific endonuclease subunit homolog B (S. cerevisiae);SLX1 structure-specific endonuclease subunit homolog A (S. cerevisiae):sulfotransferase family, cytosolic, 1A, phenol-preferring, member 4;sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3;sulfotransferase 1A3/1A4-like@:Slx1-Slx4 complex;5'-flap endonuclease activity;DNA repair;protein binding;DNA double-strand break processing involved in repair via single-strand annealing;double-strand break repair via homologous recombination;metal ion binding;crossover junction endodeoxyribonuclease activity:steroid metabolic process;small molecule metabolic process;sulfation;aryl sulfotransferase activity;cytoplasm;catecholamine metabolic process;cytosol;endoplasmic reticulum unfolded protein response;xenobiotic metabolic process;sulfotransferase activity;activation of signaling protein activity involved in unfolded protein response;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process@NA
A2463_21@145554@145560@duplication@7@55844430@55855433@16@chr16:55844430-55855433@50@1316@2095@1.59@CNVR6731.1@CES1_11, CES1_10, CES1_9, CES1_8, CES1_7, CES1_6, CES1_5@0@0@0@:carboxylesterase 1;liver carboxylesterase 1-like@:hydrolase activity;methyl salicylate esterase activity;response to toxin;methylumbelliferyl-acetate deacetylase activity;endoplasmic reticulum lumen;retinyl-palmitate esterase activity;methyl jasmonate esterase activity;metabolic process;carboxylesterase activity;methyl indole-3-acetate esterase activity@: CARBOXYLESTERASE 1; CES1
A2463_21@145562@145562@duplication@1@55860064@55860207@16@chr16:55860064-55860207@8.18@245@386@1.58@CNVR6731.1@CES1_3@0@0@0@:carboxylesterase 1;liver carboxylesterase 1-like@:hydrolase activity;methyl salicylate esterase activity;response to toxin;methylumbelliferyl-acetate deacetylase activity;endoplasmic reticulum lumen;retinyl-palmitate esterase activity;methyl jasmonate esterase activity;metabolic process;carboxylesterase activity;methyl indole-3-acetate esterase activity@: CARBOXYLESTERASE 1; CES1
A2463_21@145564@145564@deletion@1@55866917@55866967@16@chr16:55866917-55866967@13.5@78@9@0.115@NA@CES1_1@0@0@0@:carboxylesterase 1;liver carboxylesterase 1-like@:hydrolase activity;methyl salicylate esterase activity;response to toxin;methylumbelliferyl-acetate deacetylase activity;endoplasmic reticulum lumen;retinyl-palmitate esterase activity;methyl jasmonate esterase activity;metabolic process;carboxylesterase activity;methyl indole-3-acetate esterase activity@: CARBOXYLESTERASE 1; CES1
A2463_21@147127@147127@duplication@1@70211145@70211383@16@chr16:70211145-70211383@7.86@112@201@1.79@CNVR6764.1@CLEC18C_3@0@0@0@:C-type lectin domain family 18, member C@:carbohydrate binding;protein binding;extracellular region@NA
A2463_21@147423@147423@deletion@1@72097156@72097159@16@chr16:72097156-72097159@6.67@78@31@0.397@CNVR6769.1@HPR_1@0@0@0@:thioredoxin-like 4B:haptoglobin-related protein@:mitosis;mRNA processing;RNA splicing;spliceosomal complex;cell redox homeostasis:spherical high-density lipoprotein particle;proteolysis;extracellular region;hemoglobin binding;catalytic activity;serine-type endopeptidase activity@NA
A2463_21@147507@147509@duplication@3@74444804@74446144@16@chr16:74444804-74446144@9.89@185@296@1.6@CNVR6778.2, CNVR6778.3, CNVR6778.5@CLEC18B_9, CLEC18B_8, CLEC18B_7@0@0@0@:C-type lectin domain family 18, member B@:carbohydrate binding;protein binding;extracellular region@NA
A2463_21@147513@147513@deletion@1@74451958@74452196@16@chr16:74451958-74452196@13.7@69@3@0.0435@CNVR6778.2, CNVR6778.3@CLEC18B_3@0@0@0@:C-type lectin domain family 18, member B@:carbohydrate binding;protein binding;extracellular region@NA
A2463_21@151878@151885@deletion@8@18390962@18397681@17@chr17:18390962-18397681@15.3@276@145@0.525@CNVR7014.1@LGALS9C_4, LGALS9C_5, LGALS9C_6, LGALS9C_7, LGALS9C_8, LGALS9C_9, LGALS9C_10, LGALS9C_11@0@0@0@:lectin, galactoside-binding, soluble, 9C@:carbohydrate binding@NA
A2463_21@153363@153372@duplication@10@34493376@34500284@17@chr17:34493376-34500284@7.98@295@415@1.41@CNVR7077.1, CNVR7077.3, CNVR7077.11, CNVR7077.16@TBC1D3B_14, TBC1D3B_13, TBC1D3B_12, TBC1D3B_11, TBC1D3B_10, TBC1D3B_9, TBC1D3B_8, TBC1D3B_7, TBC1D3B_6, TBC1D3B_5@0@0@0@:TBC1 domain family, member 3B@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_21@153376@153381@deletion@6@34522686@34539971@17@chr17:34522686-34539971@10.8@50@1@0.02@CNVR7077.1, CNVR7077.3, CNVR7077.6@CCL3L3_3, CCL3L3_2, CCL3L3_1, CCL4L1_1, CCL4L1_2, CCL4L1_3@0@0@0@:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
A2463_21@153389@153394@deletion@6@34587259@34590454@17@chr17:34587259-34590454@10.9@49@0@0@CNVR7077.1, CNVR7077.13, CNVR7077.19, CNVR7077.10, CNVR7077.2@TBC1D3C_7, TBC1D3C_6, TBC1D3C_5, TBC1D3C_4, TBC1D3C_3, TBC1D3C_2@0@0@0@:TBC1 domain family, member 3C;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3H-like;TBC1 domain family, member 3H@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_21@153414@153414@deletion@1@34797487@34798054@17@chr17:34797487-34798054@20.7@100@1@0.01@CNVR7078.2, CNVR7078.3@TBC1D3G_14@0@0@0@:TBC1 domain family member 3H-like;TBC1 domain family, member 3H:TBC1 domain family, member 3;TBC1 domain family, member 3G;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like;TBC1 domain family, member 3H@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_21@153643@153643@duplication@1@36342585@36342632@17@chr17:36342585-36342632@4.76@29@67@2.31@CNVR7083.3@TBC1D3_12@0@0@0@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
A2463_21@154346@154346@deletion@1@39421631@39422112@17@chr17:39421631-39422112@8.31@68@19@0.279@CNVR7096.1@KRTAP9-6_1@0@0@0@:keratin associated protein 9-6@:keratin filament@NA
A2463_21@155581@155582@duplication@2@44248222@44375108@17@chr17:44248222-44375108@12.8@623@908@1.46@CNVR7114.3, CNVR7114.2, CNVR7114.10@KANSL1_2, LRRC37A_1@0@0@0@:KAT8 regulatory NSL complex subunit 1:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:histone acetyltransferase activity (H4-K8 specific);histone acetyltransferase activity (H4-K16 specific);histone acetyltransferase activity (H4-K5 specific);histone acetyltransferase complex;histone H4-K5 acetylation;MLL1 complex;histone H4-K16 acetylation;protein binding;histone H4-K8 acetylation;nucleus:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
A2463_21@155584@155586@deletion@3@44380005@44383675@17@chr17:44380005-44383675@11.5@52@0@0@CNVR7114.3, CNVR7114.2@LRRC37A_3, LRRC37A_4, LRRC37A_5@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
A2463_21@155590@155591@duplication@2@44407817@44410022@17@chr17:44407817-44410022@11.1@339@510@1.5@CNVR7114.3, CNVR7114.2, CNVR7114.1, CNVR7114.7@LRRC37A_9, LRRC37A_10@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
A2463_21@155590@155595@deletion@4@44407817@44415089@17@chr17:44407817-44415089@-11.1@424@511@1.21@CNVR7114.3, CNVR7114.2, CNVR7114.1, CNVR7114.7@LRRC37A_9, LRRC37A_10, LRRC37A_11, LRRC37A_12, LRRC37A_13, LRRC37A_14@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
A2463_21@155599@155600@deletion@2@44590080@44594799@17@chr17:44590080-44594799@29.4@142@1@0.00704@CNVR7114.2, CNVR7114.5@LRRC37A2_2, LRRC37A2_3@0@0@0@:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
A2463_21@155604@155612@duplication@9@44617543@44632945@17@chr17:44617543-44632945@59.8@1867@2968@1.59@CNVR7114.2, CNVR7114.5, CNVR7114.4@LRRC37A2_7, LRRC37A2_8, LRRC37A2_9, LRRC37A2_10, LRRC37A2_11, LRRC37A2_12, LRRC37A2_13, LRRC37A2_14, LRRC37A2_15@0@0@0@:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
A2463_21@157452@157453@duplication@2@61973092@61973595@17@chr17:61973092-61973595@5.72@23@65@2.83@NA@CSH1_3, CSH1_2@0@0@0@:chorionic somatomammotropin hormone 1 (placental lactogen);chorionic somatomammotropin hormone-like 1@:JAK-STAT cascade involved in growth hormone signaling pathway;signal transduction;hormone activity;extracellular region;female pregnancy;metal ion binding@NA
A2463_21@157607@157607@duplication@1@62888648@62888718@17@chr17:62888648-62888718@7.35@108@192@1.78@CNVR7165.1@LRRC37A3_4@0@0@0@:leucine rich repeat containing 37, member A3@:protein binding;integral to membrane@NA
A2463_21@162017@162018@deletion@2@44542732@44550298@18@chr18:44542732-44550298@97.1@536@8@0.0149@CNVR7319.1, CNVR7319.2@TCEB3CL2_1, TCEB3CL_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2:transcription elongation factor B polypeptide 3C-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_21@162017@162019@duplication@1@44542732@44556213@18@chr18:44542732-44556213@-78.8@2717@3980@1.46@CNVR7319.1, CNVR7319.2@TCEB3CL2_1, TCEB3CL_1, TCEB3C_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2:transcription elongation factor B polypeptide 3C-like:transcription elongation factor B polypeptide 3C (elongin A3);RNA polymerase II transcription factor SIII subunit A3-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_21@164951@164951@deletion@1@7032325@7032905@19@chr19:7032325-7032905@6.58@34@3@0.0882@CNVR7517.1@MBD3L5_2@0@0@0@:methyl-CpG binding domain protein 3-like 5@NA@NA
A2463_21@167047@167047@deletion@1@14877791@14877921@19@chr19:14877791-14877921@5.21@70@31@0.443@NA@EMR2_6@0@0@0@:egf-like module containing, mucin-like, hormone receptor-like 2@:transmembrane signaling receptor activity;inflammatory response;G-protein coupled receptor activity;ruffle membrane;integral to membrane;plasma membrane;cell surface receptor signaling pathway;neuropeptide signaling pathway;granulocyte chemotaxis;cell migration;leading edge membrane;G-protein coupled receptor signaling pathway;protein binding;cell adhesion;membrane;calcium ion binding;chondroitin sulfate binding@NA
A2463_21@170098@170099@duplication@2@40376632@40380711@19@chr19:40376632-40380711@5.03@240@331@1.38@CNVR7639.2@FCGBP_24, FCGBP_23@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_21@170358@170366@deletion@9@41349702@41356331@19@chr19:41349702-41356331@30.2@599@319@0.533@CNVR7642.1@CYP2A6_9, CYP2A6_8, CYP2A6_7, CYP2A6_6, CYP2A6_5, CYP2A6_4, CYP2A6_3, CYP2A6_2, CYP2A6_1@0@0@0@:cytochrome P450, family 2, subfamily A, polypeptide 6@:coumarin 7-hydroxylase activity;steroid metabolic process;oxidation-reduction process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;endoplasmic reticulum membrane;drug metabolic process;electron carrier activity;small molecule metabolic process;exogenous drug catabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;enzyme binding;heme binding;xenobiotic metabolic process;iron ion binding;coumarin catabolic process;coumarin metabolic process@: CYTOCHROME P450, SUBFAMILY IIA, POLYPEPTIDE 6; CYP2A6
A2463_21@173500@173503@duplication@4@55359207@55362710@19@chr19:55359207-55362710@14.5@69@175@2.54@CNVR7725.1, CNVR7725.6, CNVR7725.5, CNVR7725.10@KIR2DS4_7, KIR2DS4_8, KIR3DL2_1, KIR3DL2_2@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2-like@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane@NA
A2463_21@173844@173845@deletion@2@56283172@56284545@19@chr19:56283172-56284545@8.32@391@254@0.65@CNVR7734.1@CTD-2611O12.2_2, CTD-2611O12.2_3@0@0@0@:ret finger protein-like 4A-like@:protein binding;zinc ion binding@NA
A2463_21@175732@175732@duplication@1@25755498@25755948@20@chr20:25755498-25755948@6.82@161@258@1.6@CNVR7821.2, CNVR7821.4@FAM182B_3@0@0@0@:family with sequence similarity 27, member B;family with sequence similarity 27, member A;family with sequence similarity 27, member C;family with sequence similarity 182, member B@NA@NA
A2463_21@175736@175737@deletion@2@26061801@26063616@20@chr20:26061801-26063616@35.2@171@3@0.0175@CNVR7823.4, CNVR7823.3, CNVR7823.5, CNVR7823.1@FAM182A_4, FAM182A_5@0@0@0@NA@NA@NA
A2463_21@179020@179021@deletion@2@15011837@15013887@21@chr21:15011837-15013887@19.8@97@3@0.0309@CNVR7952.1@POTED_10, POTED_11@0@0@0@:POTE ankyrin domain family, member B;POTE ankyrin domain family, member C;POTE ankyrin domain family, member D@:protein binding;plasma membrane@NA
A2463_21@180970@180971@deletion@2@16269874@16275277@22@chr22:16269874-16275277@6.27@129@70@0.543@CNVR8071.2, CNVR8071.3@POTEH_7, POTEH_6@0@0@0@:POTE ankyrin domain family, member H@:protein binding@NA
A2463_21@181129@181133@duplication@5@18727044@18739404@22@chr22:18727044-18739404@8.57@54@120@2.22@CNVR8087.5, CNVR8087.2, CNVR8087.11@AC008132.1_4, AC008132.1_5, AC008132.1_6, AC008132.1_7, AC008132.1_8@0@0@0@NA@NA@NA
A2463_21@181129@181134@deletion@1@18727044@18835833@22@chr22:18727044-18835833@-7.83@281@227@0.808@CNVR8087.5, CNVR8087.2, CNVR8087.7@AC008132.1_4, AC008132.1_5, AC008132.1_6, AC008132.1_7, AC008132.1_8, AC008132.13_1@0@0@0@NA@NA@NA
A2463_21@181417@181422@duplication@6@20366369@20461301@22@chr22:20366369-20461301@14.4@1104@1500@1.36@CNVR8094.9, CNVR8094.4, CNVR8094.10@GGTLC3_5, GGTLC3_4, GGTLC3_3, GGTLC3_2, GGTLC3_1, RIMBP3_1@0@0@0@:RIMS binding protein 3@:leukotriene biosynthetic process;glutathione metabolic process;gamma-glutamyltransferase activity;anchored to external side of plasma membrane:protein binding@NA
A2463_21@181487@181489@duplication@3@21065630@21067085@22@chr22:21065630-21067085@11.4@141@249@1.77@CNVR8099.6, CNVR8099.2@PI4KA_51, PI4KA_50, PI4KA_49@0@0@0@:phosphatidylinositol 4-kinase, catalytic, alpha@:phospholipid metabolic process;1-phosphatidylinositol 4-kinase activity;small molecule metabolic process;phosphatidylinositol phosphorylation;binding;transferase activity, transferring phosphorus-containing groups;phosphotransferase activity, alcohol group as acceptor;ATP binding;Golgi-associated vesicle;phosphatidylinositol biosynthetic process;cytosol;protein binding;signal transduction;synaptic transmission;kinase activity;phosphatidylinositol-mediated signaling@NA
A2463_21@181630@181632@deletion@3@21570215@21576241@22@chr22:21570215-21576241@6.62@116@61@0.526@CNVR8100.4, CNVR8100.10, CNVR8100.7@GGT2_8, GGT2_7, GGT2_6@0@0@0@:gamma-glutamyltransferase 2;gamma-glutamyltranspeptidase 2-like@:hydrolase activity;small molecule metabolic process;leukotriene biosynthetic process;anchored to external side of plasma membrane;glutathione biosynthetic process;xenobiotic metabolic process;integral to membrane;glutathione metabolic process;plasma membrane;gamma-glutamyltransferase activity;cellular_component@NA
A2463_21@181634@181635@duplication@2@21579681@21743067@22@chr22:21579681-21743067@12@137@254@1.85@CNVR8100.4, CNVR8100.7, CNVR8100.16, CNVR8100.3@GGT2_4, RIMBP3B_1@0@0@0@:gamma-glutamyltransferase 2;gamma-glutamyltranspeptidase 2-like:RIMS binding protein 3B@:hydrolase activity;small molecule metabolic process;leukotriene biosynthetic process;anchored to external side of plasma membrane;glutathione biosynthetic process;xenobiotic metabolic process;integral to membrane;glutathione metabolic process;plasma membrane;gamma-glutamyltransferase activity;cellular_component:protein binding@NA
A2463_21@181638@181638@duplication@1@21900347@21905265@22@chr22:21900347-21905265@6.94@6@52@8.67@CNVR8101.1, CNVR8101.2@RIMBP3C_1, UBE2L3_1@0@0@0@:RIMS binding protein 3C:ubiquitin-conjugating enzyme E2L 3@:protein binding:cellular response to glucocorticoid stimulus;ubiquitin ligase complex;regulation of S phase of mitotic cell cycle;ATP binding;protein K11-linked ubiquitination;transcription coactivator activity;cellular protein modification process;cellular response to steroid hormone stimulus;protein transport;nucleus;ubiquitin protein ligase binding;ubiquitin-protein ligase activity;enzyme binding;regulation of transcription, DNA-dependent;ubiquitin-dependent protein catabolic process;cytoplasm;cell proliferation;protein binding;transcription, DNA-dependent;acid-amino acid ligase activity;protein polyubiquitination;protein ubiquitination@NA
A2463_21@181807@181808@duplication@2@23247056@23248831@22@chr22:23247056-23248831@8.17@239@355@1.49@CNVR8103.2, CNVR8103.1, CNVR8103.6, CNVR8103.11@IGLJ3_1, IGLC3_1@0@0@0@@:protein binding@NA
A2463_21@181850@181850@duplication@1@23652512@23652620@22@chr22:23652512-23652620@4.92@52@98@1.88@CNVR8107.2, CNVR8107.3@BCR_18@0@0@0@:breakpoint cluster region@:phospholipid binding;protein autophosphorylation;protein tyrosine kinase activity;GTPase activator activity;neuromuscular process controlling balance;ATP binding;actin cytoskeleton organization;negative regulation of cell migration;plasma membrane;inner ear morphogenesis;positive regulation of Rac GTPase activity;positive regulation of phagocytosis;regulation of small GTPase mediated signal transduction;response to lipopolysaccharide;intracellular signal transduction;Rac GTPase activator activity;regulation of cell cycle;platelet-derived growth factor receptor signaling pathway;protein serine/threonine kinase activity;intracellular;small GTPase mediated signal transduction;regulation of Rho protein signal transduction;protein phosphorylation;negative regulation of inflammatory response;enzyme binding;Rho guanyl-nucleotide exchange factor activity;cytoplasm;cytosol;protein binding;signal transduction;brain development;kinase activity;negative regulation of neutrophil degranulation@: LEUKEMIA, CHRONIC MYELOID; CML
A2463_21@181951@181955@deletion@5@24376424@24384231@22@chr22:24376424-24384231@29.5@142@5@0.0352@CNVR8114.13, CNVR8114.1, CNVR8114.7@GSTT1_5, GSTT1_4, GSTT1_3, GSTT1_2, GSTT1_1@0@0@0@:glutathione S-transferase theta 1@:glutathione peroxidase activity;response to drug;transferase activity;cytosol;protein binding;glutathione transferase activity;glutathione metabolic process;response to organic cyclic compound@NA
A2463_03@6@7@deletion@2@69092@139309@1@chr1:69092-139309@14.5@631@382@0.605@CNVR1.2@OR4F5_1, AL627309.1_1@0@0@0@:olfactory receptor, family 4, subfamily F, member 5@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_03@426@432@duplication@7@1635990@1640572@1@chr1:1635990-1640572@7.92@174@263@1.51@CNVR17.1@CDK11A_14, CDK11A_13, CDK11A_12, CDK11A_11, CDK11A_10, CDK11A_9, CDK11A_8@0@0@0@:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A@:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division@NA
A2463_03@1824@1830@duplication@7@12979673@13038381@1@chr1:12979673-13038381@14.5@329@522@1.59@CNVR72.3, CNVR72.4, CNVR72.9@PRAMEF7_4, PRAMEF6_4, PRAMEF6_3, PRAMEF6_2, PRAMEF22_1, PRAMEF22_2, PRAMEF22_3@0@0@0@:PRAME family member 7:PRAME family member 6;PRAME family member 23;PRAME family member 9/15-like;PRAME family member 5:PRAME family member 22@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_03@1853@1855@deletion@3@13495968@13522259@1@chr1:13495968-13522259@12@62@4@0.0645@NA@PRAMEF16_2, PRAMEF16_3, PRAMEF21_2@0@0@0@:PRAME family member 16:PRAME family member 21;PRAME family member 20@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_03@3194@3198@deletion@5@24287949@24301567@1@chr1:24287949-24301567@11.7@53@0@0@NA@PNRC2_3, SRSF10_6, SRSF10_5, SRSF10_4, SRSF10_3@0@0@0@:proline-rich nuclear receptor coactivator 2;proline-rich nuclear receptor coactivator 2-like:serine/arginine-rich splicing factor 10-like;serine/arginine-rich splicing factor 10@:protein binding;deadenylation-independent decapping of nuclear-transcribed mRNA;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;nucleus;regulation of transcription, DNA-dependent;transcription, DNA-dependent;cytoplasmic mRNA processing body:nucleoplasm;RNA splicing, via transesterification reactions;nuclear speck;RS domain binding;RNA binding;nucleus;mRNA splice site selection;unfolded protein binding;assembly of spliceosomal tri-snRNP;negative regulation of mRNA splicing, via spliceosome;regulation of transcription, DNA-dependent;nucleotide binding;cytoplasm;mRNA export from nucleus;protein binding;cytoplasmic transport;mRNA splicing, via spliceosome;nucleic acid binding@NA
A2463_03@3333@3342@duplication@10@25599040@25655415@1@chr1:25599040-25655415@83.9@674@1535@2.28@CNVR116.1, CNVR116.2@RHD_1, RHD_2, RHD_3, RHD_4, RHD_5, RHD_6, RHD_7, RHD_8, RHD_9, RHD_10@0@0@0@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
A2463_03@3357@3357@deletion@1@25735175@25735360@1@chr1:25735175-25735360@21.9@106@0@0@CNVR117.1@RHCE_2@0@0@0@:Rh blood group, CcEe antigens@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@: BLOOD GROUP--RHESUS SYSTEM E POLYPEPTIDE; RHE; RHESUS BLOOD GROUP, CcEe ANTIGENS; RHCE
A2463_03@3357@3358@duplication@1@25735175@25747277@1@chr1:25735175-25747277@-15.8@166@118@0.711@CNVR117.1@RHCE_2, RHCE_1@0@0@0@:Rh blood group, CcEe antigens@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@: BLOOD GROUP--RHESUS SYSTEM E POLYPEPTIDE; RHE; RHESUS BLOOD GROUP, CcEe ANTIGENS; RHCE
A2463_03@9365@9374@deletion@10@104202983@104234232@1@chr1:104202983-104234232@31.7@270@79@0.293@CNVR266.3, CNVR266.1, CNVR266.15@AMY1A_7, AMY1A_8, AMY1A_9, AMY1A_10, AMY1A_11, AMY1B_11, AMY1B_10, AMY1B_9, AMY1B_8, AMY1B_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
A2463_03@9437@9437@duplication@1@108771543@108771778@1@chr1:108771543-108771778@6.13@129@211@1.64@CNVR294.4@NBPF4_13@0@0@0@:neuroblastoma breakpoint family, member 4@:cytoplasm@NA
A2463_03@9460@9460@deletion@1@109007811@109008046@1@chr1:109007811-109008046@15.1@74@2@0.027@CNVR294.4@NBPF6_13@0@0@0@:neuroblastoma breakpoint family, member 6@:cytoplasm@NA
A2463_03@9766@9773@deletion@8@110230497@110235917@1@chr1:110230497-110235917@37.5@183@7@0.0383@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_1, GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
A2463_03@11143@11157@deletion@15@146227744@146244717@1@chr1:146227744-146244717@13.2@64@3@0.0469@NA@NBPF12_22, NBPF12_21, NBPF12_20, NBPF12_19, NBPF12_18, NBPF12_17, NBPF12_16, NBPF12_15, NBPF12_14, NBPF12_13, NBPF12_12, NBPF12_11, NBPF12_10, NBPF12_9, NBPF12_8@0@0@0@:neuroblastoma breakpoint family member 21-like@NA@NA
A2463_03@11159@11164@deletion@6@146246748@146253110@1@chr1:146246748-146253110@35.1@170@4@0.0235@NA@NBPF12_6, NBPF12_5, NBPF12_4, NBPF12_3, NBPF12_2, NBPF12_1@0@0@0@:neuroblastoma breakpoint family member 21-like@NA@NA
A2463_03@11168@11173@duplication@6@146399556@146405926@1@chr1:146399556-146405926@23.1@167@368@2.2@NA@NBPF12_8, NBPF12_9, NBPF12_10, NBPF12_11, NBPF12_12, NBPF12_13@0@0@0@:neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family member 14-like;neuroblastoma breakpoint family, member 12@:cytoplasm@NA
A2463_03@11236@11236@duplication@1@146461120@146461291@1@chr1:146461120-146461291@8.31@6@62@10.3@CNVR344.1, CNVR344.2@NBPF12_76@0@0@0@:neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family member 14-like;neuroblastoma breakpoint family, member 12@:cytoplasm@NA
A2463_03@11341@11341@duplication@1@148008574@148008624@1@chr1:148008574-148008624@6.86@142@236@1.66@CNVR346.2, CNVR346.4@NBPF14_17@0@0@0@:neuroblastoma breakpoint family, member 14@:cytoplasm@NA
A2463_03@11341@11343@deletion@2@148008574@148010164@1@chr1:148008574-148010164@-0.701@664@529@0.797@CNVR346.2, CNVR346.4@NBPF14_17, NBPF14_16, NBPF14_15@0@0@0@:neuroblastoma breakpoint family, member 14@:cytoplasm@NA
A2463_03@12117@12118@duplication@2@152573209@152586574@1@chr1:152573209-152586574@8.96@83@163@1.96@CNVR358.1@LCE3C_1, LCE3B_1@0@0@0@:late cornified envelope 3C:late cornified envelope 3B@:keratinization:keratinization@NA
A2463_03@14046@14053@duplication@8@161487766@161565521@1@chr1:161487766-161565521@16.7@1267@1725@1.36@CNVR383.3, CNVR383.1@FCGR2A_7, HSPA6_1, FCGR3A_5, FCGR3A_4, FCGR3A_3, FCGR3A_2, FCGR3A_1, FCGR2C_1@0@0@0@:Fc fragment of IgG, low affinity IIa, receptor (CD32):heat shock 70kDa protein 6 (HSP70B'):Fc fragment of IgG, low affinity IIIa, receptor (CD16a):Fc fragment of IgG, low affinity IIb, receptor (CD32):Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene)@:IgG binding;protein binding;integral to membrane;plasma membrane:signalosome;cell morphogenesis;response to unfolded protein;ATP binding:IgG binding;protein binding;regulation of immune response;extracellular region;integral to membrane;immune response;plasma membrane;external side of plasma membrane:IgG binding;protein binding;signal transduction;regulation of immune response;integral to membrane;immune response;plasma membrane;virus-host interaction@: MALARIA, SUSCEPTIBILITY TO; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
A2463_03@24854@24863@deletion@10@88084595@88095367@2@chr2:88084595-88095367@10.5@63@11@0.175@NA@RGPD2_19, RGPD2_18, RGPD2_17, RGPD2_16, RGPD2_15, RGPD2_14, RGPD2_13, RGPD2_12, RGPD2_11, RGPD2_10@0@0@0@:RANBP2-like and GRIP domain containing 2@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_03@25375@25382@deletion@8@97860464@97866262@2@chr2:97860464-97866262@16.2@1086@721@0.664@CNVR886.1@ANKRD36_39, ANKRD36_40, ANKRD36_41, ANKRD36_42, ANKRD36_43, ANKRD36_44, ANKRD36_45, ANKRD36_46@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_03@25391@25403@deletion@13@97875419@97890616@2@chr2:97875419-97890616@32.4@1734@1110@0.64@NA@ANKRD36_55, ANKRD36_56, ANKRD36_57, ANKRD36_58, ANKRD36_59, ANKRD36_60, ANKRD36_61, ANKRD36_62, ANKRD36_63, ANKRD36_64, ANKRD36_65, ANKRD36_66, ANKRD36_67@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_03@25407@25407@deletion@1@97910895@97911808@2@chr2:97910895-97911808@7.69@246@135@0.549@CNVR887.1@ANKRD36_71@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_03@27341@27342@duplication@2@132288153@132289375@2@chr2:132288153-132289375@5.95@159@239@1.5@NA@CCDC74A_3, CCDC74A_4@0@0@0@:coiled-coil domain containing 74A@NA@NA
A2463_03@34148@34148@duplication@1@241621649@241622254@2@chr2:241621649-241622254@7.52@162@271@1.67@NA@AQP12B_1@0@0@0@:aquaporin 12B@:transport;integral to membrane;transporter activity;membrane@NA
A2463_03@34150@34150@deletion@1@241631332@241631938@2@chr2:241631332-241631938@7.25@170@88@0.518@NA@AQP12A_1, AQP12A_2@0@0@0@:aquaporin 12A@:transport;integral to membrane;transporter activity;membrane@NA
A2463_03@39892@39894@duplication@3@75786030@75790887@3@chr3:75786030-75790887@9.04@211@318@1.51@CNVR1432.5, CNVR1432.9, CNVR1432.4@ZNF717_5, ZNF717_4, ZNF717_3@0@0@0@:zinc finger protein 717;zinc finger protein 717-like@:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_03@46667@46671@deletion@5@9174900@9213975@4@chr4:9174900-9213975@11.7@67@10@0.149@NA@FAM90A26P_4, FAM90A26P_5, FAM90A26P_6, FAM90A26P_7, USP17L13_1, USP17L10_1@0@0@0@:ubiquitin specific peptidase 17-like family member 10:ubiquitin specific peptidase 17-like family member 13@:zinc ion binding;nucleic acid binding:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
A2463_03@48556@48561@duplication@6@69403344@69434202@4@chr4:69403344-69434202@19.8@441@719@1.63@CNVR1953.1@UGT2B17_6, UGT2B17_5, UGT2B17_4, UGT2B17_3, UGT2B17_2, UGT2B17_1@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B17@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;membrane@: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
A2463_03@48592@48597@deletion@6@70146220@70160527@4@chr4:70146220-70160527@21@718@432@0.602@CNVR1957.2, CNVR1957.1@UGT2B28_1, UGT2B28_2, UGT2B28_3, UGT2B28_4, UGT2B28_5, UGT2B28_6@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B28@:carbohydrate binding;transferase activity, transferring hexosyl groups;endoplasmic reticulum;glucuronosyltransferase activity;carbohydrate metabolic process;xenobiotic metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process@NA
A2463_03@53306@53309@deletion@4@741710@751372@5@chr5:741710-751372@16.3@157@57@0.363@CNVR2280.3@ZDHHC11B_7, ZDHHC11B_6, ZDHHC11B_5, ZDHHC11B_4@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
A2463_03@55463@55463@duplication@1@61808071@61808309@5@chr5:61808071-61808309@4.79@125@194@1.55@NA@CKS1B_1@0@0@0@:kinesin heavy chain member 2A:importin 11:CDC28 protein kinase regulatory subunit 1B@:cell differentiation;microtubule motor activity;mitotic cell cycle;microtubule associated complex;ATP binding;motor activity;blood coagulation;M phase of mitotic cell cycle;cell division;antigen processing and presentation of exogenous peptide antigen via MHC class II;spindle microtubule;centrosome;mitotic spindle organization;cytosol;protein binding;mitotic prometaphase;microtubule-based movement;microtubule;spindle pole;nervous system development:binding;intracellular;cytoplasm;ribosomal protein import into nucleus;intracellular protein transport;protein transporter activity;protein binding;nucleus;nuclear pore:nucleoplasm;G1 phase of mitotic cell cycle;S phase of mitotic cell cycle;mitotic cell cycle;G1/S transition of mitotic cell cycle;cell proliferation;protein binding;regulation of cyclin-dependent protein kinase activity;cyclin-dependent protein kinase regulator activity;cell cycle;cell division@NA
A2463_03@59046@59047@deletion@2@140228082@140238021@5@chr5:140228082-140238021@22.3@1651@947@0.574@CNVR2622.1@PCDHA9_1, PCDHA10_1@0@0@0@:protocadherin alpha 1:protocadherin alpha 2:protocadherin alpha 3:protocadherin alpha 4:protocadherin alpha 5:protocadherin alpha 6:protocadherin alpha 7:protocadherin alpha 8:protocadherin alpha 9:protocadherin alpha 10@:extracellular region;cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:integral to membrane;cell adhesion;homophilic cell adhesion;plasma membrane;integral to plasma membrane;membrane;nervous system development;calcium ion binding:cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:extracellular region;cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:integral to membrane;homophilic cell adhesion;plasma membrane;membrane;calcium ion binding:extracellular region;cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development@NA
A2463_03@59065@59065@deletion@1@140557617@140560021@5@chr5:140557617-140560021@18.4@2135@1108@0.519@CNVR2624.1@PCDHB8_1@0@0@0@:protocadherin beta 8@:integral to membrane;homophilic cell adhesion;plasma membrane;membrane;calcium ion binding@NA
A2463_03@60884@60885@deletion@2@175517374@175520277@5@chr5:175517374-175520277@13.2@87@15@0.172@NA@FAM153B_3, FAM153B_4@0@0@0@:uncharacterized LOC100507387;family with sequence similarity 153, member B@NA@NA
A2463_03@61691@61697@duplication@7@304629@350868@6@chr6:304629-350868@13.2@590@817@1.38@CNVR2728.1@DUSP22_2, DUSP22_3, DUSP22_4, DUSP22_5, DUSP22_6, DUSP22_7, DUSP22_8@0@0@0@:dual specificity phosphatase 22;dual specificity protein phosphatase 22-like@:protein dephosphorylation;transforming growth factor beta receptor signaling pathway;positive regulation of JNK cascade;protein tyrosine/serine/threonine phosphatase activity;nucleus;apoptotic process;multicellular organismal development;phosphatase activity;protein tyrosine phosphatase activity;regulation of cell proliferation;cytoplasm;cell proliferation;inactivation of MAPK activity;protein binding;negative regulation of transcription from RNA polymerase II promoter;dephosphorylation@NA
A2463_03@63282@63284@duplication@3@31237988@31239645@6@chr6:31237988-31239645@5.68@353@476@1.35@CNVR2838.1@HLA-C_4, HLA-C_3, HLA-C_2@0@0@0@:major histocompatibility complex, class I, C@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;membrane@: PSORIASIS SUSCEPTIBILITY 1; PSORS1
A2463_03@63726@63735@deletion@10@31962276@31965088@6@chr6:31962276-31965088@33@867@471@0.543@CNVR2843.6, CNVR2843.3@C4A_21, C4A_22, C4A_23, C4A_24, C4A_25, C4A_26, C4A_27, C4A_28, C4A_29, C4A_30@0@0@0@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
A2463_03@63747@63748@deletion@2@31973946@31974881@6@chr6:31973946-31974881@5.17@169@102@0.604@CNVR2843.6, CNVR2843.3@AL645922.1_2, AL645922.1_1@0@0@0@NA@NA@NA
A2463_03@63768@63768@deletion@1@31994761@31994899@6@chr6:31994761-31994899@5.89@80@35@0.438@CNVR2843.6, CNVR2843.5@C4B_20@0@0@0@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
A2463_03@63953@63958@deletion@6@32485517@32498001@6@chr6:32485517-32498001@21.5@267@119@0.446@CNVR2845.21, CNVR2845.25, CNVR2845.30, CNVR2845.43, CNVR2845.6@HLA-DRB5_6, HLA-DRB5_5, HLA-DRB5_4, HLA-DRB5_3, HLA-DRB5_2, HLA-DRB5_1@0@0@0@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
A2463_03@71028@71030@deletion@3@167787840@167790192@6@chr6:167787840-167790192@14@138@54@0.391@NA@TCP10_7, TCP10_6, TCP10_5@0@0@0@:t-complex 10@:cytosol@NA
A2463_03@71760@71777@deletion@18@5972414@6013173@7@chr7:5972414-6013173@42.7@427@155@0.363@NA@RSPH10B_18, RSPH10B_17, RSPH10B_16, RSPH10B_15, RSPH10B_14, RSPH10B_13, RSPH10B_12, RSPH10B_11, RSPH10B_10, RSPH10B_9, RSPH10B_8, RSPH10B_7, RSPH10B_6, RSPH10B_5, RSPH10B_4, RSPH10B_3, RSPH10B_2, PMS2_15@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas):PMS2 postmeiotic segregation increased 2 (S. cerevisiae)@:response to drug;DNA binding;MutSalpha complex binding;ATP binding;mismatch repair;DNA repair;mismatched DNA binding;ATPase activity;nucleus;mismatch repair complex;reciprocal meiotic recombination;ATP catabolic process;single-stranded DNA binding;response to DNA damage stimulus;single base insertion or deletion binding;protein binding;somatic hypermutation of immunoglobulin genes;somatic recombination of immunoglobulin gene segments;MutLalpha complex;endonuclease activity@: COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 4; HNPCC4; MISMATCH REPAIR CANCER SYNDROME
A2463_03@71932@71941@duplication@10@6819242@6838910@7@chr7:6819242-6838910@16.1@427@639@1.5@NA@RSPH10B2_12, RSPH10B2_13, RSPH10B2_14, RSPH10B2_15, RSPH10B2_16, RSPH10B2_17, RSPH10B2_18, RSPH10B2_19, RSPH10B2_20, CCZ1B_15@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
A2463_03@76245@76245@deletion@1@99912156@99912373@7@chr7:99912156-99912373@8.22@37@0@0@CNVR3508.2, CNVR3508.1@SPDYE3_6@0@0@0@:speedy homolog E3 (Xenopus laevis)@NA@NA
A2463_03@76718@76718@duplication@1@102114809@102114982@7@chr7:102114809-102114982@4.59@67@116@1.73@CNVR3518.1@POLR2J_3@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J, 13.3kDa@:nucleoplasm;DNA binding;DNA repair;protein dimerization activity;nucleus;viral reproduction;gene expression;transcription initiation from RNA polymerase II promoter;7-methylguanosine mRNA capping;protein phosphorylation;LRR domain binding;protein kinase activity;DNA-directed RNA polymerase II, core complex;nucleotide-excision repair;transcription from RNA polymerase II promoter;DNA-directed RNA polymerase activity;protein binding;transcription-coupled nucleotide-excision repair;RNA splicing;mRNA splicing, via spliceosome;transcription, DNA-dependent;transcription elongation from RNA polymerase II promoter;positive regulation of viral transcription@NA
A2463_03@76726@76767@deletion@42@102133564@102236576@7@chr7:102133564-102236576@44.8@751@361@0.481@CNVR3518.1@RASA4B_16, RASA4B_15, RASA4B_14, RASA4B_13, RASA4B_12, RASA4B_11, RASA4B_10, RASA4B_9, RASA4B_8, RASA4B_7, RASA4B_6, RASA4B_5, RASA4B_4, RASA4B_3, RASA4B_2, RASA4B_1, SPDYE2_2, SPDYE2_3, SPDYE2_4, SPDYE2_5, SPDYE2_6, SPDYE2_7, SPDYE2_8, POLR2J3_4, POLR2J3_3, POLR2J3_2, POLR2J3_1, AC093668.1_3, AC093668.1_2, AC093668.1_1, RASA4_21, RASA4_20, RASA4_19, RASA4_18, RASA4_17, RASA4_16, RASA4_15, RASA4_14, RASA4_13, RASA4_12, RASA4_11, RASA4_10, RASA4_9@0@0@0@:RAS p21 protein activator 4B:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:speedy homolog E2 (Xenopus laevis):RAS p21 protein activator 4B;RAS p21 protein activator 4@:phospholipid binding;intracellular;GTPase activator activity;cytosol;signal transduction;protein binding;plasma membrane;regulation of small GTPase mediated signal transduction;metal ion binding;intracellular signal transduction:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity@NA
A2463_03@76792@76795@deletion@4@102309363@102319303@7@chr7:102309363-102319303@13.5@268@141@0.526@CNVR3518.1@POLR2J2_2, POLR2J2_2, POLR2J2_1, POLR2J2_1, AC105052.1_3, AC105052.1_2, AC105052.1_1@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
A2463_03@79287@79287@deletion@1@143400089@143400710@7@chr7:143400089-143400710@5.72@35@6@0.171@CNVR3594.2, CNVR3594.1@FAM115C_2@0@0@0@:family with sequence similarity 115, member C;protein FAM115C-like@NA@NA
A2463_03@79315@79315@deletion@1@144059764@144062916@7@chr7:144059764-144062916@6.12@745@483@0.648@CNVR3598.4, CNVR3598.5@ARHGEF5_2@0@0@0@:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
A2463_03@79323@79323@deletion@1@144070289@144070377@7@chr7:144070289-144070377@12.6@60@1@0.0167@CNVR3598.4, CNVR3598.5, CNVR3598.11@ARHGEF5_10@0@0@0@:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
A2463_03@80358@80358@duplication@1@6873513@6873621@8@chr8:6873513-6873621@7.57@82@161@1.96@CNVR3769.1@DEFA3_3@0@0@0@:defensin, alpha 1B;defensin, alpha 1:defensin, alpha 3, neutrophil-specific;defensin, alpha 1B;defensin, alpha 1@:defense response to virus;extracellular matrix;immune response;Golgi lumen;azurophil granule lumen;killing of cells of other organism;innate immune response;chemotaxis;extracellular space;extracellular region;defense response to bacterium;defense response to fungus;defense response:defense response to virus;Golgi lumen;azurophil granule lumen;killing of cells of other organism;innate immune response;extracellular space;defense response to bacterium;defense response to fungus;extracellular region;defense response@NA
A2463_03@80402@80402@deletion@1@7718169@7718245@8@chr8:7718169-7718245@7.04@32@0@0@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@SPAG11A_3@0@0@0@:sperm associated antigen 11A;sperm associated antigen 11B@:extracellular region;defense response@NA
A2463_03@80567@80567@duplication@1@12042886@12043034@8@chr8:12042886-12043034@5.15@57@107@1.88@CNVR3785.5, CNVR3785.3@FAM86B1_7@0@0@0@:family with sequence similarity 86, member B2;family with sequence similarity 86, member B1@NA@NA
A2463_03@80577@80577@deletion@1@12285167@12285315@8@chr8:12285167-12285315@7.34@33@0@0@CNVR3786.4, CNVR3786.16@FAM86B2_7@0@0@0@:family with sequence similarity 86, member B2@NA@NA
A2463_03@80577@80579@duplication@2@12285167@12286623@8@chr8:12285167-12286623@2.06@97@146@1.51@CNVR3786.4, CNVR3786.16@FAM86B2_7, FAM86B2_6, FAM86B2_5@0@0@0@:family with sequence similarity 86, member B2@NA@NA
A2463_03@83673@83673@deletion@1@86573700@86575726@8@chr8:86573700-86575726@43.3@321@31@0.0966@CNVR3955.1@REXO1L1_1@0@0@0@:exonuclease GOR-like;REX1, RNA exonuclease 1 homolog (S. cerevisiae)-like 1@:intracellular;nucleus;exonuclease activity;nucleic acid binding;cytoplasm@NA
A2463_03@86336@86337@deletion@2@145317757@145318304@8@chr8:145317757-145318304@5.74@26@0@0@NA@KM-PA-2_11, KM-PA-2_10@0@0@0@@:protein binding;regulation of cell cycle;nucleus;rRNA processing@NA
A2463_03@86637@86638@deletion@2@146103@152078@9@chr9:146103-152078@6.82@162@89@0.549@CNVR4135.1@CBWD1_10, CBWD1_9@0@0@0@:COBW domain containing 1;COBW domain-containing protein 1-like;COBW domain containing 5@:ATP binding@NA
A2463_03@86646@86646@deletion@1@178817@178969@9@chr9:178817-178969@11.8@56@1@0.0179@CNVR4135.1@CBWD1_1@0@0@0@:COBW domain containing 1;COBW domain-containing protein 1-like;COBW domain containing 5@:ATP binding@NA
A2463_03@88528@88528@deletion@1@40702653@40706387@9@chr9:40702653-40706387@8.24@522@311@0.596@NA@SPATA31A3_4@0@0@0@:SPATA31 subfamily A, member 3@:integral to membrane@NA
A2463_03@88534@88534@duplication@1@41306194@41306209@9@chr9:41306194-41306209@6.6@48@106@2.21@CNVR4278.2@FAM74A2_2@0@0@0@@:integral to membrane@NA
A2463_03@88544@88549@deletion@6@42368416@42380206@9@chr9:42368416-42380206@7.08@118@58@0.492@NA@ANKRD20A2_1, ANKRD20A2_2, ANKRD20A2_3, ANKRD20A2_4, ANKRD20A2_5, ANKRD20A2_6@0@0@0@:ankyrin repeat domain 20 family, member A2@:protein binding@NA
A2463_03@88584@88608@deletion@25@43624656@43908523@9@chr9:43624656-43908523@265@2622@439@0.167@CNVR4294.1@SPATA31A6_4, SPATA31A6_3, SPATA31A6_2, SPATA31A6_1, CNTNAP3B_1, CNTNAP3B_2, CNTNAP3B_3, CNTNAP3B_4, CNTNAP3B_5, CNTNAP3B_6, CNTNAP3B_7, CNTNAP3B_8, CNTNAP3B_9, CNTNAP3B_10, CNTNAP3B_11, CNTNAP3B_12, CNTNAP3B_13, CNTNAP3B_14, CNTNAP3B_15, CNTNAP3B_16, CNTNAP3B_17, CNTNAP3B_18, CNTNAP3B_19, CNTNAP3B_20, CNTNAP3B_21@0@0@0@:SPATA31 subfamily A, member 6:contactin associated protein-like 3B;contactin associated protein-like 3@:integral to membrane:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
A2463_03@88639@88641@duplication@3@67926874@67930837@9@chr9:67926874-67930837@15.3@51@165@3.24@NA@ANKRD20A1_1, ANKRD20A1_2, ANKRD20A1_3@0@0@0@:ankyrin repeat domain 20 family, member A1@:protein binding;plasma membrane@NA
A2463_03@88643@88656@deletion@14@67935876@67985922@9@chr9:67935876-67985922@31.8@1006@622@0.618@NA@ANKRD20A1_5, ANKRD20A1_6, ANKRD20A1_7, ANKRD20A1_8, ANKRD20A1_9, ANKRD20A1_10, ANKRD20A1_11, ANKRD20A1_12, ANKRD20A1_13, ANKRD20A1_14, ANKRD20A1_15, RP11-195B21.3_3, RP11-195B21.3_4, RP11-195B21.3_5@0@0@0@:ankyrin repeat domain 20 family, member A1:coiled-coil domain-containing protein 29-like;uncharacterized LOC644249@:protein binding;plasma membrane@NA
A2463_03@88722@88723@deletion@2@70912497@70912733@9@chr9:70912497-70912733@5.71@118@63@0.534@NA@CBWD3_12, CBWD3_13@0@0@0@:COBW domain-containing protein 5-like;COBW domain-containing protein 1-like;COBW domain containing 3@:ATP binding@NA
A2463_03@96435@96435@deletion@1@46248629@46248685@10@chr10:46248629-46248685@10.4@50@1@0.02@NA@FAM21C_13@0@0@0@:family with sequence similarity 21, member C@:endosome;protein binding;plasma membrane;retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_03@96454@96458@deletion@5@46312644@46329564@10@chr10:46312644-46329564@7.43@168@92@0.548@NA@FAM25E_1, AGAP4_7, AGAP4_6, AGAP4_5, AGAP4_4@0@0@0@:ArfGAP with GTPase domain, ankyrin repeat and PH domain 4;arf-GAP with GTPase, ANK repeat and PH domain-containing protein 5-like@:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity@NA
A2463_03@96468@96470@deletion@3@46605764@46611811@10@chr10:46605764-46611811@7.68@35@0@0@CNVR4712.3@PTPN20A_4, PTPN20A_3, PTPN20A_2@0@0@0@:protein tyrosine phosphatase, non-receptor type 20B;protein tyrosine phosphatase, non-receptor type 20A@:phosphatase activity;protein tyrosine phosphatase activity;microtubule;nucleus;dephosphorylation;protein dephosphorylation;microtubule organizing center@NA
A2463_03@96526@96531@deletion@6@47754716@47758904@10@chr10:47754716-47758904@7.22@78@32@0.41@CNVR4714.1@ANXA8L2_5, ANXA8L2_6, ANXA8L2_7, ANXA8L2_8, ANXA8L2_9, ANXA8L2_10@0@0@0@:annexin A8-like 2:uncharacterized LOC101060462;uncharacterized LOC100996760@:calcium-dependent phospholipid binding;calcium ion binding@NA
A2463_03@96620@96620@deletion@1@48771316@48771405@10@chr10:48771316-48771405@13.6@65@1@0.0154@CNVR4716.10, CNVR4716.3@PTPN20B_6@0@0@0@:protein tyrosine phosphatase, non-receptor type 20B;protein tyrosine phosphatase, non-receptor type 20A@:phosphatase activity;protein tyrosine phosphatase activity;microtubule;nucleus;dephosphorylation;protein dephosphorylation;microtubule organizing center@NA
A2463_03@96626@96630@deletion@5@49203412@49371714@10@chr10:49203412-49371714@15.8@307@159@0.518@CNVR4717.2@FAM25C_3, FAM25C_2, FAM25C_1, FRMPD2_29, FRMPD2_28@0@0@0@:family with sequence similarity 25, member G;family with sequence similarity 25, member C;family with sequence similarity 25, member A;family with sequence similarity 25, member B:FERM and PDZ domain containing 2@:basolateral plasma membrane;transferase activity, transferring phosphorus-containing groups;cytoplasm;tight junction;protein binding;cytoskeleton;1-phosphatidylinositol binding;tight junction assembly@NA
A2463_03@96932@96937@deletion@6@51965743@51978390@10@chr10:51965743-51978390@15@93@17@0.183@NA@ASAH2_12, ASAH2_11, ASAH2_10, ASAH2_9, ASAH2_8, ASAH2_7@0@0@0@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
A2463_03@98344@98348@deletion@5@81463367@81470520@10@chr10:81463367-81470520@11.8@116@47@0.405@CNVR4815.2, CNVR4815.4@FAM22B_1, FAM22B_2, FAM22B_3, FAM22B_4, FAM22B_5@0@0@0@NA@NA@NA
A2463_03@98350@98350@deletion@1@81471457@81472241@10@chr10:81471457-81472241@35@336@62@0.185@CNVR4815.2, CNVR4815.4@FAM22B_7@0@0@0@NA@NA@NA
A2463_03@98350@98357@duplication@7@81471457@81610362@10@chr10:81471457-81610362@-20.4@454@418@0.921@CNVR4815.2@FAM22B_7, FAM22E_1, FAM22E_2, FAM22E_3, FAM22E_4, FAM22E_5, FAM22E_6, FAM22E_7@0@0@0@NA@NA@NA
A2463_03@98603@98606@duplication@4@89120239@89124960@10@chr10:89120239-89124960@5.65@75@129@1.72@CNVR4840.3@FAM22D_2, FAM22D_3, FAM22D_4, FAM22D_5@0@0@0@:family with sequence similarity 22, member D@NA@NA
A2463_03@101608@101614@deletion@7@124344788@124353114@10@chr10:124344788-124353114@15.9@534@323@0.605@CNVR4912.4, CNVR4912.3, CNVR4912.2@DMBT1_15, DMBT1_16, DMBT1_17, DMBT1_18, DMBT1_19, DMBT1_20, DMBT1_21@0@0@0@:deleted in malignant brain tumors 1@:defense response to virus;calcium-dependent protein binding;pattern recognition receptor signaling pathway;blastocyst development;response to estrogen stimulus;tissue regeneration;proteinaceous extracellular matrix;protein transport;Gram-negative bacterial cell surface binding;positive regulation of epithelial cell differentiation;virus-host interaction;epithelial cell differentiation;induction of bacterial agglutination;phagocytic vesicle membrane;intracellular;Gram-positive bacterial cell surface binding;zymogen binding;innate immune response;cytoplasm;extrinsic to membrane;protein binding;zymogen granule membrane;extracellular region;scavenger receptor activity;pattern recognition receptor activity;inner cell mass cell proliferation;membrane@: GLIOMA SUSCEPTIBILITY 1; GLM1
A2463_03@103139@103139@deletion@1@3239175@3240043@11@chr11:3239175-3240043@6.39@103@48@0.466@CNVR5028.1@MRGPRG_1@0@0@0@:MAS-related GPR, member G@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway@NA
A2463_03@103268@103268@duplication@1@4967390@4968330@11@chr11:4967390-4968330@4.69@436@604@1.39@CNVR5040.1@OR51A4_1@0@0@0@:matrix metallopeptidase 26:olfactory receptor, family 51, subfamily A, member 4@:metallopeptidase activity;extracellular matrix;proteolysis;proteinaceous extracellular matrix;collagen catabolic process;metalloendopeptidase activity;zinc ion binding;metabolic process:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_03@106046@106048@duplication@3@55370918@55419315@11@chr11:55370918-55419315@10@546@769@1.41@CNVR5179.1@OR4C11_1, OR4P4_1, OR4S2_1@0@0@0@:olfactory receptor, family 4, subfamily C, member 11:olfactory receptor, family 4, subfamily P, member 4:olfactory receptor, family 4, subfamily S, member 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_03@110109@110109@deletion@1@89531299@89531797@11@chr11:89531299-89531797@8.63@184@90@0.489@NA@TRIM49_8@0@0@0@:tripartite motif containing 49@:protein binding;intracellular;DNA binding;zinc ion binding@NA
A2463_03@114136@114138@deletion@3@8374419@8376811@12@chr12:8374419-8376811@8.06@1182@799@0.676@CNVR5422.3, CNVR5422.5, CNVR5422.6, CNVR5422.1@FAM90A1_7, FAM90A1_6, FAM90A1_5@0@0@0@:family with sequence similarity 90, member A1@:zinc ion binding;nucleic acid binding@NA
A2463_03@127333@127341@duplication@9@19553418@19574352@14@chr14:19553418-19574352@45.2@1196@1922@1.61@CNVR6072.1@POTEG_1, POTEG_2, POTEG_3, POTEG_4, POTEG_5, POTEG_6, POTEG_7, POTEG_8, POTEG_9@0@0@0@:POTE ankyrin domain family, member G@:protein binding@NA
A2463_03@127353@127355@duplication@3@20215588@20296531@14@chr14:20215588-20296531@9.78@1055@1422@1.35@CNVR6072.12, CNVR6072.4, CNVR6072.37@OR4Q3_1, OR4M1_1, OR4N2_1@0@0@0@:olfactory receptor, family 4, subfamily N, member 2:olfactory receptor, family 4, subfamily Q, member 3:olfactory receptor, family 4, subfamily M, member 1@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_03@133432@133458@duplication@27@106539080@106791309@14@chr14:106539080-106791309@94@2228@3481@1.56@CNVR6294.48, CNVR6294.24, CNVR6294.40@IGHV1-8_2, IGHV1-8_1, IGHV3-9_2, IGHV3-9_1, IGHV3-11_2, IGHV3-11_1, IGHV3-13_2, IGHV3-13_1, IGHV3-15_2, IGHV3-15_1, IGHV3-16_2, IGHV3-16_1, IGHV1-18_2, IGHV1-18_1, IGHV3-20_2, IGHV3-20_1, IGHV3-21_2, IGHV3-21_1, IGHV3-23_2, IGHV3-23_1, IGHV1-24_2, IGHV1-24_1, IGHV2-26_2, IGHV2-26_1, IGHV4-28_2, IGHV4-28_1, IGHV3-30_2@0@0@0@:uncharacterized LOC100653243;uncharacterized LOC642131@:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding@NA
A2463_03@133491@133495@duplication@5@107095127@107131334@14@chr14:107095127-107131334@12.9@287@440@1.53@CNVR6294.56, CNVR6294.16@IGHV4-61_2, IGHV4-61_1, IGHV3-64_2, IGHV3-64_1, IGHV3-66_2@0@0@0@@:protein binding:protein binding:protein binding@NA
A2463_03@133520@133525@deletion@6@21051163@21063546@15@chr15:21051163-21063546@6.57@196@118@0.602@NA@POTEB_9, POTEB_8, POTEB_7, POTEB_6, POTEB_5, POTEB_4@0@0@0@:POTE ankyrin domain family member B-like@:protein binding@NA
A2463_03@133532@133537@deletion@6@22062317@22074702@15@chr15:22062317-22074702@7.54@168@94@0.56@NA@POTEB_9, POTEB_8, POTEB_7, POTEB_6, POTEB_5, POTEB_4@0@0@0@:POTE ankyrin domain family member B-like@:protein binding@NA
A2463_03@133621@133623@duplication@3@23259257@23259716@15@chr15:23259257-23259716@13.8@128@253@1.98@CNVR6300.4@GOLGA8I_5, GOLGA8I_6, GOLGA8I_7@0@0@0@:golgin A8 family, member I@:Golgi cisterna membrane@NA
A2463_03@133869@133870@deletion@2@28629294@28629596@15@chr15:28629294-28629596@6.7@30@0@0@CNVR6329.4@GOLGA8F_9, GOLGA8F_10@0@0@0@@:Golgi apparatus@NA
A2463_03@133887@133887@deletion@1@28771402@28771657@15@chr15:28771402-28771657@4.68@21@0@0@CNVR6330.3@GOLGA8G_12@0@0@0@:golgin A8 family, member G;golgin A8 family, member F@:Golgi apparatus@NA
A2463_03@133978@133981@deletion@4@30380944@30382159@15@chr15:30380944-30382159@5.84@172@103@0.599@NA@GOLGA8J_9, GOLGA8J_10, GOLGA8J_11, GOLGA8J_12@0@0@0@:golgin A8 family, member J@:Golgi apparatus@NA
A2463_03@134062@134063@duplication@2@30902010@30902309@15@chr15:30902010-30902309@5.5@165@243@1.47@CNVR6339.2, CNVR6339.3@GOLGA8H_9, GOLGA8H_10@0@0@0@:golgin A8 family, member H@:Golgi apparatus@NA
A2463_03@134158@134163@duplication@6@32684984@32686941@15@chr15:32684984-32686941@11.8@213@339@1.59@NA@GOLGA8K_19, GOLGA8K_18, GOLGA8K_17, GOLGA8K_16, GOLGA8K_15, GOLGA8K_14@0@0@0@:golgin A8 family, member J@:Golgi apparatus@NA
A2463_03@134182@134182@duplication@1@32738676@32738766@15@chr15:32738676-32738766@5.94@93@162@1.74@CNVR6346.1@GOLGA8O_15@0@0@0@:golgin A8 family, member O@:Golgi apparatus@NA
A2463_03@134189@134191@deletion@3@32743115@32743539@15@chr15:32743115-32743539@6.72@61@21@0.344@CNVR6346.1@GOLGA8O_8, GOLGA8O_7, GOLGA8O_6@0@0@0@:golgin A8 family, member O@:Golgi apparatus@NA
A2463_03@134204@134205@duplication@2@32890090@32890378@15@chr15:32890090-32890378@5.25@73@125@1.71@NA@GOLGA8N_7, GOLGA8N_8@0@0@0@:golgin A8 family, member R@:Golgi apparatus@NA
A2463_03@134444@134444@duplication@1@34678827@34678942@15@chr15:34678827-34678942@5.3@47@95@2.02@CNVR6351.4, CNVR6351.3@GOLGA8A_11@0@0@0@:golgin A8 family, member A@:Golgi cisterna membrane;Golgi apparatus@NA
A2463_03@134460@134460@deletion@1@34825048@34825163@15@chr15:34825048-34825163@8.26@38@0@0@CNVR6351.3@GOLGA8B_12@0@0@0@:golgin A8 family, member A:golgin A8 family, member A;golgin A8 family, member B@:Golgi cisterna membrane;Golgi apparatus:Golgi cisterna membrane;Golgi apparatus@NA
A2463_03@135050@135054@duplication@5@41860416@41862897@15@chr15:41860416-41862897@6.56@249@348@1.4@NA@TYRO3_8, TYRO3_9, TYRO3_10, TYRO3_11, TYRO3_12@0@0@0@:TYRO3 protein tyrosine kinase@:protein tyrosine kinase activity;platelet aggregation;negative regulation of toll-like receptor signaling pathway;ATP binding;vagina development;substrate adhesion-dependent cell spreading;nucleus;negative regulation of lymphocyte activation;endoplasmic reticulum membrane;phosphatidylinositol 3-kinase cascade;nuclear envelope;platelet activation;protein kinase activity;protein kinase B signaling cascade;neuron homeostasis;negative regulation of neuron apoptotic process;negative regulation of innate immune response;protein autophosphorylation;transmembrane receptor protein tyrosine kinase activity;apoptotic cell clearance;transferase activity, transferring phosphorus-containing groups;spermatogenesis;forebrain cell migration;integral to membrane;integral to plasma membrane;ovulation cycle;natural killer cell differentiation;phosphatidylinositol 3-kinase binding;negative regulation of inflammatory response;protein phosphorylation;receptor signaling protein tyrosine kinase activity;protein heterodimerization activity;secretion by cell;protein binding;signal transduction;cell adhesion;signal transduction by phosphorylation@NA
A2463_03@139296@139308@deletion@13@82934267@83015609@15@chr15:82934267-83015609@12.4@139@55@0.396@CNVR6477.6, CNVR6477.2, CNVR6477.3@RP13-996F3.5_6, RP13-996F3.5_5, RP13-996F3.5_4, RP13-996F3.5_3, RP13-996F3.5_2, RP13-996F3.5_1, RP13-996F3.4_9, RP13-996F3.4_8, RP13-996F3.4_7, RP13-996F3.4_6, RP13-996F3.4_5, RP13-996F3.4_4, RP13-996F3.4_3@0@0@0@NA@NA@NA
A2463_03@140476@140484@duplication@9@64382@68068@16@chr16:64382-68068@21.5@329@552@1.68@CNVR6565.1@WASH4P_10, WASH4P_9, WASH4P_8, WASH4P_7, WASH4P_6, WASH4P_5, WASH4P_4, WASH4P_3, WASH4P_2@0@0@0@@:intracellular membrane-bounded organelle;endosomal transport;recycling endosome;early endosome;Arp2/3 complex-mediated actin nucleation;actin binding;alpha-tubulin binding;retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;recycling endosome membrane@NA
A2463_03@142917@142928@deletion@12@16346291@16367932@16@chr16:16346291-16367932@20.1@453@255@0.563@NA@NOMO3_9, NOMO3_10, NOMO3_11, NOMO3_12, NOMO3_13, NOMO3_14, NOMO3_15, NOMO3_16, NOMO3_17, NOMO3_18, NOMO3_19, NOMO3_20@0@0@0@:NODAL modulator 3@:carbohydrate binding;integral to membrane;carboxypeptidase activity@NA
A2463_03@143001@143008@duplication@8@18540824@18554053@16@chr16:18540824-18554053@8.79@406@559@1.38@NA@NOMO2_15, NOMO2_14, NOMO2_13, NOMO2_12, NOMO2_11, NOMO2_10, NOMO2_9, NOMO2_8@0@0@0@:NODAL modulator 2@:carbohydrate binding;protein binding;integral to membrane;carboxypeptidase activity;endoplasmic reticulum membrane@NA
A2463_03@144047@144047@duplication@1@28467746@28468347@16@chr16:28467746-28468347@6.44@55@115@2.09@NA@NPIPL1_7@0@0@0@NA@NA@NA
A2463_03@144130@144134@duplication@5@28763890@28777810@16@chr16:28763890-28777810@7.26@66@127@1.92@NA@A-575C2.4_1, A-575C2.4_2, A-575C2.4_3, A-575C2.4_4, A-575C2.4_5@0@0@0@NA@NA@NA
A2463_03@145559@145563@deletion@5@55854285@55862886@16@chr16:55854285-55862886@15.7@952@629@0.661@CNVR6731.1@CES1_6, CES1_5, CES1_4, CES1_3, CES1_2@0@0@0@:carboxylesterase 1;liver carboxylesterase 1-like@:hydrolase activity;methyl salicylate esterase activity;response to toxin;methylumbelliferyl-acetate deacetylase activity;endoplasmic reticulum lumen;retinyl-palmitate esterase activity;methyl jasmonate esterase activity;metabolic process;carboxylesterase activity;methyl indole-3-acetate esterase activity@: CARBOXYLESTERASE 1; CES1
A2463_03@147100@147101@duplication@2@69997478@70010635@16@chr16:69997478-70010635@6.59@195@289@1.48@CNVR6762.3, CNVR6762.1@CLEC18A_12, RP11-419C5.2_7@0@0@0@:C-type lectin domain family 18, member A@:carbohydrate binding;protein binding;extracellular region@NA
A2463_03@147125@147126@deletion@2@70208183@70208941@16@chr16:70208183-70208941@13.5@65@2@0.0308@CNVR6764.1@CLEC18C_1, CLEC18C_2@0@0@0@:C-type lectin domain family 18, member C@:carbohydrate binding;protein binding;extracellular region@NA
A2463_03@147504@147509@duplication@6@74443449@74446144@16@chr16:74443449-74446144@13.7@397@582@1.47@CNVR6778.2, CNVR6778.3, CNVR6778.5@CLEC18B_12, CLEC18B_11, CLEC18B_10, CLEC18B_9, CLEC18B_8, CLEC18B_7@0@0@0@:C-type lectin domain family 18, member B@:carbohydrate binding;protein binding;extracellular region@NA
A2463_03@152171@152175@duplication@5@21207739@21217542@17@chr17:21207739-21217542@6.93@189@276@1.46@NA@MAP2K3_8, MAP2K3_9, MAP2K3_10, MAP2K3_11, MAP2K3_12@0@0@0@:dual specificity mitogen-activated protein kinase kinase 3-like;mitogen-activated protein kinase kinase 3@:nucleoplasm;MAPK cascade;inflammatory response;protein kinase binding;protein tyrosine kinase activity;toll-like receptor 4 signaling pathway;cardiac muscle contraction;transferase activity, transferring phosphorus-containing groups;ATP binding;Toll signaling pathway;stress-activated MAPK cascade;toll-like receptor 2 signaling pathway;regulation of cytokine biosynthetic process;MyD88-dependent toll-like receptor signaling pathway;MyD88-independent toll-like receptor signaling pathway;toll-like receptor 3 signaling pathway;protein serine/threonine kinase activity;activation of MAPK activity;protein phosphorylation;protein kinase activity;TRIF-dependent toll-like receptor signaling pathway;positive regulation of protein kinase activity;innate immune response;cytosol;protein binding;signal transduction;positive regulation of transcription, DNA-dependent;toll-like receptor signaling pathway;MAP kinase kinase activity;toll-like receptor 1 signaling pathway@NA
A2463_03@153370@153400@deletion@31@34499215@34641537@17@chr17:34499215-34641537@21.8@412@219@0.532@CNVR7077.1, CNVR7077.2@TBC1D3B_7, TBC1D3B_6, TBC1D3B_5, TBC1D3B_4, TBC1D3B_3, TBC1D3B_2, CCL3L3_3, CCL3L3_2, CCL3L3_1, CCL4L1_1, CCL4L1_2, CCL4L1_3, TBC1D3C_14, TBC1D3C_13, TBC1D3C_12, TBC1D3C_11, TBC1D3C_10, TBC1D3C_9, TBC1D3C_8, TBC1D3C_7, TBC1D3C_6, TBC1D3C_5, TBC1D3C_4, TBC1D3C_3, TBC1D3C_2, CCL3L1_3, CCL3L1_2, CCL3L1_1, CCL4L2_1, CCL4L2_2, CCL4L2_3@0@0@0@:TBC1 domain family, member 3B:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1:TBC1 domain family, member 3C;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3H-like;TBC1 domain family, member 3H:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
A2463_03@154328@154329@duplication@2@39240460@39254336@17@chr17:39240460-39254336@8.54@202@316@1.56@NA@KRTAP4-7_1, KRTAP4-8_1@0@0@0@:keratin associated protein 4-7:keratin associated protein 4-8@:keratin filament:keratin filament@NA
A2463_03@154344@154346@duplication@3@39405974@39422112@17@chr17:39405974-39422112@8.33@311@445@1.43@NA@KRTAP9-4_1, KRTAP9-9_1, KRTAP9-6_1@0@0@0@:keratin associated protein 9-4:keratin associated protein 9-9:keratin associated protein 9-6@:keratin filament:keratin filament:keratin filament@NA
A2463_03@155585@155590@duplication@6@44382876@44409347@17@chr17:44382876-44409347@23.4@292@545@1.87@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A_4, LRRC37A_5, LRRC37A_6, LRRC37A_7, LRRC37A_8, LRRC37A_9@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
A2463_03@155593@155595@duplication@3@44414663@44415089@17@chr17:44414663-44415089@24.3@62@261@4.21@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A_12, LRRC37A_13, LRRC37A_14@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
A2463_03@155599@155600@duplication@2@44590080@44594799@17@chr17:44590080-44594799@31.4@113@476@4.21@CNVR7114.2, CNVR7114.5@LRRC37A2_2, LRRC37A2_3@0@0@0@:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
A2463_03@155608@155608@duplication@1@44627782@44627885@17@chr17:44627782-44627885@5.39@46@95@2.07@CNVR7114.2, CNVR7114.5, CNVR7114.4, CNVR7114.6@LRRC37A2_11@0@0@0@:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
A2463_03@155610@155611@deletion@2@44632519@44632790@17@chr17:44632519-44632790@8.69@254@143@0.563@CNVR7114.2, CNVR7114.5, CNVR7114.4@LRRC37A2_13, LRRC37A2_14@0@0@0@:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
A2463_03@158900@158901@duplication@2@74387838@74388194@17@chr17:74387838-74388194@6.02@94@156@1.66@NA@UBE2O_17, UBE2O_16@0@0@0@:ubiquitin-conjugating enzyme E2O@:ubiquitin-protein ligase activity;acid-amino acid ligase activity;ATP binding@NA
A2463_03@162017@162018@duplication@2@44542732@44550298@18@chr18:44542732-44550298@54.3@398@1468@3.69@CNVR7319.1, CNVR7319.2@TCEB3CL2_1, TCEB3CL_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2:transcription elongation factor B polypeptide 3C-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_03@162017@162019@deletion@1@44542732@44556213@18@chr18:44542732-44556213@132@2340@1495@0.639@CNVR7319.1, CNVR7319.2@TCEB3CL2_1, TCEB3CL_1, TCEB3C_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2:transcription elongation factor B polypeptide 3C-like:transcription elongation factor B polypeptide 3C (elongin A3);RNA polymerase II transcription factor SIII subunit A3-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_03@164950@164951@deletion@2@7030624@7032905@19@chr19:7030624-7032905@7.11@40@6@0.15@CNVR7517.1@MBD3L5_1, MBD3L5_2@0@0@0@:methyl-CpG binding domain protein 3-like 5@NA@NA
A2463_03@167243@167244@duplication@2@15784341@15789215@19@chr19:15784341-15789215@8.29@5@57@11.4@CNVR7553.1@CYP4F12_2, CYP4F12_3@0@0@0@:cytochrome P450, family 4, subfamily F, polypeptide 12@:pressure natriuresis;negative regulation of blood coagulation;oxidation-reduction process;very long-chain fatty acid metabolic process;arachidonic acid metabolic process;aromatase activity;sodium ion homeostasis;renal water homeostasis;arachidonic acid epoxygenase activity;integral to membrane;leukotriene B4 catabolic process;endoplasmic reticulum membrane;epoxygenase P450 pathway;electron carrier activity;intracellular membrane-bounded organelle;drug metabolic process;alkane 1-monooxygenase activity;small molecule metabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;apical plasma membrane;heme binding;vitamin E metabolic process;cytoplasm;vitamin-K-epoxide reductase (warfarin-sensitive) activity;xenobiotic metabolic process;vitamin K biosynthetic process;leukotriene-B4 20-monooxygenase activity;long-chain fatty acid metabolic process;iron ion binding@NA
A2463_03@169778@169778@duplication@1@39262470@39262670@19@chr19:39262470-39262670@6.58@33@86@2.61@NA@LGALS7_3@0@0@0@:lectin, galactoside-binding, soluble, 7;lectin, galactoside-binding, soluble, 7B@:carbohydrate binding;heterophilic cell-cell adhesion;extracellular space;nucleus;apoptotic process;cytoplasm@NA
A2463_03@170099@170100@deletion@2@40380120@40382826@19@chr19:40380120-40382826@24.9@118@1@0.00847@CNVR7639.2@FCGBP_23, FCGBP_22@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_03@170107@170108@duplication@2@40395805@40398510@19@chr19:40395805-40398510@12.1@331@518@1.56@CNVR7639.2, CNVR7639.3@FCGBP_15, FCGBP_14@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_03@170107@170112@deletion@4@40395805@40406060@19@chr19:40395805-40406060@-17.2@410@541@1.32@CNVR7639.2, CNVR7639.3@FCGBP_15, FCGBP_14, FCGBP_13, FCGBP_12, FCGBP_11, FCGBP_10@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_03@171466@171468@deletion@3@46627144@46627906@19@chr19:46627144-46627906@7.98@204@117@0.574@CNVR7673.1@IGFL3_3, IGFL3_2, IGFL3_1@0@0@0@:IGF-like family member 3@:extracellular region@NA
A2463_03@172117@172117@duplication@1@49519805@49519971@19@chr19:49519805-49519971@4.94@64@115@1.8@CNVR7684.1@LHB_2@0@0@0@:luteinizing hormone beta polypeptide@:male gonad development;progesterone biosynthetic process;hormone activity;small molecule metabolic process;cell-cell signaling;signal transduction;extracellular region;cellular nitrogen compound metabolic process;receptor binding;peptide hormone processing@: LUTEINIZING HORMONE, BETA POLYPEPTIDE; LHB
A2463_03@173295@173301@duplication@7@54724399@54742965@19@chr19:54724399-54742965@8.16@202@303@1.5@CNVR7721.3, CNVR7721.4, CNVR7721.1@LILRB3_6, LILRB3_5, LILRB3_4, LILRB3_3, LILRB3_2, LILRB3_1, LILRA6_8@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
A2463_03@173336@173341@duplication@6@54801928@54804173@19@chr19:54801928-54804173@13.1@248@396@1.6@CNVR7722.1@LILRA3_6, LILRA3_5, LILRA3_4, LILRA3_3, LILRA3_2, LILRA3_1@0@0@0@:leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3@:antigen binding;signal transduction;protein binding;extracellular region;plasma membrane;receptor activity;defense response@NA
A2463_03@173456@173474@duplication@19@55237520@55290114@19@chr19:55237520-55290114@46@915@1450@1.58@CNVR7725.2, CNVR7725.1@KIR3DL3_3, KIR3DL3_4, KIR3DL3_5, KIR3DL3_6, KIR3DL3_7, KIR3DL3_8, KIR2DL3_1, KIR2DL3_2, KIR2DL3_3, KIR2DL3_4, KIR2DL3_5, KIR2DL3_6, KIR2DL3_7, KIR2DL3_8, KIR2DL1_1, KIR2DL1_2, KIR2DL1_3, KIR2DL1_4, KIR2DL1_5@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:integral to membrane;plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane@NA
A2463_03@173482@173489@deletion@8@55320289@55333313@19@chr19:55320289-55333313@30.7@318@124@0.39@CNVR7725.1, CNVR7725.3@KIR2DL4_5, KIR2DL4_6, KIR2DL4_7, KIR3DL1_1, KIR3DL1_2, KIR3DL1_3, KIR3DL1_4, KIR3DL1_5@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane@NA
A2463_03@173498@173503@deletion@6@55354324@55362710@19@chr19:55354324-55362710@13.2@79@14@0.177@CNVR7725.1, CNVR7725.6, CNVR7725.5@KIR2DS4_5, KIR2DS4_6, KIR2DS4_7, KIR2DS4_8, KIR3DL2_1, KIR3DL2_2@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2-like@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane@NA
A2463_03@173845@173845@duplication@1@56283969@56284545@19@chr19:56283969-56284545@6.56@237@362@1.53@CNVR7734.1@CTD-2611O12.2_3@0@0@0@:ret finger protein-like 4A-like@:protein binding;zinc ion binding@NA
A2463_03@175736@175737@duplication@2@26061801@26063616@20@chr20:26061801-26063616@5.34@135@204@1.51@CNVR7823.4, CNVR7823.3, CNVR7823.5, CNVR7823.1@FAM182A_4, FAM182A_5@0@0@0@NA@NA@NA
A2463_03@179011@179021@duplication@11@14982551@15013887@21@chr21:14982551-15013887@28.3@218@486@2.23@CNVR7952.1@POTED_1, POTED_2, POTED_3, POTED_4, POTED_5, POTED_6, POTED_7, POTED_8, POTED_9, POTED_10, POTED_11@0@0@0@:POTE ankyrin domain family, member B;POTE ankyrin domain family, member C;POTE ankyrin domain family, member D@:protein binding;plasma membrane@NA
A2463_03@180968@180970@duplication@3@16266930@16269943@22@chr22:16266930-16269943@6.33@292@423@1.45@CNVR8071.2, CNVR8071.3@POTEH_9, POTEH_8, POTEH_7@0@0@0@:POTE ankyrin domain family, member H@:protein binding@NA
A2463_03@180973@180976@duplication@4@16279196@16287885@22@chr22:16279196-16287885@13.3@648@957@1.48@CNVR8071.2, CNVR8071.3@POTEH_4, POTEH_3, POTEH_2, POTEH_1@0@0@0@:POTE ankyrin domain family, member H@:protein binding@NA
A2463_03@181134@181134@duplication@1@18834446@18835833@22@chr22:18834446-18835833@7.5@198@320@1.62@CNVR8087.2, CNVR8087.7, CNVR8087.12, CNVR8087.10@AC008132.13_1@0@0@0@NA@NA@NA
A2463_03@181850@181850@deletion@1@23652512@23652620@22@chr22:23652512-23652620@8.8@48@5@0.104@CNVR8107.2, CNVR8107.3@BCR_18@0@0@0@:breakpoint cluster region@:phospholipid binding;protein autophosphorylation;protein tyrosine kinase activity;GTPase activator activity;neuromuscular process controlling balance;ATP binding;actin cytoskeleton organization;negative regulation of cell migration;plasma membrane;inner ear morphogenesis;positive regulation of Rac GTPase activity;positive regulation of phagocytosis;regulation of small GTPase mediated signal transduction;response to lipopolysaccharide;intracellular signal transduction;Rac GTPase activator activity;regulation of cell cycle;platelet-derived growth factor receptor signaling pathway;protein serine/threonine kinase activity;intracellular;small GTPase mediated signal transduction;regulation of Rho protein signal transduction;protein phosphorylation;negative regulation of inflammatory response;enzyme binding;Rho guanyl-nucleotide exchange factor activity;cytoplasm;cytosol;protein binding;signal transduction;brain development;kinase activity;negative regulation of neutrophil degranulation@: LEUKEMIA, CHRONIC MYELOID; CML
A2463_03@181947@181947@duplication@1@24323140@24323226@22@chr22:24323140-24323226@5.32@109@177@1.62@CNVR8114.6, CNVR8114.13, CNVR8114.8, CNVR8114.14@GSTT2_2@0@0@0@@:protein binding;glutathione transferase activity;nucleus;cytoplasm@NA
A2463_03@181949@181955@deletion@7@24325063@24384231@22@chr22:24325063-24384231@25.5@128@8@0.0625@CNVR8114.13, CNVR8114.1@GSTT2_4, GSTT2_5, GSTT1_5, GSTT1_4, GSTT1_3, GSTT1_2, GSTT1_1@0@0@0@:glutathione S-transferase theta 1@:protein binding;glutathione transferase activity;nucleus;cytoplasm:glutathione peroxidase activity;response to drug;transferase activity;cytosol;protein binding;glutathione transferase activity;glutathione metabolic process;response to organic cyclic compound@NA
A2463_30@402@403@deletion@2@1577024@1577362@1@chr1:1577024-1577362@20.7@99@2@0.0202@CNVR17.1@CDK11B_10, CDK11B_9@0@0@0@:cyclin-dependent kinase 11B@:protein serine/threonine kinase activity;protein tyrosine kinase activity;protein phosphorylation;protein kinase activity;cell division;transferase activity, transferring phosphorus-containing groups;ATP binding@NA
A2463_30@425@432@duplication@8@1635663@1640572@1@chr1:1635663-1640572@30.5@311@579@1.86@CNVR17.1@CDK11A_15, CDK11A_14, CDK11A_13, CDK11A_12, CDK11A_11, CDK11A_10, CDK11A_9, CDK11A_8@0@0@0@:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A@:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division@NA
A2463_30@1835@1839@deletion@5@13330415@13368733@1@chr1:13330415-13368733@6.47@67@27@0.403@CNVR74.8, CNVR74.4@PRAMEF3_2, PRAMEF3_1, PRAMEF5_2, PRAMEF5_3, PRAMEF5_4@0@0@0@:PRAME family member 3:PRAME family member 5@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_30@1853@1855@deletion@3@13495968@13522259@1@chr1:13495968-13522259@17.8@85@2@0.0235@NA@PRAMEF16_2, PRAMEF16_3, PRAMEF21_2@0@0@0@:PRAME family member 16:PRAME family member 21;PRAME family member 20@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_30@1869@1869@duplication@1@13718405@13718962@1@chr1:13718405-13718962@6@73@130@1.78@CNVR76.2@PRAMEF17_3@0@0@0@:PRAME family member 17@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_30@2789@2792@duplication@4@21807424@21809879@1@chr1:21807424-21809879@7.61@258@365@1.41@CNVR107.2, CNVR107.1@NBPF3_12, NBPF3_13, NBPF3_14, NBPF3_15@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 3@:cytoplasm@NA
A2463_30@3334@3342@duplication@9@25611065@25655415@1@chr1:25611065-25655415@104@1018@2043@2.01@CNVR116.1, CNVR116.2@RHD_2, RHD_3, RHD_4, RHD_5, RHD_6, RHD_7, RHD_8, RHD_9, RHD_10@0@0@0@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
A2463_30@3358@3358@duplication@1@25747131@25747277@1@chr1:25747131-25747277@7.1@89@158@1.78@CNVR117.1@RHCE_1@0@0@0@:Rh blood group, CcEe antigens@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@: BLOOD GROUP--RHESUS SYSTEM E POLYPEPTIDE; RHE; RHESUS BLOOD GROUP, CcEe ANTIGENS; RHCE
A2463_30@5149@5149@deletion@1@39987049@39987242@1@chr1:39987049-39987242@6.06@30@2@0.0667@NA@BMP8A_4@0@0@0@:bone morphogenetic protein 8a@:cell differentiation;growth factor activity;extracellular space;growth;cytokine activity;cartilage development;ossification@NA
A2463_30@8507@8508@duplication@2@89476588@89477710@1@chr1:89476588-89477710@13@503@731@1.45@CNVR244.1@GBP3_8, GBP3_7@0@0@0@:guanylate binding protein 3@:defense response to virus;GTP binding;GTPase activity;membrane;cytoplasm@NA
A2463_30@9365@9368@deletion@4@104202983@104205633@1@chr1:104202983-104205633@13@282@155@0.55@CNVR266.3, CNVR266.1@AMY1A_7, AMY1A_8, AMY1A_9, AMY1A_10@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
A2463_30@9373@9374@duplication@2@104233917@104234232@1@chr1:104233917-104234232@14.9@95@213@2.24@CNVR266.3, CNVR266.5@AMY1B_8, AMY1B_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
A2463_30@9385@9386@deletion@2@104297122@104297436@1@chr1:104297122-104297436@12.7@542@337@0.622@CNVR266.3, CNVR266.5@AMY1C_6, AMY1C_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
A2463_30@9766@9773@deletion@8@110230497@110235917@1@chr1:110230497-110235917@78@363@2@0.00551@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_1, GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
A2463_30@10788@10788@deletion@1@144220788@144220959@1@chr1:144220788-144220959@8.06@103@45@0.437@CNVR333.1, CNVR333.3@RP3-377D14.1_87@0@0@0@NA@NA@NA
A2463_30@10799@10799@deletion@1@144815937@144816008@1@chr1:144815937-144816008@9.36@83@27@0.325@CNVR338.4, CNVR338.2, CNVR338.5, CNVR338.1@NBPF9_4@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 24@NA@NA
A2463_30@10804@10805@deletion@2@144823814@144824756@1@chr1:144823814-144824756@6.38@110@58@0.527@CNVR338.2, CNVR338.5, CNVR338.1@NBPF9_9, NBPF9_10@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 24@NA@NA
A2463_30@10868@10868@deletion@1@145302655@145302868@1@chr1:145302655-145302868@5.1@109@60@0.55@CNVR341.2, CNVR341.3, CNVR341.4@NBPF10_8@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family, member 10@:protein binding;calcium ion binding@NA
A2463_30@10890@10893@deletion@4@145325953@145328432@1@chr1:145325953-145328432@18.7@91@4@0.044@CNVR341.2, CNVR341.3@NBPF10_30, NBPF10_31, NBPF10_32, NBPF10_33@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family, member 10@NA@NA
A2463_30@11149@11157@deletion@9@146232495@146244717@1@chr1:146232495-146244717@12.3@64@6@0.0938@NA@NBPF12_16, NBPF12_15, NBPF12_14, NBPF12_13, NBPF12_12, NBPF12_11, NBPF12_10, NBPF12_9, NBPF12_8@0@0@0@:neuroblastoma breakpoint family member 21-like@NA@NA
A2463_30@11163@11164@deletion@2@146252364@146253110@1@chr1:146252364-146253110@8.83@140@69@0.493@NA@NBPF12_2, NBPF12_1@0@0@0@:neuroblastoma breakpoint family member 21-like@NA@NA
A2463_30@11169@11169@duplication@1@146400092@146400302@1@chr1:146400092-146400302@10.8@23@97@4.22@NA@NBPF12_9@0@0@0@:neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family member 14-like;neuroblastoma breakpoint family, member 12@:cytoplasm@NA
A2463_30@11341@11343@deletion@3@148008574@148010164@1@chr1:148008574-148010164@31.8@900@517@0.574@CNVR346.2, CNVR346.4@NBPF14_17, NBPF14_16, NBPF14_15@0@0@0@:neuroblastoma breakpoint family, member 14@:cytoplasm@NA
A2463_30@11345@11350@deletion@6@148011681@148015797@1@chr1:148011681-148015797@22.7@437@236@0.54@CNVR346.2, CNVR346.4@NBPF14_13, NBPF14_12, NBPF14_11, NBPF14_10, NBPF14_9, NBPF14_8@0@0@0@:neuroblastoma breakpoint family, member 14@:cytoplasm@NA
A2463_30@11353@11356@deletion@4@148021578@148024925@1@chr1:148021578-148024925@7@459@312@0.68@CNVR346.2, CNVR346.4@NBPF14_5, NBPF14_4, NBPF14_3, NBPF14_2@0@0@0@:neuroblastoma breakpoint family, member 14@:cytoplasm@NA
A2463_30@12117@12118@duplication@2@152573209@152586574@1@chr1:152573209-152586574@33.9@174@476@2.74@CNVR358.1@LCE3C_1, LCE3B_1@0@0@0@:late cornified envelope 3C:late cornified envelope 3B@:keratinization:keratinization@NA
A2463_30@16029@16036@duplication@8@196744018@196794801@1@chr1:196744018-196794801@23.2@1741@2316@1.33@CNVR459.1@CFHR3_1, CFHR3_2, CFHR3_3, CFHR3_4, CFHR3_5, CFHR3_6, CFHR1_1, CFHR1_2@0@0@0@:complement factor H-related 3:complement factor H-related 1:complement factor H-related 2@:extracellular space:extracellular space;complement activation:extracellular region@NA
A2463_30@16039@16040@duplication@2@196799631@196801129@1@chr1:196799631-196801129@7.24@570@760@1.33@CNVR459.1@CFHR1_5, CFHR1_6@0@0@0@:complement factor H-related 1:complement factor H-related 2@:extracellular space;complement activation:extracellular region@NA
A2463_30@19773@19774@duplication@2@248721846@248738058@1@chr1:248721846-248738058@7.1@300@415@1.38@CNVR600.3@OR2T29_1, OR2T34_1@0@0@0@:olfactory receptor, family 2, subfamily T, member 29:olfactory receptor, family 2, subfamily T, member 34@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_30@24822@24822@deletion@1@87178420@87178483@2@chr2:87178420-87178483@8.1@37@0@0@NA@RGPD1_2@0@0@0@:RANBP2-like and GRIP domain containing 1@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_30@24851@24851@deletion@1@88071689@88071883@2@chr2:88071689-88071883@7.66@55@14@0.255@NA@RGPD2_22@0@0@0@:RANBP2-like and GRIP domain containing 2@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_30@24856@24863@deletion@8@88091510@88095367@2@chr2:88091510-88095367@11.8@53@0@0@NA@RGPD2_17, RGPD2_16, RGPD2_15, RGPD2_14, RGPD2_13, RGPD2_12, RGPD2_11, RGPD2_10@0@0@0@:RANBP2-like and GRIP domain containing 2@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_30@25006@25007@deletion@2@90198717@90199190@2@chr2:90198717-90199190@5.78@229@143@0.624@CNVR867.10, CNVR867.5, CNVR867.3, CNVR867.9, CNVR867.15, CNVR867.2@IGKV1D-12_1, IGKV1D-12_2@0@0@0@@:protein binding@NA
A2463_30@25137@25138@deletion@2@96697782@96698107@2@chr2:96697782-96698107@11.8@167@78@0.467@NA@GPAT2_4, GPAT2_3@0@0@0@:glycerol-3-phosphate acyltransferase 2, mitochondrial@:glycerol-3-phosphate O-acyltransferase activity;mitochondrion;phospholipid metabolic process;triglyceride biosynthetic process;glycerophospholipid biosynthetic process;small molecule metabolic process;transferase activity, transferring acyl groups;mitochondrial outer membrane;phosphatidic acid biosynthetic process;integral to membrane;glycerol-3-phosphate metabolic process;CDP-diacylglycerol biosynthetic process;membrane;metabolic process;phospholipid biosynthetic process@NA
A2463_30@25393@25398@deletion@6@97877284@97881312@2@chr2:97877284-97881312@6.75@999@714@0.715@NA@ANKRD36_57, ANKRD36_58, ANKRD36_59, ANKRD36_60, ANKRD36_61, ANKRD36_62@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_30@25401@25403@deletion@3@97884788@97890616@2@chr2:97884788-97890616@6.76@601@414@0.689@NA@ANKRD36_65, ANKRD36_66, ANKRD36_67@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_30@25407@25407@deletion@1@97910895@97911808@2@chr2:97910895-97911808@5.13@354@235@0.664@CNVR887.1@ANKRD36_71@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_30@27163@27163@duplication@1@130843388@130843568@2@chr2:130843388-130843568@7.58@52@113@2.17@NA@POTEF_13@0@0@0@:POTE ankyrin domain family, member F@:cell cortex;protein binding;ATP binding@NA
A2463_30@27171@27172@duplication@2@130868117@130869674@2@chr2:130868117-130869674@8.08@112@189@1.69@NA@POTEF_5, POTEF_4@0@0@0@:POTE ankyrin domain family, member F@:cell cortex;protein binding;ATP binding@NA
A2463_30@27243@27251@duplication@9@131231952@131256794@2@chr2:131231952-131256794@8.54@272@389@1.43@NA@POTEI_13, POTEI_12, POTEI_11, POTEI_10, POTEI_9, POTEI_8, POTEI_7, POTEI_6, POTEI_5@0@0@0@:POTE ankyrin domain family, member I@:protein binding;ATP binding@NA
A2463_30@27326@27326@duplication@1@132010100@132010143@2@chr2:132010100-132010143@7.61@25@78@3.12@NA@POTEE_12@0@0@0@:pleckstrin homology domain containing, family B (evectins) member 2:POTE ankyrin domain family, member E@:phospholipid binding;protein binding;recycling endosome membrane:protein binding;ATP binding@NA
A2463_30@27341@27342@duplication@2@132288153@132289375@2@chr2:132288153-132289375@4.97@231@317@1.37@NA@CCDC74A_3, CCDC74A_4@0@0@0@:coiled-coil domain containing 74A@NA@NA
A2463_30@27975@27975@deletion@1@152435853@152436163@2@chr2:152435853-152436163@6.7@65@24@0.369@CNVR1026.1@NEB_105@0@0@0@:nebulin@:Z disc;muscle filament sliding;oxidation-reduction process;contractile fiber part;actin cytoskeleton;regulation of actin filament length;structural constituent of muscle;cytosol;actin binding;protein binding;myofibril;somatic muscle development;muscle organ development@: NEMALINE MYOPATHY 2; NEM2
A2463_30@27996@27997@deletion@2@152463121@152464122@2@chr2:152463121-152464122@24.2@123@7@0.0569@CNVR1026.1@NEB_84, NEB_83@0@0@0@:nebulin@:Z disc;muscle filament sliding;oxidation-reduction process;contractile fiber part;actin cytoskeleton;regulation of actin filament length;structural constituent of muscle;cytosol;actin binding;protein binding;myofibril;somatic muscle development;muscle organ development@: NEMALINE MYOPATHY 2; NEM2
A2463_30@34148@34148@duplication@1@241621649@241622254@2@chr2:241621649-241622254@7.11@240@353@1.47@NA@AQP12B_1@0@0@0@:aquaporin 12B@:transport;integral to membrane;transporter activity;membrane@NA
A2463_30@34150@34150@deletion@1@241631332@241631938@2@chr2:241631332-241631938@17.1@258@111@0.43@NA@AQP12A_1, AQP12A_2@0@0@0@:aquaporin 12A@:transport;integral to membrane;transporter activity;membrane@NA
A2463_30@39892@39894@duplication@3@75786030@75790887@3@chr3:75786030-75790887@38.4@282@652@2.31@CNVR1432.5, CNVR1432.9, CNVR1432.4@ZNF717_5, ZNF717_4, ZNF717_3@0@0@0@:zinc finger protein 717;zinc finger protein 717-like@:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_30@46667@46675@deletion@9@9174900@9237700@4@chr4:9174900-9237700@18.2@131@33@0.252@NA@FAM90A26P_4, FAM90A26P_5, FAM90A26P_6, FAM90A26P_7, USP17L13_1, USP17L10_1, USP17L11_1, USP17L12_1, USP17L13_2, USP17L15_1@0@0@0@:ubiquitin specific peptidase 17-like family member 10:ubiquitin specific peptidase 17-like family member 13:ubiquitin specific peptidase 17-like family member 11:ubiquitin specific peptidase 17-like family member 12:ubiquitin specific peptidase 17-like family member 15@:zinc ion binding;nucleic acid binding:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
A2463_30@48556@48561@duplication@6@69403344@69434202@4@chr4:69403344-69434202@51.2@628@1188@1.89@CNVR1953.1@UGT2B17_6, UGT2B17_5, UGT2B17_4, UGT2B17_3, UGT2B17_2, UGT2B17_1@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B17@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;membrane@: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
A2463_30@48592@48597@deletion@6@70146220@70160527@4@chr4:70146220-70160527@32.6@1118@677@0.606@CNVR1957.2, CNVR1957.1@UGT2B28_1, UGT2B28_2, UGT2B28_3, UGT2B28_4, UGT2B28_5, UGT2B28_6@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B28@:carbohydrate binding;transferase activity, transferring hexosyl groups;endoplasmic reticulum;glucuronosyltransferase activity;carbohydrate metabolic process;xenobiotic metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process@NA
A2463_30@51672@51672@duplication@1@145041644@145041741@4@chr4:145041644-145041741@4.5@183@259@1.42@NA@GYPA_2@0@0@0@:glycophorin B (MNS blood group):glycophorin A (MNS blood group)@:integral to membrane;plasma membrane;integral to plasma membrane:external side of plasma membrane;integral to membrane;cytoskeletal anchoring at plasma membrane;plasma membrane;molecular_function;protein homodimerization activity;integral to plasma membrane;cellular_component;identical protein binding;membrane;biological_process;regulation of response to osmotic stress;virus-host interaction@: BLOOD GROUP--Ss LOCUS; Ss: MALARIA, SUSCEPTIBILITY TO; BLOOD GROUP--MN LOCUS; MN
A2463_30@53306@53311@deletion@6@741710@756259@5@chr5:741710-756259@18.4@264@131@0.496@CNVR2280.3@ZDHHC11B_7, ZDHHC11B_6, ZDHHC11B_5, ZDHHC11B_4, ZDHHC11B_3, ZDHHC11B_2@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
A2463_30@55787@55789@deletion@3@68868273@68874935@5@chr5:68868273-68874935@6.17@81@37@0.457@CNVR2494.7, CNVR2494.46@GTF2H2C_8, GTF2H2C_9, GTF2H2C_10@0@0@0@:general transcription factor IIH, polypeptide 2C;general transcription factor IIH, polypeptide 2D@:regulation of transcription, DNA-dependent;nucleotide-excision repair;DNA repair;core TFIIH complex;protein binding;nucleus;transcription, DNA-dependent;zinc ion binding@NA
A2463_30@55791@55792@deletion@2@68878194@68881524@5@chr5:68878194-68881524@5.06@35@9@0.257@CNVR2494.7, CNVR2494.46@GTF2H2C_12, GTF2H2C_13@0@0@0@:general transcription factor IIH, polypeptide 2C;general transcription factor IIH, polypeptide 2D@:regulation of transcription, DNA-dependent;nucleotide-excision repair;DNA repair;core TFIIH complex;protein binding;nucleus;transcription, DNA-dependent;zinc ion binding@NA
A2463_30@59046@59047@deletion@2@140228082@140238021@5@chr5:140228082-140238021@43.1@2409@1348@0.56@CNVR2622.1@PCDHA9_1, PCDHA10_1@0@0@0@:protocadherin alpha 1:protocadherin alpha 2:protocadherin alpha 3:protocadherin alpha 4:protocadherin alpha 5:protocadherin alpha 6:protocadherin alpha 7:protocadherin alpha 8:protocadherin alpha 9:protocadherin alpha 10@:extracellular region;cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:integral to membrane;cell adhesion;homophilic cell adhesion;plasma membrane;integral to plasma membrane;membrane;nervous system development;calcium ion binding:cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:extracellular region;cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:integral to membrane;homophilic cell adhesion;plasma membrane;membrane;calcium ion binding:extracellular region;cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development@NA
A2463_30@61262@61267@duplication@6@177158571@177164113@5@chr5:177158571-177164113@15@330@498@1.51@NA@FAM153A_15, FAM153A_14, FAM153A_13, FAM153A_12, FAM153A_11, FAM153A_10@0@0@0@:family with sequence similarity 153, member A@NA@NA
A2463_30@61269@61276@duplication@8@177166602@177210856@5@chr5:177166602-177210856@21.8@239@432@1.81@CNVR2699.2@FAM153A_8, FAM153A_7, FAM153A_6, FAM153A_5, FAM153A_4, FAM153A_3, RP11-1026M7.2_2@0@0@0@:family with sequence similarity 153, member A@NA@NA
A2463_30@61639@61645@deletion@7@180375921@180429785@5@chr5:180375921-180429785@27.1@1017@617@0.607@CNVR2719.1@BTNL8_6, BTNL8_7, BTNL8_8, BTNL3_1, BTNL3_2, BTNL3_3, BTNL3_4@0@0@0@:butyrophilin-like 8:butyrophilin-like 3@:protein binding;integral to membrane:protein binding;integral to membrane;molecular_function;cellular_component;biological_process@NA
A2463_30@62738@62738@deletion@1@26406138@26406484@6@chr6:26406138-26406484@7.29@68@24@0.353@NA@BTN3A1_3@0@0@0@:butyrophilin, subfamily 3, member A1@:protein binding;integral to membrane;lipid metabolic process@NA
A2463_30@63768@63774@deletion@7@31994761@31996626@6@chr6:31994761-31996626@14@456@284@0.623@CNVR2843.6, CNVR2843.5@C4B_20, C4B_21, C4B_22, C4B_23, C4B_24, C4B_25, C4B_26@0@0@0@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
A2463_30@63794@63794@deletion@1@32007324@32007424@6@chr6:32007324-32007424@6.84@298@185@0.621@CNVR2843.6, CNVR2843.5@CYP21A2_5@0@0@0@:cytochrome P450, family 21, subfamily A, polypeptide 2@:oxidation-reduction process;electron carrier activity;response to antibiotic;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;steroid 21-monooxygenase activity;C21-steroid hormone biosynthetic process;heme binding;mineralocorticoid biosynthetic process;progesterone metabolic process;monooxygenase activity;cellular response to peptide hormone stimulus;iron ion binding@: ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY
A2463_30@63953@63958@deletion@6@32485517@32498001@6@chr6:32485517-32498001@39.8@395@145@0.367@CNVR2845.21, CNVR2845.25, CNVR2845.30, CNVR2845.43, CNVR2845.6@HLA-DRB5_6, HLA-DRB5_5, HLA-DRB5_4, HLA-DRB5_3, HLA-DRB5_2, HLA-DRB5_1@0@0@0@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
A2463_30@63960@63960@duplication@1@32548025@32548047@6@chr6:32548025-32548047@6.4@106@175@1.65@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.5, CNVR2845.4@HLA-DRB1_5@0@0@0@:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1@:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
A2463_30@64602@64606@deletion@5@35754776@35765065@6@chr6:35754776-35765065@10.7@640@433@0.677@CNVR2861.1@CLPSL1_2, CLPSL1_3, CLPS_3, CLPS_2, CLPS_1@0@0@0@:colipase-like 1:colipase, pancreatic@:extracellular region;enzyme activator activity;digestion;lipid catabolic process:steroid metabolic process;post-embryonic development;small molecule metabolic process;retinoid metabolic process;lipid metabolic process;extracellular region;enzyme activator activity;digestion;lipid catabolic process;lipid digestion;response to food@NA
A2463_30@70816@70816@deletion@1@161054786@161054944@6@chr6:161054786-161054944@12.9@167@69@0.413@CNVR3133.1@LPA_9@0@0@0@:lipoprotein, Lp(a)@:blood circulation;endopeptidase inhibitor activity;catalytic activity;lipoprotein metabolic process;proteolysis;heparin binding;receptor-mediated endocytosis;fibronectin binding;small molecule metabolic process;apolipoprotein binding;lipid metabolic process;negative regulation of endopeptidase activity;extracellular region;plasma lipoprotein particle;lipid transport;serine-type endopeptidase activity@: APOLIPOPROTEIN(a); LPA
A2463_30@71010@71011@duplication@2@167587242@167590622@6@chr6:167587242-167590622@7.1@204@298@1.46@NA@TCP10L2_3, TCP10L2_4@0@0@0@:t-complex 10;t-complex 10-like 2@NA@NA
A2463_30@71028@71032@deletion@5@167787840@167794824@6@chr6:167787840-167794824@21.8@359@185@0.515@NA@TCP10_7, TCP10_6, TCP10_5, TCP10_4, TCP10_3@0@0@0@:t-complex 10@:cytosol@NA
A2463_30@71940@71940@deletion@1@6837995@6838174@7@chr7:6837995-6838174@6.86@31@0@0@NA@RSPH10B2_20@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
A2463_30@73242@73242@duplication@1@38279626@38279767@7@chr7:38279626-38279767@5.16@55@101@1.84@NA@TRGC2_4@0@0@0@@:protein binding@NA
A2463_30@74781@74783@deletion@3@76121471@76129837@7@chr7:76121471-76129837@5.94@88@44@0.5@CNVR3462.1@DTX2_6, DTX2_7, DTX2_8@0@0@0@:deltex homolog 2 (Drosophila)@:ligase activity;cytoplasm;nuclear membrane;Notch signaling pathway;protein binding;nucleus;zinc ion binding;protein ubiquitination@NA
A2463_30@76245@76245@deletion@1@99912156@99912373@7@chr7:99912156-99912373@13@59@0@0@CNVR3508.2, CNVR3508.1@SPDYE3_6@0@0@0@:speedy homolog E3 (Xenopus laevis)@NA@NA
A2463_30@76726@76741@deletion@16@102133564@102158157@7@chr7:102133564-102158157@23.3@234@89@0.38@CNVR3518.1@RASA4B_16, RASA4B_15, RASA4B_14, RASA4B_13, RASA4B_12, RASA4B_11, RASA4B_10, RASA4B_9, RASA4B_8, RASA4B_7, RASA4B_6, RASA4B_5, RASA4B_4, RASA4B_3, RASA4B_2, RASA4B_1@0@0@0@:RAS p21 protein activator 4B@:phospholipid binding;intracellular;GTPase activator activity;cytosol;signal transduction;protein binding;plasma membrane;regulation of small GTPase mediated signal transduction;metal ion binding;intracellular signal transduction@NA
A2463_30@76771@76794@deletion@24@102246306@102313443@7@chr7:102246306-102313443@46.6@774@387@0.5@CNVR3518.1@RASA4_5, RASA4_4, RASA4_3, RASA4_2, UPK3BL_7, RASA4_1, UPK3BL_6, UPK3BL_6, UPK3BL_5, UPK3BL_5, UPK3BL_4, UPK3BL_4, UPK3BL_3, UPK3BL_3, UPK3BL_2, UPK3BL_2, UPK3BL_1, UPK3BL_1, SPDYE2L_2, SPDYE2L_3, SPDYE2L_4, SPDYE2L_5, SPDYE2L_6, SPDYE2L_7, SPDYE2L_8, POLR2J2_4, POLR2J2_4, POLR2J2_3, POLR2J2_3, POLR2J2_2, POLR2J2_2, POLR2J2_1, POLR2J2_1, AC105052.1_3, AC105052.1_2@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4:uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J2:WBSCR19-like protein 3;speedy homolog E6 (Xenopus laevis)@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity:integral to membrane:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
A2463_30@79013@79013@deletion@1@141760112@141760173@7@chr7:141760112-141760173@4.8@140@83@0.593@CNVR3585.3, CNVR3585.2@MGAM_34@0@0@0@:maltase-glucoamylase (alpha-glucosidase)@:glucan 1,4-alpha-glucosidase activity;carbohydrate binding;small molecule metabolic process;apical plasma membrane;carbohydrate metabolic process;catalytic activity;starch catabolic process;polysaccharide digestion;integral to membrane;alpha-glucosidase activity;plasma membrane;hydrolase activity, hydrolyzing O-glycosyl compounds;maltose alpha-glucosidase activity;amylase activity@NA
A2463_30@79292@79292@deletion@1@143421454@143421823@7@chr7:143421454-143421823@6.83@95@44@0.463@CNVR3594.2, CNVR3594.1@FAM115C_7@0@0@0@:family with sequence similarity 115, member C;protein FAM115C-like@NA@NA
A2463_30@79310@79310@duplication@1@143884023@143885476@7@chr7:143884023-143885476@7.25@256@376@1.47@CNVR3598.4, CNVR3598.3, CNVR3598.7@ARHGEF35_2@0@0@0@:Rho guanine nucleotide exchange factor (GEF) 35@NA@NA
A2463_30@79312@79312@deletion@1@143955790@143956721@7@chr7:143955790-143956721@19@401@192@0.479@CNVR3598.4, CNVR3598.7, CNVR3598.6@OR2A7_1@0@0@0@:Rho guanine nucleotide exchange factor (GEF) 35:olfactory receptor, family 2, subfamily A, member 7@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_30@79317@79323@deletion@7@144063940@144070377@7@chr7:144063940-144070377@23.3@405@211@0.521@CNVR3598.4, CNVR3598.5, CNVR3598.11@ARHGEF5_4, ARHGEF5_5, ARHGEF5_6, ARHGEF5_7, ARHGEF5_8, ARHGEF5_9, ARHGEF5_10@0@0@0@:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
A2463_30@80141@80142@duplication@2@116087@142298@8@chr8:116087-142298@5.82@113@175@1.55@CNVR3684.8, CNVR3684.5@OR4F21_1, RP11-585F1.10_2@0@0@0@:olfactory receptor, family 4, subfamily F, member 21:F-box only protein 25-like;putative uncharacterized protein C20orf69-like@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_30@80379@80381@duplication@3@7345659@7353525@8@chr8:7345659-7353525@6.32@16@57@3.56@CNVR3771.8, CNVR3771.10, CNVR3771.4, CNVR3771.6@DEFB105B_2, DEFB105B_3, DEFB107B_1@0@0@0@:defensin, beta 105B;defensin, beta 105A:defensin, beta 107B;defensin, beta 107A@:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium@NA
A2463_30@80388@80394@deletion@7@7637545@7680945@8@chr8:7637545-7680945@11.4@243@135@0.556@CNVR3772.4, CNVR3772.6, CNVR3772.2, CNVR3772.8, CNVR3772.10@AC084121.16_3, AC084121.16_2, AC084121.16_1, DEFB107A_2, DEFB107A_1, DEFB105A_3, DEFB105A_2@0@0@0@:uncharacterized LOC100133251:defensin, beta 107B;defensin, beta 107A:defensin, beta 105B;defensin, beta 105A@:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium@NA
A2463_30@80564@80566@deletion@3@11970084@12041215@8@chr8:11970084-12041215@45.7@1927@917@0.476@CNVR3785.8, CNVR3785.5, CNVR3785.6, CNVR3785.2, CNVR3785.3@ZNF705D_6, USP17L2_1, FAM86B1_8@0@0@0@:zinc finger protein 705D:ubiquitin specific peptidase 17-like family member 1, pseudogene;ubiquitin specific peptidase 17-like family member 2;ubiquitin specific peptidase 17-like family member 4;ubiquitin specific peptidase 17-like family member 7;ubiquitin specific peptidase 17-like family member 8;ubiquitin specific peptidase 17-like family member 3:family with sequence similarity 86, member B2;family with sequence similarity 86, member B1@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:protein deubiquitination;ubiquitin-specific protease activity;mitotic cell cycle G1/S transition checkpoint;nucleus;G2/M transition checkpoint;apoptotic process;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
A2463_30@80568@80569@deletion@2@12043862@12044342@8@chr8:12043862-12044342@23.2@220@66@0.3@CNVR3785.5, CNVR3785.3@FAM86B1_6, FAM86B1_5@0@0@0@:family with sequence similarity 86, member B2;family with sequence similarity 86, member B1@NA@NA
A2463_30@80573@80577@deletion@5@12051485@12285315@8@chr8:12051485-12285315@17@106@20@0.189@CNVR3786.3, CNVR3786.4@FAM86B1_1, DEFB130_2, DEFB130_1, FAM86B2_8, FAM86B2_7@0@0@0@:family with sequence similarity 86, member B2;family with sequence similarity 86, member B1:defensin, beta 130-like;defensin, beta 130:family with sequence similarity 86, member B2@:extracellular region;defense response to bacterium;defense response@NA
A2463_30@80573@80578@duplication@1@12051485@12286407@8@chr8:12051485-12286407@-12.8@179@151@0.844@CNVR3786.3, CNVR3786.4@FAM86B1_1, DEFB130_2, DEFB130_1, FAM86B2_8, FAM86B2_7, FAM86B2_6@0@0@0@:family with sequence similarity 86, member B2;family with sequence similarity 86, member B1:defensin, beta 130-like;defensin, beta 130:family with sequence similarity 86, member B2@:extracellular region;defense response to bacterium;defense response@NA
A2463_30@80580@80584@deletion@5@12287860@12338444@8@chr8:12287860-12338444@27.2@571@303@0.531@CNVR3786.4, CNVR3786.16@FAM86B2_4, FAM86B2_3, FAM86B2_2, FAM86B2_1, AC130352.1_5@0@0@0@:family with sequence similarity 86, member B2@NA@NA
A2463_30@83673@83673@deletion@1@86573700@86575726@8@chr8:86573700-86575726@44.1@487@132@0.271@CNVR3955.1@REXO1L1_1@0@0@0@:exonuclease GOR-like;REX1, RNA exonuclease 1 homolog (S. cerevisiae)-like 1@:intracellular;nucleus;exonuclease activity;nucleic acid binding;cytoplasm@NA
A2463_30@86336@86337@deletion@2@145317757@145318304@8@chr8:145317757-145318304@7.67@34@0@0@NA@KM-PA-2_11, KM-PA-2_10@0@0@0@@:protein binding;regulation of cell cycle;nucleus;rRNA processing@NA
A2463_30@88529@88529@duplication@1@40715850@40716325@9@chr9:40715850-40716325@5@475@636@1.34@NA@FAM74A3_1@0@0@0@NA@NA@NA
A2463_30@88584@88610@deletion@27@43624656@43915897@9@chr9:43624656-43915897@491@4159@609@0.146@CNVR4294.1@SPATA31A6_4, SPATA31A6_3, SPATA31A6_2, SPATA31A6_1, CNTNAP3B_1, CNTNAP3B_2, CNTNAP3B_3, CNTNAP3B_4, CNTNAP3B_5, CNTNAP3B_6, CNTNAP3B_7, CNTNAP3B_8, CNTNAP3B_9, CNTNAP3B_10, CNTNAP3B_11, CNTNAP3B_12, CNTNAP3B_13, CNTNAP3B_14, CNTNAP3B_15, CNTNAP3B_16, CNTNAP3B_17, CNTNAP3B_18, CNTNAP3B_19, CNTNAP3B_20, CNTNAP3B_21, CNTNAP3B_22, CNTNAP3B_23@0@0@0@:SPATA31 subfamily A, member 6:contactin associated protein-like 3B;contactin associated protein-like 3@:integral to membrane:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
A2463_30@88631@88633@duplication@3@65503517@65508193@9@chr9:65503517-65508193@11.3@368@541@1.47@CNVR4312.5@SPATA31A7_4, SPATA31A7_3, SPATA31A7_2@0@0@0@:SPATA31 subfamily A, member 7@:integral to membrane@NA
A2463_30@88670@88670@deletion@1@69252846@69253282@9@chr9:69252846-69253282@5.82@170@100@0.588@NA@BX255923.1_1@0@0@0@:COBW domain containing 6@:ATP binding@NA
A2463_30@88676@88678@deletion@3@69382094@69386055@9@chr9:69382094-69386055@15@77@6@0.0779@NA@ANKRD20A4_1, ANKRD20A4_2, ANKRD20A4_3@0@0@0@:ankyrin repeat domain 20 family, member A4@:protein binding@NA
A2463_30@88681@88690@deletion@10@69393823@69424176@9@chr9:69393823-69424176@56.8@1018@474@0.466@NA@ANKRD20A4_6, ANKRD20A4_7, ANKRD20A4_8, ANKRD20A4_9, ANKRD20A4_10, ANKRD20A4_11, ANKRD20A4_12, ANKRD20A4_13, ANKRD20A4_14, ANKRD20A4_15@0@0@0@:ankyrin repeat domain 20 family, member A4@:protein binding@NA
A2463_30@88722@88723@deletion@2@70912497@70912733@9@chr9:70912497-70912733@5.12@191@120@0.628@NA@CBWD3_12, CBWD3_13@0@0@0@:COBW domain-containing protein 5-like;COBW domain-containing protein 1-like;COBW domain containing 3@:ATP binding@NA
A2463_30@95350@95355@duplication@6@17865074@17891768@10@chr10:17865074-17891768@20.1@275@467@1.7@NA@MRC1L1_2, MRC1L1_3, MRC1L1_4, MRC1L1_5, MRC1L1_6, MRC1L1_7@0@0@0@:macrophage mannose receptor 1-like@:carbohydrate binding@NA
A2463_30@95367@95393@deletion@27@17921734@18152611@10@chr10:17921734-18152611@62.6@360@52@0.144@NA@MRC1L1_19, MRC1L1_20, MRC1L1_21, MRC1L1_22, MRC1L1_23, MRC1L1_24, MRC1L1_25, MRC1L1_26, MRC1L1_27, MRC1L1_28, MRC1L1_29, MRC1L1_30, TMEM236_1, TMEM236_2, TMEM236_3, TMEM236_4, MRC1_1, MRC1_2, MRC1_3, MRC1_4, MRC1_5, MRC1_6, MRC1_7, MRC1_8, MRC1_9, MRC1_10, MRC1_11@0@0@0@:macrophage mannose receptor 1-like:transmembrane protein 236;transmembrane protein 236-like:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding:integral to membrane:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
A2463_30@96435@96435@deletion@1@46248629@46248685@10@chr10:46248629-46248685@12.8@65@4@0.0615@NA@FAM21C_13@0@0@0@:family with sequence similarity 21, member C@:endosome;protein binding;plasma membrane;retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_30@96439@96439@duplication@1@46254764@46254849@10@chr10:46254764-46254849@5.26@85@139@1.64@NA@FAM21C_17@0@0@0@:family with sequence similarity 21, member C@:endosome;protein binding;plasma membrane;retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_30@96468@96470@deletion@3@46605764@46611811@10@chr10:46605764-46611811@13.4@61@0@0@CNVR4712.3@PTPN20A_4, PTPN20A_3, PTPN20A_2@0@0@0@:protein tyrosine phosphatase, non-receptor type 20B;protein tyrosine phosphatase, non-receptor type 20A@:phosphatase activity;protein tyrosine phosphatase activity;microtubule;nucleus;dephosphorylation;protein dephosphorylation;microtubule organizing center@NA
A2463_30@96529@96563@deletion@35@47756640@47948853@10@chr10:47756640-47948853@143@1064@293@0.275@NA@ANXA8L2_8, ANXA8L2_9, ANXA8L2_10, ANXA8L2_11, ANXA8L2_12, AL603965.1_2, FAM21B_1, FAM21B_2, FAM21B_3, FAM21B_4, FAM21B_5, FAM21B_6, FAM21B_7, FAM21B_8, FAM21B_9, FAM21B_10, FAM21B_11, FAM21B_12, FAM21B_13, FAM21B_14, FAM21B_15, FAM21B_16, FAM21B_17, FAM21B_18, FAM21B_19, FAM21B_20, FAM21B_21, FAM21B_22, FAM21B_23, FAM21B_24, FAM21B_25, FAM21B_26, FAM21B_27, FAM21B_28, FAM21B_29@0@0@0@:annexin A8-like 2:uncharacterized LOC101060462;uncharacterized LOC100996760:family with sequence similarity 21, member B@:calcium-dependent phospholipid binding;calcium ion binding:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_30@96620@96620@deletion@1@48771316@48771405@10@chr10:48771316-48771405@22.7@105@0@0@CNVR4716.10, CNVR4716.3@PTPN20B_6@0@0@0@:protein tyrosine phosphatase, non-receptor type 20B;protein tyrosine phosphatase, non-receptor type 20A@:phosphatase activity;protein tyrosine phosphatase activity;microtubule;nucleus;dephosphorylation;protein dephosphorylation;microtubule organizing center@NA
A2463_30@96629@96633@duplication@5@49365366@49381136@10@chr10:49365366-49381136@32.6@302@585@1.94@CNVR4717.2@FRMPD2_29, FRMPD2_28, FRMPD2_27, FRMPD2_26, FRMPD2_25@0@0@0@:FERM and PDZ domain containing 2@:basolateral plasma membrane;transferase activity, transferring phosphorus-containing groups;cytoplasm;tight junction;protein binding;cytoskeleton;1-phosphatidylinositol binding;tight junction assembly@NA
A2463_30@96844@96849@duplication@6@51224991@51243456@10@chr10:51224991-51243456@10.5@283@425@1.5@CNVR4727.1@AGAP8_7, AGAP8_6, AGAP8_5, AGAP8_4, AGAP8_3, AGAP8_2@0@0@0@:ArfGAP with GTPase domain, ankyrin repeat and PH domain 8@:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity@NA
A2463_30@96860@96860@deletion@1@51472553@51472652@10@chr10:51472553-51472652@10.7@49@0@0@CNVR4729.1@AGAP7_4@0@0@0@:translocase of inner mitochondrial membrane 23 homolog B (yeast):ArfGAP with GTPase domain, ankyrin repeat and PH domain 7@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity@NA
A2463_30@96885@96885@deletion@1@51748477@51748698@10@chr10:51748477-51748698@5.81@156@90@0.577@CNVR4732.1@AGAP6_1@0@0@0@:ArfGAP with GTPase domain, ankyrin repeat and PH domain 6;arf-GAP with GTPase, ANK repeat and PH domain-containing protein 5-like@:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity@NA
A2463_30@96900@96923@duplication@24@51847036@51892705@10@chr10:51847036-51892705@58.3@1029@1676@1.63@CNVR4734.2@FAM21A_8, FAM21A_9, FAM21A_10, FAM21A_11, FAM21A_12, FAM21A_13, FAM21A_14, FAM21A_15, FAM21A_16, FAM21A_17, FAM21A_18, FAM21A_19, FAM21A_20, FAM21A_21, FAM21A_22, FAM21A_23, FAM21A_24, FAM21A_25, FAM21A_26, FAM21A_27, FAM21A_28, FAM21A_29, FAM21A_30, FAM21A_31@0@0@0@:family with sequence similarity 21, member B;family with sequence similarity 21, member A@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_30@96932@96937@deletion@6@51965743@51978390@10@chr10:51965743-51978390@20.8@144@35@0.243@NA@ASAH2_12, ASAH2_11, ASAH2_10, ASAH2_9, ASAH2_8, ASAH2_7@0@0@0@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
A2463_30@98349@98349@duplication@1@81471007@81471122@10@chr10:81471007-81471122@7.37@201@305@1.52@CNVR4815.2, CNVR4815.4@FAM22B_6@0@0@0@NA@NA@NA
A2463_30@98355@98357@deletion@3@81608270@81610362@10@chr10:81608270-81610362@7.06@133@74@0.556@NA@FAM22E_5, FAM22E_6, FAM22E_7@0@0@0@NA@NA@NA
A2463_30@98595@98595@deletion@1@88985589@88985969@10@chr10:88985589-88985969@5.43@26@1@0.0385@CNVR4840.3, CNVR4840.5@FAM22A_1@0@0@0@:family with sequence similarity 22, member A@NA@NA
A2463_30@98603@98608@deletion@6@89120239@89127129@10@chr10:89120239-89127129@13.6@176@80@0.455@CNVR4840.3@FAM22D_2, FAM22D_3, FAM22D_4, FAM22D_5, FAM22D_6, FAM22D_7@0@0@0@:family with sequence similarity 22, member D@NA@NA
A2463_30@101605@101614@deletion@10@124341310@124353114@10@chr10:124341310-124353114@39.7@834@449@0.538@CNVR4912.4, CNVR4912.3, CNVR4912.2@DMBT1_12, DMBT1_13, DMBT1_14, DMBT1_15, DMBT1_16, DMBT1_17, DMBT1_18, DMBT1_19, DMBT1_20, DMBT1_21@0@0@0@:deleted in malignant brain tumors 1@:defense response to virus;calcium-dependent protein binding;pattern recognition receptor signaling pathway;blastocyst development;response to estrogen stimulus;tissue regeneration;proteinaceous extracellular matrix;protein transport;Gram-negative bacterial cell surface binding;positive regulation of epithelial cell differentiation;virus-host interaction;epithelial cell differentiation;induction of bacterial agglutination;phagocytic vesicle membrane;intracellular;Gram-positive bacterial cell surface binding;zymogen binding;innate immune response;cytoplasm;extrinsic to membrane;protein binding;zymogen granule membrane;extracellular region;scavenger receptor activity;pattern recognition receptor activity;inner cell mass cell proliferation;membrane@: GLIOMA SUSCEPTIBILITY 1; GLM1
A2463_30@103269@103269@deletion@1@4976003@4976943@11@chr11:4976003-4976943@5.19@458@310@0.677@CNVR5040.1@OR51A2_1@0@0@0@:matrix metallopeptidase 26:olfactory receptor, family 51, subfamily A, member 2@:metallopeptidase activity;extracellular matrix;proteolysis;proteinaceous extracellular matrix;collagen catabolic process;metalloendopeptidase activity;zinc ion binding;metabolic process:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_30@103289@103289@duplication@1@5270599@5270820@11@chr11:5270599-5270820@5.52@98@158@1.61@NA@HBG1_2@0@0@0@:hemoglobin, gamma A@:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex@NA
A2463_30@104444@104444@deletion@1@18288436@18288525@11@chr11:18288436-18288525@4.94@94@50@0.532@NA@SAA1_2@0@0@0@:serum amyloid A1@:regulation of protein secretion;platelet activation;neutrophil chemotaxis;negative regulation of inflammatory response;positive regulation of cytokine secretion;macrophage chemotaxis;positive regulation of cell adhesion;positive regulation of interleukin-1 secretion;extracellular region;lymphocyte chemotaxis;high-density lipoprotein particle;elevation of cytosolic calcium ion concentration;acute-phase response;G-protein coupled receptor binding@NA
A2463_30@104572@104572@duplication@1@18955364@18956331@11@chr11:18955364-18956331@4.71@311@423@1.36@CNVR5091.2, CNVR5091.1@MRGPRX1_1@0@0@0@:MAS-related GPR, member X1@:integral to membrane;G-protein coupled receptor activity;plasma membrane;acute-phase response;G-protein coupled receptor signaling pathway@NA
A2463_30@106046@106048@duplication@3@55370918@55419315@11@chr11:55370918-55419315@19.4@835@1194@1.43@CNVR5179.1@OR4C11_1, OR4P4_1, OR4S2_1@0@0@0@:olfactory receptor, family 4, subfamily C, member 11:olfactory receptor, family 4, subfamily P, member 4:olfactory receptor, family 4, subfamily S, member 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_30@110115@110120@deletion@6@89603790@89609185@11@chr11:89603790-89609185@45.2@1980@1212@0.612@NA@TRIM64B_6, TRIM64B_5, TRIM64B_4, TRIM64B_3, TRIM64B_2, TRIM64B_1@0@0@0@:tripartite motif containing 64;tripartite motif containing 64C;tripartite motif containing 64B@:protein binding;intracellular;zinc ion binding@NA
A2463_30@111508@111508@duplication@1@117076714@117077072@11@chr11:117076714-117077072@5.43@89@146@1.64@NA@PCSK7_17@0@0@0@:proprotein convertase subtilisin/kexin type 7@:proteolysis;integral to Golgi membrane;serine-type endopeptidase activity;peptide hormone processing@NA
A2463_30@114136@114139@deletion@4@8374419@8377428@12@chr12:8374419-8377428@21@2020@1353@0.67@CNVR5422.3, CNVR5422.5, CNVR5422.6, CNVR5422.1@FAM90A1_7, FAM90A1_6, FAM90A1_5, FAM90A1_4@0@0@0@:family with sequence similarity 90, member A1@:zinc ion binding;nucleic acid binding@NA
A2463_30@118879@118900@deletion@22@63954293@64062173@12@chr12:63954293-64062173@161@3454@1836@0.532@CNVR5566.1@DPY19L2_22, DPY19L2_21, DPY19L2_20, DPY19L2_19, DPY19L2_18, DPY19L2_17, DPY19L2_16, DPY19L2_15, DPY19L2_14, DPY19L2_13, DPY19L2_12, DPY19L2_11, DPY19L2_10, DPY19L2_9, DPY19L2_8, DPY19L2_7, DPY19L2_6, DPY19L2_5, DPY19L2_4, DPY19L2_3, DPY19L2_2, DPY19L2_1@0@0@0@:dpy-19-like 2 (C. elegans)@:spermatid development;multicellular organismal development;integral to membrane@: SPERMATOGENIC FAILURE 9; SPGF9
A2463_30@127333@127347@duplication@15@19553418@20007632@14@chr14:19553418-20007632@131@1930@3562@1.85@CNVR6072.6@POTEG_1, POTEG_2, POTEG_3, POTEG_4, POTEG_5, POTEG_6, POTEG_7, POTEG_9, POTEG_10, POTEM_10, POTEM_9, POTEM_7, POTEM_6@0@0@0@:POTE ankyrin domain family, member G:POTE ankyrin domain family, member M@:protein binding:protein binding@NA
A2463_30@133342@133342@deletion@1@106053275@106053668@14@chr14:106053275-106053668@15@99@19@0.192@CNVR6294.46@IGHA2_3@0@0@0@@:protein binding@NA
A2463_30@133425@133426@deletion@2@106471637@106478411@14@chr14:106471637-106478411@7.8@191@111@0.581@CNVR6294.36, CNVR6294.48, CNVR6294.12, CNVR6294.24@IGHV1-3_1, IGHV4-4_2@0@0@0@@:protein binding:protein binding@NA
A2463_30@133432@133435@deletion@4@106539080@106552729@14@chr14:106539080-106552729@42.8@204@5@0.0245@CNVR6294.36, CNVR6294.48, CNVR6294.24, CNVR6294.10, CNVR6294.34@IGHV1-8_2, IGHV1-8_1, IGHV3-9_2, IGHV3-9_1@0@0@0@@:protein binding:protein binding@NA
A2463_30@133458@133461@duplication@4@106791006@106805644@14@chr14:106791006-106805644@7.7@355@493@1.39@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.53@IGHV3-30_2, IGHV3-30_1, IGHV4-31_2, IGHV4-31_1@0@0@0@@:protein binding:protein binding@NA
A2463_30@133470@133471@deletion@2@106877620@106878076@14@chr14:106877620-106878076@6.12@249@158@0.635@CNVR6294.26, CNVR6294.56, CNVR6294.2, CNVR6294.18@IGHV4-39_2, IGHV4-39_1@0@0@0@@:protein binding@NA
A2463_30@133489@133490@deletion@2@107083241@107083685@14@chr14:107083241-107083685@6.13@261@167@0.64@CNVR6294.56, CNVR6294.16, CNVR6294.91@IGHV4-59_2, IGHV4-59_1@0@0@0@@:protein binding@NA
A2463_30@133489@133492@duplication@2@107083241@107095561@14@chr14:107083241-107095561@-6.97@377@420@1.11@CNVR6294.56, CNVR6294.16, CNVR6294.91, CNVR6294.30@IGHV4-59_2, IGHV4-59_1, IGHV4-61_2, IGHV4-61_1@0@0@0@@:protein binding:protein binding@NA
A2463_30@133497@133500@duplication@4@107169932@107179262@14@chr14:107169932-107179262@11.6@423@603@1.43@CNVR6294.56, CNVR6294.6, CNVR6294.92, CNVR6294.93@IGHV1-69_2, IGHV1-69_1, IGHV2-70_2, IGHV2-70_1@0@0@0@@:protein binding:protein binding@NA
A2463_30@133523@133525@deletion@3@21059387@21063546@15@chr15:21059387-21063546@6.45@42@9@0.214@NA@POTEB_6, POTEB_5, POTEB_4@0@0@0@:POTE ankyrin domain family member B-like@:protein binding@NA
A2463_30@133542@133542@deletion@1@22382474@22383423@15@chr15:22382474-22383423@9.97@582@364@0.625@CNVR6297.4, CNVR6297.17, CNVR6297.2@OR4N4_1@0@0@0@:olfactory receptor, family 4, subfamily N, member 4@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_30@133622@133623@duplication@2@23259497@23259716@15@chr15:23259497-23259716@7.12@71@131@1.85@CNVR6300.4@GOLGA8I_6, GOLGA8I_7@0@0@0@:golgin A8 family, member I@:Golgi cisterna membrane@NA
A2463_30@133636@133642@duplication@7@23406272@23412276@15@chr15:23406272-23412276@16.2@777@1082@1.39@CNVR6300.8@RP11-467N20.5_8, RP11-467N20.5_7, RP11-467N20.5_6, RP11-467N20.5_5, RP11-467N20.5_4, RP11-467N20.5_3, RP11-467N20.5_2@0@0@0@:putative golgin subfamily A member 6-like protein 6-like@NA@NA
A2463_30@133670@133670@deletion@1@23690458@23690585@15@chr15:23690458-23690585@4.76@37@11@0.297@NA@GOLGA6L2_2@0@0@0@:golgin A6 family-like 2@NA@NA
A2463_30@133869@133870@deletion@2@28629294@28629596@15@chr15:28629294-28629596@12.3@55@0@0@CNVR6329.4@GOLGA8F_9, GOLGA8F_10@0@0@0@@:Golgi apparatus@NA
A2463_30@133978@133979@deletion@2@30380944@30381243@15@chr15:30380944-30381243@22.6@117@9@0.0769@NA@GOLGA8J_9, GOLGA8J_10@0@0@0@:golgin A8 family, member J@:Golgi apparatus@NA
A2463_30@134015@134015@duplication@1@30675523@30675554@15@chr15:30675523-30675554@7.78@52@115@2.21@CNVR6337.1, CNVR6337.3@CHRFAM7A_3@0@0@0@:CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:transport;integral to membrane;ion transport;postsynaptic membrane;membrane;extracellular ligand-gated ion channel activity@NA
A2463_30@134036@134039@deletion@4@30845996@30848215@15@chr15:30845996-30848215@21.2@105@6@0.0571@NA@GOLGA8Q_2, GOLGA8Q_3, GOLGA8Q_4, GOLGA8Q_5@0@0@0@@:Golgi apparatus@NA
A2463_30@134044@134054@deletion@11@30850148@30896376@15@chr15:30850148-30896376@37.2@210@28@0.133@CNVR6339.2, CNVR6339.3, CNVR6339.1@GOLGA8Q_10, GOLGA8Q_11, GOLGA8Q_12, GOLGA8Q_13, GOLGA8Q_14, GOLGA8Q_15, GOLGA8Q_16, GOLGA8Q_17, GOLGA8Q_18, GOLGA8Q_19, GOLGA8H_1@0@0@0@:golgin A8 family, member H@:Golgi apparatus:Golgi apparatus@NA
A2463_30@134167@134171@deletion@5@32689405@32691186@15@chr15:32689405-32691186@17.9@431@244@0.566@NA@GOLGA8K_10, GOLGA8K_9, GOLGA8K_8, GOLGA8K_7, GOLGA8K_6@0@0@0@:golgin A8 family, member J@:Golgi apparatus@NA
A2463_30@134180@134191@duplication@12@32737820@32743539@15@chr15:32737820-32743539@37.5@245@547@2.23@CNVR6346.1@GOLGA8O_17, GOLGA8O_16, GOLGA8O_15, GOLGA8O_14, GOLGA8O_13, GOLGA8O_12, GOLGA8O_11, GOLGA8O_10, GOLGA8O_9, GOLGA8O_8, GOLGA8O_7, GOLGA8O_6@0@0@0@:golgin A8 family, member O@:Golgi apparatus@NA
A2463_30@134204@134205@deletion@2@32890090@32890378@15@chr15:32890090-32890378@5.94@124@69@0.556@NA@GOLGA8N_7, GOLGA8N_8@0@0@0@:golgin A8 family, member R@:Golgi apparatus@NA
A2463_30@134460@134460@deletion@1@34825048@34825163@15@chr15:34825048-34825163@4.86@61@27@0.443@CNVR6351.3@GOLGA8B_12@0@0@0@:golgin A8 family, member A:golgin A8 family, member A;golgin A8 family, member B@:Golgi cisterna membrane;Golgi apparatus:Golgi cisterna membrane;Golgi apparatus@NA
A2463_30@138284@138284@deletion@1@72954594@72955101@15@chr15:72954594-72955101@6.48@167@95@0.569@CNVR6443.1@GOLGA6B_11@0@0@0@:golgin A6 family, member B@:Golgi apparatus@NA
A2463_30@138416@138417@duplication@2@74364560@74365158@15@chr15:74364560-74365158@5.67@309@419@1.36@CNVR6448.1@GOLGA6A_14, GOLGA6A_13@0@0@0@:golgin A6 family, member C;golgin A6 family, member A;golgin A6 family, member D;golgin A6 family, member B@:Golgi apparatus@NA
A2463_30@138421@138428@duplication@8@74368025@74373076@15@chr15:74368025-74373076@10.7@458@641@1.4@CNVR6448.1@GOLGA6A_9, GOLGA6A_8, GOLGA6A_7, GOLGA6A_6, GOLGA6A_5, GOLGA6A_4, GOLGA6A_3, GOLGA6A_2@0@0@0@:golgin A6 family, member C;golgin A6 family, member A;golgin A6 family, member D;golgin A6 family, member B@:Golgi apparatus@NA
A2463_30@138645@138646@duplication@2@75562174@75562540@15@chr15:75562174-75562540@6.61@85@147@1.73@CNVR6452.1@GOLGA6C_17, GOLGA6C_18@0@0@0@:golgin A6 family, member C@:Golgi apparatus@NA
A2463_30@139295@139308@deletion@14@82933940@83015609@15@chr15:82933940-83015609@17.2@213@93@0.437@CNVR6477.6, CNVR6477.2, CNVR6477.3@RP13-996F3.5_7, RP13-996F3.5_6, RP13-996F3.5_5, RP13-996F3.5_4, RP13-996F3.5_3, RP13-996F3.5_2, RP13-996F3.5_1, RP13-996F3.4_9, RP13-996F3.4_8, RP13-996F3.4_7, RP13-996F3.4_6, RP13-996F3.4_5, RP13-996F3.4_4, RP13-996F3.4_3@0@0@0@NA@NA@NA
A2463_30@140528@140528@duplication@1@202910@203003@16@chr16:202910-203003@5.78@79@136@1.72@NA@HBZ_1@0@0@0@:hemoglobin, zeta@:negative regulation of transcription from RNA polymerase II promoter;oxygen transporter activity;iron ion binding;erythrocyte maturation;oxygen binding;heme binding;hemoglobin complex@NA
A2463_30@141416@141416@duplication@1@2152063@2152257@16@chr16:2152063-2152257@5.14@124@188@1.52@CNVR6597.1@PKD1_26@0@0@0@:polycystin-1-like;polycystic kidney disease 1 (autosomal dominant)@:peptidyl-serine phosphorylation;kidney development;placenta blood vessel development;JAK-STAT cascade;metanephric distal tubule morphogenesis;homophilic cell adhesion;nucleus;metanephric ascending thin limb development;skin development;protein export from nucleus;lung epithelium development;spinal cord development;cilium;in utero embryonic development;detection of mechanical stimulus;heart development;cation channel activity;membrane;protein domain specific binding;motile primary cilium;carbohydrate binding;anatomical structure morphogenesis;mesonephric tubule development;basolateral plasma membrane;protein kinase binding;digestive tract development;calcium ion transport;calcium-independent cell-matrix adhesion;integral to membrane;embryonic placenta development;metanephric proximal tubule development;cell cycle arrest;integral to plasma membrane;branching morphogenesis of a tube;genitalia development;positive regulation of transcription from RNA polymerase II promoter;neuropeptide signaling pathway;mesonephric duct development;cell-matrix adhesion;cytoplasmic sequestering of transcription factor;cytoplasm;positive regulation of protein binding;protein binding;metanephric collecting duct development;positive regulation of cyclin-dependent protein kinase activity involved in G1/S;ion channel binding;polycystin complex;neural tube development;cartilage condensation;cartilage development@: POLYCYSTIC KIDNEY DISEASE 1; PKD1
A2463_30@142914@142925@deletion@12@16341253@16364041@16@chr16:16341253-16364041@11.8@578@380@0.657@NA@NOMO3_6, NOMO3_7, NOMO3_8, NOMO3_9, NOMO3_10, NOMO3_11, NOMO3_12, NOMO3_13, NOMO3_14, NOMO3_15, NOMO3_16, NOMO3_17@0@0@0@:NODAL modulator 3@:carbohydrate binding;integral to membrane;carboxypeptidase activity@NA
A2463_30@143000@143014@duplication@15@18538860@18569113@16@chr16:18538860-18569113@11.2@837@1092@1.3@NA@NOMO2_16, NOMO2_15, NOMO2_14, NOMO2_13, NOMO2_12, NOMO2_11, NOMO2_10, NOMO2_9, NOMO2_8, NOMO2_7, NOMO2_6, NOMO2_5, NOMO2_4, NOMO2_3, NOMO2_2@0@0@0@:NODAL modulator 2@:carbohydrate binding;protein binding;integral to membrane;carboxypeptidase activity;endoplasmic reticulum membrane@NA
A2463_30@144047@144047@duplication@1@28467746@28468347@16@chr16:28467746-28468347@13.3@97@215@2.22@NA@NPIPL1_7@0@0@0@NA@NA@NA
A2463_30@144101@144102@deletion@2@28619800@28620176@16@chr16:28619800-28620176@7.14@259@161@0.622@CNVR6685.1, CNVR6685.2@SULT1A1_5, SULT1A1_4@0@0@0@:sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1@:small molecule metabolic process;sulfation;aryl sulfotransferase activity;amine metabolic process;catecholamine metabolic process;xenobiotic metabolic process;cytosol;steroid sulfotransferase activity;integral to membrane;sulfotransferase activity;flavonol 3-sulfotransferase activity;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process;estrogen metabolic process@NA
A2463_30@144104@144104@duplication@1@28659457@28659638@16@chr16:28659457-28659638@17.1@15@132@8.8@NA@A-575C2.4_2@0@0@0@:nuclear pore complex-interacting protein-like 2-like;putative NPIP-like protein LOC613037-like@NA@NA
A2463_30@144130@144134@duplication@5@28763890@28777810@16@chr16:28763890-28777810@11.6@112@208@1.86@NA@A-575C2.4_1, A-575C2.4_2, A-575C2.4_3, A-575C2.4_4, A-575C2.4_5@0@0@0@NA@NA@NA
A2463_30@144288@144291@duplication@4@29468954@29472854@16@chr16:29468954-29472854@6.85@51@104@2.04@CNVR6690.2, CNVR6690.3, CNVR6690.4@SLX1B_4, SLX1B_5, SLX1B_6, SULT1A4_3@0@0@0@:structure-specific endonuclease subunit SLX1-like;SLX1 structure-specific endonuclease subunit homolog B (S. cerevisiae);SLX1 structure-specific endonuclease subunit homolog A (S. cerevisiae):sulfotransferase family, cytosolic, 1A, phenol-preferring, member 4;sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3;sulfotransferase 1A3/1A4-like@:Slx1-Slx4 complex;5'-flap endonuclease activity;DNA repair;protein binding;DNA double-strand break processing involved in repair via single-strand annealing;double-strand break repair via homologous recombination;metal ion binding;crossover junction endodeoxyribonuclease activity:steroid metabolic process;small molecule metabolic process;sulfation;aryl sulfotransferase activity;cytoplasm;catecholamine metabolic process;cytosol;endoplasmic reticulum unfolded protein response;xenobiotic metabolic process;sulfotransferase activity;activation of signaling protein activity involved in unfolded protein response;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process@NA
A2463_30@147101@147101@duplication@1@70010292@70010635@16@chr16:70010292-70010635@10.4@225@363@1.61@CNVR6762.3, CNVR6762.2@RP11-419C5.2_7@0@0@0@NA@NA@NA
A2463_30@147113@147113@duplication@1@70165206@70165322@16@chr16:70165206-70165322@5.59@140@212@1.51@CNVR6764.1, CNVR6764.3@PDPR_8@0@0@0@:pyruvate dehydrogenase phosphatase regulatory subunit@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix@NA
A2463_30@147513@147513@duplication@1@74451958@74452196@16@chr16:74451958-74452196@7.7@87@159@1.83@CNVR6778.2, CNVR6778.3@CLEC18B_3@0@0@0@:C-type lectin domain family 18, member B@:carbohydrate binding;protein binding;extracellular region@NA
A2463_30@151874@151877@duplication@4@18291534@18389449@17@chr17:18291534-18389449@6.86@277@383@1.38@NA@EVPLL_10, LGALS9C_1, LGALS9C_2, LGALS9C_3@0@0@0@:envoplakin-like:lectin, galactoside-binding, soluble, 9C@:carbohydrate binding@NA
A2463_30@152122@152129@duplication@8@20353287@20359984@17@chr17:20353287-20359984@11.6@209@327@1.56@CNVR7021.1, CNVR7021.3@LGALS9B_11, LGALS9B_10, LGALS9B_9, LGALS9B_8, LGALS9B_7, LGALS9B_6, LGALS9B_5, LGALS9B_4@0@0@0@:lectin, galactoside-binding, soluble, 9B@:carbohydrate binding@NA
A2463_30@153376@153394@deletion@19@34522686@34590454@17@chr17:34522686-34590454@24.3@155@32@0.206@CNVR7077.1, CNVR7077.13, CNVR7077.19@CCL3L3_3, CCL3L3_2, CCL3L3_1, CCL4L1_1, CCL4L1_2, CCL4L1_3, TBC1D3C_14, TBC1D3C_13, TBC1D3C_12, TBC1D3C_11, TBC1D3C_10, TBC1D3C_9, TBC1D3C_8, TBC1D3C_7, TBC1D3C_6, TBC1D3C_5, TBC1D3C_4, TBC1D3C_3, TBC1D3C_2@0@0@0@:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1:TBC1 domain family, member 3C;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3H-like;TBC1 domain family, member 3H@:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_30@153414@153414@deletion@1@34797487@34798054@17@chr17:34797487-34798054@24.3@116@2@0.0172@CNVR7078.2, CNVR7078.3@TBC1D3G_14@0@0@0@:TBC1 domain family member 3H-like;TBC1 domain family, member 3H:TBC1 domain family, member 3;TBC1 domain family, member 3G;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like;TBC1 domain family, member 3H@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_30@154326@154327@deletion@2@39215917@39222097@17@chr17:39215917-39222097@6.53@89@42@0.472@NA@KRTAP2-3_1, KRTAP2-4_1@0@0@0@:keratin associated protein 2-3;keratin associated protein 2-4:keratin associated protein 2-3;keratin associated protein 2-4@:keratin filament:keratin filament@NA
A2463_30@155584@155590@duplication@7@44380005@44409347@17@chr17:44380005-44409347@46.3@434@899@2.07@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A_3, LRRC37A_4, LRRC37A_5, LRRC37A_6, LRRC37A_7, LRRC37A_8, LRRC37A_9@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
A2463_30@155593@155609@duplication@17@44414663@44630815@17@chr17:44414663-44630815@137@2338@4181@1.79@CNVR7114.2, CNVR7114.1@LRRC37A_12, LRRC37A_13, LRRC37A_14, ARL17B_4, ARL17B_3, ARL17B_2, LRRC37A2_2, LRRC37A2_3, LRRC37A2_4, LRRC37A2_5, LRRC37A2_6, LRRC37A2_7, LRRC37A2_8, LRRC37A2_9, LRRC37A2_10, LRRC37A2_11, LRRC37A2_12@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
A2463_30@162017@162018@duplication@2@44542732@44550298@18@chr18:44542732-44550298@61.5@546@1331@2.44@CNVR7319.1, CNVR7319.2@TCEB3CL2_1, TCEB3CL_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2:transcription elongation factor B polypeptide 3C-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_30@164951@164956@duplication@6@7032325@7056914@19@chr19:7032325-7056914@25.3@423@691@1.63@CNVR7517.1@MBD3L5_2, MBD3L4_2, MBD3L4_1, MBD3L2_1, MBD3L2_2, MBD3L3_2@0@0@0@:methyl-CpG binding domain protein 3-like 5:methyl-CpG binding domain protein 3-like 4:methyl-CpG-binding domain protein 3-like 2-like;methyl-CpG binding domain protein 3-like 2:methyl-CpG binding domain protein 3-like 3@:regulation of transcription, DNA-dependent;transcription, DNA-dependent:regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_30@167047@167047@deletion@1@14877791@14877921@19@chr19:14877791-14877921@13.2@97@23@0.237@NA@EMR2_6@0@0@0@:egf-like module containing, mucin-like, hormone receptor-like 2@:transmembrane signaling receptor activity;inflammatory response;G-protein coupled receptor activity;ruffle membrane;integral to membrane;plasma membrane;cell surface receptor signaling pathway;neuropeptide signaling pathway;granulocyte chemotaxis;cell migration;leading edge membrane;G-protein coupled receptor signaling pathway;protein binding;cell adhesion;membrane;calcium ion binding;chondroitin sulfate binding@NA
A2463_30@168952@168952@duplication@1@35862263@35863302@19@chr19:35862263-35863302@23.8@144@379@2.63@CNVR7627.1@GPR42_2@0@0@0@@:integral to membrane;G-protein coupled receptor activity;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
A2463_30@170099@170100@deletion@2@40380120@40382826@19@chr19:40380120-40382826@39.2@183@1@0.00546@CNVR7639.2@FCGBP_23, FCGBP_22@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_30@170104@170104@duplication@1@40389653@40389793@19@chr19:40389653-40389793@5.17@59@106@1.8@CNVR7639.2, CNVR7639.3@FCGBP_18@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_30@170107@170108@duplication@2@40395805@40398510@19@chr19:40395805-40398510@9.27@452@627@1.39@CNVR7639.2, CNVR7639.3@FCGBP_15, FCGBP_14@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_30@171465@171468@deletion@4@46623588@46627906@19@chr19:46623588-46627906@19.6@372@197@0.53@CNVR7673.1@IGFL3_4, IGFL3_3, IGFL3_2, IGFL3_1@0@0@0@:IGF-like family member 3@:extracellular region@NA
A2463_30@173109@173109@duplication@1@53517345@53518777@19@chr19:53517345-53518777@6.21@515@701@1.36@CNVR7709.2, CNVR7709.1@ERVV-1_1@0@0@0@:endogenous retrovirus group V, member 1@:integral to membrane@NA
A2463_30@173300@173305@duplication@6@54726816@54745754@19@chr19:54726816-54745754@10.9@576@778@1.35@CNVR7721.3, CNVR7721.4, CNVR7721.1@LILRB3_1, LILRA6_8, LILRA6_7, LILRA6_6, LILRA6_5, LILRA6_4@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
A2463_30@173336@173340@duplication@5@54801928@54803978@19@chr19:54801928-54803978@7.2@407@545@1.34@CNVR7722.1@LILRA3_6, LILRA3_5, LILRA3_4, LILRA3_3, LILRA3_2@0@0@0@:leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3@:antigen binding;signal transduction;protein binding;extracellular region;plasma membrane;receptor activity;defense response@NA
A2463_30@173470@173472@deletion@3@55281304@55285084@19@chr19:55281304-55285084@8.65@172@95@0.552@CNVR7725.2, CNVR7725.1, CNVR7725.7@KIR2DL1_1, KIR2DL1_2, KIR2DL1_3@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane@NA
A2463_30@173475@173504@deletion@30@55294375@55363737@19@chr19:55294375-55363737@94.4@1724@928@0.538@CNVR7725.1@KIR2DL1_6, KIR2DL1_7, KIR2DL1_8, KIR2DL4_1, KIR2DL4_2, KIR2DL4_3, KIR2DL4_4, KIR2DL4_5, KIR2DL4_6, KIR2DL4_7, KIR3DL1_1, KIR3DL1_2, KIR3DL1_3, KIR3DL1_4, KIR3DL1_5, KIR3DL1_6, KIR3DL1_7, KIR3DL1_8, KIR3DL1_9, KIR2DS4_1, KIR2DS4_2, KIR2DS4_3, KIR2DS4_4, KIR2DS4_5, KIR2DS4_6, KIR2DS4_7, KIR2DS4_8, KIR3DL2_1, KIR3DL2_2, KIR3DL2_3@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2-like@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane:regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane@NA
A2463_30@179021@179021@duplication@1@15013667@15013887@21@chr21:15013667-15013887@5.3@106@166@1.57@CNVR7952.1@POTED_11@0@0@0@:POTE ankyrin domain family, member B;POTE ankyrin domain family, member C;POTE ankyrin domain family, member D@:protein binding;plasma membrane@NA
A2463_30@180968@180976@duplication@9@16266930@16287885@22@chr22:16266930-16287885@29.6@1546@2189@1.42@CNVR8071.2, CNVR8071.3@POTEH_9, POTEH_8, POTEH_7, POTEH_6, POTEH_5, POTEH_4, POTEH_3, POTEH_2, POTEH_1@0@0@0@:POTE ankyrin domain family, member H@:protein binding@NA
A2463_30@180979@180979@deletion@1@17264510@17265299@22@chr22:17264510-17265299@20.6@99@2@0.0202@NA@XKR3_4@0@0@0@:XK, Kell blood group complex subunit-related family, member 3@:integral to membrane;plasma membrane@NA
A2463_30@181129@181129@deletion@1@18727044@18727129@22@chr22:18727044-18727129@5.28@25@1@0.04@CNVR8087.5, CNVR8087.2, CNVR8087.11@AC008132.1_4@0@0@0@NA@NA@NA
A2463_30@181134@181134@duplication@1@18834446@18835833@22@chr22:18834446-18835833@17.1@268@487@1.82@CNVR8087.2, CNVR8087.7, CNVR8087.12, CNVR8087.10@AC008132.13_1@0@0@0@NA@NA@NA
A2463_30@181417@181420@duplication@4@20366369@20367356@22@chr22:20366369-20367356@9.18@48@114@2.38@CNVR8094.9, CNVR8094.4, CNVR8094.3@GGTLC3_5, GGTLC3_4, GGTLC3_3, GGTLC3_2@0@0@0@@:leukotriene biosynthetic process;glutathione metabolic process;gamma-glutamyltransferase activity;anchored to external side of plasma membrane@NA
A2463_30@181487@181489@duplication@3@21065630@21067085@22@chr22:21065630-21067085@5.75@188@266@1.41@CNVR8099.6, CNVR8099.2@PI4KA_51, PI4KA_50, PI4KA_49@0@0@0@:phosphatidylinositol 4-kinase, catalytic, alpha@:phospholipid metabolic process;1-phosphatidylinositol 4-kinase activity;small molecule metabolic process;phosphatidylinositol phosphorylation;binding;transferase activity, transferring phosphorus-containing groups;phosphotransferase activity, alcohol group as acceptor;ATP binding;Golgi-associated vesicle;phosphatidylinositol biosynthetic process;cytosol;protein binding;signal transduction;synaptic transmission;kinase activity;phosphatidylinositol-mediated signaling@NA
A2463_30@181623@181626@deletion@4@21562428@21563415@22@chr22:21562428-21563415@7.99@170@96@0.565@CNVR8100.5, CNVR8100.4@GGT2_15, GGT2_14, GGT2_13, GGT2_12@0@0@0@:gamma-glutamyltransferase 2;gamma-glutamyltranspeptidase 2-like@:hydrolase activity;small molecule metabolic process;leukotriene biosynthetic process;anchored to external side of plasma membrane;glutathione biosynthetic process;xenobiotic metabolic process;integral to membrane;glutathione metabolic process;plasma membrane;gamma-glutamyltransferase activity;cellular_component@NA
A2463_30@181631@181631@deletion@1@21570761@21570956@22@chr22:21570761-21570956@5.18@68@31@0.456@CNVR8100.4, CNVR8100.10, CNVR8100.7@GGT2_7@0@0@0@:gamma-glutamyltransferase 2;gamma-glutamyltranspeptidase 2-like@:hydrolase activity;small molecule metabolic process;leukotriene biosynthetic process;anchored to external side of plasma membrane;glutathione biosynthetic process;xenobiotic metabolic process;integral to membrane;glutathione metabolic process;plasma membrane;gamma-glutamyltransferase activity;cellular_component@NA
A2463_30@181850@181850@deletion@1@23652512@23652620@22@chr22:23652512-23652620@9.18@66@16@0.242@CNVR8107.2, CNVR8107.3@BCR_18@0@0@0@:breakpoint cluster region@:phospholipid binding;protein autophosphorylation;protein tyrosine kinase activity;GTPase activator activity;neuromuscular process controlling balance;ATP binding;actin cytoskeleton organization;negative regulation of cell migration;plasma membrane;inner ear morphogenesis;positive regulation of Rac GTPase activity;positive regulation of phagocytosis;regulation of small GTPase mediated signal transduction;response to lipopolysaccharide;intracellular signal transduction;Rac GTPase activator activity;regulation of cell cycle;platelet-derived growth factor receptor signaling pathway;protein serine/threonine kinase activity;intracellular;small GTPase mediated signal transduction;regulation of Rho protein signal transduction;protein phosphorylation;negative regulation of inflammatory response;enzyme binding;Rho guanyl-nucleotide exchange factor activity;cytoplasm;cytosol;protein binding;signal transduction;brain development;kinase activity;negative regulation of neutrophil degranulation@: LEUKEMIA, CHRONIC MYELOID; CML
A2463_30@181947@181947@duplication@1@24323140@24323226@22@chr22:24323140-24323226@6.56@167@254@1.52@CNVR8114.6, CNVR8114.13, CNVR8114.8, CNVR8114.14@GSTT2_2@0@0@0@@:protein binding;glutathione transferase activity;nucleus;cytoplasm@NA
A2463_30@182065@182065@deletion@1@25019075@25019223@22@chr22:25019075-25019223@7.89@79@29@0.367@CNVR8117.2, CNVR8117.1@GGT1_10@0@0@0@:gamma-glutamyltransferase 2;gamma-glutamyltransferase 1@:hydrolase activity;small molecule metabolic process;regulation of inflammatory response;leukotriene biosynthetic process;anchored to external side of plasma membrane;glutathione biosynthetic process;xenobiotic metabolic process;protein binding;spermatogenesis;regulation of immune system process;integral to membrane;cysteine biosynthetic process;glutathione metabolic process;plasma membrane;gamma-glutamyltransferase activity;membrane;cellular amino acid metabolic process@: GLUTATHIONURIA
A2463_10@6@7@duplication@2@69092@139309@1@chr1:69092-139309@12.6@691@993@1.44@CNVR1.2@OR4F5_1, AL627309.1_1@0@0@0@:olfactory receptor, family 4, subfamily F, member 5@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_10@3194@3197@duplication@4@24287949@24298502@1@chr1:24287949-24298502@6.62@51@103@2.02@NA@PNRC2_3, SRSF10_6, SRSF10_5, SRSF10_4@0@0@0@:proline-rich nuclear receptor coactivator 2;proline-rich nuclear receptor coactivator 2-like:serine/arginine-rich splicing factor 10-like;serine/arginine-rich splicing factor 10@:protein binding;deadenylation-independent decapping of nuclear-transcribed mRNA;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;nucleus;regulation of transcription, DNA-dependent;transcription, DNA-dependent;cytoplasmic mRNA processing body:nucleoplasm;RNA splicing, via transesterification reactions;nuclear speck;RS domain binding;RNA binding;nucleus;mRNA splice site selection;unfolded protein binding;assembly of spliceosomal tri-snRNP;negative regulation of mRNA splicing, via spliceosome;regulation of transcription, DNA-dependent;nucleotide binding;cytoplasm;mRNA export from nucleus;protein binding;cytoplasmic transport;mRNA splicing, via spliceosome;nucleic acid binding@NA
A2463_10@8507@8508@duplication@2@89476588@89477710@1@chr1:89476588-89477710@7.89@370@517@1.4@CNVR244.1@GBP3_8, GBP3_7@0@0@0@:guanylate binding protein 3@:defense response to virus;GTP binding;GTPase activity;membrane;cytoplasm@NA
A2463_10@9353@9368@deletion@16@104162177@104205633@1@chr1:104162177-104205633@38.1@847@463@0.547@CNVR266.3, CNVR266.1@AMY2A_4, AMY2A_5, AMY2A_6, AMY2A_7, AMY2A_8, AMY2A_9, AMY2A_10, AMY1A_2, AMY1A_3, AMY1A_4, AMY1A_5, AMY1A_6, AMY1A_7, AMY1A_8, AMY1A_9, AMY1A_10@0@0@0@:amylase, alpha 2A (pancreatic):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:chloride ion binding;cation binding;small molecule metabolic process;carbohydrate metabolic process;catalytic activity;extracellular space;polysaccharide digestion;extracellular region;carbohydrate catabolic process;alpha-amylase activity;calcium ion binding:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
A2463_10@9385@9386@deletion@2@104297122@104297436@1@chr1:104297122-104297436@16.3@350@184@0.526@CNVR266.3, CNVR266.5@AMY1C_6, AMY1C_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
A2463_10@9766@9773@duplication@8@110230497@110235917@1@chr1:110230497-110235917@92.3@253@955@3.77@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_1, GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
A2463_10@11162@11162@duplication@1@146250791@146250999@1@chr1:146250791-146250999@5.5@65@117@1.8@NA@NBPF12_3@0@0@0@:neuroblastoma breakpoint family member 21-like@NA@NA
A2463_10@11169@11170@deletion@2@146400092@146401880@1@chr1:146400092-146401880@16.1@79@4@0.0506@NA@NBPF12_9, NBPF12_10@0@0@0@:neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family member 14-like;neuroblastoma breakpoint family, member 12@:cytoplasm@NA
A2463_10@11336@11350@duplication@15@148004549@148015797@1@chr1:148004549-148015797@58.1@1193@1951@1.64@CNVR346.2, CNVR346.4@NBPF14_22, NBPF14_21, NBPF14_20, NBPF14_19, NBPF14_18, NBPF14_17, NBPF14_16, NBPF14_15, NBPF14_14, NBPF14_13, NBPF14_12, NBPF14_11, NBPF14_10, NBPF14_9, NBPF14_8@0@0@0@:neuroblastoma breakpoint family, member 14@:cytoplasm@NA
A2463_10@11353@11353@duplication@1@148021578@148021628@1@chr1:148021578-148021628@5.12@73@124@1.7@CNVR346.2, CNVR346.4@NBPF14_5@0@0@0@:neuroblastoma breakpoint family, member 14@:cytoplasm@NA
A2463_10@12117@12118@deletion@2@152573209@152586574@1@chr1:152573209-152586574@30@139@0@0@CNVR358.1@LCE3C_1, LCE3B_1@0@0@0@:late cornified envelope 3C:late cornified envelope 3B@:keratinization:keratinization@NA
A2463_10@16030@16040@duplication@11@196748293@196801129@1@chr1:196748293-196801129@29.4@1934@2599@1.34@CNVR459.1@CFHR3_2, CFHR3_3, CFHR3_4, CFHR3_5, CFHR3_6, CFHR1_1, CFHR1_2, CFHR1_3, CFHR1_4, CFHR1_5, CFHR1_6@0@0@0@:complement factor H-related 3:complement factor H-related 1:complement factor H-related 2@:extracellular space:extracellular space;complement activation:extracellular region@NA
A2463_10@19776@19777@duplication@2@248789480@248802559@1@chr1:248789480-248802559@6.17@358@486@1.36@NA@OR2T11_1, OR2T35_1@0@0@0@:olfactory receptor, family 2, subfamily T, member 11:olfactory receptor, family 2, subfamily T, member 35@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_10@24856@24863@deletion@8@88091510@88095367@2@chr2:88091510-88095367@10@45@0@0@NA@RGPD2_17, RGPD2_16, RGPD2_15, RGPD2_14, RGPD2_13, RGPD2_12, RGPD2_11, RGPD2_10@0@0@0@:RANBP2-like and GRIP domain containing 2@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_10@25115@25116@deletion@2@96652500@96652954@2@chr2:96652500-96652954@6.5@87@41@0.471@NA@ANKRD36C_3, ANKRD36C_2@0@0@0@:ankyrin repeat domain-containing protein 36A-like@:ion channel inhibitor activity;protein binding@NA
A2463_10@25369@25370@duplication@2@97854825@97855027@2@chr2:97854825-97855027@31.2@130@386@2.97@CNVR886.2, CNVR886.3@ANKRD36_33, ANKRD36_34@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_10@25383@25386@deletion@4@97867940@97870000@2@chr2:97867940-97870000@13@627@405@0.646@CNVR886.1@ANKRD36_47, ANKRD36_48, ANKRD36_49, ANKRD36_50@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_10@25389@25404@deletion@16@97873549@97899608@2@chr2:97873549-97899608@194@2230@833@0.374@NA@ANKRD36_53, ANKRD36_54, ANKRD36_55, ANKRD36_56, ANKRD36_57, ANKRD36_58, ANKRD36_59, ANKRD36_60, ANKRD36_61, ANKRD36_62, ANKRD36_63, ANKRD36_64, ANKRD36_65, ANKRD36_66, ANKRD36_67, ANKRD36_68@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_10@27163@27166@duplication@4@130843388@130851081@2@chr2:130843388-130851081@8.13@92@163@1.77@NA@POTEF_13, POTEF_12, POTEF_11, POTEF_10@0@0@0@:POTE ankyrin domain family, member F@:cell cortex;protein binding;ATP binding@NA
A2463_10@27171@27172@duplication@2@130868117@130869674@2@chr2:130868117-130869674@6.19@86@146@1.7@NA@POTEF_5, POTEF_4@0@0@0@:POTE ankyrin domain family, member F@:cell cortex;protein binding;ATP binding@NA
A2463_10@27326@27327@deletion@2@132010100@132010672@2@chr2:132010100-132010672@7.14@139@76@0.547@NA@POTEE_12, POTEE_13@0@0@0@:pleckstrin homology domain containing, family B (evectins) member 2:POTE ankyrin domain family, member E@:phospholipid binding;protein binding;recycling endosome membrane:protein binding;ATP binding@NA
A2463_10@39892@39892@duplication@1@75786030@75788496@3@chr3:75786030-75788496@5.57@195@284@1.46@CNVR1432.5, CNVR1432.9, CNVR1432.4@ZNF717_5@0@0@0@:zinc finger protein 717;zinc finger protein 717-like@:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_10@45437@45438@deletion@2@195474048@195475935@3@chr3:195474048-195475935@8.19@235@139@0.591@CNVR1703.1, CNVR1703.2, CNVR1703.5, CNVR1703.4@MUC4_25, MUC4_24@0@0@0@:mucin 4, cell surface associated@:ErbB-2 class receptor binding;Golgi lumen;cell-matrix adhesion;post-translational protein modification;extracellular matrix structural constituent;protein binding;O-glycan processing;cellular protein metabolic process;proteinaceous extracellular matrix;integral to plasma membrane;membrane;extracellular matrix constituent, lubricant activity;biological_process@NA
A2463_10@46667@46675@duplication@9@9174900@9237700@4@chr4:9174900-9237700@113@123@1104@8.98@NA@FAM90A26P_4, FAM90A26P_5, FAM90A26P_6, FAM90A26P_7, USP17L13_1, USP17L10_1, USP17L11_1, USP17L12_1, USP17L13_2, USP17L15_1@0@0@0@:ubiquitin specific peptidase 17-like family member 10:ubiquitin specific peptidase 17-like family member 13:ubiquitin specific peptidase 17-like family member 11:ubiquitin specific peptidase 17-like family member 12:ubiquitin specific peptidase 17-like family member 15@:zinc ion binding;nucleic acid binding:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
A2463_10@46693@46693@duplication@1@9388004@9388098@4@chr4:9388004-9388098@9.29@29@96@3.31@CNVR1814.1, CNVR1814.2@RP11-1396O13.13_3@0@0@0@@:intracellular;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_10@48592@48597@deletion@6@70146220@70160527@4@chr4:70146220-70160527@21.6@814@511@0.628@CNVR1957.2, CNVR1957.1@UGT2B28_1, UGT2B28_2, UGT2B28_3, UGT2B28_4, UGT2B28_5, UGT2B28_6@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B28@:carbohydrate binding;transferase activity, transferring hexosyl groups;endoplasmic reticulum;glucuronosyltransferase activity;carbohydrate metabolic process;xenobiotic metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process@NA
A2463_10@48967@48970@duplication@4@75312252@75318354@4@chr4:75312252-75318354@8.54@140@224@1.6@NA@AREG_2, AREG_3, AREG_4, AREG_5@0@0@0@:amphiregulin;amphiregulin B@:growth factor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;cell proliferation;epidermal growth factor receptor signaling pathway;extracellular space;protein binding;integral to membrane;cytokine activity;cell surface;positive regulation of DNA replication@NA
A2463_10@48972@48975@deletion@4@75482007@75488112@4@chr4:75482007-75488112@19.5@89@0@0@NA@AREGB_2, AREGB_3, AREGB_4, AREGB_5@0@0@0@:amphiregulin;amphiregulin B@:growth factor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;cell proliferation;epidermal growth factor receptor signaling pathway;extracellular space;protein binding;integral to membrane;cytokine activity;cell surface;positive regulation of DNA replication@NA
A2463_10@53308@53308@deletion@1@748520@748674@5@chr5:748520-748674@10.7@49@0@0@CNVR2280.3@ZDHHC11B_5@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
A2463_10@55804@55806@duplication@3@69365063@69372398@5@chr5:69365063-69372398@7.26@103@177@1.72@CNVR2494.48, CNVR2494.39, CNVR2494.15, CNVR2494.18, CNVR2494.26, CNVR2494.43, CNVR2494.52, CNVR2494.28, CNVR2494.2@SMN2_6, SMN2_7, SMN2_8@0@0@0@:survival of motor neuron 2, centromeric;survival of motor neuron 1, telomeric@:nucleoplasm;ncRNA metabolic process;Cajal body;RNA metabolic process;spliceosomal complex;cytoplasm;cytosol;protein binding;cell death;spliceosomal complex assembly;RNA binding;mRNA processing;nucleus;gene expression;spliceosomal snRNP assembly@: SPINAL MUSCULAR ATROPHY, TYPE II; SMA2; SPINAL MUSCULAR ATROPHY, TYPE I; SMA1; SPINAL MUSCULAR ATROPHY, TYPE IV; SMA4; SPINAL MUSCULAR ATROPHY, TYPE III; SMA3
A2463_10@60885@60885@duplication@1@175520199@175520277@5@chr5:175520199-175520277@11.3@85@186@2.19@NA@FAM153B_4@0@0@0@:uncharacterized LOC100507387;family with sequence similarity 153, member B@NA@NA
A2463_10@61267@61267@deletion@1@177164044@177164113@5@chr5:177164044-177164113@9.38@44@1@0.0227@NA@FAM153A_10@0@0@0@:family with sequence similarity 153, member A@NA@NA
A2463_10@61273@61276@deletion@4@177171890@177210856@5@chr5:177171890-177210856@10.7@122@51@0.418@CNVR2699.2@FAM153A_4, FAM153A_3, RP11-1026M7.2_2@0@0@0@:family with sequence similarity 153, member A@NA@NA
A2463_10@61643@61644@duplication@2@180419814@180424488@5@chr5:180419814-180424488@7.27@225@326@1.45@CNVR2719.1@BTNL3_2, BTNL3_3@0@0@0@:butyrophilin-like 3@:protein binding;integral to membrane;molecular_function;cellular_component;biological_process@NA
A2463_10@63725@63733@duplication@9@31962023@31964377@6@chr6:31962023-31964377@41.6@993@1535@1.55@CNVR2843.6, CNVR2843.3@C4A_20, C4A_21, C4A_22, C4A_23, C4A_24, C4A_25, C4A_26, C4A_27, C4A_28@0@0@0@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
A2463_10@63768@63776@deletion@9@31994761@31997115@6@chr6:31994761-31997115@64@664@250@0.377@CNVR2843.6, CNVR2843.5@C4B_20, C4B_21, C4B_22, C4B_23, C4B_24, C4B_25, C4B_26, C4B_27, C4B_28@0@0@0@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
A2463_10@63953@63955@deletion@3@32485517@32486443@6@chr6:32485517-32486443@10.2@52@4@0.0769@CNVR2845.21, CNVR2845.25, CNVR2845.30@HLA-DRB5_6, HLA-DRB5_5, HLA-DRB5_4@0@0@0@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
A2463_10@66144@66144@deletion@1@51929754@51929848@6@chr6:51929754-51929848@8.3@117@53@0.453@NA@PKHD1_13@0@0@0@:polycystic kidney and hepatic disease 1 (autosomal recessive)@:regulation of centrosome duplication;cell-cell adhesion;apical plasma membrane;centrosome;kidney development;microtubule basal body;mitotic spindle;anchored to external side of plasma membrane;protein binding;integral to membrane;homeostatic process;negative regulation of cellular component movement;receptor activity;cilium assembly;primary cilium@: POLYCYSTIC KIDNEY DISEASE, AUTOSOMAL RECESSIVE; ARPKD
A2463_10@70816@70817@deletion@2@161054786@161056336@6@chr6:161054786-161056336@22.4@173@45@0.26@CNVR3133.1@LPA_9, LPA_8@0@0@0@:lipoprotein, Lp(a)@:blood circulation;endopeptidase inhibitor activity;catalytic activity;lipoprotein metabolic process;proteolysis;heparin binding;receptor-mediated endocytosis;fibronectin binding;small molecule metabolic process;apolipoprotein binding;lipid metabolic process;negative regulation of endopeptidase activity;extracellular region;plasma lipoprotein particle;lipid transport;serine-type endopeptidase activity@: APOLIPOPROTEIN(a); LPA
A2463_10@71754@71777@deletion@24@5959481@6013173@7@chr7:5959481-6013173@143@915@167@0.183@NA@CCZ1_12, CCZ1_13, CCZ1_14, CCZ1_15, RSPH10B_20, RSPH10B_19, RSPH10B_18, RSPH10B_17, RSPH10B_16, RSPH10B_15, RSPH10B_14, RSPH10B_13, RSPH10B_12, RSPH10B_11, RSPH10B_10, RSPH10B_9, RSPH10B_8, RSPH10B_7, RSPH10B_6, RSPH10B_5, RSPH10B_4, RSPH10B_3, RSPH10B_2, PMS2_15@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae):radial spoke head 10 homolog B (Chlamydomonas):PMS2 postmeiotic segregation increased 2 (S. cerevisiae)@:lysosomal membrane:response to drug;DNA binding;MutSalpha complex binding;ATP binding;mismatch repair;DNA repair;mismatched DNA binding;ATPase activity;nucleus;mismatch repair complex;reciprocal meiotic recombination;ATP catabolic process;single-stranded DNA binding;response to DNA damage stimulus;single base insertion or deletion binding;protein binding;somatic hypermutation of immunoglobulin genes;somatic recombination of immunoglobulin gene segments;MutLalpha complex;endonuclease activity@: COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 4; HNPCC4; MISMATCH REPAIR CANCER SYNDROME
A2463_10@71922@71944@duplication@23@6797310@6844686@7@chr7:6797310-6844686@77.7@907@1652@1.82@NA@RSPH10B2_2, RSPH10B2_3, RSPH10B2_4, RSPH10B2_5, RSPH10B2_6, RSPH10B2_7, RSPH10B2_8, RSPH10B2_9, RSPH10B2_10, RSPH10B2_11, RSPH10B2_12, RSPH10B2_13, RSPH10B2_14, RSPH10B2_15, RSPH10B2_16, RSPH10B2_17, RSPH10B2_18, RSPH10B2_19, RSPH10B2_20, CCZ1B_15, CCZ1B_14, CCZ1B_13, CCZ1B_12@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
A2463_10@73242@73242@deletion@1@38279626@38279767@7@chr7:38279626-38279767@5.26@40@11@0.275@NA@TRGC2_4@0@0@0@@:protein binding@NA
A2463_10@73260@73263@deletion@4@38388957@38393784@7@chr7:38388957-38393784@37.1@187@11@0.0588@CNVR3354.3, CNVR3354.1@TRGV5_2, TRGV5_1, TRGV4_2, TRGV4_1@0@0@0@@:protein binding:protein binding@NA
A2463_10@74245@74246@deletion@2@66648114@66660324@7@chr7:66648114-66660324@12.3@148@61@0.412@NA@TYW1_14, TYW1_15@0@0@0@:tRNA-yW synthesizing protein 1 homolog (S. cerevisiae);tRNA-yW synthesizing protein 1 homolog B (S. cerevisiae)@:tRNA processing;4 iron, 4 sulfur cluster binding;iron-sulfur cluster binding;oxidoreductase activity;FMN binding;iron ion binding;catalytic activity@NA
A2463_10@74304@74305@deletion@2@72469995@72470382@7@chr7:72469995-72470382@5.39@91@46@0.505@NA@STAG3L3_6, STAG3L3_5@0@0@0@@:nucleus;binding@NA
A2463_10@74566@74569@deletion@4@74159098@74162453@7@chr7:74159098-74162453@5.87@214@135@0.631@NA@GTF2I_21, GTF2I_22, GTF2I_23, GTF2I_24@0@0@0@:general transcription factor IIi@:neuronal cell body;transcription initiation from RNA polymerase II promoter;mitogen-activated protein kinase binding;negative regulation of angiogenesis;DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;cytoplasm;transcription from RNA polymerase II promoter;protein binding;signal transduction;nucleus;cell projection;reduction of cytosolic calcium ion concentration@NA
A2463_10@74595@74605@deletion@11@74221276@74251500@7@chr7:74221276-74251500@15.5@195@90@0.462@NA@GTF2IRD2_12, GTF2IRD2_11, GTF2IRD2_10, GTF2IRD2_9, GTF2IRD2_8, GTF2IRD2_7, GTF2IRD2_6, GTF2IRD2_5, GTF2IRD2_4, GTF2IRD2_3, GTF2IRD2_2@0@0@0@:GTF2I repeat domain containing 2@:nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_10@74664@74664@duplication@1@75055645@75055735@7@chr7:75055645-75055735@5.28@45@89@1.98@NA@POM121C_8@0@0@0@:POM121 transmembrane nucleoporin C@:nuclear membrane;protein binding;protein transport;endoplasmic reticulum membrane;nuclear pore;mRNA transport@NA
A2463_10@76243@76245@deletion@3@99909374@99912373@7@chr7:99909374-99912373@9.86@126@59@0.468@CNVR3508.2, CNVR3508.1@SPDYE3_4, SPDYE3_5, SPDYE3_6@0@0@0@:speedy homolog E3 (Xenopus laevis)@NA@NA
A2463_10@76427@76432@duplication@6@100331793@100336236@7@chr7:100331793-100336236@16@255@414@1.62@CNVR3509.1@ZAN_1, ZAN_2, ZAN_3, ZAN_4, ZAN_5, ZAN_6@0@0@0@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
A2463_10@76731@76732@duplication@2@102136588@102137066@7@chr7:102136588-102137066@7.55@81@150@1.85@CNVR3518.1@RASA4B_11, RASA4B_10@0@0@0@:RAS p21 protein activator 4B@:phospholipid binding;intracellular;GTPase activator activity;cytosol;signal transduction;protein binding;plasma membrane;regulation of small GTPase mediated signal transduction;metal ion binding;intracellular signal transduction@NA
A2463_10@76741@76752@duplication@12@102158094@102212968@7@chr7:102158094-102212968@20.3@553@834@1.51@CNVR3518.1@RASA4B_1, SPDYE2_2, SPDYE2_3, SPDYE2_4, SPDYE2_5, SPDYE2_6, SPDYE2_7, SPDYE2_8, POLR2J3_4, POLR2J3_3, POLR2J3_2, POLR2J3_1@0@0@0@:RAS p21 protein activator 4B:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:speedy homolog E2 (Xenopus laevis)@:phospholipid binding;intracellular;GTPase activator activity;cytosol;signal transduction;protein binding;plasma membrane;regulation of small GTPase mediated signal transduction;metal ion binding;intracellular signal transduction:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
A2463_10@76767@76779@duplication@13@102236460@102279646@7@chr7:102236460-102279646@19.8@311@516@1.66@CNVR3518.1@RASA4_9, RASA4_8, RASA4_7, RASA4_6, RASA4_5, RASA4_4, RASA4_3, RASA4_2, UPK3BL_7, RASA4_1, UPK3BL_6, UPK3BL_6, UPK3BL_5, UPK3BL_5, UPK3BL_4, UPK3BL_4@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4:uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity:integral to membrane:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
A2463_10@76792@76794@duplication@3@102309363@102313443@7@chr7:102309363-102313443@14.3@268@431@1.61@CNVR3518.1@POLR2J2_2, POLR2J2_2, POLR2J2_1, POLR2J2_1, AC105052.1_3, AC105052.1_2@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
A2463_10@79011@79012@deletion@2@141759273@141759766@7@chr7:141759273-141759766@4.92@77@40@0.519@CNVR3585.3@MGAM_32, MGAM_33@0@0@0@:maltase-glucoamylase (alpha-glucosidase)@:glucan 1,4-alpha-glucosidase activity;carbohydrate binding;small molecule metabolic process;apical plasma membrane;carbohydrate metabolic process;catalytic activity;starch catabolic process;polysaccharide digestion;integral to membrane;alpha-glucosidase activity;plasma membrane;hydrolase activity, hydrolyzing O-glycosyl compounds;maltose alpha-glucosidase activity;amylase activity@NA
A2463_10@79287@79289@deletion@3@143400089@143418471@7@chr7:143400089-143418471@12.8@128@48@0.375@CNVR3594.2, CNVR3594.1@FAM115C_2, FAM115C_3, FAM115C_4@0@0@0@:family with sequence similarity 115, member C;protein FAM115C-like@NA@NA
A2463_10@79311@79311@duplication@1@143929005@143929936@7@chr7:143929005-143929936@5.64@86@144@1.67@CNVR3598.4, CNVR3598.7@OR2A42_1@0@0@0@:Rho guanine nucleotide exchange factor (GEF) 35:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_10@80358@80359@duplication@2@6873513@6874372@8@chr8:6873513-6874372@10.9@86@181@2.1@CNVR3769.1@DEFA3_3, DEFA3_2@0@0@0@:defensin, alpha 1B;defensin, alpha 1:defensin, alpha 3, neutrophil-specific;defensin, alpha 1B;defensin, alpha 1@:defense response to virus;extracellular matrix;immune response;Golgi lumen;azurophil granule lumen;killing of cells of other organism;innate immune response;chemotaxis;extracellular space;extracellular region;defense response to bacterium;defense response to fungus;defense response:defense response to virus;Golgi lumen;azurophil granule lumen;killing of cells of other organism;innate immune response;extracellular space;defense response to bacterium;defense response to fungus;extracellular region;defense response@NA
A2463_10@80402@80402@deletion@1@7718169@7718245@8@chr8:7718169-7718245@8.15@38@1@0.0263@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@SPAG11A_3@0@0@0@:sperm associated antigen 11A;sperm associated antigen 11B@:extracellular region;defense response@NA
A2463_10@80584@80584@duplication@1@12338341@12338444@8@chr8:12338341-12338444@5.93@119@189@1.59@CNVR3786.4, CNVR3786.16@AC130352.1_5@0@0@0@NA@NA@NA
A2463_10@88584@88596@deletion@13@43624656@43828221@9@chr9:43624656-43828221@292@2481@374@0.151@CNVR4294.1@SPATA31A6_4, SPATA31A6_3, SPATA31A6_2, SPATA31A6_1, CNTNAP3B_1, CNTNAP3B_2, CNTNAP3B_3, CNTNAP3B_4, CNTNAP3B_5, CNTNAP3B_6, CNTNAP3B_7, CNTNAP3B_8, CNTNAP3B_9@0@0@0@:SPATA31 subfamily A, member 6:contactin associated protein-like 3B;contactin associated protein-like 3@:integral to membrane:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
A2463_10@88613@88613@deletion@1@44401891@44402255@9@chr9:44401891-44402255@28.3@139@3@0.0216@CNVR4297.3@BX088651.1_1@0@0@0@NA@NA@NA
A2463_10@88676@88678@deletion@3@69382094@69386055@9@chr9:69382094-69386055@13.7@65@2@0.0308@NA@ANKRD20A4_1, ANKRD20A4_2, ANKRD20A4_3@0@0@0@:ankyrin repeat domain 20 family, member A4@:protein binding@NA
A2463_10@88681@88690@deletion@10@69393823@69424176@9@chr9:69393823-69424176@50.9@787@351@0.446@NA@ANKRD20A4_6, ANKRD20A4_7, ANKRD20A4_8, ANKRD20A4_9, ANKRD20A4_10, ANKRD20A4_11, ANKRD20A4_12, ANKRD20A4_13, ANKRD20A4_14, ANKRD20A4_15@0@0@0@:ankyrin repeat domain 20 family, member A4@:protein binding@NA
A2463_10@95346@95355@deletion@10@17813309@17891768@10@chr10:17813309-17891768@33@240@64@0.267@NA@TMEM236_2, TMEM236_3, TMEM236_4, MRC1L1_1, MRC1L1_2, MRC1L1_3, MRC1L1_4, MRC1L1_5, MRC1L1_6, MRC1L1_7@0@0@0@:transmembrane protein 236;transmembrane protein 236-like:macrophage mannose receptor 1-like@:integral to membrane:carbohydrate binding@NA
A2463_10@95380@95389@duplication@10@18060293@18138693@10@chr10:18060293-18138693@21.7@182@360@1.98@NA@TMEM236_2, TMEM236_3, TMEM236_4, MRC1_1, MRC1_2, MRC1_3, MRC1_4, MRC1_5, MRC1_6, MRC1_7@0@0@0@:transmembrane protein 236;transmembrane protein 236-like:mannose receptor, C type 1;macrophage mannose receptor 1-like@:integral to membrane:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
A2463_10@96435@96435@deletion@1@46248629@46248685@10@chr10:46248629-46248685@10.6@48@0@0@NA@FAM21C_13@0@0@0@:family with sequence similarity 21, member C@:endosome;protein binding;plasma membrane;retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_10@96439@96439@duplication@1@46254764@46254849@10@chr10:46254764-46254849@6.06@59@112@1.9@NA@FAM21C_17@0@0@0@:family with sequence similarity 21, member C@:endosome;protein binding;plasma membrane;retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_10@96454@96467@deletion@14@46312644@46587495@10@chr10:46312644-46587495@31.2@225@48@0.213@NA@FAM25E_1, AGAP4_7, AGAP4_6, AGAP4_5, AGAP4_4, AGAP4_3, AGAP4_2, AGAP4_1, PTPN20A_10, PTPN20A_9, PTPN20A_8, PTPN20A_7, PTPN20A_6, PTPN20A_5@0@0@0@:ArfGAP with GTPase domain, ankyrin repeat and PH domain 4;arf-GAP with GTPase, ANK repeat and PH domain-containing protein 5-like:protein tyrosine phosphatase, non-receptor type 20B;protein tyrosine phosphatase, non-receptor type 20A@:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity:phosphatase activity;protein tyrosine phosphatase activity;microtubule;nucleus;dephosphorylation;protein dephosphorylation;microtubule organizing center@NA
A2463_10@96631@96633@deletion@3@49376639@49381136@10@chr10:49376639-49381136@9.31@70@20@0.286@CNVR4717.2@FRMPD2_27, FRMPD2_26, FRMPD2_25@0@0@0@:FERM and PDZ domain containing 2@:basolateral plasma membrane;transferase activity, transferring phosphorus-containing groups;cytoplasm;tight junction;protein binding;cytoskeleton;1-phosphatidylinositol binding;tight junction assembly@NA
A2463_10@96852@96860@duplication@9@51374371@51472652@10@chr10:51374371-51472652@27@693@1111@1.6@NA@TIMM23B_2, TIMM23B_3, TIMM23B_4, TIMM23B_5, TIMM23B_6, AGAP7_7, AGAP7_6, AGAP7_5, AGAP7_4@0@0@0@:translocase of inner mitochondrial membrane 23 homolog B (yeast):ArfGAP with GTPase domain, ankyrin repeat and PH domain 7@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity@NA
A2463_10@96883@96883@deletion@1@51620325@51620382@10@chr10:51620325-51620382@6.98@147@78@0.531@NA@TIMM23_2@0@0@0@:translocase of inner mitochondrial membrane 23 homolog B (yeast):translocase of inner mitochondrial membrane 23 homolog B (yeast);translocase of inner mitochondrial membrane 23 homolog (yeast)@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process:mitochondrion;mitochondrial inner membrane;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;mitochondrial intermembrane space;integral to mitochondrial inner membrane;intracellular protein transport;protein binding;integral to membrane;cellular protein metabolic process;protein targeting to mitochondrion@NA
A2463_10@96923@96937@deletion@15@51892567@51978390@10@chr10:51892567-51978390@17.8@204@89@0.436@NA@FAM21A_31, ASAH2_20, ASAH2_19, ASAH2_18, ASAH2_17, ASAH2_16, ASAH2_15, ASAH2_14, ASAH2_13, ASAH2_12, ASAH2_11, ASAH2_10, ASAH2_9, ASAH2_8, ASAH2_7@0@0@0@:family with sequence similarity 21, member B;family with sequence similarity 21, member A:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
A2463_10@98355@98357@deletion@3@81608270@81610362@10@chr10:81608270-81610362@8.64@101@44@0.436@NA@FAM22E_5, FAM22E_6, FAM22E_7@0@0@0@NA@NA@NA
A2463_10@98599@98601@duplication@3@88992361@88994465@10@chr10:88992361-88994465@12.4@169@292@1.73@CNVR4840.3, CNVR4840.5, CNVR4840.6@FAM22A_5, FAM22A_6, FAM22A_7@0@0@0@:family with sequence similarity 22, member A@NA@NA
A2463_10@99834@99835@duplication@2@101594138@101596047@10@chr10:101594138-101596047@6.65@414@560@1.35@NA@ABCC2_24, ABCC2_25@0@0@0@:ATP-binding cassette, sub-family C (CFTR/MRP), member 2@:ATPase activity, coupled to transmembrane movement of substances;transport;transporter activity;ATP binding;transmembrane transport;integral to membrane;intercellular canaliculus;ATPase activity;plasma membrane;integral to plasma membrane;apical plasma membrane;nucleoside-triphosphatase activity;organic anion transport;nucleotide binding;protein binding;organic anion transmembrane transporter activity;membrane@: DUBIN-JOHNSON SYNDROME; DJS
A2463_10@101102@101102@duplication@1@116361587@116361720@10@chr10:116361587-116361720@5.08@154@227@1.47@NA@ABLIM1_2@0@0@0@:actin binding LIM protein 1@:actin cytoskeleton;axon guidance;cytoplasm;actin binding;protein binding;visual perception;cytoskeleton organization;organ morphogenesis;zinc ion binding;positive regulation of transcription from RNA polymerase II promoter@NA
A2463_10@103289@103289@duplication@1@5270599@5270820@11@chr11:5270599-5270820@5.34@69@121@1.75@NA@HBG1_2@0@0@0@:hemoglobin, gamma A@:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex@NA
A2463_10@104572@104572@deletion@1@18955364@18956331@11@chr11:18955364-18956331@14.5@232@103@0.444@CNVR5091.2, CNVR5091.1@MRGPRX1_1@0@0@0@:MAS-related GPR, member X1@:integral to membrane;G-protein coupled receptor activity;plasma membrane;acute-phase response;G-protein coupled receptor signaling pathway@NA
A2463_10@127336@127336@deletion@1@19561995@19562100@14@chr14:19561995-19562100@4.65@22@1@0.0455@CNVR6072.1@POTEG_4@0@0@0@:POTE ankyrin domain family, member G@:protein binding@NA
A2463_10@127348@127358@deletion@11@20010104@20404761@14@chr14:20010104-20404761@28.8@2748@1890@0.688@CNVR6072.12, CNVR6072.4@POTEM_5, POTEM_4, POTEM_3, POTEM_2, POTEM_1, OR4Q3_1, OR4M1_1, OR4N2_1, OR4K2_1, OR4K5_1, OR4K1_1@0@0@0@:POTE ankyrin domain family, member M:olfactory receptor, family 4, subfamily N, member 2:olfactory receptor, family 4, subfamily Q, member 3:olfactory receptor, family 4, subfamily M, member 1:olfactory receptor, family 4, subfamily K, member 2:olfactory receptor, family 4, subfamily K, member 5:olfactory receptor, family 4, subfamily K, member 1@:protein binding:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_10@128213@128214@deletion@2@24434972@24435192@14@chr14:24434972-24435192@6.56@71@29@0.408@NA@DHRS4_4, DHRS4_5@0@0@0@:dehydrogenase/reductase (SDR family) member 4@:steroid metabolic process;oxidation-reduction process;mitochondrion;protein tetramerization;oxidoreductase activity;peroxisomal membrane;nucleus;cellular ketone metabolic process;metabolic process;receptor binding;alcohol dehydrogenase [NAD(P)+] activity;peroxisome;nucleotide binding;oxidoreductase activity, acting on NADH or NADPH, quinone or similar compound as acceptor;3-keto sterol reductase activity;alcohol metabolic process;carbonyl reductase (NADPH) activity@NA
A2463_10@133426@133426@deletion@1@106478111@106478411@14@chr14:106478111-106478411@7.47@76@28@0.368@CNVR6294.36, CNVR6294.48, CNVR6294.12, CNVR6294.24@IGHV4-4_2@0@0@0@@:protein binding@NA
A2463_10@133432@133435@deletion@4@106539080@106552729@14@chr14:106539080-106552729@32.6@151@1@0.00662@CNVR6294.36, CNVR6294.48, CNVR6294.24, CNVR6294.10, CNVR6294.34@IGHV1-8_2, IGHV1-8_1, IGHV3-9_2, IGHV3-9_1@0@0@0@@:protein binding:protein binding@NA
A2463_10@133470@133471@deletion@2@106877620@106878076@14@chr14:106877620-106878076@8.07@188@106@0.564@CNVR6294.26, CNVR6294.56, CNVR6294.2, CNVR6294.18@IGHV4-39_2, IGHV4-39_1@0@0@0@@:protein binding@NA
A2463_10@133509@133528@deletion@20@20739498@21071610@15@chr15:20739498-21071610@30.3@759@421@0.555@NA@GOLGA6L6_8, GOLGA6L6_7, GOLGA6L6_6, GOLGA6L6_5, GOLGA6L6_4, GOLGA6L6_3, GOLGA6L6_2, GOLGA6L6_1, AC012414.1_1, POTEB_11, POTEB_10, POTEB_9, POTEB_8, POTEB_7, POTEB_6, POTEB_5, POTEB_4, POTEB_3, POTEB_2, POTEB_1@0@0@0@:putative transmembrane protein FLJ36131-like;putative transmembrane protein ENSP00000320207-like;golgin A6 family-like 6:POTE ankyrin domain family member B-like@:protein binding@NA
A2463_10@133532@133542@deletion@11@22062317@22383423@15@chr15:22062317-22383423@66.3@1013@406@0.401@NA@POTEB_9, POTEB_8, POTEB_7, POTEB_6, POTEB_5, POTEB_4, POTEB_3, POTEB_2, POTEB_1, OR4M2_1, OR4N4_1@0@0@0@:POTE ankyrin domain family member B-like:olfactory receptor, family 4, subfamily M, member 2:olfactory receptor, family 4, subfamily N, member 4@:protein binding:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_10@133622@133623@duplication@2@23259497@23259716@15@chr15:23259497-23259716@11.9@53@140@2.64@CNVR6300.4@GOLGA8I_6, GOLGA8I_7@0@0@0@:golgin A8 family, member I@:Golgi cisterna membrane@NA
A2463_10@133639@133640@duplication@2@23410629@23410923@15@chr15:23410629-23410923@5.81@81@137@1.69@CNVR6300.8@RP11-467N20.5_5, RP11-467N20.5_4@0@0@0@:putative golgin subfamily A member 6-like protein 6-like@NA@NA
A2463_10@133652@133655@duplication@4@23605380@23606603@15@chr15:23605380-23606603@6.69@281@389@1.38@CNVR6301.3@GOLGA8S_9, GOLGA8S_10, GOLGA8S_11, GOLGA8S_12@0@0@0@@:Golgi apparatus@NA
A2463_10@133869@133870@duplication@2@28629294@28629596@15@chr15:28629294-28629596@18.1@33@155@4.7@CNVR6329.4@GOLGA8F_9, GOLGA8F_10@0@0@0@@:Golgi apparatus@NA
A2463_10@133902@133904@deletion@3@28947792@28949063@15@chr15:28947792-28949063@11.1@180@88@0.489@NA@GOLGA8M_16, GOLGA8M_15, GOLGA8M_14@0@0@0@:golgin A8 family, member M@:Golgi apparatus@NA
A2463_10@133911@133912@deletion@2@28953100@28953319@15@chr15:28953100-28953319@5.72@268@172@0.642@CNVR6331.1@GOLGA8M_7, GOLGA8M_6@0@0@0@:golgin A8 family, member M@:Golgi apparatus@NA
A2463_10@134023@134030@deletion@8@30699479@30702470@15@chr15:30699479-30702470@8.79@200@112@0.56@NA@GOLGA8R_12, GOLGA8R_11, GOLGA8R_10, GOLGA8R_9, GOLGA8R_8, GOLGA8R_7, GOLGA8R_6, GOLGA8R_5@0@0@0@@:Golgi apparatus@NA
A2463_10@134036@134054@duplication@19@30845996@30896376@15@chr15:30845996-30896376@39.2@406@741@1.83@CNVR6339.2, CNVR6339.3, CNVR6339.1@GOLGA8Q_2, GOLGA8Q_3, GOLGA8Q_4, GOLGA8Q_5, GOLGA8Q_6, GOLGA8Q_7, GOLGA8Q_8, GOLGA8Q_9, GOLGA8Q_10, GOLGA8Q_11, GOLGA8Q_12, GOLGA8Q_13, GOLGA8Q_14, GOLGA8Q_15, GOLGA8Q_16, GOLGA8Q_17, GOLGA8Q_18, GOLGA8Q_19, GOLGA8H_1@0@0@0@:golgin A8 family, member H@:Golgi apparatus:Golgi apparatus@NA
A2463_10@134175@134191@duplication@17@32693558@32743539@15@chr15:32693558-32743539@29@276@519@1.88@CNVR6346.1@GOLGA8K_2, AC139426.2_1, GOLGA8K_1, GOLGA8O_19, GOLGA8O_18, GOLGA8O_17, GOLGA8O_16, GOLGA8O_15, GOLGA8O_14, GOLGA8O_13, GOLGA8O_12, GOLGA8O_11, GOLGA8O_10, GOLGA8O_9, GOLGA8O_8, GOLGA8O_7, GOLGA8O_6@0@0@0@:golgin A8 family, member J:golgin A8 family, member O@:Golgi apparatus:Golgi apparatus@NA
A2463_10@134447@134458@deletion@12@34819834@34823896@15@chr15:34819834-34823896@11@125@52@0.416@CNVR6351.3@GOLGA8B_25, GOLGA8B_24, GOLGA8B_23, GOLGA8B_22, GOLGA8B_21, GOLGA8B_20, GOLGA8B_19, GOLGA8B_18, GOLGA8B_17, GOLGA8B_16, GOLGA8B_15, GOLGA8B_14@0@0@0@:golgin A8 family, member A:golgin A8 family, member A;golgin A8 family, member B@:Golgi cisterna membrane;Golgi apparatus:Golgi cisterna membrane;Golgi apparatus@NA
A2463_10@138281@138287@deletion@7@72953606@72957376@15@chr15:72953606-72957376@37.4@310@94@0.303@CNVR6443.1@GOLGA6B_8, GOLGA6B_9, GOLGA6B_10, GOLGA6B_11, GOLGA6B_12, GOLGA6B_13, GOLGA6B_14@0@0@0@:golgin A6 family, member B@:Golgi apparatus@NA
A2463_10@138636@138637@deletion@2@75557464@75557765@15@chr15:75557464-75557765@5.81@166@99@0.596@CNVR6452.1@GOLGA6C_8, GOLGA6C_9@0@0@0@:golgin A6 family, member C@:Golgi apparatus@NA
A2463_10@139473@139479@duplication@7@84850735@84909534@15@chr15:84850735-84909534@23.9@262@481@1.84@CNVR6486.2@RP11-182J1.16_3, GOLGA6L4_1, GOLGA6L4_2, GOLGA6L4_3, GOLGA6L4_4, GOLGA6L4_5, GOLGA6L4_6@0@0@0@:uncharacterized LOC100505679@:Golgi apparatus@NA
A2463_10@140482@140485@deletion@4@67292@68789@16@chr16:67292-68789@6.6@173@102@0.59@CNVR6565.1@WASH4P_4, WASH4P_3, WASH4P_2, WASH4P_1@0@0@0@@:intracellular membrane-bounded organelle;endosomal transport;recycling endosome;early endosome;Arp2/3 complex-mediated actin nucleation;actin binding;alpha-tubulin binding;retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;recycling endosome membrane@NA
A2463_10@142910@142921@duplication@12@16330759@16357072@16@chr16:16330759-16357072@8.27@336@462@1.38@NA@NOMO3_2, NOMO3_3, NOMO3_4, NOMO3_5, NOMO3_6, NOMO3_7, NOMO3_8, NOMO3_9, NOMO3_10, NOMO3_11, NOMO3_12, NOMO3_13@0@0@0@:NODAL modulator 3@:carbohydrate binding;integral to membrane;carboxypeptidase activity@NA
A2463_10@143267@143267@duplication@1@20491896@20492022@16@chr16:20491896-20492022@5.04@44@87@1.98@NA@ACSM2A_11@0@0@0@:acyl-CoA synthetase medium-chain family member 2A@:mitochondrion;butyrate-CoA ligase activity;catalytic activity;ATP binding;glucose homeostasis;medium-chain fatty-acyl-CoA metabolic process;fatty acid metabolic process;triglyceride homeostasis;metabolic process;mitochondrial matrix;metal ion binding@NA
A2463_10@143607@143607@duplication@1@22544948@22547706@16@chr16:22544948-22547706@4.98@390@530@1.36@CNVR6669.2@NPIPL3_7@0@0@0@:nuclear pore complex interacting protein pseudogene;nuclear pore complex interacting protein related gene;nuclear pore complex interacting protein-like@:integral to membrane@NA
A2463_10@144020@144020@deletion@1@28353929@28354509@16@chr16:28353929-28354509@8.15@296@175@0.591@NA@A-575C2.4_7@0@0@0@:uncharacterized LOC728741@NA@NA
A2463_10@144038@144052@deletion@15@28403074@28478223@16@chr16:28403074-28478223@29.6@203@46@0.227@NA@EIF3CL_10, EIF3CL_9, EIF3CL_8, EIF3CL_7, EIF3CL_6, EIF3CL_5, EIF3CL_4, EIF3CL_3, EIF3CL_2, NPIPL1_7, NPIPL1_6, NPIPL1_5, NPIPL1_4, NPIPL1_3, NPIPL1_2@0@0@0@:eukaryotic translation initiation factor 3, subunit C-like:ceroid-lipofuscinosis, neuronal 3@:protein binding;eukaryotic translation initiation factor 3 complex;translational initiation;translation initiation factor activity:membrane:negative regulation of apoptotic process;late endosome;mitochondrion;galactosylceramide metabolic process;neuromuscular process controlling balance;neuron projection;lysosomal lumen pH elevation;integral to endoplasmic reticulum membrane;cell death;plasma membrane;nucleus;lysosomal lumen acidification;negative regulation of catalytic activity;negative regulation of macroautophagy;unfolded protein binding;neurotransmitter metabolic process;endoplasmic reticulum;vesicle transport along microtubule;protein catabolic process;autophagic vacuole;early endosome;trans-Golgi network;cellular membrane organization;ceramide metabolic process;glucosylceramide metabolic process;negative regulation of neuron apoptotic process;membrane;globoside metabolic process;membrane raft;synaptic vesicle;vacuolar transport;protein processing;Golgi membrane;caveola;protein folding;ionotropic glutamate receptor signaling pathway;cytosolic calcium ion homeostasis;Golgi stack;integral to membrane;receptor-mediated endocytosis;arginine transport;lysosome;negative regulation of proteolysis;Golgi apparatus;lysosome organization;associative learning;sphingomyelin metabolic process;macroautophagy;lysosomal membrane;amyloid precursor protein catabolic process;cytoplasm;autophagic vacuole fusion;protein binding;regulation of action potential;cellular amino acid metabolic process@: CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3
A2463_10@144131@144131@deletion@1@28769320@28769404@16@chr16:28769320-28769404@8.53@42@2@0.0476@NA@A-575C2.4_2@0@0@0@NA@NA@NA
A2463_10@144262@144265@duplication@4@29057332@29062028@16@chr16:29057332-29062028@9.5@169@271@1.6@NA@CTB-134H23.2_3, CTB-134H23.2_4, CTB-134H23.2_5, CTB-134H23.2_6@0@0@0@NA@NA@NA
A2463_10@147101@147102@duplication@2@70010292@70012015@16@chr16:70010292-70012015@5.92@326@445@1.37@CNVR6762.3, CNVR6762.2@RP11-419C5.2_7, RP11-419C5.2_6@0@0@0@NA@NA@NA
A2463_10@147109@147120@deletion@12@70161164@70178436@16@chr16:70161164-70178436@25.6@1217@787@0.647@CNVR6764.1, CNVR6764.3@PDPR_4, PDPR_5, PDPR_6, PDPR_7, PDPR_8, PDPR_9, PDPR_10, PDPR_11, PDPR_12, PDPR_13, PDPR_14, PDPR_15@0@0@0@:pyruvate dehydrogenase phosphatase regulatory subunit@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix@NA
A2463_10@147124@147124@deletion@1@70190379@70190782@16@chr16:70190379-70190782@5.05@211@132@0.626@CNVR6764.1, CNVR6764.3@PDPR_19@0@0@0@:pyruvate dehydrogenase phosphatase regulatory subunit@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix@NA
A2463_10@147127@147127@deletion@1@70211145@70211383@16@chr16:70211145-70211383@7.14@106@50@0.472@CNVR6764.1@CLEC18C_3@0@0@0@:C-type lectin domain family 18, member C@:carbohydrate binding;protein binding;extracellular region@NA
A2463_10@147419@147420@deletion@2@72091292@72092254@16@chr16:72091292-72092254@6.19@56@20@0.357@CNVR6769.1, CNVR6769.2@HP_4, HP_5@0@0@0@:thioredoxin-like 4B:haptoglobin:haptoglobin-related protein@:mitosis;mRNA processing;RNA splicing;spliceosomal complex;cell redox homeostasis:cellular iron ion homeostasis;negative regulation of oxidoreductase activity;catalytic activity;negative regulation of hydrogen peroxide catabolic process;positive regulation of cell death;haptoglobin-hemoglobin complex;extracellular space;proteolysis;response to hydrogen peroxide;extracellular region;hemoglobin binding;defense response;serine-type endopeptidase activity:spherical high-density lipoprotein particle;proteolysis;extracellular region;hemoglobin binding;catalytic activity;serine-type endopeptidase activity@: ANHAPTOGLOBINEMIA; AHP
A2463_10@147496@147512@deletion@17@74411873@74447574@16@chr16:74411873-74447574@94.4@2256@1214@0.538@CNVR6778.2, CNVR6778.4@NPIPL2_1, NPIPL2_2, NPIPL2_3, NPIPL2_4, NPIPL2_5, NPIPL2_6, NPIPL2_7, CLEC18B_13, CLEC18B_12, CLEC18B_11, CLEC18B_10, CLEC18B_9, CLEC18B_8, CLEC18B_7, CLEC18B_6, CLEC18B_5, CLEC18B_4@0@0@0@:C-type lectin domain family 18, member B@:extracellular region:carbohydrate binding;protein binding;extracellular region@NA
A2463_10@151403@151404@duplication@2@15466752@15469578@17@chr17:15466752-15469578@7.01@404@564@1.4@NA@TVP23C_1, TVP23C-CDRT4_1, CDRT1_1@0@0@0@:FAM18B2-CDRT4 readthrough:family with sequence similarity 18, member B2:CMT1A duplicated region transcript 1@:integral to membrane:integral to membrane:protein binding;molecular_function;cellular_component;biological_process@NA
A2463_10@151875@151888@duplication@14@18380170@18541286@17@chr17:18380170-18541286@28.7@631@956@1.52@NA@LGALS9C_1, LGALS9C_2, LGALS9C_3, LGALS9C_4, LGALS9C_5, LGALS9C_6, LGALS9C_7, LGALS9C_8, LGALS9C_9, LGALS9C_10, LGALS9C_11, FAM106A_1, TBC1D28_9, TBC1D28_8@0@0@0@:lectin, galactoside-binding, soluble, 9C:protein FAM106B-like:TBC1 domain family, member 28@:carbohydrate binding:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_10@151915@151915@deletion@1@18681789@18682611@17@chr17:18681789-18682611@6.08@309@196@0.634@NA@FBXW10_14@0@0@0@:F-box/WD repeat-containing protein 10-like;F-box and WD repeat domain containing 10@:protein binding@NA
A2463_10@151958@151959@deletion@2@18996506@18997166@17@chr17:18996506-18997166@12@287@158@0.551@CNVR7018.4, CNVR7018.2, CNVR7018.6@AC007952.5_1, AC007952.5_2@0@0@0@NA@NA@NA
A2463_10@153363@153372@deletion@10@34493376@34500284@17@chr17:34493376-34500284@21.9@280@134@0.479@CNVR7077.1, CNVR7077.3, CNVR7077.11, CNVR7077.16@TBC1D3B_14, TBC1D3B_13, TBC1D3B_12, TBC1D3B_11, TBC1D3B_10, TBC1D3B_9, TBC1D3B_8, TBC1D3B_7, TBC1D3B_6, TBC1D3B_5@0@0@0@:TBC1 domain family, member 3B@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_10@153376@153381@duplication@6@34522686@34539971@17@chr17:34522686-34539971@19.9@46@185@4.02@CNVR7077.1, CNVR7077.3, CNVR7077.6@CCL3L3_3, CCL3L3_2, CCL3L3_1, CCL4L1_1, CCL4L1_2, CCL4L1_3@0@0@0@:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
A2463_10@153393@153394@duplication@2@34590136@34590454@17@chr17:34590136-34590454@15.3@31@142@4.58@CNVR7077.1, CNVR7077.13, CNVR7077.19, CNVR7077.10, CNVR7077.2@TBC1D3C_3, TBC1D3C_2@0@0@0@:TBC1 domain family, member 3C;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3H-like;TBC1 domain family, member 3H@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_10@153393@153400@deletion@6@34590136@34641537@17@chr17:34590136-34641537@10.1@182@143@0.786@CNVR7077.1, CNVR7077.19, CNVR7077.2, CNVR7077.14@TBC1D3C_3, TBC1D3C_2, CCL3L1_3, CCL3L1_2, CCL3L1_1, CCL4L2_1, CCL4L2_2, CCL4L2_3@0@0@0@:TBC1 domain family, member 3C;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3H-like;TBC1 domain family, member 3H:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
A2463_10@153414@153414@duplication@1@34797487@34798054@17@chr17:34797487-34798054@27.4@101@365@3.61@CNVR7078.2, CNVR7078.3@TBC1D3G_14@0@0@0@:TBC1 domain family member 3H-like;TBC1 domain family, member 3H:TBC1 domain family, member 3;TBC1 domain family, member 3G;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like;TBC1 domain family, member 3H@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_10@154346@154346@deletion@1@39421631@39422112@17@chr17:39421631-39422112@5.02@66@30@0.455@CNVR7096.1@KRTAP9-6_1@0@0@0@:keratin associated protein 9-6@:keratin filament@NA
A2463_10@155584@155590@deletion@7@44380005@44409347@17@chr17:44380005-44409347@13.9@344@204@0.593@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A_3, LRRC37A_4, LRRC37A_5, LRRC37A_6, LRRC37A_7, LRRC37A_8, LRRC37A_9@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
A2463_10@155592@155600@deletion@9@44412912@44594799@17@chr17:44412912-44594799@51.4@274@26@0.0949@CNVR7114.2, CNVR7114.1@LRRC37A_11, LRRC37A_12, LRRC37A_13, LRRC37A_14, ARL17B_4, ARL17B_3, ARL17B_2, LRRC37A2_2, LRRC37A2_3@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
A2463_10@160721@160721@duplication@1@10911185@10911226@18@chr18:10911185-10911226@6.25@82@144@1.76@NA@PIEZO2_4@0@0@0@:piezo-type mechanosensitive ion channel component 2@:ion channel activity;regulation of membrane potential;mechanically-gated ion channel activity;integral to membrane;cation transport;cation channel activity@NA
A2463_10@162018@162019@deletion@2@44548659@44556213@18@chr18:44548659-44556213@22.9@2383@1541@0.647@CNVR7319.1, CNVR7319.2@TCEB3CL_1, TCEB3C_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like:transcription elongation factor B polypeptide 3C (elongin A3);RNA polymerase II transcription factor SIII subunit A3-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_10@164949@164951@deletion@3@7011818@7032905@19@chr19:7011818-7032905@8.63@74@25@0.338@CNVR7517.1@AC025278.1_1, MBD3L5_1, MBD3L5_2@0@0@0@:methyl-CpG binding domain protein 3-like 5@NA@NA
A2463_10@167047@167047@duplication@1@14877791@14877921@19@chr19:14877791-14877921@7.22@64@127@1.98@NA@EMR2_6@0@0@0@:egf-like module containing, mucin-like, hormone receptor-like 2@:transmembrane signaling receptor activity;inflammatory response;G-protein coupled receptor activity;ruffle membrane;integral to membrane;plasma membrane;cell surface receptor signaling pathway;neuropeptide signaling pathway;granulocyte chemotaxis;cell migration;leading edge membrane;G-protein coupled receptor signaling pathway;protein binding;cell adhesion;membrane;calcium ion binding;chondroitin sulfate binding@NA
A2463_10@170096@170100@duplication@5@40373946@40382826@19@chr19:40373946-40382826@13.9@399@581@1.46@CNVR7639.2@FCGBP_26, FCGBP_25, FCGBP_24, FCGBP_23, FCGBP_22@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_10@170108@170112@deletion@5@40397968@40406060@19@chr19:40397968-40406060@14.1@212@102@0.481@CNVR7639.2@FCGBP_14, FCGBP_13, FCGBP_12, FCGBP_11, FCGBP_10@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_10@170814@170823@duplication@10@43679368@43709688@19@chr19:43679368-43709688@38.5@943@1419@1.5@CNVR7658.5, CNVR7658.8@PSG5_4, PSG5_3, PSG5_2, PSG5_1, PSG4_6, PSG4_5, PSG4_4, PSG4_3, PSG4_2, PSG4_1@0@0@0@:pregnancy specific beta-1-glycoprotein 5:pregnancy specific beta-1-glycoprotein 4@:protein binding;extracellular region;female pregnancy:protein binding;extracellular region;female pregnancy;defense response@NA
A2463_10@171445@171446@deletion@2@46506267@46506759@19@chr19:46506267-46506759@7.96@95@41@0.432@NA@CCDC61_3, CCDC61_4@0@0@0@:coiled-coil domain containing 61@:centrosome@NA
A2463_10@172986@172992@duplication@7@52132612@52148783@19@chr19:52132612-52148783@16.2@226@382@1.69@CNVR7702.1@SIGLEC5_3, SIGLEC5_3, SIGLEC5_2, SIGLEC5_2, SIGLEC5_1, SIGLEC14_7, SIGLEC14_6, SIGLEC14_5, SIGLEC14_4@0@0@0@:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 14@:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion;plasma membrane@NA
A2463_10@172994@172995@deletion@2@52149511@52150012@19@chr19:52149511-52150012@9.09@43@1@0.0233@CNVR7702.1@SIGLEC14_2, SIGLEC14_1, SIGLEC5_1@0@0@0@:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 14@:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion;plasma membrane@NA
A2463_10@173294@173296@deletion@3@54724026@54725251@19@chr19:54724026-54725251@7.31@80@33@0.412@CNVR7721.3, CNVR7721.4@LILRB3_7, LILRB3_6, LILRB3_5@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
A2463_10@173459@173477@duplication@19@55246721@55295265@19@chr19:55246721-55295265@63.4@1055@1715@1.63@CNVR7725.2, CNVR7725.1@KIR3DL3_6, KIR3DL3_7, KIR3DL3_8, KIR2DL3_1, KIR2DL3_2, KIR2DL3_3, KIR2DL3_4, KIR2DL3_5, KIR2DL3_6, KIR2DL3_7, KIR2DL3_8, KIR2DL1_1, KIR2DL1_2, KIR2DL1_3, KIR2DL1_4, KIR2DL1_5, KIR2DL1_6, KIR2DL1_7, KIR2DL1_8@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:integral to membrane;plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane@NA
A2463_10@173487@173498@duplication@12@55329771@55354373@19@chr19:55329771-55354373@27.7@832@1207@1.45@CNVR7725.1, CNVR7725.6@KIR3DL1_3, KIR3DL1_4, KIR3DL1_5, KIR3DL1_6, KIR3DL1_7, KIR3DL1_8, KIR3DL1_9, KIR2DS4_1, KIR2DS4_2, KIR2DS4_3, KIR2DS4_4, KIR2DS4_5@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
A2463_10@173500@173503@deletion@4@55359207@55362710@19@chr19:55359207-55362710@12.5@59@2@0.0339@CNVR7725.1, CNVR7725.6, CNVR7725.5, CNVR7725.10@KIR2DS4_7, KIR2DS4_8, KIR3DL2_1, KIR3DL2_2@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2-like@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane@NA
A2463_10@173843@173845@duplication@3@56273965@56284545@19@chr19:56273965-56284545@18@895@1257@1.4@CNVR7734.1@RFPL4A_3, CTD-2611O12.2_2, CTD-2611O12.2_3@0@0@0@:ret finger protein-like 4A;ret finger protein-like 4A-like:ret finger protein-like 4A-like@:protein binding;zinc ion binding:protein binding;zinc ion binding@NA
A2463_10@175736@175737@duplication@2@26061801@26063616@20@chr20:26061801-26063616@6.49@162@242@1.49@CNVR7823.4, CNVR7823.3, CNVR7823.5, CNVR7823.1@FAM182A_4, FAM182A_5@0@0@0@NA@NA@NA
A2463_10@178988@178994@duplication@7@10908826@10933940@21@chr21:10908826-10933940@11.3@1744@2234@1.28@CNVR7947.10, CNVR7947.6, CNVR7947.11@TPTE_23, TPTE_22, TPTE_21, TPTE_20, TPTE_19, TPTE_18, TPTE_17@0@0@0@:transmembrane phosphatase with tensin homology@:phosphatase activity;ion channel activity;protein tyrosine phosphatase activity;ion transport;protein dephosphorylation;transmembrane transport;protein binding;signal transduction;integral to membrane;protein tyrosine/serine/threonine phosphatase activity;dephosphorylation;membrane;peptidyl-tyrosine dephosphorylation@NA
A2463_10@179011@179021@duplication@11@14982551@15013887@21@chr21:14982551-15013887@29.9@246@505@2.05@CNVR7952.1@POTED_1, POTED_2, POTED_3, POTED_4, POTED_5, POTED_6, POTED_7, POTED_8, POTED_9, POTED_10, POTED_11@0@0@0@:POTE ankyrin domain family, member B;POTE ankyrin domain family, member C;POTE ankyrin domain family, member D@:protein binding;plasma membrane@NA
A2463_10@180979@180979@deletion@1@17264510@17265299@22@chr22:17264510-17265299@12.9@64@3@0.0469@NA@XKR3_4@0@0@0@:XK, Kell blood group complex subunit-related family, member 3@:integral to membrane;plasma membrane@NA
A2463_10@181127@181134@deletion@8@18723546@18835833@22@chr22:18723546-18835833@31.8@275@76@0.276@CNVR8087.5, CNVR8087.2, CNVR8087.7@AC008132.1_2, AC008132.1_3, AC008132.1_4, AC008132.1_5, AC008132.1_6, AC008132.1_7, AC008132.1_8, AC008132.13_1@0@0@0@NA@NA@NA
A2463_10@181623@181634@deletion@12@21562428@21579843@22@chr22:21562428-21579843@12.3@283@165@0.583@CNVR8100.4, CNVR8100.10, CNVR8100.7@GGT2_15, GGT2_14, GGT2_13, GGT2_12, GGT2_11, GGT2_10, GGT2_9, GGT2_8, GGT2_7, GGT2_6, GGT2_5, GGT2_4@0@0@0@:gamma-glutamyltransferase 2;gamma-glutamyltranspeptidase 2-like@:hydrolase activity;small molecule metabolic process;leukotriene biosynthetic process;anchored to external side of plasma membrane;glutathione biosynthetic process;xenobiotic metabolic process;integral to membrane;glutathione metabolic process;plasma membrane;gamma-glutamyltransferase activity;cellular_component@NA
A2463_10@181806@181806@deletion@1@23243157@23243475@22@chr22:23243157-23243475@17.6@90@5@0.0556@CNVR8103.2, CNVR8103.1, CNVR8103.6, CNVR8103.11@IGLC2_1@0@0@0@@:protein binding@NA
A2463_10@181951@181955@duplication@5@24376424@24384231@22@chr22:24376424-24384231@10.6@117@207@1.77@CNVR8114.13, CNVR8114.1, CNVR8114.7@GSTT1_5, GSTT1_4, GSTT1_3, GSTT1_2, GSTT1_1@0@0@0@:glutathione S-transferase theta 1@:glutathione peroxidase activity;response to drug;transferase activity;cytosol;protein binding;glutathione transferase activity;glutathione metabolic process;response to organic cyclic compound@NA
A2463_10@182140@182143@duplication@4@25747767@25756059@22@chr22:25747767-25756059@8.2@329@458@1.39@CNVR8120.1@LRP5L_6, LRP5L_5, LRP5L_4, LRP5L_3@0@0@0@:low density lipoprotein receptor-related protein 5-like@:Wnt-activated receptor activity;Wnt-protein binding;Wnt receptor signaling pathway involved in dorsal/ventral axis specification;canonical Wnt receptor signaling pathway@NA
A2463_10@184144@184145@duplication@2@42522854@42523636@22@chr22:42522854-42523636@8.85@279@407@1.46@CNVR8168.1, CNVR8168.3@CYP2D6_8, CYP2D6_7@0@0@0@:cytochrome P450, family 2, subfamily D, polypeptide 6@:oxidation-reduction process;mitochondrion;alkaloid catabolic process;aromatase activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;drug catabolic process;endoplasmic reticulum membrane;response to organic substance;oxidative demethylation;endoplasmic reticulum;alkaloid metabolic process;negative regulation of binding;heme binding;xenobiotic metabolic process;dopamine metabolic process;steroid metabolic process;isoquinoline alkaloid metabolic process;arachidonic acid monooxygenase activity;arachidonic acid metabolic process;steroid 21-monooxygenase activity;negative regulation of cellular organofluorine metabolic process;oxidoreductase activity;monoterpenoid metabolic process;heterocycle metabolic process;drug binding;drug metabolic process;electron carrier activity;small molecule metabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;monooxygenase activity;iron ion binding;coumarin metabolic process@: DRUG METABOLISM, POOR, CYP2D6-RELATED
A2463_12@402@427@duplication@26@1577024@1636464@1@chr1:1577024-1636464@29.9@1158@1634@1.41@CNVR17.1@CDK11B_10, CDK11B_9, CDK11B_8, CDK11B_7, CDK11B_6, CDK11B_5, CDK11B_4, CDK11B_3, CDK11B_2, CDK11B_1, SLC35E2B_10, SLC35E2B_9, SLC35E2B_8, SLC35E2B_7, SLC35E2B_6, SLC35E2B_5, SLC35E2B_4, SLC35E2B_3, CDK11A_20, CDK11A_19, CDK11A_18, CDK11A_17, CDK11A_16, CDK11A_15, CDK11A_14, CDK11A_13@0@0@0@:cyclin-dependent kinase 11B:solute carrier family 35, member E2B:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A@:protein serine/threonine kinase activity;protein tyrosine kinase activity;protein phosphorylation;protein kinase activity;cell division;transferase activity, transferring phosphorus-containing groups;ATP binding:integral to membrane;membrane;transmembrane transport:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division@NA
A2463_12@432@434@deletion@3@1640478@1643839@1@chr1:1640478-1643839@8.75@44@3@0.0682@CNVR17.1@CDK11A_8, CDK11A_7, CDK11A_6@0@0@0@:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A@:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division@NA
A2463_12@1854@1854@deletion@1@13497571@13498128@1@chr1:13497571-13498128@6.58@30@0@0@CNVR74.8@PRAMEF16_3@0@0@0@:PRAME family member 16@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_12@2181@2186@deletion@6@17265405@17273486@1@chr1:17265405-17273486@8.25@249@152@0.61@CNVR94.4, CNVR94.5@CROCC_12, CROCC_13, CROCC_14, CROCC_15, CROCC_16, CROCC_17@0@0@0@:ciliary rootlet coiled-coil, rootletin@:centriole;centrosome organization;centrosome;kinesin binding;actin cytoskeleton;cytoplasm;protein binding;vesicle-mediated transport;structural molecule activity;ciliary rootlet;protein localization;plasma membrane;cell cycle;cell projection organization;membrane@NA
A2463_12@3333@3342@duplication@10@25599040@25655415@1@chr1:25599040-25655415@22.5@883@1251@1.42@CNVR116.1, CNVR116.2@RHD_1, RHD_2, RHD_3, RHD_4, RHD_5, RHD_6, RHD_7, RHD_8, RHD_9, RHD_10@0@0@0@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
A2463_12@9350@9366@deletion@17@104160064@104203298@1@chr1:104160064-104203298@79.2@878@320@0.364@CNVR266.3, CNVR266.1@AMY2A_1, AMY2A_2, AMY2A_3, AMY2A_4, AMY2A_5, AMY2A_6, AMY2A_7, AMY2A_8, AMY2A_9, AMY2A_10, AMY1A_2, AMY1A_3, AMY1A_4, AMY1A_5, AMY1A_6, AMY1A_7, AMY1A_8@0@0@0@:amylase, alpha 2A (pancreatic):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:chloride ion binding;cation binding;small molecule metabolic process;carbohydrate metabolic process;catalytic activity;extracellular space;polysaccharide digestion;extracellular region;carbohydrate catabolic process;alpha-amylase activity;calcium ion binding:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
A2463_12@9449@9451@duplication@3@108993225@108996017@1@chr1:108993225-108996017@9.21@38@104@2.74@CNVR294.4, CNVR294.2@NBPF6_2, NBPF6_3, NBPF6_4@0@0@0@:neuroblastoma breakpoint family, member 6@:cytoplasm@NA
A2463_12@9460@9460@deletion@1@109007811@109008046@1@chr1:109007811-109008046@13.2@61@0@0@CNVR294.4@NBPF6_13@0@0@0@:neuroblastoma breakpoint family, member 6@:cytoplasm@NA
A2463_12@9766@9773@deletion@8@110230497@110235917@1@chr1:110230497-110235917@64@310@8@0.0258@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_1, GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
A2463_12@10793@10793@deletion@1@144339779@144340398@1@chr1:144339779-144340398@8.13@37@0@0@CNVR334.4, CNVR334.2@AL592284.1_1@0@0@0@:uncharacterized LOC730256;uncharacterized LOC101060698;uncharacterized LOC642441@NA@NA
A2463_12@10796@10798@deletion@3@144811749@144814894@1@chr1:144811749-144814894@10.4@277@159@0.574@CNVR338.4, CNVR338.2, CNVR338.5, CNVR338.1@NBPF9_1, NBPF9_2, NBPF9_3@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 24@NA@NA
A2463_12@10890@10895@duplication@6@145325953@145330074@1@chr1:145325953-145330074@7.48@70@132@1.89@CNVR341.2, CNVR341.3@NBPF10_30, NBPF10_31, NBPF10_32, NBPF10_33, NBPF10_34, NBPF10_35@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family, member 10@NA@NA
A2463_12@11143@11157@deletion@15@146227744@146244717@1@chr1:146227744-146244717@12@57@2@0.0351@NA@NBPF12_22, NBPF12_21, NBPF12_20, NBPF12_19, NBPF12_18, NBPF12_17, NBPF12_16, NBPF12_15, NBPF12_14, NBPF12_13, NBPF12_12, NBPF12_11, NBPF12_10, NBPF12_9, NBPF12_8@0@0@0@:neuroblastoma breakpoint family member 21-like@NA@NA
A2463_12@11159@11164@deletion@6@146246748@146253110@1@chr1:146246748-146253110@23.5@182@50@0.275@NA@NBPF12_6, NBPF12_5, NBPF12_4, NBPF12_3, NBPF12_2, NBPF12_1@0@0@0@:neuroblastoma breakpoint family member 21-like@NA@NA
A2463_12@11169@11170@duplication@2@146400092@146401880@1@chr1:146400092-146401880@11.5@60@149@2.48@NA@NBPF12_9, NBPF12_10@0@0@0@:neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family member 14-like;neuroblastoma breakpoint family, member 12@:cytoplasm@NA
A2463_12@11236@11236@duplication@1@146461120@146461291@1@chr1:146461120-146461291@4.78@4@35@8.75@CNVR344.1, CNVR344.2@NBPF12_76@0@0@0@:neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family member 14-like;neuroblastoma breakpoint family, member 12@:cytoplasm@NA
A2463_12@11333@11351@duplication@19@147599113@148016460@1@chr1:147599113-148016460@96.1@988@2082@2.11@NA@NBPF24_2, BX842679.1_1, PPIAL4A_1, NBPF14_22, NBPF14_21, NBPF14_20, NBPF14_19, NBPF14_18, NBPF14_17, NBPF14_16, NBPF14_15, NBPF14_14, NBPF14_13, NBPF14_12, NBPF14_11, NBPF14_10, NBPF14_9, NBPF14_8, NBPF14_7@0@0@0@:neuroblastoma breakpoint family, member 24:peptidylprolyl isomerase A (cyclophilin A)-like 4C;peptidyl-prolyl cis-trans isomerase A-like 4A/B/C-like;peptidylprolyl isomerase A (cyclophilin A)-like 4B;peptidylprolyl isomerase A (cyclophilin A)-like 4A:neuroblastoma breakpoint family, member 14@:cytoplasm:protein folding;peptidyl-prolyl cis-trans isomerase activity;cytoplasm:cytoplasm@NA
A2463_12@11372@11372@duplication@1@148262259@148262366@1@chr1:148262259-148262366@4.7@35@74@2.11@CNVR347.1, CNVR347.4@NBPF20_98@0@0@0@:uncharacterized LOC101060226;neuroblastoma breakpoint family member 14-like;neuroblastoma breakpoint family, member 12;neuroblastoma breakpoint family member 3-like;neuroblastoma breakpoint family, member 7@:cytoplasm@NA
A2463_12@11466@11467@deletion@2@148343595@148344742@1@chr1:148343595-148344742@5.75@156@91@0.583@CNVR347.1, CNVR347.5@NBPF20_4, NBPF20_3@0@0@0@:uncharacterized LOC101060226;neuroblastoma breakpoint family member 14-like;neuroblastoma breakpoint family, member 12;neuroblastoma breakpoint family member 3-like;neuroblastoma breakpoint family, member 7@:cytoplasm@NA
A2463_12@16029@16031@deletion@3@196744018@196749103@1@chr1:196744018-196749103@11.2@397@242@0.61@CNVR459.1, CNVR459.3@CFHR3_1, CFHR3_2, CFHR3_3@0@0@0@:complement factor H-related 3@:extracellular space@NA
A2463_12@16039@16040@deletion@2@196799631@196801129@1@chr1:196799631-196801129@5.23@337@224@0.665@CNVR459.1@CFHR1_5, CFHR1_6@0@0@0@:complement factor H-related 1:complement factor H-related 2@:extracellular space;complement activation:extracellular region@NA
A2463_12@17286@17287@deletion@2@207718654@207719023@1@chr1:207718654-207719023@6.79@31@0@0@CNVR485.1@CR1_14, CR1_15@0@0@0@:complement component (3b/4b) receptor 1 (Knops blood group)@:complement component C4b receptor activity;complement activation, classical pathway;negative regulation of complement activation, alternative pathway;innate immune response;negative regulation of serine-type endopeptidase activity;complement component C3b binding;negative regulation of complement activation, classical pathway;plasma membrane;integral to plasma membrane;complement component C3b receptor activity;complement component C4b binding;cell surface;regulation of complement activation;positive regulation of serine-type endopeptidase activity@: MALARIA, SUSCEPTIBILITY TO; KNOPS BLOOD GROUP SYSTEM; KN
A2463_12@25351@25351@deletion@1@97820413@97820478@2@chr2:97820413-97820478@5.17@107@57@0.533@CNVR886.2@ANKRD36_15@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_12@25369@25370@deletion@2@97854825@97855027@2@chr2:97854825-97855027@16.5@91@10@0.11@CNVR886.2, CNVR886.3@ANKRD36_33, ANKRD36_34@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_12@25376@25386@duplication@11@97860583@97870000@2@chr2:97860583-97870000@21.8@1423@1915@1.35@CNVR886.1@ANKRD36_40, ANKRD36_41, ANKRD36_42, ANKRD36_43, ANKRD36_44, ANKRD36_45, ANKRD36_46, ANKRD36_47, ANKRD36_48, ANKRD36_49, ANKRD36_50@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_12@25391@25403@duplication@13@97875419@97890616@2@chr2:97875419-97890616@21.1@1557@2072@1.33@NA@ANKRD36_55, ANKRD36_56, ANKRD36_57, ANKRD36_58, ANKRD36_59, ANKRD36_60, ANKRD36_61, ANKRD36_62, ANKRD36_63, ANKRD36_64, ANKRD36_65, ANKRD36_66, ANKRD36_67@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_12@26305@26305@deletion@1@112541475@112541541@2@chr2:112541475-112541541@9.39@65@14@0.215@CNVR928.1@ANAPC1_42@0@0@0@:anaphase-promoting complex subunit 1-like;anaphase promoting complex subunit 1@:nucleoplasm;regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle;anaphase-promoting complex;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle spindle assembly checkpoint;cytosol;protein K11-linked ubiquitination;protein binding;mitosis;nucleus;cell cycle checkpoint;cell division;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle@NA
A2463_12@26579@26583@deletion@5@114251335@114258060@2@chr2:114251335-114258060@107@879@132@0.15@CNVR933.1@CBWD2_12, CBWD2_13, CBWD2_14, CBWD2_15, FOXD4L1_1@0@0@0@:COBW domain containing 2;COBW domain containing 1;COBW domain-containing protein 1-like:forkhead box D4-like 1@:ATP binding:positive regulation of BMP signaling pathway;positive regulation of kidney development;axon extension involved in axon guidance;lateral line nerve glial cell development;DNA binding, bending;sequence-specific DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;regulation of sequence-specific DNA binding transcription factor activity;transcription factor complex;nucleus;dichotomous subdivision of terminal units involved in ureteric bud branching;sympathetic nervous system development;melanocyte differentiation;enteric nervous system development;positive regulation of transcription from RNA polymerase II promoter;regulation of transcription, DNA-dependent;neural crest cell migration;peripheral nervous system development;double-stranded DNA binding;RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity;iridophore differentiation;transcription factor binding;cartilage development;pattern specification process@NA
A2463_12@27163@27163@deletion@1@130843388@130843568@2@chr2:130843388-130843568@9.44@43@0@0@NA@POTEF_13@0@0@0@:POTE ankyrin domain family, member F@:cell cortex;protein binding;ATP binding@NA
A2463_12@27171@27173@deletion@3@130868117@130872627@2@chr2:130868117-130872627@11.6@105@36@0.343@NA@POTEF_5, POTEF_4, POTEF_3@0@0@0@:POTE ankyrin domain family, member F@:cell cortex;protein binding;ATP binding@NA
A2463_12@27180@27181@deletion@2@130898732@130899954@2@chr2:130898732-130899954@9.39@174@89@0.511@NA@CCDC74B_4, CCDC74B_3@0@0@0@:coiled-coil domain containing 74A;coiled-coil domain containing 74B@NA@NA
A2463_12@27341@27342@duplication@2@132288153@132289375@2@chr2:132288153-132289375@6.77@126@201@1.6@NA@CCDC74A_3, CCDC74A_4@0@0@0@:coiled-coil domain containing 74A@NA@NA
A2463_12@27996@27997@deletion@2@152463121@152464122@2@chr2:152463121-152464122@9.68@49@3@0.0612@CNVR1026.1@NEB_84, NEB_83@0@0@0@:nebulin@:Z disc;muscle filament sliding;oxidation-reduction process;contractile fiber part;actin cytoskeleton;regulation of actin filament length;structural constituent of muscle;cytosol;actin binding;protein binding;myofibril;somatic muscle development;muscle organ development@: NEMALINE MYOPATHY 2; NEM2
A2463_12@34945@34945@deletion@1@10091059@10091189@3@chr3:10091059-10091189@8.08@128@59@0.461@NA@FANCD2_17@0@0@0@:Fanconi anemia, complementation group D2@:nucleoplasm;synapsis;binding;response to DNA damage stimulus;gamete generation;DNA repair;condensed chromosome;protein binding;response to gamma radiation@: FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2
A2463_12@46677@46677@duplication@1@9250357@9251948@4@chr4:9250357-9251948@19.5@340@688@2.02@NA@USP17L18_1@0@0@0@:ubiquitin specific peptidase 17-like family member 18@:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
A2463_12@47508@47509@duplication@2@39851141@39863953@4@chr4:39851141-39863953@5.47@160@235@1.47@NA@PDS5A_27, PDS5A_26@0@0@0@:PDS5, regulator of cohesion maintenance, homolog A (S. cerevisiae)@:negative regulation of DNA replication;binding;chromatin;mitosis;protein binding;nucleus;plasma membrane;cell division@NA
A2463_12@48557@48559@deletion@3@69416396@69426386@4@chr4:69416396-69426386@5.78@112@63@0.562@CNVR1953.1@UGT2B17_5, UGT2B17_4, UGT2B17_3@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B17@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;membrane@: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
A2463_12@53309@53316@deletion@8@751249@822010@5@chr5:751249-822010@20.8@327@165@0.505@CNVR2280.3@ZDHHC11B_4, ZDHHC11B_3, ZDHHC11B_2, ZDHHC11B_1, ZDHHC11_12, ZDHHC11_11, ZDHHC11_10, ZDHHC11_9@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
A2463_12@54849@54849@duplication@1@42629141@42629205@5@chr5:42629141-42629205@7.97@80@158@1.98@CNVR2445.1@GHR_3@0@0@0@:growth hormone receptor@:neuronal cell body;mitochondrion;proline-rich region binding;JAK-STAT cascade;growth factor binding;nucleus;succinate metabolic process;positive regulation of JAK-STAT cascade;JAK-STAT cascade involved in growth hormone signaling pathway;response to morphine;activation of MAPK activity;peptide hormone binding;response to estradiol stimulus;2-oxoglutarate metabolic process;valine metabolic process;response to cytokine stimulus;hormone-mediated signaling pathway;response to food;SH2 domain binding;oxaloacetate metabolic process;growth hormone receptor signaling pathway;allantoin metabolic process;integral to membrane;response to hormone stimulus;cartilage development involved in endochondral bone morphogenesis;positive regulation of peptidyl-tyrosine phosphorylation;receptor internalization;cytoplasm;cellular response to hormone stimulus;extracellular region;growth hormone receptor complex;positive regulation of tyrosine phosphorylation of Stat5 protein;regulation of multicellular organism growth;growth hormone receptor activity;positive regulation of tyrosine phosphorylation of Stat3 protein;response to peptide hormone stimulus;fatty acid metabolic process;creatinine metabolic process;plasma membrane;positive regulation of multicellular organism growth;receptor complex;protein phosphatase binding;protein kinase binding;creatine metabolic process;response to interleukin-1;response to cycloheximide;extracellular space;positive regulation of cell differentiation;activation of Janus kinase activity;taurine metabolic process;cellular response to insulin stimulus;integral to plasma membrane;protein homodimerization activity;negative regulation of neuron death;citrate metabolic process;endocytosis;isoleucine metabolic process;activation of JAK2 kinase activity;extrinsic to membrane;response to glucocorticoid stimulus;protein binding;insulin-like growth factor receptor signaling pathway;multicellular organismal metabolic process;cell surface@: HYPERCHOLESTEROLEMIA, FAMILIAL; LARON SYNDROME; SHORT STATURE, IDIOPATHIC, AUTOSOMAL
A2463_12@55806@55806@duplication@1@69372349@69372398@5@chr5:69372349-69372398@6.96@103@181@1.76@CNVR2494.48, CNVR2494.39, CNVR2494.15, CNVR2494.18, CNVR2494.26, CNVR2494.43, CNVR2494.52, CNVR2494.28, CNVR2494.2, CNVR2494.36@SMN2_8@0@0@0@:survival of motor neuron 2, centromeric;survival of motor neuron 1, telomeric@:nucleoplasm;ncRNA metabolic process;Cajal body;RNA metabolic process;spliceosomal complex;cytoplasm;cytosol;protein binding;cell death;spliceosomal complex assembly;RNA binding;mRNA processing;nucleus;gene expression;spliceosomal snRNP assembly@: SPINAL MUSCULAR ATROPHY, TYPE II; SMA2; SPINAL MUSCULAR ATROPHY, TYPE I; SMA1; SPINAL MUSCULAR ATROPHY, TYPE IV; SMA4; SPINAL MUSCULAR ATROPHY, TYPE III; SMA3
A2463_12@55840@55844@deletion@5@70351180@70357135@5@chr5:70351180-70357135@10.1@124@54@0.435@CNVR2494.41, CNVR2494.14, CNVR2494.20, CNVR2494.62, CNVR2494.8@GTF2H2_9, GTF2H2_8, GTF2H2_7, GTF2H2_6, GTF2H2_5@0@0@0@:general transcription factor IIH, polypeptide 2, 44kDa@:nucleoplasm;nucleotide-excision repair, DNA damage removal;transcription from RNA polymerase I promoter;DNA repair;RNA polymerase II carboxy-terminal domain kinase activity;nucleus;viral reproduction;translation;gene expression;transcription elongation from RNA polymerase I promoter;response to UV;holo TFIIH complex;protein kinase activity;nucleotide-excision repair;transcription from RNA polymerase II promoter;transcription-coupled nucleotide-excision repair;transcription, DNA-dependent;zinc ion binding;transcription elongation from RNA polymerase II promoter;termination of RNA polymerase I transcription;sequence-specific DNA binding transcription factor activity;G-protein coupled receptor internalization;DNA-dependent ATPase activity;protein N-terminus binding;transcription initiation from RNA polymerase I promoter;7-methylguanosine mRNA capping;transcription initiation from RNA polymerase II promoter;protein phosphorylation;translation factor activity, nucleic acid binding;regulation of transcription, DNA-dependent;core TFIIH complex;protein binding;positive regulation of viral transcription;nucleic acid binding@NA
A2463_12@61260@61273@duplication@14@177156025@177171968@5@chr5:177156025-177171968@31@432@731@1.69@NA@FAM153A_17, FAM153A_16, FAM153A_15, FAM153A_14, FAM153A_13, FAM153A_12, FAM153A_11, FAM153A_10, FAM153A_9, FAM153A_8, FAM153A_7, FAM153A_6, FAM153A_5, FAM153A_4@0@0@0@:family with sequence similarity 153, member A@NA@NA
A2463_12@63725@63725@deletion@1@31962023@31962161@6@chr6:31962023-31962161@13.8@66@1@0.0152@CNVR2843.6, CNVR2843.3@C4A_20@0@0@0@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
A2463_12@63768@63769@duplication@2@31994761@31995222@6@chr6:31994761-31995222@8.05@107@189@1.77@CNVR2843.6, CNVR2843.5@C4B_20, C4B_21@0@0@0@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
A2463_12@63800@63803@deletion@4@32009127@32010139@6@chr6:32009127-32010139@16@139@44@0.317@CNVR2843.6, CNVR2843.5@TNXB_13, TNXB_12, TNXB_11, TNXB_10@0@0@0@:cytochrome P450, family 21, subfamily A, polypeptide 2:tenascin-X-like;tenascin XB@:oxidation-reduction process;electron carrier activity;response to antibiotic;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;steroid 21-monooxygenase activity;C21-steroid hormone biosynthetic process;heme binding;mineralocorticoid biosynthetic process;progesterone metabolic process;monooxygenase activity;cellular response to peptide hormone stimulus;iron ion binding:integrin binding;extracellular matrix;cell-cell adhesion;elastic fiber assembly;collagen fibril organization;fibrillar collagen;actin cytoskeleton organization;extracellular space;heparin binding;proteinaceous extracellular matrix;fatty acid metabolic process;regulation of JUN kinase activity;receptor binding;intracellular;cell-matrix adhesion;extracellular matrix organization;lipid metabolic process;protein binding;signal transduction;extracellular region;collagen binding;cell adhesion;triglyceride metabolic process;fibril organization;collagen metabolic process@: ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY: EHLERS-DANLOS-LIKE SYNDROME DUE TO TENASCIN-X DEFICIENCY; EHLERS-DANLOS SYNDROME, TYPE III
A2463_12@63953@63956@deletion@4@32485517@32487428@6@chr6:32485517-32487428@18.4@96@8@0.0833@CNVR2845.21, CNVR2845.25, CNVR2845.30@HLA-DRB5_6, HLA-DRB5_5, HLA-DRB5_4, HLA-DRB5_3@0@0@0@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
A2463_12@70816@70817@deletion@2@161054786@161056336@6@chr6:161054786-161056336@10.2@142@64@0.451@CNVR3133.1@LPA_9, LPA_8@0@0@0@:lipoprotein, Lp(a)@:blood circulation;endopeptidase inhibitor activity;catalytic activity;lipoprotein metabolic process;proteolysis;heparin binding;receptor-mediated endocytosis;fibronectin binding;small molecule metabolic process;apolipoprotein binding;lipid metabolic process;negative regulation of endopeptidase activity;extracellular region;plasma lipoprotein particle;lipid transport;serine-type endopeptidase activity@: APOLIPOPROTEIN(a); LPA
A2463_12@71030@71030@deletion@1@167790035@167790192@6@chr6:167790035-167790192@8.77@41@1@0.0244@NA@TCP10_5@0@0@0@:t-complex 10@:cytosol@NA
A2463_12@71747@71749@duplication@3@5941289@5944900@7@chr7:5941289-5944900@7.99@284@411@1.45@NA@CCZ1_5, CCZ1_6, CCZ1_7@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
A2463_12@71762@71776@deletion@15@5977390@6006747@7@chr7:5977390-6006747@19.1@332@174@0.524@NA@RSPH10B_16, RSPH10B_15, RSPH10B_14, RSPH10B_13, RSPH10B_12, RSPH10B_11, RSPH10B_10, RSPH10B_9, RSPH10B_8, RSPH10B_7, RSPH10B_6, RSPH10B_5, RSPH10B_4, RSPH10B_3, RSPH10B_2@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
A2463_12@71919@71921@deletion@3@6736971@6744804@7@chr7:6736971-6744804@9.84@124@55@0.444@NA@ZNF12_4, ZNF12_3, ZNF12_2@0@0@0@:zinc finger protein 12@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_12@71926@71934@duplication@9@6805338@6821107@7@chr7:6805338-6821107@8.1@194@297@1.53@NA@RSPH10B2_6, RSPH10B2_7, RSPH10B2_8, RSPH10B2_9, RSPH10B2_10, RSPH10B2_11, RSPH10B2_12, RSPH10B2_13, RSPH10B2_14@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
A2463_12@73262@73263@duplication@2@38393317@38393784@7@chr7:38393317-38393784@5.09@110@171@1.55@CNVR3354.3, CNVR3354.1@TRGV4_2, TRGV4_1@0@0@0@@:protein binding@NA
A2463_12@74245@74246@deletion@2@66648114@66660324@7@chr7:66648114-66660324@9.49@117@49@0.419@NA@TYW1_14, TYW1_15@0@0@0@:tRNA-yW synthesizing protein 1 homolog (S. cerevisiae);tRNA-yW synthesizing protein 1 homolog B (S. cerevisiae)@:tRNA processing;4 iron, 4 sulfur cluster binding;iron-sulfur cluster binding;oxidoreductase activity;FMN binding;iron ion binding;catalytic activity@NA
A2463_12@74566@74568@duplication@3@74159098@74160750@7@chr7:74159098-74160750@9.12@209@317@1.52@NA@GTF2I_21, GTF2I_22, GTF2I_23@0@0@0@:general transcription factor IIi@:neuronal cell body;transcription initiation from RNA polymerase II promoter;mitogen-activated protein kinase binding;negative regulation of angiogenesis;DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;cytoplasm;transcription from RNA polymerase II promoter;protein binding;signal transduction;nucleus;cell projection;reduction of cytosolic calcium ion concentration@NA
A2463_12@74581@74582@duplication@2@74191614@74193503@7@chr7:74191614-74193503@6.89@140@218@1.56@NA@NCF1_2, NCF1_3@0@0@0@:neutrophil cytosolic factor 1@:inflammatory response;antigen processing and presentation of peptide antigen via MHC class I;phagosome maturation;NADPH oxidase complex;neutrophil mediated killing of gram-positive bacterium;cell communication;interaction with host;leukotriene metabolic process;response to yeast;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;respiratory burst;GTPase activity;negative regulation of smooth muscle contraction;GTP catabolic process;cytosol;defense response to fungus;defense response to bacterium;antigen processing and presentation of exogenous peptide antigen via MHC class I;leukocyte mediated cytotoxicity;neutrophil mediated killing of fungus;phosphatidylinositol binding;defense response to Gram-positive bacterium;GTP binding;respiratory burst involved in defense response;superoxide-generating NADPH oxidase activity;hydrogen peroxide biosynthetic process;protein targeting to membrane;electron carrier activity;superoxide metabolic process;innate immune response;phagolysosome;cytoplasm;cell proliferation;superoxide anion generation;protein binding;SH3 domain binding;cellular defense response;response to bacterium@: GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE,
A2463_12@74597@74598@duplication@2@74225431@74227349@7@chr7:74225431-74227349@5.55@38@81@2.13@NA@GTF2IRD2_10, GTF2IRD2_9@0@0@0@:GTF2I repeat domain containing 2@:nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_12@74628@74634@deletion@7@74536693@74550867@7@chr7:74536693-74550867@7.64@158@86@0.544@NA@GTF2IRD2B_4, GTF2IRD2B_5, GTF2IRD2B_6, GTF2IRD2B_7, GTF2IRD2B_8, GTF2IRD2B_9, GTF2IRD2B_10@0@0@0@:GTF2I repeat domain containing 2B@:nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_12@74781@74783@deletion@3@76121471@76129837@7@chr7:76121471-76129837@7.26@54@15@0.278@CNVR3462.1@DTX2_6, DTX2_7, DTX2_8@0@0@0@:deltex homolog 2 (Drosophila)@:ligase activity;cytoplasm;nuclear membrane;Notch signaling pathway;protein binding;nucleus;zinc ion binding;protein ubiquitination@NA
A2463_12@76427@76432@duplication@6@100331793@100336236@7@chr7:100331793-100336236@11.5@231@357@1.55@CNVR3509.1@ZAN_1, ZAN_2, ZAN_3, ZAN_4, ZAN_5, ZAN_6@0@0@0@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
A2463_12@76792@76792@deletion@1@102309363@102309451@7@chr7:102309363-102309451@5.95@27@0@0@CNVR3518.1@POLR2J2_2, POLR2J2_2@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
A2463_12@79311@79311@deletion@1@143929005@143929936@7@chr7:143929005-143929936@11.7@65@7@0.108@CNVR3598.4, CNVR3598.7@OR2A42_1@0@0@0@:Rho guanine nucleotide exchange factor (GEF) 35:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_12@79313@79313@deletion@1@143964011@143966343@7@chr7:143964011-143966343@9.01@188@94@0.5@CNVR3598.4@CTAGE8_1@0@0@0@:Rho guanine nucleotide exchange factor (GEF) 35:CTAGE family, member 6, pseudogene;CTAGE family, member 15, pseudogene@:integral to membrane@NA
A2463_12@79315@79315@deletion@1@144059764@144062916@7@chr7:144059764-144062916@8.83@597@365@0.611@CNVR3598.4, CNVR3598.5@ARHGEF5_2@0@0@0@:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
A2463_12@80564@80573@duplication@10@11970084@12051579@8@chr8:11970084-12051579@16.1@1243@1725@1.39@CNVR3785.8, CNVR3785.5, CNVR3785.2, CNVR3785.3@ZNF705D_6, USP17L2_1, FAM86B1_8, FAM86B1_7, FAM86B1_6, FAM86B1_5, FAM86B1_4, FAM86B1_3, FAM86B1_2, FAM86B1_1@0@0@0@:zinc finger protein 705D:ubiquitin specific peptidase 17-like family member 1, pseudogene;ubiquitin specific peptidase 17-like family member 2;ubiquitin specific peptidase 17-like family member 4;ubiquitin specific peptidase 17-like family member 7;ubiquitin specific peptidase 17-like family member 8;ubiquitin specific peptidase 17-like family member 3:family with sequence similarity 86, member B2;family with sequence similarity 86, member B1@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:protein deubiquitination;ubiquitin-specific protease activity;mitotic cell cycle G1/S transition checkpoint;nucleus;G2/M transition checkpoint;apoptotic process;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
A2463_12@86630@86635@duplication@6@35505@123454@9@chr9:35505-123454@29.6@925@1427@1.54@CNVR4135.1@FAM138C_1, FOXD4_1, CBWD1_15, CBWD1_14, CBWD1_13, CBWD1_12@0@0@0@:forkhead box D4:COBW domain containing 1;COBW domain-containing protein 1-like;COBW domain containing 5@:positive regulation of BMP signaling pathway;positive regulation of kidney development;axon extension involved in axon guidance;lateral line nerve glial cell development;DNA binding, bending;sequence-specific DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;regulation of sequence-specific DNA binding transcription factor activity;transcription factor complex;nucleus;dichotomous subdivision of terminal units involved in ureteric bud branching;sympathetic nervous system development;melanocyte differentiation;enteric nervous system development;positive regulation of transcription from RNA polymerase II promoter;multicellular organismal development;regulation of transcription, DNA-dependent;neural crest cell migration;peripheral nervous system development;double-stranded DNA binding;RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity;iridophore differentiation;transcription factor binding;cartilage development;pattern specification process:ATP binding@NA
A2463_12@86646@86646@duplication@1@178817@178969@9@chr9:178817-178969@4.5@63@109@1.73@CNVR4135.1@CBWD1_1@0@0@0@:COBW domain containing 1;COBW domain-containing protein 1-like;COBW domain containing 5@:ATP binding@NA
A2463_12@88493@88493@duplication@1@39085734@39085820@9@chr9:39085734-39085820@4.65@89@143@1.61@NA@CNTNAP3_21@0@0@0@:contactin associated protein-like 3@:binding;signal transduction;protein binding;integral to membrane;extracellular region;cell adhesion;plasma membrane;cell recognition;receptor binding@NA
A2463_12@88527@88528@deletion@2@40702337@40706387@9@chr9:40702337-40706387@5.68@458@304@0.664@NA@SPATA31A3_3, SPATA31A3_4@0@0@0@:SPATA31 subfamily A, member 3@:integral to membrane@NA
A2463_12@88631@88631@deletion@1@65503517@65507251@9@chr9:65503517-65507251@18.2@118@18@0.153@CNVR4312.5@SPATA31A7_4@0@0@0@:SPATA31 subfamily A, member 7@:integral to membrane@NA
A2463_12@88639@88643@deletion@5@67926874@67936012@9@chr9:67926874-67936012@11.6@112@43@0.384@NA@ANKRD20A1_1, ANKRD20A1_2, ANKRD20A1_3, ANKRD20A1_4, ANKRD20A1_5@0@0@0@:ankyrin repeat domain 20 family, member A1@:protein binding;plasma membrane@NA
A2463_12@88658@88678@deletion@21@69200360@69386055@9@chr9:69200360-69386055@36.2@813@463@0.569@NA@FOXD4L6_1, CBWD6_15, CBWD6_14, CBWD6_13, CBWD6_12, CBWD6_11, CBWD6_10, CBWD6_9, CBWD6_8, CBWD6_7, CBWD6_6, CBWD6_5, BX255923.1_1, CBWD6_4, CBWD6_3, CBWD6_2, CBWD6_1, CR769776.1_1, ANKRD20A4_1, ANKRD20A4_2, ANKRD20A4_3@0@0@0@:forkhead box D4-like 6;forkhead box protein D4-like 6-like:COBW domain containing 6:ankyrin repeat domain 20 family, member A4@:positive regulation of BMP signaling pathway;positive regulation of kidney development;axon extension involved in axon guidance;lateral line nerve glial cell development;DNA binding, bending;sequence-specific DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;regulation of sequence-specific DNA binding transcription factor activity;transcription factor complex;nucleus;dichotomous subdivision of terminal units involved in ureteric bud branching;sympathetic nervous system development;melanocyte differentiation;enteric nervous system development;positive regulation of transcription from RNA polymerase II promoter;regulation of transcription, DNA-dependent;neural crest cell migration;peripheral nervous system development;double-stranded DNA binding;RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity;iridophore differentiation;transcription factor binding;cartilage development;pattern specification process:ATP binding:protein binding@NA
A2463_12@88681@88688@deletion@8@69393823@69420426@9@chr9:69393823-69420426@25.5@221@71@0.321@NA@ANKRD20A4_6, ANKRD20A4_7, ANKRD20A4_8, ANKRD20A4_9, ANKRD20A4_10, ANKRD20A4_11, ANKRD20A4_12, ANKRD20A4_13@0@0@0@:ankyrin repeat domain 20 family, member A4@:protein binding@NA
A2463_12@88720@88723@deletion@4@70889799@70912733@9@chr9:70889799-70912733@11.6@143@62@0.434@NA@CBWD3_10, CBWD3_11, CBWD3_12, CBWD3_13@0@0@0@:COBW domain-containing protein 5-like;COBW domain-containing protein 1-like;COBW domain containing 3@:ATP binding@NA
A2463_12@88725@88726@deletion@2@70914398@70919121@9@chr9:70914398-70919121@6.29@167@94@0.563@NA@CBWD3_15, FOXD4L3_1@0@0@0@:COBW domain-containing protein 5-like;COBW domain-containing protein 1-like;COBW domain containing 3:forkhead box D4-like 3@:ATP binding:sequence-specific DNA binding;nucleus;regulation of transcription, DNA-dependent;sequence-specific DNA binding transcription factor activity@NA
A2463_12@91242@91247@duplication@6@117085415@117088637@9@chr9:117085415-117088637@56.8@373@1018@2.73@CNVR4448.1@ORM1_1, ORM1_2, ORM1_3, ORM1_4, ORM1_5, ORM1_6@0@0@0@:orosomucoid 1@:protein binding;extracellular space;regulation of immune system process;transport;inflammatory response;extracellular region;acute-phase response@NA
A2463_12@95376@95377@duplication@2@17949551@17951363@10@chr10:17949551-17951363@14.4@56@164@2.93@NA@MRC1L1_28, MRC1L1_29@0@0@0@:macrophage mannose receptor 1-like@:carbohydrate binding@NA
A2463_12@95380@95411@deletion@32@18060293@18198276@10@chr10:18060293-18198276@48.1@222@1@0.0045@NA@TMEM236_2, TMEM236_3, TMEM236_4, MRC1_1, MRC1_2, MRC1_3, MRC1_4, MRC1_5, MRC1_6, MRC1_7, MRC1_8, MRC1_9, MRC1_10, MRC1_11, MRC1_12, MRC1_13, MRC1_14, MRC1_15, MRC1_16, MRC1_17, MRC1_18, MRC1_19, MRC1_20, MRC1_21, MRC1_22, MRC1_23, MRC1_24, MRC1_25, MRC1_26, MRC1_27, MRC1_28, MRC1_29@0@0@0@:transmembrane protein 236;transmembrane protein 236-like:mannose receptor, C type 1;macrophage mannose receptor 1-like@:integral to membrane:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
A2463_12@96435@96435@deletion@1@46248629@46248685@10@chr10:46248629-46248685@7.02@36@3@0.0833@NA@FAM21C_13@0@0@0@:family with sequence similarity 21, member C@:endosome;protein binding;plasma membrane;retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_12@96454@96458@deletion@5@46312644@46329564@10@chr10:46312644-46329564@6.89@131@68@0.519@NA@FAM25E_1, AGAP4_7, AGAP4_6, AGAP4_5, AGAP4_4@0@0@0@:ArfGAP with GTPase domain, ankyrin repeat and PH domain 4;arf-GAP with GTPase, ANK repeat and PH domain-containing protein 5-like@:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity@NA
A2463_12@96499@96499@duplication@1@47207813@47207846@10@chr10:47207813-47207846@4.93@55@101@1.84@CNVR4712.9@AGAP10_6@0@0@0@:ArfGAP with GTPase domain, ankyrin repeat and PH domain 9@:phospholipid binding;protein binding;ARF GTPase activator activity;GTP binding;GTPase activity;zinc ion binding;regulation of ARF GTPase activity@NA
A2463_12@96548@96563@duplication@16@47913577@47948853@10@chr10:47913577-47948853@16.3@304@472@1.55@CNVR4715.2, CNVR4715.1@FAM21B_14, FAM21B_15, FAM21B_16, FAM21B_17, FAM21B_18, FAM21B_19, FAM21B_20, FAM21B_21, FAM21B_22, FAM21B_23, FAM21B_24, FAM21B_25, FAM21B_26, FAM21B_27, FAM21B_28, FAM21B_29@0@0@0@:family with sequence similarity 21, member B@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_12@96620@96620@duplication@1@48771316@48771405@10@chr10:48771316-48771405@8.3@68@144@2.12@CNVR4716.10, CNVR4716.3@PTPN20B_6@0@0@0@:protein tyrosine phosphatase, non-receptor type 20B;protein tyrosine phosphatase, non-receptor type 20A@:phosphatase activity;protein tyrosine phosphatase activity;microtubule;nucleus;dephosphorylation;protein dephosphorylation;microtubule organizing center@NA
A2463_12@96626@96631@duplication@6@49203412@49376736@10@chr10:49203412-49376736@9.33@323@461@1.43@CNVR4717.2@FAM25C_3, FAM25C_2, FAM25C_1, FRMPD2_29, FRMPD2_28, FRMPD2_27@0@0@0@:family with sequence similarity 25, member G;family with sequence similarity 25, member C;family with sequence similarity 25, member A;family with sequence similarity 25, member B:FERM and PDZ domain containing 2@:basolateral plasma membrane;transferase activity, transferring phosphorus-containing groups;cytoplasm;tight junction;protein binding;cytoskeleton;1-phosphatidylinositol binding;tight junction assembly@NA
A2463_12@96859@96860@deletion@2@51469924@51472652@10@chr10:51469924-51472652@13@61@1@0.0164@CNVR4729.1@AGAP7_5, AGAP7_4@0@0@0@:translocase of inner mitochondrial membrane 23 homolog B (yeast):ArfGAP with GTPase domain, ankyrin repeat and PH domain 7@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity@NA
A2463_12@96883@96886@deletion@4@51620325@51749136@10@chr10:51620325-51749136@12.8@329@189@0.574@NA@TIMM23_2, TIMM23_1, AGAP6_1, AGAP6_2@0@0@0@:translocase of inner mitochondrial membrane 23 homolog B (yeast):translocase of inner mitochondrial membrane 23 homolog B (yeast);translocase of inner mitochondrial membrane 23 homolog (yeast):ArfGAP with GTPase domain, ankyrin repeat and PH domain 6;arf-GAP with GTPase, ANK repeat and PH domain-containing protein 5-like@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process:mitochondrion;mitochondrial inner membrane;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;mitochondrial intermembrane space;integral to mitochondrial inner membrane;intracellular protein transport;protein binding;integral to membrane;cellular protein metabolic process;protein targeting to mitochondrion:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity@NA
A2463_12@96908@96934@deletion@27@51857436@51970894@10@chr10:51857436-51970894@16.9@592@375@0.633@NA@FAM21A_16, FAM21A_17, FAM21A_18, FAM21A_19, FAM21A_20, FAM21A_21, FAM21A_22, FAM21A_23, FAM21A_24, FAM21A_25, FAM21A_26, FAM21A_27, FAM21A_28, FAM21A_29, FAM21A_30, FAM21A_31, ASAH2_20, ASAH2_19, ASAH2_18, ASAH2_17, ASAH2_16, ASAH2_15, ASAH2_14, ASAH2_13, ASAH2_12, ASAH2_11, ASAH2_10@0@0@0@:family with sequence similarity 21, member B;family with sequence similarity 21, member A:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
A2463_12@98350@98350@duplication@1@81471457@81472241@10@chr10:81471457-81472241@10.1@229@384@1.68@CNVR4815.2, CNVR4815.4@FAM22B_7@0@0@0@NA@NA@NA
A2463_12@98350@98357@deletion@7@81471457@81610362@10@chr10:81471457-81610362@5.24@340@385@1.13@CNVR4815.2@FAM22B_7, FAM22E_1, FAM22E_2, FAM22E_3, FAM22E_4, FAM22E_5, FAM22E_6, FAM22E_7@0@0@0@NA@NA@NA
A2463_12@98595@98595@deletion@1@88985589@88985969@10@chr10:88985589-88985969@4.66@21@0@0@CNVR4840.3, CNVR4840.5@FAM22A_1@0@0@0@:family with sequence similarity 22, member A@NA@NA
A2463_12@103268@103268@duplication@1@4967390@4968330@11@chr11:4967390-4968330@8.44@370@557@1.51@CNVR5040.1@OR51A4_1@0@0@0@:matrix metallopeptidase 26:olfactory receptor, family 51, subfamily A, member 4@:metallopeptidase activity;extracellular matrix;proteolysis;proteinaceous extracellular matrix;collagen catabolic process;metalloendopeptidase activity;zinc ion binding;metabolic process:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_12@104572@104572@deletion@1@18955364@18956331@11@chr11:18955364-18956331@12.7@193@81@0.42@CNVR5091.2, CNVR5091.1@MRGPRX1_1@0@0@0@:MAS-related GPR, member X1@:integral to membrane;G-protein coupled receptor activity;plasma membrane;acute-phase response;G-protein coupled receptor signaling pathway@NA
A2463_12@106038@106041@deletion@4@55032377@55036814@11@chr11:55032377-55036814@28.1@587@285@0.486@CNVR5178.5@TRIM48_2, TRIM48_3, TRIM48_4, TRIM48_5@0@0@0@:tripartite motif containing 48@:protein binding;intracellular;zinc ion binding@NA
A2463_12@106046@106048@deletion@3@55370918@55419315@11@chr11:55370918-55419315@15.7@591@352@0.596@CNVR5179.1@OR4C11_1, OR4P4_1, OR4S2_1@0@0@0@:olfactory receptor, family 4, subfamily C, member 11:olfactory receptor, family 4, subfamily P, member 4:olfactory receptor, family 4, subfamily S, member 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_12@114080@114080@duplication@1@7945547@7945808@12@chr12:7945547-7945808@6.24@65@124@1.91@NA@NANOG_2@0@0@0@:NECAP endocytosis associated 1:Nanog homeobox@:coated pit;protein binding;endocytosis;protein transport;clathrin vesicle coat;plasma membrane;membrane:cell differentiation;regulation of cell differentiation;somatic stem cell maintenance;sequence-specific DNA binding;transcription corepressor activity;embryo development;DNA binding;sequence-specific DNA binding transcription factor activity;nucleus;positive regulation of transcription from RNA polymerase II promoter;regulation of gene expression;regulation of transcription, DNA-dependent;cell proliferation;endodermal cell fate specification;nucleolus;transcription, DNA-dependent@NA
A2463_12@120278@120279@duplication@2@95922584@95928032@12@chr12:95922584-95928032@8.93@592@855@1.44@NA@USP44_3, USP44_2@0@0@0@:ubiquitin specific peptidase 44@:protein deubiquitination;cysteine-type peptidase activity;ubiquitin-specific protease activity;proteasomal ubiquitin-dependent protein catabolic process;regulation of spindle checkpoint;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process;protein binding;mitosis;regulation of mitotic cell cycle spindle assembly checkpoint;nucleus;anaphase;cell division;zinc ion binding;negative regulation of mitotic anaphase-promoting complex activity@NA
A2463_12@127333@127338@duplication@6@19553418@19566082@14@chr14:19553418-19566082@29.3@828@1285@1.55@CNVR6072.1@POTEG_1, POTEG_2, POTEG_3, POTEG_4, POTEG_5, POTEG_6@0@0@0@:POTE ankyrin domain family, member G@:protein binding@NA
A2463_12@127346@127358@duplication@13@20002226@20404761@14@chr14:20002226-20404761@92.2@2556@4246@1.66@CNVR6072.12, CNVR6072.4@POTEM_7, POTEM_6, POTEM_5, POTEM_4, POTEM_3, POTEM_2, POTEM_1, OR4Q3_1, OR4M1_1, OR4N2_1, OR4K2_1, OR4K5_1, OR4K1_1@0@0@0@:POTE ankyrin domain family, member M:olfactory receptor, family 4, subfamily N, member 2:olfactory receptor, family 4, subfamily Q, member 3:olfactory receptor, family 4, subfamily M, member 1:olfactory receptor, family 4, subfamily K, member 2:olfactory receptor, family 4, subfamily K, member 5:olfactory receptor, family 4, subfamily K, member 1@:protein binding:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_12@133470@133473@deletion@4@106877620@106926644@14@chr14:106877620-106926644@7.38@295@187@0.634@CNVR6294.26, CNVR6294.56, CNVR6294.18@IGHV4-39_2, IGHV4-39_1, IGHV3-43_2, IGHV3-43_1@0@0@0@@:protein binding:protein binding@NA
A2463_12@133491@133492@duplication@2@107095127@107095561@14@chr14:107095127-107095561@9.43@70@147@2.1@CNVR6294.56, CNVR6294.16, CNVR6294.91@IGHV4-61_2, IGHV4-61_1@0@0@0@@:protein binding@NA
A2463_12@133532@133535@deletion@4@22062317@22070610@15@chr15:22062317-22070610@5.89@54@19@0.352@NA@POTEB_9, POTEB_8, POTEB_7, POTEB_6@0@0@0@:POTE ankyrin domain family member B-like@:protein binding@NA
A2463_12@133541@133542@deletion@2@22368577@22383423@15@chr15:22368577-22383423@25.9@702@354@0.504@CNVR6297.4, CNVR6297.17, CNVR6297.2@OR4M2_1, OR4N4_1@0@0@0@:olfactory receptor, family 4, subfamily M, member 2:olfactory receptor, family 4, subfamily N, member 4@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_12@133869@133870@deletion@2@28629294@28629596@15@chr15:28629294-28629596@10.8@50@1@0.02@CNVR6329.4@GOLGA8F_9, GOLGA8F_10@0@0@0@@:Golgi apparatus@NA
A2463_12@134036@134054@duplication@19@30845996@30896376@15@chr15:30845996-30896376@13.3@346@505@1.46@CNVR6339.2, CNVR6339.3, CNVR6339.1@GOLGA8Q_2, GOLGA8Q_3, GOLGA8Q_4, GOLGA8Q_5, GOLGA8Q_6, GOLGA8Q_7, GOLGA8Q_8, GOLGA8Q_9, GOLGA8Q_10, GOLGA8Q_11, GOLGA8Q_12, GOLGA8Q_13, GOLGA8Q_14, GOLGA8Q_15, GOLGA8Q_16, GOLGA8Q_17, GOLGA8Q_18, GOLGA8Q_19, GOLGA8H_1@0@0@0@:golgin A8 family, member H@:Golgi apparatus:Golgi apparatus@NA
A2463_12@134173@134177@duplication@5@32692342@32695395@15@chr15:32692342-32695395@8.9@64@133@2.08@NA@GOLGA8K_4, GOLGA8K_3, GOLGA8K_2, AC139426.2_1, GOLGA8K_1@0@0@0@:golgin A8 family, member J@:Golgi apparatus@NA
A2463_12@134180@134192@deletion@13@32737820@32743840@15@chr15:32737820-32743840@16.1@220@107@0.486@CNVR6346.1@GOLGA8O_17, GOLGA8O_16, GOLGA8O_15, GOLGA8O_14, GOLGA8O_13, GOLGA8O_12, GOLGA8O_11, GOLGA8O_10, GOLGA8O_9, GOLGA8O_8, GOLGA8O_7, GOLGA8O_6, GOLGA8O_5@0@0@0@:golgin A8 family, member O@:Golgi apparatus@NA
A2463_12@134204@134205@deletion@2@32890090@32890378@15@chr15:32890090-32890378@6.01@76@34@0.447@NA@GOLGA8N_7, GOLGA8N_8@0@0@0@:golgin A8 family, member R@:Golgi apparatus@NA
A2463_12@134431@134432@deletion@2@34673613@34674057@15@chr15:34673613-34674057@6.89@113@55@0.487@CNVR6351.4, CNVR6351.3@GOLGA8A_24, GOLGA8A_23@0@0@0@:golgin A8 family, member A@:Golgi cisterna membrane;Golgi apparatus@NA
A2463_12@134442@134447@duplication@6@34677629@34820035@15@chr15:34677629-34820035@9.43@146@242@1.66@CNVR6351.3@GOLGA8A_13, GOLGA8A_12, GOLGA8A_11, GOLGA8A_10, GOLGA8A_9, GOLGA8B_25@0@0@0@:golgin A8 family, member A:golgin A8 family, member A;golgin A8 family, member B@:Golgi cisterna membrane;Golgi apparatus:Golgi cisterna membrane;Golgi apparatus@NA
A2463_12@134457@134460@deletion@4@34823677@34825163@15@chr15:34823677-34825163@11.3@53@1@0.0189@CNVR6351.3@GOLGA8B_15, GOLGA8B_14, GOLGA8B_13, GOLGA8B_12@0@0@0@:golgin A8 family, member A:golgin A8 family, member A;golgin A8 family, member B@:Golgi cisterna membrane;Golgi apparatus:Golgi cisterna membrane;Golgi apparatus@NA
A2463_12@138284@138286@duplication@3@72954594@72956852@15@chr15:72954594-72956852@14.7@128@270@2.11@CNVR6443.1@GOLGA6B_11, GOLGA6B_12, GOLGA6B_13@0@0@0@:golgin A6 family, member B@:Golgi apparatus@NA
A2463_12@138636@138639@deletion@4@75557464@75558954@15@chr15:75557464-75558954@9.33@133@63@0.474@CNVR6452.1@GOLGA6C_8, GOLGA6C_9, GOLGA6C_10, GOLGA6C_11@0@0@0@:golgin A6 family, member C@:Golgi apparatus@NA
A2463_12@138661@138664@deletion@4@75586071@75586816@15@chr15:75586071-75586816@13.9@122@40@0.328@CNVR6452.1@GOLGA6D_15, GOLGA6D_16, GOLGA6D_17, GOLGA6D_18@0@0@0@:golgin A6 family, member D@:Golgi apparatus@NA
A2463_12@139302@139308@duplication@7@83011416@83015609@15@chr15:83011416-83015609@15.2@31@134@4.32@CNVR6477.6, CNVR6477.2@RP13-996F3.4_9, RP13-996F3.4_8, RP13-996F3.4_7, RP13-996F3.4_6, RP13-996F3.4_5, RP13-996F3.4_4, RP13-996F3.4_3@0@0@0@NA@NA@NA
A2463_12@139479@139479@deletion@1@84908541@84909534@15@chr15:84908541-84909534@6.49@153@82@0.536@CNVR6486.2@GOLGA6L4_6@0@0@0@@:Golgi apparatus@NA
A2463_12@140476@140477@deletion@2@64382@64720@16@chr16:64382-64720@7.42@38@3@0.0789@CNVR6565.1@WASH4P_10, WASH4P_9@0@0@0@@:intracellular membrane-bounded organelle;endosomal transport;recycling endosome;early endosome;Arp2/3 complex-mediated actin nucleation;actin binding;alpha-tubulin binding;retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;recycling endosome membrane@NA
A2463_12@143002@143003@deletion@2@18542360@18542929@16@chr16:18542360-18542929@10.5@116@43@0.371@NA@NOMO2_14, NOMO2_13@0@0@0@:NODAL modulator 2@:carbohydrate binding;protein binding;integral to membrane;carboxypeptidase activity;endoplasmic reticulum membrane@NA
A2463_12@143443@143444@deletion@2@21413606@21416614@16@chr16:21413606-21416614@6.16@99@48@0.485@CNVR6668.3@NPIPL3_14, NPIPL3_13, NPIPL3_12, NPIPL3_11, NPIPL3_10, NPIPL3_9, NPIPL3_8, NPIPL3_7@0@0@0@@:integral to membrane;molecular_function;cellular_component;biological_process@NA
A2463_12@144096@144102@deletion@7@28617143@28620176@16@chr16:28617143-28620176@9.31@534@359@0.672@CNVR6685.1, CNVR6685.2@SULT1A1_10, SULT1A1_9, SULT1A1_8, SULT1A1_7, SULT1A1_6, SULT1A1_5, SULT1A1_4@0@0@0@:sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1@:small molecule metabolic process;sulfation;aryl sulfotransferase activity;amine metabolic process;catecholamine metabolic process;xenobiotic metabolic process;cytosol;steroid sulfotransferase activity;integral to membrane;sulfotransferase activity;flavonol 3-sulfotransferase activity;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process;estrogen metabolic process@NA
A2463_12@144104@144104@duplication@1@28659457@28659638@16@chr16:28659457-28659638@5.61@12@50@4.17@NA@A-575C2.4_2@0@0@0@:nuclear pore complex-interacting protein-like 2-like;putative NPIP-like protein LOC613037-like@NA@NA
A2463_12@144130@144134@duplication@5@28763890@28777810@16@chr16:28763890-28777810@8.85@77@150@1.95@NA@A-575C2.4_1, A-575C2.4_2, A-575C2.4_3, A-575C2.4_4, A-575C2.4_5@0@0@0@NA@NA@NA
A2463_12@147101@147101@deletion@1@70010292@70010635@16@chr16:70010292-70010635@10.5@140@57@0.407@CNVR6762.3, CNVR6762.2@RP11-419C5.2_7@0@0@0@NA@NA@NA
A2463_12@149172@149172@deletion@1@2965964@2966901@17@chr17:2965964-2966901@11.2@213@100@0.469@NA@OR1D5_1@0@0@0@:olfactory receptor, family 1, subfamily D, member 5@:integral to membrane;sensory perception of smell;G-protein coupled receptor activity;plasma membrane;detection of chemical stimulus involved in sensory perception of smell;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_12@151886@151886@duplication@1@18429609@18430117@17@chr17:18429609-18430117@5.16@79@134@1.7@NA@FAM106A_1@0@0@0@:protein FAM106B-like@NA@NA
A2463_12@153376@153394@deletion@19@34522686@34590454@17@chr17:34522686-34590454@18.8@100@11@0.11@CNVR7077.1, CNVR7077.13, CNVR7077.19@CCL3L3_3, CCL3L3_2, CCL3L3_1, CCL4L1_1, CCL4L1_2, CCL4L1_3, TBC1D3C_14, TBC1D3C_13, TBC1D3C_12, TBC1D3C_11, TBC1D3C_10, TBC1D3C_9, TBC1D3C_8, TBC1D3C_7, TBC1D3C_6, TBC1D3C_5, TBC1D3C_4, TBC1D3C_3, TBC1D3C_2@0@0@0@:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1:TBC1 domain family, member 3C;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3H-like;TBC1 domain family, member 3H@:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_12@153414@153414@deletion@1@34797487@34798054@17@chr17:34797487-34798054@12.9@59@0@0@CNVR7078.2, CNVR7078.3@TBC1D3G_14@0@0@0@:TBC1 domain family member 3H-like;TBC1 domain family, member 3H:TBC1 domain family, member 3;TBC1 domain family, member 3G;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like;TBC1 domain family, member 3H@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_12@155584@155590@deletion@7@44380005@44409347@17@chr17:44380005-44409347@31.2@317@105@0.331@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A_3, LRRC37A_4, LRRC37A_5, LRRC37A_6, LRRC37A_7, LRRC37A_8, LRRC37A_9@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
A2463_12@155592@155600@deletion@9@44412912@44594799@17@chr17:44412912-44594799@63.2@318@13@0.0409@CNVR7114.2, CNVR7114.1@LRRC37A_11, LRRC37A_12, LRRC37A_13, LRRC37A_14, ARL17B_4, ARL17B_3, ARL17B_2, LRRC37A2_2, LRRC37A2_3@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
A2463_12@155606@155609@deletion@4@44623622@44630815@17@chr17:44623622-44630815@12.3@1174@811@0.691@CNVR7114.2, CNVR7114.5, CNVR7114.4, CNVR7114.6@LRRC37A2_9, LRRC37A2_10, LRRC37A2_11, LRRC37A2_12@0@0@0@:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
A2463_12@162019@162019@deletion@1@44554574@44556213@18@chr18:44554574-44556213@18.8@1784@968@0.543@CNVR7319.1@TCEB3C_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C (elongin A3);RNA polymerase II transcription factor SIII subunit A3-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_12@169778@169778@deletion@1@39262470@39262670@19@chr19:39262470-39262670@6.77@32@1@0.0312@NA@LGALS7_3@0@0@0@:lectin, galactoside-binding, soluble, 7;lectin, galactoside-binding, soluble, 7B@:carbohydrate binding;heterophilic cell-cell adhesion;extracellular space;nucleus;apoptotic process;cytoplasm@NA
A2463_12@170098@170100@duplication@3@40376632@40382826@19@chr19:40376632-40382826@27.4@250@517@2.07@CNVR7639.2@FCGBP_24, FCGBP_23, FCGBP_22@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_12@170104@170109@deletion@6@40389653@40399855@19@chr19:40389653-40399855@64.9@452@103@0.228@CNVR7639.2, CNVR7639.3@FCGBP_18, FCGBP_17, FCGBP_16, FCGBP_15, FCGBP_14, FCGBP_13@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_12@170781@170784@duplication@4@43258448@43268433@19@chr19:43258448-43268433@7.37@374@512@1.37@NA@PSG8_5, PSG8_4, PSG8_3, PSG8_2@0@0@0@:pregnancy specific beta-1-glycoprotein 8@:protein binding;extracellular region@NA
A2463_12@173301@173308@duplication@8@54742830@54746600@19@chr19:54742830-54746600@10.3@546@742@1.36@CNVR7721.3, CNVR7721.6@LILRA6_8, LILRA6_7, LILRA6_6, LILRA6_5, LILRA6_4, LILRA6_3, LILRA6_2, LILRA6_1@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
A2463_12@173482@173504@deletion@23@55320289@55363737@19@chr19:55320289-55363737@44.9@899@507@0.564@CNVR7725.1, CNVR7725.6@KIR2DL4_5, KIR2DL4_6, KIR2DL4_7, KIR3DL1_1, KIR3DL1_2, KIR3DL1_3, KIR3DL1_4, KIR3DL1_5, KIR3DL1_6, KIR3DL1_7, KIR3DL1_8, KIR3DL1_9, KIR2DS4_1, KIR2DS4_2, KIR2DS4_3, KIR2DS4_4, KIR2DS4_5, KIR2DS4_6, KIR2DS4_7, KIR2DS4_8, KIR3DL2_1, KIR3DL2_2, KIR3DL2_3@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2-like@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane@NA
A2463_12@173902@173903@deletion@2@56658282@56662350@19@chr19:56658282-56662350@6.06@49@15@0.306@NA@ZNF444_3, AC024580.1_2@0@0@0@:zinc finger protein 444@:intracellular;DNA binding;regulation of transcription, DNA-dependent;sequence-specific DNA binding transcription factor activity;viral reproduction;nucleus;transcription, DNA-dependent;zinc ion binding@NA
A2463_12@174394@174395@deletion@2@1558985@1569278@20@chr20:1558985-1569278@5.5@146@85@0.582@CNVR7763.1@RP4-576H24.4_2, SIRPB1_2, RP4-576H24.4_1@0@0@0@:signal-regulatory protein beta 1;signal-regulatory protein beta-1-like;signal-regulatory protein beta-1 isoform 3-like@:protein binding:protein binding;signal transduction;integral to membrane;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway@NA
A2463_12@180968@180968@duplication@1@16266930@16267095@22@chr22:16266930-16267095@11.2@248@423@1.71@CNVR8071.2, CNVR8071.3@POTEH_9@0@0@0@:POTE ankyrin domain family, member H@:protein binding@NA
A2463_12@180979@180979@duplication@1@17264510@17265299@22@chr22:17264510-17265299@9.61@45@124@2.76@NA@XKR3_4@0@0@0@:XK, Kell blood group complex subunit-related family, member 3@:integral to membrane;plasma membrane@NA
A2463_12@181127@181133@deletion@7@18723546@18739404@22@chr22:18723546-18739404@8.83@55@11@0.2@CNVR8087.5, CNVR8087.2, CNVR8087.11@AC008132.1_2, AC008132.1_3, AC008132.1_4, AC008132.1_5, AC008132.1_6, AC008132.1_7, AC008132.1_8@0@0@0@NA@NA@NA
A2463_12@181622@181622@deletion@1@21480538@21481925@22@chr22:21480538-21481925@5.92@78@34@0.436@CNVR8100.6, CNVR8100.12@POM121L7_1@0@0@0@:putative POM121-like protein 1-like@NA@NA
A2463_12@181951@181954@duplication@4@24376424@24381787@22@chr22:24376424-24381787@7.67@90@157@1.74@CNVR8114.13, CNVR8114.1, CNVR8114.7@GSTT1_5, GSTT1_4, GSTT1_3, GSTT1_2@0@0@0@:glutathione S-transferase theta 1@:glutathione peroxidase activity;response to drug;transferase activity;cytosol;protein binding;glutathione transferase activity;glutathione metabolic process;response to organic cyclic compound@NA
A2463_07@422@427@duplication@6@1634916@1636464@1@chr1:1634916-1636464@10.5@212@326@1.54@CNVR17.1@CDK11A_18, CDK11A_17, CDK11A_16, CDK11A_15, CDK11A_14, CDK11A_13@0@0@0@:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A@:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division@NA
A2463_07@431@434@deletion@4@1640234@1643839@1@chr1:1640234-1643839@10.7@48@0@0@CNVR17.1@CDK11A_9, CDK11A_8, CDK11A_7, CDK11A_6@0@0@0@:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A@:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division@NA
A2463_07@1817@1826@duplication@10@12941676@13001395@1@chr1:12941676-13001395@14.8@864@1172@1.36@CNVR72.3, CNVR72.4, CNVR72.2@PRAMEF4_3, PRAMEF4_2, PRAMEF10_4, PRAMEF10_3, PRAMEF10_2, PRAMEF7_2, PRAMEF7_3, PRAMEF7_4, PRAMEF6_4, PRAMEF6_3@0@0@0@:PRAME family member 4:PRAME family member 10:PRAME family member 7:PRAME family member 6;PRAME family member 23;PRAME family member 9/15-like;PRAME family member 5@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_07@1854@1854@duplication@1@13497571@13498128@1@chr1:13497571-13498128@5.69@49@98@2@CNVR74.8@PRAMEF16_3@0@0@0@:PRAME family member 16@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_07@1869@1869@deletion@1@13718405@13718962@1@chr1:13718405-13718962@4.94@59@25@0.424@CNVR76.2@PRAMEF17_3@0@0@0@:PRAME family member 17@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_07@8507@8508@duplication@2@89476588@89477710@1@chr1:89476588-89477710@10.7@355@524@1.48@CNVR244.1@GBP3_8, GBP3_7@0@0@0@:guanylate binding protein 3@:defense response to virus;GTP binding;GTPase activity;membrane;cytoplasm@NA
A2463_07@9385@9386@duplication@2@104297122@104297436@1@chr1:104297122-104297436@19.2@385@647@1.68@CNVR266.3, CNVR266.5@AMY1C_6, AMY1C_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
A2463_07@9766@9773@deletion@8@110230497@110235917@1@chr1:110230497-110235917@49.2@229@2@0.00873@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_1, GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
A2463_07@10788@10788@duplication@1@144220788@144220959@1@chr1:144220788-144220959@5.12@73@126@1.73@CNVR333.1, CNVR333.3@RP3-377D14.1_87@0@0@0@NA@NA@NA
A2463_07@10793@10793@deletion@1@144339779@144340398@1@chr1:144339779-144340398@5.19@23@0@0@CNVR334.4, CNVR334.2@AL592284.1_1@0@0@0@:uncharacterized LOC730256;uncharacterized LOC101060698;uncharacterized LOC642441@NA@NA
A2463_07@10799@10799@deletion@1@144815937@144816008@1@chr1:144815937-144816008@7.32@58@16@0.276@CNVR338.4, CNVR338.2, CNVR338.5, CNVR338.1@NBPF9_4@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 24@NA@NA
A2463_07@10868@10868@deletion@1@145302655@145302868@1@chr1:145302655-145302868@6.04@87@40@0.46@CNVR341.2, CNVR341.3, CNVR341.4@NBPF10_8@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family, member 10@:protein binding;calcium ion binding@NA
A2463_07@10890@10893@deletion@4@145325953@145328432@1@chr1:145325953-145328432@12.2@59@3@0.0508@CNVR341.2, CNVR341.3@NBPF10_30, NBPF10_31, NBPF10_32, NBPF10_33@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family, member 10@NA@NA
A2463_07@11127@11136@duplication@10@146215076@146222344@1@chr1:146215076-146222344@9.32@128@220@1.72@NA@NBPF12_38, NBPF12_37, NBPF12_36, NBPF12_35, NBPF12_34, NBPF12_33, NBPF12_32, NBPF12_31, NBPF12_30, NBPF12_29@0@0@0@:neuroblastoma breakpoint family member 21-like@NA@NA
A2463_07@11149@11157@duplication@9@146232495@146244717@1@chr1:146232495-146244717@21@29@172@5.93@NA@NBPF12_16, NBPF12_15, NBPF12_14, NBPF12_13, NBPF12_12, NBPF12_11, NBPF12_10, NBPF12_9, NBPF12_8@0@0@0@:neuroblastoma breakpoint family member 21-like@NA@NA
A2463_07@11160@11164@duplication@5@146247871@146253110@1@chr1:146247871-146253110@6.69@151@226@1.5@NA@NBPF12_5, NBPF12_4, NBPF12_3, NBPF12_2, NBPF12_1@0@0@0@:neuroblastoma breakpoint family member 21-like@NA@NA
A2463_07@11168@11175@deletion@8@146399556@146408167@1@chr1:146399556-146408167@21.8@389@197@0.506@NA@NBPF12_8, NBPF12_9, NBPF12_10, NBPF12_11, NBPF12_12, NBPF12_13, NBPF12_14, NBPF12_15@0@0@0@:neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family member 14-like;neuroblastoma breakpoint family, member 12@:cytoplasm@NA
A2463_07@11242@11242@deletion@1@146465879@146466121@1@chr1:146465879-146466121@5.55@157@90@0.573@CNVR344.2@NBPF12_82@0@0@0@:neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family member 14-like;neuroblastoma breakpoint family, member 12@:cytoplasm@NA
A2463_07@11508@11508@deletion@1@149762794@149763073@1@chr1:149762794-149763073@36.7@338@71@0.21@CNVR351.3, CNVR351.5@FCGR1A_6@0@0@0@:Fc fragment of IgG, high affinity Ib, receptor (CD64);Fc fragment of IgG, high affinity Ia, receptor (CD64):histone cluster 2, H2bf@:IgG receptor activity;phagocytosis, recognition;antibody-dependent cellular cytotoxicity;regulation of immune response;phagocytosis, engulfment;antigen processing and presentation of peptide antigen via MHC class I;immune response;clathrin-coated endocytic vesicle membrane;interferon-gamma-mediated signaling pathway;integral to membrane;Fc-gamma receptor signaling pathway;positive regulation of type III hypersensitivity;plasma membrane;receptor-mediated endocytosis;positive regulation of phagocytosis;cytokine-mediated signaling pathway;early endosome membrane;cell surface receptor signaling pathway;IgG binding;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;positive regulation of type IIa hypersensitivity;antigen processing and presentation of exogenous antigen;external side of plasma membrane;signal transduction;protein binding;defense response to bacterium;antigen processing and presentation of exogenous peptide antigen via MHC class I;receptor signaling protein activity;response to bacterium:sequence-specific DNA binding;intracellular;nucleus;protein heterodimerization activity;DNA binding;nucleosome assembly;nucleosome@NA
A2463_07@12117@12118@deletion@2@152573209@152586574@1@chr1:152573209-152586574@25.9@120@0@0@CNVR358.1@LCE3C_1, LCE3B_1@0@0@0@:late cornified envelope 3C:late cornified envelope 3B@:keratinization:keratinization@NA
A2463_07@12129@12129@deletion@1@152770272@152770615@1@chr1:152770272-152770615@6.77@85@36@0.424@CNVR360.1@LCE1D_2@0@0@0@:late cornified envelope 1D@:cytoplasmic part;cornified envelope;cellular response to calcium ion;keratinization;perinuclear region of cytoplasm;cytoplasm@NA
A2463_07@16029@16037@deletion@9@196744018@196796135@1@chr1:196744018-196796135@38.5@1487@908@0.611@CNVR459.1@CFHR3_1, CFHR3_2, CFHR3_3, CFHR3_4, CFHR3_5, CFHR3_6, CFHR1_1, CFHR1_2, CFHR1_3@0@0@0@:complement factor H-related 3:complement factor H-related 1:complement factor H-related 2@:extracellular space:extracellular space;complement activation:extracellular region@NA
A2463_07@16039@16040@deletion@2@196799631@196801129@1@chr1:196799631-196801129@7.18@441@290@0.658@CNVR459.1@CFHR1_5, CFHR1_6@0@0@0@:complement factor H-related 1:complement factor H-related 2@:extracellular space;complement activation:extracellular region@NA
A2463_07@17286@17287@duplication@2@207718654@207719023@1@chr1:207718654-207719023@5.26@40@83@2.08@CNVR485.1@CR1_14, CR1_15@0@0@0@:complement component (3b/4b) receptor 1 (Knops blood group)@:complement component C4b receptor activity;complement activation, classical pathway;negative regulation of complement activation, alternative pathway;innate immune response;negative regulation of serine-type endopeptidase activity;complement component C3b binding;negative regulation of complement activation, classical pathway;plasma membrane;integral to plasma membrane;complement component C3b receptor activity;complement component C4b binding;cell surface;regulation of complement activation;positive regulation of serine-type endopeptidase activity@: MALARIA, SUSCEPTIBILITY TO; KNOPS BLOOD GROUP SYSTEM; KN
A2463_07@17294@17294@deletion@1@207737210@207737385@1@chr1:207737210-207737385@5.71@44@12@0.273@CNVR485.1, CNVR485.2@CR1_22@0@0@0@:complement component (3b/4b) receptor 1 (Knops blood group)@:complement component C4b receptor activity;complement activation, classical pathway;negative regulation of complement activation, alternative pathway;innate immune response;negative regulation of serine-type endopeptidase activity;complement component C3b binding;negative regulation of complement activation, classical pathway;plasma membrane;integral to plasma membrane;complement component C3b receptor activity;complement component C4b binding;cell surface;regulation of complement activation;positive regulation of serine-type endopeptidase activity@: MALARIA, SUSCEPTIBILITY TO; KNOPS BLOOD GROUP SYSTEM; KN
A2463_07@19978@19981@deletion@4@7023503@7033834@2@chr2:7023503-7033834@8.49@374@241@0.644@NA@RSAD2_2, RSAD2_3, RSAD2_4, RSAD2_5@0@0@0@:radical S-adenosyl methionine domain containing 2@:defense response to virus;mitochondrion;mitochondrial inner membrane;positive regulation of toll-like receptor 9 signaling pathway;positive regulation of toll-like receptor 7 signaling pathway;catalytic activity;mitochondrial outer membrane;negative regulation of protein secretion;regulation of ossification;endoplasmic reticulum membrane;CD4-positive, alpha-beta T cell activation;virus-host interaction;ossification;4 iron, 4 sulfur cluster binding;negative regulation of viral genome replication;response to virus;protein self-association;Golgi apparatus;endoplasmic reticulum;positive regulation of T-helper 2 cell cytokine production;innate immune response;protein binding;iron-sulfur cluster binding;lipid particle;CD4-positive, alpha-beta T cell differentiation;molecular_function;metal ion binding@NA
A2463_07@24984@24985@deletion@2@89986353@89987079@2@chr2:89986353-89987079@5.49@137@79@0.577@CNVR867.10, CNVR867.7, CNVR867.1@IGKV2D-29_1, IGKV2D-29_2@0@0@0@@:protein binding@NA
A2463_07@25350@25351@deletion@2@97818242@97820478@2@chr2:97818242-97820478@5.11@144@85@0.59@CNVR886.2@ANKRD36_14, ANKRD36_15@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_07@26008@26011@deletion@4@108454714@108460186@2@chr2:108454714-108460186@6.46@128@69@0.539@NA@RGPD4_3, RGPD4_4, RGPD4_5, RGPD4_6@0@0@0@:RANBP2-like and GRIP domain containing 4@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_07@26021@26024@deletion@4@108479139@108486433@2@chr2:108479139-108486433@6.93@356@232@0.652@NA@RGPD4_16, RGPD4_17, RGPD4_18, RGPD4_19@0@0@0@:RANBP2-like and GRIP domain containing 4@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_07@26088@26088@deletion@1@109293063@109293154@2@chr2:109293063-109293154@8.2@79@27@0.342@NA@LIMS1_7@0@0@0@:LIM and senescent cell antigen-like domains 1@:negative regulation of transcription, DNA-dependent;cell aging;perinuclear region of cytoplasm;cellular response to transforming growth factor beta stimulus;cytosol;protein binding;focal adhesion;plasma membrane;zinc ion binding;cell junction assembly@NA
A2463_07@26305@26305@deletion@1@112541475@112541541@2@chr2:112541475-112541541@6.12@80@35@0.438@CNVR928.1@ANAPC1_42@0@0@0@:anaphase-promoting complex subunit 1-like;anaphase promoting complex subunit 1@:nucleoplasm;regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle;anaphase-promoting complex;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle spindle assembly checkpoint;cytosol;protein K11-linked ubiquitination;protein binding;mitosis;nucleus;cell cycle checkpoint;cell division;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle@NA
A2463_07@26412@26414@duplication@3@113127756@113138540@2@chr2:113127756-113138540@7.5@176@268@1.52@NA@RGPD8_23, RGPD8_22, RGPD8_21@0@0@0@:RANBP2-like and GRIP domain containing 8@:protein binding;intracellular;intracellular transport;nuclear pore;protein targeting to Golgi;Ran GTPase binding;biological_process@NA
A2463_07@27987@27987@deletion@1@152450522@152450832@2@chr2:152450522-152450832@5.33@51@18@0.353@CNVR1026.1@NEB_93@0@0@0@:nebulin@:Z disc;muscle filament sliding;oxidation-reduction process;contractile fiber part;actin cytoskeleton;regulation of actin filament length;structural constituent of muscle;cytosol;actin binding;protein binding;myofibril;somatic muscle development;muscle organ development@: NEMALINE MYOPATHY 2; NEM2
A2463_07@27996@27997@deletion@2@152463121@152464122@2@chr2:152463121-152464122@17.1@92@8@0.087@CNVR1026.1@NEB_84, NEB_83@0@0@0@:nebulin@:Z disc;muscle filament sliding;oxidation-reduction process;contractile fiber part;actin cytoskeleton;regulation of actin filament length;structural constituent of muscle;cytosol;actin binding;protein binding;myofibril;somatic muscle development;muscle organ development@: NEMALINE MYOPATHY 2; NEM2
A2463_07@39892@39894@duplication@3@75786030@75790887@3@chr3:75786030-75790887@21.9@243@485@2@CNVR1432.5, CNVR1432.9, CNVR1432.4@ZNF717_5, ZNF717_4, ZNF717_3@0@0@0@:zinc finger protein 717;zinc finger protein 717-like@:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_07@45433@45438@duplication@6@195447880@195475935@3@chr3:195447880-195475935@17.8@803@1116@1.39@CNVR1703.1, CNVR1703.2, CNVR1703.5, CNVR1703.3@MUC20_1, MUC20_2, MUC20_3, MUC20_4, MUC4_25, MUC4_24@0@0@0@:mucin 20, cell surface associated:mucin 4, cell surface associated@:microvillus membrane;apical plasma membrane;activation of MAPK activity;Golgi lumen;post-translational protein modification;protein binding;O-glycan processing;hepatocyte growth factor receptor signaling pathway;cellular protein metabolic process;extracellular region;protein homooligomerization;basal plasma membrane:ErbB-2 class receptor binding;Golgi lumen;cell-matrix adhesion;post-translational protein modification;extracellular matrix structural constituent;protein binding;O-glycan processing;cellular protein metabolic process;proteinaceous extracellular matrix;integral to plasma membrane;membrane;extracellular matrix constituent, lubricant activity;biological_process@NA
A2463_07@46667@46675@deletion@9@9174900@9237700@4@chr4:9174900-9237700@18@126@30@0.238@NA@FAM90A26P_4, FAM90A26P_5, FAM90A26P_6, FAM90A26P_7, USP17L13_1, USP17L10_1, USP17L11_1, USP17L12_1, USP17L13_2, USP17L15_1@0@0@0@:ubiquitin specific peptidase 17-like family member 10:ubiquitin specific peptidase 17-like family member 13:ubiquitin specific peptidase 17-like family member 11:ubiquitin specific peptidase 17-like family member 12:ubiquitin specific peptidase 17-like family member 15@:zinc ion binding;nucleic acid binding:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
A2463_07@46677@46677@duplication@1@9250357@9251948@4@chr4:9250357-9251948@5.55@335@471@1.41@NA@USP17L18_1@0@0@0@:ubiquitin specific peptidase 17-like family member 18@:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
A2463_07@48556@48561@duplication@6@69403344@69434202@4@chr4:69403344-69434202@35@519@923@1.78@CNVR1953.1@UGT2B17_6, UGT2B17_5, UGT2B17_4, UGT2B17_3, UGT2B17_2, UGT2B17_1@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B17@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;membrane@: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
A2463_07@48556@48564@deletion@3@69403344@69520900@4@chr4:69403344-69520900@-61.6@799@1078@1.35@CNVR1953.1@UGT2B17_6, UGT2B17_5, UGT2B17_4, UGT2B17_3, UGT2B17_2, UGT2B17_1, UGT2B15_6, UGT2B15_5, UGT2B15_4@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B17:UDP glucuronosyltransferase 2 family, polypeptide B15@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;membrane:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;cellular glucuronidation;xenobiotic metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process@: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
A2463_07@48592@48597@duplication@6@70146220@70160527@4@chr4:70146220-70160527@17.1@786@1089@1.39@CNVR1957.2, CNVR1957.1@UGT2B28_1, UGT2B28_2, UGT2B28_3, UGT2B28_4, UGT2B28_5, UGT2B28_6@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B28@:carbohydrate binding;transferase activity, transferring hexosyl groups;endoplasmic reticulum;glucuronosyltransferase activity;carbohydrate metabolic process;xenobiotic metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process@NA
A2463_07@52974@52986@deletion@13@185689471@185736252@4@chr4:185689471-185736252@23.1@917@585@0.638@NA@ACSL1_12, ACSL1_11, ACSL1_10, ACSL1_9, ACSL1_8, ACSL1_7, ACSL1_6, ACSL1_5, ACSL1_4, ACSL1_3, ACSL1_2, RP11-701P16.2_1, RP11-701P16.2_2@0@0@0@:acyl-CoA synthetase long-chain family member 1@:mitochondrion;triglyceride biosynthetic process;response to oleic acid;ATP binding;fatty acid metabolic process;plasma membrane;endoplasmic reticulum membrane;linoleic acid metabolic process;response to organic substance;endoplasmic reticulum;ligase activity;lipid biosynthetic process;triglyceride metabolic process;response to organic cyclic compound;long-chain fatty acid import;response to drug;fatty acid transport;catalytic activity;mitochondrial outer membrane;adiponectin-mediated signaling pathway;positive regulation of protein serine/threonine kinase activity;integral to membrane;peroxisomal membrane;response to nutrient;metabolic process;xenobiotic catabolic process;small molecule metabolic process;unsaturated fatty acid metabolic process;cellular lipid metabolic process;long-chain fatty-acyl-CoA biosynthetic process;long-chain fatty acid-CoA ligase activity;long-chain fatty acid metabolic process;regulation of fatty acid oxidation;alpha-linolenic acid metabolic process@NA
A2463_07@55787@55787@duplication@1@68868273@68868377@5@chr5:68868273-68868377@6.44@51@107@2.1@CNVR2494.7, CNVR2494.46@GTF2H2C_8@0@0@0@:general transcription factor IIH, polypeptide 2C;general transcription factor IIH, polypeptide 2D@:regulation of transcription, DNA-dependent;nucleotide-excision repair;DNA repair;core TFIIH complex;protein binding;nucleus;transcription, DNA-dependent;zinc ion binding@NA
A2463_07@55789@55791@deletion@3@68874849@68878256@5@chr5:68874849-68878256@7.52@132@69@0.523@CNVR2494.7, CNVR2494.46@GTF2H2C_10, GTF2H2C_11, GTF2H2C_12@0@0@0@:general transcription factor IIH, polypeptide 2C;general transcription factor IIH, polypeptide 2D@:regulation of transcription, DNA-dependent;nucleotide-excision repair;DNA repair;core TFIIH complex;protein binding;nucleus;transcription, DNA-dependent;zinc ion binding@NA
A2463_07@55806@55806@deletion@1@69372349@69372398@5@chr5:69372349-69372398@21.8@104@1@0.00962@CNVR2494.48, CNVR2494.39, CNVR2494.15, CNVR2494.18, CNVR2494.26, CNVR2494.43, CNVR2494.52, CNVR2494.28, CNVR2494.2, CNVR2494.36@SMN2_8@0@0@0@:survival of motor neuron 2, centromeric;survival of motor neuron 1, telomeric@:nucleoplasm;ncRNA metabolic process;Cajal body;RNA metabolic process;spliceosomal complex;cytoplasm;cytosol;protein binding;cell death;spliceosomal complex assembly;RNA binding;mRNA processing;nucleus;gene expression;spliceosomal snRNP assembly@: SPINAL MUSCULAR ATROPHY, TYPE II; SMA2; SPINAL MUSCULAR ATROPHY, TYPE I; SMA1; SPINAL MUSCULAR ATROPHY, TYPE IV; SMA4; SPINAL MUSCULAR ATROPHY, TYPE III; SMA3
A2463_07@55830@55831@duplication@2@70307103@70308742@5@chr5:70307103-70308742@4.96@247@339@1.37@CNVR2494.41, CNVR2494.14, CNVR2494.30, CNVR2494.20, CNVR2494.62, CNVR2494.8, CNVR2494.35@NAIP_5, NAIP_4@0@0@0@:baculoviral IAP repeat-containing protein 1-like;NLR family, apoptosis inhibitory protein@:negative regulation of apoptotic process;inflammatory response;basolateral plasma membrane;nucleoside-triphosphatase activity;cysteine-type endopeptidase inhibitor activity;intracellular;nucleotide binding;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;ATP binding;cytoplasm;innate immune response;protein binding;negative regulation of neuron apoptotic process;metal ion binding;nervous system development@NA
A2463_07@59488@59488@deletion@1@147553798@147553933@5@chr5:147553798-147553933@6.71@30@0@0@CNVR2637.2, CNVR2637.1@SPINK14_3@0@0@0@:serine peptidase inhibitor, Kazal type 14 (putative)@:serine-type endopeptidase inhibitor activity;protein binding;extracellular region@NA
A2463_07@60884@60885@duplication@2@175517374@175520277@5@chr5:175517374-175520277@6.05@84@145@1.73@NA@FAM153B_3, FAM153B_4@0@0@0@:uncharacterized LOC100507387;family with sequence similarity 153, member B@NA@NA
A2463_07@61266@61270@duplication@5@177163581@177167802@5@chr5:177163581-177167802@7.37@268@375@1.4@NA@FAM153A_11, FAM153A_10, FAM153A_9, FAM153A_8, FAM153A_7@0@0@0@:family with sequence similarity 153, member A@NA@NA
A2463_07@61640@61645@deletion@6@180376240@180429785@5@chr5:180376240-180429785@15.5@740@469@0.634@CNVR2719.1@BTNL8_7, BTNL8_8, BTNL3_1, BTNL3_2, BTNL3_3, BTNL3_4@0@0@0@:butyrophilin-like 8:butyrophilin-like 3@:protein binding;integral to membrane:protein binding;integral to membrane;molecular_function;cellular_component;biological_process@NA
A2463_07@61691@61697@duplication@7@304629@350868@6@chr6:304629-350868@11.9@639@863@1.35@CNVR2728.1@DUSP22_2, DUSP22_3, DUSP22_4, DUSP22_5, DUSP22_6, DUSP22_7, DUSP22_8@0@0@0@:dual specificity phosphatase 22;dual specificity protein phosphatase 22-like@:protein dephosphorylation;transforming growth factor beta receptor signaling pathway;positive regulation of JNK cascade;protein tyrosine/serine/threonine phosphatase activity;nucleus;apoptotic process;multicellular organismal development;phosphatase activity;protein tyrosine phosphatase activity;regulation of cell proliferation;cytoplasm;cell proliferation;inactivation of MAPK activity;protein binding;negative regulation of transcription from RNA polymerase II promoter;dephosphorylation@NA
A2463_07@63725@63726@deletion@2@31962023@31962484@6@chr6:31962023-31962484@5.67@299@193@0.645@CNVR2843.6, CNVR2843.3@C4A_20, C4A_21@0@0@0@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
A2463_07@63773@63776@deletion@4@31996235@31997115@6@chr6:31996235-31997115@21@526@290@0.551@CNVR2843.6, CNVR2843.5@C4B_25, C4B_26, C4B_27, C4B_28@0@0@0@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
A2463_07@63953@63955@deletion@3@32485517@32486443@6@chr6:32485517-32486443@6.75@44@10@0.227@CNVR2845.21, CNVR2845.25, CNVR2845.30@HLA-DRB5_6, HLA-DRB5_5, HLA-DRB5_4@0@0@0@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
A2463_07@63966@63968@deletion@3@32609088@32610541@6@chr6:32609088-32610541@20.3@567@323@0.57@CNVR2845.21, CNVR2845.25, CNVR2845.37, CNVR2845.27, CNVR2845.22, CNVR2845.39, CNVR2845.20@HLA-DQA1_2, HLA-DQA1_3, HLA-DQA1_4@0@0@0@:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
A2463_07@64602@64606@deletion@5@35754776@35765065@6@chr6:35754776-35765065@8.28@477@319@0.669@CNVR2861.1@CLPSL1_2, CLPSL1_3, CLPS_3, CLPS_2, CLPS_1@0@0@0@:colipase-like 1:colipase, pancreatic@:extracellular region;enzyme activator activity;digestion;lipid catabolic process:steroid metabolic process;post-embryonic development;small molecule metabolic process;retinoid metabolic process;lipid metabolic process;extracellular region;enzyme activator activity;digestion;lipid catabolic process;lipid digestion;response to food@NA
A2463_07@70808@70817@deletion@10@161032595@161056336@6@chr6:161032595-161056336@16.9@261@125@0.479@CNVR3133.1@LPA_17, LPA_16, LPA_15, LPA_14, LPA_13, LPA_12, LPA_11, LPA_10, LPA_9, LPA_8@0@0@0@:lipoprotein, Lp(a)@:blood circulation;endopeptidase inhibitor activity;catalytic activity;lipoprotein metabolic process;proteolysis;heparin binding;receptor-mediated endocytosis;fibronectin binding;small molecule metabolic process;apolipoprotein binding;lipid metabolic process;negative regulation of endopeptidase activity;extracellular region;plasma lipoprotein particle;lipid transport;serine-type endopeptidase activity@: APOLIPOPROTEIN(a); LPA
A2463_07@71762@71773@duplication@12@5977390@6000495@7@chr7:5977390-6000495@15.8@280@445@1.59@NA@RSPH10B_16, RSPH10B_15, RSPH10B_14, RSPH10B_13, RSPH10B_12, RSPH10B_11, RSPH10B_10, RSPH10B_9, RSPH10B_8, RSPH10B_7, RSPH10B_6, RSPH10B_5@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
A2463_07@71925@71925@deletion@1@6803560@6803732@7@chr7:6803560-6803732@5.74@38@8@0.211@NA@RSPH10B2_5@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
A2463_07@71933@71939@deletion@7@6820441@6836397@7@chr7:6820441-6836397@7.41@432@290@0.671@NA@RSPH10B2_13, RSPH10B2_14, RSPH10B2_15, RSPH10B2_16, RSPH10B2_17, RSPH10B2_18, RSPH10B2_19@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
A2463_07@74568@74568@duplication@1@74160677@74160750@7@chr7:74160677-74160750@4.99@5@37@7.4@NA@GTF2I_23@0@0@0@:general transcription factor IIi@:neuronal cell body;transcription initiation from RNA polymerase II promoter;mitogen-activated protein kinase binding;negative regulation of angiogenesis;DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;cytoplasm;transcription from RNA polymerase II promoter;protein binding;signal transduction;nucleus;cell projection;reduction of cytosolic calcium ion concentration@NA
A2463_07@74570@74573@deletion@4@74163363@74166502@7@chr7:74163363-74166502@7.86@110@51@0.464@NA@GTF2I_25, GTF2I_26, GTF2I_27, GTF2I_28@0@0@0@:general transcription factor IIi@:neuronal cell body;transcription initiation from RNA polymerase II promoter;mitogen-activated protein kinase binding;negative regulation of angiogenesis;DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;cytoplasm;transcription from RNA polymerase II promoter;protein binding;signal transduction;nucleus;cell projection;reduction of cytosolic calcium ion concentration@NA
A2463_07@74584@74584@duplication@1@74195127@74195181@7@chr7:74195127-74195181@4.82@8@40@5@NA@NCF1_5@0@0@0@:neutrophil cytosolic factor 1@:inflammatory response;antigen processing and presentation of peptide antigen via MHC class I;phagosome maturation;NADPH oxidase complex;neutrophil mediated killing of gram-positive bacterium;cell communication;interaction with host;leukotriene metabolic process;response to yeast;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;respiratory burst;GTPase activity;negative regulation of smooth muscle contraction;GTP catabolic process;cytosol;defense response to fungus;defense response to bacterium;antigen processing and presentation of exogenous peptide antigen via MHC class I;leukocyte mediated cytotoxicity;neutrophil mediated killing of fungus;phosphatidylinositol binding;defense response to Gram-positive bacterium;GTP binding;respiratory burst involved in defense response;superoxide-generating NADPH oxidase activity;hydrogen peroxide biosynthetic process;protein targeting to membrane;electron carrier activity;superoxide metabolic process;innate immune response;phagolysosome;cytoplasm;cell proliferation;superoxide anion generation;protein binding;SH3 domain binding;cellular defense response;response to bacterium@: GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE,
A2463_07@74597@74598@deletion@2@74225431@74227349@7@chr7:74225431-74227349@11.3@53@1@0.0189@NA@GTF2IRD2_10, GTF2IRD2_9@0@0@0@:GTF2I repeat domain containing 2@:nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_07@74607@74607@duplication@1@74422161@74422230@7@chr7:74422161-74422230@5.25@3@36@12@NA@GATSL1_2@0@0@0@:GATS protein-like 1@NA@NA
A2463_07@74663@74664@duplication@2@75054919@75055735@7@chr7:75054919-75055735@8.95@95@177@1.86@NA@POM121C_9, POM121C_8@0@0@0@:POM121 transmembrane nucleoporin C@:nuclear membrane;protein binding;protein transport;endoplasmic reticulum membrane;nuclear pore;mRNA transport@NA
A2463_07@76427@76432@duplication@6@100331793@100336236@7@chr7:100331793-100336236@20.9@263@463@1.76@CNVR3509.1@ZAN_1, ZAN_2, ZAN_3, ZAN_4, ZAN_5, ZAN_6@0@0@0@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
A2463_07@76737@76737@deletion@1@102147143@102147271@7@chr7:102147143-102147271@6.11@38@7@0.184@CNVR3518.1@RASA4B_5@0@0@0@:RAS p21 protein activator 4B@:phospholipid binding;intracellular;GTPase activator activity;cytosol;signal transduction;protein binding;plasma membrane;regulation of small GTPase mediated signal transduction;metal ion binding;intracellular signal transduction@NA
A2463_07@76751@76752@deletion@2@102210283@102212968@7@chr7:102210283-102212968@7.39@358@228@0.637@CNVR3518.1@POLR2J3_2, POLR2J3_1@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
A2463_07@76775@76779@deletion@5@102257073@102279646@7@chr7:102257073-102279646@10.3@216@115@0.532@CNVR3518.1@RASA4_1, UPK3BL_6, UPK3BL_6, UPK3BL_5, UPK3BL_5, UPK3BL_4, UPK3BL_4@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4:uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity:integral to membrane:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
A2463_07@77093@77102@deletion@10@105893464@105925330@7@chr7:105893464-105925330@39.4@800@431@0.539@NA@NAMPT_10, NAMPT_9, NAMPT_8, NAMPT_7, NAMPT_6, NAMPT_5, NAMPT_4, NAMPT_3, NAMPT_2, NAMPT_1@0@0@0@:nicotinamide phosphoribosyltransferase@:nicotinate phosphoribosyltransferase activity;small molecule metabolic process;positive regulation of nitric-oxide synthase biosynthetic process;NAD metabolic process;cytoplasm;cell-cell signaling;NAD biosynthetic process;cytosol;signal transduction;cytokine activity;positive regulation of cell proliferation;water-soluble vitamin metabolic process;nicotinate-nucleotide diphosphorylase (carboxylating) activity;nicotinamide metabolic process;vitamin metabolic process;nicotinamide phosphoribosyltransferase activity@NA
A2463_07@79287@79289@deletion@3@143400089@143418471@7@chr7:143400089-143418471@7.62@134@72@0.537@CNVR3594.2, CNVR3594.1@FAM115C_2, FAM115C_3, FAM115C_4@0@0@0@:family with sequence similarity 115, member C;protein FAM115C-like@NA@NA
A2463_07@79310@79311@deletion@2@143884023@143929936@7@chr7:143884023-143929936@13.6@285@155@0.544@CNVR3598.4, CNVR3598.3, CNVR3598.7@ARHGEF35_2, OR2A42_1@0@0@0@:Rho guanine nucleotide exchange factor (GEF) 35:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_07@79313@79313@deletion@1@143964011@143966343@7@chr7:143964011-143966343@23.2@254@77@0.303@CNVR3598.4@CTAGE8_1@0@0@0@:Rho guanine nucleotide exchange factor (GEF) 35:CTAGE family, member 6, pseudogene;CTAGE family, member 15, pseudogene@:integral to membrane@NA
A2463_07@79313@79314@duplication@1@143964011@144016150@7@chr7:143964011-144016150@-29.7@454@362@0.797@CNVR3598.4@CTAGE8_1, OR2A1_1@0@0@0@:Rho guanine nucleotide exchange factor (GEF) 35:CTAGE family, member 6, pseudogene;CTAGE family, member 15, pseudogene:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1@:integral to membrane:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_07@79313@79315@deletion@1@143964011@144062916@7@chr7:143964011-144062916@38.5@1261@686@0.544@CNVR3598.4@CTAGE8_1, OR2A1_1, ARHGEF5_2@0@0@0@:Rho guanine nucleotide exchange factor (GEF) 35:CTAGE family, member 6, pseudogene;CTAGE family, member 15, pseudogene:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:integral to membrane:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
A2463_07@80358@80358@duplication@1@6873513@6873621@8@chr8:6873513-6873621@6.57@87@154@1.77@CNVR3769.1@DEFA3_3@0@0@0@:defensin, alpha 1B;defensin, alpha 1:defensin, alpha 3, neutrophil-specific;defensin, alpha 1B;defensin, alpha 1@:defense response to virus;extracellular matrix;immune response;Golgi lumen;azurophil granule lumen;killing of cells of other organism;innate immune response;chemotaxis;extracellular space;extracellular region;defense response to bacterium;defense response to fungus;defense response:defense response to virus;Golgi lumen;azurophil granule lumen;killing of cells of other organism;innate immune response;extracellular space;defense response to bacterium;defense response to fungus;extracellular region;defense response@NA
A2463_07@80375@80386@deletion@12@7332534@7399402@8@chr8:7332534-7399402@12.5@278@158@0.568@CNVR3771.8, CNVR3771.4, CNVR3771.2@DEFB104B_1, DEFB106B_2, DEFB106B_1, DEFB105B_1, DEFB105B_2, DEFB105B_3, DEFB107B_1, DEFB107B_2, RP11-1118M6.1_1, RP11-1118M6.1_2, RP11-1118M6.1_3, RP11-1118M6.1_4@0@0@0@:defensin, beta 104A;defensin, beta 104B:defensin, beta 106B;defensin, beta 106A:defensin, beta 105B;defensin, beta 105A:defensin, beta 107B;defensin, beta 107A:uncharacterized LOC100133251@:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium@NA
A2463_07@80398@80402@deletion@5@7694008@7718245@8@chr8:7694008-7718245@10.2@156@79@0.506@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@DEFB104A_1, DEFB104A_2, SPAG11A_1, SPAG11A_2, SPAG11A_3@0@0@0@:defensin, beta 104A;defensin, beta 104B:sperm associated antigen 11A;sperm associated antigen 11B@:extracellular region;defense response to bacterium:extracellular region;defense response@NA
A2463_07@83673@83673@duplication@1@86573700@86575726@8@chr8:86573700-86575726@10.9@374@588@1.57@CNVR3955.1@REXO1L1_1@0@0@0@:exonuclease GOR-like;REX1, RNA exonuclease 1 homolog (S. cerevisiae)-like 1@:intracellular;nucleus;exonuclease activity;nucleic acid binding;cytoplasm@NA
A2463_07@88528@88529@duplication@2@40702653@40716325@9@chr9:40702653-40716325@6.96@941@1242@1.32@NA@SPATA31A3_4, FAM74A3_1@0@0@0@:SPATA31 subfamily A, member 3@:integral to membrane@NA
A2463_07@88544@88546@deletion@3@42368416@42372375@9@chr9:42368416-42372375@11.9@119@41@0.345@NA@ANKRD20A2_1, ANKRD20A2_2, ANKRD20A2_3@0@0@0@:ankyrin repeat domain 20 family, member A2@:protein binding@NA
A2463_07@88584@88590@deletion@7@43624656@43737520@9@chr9:43624656-43737520@36@1767@981@0.555@NA@SPATA31A6_4, SPATA31A6_3, SPATA31A6_2, SPATA31A6_1, CNTNAP3B_1, CNTNAP3B_2, CNTNAP3B_3@0@0@0@:SPATA31 subfamily A, member 6:contactin associated protein-like 3B;contactin associated protein-like 3@:integral to membrane:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
A2463_07@88593@88606@deletion@14@43816638@43905828@9@chr9:43816638-43905828@37.2@831@472@0.568@NA@CNTNAP3B_6, CNTNAP3B_7, CNTNAP3B_8, CNTNAP3B_9, CNTNAP3B_10, CNTNAP3B_11, CNTNAP3B_12, CNTNAP3B_13, CNTNAP3B_14, CNTNAP3B_15, CNTNAP3B_16, CNTNAP3B_17, CNTNAP3B_18, CNTNAP3B_19@0@0@0@:contactin associated protein-like 3B;contactin associated protein-like 3@:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
A2463_07@88643@88644@deletion@2@67935876@67938658@9@chr9:67935876-67938658@7.14@172@102@0.593@NA@ANKRD20A1_5, ANKRD20A1_6@0@0@0@:ankyrin repeat domain 20 family, member A1@:protein binding;plasma membrane@NA
A2463_07@88648@88657@deletion@10@67954723@67987998@9@chr9:67954723-67987998@33.9@776@454@0.585@NA@ANKRD20A1_10, ANKRD20A1_11, ANKRD20A1_12, ANKRD20A1_13, ANKRD20A1_14, ANKRD20A1_15, RP11-195B21.3_3, RP11-195B21.3_4, RP11-195B21.3_5, RP11-195B21.3_6@0@0@0@:ankyrin repeat domain 20 family, member A1:coiled-coil domain-containing protein 29-like;uncharacterized LOC644249@:protein binding;plasma membrane@NA
A2463_07@91050@91050@deletion@1@115969493@115969576@9@chr9:115969493-115969576@6.43@47@12@0.255@NA@FKBP15_3@0@0@0@:FK506 binding protein 15, 133kDa@:axon;endocytosis;early endosome;termination of G-protein coupled receptor signaling pathway;protein folding;growth cone;actin filament;actin binding;negative regulation of phosphatase activity@NA
A2463_07@91242@91247@duplication@6@117085415@117088637@9@chr9:117085415-117088637@10.4@407@575@1.41@CNVR4448.1@ORM1_1, ORM1_2, ORM1_3, ORM1_4, ORM1_5, ORM1_6@0@0@0@:orosomucoid 1@:protein binding;extracellular space;regulation of immune system process;transport;inflammatory response;extracellular region;acute-phase response@NA
A2463_07@95377@95377@duplication@1@17951323@17951363@10@chr10:17951323-17951363@4.85@12@45@3.75@NA@MRC1L1_29@0@0@0@:macrophage mannose receptor 1-like@:carbohydrate binding@NA
A2463_07@95389@95411@deletion@23@18138509@18198276@10@chr10:18138509-18198276@18.7@180@66@0.367@NA@MRC1_7, MRC1_8, MRC1_9, MRC1_10, MRC1_11, MRC1_12, MRC1_13, MRC1_14, MRC1_15, MRC1_16, MRC1_17, MRC1_18, MRC1_19, MRC1_20, MRC1_21, MRC1_22, MRC1_23, MRC1_24, MRC1_25, MRC1_26, MRC1_27, MRC1_28, MRC1_29@0@0@0@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
A2463_07@96435@96435@duplication@1@46248629@46248685@10@chr10:46248629-46248685@6.28@49@103@2.1@NA@FAM21C_13@0@0@0@:family with sequence similarity 21, member C@:endosome;protein binding;plasma membrane;retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_07@96438@96439@deletion@2@46252461@46254849@10@chr10:46252461-46254849@7.27@117@59@0.504@NA@FAM21C_16, FAM21C_17@0@0@0@:family with sequence similarity 21, member C@:endosome;protein binding;plasma membrane;retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_07@96454@96458@deletion@5@46312644@46329564@10@chr10:46312644-46329564@14.3@185@75@0.405@NA@FAM25E_1, AGAP4_7, AGAP4_6, AGAP4_5, AGAP4_4@0@0@0@:ArfGAP with GTPase domain, ankyrin repeat and PH domain 4;arf-GAP with GTPase, ANK repeat and PH domain-containing protein 5-like@:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity@NA
A2463_07@96468@96470@deletion@3@46605764@46611811@10@chr10:46605764-46611811@8.03@38@1@0.0263@CNVR4712.3@PTPN20A_4, PTPN20A_3, PTPN20A_2@0@0@0@:protein tyrosine phosphatase, non-receptor type 20B;protein tyrosine phosphatase, non-receptor type 20A@:phosphatase activity;protein tyrosine phosphatase activity;microtubule;nucleus;dephosphorylation;protein dephosphorylation;microtubule organizing center@NA
A2463_07@96547@96554@duplication@8@47911501@47933959@10@chr10:47911501-47933959@16.3@190@336@1.77@CNVR4715.2@FAM21B_13, FAM21B_14, FAM21B_15, FAM21B_16, FAM21B_17, FAM21B_18, FAM21B_19, FAM21B_20@0@0@0@:family with sequence similarity 21, member B@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_07@96560@96563@duplication@4@47943489@47948853@10@chr10:47943489-47948853@6.88@170@252@1.48@CNVR4715.2, CNVR4715.1@FAM21B_26, FAM21B_27, FAM21B_28, FAM21B_29@0@0@0@:family with sequence similarity 21, member B@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_07@96579@96581@duplication@3@48048895@48055018@10@chr10:48048895-48055018@8.72@39@102@2.62@CNVR4715.2@ASAH2C_3, ASAH2C_2, ASAH2C_1@0@0@0@@:ceramidase activity;sphingolipid metabolic process@NA
A2463_07@96620@96620@deletion@1@48771316@48771405@10@chr10:48771316-48771405@14.2@66@0@0@CNVR4716.10, CNVR4716.3@PTPN20B_6@0@0@0@:protein tyrosine phosphatase, non-receptor type 20B;protein tyrosine phosphatase, non-receptor type 20A@:phosphatase activity;protein tyrosine phosphatase activity;microtubule;nucleus;dephosphorylation;protein dephosphorylation;microtubule organizing center@NA
A2463_07@96860@96860@deletion@1@51472553@51472652@10@chr10:51472553-51472652@8.49@38@0@0@CNVR4729.1@AGAP7_4@0@0@0@:translocase of inner mitochondrial membrane 23 homolog B (yeast):ArfGAP with GTPase domain, ankyrin repeat and PH domain 7@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity@NA
A2463_07@96883@96883@deletion@1@51620325@51620382@10@chr10:51620325-51620382@6.84@146@77@0.527@NA@TIMM23_2@0@0@0@:translocase of inner mitochondrial membrane 23 homolog B (yeast):translocase of inner mitochondrial membrane 23 homolog B (yeast);translocase of inner mitochondrial membrane 23 homolog (yeast)@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process:mitochondrion;mitochondrial inner membrane;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;mitochondrial intermembrane space;integral to mitochondrial inner membrane;intracellular protein transport;protein binding;integral to membrane;cellular protein metabolic process;protein targeting to mitochondrion@NA
A2463_07@96900@96908@deletion@9@51847036@51857562@10@chr10:51847036-51857562@16.6@163@63@0.387@NA@FAM21A_8, FAM21A_9, FAM21A_10, FAM21A_11, FAM21A_12, FAM21A_13, FAM21A_14, FAM21A_15, FAM21A_16@0@0@0@:family with sequence similarity 21, member B;family with sequence similarity 21, member A@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_07@96920@96939@deletion@20@51887344@51994312@10@chr10:51887344-51994312@25.7@455@240@0.527@NA@FAM21A_28, FAM21A_29, FAM21A_30, FAM21A_31, ASAH2_20, ASAH2_19, ASAH2_18, ASAH2_17, ASAH2_16, ASAH2_15, ASAH2_14, ASAH2_13, ASAH2_12, ASAH2_11, ASAH2_10, ASAH2_9, ASAH2_8, ASAH2_7, ASAH2_6, ASAH2_5@0@0@0@:family with sequence similarity 21, member B;family with sequence similarity 21, member A:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
A2463_07@96952@96952@deletion@1@52504963@52505034@10@chr10:52504963-52505034@4.7@22@1@0.0455@NA@ASAH2B_3@0@0@0@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2B@NA@NA
A2463_07@98355@98357@duplication@3@81608270@81610362@10@chr10:81608270-81610362@22.4@93@271@2.91@NA@FAM22E_5, FAM22E_6, FAM22E_7@0@0@0@NA@NA@NA
A2463_07@98599@98599@deletion@1@88992361@88992742@10@chr10:88992361-88992742@6.02@44@11@0.25@CNVR4840.3, CNVR4840.5, CNVR4840.6@FAM22A_5@0@0@0@:family with sequence similarity 22, member A@NA@NA
A2463_07@98602@98603@duplication@2@89118024@89120937@10@chr10:89118024-89120937@6.75@381@533@1.4@CNVR4840.3@FAM22D_1, FAM22D_2@0@0@0@:family with sequence similarity 22, member D@NA@NA
A2463_07@101608@101615@deletion@8@124344788@124354044@10@chr10:124344788-124354044@18.6@561@336@0.599@CNVR4912.4, CNVR4912.3, CNVR4912.2@DMBT1_15, DMBT1_16, DMBT1_17, DMBT1_18, DMBT1_19, DMBT1_20, DMBT1_21, DMBT1_22@0@0@0@:deleted in malignant brain tumors 1@:defense response to virus;calcium-dependent protein binding;pattern recognition receptor signaling pathway;blastocyst development;response to estrogen stimulus;tissue regeneration;proteinaceous extracellular matrix;protein transport;Gram-negative bacterial cell surface binding;positive regulation of epithelial cell differentiation;virus-host interaction;epithelial cell differentiation;induction of bacterial agglutination;phagocytic vesicle membrane;intracellular;Gram-positive bacterial cell surface binding;zymogen binding;innate immune response;cytoplasm;extrinsic to membrane;protein binding;zymogen granule membrane;extracellular region;scavenger receptor activity;pattern recognition receptor activity;inner cell mass cell proliferation;membrane@: GLIOMA SUSCEPTIBILITY 1; GLM1
A2463_07@103269@103269@duplication@1@4976003@4976943@11@chr11:4976003-4976943@14.9@297@532@1.79@CNVR5040.1@OR51A2_1@0@0@0@:matrix metallopeptidase 26:olfactory receptor, family 51, subfamily A, member 2@:metallopeptidase activity;extracellular matrix;proteolysis;proteinaceous extracellular matrix;collagen catabolic process;metalloendopeptidase activity;zinc ion binding;metabolic process:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_07@103289@103289@deletion@1@5270599@5270820@11@chr11:5270599-5270820@8.15@73@23@0.315@NA@HBG1_2@0@0@0@:hemoglobin, gamma A@:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex@NA
A2463_07@106035@106035@duplication@1@51411449@51412395@11@chr11:51411449-51412395@4.94@254@358@1.41@NA@OR4A5_1@0@0@0@:olfactory receptor, family 4, subfamily A, member 5@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_07@106046@106048@deletion@3@55370918@55419315@11@chr11:55370918-55419315@8.53@615@412@0.67@CNVR5179.1@OR4C11_1, OR4P4_1, OR4S2_1@0@0@0@:olfactory receptor, family 4, subfamily C, member 11:olfactory receptor, family 4, subfamily P, member 4:olfactory receptor, family 4, subfamily S, member 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_07@110121@110125@deletion@5@89768381@89773130@11@chr11:89768381-89773130@7.46@231@142@0.615@NA@TRIM49C_3, TRIM49C_4, TRIM49C_5, TRIM49C_6, TRIM49C_7@0@0@0@:tripartite motif containing 49D, pseudogene;tripartite motif containing 49-like 1;tripartite motif containing 49C;tripartite motif-containing protein 49-like protein 1-like@:protein binding;intracellular;DNA binding;zinc ion binding@NA
A2463_07@114136@114139@deletion@4@8374419@8377428@12@chr12:8374419-8377428@23.5@1501@902@0.601@CNVR5422.3, CNVR5422.5, CNVR5422.6, CNVR5422.1@FAM90A1_7, FAM90A1_6, FAM90A1_5, FAM90A1_4@0@0@0@:family with sequence similarity 90, member A1@:zinc ion binding;nucleic acid binding@NA
A2463_07@114424@114430@deletion@7@10583717@10599261@12@chr12:10583717-10599261@25@885@546@0.617@CNVR5430.1@KLRC2_6, KLRC2_5, KLRC2_4, KLRC2_3, NKG2-E_3, KLRC2_2, NKG2-E_2, KLRC2_1, NKG2-E_1, KLRC1_8@0@0@0@:killer cell lectin-like receptor subfamily C, member 2:killer cell lectin-like receptor subfamily C, member 1@:carbohydrate binding:transmembrane signaling receptor activity;carbohydrate binding;protein binding;signal transduction;cellular defense response;integral to plasma membrane:transmembrane signaling receptor activity;carbohydrate binding;regulation of immune response;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway@NA
A2463_07@115528@115528@deletion@1@31240873@31240917@12@chr12:31240873-31240917@4.76@62@28@0.452@CNVR5483.1@DDX11_6@0@0@0@:DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11@:nucleoplasm;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;S phase of mitotic cell cycle;DNA binding;nucleobase-containing compound metabolic process;ATP binding;ATP-dependent DNA helicase activity;DNA helicase activity;midbody;RNA binding;DNA-dependent ATPase activity;nucleus;positive regulation of cell proliferation;virus-host interaction;nuclear chromatin;4 iron, 4 sulfur cluster binding;helicase activity;hydrolase activity, acting on acid anhydrides;DNA duplex unwinding;endoplasmic reticulum unfolded protein response;G2/M transition of mitotic cell cycle;protein binding;sister chromatid cohesion;activation of signaling protein activity involved in unfolded protein response;nucleolus;spindle pole;ATP-dependent helicase activity;metal ion binding;nucleic acid binding;mitotic sister chromatid segregation@: WARSAW BREAKAGE SYNDROME
A2463_07@115535@115535@deletion@1@31247525@31247568@12@chr12:31247525-31247568@5.07@98@51@0.52@CNVR5483.1@DDX11_13@0@0@0@:DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11@:nucleoplasm;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;S phase of mitotic cell cycle;DNA binding;nucleobase-containing compound metabolic process;ATP binding;ATP-dependent DNA helicase activity;DNA helicase activity;midbody;RNA binding;DNA-dependent ATPase activity;nucleus;positive regulation of cell proliferation;virus-host interaction;nuclear chromatin;4 iron, 4 sulfur cluster binding;helicase activity;hydrolase activity, acting on acid anhydrides;DNA duplex unwinding;endoplasmic reticulum unfolded protein response;G2/M transition of mitotic cell cycle;protein binding;sister chromatid cohesion;activation of signaling protein activity involved in unfolded protein response;nucleolus;spindle pole;ATP-dependent helicase activity;metal ion binding;nucleic acid binding;mitotic sister chromatid segregation@: WARSAW BREAKAGE SYNDROME
A2463_07@115537@115537@deletion@1@31249276@31249313@12@chr12:31249276-31249313@5.21@119@65@0.546@CNVR5483.1@DDX11_15@0@0@0@:DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11@:nucleoplasm;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;S phase of mitotic cell cycle;DNA binding;nucleobase-containing compound metabolic process;ATP binding;ATP-dependent DNA helicase activity;DNA helicase activity;midbody;RNA binding;DNA-dependent ATPase activity;nucleus;positive regulation of cell proliferation;virus-host interaction;nuclear chromatin;4 iron, 4 sulfur cluster binding;helicase activity;hydrolase activity, acting on acid anhydrides;DNA duplex unwinding;endoplasmic reticulum unfolded protein response;G2/M transition of mitotic cell cycle;protein binding;sister chromatid cohesion;activation of signaling protein activity involved in unfolded protein response;nucleolus;spindle pole;ATP-dependent helicase activity;metal ion binding;nucleic acid binding;mitotic sister chromatid segregation@: WARSAW BREAKAGE SYNDROME
A2463_07@117171@117172@deletion@2@52865851@52867521@12@chr12:52865851-52867521@5.76@353@233@0.66@NA@KRT6C_2, KRT6C_1@0@0@0@:keratin 6C@:intermediate filament;structural molecule activity;keratin filament;cytoskeleton organization@NA
A2463_07@127333@127337@duplication@5@19553418@19563541@14@chr14:19553418-19563541@11.1@762@1066@1.4@CNVR6072.1@POTEG_1, POTEG_2, POTEG_3, POTEG_4, POTEG_5@0@0@0@:POTE ankyrin domain family, member G@:protein binding@NA
A2463_07@127348@127352@deletion@5@20010104@20020220@14@chr14:20010104-20020220@9.7@267@155@0.581@CNVR6072.6, CNVR6072.12@POTEM_5, POTEM_4, POTEM_3, POTEM_2, POTEM_1@0@0@0@:POTE ankyrin domain family, member M@:protein binding@NA
A2463_07@127348@127358@duplication@6@20010104@20404761@14@chr14:20010104-20404761@3.67@2809@3629@1.29@CNVR6072.12, CNVR6072.4@POTEM_5, POTEM_4, POTEM_3, POTEM_2, POTEM_1, OR4Q3_1, OR4M1_1, OR4N2_1, OR4K2_1, OR4K5_1, OR4K1_1@0@0@0@:POTE ankyrin domain family, member M:olfactory receptor, family 4, subfamily N, member 2:olfactory receptor, family 4, subfamily Q, member 3:olfactory receptor, family 4, subfamily M, member 1:olfactory receptor, family 4, subfamily K, member 2:olfactory receptor, family 4, subfamily K, member 5:olfactory receptor, family 4, subfamily K, member 1@:protein binding:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_07@133426@133426@deletion@1@106478111@106478411@14@chr14:106478111-106478411@7.25@74@27@0.365@CNVR6294.36, CNVR6294.48, CNVR6294.12, CNVR6294.24@IGHV4-4_2@0@0@0@@:protein binding@NA
A2463_07@133458@133459@deletion@2@106791006@106791456@14@chr14:106791006-106791456@8.79@212@116@0.547@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.53@IGHV3-30_2, IGHV3-30_1@0@0@0@@:protein binding@NA
A2463_07@133491@133492@deletion@2@107095127@107095561@14@chr14:107095127-107095561@20.3@100@4@0.04@CNVR6294.56, CNVR6294.16, CNVR6294.91@IGHV4-61_2, IGHV4-61_1@0@0@0@@:protein binding@NA
A2463_07@133523@133525@deletion@3@21059387@21063546@15@chr15:21059387-21063546@6.02@30@2@0.0667@NA@POTEB_6, POTEB_5, POTEB_4@0@0@0@:POTE ankyrin domain family member B-like@:protein binding@NA
A2463_07@133541@133541@duplication@1@22368577@22369517@15@chr15:22368577-22369517@4.97@410@562@1.37@CNVR6297.9, CNVR6297.4, CNVR6297.17, CNVR6297.18@OR4M2_1@0@0@0@:olfactory receptor, family 4, subfamily M, member 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_07@133636@133636@deletion@1@23406272@23408073@15@chr15:23406272-23408073@9.29@399@234@0.586@CNVR6300.8@RP11-467N20.5_8@0@0@0@:putative golgin subfamily A member 6-like protein 6-like@NA@NA
A2463_07@133869@133870@deletion@2@28629294@28629596@15@chr15:28629294-28629596@6.48@29@0@0@CNVR6329.4@GOLGA8F_9, GOLGA8F_10@0@0@0@@:Golgi apparatus@NA
A2463_07@133901@133901@deletion@1@28947612@28947708@15@chr15:28947612-28947708@5.65@85@40@0.471@NA@GOLGA8M_17@0@0@0@:golgin A8 family, member M@:Golgi apparatus@NA
A2463_07@134023@134030@deletion@8@30699479@30702470@15@chr15:30699479-30702470@13.1@207@104@0.502@NA@GOLGA8R_12, GOLGA8R_11, GOLGA8R_10, GOLGA8R_9, GOLGA8R_8, GOLGA8R_7, GOLGA8R_6, GOLGA8R_5@0@0@0@@:Golgi apparatus@NA
A2463_07@134040@134043@deletion@4@30848479@30850040@15@chr15:30848479-30850040@13.6@154@62@0.403@NA@GOLGA8Q_6, GOLGA8Q_7, GOLGA8Q_8, GOLGA8Q_9@0@0@0@@:Golgi apparatus@NA
A2463_07@134055@134078@deletion@24@30898047@30927833@15@chr15:30898047-30927833@69.5@1512@833@0.551@CNVR6339.2, CNVR6339.3, CNVR6339.4@GOLGA8H_2, GOLGA8H_3, GOLGA8H_4, GOLGA8H_5, GOLGA8H_6, GOLGA8H_7, GOLGA8H_8, GOLGA8H_9, GOLGA8H_10, GOLGA8H_11, GOLGA8H_12, GOLGA8H_13, GOLGA8H_14, GOLGA8H_15, GOLGA8H_16, GOLGA8H_17, GOLGA8H_18, GOLGA8H_19, ARHGAP11B_1, ARHGAP11B_2, ARHGAP11B_3, ARHGAP11B_4, ARHGAP11B_5, ARHGAP11B_6@0@0@0@:golgin A8 family, member H:Rho GTPase activating protein 11B;OTU domain containing 7A pseudogene@:Golgi apparatus:cytosol;signal transduction;intracellular;small GTPase mediated signal transduction;GTPase activator activity;regulation of small GTPase mediated signal transduction@NA
A2463_07@134148@134151@duplication@4@32322799@32404100@15@chr15:32322799-32404100@10.9@287@425@1.48@NA@CHRNA7_1, CHRNA7_2, CHRNA7_3, CHRNA7_4@0@0@0@:cholinergic receptor, nicotinic, alpha 7 (neuronal);CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:cellular calcium ion homeostasis;transport;beta-amyloid binding;calcium ion transport;acetylcholine receptor activity;ion transport;acetylcholine-activated cation-selective channel activity;integral to membrane;chloride channel regulator activity;cell junction;plasma membrane;positive regulation of cell proliferation;protein homodimerization activity;acetylcholine-gated channel complex;response to chemical stimulus;activation of MAPK activity;negative regulation of tumor necrosis factor production;response to hypoxia;response to nicotine;acetylcholine binding;positive regulation of angiogenesis;signal transduction;memory;toxin binding;synaptic transmission;postsynaptic membrane;membrane;cognition;extracellular ligand-gated ion channel activity@NA
A2463_07@134160@134169@deletion@10@32685495@32690870@15@chr15:32685495-32690870@20.6@405@222@0.548@NA@GOLGA8K_17, GOLGA8K_16, GOLGA8K_15, GOLGA8K_14, GOLGA8K_13, GOLGA8K_12, GOLGA8K_11, GOLGA8K_10, GOLGA8K_9, GOLGA8K_8@0@0@0@:golgin A8 family, member J@:Golgi apparatus@NA
A2463_07@134173@134177@deletion@5@32692342@32695395@15@chr15:32692342-32695395@15.4@110@29@0.264@NA@GOLGA8K_4, GOLGA8K_3, GOLGA8K_2, AC139426.2_1, GOLGA8K_1@0@0@0@:golgin A8 family, member J@:Golgi apparatus@NA
A2463_07@134180@134181@duplication@2@32737820@32738099@15@chr15:32737820-32738099@8.15@23@78@3.39@CNVR6346.1@GOLGA8O_17, GOLGA8O_16@0@0@0@:golgin A8 family, member O@:Golgi apparatus@NA
A2463_07@134189@134190@duplication@2@32743115@32743403@15@chr15:32743115-32743403@14.1@61@167@2.74@CNVR6346.1@GOLGA8O_8, GOLGA8O_7@0@0@0@:golgin A8 family, member O@:Golgi apparatus@NA
A2463_07@134198@134199@deletion@2@32885756@32887588@15@chr15:32885756-32887588@5.13@120@67@0.558@NA@GOLGA8N_1, GOLGA8N_2@0@0@0@:golgin A8 family, member R@:Golgi apparatus@NA
A2463_07@134204@134216@deletion@13@32890090@32896179@15@chr15:32890090-32896179@23.1@157@35@0.223@NA@GOLGA8N_7, GOLGA8N_8, GOLGA8N_9, GOLGA8N_10, GOLGA8N_11, GOLGA8N_12, GOLGA8N_13, GOLGA8N_14, GOLGA8N_15, GOLGA8N_16, GOLGA8N_17, GOLGA8N_18, GOLGA8N_19@0@0@0@:golgin A8 family, member R@:Golgi apparatus@NA
A2463_07@134444@134448@deletion@5@34678827@34820278@15@chr15:34678827-34820278@18.1@161@51@0.317@CNVR6351.3@GOLGA8A_11, GOLGA8A_10, GOLGA8A_9, GOLGA8B_25, GOLGA8B_24@0@0@0@:golgin A8 family, member A:golgin A8 family, member A;golgin A8 family, member B@:Golgi cisterna membrane;Golgi apparatus:Golgi cisterna membrane;Golgi apparatus@NA
A2463_07@134459@134460@duplication@2@34824163@34825163@15@chr15:34824163-34825163@6.96@49@105@2.14@CNVR6351.3@GOLGA8B_13, GOLGA8B_12@0@0@0@:golgin A8 family, member A:golgin A8 family, member A;golgin A8 family, member B@:Golgi cisterna membrane;Golgi apparatus:Golgi cisterna membrane;Golgi apparatus@NA
A2463_07@135680@135681@duplication@2@43873201@43873586@15@chr15:43873201-43873586@5.68@466@623@1.34@CNVR6365.1@PPIP5K1_10, PPIP5K1_9@0@0@0@:diphosphoinositol pentakisphosphate kinase 1@:inositol hexakisphosphate 3-kinase activity;inositol hexakisphosphate 1-kinase activity;inositol metabolic process;diphosphoinositol-pentakisphosphate kinase activity;ATP binding;acid phosphatase activity;cytoplasm;cytosol;inositol hexakisphosphate 5-kinase activity;nucleus;kinase activity;inositol-1,3,4,5,6-pentakisphosphate kinase activity@NA
A2463_07@135936@135937@duplication@2@45361076@45364636@15@chr15:45361076-45364636@6.57@38@87@2.29@NA@SORD_7, SORD_8@0@0@0@:sorbitol dehydrogenase@:carbohydrate binding;oxidation-reduction process;transferase activity, transferring acyl groups other than amino-acyl groups;mitochondrion;flagellum;L-xylitol catabolic process;extracellular space;oxidoreductase activity;NAD binding;sorbitol metabolic process;mitochondrial membrane;glucose metabolic process;sperm motility;fructose biosynthetic process;cilium;nucleotide binding;L-xylitol metabolic process;L-iditol 2-dehydrogenase activity;sorbitol catabolic process;membrane;zinc ion binding@NA
A2463_07@138284@138285@duplication@2@72954594@72955446@15@chr15:72954594-72955446@7.92@124@210@1.69@CNVR6443.1@GOLGA6B_11, GOLGA6B_12@0@0@0@:golgin A6 family, member B@:Golgi apparatus@NA
A2463_07@139271@139274@deletion@4@82635474@82638127@15@chr15:82635474-82638127@6.6@38@6@0.158@CNVR6475.4, CNVR6475.2@GOLGA6L10_8, GOLGA6L10_7, GOLGA6L10_6, GOLGA6L10_5@0@0@0@:golgin A6 family-like 3;golgin A6 family-like 10@NA@NA
A2463_07@139471@139479@deletion@9@84841255@84909534@15@chr15:84841255-84909534@23.9@308@133@0.432@CNVR6486.2@RP11-182J1.16_1, RP11-182J1.16_2, RP11-182J1.16_3, GOLGA6L4_1, GOLGA6L4_2, GOLGA6L4_3, GOLGA6L4_4, GOLGA6L4_5, GOLGA6L4_6@0@0@0@:uncharacterized LOC100505679@:Golgi apparatus@NA
A2463_07@140476@140483@deletion@8@64382@67750@16@chr16:64382-67750@21.9@358@187@0.522@CNVR6565.1@WASH4P_10, WASH4P_9, WASH4P_8, WASH4P_7, WASH4P_6, WASH4P_5, WASH4P_4, WASH4P_3@0@0@0@@:intracellular membrane-bounded organelle;endosomal transport;recycling endosome;early endosome;Arp2/3 complex-mediated actin nucleation;actin binding;alpha-tubulin binding;retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;recycling endosome membrane@NA
A2463_07@142681@142686@deletion@6@14988856@15039838@16@chr16:14988856-15039838@9.53@247@141@0.571@CNVR6645.2@NOMO1_30, NOMO1_31, NPIP_1, NPIP_2, NPIP_3, NPIP_4@0@0@0@:NODAL modulator 1;nodal modulator 1-like:nuclear pore complex-interacting protein-like;nuclear pore complex interacting protein;nuclear pore complex-interacting protein-like 1-like@:carbohydrate binding;integral to membrane;carboxypeptidase activity;molecular_function;cellular_component;biological_process:nuclear membrane;protein transport;nuclear pore;mRNA transport@NA
A2463_07@142691@142706@deletion@16@15069058@15123913@16@chr16:15069058-15123913@59.7@1405@785@0.559@CNVR6646.1@PDXDC1_1, PDXDC1_2, PDXDC1_3, PDXDC1_4, PDXDC1_5, PDXDC1_6, PDXDC1_7, PDXDC1_8, PDXDC1_9, PDXDC1_10, PDXDC1_11, PDXDC1_12, PDXDC1_13, PDXDC1_14, PDXDC1_15, PDXDC1_16@0@0@0@:pyridoxal-dependent decarboxylase domain containing 1;pyridoxal-dependent decarboxylase domain-containing protein 1-like@:carboxylic acid metabolic process;pyridoxal phosphate binding;carboxy-lyase activity@NA
A2463_07@142750@142750@deletion@1@15457517@15457926@16@chr16:15457517-15457926@7.67@253@145@0.573@CNVR6649.1@PKD1P1_8@0@0@0@:NPIP-like protein 1-like;nuclear pore complex-interacting protein-like 1-like@NA@NA
A2463_07@142952@142952@deletion@1@16484625@16484731@16@chr16:16484625-16484731@10.5@48@0@0@CNVR6654.1@RP11-467M13.1_5@0@0@0@NA@NA@NA
A2463_07@142971@142971@duplication@1@18414875@18414981@16@chr16:18414875-18414981@8.38@51@121@2.37@CNVR6658.1@RP11-1212A22.2_7@0@0@0@NA@NA@NA
A2463_07@143002@143003@deletion@2@18542360@18542929@16@chr16:18542360-18542929@15.9@134@36@0.269@NA@NOMO2_14, NOMO2_13@0@0@0@:NODAL modulator 2@:carbohydrate binding;protein binding;integral to membrane;carboxypeptidase activity;endoplasmic reticulum membrane@NA
A2463_07@143481@143483@duplication@3@21763257@21764445@16@chr16:21763257-21764445@5.81@98@158@1.61@CNVR6668.5, CNVR6668.2, CNVR6668.7@OTOA_24, OTOA_25, OTOA_26@0@0@0@:otoancorin@:proteinaceous extracellular matrix;apical plasma membrane;sensory perception of sound;anchored to membrane@: DEAFNESS, AUTOSOMAL RECESSIVE 22; DFNB22
A2463_07@144096@144102@deletion@7@28617143@28620176@16@chr16:28617143-28620176@43.9@545@228@0.418@CNVR6685.1, CNVR6685.2@SULT1A1_10, SULT1A1_9, SULT1A1_8, SULT1A1_7, SULT1A1_6, SULT1A1_5, SULT1A1_4@0@0@0@:sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1@:small molecule metabolic process;sulfation;aryl sulfotransferase activity;amine metabolic process;catecholamine metabolic process;xenobiotic metabolic process;cytosol;steroid sulfotransferase activity;integral to membrane;sulfotransferase activity;flavonol 3-sulfotransferase activity;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process;estrogen metabolic process@NA
A2463_07@144117@144130@deletion@14@28734486@28763913@16@chr16:28734486-28763913@23.5@366@170@0.464@CNVR6686.3, CNVR6686.2@EIF3C_9, EIF3C_10, EIF3C_11, EIF3C_12, EIF3C_13, EIF3C_14, EIF3C_15, EIF3C_16, EIF3C_17, EIF3C_18, EIF3C_19, EIF3C_20, EIF3C_21, A-575C2.4_1@0@0@0@:eukaryotic translation initiation factor 3, subunit C@:cytosol;protein binding;eukaryotic translation initiation factor 3 complex;translational initiation;cellular protein metabolic process;binding;gene expression;translation;translation initiation factor activity@NA
A2463_07@145013@145013@deletion@1@32264676@32265036@16@chr16:32264676-32265036@4.86@229@144@0.629@CNVR6701.6, CNVR6701.2@TP53TG3D_1@0@0@0@:TP53 target 3B;TP53 target 3;TP53-target gene 3 protein-like;TP53 target 3C@:nucleus;cytoplasm@NA
A2463_07@147100@147101@deletion@2@69997478@70010635@16@chr16:69997478-70010635@13.4@226@106@0.469@CNVR6762.3, CNVR6762.1@CLEC18A_12, RP11-419C5.2_7@0@0@0@:C-type lectin domain family 18, member A@:carbohydrate binding;protein binding;extracellular region@NA
A2463_07@147125@147126@duplication@2@70208183@70208941@16@chr16:70208183-70208941@7.79@70@136@1.94@CNVR6764.1@CLEC18C_1, CLEC18C_2@0@0@0@:C-type lectin domain family 18, member C@:carbohydrate binding;protein binding;extracellular region@NA
A2463_07@147125@147127@deletion@1@70208183@70211383@16@chr16:70208183-70211383@-11.7@179@188@1.05@CNVR6764.1@CLEC18C_1, CLEC18C_2, CLEC18C_3@0@0@0@:C-type lectin domain family 18, member C@:carbohydrate binding;protein binding;extracellular region@NA
A2463_07@151556@151557@duplication@2@16664740@16665847@17@chr17:16664740-16665847@5.15@509@672@1.32@NA@CCDC144A_13, CCDC144A_13, CCDC144A_14, CCDC144A_14@0@0@0@:coiled-coil domain containing 144A@NA@NA
A2463_07@151880@151881@deletion@2@18394048@18394637@17@chr17:18394048-18394637@7@51@13@0.255@CNVR7014.1@LGALS9C_6, LGALS9C_7@0@0@0@:lectin, galactoside-binding, soluble, 9C@:carbohydrate binding@NA
A2463_07@151885@151886@deletion@2@18397536@18430117@17@chr17:18397536-18430117@5.27@126@73@0.579@NA@LGALS9C_11, FAM106A_1@0@0@0@:lectin, galactoside-binding, soluble, 9C:protein FAM106B-like@:carbohydrate binding@NA
A2463_07@152122@152130@duplication@9@20353287@20361697@17@chr17:20353287-20361697@15.8@249@405@1.63@CNVR7021.1, CNVR7021.3@LGALS9B_11, LGALS9B_10, LGALS9B_9, LGALS9B_8, LGALS9B_7, LGALS9B_6, LGALS9B_5, LGALS9B_4, LGALS9B_3@0@0@0@:lectin, galactoside-binding, soluble, 9B@:carbohydrate binding@NA
A2463_07@153370@153400@deletion@31@34499215@34641537@17@chr17:34499215-34641537@36.6@436@186@0.427@CNVR7077.1, CNVR7077.2@TBC1D3B_7, TBC1D3B_6, TBC1D3B_5, TBC1D3B_4, TBC1D3B_3, TBC1D3B_2, CCL3L3_3, CCL3L3_2, CCL3L3_1, CCL4L1_1, CCL4L1_2, CCL4L1_3, TBC1D3C_14, TBC1D3C_13, TBC1D3C_12, TBC1D3C_11, TBC1D3C_10, TBC1D3C_9, TBC1D3C_8, TBC1D3C_7, TBC1D3C_6, TBC1D3C_5, TBC1D3C_4, TBC1D3C_3, TBC1D3C_2, CCL3L1_3, CCL3L1_2, CCL3L1_1, CCL4L2_1, CCL4L2_2, CCL4L2_3@0@0@0@:TBC1 domain family, member 3B:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1:TBC1 domain family, member 3C;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3H-like;TBC1 domain family, member 3H:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
A2463_07@153414@153414@duplication@1@34797487@34798054@17@chr17:34797487-34798054@6.38@92@160@1.74@CNVR7078.2, CNVR7078.3@TBC1D3G_14@0@0@0@:TBC1 domain family member 3H-like;TBC1 domain family, member 3H:TBC1 domain family, member 3;TBC1 domain family, member 3G;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like;TBC1 domain family, member 3H@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_07@153628@153628@deletion@1@36288195@36288301@17@chr17:36288195-36288301@5.29@226@139@0.615@NA@TBC1D3F_6@0@0@0@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family member 3G-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_07@155592@155595@deletion@4@44412912@44415089@17@chr17:44412912-44415089@15.5@70@0@0@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A_11, LRRC37A_12, LRRC37A_13, LRRC37A_14@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
A2463_07@155599@155600@deletion@2@44590080@44594799@17@chr17:44590080-44594799@25.2@121@2@0.0165@CNVR7114.2, CNVR7114.5@LRRC37A2_2, LRRC37A2_3@0@0@0@:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
A2463_07@155610@155613@duplication@4@44632519@44634996@17@chr17:44632519-44634996@7.88@328@466@1.42@CNVR7114.2, CNVR7114.5, CNVR7114.4@LRRC37A2_13, LRRC37A2_14, LRRC37A2_15, ARL17A_4@0@0@0@:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
A2463_07@160293@160296@deletion@4@2728456@2738543@18@chr18:2728456-2738543@5.63@493@348@0.706@NA@SMCHD1_23, SMCHD1_24, SMCHD1_25, SMCHD1_26@0@0@0@:structural maintenance of chromosomes flexible hinge domain containing 1@:Barr body;inactivation of X chromosome by DNA methylation;protein binding;chromosome organization;chromosome;dosage compensation by inactivation of X chromosome;ATP binding@NA
A2463_07@162017@162018@duplication@2@44542732@44550298@18@chr18:44542732-44550298@71.2@418@1766@4.22@CNVR7319.1, CNVR7319.2@TCEB3CL2_1, TCEB3CL_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2:transcription elongation factor B polypeptide 3C-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_07@162017@162019@deletion@1@44542732@44556213@18@chr18:44542732-44556213@159@2677@1841@0.688@CNVR7319.1, CNVR7319.2@TCEB3CL2_1, TCEB3CL_1, TCEB3C_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2:transcription elongation factor B polypeptide 3C-like:transcription elongation factor B polypeptide 3C (elongin A3);RNA polymerase II transcription factor SIII subunit A3-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_07@164950@164953@duplication@4@7030624@7040155@19@chr19:7030624-7040155@7.76@69@134@1.94@CNVR7517.1@MBD3L5_1, MBD3L5_2, MBD3L4_2, MBD3L4_1@0@0@0@:methyl-CpG binding domain protein 3-like 5:methyl-CpG binding domain protein 3-like 4@:regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_07@168952@168952@deletion@1@35862263@35863302@19@chr19:35862263-35863302@15.4@102@18@0.176@CNVR7627.1@GPR42_2@0@0@0@@:integral to membrane;G-protein coupled receptor activity;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
A2463_07@169778@169778@deletion@1@39262470@39262670@19@chr19:39262470-39262670@8.47@38@0@0@NA@LGALS7_3@0@0@0@:lectin, galactoside-binding, soluble, 7;lectin, galactoside-binding, soluble, 7B@:carbohydrate binding;heterophilic cell-cell adhesion;extracellular space;nucleus;apoptotic process;cytoplasm@NA
A2463_07@170098@170100@duplication@3@40376632@40382826@19@chr19:40376632-40382826@28.7@264@540@2.05@CNVR7639.2@FCGBP_24, FCGBP_23, FCGBP_22@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_07@170187@170188@duplication@2@40872518@40872822@19@chr19:40872518-40872822@5.06@56@100@1.79@NA@PLD3_4, PLD3_5@0@0@0@:phospholipase D family, member 3@:phospholipid metabolic process;NAPE-specific phospholipase D activity;glycerophospholipid biosynthetic process;small molecule metabolic process;catalytic activity;phosphatidylglycerol biosynthetic process;phospholipase D activity;protein binding;integral to membrane;lipid catabolic process;endoplasmic reticulum membrane;metabolic process@NA
A2463_07@172987@172987@deletion@1@52133087@52133469@19@chr19:52133087-52133469@6.59@36@4@0.111@CNVR7702.1@SIGLEC5_2, SIGLEC5_2@0@0@0@:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 5@:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion@NA
A2463_07@173099@173101@deletion@3@53343979@53357525@19@chr19:53343979-53357525@20.6@699@374@0.535@CNVR7708.1@ZNF468_4, ZNF468_3, ZNF468_2@0@0@0@:zinc finger protein 28:zinc finger protein 468@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_07@173295@173298@deletion@4@54724399@54726434@19@chr19:54724399-54726434@14@125@43@0.344@CNVR7721.3, CNVR7721.4@LILRB3_6, LILRB3_5, LILRB3_4, LILRB3_3@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
A2463_07@173400@173400@duplication@1@55020246@55020295@19@chr19:55020246-55020295@4.71@29@66@2.28@NA@LAIR2_4@0@0@0@:leukocyte-associated immunoglobulin-like receptor 2@:extracellular region@NA
A2463_07@173482@173484@duplication@3@55320289@55325566@19@chr19:55320289-55325566@6.69@87@148@1.7@CNVR7725.1, CNVR7725.3@KIR2DL4_5, KIR2DL4_6, KIR2DL4_7@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane@NA
A2463_07@173500@173503@duplication@4@55359207@55362710@19@chr19:55359207-55362710@5.91@62@112@1.81@CNVR7725.1, CNVR7725.6, CNVR7725.5, CNVR7725.10@KIR2DS4_7, KIR2DS4_8, KIR3DL2_1, KIR3DL2_2@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2-like@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane@NA
A2463_07@174394@174395@deletion@2@1558985@1569278@20@chr20:1558985-1569278@7.29@169@95@0.562@CNVR7763.1@RP4-576H24.4_2, SIRPB1_2, RP4-576H24.4_1@0@0@0@:signal-regulatory protein beta 1;signal-regulatory protein beta-1-like;signal-regulatory protein beta-1 isoform 3-like@:protein binding:protein binding;signal transduction;integral to membrane;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway@NA
A2463_07@175736@175737@duplication@2@26061801@26063616@20@chr20:26061801-26063616@4.91@159@228@1.43@CNVR7823.4, CNVR7823.3, CNVR7823.5, CNVR7823.1@FAM182A_4, FAM182A_5@0@0@0@NA@NA@NA
A2463_07@179011@179021@deletion@11@14982551@15013887@21@chr21:14982551-15013887@40.4@252@45@0.179@CNVR7952.1@POTED_1, POTED_2, POTED_3, POTED_4, POTED_5, POTED_6, POTED_7, POTED_8, POTED_9, POTED_10, POTED_11@0@0@0@:POTE ankyrin domain family, member B;POTE ankyrin domain family, member C;POTE ankyrin domain family, member D@:protein binding;plasma membrane@NA
A2463_07@180966@180966@duplication@1@16157307@16157938@22@chr22:16157307-16157938@5.28@59@109@1.85@CNVR8071.2, CNVR8071.5@AP000525.1_1@0@0@0@:uncharacterized LOC101060615@NA@NA
A2463_07@181131@181133@duplication@3@18734088@18739404@22@chr22:18734088-18739404@6.52@40@90@2.25@CNVR8087.5, CNVR8087.2, CNVR8087.11@AC008132.1_6, AC008132.1_7, AC008132.1_8@0@0@0@NA@NA@NA
A2463_07@181417@181420@deletion@4@20366369@20367356@22@chr22:20366369-20367356@5.91@26@0@0@CNVR8094.9, CNVR8094.4, CNVR8094.3@GGTLC3_5, GGTLC3_4, GGTLC3_3, GGTLC3_2@0@0@0@@:leukotriene biosynthetic process;glutathione metabolic process;gamma-glutamyltransferase activity;anchored to external side of plasma membrane@NA
A2463_07@181622@181622@duplication@1@21480538@21481925@22@chr22:21480538-21481925@14.5@101@243@2.41@CNVR8100.6, CNVR8100.12@POM121L7_1@0@0@0@:putative POM121-like protein 1-like@NA@NA
A2463_07@183633@183641@deletion@9@39358501@39388450@22@chr22:39358501-39388450@17.2@422@243@0.576@CNVR8164.1@APOBEC3A_6, APOBEC3B_1, APOBEC3B_2, APOBEC3B_3, APOBEC3B_4, APOBEC3B_5, APOBEC3B_6, APOBEC3B_7, APOBEC3B_8@0@0@0@:apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A;APOBEC3A and APOBEC3B deletion hybrid:apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B@:cytidine deamination;defense response to virus;negative regulation of viral genome replication;DNA cytosine deamination;clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine;catalytic activity;DNA demethylation;cytoplasm;innate immune response;cytidine deaminase activity;nucleus;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines;cellular response to xenobiotic stimulus;zinc ion binding;negative regulation of transposition:RNA binding;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines;negative regulation of transposition;catalytic activity;zinc ion binding@NA
A2463_07@184151@184152@duplication@2@42526615@42536467@22@chr22:42526615-42536467@6.78@182@275@1.51@CNVR8168.1, CNVR8168.3, CNVR8168.4@CYP2D6_1, CYP2D7P1_5@0@0@0@:cytochrome P450, family 2, subfamily D, polypeptide 6@:oxidation-reduction process;mitochondrion;alkaloid catabolic process;aromatase activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;drug catabolic process;endoplasmic reticulum membrane;response to organic substance;oxidative demethylation;endoplasmic reticulum;alkaloid metabolic process;negative regulation of binding;heme binding;xenobiotic metabolic process;dopamine metabolic process;steroid metabolic process;isoquinoline alkaloid metabolic process;arachidonic acid monooxygenase activity;arachidonic acid metabolic process;steroid 21-monooxygenase activity;negative regulation of cellular organofluorine metabolic process;oxidoreductase activity;monoterpenoid metabolic process;heterocycle metabolic process;drug binding;drug metabolic process;electron carrier activity;small molecule metabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;monooxygenase activity;iron ion binding;coumarin metabolic process:oxidation-reduction process;electron carrier activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;monooxygenase activity;iron ion binding;heme binding@: DRUG METABOLISM, POOR, CYP2D6-RELATED
A2463_27@6@6@duplication@1@69092@70008@1@chr1:69092-70008@7.13@112@185@1.65@CNVR1.1, CNVR1.2@OR4F5_1@0@0@0@:olfactory receptor, family 4, subfamily F, member 5@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_27@1820@1821@deletion@2@12954418@12955678@1@chr1:12954418-12955678@15.3@246@127@0.516@CNVR72.3, CNVR72.4, CNVR72.2@PRAMEF10_3, PRAMEF10_2@0@0@0@:PRAME family member 10@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_27@1829@1831@duplication@3@13036223@13052998@1@chr1:13036223-13052998@6.26@346@468@1.35@CNVR72.3@PRAMEF22_2, PRAMEF22_3, WI2-3308P17.2_1@0@0@0@:PRAME family member 6;PRAME family member 23;PRAME family member 9/15-like;PRAME family member 5:PRAME family member 22@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_27@1835@1838@deletion@4@13330415@13366425@1@chr1:13330415-13366425@9.58@73@21@0.288@CNVR74.8, CNVR74.4@PRAMEF3_2, PRAMEF3_1, PRAMEF5_2, PRAMEF5_3@0@0@0@:PRAME family member 3:PRAME family member 5@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_27@3194@3197@deletion@4@24287949@24298502@1@chr1:24287949-24298502@14.6@82@11@0.134@NA@PNRC2_3, SRSF10_6, SRSF10_5, SRSF10_4@0@0@0@:proline-rich nuclear receptor coactivator 2;proline-rich nuclear receptor coactivator 2-like:serine/arginine-rich splicing factor 10-like;serine/arginine-rich splicing factor 10@:protein binding;deadenylation-independent decapping of nuclear-transcribed mRNA;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;nucleus;regulation of transcription, DNA-dependent;transcription, DNA-dependent;cytoplasmic mRNA processing body:nucleoplasm;RNA splicing, via transesterification reactions;nuclear speck;RS domain binding;RNA binding;nucleus;mRNA splice site selection;unfolded protein binding;assembly of spliceosomal tri-snRNP;negative regulation of mRNA splicing, via spliceosome;regulation of transcription, DNA-dependent;nucleotide binding;cytoplasm;mRNA export from nucleus;protein binding;cytoplasmic transport;mRNA splicing, via spliceosome;nucleic acid binding@NA
A2463_27@6139@6142@deletion@4@46531727@46546422@1@chr1:46531727-46546422@18.2@382@211@0.552@NA@PIK3R3_5, PIK3R3_4, PIK3R3_3, PIK3R3_2@0@0@0@:phosphoinositide-3-kinase, regulatory subunit 3 (gamma)@:phospholipid metabolic process;platelet activation;small molecule metabolic process;phosphatidylinositol 3-kinase complex;phosphatidylinositol-3-phosphate biosynthetic process;T cell costimulation;1-phosphatidylinositol-3-kinase activity;cytosol;phosphatidylinositol biosynthetic process;protein binding;blood coagulation;insulin receptor signaling pathway;1-phosphatidylinositol-3-kinase regulator activity;kinase activity;phosphatidylinositol 3-kinase regulator activity@NA
A2463_27@7891@7891@deletion@1@75184894@75185056@1@chr1:75184894-75185056@7.68@99@44@0.444@NA@CRYZ_5@0@0@0@:crystallin, zeta (quinone reductase)@:oxidation-reduction process;transferase activity, transferring acyl groups other than amino-acyl groups;intracellular membrane-bounded organelle;protein homotetramerization;mRNA 3'-UTR binding;Golgi apparatus;nucleotide binding;NADPH binding;cytoplasm;cytosol;NADPH:quinone reductase activity;oxidoreductase activity;visual perception;zinc ion binding;xenobiotic catabolic process@NA
A2463_27@9373@9374@deletion@2@104233917@104234232@1@chr1:104233917-104234232@20.7@100@4@0.04@CNVR266.3, CNVR266.5@AMY1B_8, AMY1B_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
A2463_27@9449@9451@deletion@3@108993225@108996017@1@chr1:108993225-108996017@12.2@71@11@0.155@CNVR294.4, CNVR294.2@NBPF6_2, NBPF6_3, NBPF6_4@0@0@0@:neuroblastoma breakpoint family, member 6@:cytoplasm@NA
A2463_27@9766@9773@duplication@8@110230497@110235917@1@chr1:110230497-110235917@47@364@745@2.05@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_1, GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
A2463_27@10788@10795@deletion@8@144220788@144520832@1@chr1:144220788-144520832@19.2@242@109@0.45@NA@RP3-377D14.1_87, RP3-377D14.1_88, RP3-377D14.1_89, RP3-377D14.1_90, RP3-377D14.1_91, AL592284.1_1, PPIAL4B_1, AL592284.1_2@0@0@0@:uncharacterized LOC730256;uncharacterized LOC101060698;uncharacterized LOC642441:peptidylprolyl isomerase A (cyclophilin A)-like 4C;peptidyl-prolyl cis-trans isomerase A-like 4A/B/C-like;peptidylprolyl isomerase A (cyclophilin A)-like 4B;peptidylprolyl isomerase A (cyclophilin A)-like 4A@:protein folding;peptidyl-prolyl cis-trans isomerase activity;cytoplasm@NA
A2463_27@10788@10796@duplication@1@144220788@144811957@1@chr1:144220788-144811957@-26.3@478@436@0.912@NA@RP3-377D14.1_87, RP3-377D14.1_89, RP3-377D14.1_90, RP3-377D14.1_91, AL592284.1_1, PPIAL4B_1, AL592284.1_2, NBPF9_1@0@0@0@:uncharacterized LOC730256;uncharacterized LOC101060698;uncharacterized LOC642441:peptidylprolyl isomerase A (cyclophilin A)-like 4C;peptidyl-prolyl cis-trans isomerase A-like 4A/B/C-like;peptidylprolyl isomerase A (cyclophilin A)-like 4B;peptidylprolyl isomerase A (cyclophilin A)-like 4A:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 24@:protein folding;peptidyl-prolyl cis-trans isomerase activity;cytoplasm@NA
A2463_27@10868@10868@deletion@1@145302655@145302868@1@chr1:145302655-145302868@5.27@108@59@0.546@CNVR341.2, CNVR341.3, CNVR341.4@NBPF10_8@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family, member 10@:protein binding;calcium ion binding@NA
A2463_27@10890@10893@deletion@4@145325953@145328432@1@chr1:145325953-145328432@17.9@94@9@0.0957@CNVR341.2, CNVR341.3@NBPF10_30, NBPF10_31, NBPF10_32, NBPF10_33@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family, member 10@NA@NA
A2463_27@11078@11080@duplication@3@145752429@145756613@1@chr1:145752429-145756613@7.26@99@166@1.68@NA@PDZK1_4, PDZK1_5, PDZK1_6@0@0@0@:PDZ domain containing 1@:PDZ domain binding;transport;transporter activity;cytoplasm;cell proliferation;protein binding;positive regulation of ion transmembrane transport;scavenger receptor binding;brush border membrane;establishment of protein localization to plasma membrane;carnitine transport;drug transport@NA
A2463_27@11143@11157@deletion@15@146227744@146244717@1@chr1:146227744-146244717@20.5@97@3@0.0309@NA@NBPF12_22, NBPF12_21, NBPF12_20, NBPF12_19, NBPF12_18, NBPF12_17, NBPF12_16, NBPF12_15, NBPF12_14, NBPF12_13, NBPF12_12, NBPF12_11, NBPF12_10, NBPF12_9, NBPF12_8@0@0@0@:neuroblastoma breakpoint family member 21-like@NA@NA
A2463_27@11161@11162@deletion@2@146248917@146250999@1@chr1:146248917-146250999@21.4@103@3@0.0291@NA@NBPF12_4, NBPF12_3@0@0@0@:neuroblastoma breakpoint family member 21-like@NA@NA
A2463_27@11169@11169@deletion@1@146400092@146400302@1@chr1:146400092-146400302@5.9@26@0@0@NA@NBPF12_9@0@0@0@:neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family member 14-like;neuroblastoma breakpoint family, member 12@:cytoplasm@NA
A2463_27@11169@11171@duplication@2@146400092@146403757@1@chr1:146400092-146403757@7.45@124@207@1.67@NA@NBPF12_9, NBPF12_10, NBPF12_11@0@0@0@:neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family member 14-like;neuroblastoma breakpoint family, member 12@:cytoplasm@NA
A2463_27@11335@11351@duplication@17@147954851@148016460@1@chr1:147954851-148016460@82.5@1869@2981@1.59@CNVR346.2, CNVR346.3, CNVR346.4@PPIAL4A_1, NBPF14_22, NBPF14_21, NBPF14_20, NBPF14_19, NBPF14_18, NBPF14_17, NBPF14_16, NBPF14_15, NBPF14_14, NBPF14_13, NBPF14_12, NBPF14_11, NBPF14_10, NBPF14_9, NBPF14_8, NBPF14_7@0@0@0@:peptidylprolyl isomerase A (cyclophilin A)-like 4C;peptidyl-prolyl cis-trans isomerase A-like 4A/B/C-like;peptidylprolyl isomerase A (cyclophilin A)-like 4B;peptidylprolyl isomerase A (cyclophilin A)-like 4A:neuroblastoma breakpoint family, member 14@:protein folding;peptidyl-prolyl cis-trans isomerase activity;cytoplasm:cytoplasm@NA
A2463_27@11354@11356@duplication@3@148022928@148024925@1@chr1:148022928-148024925@8.23@363@502@1.38@CNVR346.2, CNVR346.4@NBPF14_4, NBPF14_3, NBPF14_2@0@0@0@:neuroblastoma breakpoint family, member 14@:cytoplasm@NA
A2463_27@12117@12118@deletion@2@152573209@152586574@1@chr1:152573209-152586574@41.7@197@2@0.0102@CNVR358.1@LCE3C_1, LCE3B_1@0@0@0@:late cornified envelope 3C:late cornified envelope 3B@:keratinization:keratinization@NA
A2463_27@16029@16040@deletion@12@196744018@196801129@1@chr1:196744018-196801129@39.9@2821@1904@0.675@CNVR459.1@CFHR3_1, CFHR3_2, CFHR3_3, CFHR3_4, CFHR3_5, CFHR3_6, CFHR1_1, CFHR1_2, CFHR1_3, CFHR1_4, CFHR1_5, CFHR1_6@0@0@0@:complement factor H-related 3:complement factor H-related 1:complement factor H-related 2@:extracellular space:extracellular space;complement activation:extracellular region@NA
A2463_27@17286@17291@deletion@6@207718654@207726196@1@chr1:207718654-207726196@10.2@93@34@0.366@CNVR485.1@CR1_14, CR1_15, CR1_16, CR1_17, CR1_18, CR1_19@0@0@0@:complement component (3b/4b) receptor 1 (Knops blood group)@:complement component C4b receptor activity;complement activation, classical pathway;negative regulation of complement activation, alternative pathway;innate immune response;negative regulation of serine-type endopeptidase activity;complement component C3b binding;negative regulation of complement activation, classical pathway;plasma membrane;integral to plasma membrane;complement component C3b receptor activity;complement component C4b binding;cell surface;regulation of complement activation;positive regulation of serine-type endopeptidase activity@: MALARIA, SUSCEPTIBILITY TO; KNOPS BLOOD GROUP SYSTEM; KN
A2463_27@17294@17295@duplication@2@207737210@207737579@1@chr1:207737210-207737579@5.65@109@169@1.55@CNVR485.1, CNVR485.2@CR1_22, CR1_23@0@0@0@:complement component (3b/4b) receptor 1 (Knops blood group)@:complement component C4b receptor activity;complement activation, classical pathway;negative regulation of complement activation, alternative pathway;innate immune response;negative regulation of serine-type endopeptidase activity;complement component C3b binding;negative regulation of complement activation, classical pathway;plasma membrane;integral to plasma membrane;complement component C3b receptor activity;complement component C4b binding;cell surface;regulation of complement activation;positive regulation of serine-type endopeptidase activity@: MALARIA, SUSCEPTIBILITY TO; KNOPS BLOOD GROUP SYSTEM; KN
A2463_27@22191@22194@duplication@4@38956699@38972329@2@chr2:38956699-38972329@10.4@381@535@1.4@CNVR759.1@GALM_5, GALM_6, GALM_7, SRSF7_8@0@0@0@:galactose mutarotase (aldose 1-epimerase):serine/arginine-rich splicing factor 7@:isomerase activity;carbohydrate binding;aldose 1-epimerase activity;hexose metabolic process;carbohydrate metabolic process;catalytic activity;cytoplasm:nucleoplasm;negative regulation of mRNA splicing, via spliceosome;mRNA 3'-end processing;termination of RNA polymerase II transcription;nucleotide binding;transcription from RNA polymerase II promoter;protein binding;mRNA export from nucleus;RNA binding;mRNA processing;nucleus;RNA splicing;mRNA splicing, via spliceosome;gene expression;zinc ion binding;nucleic acid binding@NA
A2463_27@24822@24822@deletion@1@87178420@87178483@2@chr2:87178420-87178483@8.41@38@0@0@NA@RGPD1_2@0@0@0@:RANBP2-like and GRIP domain containing 1@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_27@24840@24840@duplication@1@87212700@87214922@2@chr2:87212700-87214922@8.74@243@367@1.51@NA@RGPD1_20@0@0@0@:RANBP2-like and GRIP domain containing 1@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_27@24853@24853@deletion@1@88081644@88083866@2@chr2:88081644-88083866@6.92@306@193@0.631@NA@RGPD2_20@0@0@0@:RANBP2-like and GRIP domain containing 2@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_27@24856@24863@duplication@8@88091510@88095367@2@chr2:88091510-88095367@9.53@56@125@2.23@NA@RGPD2_17, RGPD2_16, RGPD2_15, RGPD2_14, RGPD2_13, RGPD2_12, RGPD2_11, RGPD2_10@0@0@0@:RANBP2-like and GRIP domain containing 2@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_27@25369@25370@deletion@2@97854825@97855027@2@chr2:97854825-97855027@37.1@177@4@0.0226@CNVR886.2, CNVR886.3@ANKRD36_33, ANKRD36_34@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_27@26008@26011@duplication@4@108454714@108460186@2@chr2:108454714-108460186@13.4@164@288@1.76@NA@RGPD4_3, RGPD4_4, RGPD4_5, RGPD4_6@0@0@0@:RANBP2-like and GRIP domain containing 4@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_27@26021@26022@duplication@2@108479139@108479488@2@chr2:108479139-108479488@15@406@611@1.5@NA@RGPD4_16, RGPD4_17@0@0@0@:RANBP2-like and GRIP domain containing 4@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_27@26088@26088@deletion@1@109293063@109293154@2@chr2:109293063-109293154@6.73@115@59@0.513@NA@LIMS1_7@0@0@0@:LIM and senescent cell antigen-like domains 1@:negative regulation of transcription, DNA-dependent;cell aging;perinuclear region of cytoplasm;cellular response to transforming growth factor beta stimulus;cytosol;protein binding;focal adhesion;plasma membrane;zinc ion binding;cell junction assembly@NA
A2463_27@26318@26318@duplication@1@112566525@112566758@2@chr2:112566525-112566758@7.24@182@276@1.52@CNVR928.1@ANAPC1_29@0@0@0@:anaphase-promoting complex subunit 1-like;anaphase promoting complex subunit 1@:nucleoplasm;regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle;anaphase-promoting complex;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle spindle assembly checkpoint;cytosol;protein K11-linked ubiquitination;protein binding;mitosis;nucleus;cell cycle checkpoint;cell division;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle@NA
A2463_27@27326@27326@deletion@1@132010100@132010143@2@chr2:132010100-132010143@5.14@26@2@0.0769@NA@POTEE_12@0@0@0@:pleckstrin homology domain containing, family B (evectins) member 2:POTE ankyrin domain family, member E@:phospholipid binding;protein binding;recycling endosome membrane:protein binding;ATP binding@NA
A2463_27@27341@27342@deletion@2@132288153@132289375@2@chr2:132288153-132289375@5.63@239@154@0.644@NA@CCDC74A_3, CCDC74A_4@0@0@0@:coiled-coil domain containing 74A@NA@NA
A2463_27@27975@27975@duplication@1@152435853@152436163@2@chr2:152435853-152436163@8.27@69@138@2@CNVR1026.1@NEB_105@0@0@0@:nebulin@:Z disc;muscle filament sliding;oxidation-reduction process;contractile fiber part;actin cytoskeleton;regulation of actin filament length;structural constituent of muscle;cytosol;actin binding;protein binding;myofibril;somatic muscle development;muscle organ development@: NEMALINE MYOPATHY 2; NEM2
A2463_27@27996@27997@duplication@2@152463121@152464122@2@chr2:152463121-152464122@8.29@122@203@1.66@CNVR1026.1@NEB_84, NEB_83@0@0@0@:nebulin@:Z disc;muscle filament sliding;oxidation-reduction process;contractile fiber part;actin cytoskeleton;regulation of actin filament length;structural constituent of muscle;cytosol;actin binding;protein binding;myofibril;somatic muscle development;muscle organ development@: NEMALINE MYOPATHY 2; NEM2
A2463_27@39893@39894@deletion@2@75790428@75790887@3@chr3:75790428-75790887@8.88@41@1@0.0244@CNVR1432.5, CNVR1432.9, CNVR1432.4@ZNF717_4, ZNF717_3@0@0@0@:zinc finger protein 717;zinc finger protein 717-like@:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_27@46667@46676@deletion@10@9174900@9247197@4@chr4:9174900-9247197@25.3@185@49@0.265@NA@FAM90A26P_4, FAM90A26P_5, FAM90A26P_6, FAM90A26P_7, USP17L13_1, USP17L10_1, USP17L11_1, USP17L12_1, USP17L13_2, USP17L15_1, USP17L17_1@0@0@0@:ubiquitin specific peptidase 17-like family member 10:ubiquitin specific peptidase 17-like family member 13:ubiquitin specific peptidase 17-like family member 11:ubiquitin specific peptidase 17-like family member 12:ubiquitin specific peptidase 17-like family member 15:ubiquitin specific peptidase 17-like family member 17@:zinc ion binding;nucleic acid binding:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
A2463_27@48559@48559@duplication@1@69426256@69426386@4@chr4:69426256-69426386@7.41@67@130@1.94@CNVR1953.1@UGT2B17_3@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B17@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;membrane@: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
A2463_27@48592@48597@deletion@6@70146220@70160527@4@chr4:70146220-70160527@31.4@1160@715@0.616@CNVR1957.2, CNVR1957.1@UGT2B28_1, UGT2B28_2, UGT2B28_3, UGT2B28_4, UGT2B28_5, UGT2B28_6@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B28@:carbohydrate binding;transferase activity, transferring hexosyl groups;endoplasmic reticulum;glucuronosyltransferase activity;carbohydrate metabolic process;xenobiotic metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process@NA
A2463_27@48968@48969@deletion@2@75314765@75316249@4@chr4:75314765-75316249@5.45@125@72@0.576@NA@AREG_3, AREG_4@0@0@0@:amphiregulin;amphiregulin B@:growth factor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;cell proliferation;epidermal growth factor receptor signaling pathway;extracellular space;protein binding;integral to membrane;cytokine activity;cell surface;positive regulation of DNA replication@NA
A2463_27@48972@48973@duplication@2@75482007@75484724@4@chr4:75482007-75484724@10@52@125@2.4@NA@AREGB_2, AREGB_3@0@0@0@:amphiregulin;amphiregulin B@:growth factor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;cell proliferation;epidermal growth factor receptor signaling pathway;extracellular space;protein binding;integral to membrane;cytokine activity;cell surface;positive regulation of DNA replication@NA
A2463_27@53237@53238@deletion@2@272827@304336@5@chr5:272827-304336@6.49@144@82@0.569@NA@PDCD6_2, PDCD6_3@0@0@0@:programmed cell death 6:aryl-hydrocarbon receptor repressor@:cellular response to stress;calcium-dependent protein binding;intracellular protein transport;activation of cysteine-type endopeptidase activity involved in apoptotic process;protein dimerization activity;apoptotic process;nucleus;protein homodimerization activity;endoplasmic reticulum membrane;response to calcium ion;endoplasmic reticulum;binding, bridging;cytoplasm;nuclear membrane;cytoplasmic vesicle;protein binding;calcium ion binding:negative regulation of transcription, DNA-dependent;DNA binding;regulation of transcription, DNA-dependent;signal transducer activity;cytoplasm;signal transduction;negative regulation of transcription from RNA polymerase II promoter;protein dimerization activity;nucleus;transcription, DNA-dependent;positive regulation of protein sumoylation@NA
A2463_27@53306@53306@deletion@1@741710@741743@5@chr5:741710-741743@5.42@69@31@0.449@CNVR2280.3@ZDHHC11B_7@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
A2463_27@53308@53311@deletion@4@748520@756259@5@chr5:748520-756259@20.3@118@18@0.153@CNVR2280.3@ZDHHC11B_5, ZDHHC11B_4, ZDHHC11B_3, ZDHHC11B_2@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
A2463_27@53318@53321@duplication@4@833889@843839@5@chr5:833889-843839@12.7@469@659@1.41@CNVR2280.3, CNVR2280.8@ZDHHC11_7, ZDHHC11_6, ZDHHC11_5, ZDHHC11_4@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
A2463_27@55787@55789@deletion@3@68868273@68874935@5@chr5:68868273-68874935@7.89@86@35@0.407@CNVR2494.7, CNVR2494.46@GTF2H2C_8, GTF2H2C_9, GTF2H2C_10@0@0@0@:general transcription factor IIH, polypeptide 2C;general transcription factor IIH, polypeptide 2D@:regulation of transcription, DNA-dependent;nucleotide-excision repair;DNA repair;core TFIIH complex;protein binding;nucleus;transcription, DNA-dependent;zinc ion binding@NA
A2463_27@55806@55806@deletion@1@69372349@69372398@5@chr5:69372349-69372398@35.8@168@0@0@CNVR2494.48, CNVR2494.39, CNVR2494.15, CNVR2494.18, CNVR2494.26, CNVR2494.43, CNVR2494.52, CNVR2494.28, CNVR2494.2, CNVR2494.36@SMN2_8@0@0@0@:survival of motor neuron 2, centromeric;survival of motor neuron 1, telomeric@:nucleoplasm;ncRNA metabolic process;Cajal body;RNA metabolic process;spliceosomal complex;cytoplasm;cytosol;protein binding;cell death;spliceosomal complex assembly;RNA binding;mRNA processing;nucleus;gene expression;spliceosomal snRNP assembly@: SPINAL MUSCULAR ATROPHY, TYPE II; SMA2; SPINAL MUSCULAR ATROPHY, TYPE I; SMA1; SPINAL MUSCULAR ATROPHY, TYPE IV; SMA4; SPINAL MUSCULAR ATROPHY, TYPE III; SMA3
A2463_27@55835@55835@deletion@1@70338009@70338111@5@chr5:70338009-70338111@7.31@33@0@0@CNVR2494.41, CNVR2494.14, CNVR2494.20, CNVR2494.62, CNVR2494.8@GTF2H2_14@0@0@0@:general transcription factor IIH, polypeptide 2, 44kDa@:nucleoplasm;nucleotide-excision repair, DNA damage removal;transcription from RNA polymerase I promoter;DNA repair;RNA polymerase II carboxy-terminal domain kinase activity;nucleus;viral reproduction;translation;gene expression;transcription elongation from RNA polymerase I promoter;response to UV;holo TFIIH complex;protein kinase activity;nucleotide-excision repair;transcription from RNA polymerase II promoter;transcription-coupled nucleotide-excision repair;transcription, DNA-dependent;zinc ion binding;transcription elongation from RNA polymerase II promoter;termination of RNA polymerase I transcription;sequence-specific DNA binding transcription factor activity;G-protein coupled receptor internalization;DNA-dependent ATPase activity;protein N-terminus binding;transcription initiation from RNA polymerase I promoter;7-methylguanosine mRNA capping;transcription initiation from RNA polymerase II promoter;protein phosphorylation;translation factor activity, nucleic acid binding;regulation of transcription, DNA-dependent;core TFIIH complex;protein binding;positive regulation of viral transcription;nucleic acid binding@NA
A2463_27@55837@55837@deletion@1@70343834@70343940@5@chr5:70343834-70343940@12.5@57@0@0@CNVR2494.41, CNVR2494.14, CNVR2494.20, CNVR2494.62, CNVR2494.8@GTF2H2_12@0@0@0@:general transcription factor IIH, polypeptide 2, 44kDa@:nucleoplasm;nucleotide-excision repair, DNA damage removal;transcription from RNA polymerase I promoter;DNA repair;RNA polymerase II carboxy-terminal domain kinase activity;nucleus;viral reproduction;translation;gene expression;transcription elongation from RNA polymerase I promoter;response to UV;holo TFIIH complex;protein kinase activity;nucleotide-excision repair;transcription from RNA polymerase II promoter;transcription-coupled nucleotide-excision repair;transcription, DNA-dependent;zinc ion binding;transcription elongation from RNA polymerase II promoter;termination of RNA polymerase I transcription;sequence-specific DNA binding transcription factor activity;G-protein coupled receptor internalization;DNA-dependent ATPase activity;protein N-terminus binding;transcription initiation from RNA polymerase I promoter;7-methylguanosine mRNA capping;transcription initiation from RNA polymerase II promoter;protein phosphorylation;translation factor activity, nucleic acid binding;regulation of transcription, DNA-dependent;core TFIIH complex;protein binding;positive regulation of viral transcription;nucleic acid binding@NA
A2463_27@55842@55842@deletion@1@70355948@70355997@5@chr5:70355948-70355997@4.86@22@0@0@CNVR2494.41, CNVR2494.14, CNVR2494.20, CNVR2494.62, CNVR2494.8@GTF2H2_7@0@0@0@:general transcription factor IIH, polypeptide 2, 44kDa@:nucleoplasm;nucleotide-excision repair, DNA damage removal;transcription from RNA polymerase I promoter;DNA repair;RNA polymerase II carboxy-terminal domain kinase activity;nucleus;viral reproduction;translation;gene expression;transcription elongation from RNA polymerase I promoter;response to UV;holo TFIIH complex;protein kinase activity;nucleotide-excision repair;transcription from RNA polymerase II promoter;transcription-coupled nucleotide-excision repair;transcription, DNA-dependent;zinc ion binding;transcription elongation from RNA polymerase II promoter;termination of RNA polymerase I transcription;sequence-specific DNA binding transcription factor activity;G-protein coupled receptor internalization;DNA-dependent ATPase activity;protein N-terminus binding;transcription initiation from RNA polymerase I promoter;7-methylguanosine mRNA capping;transcription initiation from RNA polymerase II promoter;protein phosphorylation;translation factor activity, nucleic acid binding;regulation of transcription, DNA-dependent;core TFIIH complex;protein binding;positive regulation of viral transcription;nucleic acid binding@NA
A2463_27@60887@60889@duplication@3@175523828@175525561@5@chr5:175523828-175525561@6.87@212@302@1.42@NA@FAM153B_6, FAM153B_7, FAM153B_8@0@0@0@:uncharacterized LOC100507387;family with sequence similarity 153, member B@NA@NA
A2463_27@61260@61264@deletion@5@177156025@177161405@5@chr5:177156025-177161405@10.6@159@80@0.503@NA@FAM153A_17, FAM153A_16, FAM153A_15, FAM153A_14, FAM153A_13@0@0@0@:family with sequence similarity 153, member A@NA@NA
A2463_27@61266@61267@deletion@2@177163581@177164113@5@chr5:177163581-177164113@24.8@166@34@0.205@NA@FAM153A_11, FAM153A_10@0@0@0@:family with sequence similarity 153, member A@NA@NA
A2463_27@61269@61276@deletion@8@177166602@177210856@5@chr5:177166602-177210856@22.8@242@98@0.405@CNVR2699.2@FAM153A_8, FAM153A_7, FAM153A_6, FAM153A_5, FAM153A_4, FAM153A_3, RP11-1026M7.2_2@0@0@0@:family with sequence similarity 153, member A@NA@NA
A2463_27@62738@62738@duplication@1@26406138@26406484@6@chr6:26406138-26406484@5.16@69@118@1.71@NA@BTN3A1_3@0@0@0@:butyrophilin, subfamily 3, member A1@:protein binding;integral to membrane;lipid metabolic process@NA
A2463_27@63290@63290@deletion@1@31323945@31324219@6@chr6:31323945-31324219@7.54@189@107@0.566@CNVR2841.12, CNVR2841.14, CNVR2841.8@HLA-B_3@0@0@0@:major histocompatibility complex, class I, B@:MHC class I protein complex;regulation of immune response;regulation of interleukin-12 production;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;regulation of T cell anergy;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;receptor binding;early endosome membrane;virus-host interaction;regulation of interleukin-6 production;regulation of dendritic cell differentiation;phagocytic vesicle membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;MHC class I receptor activity;membrane@: SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO; SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1; SPDA1
A2463_27@63292@63292@deletion@1@31324864@31324935@6@chr6:31324864-31324935@4.58@91@50@0.549@CNVR2841.12, CNVR2841.14, CNVR2841.8, CNVR2841.23@HLA-B_1@0@0@0@:major histocompatibility complex, class I, B@:MHC class I protein complex;regulation of immune response;regulation of interleukin-12 production;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;regulation of T cell anergy;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;receptor binding;early endosome membrane;virus-host interaction;regulation of interleukin-6 production;regulation of dendritic cell differentiation;phagocytic vesicle membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;MHC class I receptor activity;membrane@: SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO; SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1; SPDA1
A2463_27@63725@63725@deletion@1@31962023@31962161@6@chr6:31962023-31962161@5.56@128@72@0.562@CNVR2843.6, CNVR2843.3@C4A_20@0@0@0@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
A2463_27@63734@63735@deletion@2@31964607@31965088@6@chr6:31964607-31965088@4.97@28@4@0.143@CNVR2843.6, CNVR2843.3@C4A_29, C4A_30@0@0@0@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
A2463_27@63747@63748@deletion@2@31973946@31974881@6@chr6:31973946-31974881@8.45@239@143@0.598@CNVR2843.6, CNVR2843.3@AL645922.1_2, AL645922.1_1@0@0@0@NA@NA@NA
A2463_27@63769@63776@deletion@8@31995014@31997115@6@chr6:31995014-31997115@50.6@824@420@0.51@CNVR2843.6, CNVR2843.5@C4B_21, C4B_22, C4B_23, C4B_24, C4B_25, C4B_26, C4B_27, C4B_28@0@0@0@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
A2463_27@63953@63958@deletion@6@32485517@32498001@6@chr6:32485517-32498001@47@418@140@0.335@CNVR2845.21, CNVR2845.25, CNVR2845.30, CNVR2845.43, CNVR2845.6@HLA-DRB5_6, HLA-DRB5_5, HLA-DRB5_4, HLA-DRB5_3, HLA-DRB5_2, HLA-DRB5_1@0@0@0@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
A2463_27@63961@63963@deletion@3@32548524@32552155@6@chr6:32548524-32552155@35.8@574@274@0.477@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.5, CNVR2845.54@HLA-DRB1_4, HLA-DRB1_3, HLA-DRB1_2@0@0@0@:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1@:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
A2463_27@70816@70817@duplication@2@161054786@161056336@6@chr6:161054786-161056336@25.9@263@514@1.95@CNVR3133.1@LPA_9, LPA_8@0@0@0@:lipoprotein, Lp(a)@:blood circulation;endopeptidase inhibitor activity;catalytic activity;lipoprotein metabolic process;proteolysis;heparin binding;receptor-mediated endocytosis;fibronectin binding;small molecule metabolic process;apolipoprotein binding;lipid metabolic process;negative regulation of endopeptidase activity;extracellular region;plasma lipoprotein particle;lipid transport;serine-type endopeptidase activity@: APOLIPOPROTEIN(a); LPA
A2463_27@71030@71030@deletion@1@167790035@167790192@6@chr6:167790035-167790192@11.3@65@9@0.138@NA@TCP10_5@0@0@0@:t-complex 10@:cytosol@NA
A2463_27@71754@71754@duplication@1@5959481@5959597@7@chr7:5959481-5959597@6.37@125@197@1.58@NA@CCZ1_12@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
A2463_27@71778@71778@duplication@1@6017220@6017388@7@chr7:6017220-6017388@6.13@278@390@1.4@NA@PMS2_14@0@0@0@:PMS2 postmeiotic segregation increased 2 (S. cerevisiae)@:response to drug;DNA binding;MutSalpha complex binding;ATP binding;mismatch repair;DNA repair;mismatched DNA binding;ATPase activity;nucleus;mismatch repair complex;reciprocal meiotic recombination;ATP catabolic process;single-stranded DNA binding;response to DNA damage stimulus;single base insertion or deletion binding;protein binding;somatic hypermutation of immunoglobulin genes;somatic recombination of immunoglobulin gene segments;MutLalpha complex;endonuclease activity@: COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 4; HNPCC4; MISMATCH REPAIR CANCER SYNDROME
A2463_27@73242@73242@duplication@1@38279626@38279767@7@chr7:38279626-38279767@9.01@58@129@2.22@NA@TRGC2_4@0@0@0@@:protein binding@NA
A2463_27@73249@73250@duplication@2@38301773@38305279@7@chr7:38301773-38305279@13.8@370@556@1.5@CNVR3353.1@TRGC1_2, TRGC1_1@0@0@0@:TCR gamma alternate reading frame protein@:protein binding@NA
A2463_27@73259@73263@duplication@5@38370381@38393784@7@chr7:38370381-38393784@33.1@317@611@1.93@NA@TRGV8_1, TRGV5_2, TRGV5_1, TRGV4_2, TRGV4_1@0@0@0@@:protein binding:protein binding:protein binding@NA
A2463_27@74565@74574@duplication@10@74157789@74167509@7@chr7:74157789-74167509@17.7@597@842@1.41@NA@GTF2I_20, GTF2I_21, GTF2I_22, GTF2I_23, GTF2I_24, GTF2I_25, GTF2I_26, GTF2I_27, GTF2I_28, GTF2I_29@0@0@0@:general transcription factor IIi@:neuronal cell body;transcription initiation from RNA polymerase II promoter;mitogen-activated protein kinase binding;negative regulation of angiogenesis;DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;cytoplasm;transcription from RNA polymerase II promoter;protein binding;signal transduction;nucleus;cell projection;reduction of cytosolic calcium ion concentration@NA
A2463_27@74578@74579@duplication@2@74172293@74173168@7@chr7:74172293-74173168@5.19@122@182@1.49@NA@GTF2I_33, GTF2I_34@0@0@0@:general transcription factor IIi@:neuronal cell body;transcription initiation from RNA polymerase II promoter;mitogen-activated protein kinase binding;negative regulation of angiogenesis;DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;cytoplasm;transcription from RNA polymerase II promoter;protein binding;signal transduction;nucleus;cell projection;reduction of cytosolic calcium ion concentration@NA
A2463_27@74583@74583@deletion@1@74193604@74193768@7@chr7:74193604-74193768@6.25@230@142@0.617@NA@NCF1_4@0@0@0@:neutrophil cytosolic factor 1@:inflammatory response;antigen processing and presentation of peptide antigen via MHC class I;phagosome maturation;NADPH oxidase complex;neutrophil mediated killing of gram-positive bacterium;cell communication;interaction with host;leukotriene metabolic process;response to yeast;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;respiratory burst;GTPase activity;negative regulation of smooth muscle contraction;GTP catabolic process;cytosol;defense response to fungus;defense response to bacterium;antigen processing and presentation of exogenous peptide antigen via MHC class I;leukocyte mediated cytotoxicity;neutrophil mediated killing of fungus;phosphatidylinositol binding;defense response to Gram-positive bacterium;GTP binding;respiratory burst involved in defense response;superoxide-generating NADPH oxidase activity;hydrogen peroxide biosynthetic process;protein targeting to membrane;electron carrier activity;superoxide metabolic process;innate immune response;phagolysosome;cytoplasm;cell proliferation;superoxide anion generation;protein binding;SH3 domain binding;cellular defense response;response to bacterium@: GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE,
A2463_27@74597@74598@deletion@2@74225431@74227349@7@chr7:74225431-74227349@12.7@63@4@0.0635@NA@GTF2IRD2_10, GTF2IRD2_9@0@0@0@:GTF2I repeat domain containing 2@:nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_27@74600@74604@duplication@5@74234500@74248066@7@chr7:74234500-74248066@9.75@176@276@1.57@NA@GTF2IRD2_7, GTF2IRD2_6, GTF2IRD2_5, GTF2IRD2_4, GTF2IRD2_3@0@0@0@:GTF2I repeat domain containing 2@:nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_27@74781@74783@duplication@3@76121471@76129837@7@chr7:76121471-76129837@8.6@92@164@1.78@CNVR3462.1@DTX2_6, DTX2_7, DTX2_8@0@0@0@:deltex homolog 2 (Drosophila)@:ligase activity;cytoplasm;nuclear membrane;Notch signaling pathway;protein binding;nucleus;zinc ion binding;protein ubiquitination@NA
A2463_27@76245@76245@deletion@1@99912156@99912373@7@chr7:99912156-99912373@12.8@60@1@0.0167@CNVR3508.2, CNVR3508.1@SPDYE3_6@0@0@0@:speedy homolog E3 (Xenopus laevis)@NA@NA
A2463_27@76427@76432@deletion@6@100331793@100336236@7@chr7:100331793-100336236@82.6@386@4@0.0104@CNVR3509.1@ZAN_1, ZAN_2, ZAN_3, ZAN_4, ZAN_5, ZAN_6@0@0@0@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
A2463_27@76727@76737@duplication@11@102134273@102147271@7@chr7:102134273-102147271@24.6@223@429@1.92@CNVR3518.1@RASA4B_15, RASA4B_14, RASA4B_13, RASA4B_12, RASA4B_11, RASA4B_10, RASA4B_9, RASA4B_8, RASA4B_7, RASA4B_6, RASA4B_5@0@0@0@:RAS p21 protein activator 4B@:phospholipid binding;intracellular;GTPase activator activity;cytosol;signal transduction;protein binding;plasma membrane;regulation of small GTPase mediated signal transduction;metal ion binding;intracellular signal transduction@NA
A2463_27@76748@76754@duplication@7@102201564@102220243@7@chr7:102201564-102220243@8.82@522@696@1.33@CNVR3518.1@SPDYE2_8, POLR2J3_4, POLR2J3_3, POLR2J3_2, POLR2J3_1, AC093668.1_3, AC093668.1_2, AC093668.1_1@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:speedy homolog E2 (Xenopus laevis):RAS p21 protein activator 4B;RAS p21 protein activator 4@:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity@NA
A2463_27@76771@76779@duplication@9@102246306@102279646@7@chr7:102246306-102279646@22.5@422@679@1.61@CNVR3518.1@RASA4_5, RASA4_4, RASA4_3, RASA4_2, UPK3BL_7, RASA4_1, UPK3BL_6, UPK3BL_6, UPK3BL_5, UPK3BL_5, UPK3BL_4, UPK3BL_4@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4:uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity:integral to membrane:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
A2463_27@76792@76792@deletion@1@102309363@102309451@7@chr7:102309363-102309451@8.18@41@3@0.0732@CNVR3518.1@POLR2J2_2, POLR2J2_2@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
A2463_27@76792@76795@duplication@3@102309363@102319303@7@chr7:102309363-102319303@1.71@405@522@1.29@CNVR3518.1@POLR2J2_2, POLR2J2_2, POLR2J2_1, POLR2J2_1, AC105052.1_3, AC105052.1_2, AC105052.1_1@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
A2463_27@79013@79013@duplication@1@141760112@141760173@7@chr7:141760112-141760173@5.89@141@213@1.51@CNVR3585.3, CNVR3585.2@MGAM_34@0@0@0@:maltase-glucoamylase (alpha-glucosidase)@:glucan 1,4-alpha-glucosidase activity;carbohydrate binding;small molecule metabolic process;apical plasma membrane;carbohydrate metabolic process;catalytic activity;starch catabolic process;polysaccharide digestion;integral to membrane;alpha-glucosidase activity;plasma membrane;hydrolase activity, hydrolyzing O-glycosyl compounds;maltose alpha-glucosidase activity;amylase activity@NA
A2463_27@79287@79289@duplication@3@143400089@143418471@7@chr7:143400089-143418471@16.9@168@314@1.87@CNVR3594.2, CNVR3594.1@FAM115C_2, FAM115C_3, FAM115C_4@0@0@0@:family with sequence similarity 115, member C;protein FAM115C-like@NA@NA
A2463_27@79309@79310@deletion@2@143880598@143885476@7@chr7:143880598-143885476@29.6@764@426@0.558@CNVR3598.4, CNVR3598.3@CTAGE4_1, ARHGEF35_2@0@0@0@:CTAGE family, member 4:Rho guanine nucleotide exchange factor (GEF) 35@:integral to membrane;nucleotide binding;cellular_component;biological_process@NA
A2463_27@79312@79325@duplication@14@143955790@144072768@7@chr7:143955790-144072768@73.2@2550@3784@1.48@CNVR3598.4@OR2A7_1, CTAGE8_1, OR2A1_1, ARHGEF5_2, ARHGEF5_3, ARHGEF5_4, ARHGEF5_5, ARHGEF5_6, ARHGEF5_7, ARHGEF5_8, ARHGEF5_9, ARHGEF5_10, ARHGEF5_11, ARHGEF5_12@0@0@0@:Rho guanine nucleotide exchange factor (GEF) 35:olfactory receptor, family 2, subfamily A, member 7:CTAGE family, member 6, pseudogene;CTAGE family, member 15, pseudogene:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
A2463_27@80141@80143@deletion@3@116087@150533@8@chr8:116087-150533@6.86@128@70@0.547@CNVR3684.5, CNVR3684.11@OR4F21_1, RP11-585F1.10_2, RP11-585F1.10_1@0@0@0@:olfactory receptor, family 4, subfamily F, member 21:F-box only protein 25-like;putative uncharacterized protein C20orf69-like@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_27@80365@80366@duplication@2@7218633@7220468@8@chr8:7218633-7220468@4.76@295@394@1.34@CNVR3771.8, CNVR3771.10, CNVR3771.4@ZNF705G_4, ZNF705G_3@0@0@0@:zinc finger protein 705G@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_27@80376@80376@duplication@1@7340127@7340274@8@chr8:7340127-7340274@5.44@111@172@1.55@CNVR3771.8, CNVR3771.10, CNVR3771.4@DEFB106B_2@0@0@0@:defensin, beta 106B;defensin, beta 106A@:extracellular region;defense response to bacterium@NA
A2463_27@80402@80402@duplication@1@7718169@7718245@8@chr8:7718169-7718245@4.72@54@96@1.78@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@SPAG11A_3@0@0@0@:sperm associated antigen 11A;sperm associated antigen 11B@:extracellular region;defense response@NA
A2463_27@80564@80565@duplication@2@11970084@11996269@8@chr8:11970084-11996269@45.1@1940@3354@1.73@CNVR3785.8, CNVR3785.5, CNVR3785.6@ZNF705D_6, USP17L2_1@0@0@0@:zinc finger protein 705D:ubiquitin specific peptidase 17-like family member 1, pseudogene;ubiquitin specific peptidase 17-like family member 2;ubiquitin specific peptidase 17-like family member 4;ubiquitin specific peptidase 17-like family member 7;ubiquitin specific peptidase 17-like family member 8;ubiquitin specific peptidase 17-like family member 3@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:protein deubiquitination;ubiquitin-specific protease activity;mitotic cell cycle G1/S transition checkpoint;nucleus;G2/M transition checkpoint;apoptotic process;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
A2463_27@83673@83673@duplication@1@86573700@86575726@8@chr8:86573700-86575726@6.04@494@665@1.35@CNVR3955.1@REXO1L1_1@0@0@0@:exonuclease GOR-like;REX1, RNA exonuclease 1 homolog (S. cerevisiae)-like 1@:intracellular;nucleus;exonuclease activity;nucleic acid binding;cytoplasm@NA
A2463_27@86358@86359@deletion@2@145486843@145487390@8@chr8:145486843-145487390@5.76@26@0@0@NA@BOP1_13, BOP1_12@0@0@0@:block of proliferation 1@:nucleoplasm;regulation of cell cycle;ribonucleoprotein complex;maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);ribosome biogenesis;cell proliferation;protein binding;PeBoW complex;nucleus;rRNA processing@NA
A2463_27@88521@88521@deletion@1@39887323@39891057@9@chr9:39887323-39891057@7.05@328@208@0.634@NA@SPATA31A2_4@0@0@0@:SPATA31 subfamily A, member 2@:integral to membrane@NA
A2463_27@88528@88528@duplication@1@40702653@40706387@9@chr9:40702653-40706387@9.62@786@1084@1.38@NA@SPATA31A3_4@0@0@0@:SPATA31 subfamily A, member 3@:integral to membrane@NA
A2463_27@88535@88539@deletion@5@41311441@41327364@9@chr9:41311441-41327364@9.44@57@10@0.175@CNVR4278.2@FAM74A2_1, SPATA31A4_4, SPATA31A4_3, SPATA31A4_2, SPATA31A4_1@0@0@0@:SPATA31 subfamily A, member 4@:integral to membrane:integral to membrane@NA
A2463_27@88590@88590@duplication@1@43737328@43737520@9@chr9:43737328-43737520@6.87@108@179@1.66@CNVR4294.1@CNTNAP3B_3@0@0@0@:contactin associated protein-like 3B;contactin associated protein-like 3@:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
A2463_27@88631@88633@duplication@3@65503517@65508193@9@chr9:65503517-65508193@29.5@373@679@1.82@CNVR4312.5@SPATA31A7_4, SPATA31A7_3, SPATA31A7_2@0@0@0@:SPATA31 subfamily A, member 7@:integral to membrane@NA
A2463_27@88639@88641@deletion@3@67926874@67930837@9@chr9:67926874-67930837@17@77@0@0@NA@ANKRD20A1_1, ANKRD20A1_2, ANKRD20A1_3@0@0@0@:ankyrin repeat domain 20 family, member A1@:protein binding;plasma membrane@NA
A2463_27@93219@93219@duplication@1@136081306@136081327@9@chr9:136081306-136081327@4.78@65@110@1.69@NA@OBP2B_6@0@0@0@:odorant binding protein 2B@:odorant binding;transport;extracellular region;chemosensory behavior;sensory perception of smell;cellular_component@NA
A2463_27@93561@93561@deletion@1@138438028@138438098@9@chr9:138438028-138438098@5.96@28@1@0.0357@NA@OBP2A_1@0@0@0@:odorant binding protein 2A@:odorant binding;sensory perception of chemical stimulus;response to stimulus;transport;extracellular region;sensory perception of smell;cellular_component@NA
A2463_27@93566@93566@deletion@1@138441155@138441176@9@chr9:138441155-138441176@8.34@39@1@0.0256@CNVR4529.1@OBP2A_6@0@0@0@:odorant binding protein 2A@:odorant binding;sensory perception of chemical stimulus;response to stimulus;transport;extracellular region;sensory perception of smell;cellular_component@NA
A2463_27@95348@95348@duplication@1@17837921@17838503@10@chr10:17837921-17838503@4.64@11@42@3.82@NA@TMEM236_4@0@0@0@:transmembrane protein 236;transmembrane protein 236-like@:integral to membrane@NA
A2463_27@95377@95377@duplication@1@17951323@17951363@10@chr10:17951323-17951363@7.56@20@71@3.55@NA@MRC1L1_29@0@0@0@:macrophage mannose receptor 1-like@:carbohydrate binding@NA
A2463_27@95389@95389@deletion@1@18138509@18138693@10@chr10:18138509-18138693@5.39@27@2@0.0741@NA@MRC1_7@0@0@0@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
A2463_27@95410@95411@deletion@2@18196464@18198276@10@chr10:18196464-18198276@6.07@139@79@0.568@NA@MRC1_28, MRC1_29@0@0@0@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
A2463_27@95814@95815@duplication@2@27349275@27349469@10@chr10:27349275-27349469@6.26@390@522@1.34@NA@ANKRD26_15, ANKRD26_14@0@0@0@:ankyrin repeat domain 26@:regulation of feeding behavior;centrosome;transferase activity;cofactor binding;negative regulation of multicellular organism growth;regulation of fatty acid metabolic process;actin filament;protein binding;negative regulation of organ growth@NA
A2463_27@96468@96475@deletion@8@46605764@46965885@10@chr10:46605764-46965885@20.7@398@220@0.553@CNVR4712.9, CNVR4712.2, CNVR4712.7@PTPN20A_4, PTPN20A_3, PTPN20A_2, SYT15_8, SYT15_7, SYT15_6, SYT15_5@0@0@0@:protein tyrosine phosphatase, non-receptor type 20B;protein tyrosine phosphatase, non-receptor type 20A:synaptotagmin XV@:phosphatase activity;protein tyrosine phosphatase activity;microtubule;nucleus;dephosphorylation;protein dephosphorylation;microtubule organizing center:protein binding;synaptic vesicle;integral to membrane;transporter activity;plasma membrane;membrane;extrinsic to membrane@NA
A2463_27@96478@96480@deletion@3@46969250@47000257@10@chr10:46969250-47000257@8.4@505@337@0.667@CNVR4712.9, CNVR4712.2, CNVR4712.7, CNVR4712.4@SYT15_2, SYT15_1, GPRIN2_1@0@0@0@:synaptotagmin XV:G protein regulated inducer of neurite outgrowth 2@:protein binding;synaptic vesicle;integral to membrane;transporter activity;plasma membrane;membrane;extrinsic to membrane@NA
A2463_27@96626@96633@deletion@8@49203412@49381136@10@chr10:49203412-49381136@35.3@589@297@0.504@CNVR4717.2@FAM25C_3, FAM25C_2, FAM25C_1, FRMPD2_29, FRMPD2_28, FRMPD2_27, FRMPD2_26, FRMPD2_25@0@0@0@:family with sequence similarity 25, member G;family with sequence similarity 25, member C;family with sequence similarity 25, member A;family with sequence similarity 25, member B:FERM and PDZ domain containing 2@:basolateral plasma membrane;transferase activity, transferring phosphorus-containing groups;cytoplasm;tight junction;protein binding;cytoskeleton;1-phosphatidylinositol binding;tight junction assembly@NA
A2463_27@96932@96937@deletion@6@51965743@51978390@10@chr10:51965743-51978390@16.9@137@45@0.328@NA@ASAH2_12, ASAH2_11, ASAH2_10, ASAH2_9, ASAH2_8, ASAH2_7@0@0@0@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
A2463_27@96952@96952@deletion@1@52504963@52505034@10@chr10:52504963-52505034@5.05@23@0@0@NA@ASAH2B_3@0@0@0@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2B@NA@NA
A2463_27@98005@98005@deletion@1@75436478@75436528@10@chr10:75436478-75436528@4.78@61@28@0.459@CNVR4799.1@AGAP5_7@0@0@0@:ankyrin repeat and GTPase domain Arf GTPase activating protein 11;ArfGAP with GTPase domain, ankyrin repeat and PH domain 5;ArfGAP with GTPase domain, ankyrin repeat and PH domain 10;arf-GAP with GTPase, ANK repeat and PH domain-containing protein 5-like@:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity@NA
A2463_27@98350@98350@duplication@1@81471457@81472241@10@chr10:81471457-81472241@18.8@448@739@1.65@CNVR4815.2, CNVR4815.4@FAM22B_7@0@0@0@NA@NA@NA
A2463_27@98350@98357@deletion@7@81471457@81610362@10@chr10:81471457-81610362@6.34@643@741@1.15@CNVR4815.2@FAM22B_7, FAM22E_1, FAM22E_2, FAM22E_3, FAM22E_4, FAM22E_5, FAM22E_6, FAM22E_7@0@0@0@NA@NA@NA
A2463_27@98595@98595@deletion@1@88985589@88985969@10@chr10:88985589-88985969@5.46@26@1@0.0385@CNVR4840.3, CNVR4840.5@FAM22A_1@0@0@0@:family with sequence similarity 22, member A@NA@NA
A2463_27@98599@98600@deletion@2@88992361@88993346@10@chr10:88992361-88993346@12@71@11@0.155@CNVR4840.3, CNVR4840.5, CNVR4840.6@FAM22A_5, FAM22A_6@0@0@0@:family with sequence similarity 22, member A@NA@NA
A2463_27@98603@98606@deletion@4@89120239@89124960@10@chr10:89120239-89124960@9.32@116@52@0.448@CNVR4840.3@FAM22D_2, FAM22D_3, FAM22D_4, FAM22D_5@0@0@0@:family with sequence similarity 22, member D@NA@NA
A2463_27@103289@103290@deletion@2@5270599@5271034@11@chr11:5270599-5271034@14.6@112@30@0.268@NA@HBG1_2, HBG1_1@0@0@0@:hemoglobin, gamma A@:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex@NA
A2463_27@105520@105520@deletion@1@46396983@46397181@11@chr11:46396983-46397181@5.73@93@47@0.505@NA@DGKZ_21@0@0@0@:diacylglycerol kinase, zeta@:lipid phosphorylation;diacylglycerol kinase activity;ATP binding;mitotic cell cycle G1/S transition DNA damage checkpoint;blood coagulation;protein C-terminus binding;plasma membrane;nucleus;negative regulation of catalytic activity;intracellular signal transduction;enzyme inhibitor activity;platelet activation;protein kinase C-activating G-protein coupled receptor signaling pathway;cell migration;intracellular;cytoplasm;protein binding;lipid kinase activity;negative regulation of Ras protein signal transduction;lamellipodium;negative regulation of mitotic cell cycle;metal ion binding@NA
A2463_27@106038@106041@deletion@4@55032377@55036814@11@chr11:55032377-55036814@33.1@931@526@0.565@CNVR5178.5@TRIM48_2, TRIM48_3, TRIM48_4, TRIM48_5@0@0@0@:tripartite motif containing 48@:protein binding;intracellular;zinc ion binding@NA
A2463_27@106046@106048@duplication@3@55370918@55419315@11@chr11:55370918-55419315@14.6@891@1205@1.35@CNVR5179.1@OR4C11_1, OR4P4_1, OR4S2_1@0@0@0@:olfactory receptor, family 4, subfamily C, member 11:olfactory receptor, family 4, subfamily P, member 4:olfactory receptor, family 4, subfamily S, member 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_27@110109@110109@deletion@1@89531299@89531797@11@chr11:89531299-89531797@5.07@272@178@0.654@NA@TRIM49_8@0@0@0@:tripartite motif containing 49@:protein binding;intracellular;DNA binding;zinc ion binding@NA
A2463_27@110121@110126@duplication@6@89768381@89774718@11@chr11:89768381-89774718@11.9@589@813@1.38@NA@TRIM49C_3, TRIM49C_4, TRIM49C_5, TRIM49C_6, TRIM49C_7, TRIM49C_8@0@0@0@:tripartite motif containing 49D, pseudogene;tripartite motif containing 49-like 1;tripartite motif containing 49C;tripartite motif-containing protein 49-like protein 1-like@:protein binding;intracellular;DNA binding;zinc ion binding@NA
A2463_27@114469@114469@duplication@1@11035135@11035297@12@chr12:11035135-11035297@6.61@94@159@1.69@NA@PRH1_3@0@0@0@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):proline-rich protein HaeIII subfamily 1@:extracellular space;visual perception:protein binding;extracellular space@NA
A2463_27@114475@114475@deletion@1@11083262@11083661@12@chr12:11083262-11083661@11.6@138@57@0.413@NA@PRH2_3@0@0@0@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):proline-rich protein HaeIII subfamily 2;proline-rich protein HaeIII subfamily 1@:extracellular space;visual perception:protein binding;extracellular space@NA
A2463_27@114483@114483@deletion@1@11243900@11244828@12@chr12:11243900-11244828@80.8@423@5@0.0118@CNVR5434.1@TAS2R43_1@0@0@0@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):taste receptor, type 2, member 14:taste receptor, type 2, member 43@:extracellular space;visual perception:bitter taste receptor activity;taste receptor activity;integral to membrane;sensory perception of taste;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of bitter taste:G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;motile cilium;taste receptor activity;bitter taste receptor activity;integral to membrane;sensory perception of taste;detection of chemical stimulus involved in sensory perception of bitter taste;cilium membrane@NA
A2463_27@114493@114496@duplication@4@11506042@11508487@12@chr12:11506042-11508487@27.2@513@816@1.59@CNVR5435.2, CNVR5435.1@PRB1_4, PRB1_3, PRB1_2, PRB1_1@0@0@0@:proline-rich protein BstNI subfamily 1@NA@NA
A2463_27@117094@117094@deletion@1@52681381@52681505@12@chr12:52681381-52681505@5.25@151@90@0.596@CNVR5534.1@KRT81_6@0@0@0@:keratin 86:keratin 86:keratin 81@:intermediate filament;structural molecule activity;keratin filament;cytoskeleton organization:intermediate filament;structural molecule activity;keratin filament;cytoskeleton organization:protein binding;structural molecule activity;keratin filament@: MONILETHRIX: MONILETHRIX: MONILETHRIX
A2463_27@123031@123031@duplication@1@123186740@123187830@12@chr12:123186740-123187830@17.1@817@1226@1.5@CNVR5708.1, CNVR5708.2@HCAR2_1@0@0@0@:hydroxycarboxylic acid receptor 1:hydroxycarboxylic acid receptor 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;response to estradiol stimulus:G-protein coupled purinergic nucleotide receptor activity;nicotinic acid receptor activity;positive regulation of adiponectin secretion;G-protein coupled receptor signaling pathway;positive regulation of neutrophil apoptotic process;integral to membrane;neutrophil apoptotic process;negative regulation of lipid catabolic process;plasma membrane@NA
A2463_27@127333@127333@duplication@1@19553418@19553937@14@chr14:19553418-19553937@6.18@687@913@1.33@CNVR6072.1@POTEG_1@0@0@0@:POTE ankyrin domain family, member G@:protein binding@NA
A2463_27@127333@127336@deletion@3@19553418@19562100@14@chr14:19553418-19562100@-7.36@900@985@1.09@CNVR6072.1@POTEG_1, POTEG_2, POTEG_3, POTEG_4@0@0@0@:POTE ankyrin domain family, member G@:protein binding@NA
A2463_27@127338@127340@duplication@3@19566013@19573144@14@chr14:19566013-19573144@6.71@718@932@1.3@CNVR6072.1@POTEG_6, POTEG_7, POTEG_8@0@0@0@:POTE ankyrin domain family, member G@:protein binding@NA
A2463_27@127353@127358@deletion@6@20215588@20404761@14@chr14:20215588-20404761@27.4@3567@2503@0.702@CNVR6072.12, CNVR6072.4, CNVR6072.5@OR4Q3_1, OR4M1_1, OR4N2_1, OR4K2_1, OR4K5_1, OR4K1_1@0@0@0@:olfactory receptor, family 4, subfamily N, member 2:olfactory receptor, family 4, subfamily Q, member 3:olfactory receptor, family 4, subfamily M, member 1:olfactory receptor, family 4, subfamily K, member 2:olfactory receptor, family 4, subfamily K, member 5:olfactory receptor, family 4, subfamily K, member 1@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_27@127495@127495@duplication@1@21359847@21360328@14@chr14:21359847-21360328@5.96@262@368@1.4@CNVR6076.1@RNASE3_2@0@0@0@:ribonuclease, RNase A family, 3@:ribonuclease activity;extracellular region;defense response to bacterium;pancreatic ribonuclease activity;RNA catabolic process;nucleic acid binding@NA
A2463_27@127800@127804@duplication@5@22931925@22938606@14@chr14:22931925-22938606@11.7@680@914@1.34@NA@TRDC_1, TRDC_2, TRDC_3, TRDV3_2, TRDV3_1@0@0@0@@:integral to membrane:protein binding@NA
A2463_27@131032@131034@deletion@3@74004127@74010359@14@chr14:74004127-74010359@71@554@161@0.291@CNVR6188.1, CNVR6188.4@ACOT1_1, ACOT1_2, ACOT1_3@0@0@0@:HEAT repeat containing 4:acyl-CoA thioesterase 1@:protein binding;binding:hydrolase activity;mitochondrion;acyl-CoA metabolic process;very long-chain fatty acid metabolic process;thiolester hydrolase activity;acyl-CoA hydrolase activity;cytosol;palmitoyl-CoA hydrolase activity;long-chain fatty acid metabolic process;carboxylesterase activity@NA
A2463_27@133425@133427@duplication@3@106471637@106478539@14@chr14:106471637-106478539@17.7@274@455@1.66@CNVR6294.36, CNVR6294.48, CNVR6294.12, CNVR6294.24@IGHV1-3_1, IGHV4-4_2, IGHV4-4_1@0@0@0@@:protein binding:protein binding@NA
A2463_27@133457@133459@duplication@3@106780901@106791456@14@chr14:106780901-106791456@7.35@340@470@1.38@CNVR6294.48, CNVR6294.24, CNVR6294.40, CNVR6294.38, CNVR6294.17, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.53@IGHV4-28_1, IGHV3-30_2, IGHV3-30_1@0@0@0@:uncharacterized LOC100653243;uncharacterized LOC642131@:protein binding:protein binding@NA
A2463_27@133622@133623@deletion@2@23259497@23259716@15@chr15:23259497-23259716@7.63@81@33@0.407@CNVR6300.4@GOLGA8I_6, GOLGA8I_7@0@0@0@:golgin A8 family, member I@:Golgi cisterna membrane@NA
A2463_27@133670@133670@deletion@1@23690458@23690585@15@chr15:23690458-23690585@5.09@36@9@0.25@NA@GOLGA6L2_2@0@0@0@:golgin A6 family-like 2@NA@NA
A2463_27@133869@133870@deletion@2@28629294@28629596@15@chr15:28629294-28629596@13.5@61@0@0@CNVR6329.4@GOLGA8F_9, GOLGA8F_10@0@0@0@@:Golgi apparatus@NA
A2463_27@133985@133986@deletion@2@30384912@30385191@15@chr15:30384912-30385191@26.3@141@14@0.0993@NA@GOLGA8J_16, GOLGA8J_17@0@0@0@:golgin A8 family, member J@:Golgi apparatus@NA
A2463_27@134004@134007@duplication@4@30436983@30437770@15@chr15:30436983-30437770@6.42@244@338@1.39@NA@GOLGA8T_16, GOLGA8T_17, GOLGA8T_18, GOLGA8T_19@0@0@0@:golgin A8 family, member J;golgin A8 family, member K@:Golgi apparatus@NA
A2463_27@134010@134025@deletion@16@30663302@30700498@15@chr15:30663302-30700498@27@401@197@0.491@CNVR6337.1@CHRFAM7A_8, CHRFAM7A_7, CHRFAM7A_6, CHRFAM7A_5, CHRFAM7A_4, CHRFAM7A_3, GOLGA8R_19, GOLGA8R_18, GOLGA8R_17, GOLGA8R_16, GOLGA8R_15, GOLGA8R_14, GOLGA8R_13, GOLGA8R_12, GOLGA8R_11, GOLGA8R_10@0@0@0@:CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:transport;integral to membrane;ion transport;postsynaptic membrane;membrane;extracellular ligand-gated ion channel activity:Golgi apparatus@NA
A2463_27@134068@134070@duplication@3@30905308@30906253@15@chr15:30905308-30906253@14.9@233@388@1.67@CNVR6339.2, CNVR6339.3@GOLGA8H_15, GOLGA8H_16, GOLGA8H_17@0@0@0@:golgin A8 family, member H@:Golgi apparatus@NA
A2463_27@134155@134157@deletion@3@32451771@32460659@15@chr15:32451771-32460659@5.29@103@58@0.563@CNVR6345.2, CNVR6345.1@CHRNA7_8, CHRNA7_9, CHRNA7_10@0@0@0@:cholinergic receptor, nicotinic, alpha 7 (neuronal);CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:cellular calcium ion homeostasis;transport;beta-amyloid binding;calcium ion transport;acetylcholine receptor activity;ion transport;acetylcholine-activated cation-selective channel activity;integral to membrane;chloride channel regulator activity;cell junction;plasma membrane;positive regulation of cell proliferation;protein homodimerization activity;acetylcholine-gated channel complex;response to chemical stimulus;activation of MAPK activity;negative regulation of tumor necrosis factor production;response to hypoxia;response to nicotine;acetylcholine binding;positive regulation of angiogenesis;signal transduction;memory;toxin binding;synaptic transmission;postsynaptic membrane;membrane;cognition;extracellular ligand-gated ion channel activity@NA
A2463_27@134162@134171@deletion@10@32686347@32691186@15@chr15:32686347-32691186@39.1@668@348@0.521@NA@GOLGA8K_15, GOLGA8K_14, GOLGA8K_13, GOLGA8K_12, GOLGA8K_11, GOLGA8K_10, GOLGA8K_9, GOLGA8K_8, GOLGA8K_7, GOLGA8K_6@0@0@0@:golgin A8 family, member J@:Golgi apparatus@NA
A2463_27@134180@134192@deletion@13@32737820@32743840@15@chr15:32737820-32743840@26.3@368@183@0.497@CNVR6346.1@GOLGA8O_17, GOLGA8O_16, GOLGA8O_15, GOLGA8O_14, GOLGA8O_13, GOLGA8O_12, GOLGA8O_11, GOLGA8O_10, GOLGA8O_9, GOLGA8O_8, GOLGA8O_7, GOLGA8O_6, GOLGA8O_5@0@0@0@:golgin A8 family, member O@:Golgi apparatus@NA
A2463_27@134441@134448@deletion@8@34677456@34820278@15@chr15:34677456-34820278@31.8@289@98@0.339@CNVR6351.3@GOLGA8A_14, GOLGA8A_13, GOLGA8A_12, GOLGA8A_11, GOLGA8A_10, GOLGA8A_9, GOLGA8B_25, GOLGA8B_24@0@0@0@:golgin A8 family, member A:golgin A8 family, member A;golgin A8 family, member B@:Golgi cisterna membrane;Golgi apparatus:Golgi cisterna membrane;Golgi apparatus@NA
A2463_27@138281@138286@deletion@6@72953606@72956852@15@chr15:72953606-72956852@56.2@434@117@0.27@CNVR6443.1@GOLGA6B_8, GOLGA6B_9, GOLGA6B_10, GOLGA6B_11, GOLGA6B_12, GOLGA6B_13@0@0@0@:golgin A6 family, member B@:Golgi apparatus@NA
A2463_27@138417@138422@duplication@6@74365084@74368326@15@chr15:74365084-74368326@12.1@388@554@1.43@CNVR6448.1@GOLGA6A_13, GOLGA6A_12, GOLGA6A_11, GOLGA6A_10, GOLGA6A_9, GOLGA6A_8@0@0@0@:golgin A6 family, member C;golgin A6 family, member A;golgin A6 family, member D;golgin A6 family, member B@:Golgi apparatus@NA
A2463_27@138632@138635@deletion@4@75555690@75556424@15@chr15:75555690-75556424@11.1@180@92@0.511@CNVR6452.1@GOLGA6C_4, GOLGA6C_5, GOLGA6C_6, GOLGA6C_7@0@0@0@:golgin A6 family, member C@:Golgi apparatus@NA
A2463_27@138654@138664@deletion@11@75581739@75586816@15@chr15:75581739-75586816@16.7@368@209@0.568@CNVR6452.1@GOLGA6D_8, GOLGA6D_9, GOLGA6D_10, GOLGA6D_11, GOLGA6D_12, GOLGA6D_13, GOLGA6D_14, GOLGA6D_15, GOLGA6D_16, GOLGA6D_17, GOLGA6D_18@0@0@0@:golgin A6 family, member D@:Golgi apparatus@NA
A2463_27@139302@139308@duplication@7@83011416@83015609@15@chr15:83011416-83015609@13.8@49@143@2.92@CNVR6477.6, CNVR6477.2@RP13-996F3.4_9, RP13-996F3.4_8, RP13-996F3.4_7, RP13-996F3.4_6, RP13-996F3.4_5, RP13-996F3.4_4, RP13-996F3.4_3@0@0@0@NA@NA@NA
A2463_27@139472@139473@duplication@2@84842761@84850895@15@chr15:84842761-84850895@5.89@126@191@1.52@CNVR6486.5, CNVR6486.2@RP11-182J1.16_2, RP11-182J1.16_3@0@0@0@:uncharacterized LOC100505679@NA@NA
A2463_27@139478@139479@duplication@2@84908071@84909534@15@chr15:84908071-84909534@18@299@501@1.68@CNVR6486.2@GOLGA6L4_5, GOLGA6L4_6@0@0@0@@:Golgi apparatus@NA
A2463_27@140482@140484@deletion@3@67292@68068@16@chr16:67292-68068@8.31@242@147@0.607@CNVR6565.1@WASH4P_4, WASH4P_3, WASH4P_2@0@0@0@@:intracellular membrane-bounded organelle;endosomal transport;recycling endosome;early endosome;Arp2/3 complex-mediated actin nucleation;actin binding;alpha-tubulin binding;retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;recycling endosome membrane@NA
A2463_27@142750@142750@duplication@1@15457517@15457926@16@chr16:15457517-15457926@9.76@352@517@1.47@CNVR6649.1@PKD1P1_8@0@0@0@:NPIP-like protein 1-like;nuclear pore complex-interacting protein-like 1-like@NA@NA
A2463_27@142927@142928@duplication@2@16367547@16367932@16@chr16:16367547-16367932@6.4@120@188@1.57@NA@NOMO3_19, NOMO3_20@0@0@0@:NODAL modulator 3@:carbohydrate binding;integral to membrane;carboxypeptidase activity@NA
A2463_27@143063@143063@deletion@1@18871990@18872098@16@chr16:18871990-18872098@7.36@239@143@0.598@CNVR6659.1, CNVR6659.2@SMG1_26@0@0@0@:serine/threonine-protein kinase SMG1-like;smg-1 homolog, phosphatidylinositol 3-kinase-related kinase (C. elegans)@:protein autophosphorylation;peptidyl-serine phosphorylation;phosphatidylinositol phosphorylation;binding;RNA metabolic process;transferase activity, transferring phosphorus-containing groups;phosphotransferase activity, alcohol group as acceptor;ATP binding;DNA repair;mRNA metabolic process;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;nucleus;gene expression;protein serine/threonine kinase activity;protein kinase activity;response to stress;cytoplasm;cytosol;mRNA export from nucleus;protein binding;kinase activity;metal ion binding@NA
A2463_27@143483@143483@duplication@1@21764349@21764445@16@chr16:21764349-21764445@5.81@100@161@1.61@CNVR6668.5, CNVR6668.2, CNVR6668.7@OTOA_26@0@0@0@:otoancorin@:proteinaceous extracellular matrix;apical plasma membrane;sensory perception of sound;anchored to membrane@: DEAFNESS, AUTOSOMAL RECESSIVE 22; DFNB22
A2463_27@144047@144047@duplication@1@28467746@28468347@16@chr16:28467746-28468347@13.2@103@218@2.12@NA@NPIPL1_7@0@0@0@NA@NA@NA
A2463_27@144264@144265@duplication@2@29061824@29062028@16@chr16:29061824-29062028@7.99@204@305@1.5@NA@CTB-134H23.2_5, CTB-134H23.2_6@0@0@0@NA@NA@NA
A2463_27@144501@144503@deletion@3@30208296@30208787@16@chr16:30208296-30208787@9.21@42@0@0@CNVR6694.1, CNVR6694.2, CNVR6694.3@SLX1A_4, SLX1A_5, SLX1A_6@0@0@0@:structure-specific endonuclease subunit SLX1-like;SLX1 structure-specific endonuclease subunit homolog B (S. cerevisiae);SLX1 structure-specific endonuclease subunit homolog A (S. cerevisiae):sulfotransferase family, cytosolic, 1A, phenol-preferring, member 4;sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3;sulfotransferase 1A3/1A4-like@:Slx1-Slx4 complex;5'-flap endonuclease activity;DNA repair;protein binding;DNA double-strand break processing involved in repair via single-strand annealing;double-strand break repair via homologous recombination;metal ion binding;crossover junction endodeoxyribonuclease activity:steroid metabolic process;small molecule metabolic process;sulfation;aryl sulfotransferase activity;cytoplasm;catecholamine metabolic process;cytosol;endoplasmic reticulum unfolded protein response;xenobiotic metabolic process;sulfotransferase activity;activation of signaling protein activity involved in unfolded protein response;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process@NA
A2463_27@147091@147099@deletion@9@69988238@69996970@16@chr16:69988238-69996970@17.4@234@109@0.466@CNVR6762.3, CNVR6762.1, CNVR6762.4@CLEC18A_3, CLEC18A_4, CLEC18A_5, CLEC18A_6, CLEC18A_7, CLEC18A_8, CLEC18A_9, CLEC18A_10, CLEC18A_11@0@0@0@:C-type lectin domain family 18, member A@:carbohydrate binding;protein binding;extracellular region@NA
A2463_27@147109@147109@deletion@1@70161164@70161296@16@chr16:70161164-70161296@4.87@57@25@0.439@CNVR6764.1, CNVR6764.3@PDPR_4@0@0@0@:pyruvate dehydrogenase phosphatase regulatory subunit@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix@NA
A2463_27@147125@147126@deletion@2@70208183@70208941@16@chr16:70208183-70208941@22@105@3@0.0286@CNVR6764.1@CLEC18C_1, CLEC18C_2@0@0@0@:C-type lectin domain family 18, member C@:carbohydrate binding;protein binding;extracellular region@NA
A2463_27@147419@147419@deletion@1@72091292@72091365@16@chr16:72091292-72091365@11.5@52@0@0@CNVR6769.1, CNVR6769.2@HP_4@0@0@0@:thioredoxin-like 4B:haptoglobin:haptoglobin-related protein@:mitosis;mRNA processing;RNA splicing;spliceosomal complex;cell redox homeostasis:cellular iron ion homeostasis;negative regulation of oxidoreductase activity;catalytic activity;negative regulation of hydrogen peroxide catabolic process;positive regulation of cell death;haptoglobin-hemoglobin complex;extracellular space;proteolysis;response to hydrogen peroxide;extracellular region;hemoglobin binding;defense response;serine-type endopeptidase activity:spherical high-density lipoprotein particle;proteolysis;extracellular region;hemoglobin binding;catalytic activity;serine-type endopeptidase activity@: ANHAPTOGLOBINEMIA; AHP
A2463_27@147421@147421@duplication@1@72093014@72093087@16@chr16:72093014-72093087@7.47@111@187@1.68@CNVR6769.1, CNVR6769.2@HP_6@0@0@0@:thioredoxin-like 4B:haptoglobin:haptoglobin-related protein@:mitosis;mRNA processing;RNA splicing;spliceosomal complex;cell redox homeostasis:cellular iron ion homeostasis;negative regulation of oxidoreductase activity;catalytic activity;negative regulation of hydrogen peroxide catabolic process;positive regulation of cell death;haptoglobin-hemoglobin complex;extracellular space;proteolysis;response to hydrogen peroxide;extracellular region;hemoglobin binding;defense response;serine-type endopeptidase activity:spherical high-density lipoprotein particle;proteolysis;extracellular region;hemoglobin binding;catalytic activity;serine-type endopeptidase activity@: ANHAPTOGLOBINEMIA; AHP
A2463_27@147506@147508@duplication@3@74444435@74445673@16@chr16:74444435-74445673@14.2@304@466@1.53@CNVR6778.2, CNVR6778.3, CNVR6778.5@CLEC18B_10, CLEC18B_9, CLEC18B_8@0@0@0@:C-type lectin domain family 18, member B@:carbohydrate binding;protein binding;extracellular region@NA
A2463_27@151876@151879@deletion@4@18387190@18392350@17@chr17:18387190-18392350@6.11@224@143@0.638@CNVR7014.1@LGALS9C_2, LGALS9C_3, LGALS9C_4, LGALS9C_5@0@0@0@:lectin, galactoside-binding, soluble, 9C@:carbohydrate binding@NA
A2463_27@153363@153368@deletion@6@34493376@34497369@17@chr17:34493376-34497369@24.9@134@15@0.112@CNVR7077.1, CNVR7077.3, CNVR7077.11, CNVR7077.16@TBC1D3B_14, TBC1D3B_13, TBC1D3B_12, TBC1D3B_11, TBC1D3B_10, TBC1D3B_9@0@0@0@:TBC1 domain family, member 3B@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_27@153372@153373@deletion@2@34500205@34500806@17@chr17:34500205-34500806@10.8@52@2@0.0385@CNVR7077.1, CNVR7077.3, CNVR7077.11, CNVR7077.16@TBC1D3B_5, TBC1D3B_4@0@0@0@:TBC1 domain family, member 3B@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_27@153376@153394@duplication@19@34522686@34590454@17@chr17:34522686-34590454@39.6@161@435@2.7@CNVR7077.1, CNVR7077.13, CNVR7077.19@CCL3L3_3, CCL3L3_2, CCL3L3_1, CCL4L1_1, CCL4L1_2, CCL4L1_3, TBC1D3C_14, TBC1D3C_13, TBC1D3C_12, TBC1D3C_11, TBC1D3C_10, TBC1D3C_9, TBC1D3C_8, TBC1D3C_7, TBC1D3C_6, TBC1D3C_5, TBC1D3C_4, TBC1D3C_3, TBC1D3C_2@0@0@0@:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1:TBC1 domain family, member 3C;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3H-like;TBC1 domain family, member 3H@:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_27@153376@153395@deletion@1@34522686@34624349@17@chr17:34522686-34624349@-74.8@188@435@2.31@CNVR7077.1, CNVR7077.13, CNVR7077.19, CNVR7077.2@CCL3L3_3, CCL3L3_2, CCL3L3_1, CCL4L1_1, CCL4L1_2, CCL4L1_3, TBC1D3C_14, TBC1D3C_13, TBC1D3C_12, TBC1D3C_11, TBC1D3C_10, TBC1D3C_9, TBC1D3C_8, TBC1D3C_7, TBC1D3C_6, TBC1D3C_5, TBC1D3C_4, TBC1D3C_3, TBC1D3C_2, CCL3L1_3@0@0@0@:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1:TBC1 domain family, member 3C;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3H-like;TBC1 domain family, member 3H:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3@:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity@NA
A2463_27@153397@153400@duplication@4@34625572@34641537@17@chr17:34625572-34641537@7@182@267@1.47@CNVR7077.1, CNVR7077.2, CNVR7077.12@CCL3L1_1, CCL4L2_1, CCL4L2_2, CCL4L2_3@0@0@0@:TBC1 domain family, member 3C;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3H-like;TBC1 domain family, member 3H:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
A2463_27@155584@155590@deletion@7@44380005@44409347@17@chr17:44380005-44409347@23.3@499@270@0.541@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A_3, LRRC37A_4, LRRC37A_5, LRRC37A_6, LRRC37A_7, LRRC37A_8, LRRC37A_9@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
A2463_27@155592@155609@deletion@18@44412912@44630815@17@chr17:44412912-44630815@98.6@2631@1585@0.602@CNVR7114.2, CNVR7114.1@LRRC37A_11, LRRC37A_12, LRRC37A_13, LRRC37A_14, ARL17B_4, ARL17B_3, ARL17B_2, LRRC37A2_2, LRRC37A2_3, LRRC37A2_4, LRRC37A2_5, LRRC37A2_6, LRRC37A2_7, LRRC37A2_8, LRRC37A2_9, LRRC37A2_10, LRRC37A2_11, LRRC37A2_12@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
A2463_27@162017@162018@duplication@2@44542732@44550298@18@chr18:44542732-44550298@42.4@663@1205@1.82@CNVR7319.1, CNVR7319.2@TCEB3CL2_1, TCEB3CL_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2:transcription elongation factor B polypeptide 3C-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_27@162017@162019@deletion@1@44542732@44556213@18@chr18:44542732-44556213@-37.7@3580@2824@0.789@CNVR7319.1, CNVR7319.2@TCEB3CL2_1, TCEB3CL_1, TCEB3C_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2:transcription elongation factor B polypeptide 3C-like:transcription elongation factor B polypeptide 3C (elongin A3);RNA polymerase II transcription factor SIII subunit A3-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_27@164727@164736@duplication@10@6375714@6387570@19@chr19:6375714-6387570@31.2@826@1215@1.47@NA@PSPN_1, GTF2F1_13, GTF2F1_12, GTF2F1_11, GTF2F1_10, GTF2F1_9, GTF2F1_8, GTF2F1_7, GTF2F1_6, GTF2F1_5@0@0@0@:persephin:general transcription factor IIF, polypeptide 1, 74kDa@:growth factor activity;extracellular space;central nervous system development;branching involved in ureteric bud morphogenesis;axon guidance;receptor binding;nervous system development:nucleoplasm;DNA binding;catalytic activity;phosphatase activator activity;transcription coactivator activity;cell junction;nucleus;viral reproduction;gene expression;positive regulation of transcription from RNA polymerase II promoter;transcription initiation from RNA polymerase II promoter;7-methylguanosine mRNA capping;response to virus;transcription from RNA polymerase II promoter;protein binding;positive regulation of transcription, DNA-dependent;transcription factor TFIIF complex;RNA splicing;mRNA splicing, via spliceosome;transcription factor binding;transcription elongation from RNA polymerase II promoter;positive regulation of viral transcription@NA
A2463_27@164952@164953@deletion@2@7037873@7040155@19@chr19:7037873-7040155@6.47@36@5@0.139@CNVR7517.1@MBD3L4_2, MBD3L4_1@0@0@0@:methyl-CpG binding domain protein 3-like 4@:regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_27@164955@164957@duplication@3@7051053@7058616@19@chr19:7051053-7058616@9.97@370@516@1.39@CNVR7517.1@MBD3L2_2, MBD3L3_2, MBD3L3_1@0@0@0@:methyl-CpG-binding domain protein 3-like 2-like;methyl-CpG binding domain protein 3-like 2:methyl-CpG binding domain protein 3-like 3@:regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_27@167047@167047@deletion@1@14877791@14877921@19@chr19:14877791-14877921@8.17@104@46@0.442@NA@EMR2_6@0@0@0@:egf-like module containing, mucin-like, hormone receptor-like 2@:transmembrane signaling receptor activity;inflammatory response;G-protein coupled receptor activity;ruffle membrane;integral to membrane;plasma membrane;cell surface receptor signaling pathway;neuropeptide signaling pathway;granulocyte chemotaxis;cell migration;leading edge membrane;G-protein coupled receptor signaling pathway;protein binding;cell adhesion;membrane;calcium ion binding;chondroitin sulfate binding@NA
A2463_27@168951@168951@duplication@1@35849794@35850833@19@chr19:35849794-35850833@13.2@598@879@1.47@CNVR7627.1@FFAR3_2@0@0@0@:free fatty acid receptor 3@:lipid binding;integral to membrane;G-protein coupled receptor activity;plasma membrane;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
A2463_27@168951@168952@deletion@1@35849794@35863302@19@chr19:35849794-35863302@-22@757@948@1.25@CNVR7627.1@FFAR3_2, GPR42_2@0@0@0@:free fatty acid receptor 3@:lipid binding;integral to membrane;G-protein coupled receptor activity;plasma membrane;integral to plasma membrane;G-protein coupled receptor signaling pathway:integral to membrane;G-protein coupled receptor activity;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
A2463_27@169778@169778@deletion@1@39262470@39262670@19@chr19:39262470-39262670@11.7@56@2@0.0357@NA@LGALS7_3@0@0@0@:lectin, galactoside-binding, soluble, 7;lectin, galactoside-binding, soluble, 7B@:carbohydrate binding;heterophilic cell-cell adhesion;extracellular space;nucleus;apoptotic process;cytoplasm@NA
A2463_27@169783@169783@duplication@1@39281330@39281530@19@chr19:39281330-39281530@5.51@179@259@1.45@NA@LGALS7B_3@0@0@0@:lectin, galactoside-binding, soluble, 7;lectin, galactoside-binding, soluble, 7B@:carbohydrate binding;heterophilic cell-cell adhesion;extracellular space;nucleus;apoptotic process;cytoplasm@NA
A2463_27@170099@170100@deletion@2@40380120@40382826@19@chr19:40380120-40382826@26.2@202@57@0.282@CNVR7639.2@FCGBP_23, FCGBP_22@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_27@170107@170108@duplication@2@40395805@40398510@19@chr19:40395805-40398510@12.3@455@651@1.43@CNVR7639.2, CNVR7639.3@FCGBP_15, FCGBP_14@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_27@172134@172136@deletion@3@49557549@49558632@19@chr19:49557549-49558632@20.5@165@49@0.297@CNVR7684.1@CGB7_5, CGB7_4, CGB7_3@0@0@0@:chorionic gonadotropin, beta polypeptide 7@:small molecule metabolic process;hormone activity;female gamete generation;cell-cell signaling;signal transduction;extracellular region;apoptotic process;cellular nitrogen compound metabolic process;peptide hormone processing@NA
A2463_27@173295@173303@duplication@9@54724399@54744452@19@chr19:54724399-54744452@43.7@432@803@1.86@CNVR7721.3, CNVR7721.4, CNVR7721.1@LILRB3_6, LILRB3_5, LILRB3_4, LILRB3_3, LILRB3_2, LILRB3_1, LILRA6_8, LILRA6_7, LILRA6_6@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
A2463_27@173336@173341@deletion@6@54801928@54804173@19@chr19:54801928-54804173@15.5@470@285@0.606@CNVR7722.1@LILRA3_6, LILRA3_5, LILRA3_4, LILRA3_3, LILRA3_2, LILRA3_1@0@0@0@:leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3@:antigen binding;signal transduction;protein binding;extracellular region;plasma membrane;receptor activity;defense response@NA
A2463_27@173439@173439@deletion@1@55147946@55148103@19@chr19:55147946-55148103@4.73@115@66@0.574@NA@LILRB1_14@0@0@0@:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1@:interferon-gamma secretion;defense response to virus;dendritic cell differentiation;negative regulation of interferon-gamma production;regulation of immune response;negative regulation of dendritic cell differentiation;HLA-A specific inhibitory MHC class I receptor activity;negative regulation of alpha-beta T cell activation;negative regulation of transforming growth factor-beta secretion;negative regulation of interleukin-10 secretion;T cell proliferation involved in immune response;plasma membrane;negative regulation of mononuclear cell proliferation;positive regulation of gamma-delta T cell activation involved in immune response;negative regulation of interferon-beta secretion;negative regulation of calcium ion transport;response to virus;negative regulation of serotonin secretion;negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell;cellular response to lipopolysaccharide;negative regulation of cell cycle;positive regulation of cytolysis;negative regulation of T cell mediated cytotoxicity;positive regulation of defense response to virus by host;MHC class I receptor activity;negative regulation of natural killer cell mediated cytotoxicity;negative regulation of dendritic cell apoptotic process;negative regulation of T cell proliferation;negative regulation of CD8-positive, alpha-beta T cell activation;immune response-inhibiting cell surface receptor signaling pathway;Fc receptor mediated inhibitory signaling pathway;negative regulation of cytokine secretion involved in immune response;SH2 domain binding;negative regulation of interleukin-12 secretion;HLA-B specific inhibitory MHC class I receptor activity;negative regulation of osteoclast development;integral to membrane;interferon-gamma production;MHC class I protein binding;protein homodimerization activity;positive regulation of transcription from RNA polymerase II promoter;protein phosphatase 1 binding;positive regulation of gene expression;external side of plasma membrane;receptor internalization;cytoplasm;negative regulation of tumor necrosis factor biosynthetic process;protein binding;signal transduction;negative regulation of interferon-gamma biosynthetic process;negative regulation of endocytosis;positive regulation of apoptotic process@NA
A2463_27@173480@173482@deletion@3@55316249@55320338@19@chr19:55316249-55320338@13.6@63@1@0.0159@CNVR7725.1, CNVR7725.3@KIR2DL4_3, KIR2DL4_4, KIR2DL4_5@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane@NA
A2463_27@173488@173495@deletion@8@55331169@55346569@19@chr19:55331169-55346569@18.8@740@472@0.638@CNVR7725.1, CNVR7725.6@KIR3DL1_4, KIR3DL1_5, KIR3DL1_6, KIR3DL1_7, KIR3DL1_8, KIR3DL1_9, KIR2DS4_1, KIR2DS4_2@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
A2463_27@173500@173504@deletion@5@55359207@55363737@19@chr19:55359207-55363737@24.5@174@46@0.264@CNVR7725.1, CNVR7725.6, CNVR7725.5@KIR2DS4_7, KIR2DS4_8, KIR3DL2_1, KIR3DL2_2, KIR3DL2_3@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2-like@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane@NA
A2463_27@173842@173842@duplication@1@56273168@56273452@19@chr19:56273168-56273452@6.05@84@142@1.69@CNVR7734.1@RFPL4A_2@0@0@0@:ret finger protein-like 4A;ret finger protein-like 4A-like@:protein binding;zinc ion binding@NA
A2463_27@174394@174395@deletion@2@1558985@1569278@20@chr20:1558985-1569278@10.8@244@136@0.557@CNVR7763.1@RP4-576H24.4_2, SIRPB1_2, RP4-576H24.4_1@0@0@0@:signal-regulatory protein beta 1;signal-regulatory protein beta-1-like;signal-regulatory protein beta-1 isoform 3-like@:protein binding:protein binding;signal transduction;integral to membrane;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway@NA
A2463_27@175736@175737@deletion@2@26061801@26063616@20@chr20:26061801-26063616@4.78@233@153@0.657@CNVR7823.4, CNVR7823.3, CNVR7823.5, CNVR7823.1@FAM182A_4, FAM182A_5@0@0@0@NA@NA@NA
A2463_27@178985@178986@duplication@2@10862623@10863067@21@chr21:10862623-10863067@8.98@403@559@1.39@CNVR7947.10, CNVR7947.6, CNVR7947.7@IGHV1OR21-1_1, IGHV1OR21-1_2@0@0@0@@:protein binding;extracellular region@NA
A2463_27@180968@180973@duplication@6@16266930@16279301@22@chr22:16266930-16279301@18.3@1231@1643@1.33@CNVR8071.2, CNVR8071.3@POTEH_9, POTEH_8, POTEH_7, POTEH_6, POTEH_5, POTEH_4@0@0@0@:POTE ankyrin domain family, member H@:protein binding@NA
A2463_27@180976@180976@deletion@1@16287255@16287885@22@chr22:16287255-16287885@15.7@368@193@0.524@CNVR8071.2, CNVR8071.3, CNVR8071.9@POTEH_1@0@0@0@:POTE ankyrin domain family, member H@:protein binding@NA
A2463_27@180979@180979@deletion@1@17264510@17265299@22@chr22:17264510-17265299@21.5@101@1@0.0099@NA@XKR3_4@0@0@0@:XK, Kell blood group complex subunit-related family, member 3@:integral to membrane;plasma membrane@NA
A2463_27@181129@181134@deletion@6@18727044@18835833@22@chr22:18727044-18835833@8.67@368@241@0.655@CNVR8087.5, CNVR8087.2, CNVR8087.7@AC008132.1_4, AC008132.1_5, AC008132.1_6, AC008132.1_7, AC008132.1_8, AC008132.13_1@0@0@0@NA@NA@NA
A2463_27@181417@181422@deletion@6@20366369@20461301@22@chr22:20366369-20461301@11.8@1442@1053@0.73@CNVR8094.9, CNVR8094.4, CNVR8094.10@GGTLC3_5, GGTLC3_4, GGTLC3_3, GGTLC3_2, GGTLC3_1, RIMBP3_1@0@0@0@:RIMS binding protein 3@:leukotriene biosynthetic process;glutathione metabolic process;gamma-glutamyltransferase activity;anchored to external side of plasma membrane:protein binding@NA
A2463_27@181622@181634@duplication@13@21480538@21579843@22@chr22:21480538-21579843@24.3@516@787@1.53@CNVR8100.5, CNVR8100.4@POM121L7_1, GGT2_15, GGT2_14, GGT2_13, GGT2_12, GGT2_11, GGT2_10, GGT2_9, GGT2_8, GGT2_7, GGT2_6, GGT2_5, GGT2_4@0@0@0@:putative POM121-like protein 1-like:gamma-glutamyltransferase 2;gamma-glutamyltranspeptidase 2-like@:hydrolase activity;small molecule metabolic process;leukotriene biosynthetic process;anchored to external side of plasma membrane;glutathione biosynthetic process;xenobiotic metabolic process;integral to membrane;glutathione metabolic process;plasma membrane;gamma-glutamyltransferase activity;cellular_component@NA
A2463_27@181638@181638@duplication@1@21900347@21905265@22@chr22:21900347-21905265@9.47@9@69@7.67@CNVR8101.1, CNVR8101.2@RIMBP3C_1, UBE2L3_1@0@0@0@:RIMS binding protein 3C:ubiquitin-conjugating enzyme E2L 3@:protein binding:cellular response to glucocorticoid stimulus;ubiquitin ligase complex;regulation of S phase of mitotic cell cycle;ATP binding;protein K11-linked ubiquitination;transcription coactivator activity;cellular protein modification process;cellular response to steroid hormone stimulus;protein transport;nucleus;ubiquitin protein ligase binding;ubiquitin-protein ligase activity;enzyme binding;regulation of transcription, DNA-dependent;ubiquitin-dependent protein catabolic process;cytoplasm;cell proliferation;protein binding;transcription, DNA-dependent;acid-amino acid ligase activity;protein polyubiquitination;protein ubiquitination@NA
A2463_27@181765@181765@deletion@1@22988817@22988991@22@chr22:22988817-22988991@5.55@61@25@0.41@CNVR8103.5, CNVR8103.2, CNVR8103.13@GGTLC2_1@0@0@0@:gamma-glutamyltransferase light chain 2@:leukotriene biosynthetic process;glutathione metabolic process;gamma-glutamyltransferase activity;anchored to external side of plasma membrane@NA
A2463_27@181807@181808@duplication@2@23247056@23248831@22@chr22:23247056-23248831@6.54@331@452@1.37@CNVR8103.2, CNVR8103.1, CNVR8103.6, CNVR8103.11@IGLJ3_1, IGLC3_1@0@0@0@@:protein binding@NA
A2463_27@181951@181955@duplication@5@24376424@24384231@22@chr22:24376424-24384231@11.9@174@284@1.63@CNVR8114.13, CNVR8114.1, CNVR8114.7@GSTT1_5, GSTT1_4, GSTT1_3, GSTT1_2, GSTT1_1@0@0@0@:glutathione S-transferase theta 1@:glutathione peroxidase activity;response to drug;transferase activity;cytosol;protein binding;glutathione transferase activity;glutathione metabolic process;response to organic cyclic compound@NA
A2463_27@184144@184144@deletion@1@42522854@42522994@22@chr22:42522854-42522994@6.11@193@116@0.601@CNVR8168.1, CNVR8168.3@CYP2D6_8@0@0@0@:cytochrome P450, family 2, subfamily D, polypeptide 6@:oxidation-reduction process;mitochondrion;alkaloid catabolic process;aromatase activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;drug catabolic process;endoplasmic reticulum membrane;response to organic substance;oxidative demethylation;endoplasmic reticulum;alkaloid metabolic process;negative regulation of binding;heme binding;xenobiotic metabolic process;dopamine metabolic process;steroid metabolic process;isoquinoline alkaloid metabolic process;arachidonic acid monooxygenase activity;arachidonic acid metabolic process;steroid 21-monooxygenase activity;negative regulation of cellular organofluorine metabolic process;oxidoreductase activity;monoterpenoid metabolic process;heterocycle metabolic process;drug binding;drug metabolic process;electron carrier activity;small molecule metabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;monooxygenase activity;iron ion binding;coumarin metabolic process@: DRUG METABOLISM, POOR, CYP2D6-RELATED
A2463_27@184153@184153@duplication@1@42536567@42536707@22@chr22:42536567-42536707@6.16@203@295@1.45@CNVR8168.1, CNVR8168.3, CNVR8168.4@CYP2D7P1_4@0@0@0@@:oxidation-reduction process;electron carrier activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;monooxygenase activity;iron ion binding;heme binding@NA
A2463_27@184168@184168@duplication@1@42911158@42911274@22@chr22:42911158-42911274@6.01@20@61@3.05@CNVR8171.2, CNVR8171.3@RRP7A_4@0@0@0@:ribosomal RNA processing 7 homolog A (S. cerevisiae)@:RNA binding;nucleotide binding@NA
A2463_28@6@7@duplication@2@69092@139309@1@chr1:69092-139309@20.6@870@1507@1.73@CNVR1.2@OR4F5_1, AL627309.1_1@0@0@0@:olfactory receptor, family 4, subfamily F, member 5@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_28@398@403@deletion@6@1573125@1577362@1@chr1:1573125-1577362@22.1@433@236@0.545@CNVR17.1@CDK11B_14, CDK11B_13, CDK11B_12, CDK11B_11, CDK11B_10, CDK11B_9@0@0@0@:cyclin-dependent kinase 11B@:protein serine/threonine kinase activity;protein tyrosine kinase activity;protein phosphorylation;protein kinase activity;cell division;transferase activity, transferring phosphorus-containing groups;ATP binding@NA
A2463_28@429@432@duplication@4@1638849@1640572@1@chr1:1638849-1640572@9.8@129@233@1.81@CNVR17.1@CDK11A_11, CDK11A_10, CDK11A_9, CDK11A_8@0@0@0@:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A@:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division@NA
A2463_28@1835@1838@deletion@4@13330415@13366425@1@chr1:13330415-13366425@8.55@70@21@0.3@CNVR74.8, CNVR74.4@PRAMEF3_2, PRAMEF3_1, PRAMEF5_2, PRAMEF5_3@0@0@0@:PRAME family member 3:PRAME family member 5@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_28@3194@3197@deletion@4@24287949@24298502@1@chr1:24287949-24298502@14.9@84@10@0.119@NA@PNRC2_3, SRSF10_6, SRSF10_5, SRSF10_4@0@0@0@:proline-rich nuclear receptor coactivator 2;proline-rich nuclear receptor coactivator 2-like:serine/arginine-rich splicing factor 10-like;serine/arginine-rich splicing factor 10@:protein binding;deadenylation-independent decapping of nuclear-transcribed mRNA;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;nucleus;regulation of transcription, DNA-dependent;transcription, DNA-dependent;cytoplasmic mRNA processing body:nucleoplasm;RNA splicing, via transesterification reactions;nuclear speck;RS domain binding;RNA binding;nucleus;mRNA splice site selection;unfolded protein binding;assembly of spliceosomal tri-snRNP;negative regulation of mRNA splicing, via spliceosome;regulation of transcription, DNA-dependent;nucleotide binding;cytoplasm;mRNA export from nucleus;protein binding;cytoplasmic transport;mRNA splicing, via spliceosome;nucleic acid binding@NA
A2463_28@3333@3342@duplication@10@25599040@25655415@1@chr1:25599040-25655415@66.7@1121@2098@1.87@CNVR116.1, CNVR116.2@RHD_1, RHD_2, RHD_3, RHD_4, RHD_5, RHD_6, RHD_7, RHD_8, RHD_9, RHD_10@0@0@0@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
A2463_28@5149@5149@deletion@1@39987049@39987242@1@chr1:39987049-39987242@7.18@33@0@0@NA@BMP8A_4@0@0@0@:bone morphogenetic protein 8a@:cell differentiation;growth factor activity;extracellular space;growth;cytokine activity;cartilage development;ossification@NA
A2463_28@8507@8508@duplication@2@89476588@89477710@1@chr1:89476588-89477710@12.9@470@753@1.6@CNVR244.1@GBP3_8, GBP3_7@0@0@0@:guanylate binding protein 3@:defense response to virus;GTP binding;GTPase activity;membrane;cytoplasm@NA
A2463_28@9357@9358@deletion@2@104166489@104166843@1@chr1:104166489-104166843@5.13@341@215@0.63@CNVR266.3, CNVR266.1@AMY2A_8, AMY2A_9@0@0@0@:amylase, alpha 2A (pancreatic)@:chloride ion binding;cation binding;small molecule metabolic process;carbohydrate metabolic process;catalytic activity;extracellular space;polysaccharide digestion;extracellular region;carbohydrate catabolic process;alpha-amylase activity;calcium ion binding@NA
A2463_28@9373@9386@deletion@14@104233917@104297436@1@chr1:104233917-104297436@42.6@596@210@0.352@CNVR266.3, CNVR266.5@AMY1B_8, AMY1B_7, AMY1B_6, AMY1B_5, AMY1B_4, AMY1B_3, AMY1B_2, AMY1C_1, AMY1C_2, AMY1C_3, AMY1C_4, AMY1C_5, AMY1C_6, AMY1C_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
A2463_28@9436@9436@deletion@1@108769302@108769515@1@chr1:108769302-108769515@9.66@54@5@0.0926@CNVR294.4@NBPF4_14@0@0@0@:neuroblastoma breakpoint family, member 4@:cytoplasm@NA
A2463_28@9767@9773@duplication@7@110230793@110235917@1@chr1:110230793-110235917@26.5@375@667@1.78@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
A2463_28@10788@10795@duplication@8@144220788@144520832@1@chr1:144220788-144520832@16.6@238@435@1.83@NA@RP3-377D14.1_87, RP3-377D14.1_88, RP3-377D14.1_89, RP3-377D14.1_90, RP3-377D14.1_91, AL592284.1_1, PPIAL4B_1, AL592284.1_2@0@0@0@:uncharacterized LOC730256;uncharacterized LOC101060698;uncharacterized LOC642441:peptidylprolyl isomerase A (cyclophilin A)-like 4C;peptidyl-prolyl cis-trans isomerase A-like 4A/B/C-like;peptidylprolyl isomerase A (cyclophilin A)-like 4B;peptidylprolyl isomerase A (cyclophilin A)-like 4A@:protein folding;peptidyl-prolyl cis-trans isomerase activity;cytoplasm@NA
A2463_28@10805@10805@deletion@1@144824706@144824756@1@chr1:144824706-144824756@6.26@48@12@0.25@CNVR338.2, CNVR338.5, CNVR338.1@NBPF9_10@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 24@NA@NA
A2463_28@10868@10868@deletion@1@145302655@145302868@1@chr1:145302655-145302868@6.93@109@47@0.431@CNVR341.2, CNVR341.3, CNVR341.4@NBPF10_8@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family, member 10@:protein binding;calcium ion binding@NA
A2463_28@10892@10896@deletion@5@145327494@145330855@1@chr1:145327494-145330855@11.7@128@52@0.406@CNVR341.2, CNVR341.3@NBPF10_32, NBPF10_33, NBPF10_34, NBPF10_35, NBPF10_36@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family, member 10@NA@NA
A2463_28@11149@11158@deletion@10@146232495@146246283@1@chr1:146232495-146246283@11.3@199@101@0.508@NA@NBPF12_16, NBPF12_15, NBPF12_14, NBPF12_13, NBPF12_12, NBPF12_11, NBPF12_10, NBPF12_9, NBPF12_8, NBPF12_7@0@0@0@:neuroblastoma breakpoint family member 21-like@NA@NA
A2463_28@11169@11169@deletion@1@146400092@146400302@1@chr1:146400092-146400302@5.7@27@1@0.037@NA@NBPF12_9@0@0@0@:neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family member 14-like;neuroblastoma breakpoint family, member 12@:cytoplasm@NA
A2463_28@11335@11351@deletion@17@147954851@148016460@1@chr1:147954851-148016460@111@1845@708@0.384@CNVR346.2, CNVR346.3, CNVR346.4@PPIAL4A_1, NBPF14_22, NBPF14_21, NBPF14_20, NBPF14_19, NBPF14_18, NBPF14_17, NBPF14_16, NBPF14_15, NBPF14_14, NBPF14_13, NBPF14_12, NBPF14_11, NBPF14_10, NBPF14_9, NBPF14_8, NBPF14_7@0@0@0@:peptidylprolyl isomerase A (cyclophilin A)-like 4C;peptidyl-prolyl cis-trans isomerase A-like 4A/B/C-like;peptidylprolyl isomerase A (cyclophilin A)-like 4B;peptidylprolyl isomerase A (cyclophilin A)-like 4A:neuroblastoma breakpoint family, member 14@:protein folding;peptidyl-prolyl cis-trans isomerase activity;cytoplasm:cytoplasm@NA
A2463_28@11355@11356@deletion@2@148023598@148024925@1@chr1:148023598-148024925@7.85@118@52@0.441@CNVR346.2, CNVR346.4@NBPF14_3, NBPF14_2@0@0@0@:neuroblastoma breakpoint family, member 14@:cytoplasm@NA
A2463_28@12117@12118@duplication@2@152573209@152586574@1@chr1:152573209-152586574@20.6@173@435@2.51@CNVR358.1@LCE3C_1, LCE3B_1@0@0@0@:late cornified envelope 3C:late cornified envelope 3B@:keratinization:keratinization@NA
A2463_28@14050@14051@deletion@2@161518212@161518821@1@chr1:161518212-161518821@4.9@347@237@0.683@CNVR383.3, CNVR383.1@FCGR3A_3, FCGR3A_2@0@0@0@:Fc fragment of IgG, low affinity IIIa, receptor (CD16a)@:IgG binding;protein binding;regulation of immune response;extracellular region;integral to membrane;immune response;plasma membrane;external side of plasma membrane@NA
A2463_28@16029@16032@duplication@4@196744018@196757528@1@chr1:196744018-196757528@7.07@987@1295@1.31@CNVR459.1@CFHR3_1, CFHR3_2, CFHR3_3, CFHR3_4@0@0@0@:complement factor H-related 3@:extracellular space@NA
A2463_28@17278@17279@deletion@2@207700099@207700468@1@chr1:207700099-207700468@7.43@39@3@0.0769@CNVR485.1@CR1_6, CR1_7@0@0@0@:complement component (3b/4b) receptor 1 (Knops blood group)@:complement component C4b receptor activity;complement activation, classical pathway;negative regulation of complement activation, alternative pathway;innate immune response;negative regulation of serine-type endopeptidase activity;complement component C3b binding;negative regulation of complement activation, classical pathway;plasma membrane;integral to plasma membrane;complement component C3b receptor activity;complement component C4b binding;cell surface;regulation of complement activation;positive regulation of serine-type endopeptidase activity@: MALARIA, SUSCEPTIBILITY TO; KNOPS BLOOD GROUP SYSTEM; KN
A2463_28@19773@19773@duplication@1@248721846@248722792@1@chr1:248721846-248722792@5.42@52@106@2.04@NA@OR2T29_1@0@0@0@:olfactory receptor, family 2, subfamily T, member 29@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_28@19773@19778@deletion@5@248721846@248814185@1@chr1:248721846-248814185@124@1326@371@0.28@CNVR600.1@OR2T29_1, OR2T34_1, OR2T10_1, OR2T11_1, OR2T35_1, OR2T27_1@0@0@0@:olfactory receptor, family 2, subfamily T, member 29:olfactory receptor, family 2, subfamily T, member 34:olfactory receptor, family 2, subfamily T, member 10:olfactory receptor, family 2, subfamily T, member 11:olfactory receptor, family 2, subfamily T, member 35:olfactory receptor, family 2, subfamily T, member 27@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_28@24822@24822@deletion@1@87178420@87178483@2@chr2:87178420-87178483@7.84@41@3@0.0732@NA@RGPD1_2@0@0@0@:RANBP2-like and GRIP domain containing 1@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_28@24840@24846@deletion@7@87212700@87248906@2@chr2:87212700-87248906@13.3@302@148@0.49@NA@RGPD1_20, RGPD1_21, RGPD1_22, RGPD1_23, PLGLB1_3, PLGLB1_2, PLGLB1_1@0@0@0@:RANBP2-like and GRIP domain containing 1:plasminogen-like B1;plasminogen-like B2@:protein binding;intracellular;intracellular transport;protein targeting to Golgi:extracellular region@NA
A2463_28@24856@24863@deletion@8@88091510@88095367@2@chr2:88091510-88095367@12.3@58@1@0.0172@NA@RGPD2_17, RGPD2_16, RGPD2_15, RGPD2_14, RGPD2_13, RGPD2_12, RGPD2_11, RGPD2_10@0@0@0@:RANBP2-like and GRIP domain containing 2@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_28@25389@25390@deletion@2@97873549@97873743@2@chr2:97873549-97873743@5.61@446@289@0.648@CNVR886.1@ANKRD36_53, ANKRD36_54@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_28@26008@26015@deletion@8@108454714@108475751@2@chr2:108454714-108475751@11.2@350@213@0.609@NA@RGPD4_3, RGPD4_4, RGPD4_5, RGPD4_6, RGPD4_7, RGPD4_8, RGPD4_9, RGPD4_10@0@0@0@:RANBP2-like and GRIP domain containing 4@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_28@26426@26426@deletion@1@113161544@113161752@2@chr2:113161544-113161752@4.96@113@58@0.513@NA@RGPD8_9@0@0@0@:RANBP2-like and GRIP domain containing 8@:protein binding;intracellular;intracellular transport;nuclear pore;protein targeting to Golgi;Ran GTPase binding;biological_process@NA
A2463_28@27996@27997@duplication@2@152463121@152464122@2@chr2:152463121-152464122@19.4@112@372@3.32@CNVR1026.1@NEB_84, NEB_83@0@0@0@:nebulin@:Z disc;muscle filament sliding;oxidation-reduction process;contractile fiber part;actin cytoskeleton;regulation of actin filament length;structural constituent of muscle;cytosol;actin binding;protein binding;myofibril;somatic muscle development;muscle organ development@: NEMALINE MYOPATHY 2; NEM2
A2463_28@33042@33043@duplication@2@228194463@228195562@2@chr2:228194463-228195562@8.72@286@447@1.56@NA@MFF_3, MFF_4@0@0@0@:mitochondrial fission factor@:mitochondrion;integral to mitochondrial membrane;positive regulation of release of cytochrome c from mitochondria;peroxisome fission;peroxisome;mitochondrion morphogenesis;regulation of mitochondrion organization;release of cytochrome c from mitochondria;cytoplasm;mitochondrial fragmentation involved in apoptotic process;mitochondrial outer membrane;protein binding;regulation of peroxisome organization;protein homooligomerization;protein targeting to mitochondrion@NA
A2463_28@39893@39894@deletion@2@75790428@75790887@3@chr3:75790428-75790887@5.18@26@2@0.0769@CNVR1432.5, CNVR1432.9, CNVR1432.4@ZNF717_4, ZNF717_3@0@0@0@:zinc finger protein 717;zinc finger protein 717-like@:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_28@45433@45433@deletion@1@195447880@195447954@3@chr3:195447880-195447954@4.89@85@40@0.471@CNVR1703.1, CNVR1703.2@MUC20_1@0@0@0@:mucin 20, cell surface associated@:microvillus membrane;apical plasma membrane;activation of MAPK activity;Golgi lumen;post-translational protein modification;protein binding;O-glycan processing;hepatocyte growth factor receptor signaling pathway;cellular protein metabolic process;extracellular region;protein homooligomerization;basal plasma membrane@NA
A2463_28@46667@46671@deletion@5@9174900@9213975@4@chr4:9174900-9213975@14.4@127@40@0.315@NA@FAM90A26P_4, FAM90A26P_5, FAM90A26P_6, FAM90A26P_7, USP17L13_1, USP17L10_1@0@0@0@:ubiquitin specific peptidase 17-like family member 10:ubiquitin specific peptidase 17-like family member 13@:zinc ion binding;nucleic acid binding:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
A2463_28@46676@46676@duplication@1@9245606@9247197@4@chr4:9245606-9247197@5.26@53@106@2@NA@USP17L17_1@0@0@0@:ubiquitin specific peptidase 17-like family member 17@:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
A2463_28@48556@48561@deletion@6@69403344@69434202@4@chr4:69403344-69434202@102@589@23@0.039@CNVR1953.1@UGT2B17_6, UGT2B17_5, UGT2B17_4, UGT2B17_3, UGT2B17_2, UGT2B17_1@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B17@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;membrane@: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
A2463_28@48592@48597@duplication@6@70146220@70160527@4@chr4:70146220-70160527@8.76@1137@1492@1.31@CNVR1957.2, CNVR1957.1@UGT2B28_1, UGT2B28_2, UGT2B28_3, UGT2B28_4, UGT2B28_5, UGT2B28_6@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B28@:carbohydrate binding;transferase activity, transferring hexosyl groups;endoplasmic reticulum;glucuronosyltransferase activity;carbohydrate metabolic process;xenobiotic metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process@NA
A2463_28@48973@48974@duplication@2@75484524@75486006@4@chr4:75484524-75486006@8.01@87@164@1.89@NA@AREGB_3, AREGB_4@0@0@0@:amphiregulin;amphiregulin B@:growth factor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;cell proliferation;epidermal growth factor receptor signaling pathway;extracellular space;protein binding;integral to membrane;cytokine activity;cell surface;positive regulation of DNA replication@NA
A2463_28@55776@55776@deletion@1@68830522@68830666@5@chr5:68830522-68830666@5.46@66@26@0.394@CNVR2494.7, CNVR2494.4, CNVR2494.46@OCLN_5@0@0@0@:occludin@:S-adenosylmethionine metabolic process;cell-cell junction organization;cellular component disassembly involved in execution phase of apoptosis;response to testosterone stimulus;tight junction;integral to membrane;cell junction;plasma membrane;apoptotic process;thiopurine S-methyltransferase activity;S-adenosylhomocysteine metabolic process;apical plasma membrane;protein complex assembly;cytosol;cell-cell junction;protein binding;structural molecule activity;response to organic cyclic compound;apicolateral plasma membrane@: BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA;
A2463_28@55780@55782@duplication@3@68849398@68862035@5@chr5:68849398-68862035@7.87@421@600@1.43@CNVR2494.7, CNVR2494.46@OCLN_9, GTF2H2C_2, GTF2H2C_3@0@0@0@:occludin:general transcription factor IIH, polypeptide 2C;general transcription factor IIH, polypeptide 2D@:S-adenosylmethionine metabolic process;cell-cell junction organization;cellular component disassembly involved in execution phase of apoptosis;response to testosterone stimulus;tight junction;integral to membrane;cell junction;plasma membrane;apoptotic process;thiopurine S-methyltransferase activity;S-adenosylhomocysteine metabolic process;apical plasma membrane;protein complex assembly;cytosol;cell-cell junction;protein binding;structural molecule activity;response to organic cyclic compound;apicolateral plasma membrane:regulation of transcription, DNA-dependent;nucleotide-excision repair;DNA repair;core TFIIH complex;protein binding;nucleus;transcription, DNA-dependent;zinc ion binding@: BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA;
A2463_28@55785@55786@deletion@2@68863555@68864034@5@chr5:68863555-68864034@5.16@97@48@0.495@CNVR2494.7, CNVR2494.46@GTF2H2C_6, GTF2H2C_7@0@0@0@:general transcription factor IIH, polypeptide 2C;general transcription factor IIH, polypeptide 2D@:regulation of transcription, DNA-dependent;nucleotide-excision repair;DNA repair;core TFIIH complex;protein binding;nucleus;transcription, DNA-dependent;zinc ion binding@NA
A2463_28@55835@55835@deletion@1@70338009@70338111@5@chr5:70338009-70338111@6.12@29@1@0.0345@CNVR2494.41, CNVR2494.14, CNVR2494.20, CNVR2494.62, CNVR2494.8@GTF2H2_14@0@0@0@:general transcription factor IIH, polypeptide 2, 44kDa@:nucleoplasm;nucleotide-excision repair, DNA damage removal;transcription from RNA polymerase I promoter;DNA repair;RNA polymerase II carboxy-terminal domain kinase activity;nucleus;viral reproduction;translation;gene expression;transcription elongation from RNA polymerase I promoter;response to UV;holo TFIIH complex;protein kinase activity;nucleotide-excision repair;transcription from RNA polymerase II promoter;transcription-coupled nucleotide-excision repair;transcription, DNA-dependent;zinc ion binding;transcription elongation from RNA polymerase II promoter;termination of RNA polymerase I transcription;sequence-specific DNA binding transcription factor activity;G-protein coupled receptor internalization;DNA-dependent ATPase activity;protein N-terminus binding;transcription initiation from RNA polymerase I promoter;7-methylguanosine mRNA capping;transcription initiation from RNA polymerase II promoter;protein phosphorylation;translation factor activity, nucleic acid binding;regulation of transcription, DNA-dependent;core TFIIH complex;protein binding;positive regulation of viral transcription;nucleic acid binding@NA
A2463_28@55837@55837@deletion@1@70343834@70343940@5@chr5:70343834-70343940@12@56@0@0@CNVR2494.41, CNVR2494.14, CNVR2494.20, CNVR2494.62, CNVR2494.8@GTF2H2_12@0@0@0@:general transcription factor IIH, polypeptide 2, 44kDa@:nucleoplasm;nucleotide-excision repair, DNA damage removal;transcription from RNA polymerase I promoter;DNA repair;RNA polymerase II carboxy-terminal domain kinase activity;nucleus;viral reproduction;translation;gene expression;transcription elongation from RNA polymerase I promoter;response to UV;holo TFIIH complex;protein kinase activity;nucleotide-excision repair;transcription from RNA polymerase II promoter;transcription-coupled nucleotide-excision repair;transcription, DNA-dependent;zinc ion binding;transcription elongation from RNA polymerase II promoter;termination of RNA polymerase I transcription;sequence-specific DNA binding transcription factor activity;G-protein coupled receptor internalization;DNA-dependent ATPase activity;protein N-terminus binding;transcription initiation from RNA polymerase I promoter;7-methylguanosine mRNA capping;transcription initiation from RNA polymerase II promoter;protein phosphorylation;translation factor activity, nucleic acid binding;regulation of transcription, DNA-dependent;core TFIIH complex;protein binding;positive regulation of viral transcription;nucleic acid binding@NA
A2463_28@59488@59488@deletion@1@147553798@147553933@5@chr5:147553798-147553933@5.79@26@0@0@CNVR2637.2, CNVR2637.1@SPINK14_3@0@0@0@:serine peptidase inhibitor, Kazal type 14 (putative)@:serine-type endopeptidase inhibitor activity;protein binding;extracellular region@NA
A2463_28@60884@60885@duplication@2@175517374@175520277@5@chr5:175517374-175520277@5.53@103@171@1.66@NA@FAM153B_3, FAM153B_4@0@0@0@:uncharacterized LOC100507387;family with sequence similarity 153, member B@NA@NA
A2463_28@61271@61277@deletion@7@177168258@177220472@5@chr5:177168258-177220472@7.02@197@118@0.599@CNVR2699.2@FAM153A_6, FAM153A_5, FAM153A_4, FAM153A_3, RP11-1026M7.2_2, RP11-1026M7.2_3@0@0@0@:family with sequence similarity 153, member A@NA@NA
A2463_28@61639@61645@deletion@7@180375921@180429785@5@chr5:180375921-180429785@33.5@1037@568@0.548@CNVR2719.1@BTNL8_6, BTNL8_7, BTNL8_8, BTNL3_1, BTNL3_2, BTNL3_3, BTNL3_4@0@0@0@:butyrophilin-like 8:butyrophilin-like 3@:protein binding;integral to membrane:protein binding;integral to membrane;molecular_function;cellular_component;biological_process@NA
A2463_28@63725@63725@deletion@1@31962023@31962161@6@chr6:31962023-31962161@5.87@121@59@0.488@CNVR2843.6, CNVR2843.3@C4A_20@0@0@0@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
A2463_28@63732@63735@deletion@4@31963985@31965088@6@chr6:31963985-31965088@16@569@305@0.536@CNVR2843.6, CNVR2843.3@C4A_27, C4A_28, C4A_29, C4A_30@0@0@0@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
A2463_28@63776@63776@duplication@1@31996945@31997115@6@chr6:31996945-31997115@7.55@314@508@1.62@CNVR2843.6, CNVR2843.5@C4B_28@0@0@0@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
A2463_28@63863@63864@duplication@2@32147787@32148103@6@chr6:32147787-32148103@6.03@279@401@1.44@CNVR2844.1@RNF5_5, RNF5_6@0@0@0@:ring finger protein 5, E3 ubiquitin protein ligase@:ubiquitin-protein ligase activity;protein K63-linked ubiquitination;cellular protein catabolic process;ER-associated misfolded protein catabolic process;protein K48-linked ubiquitination;protein binding;integral to membrane;mitochondrial membrane;endoplasmic reticulum membrane;zinc ion binding@NA
A2463_28@63953@63956@deletion@4@32485517@32487428@6@chr6:32485517-32487428@29.9@178@19@0.107@CNVR2845.21, CNVR2845.25, CNVR2845.30@HLA-DRB5_6, HLA-DRB5_5, HLA-DRB5_4, HLA-DRB5_3@0@0@0@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
A2463_28@63959@63961@duplication@3@32546869@32548633@6@chr6:32546869-32548633@7.79@333@477@1.43@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.5, CNVR2845.4@HLA-DRB1_6, HLA-DRB1_5, HLA-DRB1_4@0@0@0@:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1@:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
A2463_28@63965@63968@deletion@4@32605237@32610541@6@chr6:32605237-32610541@33.6@929@447@0.481@CNVR2845.21, CNVR2845.25, CNVR2845.37, CNVR2845.63, CNVR2845.27, CNVR2845.22, CNVR2845.39, CNVR2845.20@HLA-DQA1_1, HLA-DQA1_2, HLA-DQA1_3, HLA-DQA1_4@0@0@0@:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
A2463_28@70816@70819@deletion@4@161054786@161061880@6@chr6:161054786-161061880@23.7@223@58@0.26@CNVR3133.1@LPA_9, LPA_8, LPA_7, LPA_6@0@0@0@:lipoprotein, Lp(a)@:blood circulation;endopeptidase inhibitor activity;catalytic activity;lipoprotein metabolic process;proteolysis;heparin binding;receptor-mediated endocytosis;fibronectin binding;small molecule metabolic process;apolipoprotein binding;lipid metabolic process;negative regulation of endopeptidase activity;extracellular region;plasma lipoprotein particle;lipid transport;serine-type endopeptidase activity@: APOLIPOPROTEIN(a); LPA
A2463_28@71011@71015@duplication@5@167590486@167595404@6@chr6:167590486-167595404@13@528@769@1.46@NA@TCP10L2_4, TCP10L2_5, TCP10L2_6, TCP10L2_7, TCP10L2_8@0@0@0@:t-complex 10;t-complex 10-like 2@NA@NA
A2463_28@71028@71031@deletion@4@167787840@167791580@6@chr6:167787840-167791580@23.2@315@147@0.467@NA@TCP10_7, TCP10_6, TCP10_5, TCP10_4@0@0@0@:t-complex 10@:cytosol@NA
A2463_28@71742@71753@deletion@12@5925696@5958531@7@chr7:5925696-5958531@35.9@1259@786@0.624@NA@OCM_4, CCZ1_1, CCZ1_2, CCZ1_3, CCZ1_4, CCZ1_5, CCZ1_6, CCZ1_7, CCZ1_8, CCZ1_9, CCZ1_10, CCZ1_11@0@0@0@:oncomodulin:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:calcium ion binding:lysosomal membrane@NA
A2463_28@71773@71777@deletion@5@6000323@6013173@7@chr7:6000323-6013173@21@244@90@0.369@NA@RSPH10B_5, RSPH10B_4, RSPH10B_3, RSPH10B_2, PMS2_15@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas):PMS2 postmeiotic segregation increased 2 (S. cerevisiae)@:response to drug;DNA binding;MutSalpha complex binding;ATP binding;mismatch repair;DNA repair;mismatched DNA binding;ATPase activity;nucleus;mismatch repair complex;reciprocal meiotic recombination;ATP catabolic process;single-stranded DNA binding;response to DNA damage stimulus;single base insertion or deletion binding;protein binding;somatic hypermutation of immunoglobulin genes;somatic recombination of immunoglobulin gene segments;MutLalpha complex;endonuclease activity@: COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 4; HNPCC4; MISMATCH REPAIR CANCER SYNDROME
A2463_28@73260@73263@deletion@4@38388957@38393784@7@chr7:38388957-38393784@51.3@273@11@0.0403@CNVR3354.3, CNVR3354.1@TRGV5_2, TRGV5_1, TRGV4_2, TRGV4_1@0@0@0@@:protein binding:protein binding@NA
A2463_28@74471@74472@deletion@2@73526264@73530288@7@chr7:73526264-73530288@4.96@72@34@0.472@NA@LIMK1_11, LIMK1_12, LIMK1_12, LIMK1_13@0@0@0@:LIM domain kinase 1@:positive regulation of axon extension;protein tyrosine kinase activity;transferase activity, transferring phosphorus-containing groups;phosphotransferase activity, alcohol group as acceptor;actin cytoskeleton organization;ATP binding;neuron projection;focal adhesion;positive regulation of actin filament bundle assembly;nucleus;protein serine/threonine kinase activity;protein phosphorylation;lipopolysaccharide biosynthetic process;protein heterodimerization activity;protein kinase activity;negative regulation of ubiquitin-protein ligase activity;axon guidance;Rho protein signal transduction;cytoplasm;cytosol;protein binding;signal transduction;heat shock protein binding;zinc ion binding;membrane;nervous system development@NA
A2463_28@74582@74582@duplication@1@74193429@74193503@7@chr7:74193429-74193503@5.11@72@131@1.82@NA@NCF1_3@0@0@0@:neutrophil cytosolic factor 1@:inflammatory response;antigen processing and presentation of peptide antigen via MHC class I;phagosome maturation;NADPH oxidase complex;neutrophil mediated killing of gram-positive bacterium;cell communication;interaction with host;leukotriene metabolic process;response to yeast;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;respiratory burst;GTPase activity;negative regulation of smooth muscle contraction;GTP catabolic process;cytosol;defense response to fungus;defense response to bacterium;antigen processing and presentation of exogenous peptide antigen via MHC class I;leukocyte mediated cytotoxicity;neutrophil mediated killing of fungus;phosphatidylinositol binding;defense response to Gram-positive bacterium;GTP binding;respiratory burst involved in defense response;superoxide-generating NADPH oxidase activity;hydrogen peroxide biosynthetic process;protein targeting to membrane;electron carrier activity;superoxide metabolic process;innate immune response;phagolysosome;cytoplasm;cell proliferation;superoxide anion generation;protein binding;SH3 domain binding;cellular defense response;response to bacterium@: GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE,
A2463_28@76727@76737@duplication@11@102134273@102147271@7@chr7:102134273-102147271@9.97@218@349@1.6@CNVR3518.1@RASA4B_15, RASA4B_14, RASA4B_13, RASA4B_12, RASA4B_11, RASA4B_10, RASA4B_9, RASA4B_8, RASA4B_7, RASA4B_6, RASA4B_5@0@0@0@:RAS p21 protein activator 4B@:phospholipid binding;intracellular;GTPase activator activity;cytosol;signal transduction;protein binding;plasma membrane;regulation of small GTPase mediated signal transduction;metal ion binding;intracellular signal transduction@NA
A2463_28@76786@76793@duplication@8@102296696@102312048@7@chr7:102296696-102312048@16.1@108@257@2.38@CNVR3518.1@SPDYE2L_5, SPDYE2L_6, SPDYE2L_7, SPDYE2L_8, POLR2J2_4, POLR2J2_4, POLR2J2_3, POLR2J2_3, POLR2J2_2, POLR2J2_2, POLR2J2_1, POLR2J2_1@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:polymerase (RNA) II (DNA directed) polypeptide J2:WBSCR19-like protein 3;speedy homolog E6 (Xenopus laevis)@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
A2463_28@80367@80394@deletion@28@7272484@7680945@8@chr8:7272484-7680945@31.1@951@584@0.614@NA@DEFB4B_2, DEFB4B_1, DEFB103B_2, DEFB103B_1, SPAG11B_3, SPAG11B_2, SPAG11B_1, DEFB104B_2, DEFB104B_1, DEFB106B_2, DEFB106B_1, DEFB105B_1, DEFB105B_2, DEFB105B_3, DEFB107B_1, DEFB107B_2, RP11-1118M6.1_1, RP11-1118M6.1_2, RP11-1118M6.1_3, RP11-1118M6.1_4, AC084121.16_4, AC084121.16_3, AC084121.16_2, AC084121.16_1, DEFB107A_2, DEFB107A_1, DEFB105A_3, DEFB105A_2@0@0@0@:defensin, beta 4B;defensin, beta 4A:defensin, beta 103B;defensin, beta 103A:sperm associated antigen 11B:defensin, beta 104A;defensin, beta 104B:defensin, beta 106B;defensin, beta 106A:defensin, beta 105B;defensin, beta 105A:defensin, beta 107B;defensin, beta 107A:uncharacterized LOC100133251:uncharacterized LOC100133251:defensin, beta 107B;defensin, beta 107A:defensin, beta 105B;defensin, beta 105A@:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response:extracellular region;defense response to bacterium;Golgi lumen;positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria;defense response;innate immune response:spermatogenesis;defense response to bacterium;extracellular region;molecular_function;defense response:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium@NA
A2463_28@80399@80410@deletion@12@7698557@7807650@8@chr8:7698557-7807650@34.3@646@332@0.514@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@DEFB104A_2, SPAG11A_1, SPAG11A_2, SPAG11A_3, SPAG11A_4, DEFB103A_1, DEFB103A_2, DEFB4A_1, DEFB4A_2, ZNF705B_2, ZNF705B_3, ZNF705B_4@0@0@0@:defensin, beta 104A;defensin, beta 104B:sperm associated antigen 11A;sperm associated antigen 11B:defensin, beta 103B;defensin, beta 103A:defensin, beta 4B;defensin, beta 4A:zinc finger protein 705B@:extracellular region;defense response to bacterium:extracellular region;defense response:extracellular region;defense response to bacterium;Golgi lumen;positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria;defense response;innate immune response:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response:intracellular;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_28@80564@80569@deletion@6@11970084@12044342@8@chr8:11970084-12044342@38.8@2047@907@0.443@CNVR3785.8, CNVR3785.5, CNVR3785.2, CNVR3785.3@ZNF705D_6, USP17L2_1, FAM86B1_8, FAM86B1_7, FAM86B1_6, FAM86B1_5@0@0@0@:zinc finger protein 705D:ubiquitin specific peptidase 17-like family member 1, pseudogene;ubiquitin specific peptidase 17-like family member 2;ubiquitin specific peptidase 17-like family member 4;ubiquitin specific peptidase 17-like family member 7;ubiquitin specific peptidase 17-like family member 8;ubiquitin specific peptidase 17-like family member 3:family with sequence similarity 86, member B2;family with sequence similarity 86, member B1@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:protein deubiquitination;ubiquitin-specific protease activity;mitotic cell cycle G1/S transition checkpoint;nucleus;G2/M transition checkpoint;apoptotic process;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
A2463_28@80573@80584@deletion@12@12051485@12338444@8@chr8:12051485-12338444@65.1@701@214@0.305@CNVR3786.4@FAM86B1_1, DEFB130_2, DEFB130_1, FAM86B2_8, FAM86B2_7, FAM86B2_6, FAM86B2_5, FAM86B2_4, FAM86B2_3, FAM86B2_2, FAM86B2_1, AC130352.1_5@0@0@0@:family with sequence similarity 86, member B2;family with sequence similarity 86, member B1:defensin, beta 130-like;defensin, beta 130:family with sequence similarity 86, member B2@:extracellular region;defense response to bacterium;defense response@NA
A2463_28@84015@84015@deletion@1@95559048@95559292@8@chr8:95559048-95559292@4.79@107@55@0.514@CNVR3969.1@AC023632.1_1@0@0@0@:KIAA1429@:mRNA processing;binding;nucleus;RNA splicing@NA
A2463_28@86630@86630@deletion@1@35505@35519@9@chr9:35505-35519@5.27@32@5@0.156@CNVR4134.1@FAM138C_1@0@0@0@NA@NA@NA
A2463_28@88493@88494@deletion@2@39085734@39086846@9@chr9:39085734-39086846@16.3@317@147@0.464@NA@CNTNAP3_21, CNTNAP3_20@0@0@0@:contactin associated protein-like 3@:binding;signal transduction;protein binding;integral to membrane;extracellular region;cell adhesion;plasma membrane;cell recognition;receptor binding@NA
A2463_28@88507@88507@deletion@1@39175947@39176089@9@chr9:39175947-39176089@7.57@274@145@0.529@CNVR4262.1@CNTNAP3_7@0@0@0@:contactin associated protein-like 3@:binding;signal transduction;protein binding;integral to membrane;extracellular region;cell adhesion;plasma membrane;cell recognition;receptor binding@NA
A2463_28@88524@88524@duplication@1@40028621@40028741@9@chr9:40028621-40028741@5.62@3@41@13.7@CNVR4270.4@AL353791.1_1@0@0@0@NA@NA@NA
A2463_28@88534@88539@duplication@6@41306194@41327364@9@chr9:41306194-41327364@44.7@128@539@4.21@CNVR4278.2@FAM74A2_2, FAM74A2_1, SPATA31A4_4, SPATA31A4_3, SPATA31A4_2, SPATA31A4_1@0@0@0@:SPATA31 subfamily A, member 4@:integral to membrane:integral to membrane@NA
A2463_28@88549@88549@duplication@1@42380152@42380206@9@chr9:42380152-42380206@8.94@10@78@7.8@NA@ANKRD20A2_6@0@0@0@:ankyrin repeat domain 20 family, member A2@:protein binding@NA
A2463_28@88584@88587@deletion@4@43624656@43630701@9@chr9:43624656-43630701@24.8@2274@1206@0.53@NA@SPATA31A6_4, SPATA31A6_3, SPATA31A6_2, SPATA31A6_1@0@0@0@:SPATA31 subfamily A, member 6@:integral to membrane@NA
A2463_28@88593@88610@deletion@18@43816638@43915897@9@chr9:43816638-43915897@55.4@1306@702@0.538@NA@CNTNAP3B_6, CNTNAP3B_7, CNTNAP3B_8, CNTNAP3B_9, CNTNAP3B_10, CNTNAP3B_11, CNTNAP3B_12, CNTNAP3B_13, CNTNAP3B_14, CNTNAP3B_15, CNTNAP3B_16, CNTNAP3B_17, CNTNAP3B_18, CNTNAP3B_19, CNTNAP3B_20, CNTNAP3B_21, CNTNAP3B_22, CNTNAP3B_23@0@0@0@:contactin associated protein-like 3B;contactin associated protein-like 3@:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
A2463_28@88623@88623@duplication@1@46386623@46387002@9@chr9:46386623-46387002@5.95@50@108@2.16@CNVR4307.4, CNVR4307.2, CNVR4307.3@FAM27E1_1@0@0@0@:family with sequence similarity 27, member E3@NA@NA
A2463_28@88639@88640@deletion@2@67926874@67930501@9@chr9:67926874-67930501@11@52@1@0.0192@NA@ANKRD20A1_1, ANKRD20A1_2@0@0@0@:ankyrin repeat domain 20 family, member A1@:protein binding;plasma membrane@NA
A2463_28@88642@88643@duplication@2@67934724@67936012@9@chr9:67934724-67936012@5.81@95@159@1.67@NA@ANKRD20A1_4, ANKRD20A1_5@0@0@0@:ankyrin repeat domain 20 family, member A1@:protein binding;plasma membrane@NA
A2463_28@88652@88656@duplication@5@67966594@67985922@9@chr9:67966594-67985922@15.5@1126@1590@1.41@NA@ANKRD20A1_14, ANKRD20A1_15, RP11-195B21.3_3, RP11-195B21.3_4, RP11-195B21.3_5@0@0@0@:ankyrin repeat domain 20 family, member A1:coiled-coil domain-containing protein 29-like;uncharacterized LOC644249@:protein binding;plasma membrane@NA
A2463_28@88669@88670@duplication@2@69247523@69253282@9@chr9:69247523-69253282@5.29@227@323@1.42@NA@CBWD6_5, BX255923.1_1@0@0@0@:COBW domain containing 6@:ATP binding@NA
A2463_28@90056@90056@deletion@1@99700647@99701431@9@chr9:99700647-99701431@5.03@194@111@0.572@CNVR4411.1@FAM22G_7@0@0@0@:family with sequence similarity 22, member G@NA@NA
A2463_28@90481@90481@deletion@1@107366953@107367908@9@chr9:107366953-107367908@4.71@405@254@0.627@CNVR4426.1@OR13C2_1@0@0@0@:olfactory receptor, family 13, subfamily C, member 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_28@93599@93600@duplication@2@138649003@138649227@9@chr9:138649003-138649227@6.52@132@213@1.61@NA@KCNT1_8, KCNT1_9@0@0@0@:potassium channel, subfamily T, member 1@:potassium ion transport;potassium ion transmembrane transport;voltage-gated potassium channel activity;nucleotide binding;calcium-activated potassium channel activity;integral to membrane;voltage-gated potassium channel complex;membrane;potassium channel activity@NA
A2463_28@95377@95380@deletion@4@17951323@18060364@10@chr10:17951323-18060364@6.75@30@0@0@NA@MRC1L1_29, MRC1L1_30, TMEM236_1, TMEM236_2@0@0@0@:macrophage mannose receptor 1-like:transmembrane protein 236;transmembrane protein 236-like@:carbohydrate binding:integral to membrane@NA
A2463_28@95388@95393@deletion@6@18134219@18152611@10@chr10:18134219-18152611@9.62@50@4@0.08@NA@MRC1_6, MRC1_7, MRC1_8, MRC1_9, MRC1_10, MRC1_11@0@0@0@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
A2463_28@95948@95948@deletion@1@29580773@29580935@10@chr10:29580773-29580935@6.07@49@13@0.265@NA@LYZL1_2@0@0@0@:lysozyme-like 1@:extracellular region;lysozyme activity;cell wall macromolecule catabolic process@NA
A2463_28@96435@96435@deletion@1@46248629@46248685@10@chr10:46248629-46248685@13.2@67@2@0.0299@NA@FAM21C_13@0@0@0@:family with sequence similarity 21, member C@:endosome;protein binding;plasma membrane;retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_28@96454@96460@deletion@7@46312644@46339842@10@chr10:46312644-46339842@16.1@227@83@0.366@NA@FAM25E_1, AGAP4_7, AGAP4_6, AGAP4_5, AGAP4_4, AGAP4_3, AGAP4_2@0@0@0@:ArfGAP with GTPase domain, ankyrin repeat and PH domain 4;arf-GAP with GTPase, ANK repeat and PH domain-containing protein 5-like@:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity@NA
A2463_28@96463@96470@duplication@8@46552470@46611811@10@chr10:46552470-46611811@23.8@86@282@3.28@CNVR4712.3@PTPN20A_9, PTPN20A_8, PTPN20A_7, PTPN20A_6, PTPN20A_5, PTPN20A_4, PTPN20A_3, PTPN20A_2@0@0@0@:protein tyrosine phosphatase, non-receptor type 20B;protein tyrosine phosphatase, non-receptor type 20A@:phosphatase activity;protein tyrosine phosphatase activity;microtubule;nucleus;dephosphorylation;protein dephosphorylation;microtubule organizing center@NA
A2463_28@96529@96531@duplication@3@47756640@47758904@10@chr10:47756640-47758904@14.4@34@148@4.35@CNVR4714.1@ANXA8L2_8, ANXA8L2_9, ANXA8L2_10@0@0@0@:annexin A8-like 2:uncharacterized LOC101060462;uncharacterized LOC100996760@:calcium-dependent phospholipid binding;calcium ion binding@NA
A2463_28@96552@96553@deletion@2@47926004@47929897@10@chr10:47926004-47929897@10.5@48@0@0@CNVR4715.2, CNVR4715.1@FAM21B_18, FAM21B_19@0@0@0@:family with sequence similarity 21, member B@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_28@96565@96589@deletion@25@48003969@48237210@10@chr10:48003969-48237210@115@845@177@0.209@CNVR4716.14@ASAH2C_17, ASAH2C_16, ASAH2C_15, ASAH2C_14, ASAH2C_13, ASAH2C_12, ASAH2C_11, ASAH2C_10, ASAH2C_9, ASAH2C_8, ASAH2C_7, ASAH2C_6, ASAH2C_5, ASAH2C_4, ASAH2C_3, ASAH2C_2, ASAH2C_1, AGAP9_1, AGAP9_2, AGAP9_3, AGAP9_4, AGAP9_5, AGAP9_6, AGAP9_7, AGAP9_8@0@0@0@:ArfGAP with GTPase domain, ankyrin repeat and PH domain 9@:ceramidase activity;sphingolipid metabolic process:phospholipid binding;protein binding;ARF GTPase activator activity;GTP binding;GTPase activity;zinc ion binding;regulation of ARF GTPase activity@NA
A2463_28@96622@96624@deletion@3@48792688@48798739@10@chr10:48792688-48798739@7.51@80@29@0.362@CNVR4716.10, CNVR4716.3@PTPN20B_4, PTPN20B_3, PTPN20B_2@0@0@0@:protein tyrosine phosphatase, non-receptor type 20B;protein tyrosine phosphatase, non-receptor type 20A@:phosphatase activity;protein tyrosine phosphatase activity;microtubule;nucleus;dephosphorylation;protein dephosphorylation;microtubule organizing center@NA
A2463_28@96908@96910@deletion@3@51857436@51863903@10@chr10:51857436-51863903@14.3@205@83@0.405@NA@FAM21A_16, FAM21A_17, FAM21A_18@0@0@0@:family with sequence similarity 21, member B;family with sequence similarity 21, member A@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_28@96923@96937@duplication@15@51892567@51978390@10@chr10:51892567-51978390@47.3@268@726@2.71@NA@FAM21A_31, ASAH2_20, ASAH2_19, ASAH2_18, ASAH2_17, ASAH2_16, ASAH2_15, ASAH2_14, ASAH2_13, ASAH2_12, ASAH2_11, ASAH2_10, ASAH2_9, ASAH2_8, ASAH2_7@0@0@0@:family with sequence similarity 21, member B;family with sequence similarity 21, member A:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
A2463_28@96952@96953@deletion@2@52504963@52509162@10@chr10:52504963-52509162@5.01@24@1@0.0417@NA@ASAH2B_3, ASAH2B_4@0@0@0@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2B@NA@NA
A2463_28@98334@98334@duplication@1@81272407@81272870@10@chr10:81272407-81272870@5.67@306@462@1.51@NA@EIF5AL1_1@0@0@0@:eukaryotic translation initiation factor 5A-like 1@:ribosome binding;translation elongation factor activity;positive regulation of translational termination;mRNA transport;RNA binding;protein transport;translational frameshifting;endoplasmic reticulum membrane;peptidyl-lysine modification to hypusine;nuclear pore;positive regulation of translational elongation@NA
A2463_28@98349@98350@deletion@2@81471007@81472241@10@chr10:81471007-81472241@6.92@617@392@0.635@CNVR4815.2, CNVR4815.4@FAM22B_6, FAM22B_7@0@0@0@NA@NA@NA
A2463_28@98349@98352@duplication@2@81471007@81604628@10@chr10:81471007-81604628@-27.1@650@480@0.738@CNVR4815.2@FAM22B_6, FAM22B_7, FAM22E_1, FAM22E_2@0@0@0@NA@NA@NA
A2463_28@98595@98595@deletion@1@88985589@88985969@10@chr10:88985589-88985969@5.9@28@1@0.0357@CNVR4840.3, CNVR4840.5@FAM22A_1@0@0@0@:family with sequence similarity 22, member A@NA@NA
A2463_28@98603@98606@deletion@4@89120239@89124960@10@chr10:89120239-89124960@10.6@104@34@0.327@CNVR4840.3@FAM22D_2, FAM22D_3, FAM22D_4, FAM22D_5@0@0@0@:family with sequence similarity 22, member D@NA@NA
A2463_28@101608@101614@duplication@7@124344788@124353114@10@chr10:124344788-124353114@61.9@839@1728@2.06@CNVR4912.4, CNVR4912.3, CNVR4912.2@DMBT1_15, DMBT1_16, DMBT1_17, DMBT1_18, DMBT1_19, DMBT1_20, DMBT1_21@0@0@0@:deleted in malignant brain tumors 1@:defense response to virus;calcium-dependent protein binding;pattern recognition receptor signaling pathway;blastocyst development;response to estrogen stimulus;tissue regeneration;proteinaceous extracellular matrix;protein transport;Gram-negative bacterial cell surface binding;positive regulation of epithelial cell differentiation;virus-host interaction;epithelial cell differentiation;induction of bacterial agglutination;phagocytic vesicle membrane;intracellular;Gram-positive bacterial cell surface binding;zymogen binding;innate immune response;cytoplasm;extrinsic to membrane;protein binding;zymogen granule membrane;extracellular region;scavenger receptor activity;pattern recognition receptor activity;inner cell mass cell proliferation;membrane@: GLIOMA SUSCEPTIBILITY 1; GLM1
A2463_28@101622@101622@deletion@1@124361314@124361636@10@chr10:124361314-124361636@10.6@53@2@0.0377@CNVR4912.1@DMBT1_29@0@0@0@:deleted in malignant brain tumors 1@:defense response to virus;calcium-dependent protein binding;pattern recognition receptor signaling pathway;blastocyst development;response to estrogen stimulus;tissue regeneration;proteinaceous extracellular matrix;protein transport;Gram-negative bacterial cell surface binding;positive regulation of epithelial cell differentiation;virus-host interaction;epithelial cell differentiation;induction of bacterial agglutination;phagocytic vesicle membrane;intracellular;Gram-positive bacterial cell surface binding;zymogen binding;innate immune response;cytoplasm;extrinsic to membrane;protein binding;zymogen granule membrane;extracellular region;scavenger receptor activity;pattern recognition receptor activity;inner cell mass cell proliferation;membrane@: GLIOMA SUSCEPTIBILITY 1; GLM1
A2463_28@102337@102338@deletion@2@135439427@135439807@10@chr10:135439427-135439807@5.83@49@14@0.286@CNVR4989.11, CNVR4989.4@FRG2B_3, FRG2B_2@0@0@0@:FSHD region gene 2 family, member B@:nucleus@NA
A2463_28@106037@106045@duplication@9@55029745@55340536@11@chr11:55029745-55340536@99@3263@6128@1.88@NA@TRIM48_1, TRIM48_2, TRIM48_3, TRIM48_5, OR4A16_1, OR4A15_1, OR4C15_1, OR4C16_1@0@0@0@:tripartite motif containing 48:olfactory receptor, family 4, subfamily A, member 16:olfactory receptor, family 4, subfamily A, member 15:olfactory receptor, family 4, subfamily C, member 15:olfactory receptor, family 4, subfamily C, member 16@:protein binding;intracellular;zinc ion binding:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_28@106049@106073@duplication@25@55432644@56000661@11@chr11:55432644-56000661@299@9089@17447@1.92@NA@OR4C6_1, OR5D13_1, OR5D14_1, OR5L1_1, OR5D18_1, OR5L2_1, OR5D16_1, TRIM51_2, TRIM51_3, TRIM51_4, TRIM51_6, TRIM51_7, OR5W2_1, OR5I1_1, OR10AG1_1, OR5F1_1, OR5AS1_1, OR8I2_1, OR8H2_1, OR8H3_1, OR8J3_1, OR8K5_1, OR5J2_1, OR5T2_1@0@0@0@:olfactory receptor, family 4, subfamily C, member 6:olfactory receptor, family 5, subfamily D, member 13:olfactory receptor, family 5, subfamily D, member 14:olfactory receptor, family 5, subfamily L, member 1:olfactory receptor, family 5, subfamily D, member 18:olfactory receptor, family 5, subfamily L, member 2:olfactory receptor, family 5, subfamily D, member 16:tripartite motif-containing 51G, pseudogene;tripartite motif-containing 51:olfactory receptor, family 5, subfamily W, member 2:olfactory receptor, family 5, subfamily I, member 1:olfactory receptor, family 10, subfamily AG, member 1:olfactory receptor, family 5, subfamily F, member 1:olfactory receptor, family 5, subfamily AS, member 1:olfactory receptor, family 8, subfamily I, member 2:olfactory receptor, family 8, subfamily H, member 2:olfactory receptor, family 8, subfamily H, member 3:olfactory receptor, family 8, subfamily J, member 3:olfactory receptor, family 8, subfamily K, member 5:olfactory receptor, family 5, subfamily J, member 2:olfactory receptor, family 5, subfamily T, member 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:protein binding;intracellular;zinc ion binding:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:signal transduction;integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;sensory perception of smell;G-protein coupled receptor activity;plasma membrane;detection of chemical stimulus involved in sensory perception of smell;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_28@114136@114139@deletion@4@8374419@8377428@12@chr12:8374419-8377428@13.3@1936@1320@0.682@CNVR5422.3, CNVR5422.5, CNVR5422.6, CNVR5422.1@FAM90A1_7, FAM90A1_6, FAM90A1_5, FAM90A1_4@0@0@0@:family with sequence similarity 90, member A1@:zinc ion binding;nucleic acid binding@NA
A2463_28@114493@114496@deletion@4@11506042@11508487@12@chr12:11506042-11508487@94@501@7@0.014@CNVR5435.2, CNVR5435.1@PRB1_4, PRB1_3, PRB1_2, PRB1_1@0@0@0@:proline-rich protein BstNI subfamily 1@NA@NA
A2463_28@115528@115528@deletion@1@31240873@31240917@12@chr12:31240873-31240917@5.61@74@30@0.405@CNVR5483.1@DDX11_6@0@0@0@:DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11@:nucleoplasm;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;S phase of mitotic cell cycle;DNA binding;nucleobase-containing compound metabolic process;ATP binding;ATP-dependent DNA helicase activity;DNA helicase activity;midbody;RNA binding;DNA-dependent ATPase activity;nucleus;positive regulation of cell proliferation;virus-host interaction;nuclear chromatin;4 iron, 4 sulfur cluster binding;helicase activity;hydrolase activity, acting on acid anhydrides;DNA duplex unwinding;endoplasmic reticulum unfolded protein response;G2/M transition of mitotic cell cycle;protein binding;sister chromatid cohesion;activation of signaling protein activity involved in unfolded protein response;nucleolus;spindle pole;ATP-dependent helicase activity;metal ion binding;nucleic acid binding;mitotic sister chromatid segregation@: WARSAW BREAKAGE SYNDROME
A2463_28@115535@115535@deletion@1@31247525@31247568@12@chr12:31247525-31247568@8.1@116@46@0.397@CNVR5483.1@DDX11_13@0@0@0@:DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11@:nucleoplasm;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;S phase of mitotic cell cycle;DNA binding;nucleobase-containing compound metabolic process;ATP binding;ATP-dependent DNA helicase activity;DNA helicase activity;midbody;RNA binding;DNA-dependent ATPase activity;nucleus;positive regulation of cell proliferation;virus-host interaction;nuclear chromatin;4 iron, 4 sulfur cluster binding;helicase activity;hydrolase activity, acting on acid anhydrides;DNA duplex unwinding;endoplasmic reticulum unfolded protein response;G2/M transition of mitotic cell cycle;protein binding;sister chromatid cohesion;activation of signaling protein activity involved in unfolded protein response;nucleolus;spindle pole;ATP-dependent helicase activity;metal ion binding;nucleic acid binding;mitotic sister chromatid segregation@: WARSAW BREAKAGE SYNDROME
A2463_28@115537@115537@deletion@1@31249276@31249313@12@chr12:31249276-31249313@9.58@151@60@0.397@CNVR5483.1@DDX11_15@0@0@0@:DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11@:nucleoplasm;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;S phase of mitotic cell cycle;DNA binding;nucleobase-containing compound metabolic process;ATP binding;ATP-dependent DNA helicase activity;DNA helicase activity;midbody;RNA binding;DNA-dependent ATPase activity;nucleus;positive regulation of cell proliferation;virus-host interaction;nuclear chromatin;4 iron, 4 sulfur cluster binding;helicase activity;hydrolase activity, acting on acid anhydrides;DNA duplex unwinding;endoplasmic reticulum unfolded protein response;G2/M transition of mitotic cell cycle;protein binding;sister chromatid cohesion;activation of signaling protein activity involved in unfolded protein response;nucleolus;spindle pole;ATP-dependent helicase activity;metal ion binding;nucleic acid binding;mitotic sister chromatid segregation@: WARSAW BREAKAGE SYNDROME
A2463_28@127348@127352@deletion@5@20010104@20020220@14@chr14:20010104-20020220@15.2@351@189@0.538@CNVR6072.6, CNVR6072.12@POTEM_5, POTEM_4, POTEM_3, POTEM_2, POTEM_1@0@0@0@:POTE ankyrin domain family, member M@:protein binding@NA
A2463_28@128213@128214@deletion@2@24434972@24435192@14@chr14:24434972-24435192@5.11@90@46@0.511@NA@DHRS4_4, DHRS4_5@0@0@0@:dehydrogenase/reductase (SDR family) member 4@:steroid metabolic process;oxidation-reduction process;mitochondrion;protein tetramerization;oxidoreductase activity;peroxisomal membrane;nucleus;cellular ketone metabolic process;metabolic process;receptor binding;alcohol dehydrogenase [NAD(P)+] activity;peroxisome;nucleotide binding;oxidoreductase activity, acting on NADH or NADPH, quinone or similar compound as acceptor;3-keto sterol reductase activity;alcohol metabolic process;carbonyl reductase (NADPH) activity@NA
A2463_28@129699@129700@duplication@2@55231174@55236940@14@chr14:55231174-55236940@5.31@190@278@1.46@NA@SAMD4A_7, SAMD4A_8@0@0@0@:sterile alpha motif domain containing 4A@:protein binding;synapse;negative regulation of translation;positive regulation of translation;cell junction;translation repressor activity;dendrite;cytoplasm:protein binding;synapse;negative regulation of translation;positive regulation of translation;cell junction;translation repressor activity;dendrite;cytoplasm@NA
A2463_28@131032@131033@duplication@2@74004127@74008399@14@chr14:74004127-74008399@7.74@300@452@1.51@CNVR6188.1, CNVR6188.4@ACOT1_1, ACOT1_2@0@0@0@:HEAT repeat containing 4:acyl-CoA thioesterase 1@:protein binding;binding:hydrolase activity;mitochondrion;acyl-CoA metabolic process;very long-chain fatty acid metabolic process;thiolester hydrolase activity;acyl-CoA hydrolase activity;cytosol;palmitoyl-CoA hydrolase activity;long-chain fatty acid metabolic process;carboxylesterase activity@NA
A2463_28@133426@133426@deletion@1@106478111@106478411@14@chr14:106478111-106478411@4.94@105@53@0.505@CNVR6294.36, CNVR6294.48, CNVR6294.12, CNVR6294.24@IGHV4-4_2@0@0@0@@:protein binding@NA
A2463_28@133432@133435@duplication@4@106539080@106552729@14@chr14:106539080-106552729@20.5@198@407@2.06@CNVR6294.36, CNVR6294.48, CNVR6294.24, CNVR6294.10, CNVR6294.34@IGHV1-8_2, IGHV1-8_1, IGHV3-9_2, IGHV3-9_1@0@0@0@@:protein binding:protein binding@NA
A2463_28@133472@133473@duplication@2@106926189@106926644@14@chr14:106926189-106926644@10.2@220@367@1.67@CNVR6294.56, CNVR6294.1@IGHV3-43_2, IGHV3-43_1@0@0@0@@:protein binding@NA
A2463_28@133488@133490@duplication@3@107082713@107083685@14@chr14:107082713-107083685@9.07@346@507@1.47@CNVR6294.56, CNVR6294.16, CNVR6294.91@IGHV4-59_3, IGHV4-59_2, IGHV4-59_1@0@0@0@@:protein binding@NA
A2463_28@133488@133492@deletion@2@107082713@107095561@14@chr14:107082713-107095561@-6.54@463@520@1.12@CNVR6294.56, CNVR6294.16, CNVR6294.91, CNVR6294.30@IGHV4-59_3, IGHV4-59_2, IGHV4-59_1, IGHV4-61_2, IGHV4-61_1@0@0@0@@:protein binding:protein binding@NA
A2463_28@133509@133528@duplication@20@20739498@21071610@15@chr15:20739498-21071610@30.3@930@1449@1.56@NA@GOLGA6L6_8, GOLGA6L6_7, GOLGA6L6_6, GOLGA6L6_5, GOLGA6L6_4, GOLGA6L6_3, GOLGA6L6_2, GOLGA6L6_1, AC012414.1_1, POTEB_11, POTEB_10, POTEB_9, POTEB_8, POTEB_7, POTEB_6, POTEB_5, POTEB_4, POTEB_3, POTEB_2, POTEB_1@0@0@0@:putative transmembrane protein FLJ36131-like;putative transmembrane protein ENSP00000320207-like;golgin A6 family-like 6:POTE ankyrin domain family member B-like@:protein binding@NA
A2463_28@133541@133542@duplication@2@22368577@22383423@15@chr15:22368577-22383423@12.7@1077@1608@1.49@CNVR6297.4, CNVR6297.17, CNVR6297.2@OR4M2_1, OR4N4_1@0@0@0@:olfactory receptor, family 4, subfamily M, member 2:olfactory receptor, family 4, subfamily N, member 4@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_28@133622@133623@deletion@2@23259497@23259716@15@chr15:23259497-23259716@9.63@66@15@0.227@CNVR6300.4@GOLGA8I_6, GOLGA8I_7@0@0@0@:golgin A8 family, member I@:Golgi cisterna membrane@NA
A2463_28@133869@133872@duplication@4@28629294@28630527@15@chr15:28629294-28630527@16.5@167@332@1.99@CNVR6329.4@GOLGA8F_9, GOLGA8F_10, GOLGA8F_11, GOLGA8F_12@0@0@0@@:Golgi apparatus@NA
A2463_28@133884@133897@deletion@14@28769090@28776274@15@chr15:28769090-28776274@13.7@110@34@0.309@CNVR6330.3@GOLGA8G_15, GOLGA8G_14, GOLGA8G_13, GOLGA8G_12, GOLGA8G_11, GOLGA8G_10, GOLGA8G_9, GOLGA8G_8, GOLGA8G_7, GOLGA8G_6, GOLGA8G_5, GOLGA8G_4, GOLGA8G_3, GOLGA8G_2@0@0@0@:golgin A8 family, member G;golgin A8 family, member F@:Golgi apparatus@NA
A2463_28@133900@133900@deletion@1@28947361@28947515@15@chr15:28947361-28947515@4.76@84@40@0.476@NA@GOLGA8M_18@0@0@0@:golgin A8 family, member M@:Golgi apparatus@NA
A2463_28@133971@133971@deletion@1@30376975@30377093@15@chr15:30376975-30377093@4.7@24@2@0.0833@NA@GOLGA8J_2@0@0@0@:golgin A8 family, member J@:Golgi apparatus@NA
A2463_28@133978@133984@deletion@7@30380944@30384336@15@chr15:30380944-30384336@41@344@94@0.273@NA@GOLGA8J_9, GOLGA8J_10, GOLGA8J_11, GOLGA8J_12, GOLGA8J_13, GOLGA8J_14, GOLGA8J_15@0@0@0@:golgin A8 family, member J@:Golgi apparatus@NA
A2463_28@133996@134000@deletion@5@30431879@30434261@15@chr15:30431879-30434261@42.9@219@6@0.0274@NA@GOLGA8T_8, GOLGA8T_9, GOLGA8T_10, GOLGA8T_11, GOLGA8T_12@0@0@0@:golgin A8 family, member J;golgin A8 family, member K@:Golgi apparatus@NA
A2463_28@134005@134007@deletion@3@30437163@30437770@15@chr15:30437163-30437770@12@125@48@0.384@NA@GOLGA8T_17, GOLGA8T_18, GOLGA8T_19@0@0@0@:golgin A8 family, member J;golgin A8 family, member K@:Golgi apparatus@NA
A2463_28@134189@134190@deletion@2@32743115@32743403@15@chr15:32743115-32743403@12@63@5@0.0794@CNVR6346.1@GOLGA8O_8, GOLGA8O_7@0@0@0@:golgin A8 family, member O@:Golgi apparatus@NA
A2463_28@134431@134432@duplication@2@34673613@34674057@15@chr15:34673613-34674057@6.08@174@272@1.56@CNVR6351.4, CNVR6351.3@GOLGA8A_24, GOLGA8A_23@0@0@0@:golgin A8 family, member A@:Golgi cisterna membrane;Golgi apparatus@NA
A2463_28@134441@134448@deletion@8@34677456@34820278@15@chr15:34677456-34820278@22@282@119@0.422@CNVR6351.3@GOLGA8A_14, GOLGA8A_13, GOLGA8A_12, GOLGA8A_11, GOLGA8A_10, GOLGA8A_9, GOLGA8B_25, GOLGA8B_24@0@0@0@:golgin A8 family, member A:golgin A8 family, member A;golgin A8 family, member B@:Golgi cisterna membrane;Golgi apparatus:Golgi cisterna membrane;Golgi apparatus@NA
A2463_28@134458@134460@duplication@3@34823850@34825163@15@chr15:34823850-34825163@12.4@74@182@2.46@CNVR6351.3@GOLGA8B_14, GOLGA8B_13, GOLGA8B_12@0@0@0@:golgin A8 family, member A:golgin A8 family, member A;golgin A8 family, member B@:Golgi cisterna membrane;Golgi apparatus:Golgi cisterna membrane;Golgi apparatus@NA
A2463_28@135052@135053@deletion@2@41862226@41862538@15@chr15:41862226-41862538@5.59@137@76@0.555@NA@TYRO3_10, TYRO3_11@0@0@0@:TYRO3 protein tyrosine kinase@:protein tyrosine kinase activity;platelet aggregation;negative regulation of toll-like receptor signaling pathway;ATP binding;vagina development;substrate adhesion-dependent cell spreading;nucleus;negative regulation of lymphocyte activation;endoplasmic reticulum membrane;phosphatidylinositol 3-kinase cascade;nuclear envelope;platelet activation;protein kinase activity;protein kinase B signaling cascade;neuron homeostasis;negative regulation of neuron apoptotic process;negative regulation of innate immune response;protein autophosphorylation;transmembrane receptor protein tyrosine kinase activity;apoptotic cell clearance;transferase activity, transferring phosphorus-containing groups;spermatogenesis;forebrain cell migration;integral to membrane;integral to plasma membrane;ovulation cycle;natural killer cell differentiation;phosphatidylinositol 3-kinase binding;negative regulation of inflammatory response;protein phosphorylation;receptor signaling protein tyrosine kinase activity;protein heterodimerization activity;secretion by cell;protein binding;signal transduction;cell adhesion;signal transduction by phosphorylation@NA
A2463_28@135711@135722@deletion@12@43902511@43908888@15@chr15:43902511-43908888@13.2@203@99@0.488@CNVR6365.1@STRC_15, STRC_14, STRC_13, STRC_12, STRC_11, STRC_10, STRC_9, STRC_8, STRC_7, STRC_6, STRC_5, STRC_4@0@0@0@:diphosphoinositol pentakisphosphate kinase 1:stereocilin@:inositol hexakisphosphate 3-kinase activity;inositol hexakisphosphate 1-kinase activity;inositol metabolic process;diphosphoinositol-pentakisphosphate kinase activity;ATP binding;acid phosphatase activity;cytoplasm;cytosol;inositol hexakisphosphate 5-kinase activity;nucleus;kinase activity;inositol-1,3,4,5,6-pentakisphosphate kinase activity:detection of mechanical stimulus involved in sensory perception of sound;stereocilium bundle tip;stereocilium;cell surface;kinocilium;auditory receptor cell stereocilium organization@: DEAFNESS, AUTOSOMAL RECESSIVE 16; DFNB16; DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY
A2463_28@138412@138414@deletion@3@74363252@74363811@15@chr15:74363252-74363811@5.7@98@50@0.51@CNVR6448.1@GOLGA6A_18, GOLGA6A_17, GOLGA6A_16@0@0@0@:golgin A6 family, member C;golgin A6 family, member A;golgin A6 family, member D;golgin A6 family, member B@:Golgi apparatus@NA
A2463_28@138417@138422@deletion@6@74365084@74368326@15@chr15:74365084-74368326@26.1@358@155@0.433@CNVR6448.1@GOLGA6A_13, GOLGA6A_12, GOLGA6A_11, GOLGA6A_10, GOLGA6A_9, GOLGA6A_8@0@0@0@:golgin A6 family, member C;golgin A6 family, member A;golgin A6 family, member D;golgin A6 family, member B@:Golgi apparatus@NA
A2463_28@138451@138452@duplication@2@74494497@74494860@15@chr15:74494497-74494860@4.97@183@266@1.45@NA@STRA6_2, STRA6_1@0@0@0@:stimulated by retinoic acid gene 6 homolog (mouse)@:head development;embryonic camera-type eye formation;pulmonary valve morphogenesis;pulmonary artery morphogenesis;kidney development;paramesonephric duct development;vitamin A import;positive regulation of behavior;digestive tract morphogenesis;plasma membrane;diaphragm development;blood vessel development;neuromuscular process;lung alveolus development;head morphogenesis;embryonic digestive tract development;heart development;feeding behavior;learning;ear development;uterus morphogenesis;adrenal gland development;eyelid development in camera-type eye;vitamin transporter activity;lung development;smooth muscle tissue development;integral to membrane;receptor activity;nose morphogenesis;artery morphogenesis;ventricular septum development;alveolar primary septum development;retinoic acid metabolic process;protein complex;face morphogenesis;developmental growth;female genitalia development;vocal learning;lung vasculature development;cognition@: MICROPHTHALMIA, SYNDROMIC 9; MCOPS9
A2463_28@141631@141631@deletion@1@2627427@2627501@16@chr16:2627427-2627501@6.29@140@69@0.493@CNVR6601.1@PDPK1_7@0@0@0@:3-phosphoinositide dependent protein kinase-1@:3-phosphoinositide-dependent protein kinase activity;nucleoplasm;fibroblast growth factor receptor signaling pathway;protein tyrosine kinase activity;negative regulation of transforming growth factor beta receptor signaling pathway;negative regulation of toll-like receptor signaling pathway;regulation of endothelial cell migration;focal adhesion assembly;ATP binding;insulin receptor signaling pathway;plasma membrane;intracellular signal transduction;positive regulation of establishment of protein localization to plasma membrane;platelet activation;protein kinase activity;regulation of mast cell degranulation;cytosol;epidermal growth factor receptor signaling pathway;hyperosmotic response;nerve growth factor receptor signaling pathway;type B pancreatic cell development;synaptic transmission;regulation of apoptotic process;transcription, DNA-dependent;protein autophosphorylation;regulation of I-kappaB kinase/NF-kappaB cascade;protein kinase binding;T cell costimulation;insulin receptor binding;transferase activity, transferring phosphorus-containing groups;actin cytoskeleton organization;blood coagulation;negative regulation of protein kinase activity;cellular response to insulin stimulus;focal adhesion;phosphatidylinositol-mediated signaling;negative regulation of cardiac muscle cell apoptotic process;protein serine/threonine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;cytoplasm;activation of protein kinase B activity;protein binding;T cell receptor signaling pathway;cytoplasmic membrane-bounded vesicle;peptidyl-threonine phosphorylation;kinase activity@NA
A2463_28@142666@142667@deletion@2@14960413@14962492@16@chr16:14960413-14962492@8.81@274@152@0.555@NA@NOMO1_15, NOMO1_16@0@0@0@:NODAL modulator 1;nodal modulator 1-like@:carbohydrate binding;integral to membrane;carboxypeptidase activity;molecular_function;cellular_component;biological_process@NA
A2463_28@142910@142928@deletion@19@16330759@16367932@16@chr16:16330759-16367932@31.6@736@405@0.55@NA@NOMO3_2, NOMO3_3, NOMO3_4, NOMO3_5, NOMO3_6, NOMO3_7, NOMO3_8, NOMO3_9, NOMO3_10, NOMO3_11, NOMO3_12, NOMO3_13, NOMO3_14, NOMO3_15, NOMO3_16, NOMO3_17, NOMO3_18, NOMO3_19, NOMO3_20@0@0@0@:NODAL modulator 3@:carbohydrate binding;integral to membrane;carboxypeptidase activity@NA
A2463_28@144053@144053@deletion@1@28481695@28481759@16@chr16:28481695-28481759@8.03@125@52@0.416@NA@NPIPL1_1@0@0@0@:ceroid-lipofuscinosis, neuronal 3@:membrane:negative regulation of apoptotic process;late endosome;mitochondrion;galactosylceramide metabolic process;neuromuscular process controlling balance;neuron projection;lysosomal lumen pH elevation;integral to endoplasmic reticulum membrane;cell death;plasma membrane;nucleus;lysosomal lumen acidification;negative regulation of catalytic activity;negative regulation of macroautophagy;unfolded protein binding;neurotransmitter metabolic process;endoplasmic reticulum;vesicle transport along microtubule;protein catabolic process;autophagic vacuole;early endosome;trans-Golgi network;cellular membrane organization;ceramide metabolic process;glucosylceramide metabolic process;negative regulation of neuron apoptotic process;membrane;globoside metabolic process;membrane raft;synaptic vesicle;vacuolar transport;protein processing;Golgi membrane;caveola;protein folding;ionotropic glutamate receptor signaling pathway;cytosolic calcium ion homeostasis;Golgi stack;integral to membrane;receptor-mediated endocytosis;arginine transport;lysosome;negative regulation of proteolysis;Golgi apparatus;lysosome organization;associative learning;sphingomyelin metabolic process;macroautophagy;lysosomal membrane;amyloid precursor protein catabolic process;cytoplasm;autophagic vacuole fusion;protein binding;regulation of action potential;cellular amino acid metabolic process@: CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3
A2463_28@147099@147102@deletion@4@69996880@70012015@16@chr16:69996880-70012015@20.9@641@351@0.548@CNVR6762.3, CNVR6762.1@CLEC18A_11, CLEC18A_12, RP11-419C5.2_7, RP11-419C5.2_6@0@0@0@:C-type lectin domain family 18, member A@:carbohydrate binding;protein binding;extracellular region@NA
A2463_28@147423@147427@duplication@5@72097156@72110980@16@chr16:72097156-72110980@42.8@1020@1955@1.92@CNVR6769.1@HPR_1, HPR_2, HPR_3, HPR_4, HPR_5@0@0@0@:thioredoxin-like 4B:haptoglobin-related protein@:mitosis;mRNA processing;RNA splicing;spliceosomal complex;cell redox homeostasis:spherical high-density lipoprotein particle;proteolysis;extracellular region;hemoglobin binding;catalytic activity;serine-type endopeptidase activity@NA
A2463_28@147513@147513@deletion@1@74451958@74452196@16@chr16:74451958-74452196@15.8@86@5@0.0581@CNVR6778.2, CNVR6778.3@CLEC18B_3@0@0@0@:C-type lectin domain family 18, member B@:carbohydrate binding;protein binding;extracellular region@NA
A2463_28@151877@151881@deletion@5@18389249@18394637@17@chr17:18389249-18394637@18.4@214@91@0.425@CNVR7014.1@LGALS9C_3, LGALS9C_4, LGALS9C_5, LGALS9C_6, LGALS9C_7@0@0@0@:lectin, galactoside-binding, soluble, 9C@:carbohydrate binding@NA
A2463_28@151886@151886@deletion@1@18429609@18430117@17@chr17:18429609-18430117@4.43@132@73@0.553@NA@FAM106A_1@0@0@0@:protein FAM106B-like@NA@NA
A2463_28@152126@152132@duplication@7@20356331@20370783@17@chr17:20356331-20370783@13.1@280@467@1.67@CNVR7021.1, CNVR7021.3@LGALS9B_7, LGALS9B_6, LGALS9B_5, LGALS9B_4, LGALS9B_3, LGALS9B_2, LGALS9B_1@0@0@0@:lectin, galactoside-binding, soluble, 9B@:carbohydrate binding@NA
A2463_28@153363@153363@deletion@1@34493376@34493943@17@chr17:34493376-34493943@6.75@61@18@0.295@CNVR7077.1, CNVR7077.3, CNVR7077.11, CNVR7077.16@TBC1D3B_14@0@0@0@:TBC1 domain family, member 3B@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_28@153372@153373@deletion@2@34500205@34500806@17@chr17:34500205-34500806@9.19@47@3@0.0638@CNVR7077.1, CNVR7077.3, CNVR7077.11, CNVR7077.16@TBC1D3B_5, TBC1D3B_4@0@0@0@:TBC1 domain family, member 3B@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_28@153378@153394@duplication@17@34523998@34590454@17@chr17:34523998-34590454@59.9@154@646@4.19@CNVR7077.1, CNVR7077.13, CNVR7077.19@CCL3L3_1, CCL4L1_1, CCL4L1_2, CCL4L1_3, TBC1D3C_14, TBC1D3C_13, TBC1D3C_12, TBC1D3C_11, TBC1D3C_10, TBC1D3C_9, TBC1D3C_8, TBC1D3C_7, TBC1D3C_6, TBC1D3C_5, TBC1D3C_4, TBC1D3C_3, TBC1D3C_2@0@0@0@:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1:TBC1 domain family, member 3C;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3H-like;TBC1 domain family, member 3H@:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_28@153400@153400@duplication@1@34641451@34641537@17@chr17:34641451-34641537@5.69@146@240@1.64@CNVR7077.1, CNVR7077.2, CNVR7077.12@CCL4L2_3@0@0@0@:TBC1 domain family, member 3C;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3H-like;TBC1 domain family, member 3H:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
A2463_28@153414@153414@duplication@1@34797487@34798054@17@chr17:34797487-34798054@13.9@113@309@2.73@CNVR7078.2, CNVR7078.3@TBC1D3G_14@0@0@0@:TBC1 domain family member 3H-like;TBC1 domain family, member 3H:TBC1 domain family, member 3;TBC1 domain family, member 3G;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like;TBC1 domain family, member 3H@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_28@153650@153659@duplication@10@36351930@36375177@17@chr17:36351930-36375177@35.9@1942@2817@1.45@CNVR7083.3@RP11-1407O15.2_12, RP11-1407O15.2_11, RP11-1407O15.2_10, RP11-1407O15.2_9, RP11-1407O15.2_8, RP11-1407O15.2_7, RP11-1407O15.2_6, RP11-1407O15.2_5, RP11-1407O15.2_4, RP11-1407O15.2_3@0@0@0@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
A2463_28@154328@154329@duplication@2@39240460@39254336@17@chr17:39240460-39254336@9.46@283@444@1.57@NA@KRTAP4-7_1, KRTAP4-8_1@0@0@0@:keratin associated protein 4-7:keratin associated protein 4-8@:keratin filament:keratin filament@NA
A2463_28@155581@155582@deletion@2@44248222@44375108@17@chr17:44248222-44375108@21@802@499@0.622@CNVR7114.3, CNVR7114.2, CNVR7114.10@KANSL1_2, LRRC37A_1@0@0@0@:KAT8 regulatory NSL complex subunit 1:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:histone acetyltransferase activity (H4-K8 specific);histone acetyltransferase activity (H4-K16 specific);histone acetyltransferase activity (H4-K5 specific);histone acetyltransferase complex;histone H4-K5 acetylation;MLL1 complex;histone H4-K16 acetylation;protein binding;histone H4-K8 acetylation;nucleus:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
A2463_28@155584@155588@duplication@5@44380005@44400393@17@chr17:44380005-44400393@28.8@158@420@2.66@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A_3, LRRC37A_4, LRRC37A_5, LRRC37A_6, LRRC37A_7@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
A2463_28@155591@155591@deletion@1@44409919@44410022@17@chr17:44409919-44410022@7.26@159@76@0.478@CNVR7114.3, CNVR7114.2, CNVR7114.1, CNVR7114.7@LRRC37A_10@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
A2463_28@155591@155595@duplication@4@44409919@44415089@17@chr17:44409919-44415089@14.9@297@512@1.72@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A_10, LRRC37A_11, LRRC37A_12, LRRC37A_13, LRRC37A_14@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
A2463_28@155599@155600@duplication@2@44590080@44594799@17@chr17:44590080-44594799@23.6@233@712@3.06@CNVR7114.2, CNVR7114.5@LRRC37A2_2, LRRC37A2_3@0@0@0@:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
A2463_28@155604@155605@deletion@2@44617543@44618247@17@chr17:44617543-44618247@12.3@310@157@0.506@CNVR7114.2, CNVR7114.5, CNVR7114.4@LRRC37A2_7, LRRC37A2_8@0@0@0@:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
A2463_28@155610@155613@deletion@4@44632519@44634996@17@chr17:44632519-44634996@31.9@373@108@0.29@CNVR7114.2, CNVR7114.5, CNVR7114.4@LRRC37A2_13, LRRC37A2_14, LRRC37A2_15, ARL17A_4@0@0@0@:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
A2463_28@155626@155627@deletion@2@44771214@44772028@17@chr17:44771214-44772028@6@45@11@0.244@CNVR7114.2, CNVR7114.4@NSF_11, NSF_12@0@0@0@:N-ethylmaleimide-sensitive factor@:PDZ domain binding;Rab GTPase binding;regulation of exocytosis;ATP binding;Golgi stack;protein transport;protein C-terminus binding;plasma membrane;dendritic shaft;potassium ion transport;nucleoside-triphosphatase activity;exocytosis;positive regulation of receptor recycling;nucleotide binding;plasma membrane fusion;cytoplasm;cytosol;protein binding;vesicle-mediated transport;ATPase activity, coupled;protein complex binding;synaptic transmission;syntaxin binding;metal ion binding@NA
A2463_28@157607@157608@deletion@2@62888648@62893375@17@chr17:62888648-62893375@24@1272@653@0.513@CNVR7165.1, CNVR7165.3@LRRC37A3_4, LRRC37A3_3@0@0@0@:leucine rich repeat containing 37, member A3@:protein binding;integral to membrane@NA
A2463_28@162017@162017@deletion@1@44542732@44544371@18@chr18:44542732-44544371@33.2@224@14@0.0625@CNVR7319.1@TCEB3CL2_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_28@162017@162018@duplication@1@44542732@44550298@18@chr18:44542732-44550298@-17.9@491@877@1.79@CNVR7319.1, CNVR7319.2@TCEB3CL2_1, TCEB3CL_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2:transcription elongation factor B polypeptide 3C-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_28@162017@162019@deletion@1@44542732@44556213@18@chr18:44542732-44556213@38.8@3550@2617@0.737@CNVR7319.1, CNVR7319.2@TCEB3CL2_1, TCEB3CL_1, TCEB3C_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2:transcription elongation factor B polypeptide 3C-like:transcription elongation factor B polypeptide 3C (elongin A3);RNA polymerase II transcription factor SIII subunit A3-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_28@163496@163500@duplication@5@1251839@1257271@19@chr19:1251839-1257271@6.11@692@911@1.32@NA@MIDN_4, MIDN_5, MIDN_6, MIDN_7, MIDN_8@0@0@0@:midnolin@:protein binding;nucleolus@NA
A2463_28@164950@164951@deletion@2@7030624@7032905@19@chr19:7030624-7032905@9.81@48@2@0.0417@CNVR7517.1@MBD3L5_1, MBD3L5_2@0@0@0@:methyl-CpG binding domain protein 3-like 5@NA@NA
A2463_28@166378@166378@duplication@1@12504112@12504237@19@chr19:12504112-12504237@5.84@22@68@3.09@CNVR7541.1@CTD-3105H18.16_2, ZNF799_2@0@0@0@:zinc finger protein 799@:intracellular;regulation of transcription, DNA-dependent;nucleic acid binding:nucleus;intracellular;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:intracellular;regulation of transcription, DNA-dependent;nucleic acid binding@NA
A2463_28@167243@167253@duplication@11@15784341@15807322@19@chr19:15784341-15807322@22.9@607@935@1.54@CNVR7553.1@CYP4F12_2, CYP4F12_3, CYP4F12_4, CYP4F12_5, CYP4F12_6, CYP4F12_7, CYP4F12_8, CYP4F12_9, CYP4F12_10, CYP4F12_11, CYP4F12_12@0@0@0@:cytochrome P450, family 4, subfamily F, polypeptide 12@:pressure natriuresis;negative regulation of blood coagulation;oxidation-reduction process;very long-chain fatty acid metabolic process;arachidonic acid metabolic process;aromatase activity;sodium ion homeostasis;renal water homeostasis;arachidonic acid epoxygenase activity;integral to membrane;leukotriene B4 catabolic process;endoplasmic reticulum membrane;epoxygenase P450 pathway;electron carrier activity;intracellular membrane-bounded organelle;drug metabolic process;alkane 1-monooxygenase activity;small molecule metabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;apical plasma membrane;heme binding;vitamin E metabolic process;cytoplasm;vitamin-K-epoxide reductase (warfarin-sensitive) activity;xenobiotic metabolic process;vitamin K biosynthetic process;leukotriene-B4 20-monooxygenase activity;long-chain fatty acid metabolic process;iron ion binding@NA
A2463_28@168441@168442@deletion@2@22939008@22939580@19@chr19:22939008-22939580@9.56@320@176@0.55@NA@ZNF99_8, ZNF99_7@0@0@0@:zinc finger protein 99@:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_28@170095@170100@deletion@6@40370196@40382826@19@chr19:40370196-40382826@27.7@578@307@0.531@CNVR7639.2@FCGBP_27, FCGBP_26, FCGBP_25, FCGBP_24, FCGBP_23, FCGBP_22@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_28@170359@170367@deletion@9@41350537@41381779@19@chr19:41350537-41381779@28.4@738@409@0.554@CNVR7642.1@CYP2A6_8, CYP2A6_7, CYP2A6_6, CYP2A6_5, CYP2A6_4, CYP2A6_3, CYP2A6_2, CYP2A6_1, CYP2A7_9@0@0@0@:cytochrome P450, family 2, subfamily A, polypeptide 6:cytochrome P450, family 2, subfamily A, polypeptide 7@:coumarin 7-hydroxylase activity;steroid metabolic process;oxidation-reduction process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;endoplasmic reticulum membrane;drug metabolic process;electron carrier activity;small molecule metabolic process;exogenous drug catabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;enzyme binding;heme binding;xenobiotic metabolic process;iron ion binding;coumarin catabolic process;coumarin metabolic process:oxidation-reduction process;electron carrier activity;aromatase activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;oxygen binding;heme binding;monooxygenase activity;endoplasmic reticulum membrane;iron ion binding@: CYTOCHROME P450, SUBFAMILY IIA, POLYPEPTIDE 6; CYP2A6
A2463_28@172135@172136@deletion@2@49558099@49558632@19@chr19:49558099-49558632@5.46@102@52@0.51@CNVR7684.1@CGB7_4, CGB7_3@0@0@0@:chorionic gonadotropin, beta polypeptide 7@:small molecule metabolic process;hormone activity;female gamete generation;cell-cell signaling;signal transduction;extracellular region;apoptotic process;cellular nitrogen compound metabolic process;peptide hormone processing@NA
A2463_28@172563@172565@deletion@3@50462618@50463678@19@chr19:50462618-50463678@5.51@105@54@0.514@NA@SIGLEC11_5, SIGLEC11_4, SIGLEC11_3@0@0@0@:sialic acid binding Ig-like lectin 11@:carbohydrate binding;protein binding;integral to membrane;cell adhesion@NA
A2463_28@172988@172995@deletion@8@52133553@52150012@19@chr19:52133553-52150012@25.9@298@121@0.406@CNVR7702.1@SIGLEC5_1, SIGLEC14_7, SIGLEC14_6, SIGLEC14_5, SIGLEC14_4, SIGLEC14_3, SIGLEC14_2, SIGLEC14_1, SIGLEC5_1@0@0@0@:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 14@:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion;plasma membrane@NA
A2463_28@173301@173308@deletion@8@54742830@54746600@19@chr19:54742830-54746600@43.9@855@402@0.47@CNVR7721.3, CNVR7721.6@LILRA6_8, LILRA6_7, LILRA6_6, LILRA6_5, LILRA6_4, LILRA6_3, LILRA6_2, LILRA6_1@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
A2463_28@173456@173457@deletion@2@55237520@55239376@19@chr19:55237520-55239376@5.81@26@0@0@NA@KIR3DL3_3, KIR3DL3_4@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:integral to membrane;plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane@NA
A2463_28@173459@173480@duplication@22@55246721@55316532@19@chr19:55246721-55316532@101@1239@2383@1.92@CNVR7725.2, CNVR7725.1@KIR3DL3_6, KIR3DL3_7, KIR3DL3_8, KIR2DL3_1, KIR2DL3_2, KIR2DL3_3, KIR2DL3_4, KIR2DL3_5, KIR2DL3_6, KIR2DL3_7, KIR2DL3_8, KIR2DL1_1, KIR2DL1_2, KIR2DL1_3, KIR2DL1_4, KIR2DL1_5, KIR2DL1_6, KIR2DL1_7, KIR2DL1_8, KIR2DL4_1, KIR2DL4_2, KIR2DL4_3@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:integral to membrane;plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane@NA
A2463_28@173482@173486@deletion@5@55320289@55329024@19@chr19:55320289-55329024@22.8@147@29@0.197@CNVR7725.1, CNVR7725.3@KIR2DL4_5, KIR2DL4_6, KIR2DL4_7, KIR3DL1_1, KIR3DL1_2@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane@NA
A2463_28@173488@173498@duplication@11@55331169@55354373@19@chr19:55331169-55354373@21.5@999@1413@1.41@CNVR7725.1, CNVR7725.6@KIR3DL1_4, KIR3DL1_5, KIR3DL1_6, KIR3DL1_7, KIR3DL1_8, KIR3DL1_9, KIR2DS4_1, KIR2DS4_2, KIR2DS4_3, KIR2DS4_4, KIR2DS4_5@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
A2463_28@173500@173503@deletion@4@55359207@55362710@19@chr19:55359207-55362710@20.4@94@0@0@CNVR7725.1, CNVR7725.6, CNVR7725.5, CNVR7725.10@KIR2DS4_7, KIR2DS4_8, KIR3DL2_1, KIR3DL2_2@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2-like@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane@NA
A2463_28@173902@173903@deletion@2@56658282@56662350@19@chr19:56658282-56662350@9.6@83@24@0.289@NA@ZNF444_3, AC024580.1_2@0@0@0@:zinc finger protein 444@:intracellular;DNA binding;regulation of transcription, DNA-dependent;sequence-specific DNA binding transcription factor activity;viral reproduction;nucleus;transcription, DNA-dependent;zinc ion binding@NA
A2463_28@174817@174817@deletion@1@4055395@4055595@20@chr20:4055395-4055595@5.69@185@101@0.546@NA@RP11-352D3.2_1@0@0@0@NA@NA@NA
A2463_28@175736@175737@duplication@2@26061801@26063616@20@chr20:26061801-26063616@7.13@204@313@1.53@CNVR7823.4, CNVR7823.3, CNVR7823.5, CNVR7823.1@FAM182A_4, FAM182A_5@0@0@0@NA@NA@NA
A2463_28@180976@180976@deletion@1@16287255@16287885@22@chr22:16287255-16287885@7.77@351@191@0.544@CNVR8071.2, CNVR8071.3, CNVR8071.9@POTEH_1@0@0@0@:POTE ankyrin domain family, member H@:protein binding@NA
A2463_28@181127@181134@deletion@8@18723546@18835833@22@chr22:18723546-18835833@25.5@329@108@0.328@CNVR8087.5, CNVR8087.2, CNVR8087.7@AC008132.1_2, AC008132.1_3, AC008132.1_4, AC008132.1_5, AC008132.1_6, AC008132.1_7, AC008132.1_8, AC008132.13_1@0@0@0@NA@NA@NA
A2463_28@181622@181631@duplication@10@21480538@21570956@22@chr22:21480538-21570956@15.6@401@616@1.54@CNVR8100.5, CNVR8100.4@POM121L7_1, GGT2_15, GGT2_14, GGT2_13, GGT2_12, GGT2_11, GGT2_10, GGT2_9, GGT2_8, GGT2_7@0@0@0@:putative POM121-like protein 1-like:gamma-glutamyltransferase 2;gamma-glutamyltranspeptidase 2-like@:hydrolase activity;small molecule metabolic process;leukotriene biosynthetic process;anchored to external side of plasma membrane;glutathione biosynthetic process;xenobiotic metabolic process;integral to membrane;glutathione metabolic process;plasma membrane;gamma-glutamyltransferase activity;cellular_component@NA
A2463_28@181774@181785@deletion@12@23040437@23090398@22@chr22:23040437-23090398@38.9@1119@616@0.55@CNVR8103.5, CNVR8103.2, CNVR8103.1, CNVR8103.18, CNVR8103.29@IGLV2-23_1, IGLV2-23_2, IGLV3-22_1, IGLV3-22_2, IGLV3-21_2, IGLV3-21_3, IGLV3-19_1, IGLV3-19_2, IGLV2-18_1, IGLV2-18_2, IGLV3-16_1, IGLV3-16_2@0@0@0@@:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding@NA
A2463_28@181807@181808@deletion@2@23247056@23248831@22@chr22:23247056-23248831@7.17@314@194@0.618@CNVR8103.2, CNVR8103.1, CNVR8103.6, CNVR8103.11@IGLJ3_1, IGLC3_1@0@0@0@@:protein binding@NA
A2463_28@181936@181938@duplication@3@24300473@24302568@22@chr22:24300473-24302568@6.26@49@102@2.08@CNVR8114.6, CNVR8114.12, CNVR8114.13, CNVR8114.8@GSTT2B_4, GSTT2B_3, GSTT2B_2@0@0@0@:glutathione S-transferase theta 2B (gene/pseudogene);glutathione S-transferase theta 2@:protein binding;glutathione transferase activity;nucleus;transferase activity;cytoplasm@NA
A2463_28@181951@181955@deletion@5@24376424@24384231@22@chr22:24376424-24384231@37.1@174@1@0.00575@CNVR8114.13, CNVR8114.1, CNVR8114.7@GSTT1_5, GSTT1_4, GSTT1_3, GSTT1_2, GSTT1_1@0@0@0@:glutathione S-transferase theta 1@:glutathione peroxidase activity;response to drug;transferase activity;cytosol;protein binding;glutathione transferase activity;glutathione metabolic process;response to organic cyclic compound@NA
A2463_28@182070@182070@deletion@1@25024243@25024355@22@chr22:25024243-25024355@5.47@149@79@0.53@CNVR8117.1@GGT1_15@0@0@0@:gamma-glutamyltransferase 2;gamma-glutamyltransferase 1@:hydrolase activity;small molecule metabolic process;regulation of inflammatory response;leukotriene biosynthetic process;anchored to external side of plasma membrane;glutathione biosynthetic process;xenobiotic metabolic process;protein binding;spermatogenesis;regulation of immune system process;integral to membrane;cysteine biosynthetic process;glutathione metabolic process;plasma membrane;gamma-glutamyltransferase activity;membrane;cellular amino acid metabolic process@: GLUTATHIONURIA
A2463_29@322@324@deletion@3@1414025@1416316@1@chr1:1414025-1416316@12.7@71@10@0.141@CNVR15.1@ATAD3B_3, ATAD3B_4, ATAD3B_5@0@0@0@:ATPase family, AAA domain containing 3B@:nucleoside-triphosphatase activity;mitochondrial inner membrane;nucleotide binding;ATP binding@NA
A2463_29@339@340@duplication@2@1453097@1454370@1@chr1:1453097-1454370@5.5@79@134@1.7@NA@ATAD3A_4, ATAD3A_5@0@0@0@:ATPase family, AAA domain containing 3A@:negative regulation of apoptotic process;mitochondrion;nucleoside-triphosphatase activity;mitochondrial inner membrane;cell growth;nucleotide binding;ATP binding;mitochondrial nucleoid;integral to membrane@NA
A2463_29@401@411@deletion@11@1576410@1588935@1@chr1:1576410-1588935@22.2@905@570@0.63@CNVR17.1@CDK11B_11, CDK11B_10, CDK11B_9, CDK11B_8, CDK11B_7, CDK11B_6, CDK11B_5, CDK11B_4, CDK11B_3, CDK11B_2, CDK11B_1@0@0@0@:cyclin-dependent kinase 11B@:protein serine/threonine kinase activity;protein tyrosine kinase activity;protein phosphorylation;protein kinase activity;cell division;transferase activity, transferring phosphorus-containing groups;ATP binding@NA
A2463_29@422@422@deletion@1@1634916@1635063@1@chr1:1634916-1635063@8@39@2@0.0513@CNVR17.1@CDK11A_18@0@0@0@:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A@:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division@NA
A2463_29@426@431@deletion@6@1635990@1640391@1@chr1:1635990-1640391@20.9@170@53@0.312@CNVR17.1@CDK11A_14, CDK11A_13, CDK11A_12, CDK11A_11, CDK11A_10, CDK11A_9@0@0@0@:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A@:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division@NA
A2463_29@434@440@duplication@7@1643704@1666274@1@chr1:1643704-1666274@33.5@617@1037@1.68@CNVR17.1@CDK11A_6, CDK11A_5, CDK11A_4, CDK11A_3, CDK11A_2, SLC35E2_6, SLC35E2_5@0@0@0@:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A:solute carrier family 35, member E2@:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division:integral to membrane;membrane@NA
A2463_29@1608@1608@deletion@1@11854416@11854595@1@chr1:11854416-11854595@4.66@156@94@0.603@NA@MTHFR_7@0@0@0@:methylenetetrahydrofolate reductase (NAD(P)H)@:tetrahydrofolate interconversion;blood circulation;oxidation-reduction process;methionine metabolic process;small molecule metabolic process;folic acid metabolic process;cytosol;methylenetetrahydrofolate reductase (NADPH) activity;homocysteine metabolic process;methionine biosynthetic process;modified amino acid binding;water-soluble vitamin metabolic process;vitamin metabolic process;cellular amino acid metabolic process@: HOMOCYSTEINEMIA; NEURAL TUBE DEFECTS, FOLATE-SENSITIVE; HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATE; STROKE, ISCHEMIC
A2463_29@1806@1826@duplication@21@12853378@13001395@1@chr1:12853378-13001395@84@3910@5605@1.43@CNVR72.3, CNVR72.4@PRAMEF1_2, PRAMEF1_3, PRAMEF1_4, PRAMEF11_4, PRAMEF11_3, PRAMEF11_2, HNRNPCL1_2, PRAMEF2_2, PRAMEF2_3, PRAMEF2_4, PRAMEF4_4, PRAMEF4_3, PRAMEF4_2, PRAMEF10_4, PRAMEF10_3, PRAMEF10_2, PRAMEF7_2, PRAMEF7_3, PRAMEF7_4, PRAMEF6_4, PRAMEF6_3@0@0@0@:PRAME family member 1:PRAME family member 11:heterogeneous nuclear ribonucleoprotein C-like 1-like;heterogeneous nuclear ribonucleoprotein C-like;heterogeneous nuclear ribonucleoprotein C-like 1:PRAME family member 2:PRAME family member 4:PRAME family member 10:PRAME family member 7:PRAME family member 6;PRAME family member 23;PRAME family member 9/15-like;PRAME family member 5@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:ribonucleoprotein complex;RNA binding;nucleus;nucleotide binding;nucleic acid binding:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_29@1835@1838@duplication@4@13330415@13366425@1@chr1:13330415-13366425@5.83@57@106@1.86@CNVR74.8, CNVR74.4@PRAMEF3_2, PRAMEF3_1, PRAMEF5_2, PRAMEF5_3@0@0@0@:PRAME family member 3:PRAME family member 5@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_29@1853@1854@duplication@2@13495968@13498128@1@chr1:13495968-13498128@5.25@45@89@1.98@CNVR74.8@PRAMEF16_2, PRAMEF16_3@0@0@0@:PRAME family member 16@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_29@1868@1869@deletion@2@13716802@13718962@1@chr1:13716802-13718962@8.2@86@34@0.395@CNVR76.2@PRAMEF17_2, PRAMEF17_3@0@0@0@:PRAME family member 17@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_29@2788@2788@duplication@1@21806545@21806716@1@chr1:21806545-21806716@5.03@88@144@1.64@CNVR107.2, CNVR107.1@NBPF3_11@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 3@:cytoplasm@NA
A2463_29@3196@3198@duplication@3@24298064@24301567@1@chr1:24298064-24301567@5.26@53@98@1.85@NA@SRSF10_5, SRSF10_4, SRSF10_3@0@0@0@:serine/arginine-rich splicing factor 10-like;serine/arginine-rich splicing factor 10@:nucleoplasm;RNA splicing, via transesterification reactions;nuclear speck;RS domain binding;RNA binding;nucleus;mRNA splice site selection;unfolded protein binding;assembly of spliceosomal tri-snRNP;negative regulation of mRNA splicing, via spliceosome;regulation of transcription, DNA-dependent;nucleotide binding;cytoplasm;mRNA export from nucleus;protein binding;cytoplasmic transport;mRNA splicing, via spliceosome;nucleic acid binding@NA
A2463_29@3334@3342@duplication@9@25611065@25655415@1@chr1:25611065-25655415@63.5@948@1686@1.78@CNVR116.1, CNVR116.2@RHD_2, RHD_3, RHD_4, RHD_5, RHD_6, RHD_7, RHD_8, RHD_9, RHD_10@0@0@0@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
A2463_29@3357@3357@deletion@1@25735175@25735360@1@chr1:25735175-25735360@23.2@111@0@0@CNVR117.1@RHCE_2@0@0@0@:Rh blood group, CcEe antigens@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@: BLOOD GROUP--RHESUS SYSTEM E POLYPEPTIDE; RHE; RHESUS BLOOD GROUP, CcEe ANTIGENS; RHCE
A2463_29@5149@5149@deletion@1@39987049@39987242@1@chr1:39987049-39987242@5@22@0@0@NA@BMP8A_4@0@0@0@:bone morphogenetic protein 8a@:cell differentiation;growth factor activity;extracellular space;growth;cytokine activity;cartilage development;ossification@NA
A2463_29@5194@5194@deletion@1@40229385@40229463@1@chr1:40229385-40229463@9.19@59@11@0.186@NA@BMP8B_5@0@0@0@:peptidylprolyl isomerase E (cyclophilin E):bone morphogenetic protein 8b@:regulation of transcription, DNA-dependent;nucleotide binding;catalytic step 2 spliceosome;protein folding;protein binding;protein peptidyl-prolyl isomerization;peptidyl-prolyl cis-trans isomerase activity;cyclosporin A binding;RNA binding;mRNA splicing, via spliceosome;nucleus;nucleic acid binding:cell differentiation;growth factor activity;extracellular space;growth;extracellular region;cytokine activity;cartilage development;skeletal system development;ossification@NA
A2463_29@8507@8508@duplication@2@89476588@89477710@1@chr1:89476588-89477710@8.07@460@642@1.4@CNVR244.1@GBP3_8, GBP3_7@0@0@0@:guanylate binding protein 3@:defense response to virus;GTP binding;GTPase activity;membrane;cytoplasm@NA
A2463_29@9352@9358@deletion@7@104161534@104166843@1@chr1:104161534-104166843@8.82@653@450@0.689@CNVR266.3, CNVR266.1@AMY2A_3, AMY2A_4, AMY2A_5, AMY2A_6, AMY2A_7, AMY2A_8, AMY2A_9@0@0@0@:amylase, alpha 2A (pancreatic)@:chloride ion binding;cation binding;small molecule metabolic process;carbohydrate metabolic process;catalytic activity;extracellular space;polysaccharide digestion;extracellular region;carbohydrate catabolic process;alpha-amylase activity;calcium ion binding@NA
A2463_29@9365@9374@duplication@10@104202983@104234232@1@chr1:104202983-104234232@33.8@225@526@2.34@CNVR266.3, CNVR266.1, CNVR266.15@AMY1A_7, AMY1A_8, AMY1A_9, AMY1A_10, AMY1A_11, AMY1B_11, AMY1B_10, AMY1B_9, AMY1B_8, AMY1B_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
A2463_29@9768@9773@duplication@6@110231296@110235917@1@chr1:110231296-110235917@13.4@337@507@1.5@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
A2463_29@10793@10793@deletion@1@144339779@144340398@1@chr1:144339779-144340398@10.5@48@0@0@CNVR334.4, CNVR334.2@AL592284.1_1@0@0@0@:uncharacterized LOC730256;uncharacterized LOC101060698;uncharacterized LOC642441@NA@NA
A2463_29@10869@10869@duplication@1@145303911@145303982@1@chr1:145303911-145303982@7.3@161@260@1.61@CNVR341.2, CNVR341.3@NBPF10_9@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family, member 10@:protein binding;calcium ion binding@NA
A2463_29@11082@11082@deletion@1@145762040@145762329@1@chr1:145762040-145762329@7.79@136@66@0.485@NA@PDZK1_8@0@0@0@:PDZ domain containing 1@:PDZ domain binding;transport;transporter activity;cytoplasm;cell proliferation;protein binding;positive regulation of ion transmembrane transport;scavenger receptor binding;brush border membrane;establishment of protein localization to plasma membrane;carnitine transport;drug transport@NA
A2463_29@11149@11157@deletion@9@146232495@146244717@1@chr1:146232495-146244717@8.83@39@0@0@NA@NBPF12_16, NBPF12_15, NBPF12_14, NBPF12_13, NBPF12_12, NBPF12_11, NBPF12_10, NBPF12_9, NBPF12_8@0@0@0@:neuroblastoma breakpoint family member 21-like@NA@NA
A2463_29@11169@11169@deletion@1@146400092@146400302@1@chr1:146400092-146400302@5.34@25@1@0.04@NA@NBPF12_9@0@0@0@:neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family member 14-like;neuroblastoma breakpoint family, member 12@:cytoplasm@NA
A2463_29@11341@11351@duplication@11@148008574@148016460@1@chr1:148008574-148016460@59@1350@2309@1.71@CNVR346.2, CNVR346.4@NBPF14_17, NBPF14_16, NBPF14_15, NBPF14_14, NBPF14_13, NBPF14_12, NBPF14_11, NBPF14_10, NBPF14_9, NBPF14_8, NBPF14_7@0@0@0@:neuroblastoma breakpoint family, member 14@:cytoplasm@NA
A2463_29@11479@11479@deletion@1@148591202@148591373@1@chr1:148591202-148591373@6.78@32@1@0.0312@CNVR348.1, CNVR348.4@NBPF15_17@0@0@0@:neuroblastoma breakpoint family, member 15@:cytoplasm@NA
A2463_29@16029@16031@duplication@3@196744018@196749103@1@chr1:196744018-196749103@7.32@584@772@1.32@CNVR459.1, CNVR459.3@CFHR3_1, CFHR3_2, CFHR3_3@0@0@0@:complement factor H-related 3@:extracellular space@NA
A2463_29@16035@16036@duplication@2@196788976@196794801@1@chr1:196788976-196794801@6.23@302@430@1.42@CNVR459.1@CFHR1_1, CFHR1_2@0@0@0@:complement factor H-related 1:complement factor H-related 2@:extracellular space;complement activation:extracellular region@NA
A2463_29@16038@16038@deletion@1@196797201@196797376@1@chr1:196797201-196797376@7.97@116@52@0.448@CNVR459.1@CFHR1_4@0@0@0@:complement factor H-related 1:complement factor H-related 2@:extracellular space;complement activation:extracellular region@NA
A2463_29@17278@17279@deletion@2@207700099@207700468@1@chr1:207700099-207700468@7.03@33@1@0.0303@CNVR485.1@CR1_6, CR1_7@0@0@0@:complement component (3b/4b) receptor 1 (Knops blood group)@:complement component C4b receptor activity;complement activation, classical pathway;negative regulation of complement activation, alternative pathway;innate immune response;negative regulation of serine-type endopeptidase activity;complement component C3b binding;negative regulation of complement activation, classical pathway;plasma membrane;integral to plasma membrane;complement component C3b receptor activity;complement component C4b binding;cell surface;regulation of complement activation;positive regulation of serine-type endopeptidase activity@: MALARIA, SUSCEPTIBILITY TO; KNOPS BLOOD GROUP SYSTEM; KN
A2463_29@17294@17294@deletion@1@207737210@207737385@1@chr1:207737210-207737385@7.71@39@3@0.0769@CNVR485.1, CNVR485.2@CR1_22@0@0@0@:complement component (3b/4b) receptor 1 (Knops blood group)@:complement component C4b receptor activity;complement activation, classical pathway;negative regulation of complement activation, alternative pathway;innate immune response;negative regulation of serine-type endopeptidase activity;complement component C3b binding;negative regulation of complement activation, classical pathway;plasma membrane;integral to plasma membrane;complement component C3b receptor activity;complement component C4b binding;cell surface;regulation of complement activation;positive regulation of serine-type endopeptidase activity@: MALARIA, SUSCEPTIBILITY TO; KNOPS BLOOD GROUP SYSTEM; KN
A2463_29@19775@19777@duplication@3@248756132@248802559@1@chr1:248756132-248802559@8.99@639@854@1.34@CNVR600.1@OR2T10_1, OR2T11_1, OR2T35_1@0@0@0@:olfactory receptor, family 2, subfamily T, member 10:olfactory receptor, family 2, subfamily T, member 11:olfactory receptor, family 2, subfamily T, member 35@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_29@24822@24822@duplication@1@87178420@87178483@2@chr2:87178420-87178483@9.87@34@111@3.26@NA@RGPD1_2@0@0@0@:RANBP2-like and GRIP domain containing 1@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_29@24862@24863@deletion@2@88094928@88095367@2@chr2:88094928-88095367@6.19@29@1@0.0345@NA@RGPD2_11, RGPD2_10@0@0@0@:RANBP2-like and GRIP domain containing 2@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_29@25006@25007@deletion@2@90198717@90199190@2@chr2:90198717-90199190@8.32@177@93@0.525@CNVR867.10, CNVR867.5, CNVR867.3, CNVR867.9, CNVR867.15, CNVR867.2@IGKV1D-12_1, IGKV1D-12_2@0@0@0@@:protein binding@NA
A2463_29@25376@25382@duplication@7@97860583@97866262@2@chr2:97860583-97866262@23.1@1183@1634@1.38@CNVR886.1@ANKRD36_40, ANKRD36_41, ANKRD36_42, ANKRD36_43, ANKRD36_44, ANKRD36_45, ANKRD36_46@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_29@25393@25402@duplication@10@97877284@97884983@2@chr2:97877284-97884983@16.5@1759@2303@1.31@NA@ANKRD36_57, ANKRD36_58, ANKRD36_59, ANKRD36_60, ANKRD36_61, ANKRD36_62, ANKRD36_63, ANKRD36_64, ANKRD36_65, ANKRD36_66@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_29@26306@26306@deletion@1@112541901@112541977@2@chr2:112541901-112541977@5.65@207@124@0.599@CNVR928.1@ANAPC1_41@0@0@0@:anaphase-promoting complex subunit 1-like;anaphase promoting complex subunit 1@:nucleoplasm;regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle;anaphase-promoting complex;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle spindle assembly checkpoint;cytosol;protein K11-linked ubiquitination;protein binding;mitosis;nucleus;cell cycle checkpoint;cell division;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle@NA
A2463_29@26310@26310@duplication@1@112551656@112551708@2@chr2:112551656-112551708@4.67@141@210@1.49@CNVR928.1@ANAPC1_37@0@0@0@:anaphase-promoting complex subunit 1-like;anaphase promoting complex subunit 1@:nucleoplasm;regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle;anaphase-promoting complex;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle spindle assembly checkpoint;cytosol;protein K11-linked ubiquitination;protein binding;mitosis;nucleus;cell cycle checkpoint;cell division;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle@NA
A2463_29@26579@26582@deletion@4@114251335@114253320@2@chr2:114251335-114253320@9.36@390@251@0.644@CNVR933.1@CBWD2_12, CBWD2_13, CBWD2_14, CBWD2_15@0@0@0@:COBW domain containing 2;COBW domain containing 1;COBW domain-containing protein 1-like@:ATP binding@NA
A2463_29@27324@27326@deletion@3@132002981@132010143@2@chr2:132002981-132010143@5.89@32@4@0.125@NA@POTEE_10, POTEE_11, POTEE_12@0@0@0@:pleckstrin homology domain containing, family B (evectins) member 2:POTE ankyrin domain family, member E@:phospholipid binding;protein binding;recycling endosome membrane:protein binding;ATP binding@NA
A2463_29@27342@27342@deletion@1@132289238@132289375@2@chr2:132289238-132289375@12.2@74@11@0.149@NA@CCDC74A_4@0@0@0@:coiled-coil domain containing 74A@NA@NA
A2463_29@27995@27997@deletion@3@152461075@152464122@2@chr2:152461075-152464122@23.5@116@4@0.0345@CNVR1026.1@NEB_85, NEB_84, NEB_83@0@0@0@:nebulin@:Z disc;muscle filament sliding;oxidation-reduction process;contractile fiber part;actin cytoskeleton;regulation of actin filament length;structural constituent of muscle;cytosol;actin binding;protein binding;myofibril;somatic muscle development;muscle organ development@: NEMALINE MYOPATHY 2; NEM2
A2463_29@29807@29808@deletion@2@179523733@179523982@2@chr2:179523733-179523982@6.86@38@5@0.132@CNVR1066.1@TTN_155, TTN_154@0@0@0@:titin@:muscle alpha-actinin binding;condensed nuclear chromosome;platelet degranulation;skeletal muscle thin filament assembly;protein tyrosine kinase activity;forward locomotion;binding;regulation of catalytic activity;ATP binding;cardiac muscle tissue morphogenesis;nucleus;sarcomerogenesis;cardiac myofibril assembly;identical protein binding;cardiac muscle fiber development;somitogenesis;platelet activation;response to calcium ion;protein self-association;actinin binding;ankyrin binding;enzyme binding;protein kinase activity;in utero embryonic development;adult heart development;structural constituent of muscle;cytosol;heart morphogenesis;calcium ion binding;Z disc;muscle filament sliding;M band;calmodulin binding;cardiac muscle contraction;striated muscle contraction;transferase activity, transferring phosphorus-containing groups;A band;skeletal muscle myosin thick filament assembly;mitotic chromosome condensation;blood coagulation;striated muscle thin filament;sarcomere;regulation of protein kinase activity;protein serine/threonine kinase activity;Golgi apparatus;protein phosphorylation;protease binding;cytoplasm;protein binding;striated muscle cell development;actin filament binding;extracellular region;I band;telethonin binding;sarcomere organization;cardiac muscle hypertrophy;detection of muscle stretch;muscle contraction;nucleic acid binding@: MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2J; LGMD2J; MYOPATHY, EARLY-ONSET, WITH FATAL CARDIOMYOPATHY; TIBIAL MUSCULAR DYSTROPHY, TARDIVE; CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 9; CMH9; CARDIOMYOPATHY, DILATED, 1G; CMD1G; HEREDITARY MYOPATHY WITH EARLY RESPIRATORY FAILURE; HMERF
A2463_29@33410@33412@duplication@3@233273415@233274158@2@chr2:233273415-233274158@11.1@43@124@2.88@NA@ALPPL2_8, ALPPL2_9, ALPPL2_10@0@0@0@:alkaline phosphatase, placental-like 2@:phosphatase activity;catalytic activity;phosphorylation;plasma membrane;metabolic process;membrane;anchored to membrane;alkaline phosphatase activity;metal ion binding@NA
A2463_29@46671@46676@deletion@6@9212384@9247197@4@chr4:9212384-9247197@9.28@67@17@0.254@NA@USP17L13_1, USP17L10_1, USP17L11_1, USP17L12_1, USP17L13_2, USP17L15_1, USP17L17_1@0@0@0@:ubiquitin specific peptidase 17-like family member 10:ubiquitin specific peptidase 17-like family member 13:ubiquitin specific peptidase 17-like family member 11:ubiquitin specific peptidase 17-like family member 12:ubiquitin specific peptidase 17-like family member 15:ubiquitin specific peptidase 17-like family member 17@:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
A2463_29@46671@46677@duplication@1@9212384@9251948@4@chr4:9212384-9251948@3.11@594@889@1.5@NA@USP17L13_1, USP17L10_1, USP17L11_1, USP17L12_1, USP17L13_2, USP17L15_1, USP17L17_1, USP17L18_1@0@0@0@:ubiquitin specific peptidase 17-like family member 10:ubiquitin specific peptidase 17-like family member 13:ubiquitin specific peptidase 17-like family member 11:ubiquitin specific peptidase 17-like family member 12:ubiquitin specific peptidase 17-like family member 15:ubiquitin specific peptidase 17-like family member 17:ubiquitin specific peptidase 17-like family member 18@:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
A2463_29@47649@47649@duplication@1@42088100@42088143@4@chr4:42088100-42088143@4.82@39@80@2.05@NA@SLC30A9_18@0@0@0@:solute carrier family 30 (zinc transporter), member 9@:cation transmembrane transporter activity;zinc ion transport;cation transport;sequence-specific DNA binding transcription factor activity;nucleotide binding;nucleotide-excision repair;transmembrane transport;chromatin binding;ligand-dependent nuclear receptor binding;integral to membrane;nucleus;cytoskeleton;transcription, DNA-dependent;ligand-dependent nuclear receptor transcription coactivator activity;positive regulation of transcription from RNA polymerase II promoter@NA
A2463_29@48556@48561@deletion@6@69403344@69434202@4@chr4:69403344-69434202@83.7@457@31@0.0678@CNVR1953.1@UGT2B17_6, UGT2B17_5, UGT2B17_4, UGT2B17_3, UGT2B17_2, UGT2B17_1@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B17@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;membrane@: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
A2463_29@48593@48597@duplication@5@70148233@70160527@4@chr4:70148233-70160527@12.1@617@843@1.37@CNVR1957.2, CNVR1957.1@UGT2B28_2, UGT2B28_3, UGT2B28_4, UGT2B28_5, UGT2B28_6@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B28@:carbohydrate binding;transferase activity, transferring hexosyl groups;endoplasmic reticulum;glucuronosyltransferase activity;carbohydrate metabolic process;xenobiotic metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process@NA
A2463_29@55806@55806@duplication@1@69372349@69372398@5@chr5:69372349-69372398@6.34@138@221@1.6@CNVR2494.48, CNVR2494.39, CNVR2494.15, CNVR2494.18, CNVR2494.26, CNVR2494.43, CNVR2494.52, CNVR2494.28, CNVR2494.2, CNVR2494.36@SMN2_8@0@0@0@:survival of motor neuron 2, centromeric;survival of motor neuron 1, telomeric@:nucleoplasm;ncRNA metabolic process;Cajal body;RNA metabolic process;spliceosomal complex;cytoplasm;cytosol;protein binding;cell death;spliceosomal complex assembly;RNA binding;mRNA processing;nucleus;gene expression;spliceosomal snRNP assembly@: SPINAL MUSCULAR ATROPHY, TYPE II; SMA2; SPINAL MUSCULAR ATROPHY, TYPE I; SMA1; SPINAL MUSCULAR ATROPHY, TYPE IV; SMA4; SPINAL MUSCULAR ATROPHY, TYPE III; SMA3
A2463_29@59046@59047@deletion@2@140228082@140238021@5@chr5:140228082-140238021@27@1880@1075@0.572@CNVR2622.1@PCDHA9_1, PCDHA10_1@0@0@0@:protocadherin alpha 1:protocadherin alpha 2:protocadherin alpha 3:protocadherin alpha 4:protocadherin alpha 5:protocadherin alpha 6:protocadherin alpha 7:protocadherin alpha 8:protocadherin alpha 9:protocadherin alpha 10@:extracellular region;cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:integral to membrane;cell adhesion;homophilic cell adhesion;plasma membrane;integral to plasma membrane;membrane;nervous system development;calcium ion binding:cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:extracellular region;cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:integral to membrane;homophilic cell adhesion;plasma membrane;membrane;calcium ion binding:extracellular region;cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development@NA
A2463_29@61262@61264@deletion@3@177158571@177161405@5@chr5:177158571-177161405@5.35@29@4@0.138@NA@FAM153A_15, FAM153A_14, FAM153A_13@0@0@0@:family with sequence similarity 153, member A@NA@NA
A2463_29@61266@61267@deletion@2@177163581@177164113@5@chr5:177163581-177164113@19.7@120@19@0.158@NA@FAM153A_11, FAM153A_10@0@0@0@:family with sequence similarity 153, member A@NA@NA
A2463_29@61269@61276@deletion@8@177166602@177210856@5@chr5:177166602-177210856@17.3@179@74@0.413@CNVR2699.2@FAM153A_8, FAM153A_7, FAM153A_6, FAM153A_5, FAM153A_4, FAM153A_3, RP11-1026M7.2_2@0@0@0@:family with sequence similarity 153, member A@NA@NA
A2463_29@61289@61289@deletion@1@177474030@177474122@5@chr5:177474030-177474122@5.91@151@84@0.556@NA@FAM153C_11@0@0@0@NA@NA@NA
A2463_29@62738@62738@deletion@1@26406138@26406484@6@chr6:26406138-26406484@9.15@53@7@0.132@NA@BTN3A1_3@0@0@0@:butyrophilin, subfamily 3, member A1@:protein binding;integral to membrane;lipid metabolic process@NA
A2463_29@63558@63558@deletion@1@31783535@31785459@6@chr6:31783535-31785459@4.87@152@90@0.592@NA@HSPA1A_1@0@0@0@:heat shock 70kDa protein 1A;heat shock 70kDa protein 1B@:negative regulation of apoptotic process;protein binding involved in protein folding;mitochondrion;negative regulation of cell proliferation;nuclear speck;aggresome;positive regulation of erythrocyte differentiation;RNA metabolic process;negative regulation of inclusion body assembly;ATP binding;negative regulation of cell growth;mRNA metabolic process;nucleus;response to unfolded protein;gene expression;protein N-terminus binding;ubiquitin protein ligase binding;unfolded protein binding;signalosome;mRNA catabolic process;ribonucleoprotein complex;cell morphogenesis;endoplasmic reticulum;inclusion body;perinuclear region of cytoplasm;response to stress;cytoplasm;cytosol;protein binding;protein refolding@NA
A2463_29@63809@63811@duplication@3@32011527@32012493@6@chr6:32011527-32012493@5.68@286@395@1.38@CNVR2843.6, CNVR2843.5@TNXB_4, TNXB_3, TNXB_2@0@0@0@:tenascin-X-like;tenascin XB@:integrin binding;extracellular matrix;cell-cell adhesion;elastic fiber assembly;collagen fibril organization;fibrillar collagen;actin cytoskeleton organization;extracellular space;heparin binding;proteinaceous extracellular matrix;fatty acid metabolic process;regulation of JUN kinase activity;receptor binding;intracellular;cell-matrix adhesion;extracellular matrix organization;lipid metabolic process;protein binding;signal transduction;extracellular region;collagen binding;cell adhesion;triglyceride metabolic process;fibril organization;collagen metabolic process@: EHLERS-DANLOS-LIKE SYNDROME DUE TO TENASCIN-X DEFICIENCY; EHLERS-DANLOS SYNDROME, TYPE III
A2463_29@63945@63945@deletion@1@32369563@32369582@6@chr6:32369563-32369582@5.38@62@26@0.419@NA@BTNL2_4@0@0@0@:butyrophilin-like 2 (MHC class II associated)@:protein binding;integral to membrane@: SARCOIDOSIS, SUSCEPTIBILITY TO, 2; SS2
A2463_29@63953@63957@duplication@5@32485517@32489951@6@chr6:32485517-32489951@24.8@172@372@2.16@CNVR2845.21, CNVR2845.25, CNVR2845.30@HLA-DRB5_6, HLA-DRB5_5, HLA-DRB5_4, HLA-DRB5_3, HLA-DRB5_2@0@0@0@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
A2463_29@63965@63968@duplication@4@32605237@32610541@6@chr6:32605237-32610541@14.2@802@1109@1.38@CNVR2845.21, CNVR2845.25, CNVR2845.37, CNVR2845.63, CNVR2845.27, CNVR2845.22, CNVR2845.39, CNVR2845.20@HLA-DQA1_1, HLA-DQA1_2, HLA-DQA1_3, HLA-DQA1_4@0@0@0@:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
A2463_29@64604@64606@deletion@3@35762924@35765065@6@chr6:35762924-35765065@5.31@141@85@0.603@CNVR2861.1@CLPS_3, CLPS_2, CLPS_1@0@0@0@:colipase, pancreatic@:steroid metabolic process;post-embryonic development;small molecule metabolic process;retinoid metabolic process;lipid metabolic process;extracellular region;enzyme activator activity;digestion;lipid catabolic process;lipid digestion;response to food@NA
A2463_29@70808@70808@duplication@1@161032595@161032753@6@chr6:161032595-161032753@7.82@94@175@1.86@CNVR3133.1@LPA_17@0@0@0@:lipoprotein, Lp(a)@:blood circulation;endopeptidase inhibitor activity;catalytic activity;lipoprotein metabolic process;proteolysis;heparin binding;receptor-mediated endocytosis;fibronectin binding;small molecule metabolic process;apolipoprotein binding;lipid metabolic process;negative regulation of endopeptidase activity;extracellular region;plasma lipoprotein particle;lipid transport;serine-type endopeptidase activity@: APOLIPOPROTEIN(a); LPA
A2463_29@70816@70816@deletion@1@161054786@161054944@6@chr6:161054786-161054944@5.95@128@68@0.531@CNVR3133.1@LPA_9@0@0@0@:lipoprotein, Lp(a)@:blood circulation;endopeptidase inhibitor activity;catalytic activity;lipoprotein metabolic process;proteolysis;heparin binding;receptor-mediated endocytosis;fibronectin binding;small molecule metabolic process;apolipoprotein binding;lipid metabolic process;negative regulation of endopeptidase activity;extracellular region;plasma lipoprotein particle;lipid transport;serine-type endopeptidase activity@: APOLIPOPROTEIN(a); LPA
A2463_29@71028@71032@duplication@5@167787840@167794824@6@chr6:167787840-167794824@9.53@284@405@1.43@NA@TCP10_7, TCP10_6, TCP10_5, TCP10_4, TCP10_3@0@0@0@:t-complex 10@:cytosol@NA
A2463_29@71744@71750@duplication@7@5939916@5949747@7@chr7:5939916-5949747@10.4@735@981@1.33@NA@CCZ1_2, CCZ1_3, CCZ1_4, CCZ1_5, CCZ1_6, CCZ1_7, CCZ1_8@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
A2463_29@71759@71766@deletion@8@5967828@5984809@7@chr7:5967828-5984809@7.14@460@310@0.674@NA@RSPH10B_19, RSPH10B_18, RSPH10B_17, RSPH10B_16, RSPH10B_15, RSPH10B_14, RSPH10B_13, RSPH10B_12@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
A2463_29@71773@71777@deletion@5@6000323@6013173@7@chr7:6000323-6013173@38.8@196@7@0.0357@NA@RSPH10B_5, RSPH10B_4, RSPH10B_3, RSPH10B_2, PMS2_15@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas):PMS2 postmeiotic segregation increased 2 (S. cerevisiae)@:response to drug;DNA binding;MutSalpha complex binding;ATP binding;mismatch repair;DNA repair;mismatched DNA binding;ATPase activity;nucleus;mismatch repair complex;reciprocal meiotic recombination;ATP catabolic process;single-stranded DNA binding;response to DNA damage stimulus;single base insertion or deletion binding;protein binding;somatic hypermutation of immunoglobulin genes;somatic recombination of immunoglobulin gene segments;MutLalpha complex;endonuclease activity@: COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 4; HNPCC4; MISMATCH REPAIR CANCER SYNDROME
A2463_29@71922@71922@duplication@1@6797310@6797562@7@chr7:6797310-6797562@10.2@229@384@1.68@NA@RSPH10B2_2@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
A2463_29@71939@71939@duplication@1@6836200@6836397@7@chr7:6836200-6836397@7.35@77@148@1.92@NA@RSPH10B2_19@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
A2463_29@74595@74598@deletion@4@74221276@74227349@7@chr7:74221276-74227349@14.7@72@3@0.0417@NA@GTF2IRD2_12, GTF2IRD2_11, GTF2IRD2_10, GTF2IRD2_9@0@0@0@:GTF2I repeat domain containing 2@:nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_29@74664@74664@deletion@1@75055645@75055735@7@chr7:75055645-75055735@10.3@47@0@0@NA@POM121C_8@0@0@0@:POM121 transmembrane nucleoporin C@:nuclear membrane;protein binding;protein transport;endoplasmic reticulum membrane;nuclear pore;mRNA transport@NA
A2463_29@76727@76727@duplication@1@102134273@102134416@7@chr7:102134273-102134416@7.74@27@85@3.15@CNVR3518.1@RASA4B_15@0@0@0@:RAS p21 protein activator 4B@:phospholipid binding;intracellular;GTPase activator activity;cytosol;signal transduction;protein binding;plasma membrane;regulation of small GTPase mediated signal transduction;metal ion binding;intracellular signal transduction@NA
A2463_29@76737@76741@duplication@5@102147143@102158157@7@chr7:102147143-102158157@11.5@65@157@2.42@CNVR3518.1@RASA4B_5, RASA4B_4, RASA4B_3, RASA4B_2, RASA4B_1@0@0@0@:RAS p21 protein activator 4B@:phospholipid binding;intracellular;GTPase activator activity;cytosol;signal transduction;protein binding;plasma membrane;regulation of small GTPase mediated signal transduction;metal ion binding;intracellular signal transduction@NA
A2463_29@76779@76779@deletion@1@102279571@102279646@7@chr7:102279571-102279646@10.5@141@58@0.411@CNVR3518.1@UPK3BL_4, UPK3BL_4@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4:uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity:integral to membrane:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
A2463_29@76786@76793@duplication@8@102296696@102312048@7@chr7:102296696-102312048@12.6@110@217@1.97@CNVR3518.1@SPDYE2L_5, SPDYE2L_6, SPDYE2L_7, SPDYE2L_8, POLR2J2_4, POLR2J2_4, POLR2J2_3, POLR2J2_3, POLR2J2_2, POLR2J2_2, POLR2J2_1, POLR2J2_1@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:polymerase (RNA) II (DNA directed) polypeptide J2:WBSCR19-like protein 3;speedy homolog E6 (Xenopus laevis)@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
A2463_29@79309@79312@duplication@4@143880598@143956721@7@chr7:143880598-143956721@25.5@1011@1597@1.58@CNVR3598.4, CNVR3598.7@CTAGE4_1, ARHGEF35_2, OR2A42_1, OR2A7_1@0@0@0@:CTAGE family, member 4:Rho guanine nucleotide exchange factor (GEF) 35:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1:olfactory receptor, family 2, subfamily A, member 7@:integral to membrane;nucleotide binding;cellular_component;biological_process:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_29@79309@79313@deletion@1@143880598@143966343@7@chr7:143880598-143966343@-40.4@1256@1690@1.35@CNVR3598.4, CNVR3598.7@CTAGE4_1, ARHGEF35_2, OR2A42_1, OR2A7_1, CTAGE8_1@0@0@0@:CTAGE family, member 4:Rho guanine nucleotide exchange factor (GEF) 35:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1:olfactory receptor, family 2, subfamily A, member 7:CTAGE family, member 6, pseudogene;CTAGE family, member 15, pseudogene@:integral to membrane;nucleotide binding;cellular_component;biological_process:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane@NA
A2463_29@79319@79319@duplication@1@144068255@144068414@7@chr7:144068255-144068414@8.21@170@282@1.66@CNVR3598.4, CNVR3598.5, CNVR3598.11@ARHGEF5_6@0@0@0@:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
A2463_29@80367@80386@deletion@20@7272484@7399402@8@chr8:7272484-7399402@23.6@515@284@0.551@CNVR3771.8, CNVR3771.10, CNVR3771.4@DEFB4B_2, DEFB4B_1, DEFB103B_2, DEFB103B_1, SPAG11B_3, SPAG11B_2, SPAG11B_1, DEFB104B_2, DEFB104B_1, DEFB106B_2, DEFB106B_1, DEFB105B_1, DEFB105B_2, DEFB105B_3, DEFB107B_1, DEFB107B_2, RP11-1118M6.1_1, RP11-1118M6.1_2, RP11-1118M6.1_3, RP11-1118M6.1_4@0@0@0@:defensin, beta 4B;defensin, beta 4A:defensin, beta 103B;defensin, beta 103A:sperm associated antigen 11B:defensin, beta 104A;defensin, beta 104B:defensin, beta 106B;defensin, beta 106A:defensin, beta 105B;defensin, beta 105A:defensin, beta 107B;defensin, beta 107A:uncharacterized LOC100133251@:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response:extracellular region;defense response to bacterium;Golgi lumen;positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria;defense response;innate immune response:spermatogenesis;defense response to bacterium;extracellular region;molecular_function;defense response:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium@NA
A2463_29@80409@80411@deletion@3@7806652@7808269@8@chr8:7806652-7808269@23.3@127@13@0.102@CNVR3772.4, CNVR3772.6, CNVR3772.10, CNVR3772.13@ZNF705B_3, ZNF705B_4, ZNF705B_5@0@0@0@:zinc finger protein 705B@:intracellular;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_29@80564@80577@deletion@14@11970084@12285315@8@chr8:11970084-12285315@72.9@1855@776@0.418@NA@ZNF705D_6, USP17L2_1, FAM86B1_8, FAM86B1_7, FAM86B1_6, FAM86B1_5, FAM86B1_4, FAM86B1_3, FAM86B1_2, FAM86B1_1, DEFB130_2, DEFB130_1, FAM86B2_8, FAM86B2_7@0@0@0@:zinc finger protein 705D:ubiquitin specific peptidase 17-like family member 1, pseudogene;ubiquitin specific peptidase 17-like family member 2;ubiquitin specific peptidase 17-like family member 4;ubiquitin specific peptidase 17-like family member 7;ubiquitin specific peptidase 17-like family member 8;ubiquitin specific peptidase 17-like family member 3:family with sequence similarity 86, member B2;family with sequence similarity 86, member B1:defensin, beta 130-like;defensin, beta 130:family with sequence similarity 86, member B2@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:protein deubiquitination;ubiquitin-specific protease activity;mitotic cell cycle G1/S transition checkpoint;nucleus;G2/M transition checkpoint;apoptotic process;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:extracellular region;defense response to bacterium;defense response@NA
A2463_29@83673@83673@deletion@1@86573700@86575726@8@chr8:86573700-86575726@16.3@369@169@0.458@CNVR3955.1@REXO1L1_1@0@0@0@:exonuclease GOR-like;REX1, RNA exonuclease 1 homolog (S. cerevisiae)-like 1@:intracellular;nucleus;exonuclease activity;nucleic acid binding;cytoplasm@NA
A2463_29@88493@88494@duplication@2@39085734@39086846@9@chr9:39085734-39086846@5.52@258@356@1.38@NA@CNTNAP3_21, CNTNAP3_20@0@0@0@:contactin associated protein-like 3@:binding;signal transduction;protein binding;integral to membrane;extracellular region;cell adhesion;plasma membrane;cell recognition;receptor binding@NA
A2463_29@88529@88529@deletion@1@40715850@40716325@9@chr9:40715850-40716325@5@427@283@0.663@NA@FAM74A3_1@0@0@0@NA@NA@NA
A2463_29@88534@88536@deletion@3@41306194@41324995@9@chr9:41306194-41324995@22.5@106@2@0.0189@CNVR4278.2@FAM74A2_2, FAM74A2_1, SPATA31A4_4@0@0@0@:SPATA31 subfamily A, member 4@:integral to membrane:integral to membrane@NA
A2463_29@88584@88611@duplication@28@43624656@43920370@9@chr9:43624656-43920370@132@3228@5724@1.77@CNVR4294.1@SPATA31A6_4, SPATA31A6_3, SPATA31A6_2, SPATA31A6_1, CNTNAP3B_1, CNTNAP3B_2, CNTNAP3B_3, CNTNAP3B_4, CNTNAP3B_5, CNTNAP3B_6, CNTNAP3B_7, CNTNAP3B_8, CNTNAP3B_9, CNTNAP3B_10, CNTNAP3B_11, CNTNAP3B_12, CNTNAP3B_13, CNTNAP3B_14, CNTNAP3B_15, CNTNAP3B_16, CNTNAP3B_17, CNTNAP3B_18, CNTNAP3B_19, CNTNAP3B_20, CNTNAP3B_21, CNTNAP3B_22, CNTNAP3B_23, CNTNAP3B_24@0@0@0@:SPATA31 subfamily A, member 6:contactin associated protein-like 3B;contactin associated protein-like 3@:integral to membrane:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
A2463_29@88622@88622@deletion@1@45733589@45733965@9@chr9:45733589-45733965@7.35@74@27@0.365@CNVR4305.1, CNVR4305.7@FAM27E2_1@0@0@0@NA@NA@NA
A2463_29@88633@88633@deletion@1@65508137@65508193@9@chr9:65508137-65508193@12.2@56@0@0@CNVR4312.5@SPATA31A7_2@0@0@0@:SPATA31 subfamily A, member 7@:integral to membrane@NA
A2463_29@88639@88642@deletion@4@67926874@67934829@9@chr9:67926874-67934829@11.5@90@28@0.311@NA@ANKRD20A1_1, ANKRD20A1_2, ANKRD20A1_3, ANKRD20A1_4@0@0@0@:ankyrin repeat domain 20 family, member A1@:protein binding;plasma membrane@NA
A2463_29@88644@88656@duplication@13@67938604@67985922@9@chr9:67938604-67985922@38@1505@2213@1.47@NA@ANKRD20A1_6, ANKRD20A1_7, ANKRD20A1_8, ANKRD20A1_9, ANKRD20A1_10, ANKRD20A1_11, ANKRD20A1_12, ANKRD20A1_13, ANKRD20A1_14, ANKRD20A1_15, RP11-195B21.3_3, RP11-195B21.3_4, RP11-195B21.3_5@0@0@0@:ankyrin repeat domain 20 family, member A1:coiled-coil domain-containing protein 29-like;uncharacterized LOC644249@:protein binding;plasma membrane@NA
A2463_29@88676@88678@deletion@3@69382094@69386055@9@chr9:69382094-69386055@10@46@1@0.0217@NA@ANKRD20A4_1, ANKRD20A4_2, ANKRD20A4_3@0@0@0@:ankyrin repeat domain 20 family, member A4@:protein binding@NA
A2463_29@88681@88690@deletion@10@69393823@69424176@9@chr9:69393823-69424176@49.9@822@382@0.465@NA@ANKRD20A4_6, ANKRD20A4_7, ANKRD20A4_8, ANKRD20A4_9, ANKRD20A4_10, ANKRD20A4_11, ANKRD20A4_12, ANKRD20A4_13, ANKRD20A4_14, ANKRD20A4_15@0@0@0@:ankyrin repeat domain 20 family, member A4@:protein binding@NA
A2463_29@91243@91246@duplication@4@117085944@117087432@9@chr9:117085944-117087432@9.8@511@696@1.36@CNVR4448.1@ORM1_2, ORM1_3, ORM1_4, ORM1_5@0@0@0@:orosomucoid 1@:protein binding;extracellular space;regulation of immune system process;transport;inflammatory response;extracellular region;acute-phase response@NA
A2463_29@95348@95353@duplication@6@17837921@17882805@10@chr10:17837921-17882805@7.72@230@329@1.43@NA@TMEM236_4, MRC1L1_1, MRC1L1_2, MRC1L1_3, MRC1L1_4, MRC1L1_5@0@0@0@:transmembrane protein 236;transmembrane protein 236-like:macrophage mannose receptor 1-like@:integral to membrane:carbohydrate binding@NA
A2463_29@95377@95389@deletion@13@17951323@18138693@10@chr10:17951323-18138693@25.7@122@4@0.0328@NA@MRC1L1_29, MRC1L1_30, TMEM236_1, TMEM236_2, TMEM236_3, TMEM236_4, MRC1_1, MRC1_2, MRC1_3, MRC1_4, MRC1_5, MRC1_6, MRC1_7@0@0@0@:macrophage mannose receptor 1-like:transmembrane protein 236;transmembrane protein 236-like:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding:integral to membrane:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
A2463_29@96435@96435@duplication@1@46248629@46248685@10@chr10:46248629-46248685@6.22@44@96@2.18@NA@FAM21C_13@0@0@0@:family with sequence similarity 21, member C@:endosome;protein binding;plasma membrane;retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_29@96439@96439@deletion@1@46254764@46254849@10@chr10:46254764-46254849@12.7@84@15@0.179@NA@FAM21C_17@0@0@0@:family with sequence similarity 21, member C@:endosome;protein binding;plasma membrane;retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_29@96454@96458@deletion@5@46312644@46329564@10@chr10:46312644-46329564@17@153@43@0.281@NA@FAM25E_1, AGAP4_7, AGAP4_6, AGAP4_5, AGAP4_4@0@0@0@:ArfGAP with GTPase domain, ankyrin repeat and PH domain 4;arf-GAP with GTPase, ANK repeat and PH domain-containing protein 5-like@:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity@NA
A2463_29@96468@96470@duplication@3@46605764@46611811@10@chr10:46605764-46611811@8.47@39@104@2.67@CNVR4712.3@PTPN20A_4, PTPN20A_3, PTPN20A_2@0@0@0@:protein tyrosine phosphatase, non-receptor type 20B;protein tyrosine phosphatase, non-receptor type 20A@:phosphatase activity;protein tyrosine phosphatase activity;microtubule;nucleus;dephosphorylation;protein dephosphorylation;microtubule organizing center@NA
A2463_29@96528@96531@deletion@4@47756034@47758904@10@chr10:47756034-47758904@7.57@90@42@0.467@CNVR4714.1@ANXA8L2_7, ANXA8L2_8, ANXA8L2_9, ANXA8L2_10@0@0@0@:annexin A8-like 2:uncharacterized LOC101060462;uncharacterized LOC100996760@:calcium-dependent phospholipid binding;calcium ion binding@NA
A2463_29@96536@96563@duplication@28@47894573@47948853@10@chr10:47894573-47948853@139@668@1823@2.73@CNVR4715.2@FAM21B_2, FAM21B_3, FAM21B_4, FAM21B_5, FAM21B_6, FAM21B_7, FAM21B_8, FAM21B_9, FAM21B_10, FAM21B_11, FAM21B_12, FAM21B_13, FAM21B_14, FAM21B_15, FAM21B_16, FAM21B_17, FAM21B_18, FAM21B_19, FAM21B_20, FAM21B_21, FAM21B_22, FAM21B_23, FAM21B_24, FAM21B_25, FAM21B_26, FAM21B_27, FAM21B_28, FAM21B_29@0@0@0@:family with sequence similarity 21, member B@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_29@96576@96581@deletion@6@48029221@48055018@10@chr10:48029221-48055018@9.59@148@75@0.507@CNVR4715.2@ASAH2C_6, ASAH2C_5, ASAH2C_4, ASAH2C_3, ASAH2C_2, ASAH2C_1@0@0@0@@:ceramidase activity;sphingolipid metabolic process@NA
A2463_29@96620@96620@duplication@1@48771316@48771405@10@chr10:48771316-48771405@8.93@72@155@2.15@CNVR4716.10, CNVR4716.3@PTPN20B_6@0@0@0@:protein tyrosine phosphatase, non-receptor type 20B;protein tyrosine phosphatase, non-receptor type 20A@:phosphatase activity;protein tyrosine phosphatase activity;microtubule;nucleus;dephosphorylation;protein dephosphorylation;microtubule organizing center@NA
A2463_29@96631@96633@deletion@3@49376639@49381136@10@chr10:49376639-49381136@21.3@112@10@0.0893@CNVR4717.2@FRMPD2_27, FRMPD2_26, FRMPD2_25@0@0@0@:FERM and PDZ domain containing 2@:basolateral plasma membrane;transferase activity, transferring phosphorus-containing groups;cytoplasm;tight junction;protein binding;cytoskeleton;1-phosphatidylinositol binding;tight junction assembly@NA
A2463_29@96844@96844@deletion@1@51224991@51226465@10@chr10:51224991-51226465@7.37@204@113@0.554@CNVR4727.1@AGAP8_7@0@0@0@:ArfGAP with GTPase domain, ankyrin repeat and PH domain 8@:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity@NA
A2463_29@96857@96859@duplication@3@51464465@51469958@10@chr10:51464465-51469958@7.78@604@832@1.38@CNVR4729.1@AGAP7_7, AGAP7_6, AGAP7_5@0@0@0@:translocase of inner mitochondrial membrane 23 homolog B (yeast):ArfGAP with GTPase domain, ankyrin repeat and PH domain 7@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity@NA
A2463_29@96883@96883@deletion@1@51620325@51620382@10@chr10:51620325-51620382@5.13@163@96@0.589@NA@TIMM23_2@0@0@0@:translocase of inner mitochondrial membrane 23 homolog B (yeast):translocase of inner mitochondrial membrane 23 homolog B (yeast);translocase of inner mitochondrial membrane 23 homolog (yeast)@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process:mitochondrion;mitochondrial inner membrane;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;mitochondrial intermembrane space;integral to mitochondrial inner membrane;intracellular protein transport;protein binding;integral to membrane;cellular protein metabolic process;protein targeting to mitochondrion@NA
A2463_29@96894@96923@deletion@30@51827866@51892705@10@chr10:51827866-51892705@173@1093@197@0.18@NA@FAM21A_2, FAM21A_3, FAM21A_4, FAM21A_5, FAM21A_6, FAM21A_7, FAM21A_8, FAM21A_9, FAM21A_10, FAM21A_11, FAM21A_12, FAM21A_13, FAM21A_14, FAM21A_15, FAM21A_16, FAM21A_17, FAM21A_18, FAM21A_19, FAM21A_20, FAM21A_21, FAM21A_22, FAM21A_23, FAM21A_24, FAM21A_25, FAM21A_26, FAM21A_27, FAM21A_28, FAM21A_29, FAM21A_30, FAM21A_31@0@0@0@:family with sequence similarity 21, member B;family with sequence similarity 21, member A@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_29@96933@96937@duplication@5@51970584@51978390@10@chr10:51970584-51978390@11.9@128@231@1.8@NA@ASAH2_11, ASAH2_10, ASAH2_9, ASAH2_8, ASAH2_7@0@0@0@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
A2463_29@98005@98006@deletion@2@75436478@75439864@10@chr10:75436478-75439864@6.62@56@18@0.321@CNVR4799.1@AGAP5_7, AGAP5_6@0@0@0@:ankyrin repeat and GTPase domain Arf GTPase activating protein 11;ArfGAP with GTPase domain, ankyrin repeat and PH domain 5;ArfGAP with GTPase domain, ankyrin repeat and PH domain 10;arf-GAP with GTPase, ANK repeat and PH domain-containing protein 5-like@:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity@NA
A2463_29@98335@98335@deletion@1@81316966@81317341@10@chr10:81316966-81317341@7.99@148@73@0.493@NA@SFTPA2_6@0@0@0@:surfactant protein A2@:collagen;respiratory gaseous exchange;carbohydrate binding;extracellular space;extracellular region@: PULMONARY FIBROSIS, IDIOPATHIC; IPF
A2463_29@98344@98350@deletion@7@81463367@81472241@10@chr10:81463367-81472241@35.1@609@272@0.447@CNVR4815.2, CNVR4815.4@FAM22B_1, FAM22B_2, FAM22B_3, FAM22B_4, FAM22B_5, FAM22B_6, FAM22B_7@0@0@0@NA@NA@NA
A2463_29@98344@98357@duplication@7@81463367@81610362@10@chr10:81463367-81610362@-47.7@737@536@0.727@CNVR4815.2@FAM22B_1, FAM22B_2, FAM22B_3, FAM22B_4, FAM22B_5, FAM22B_6, FAM22B_7, FAM22E_1, FAM22E_2, FAM22E_3, FAM22E_4, FAM22E_5, FAM22E_6, FAM22E_7@0@0@0@NA@NA@NA
A2463_29@98595@98595@duplication@1@88985589@88985969@10@chr10:88985589-88985969@12.9@10@102@10.2@CNVR4840.3, CNVR4840.5@FAM22A_1@0@0@0@:family with sequence similarity 22, member A@NA@NA
A2463_29@98603@98606@duplication@4@89120239@89124960@10@chr10:89120239-89124960@17.3@69@203@2.94@CNVR4840.3@FAM22D_2, FAM22D_3, FAM22D_4, FAM22D_5@0@0@0@:family with sequence similarity 22, member D@NA@NA
A2463_29@103268@103268@deletion@1@4967390@4968330@11@chr11:4967390-4968330@6.6@506@325@0.642@CNVR5040.1@OR51A4_1@0@0@0@:matrix metallopeptidase 26:olfactory receptor, family 51, subfamily A, member 4@:metallopeptidase activity;extracellular matrix;proteolysis;proteinaceous extracellular matrix;collagen catabolic process;metalloendopeptidase activity;zinc ion binding;metabolic process:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_29@103268@103269@duplication@1@4967390@4976943@11@chr11:4967390-4976943@-12.4@907@1028@1.13@CNVR5040.1@OR51A4_1, OR51A2_1@0@0@0@:matrix metallopeptidase 26:olfactory receptor, family 51, subfamily A, member 4:olfactory receptor, family 51, subfamily A, member 2@:metallopeptidase activity;extracellular matrix;proteolysis;proteinaceous extracellular matrix;collagen catabolic process;metalloendopeptidase activity;zinc ion binding;metabolic process:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_29@103289@103290@deletion@2@5270599@5271034@11@chr11:5270599-5271034@13.3@78@10@0.128@NA@HBG1_2, HBG1_1@0@0@0@:hemoglobin, gamma A@:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex@NA
A2463_29@103346@103346@deletion@1@5877980@5878932@11@chr11:5877980-5878932@10.5@262@135@0.515@CNVR5050.1@OR52E8_1@0@0@0@:tripartite motif containing 5:olfactory receptor, family 52, subfamily E, member 8@:defense response to virus;Golgi apparatus;intracellular;protein trimerization;ligase activity;cytoplasm;protein binding;nucleus;protein homodimerization activity;identical protein binding;zinc ion binding;cytoplasmic mRNA processing body;protein ubiquitination;virus-host interaction:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_29@106046@106048@duplication@3@55370918@55419315@11@chr11:55370918-55419315@9.18@808@1085@1.34@CNVR5179.1@OR4C11_1, OR4P4_1, OR4S2_1@0@0@0@:olfactory receptor, family 4, subfamily C, member 11:olfactory receptor, family 4, subfamily P, member 4:olfactory receptor, family 4, subfamily S, member 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_29@110126@110126@deletion@1@89774220@89774718@11@chr11:89774220-89774718@4.96@219@136@0.621@NA@TRIM49C_8@0@0@0@:tripartite motif containing 49D, pseudogene;tripartite motif containing 49-like 1;tripartite motif containing 49C;tripartite motif-containing protein 49-like protein 1-like@:protein binding;intracellular;DNA binding;zinc ion binding@NA
A2463_29@113033@113033@deletion@1@176050@176602@12@chr12:176050-176602@7.98@238@133@0.559@CNVR5380.1, CNVR5380.4, CNVR5380.3@IQSEC3_1@0@0@0@:IQ motif and Sec7 domain 3;IQ motif and SEC7 domain-containing protein 3-like@:phospholipid binding;inhibitory synapse;intracellular;ARF guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;protein binding;cell junction;nucleus;regulation of ARF protein signal transduction;postsynaptic membrane@NA
A2463_29@113481@113483@deletion@3@4853684@4855424@12@chr12:4853684-4855424@14.4@245@120@0.49@NA@GALNT8_4, GALNT8_5, GALNT8_6@0@0@0@:UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 8 (GalNAc-T8)@:carbohydrate binding;O-glycan processing;integral to membrane;cellular protein metabolic process;Golgi membrane;post-translational protein modification;polypeptide N-acetylgalactosaminyltransferase activity@NA
A2463_29@114424@114426@deletion@3@10583717@10586541@12@chr12:10583717-10586541@5.54@383@263@0.687@CNVR5430.1@KLRC2_6, KLRC2_5, KLRC2_4@0@0@0@:killer cell lectin-like receptor subfamily C, member 2@:carbohydrate binding:transmembrane signaling receptor activity;carbohydrate binding;protein binding;signal transduction;cellular defense response;integral to plasma membrane@NA
A2463_29@114468@114469@deletion@2@11034835@11035297@12@chr12:11034835-11035297@5.03@129@76@0.589@NA@PRH1_4, PRH1_3@0@0@0@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):proline-rich protein HaeIII subfamily 1@:extracellular space;visual perception:protein binding;extracellular space@NA
A2463_29@114483@114483@duplication@1@11243900@11244828@12@chr12:11243900-11244828@12.4@384@635@1.65@CNVR5434.1@TAS2R43_1@0@0@0@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):taste receptor, type 2, member 14:taste receptor, type 2, member 43@:extracellular space;visual perception:bitter taste receptor activity;taste receptor activity;integral to membrane;sensory perception of taste;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of bitter taste:G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;motile cilium;taste receptor activity;bitter taste receptor activity;integral to membrane;sensory perception of taste;detection of chemical stimulus involved in sensory perception of bitter taste;cilium membrane@NA
A2463_29@114493@114496@deletion@4@11506042@11508487@12@chr12:11506042-11508487@18@405@222@0.548@CNVR5435.2, CNVR5435.1@PRB1_4, PRB1_3, PRB1_2, PRB1_1@0@0@0@:proline-rich protein BstNI subfamily 1@NA@NA
A2463_29@115535@115537@deletion@3@31247525@31249313@12@chr12:31247525-31249313@6.17@345@238@0.69@CNVR5483.1@DDX11_13, DDX11_14, DDX11_15@0@0@0@:DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11@:nucleoplasm;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;S phase of mitotic cell cycle;DNA binding;nucleobase-containing compound metabolic process;ATP binding;ATP-dependent DNA helicase activity;DNA helicase activity;midbody;RNA binding;DNA-dependent ATPase activity;nucleus;positive regulation of cell proliferation;virus-host interaction;nuclear chromatin;4 iron, 4 sulfur cluster binding;helicase activity;hydrolase activity, acting on acid anhydrides;DNA duplex unwinding;endoplasmic reticulum unfolded protein response;G2/M transition of mitotic cell cycle;protein binding;sister chromatid cohesion;activation of signaling protein activity involved in unfolded protein response;nucleolus;spindle pole;ATP-dependent helicase activity;metal ion binding;nucleic acid binding;mitotic sister chromatid segregation@: WARSAW BREAKAGE SYNDROME
A2463_29@117158@117158@deletion@1@52842627@52842751@12@chr12:52842627-52842751@8.16@160@80@0.5@NA@KRT6B_6@0@0@0@:keratin 6B@:keratin filament;structural constituent of cytoskeleton;ectoderm development@: PACHYONYCHIA CONGENITA, TYPE 2; PC2
A2463_29@117169@117172@deletion@4@52865206@52867521@12@chr12:52865206-52867521@36.3@789@417@0.529@NA@KRT6C_4, KRT6C_3, KRT6C_2, KRT6C_1@0@0@0@:keratin 6C@:intermediate filament;structural molecule activity;keratin filament;cytoskeleton organization@NA
A2463_29@124192@124194@duplication@3@24890143@24895906@13@chr13:24890143-24895906@6.55@275@386@1.4@NA@C1QTNF9_2, C1QTNF9_3, C1QTNF9_4, C1QTNF9B-AS1_1@0@0@0@:spermatogenesis associated 13:C1q and tumor necrosis factor related protein 9:C1QTNF9B antisense RNA 1@:lamellipodium assembly;phospholipid binding;Rac guanyl-nucleotide exchange factor activity;guanyl-nucleotide exchange factor activity;ruffle membrane;nucleus;regulation of cell migration;cell migration;regulation of Rho protein signal transduction;intracellular;Rho guanyl-nucleotide exchange factor activity;cytoplasm;filopodium assembly;filopodium;protein binding;lamellipodium:collagen;protein binding;hormone activity@NA
A2463_29@127333@127335@deletion@3@19553418@19559164@14@chr14:19553418-19559164@12.9@710@473@0.666@CNVR6072.1@POTEG_1, POTEG_2, POTEG_3@0@0@0@:POTE ankyrin domain family, member G@:protein binding@NA
A2463_29@127348@127358@deletion@11@20010104@20404761@14@chr14:20010104-20404761@40.3@3238@2131@0.658@CNVR6072.12, CNVR6072.4@POTEM_5, POTEM_4, POTEM_3, POTEM_2, POTEM_1, OR4Q3_1, OR4M1_1, OR4N2_1, OR4K2_1, OR4K5_1, OR4K1_1@0@0@0@:POTE ankyrin domain family, member M:olfactory receptor, family 4, subfamily N, member 2:olfactory receptor, family 4, subfamily Q, member 3:olfactory receptor, family 4, subfamily M, member 1:olfactory receptor, family 4, subfamily K, member 2:olfactory receptor, family 4, subfamily K, member 5:olfactory receptor, family 4, subfamily K, member 1@:protein binding:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_29@131032@131034@deletion@3@74004127@74010359@14@chr14:74004127-74010359@64@408@58@0.142@CNVR6188.1, CNVR6188.4@ACOT1_1, ACOT1_2, ACOT1_3@0@0@0@:HEAT repeat containing 4:acyl-CoA thioesterase 1@:protein binding;binding:hydrolase activity;mitochondrion;acyl-CoA metabolic process;very long-chain fatty acid metabolic process;thiolester hydrolase activity;acyl-CoA hydrolase activity;cytosol;palmitoyl-CoA hydrolase activity;long-chain fatty acid metabolic process;carboxylesterase activity@NA
A2463_29@133349@133352@deletion@4@106090814@106092403@14@chr14:106090814-106092403@12.3@543@346@0.637@CNVR6294.46, CNVR6294.20, CNVR6294.54, CNVR6294.43, CNVR6294.50, CNVR6294.61@IGHG4_4, IGHG4_3, IGHG4_2, IGHG4_1@0@0@0@@:antigen binding;protein binding;complement activation;extracellular region;immune response;membrane;complement activation, classical pathway;innate immune response@NA
A2463_29@133432@133435@duplication@4@106539080@106552729@14@chr14:106539080-106552729@16.9@177@328@1.85@CNVR6294.36, CNVR6294.48, CNVR6294.24, CNVR6294.10, CNVR6294.34@IGHV1-8_2, IGHV1-8_1, IGHV3-9_2, IGHV3-9_1@0@0@0@@:protein binding:protein binding@NA
A2463_29@133491@133492@deletion@2@107095127@107095561@14@chr14:107095127-107095561@8.7@80@29@0.362@CNVR6294.56, CNVR6294.16, CNVR6294.91@IGHV4-61_2, IGHV4-61_1@0@0@0@@:protein binding@NA
A2463_29@133495@133495@deletion@1@107131034@107131334@14@chr14:107131034-107131334@5.21@56@22@0.393@CNVR6294.56, CNVR6294.16@IGHV3-66_2@0@0@0@@:protein binding@NA
A2463_29@133622@133623@deletion@2@23259497@23259716@15@chr15:23259497-23259716@6.23@50@16@0.32@CNVR6300.4@GOLGA8I_6, GOLGA8I_7@0@0@0@:golgin A8 family, member I@:Golgi cisterna membrane@NA
A2463_29@133636@133642@deletion@7@23406272@23412276@15@chr15:23406272-23412276@50.2@645@236@0.366@CNVR6300.8@RP11-467N20.5_8, RP11-467N20.5_7, RP11-467N20.5_6, RP11-467N20.5_5, RP11-467N20.5_4, RP11-467N20.5_3, RP11-467N20.5_2@0@0@0@:putative golgin subfamily A member 6-like protein 6-like@NA@NA
A2463_29@133884@133887@duplication@4@28769090@28771657@15@chr15:28769090-28771657@5.92@57@106@1.86@CNVR6330.3@GOLGA8G_15, GOLGA8G_14, GOLGA8G_13, GOLGA8G_12@0@0@0@:golgin A8 family, member G;golgin A8 family, member F@:Golgi apparatus@NA
A2463_29@133910@133912@deletion@3@28952895@28953319@15@chr15:28952895-28953319@10.1@423@266@0.629@CNVR6331.1@GOLGA8M_8, GOLGA8M_7, GOLGA8M_6@0@0@0@:golgin A8 family, member M@:Golgi apparatus@NA
A2463_29@133971@133981@deletion@11@30376975@30382159@15@chr15:30376975-30382159@26.8@190@46@0.242@NA@GOLGA8J_2, GOLGA8J_3, GOLGA8J_4, GOLGA8J_5, GOLGA8J_6, GOLGA8J_7, GOLGA8J_8, GOLGA8J_9, GOLGA8J_10, GOLGA8J_11, GOLGA8J_12@0@0@0@:golgin A8 family, member J@:Golgi apparatus@NA
A2463_29@133997@134012@deletion@16@30433046@30665348@15@chr15:30433046-30665348@92.3@615@130@0.211@CNVR6337.1@GOLGA8T_9, GOLGA8T_10, GOLGA8T_11, GOLGA8T_12, GOLGA8T_13, GOLGA8T_14, GOLGA8T_15, GOLGA8T_16, GOLGA8T_17, GOLGA8T_18, GOLGA8T_19, CHRFAM7A_10, CHRFAM7A_9, CHRFAM7A_8, CHRFAM7A_7, CHRFAM7A_6@0@0@0@:golgin A8 family, member J;golgin A8 family, member K:CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:Golgi apparatus:transport;integral to membrane;ion transport;postsynaptic membrane;membrane;extracellular ligand-gated ion channel activity@NA
A2463_29@134036@134054@deletion@19@30845996@30896376@15@chr15:30845996-30896376@57.4@422@112@0.265@CNVR6339.2, CNVR6339.3, CNVR6339.1@GOLGA8Q_2, GOLGA8Q_3, GOLGA8Q_4, GOLGA8Q_5, GOLGA8Q_6, GOLGA8Q_7, GOLGA8Q_8, GOLGA8Q_9, GOLGA8Q_10, GOLGA8Q_11, GOLGA8Q_12, GOLGA8Q_13, GOLGA8Q_14, GOLGA8Q_15, GOLGA8Q_16, GOLGA8Q_17, GOLGA8Q_18, GOLGA8Q_19, GOLGA8H_1@0@0@0@:golgin A8 family, member H@:Golgi apparatus:Golgi apparatus@NA
A2463_29@134155@134156@duplication@2@32451771@32455536@15@chr15:32451771-32455536@6.65@12@55@4.58@CNVR6345.2, CNVR6345.1@CHRNA7_8, CHRNA7_9@0@0@0@:cholinergic receptor, nicotinic, alpha 7 (neuronal);CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:cellular calcium ion homeostasis;transport;beta-amyloid binding;calcium ion transport;acetylcholine receptor activity;ion transport;acetylcholine-activated cation-selective channel activity;integral to membrane;chloride channel regulator activity;cell junction;plasma membrane;positive regulation of cell proliferation;protein homodimerization activity;acetylcholine-gated channel complex;response to chemical stimulus;activation of MAPK activity;negative regulation of tumor necrosis factor production;response to hypoxia;response to nicotine;acetylcholine binding;positive regulation of angiogenesis;signal transduction;memory;toxin binding;synaptic transmission;postsynaptic membrane;membrane;cognition;extracellular ligand-gated ion channel activity@NA
A2463_29@134158@134161@deletion@4@32684984@32685771@15@chr15:32684984-32685771@25.7@153@26@0.17@NA@GOLGA8K_19, GOLGA8K_18, GOLGA8K_17, GOLGA8K_16@0@0@0@:golgin A8 family, member J@:Golgi apparatus@NA
A2463_29@134173@134177@deletion@5@32692342@32695395@15@chr15:32692342-32695395@11.3@92@31@0.337@NA@GOLGA8K_4, GOLGA8K_3, GOLGA8K_2, AC139426.2_1, GOLGA8K_1@0@0@0@:golgin A8 family, member J@:Golgi apparatus@NA
A2463_29@134180@134190@duplication@11@32737820@32743403@15@chr15:32737820-32743403@12.5@169@281@1.66@CNVR6346.1@GOLGA8O_17, GOLGA8O_16, GOLGA8O_15, GOLGA8O_14, GOLGA8O_13, GOLGA8O_12, GOLGA8O_11, GOLGA8O_10, GOLGA8O_9, GOLGA8O_8, GOLGA8O_7@0@0@0@:golgin A8 family, member O@:Golgi apparatus@NA
A2463_29@134198@134202@deletion@5@32885756@32889690@15@chr15:32885756-32889690@8.31@208@117@0.562@NA@GOLGA8N_1, GOLGA8N_2, GOLGA8N_3, GOLGA8N_4, GOLGA8N_5@0@0@0@:golgin A8 family, member R@:Golgi apparatus@NA
A2463_29@134444@134447@deletion@4@34678827@34820035@15@chr15:34678827-34820035@15.1@142@48@0.338@CNVR6351.3@GOLGA8A_11, GOLGA8A_10, GOLGA8A_9, GOLGA8B_25@0@0@0@:golgin A8 family, member A:golgin A8 family, member A;golgin A8 family, member B@:Golgi cisterna membrane;Golgi apparatus:Golgi cisterna membrane;Golgi apparatus@NA
A2463_29@134459@134460@duplication@2@34824163@34825163@15@chr15:34824163-34825163@7.32@53@114@2.15@CNVR6351.3@GOLGA8B_13, GOLGA8B_12@0@0@0@:golgin A8 family, member A:golgin A8 family, member A;golgin A8 family, member B@:Golgi cisterna membrane;Golgi apparatus:Golgi cisterna membrane;Golgi apparatus@NA
A2463_29@138281@138288@deletion@8@72953606@72958039@15@chr15:72953606-72958039@8.45@353@229@0.649@CNVR6443.1@GOLGA6B_8, GOLGA6B_9, GOLGA6B_10, GOLGA6B_11, GOLGA6B_12, GOLGA6B_13, GOLGA6B_14, GOLGA6B_15@0@0@0@:golgin A6 family, member B@:Golgi apparatus@NA
A2463_29@138414@138416@deletion@3@74363709@74364650@15@chr15:74363709-74364650@11.4@118@42@0.356@CNVR6448.1@GOLGA6A_16, GOLGA6A_15, GOLGA6A_14@0@0@0@:golgin A6 family, member C;golgin A6 family, member A;golgin A6 family, member D;golgin A6 family, member B@:Golgi apparatus@NA
A2463_29@138636@138638@deletion@3@75557464@75558045@15@chr15:75557464-75558045@8.77@167@88@0.527@CNVR6452.1@GOLGA6C_8, GOLGA6C_9, GOLGA6C_10@0@0@0@:golgin A6 family, member C@:Golgi apparatus@NA
A2463_29@139296@139308@deletion@13@82934267@83015609@15@chr15:82934267-83015609@14.2@185@85@0.459@CNVR6477.6, CNVR6477.2, CNVR6477.3@RP13-996F3.5_6, RP13-996F3.5_5, RP13-996F3.5_4, RP13-996F3.5_3, RP13-996F3.5_2, RP13-996F3.5_1, RP13-996F3.4_9, RP13-996F3.4_8, RP13-996F3.4_7, RP13-996F3.4_6, RP13-996F3.4_5, RP13-996F3.4_4, RP13-996F3.4_3@0@0@0@NA@NA@NA
A2463_29@139474@139474@duplication@1@84904588@84904670@15@chr15:84904588-84904670@10.3@12@83@6.92@CNVR6486.2@GOLGA6L4_1@0@0@0@@:Golgi apparatus@NA
A2463_29@140476@140478@duplication@3@64382@65633@16@chr16:64382-65633@8.63@71@143@2.01@CNVR6565.1@WASH4P_10, WASH4P_9, WASH4P_8@0@0@0@@:intracellular membrane-bounded organelle;endosomal transport;recycling endosome;early endosome;Arp2/3 complex-mediated actin nucleation;actin binding;alpha-tubulin binding;retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;recycling endosome membrane@NA
A2463_29@142753@142753@duplication@1@15460511@15460617@16@chr16:15460511-15460617@6.39@36@87@2.42@CNVR6649.1@PKD1P1_5@0@0@0@:NPIP-like protein 1-like;nuclear pore complex-interacting protein-like 1-like@NA@NA
A2463_29@142910@142928@deletion@19@16330759@16367932@16@chr16:16330759-16367932@28.3@595@333@0.56@NA@NOMO3_2, NOMO3_3, NOMO3_4, NOMO3_5, NOMO3_6, NOMO3_7, NOMO3_8, NOMO3_9, NOMO3_10, NOMO3_11, NOMO3_12, NOMO3_13, NOMO3_14, NOMO3_15, NOMO3_16, NOMO3_17, NOMO3_18, NOMO3_19, NOMO3_20@0@0@0@:NODAL modulator 3@:carbohydrate binding;integral to membrane;carboxypeptidase activity@NA
A2463_29@143003@143005@duplication@3@18542789@18549998@16@chr16:18542789-18549998@6.99@333@457@1.37@NA@NOMO2_13, NOMO2_12, NOMO2_11@0@0@0@:NODAL modulator 2@:carbohydrate binding;protein binding;integral to membrane;carboxypeptidase activity;endoplasmic reticulum membrane@NA
A2463_29@143482@143485@deletion@4@21763691@21771861@16@chr16:21763691-21771861@11.6@195@99@0.508@CNVR6668.5, CNVR6668.2, CNVR6668.7@OTOA_25, OTOA_26, OTOA_27, OTOA_28@0@0@0@:otoancorin@:proteinaceous extracellular matrix;apical plasma membrane;sensory perception of sound;anchored to membrane@: DEAFNESS, AUTOSOMAL RECESSIVE 22; DFNB22
A2463_29@144047@144052@deletion@6@28467746@28478223@16@chr16:28467746-28478223@39.6@202@8@0.0396@NA@NPIPL1_7, NPIPL1_6, NPIPL1_5, NPIPL1_4, NPIPL1_3, NPIPL1_2@0@0@0@:ceroid-lipofuscinosis, neuronal 3@:membrane:negative regulation of apoptotic process;late endosome;mitochondrion;galactosylceramide metabolic process;neuromuscular process controlling balance;neuron projection;lysosomal lumen pH elevation;integral to endoplasmic reticulum membrane;cell death;plasma membrane;nucleus;lysosomal lumen acidification;negative regulation of catalytic activity;negative regulation of macroautophagy;unfolded protein binding;neurotransmitter metabolic process;endoplasmic reticulum;vesicle transport along microtubule;protein catabolic process;autophagic vacuole;early endosome;trans-Golgi network;cellular membrane organization;ceramide metabolic process;glucosylceramide metabolic process;negative regulation of neuron apoptotic process;membrane;globoside metabolic process;membrane raft;synaptic vesicle;vacuolar transport;protein processing;Golgi membrane;caveola;protein folding;ionotropic glutamate receptor signaling pathway;cytosolic calcium ion homeostasis;Golgi stack;integral to membrane;receptor-mediated endocytosis;arginine transport;lysosome;negative regulation of proteolysis;Golgi apparatus;lysosome organization;associative learning;sphingomyelin metabolic process;macroautophagy;lysosomal membrane;amyloid precursor protein catabolic process;cytoplasm;autophagic vacuole fusion;protein binding;regulation of action potential;cellular amino acid metabolic process@: CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3
A2463_29@144047@144053@duplication@1@28467746@28481759@16@chr16:28467746-28481759@-31.5@295@181@0.614@NA@NPIPL1_7, NPIPL1_6, NPIPL1_5, NPIPL1_4, NPIPL1_3, NPIPL1_2, NPIPL1_1@0@0@0@:ceroid-lipofuscinosis, neuronal 3@:membrane:negative regulation of apoptotic process;late endosome;mitochondrion;galactosylceramide metabolic process;neuromuscular process controlling balance;neuron projection;lysosomal lumen pH elevation;integral to endoplasmic reticulum membrane;cell death;plasma membrane;nucleus;lysosomal lumen acidification;negative regulation of catalytic activity;negative regulation of macroautophagy;unfolded protein binding;neurotransmitter metabolic process;endoplasmic reticulum;vesicle transport along microtubule;protein catabolic process;autophagic vacuole;early endosome;trans-Golgi network;cellular membrane organization;ceramide metabolic process;glucosylceramide metabolic process;negative regulation of neuron apoptotic process;membrane;globoside metabolic process;membrane raft;synaptic vesicle;vacuolar transport;protein processing;Golgi membrane;caveola;protein folding;ionotropic glutamate receptor signaling pathway;cytosolic calcium ion homeostasis;Golgi stack;integral to membrane;receptor-mediated endocytosis;arginine transport;lysosome;negative regulation of proteolysis;Golgi apparatus;lysosome organization;associative learning;sphingomyelin metabolic process;macroautophagy;lysosomal membrane;amyloid precursor protein catabolic process;cytoplasm;autophagic vacuole fusion;protein binding;regulation of action potential;cellular amino acid metabolic process@: CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3
A2463_29@144095@144095@deletion@1@28607105@28607251@16@chr16:28607105-28607251@5.34@42@12@0.286@NA@SULT1A2_2@0@0@0@:sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2@:steroid metabolic process;small molecule metabolic process;sulfation;aryl sulfotransferase activity;catecholamine metabolic process;cytosol;xenobiotic metabolic process;phenol-containing compound metabolic process;sulfotransferase activity;amine biosynthetic process;flavonol 3-sulfotransferase activity;3'-phosphoadenosine 5'-phosphosulfate metabolic process@NA
A2463_29@144098@144103@duplication@6@28618083@28649801@16@chr16:28618083-28649801@8.12@449@600@1.34@NA@SULT1A1_8, SULT1A1_7, SULT1A1_6, SULT1A1_5, SULT1A1_4, A-575C2.4_1@0@0@0@:sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1:nuclear pore complex-interacting protein-like 2-like;putative NPIP-like protein LOC613037-like@:small molecule metabolic process;sulfation;aryl sulfotransferase activity;amine metabolic process;catecholamine metabolic process;xenobiotic metabolic process;cytosol;steroid sulfotransferase activity;integral to membrane;sulfotransferase activity;flavonol 3-sulfotransferase activity;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process;estrogen metabolic process@NA
A2463_29@144130@144134@deletion@5@28763890@28777810@16@chr16:28763890-28777810@15.6@104@23@0.221@NA@A-575C2.4_1, A-575C2.4_2, A-575C2.4_3, A-575C2.4_4, A-575C2.4_5@0@0@0@NA@NA@NA
A2463_29@145554@145558@duplication@5@55844430@55853551@16@chr16:55844430-55853551@14.4@1157@1539@1.33@CNVR6731.1@CES1_11, CES1_10, CES1_9, CES1_8, CES1_7@0@0@0@:carboxylesterase 1;liver carboxylesterase 1-like@:hydrolase activity;methyl salicylate esterase activity;response to toxin;methylumbelliferyl-acetate deacetylase activity;endoplasmic reticulum lumen;retinyl-palmitate esterase activity;methyl jasmonate esterase activity;metabolic process;carboxylesterase activity;methyl indole-3-acetate esterase activity@: CARBOXYLESTERASE 1; CES1
A2463_29@147100@147101@deletion@2@69997478@70010635@16@chr16:69997478-70010635@11.8@236@118@0.5@CNVR6762.3, CNVR6762.1@CLEC18A_12, RP11-419C5.2_7@0@0@0@:C-type lectin domain family 18, member A@:carbohydrate binding;protein binding;extracellular region@NA
A2463_29@147126@147126@deletion@1@70208851@70208941@16@chr16:70208851-70208941@9.69@47@2@0.0426@CNVR6764.1@CLEC18C_2@0@0@0@:C-type lectin domain family 18, member C@:carbohydrate binding;protein binding;extracellular region@NA
A2463_29@151877@151881@duplication@5@18389249@18394637@17@chr17:18389249-18394637@6.27@169@246@1.46@CNVR7014.1@LGALS9C_3, LGALS9C_4, LGALS9C_5, LGALS9C_6, LGALS9C_7@0@0@0@:lectin, galactoside-binding, soluble, 9C@:carbohydrate binding@NA
A2463_29@151896@151898@deletion@3@18584055@18631071@17@chr17:18584055-18631071@7.92@169@97@0.574@NA@ZNF286B_3, ZNF286B_2, TRIM16L_4@0@0@0@:zinc finger protein 286B:tripartite motif containing 16-like@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding:protein binding;cytoplasm@NA
A2463_29@153376@153394@deletion@19@34522686@34590454@17@chr17:34522686-34590454@25.3@138@17@0.123@CNVR7077.1, CNVR7077.13, CNVR7077.19@CCL3L3_3, CCL3L3_2, CCL3L3_1, CCL4L1_1, CCL4L1_2, CCL4L1_3, TBC1D3C_14, TBC1D3C_13, TBC1D3C_12, TBC1D3C_11, TBC1D3C_10, TBC1D3C_9, TBC1D3C_8, TBC1D3C_7, TBC1D3C_6, TBC1D3C_5, TBC1D3C_4, TBC1D3C_3, TBC1D3C_2@0@0@0@:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1:TBC1 domain family, member 3C;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3H-like;TBC1 domain family, member 3H@:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_29@153414@153414@deletion@1@34797487@34798054@17@chr17:34797487-34798054@9.81@53@5@0.0943@CNVR7078.2, CNVR7078.3@TBC1D3G_14@0@0@0@:TBC1 domain family member 3H-like;TBC1 domain family, member 3H:TBC1 domain family, member 3;TBC1 domain family, member 3G;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like;TBC1 domain family, member 3H@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_29@154791@154791@duplication@1@40811853@40811964@17@chr17:40811853-40811964@5.15@31@71@2.29@NA@TUBG2_2@0@0@0@:tubulin, gamma 2@:spindle microtubule;microtubule-based process;mitotic cell cycle;centrosome;GTPase activity;protein complex;GTP catabolic process;G2/M transition of mitotic cell cycle;cytosol;microtubule cytoskeleton;protein polymerization;structural molecule activity;cytoplasmic microtubule;GTP binding;microtubule;pericentriolar material@NA
A2463_29@155584@155590@deletion@7@44380005@44409347@17@chr17:44380005-44409347@37.8@449@176@0.392@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A_3, LRRC37A_4, LRRC37A_5, LRRC37A_6, LRRC37A_7, LRRC37A_8, LRRC37A_9@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
A2463_29@155592@155600@deletion@9@44412912@44594799@17@chr17:44412912-44594799@91.6@470@12@0.0255@CNVR7114.2, CNVR7114.1@LRRC37A_11, LRRC37A_12, LRRC37A_13, LRRC37A_14, ARL17B_4, ARL17B_3, ARL17B_2, LRRC37A2_2, LRRC37A2_3@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
A2463_29@155606@155609@deletion@4@44623622@44630815@17@chr17:44623622-44630815@21.9@1681@1096@0.652@CNVR7114.2, CNVR7114.5, CNVR7114.4, CNVR7114.6@LRRC37A2_9, LRRC37A2_10, LRRC37A2_11, LRRC37A2_12@0@0@0@:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
A2463_29@162017@162017@duplication@1@44542732@44544371@18@chr18:44542732-44544371@35.1@291@1149@3.95@CNVR7319.1@TCEB3CL2_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_29@162019@162019@deletion@1@44554574@44556213@18@chr18:44554574-44556213@10.9@2242@1413@0.63@CNVR7319.1@TCEB3C_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C (elongin A3);RNA polymerase II transcription factor SIII subunit A3-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_29@164950@164957@deletion@8@7030624@7058616@19@chr19:7030624-7058616@24@371@179@0.482@CNVR7517.1@MBD3L5_1, MBD3L5_2, MBD3L4_2, MBD3L4_1, MBD3L2_1, MBD3L2_2, MBD3L3_2, MBD3L3_1@0@0@0@:methyl-CpG binding domain protein 3-like 5:methyl-CpG binding domain protein 3-like 4:methyl-CpG-binding domain protein 3-like 2-like;methyl-CpG binding domain protein 3-like 2:methyl-CpG binding domain protein 3-like 3@:regulation of transcription, DNA-dependent;transcription, DNA-dependent:regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_29@168952@168952@duplication@1@35862263@35863302@19@chr19:35862263-35863302@15.7@153@340@2.22@CNVR7627.1@GPR42_2@0@0@0@@:integral to membrane;G-protein coupled receptor activity;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
A2463_29@169778@169778@duplication@1@39262470@39262670@19@chr19:39262470-39262670@4.8@50@94@1.88@NA@LGALS7_3@0@0@0@:lectin, galactoside-binding, soluble, 7;lectin, galactoside-binding, soluble, 7B@:carbohydrate binding;heterophilic cell-cell adhesion;extracellular space;nucleus;apoptotic process;cytoplasm@NA
A2463_29@172987@172995@deletion@9@52133087@52150012@19@chr19:52133087-52150012@14.5@291@164@0.564@CNVR7702.1@SIGLEC5_2, SIGLEC5_2, SIGLEC5_1, SIGLEC14_7, SIGLEC14_6, SIGLEC14_5, SIGLEC14_4, SIGLEC14_3, SIGLEC14_2, SIGLEC14_1, SIGLEC5_1@0@0@0@:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 14@:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion;plasma membrane@NA
A2463_29@173295@173295@duplication@1@54724399@54724700@19@chr19:54724399-54724700@4.72@77@128@1.66@CNVR7721.3, CNVR7721.4@LILRB3_6@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
A2463_29@173303@173308@deletion@6@54744151@54746600@19@chr19:54744151-54746600@26.3@646@364@0.563@CNVR7721.3, CNVR7721.6@LILRA6_6, LILRA6_5, LILRA6_4, LILRA6_3, LILRA6_2, LILRA6_1@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
A2463_29@173460@173462@deletion@3@55247288@55250044@19@chr19:55247288-55250044@21.4@114@11@0.0965@CNVR7725.2, CNVR7725.4, CNVR7725.1@KIR3DL3_7, KIR3DL3_8, KIR2DL3_1@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:integral to membrane;plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity@NA
A2463_29@173467@173470@duplication@4@55263102@55281336@19@chr19:55263102-55281336@31.2@309@622@2.01@CNVR7725.2, CNVR7725.1@KIR2DL3_6, KIR2DL3_7, KIR2DL3_8, KIR2DL1_1@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane@NA
A2463_29@173473@173504@duplication@32@55286618@55363737@19@chr19:55286618-55363737@112@1392@2447@1.76@CNVR7725.1@KIR2DL1_4, KIR2DL1_5, KIR2DL1_6, KIR2DL1_7, KIR2DL1_8, KIR2DL4_1, KIR2DL4_2, KIR2DL4_3, KIR2DL4_4, KIR2DL4_5, KIR2DL4_6, KIR2DL4_7, KIR3DL1_1, KIR3DL1_2, KIR3DL1_3, KIR3DL1_4, KIR3DL1_5, KIR3DL1_6, KIR3DL1_7, KIR3DL1_8, KIR3DL1_9, KIR2DS4_1, KIR2DS4_2, KIR2DS4_3, KIR2DS4_4, KIR2DS4_5, KIR2DS4_6, KIR2DS4_7, KIR2DS4_8, KIR3DL2_1, KIR3DL2_2, KIR3DL2_3@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2-like@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane:regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane@NA
A2463_29@174095@174100@duplication@6@58350392@58371508@19@chr19:58350392-58371508@15.2@1156@1576@1.36@NA@ZNF587B_2, ZNF587B_3, ZNF587B_4, ZNF587_1, ZNF587_2, CTD-2583A14.10_2, CTD-2583A14.10_3, ZNF587_3@0@0@0@:zinc finger protein 587B:zinc finger protein 814:zinc finger protein 587@:zinc ion binding:nucleus;intracellular;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding:intracellular;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_29@174394@174395@deletion@2@1558985@1569278@20@chr20:1558985-1569278@10.8@204@101@0.495@CNVR7763.1@RP4-576H24.4_2, SIRPB1_2, RP4-576H24.4_1@0@0@0@:signal-regulatory protein beta 1;signal-regulatory protein beta-1-like;signal-regulatory protein beta-1 isoform 3-like@:protein binding:protein binding;signal transduction;integral to membrane;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway@NA
A2463_29@178990@178993@duplication@4@10914364@10921995@21@chr21:10914364-10921995@8.47@1228@1574@1.28@CNVR7947.10, CNVR7947.6, CNVR7947.11@TPTE_21, TPTE_20, TPTE_19, TPTE_18@0@0@0@:transmembrane phosphatase with tensin homology@:phosphatase activity;ion channel activity;protein tyrosine phosphatase activity;ion transport;protein dephosphorylation;transmembrane transport;protein binding;signal transduction;integral to membrane;protein tyrosine/serine/threonine phosphatase activity;dephosphorylation;membrane;peptidyl-tyrosine dephosphorylation@NA
A2463_29@179011@179021@deletion@11@14982551@15013887@21@chr21:14982551-15013887@50.6@278@28@0.101@CNVR7952.1@POTED_1, POTED_2, POTED_3, POTED_4, POTED_5, POTED_6, POTED_7, POTED_8, POTED_9, POTED_10, POTED_11@0@0@0@:POTE ankyrin domain family, member B;POTE ankyrin domain family, member C;POTE ankyrin domain family, member D@:protein binding;plasma membrane@NA
A2463_29@180978@180978@duplication@1@17071768@17073440@22@chr22:17071768-17073440@7.64@672@952@1.42@NA@CCT8L2_1@0@0@0@:chaperonin containing TCP1, subunit 8 (theta)-like 2@:transport;cellular protein metabolic process;anion channel activity;calcium-activated potassium channel activity;ATP binding;cytoplasm@NA
A2463_29@181134@181134@duplication@1@18834446@18835833@22@chr22:18834446-18835833@12.2@181@340@1.88@CNVR8087.2, CNVR8087.7, CNVR8087.12, CNVR8087.10@AC008132.13_1@0@0@0@NA@NA@NA
A2463_29@181303@181304@deletion@2@19753426@19754390@22@chr22:19753426-19754390@7.33@255@155@0.608@NA@TBX1_8, TBX1_9@0@0@0@:T-box 1@:sequence-specific DNA binding;positive regulation of secondary heart field cardioblast proliferation;cellular response to fibroblast growth factor stimulus;nucleus;inner ear morphogenesis;blood vessel development;muscle cell fate commitment;muscle organ development;semicircular canal morphogenesis;blood vessel morphogenesis;mesoderm development;positive regulation of epithelial cell proliferation;sensory perception of sound;embryonic viscerocranium morphogenesis;outer ear morphogenesis;positive regulation of transcription, DNA-dependent;odontogenesis of dentin-containing tooth;heart morphogenesis;transcription, DNA-dependent;aorta morphogenesis;thyroid gland development;anterior/posterior pattern specification;protein dimerization activity;determination of left/right symmetry;positive regulation of transcription from RNA polymerase II promoter;artery morphogenesis;soft palate development;outflow tract septum morphogenesis;pharyngeal system development;regulation of transcription, DNA-dependent;face morphogenesis;thymus development;cell proliferation;blood vessel remodeling;social behavior;positive regulation of protein phosphorylation;vagus nerve morphogenesis;cochlea morphogenesis;tongue morphogenesis;pattern specification process;retinoic acid receptor signaling pathway;cell fate specification;middle ear morphogenesis;positive regulation of tongue muscle cell differentiation;outflow tract morphogenesis;positive regulation of mesenchymal cell proliferation;lymph vessel development;mesenchymal cell apoptotic process;ear morphogenesis;negative regulation of cell differentiation;neural crest cell migration;regulation of organ morphogenesis;negative regulation of mesenchymal cell apoptotic process;embryonic cranial skeleton morphogenesis;heart development;parathyroid gland development;muscle organ morphogenesis;DNA binding;positive regulation of MAPK cascade;sequence-specific DNA binding transcription factor activity;coronary artery morphogenesis;enamel mineralization;positive regulation of cell proliferation;protein homodimerization activity;epithelial cell differentiation;angiogenesis;cellular response to retinoic acid;otic vesicle morphogenesis;regulation of transcription from RNA polymerase II promoter;protein binding;muscle tissue morphogenesis@: VELOCARDIOFACIAL SYNDROME; CONOTRUNCAL HEART MALFORMATIONS; CTHM; DIGEORGE SYNDROME; DGS
A2463_29@181483@181484@deletion@2@21062336@21063667@22@chr22:21062336-21063667@5.88@94@49@0.521@CNVR8099.6, CNVR8099.2@PI4KA_55, PI4KA_54@0@0@0@:phosphatidylinositol 4-kinase, catalytic, alpha@:phospholipid metabolic process;1-phosphatidylinositol 4-kinase activity;small molecule metabolic process;phosphatidylinositol phosphorylation;binding;transferase activity, transferring phosphorus-containing groups;phosphotransferase activity, alcohol group as acceptor;ATP binding;Golgi-associated vesicle;phosphatidylinositol biosynthetic process;cytosol;protein binding;signal transduction;synaptic transmission;kinase activity;phosphatidylinositol-mediated signaling@NA
A2463_29@181487@181489@deletion@3@21065630@21067085@22@chr22:21065630-21067085@11.7@130@55@0.423@CNVR8099.6, CNVR8099.2@PI4KA_51, PI4KA_50, PI4KA_49@0@0@0@:phosphatidylinositol 4-kinase, catalytic, alpha@:phospholipid metabolic process;1-phosphatidylinositol 4-kinase activity;small molecule metabolic process;phosphatidylinositol phosphorylation;binding;transferase activity, transferring phosphorus-containing groups;phosphotransferase activity, alcohol group as acceptor;ATP binding;Golgi-associated vesicle;phosphatidylinositol biosynthetic process;cytosol;protein binding;signal transduction;synaptic transmission;kinase activity;phosphatidylinositol-mediated signaling@NA
A2463_29@181807@181808@deletion@2@23247056@23248831@22@chr22:23247056-23248831@8.13@257@156@0.607@CNVR8103.2, CNVR8103.1, CNVR8103.6, CNVR8103.11@IGLJ3_1, IGLC3_1@0@0@0@@:protein binding@NA
A2463_29@181850@181850@deletion@1@23652512@23652620@22@chr22:23652512-23652620@10.4@57@6@0.105@CNVR8107.2, CNVR8107.3@BCR_18@0@0@0@:breakpoint cluster region@:phospholipid binding;protein autophosphorylation;protein tyrosine kinase activity;GTPase activator activity;neuromuscular process controlling balance;ATP binding;actin cytoskeleton organization;negative regulation of cell migration;plasma membrane;inner ear morphogenesis;positive regulation of Rac GTPase activity;positive regulation of phagocytosis;regulation of small GTPase mediated signal transduction;response to lipopolysaccharide;intracellular signal transduction;Rac GTPase activator activity;regulation of cell cycle;platelet-derived growth factor receptor signaling pathway;protein serine/threonine kinase activity;intracellular;small GTPase mediated signal transduction;regulation of Rho protein signal transduction;protein phosphorylation;negative regulation of inflammatory response;enzyme binding;Rho guanyl-nucleotide exchange factor activity;cytoplasm;cytosol;protein binding;signal transduction;brain development;kinase activity;negative regulation of neutrophil degranulation@: LEUKEMIA, CHRONIC MYELOID; CML
A2463_29@181951@181955@duplication@5@24376424@24384231@22@chr22:24376424-24384231@15.3@132@256@1.94@CNVR8114.13, CNVR8114.1, CNVR8114.7@GSTT1_5, GSTT1_4, GSTT1_3, GSTT1_2, GSTT1_1@0@0@0@:glutathione S-transferase theta 1@:glutathione peroxidase activity;response to drug;transferase activity;cytosol;protein binding;glutathione transferase activity;glutathione metabolic process;response to organic cyclic compound@NA
A2463_26@399@411@deletion@13@1573863@1588935@1@chr1:1573863-1588935@9.86@341@182@0.534@CNVR17.1@CDK11B_13, CDK11B_12, CDK11B_11, CDK11B_10, CDK11B_9, CDK11B_8, CDK11B_7, CDK11B_6, CDK11B_5, CDK11B_4, CDK11B_3, CDK11B_2, CDK11B_1@0@0@0@:cyclin-dependent kinase 11B@:protein serine/threonine kinase activity;protein tyrosine kinase activity;protein phosphorylation;protein kinase activity;cell division;transferase activity, transferring phosphorus-containing groups;ATP binding@NA
A2463_26@1808@1824@deletion@17@12855588@12980233@1@chr1:12855588-12980233@12.2@931@539@0.579@CNVR72.3, CNVR72.4@PRAMEF1_4, PRAMEF11_4, PRAMEF11_3, PRAMEF11_2, HNRNPCL1_2, PRAMEF2_2, PRAMEF2_3, PRAMEF2_4, PRAMEF4_4, PRAMEF4_3, PRAMEF4_2, PRAMEF10_4, PRAMEF10_3, PRAMEF10_2, PRAMEF7_2, PRAMEF7_3, PRAMEF7_4@0@0@0@:PRAME family member 1:PRAME family member 11:heterogeneous nuclear ribonucleoprotein C-like 1-like;heterogeneous nuclear ribonucleoprotein C-like;heterogeneous nuclear ribonucleoprotein C-like 1:PRAME family member 2:PRAME family member 4:PRAME family member 10:PRAME family member 7@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:ribonucleoprotein complex;RNA binding;nucleus;nucleotide binding;nucleic acid binding:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_26@2817@2827@duplication@11@21938520@21978315@1@chr1:21938520-21978315@8.86@181@314@1.73@NA@RAP1GAP_11, RAP1GAP_10, RAP1GAP_9, RAP1GAP_8, RAP1GAP_7, RAP1GAP_6, RAP1GAP_5, RAP1GAP_4, RAP1GAP_3, RAP1GAP_2, RAP1GAP_1@0@0@0@:RAP1 GTPase activating protein@:regulation of Ras GTPase activity;intracellular;positive regulation of GTPase activity;GTPase regulator activity;GTPase activity;GTPase activator activity;Golgi membrane;GTP catabolic process;Ras GTPase binding;cytosol;protein binding;signal transduction;protein homodimerization activity;regulation of small GTPase mediated signal transduction;membrane@NA
A2463_26@3334@3341@duplication@8@25611065@25648453@1@chr1:25611065-25648453@11.2@194@414@2.13@CNVR116.1, CNVR116.2@RHD_2, RHD_3, RHD_4, RHD_5, RHD_6, RHD_7, RHD_8, RHD_9@0@0@0@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
A2463_26@3357@3357@deletion@1@25735175@25735360@1@chr1:25735175-25735360@6.52@42@0@0@CNVR117.1@RHCE_2@0@0@0@:Rh blood group, CcEe antigens@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@: BLOOD GROUP--RHESUS SYSTEM E POLYPEPTIDE; RHE; RHESUS BLOOD GROUP, CcEe ANTIGENS; RHCE
A2463_26@9340@9386@deletion@47@104114226@104297436@1@chr1:104114226-104297436@47.2@967@369@0.382@CNVR266.3@AMY2B_3, AMY2B_4, AMY2B_5, AMY2B_6, AMY2B_7, AMY2B_8, AMY2B_9, AMY2B_10, AMY2B_11, AMY2B_12, AMY2A_1, AMY2A_2, AMY2A_3, AMY2A_4, AMY2A_5, AMY2A_6, AMY2A_7, AMY2A_8, AMY2A_9, AMY2A_10, AMY1A_2, AMY1A_3, AMY1A_4, AMY1A_5, AMY1A_6, AMY1A_7, AMY1A_8, AMY1A_9, AMY1A_10, AMY1A_11, AMY1B_11, AMY1B_10, AMY1B_9, AMY1B_8, AMY1B_7, AMY1B_6, AMY1B_5, AMY1B_4, AMY1B_3, AMY1B_2, AMY1C_1, AMY1C_2, AMY1C_3, AMY1C_4, AMY1C_5, AMY1C_6, AMY1C_7@0@0@0@:actin, gamma 1 pseudogene 4;amylase, alpha 2B (pancreatic):amylase, alpha 2A (pancreatic):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:extracellular region;cation binding;digestion;carbohydrate metabolic process;catalytic activity;alpha-amylase activity;metal ion binding:chloride ion binding;cation binding;small molecule metabolic process;carbohydrate metabolic process;catalytic activity;extracellular space;polysaccharide digestion;extracellular region;carbohydrate catabolic process;alpha-amylase activity;calcium ion binding:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
A2463_26@9766@9773@duplication@8@110230497@110235917@1@chr1:110230497-110235917@10.6@36@143@3.97@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_1, GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
A2463_26@10692@10695@deletion@4@120927138@120935468@1@chr1:120927138-120935468@10.7@162@40@0.247@CNVR320.1@FCGR1B_5, FCGR1B_4, FCGR1B_3, FCGR1B_2@0@0@0@:Fc fragment of IgG, high affinity Ib, receptor (CD64);Fc fragment of IgG, high affinity Ic, receptor (CD64), pseudogene@:IgG binding;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;antigen processing and presentation of peptide antigen via MHC class I;immune response;immunoglobulin receptor activity;clathrin-coated endocytic vesicle membrane;protein binding;interferon-gamma-mediated signaling pathway;integral to membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I;plasma membrane;Fc receptor signaling pathway;cytokine-mediated signaling pathway;early endosome membrane@NA
A2463_26@10796@10810@deletion@15@144811749@144828784@1@chr1:144811749-144828784@13.1@498@245@0.492@CNVR338.2, CNVR338.5, CNVR338.1@NBPF9_1, NBPF9_2, NBPF9_3, NBPF9_4, NBPF9_5, NBPF9_6, NBPF9_7, NBPF9_8, NBPF9_9, NBPF9_10, NBPF9_11, NBPF9_12, NBPF9_13, NBPF9_14, NBPF9_15@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 24@NA@NA
A2463_26@10856@10873@deletion@18@145248858@145311154@1@chr1:145248858-145311154@27.5@1607@810@0.504@CNVR341.2, CNVR341.1@NOTCH2NL_3, RP11-458D21.5_2, NOTCH2NL_4, RP11-458D21.5_3, NOTCH2NL_5, RP11-458D21.5_4, NOTCH2NL_6, RP11-458D21.5_5, NBPF10_1, NBPF10_2, NBPF10_3, NBPF10_4, NBPF10_5, NBPF10_6, NBPF10_7, NBPF10_8, NBPF10_9, NBPF10_10, NBPF10_11, NBPF10_12, NBPF10_13@0@0@0@:notch 2 N-terminal like:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family, member 10@:multicellular organismal development;cell differentiation;protein binding;Notch signaling pathway;extracellular region;calcium ion binding;cytoplasm:protein binding;calcium ion binding@NA
A2463_26@11077@11095@deletion@19@145748339@145816740@1@chr1:145748339-145816740@29.9@403@117@0.29@NA@PDZK1_3, PDZK1_4, PDZK1_5, PDZK1_6, PDZK1_7, PDZK1_8, PDZK1_9, GPR89A_14, GPR89A_13, GPR89A_12, GPR89A_11, GPR89A_10, GPR89A_9, GPR89A_8, GPR89A_7, GPR89A_6, GPR89A_5, GPR89A_4, GPR89A_3@0@0@0@:PDZ domain containing 1:G protein-coupled receptor 89A;G protein-coupled receptor 89B;Golgi pH regulator B-like@:PDZ domain binding;transport;transporter activity;cytoplasm;cell proliferation;protein binding;positive regulation of ion transmembrane transport;scavenger receptor binding;brush border membrane;establishment of protein localization to plasma membrane;carnitine transport;drug transport:Golgi-associated vesicle membrane;voltage-gated anion channel activity;regulation of anion transport;Golgi membrane;signal transducer activity;intracellular pH reduction;voltage-gated ion channel activity;positive regulation of I-kappaB kinase/NF-kappaB cascade;Golgi cisterna membrane;signal transduction;integral to membrane;protein transport@NA
A2463_26@11158@11184@deletion@27@146246073@146420191@1@chr1:146246073-146420191@22.8@379@154@0.406@NA@NBPF12_7, NBPF12_6, NBPF12_5, NBPF12_4, NBPF12_3, NBPF12_2, NBPF12_1, NBPF12_5, NBPF12_6, NBPF12_7, NBPF12_8, NBPF12_9, NBPF12_10, NBPF12_11, NBPF12_12, NBPF12_13, NBPF12_14, NBPF12_15, NBPF12_16, NBPF12_17, NBPF12_18, NBPF12_19, NBPF12_20, NBPF12_21, NBPF12_22, NBPF12_23, NBPF12_24@0@0@0@:neuroblastoma breakpoint family member 21-like:neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family member 14-like;neuroblastoma breakpoint family, member 12@:cytoplasm@NA
A2463_26@11300@11304@deletion@5@147400651@147416212@1@chr1:147400651-147416212@6.46@108@44@0.407@NA@GPR89B_1, GPR89B_2, GPR89B_3, GPR89B_4, GPR89B_5@0@0@0@:G protein-coupled receptor 89A;G protein-coupled receptor 89B@:Golgi-associated vesicle membrane;voltage-gated anion channel activity;regulation of anion transport;Golgi membrane;signal transducer activity;intracellular pH reduction;voltage-gated ion channel activity;positive regulation of I-kappaB kinase/NF-kappaB cascade;Golgi cisterna membrane;signal transduction;integral to membrane;protein transport@NA
A2463_26@11341@11357@deletion@17@148008574@148025848@1@chr1:148008574-148025848@43.3@671@166@0.247@CNVR346.2, CNVR346.4@NBPF14_17, NBPF14_16, NBPF14_15, NBPF14_14, NBPF14_13, NBPF14_12, NBPF14_11, NBPF14_10, NBPF14_9, NBPF14_8, NBPF14_7, NBPF14_6, NBPF14_5, NBPF14_4, NBPF14_3, NBPF14_2, NBPF14_1@0@0@0@:neuroblastoma breakpoint family, member 14@:cytoplasm@NA
A2463_26@11464@11479@deletion@16@148341796@148591373@1@chr1:148341796-148591373@13.9@300@123@0.41@NA@NBPF20_6, NBPF20_5, NBPF20_4, NBPF20_3, NBPF20_2, NBPF15_7, NBPF15_8, NBPF15_9, NBPF15_10, NBPF15_11, NBPF15_12, NBPF15_13, NBPF15_14, NBPF15_15, NBPF15_16, NBPF15_17@0@0@0@:uncharacterized LOC101060226;neuroblastoma breakpoint family member 14-like;neuroblastoma breakpoint family, member 12;neuroblastoma breakpoint family member 3-like;neuroblastoma breakpoint family, member 7:neuroblastoma breakpoint family, member 15@:cytoplasm:cytoplasm@NA
A2463_26@19477@19492@deletion@16@243289752@243364137@1@chr1:243289752-243364137@12.9@881@509@0.578@NA@CEP170_20, CEP170_19, CEP170_18, CEP170_17, CEP170_16, CEP170_15, CEP170_14, CEP170_13, CEP170_12, CEP170_11, CEP170_10, CEP170_9, CEP170_8, CEP170_7, CEP170_6, CEP170_5@0@0@0@:centrosomal protein 170kDa@:centriole;protein binding;microtubule;centrosome;spindle@NA
A2463_26@23284@23288@deletion@5@61463162@61468954@2@chr2:61463162-61468954@7.4@251@117@0.466@NA@USP34_56, USP34_55, USP34_54, USP34_53, USP34_52@0@0@0@:ubiquitin specific peptidase 34@:ubiquitin-specific protease activity;protein K48-linked deubiquitination;binding;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process;protein binding;cysteine-type endopeptidase activity;Wnt receptor signaling pathway;positive regulation of canonical Wnt receptor signaling pathway@NA
A2463_26@24935@24965@deletion@31@89246820@89544574@2@chr2:89246820-89544574@27.4@1011@524@0.518@CNVR866.7, CNVR866.10, CNVR866.11@IGKV1-5_2, IGKV1-5_1, IGKV1-6_2, IGKV1-6_1, IGKV3-7_2, IGKV3-7_1, IGKV1-8_2, IGKV1-8_1, IGKV1-9_2, IGKV1-9_1, IGKV3-11_2, IGKV3-11_1, IGKV1-12_2, IGKV1-12_1, IGKV3-15_2, IGKV3-15_1, IGKV1-16_2, IGKV1-16_1, IGKV1-17_2, IGKV1-17_1, IGKV3-20_2, IGKV3-20_1, IGKV6-21_2, IGKV6-21_1, IGKV2-24_2, IGKV2-24_1, IGKV1-27_2, IGKV1-27_1, IGKV2-28_2, IGKV2-28_1, IGKV2-30_2@0@0@0@@:protein binding:protein binding:protein binding:protein binding:protein binding:regulation of immune response;complement activation;immune response;complement activation, classical pathway;innate immune response;antigen binding;protein binding;extracellular region;plasma membrane:protein binding:protein binding:protein binding:protein binding:regulation of immune response;complement activation;immune response;complement activation, classical pathway;innate immune response;antigen binding;protein binding;extracellular region;plasma membrane:protein binding:protein binding:protein binding:protein binding:protein binding@NA
A2463_26@24998@25011@deletion@14@90121659@90229531@2@chr2:90121659-90229531@10.7@393@209@0.532@CNVR867.10, CNVR867.5, CNVR867.3, CNVR867.9@IGKV1D-17_1, IGKV1D-17_2, IGKV1D-16_1, IGKV1D-16_2, IGKV3D-15_1, IGKV3D-15_2, IGKV1D-13_1, IGKV1D-13_2, IGKV1D-12_1, IGKV1D-12_2, IGKV3D-11_1, IGKV3D-11_2, IGKV1D-42_1, IGKV1D-42_2@0@0@0@@:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding@NA
A2463_26@25106@25116@deletion@11@96624340@96652954@2@chr2:96624340-96652954@8.93@419@239@0.57@CNVR881.2@ANKRD36C_12, ANKRD36C_11, ANKRD36C_10, ANKRD36C_9, ANKRD36C_8, ANKRD36C_7, ANKRD36C_6, ANKRD36C_5, ANKRD36C_4, ANKRD36C_3, ANKRD36C_2@0@0@0@:ankyrin repeat domain-containing protein 36A-like@:ion channel inhibitor activity;protein binding@NA
A2463_26@25350@25404@deletion@55@97818242@97899608@2@chr2:97818242-97899608@48.5@2301@1257@0.546@NA@ANKRD36_14, ANKRD36_15, ANKRD36_16, ANKRD36_17, ANKRD36_18, ANKRD36_19, ANKRD36_20, ANKRD36_21, ANKRD36_22, ANKRD36_23, ANKRD36_24, ANKRD36_25, ANKRD36_26, ANKRD36_27, ANKRD36_28, ANKRD36_29, ANKRD36_30, ANKRD36_31, ANKRD36_32, ANKRD36_33, ANKRD36_34, ANKRD36_35, ANKRD36_36, ANKRD36_37, ANKRD36_38, ANKRD36_39, ANKRD36_40, ANKRD36_41, ANKRD36_42, ANKRD36_43, ANKRD36_44, ANKRD36_45, ANKRD36_46, ANKRD36_47, ANKRD36_48, ANKRD36_49, ANKRD36_50, ANKRD36_51, ANKRD36_52, ANKRD36_53, ANKRD36_54, ANKRD36_55, ANKRD36_56, ANKRD36_57, ANKRD36_58, ANKRD36_59, ANKRD36_60, ANKRD36_61, ANKRD36_62, ANKRD36_63, ANKRD36_64, ANKRD36_65, ANKRD36_66, ANKRD36_67, ANKRD36_68@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_26@25977@25996@deletion@20@107029541@107074134@2@chr2:107029541-107074134@23.1@1540@800@0.519@NA@RGPD3_22, RGPD3_21, RGPD3_20, RGPD3_19, RGPD3_18, RGPD3_17, RGPD3_16, RGPD3_15, RGPD3_14, RGPD3_13, RGPD3_12, RGPD3_11, RGPD3_10, RGPD3_9, RGPD3_8, RGPD3_7, RGPD3_6, RGPD3_5, RGPD3_4, RGPD3_3@0@0@0@:RANBP2-like and GRIP domain containing 3@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_26@26013@26028@deletion@16@108471013@108507187@2@chr2:108471013-108507187@15.2@1043@559@0.536@NA@RGPD4_8, RGPD4_9, RGPD4_10, RGPD4_11, RGPD4_12, RGPD4_13, RGPD4_14, RGPD4_15, RGPD4_16, RGPD4_17, RGPD4_18, RGPD4_19, RGPD4_20, RGPD4_21, RGPD4_22, RGPD4_23@0@0@0@:RANBP2-like and GRIP domain containing 4@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_26@26094@26107@deletion@14@109347231@109371540@2@chr2:109347231-109371540@12@1315@777@0.591@NA@RANBP2_3, RANBP2_4, RANBP2_5, RANBP2_6, RANBP2_7, RANBP2_8, RANBP2_9, RANBP2_10, RANBP2_11, RANBP2_12, RANBP2_13, RANBP2_14, RANBP2_15, RANBP2_16@0@0@0@:RAN binding protein 2@:mitotic cell cycle;intracellular transport;mRNA transport;transmembrane transport;protein folding;protein sumoylation;peptidyl-prolyl cis-trans isomerase activity;M phase of mitotic cell cycle;viral reproduction;hexose transport;cytokine-mediated signaling pathway;glucose transport;small molecule metabolic process;intracellular;carbohydrate metabolic process;Ran GTPase binding;ligase activity;cytosol;protein binding;regulation of glucose transport;mitotic prometaphase;protein import into nucleus;zinc ion binding;nuclear pore@: ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3; IIAE3
A2463_26@26299@26324@deletion@26@112526869@112582744@2@chr2:112526869-112582744@29.1@602@276@0.458@CNVR928.1@ANAPC1_48, ANAPC1_47, ANAPC1_46, ANAPC1_45, ANAPC1_44, ANAPC1_43, ANAPC1_42, ANAPC1_41, ANAPC1_40, ANAPC1_39, ANAPC1_38, ANAPC1_37, ANAPC1_36, ANAPC1_35, ANAPC1_34, ANAPC1_33, ANAPC1_32, ANAPC1_31, ANAPC1_30, ANAPC1_29, ANAPC1_28, ANAPC1_27, ANAPC1_26, ANAPC1_25, ANAPC1_24, ANAPC1_23@0@0@0@:anaphase-promoting complex subunit 1-like;anaphase promoting complex subunit 1@:nucleoplasm;regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle;anaphase-promoting complex;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle spindle assembly checkpoint;cytosol;protein K11-linked ubiquitination;protein binding;mitosis;nucleus;cell cycle checkpoint;cell division;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle@NA
A2463_26@26414@26434@deletion@21@113138402@113191030@2@chr2:113138402-113191030@15.1@718@362@0.504@NA@RGPD8_21, RGPD8_20, RGPD8_19, RGPD8_18, RGPD8_17, RGPD8_16, RGPD8_15, RGPD8_14, RGPD8_13, RGPD8_12, RGPD8_11, RGPD8_10, RGPD8_9, RGPD8_8, RGPD8_7, RGPD8_6, RGPD8_5, RGPD8_4, RGPD8_3, RGPD8_2, RGPD8_1@0@0@0@:RANBP2-like and GRIP domain containing 8@:protein binding;intracellular;intracellular transport;nuclear pore;protein targeting to Golgi;Ran GTPase binding;biological_process@NA
A2463_26@26567@26583@deletion@17@114195447@114258060@2@chr2:114195447-114258060@27.2@825@346@0.419@CNVR933.1@CBWD2_1, CBWD2_2, CBWD2_3, CBWD2_4, AC016745.1_1, CBWD2_5, CBWD2_6, CBWD2_7, CBWD2_8, CBWD2_9, CBWD2_10, CBWD2_11, CBWD2_12, CBWD2_13, CBWD2_14, CBWD2_15, FOXD4L1_1@0@0@0@:COBW domain containing 2;COBW domain containing 1;COBW domain-containing protein 1-like:forkhead box D4-like 1@:ATP binding:positive regulation of BMP signaling pathway;positive regulation of kidney development;axon extension involved in axon guidance;lateral line nerve glial cell development;DNA binding, bending;sequence-specific DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;regulation of sequence-specific DNA binding transcription factor activity;transcription factor complex;nucleus;dichotomous subdivision of terminal units involved in ureteric bud branching;sympathetic nervous system development;melanocyte differentiation;enteric nervous system development;positive regulation of transcription from RNA polymerase II promoter;regulation of transcription, DNA-dependent;neural crest cell migration;peripheral nervous system development;double-stranded DNA binding;RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity;iridophore differentiation;transcription factor binding;cartilage development;pattern specification process@NA
A2463_26@27160@27175@deletion@16@130737690@130878088@2@chr2:130737690-130878088@12.7@592@307@0.519@NA@RAB6C_1, POTEF_15, POTEF_14, POTEF_13, POTEF_12, POTEF_11, POTEF_10, POTEF_9, POTEF_8, POTEF_7, POTEF_6, POTEF_5, POTEF_4, POTEF_3, POTEF_2, POTEF_1@0@0@0@:RAB6C-like;RAB6C, member RAS oncogene family:POTE ankyrin domain family, member F@:regulation of centrosome duplication;centrosome;intracellular;response to drug;small GTPase mediated signal transduction;GTPase activity;GTP catabolic process;intracellular protein transport;signal transduction;nucleocytoplasmic transport;cell cycle process;protein transport;GTP binding;nucleus;membrane:cell cortex;protein binding;ATP binding@NA
A2463_26@27271@27288@deletion@18@131356216@131415450@2@chr2:131356216-131415450@12@441@223@0.506@NA@CFC1_3, CFC1_2, CFC1_1, POTEJ_1, POTEJ_2, POTEJ_3, POTEJ_4, POTEJ_5, POTEJ_6, POTEJ_7, POTEJ_8, POTEJ_9, POTEJ_10, POTEJ_11, POTEJ_12, POTEJ_13, POTEJ_14, POTEJ_15@0@0@0@:cripto, FRL-1, cryptic family 1:POTE ankyrin domain family, member J@:gastrulation;nodal signaling pathway;protein binding;extracellular region;nodal binding;plasma membrane;molecular_function;determination of left/right symmetry;cellular_component;anchored to membrane:protein binding;ATP binding@: TRANSPOSITION OF THE GREAT ARTERIES, DEXTRO-LOOPED 2; DTGA2; CONOTRUNCAL HEART MALFORMATIONS; CTHM; HETEROTAXY, VISCERAL, 2, AUTOSOMAL; HTX2
A2463_26@29535@29537@deletion@3@178080268@178080916@2@chr2:178080268-178080916@5.75@80@24@0.3@NA@HNRNPA3_2, HNRNPA3_3, HNRNPA3_4@0@0@0@:heterogeneous nuclear ribonucleoprotein A3@:nucleoplasm;ribonucleoprotein complex;nucleotide binding;catalytic step 2 spliceosome;RNA binding;nucleolus;RNA splicing;mRNA splicing, via spliceosome;nucleus;gene expression;nucleic acid binding@NA
A2463_26@29805@29809@deletion@5@179516992@179527782@2@chr2:179516992-179527782@8.58@207@73@0.353@CNVR1066.1@TTN_157, TTN_156, TTN_155, TTN_154, TTN_153@0@0@0@:titin@:muscle alpha-actinin binding;condensed nuclear chromosome;platelet degranulation;skeletal muscle thin filament assembly;protein tyrosine kinase activity;forward locomotion;binding;regulation of catalytic activity;ATP binding;cardiac muscle tissue morphogenesis;nucleus;sarcomerogenesis;cardiac myofibril assembly;identical protein binding;cardiac muscle fiber development;somitogenesis;platelet activation;response to calcium ion;protein self-association;actinin binding;ankyrin binding;enzyme binding;protein kinase activity;in utero embryonic development;adult heart development;structural constituent of muscle;cytosol;heart morphogenesis;calcium ion binding;Z disc;muscle filament sliding;M band;calmodulin binding;cardiac muscle contraction;striated muscle contraction;transferase activity, transferring phosphorus-containing groups;A band;skeletal muscle myosin thick filament assembly;mitotic chromosome condensation;blood coagulation;striated muscle thin filament;sarcomere;regulation of protein kinase activity;protein serine/threonine kinase activity;Golgi apparatus;protein phosphorylation;protease binding;cytoplasm;protein binding;striated muscle cell development;actin filament binding;extracellular region;I band;telethonin binding;sarcomere organization;cardiac muscle hypertrophy;detection of muscle stretch;muscle contraction;nucleic acid binding@: MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2J; LGMD2J; MYOPATHY, EARLY-ONSET, WITH FATAL CARDIOMYOPATHY; TIBIAL MUSCULAR DYSTROPHY, TARDIVE; CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 9; CMH9; CARDIOMYOPATHY, DILATED, 1G; CMD1G; HEREDITARY MYOPATHY WITH EARLY RESPIRATORY FAILURE; HMERF
A2463_26@39892@39894@deletion@3@75786030@75790887@3@chr3:75786030-75790887@12.1@94@1@0.0106@CNVR1432.5, CNVR1432.9, CNVR1432.4@ZNF717_5, ZNF717_4, ZNF717_3@0@0@0@:zinc finger protein 717;zinc finger protein 717-like@:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_26@55781@55791@deletion@11@68860961@68878256@5@chr5:68860961-68878256@8.83@146@57@0.39@CNVR2494.7, CNVR2494.46@GTF2H2C_2, GTF2H2C_3, GTF2H2C_4, GTF2H2C_5, GTF2H2C_6, GTF2H2C_7, GTF2H2C_8, GTF2H2C_9, GTF2H2C_10, GTF2H2C_11, GTF2H2C_12@0@0@0@:general transcription factor IIH, polypeptide 2C;general transcription factor IIH, polypeptide 2D@:regulation of transcription, DNA-dependent;nucleotide-excision repair;DNA repair;core TFIIH complex;protein binding;nucleus;transcription, DNA-dependent;zinc ion binding@NA
A2463_26@61257@61277@deletion@21@177151115@177220472@5@chr5:177151115-177220472@20.8@287@101@0.352@NA@FAM153A_20, FAM153A_19, FAM153A_18, FAM153A_17, FAM153A_16, FAM153A_15, FAM153A_14, FAM153A_13, FAM153A_12, FAM153A_11, FAM153A_10, FAM153A_9, FAM153A_8, FAM153A_7, FAM153A_6, FAM153A_5, FAM153A_4, FAM153A_3, RP11-1026M7.2_2, RP11-1026M7.2_3@0@0@0@:family with sequence similarity 153, member A@NA@NA
A2463_26@63290@63292@deletion@3@31323945@31324935@6@chr6:31323945-31324935@9.21@132@33@0.25@CNVR2841.12, CNVR2841.14, CNVR2841.8@HLA-B_3, HLA-B_2, HLA-B_1@0@0@0@:major histocompatibility complex, class I, B@:MHC class I protein complex;regulation of immune response;regulation of interleukin-12 production;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;regulation of T cell anergy;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;receptor binding;early endosome membrane;virus-host interaction;regulation of interleukin-6 production;regulation of dendritic cell differentiation;phagocytic vesicle membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;MHC class I receptor activity;membrane@: SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO; SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1; SPDA1
A2463_26@63725@63736@deletion@12@31962023@31965541@6@chr6:31962023-31965541@15.7@448@234@0.522@CNVR2843.6, CNVR2843.3@C4A_20, C4A_21, C4A_22, C4A_23, C4A_24, C4A_25, C4A_26, C4A_27, C4A_28, C4A_29, C4A_30, C4A_31@0@0@0@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
A2463_26@63774@63779@deletion@6@31996471@31998278@6@chr6:31996471-31998278@6.7@236@154@0.653@CNVR2843.6, CNVR2843.5@C4B_26, C4B_27, C4B_28, C4B_29, C4B_30, C4B_31@0@0@0@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
A2463_26@63800@63810@deletion@11@32009127@32011906@6@chr6:32009127-32011906@8.37@224@181@0.808@CNVR2843.6, CNVR2843.5@TNXB_13, TNXB_12, TNXB_11, TNXB_10, TNXB_9, TNXB_8, TNXB_7, TNXB_6, TNXB_5, TNXB_4, TNXB_3@0@0@0@:cytochrome P450, family 21, subfamily A, polypeptide 2:tenascin-X-like;tenascin XB@:oxidation-reduction process;electron carrier activity;response to antibiotic;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;steroid 21-monooxygenase activity;C21-steroid hormone biosynthetic process;heme binding;mineralocorticoid biosynthetic process;progesterone metabolic process;monooxygenase activity;cellular response to peptide hormone stimulus;iron ion binding:integrin binding;extracellular matrix;cell-cell adhesion;elastic fiber assembly;collagen fibril organization;fibrillar collagen;actin cytoskeleton organization;extracellular space;heparin binding;proteinaceous extracellular matrix;fatty acid metabolic process;regulation of JUN kinase activity;receptor binding;intracellular;cell-matrix adhesion;extracellular matrix organization;lipid metabolic process;protein binding;signal transduction;extracellular region;collagen binding;cell adhesion;triglyceride metabolic process;fibril organization;collagen metabolic process@: ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY: EHLERS-DANLOS-LIKE SYNDROME DUE TO TENASCIN-X DEFICIENCY; EHLERS-DANLOS SYNDROME, TYPE III
A2463_26@63959@63974@deletion@16@32546869@32634384@6@chr6:32546869-32634384@17.9@628@335@0.533@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.34@HLA-DRB1_6, HLA-DRB1_5, HLA-DRB1_4, HLA-DRB1_3, HLA-DRB1_2, HLA-DRB1_1, HLA-DQA1_1, HLA-DQA1_2, HLA-DQA1_3, HLA-DQA1_4, HLA-DQB1_6, HLA-DQB1_5, HLA-DQB1_4, HLA-DQB1_3, HLA-DQB1_2, HLA-DQB1_1@0@0@0@:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
A2463_26@66865@66871@deletion@7@74227534@74229749@6@chr6:74227534-74229749@8.76@158@64@0.405@NA@EEF1A1_7, EEF1A1_6, EEF1A1_5, EEF1A1_4, EEF1A1_3, EEF1A1_2, EEF1A1_1@0@0@0@:eukaryotic translation elongation factor 1 alpha 1@:translational elongation;protein kinase binding;translation elongation factor activity;GTPase activity;regulation of transcription, DNA-dependent;cytoplasm;cytosol;protein binding;cellular protein metabolic process;GTP binding;nucleus;eukaryotic translation elongation factor 1 complex;transcription, DNA-dependent;translation;gene expression@NA
A2463_26@70823@70826@deletion@4@161085199@161128838@6@chr6:161085199-161128838@7.39@238@104@0.437@NA@LPA_2, PLG_1, PLG_2, PLG_3@0@0@0@:lipoprotein, Lp(a):plasminogen@:blood circulation;endopeptidase inhibitor activity;catalytic activity;lipoprotein metabolic process;proteolysis;heparin binding;receptor-mediated endocytosis;fibronectin binding;small molecule metabolic process;apolipoprotein binding;lipid metabolic process;negative regulation of endopeptidase activity;extracellular region;plasma lipoprotein particle;lipid transport;serine-type endopeptidase activity:platelet degranulation;negative regulation of cell proliferation;extrinsic to plasma membrane;induction of apoptosis;proteolysis;tissue regeneration;negative regulation of cell-substrate adhesion;plasma membrane;negative regulation of cell-cell adhesion mediated by cadherin;positive regulation of fibrinolysis;labyrinthine layer blood vessel development;platelet activation;platelet alpha granule lumen;tissue remodeling;extracellular matrix disassembly;negative regulation of fibrinolysis;proteolysis involved in cellular protein catabolic process;protein domain specific binding;serine-type endopeptidase activity;fibrinolysis;muscle cell homeostasis;endopeptidase activity;mononuclear cell migration;catalytic activity;extrinsic to external side of plasma membrane;blood coagulation;extracellular space;myoblast differentiation;trophoblast giant cell differentiation;apoptotic process;intracellular membrane-bounded organelle;apolipoprotein binding;cell surface binding;extracellular matrix organization;protein binding;extracellular region@: APOLIPOPROTEIN(a); LPA: PLASMINOGEN DEFICIENCY, TYPE I
A2463_26@71744@71780@deletion@37@5939916@6022622@7@chr7:5939916-6022622@29.4@886@445@0.502@NA@CCZ1_2, CCZ1_3, CCZ1_4, CCZ1_5, CCZ1_6, CCZ1_7, CCZ1_8, CCZ1_9, CCZ1_10, CCZ1_11, CCZ1_12, CCZ1_13, CCZ1_14, CCZ1_15, RSPH10B_20, RSPH10B_19, RSPH10B_18, RSPH10B_17, RSPH10B_16, RSPH10B_15, RSPH10B_14, RSPH10B_13, RSPH10B_12, RSPH10B_11, RSPH10B_10, RSPH10B_9, RSPH10B_8, RSPH10B_7, RSPH10B_6, RSPH10B_5, RSPH10B_4, RSPH10B_3, RSPH10B_2, PMS2_15, PMS2_14, PMS2_13, PMS2_12@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae):radial spoke head 10 homolog B (Chlamydomonas):PMS2 postmeiotic segregation increased 2 (S. cerevisiae)@:lysosomal membrane:response to drug;DNA binding;MutSalpha complex binding;ATP binding;mismatch repair;DNA repair;mismatched DNA binding;ATPase activity;nucleus;mismatch repair complex;reciprocal meiotic recombination;ATP catabolic process;single-stranded DNA binding;response to DNA damage stimulus;single base insertion or deletion binding;protein binding;somatic hypermutation of immunoglobulin genes;somatic recombination of immunoglobulin gene segments;MutLalpha complex;endonuclease activity@: COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 4; HNPCC4; MISMATCH REPAIR CANCER SYNDROME
A2463_26@71945@71955@deletion@11@6845636@6865828@7@chr7:6845636-6865828@13.7@379@176@0.464@NA@CCZ1B_11, CCZ1B_10, CCZ1B_9, CCZ1B_8, CCZ1B_7, CCZ1B_6, CCZ1B_5, CCZ1B_4, CCZ1B_3, CCZ1B_2, CCZ1B_1@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
A2463_26@74626@74640@deletion@15@74524758@74565103@7@chr7:74524758-74565103@9.01@262@110@0.42@NA@GTF2IRD2B_2, GTF2IRD2B_3, GTF2IRD2B_4, GTF2IRD2B_5, GTF2IRD2B_6, GTF2IRD2B_7, GTF2IRD2B_8, GTF2IRD2B_9, GTF2IRD2B_10, GTF2IRD2B_11, GTF2IRD2B_12, GTF2IRD2B_13, GTF2IRD2B_14, GTF2IRD2B_15, GTF2IRD2B_16@0@0@0@:GTF2I repeat domain containing 2B@:nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_26@76243@76245@deletion@3@99909374@99912373@7@chr7:99909374-99912373@8.07@43@1@0.0233@CNVR3508.2, CNVR3508.1@SPDYE3_4, SPDYE3_5, SPDYE3_6@0@0@0@:speedy homolog E3 (Xenopus laevis)@NA@NA
A2463_26@76427@76432@deletion@6@100331793@100336236@7@chr7:100331793-100336236@22.4@131@1@0.00763@CNVR3509.1@ZAN_1, ZAN_2, ZAN_3, ZAN_4, ZAN_5, ZAN_6@0@0@0@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
A2463_26@76743@76753@deletion@11@102194807@102214371@7@chr7:102194807-102214371@8.16@182@59@0.324@CNVR3518.1@SPDYE2_3, SPDYE2_4, SPDYE2_5, SPDYE2_6, SPDYE2_7, SPDYE2_8, POLR2J3_4, POLR2J3_3, POLR2J3_2, POLR2J3_1, AC093668.1_3, AC093668.1_2@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:speedy homolog E2 (Xenopus laevis)@:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
A2463_26@76792@76794@deletion@3@102309363@102313443@7@chr7:102309363-102313443@6.18@107@43@0.402@CNVR3518.1@POLR2J2_2, POLR2J2_2, POLR2J2_1, POLR2J2_1, AC105052.1_3, AC105052.1_2@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
A2463_26@79309@79315@deletion@7@143880598@144062916@7@chr7:143880598-144062916@15.7@592@234@0.395@CNVR3598.4@CTAGE4_1, ARHGEF35_2, OR2A42_1, OR2A7_1, CTAGE8_1, OR2A1_1, ARHGEF5_2@0@0@0@:CTAGE family, member 4:Rho guanine nucleotide exchange factor (GEF) 35:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1:olfactory receptor, family 2, subfamily A, member 7:CTAGE family, member 6, pseudogene;CTAGE family, member 15, pseudogene:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:integral to membrane;nucleotide binding;cellular_component;biological_process:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
A2463_26@80392@80403@deletion@12@7673082@7721057@8@chr8:7673082-7721057@12.9@159@44@0.277@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@DEFB107A_1, DEFB105A_3, DEFB105A_2, DEFB105A_1, DEFB106A_1, DEFB106A_2, DEFB104A_1, DEFB104A_2, SPAG11A_1, SPAG11A_2, SPAG11A_3, SPAG11A_4@0@0@0@:defensin, beta 107B;defensin, beta 107A:defensin, beta 105B;defensin, beta 105A:defensin, beta 106B;defensin, beta 106A:defensin, beta 104A;defensin, beta 104B:sperm associated antigen 11A;sperm associated antigen 11B@:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response@NA
A2463_26@86629@86646@deletion@18@35061@178969@9@chr9:35061-178969@19.1@745@427@0.573@CNVR4135.1@FAM138C_2, FAM138C_1, FOXD4_1, CBWD1_15, CBWD1_14, CBWD1_13, CBWD1_12, CBWD1_11, CBWD1_10, CBWD1_9, CBWD1_8, CBWD1_7, CBWD1_6, CBWD1_5, CBWD1_4, CBWD1_3, CBWD1_2, CBWD1_1@0@0@0@:forkhead box D4:COBW domain containing 1;COBW domain-containing protein 1-like;COBW domain containing 5@:positive regulation of BMP signaling pathway;positive regulation of kidney development;axon extension involved in axon guidance;lateral line nerve glial cell development;DNA binding, bending;sequence-specific DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;regulation of sequence-specific DNA binding transcription factor activity;transcription factor complex;nucleus;dichotomous subdivision of terminal units involved in ureteric bud branching;sympathetic nervous system development;melanocyte differentiation;enteric nervous system development;positive regulation of transcription from RNA polymerase II promoter;multicellular organismal development;regulation of transcription, DNA-dependent;neural crest cell migration;peripheral nervous system development;double-stranded DNA binding;RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity;iridophore differentiation;transcription factor binding;cartilage development;pattern specification process:ATP binding@NA
A2463_26@88584@88609@deletion@26@43624656@43915590@9@chr9:43624656-43915590@21.8@969@410@0.423@CNVR4294.1@SPATA31A6_4, SPATA31A6_3, SPATA31A6_2, SPATA31A6_1, CNTNAP3B_1, CNTNAP3B_2, CNTNAP3B_3, CNTNAP3B_4, CNTNAP3B_5, CNTNAP3B_6, CNTNAP3B_7, CNTNAP3B_8, CNTNAP3B_9, CNTNAP3B_10, CNTNAP3B_11, CNTNAP3B_12, CNTNAP3B_13, CNTNAP3B_14, CNTNAP3B_15, CNTNAP3B_16, CNTNAP3B_17, CNTNAP3B_18, CNTNAP3B_19, CNTNAP3B_20, CNTNAP3B_21, CNTNAP3B_22@0@0@0@:SPATA31 subfamily A, member 6:contactin associated protein-like 3B;contactin associated protein-like 3@:integral to membrane:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
A2463_26@88658@88665@deletion@8@69200360@69235606@9@chr9:69200360-69235606@9.76@165@64@0.388@NA@FOXD4L6_1, CBWD6_15, CBWD6_14, CBWD6_13, CBWD6_12, CBWD6_11, CBWD6_10, CBWD6_9@0@0@0@:forkhead box D4-like 6;forkhead box protein D4-like 6-like:COBW domain containing 6@:positive regulation of BMP signaling pathway;positive regulation of kidney development;axon extension involved in axon guidance;lateral line nerve glial cell development;DNA binding, bending;sequence-specific DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;regulation of sequence-specific DNA binding transcription factor activity;transcription factor complex;nucleus;dichotomous subdivision of terminal units involved in ureteric bud branching;sympathetic nervous system development;melanocyte differentiation;enteric nervous system development;positive regulation of transcription from RNA polymerase II promoter;regulation of transcription, DNA-dependent;neural crest cell migration;peripheral nervous system development;double-stranded DNA binding;RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity;iridophore differentiation;transcription factor binding;cartilage development;pattern specification process:ATP binding@NA
A2463_26@88679@88690@deletion@12@69389940@69424176@9@chr9:69389940-69424176@8.6@304@164@0.539@NA@ANKRD20A4_4, ANKRD20A4_5, ANKRD20A4_6, ANKRD20A4_7, ANKRD20A4_8, ANKRD20A4_9, ANKRD20A4_10, ANKRD20A4_11, ANKRD20A4_12, ANKRD20A4_13, ANKRD20A4_14, ANKRD20A4_15@0@0@0@:ankyrin repeat domain 20 family, member A4@:protein binding@NA
A2463_26@88718@88726@deletion@9@70881137@70919121@9@chr9:70881137-70919121@11@155@50@0.323@NA@CBWD3_8, CBWD3_9, CBWD3_10, CBWD3_11, CBWD3_12, CBWD3_13, CBWD3_14, CBWD3_15, FOXD4L3_1@0@0@0@:COBW domain-containing protein 5-like;COBW domain-containing protein 1-like;COBW domain containing 3:forkhead box D4-like 3@:ATP binding:sequence-specific DNA binding;nucleus;regulation of transcription, DNA-dependent;sequence-specific DNA binding transcription factor activity@NA
A2463_26@91242@91246@duplication@5@117085415@117087432@9@chr9:117085415-117087432@9.81@154@438@2.84@CNVR4448.1@ORM1_1, ORM1_2, ORM1_3, ORM1_4, ORM1_5@0@0@0@:orosomucoid 1@:protein binding;extracellular space;regulation of immune system process;transport;inflammatory response;extracellular region;acute-phase response@NA
A2463_26@94602@94618@deletion@17@5008107@5046027@10@chr10:5008107-5046027@10.9@322@168@0.522@NA@AKR1C1_2, AKR1C1_3, AKR1C1_4, AKR1C1_5, AKR1C1_6, AKR1C1_7, AKR1C1_8, AKR1C1_9, AKR1C2_9, AKR1C2_8, AKR1C2_7, AKR1C2_6, AKR1C2_5, AKR1C2_4, AKR1C2_3, AKR1C2_2, AKR1C2_1@0@0@0@:aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase):aldo-keto reductase family 1, member C2 (dihydrodiol dehydrogenase 2; bile acid binding protein; 3-alpha hydroxysteroid dehydrogenase, type III);aldo-keto reductase family 1 member C2-like@:trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity;bile acid and bile salt transport;oxidation-reduction process;phenanthrene 9,10-monooxygenase activity;indanol dehydrogenase activity;daunorubicin metabolic process;carboxylic acid binding;retinal metabolic process;response to organophosphorus;cholesterol homeostasis;ketosteroid monooxygenase activity;progesterone metabolic process;oxidoreductase activity;17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity;aldo-keto reductase (NADP) activity;digestion;androsterone dehydrogenase (B-specific) activity;doxorubicin metabolic process;alditol:NADP+ 1-oxidoreductase activity;bile acid binding;oxidoreductase activity, acting on NADH or NADPH, quinone or similar compound as acceptor;bile acid metabolic process;xenobiotic metabolic process;cytosol;protein homooligomerization;intestinal cholesterol absorption;cellular response to jasmonic acid stimulus:trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity;steroid metabolic process;oxidation-reduction process;phenanthrene 9,10-monooxygenase activity;prostaglandin F receptor activity;daunorubicin metabolic process;carboxylic acid binding;ketosteroid monooxygenase activity;progesterone metabolic process;oxidoreductase activity;digestion;positive regulation of cell proliferation;prostaglandin metabolic process;doxorubicin metabolic process;response to prostaglandin stimulus;positive regulation of protein kinase B signaling cascade;alditol:NADP+ 1-oxidoreductase activity;androsterone dehydrogenase (A-specific) activity;bile acid binding;G-protein coupled receptor signaling pathway;oxidoreductase activity, acting on NADH or NADPH, quinone or similar compound as acceptor;cytoplasm;cellular response to jasmonic acid stimulus@: 46,XY SEX REVERSAL 8; SRXY8
A2463_26@95563@95568@deletion@6@22606814@22607947@10@chr10:22606814-22607947@8.06@277@124@0.448@NA@BMI1_2, COMMD3_2, BMI1_3, COMMD3_3, BMI1_4, COMMD3_4, COMMD3_5, COMMD3_6, BMI1_5, COMMD3_7@0@0@0@:COMM domain containing 3:COMMD3-BMI1 readthrough;BMI1 polycomb ring finger oncogene@:protein binding:embryonic skeletal system development;negative regulation of apoptotic process;nuclear body;ubiquitin ligase complex;embryonic skeletal system morphogenesis;sequence-specific DNA binding;positive regulation of fibroblast proliferation;nucleus;histone acetylation;in utero embryonic development;chromatin binding;positive regulation of B cell proliferation;humoral immune response;nucleolus;hemopoiesis;transcription, DNA-dependent;rostrocaudal neural tube patterning;RING-like zinc finger domain binding;zinc ion binding;skeletal system development;positive regulation of ubiquitin-protein ligase activity;positive regulation of immature T cell proliferation in thymus;segment specification;PcG protein complex;histone ubiquitination;ubiquitin-protein ligase activity;regulation of gene expression;somatic stem cell division;cytoplasm;protein binding;brain development;negative regulation of transcription from RNA polymerase II promoter;PRC1 complex@NA
A2463_26@96233@96247@deletion@15@37451578@37488716@10@chr10:37451578-37488716@9.52@506@263@0.52@CNVR4692.1, CNVR4692.2@ANKRD30A_16, ANKRD30A_17, ANKRD30A_18, ANKRD30A_19, ANKRD30A_20, ANKRD30A_21, ANKRD30A_22, ANKRD30A_23, ANKRD30A_24, ANKRD30A_25, ANKRD30A_26, ANKRD30A_27, ANKRD30A_28, ANKRD30A_29, ANKRD30A_30@0@0@0@:ankyrin repeat domain 30A@:protein binding;nucleus;DNA binding;regulation of transcription, DNA-dependent;sequence-specific DNA binding transcription factor activity@NA
A2463_26@96433@96455@deletion@23@46246931@46322838@10@chr10:46246931-46322838@21.4@508@301@0.593@CNVR4711.1@FAM21C_11, FAM21C_12, FAM21C_13, FAM21C_14, FAM21C_15, FAM21C_16, FAM21C_17, FAM21C_18, FAM21C_19, FAM21C_20, FAM21C_21, FAM21C_22, FAM21C_23, FAM21C_24, FAM21C_25, FAM21C_26, FAM21C_27, FAM21C_28, FAM21C_29, FAM21C_30, FAM25E_2, FAM25E_1, AGAP4_7@0@0@0@:family with sequence similarity 21, member C:ArfGAP with GTPase domain, ankyrin repeat and PH domain 4;arf-GAP with GTPase, ANK repeat and PH domain-containing protein 5-like@:endosome;protein binding;plasma membrane;retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity@NA
A2463_26@96540@96581@deletion@42@47903160@48055018@10@chr10:47903160-48055018@59@482@99@0.205@CNVR4715.2@FAM21B_6, FAM21B_7, FAM21B_8, FAM21B_9, FAM21B_10, FAM21B_11, FAM21B_12, FAM21B_13, FAM21B_14, FAM21B_15, FAM21B_16, FAM21B_17, FAM21B_18, FAM21B_19, FAM21B_20, FAM21B_21, FAM21B_22, FAM21B_23, FAM21B_24, FAM21B_25, FAM21B_26, FAM21B_27, FAM21B_28, FAM21B_29, ASAH2C_18, ASAH2C_17, ASAH2C_16, ASAH2C_15, ASAH2C_14, ASAH2C_13, ASAH2C_12, ASAH2C_11, ASAH2C_10, ASAH2C_9, ASAH2C_8, ASAH2C_7, ASAH2C_6, ASAH2C_5, ASAH2C_4, ASAH2C_3, ASAH2C_2, ASAH2C_1@0@0@0@:family with sequence similarity 21, member B@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome:ceramidase activity;sphingolipid metabolic process@NA
A2463_26@96700@96711@duplication@12@49998773@50029221@10@chr10:49998773-50029221@8.2@256@402@1.57@NA@WDFY4_22, WDFY4_23, WDFY4_24, WDFY4_25, WDFY4_26, WDFY4_27, WDFY4_28, WDFY4_29, WDFY4_30, WDFY4_31, WDFY4_32, WDFY4_33@0@0@0@:WDFY family member 4@:protein binding;integral to membrane;binding@NA
A2463_26@96858@96863@deletion@6@51466577@51486201@10@chr10:51466577-51486201@7.72@71@17@0.239@CNVR4729.1@AGAP7_6, AGAP7_5, AGAP7_4, AGAP7_3, AGAP7_2, AGAP7_1@0@0@0@:translocase of inner mitochondrial membrane 23 homolog B (yeast):ArfGAP with GTPase domain, ankyrin repeat and PH domain 7@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity@NA
A2463_26@97750@97770@duplication@21@73558112@73575035@10@chr10:73558112-73575035@15.6@522@828@1.59@NA@CDH23_3, CDH23_4, CDH23_5, CDH23_6, CDH23_7, CDH23_8, CDH23_9, CDH23_10, CDH23_11, CDH23_12, CDH23_13, CDH23_14, CDH23_15, CDH23_16, CDH23_17, CDH23_18, CDH23_19, CDH23_20, CDH23_21, CDH23_22, CDH23_23@0@0@0@:cadherin-23-like;cadherin-related 23@:locomotory behavior;photoreceptor cell maintenance;calcium ion transport;stereocilium bundle tip;auditory receptor cell stereocilium organization;cytosolic calcium ion homeostasis;integral to membrane;homophilic cell adhesion;plasma membrane;post-embryonic organ morphogenesis;photoreceptor inner segment;microtubule basal body;sensory perception of sound;cilium;stereocilium;equilibrioception;protein binding;synapse;calcium-dependent cell-cell adhesion;sensory perception of light stimulus;membrane;calcium ion binding@: USHER SYNDROME, TYPE I; USH1; DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12; USHER SYNDROME, TYPE ID; USH1D
A2463_26@98233@98260@duplication@28@79552199@79613295@10@chr10:79552199-79613295@14.4@618@913@1.48@NA@DLG5_32, DLG5_31, DLG5_30, DLG5_29, DLG5_28, DLG5_27, DLG5_26, DLG5_25, DLG5_24, DLG5_23, DLG5_22, DLG5_21, DLG5_20, DLG5_19, DLG5_18, DLG5_17, DLG5_16, DLG5_15, DLG5_14, DLG5_13, DLG5_12, DLG5_11, DLG5_10, DLG5_9, DLG5_8, DLG5_7, DLG5_6, DLG5_5@0@0@0@:discs, large homolog 5 (Drosophila)@:cell-cell adhesion;negative regulation of cell proliferation;beta-catenin binding;intracellular;cell-cell adherens junction;cytoplasm;cytoskeletal protein binding;protein binding;signal transduction;receptor signaling complex scaffold activity;plasma membrane;regulation of apoptotic process;intracellular signal transduction@NA
A2463_26@98313@98323@duplication@11@81058164@81072506@10@chr10:81058164-81072506@10.2@248@429@1.73@NA@ZMIZ1_15, ZMIZ1_16, ZMIZ1_17, ZMIZ1_18, ZMIZ1_19, ZMIZ1_20, ZMIZ1_21, ZMIZ1_22, ZMIZ1_23, ZMIZ1_24, ZMIZ1_25@0@0@0@:zinc finger, MIZ-type containing 1@:artery morphogenesis;vasculogenesis;nuclear speck;in utero embryonic development;regulation of transcription, DNA-dependent;cell aging;cytoplasm;vitellogenesis;developmental growth;heart morphogenesis;positive regulation of fibroblast proliferation;transcription, DNA-dependent;zinc ion binding;positive regulation of transcription from RNA polymerase II promoter@NA
A2463_26@98348@98357@deletion@10@81470139@81610362@10@chr10:81470139-81610362@8.53@227@132@0.581@CNVR4815.2@FAM22B_5, FAM22B_6, FAM22B_7, FAM22E_1, FAM22E_2, FAM22E_3, FAM22E_4, FAM22E_5, FAM22E_6, FAM22E_7@0@0@0@NA@NA@NA
A2463_26@102176@102202@duplication@27@134754501@135015402@10@chr10:134754501-135015402@17.2@539@866@1.61@NA@TTC40_4, TTC40_3, TTC40_2, TTC40_1, GPR123_3, GPR123_4, GPR123_5, GPR123_6, GPR123_7, KNDC1_1, KNDC1_2, KNDC1_3, KNDC1_4, KNDC1_5, KNDC1_6, KNDC1_7, KNDC1_8, KNDC1_9, KNDC1_10, KNDC1_11, KNDC1_12, KNDC1_13, KNDC1_14, KNDC1_15, KNDC1_16, KNDC1_17@0@0@0@:tetratricopeptide repeat domain 40:G protein-coupled receptor 123:kinase non-catalytic C-lobe domain (KIND) containing 1@:transmembrane signaling receptor activity;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;cytoplasm;signal transduction;integral to membrane;plasma membrane;membrane;cell surface receptor signaling pathway:neuronal cell body;regulation of dendrite development;transferase activity, transferring phosphorus-containing groups;guanyl-nucleotide exchange factor activity;cerebellar granule cell differentiation;regulation of small GTPase mediated signal transduction;Ras guanyl-nucleotide exchange factor activity;dendrite;biological_process;protein serine/threonine kinase activity;small GTPase mediated signal transduction;intracellular;regulation of dendrite morphogenesis;protein binding;positive regulation of protein phosphorylation;molecular_function;cellular_component;guanyl-nucleotide exchange factor complex@NA
A2463_26@102263@102275@duplication@13@135122895@135165644@10@chr10:135122895-135165644@10.5@285@483@1.69@NA@ZNF511_2, ZNF511_3, ZNF511_4, ZNF511_5, ZNF511_6, CALY_5, CALY_4, CALY_3, CALY_2, PRAP1_1, PRAP1_2, PRAP1_3, PRAP1_4@0@0@0@:tubulin, gamma complex associated protein 2:zinc finger protein 511:calcyon neuron-specific vesicular protein:proline-rich acidic protein 1@:mitotic cell cycle;centrosome;protein complex assembly;microtubule organizing center;G2/M transition of mitotic cell cycle;microtubule nucleation;cytosol;protein binding;cytoplasmic microtubule;nucleus;microtubule cytoskeleton organization;spindle pole:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:cytoplasmic vesicle membrane;positive regulation of endocytosis;endocytosis;dopamine receptor binding;clathrin coat assembly;dopamine receptor signaling pathway;cytoplasmic vesicle;integral to membrane;clathrin light chain binding;integral to plasma membrane:extracellular region@NA
A2463_26@110109@110120@deletion@12@89531299@89609185@11@chr11:89531299-89609185@9.3@704@409@0.581@NA@TRIM49_8, TRIM49_7, TRIM49_6, TRIM49_5, TRIM49_4, TRIM49_3, TRIM64B_6, TRIM64B_5, TRIM64B_4, TRIM64B_3, TRIM64B_2, TRIM64B_1@0@0@0@:tripartite motif containing 49:tripartite motif containing 64;tripartite motif containing 64C;tripartite motif containing 64B@:protein binding;intracellular;DNA binding;zinc ion binding:protein binding;intracellular;zinc ion binding@NA
A2463_26@114132@114139@deletion@8@8326923@8377428@12@chr12:8326923-8377428@9.37@702@381@0.543@CNVR5422.3, CNVR5422.5, CNVR5422.7@ZNF705A_2, ZNF705A_3, ZNF705A_4, ZNF705A_5, FAM90A1_7, FAM90A1_6, FAM90A1_5, FAM90A1_4@0@0@0@:zinc finger protein 705A;zinc finger protein 705E:family with sequence similarity 90, member A1@:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding:zinc ion binding;nucleic acid binding@NA
A2463_26@114219@114224@deletion@6@9086462@9090656@12@chr12:9086462-9090656@7.82@91@28@0.308@NA@PHC1_9, PHC1_10, PHC1_11, PHC1_12, PHC1_13, PHC1_14@0@0@0@:polyhomeotic homolog 1 (Drosophila)@:multicellular organismal development;cellular response to retinoic acid;sex chromatin;nuclear body;DNA binding;chromatin binding;protein binding;nucleus;PcG protein complex;zinc ion binding;PRC1 complex@NA
A2463_26@114422@114429@deletion@8@10572466@10588585@12@chr12:10572466-10588585@7.84@248@120@0.484@CNVR5430.1@KLRC3_2, KLRC3_1, KLRC2_6, KLRC2_5, KLRC2_4, KLRC2_3, NKG2-E_3, KLRC2_2, NKG2-E_2, KLRC2_1, NKG2-E_1@0@0@0@:killer cell lectin-like receptor subfamily C, member 3:killer cell lectin-like receptor subfamily C, member 2@:transmembrane signaling receptor activity;carbohydrate binding;integral to membrane;cellular defense response:carbohydrate binding:transmembrane signaling receptor activity;carbohydrate binding;protein binding;signal transduction;cellular defense response;integral to plasma membrane@NA
A2463_26@115528@115537@deletion@10@31240873@31249313@12@chr12:31240873-31249313@10.8@402@222@0.552@CNVR5483.1@DDX11_6, DDX11_7, DDX11_8, DDX11_9, DDX11_10, DDX11_11, DDX11_12, DDX11_13, DDX11_14, DDX11_15@0@0@0@:DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11@:nucleoplasm;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;S phase of mitotic cell cycle;DNA binding;nucleobase-containing compound metabolic process;ATP binding;ATP-dependent DNA helicase activity;DNA helicase activity;midbody;RNA binding;DNA-dependent ATPase activity;nucleus;positive regulation of cell proliferation;virus-host interaction;nuclear chromatin;4 iron, 4 sulfur cluster binding;helicase activity;hydrolase activity, acting on acid anhydrides;DNA duplex unwinding;endoplasmic reticulum unfolded protein response;G2/M transition of mitotic cell cycle;protein binding;sister chromatid cohesion;activation of signaling protein activity involved in unfolded protein response;nucleolus;spindle pole;ATP-dependent helicase activity;metal ion binding;nucleic acid binding;mitotic sister chromatid segregation@: WARSAW BREAKAGE SYNDROME
A2463_26@117161@117181@deletion@21@52843797@52886972@12@chr12:52843797-52886972@25.3@1288@664@0.516@NA@KRT6B_3, KRT6B_2, KRT6B_1, KRT6C_9, KRT6C_8, KRT6C_7, KRT6C_6, KRT6C_5, KRT6C_4, KRT6C_3, KRT6C_2, KRT6C_1, KRT6A_9, KRT6A_8, KRT6A_7, KRT6A_6, KRT6A_5, KRT6A_4, KRT6A_3, KRT6A_2, KRT6A_1@0@0@0@:keratin 6B:keratin 6C:keratin 6A@:keratin filament;structural constituent of cytoskeleton;ectoderm development:intermediate filament;structural molecule activity;keratin filament;cytoskeleton organization:cell differentiation;protein binding;intermediate filament;keratin filament;positive regulation of cell proliferation;structural constituent of cytoskeleton;ectoderm development@: PACHYONYCHIA CONGENITA, TYPE 2; PC2: PACHYONYCHIA CONGENITA, TYPE 1; PC1
A2463_26@117612@117618@deletion@7@54675580@54677751@12@chr12:54675580-54677751@6.67@250@123@0.492@NA@HNRNPA1_3, HNRNPA1_4, HNRNPA1_5, HNRNPA1_6, HNRNPA1_7, HNRNPA1_8, HNRNPA1_9@0@0@0@:heterogeneous nuclear ribonucleoprotein A1@:nucleoplasm;single-stranded RNA binding;catalytic step 2 spliceosome;mRNA transport;RNA binding;nucleus;gene expression;virus-host interaction;nuclear export;RNA export from nucleus;ribonucleoprotein complex;intermediate filament cytoskeleton;single-stranded DNA binding;nuclear import;nucleotide binding;spliceosomal complex;cytoplasm;mRNA processing;nucleolus;alternative mRNA splicing, via spliceosome;mRNA splicing, via spliceosome;RNA splicing;nucleic acid binding@NA
A2463_26@118884@118894@deletion@11@63977593@64020306@12@chr12:63977593-64020306@10.2@472@261@0.553@CNVR5566.1@DPY19L2_17, DPY19L2_16, DPY19L2_15, DPY19L2_14, DPY19L2_13, DPY19L2_12, DPY19L2_11, DPY19L2_10, DPY19L2_9, DPY19L2_8, DPY19L2_7@0@0@0@:dpy-19-like 2 (C. elegans)@:spermatid development;multicellular organismal development;integral to membrane@: SPERMATOGENIC FAILURE 9; SPGF9
A2463_26@127347@127352@deletion@6@20007563@20020220@14@chr14:20007563-20020220@5.95@108@41@0.38@CNVR6072.6, CNVR6072.12@POTEM_6, POTEM_5, POTEM_4, POTEM_3, POTEM_2, POTEM_1@0@0@0@:POTE ankyrin domain family, member M@:protein binding@NA
A2463_26@128917@128941@deletion@25@36096297@36219896@14@chr14:36096297-36219896@16.3@979@558@0.57@NA@RALGAPA1_33, RALGAPA1_32, RALGAPA1_31, RALGAPA1_30, RALGAPA1_29, RALGAPA1_28, RALGAPA1_27, RALGAPA1_26, RALGAPA1_25, RALGAPA1_24, RALGAPA1_23, RALGAPA1_22, RALGAPA1_21, RALGAPA1_20, RALGAPA1_19, RALGAPA1_18, RALGAPA1_17, RALGAPA1_16, RALGAPA1_15, RALGAPA1_14, RALGAPA1_13, RALGAPA1_12, RALGAPA1_11, RALGAPA1_10, RALGAPA1_9@0@0@0@:Ral GTPase activating protein, alpha subunit 1 (catalytic)@:activation of Ral GTPase activity;mitochondrion;binding;positive regulation of GTPase activity;intracellular;protein heterodimerization activity;regulation of transcription, DNA-dependent;GTPase activator activity;Ral GTPase activator activity;cytoplasm;cytosol;nucleus;regulation of small GTPase mediated signal transduction@NA
A2463_26@131901@131909@deletion@9@90726460@90738751@14@chr14:90726460-90738751@8.82@304@165@0.543@NA@PSMC1_3, PSMC1_4, PSMC1_5, PSMC1_6, PSMC1_7, PSMC1_8, PSMC1_9, PSMC1_10, PSMC1_11@0@0@0@:proteasome (prosome, macropain) 26S subunit, ATPase, 1@:nucleoplasm;proteasome complex;S phase of mitotic cell cycle;mitotic cell cycle;antigen processing and presentation of peptide antigen via MHC class I;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;ATP binding;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;four-way junction helicase activity;DNA repair;peptidase activity;mRNA metabolic process;proteolysis;ATPase activity;nucleus;viral reproduction;gene expression;cell cycle checkpoint;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;protein catabolic process;cytosol;antigen processing and presentation of exogenous peptide antigen via MHC class I;regulation of apoptotic process;cellular nitrogen compound metabolic process;RNA metabolic process;G1/S transition of mitotic cell cycle;regulation of cellular amino acid metabolic process;apoptotic process;ATP catabolic process;DNA recombination;hydrolase activity;regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;small molecule metabolic process;nucleoside-triphosphatase activity;nucleotide binding;M/G1 transition of mitotic cell cycle;cytoplasm;protein binding;proteasome accessory complex;protein polyubiquitination@NA
A2463_26@133432@133436@deletion@5@106539080@106573537@14@chr14:106539080-106573537@11.5@84@13@0.155@CNVR6294.36, CNVR6294.48, CNVR6294.24, CNVR6294.10, CNVR6294.34@IGHV1-8_2, IGHV1-8_1, IGHV3-9_2, IGHV3-9_1, IGHV3-11_2@0@0@0@@:protein binding:protein binding:protein binding@NA
A2463_26@133532@133537@deletion@6@22062317@22074702@15@chr15:22062317-22074702@6.44@54@11@0.204@NA@POTEB_9, POTEB_8, POTEB_7, POTEB_6, POTEB_5, POTEB_4@0@0@0@:POTE ankyrin domain family member B-like@:protein binding@NA
A2463_26@133618@133654@deletion@37@23257059@23605962@15@chr15:23257059-23605962@43.5@593@191@0.322@CNVR6300.8@GOLGA8I_2, GOLGA8I_3, GOLGA8I_4, GOLGA8I_5, GOLGA8I_6, GOLGA8I_7, GOLGA8I_8, GOLGA8I_9, GOLGA8I_10, GOLGA8I_11, GOLGA8I_12, GOLGA8I_13, GOLGA8I_14, GOLGA8I_15, GOLGA8I_16, GOLGA8I_17, GOLGA8I_18, GOLGA8I_19, RP11-467N20.5_8, RP11-467N20.5_7, RP11-467N20.5_6, RP11-467N20.5_5, RP11-467N20.5_4, RP11-467N20.5_3, RP11-467N20.5_2, RP11-467N20.5_1, GOLGA8S_1, GOLGA8S_2, GOLGA8S_3, GOLGA8S_4, GOLGA8S_5, GOLGA8S_6, GOLGA8S_7, GOLGA8S_8, GOLGA8S_9, GOLGA8S_10, GOLGA8S_11@0@0@0@:golgin A8 family, member I:putative golgin subfamily A member 6-like protein 6-like@:Golgi cisterna membrane:Golgi apparatus@NA
A2463_26@133826@133833@deletion@8@28467175@28478707@15@chr15:28467175-28478707@6.9@283@161@0.569@CNVR6328.1@HERC2_36, HERC2_35, HERC2_34, HERC2_33, HERC2_32, HERC2_31, HERC2_30, HERC2_29@0@0@0@:putative HERC2-like protein 3-like;HECT and RLD domain containing E3 ubiquitin protein ligase 2@:mitochondrial inner membrane;protein ubiquitination involved in ubiquitin-dependent protein catabolic process;guanyl-nucleotide exchange factor activity;SUMO binding;DNA repair;intracellular protein transport;spermatogenesis;cellular protein modification process;nucleus;ubiquitin protein ligase binding;ubiquitin-protein ligase activity;centriole;intracellular;response to DNA damage stimulus;heme binding;cytoplasm;protein binding;zinc ion binding;protein ubiquitination;metal ion binding@: SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1; SHEP1
A2463_26@133903@133917@deletion@15@28948466@28957469@15@chr15:28948466-28957469@13.7@294@120@0.408@CNVR6331.1@GOLGA8M_15, GOLGA8M_14, GOLGA8M_13, GOLGA8M_12, GOLGA8M_11, GOLGA8M_10, GOLGA8M_9, GOLGA8M_8, GOLGA8M_7, GOLGA8M_6, GOLGA8M_5, GOLGA8M_4, GOLGA8M_3, GOLGA8M_2, GOLGA8M_1@0@0@0@:golgin A8 family, member M@:Golgi apparatus@NA
A2463_26@133977@134007@deletion@31@30379779@30437770@15@chr15:30379779-30437770@32.1@333@89@0.267@CNVR6336.1@GOLGA8J_8, GOLGA8J_9, GOLGA8J_10, GOLGA8J_11, GOLGA8J_12, GOLGA8J_13, GOLGA8J_14, GOLGA8J_15, GOLGA8J_16, GOLGA8J_17, GOLGA8J_18, GOLGA8J_19, GOLGA8T_1, GOLGA8T_2, GOLGA8T_3, GOLGA8T_4, GOLGA8T_5, GOLGA8T_6, GOLGA8T_7, GOLGA8T_8, GOLGA8T_9, GOLGA8T_10, GOLGA8T_11, GOLGA8T_12, GOLGA8T_13, GOLGA8T_14, GOLGA8T_15, GOLGA8T_16, GOLGA8T_17, GOLGA8T_18, GOLGA8T_19@0@0@0@:golgin A8 family, member J:golgin A8 family, member J;golgin A8 family, member K@:Golgi apparatus:Golgi apparatus@NA
A2463_26@134058@134067@deletion@10@30900234@30904875@15@chr15:30900234-30904875@7.46@203@107@0.527@CNVR6339.2, CNVR6339.3@GOLGA8H_5, GOLGA8H_6, GOLGA8H_7, GOLGA8H_8, GOLGA8H_9, GOLGA8H_10, GOLGA8H_11, GOLGA8H_12, GOLGA8H_13, GOLGA8H_14@0@0@0@:golgin A8 family, member H@:Golgi apparatus@NA
A2463_26@134158@134205@deletion@48@32684984@32890378@15@chr15:32684984-32890378@35.9@415@153@0.369@NA@GOLGA8K_19, GOLGA8K_18, GOLGA8K_17, GOLGA8K_16, GOLGA8K_15, GOLGA8K_14, GOLGA8K_13, GOLGA8K_12, GOLGA8K_11, GOLGA8K_10, GOLGA8K_9, GOLGA8K_8, GOLGA8K_7, GOLGA8K_6, GOLGA8K_5, GOLGA8K_4, GOLGA8K_3, GOLGA8K_2, AC139426.2_1, GOLGA8K_1, GOLGA8O_19, GOLGA8O_18, GOLGA8O_17, GOLGA8O_16, GOLGA8O_15, GOLGA8O_14, GOLGA8O_13, GOLGA8O_12, GOLGA8O_11, GOLGA8O_10, GOLGA8O_9, GOLGA8O_8, GOLGA8O_7, GOLGA8O_6, GOLGA8O_5, GOLGA8O_4, GOLGA8O_3, GOLGA8O_2, GOLGA8O_1, AC135983.2_1, GOLGA8N_1, GOLGA8N_2, GOLGA8N_3, GOLGA8N_4, GOLGA8N_5, GOLGA8N_6, GOLGA8N_7, GOLGA8N_8@0@0@0@:golgin A8 family, member J:golgin A8 family, member O:uncharacterized LOC101060580;uncharacterized LOC101060563;uncharacterized LOC100996890;uncharacterized LOC100996413;uncharacterized LOC101060588:golgin A8 family, member R@:Golgi apparatus:Golgi apparatus:Golgi apparatus@NA
A2463_26@135047@135060@duplication@14@41856383@41866013@15@chr15:41856383-41866013@9.64@266@430@1.62@NA@TYRO3_5, TYRO3_6, TYRO3_7, TYRO3_8, TYRO3_9, TYRO3_10, TYRO3_11, TYRO3_12, TYRO3_13, TYRO3_14, TYRO3_15, TYRO3_16, TYRO3_17, TYRO3_18@0@0@0@:TYRO3 protein tyrosine kinase@:protein tyrosine kinase activity;platelet aggregation;negative regulation of toll-like receptor signaling pathway;ATP binding;vagina development;substrate adhesion-dependent cell spreading;nucleus;negative regulation of lymphocyte activation;endoplasmic reticulum membrane;phosphatidylinositol 3-kinase cascade;nuclear envelope;platelet activation;protein kinase activity;protein kinase B signaling cascade;neuron homeostasis;negative regulation of neuron apoptotic process;negative regulation of innate immune response;protein autophosphorylation;transmembrane receptor protein tyrosine kinase activity;apoptotic cell clearance;transferase activity, transferring phosphorus-containing groups;spermatogenesis;forebrain cell migration;integral to membrane;integral to plasma membrane;ovulation cycle;natural killer cell differentiation;phosphatidylinositol 3-kinase binding;negative regulation of inflammatory response;protein phosphorylation;receptor signaling protein tyrosine kinase activity;protein heterodimerization activity;secretion by cell;protein binding;signal transduction;cell adhesion;signal transduction by phosphorylation@NA
A2463_26@135680@135681@deletion@2@43873201@43873586@15@chr15:43873201-43873586@5.29@145@55@0.379@CNVR6365.1@PPIP5K1_10, PPIP5K1_9@0@0@0@:diphosphoinositol pentakisphosphate kinase 1@:inositol hexakisphosphate 3-kinase activity;inositol hexakisphosphate 1-kinase activity;inositol metabolic process;diphosphoinositol-pentakisphosphate kinase activity;ATP binding;acid phosphatase activity;cytoplasm;cytosol;inositol hexakisphosphate 5-kinase activity;nucleus;kinase activity;inositol-1,3,4,5,6-pentakisphosphate kinase activity@NA
A2463_26@135705@135726@deletion@22@43896560@43922930@15@chr15:43896560-43922930@19.4@422@186@0.441@CNVR6365.1@STRC_21, STRC_20, STRC_19, STRC_18, STRC_17, STRC_16, STRC_15, STRC_14, STRC_13, STRC_12, STRC_11, STRC_10, STRC_9, STRC_8, STRC_7, STRC_6, STRC_5, STRC_4, STRC_3, STRC_2, STRC_1, CATSPER2_13@0@0@0@:diphosphoinositol pentakisphosphate kinase 1:stereocilin:cation channel, sperm associated 2@:inositol hexakisphosphate 3-kinase activity;inositol hexakisphosphate 1-kinase activity;inositol metabolic process;diphosphoinositol-pentakisphosphate kinase activity;ATP binding;acid phosphatase activity;cytoplasm;cytosol;inositol hexakisphosphate 5-kinase activity;nucleus;kinase activity;inositol-1,3,4,5,6-pentakisphosphate kinase activity:detection of mechanical stimulus involved in sensory perception of sound;stereocilium bundle tip;stereocilium;cell surface;kinocilium;auditory receptor cell stereocilium organization:cell differentiation;CatSper complex;ion transport;transmembrane transport;voltage-gated ion channel activity;flagellar membrane;spermatogenesis;integral to membrane;multicellular organismal development;fertilization;sperm motility;ion channel activity;ciliary or flagellar motility;calcium channel activity;cilium;protein binding;microtubule-based flagellum;membrane@: DEAFNESS, AUTOSOMAL RECESSIVE 16; DFNB16; DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY: DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY
A2463_26@138281@138290@deletion@10@72953606@72958469@15@chr15:72953606-72958469@16.1@161@34@0.211@CNVR6443.1@GOLGA6B_8, GOLGA6B_9, GOLGA6B_10, GOLGA6B_11, GOLGA6B_12, GOLGA6B_13, GOLGA6B_14, GOLGA6B_15, GOLGA6B_16, GOLGA6B_17@0@0@0@:golgin A6 family, member B@:Golgi apparatus@NA
A2463_26@139472@139482@deletion@11@84842761@84911344@15@chr15:84842761-84911344@12.5@123@29@0.236@CNVR6486.2@RP11-182J1.16_2, RP11-182J1.16_3, GOLGA6L4_1, GOLGA6L4_2, GOLGA6L4_3, GOLGA6L4_4, GOLGA6L4_5, GOLGA6L4_6, GOLGA6L4_7, GOLGA6L4_8, GOLGA6L4_9@0@0@0@:uncharacterized LOC100505679@:Golgi apparatus@NA
A2463_26@142654@142676@deletion@23@14935220@14975542@16@chr16:14935220-14975542@20.2@506@240@0.474@NA@NOMO1_3, NOMO1_4, NOMO1_5, NOMO1_6, NOMO1_7, NOMO1_8, NOMO1_9, NOMO1_10, NOMO1_11, NOMO1_12, NOMO1_13, NOMO1_14, NOMO1_15, NOMO1_16, NOMO1_17, NOMO1_18, NOMO1_19, NOMO1_20, NOMO1_21, NOMO1_22, NOMO1_23, NOMO1_24, NOMO1_25@0@0@0@:NODAL modulator 1;nodal modulator 1-like@:carbohydrate binding;integral to membrane;carboxypeptidase activity;molecular_function;cellular_component;biological_process@NA
A2463_26@142725@142757@deletion@33@15157054@15472151@16@chr16:15157054-15472151@20.6@1206@734@0.609@NA@RRN3_17, RRN3_16, RRN3_15, RRN3_14, RRN3_13, RRN3_12, RRN3_11, RRN3_10, RRN3_9, RRN3_8, RRN3_7, RRN3_6, RRN3_5, RRN3_4, RRN3_3, RRN3_2, RRN3_1, NPIPP1_8, NPIPP1_7, NPIPP1_6, NPIPP1_5, NPIPP1_4, NPIPP1_3, NPIPP1_2, NPIPP1_1, PKD1P1_8, PKD1P1_7, PKD1P1_6, PKD1P1_5, PKD1P1_4, PKD1P1_3, PKD1P1_2, PKD1P1_1@0@0@0@:pyridoxal-dependent decarboxylase domain containing 1;pyridoxal-dependent decarboxylase domain-containing protein 1-like:RRN3 RNA polymerase I transcription factor homolog (S. cerevisiae):nuclear pore complex-interacting protein-like:NPIP-like protein 1-like;nuclear pore complex-interacting protein-like 1-like@:carboxylic acid metabolic process;pyridoxal phosphate binding;carboxy-lyase activity:nucleoplasm;negative regulation of apoptotic process;regulation of DNA-dependent transcription, initiation;cytoplasm organization;binding;transcription from RNA polymerase I promoter;homeostasis of number of cells;translation initiation factor activity;ribosome biogenesis;gene expression;RNA polymerase binding;transcription initiation from RNA polymerase I promoter;nucleolus organization;in utero embryonic development;cell proliferation;DNA-dependent transcription, initiation;positive regulation of transcription, DNA-dependent;nucleolus:neuropeptide signaling pathway;integral to membrane;plasma membrane;membrane@NA
A2463_26@142901@142928@deletion@28@16297268@16367932@16@chr16:16297268-16367932@27.9@501@198@0.395@NA@ABCC6_8, ABCC6_7, ABCC6_6, ABCC6_5, ABCC6_4, ABCC6_3, ABCC6_2, ABCC6_1, NOMO3_1, NOMO3_2, NOMO3_3, NOMO3_4, NOMO3_5, NOMO3_6, NOMO3_7, NOMO3_8, NOMO3_9, NOMO3_10, NOMO3_11, NOMO3_12, NOMO3_13, NOMO3_14, NOMO3_15, NOMO3_16, NOMO3_17, NOMO3_18, NOMO3_19, NOMO3_20@0@0@0@:ATP-binding cassette, sub-family C (CFTR/MRP), member 6:NODAL modulator 3@:ATPase activity, coupled to transmembrane movement of substances;transport;transporter activity;lateral plasma membrane;response to drug;ATP binding;transmembrane transport;integral to membrane;ATPase activity;plasma membrane;ATP catabolic process;apical plasma membrane;nucleoside-triphosphatase activity;nucleotide binding;visual perception;membrane:carbohydrate binding;integral to membrane;carboxypeptidase activity@: PSEUDOXANTHOMA ELASTICUM; PXE; PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE; ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 2; GACI2
A2463_26@143081@143086@deletion@6@18896413@18907529@16@chr16:18896413-18907529@6.83@214@108@0.505@CNVR6659.1@SMG1_8, SMG1_7, SMG1_6, SMG1_5, SMG1_4, SMG1_3@0@0@0@:serine/threonine-protein kinase SMG1-like;smg-1 homolog, phosphatidylinositol 3-kinase-related kinase (C. elegans)@:protein autophosphorylation;peptidyl-serine phosphorylation;phosphatidylinositol phosphorylation;binding;RNA metabolic process;transferase activity, transferring phosphorus-containing groups;phosphotransferase activity, alcohol group as acceptor;ATP binding;DNA repair;mRNA metabolic process;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;nucleus;gene expression;protein serine/threonine kinase activity;protein kinase activity;response to stress;cytoplasm;cytosol;mRNA export from nucleus;protein binding;kinase activity;metal ion binding@NA
A2463_26@144264@144266@deletion@3@29061824@29064047@16@chr16:29061824-29064047@6.28@113@34@0.301@NA@CTB-134H23.2_5, CTB-134H23.2_6, CTB-134H23.2_7@0@0@0@NA@NA@NA
A2463_26@147416@147421@deletion@6@72088553@72093087@16@chr16:72088553-72093087@6.57@141@77@0.546@CNVR6769.1, CNVR6769.2@HP_1, HP_2, HP_3, HP_4, HP_5, HP_6@0@0@0@:thioredoxin-like 4B:haptoglobin:haptoglobin-related protein@:mitosis;mRNA processing;RNA splicing;spliceosomal complex;cell redox homeostasis:cellular iron ion homeostasis;negative regulation of oxidoreductase activity;catalytic activity;negative regulation of hydrogen peroxide catabolic process;positive regulation of cell death;haptoglobin-hemoglobin complex;extracellular space;proteolysis;response to hydrogen peroxide;extracellular region;hemoglobin binding;defense response;serine-type endopeptidase activity:spherical high-density lipoprotein particle;proteolysis;extracellular region;hemoglobin binding;catalytic activity;serine-type endopeptidase activity@: ANHAPTOGLOBINEMIA; AHP
A2463_26@147497@147513@deletion@17@74415415@74452196@16@chr16:74415415-74452196@20.8@702@359@0.511@CNVR6778.2, CNVR6778.3@NPIPL2_2, NPIPL2_3, NPIPL2_4, NPIPL2_5, NPIPL2_6, NPIPL2_7, CLEC18B_13, CLEC18B_12, CLEC18B_11, CLEC18B_10, CLEC18B_9, CLEC18B_8, CLEC18B_7, CLEC18B_6, CLEC18B_5, CLEC18B_4, CLEC18B_3@0@0@0@:C-type lectin domain family 18, member B@:extracellular region:carbohydrate binding;protein binding;extracellular region@NA
A2463_26@151112@151121@deletion@10@10411681@10417441@17@chr17:10411681-10417441@8@400@225@0.562@NA@MYH1_16, MYH1_15, MYH1_14, MYH1_13, MYH1_12, MYH1_11, MYH1_10, MYH1_9, MYH1_8, MYH1_7@0@0@0@:myosin, heavy chain 1, skeletal muscle, adult@:intercalated disc;calmodulin binding;myosin complex;nucleotide binding;myosin filament;A band;ATP binding;motor activity;actin binding;protein binding;nucleolus;nucleus;focal adhesion;muscle myosin complex@NA
A2463_26@151415@151417@deletion@3@15517148@15522826@17@chr17:15517148-15522826@8.21@166@56@0.337@NA@CDRT1_3, TRIM16_9, CDRT1_2, TRIM16_8, CDRT1_1@0@0@0@:CMT1A duplicated region transcript 1@:protein binding;molecular_function;cellular_component;biological_process:protein binding;intracellular;zinc ion binding;cytoplasm@NA
A2463_26@151544@151558@deletion@15@16593716@16667489@17@chr17:16593716-16667489@14.8@954@531@0.557@NA@CCDC144A_1, CCDC144A_1, CCDC144A_2, CCDC144A_2, CCDC144A_3, CCDC144A_3, CCDC144A_4, CCDC144A_4, CCDC144A_5, CCDC144A_5, CCDC144A_6, CCDC144A_6, CCDC144A_7, CCDC144A_7, CCDC144A_8, CCDC144A_8, CCDC144A_9, CCDC144A_9, CCDC144A_10, CCDC144A_10, CCDC144A_11, CCDC144A_11, CCDC144A_12, CCDC144A_12, CCDC144A_13, CCDC144A_13, CCDC144A_14, CCDC144A_14, CCDC144A_15, CCDC144A_15@0@0@0@:coiled-coil domain containing 144A@NA@NA
A2463_26@151876@151886@deletion@11@18387190@18430117@17@chr17:18387190-18430117@13.3@134@38@0.284@NA@LGALS9C_2, LGALS9C_3, LGALS9C_4, LGALS9C_5, LGALS9C_6, LGALS9C_7, LGALS9C_8, LGALS9C_9, LGALS9C_10, LGALS9C_11, FAM106A_1@0@0@0@:lectin, galactoside-binding, soluble, 9C:protein FAM106B-like@:carbohydrate binding@NA
A2463_26@153363@153372@deletion@10@34493376@34500284@17@chr17:34493376-34500284@12.3@84@7@0.0833@CNVR7077.1, CNVR7077.3, CNVR7077.11, CNVR7077.16@TBC1D3B_14, TBC1D3B_13, TBC1D3B_12, TBC1D3B_11, TBC1D3B_10, TBC1D3B_9, TBC1D3B_8, TBC1D3B_7, TBC1D3B_6, TBC1D3B_5@0@0@0@:TBC1 domain family, member 3B@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_26@153395@153400@deletion@6@34624260@34641537@17@chr17:34624260-34641537@7.26@40@0@0@CNVR7077.1, CNVR7077.2, CNVR7077.12@CCL3L1_3, CCL3L1_2, CCL3L1_1, CCL4L2_1, CCL4L2_2, CCL4L2_3@0@0@0@:TBC1 domain family, member 3C;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3H-like;TBC1 domain family, member 3H:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
A2463_26@153657@153665@deletion@9@36361698@36462598@17@chr17:36361698-36462598@10.2@332@169@0.509@CNVR7083.3@RP11-1407O15.2_5, RP11-1407O15.2_4, RP11-1407O15.2_3, RP11-1407O15.2_2, RP11-1407O15.2_1, MRPL45_1, MRPL45_2, MRPL45_3, MRPL45_4@0@0@0@:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like:mitochondrial ribosomal protein L45@:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding:intracellular protein transport;structural constituent of ribosome;mitochondrion;ribosome;translation;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex@NA
A2463_26@154322@154338@deletion@17@39190571@39334416@17@chr17:39190571-39334416@12@785@441@0.562@NA@KRTAP1-3_1, KRTAP1-1_1, KRTAP2-1_1, KRTAP2-2_1, KRTAP2-3_1, KRTAP2-4_1, KRTAP4-7_1, KRTAP4-8_1, KRTAP4-16P_1, KRTAP4-9_1, KRTAP4-11_1, KRTAP4-12_1, KRTAP4-6_1, KRTAP4-5_1, KRTAP4-4_1, KRTAP4-3_1, KRTAP4-2_1@0@0@0@:keratin associated protein 1-3:keratin associated protein 1-1:keratin associated protein 2-1:keratin associated protein 2-2:keratin associated protein 2-3;keratin associated protein 2-4:keratin associated protein 2-3;keratin associated protein 2-4:keratin associated protein 4-7:keratin associated protein 4-8:keratin associated protein 4-9:keratin associated protein 4-11:keratin associated protein 4-12:keratin associated protein 4-6:keratin associated protein 4-5:keratin associated protein 4-4:keratin associated protein 4-3:keratin associated protein 4-2@:extracellular region;keratin filament;structural constituent of epidermis;biological_process:extracellular region;keratin filament;biological_process:keratin filament:keratin filament:keratin filament:keratin filament:keratin filament:keratin filament:keratin filament:keratin filament:keratin filament:keratin filament:keratin filament:keratin filament:keratin filament:keratin filament:keratin filament@NA
A2463_26@155718@155728@deletion@11@45623276@45669911@17@chr17:45623276-45669911@11.8@285@139@0.488@CNVR7118.2@NPEPPS_2, NPEPPS_3, NPEPPS_4, NPEPPS_5, NPEPPS_6, NPEPPS_7, NPEPPS_8, NPEPPS_9, NPEPPS_10, NPEPPS_11, NPEPPS_12@0@0@0@:aminopeptidase puromycin sensitive@:metallopeptidase activity;antigen processing and presentation of peptide antigen via MHC class I;aminopeptidase activity;cytosol;proteolysis;cellular response to hypoxia;nucleus;zinc ion binding;protein polyubiquitination@NA
A2463_26@157000@157010@deletion@11@58282809@58297148@17@chr17:58282809-58297148@9.81@317@161@0.508@NA@USP32_26, USP32_25, USP32_24, USP32_23, USP32_22, USP32_21, USP32_20, USP32_19, USP32_18, USP32_17, USP32_16@0@0@0@:ubiquitin specific peptidase 32@:protein deubiquitination;cysteine-type peptidase activity;Golgi apparatus;ubiquitin thiolesterase activity;membrane;calcium ion binding;ubiquitin-dependent protein catabolic process@NA
A2463_26@157599@157608@deletion@10@62854898@62893375@17@chr17:62854898-62893375@9.27@997@545@0.547@CNVR7165.1@LRRC37A3_12, LRRC37A3_11, LRRC37A3_10, LRRC37A3_9, LRRC37A3_8, LRRC37A3_7, LRRC37A3_6, LRRC37A3_5, LRRC37A3_4, LRRC37A3_3@0@0@0@:leucine rich repeat containing 37, member A3@:protein binding;integral to membrane@NA
A2463_26@160150@160153@deletion@4@47391@49557@18@chr18:47391-49557@6.35@214@84@0.393@CNVR7228.2@RP11-683L23.1_4, RP11-683L23.1_3, RP11-683L23.1_2, RP11-683L23.1_1@0@0@0@@:GTPase activity;protein complex;GTP catabolic process;cytoplasm;microtubule cytoskeleton;protein polymerization;microtubule-based movement;structural molecule activity;microtubule;GTP binding;plasma membrane@NA
A2463_26@160945@160954@deletion@10@14796221@14822676@18@chr18:14796221-14822676@8.3@318@160@0.503@CNVR7273.1@ANKRD30B_17, ANKRD30B_18, ANKRD30B_19, ANKRD30B_20, ANKRD30B_21, ANKRD30B_22, ANKRD30B_23, ANKRD30B_24, ANKRD30B_25, ANKRD30B_26@0@0@0@:ankyrin repeat domain 30B@:protein binding;molecular_function;cellular_component;biological_process@NA
A2463_26@170095@170100@deletion@6@40370196@40382826@19@chr19:40370196-40382826@15@206@57@0.277@CNVR7639.2@FCGBP_27, FCGBP_26, FCGBP_25, FCGBP_24, FCGBP_23, FCGBP_22@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_26@180971@180977@deletion@7@16275208@16449804@22@chr22:16275208-16449804@13.6@395@250@0.633@CNVR8071.2, CNVR8071.3@POTEH_6, POTEH_5, POTEH_4, POTEH_3, POTEH_2, POTEH_1, OR11H1_1@0@0@0@:POTE ankyrin domain family, member H:olfactory receptor, family 11, subfamily H, member 1;olfactory receptor, family 11, subfamily H, member 2@:protein binding:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_26@181622@181634@deletion@13@21480538@21579843@22@chr22:21480538-21579843@9.2@113@37@0.327@CNVR8100.5, CNVR8100.4@POM121L7_1, GGT2_15, GGT2_14, GGT2_13, GGT2_12, GGT2_11, GGT2_10, GGT2_9, GGT2_8, GGT2_7, GGT2_6, GGT2_5, GGT2_4@0@0@0@:putative POM121-like protein 1-like:gamma-glutamyltransferase 2;gamma-glutamyltranspeptidase 2-like@:hydrolase activity;small molecule metabolic process;leukotriene biosynthetic process;anchored to external side of plasma membrane;glutathione biosynthetic process;xenobiotic metabolic process;integral to membrane;glutathione metabolic process;plasma membrane;gamma-glutamyltransferase activity;cellular_component@NA
A2463_26@183631@183641@deletion@11@39357393@39388450@22@chr22:39357393-39388450@8.72@164@77@0.47@CNVR8164.1@APOBEC3A_4, APOBEC3A_5, APOBEC3A_6, APOBEC3B_1, APOBEC3B_2, APOBEC3B_3, APOBEC3B_4, APOBEC3B_5, APOBEC3B_6, APOBEC3B_7, APOBEC3B_8@0@0@0@:apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A;APOBEC3A and APOBEC3B deletion hybrid:apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B@:cytidine deamination;defense response to virus;negative regulation of viral genome replication;DNA cytosine deamination;clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine;catalytic activity;DNA demethylation;cytoplasm;innate immune response;cytidine deaminase activity;nucleus;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines;cellular response to xenobiotic stimulus;zinc ion binding;negative regulation of transposition:RNA binding;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines;negative regulation of transposition;catalytic activity;zinc ion binding@NA
A2463_26@184143@184152@deletion@10@42522577@42536467@22@chr22:42522577-42536467@13.4@391@176@0.45@CNVR8168.1, CNVR8168.3, CNVR8168.2, CNVR8168.4@CYP2D6_9, CYP2D6_8, CYP2D6_7, CYP2D6_6, CYP2D6_5, CYP2D6_4, CYP2D6_3, CYP2D6_2, CYP2D6_1, CYP2D7P1_5@0@0@0@:cytochrome P450, family 2, subfamily D, polypeptide 6@:oxidation-reduction process;mitochondrion;alkaloid catabolic process;aromatase activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;drug catabolic process;endoplasmic reticulum membrane;response to organic substance;oxidative demethylation;endoplasmic reticulum;alkaloid metabolic process;negative regulation of binding;heme binding;xenobiotic metabolic process;dopamine metabolic process;steroid metabolic process;isoquinoline alkaloid metabolic process;arachidonic acid monooxygenase activity;arachidonic acid metabolic process;steroid 21-monooxygenase activity;negative regulation of cellular organofluorine metabolic process;oxidoreductase activity;monoterpenoid metabolic process;heterocycle metabolic process;drug binding;drug metabolic process;electron carrier activity;small molecule metabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;monooxygenase activity;iron ion binding;coumarin metabolic process:oxidation-reduction process;electron carrier activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;monooxygenase activity;iron ion binding;heme binding@: DRUG METABOLISM, POOR, CYP2D6-RELATED
A2463_32@428@434@deletion@7@1637082@1643839@1@chr1:1637082-1643839@11.5@127@55@0.433@CNVR17.1@CDK11A_12, CDK11A_11, CDK11A_10, CDK11A_9, CDK11A_8, CDK11A_7, CDK11A_6@0@0@0@:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A@:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division@NA
A2463_32@1817@1819@deletion@3@12941676@12953305@1@chr1:12941676-12953305@18.3@404@219@0.542@CNVR72.3, CNVR72.4, CNVR72.12, CNVR72.13@PRAMEF4_3, PRAMEF4_2, PRAMEF10_4@0@0@0@:PRAME family member 4:PRAME family member 10@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_32@1824@1826@duplication@3@12979673@13001395@1@chr1:12979673-13001395@7.14@260@371@1.43@CNVR72.3, CNVR72.4, CNVR72.2@PRAMEF7_4, PRAMEF6_4, PRAMEF6_3@0@0@0@:PRAME family member 7:PRAME family member 6;PRAME family member 23;PRAME family member 9/15-like;PRAME family member 5@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_32@1829@1831@deletion@3@13036223@13052998@1@chr1:13036223-13052998@5.47@236@152@0.644@CNVR72.3@PRAMEF22_2, PRAMEF22_3, WI2-3308P17.2_1@0@0@0@:PRAME family member 6;PRAME family member 23;PRAME family member 9/15-like;PRAME family member 5:PRAME family member 22@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_32@5149@5150@duplication@2@39987049@39988154@1@chr1:39987049-39988154@5.1@66@112@1.7@NA@BMP8A_4, BMP8A_5@0@0@0@:bone morphogenetic protein 8a@:cell differentiation;growth factor activity;extracellular space;growth;cytokine activity;cartilage development;ossification@NA
A2463_32@8507@8508@duplication@2@89476588@89477710@1@chr1:89476588-89477710@16.6@340@544@1.6@CNVR244.1@GBP3_8, GBP3_7@0@0@0@:guanylate binding protein 3@:defense response to virus;GTP binding;GTPase activity;membrane;cytoplasm@NA
A2463_32@9365@9366@deletion@2@104202983@104203298@1@chr1:104202983-104203298@9.68@209@115@0.55@CNVR266.3, CNVR266.1@AMY1A_7, AMY1A_8@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
A2463_32@9448@9448@deletion@1@108786207@108786383@1@chr1:108786207-108786383@5.58@29@3@0.103@CNVR294.4, CNVR294.1@NBPF4_2@0@0@0@:neuroblastoma breakpoint family, member 4@:cytoplasm@NA
A2463_32@9766@9773@deletion@8@110230497@110235917@1@chr1:110230497-110235917@46.6@224@7@0.0312@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_1, GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
A2463_32@10788@10793@deletion@6@144220788@144340398@1@chr1:144220788-144340398@8.45@86@34@0.395@CNVR334.4@RP3-377D14.1_87, RP3-377D14.1_88, RP3-377D14.1_89, RP3-377D14.1_90, RP3-377D14.1_91, AL592284.1_1@0@0@0@:uncharacterized LOC730256;uncharacterized LOC101060698;uncharacterized LOC642441@NA@NA
A2463_32@11080@11080@deletion@1@145756418@145756613@1@chr1:145756418-145756613@5.8@26@0@0@NA@PDZK1_6@0@0@0@:PDZ domain containing 1@:PDZ domain binding;transport;transporter activity;cytoplasm;cell proliferation;protein binding;positive regulation of ion transmembrane transport;scavenger receptor binding;brush border membrane;establishment of protein localization to plasma membrane;carnitine transport;drug transport@NA
A2463_32@11169@11173@duplication@5@146400092@146405926@1@chr1:146400092-146405926@7.21@92@156@1.7@NA@NBPF12_9, NBPF12_10, NBPF12_11, NBPF12_12, NBPF12_13@0@0@0@:neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family member 14-like;neuroblastoma breakpoint family, member 12@:cytoplasm@NA
A2463_32@11335@11357@deletion@23@147954851@148025848@1@chr1:147954851-148025848@304@1911@289@0.151@CNVR346.2, CNVR346.3, CNVR346.4@PPIAL4A_1, NBPF14_22, NBPF14_21, NBPF14_20, NBPF14_19, NBPF14_18, NBPF14_17, NBPF14_16, NBPF14_15, NBPF14_14, NBPF14_13, NBPF14_12, NBPF14_11, NBPF14_10, NBPF14_9, NBPF14_8, NBPF14_7, NBPF14_6, NBPF14_5, NBPF14_4, NBPF14_3, NBPF14_2, NBPF14_1@0@0@0@:peptidylprolyl isomerase A (cyclophilin A)-like 4C;peptidyl-prolyl cis-trans isomerase A-like 4A/B/C-like;peptidylprolyl isomerase A (cyclophilin A)-like 4B;peptidylprolyl isomerase A (cyclophilin A)-like 4A:neuroblastoma breakpoint family, member 14@:protein folding;peptidyl-prolyl cis-trans isomerase activity;cytoplasm:cytoplasm@NA
A2463_32@11464@11465@deletion@2@148341796@148342542@1@chr1:148341796-148342542@9.56@289@172@0.595@CNVR347.1, CNVR347.5@NBPF20_6, NBPF20_5@0@0@0@:uncharacterized LOC101060226;neuroblastoma breakpoint family member 14-like;neuroblastoma breakpoint family, member 12;neuroblastoma breakpoint family member 3-like;neuroblastoma breakpoint family, member 7@:cytoplasm@NA
A2463_32@14056@14056@deletion@1@161599569@161599825@1@chr1:161599569-161599825@5.13@56@23@0.411@CNVR383.1@FCGR3B_3@0@0@0@:Fc fragment of IgG, low affinity IIIa, receptor (CD16a):Fc fragment of IgG, low affinity IIb, receptor (CD32):Fc fragment of IgG, low affinity IIIb, receptor (CD16b)@:IgG binding;protein binding;regulation of immune response;extracellular region;integral to membrane;immune response;plasma membrane;external side of plasma membrane:IgG binding;protein binding;signal transduction;regulation of immune response;integral to membrane;immune response;plasma membrane;virus-host interaction:IgG binding;protein binding;extracellular region;immune response;plasma membrane;anchored to membrane@: MALARIA, SUSCEPTIBILITY TO; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
A2463_32@16026@16026@duplication@1@196712583@196712758@1@chr1:196712583-196712758@8.03@256@382@1.49@CNVR459.1@CFH_20@0@0@0@:complement factor H@:complement activation, alternative pathway;extracellular space;complement activation;extracellular region;regulation of complement activation;innate immune response@: HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1; AHUS1; MACULAR DEGENERATION, AGE-RELATED, 4; ARMD4; COMPLEMENT FACTOR H DEFICIENCY; CFHD; BASAL LAMINAR DRUSEN
A2463_32@16029@16037@duplication@9@196744018@196796135@1@chr1:196744018-196796135@11.8@1367@1758@1.29@CNVR459.1@CFHR3_1, CFHR3_2, CFHR3_3, CFHR3_4, CFHR3_5, CFHR3_6, CFHR1_1, CFHR1_2, CFHR1_3@0@0@0@:complement factor H-related 3:complement factor H-related 1:complement factor H-related 2@:extracellular space:extracellular space;complement activation:extracellular region@NA
A2463_32@16029@16038@deletion@1@196744018@196797376@1@chr1:196744018-196797376@-110@1509@1822@1.21@CNVR459.1@CFHR3_1, CFHR3_2, CFHR3_3, CFHR3_4, CFHR3_5, CFHR3_6, CFHR1_1, CFHR1_2, CFHR1_3, CFHR1_4@0@0@0@:complement factor H-related 3:complement factor H-related 1:complement factor H-related 2@:extracellular space:extracellular space;complement activation:extracellular region@NA
A2463_32@22096@22097@duplication@2@37429928@37430151@2@chr2:37429928-37430151@11.2@379@554@1.46@NA@CEBPZ_15, CEBPZ_14@0@0@0@:CCAAT/enhancer binding protein (C/EBP), zeta@:binding;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription from RNA polymerase II promoter@NA
A2463_32@24820@24822@duplication@3@87092796@87178483@2@chr2:87092796-87178483@7.98@49@109@2.22@CNVR859.2@AC111200.1_2, RGPD1_1, RGPD1_2@0@0@0@:RANBP2-like and GRIP domain containing 1@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_32@25369@25370@deletion@2@97854825@97855027@2@chr2:97854825-97855027@26.2@122@1@0.0082@CNVR886.2, CNVR886.3@ANKRD36_33, ANKRD36_34@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_32@26008@26011@duplication@4@108454714@108460186@2@chr2:108454714-108460186@19@121@283@2.34@NA@RGPD4_3, RGPD4_4, RGPD4_5, RGPD4_6@0@0@0@:RANBP2-like and GRIP domain containing 4@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_32@26021@26022@duplication@2@108479139@108479488@2@chr2:108479139-108479488@17.5@284@479@1.69@NA@RGPD4_16, RGPD4_17@0@0@0@:RANBP2-like and GRIP domain containing 4@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_32@27209@27211@duplication@3@130952653@130955933@2@chr2:130952653-130955933@6.92@127@198@1.56@NA@TUBA3E_3, TUBA3E_2, TUBA3E_1@0@0@0@:tubulin, alpha 3e@:GTPase activity;structural constituent of cytoskeleton;protein complex;GTP catabolic process;cytoplasm;microtubule cytoskeleton;protein polymerization;microtubule-based movement;structural molecule activity;cytoplasmic microtubule;GTP binding;microtubule;microtubule cytoskeleton organization;protein domain specific binding@NA
A2463_32@27987@27987@duplication@1@152450522@152450832@2@chr2:152450522-152450832@4.64@48@88@1.83@CNVR1026.1@NEB_93@0@0@0@:nebulin@:Z disc;muscle filament sliding;oxidation-reduction process;contractile fiber part;actin cytoskeleton;regulation of actin filament length;structural constituent of muscle;cytosol;actin binding;protein binding;myofibril;somatic muscle development;muscle organ development@: NEMALINE MYOPATHY 2; NEM2
A2463_32@39893@39894@deletion@2@75790428@75790887@3@chr3:75790428-75790887@6.2@28@0@0@CNVR1432.5, CNVR1432.9, CNVR1432.4@ZNF717_4, ZNF717_3@0@0@0@:zinc finger protein 717;zinc finger protein 717-like@:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_32@42142@42143@deletion@2@130132390@130132975@3@chr3:130132390-130132975@6.18@105@55@0.524@CNVR1540.1@COL6A5_21, COL6A5_22@0@0@0@:collagen, type VI, alpha 5@:collagen;protein binding;extracellular matrix;extracellular region;cell adhesion@NA
A2463_32@45459@45460@deletion@2@195505175@195518368@3@chr3:195505175-195518368@8.19@2092@1482@0.708@CNVR1704.1@MUC4_3, MUC4_2@0@0@0@:mucin 4, cell surface associated@:ErbB-2 class receptor binding;Golgi lumen;cell-matrix adhesion;post-translational protein modification;extracellular matrix structural constituent;protein binding;O-glycan processing;cellular protein metabolic process;proteinaceous extracellular matrix;integral to plasma membrane;membrane;extracellular matrix constituent, lubricant activity;biological_process@NA
A2463_32@46667@46672@deletion@6@9174900@9218723@4@chr4:9174900-9218723@18.7@116@21@0.181@NA@FAM90A26P_4, FAM90A26P_5, FAM90A26P_6, FAM90A26P_7, USP17L13_1, USP17L10_1, USP17L11_1@0@0@0@:ubiquitin specific peptidase 17-like family member 10:ubiquitin specific peptidase 17-like family member 13:ubiquitin specific peptidase 17-like family member 11@:zinc ion binding;nucleic acid binding:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
A2463_32@48556@48558@duplication@3@69403344@69417629@4@chr4:69403344-69417629@11.2@122@219@1.8@CNVR1953.1@UGT2B17_6, UGT2B17_5, UGT2B17_4@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B17@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;membrane@: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
A2463_32@48560@48561@duplication@2@69431291@69434202@4@chr4:69431291-69434202@20.8@348@593@1.7@CNVR1953.1@UGT2B17_2, UGT2B17_1@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B17@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;membrane@: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
A2463_32@48596@48597@duplication@2@70156311@70160527@4@chr4:70156311-70160527@4.84@193@268@1.39@CNVR1957.2, CNVR1957.1@UGT2B28_5, UGT2B28_6@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B28@:carbohydrate binding;transferase activity, transferring hexosyl groups;endoplasmic reticulum;glucuronosyltransferase activity;carbohydrate metabolic process;xenobiotic metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process@NA
A2463_32@48972@48975@deletion@4@75482007@75488112@4@chr4:75482007-75488112@5.99@81@39@0.481@NA@AREGB_2, AREGB_3, AREGB_4, AREGB_5@0@0@0@:amphiregulin;amphiregulin B@:growth factor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;cell proliferation;epidermal growth factor receptor signaling pathway;extracellular space;protein binding;integral to membrane;cytokine activity;cell surface;positive regulation of DNA replication@NA
A2463_32@53195@53195@duplication@1@191002091@191003541@4@chr4:191002091-191003541@8.71@17@75@4.41@CNVR2258.2@DUX4L4_1@0@0@0@:double homeobox 4 like 4@:transcription regulatory region sequence-specific DNA binding;sequence-specific DNA binding;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;sequence-specific DNA binding transcription factor activity@NA
A2463_32@53303@53312@deletion@10@716924@767067@5@chr5:716924-767067@57@503@164@0.326@CNVR2280.3@ZDHHC11B_10, ZDHHC11B_9, ZDHHC11B_8, ZDHHC11B_7, ZDHHC11B_6, ZDHHC11B_5, ZDHHC11B_4, ZDHHC11B_3, ZDHHC11B_2, ZDHHC11B_1@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
A2463_32@55806@55806@deletion@1@69372349@69372398@5@chr5:69372349-69372398@21.4@99@0@0@CNVR2494.48, CNVR2494.39, CNVR2494.15, CNVR2494.18, CNVR2494.26, CNVR2494.43, CNVR2494.52, CNVR2494.28, CNVR2494.2, CNVR2494.36@SMN2_8@0@0@0@:survival of motor neuron 2, centromeric;survival of motor neuron 1, telomeric@:nucleoplasm;ncRNA metabolic process;Cajal body;RNA metabolic process;spliceosomal complex;cytoplasm;cytosol;protein binding;cell death;spliceosomal complex assembly;RNA binding;mRNA processing;nucleus;gene expression;spliceosomal snRNP assembly@: SPINAL MUSCULAR ATROPHY, TYPE II; SMA2; SPINAL MUSCULAR ATROPHY, TYPE I; SMA1; SPINAL MUSCULAR ATROPHY, TYPE IV; SMA4; SPINAL MUSCULAR ATROPHY, TYPE III; SMA3
A2463_32@55835@55835@deletion@1@70338009@70338111@5@chr5:70338009-70338111@5.13@23@0@0@CNVR2494.41, CNVR2494.14, CNVR2494.20, CNVR2494.62, CNVR2494.8@GTF2H2_14@0@0@0@:general transcription factor IIH, polypeptide 2, 44kDa@:nucleoplasm;nucleotide-excision repair, DNA damage removal;transcription from RNA polymerase I promoter;DNA repair;RNA polymerase II carboxy-terminal domain kinase activity;nucleus;viral reproduction;translation;gene expression;transcription elongation from RNA polymerase I promoter;response to UV;holo TFIIH complex;protein kinase activity;nucleotide-excision repair;transcription from RNA polymerase II promoter;transcription-coupled nucleotide-excision repair;transcription, DNA-dependent;zinc ion binding;transcription elongation from RNA polymerase II promoter;termination of RNA polymerase I transcription;sequence-specific DNA binding transcription factor activity;G-protein coupled receptor internalization;DNA-dependent ATPase activity;protein N-terminus binding;transcription initiation from RNA polymerase I promoter;7-methylguanosine mRNA capping;transcription initiation from RNA polymerase II promoter;protein phosphorylation;translation factor activity, nucleic acid binding;regulation of transcription, DNA-dependent;core TFIIH complex;protein binding;positive regulation of viral transcription;nucleic acid binding@NA
A2463_32@55837@55837@deletion@1@70343834@70343940@5@chr5:70343834-70343940@9.06@41@0@0@CNVR2494.41, CNVR2494.14, CNVR2494.20, CNVR2494.62, CNVR2494.8@GTF2H2_12@0@0@0@:general transcription factor IIH, polypeptide 2, 44kDa@:nucleoplasm;nucleotide-excision repair, DNA damage removal;transcription from RNA polymerase I promoter;DNA repair;RNA polymerase II carboxy-terminal domain kinase activity;nucleus;viral reproduction;translation;gene expression;transcription elongation from RNA polymerase I promoter;response to UV;holo TFIIH complex;protein kinase activity;nucleotide-excision repair;transcription from RNA polymerase II promoter;transcription-coupled nucleotide-excision repair;transcription, DNA-dependent;zinc ion binding;transcription elongation from RNA polymerase II promoter;termination of RNA polymerase I transcription;sequence-specific DNA binding transcription factor activity;G-protein coupled receptor internalization;DNA-dependent ATPase activity;protein N-terminus binding;transcription initiation from RNA polymerase I promoter;7-methylguanosine mRNA capping;transcription initiation from RNA polymerase II promoter;protein phosphorylation;translation factor activity, nucleic acid binding;regulation of transcription, DNA-dependent;core TFIIH complex;protein binding;positive regulation of viral transcription;nucleic acid binding@NA
A2463_32@60875@60877@duplication@3@175386973@175388437@5@chr5:175386973-175388437@6.31@93@153@1.65@NA@THOC3_6, THOC3_5, THOC3_4@0@0@0@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
A2463_32@60882@60885@deletion@4@175487236@175520277@5@chr5:175487236-175520277@12.9@99@27@0.273@NA@RP11-826N14.2_2, FAM153B_3, FAM153B_4@0@0@0@:uncharacterized LOC100507387;family with sequence similarity 153, member B@NA@NA
A2463_32@61266@61273@deletion@8@177163581@177171968@5@chr5:177163581-177171968@21.9@334@171@0.512@NA@FAM153A_11, FAM153A_10, FAM153A_9, FAM153A_8, FAM153A_7, FAM153A_6, FAM153A_5, FAM153A_4@0@0@0@:family with sequence similarity 153, member A@NA@NA
A2463_32@63291@63292@deletion@2@31324466@31324935@6@chr6:31324466-31324935@12.5@190@91@0.479@CNVR2841.12, CNVR2841.14, CNVR2841.8@HLA-B_2, HLA-B_1@0@0@0@:major histocompatibility complex, class I, B@:MHC class I protein complex;regulation of immune response;regulation of interleukin-12 production;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;regulation of T cell anergy;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;receptor binding;early endosome membrane;virus-host interaction;regulation of interleukin-6 production;regulation of dendritic cell differentiation;phagocytic vesicle membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;MHC class I receptor activity;membrane@: SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO; SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1; SPDA1
A2463_32@63725@63730@deletion@6@31962023@31963571@6@chr6:31962023-31963571@25.5@397@205@0.516@CNVR2843.6, CNVR2843.3@C4A_20, C4A_21, C4A_22, C4A_23, C4A_24, C4A_25@0@0@0@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
A2463_32@63732@63735@deletion@4@31963985@31965088@6@chr6:31963985-31965088@13.2@408@244@0.598@CNVR2843.6, CNVR2843.3@C4A_27, C4A_28, C4A_29, C4A_30@0@0@0@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
A2463_32@63790@63796@deletion@7@32006201@32007982@6@chr6:32006201-32007982@45.6@1111@623@0.561@CNVR2843.6, CNVR2843.5@CYP21A2_1, CYP21A2_2, CYP21A2_3, CYP21A2_4, CYP21A2_5, CYP21A2_6, CYP21A2_7@0@0@0@:cytochrome P450, family 21, subfamily A, polypeptide 2@:oxidation-reduction process;electron carrier activity;response to antibiotic;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;steroid 21-monooxygenase activity;C21-steroid hormone biosynthetic process;heme binding;mineralocorticoid biosynthetic process;progesterone metabolic process;monooxygenase activity;cellular response to peptide hormone stimulus;iron ion binding@: ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY
A2463_32@63958@63958@duplication@1@32497903@32498001@6@chr6:32497903-32498001@4.63@112@170@1.52@CNVR2845.21, CNVR2845.25, CNVR2845.43, CNVR2845.6, CNVR2845.48@HLA-DRB5_1@0@0@0@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
A2463_32@63958@63960@deletion@2@32497903@32548047@6@chr6:32497903-32548047@0.99@229@197@0.86@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.5@HLA-DRB5_1, HLA-DRB1_6, HLA-DRB1_5@0@0@0@:major histocompatibility complex, class II, DR beta 5:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
A2463_32@63966@63969@deletion@4@32609088@32628026@6@chr6:32609088-32628026@18.9@547@321@0.587@CNVR2845.21, CNVR2845.25, CNVR2845.27, CNVR2845.22, CNVR2845.39, CNVR2845.20@HLA-DQA1_2, HLA-DQA1_3, HLA-DQA1_4, HLA-DQB1_6@0@0@0@:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@NA
A2463_32@64601@64606@duplication@6@35748889@35765065@6@chr6:35748889-35765065@21.5@496@760@1.53@CNVR2861.1@CLPSL1_1, CLPSL1_2, CLPSL1_3, CLPS_3, CLPS_2, CLPS_1@0@0@0@:colipase-like 1:colipase, pancreatic@:extracellular region;enzyme activator activity;digestion;lipid catabolic process:steroid metabolic process;post-embryonic development;small molecule metabolic process;retinoid metabolic process;lipid metabolic process;extracellular region;enzyme activator activity;digestion;lipid catabolic process;lipid digestion;response to food@NA
A2463_32@69212@69212@deletion@1@132021610@132022541@6@chr6:132021610-132022541@5.3@120@67@0.558@CNVR3068.1, CNVR3068.2@OR2A4_1@0@0@0@:ectonucleotide pyrophosphatase/phosphodiesterase 3:olfactory receptor, family 2, subfamily A, member 4@:nucleotide diphosphatase activity;immune response;phosphate-containing compound metabolic process;catalytic activity;phosphodiesterase I activity;integral to plasma membrane;metabolic process;hydrolase activity;nucleoside-triphosphate diphosphatase activity;nucleoside triphosphate catabolic process;polysaccharide binding;perinuclear region of cytoplasm;extracellular region;scavenger receptor activity;NADH pyrophosphatase activity;nucleic acid binding;metal ion binding:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_32@70816@70817@deletion@2@161054786@161056336@6@chr6:161054786-161056336@6.07@174@105@0.603@CNVR3133.1@LPA_9, LPA_8@0@0@0@:lipoprotein, Lp(a)@:blood circulation;endopeptidase inhibitor activity;catalytic activity;lipoprotein metabolic process;proteolysis;heparin binding;receptor-mediated endocytosis;fibronectin binding;small molecule metabolic process;apolipoprotein binding;lipid metabolic process;negative regulation of endopeptidase activity;extracellular region;plasma lipoprotein particle;lipid transport;serine-type endopeptidase activity@: APOLIPOPROTEIN(a); LPA
A2463_32@71776@71779@duplication@4@6006495@6018327@7@chr7:6006495-6018327@11.4@599@819@1.37@NA@RSPH10B_2, PMS2_15, PMS2_14, PMS2_13@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas):PMS2 postmeiotic segregation increased 2 (S. cerevisiae)@:response to drug;DNA binding;MutSalpha complex binding;ATP binding;mismatch repair;DNA repair;mismatched DNA binding;ATPase activity;nucleus;mismatch repair complex;reciprocal meiotic recombination;ATP catabolic process;single-stranded DNA binding;response to DNA damage stimulus;single base insertion or deletion binding;protein binding;somatic hypermutation of immunoglobulin genes;somatic recombination of immunoglobulin gene segments;MutLalpha complex;endonuclease activity@: COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 4; HNPCC4; MISMATCH REPAIR CANCER SYNDROME
A2463_32@74566@74573@duplication@8@74159098@74166502@7@chr7:74159098-74166502@11.7@301@444@1.48@NA@GTF2I_21, GTF2I_22, GTF2I_23, GTF2I_24, GTF2I_25, GTF2I_26, GTF2I_27, GTF2I_28@0@0@0@:general transcription factor IIi@:neuronal cell body;transcription initiation from RNA polymerase II promoter;mitogen-activated protein kinase binding;negative regulation of angiogenesis;DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;cytoplasm;transcription from RNA polymerase II promoter;protein binding;signal transduction;nucleus;cell projection;reduction of cytosolic calcium ion concentration@NA
A2463_32@74597@74598@duplication@2@74225431@74227349@7@chr7:74225431-74227349@17.9@43@166@3.86@NA@GTF2IRD2_10, GTF2IRD2_9@0@0@0@:GTF2I repeat domain containing 2@:nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_32@74629@74635@deletion@7@74538938@74552657@7@chr7:74538938-74552657@20@171@52@0.304@NA@GTF2IRD2B_5, GTF2IRD2B_6, GTF2IRD2B_7, GTF2IRD2B_8, GTF2IRD2B_9, GTF2IRD2B_10, GTF2IRD2B_11@0@0@0@:GTF2I repeat domain containing 2B@:nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_32@74659@74659@deletion@1@75050793@75052486@7@chr7:75050793-75052486@4.89@264@171@0.648@NA@POM121C_13@0@0@0@:POM121 transmembrane nucleoporin C@:nuclear membrane;protein binding;protein transport;endoplasmic reticulum membrane;nuclear pore;mRNA transport@NA
A2463_32@74792@74793@deletion@2@76240783@76241130@7@chr7:76240783-76241130@9.66@72@20@0.278@CNVR3463.10@POMZP3_6, POMZP3_5@0@0@0@:uroplakin 3B:POM121 and ZP3 fusion@:negative regulation of gene expression;integral to membrane;plasma membrane:molecular_function;cellular_component;biological_process@NA
A2463_32@79309@79315@duplication@7@143880598@144062916@7@chr7:143880598-144062916@77.8@2083@3332@1.6@CNVR3598.4@CTAGE4_1, ARHGEF35_2, OR2A42_1, OR2A7_1, CTAGE8_1, OR2A1_1, ARHGEF5_2@0@0@0@:CTAGE family, member 4:Rho guanine nucleotide exchange factor (GEF) 35:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1:olfactory receptor, family 2, subfamily A, member 7:CTAGE family, member 6, pseudogene;CTAGE family, member 15, pseudogene:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:integral to membrane;nucleotide binding;cellular_component;biological_process:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
A2463_32@80358@80359@deletion@2@6873513@6874372@8@chr8:6873513-6874372@6.46@83@37@0.446@CNVR3769.1@DEFA3_3, DEFA3_2@0@0@0@:defensin, alpha 1B;defensin, alpha 1:defensin, alpha 3, neutrophil-specific;defensin, alpha 1B;defensin, alpha 1@:defense response to virus;extracellular matrix;immune response;Golgi lumen;azurophil granule lumen;killing of cells of other organism;innate immune response;chemotaxis;extracellular space;extracellular region;defense response to bacterium;defense response to fungus;defense response:defense response to virus;Golgi lumen;azurophil granule lumen;killing of cells of other organism;innate immune response;extracellular space;defense response to bacterium;defense response to fungus;extracellular region;defense response@NA
A2463_32@80362@80366@duplication@5@7215499@7220468@8@chr8:7215499-7220468@31.8@1044@1558@1.49@CNVR3771.8, CNVR3771.10, CNVR3771.4@ZNF705G_7, ZNF705G_6, ZNF705G_5, ZNF705G_4, ZNF705G_3@0@0@0@:zinc finger protein 705G@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_32@80368@80368@duplication@1@7274293@7274349@8@chr8:7274293-7274349@5.15@9@42@4.67@CNVR3771.8, CNVR3771.10, CNVR3771.4@DEFB4B_1@0@0@0@:defensin, beta 4B;defensin, beta 4A@:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response@NA
A2463_32@80371@80375@deletion@5@7308236@7332590@8@chr8:7308236-7332590@12.4@310@181@0.584@CNVR3771.8, CNVR3771.10, CNVR3771.4@SPAG11B_3, SPAG11B_2, SPAG11B_1, DEFB104B_2, DEFB104B_1@0@0@0@:sperm associated antigen 11B:defensin, beta 104A;defensin, beta 104B@:spermatogenesis;defense response to bacterium;extracellular region;molecular_function;defense response:extracellular region;defense response to bacterium@NA
A2463_32@80402@80402@duplication@1@7718169@7718245@8@chr8:7718169-7718245@9.23@38@106@2.79@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@SPAG11A_3@0@0@0@:sperm associated antigen 11A;sperm associated antigen 11B@:extracellular region;defense response@NA
A2463_32@80406@80412@deletion@7@7752236@7809913@8@chr8:7752236-7809913@34.7@338@124@0.367@CNVR3772.4, CNVR3772.6, CNVR3772.10, CNVR3772.13@DEFB4A_1, DEFB4A_2, ZNF705B_2, ZNF705B_3, ZNF705B_4, ZNF705B_5, ZNF705B_6@0@0@0@:defensin, beta 4B;defensin, beta 4A:zinc finger protein 705B@:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response:intracellular;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_32@80564@80564@deletion@1@11970084@11970667@8@chr8:11970084-11970667@8.52@144@71@0.493@CNVR3785.8, CNVR3785.5@ZNF705D_6@0@0@0@:zinc finger protein 705D@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_32@80569@80572@deletion@4@12044210@12049350@8@chr8:12044210-12049350@20@117@17@0.145@CNVR3785.5, CNVR3785.3@FAM86B1_5, FAM86B1_4, FAM86B1_3, FAM86B1_2@0@0@0@:family with sequence similarity 86, member B2;family with sequence similarity 86, member B1@NA@NA
A2463_32@80576@80579@deletion@4@12283399@12286623@8@chr8:12283399-12286623@18.8@106@14@0.132@CNVR3786.4, CNVR3786.16@FAM86B2_8, FAM86B2_7, FAM86B2_6, FAM86B2_5@0@0@0@:family with sequence similarity 86, member B2@NA@NA
A2463_32@80584@80584@deletion@1@12338341@12338444@8@chr8:12338341-12338444@22.1@120@10@0.0833@CNVR3786.4, CNVR3786.16@AC130352.1_5@0@0@0@NA@NA@NA
A2463_32@86646@86646@duplication@1@178817@178969@9@chr9:178817-178969@6.67@66@125@1.89@CNVR4135.1@CBWD1_1@0@0@0@:COBW domain containing 1;COBW domain-containing protein 1-like;COBW domain containing 5@:ATP binding@NA
A2463_32@88527@88529@deletion@3@40702337@40716325@9@chr9:40702337-40716325@12.8@922@605@0.656@NA@SPATA31A3_3, SPATA31A3_4, FAM74A3_1@0@0@0@:SPATA31 subfamily A, member 3@:integral to membrane@NA
A2463_32@88534@88534@deletion@1@41306194@41306209@9@chr9:41306194-41306209@10.7@49@0@0@CNVR4278.2@FAM74A2_2@0@0@0@@:integral to membrane@NA
A2463_32@88558@88558@duplication@1@42409510@42410483@9@chr9:42409510-42410483@7.7@87@160@1.84@NA@ANKRD20A2_15, RP11-146D12.2_1@0@0@0@:ankyrin repeat domain 20 family, member A2@:protein binding@NA
A2463_32@88584@88611@duplication@28@43624656@43920370@9@chr9:43624656-43920370@107@2869@4838@1.69@CNVR4294.1@SPATA31A6_4, SPATA31A6_3, SPATA31A6_2, SPATA31A6_1, CNTNAP3B_1, CNTNAP3B_2, CNTNAP3B_3, CNTNAP3B_4, CNTNAP3B_5, CNTNAP3B_6, CNTNAP3B_7, CNTNAP3B_8, CNTNAP3B_9, CNTNAP3B_10, CNTNAP3B_11, CNTNAP3B_12, CNTNAP3B_13, CNTNAP3B_14, CNTNAP3B_15, CNTNAP3B_16, CNTNAP3B_17, CNTNAP3B_18, CNTNAP3B_19, CNTNAP3B_20, CNTNAP3B_21, CNTNAP3B_22, CNTNAP3B_23, CNTNAP3B_24@0@0@0@:SPATA31 subfamily A, member 6:contactin associated protein-like 3B;contactin associated protein-like 3@:integral to membrane:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
A2463_32@88620@88622@deletion@3@45727245@45733965@9@chr9:45727245-45733965@5.97@161@97@0.602@CNVR4305.1@FAM27A_1, AL953889.1_2, AL953889.1_1, FAM27A_2, FAM27E2_1@0@0@0@NA@NA@NA
A2463_32@88643@88643@deletion@1@67935876@67936012@9@chr9:67935876-67936012@5.75@26@0@0@NA@ANKRD20A1_5@0@0@0@:ankyrin repeat domain 20 family, member A1@:protein binding;plasma membrane@NA
A2463_32@88643@88644@duplication@1@67935876@67938658@9@chr9:67935876-67938658@2.49@164@228@1.39@NA@ANKRD20A1_5, ANKRD20A1_6@0@0@0@:ankyrin repeat domain 20 family, member A1@:protein binding;plasma membrane@NA
A2463_32@88647@88652@deletion@6@67951933@67966773@9@chr9:67951933-67966773@12.9@198@99@0.5@NA@ANKRD20A1_9, ANKRD20A1_10, ANKRD20A1_11, ANKRD20A1_12, ANKRD20A1_13, ANKRD20A1_14@0@0@0@:ankyrin repeat domain 20 family, member A1@:protein binding;plasma membrane@NA
A2463_32@88656@88656@deletion@1@67985712@67985922@9@chr9:67985712-67985922@9.2@45@2@0.0444@CNVR4321.1@RP11-195B21.3_5@0@0@0@:coiled-coil domain-containing protein 29-like;uncharacterized LOC644249@NA@NA
A2463_32@88676@88678@deletion@3@69382094@69386055@9@chr9:69382094-69386055@10.8@62@9@0.145@NA@ANKRD20A4_1, ANKRD20A4_2, ANKRD20A4_3@0@0@0@:ankyrin repeat domain 20 family, member A4@:protein binding@NA
A2463_32@88681@88684@deletion@4@69393823@69407240@9@chr9:69393823-69407240@11.4@117@46@0.393@NA@ANKRD20A4_6, ANKRD20A4_7, ANKRD20A4_8, ANKRD20A4_9@0@0@0@:ankyrin repeat domain 20 family, member A4@:protein binding@NA
A2463_32@88690@88690@deletion@1@69423203@69424176@9@chr9:69423203-69424176@5.3@390@260@0.667@NA@ANKRD20A4_15@0@0@0@:ankyrin repeat domain 20 family, member A4@:protein binding@NA
A2463_32@93347@93347@deletion@1@136419480@136419815@9@chr9:136419480-136419815@7.51@34@0@0@NA@ADAMTSL2_10@0@0@0@:ADAMTS-like protein 2-like;ADAMTS-like 2@:peptidase activity;protein binding;extracellular matrix;proteinaceous extracellular matrix;negative regulation of transforming growth factor beta receptor signaling pathway;metalloendopeptidase activity;zinc ion binding@: GELEOPHYSIC DYSPLASIA 1; GPHYSD1
A2463_32@95970@95971@deletion@2@29783844@29784110@10@chr10:29783844-29784110@7.24@115@60@0.522@NA@SVIL_22, SVIL_21@0@0@0@:supervillin@:podosome;actin cytoskeleton;invadopodium;cytoplasm;actin binding;actin filament binding;cell junction;nucleus;plasma membrane;cytoskeleton organization;skeletal muscle tissue development;costamere@NA
A2463_32@96455@96470@duplication@16@46321364@46611811@10@chr10:46321364-46611811@49.3@250@629@2.52@NA@AGAP4_7, AGAP4_6, AGAP4_5, AGAP4_4, AGAP4_3, AGAP4_2, AGAP4_1, PTPN20A_10, PTPN20A_9, PTPN20A_8, PTPN20A_7, PTPN20A_6, PTPN20A_5, PTPN20A_4, PTPN20A_3, PTPN20A_2@0@0@0@:ArfGAP with GTPase domain, ankyrin repeat and PH domain 4;arf-GAP with GTPase, ANK repeat and PH domain-containing protein 5-like:protein tyrosine phosphatase, non-receptor type 20B;protein tyrosine phosphatase, non-receptor type 20A@:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity:phosphatase activity;protein tyrosine phosphatase activity;microtubule;nucleus;dephosphorylation;protein dephosphorylation;microtubule organizing center@NA
A2463_32@96534@96534@duplication@1@47769181@47769665@10@chr10:47769181-47769665@6.37@148@228@1.54@CNVR4714.1@AL603965.1_2@0@0@0@:uncharacterized LOC101060462;uncharacterized LOC100996760@NA@NA
A2463_32@96541@96564@deletion@24@47906679@48001973@10@chr10:47906679-48001973@89.6@554@103@0.186@CNVR4715.2@FAM21B_7, FAM21B_8, FAM21B_9, FAM21B_10, FAM21B_11, FAM21B_12, FAM21B_13, FAM21B_14, FAM21B_15, FAM21B_16, FAM21B_17, FAM21B_18, FAM21B_19, FAM21B_20, FAM21B_21, FAM21B_22, FAM21B_23, FAM21B_24, FAM21B_25, FAM21B_26, FAM21B_27, FAM21B_28, FAM21B_29, ASAH2C_18@0@0@0@:family with sequence similarity 21, member B@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome:ceramidase activity;sphingolipid metabolic process@NA
A2463_32@96620@96620@duplication@1@48771316@48771405@10@chr10:48771316-48771405@12.1@66@164@2.48@CNVR4716.10, CNVR4716.3@PTPN20B_6@0@0@0@:protein tyrosine phosphatase, non-receptor type 20B;protein tyrosine phosphatase, non-receptor type 20A@:phosphatase activity;protein tyrosine phosphatase activity;microtubule;nucleus;dephosphorylation;protein dephosphorylation;microtubule organizing center@NA
A2463_32@96631@96634@deletion@4@49376639@49382998@10@chr10:49376639-49382998@8.86@71@22@0.31@CNVR4717.2@FRMPD2_27, FRMPD2_26, FRMPD2_25, FRMPD2_24@0@0@0@:FERM and PDZ domain containing 2@:basolateral plasma membrane;transferase activity, transferring phosphorus-containing groups;cytoplasm;tight junction;protein binding;cytoskeleton;1-phosphatidylinositol binding;tight junction assembly@NA
A2463_32@96844@96852@deletion@9@51224991@51374428@10@chr10:51224991-51374428@19.8@314@151@0.481@NA@AGAP8_7, AGAP8_6, AGAP8_5, AGAP8_4, AGAP8_3, AGAP8_2, AGAP8_1, TIMM23B_1, TIMM23B_2@0@0@0@:ArfGAP with GTPase domain, ankyrin repeat and PH domain 8:translocase of inner mitochondrial membrane 23 homolog B (yeast)@:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process@NA
A2463_32@96860@96860@duplication@1@51472553@51472652@10@chr10:51472553-51472652@4.58@33@69@2.09@CNVR4729.1@AGAP7_4@0@0@0@:translocase of inner mitochondrial membrane 23 homolog B (yeast):ArfGAP with GTPase domain, ankyrin repeat and PH domain 7@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity@NA
A2463_32@96883@96883@duplication@1@51620325@51620382@10@chr10:51620325-51620382@5.99@140@215@1.54@NA@TIMM23_2@0@0@0@:translocase of inner mitochondrial membrane 23 homolog B (yeast):translocase of inner mitochondrial membrane 23 homolog B (yeast);translocase of inner mitochondrial membrane 23 homolog (yeast)@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process:mitochondrion;mitochondrial inner membrane;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;mitochondrial intermembrane space;integral to mitochondrial inner membrane;intracellular protein transport;protein binding;integral to membrane;cellular protein metabolic process;protein targeting to mitochondrion@NA
A2463_32@96906@96922@duplication@17@51854909@51890838@10@chr10:51854909-51890838@29.5@602@928@1.54@CNVR4734.2@FAM21A_14, FAM21A_15, FAM21A_16, FAM21A_17, FAM21A_18, FAM21A_19, FAM21A_20, FAM21A_21, FAM21A_22, FAM21A_23, FAM21A_24, FAM21A_25, FAM21A_26, FAM21A_27, FAM21A_28, FAM21A_29, FAM21A_30@0@0@0@:family with sequence similarity 21, member B;family with sequence similarity 21, member A@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_32@96932@96937@deletion@6@51965743@51978390@10@chr10:51965743-51978390@9.75@91@35@0.385@NA@ASAH2_12, ASAH2_11, ASAH2_10, ASAH2_9, ASAH2_8, ASAH2_7@0@0@0@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
A2463_32@98346@98350@deletion@5@81468456@81472241@10@chr10:81468456-81472241@33.3@541@242@0.447@CNVR4815.2, CNVR4815.4@FAM22B_3, FAM22B_4, FAM22B_5, FAM22B_6, FAM22B_7@0@0@0@NA@NA@NA
A2463_32@98353@98357@duplication@5@81606587@81610362@10@chr10:81606587-81610362@34.8@100@371@3.71@NA@FAM22E_3, FAM22E_4, FAM22E_5, FAM22E_6, FAM22E_7@0@0@0@NA@NA@NA
A2463_32@98599@98601@duplication@3@88992361@88994465@10@chr10:88992361-88994465@9.22@160@256@1.6@CNVR4840.3, CNVR4840.5, CNVR4840.6@FAM22A_5, FAM22A_6, FAM22A_7@0@0@0@:family with sequence similarity 22, member A@NA@NA
A2463_32@103268@103268@duplication@1@4967390@4968330@11@chr11:4967390-4968330@5.73@458@622@1.36@CNVR5040.1@OR51A4_1@0@0@0@:matrix metallopeptidase 26:olfactory receptor, family 51, subfamily A, member 4@:metallopeptidase activity;extracellular matrix;proteolysis;proteinaceous extracellular matrix;collagen catabolic process;metalloendopeptidase activity;zinc ion binding;metabolic process:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_32@103289@103290@deletion@2@5270599@5271034@11@chr11:5270599-5271034@12.1@72@11@0.153@NA@HBG1_2, HBG1_1@0@0@0@:hemoglobin, gamma A@:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex@NA
A2463_32@103342@103342@deletion@1@5798891@5799864@11@chr11:5798891-5799864@5.17@214@134@0.626@CNVR5049.1@OR52N5_1@0@0@0@:tripartite motif containing 5:olfactory receptor, family 52, subfamily N, member 5@:defense response to virus;Golgi apparatus;intracellular;protein trimerization;ligase activity;cytoplasm;protein binding;nucleus;protein homodimerization activity;identical protein binding;zinc ion binding;cytoplasmic mRNA processing body;protein ubiquitination;virus-host interaction:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_32@106046@106048@deletion@3@55370918@55419315@11@chr11:55370918-55419315@7.51@571@389@0.681@CNVR5179.1@OR4C11_1, OR4P4_1, OR4S2_1@0@0@0@:olfactory receptor, family 4, subfamily C, member 11:olfactory receptor, family 4, subfamily P, member 4:olfactory receptor, family 4, subfamily S, member 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_32@110110@110114@duplication@5@89532885@89537637@11@chr11:89532885-89537637@15.2@307@490@1.6@NA@TRIM49_7, TRIM49_6, TRIM49_5, TRIM49_4, TRIM49_3@0@0@0@:tripartite motif containing 49@:protein binding;intracellular;DNA binding;zinc ion binding@NA
A2463_32@110121@110125@deletion@5@89768381@89773130@11@chr11:89768381-89773130@35.5@208@26@0.125@NA@TRIM49C_3, TRIM49C_4, TRIM49C_5, TRIM49C_6, TRIM49C_7@0@0@0@:tripartite motif containing 49D, pseudogene;tripartite motif containing 49-like 1;tripartite motif containing 49C;tripartite motif-containing protein 49-like protein 1-like@:protein binding;intracellular;DNA binding;zinc ion binding@NA
A2463_32@114483@114483@deletion@1@11243900@11244828@12@chr12:11243900-11244828@52.6@262@1@0.00382@CNVR5434.1@TAS2R43_1@0@0@0@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):taste receptor, type 2, member 14:taste receptor, type 2, member 43@:extracellular space;visual perception:bitter taste receptor activity;taste receptor activity;integral to membrane;sensory perception of taste;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of bitter taste:G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;motile cilium;taste receptor activity;bitter taste receptor activity;integral to membrane;sensory perception of taste;detection of chemical stimulus involved in sensory perception of bitter taste;cilium membrane@NA
A2463_32@127334@127335@deletion@2@19558718@19559164@14@chr14:19558718-19559164@4.89@138@83@0.601@CNVR6072.1@POTEG_2, POTEG_3@0@0@0@:POTE ankyrin domain family, member G@:protein binding@NA
A2463_32@127353@127358@duplication@6@20215588@20404761@14@chr14:20215588-20404761@45@2365@3348@1.42@CNVR6072.12, CNVR6072.4, CNVR6072.5@OR4Q3_1, OR4M1_1, OR4N2_1, OR4K2_1, OR4K5_1, OR4K1_1@0@0@0@:olfactory receptor, family 4, subfamily N, member 2:olfactory receptor, family 4, subfamily Q, member 3:olfactory receptor, family 4, subfamily M, member 1:olfactory receptor, family 4, subfamily K, member 2:olfactory receptor, family 4, subfamily K, member 5:olfactory receptor, family 4, subfamily K, member 1@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_32@127739@127740@duplication@2@22446920@22447360@14@chr14:22446920-22447360@4.92@121@180@1.49@NA@TRAV8-6_1, TRAV8-6_2@0@0@0@@:protein binding@NA
A2463_32@133470@133471@deletion@2@106877620@106878076@14@chr14:106877620-106878076@38.4@178@0@0@CNVR6294.26, CNVR6294.56, CNVR6294.2, CNVR6294.18@IGHV4-39_2, IGHV4-39_1@0@0@0@@:protein binding@NA
A2463_32@133491@133492@duplication@2@107095127@107095561@14@chr14:107095127-107095561@11@96@188@1.96@CNVR6294.56, CNVR6294.16, CNVR6294.91@IGHV4-61_2, IGHV4-61_1@0@0@0@@:protein binding@NA
A2463_32@133497@133498@duplication@2@107169932@107170367@14@chr14:107169932-107170367@5.17@206@290@1.41@CNVR6294.56, CNVR6294.6, CNVR6294.92@IGHV1-69_2, IGHV1-69_1@0@0@0@@:protein binding@NA
A2463_32@133509@133528@deletion@20@20739498@21071610@15@chr15:20739498-21071610@39.6@703@341@0.485@NA@GOLGA6L6_8, GOLGA6L6_7, GOLGA6L6_6, GOLGA6L6_5, GOLGA6L6_4, GOLGA6L6_3, GOLGA6L6_2, GOLGA6L6_1, AC012414.1_1, POTEB_11, POTEB_10, POTEB_9, POTEB_8, POTEB_7, POTEB_6, POTEB_5, POTEB_4, POTEB_3, POTEB_2, POTEB_1@0@0@0@:putative transmembrane protein FLJ36131-like;putative transmembrane protein ENSP00000320207-like;golgin A6 family-like 6:POTE ankyrin domain family member B-like@:protein binding@NA
A2463_32@133532@133532@duplication@1@22062317@22062482@15@chr15:22062317-22062482@5.27@18@54@3@NA@POTEB_9@0@0@0@:POTE ankyrin domain family member B-like@:protein binding@NA
A2463_32@133542@133542@deletion@1@22382474@22383423@15@chr15:22382474-22383423@6.28@397@259@0.652@CNVR6297.4, CNVR6297.17, CNVR6297.2@OR4N4_1@0@0@0@:olfactory receptor, family 4, subfamily N, member 4@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_32@133552@133552@deletion@1@22742397@22743598@15@chr15:22742397-22743598@64.1@819@204@0.249@CNVR6298.5@GOLGA6L1_8@0@0@0@:golgin A6 family-like 1;putative transmembrane protein FLJ36131-like;putative transmembrane protein ENSP00000320207-like;putative golgin subfamily A member 6-like@NA@NA
A2463_32@133622@133623@duplication@2@23259497@23259716@15@chr15:23259497-23259716@7.19@53@109@2.06@CNVR6300.4@GOLGA8I_6, GOLGA8I_7@0@0@0@:golgin A8 family, member I@:Golgi cisterna membrane@NA
A2463_32@133636@133641@duplication@6@23406272@23411062@15@chr15:23406272-23411062@31.7@511@886@1.73@CNVR6300.8@RP11-467N20.5_8, RP11-467N20.5_7, RP11-467N20.5_6, RP11-467N20.5_5, RP11-467N20.5_4, RP11-467N20.5_3@0@0@0@:putative golgin subfamily A member 6-like protein 6-like@NA@NA
A2463_32@133869@133870@deletion@2@28629294@28629596@15@chr15:28629294-28629596@5.58@25@0@0@CNVR6329.4@GOLGA8F_9, GOLGA8F_10@0@0@0@@:Golgi apparatus@NA
A2463_32@134030@134030@deletion@1@30702433@30702470@15@chr15:30702433-30702470@9.52@45@1@0.0222@NA@GOLGA8R_5@0@0@0@@:Golgi apparatus@NA
A2463_32@134055@134078@deletion@24@30898047@30927833@15@chr15:30898047-30927833@87.6@1423@708@0.498@CNVR6339.2, CNVR6339.3, CNVR6339.4@GOLGA8H_2, GOLGA8H_3, GOLGA8H_4, GOLGA8H_5, GOLGA8H_6, GOLGA8H_7, GOLGA8H_8, GOLGA8H_9, GOLGA8H_10, GOLGA8H_11, GOLGA8H_12, GOLGA8H_13, GOLGA8H_14, GOLGA8H_15, GOLGA8H_16, GOLGA8H_17, GOLGA8H_18, GOLGA8H_19, ARHGAP11B_1, ARHGAP11B_2, ARHGAP11B_3, ARHGAP11B_4, ARHGAP11B_5, ARHGAP11B_6@0@0@0@:golgin A8 family, member H:Rho GTPase activating protein 11B;OTU domain containing 7A pseudogene@:Golgi apparatus:cytosol;signal transduction;intracellular;small GTPase mediated signal transduction;GTPase activator activity;regulation of small GTPase mediated signal transduction@NA
A2463_32@134149@134153@duplication@5@32323102@32449976@15@chr15:32323102-32449976@12.7@254@392@1.54@NA@CHRNA7_2, CHRNA7_3, CHRNA7_4, CHRNA7_5, CHRNA7_6@0@0@0@:cholinergic receptor, nicotinic, alpha 7 (neuronal);CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:cellular calcium ion homeostasis;transport;beta-amyloid binding;calcium ion transport;acetylcholine receptor activity;ion transport;acetylcholine-activated cation-selective channel activity;integral to membrane;chloride channel regulator activity;cell junction;plasma membrane;positive regulation of cell proliferation;protein homodimerization activity;acetylcholine-gated channel complex;response to chemical stimulus;activation of MAPK activity;negative regulation of tumor necrosis factor production;response to hypoxia;response to nicotine;acetylcholine binding;positive regulation of angiogenesis;signal transduction;memory;toxin binding;synaptic transmission;postsynaptic membrane;membrane;cognition;extracellular ligand-gated ion channel activity@NA
A2463_32@134204@134205@deletion@2@32890090@32890378@15@chr15:32890090-32890378@16@80@5@0.0625@NA@GOLGA8N_7, GOLGA8N_8@0@0@0@:golgin A8 family, member R@:Golgi apparatus@NA
A2463_32@134431@134432@deletion@2@34673613@34674057@15@chr15:34673613-34674057@9.26@138@66@0.478@CNVR6351.4, CNVR6351.3@GOLGA8A_24, GOLGA8A_23@0@0@0@:golgin A8 family, member A@:Golgi cisterna membrane;Golgi apparatus@NA
A2463_32@134442@134448@duplication@7@34677629@34820278@15@chr15:34677629-34820278@17.1@188@340@1.81@CNVR6351.3@GOLGA8A_13, GOLGA8A_12, GOLGA8A_11, GOLGA8A_10, GOLGA8A_9, GOLGA8B_25, GOLGA8B_24@0@0@0@:golgin A8 family, member A:golgin A8 family, member A;golgin A8 family, member B@:Golgi cisterna membrane;Golgi apparatus:Golgi cisterna membrane;Golgi apparatus@NA
A2463_32@134457@134460@deletion@4@34823677@34825163@15@chr15:34823677-34825163@14.1@64@0@0@CNVR6351.3@GOLGA8B_15, GOLGA8B_14, GOLGA8B_13, GOLGA8B_12@0@0@0@:golgin A8 family, member A:golgin A8 family, member A;golgin A8 family, member B@:Golgi cisterna membrane;Golgi apparatus:Golgi cisterna membrane;Golgi apparatus@NA
A2463_32@135699@135706@duplication@8@43892395@43897044@15@chr15:43892395-43897044@12.7@1075@1408@1.31@CNVR6365.1@STRC_27, STRC_26, STRC_25, STRC_24, STRC_23, STRC_22, STRC_21, STRC_20@0@0@0@:diphosphoinositol pentakisphosphate kinase 1:stereocilin@:inositol hexakisphosphate 3-kinase activity;inositol hexakisphosphate 1-kinase activity;inositol metabolic process;diphosphoinositol-pentakisphosphate kinase activity;ATP binding;acid phosphatase activity;cytoplasm;cytosol;inositol hexakisphosphate 5-kinase activity;nucleus;kinase activity;inositol-1,3,4,5,6-pentakisphosphate kinase activity:detection of mechanical stimulus involved in sensory perception of sound;stereocilium bundle tip;stereocilium;cell surface;kinocilium;auditory receptor cell stereocilium organization@: DEAFNESS, AUTOSOMAL RECESSIVE 16; DFNB16; DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY
A2463_32@136923@136929@duplication@7@57730199@57754090@15@chr15:57730199-57754090@23.4@1132@1623@1.43@NA@CGNL1_2, CGNL1_3, CGNL1_4, CGNL1_5, CGNL1_6, CGNL1_7, CGNL1_8@0@0@0@:cingulin-like 1@:tight junction;motor activity;myosin complex;actin cytoskeleton;apical junction complex@: AROMATASE EXCESS SYNDROME; AEXS
A2463_32@138284@138287@deletion@4@72954594@72957376@15@chr15:72954594-72957376@31.4@159@10@0.0629@CNVR6443.1@GOLGA6B_11, GOLGA6B_12, GOLGA6B_13, GOLGA6B_14@0@0@0@:golgin A6 family, member B@:Golgi apparatus@NA
A2463_32@138416@138417@duplication@2@74364560@74365158@15@chr15:74364560-74365158@5.65@232@323@1.39@CNVR6448.1@GOLGA6A_14, GOLGA6A_13@0@0@0@:golgin A6 family, member C;golgin A6 family, member A;golgin A6 family, member D;golgin A6 family, member B@:Golgi apparatus@NA
A2463_32@138657@138662@duplication@6@75582723@75586359@15@chr15:75582723-75586359@8.39@188@283@1.51@CNVR6452.1@GOLGA6D_11, GOLGA6D_12, GOLGA6D_13, GOLGA6D_14, GOLGA6D_15, GOLGA6D_16@0@0@0@:golgin A6 family, member D@:Golgi apparatus@NA
A2463_32@139305@139308@deletion@4@83013228@83015609@15@chr15:83013228-83015609@5.57@32@5@0.156@CNVR6477.6, CNVR6477.2@RP13-996F3.4_6, RP13-996F3.4_5, RP13-996F3.4_4, RP13-996F3.4_3@0@0@0@NA@NA@NA
A2463_32@139479@139480@duplication@2@84908541@84909861@15@chr15:84908541-84909861@6.15@206@296@1.44@CNVR6486.2@GOLGA6L4_6, GOLGA6L4_7@0@0@0@@:Golgi apparatus@NA
A2463_32@143493@143493@deletion@1@21858735@21858862@16@chr16:21858735-21858862@10.6@109@40@0.367@CNVR6668.5, CNVR6668.7@NPIPL3_2@0@0@0@:nuclear pore complex interacting protein-like 3;nuclear pore complex interacting protein-like;nuclear pore complex-interacting protein-like 3-like@NA@NA
A2463_32@144047@144052@deletion@6@28467746@28478223@16@chr16:28467746-28478223@20.6@115@14@0.122@NA@NPIPL1_7, NPIPL1_6, NPIPL1_5, NPIPL1_4, NPIPL1_3, NPIPL1_2@0@0@0@:ceroid-lipofuscinosis, neuronal 3@:membrane:negative regulation of apoptotic process;late endosome;mitochondrion;galactosylceramide metabolic process;neuromuscular process controlling balance;neuron projection;lysosomal lumen pH elevation;integral to endoplasmic reticulum membrane;cell death;plasma membrane;nucleus;lysosomal lumen acidification;negative regulation of catalytic activity;negative regulation of macroautophagy;unfolded protein binding;neurotransmitter metabolic process;endoplasmic reticulum;vesicle transport along microtubule;protein catabolic process;autophagic vacuole;early endosome;trans-Golgi network;cellular membrane organization;ceramide metabolic process;glucosylceramide metabolic process;negative regulation of neuron apoptotic process;membrane;globoside metabolic process;membrane raft;synaptic vesicle;vacuolar transport;protein processing;Golgi membrane;caveola;protein folding;ionotropic glutamate receptor signaling pathway;cytosolic calcium ion homeostasis;Golgi stack;integral to membrane;receptor-mediated endocytosis;arginine transport;lysosome;negative regulation of proteolysis;Golgi apparatus;lysosome organization;associative learning;sphingomyelin metabolic process;macroautophagy;lysosomal membrane;amyloid precursor protein catabolic process;cytoplasm;autophagic vacuole fusion;protein binding;regulation of action potential;cellular amino acid metabolic process@: CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3
A2463_32@144096@144102@duplication@7@28617143@28620176@16@chr16:28617143-28620176@55@513@1012@1.97@CNVR6685.1, CNVR6685.2@SULT1A1_10, SULT1A1_9, SULT1A1_8, SULT1A1_7, SULT1A1_6, SULT1A1_5, SULT1A1_4@0@0@0@:sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1@:small molecule metabolic process;sulfation;aryl sulfotransferase activity;amine metabolic process;catecholamine metabolic process;xenobiotic metabolic process;cytosol;steroid sulfotransferase activity;integral to membrane;sulfotransferase activity;flavonol 3-sulfotransferase activity;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process;estrogen metabolic process@NA
A2463_32@144130@144134@deletion@5@28763890@28777810@16@chr16:28763890-28777810@10.5@77@21@0.273@NA@A-575C2.4_1, A-575C2.4_2, A-575C2.4_3, A-575C2.4_4, A-575C2.4_5@0@0@0@NA@NA@NA
A2463_32@145262@145263@duplication@2@50100044@50100450@16@chr16:50100044-50100450@4.9@76@123@1.62@NA@HEATR3_1, HEATR3_2@0@0@0@:HEAT repeat containing 3@:binding@NA
A2463_32@147091@147091@duplication@1@69988238@69988476@16@chr16:69988238-69988476@5.12@63@110@1.75@CNVR6762.3, CNVR6762.1@CLEC18A_3@0@0@0@:C-type lectin domain family 18, member A@:carbohydrate binding;protein binding;extracellular region@NA
A2463_32@147505@147508@deletion@4@74443751@74445673@16@chr16:74443751-74445673@10.7@289@172@0.595@CNVR6778.2, CNVR6778.3, CNVR6778.5@CLEC18B_11, CLEC18B_10, CLEC18B_9, CLEC18B_8@0@0@0@:C-type lectin domain family 18, member B@:carbohydrate binding;protein binding;extracellular region@NA
A2463_32@151415@151415@deletion@1@15517148@15517347@17@chr17:15517148-15517347@5.05@83@42@0.506@NA@CDRT1_3, TRIM16_9@0@0@0@:CMT1A duplicated region transcript 1@:protein binding;molecular_function;cellular_component;biological_process:protein binding;intracellular;zinc ion binding;cytoplasm@NA
A2463_32@151876@151878@deletion@3@18387190@18391071@17@chr17:18387190-18391071@5.58@118@66@0.559@CNVR7014.1@LGALS9C_2, LGALS9C_3, LGALS9C_4@0@0@0@:lectin, galactoside-binding, soluble, 9C@:carbohydrate binding@NA
A2463_32@151958@151959@deletion@2@18996506@18997166@17@chr17:18996506-18997166@16.6@278@133@0.478@CNVR7018.4, CNVR7018.2, CNVR7018.6@AC007952.5_1, AC007952.5_2@0@0@0@NA@NA@NA
A2463_32@153371@153381@deletion@11@34499654@34539971@17@chr17:34499654-34539971@11@86@26@0.302@CNVR7077.1, CNVR7077.3, CNVR7077.6@TBC1D3B_6, TBC1D3B_5, TBC1D3B_4, TBC1D3B_3, TBC1D3B_2, CCL3L3_3, CCL3L3_2, CCL3L3_1, CCL4L1_1, CCL4L1_2, CCL4L1_3@0@0@0@:TBC1 domain family, member 3B:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
A2463_32@153414@153414@deletion@1@34797487@34798054@17@chr17:34797487-34798054@19@88@0@0@CNVR7078.2, CNVR7078.3@TBC1D3G_14@0@0@0@:TBC1 domain family member 3H-like;TBC1 domain family, member 3H:TBC1 domain family, member 3;TBC1 domain family, member 3G;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like;TBC1 domain family, member 3H@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_32@153648@153659@duplication@12@36346763@36375177@17@chr17:36346763-36375177@21.4@1424@1900@1.33@CNVR7083.3@TBC1D3_7, TBC1D3_6, RP11-1407O15.2_12, RP11-1407O15.2_11, RP11-1407O15.2_10, RP11-1407O15.2_9, RP11-1407O15.2_8, RP11-1407O15.2_7, RP11-1407O15.2_6, RP11-1407O15.2_5, RP11-1407O15.2_4, RP11-1407O15.2_3@0@0@0@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
A2463_32@155581@155612@deletion@32@44248222@44632945@17@chr17:44248222-44632945@157@3012@1480@0.491@CNVR7114.2@KANSL1_2, LRRC37A_1, LRRC37A_2, LRRC37A_3, LRRC37A_4, LRRC37A_5, LRRC37A_6, LRRC37A_7, LRRC37A_8, LRRC37A_9, LRRC37A_10, LRRC37A_11, LRRC37A_12, LRRC37A_13, LRRC37A_14, ARL17B_4, ARL17B_3, ARL17B_2, LRRC37A2_2, LRRC37A2_3, LRRC37A2_4, LRRC37A2_5, LRRC37A2_6, LRRC37A2_7, LRRC37A2_8, LRRC37A2_9, LRRC37A2_10, LRRC37A2_11, LRRC37A2_12, LRRC37A2_13, LRRC37A2_14, LRRC37A2_15@0@0@0@:KAT8 regulatory NSL complex subunit 1:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:histone acetyltransferase activity (H4-K8 specific);histone acetyltransferase activity (H4-K16 specific);histone acetyltransferase activity (H4-K5 specific);histone acetyltransferase complex;histone H4-K5 acetylation;MLL1 complex;histone H4-K16 acetylation;protein binding;histone H4-K8 acetylation;nucleus:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
A2463_32@160150@160153@duplication@4@47391@49557@18@chr18:47391-49557@43.5@589@1129@1.92@CNVR7228.2@RP11-683L23.1_4, RP11-683L23.1_3, RP11-683L23.1_2, RP11-683L23.1_1@0@0@0@@:GTPase activity;protein complex;GTP catabolic process;cytoplasm;microtubule cytoskeleton;protein polymerization;microtubule-based movement;structural molecule activity;microtubule;GTP binding;plasma membrane@NA
A2463_32@162017@162017@deletion@1@44542732@44544371@18@chr18:44542732-44544371@6.74@181@104@0.575@CNVR7319.1@TCEB3CL2_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_32@162017@162018@duplication@1@44542732@44550298@18@chr18:44542732-44550298@21.1@386@783@2.03@CNVR7319.1, CNVR7319.2@TCEB3CL2_1, TCEB3CL_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2:transcription elongation factor B polypeptide 3C-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_32@163107@163107@duplication@1@110680@111596@19@chr19:110680-111596@5.06@195@278@1.43@CNVR7451.1, CNVR7451.3@OR4F17_2@0@0@0@:olfactory receptor, family 4, subfamily F, member 17@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_32@164951@164951@deletion@1@7032325@7032905@19@chr19:7032325-7032905@5.88@31@3@0.0968@CNVR7517.1@MBD3L5_2@0@0@0@:methyl-CpG binding domain protein 3-like 5@NA@NA
A2463_32@168646@168646@deletion@1@33490493@33490611@19@chr19:33490493-33490611@5.09@226@143@0.633@CNVR7617.1@RHPN2_10@0@0@0@:rhophilin, Rho GTPase binding protein 2@:signal transduction;protein binding;intracellular;perinuclear region of cytoplasm@NA
A2463_32@168951@168951@deletion@1@35849794@35850833@19@chr19:35849794-35850833@11.2@417@243@0.583@CNVR7627.1@FFAR3_2@0@0@0@:free fatty acid receptor 3@:lipid binding;integral to membrane;G-protein coupled receptor activity;plasma membrane;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
A2463_32@168951@168952@duplication@1@35849794@35863302@19@chr19:35849794-35863302@-6.49@516@601@1.16@CNVR7627.1@FFAR3_2, GPR42_2@0@0@0@:free fatty acid receptor 3@:lipid binding;integral to membrane;G-protein coupled receptor activity;plasma membrane;integral to plasma membrane;G-protein coupled receptor signaling pathway:integral to membrane;G-protein coupled receptor activity;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
A2463_32@169778@169778@deletion@1@39262470@39262670@19@chr19:39262470-39262670@8.06@36@0@0@NA@LGALS7_3@0@0@0@:lectin, galactoside-binding, soluble, 7;lectin, galactoside-binding, soluble, 7B@:carbohydrate binding;heterophilic cell-cell adhesion;extracellular space;nucleus;apoptotic process;cytoplasm@NA
A2463_32@170098@170100@duplication@3@40376632@40382826@19@chr19:40376632-40382826@23.3@272@492@1.81@CNVR7639.2@FCGBP_24, FCGBP_23, FCGBP_22@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_32@170106@170109@deletion@4@40392317@40399855@19@chr19:40392317-40399855@16.4@469@284@0.606@CNVR7639.2, CNVR7639.3@FCGBP_16, FCGBP_15, FCGBP_14, FCGBP_13@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_32@172987@172987@duplication@1@52133087@52133469@19@chr19:52133087-52133469@4.65@35@72@2.06@CNVR7702.1@SIGLEC5_2, SIGLEC5_2@0@0@0@:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 5@:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion@NA
A2463_32@173452@173457@deletion@6@55179087@55239376@19@chr19:55179087-55239376@10.8@173@88@0.509@NA@LILRB4_13, LILRB4_14, KIR3DL3_1, KIR3DL3_2, KIR3DL3_3, KIR3DL3_4@0@0@0@:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4@:antigen binding;protein binding;signal transduction;integral to membrane;negative regulation of osteoclast differentiation;plasma membrane;receptor activity:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:integral to membrane;plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane@NA
A2463_32@173459@173477@duplication@19@55246721@55295265@19@chr19:55246721-55295265@63.5@963@1593@1.65@CNVR7725.2, CNVR7725.1@KIR3DL3_6, KIR3DL3_7, KIR3DL3_8, KIR2DL3_1, KIR2DL3_2, KIR2DL3_3, KIR2DL3_4, KIR2DL3_5, KIR2DL3_6, KIR2DL3_7, KIR2DL3_8, KIR2DL1_1, KIR2DL1_2, KIR2DL1_3, KIR2DL1_4, KIR2DL1_5, KIR2DL1_6, KIR2DL1_7, KIR2DL1_8@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:integral to membrane;plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane@NA
A2463_32@173482@173504@deletion@23@55320289@55363737@19@chr19:55320289-55363737@55.7@1000@541@0.541@CNVR7725.1, CNVR7725.6@KIR2DL4_5, KIR2DL4_6, KIR2DL4_7, KIR3DL1_1, KIR3DL1_2, KIR3DL1_3, KIR3DL1_4, KIR3DL1_5, KIR3DL1_6, KIR3DL1_7, KIR3DL1_8, KIR3DL1_9, KIR2DS4_1, KIR2DS4_2, KIR2DS4_3, KIR2DS4_4, KIR2DS4_5, KIR2DS4_6, KIR2DS4_7, KIR2DS4_8, KIR3DL2_1, KIR3DL2_2, KIR3DL2_3@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2-like@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane@NA
A2463_32@179011@179021@deletion@11@14982551@15013887@21@chr21:14982551-15013887@41.6@231@28@0.121@CNVR7952.1@POTED_1, POTED_2, POTED_3, POTED_4, POTED_5, POTED_6, POTED_7, POTED_8, POTED_9, POTED_10, POTED_11@0@0@0@:POTE ankyrin domain family, member B;POTE ankyrin domain family, member C;POTE ankyrin domain family, member D@:protein binding;plasma membrane@NA
A2463_32@181134@181134@duplication@1@18834446@18835833@22@chr22:18834446-18835833@22.5@211@464@2.2@CNVR8087.2, CNVR8087.7, CNVR8087.12, CNVR8087.10@AC008132.13_1@0@0@0@NA@NA@NA
A2463_32@181487@181489@deletion@3@21065630@21067085@22@chr22:21065630-21067085@8.51@136@71@0.522@CNVR8099.6, CNVR8099.2@PI4KA_51, PI4KA_50, PI4KA_49@0@0@0@:phosphatidylinositol 4-kinase, catalytic, alpha@:phospholipid metabolic process;1-phosphatidylinositol 4-kinase activity;small molecule metabolic process;phosphatidylinositol phosphorylation;binding;transferase activity, transferring phosphorus-containing groups;phosphotransferase activity, alcohol group as acceptor;ATP binding;Golgi-associated vesicle;phosphatidylinositol biosynthetic process;cytosol;protein binding;signal transduction;synaptic transmission;kinase activity;phosphatidylinositol-mediated signaling@NA
A2463_32@181734@181734@deletion@1@22707460@22707781@22@chr22:22707460-22707781@7.19@60@19@0.317@CNVR8103.20, CNVR8103.5, CNVR8103.2, CNVR8103.12, CNVR8103.10, CNVR8103.9, CNVR8103.22@IGLV5-48_2@0@0@0@@:protein binding@NA
A2463_32@183634@183640@deletion@7@39378460@39388154@22@chr22:39378460-39388154@16.5@345@192@0.557@CNVR8164.1@APOBEC3B_1, APOBEC3B_2, APOBEC3B_3, APOBEC3B_4, APOBEC3B_5, APOBEC3B_6, APOBEC3B_7@0@0@0@:apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B@:RNA binding;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines;negative regulation of transposition;catalytic activity;zinc ion binding@NA
A2463_31@418@418@deletion@1@1607504@1607638@1@chr1:1607504-1607638@12.8@61@2@0.0328@CNVR17.1@SLC35E2B_4@0@0@0@:solute carrier family 35, member E2B@:integral to membrane;membrane;transmembrane transport@NA
A2463_31@1806@1806@deletion@1@12853378@12853663@1@chr1:12853378-12853663@6.45@106@53@0.5@CNVR72.3, CNVR72.10@PRAMEF1_2@0@0@0@:PRAME family member 1@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_31@1809@1811@deletion@3@12884801@12888523@1@chr1:12884801-12888523@23.6@732@425@0.581@CNVR72.3, CNVR72.10, CNVR72.11, CNVR72.4@PRAMEF11_4, PRAMEF11_3, PRAMEF11_2@0@0@0@:PRAME family member 11@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_31@1816@1829@deletion@14@12939366@13036800@1@chr1:12939366-13036800@96.6@1482@682@0.46@CNVR72.3, CNVR72.4, CNVR72.2@PRAMEF4_4, PRAMEF4_3, PRAMEF4_2, PRAMEF10_4, PRAMEF10_3, PRAMEF10_2, PRAMEF7_2, PRAMEF7_3, PRAMEF7_4, PRAMEF6_4, PRAMEF6_3, PRAMEF6_2, PRAMEF22_1, PRAMEF22_2@0@0@0@:PRAME family member 4:PRAME family member 10:PRAME family member 7:PRAME family member 6;PRAME family member 23;PRAME family member 9/15-like;PRAME family member 5:PRAME family member 22@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_31@1835@1838@duplication@4@13330415@13366425@1@chr1:13330415-13366425@7.21@57@113@1.98@CNVR74.8, CNVR74.4@PRAMEF3_2, PRAMEF3_1, PRAMEF5_2, PRAMEF5_3@0@0@0@:PRAME family member 3:PRAME family member 5@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_31@1854@1854@duplication@1@13497571@13498128@1@chr1:13497571-13498128@6.97@53@110@2.08@CNVR74.8@PRAMEF16_3@0@0@0@:PRAME family member 16@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_31@1861@1861@deletion@1@13668906@13669463@1@chr1:13668906-13669463@7.66@80@31@0.388@CNVR76.2, CNVR76.5@PRAMEF14_4@0@0@0@:PRAME family member 14@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_31@3194@3197@duplication@4@24287949@24298502@1@chr1:24287949-24298502@9.87@65@139@2.14@NA@PNRC2_3, SRSF10_6, SRSF10_5, SRSF10_4@0@0@0@:proline-rich nuclear receptor coactivator 2;proline-rich nuclear receptor coactivator 2-like:serine/arginine-rich splicing factor 10-like;serine/arginine-rich splicing factor 10@:protein binding;deadenylation-independent decapping of nuclear-transcribed mRNA;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;nucleus;regulation of transcription, DNA-dependent;transcription, DNA-dependent;cytoplasmic mRNA processing body:nucleoplasm;RNA splicing, via transesterification reactions;nuclear speck;RS domain binding;RNA binding;nucleus;mRNA splice site selection;unfolded protein binding;assembly of spliceosomal tri-snRNP;negative regulation of mRNA splicing, via spliceosome;regulation of transcription, DNA-dependent;nucleotide binding;cytoplasm;mRNA export from nucleus;protein binding;cytoplasmic transport;mRNA splicing, via spliceosome;nucleic acid binding@NA
A2463_31@3333@3342@deletion@10@25599040@25655415@1@chr1:25599040-25655415@187@960@62@0.0646@CNVR116.1, CNVR116.2@RHD_1, RHD_2, RHD_3, RHD_4, RHD_5, RHD_6, RHD_7, RHD_8, RHD_9, RHD_10@0@0@0@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
A2463_31@9353@9354@deletion@2@104162177@104163306@1@chr1:104162177-104163306@11.1@431@270@0.626@CNVR266.3, CNVR266.1@AMY2A_4, AMY2A_5@0@0@0@:amylase, alpha 2A (pancreatic)@:chloride ion binding;cation binding;small molecule metabolic process;carbohydrate metabolic process;catalytic activity;extracellular space;polysaccharide digestion;extracellular region;carbohydrate catabolic process;alpha-amylase activity;calcium ion binding@NA
A2463_31@9365@9374@duplication@10@104202983@104234232@1@chr1:104202983-104234232@13.9@317@475@1.5@CNVR266.3, CNVR266.1, CNVR266.15@AMY1A_7, AMY1A_8, AMY1A_9, AMY1A_10, AMY1A_11, AMY1B_11, AMY1B_10, AMY1B_9, AMY1B_8, AMY1B_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
A2463_31@9385@9386@deletion@2@104297122@104297436@1@chr1:104297122-104297436@6.29@471@320@0.679@CNVR266.3, CNVR266.5@AMY1C_6, AMY1C_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
A2463_31@9766@9773@deletion@8@110230497@110235917@1@chr1:110230497-110235917@63.6@312@13@0.0417@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_1, GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
A2463_31@10788@10788@duplication@1@144220788@144220959@1@chr1:144220788-144220959@7.71@73@141@1.93@CNVR333.1, CNVR333.3@RP3-377D14.1_87@0@0@0@NA@NA@NA
A2463_31@10793@10793@deletion@1@144339779@144340398@1@chr1:144339779-144340398@7.79@35@0@0@CNVR334.4, CNVR334.2@AL592284.1_1@0@0@0@:uncharacterized LOC730256;uncharacterized LOC101060698;uncharacterized LOC642441@NA@NA
A2463_31@10799@10799@deletion@1@144815937@144816008@1@chr1:144815937-144816008@5.3@65@29@0.446@CNVR338.4, CNVR338.2, CNVR338.5, CNVR338.1@NBPF9_4@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 24@NA@NA
A2463_31@10892@10896@duplication@5@145327494@145330855@1@chr1:145327494-145330855@6.8@119@187@1.57@CNVR341.2, CNVR341.3@NBPF10_32, NBPF10_33, NBPF10_34, NBPF10_35, NBPF10_36@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family, member 10@NA@NA
A2463_31@11127@11157@deletion@31@146215076@146244717@1@chr1:146215076-146244717@26@269@107@0.398@NA@NBPF12_38, NBPF12_37, NBPF12_36, NBPF12_35, NBPF12_34, NBPF12_33, NBPF12_32, NBPF12_31, NBPF12_30, NBPF12_29, NBPF12_28, NBPF12_27, NBPF12_26, NBPF12_25, NBPF12_24, NBPF12_23, NBPF12_22, NBPF12_21, NBPF12_20, NBPF12_19, NBPF12_18, NBPF12_17, NBPF12_16, NBPF12_15, NBPF12_14, NBPF12_13, NBPF12_12, NBPF12_11, NBPF12_10, NBPF12_9, NBPF12_8@0@0@0@:neuroblastoma breakpoint family member 21-like@NA@NA
A2463_31@11162@11162@deletion@1@146250791@146250999@1@chr1:146250791-146250999@17.3@87@5@0.0575@NA@NBPF12_3@0@0@0@:neuroblastoma breakpoint family member 21-like@NA@NA
A2463_31@11170@11184@duplication@15@146401672@146420191@1@chr1:146401672-146420191@14.4@396@583@1.47@NA@NBPF12_10, NBPF12_11, NBPF12_12, NBPF12_13, NBPF12_14, NBPF12_15, NBPF12_16, NBPF12_17, NBPF12_18, NBPF12_19, NBPF12_20, NBPF12_21, NBPF12_22, NBPF12_23, NBPF12_24@0@0@0@:neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family member 14-like;neuroblastoma breakpoint family, member 12@:cytoplasm@NA
A2463_31@11353@11353@deletion@1@148021578@148021628@1@chr1:148021578-148021628@5.93@87@42@0.483@CNVR346.2, CNVR346.4@NBPF14_5@0@0@0@:neuroblastoma breakpoint family, member 14@:cytoplasm@NA
A2463_31@11371@11372@deletion@2@148261458@148262366@1@chr1:148261458-148262366@4.93@36@10@0.278@CNVR347.1, CNVR347.4@NBPF20_99, NBPF20_98@0@0@0@:uncharacterized LOC101060226;neuroblastoma breakpoint family member 14-like;neuroblastoma breakpoint family, member 12;neuroblastoma breakpoint family member 3-like;neuroblastoma breakpoint family, member 7@:cytoplasm@NA
A2463_31@11479@11479@deletion@1@148591202@148591373@1@chr1:148591202-148591373@6.25@29@1@0.0345@CNVR348.1, CNVR348.4@NBPF15_17@0@0@0@:neuroblastoma breakpoint family, member 15@:cytoplasm@NA
A2463_31@16029@16037@duplication@9@196744018@196796135@1@chr1:196744018-196796135@33.1@1541@2134@1.38@CNVR459.1@CFHR3_1, CFHR3_2, CFHR3_3, CFHR3_4, CFHR3_5, CFHR3_6, CFHR1_1, CFHR1_2, CFHR1_3@0@0@0@:complement factor H-related 3:complement factor H-related 1:complement factor H-related 2@:extracellular space:extracellular space;complement activation:extracellular region@NA
A2463_31@16039@16040@duplication@2@196799631@196801129@1@chr1:196799631-196801129@12.1@455@655@1.44@CNVR459.1@CFHR1_5, CFHR1_6@0@0@0@:complement factor H-related 1:complement factor H-related 2@:extracellular space;complement activation:extracellular region@NA
A2463_31@17278@17279@deletion@2@207700099@207700468@1@chr1:207700099-207700468@6.88@35@3@0.0857@CNVR485.1@CR1_6, CR1_7@0@0@0@:complement component (3b/4b) receptor 1 (Knops blood group)@:complement component C4b receptor activity;complement activation, classical pathway;negative regulation of complement activation, alternative pathway;innate immune response;negative regulation of serine-type endopeptidase activity;complement component C3b binding;negative regulation of complement activation, classical pathway;plasma membrane;integral to plasma membrane;complement component C3b receptor activity;complement component C4b binding;cell surface;regulation of complement activation;positive regulation of serine-type endopeptidase activity@: MALARIA, SUSCEPTIBILITY TO; KNOPS BLOOD GROUP SYSTEM; KN
A2463_31@17286@17287@duplication@2@207718654@207719023@1@chr1:207718654-207719023@4.96@47@88@1.87@CNVR485.1@CR1_14, CR1_15@0@0@0@:complement component (3b/4b) receptor 1 (Knops blood group)@:complement component C4b receptor activity;complement activation, classical pathway;negative regulation of complement activation, alternative pathway;innate immune response;negative regulation of serine-type endopeptidase activity;complement component C3b binding;negative regulation of complement activation, classical pathway;plasma membrane;integral to plasma membrane;complement component C3b receptor activity;complement component C4b binding;cell surface;regulation of complement activation;positive regulation of serine-type endopeptidase activity@: MALARIA, SUSCEPTIBILITY TO; KNOPS BLOOD GROUP SYSTEM; KN
A2463_31@24562@24563@deletion@2@85570366@85570921@2@chr2:85570366-85570921@7.19@152@85@0.559@NA@RETSAT_11, RETSAT_10@0@0@0@:retinol saturase (all-trans-retinol 13,14-reductase)@:all-trans-retinol 13,14-reductase activity;nuclear membrane;oxidation-reduction process;oxidoreductase activity;retinol metabolic process;endoplasmic reticulum membrane;nuclear outer membrane@NA
A2463_31@24862@24871@deletion@10@88094928@88118142@2@chr2:88094928-88118142@11.6@141@63@0.447@NA@RGPD2_11, RGPD2_10, RGPD2_9, RGPD2_8, RGPD2_7, RGPD2_6, RGPD2_5, RGPD2_4, RGPD2_3, RGPD2_2@0@0@0@:RANBP2-like and GRIP domain containing 2@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_31@25004@25005@duplication@2@90192949@90193424@2@chr2:90192949-90193424@12.4@233@374@1.61@CNVR867.10, CNVR867.5, CNVR867.3, CNVR867.9, CNVR867.15@IGKV1D-13_1, IGKV1D-13_2@0@0@0@@:protein binding@NA
A2463_31@25089@25091@deletion@3@96259773@96262180@2@chr2:96259773-96262180@17.1@439@252@0.574@NA@TRIM43_2, TRIM43_3, TRIM43_4@0@0@0@:tripartite motif containing 43B;tripartite motif containing 43@:protein binding;intracellular;zinc ion binding@NA
A2463_31@25369@25370@duplication@2@97854825@97855027@2@chr2:97854825-97855027@33.8@145@416@2.87@CNVR886.2, CNVR886.3@ANKRD36_33, ANKRD36_34@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_31@25379@25380@duplication@2@97864201@97864395@2@chr2:97864201-97864395@8.93@421@586@1.39@CNVR886.1@ANKRD36_43, ANKRD36_44@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_31@26008@26011@deletion@4@108454714@108460186@2@chr2:108454714-108460186@9.76@146@71@0.486@NA@RGPD4_3, RGPD4_4, RGPD4_5, RGPD4_6@0@0@0@:RANBP2-like and GRIP domain containing 4@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_31@26021@26022@deletion@2@108479139@108479488@2@chr2:108479139-108479488@8.7@345@217@0.629@NA@RGPD4_16, RGPD4_17@0@0@0@:RANBP2-like and GRIP domain containing 4@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_31@27163@27163@deletion@1@130843388@130843568@2@chr2:130843388-130843568@10.7@50@1@0.02@NA@POTEF_13@0@0@0@:POTE ankyrin domain family, member F@:cell cortex;protein binding;ATP binding@NA
A2463_31@27171@27172@deletion@2@130868117@130869674@2@chr2:130868117-130869674@8.65@105@46@0.438@NA@POTEF_5, POTEF_4@0@0@0@:POTE ankyrin domain family, member F@:cell cortex;protein binding;ATP binding@NA
A2463_31@27179@27181@deletion@3@130897753@130899954@2@chr2:130897753-130899954@6.76@227@141@0.621@NA@CCDC74B_5, CCDC74B_4, CCDC74B_3@0@0@0@:coiled-coil domain containing 74A;coiled-coil domain containing 74B@NA@NA
A2463_31@27211@27211@deletion@1@130955932@130955933@2@chr2:130955932-130955933@4.97@22@0@0@CNVR985.1@TUBA3E_1@0@0@0@:tubulin, alpha 3e@:GTPase activity;structural constituent of cytoskeleton;protein complex;GTP catabolic process;cytoplasm;microtubule cytoskeleton;protein polymerization;microtubule-based movement;structural molecule activity;cytoplasmic microtubule;GTP binding;microtubule;microtubule cytoskeleton organization;protein domain specific binding@NA
A2463_31@27255@27255@duplication@1@131266289@131266808@2@chr2:131266289-131266808@6.25@192@283@1.47@NA@POTEI_1@0@0@0@:POTE ankyrin domain family, member I@:protein binding;ATP binding@NA
A2463_31@27279@27279@deletion@1@131381638@131381707@2@chr2:131381638-131381707@6.15@137@76@0.555@NA@POTEJ_6@0@0@0@:POTE ankyrin domain family, member J@:protein binding;ATP binding@NA
A2463_31@27342@27342@duplication@1@132289238@132289375@2@chr2:132289238-132289375@7.42@94@165@1.76@NA@CCDC74A_4@0@0@0@:coiled-coil domain containing 74A@NA@NA
A2463_31@27995@27997@duplication@3@152461075@152464122@2@chr2:152461075-152464122@6.64@115@182@1.58@CNVR1026.1@NEB_85, NEB_84, NEB_83@0@0@0@:nebulin@:Z disc;muscle filament sliding;oxidation-reduction process;contractile fiber part;actin cytoskeleton;regulation of actin filament length;structural constituent of muscle;cytosol;actin binding;protein binding;myofibril;somatic muscle development;muscle organ development@: NEMALINE MYOPATHY 2; NEM2
A2463_31@38339@38339@duplication@1@50879107@50879146@3@chr3:50879107-50879146@4.5@16@47@2.94@NA@DOCK3_3@0@0@0@:dedicator of cytokinesis 3@:GTPase binding;protein binding;SH3 domain binding;binding;GTP binding;guanyl-nucleotide exchange factor activity;cytoplasm@NA
A2463_31@39892@39892@duplication@1@75786030@75788496@3@chr3:75786030-75788496@9.23@224@349@1.56@CNVR1432.5, CNVR1432.9, CNVR1432.4@ZNF717_5@0@0@0@:zinc finger protein 717;zinc finger protein 717-like@:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_31@39892@39894@deletion@2@75786030@75790887@3@chr3:75786030-75790887@-16.9@258@349@1.35@CNVR1432.5, CNVR1432.9, CNVR1432.4@ZNF717_5, ZNF717_4, ZNF717_3@0@0@0@:zinc finger protein 717;zinc finger protein 717-like@:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_31@46667@46671@deletion@5@9174900@9213975@4@chr4:9174900-9213975@21.5@118@14@0.119@NA@FAM90A26P_4, FAM90A26P_5, FAM90A26P_6, FAM90A26P_7, USP17L13_1, USP17L10_1@0@0@0@:ubiquitin specific peptidase 17-like family member 10:ubiquitin specific peptidase 17-like family member 13@:zinc ion binding;nucleic acid binding:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
A2463_31@48556@48561@deletion@6@69403344@69434202@4@chr4:69403344-69434202@111@622@64@0.103@CNVR1953.1@UGT2B17_6, UGT2B17_5, UGT2B17_4, UGT2B17_3, UGT2B17_2, UGT2B17_1@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B17@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;membrane@: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
A2463_31@48565@48565@deletion@1@69528727@69528857@4@chr4:69528727-69528857@6@108@56@0.519@CNVR1953.1@UGT2B15_3@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B15@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;cellular glucuronidation;xenobiotic metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process@NA
A2463_31@48592@48595@duplication@4@70146220@70155470@4@chr4:70146220-70155470@7.99@655@859@1.31@CNVR1957.2, CNVR1957.1@UGT2B28_1, UGT2B28_2, UGT2B28_3, UGT2B28_4@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B28@:carbohydrate binding;transferase activity, transferring hexosyl groups;endoplasmic reticulum;glucuronosyltransferase activity;carbohydrate metabolic process;xenobiotic metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process@NA
A2463_31@53307@53308@duplication@2@745299@748674@5@chr5:745299-748674@6.59@122@191@1.57@CNVR2280.3@ZDHHC11B_6, ZDHHC11B_5@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
A2463_31@53313@53320@deletion@8@801223@840765@5@chr5:801223-840765@36.5@670@356@0.531@CNVR2280.3@ZDHHC11_12, ZDHHC11_11, ZDHHC11_10, ZDHHC11_9, ZDHHC11_8, ZDHHC11_7, ZDHHC11_6, ZDHHC11_5@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
A2463_31@55835@55837@deletion@3@70338009@70343940@5@chr5:70338009-70343940@18.5@142@42@0.296@CNVR2494.41, CNVR2494.14, CNVR2494.20, CNVR2494.62, CNVR2494.8@GTF2H2_14, GTF2H2_13, GTF2H2_12@0@0@0@:general transcription factor IIH, polypeptide 2, 44kDa@:nucleoplasm;nucleotide-excision repair, DNA damage removal;transcription from RNA polymerase I promoter;DNA repair;RNA polymerase II carboxy-terminal domain kinase activity;nucleus;viral reproduction;translation;gene expression;transcription elongation from RNA polymerase I promoter;response to UV;holo TFIIH complex;protein kinase activity;nucleotide-excision repair;transcription from RNA polymerase II promoter;transcription-coupled nucleotide-excision repair;transcription, DNA-dependent;zinc ion binding;transcription elongation from RNA polymerase II promoter;termination of RNA polymerase I transcription;sequence-specific DNA binding transcription factor activity;G-protein coupled receptor internalization;DNA-dependent ATPase activity;protein N-terminus binding;transcription initiation from RNA polymerase I promoter;7-methylguanosine mRNA capping;transcription initiation from RNA polymerase II promoter;protein phosphorylation;translation factor activity, nucleic acid binding;regulation of transcription, DNA-dependent;core TFIIH complex;protein binding;positive regulation of viral transcription;nucleic acid binding@NA
A2463_31@59065@59065@deletion@1@140557617@140560021@5@chr5:140557617-140560021@36.6@2700@1396@0.517@CNVR2624.1@PCDHB8_1@0@0@0@:protocadherin beta 8@:integral to membrane;homophilic cell adhesion;plasma membrane;membrane;calcium ion binding@NA
A2463_31@60878@60880@duplication@3@175391955@175395211@5@chr5:175391955-175395211@5.29@186@260@1.4@NA@THOC3_3, THOC3_2, THOC3_1@0@0@0@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
A2463_31@60884@60885@deletion@2@175517374@175520277@5@chr5:175517374-175520277@15.3@101@20@0.198@NA@FAM153B_3, FAM153B_4@0@0@0@:uncharacterized LOC100507387;family with sequence similarity 153, member B@NA@NA
A2463_31@61260@61264@deletion@5@177156025@177161405@5@chr5:177156025-177161405@10.8@133@60@0.451@NA@FAM153A_17, FAM153A_16, FAM153A_15, FAM153A_14, FAM153A_13@0@0@0@:family with sequence similarity 153, member A@NA@NA
A2463_31@61266@61267@deletion@2@177163581@177164113@5@chr5:177163581-177164113@15.5@136@45@0.331@NA@FAM153A_11, FAM153A_10@0@0@0@:family with sequence similarity 153, member A@NA@NA
A2463_31@61269@61275@deletion@7@177166602@177175644@5@chr5:177166602-177175644@17.6@177@70@0.395@NA@FAM153A_8, FAM153A_7, FAM153A_6, FAM153A_5, FAM153A_4, FAM153A_3, FAM153A_2@0@0@0@:family with sequence similarity 153, member A@NA@NA
A2463_31@61641@61645@deletion@5@180376905@180429785@5@chr5:180376905-180429785@24@804@482@0.6@CNVR2719.1@BTNL8_8, BTNL3_1, BTNL3_2, BTNL3_3, BTNL3_4@0@0@0@:butyrophilin-like 8:butyrophilin-like 3@:protein binding;integral to membrane:protein binding;integral to membrane;molecular_function;cellular_component;biological_process@NA
A2463_31@63291@63292@duplication@2@31324466@31324935@6@chr6:31324466-31324935@16.4@229@394@1.72@CNVR2841.12, CNVR2841.14, CNVR2841.8@HLA-B_2, HLA-B_1@0@0@0@:major histocompatibility complex, class I, B@:MHC class I protein complex;regulation of immune response;regulation of interleukin-12 production;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;regulation of T cell anergy;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;receptor binding;early endosome membrane;virus-host interaction;regulation of interleukin-6 production;regulation of dendritic cell differentiation;phagocytic vesicle membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;MHC class I receptor activity;membrane@: SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO; SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1; SPDA1
A2463_31@63725@63734@deletion@10@31962023@31964838@6@chr6:31962023-31964838@64.2@1147@571@0.498@CNVR2843.6, CNVR2843.3@C4A_20, C4A_21, C4A_22, C4A_23, C4A_24, C4A_25, C4A_26, C4A_27, C4A_28, C4A_29@0@0@0@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
A2463_31@63747@63748@deletion@2@31973946@31974881@6@chr6:31973946-31974881@7.67@194@113@0.582@CNVR2843.6, CNVR2843.3@AL645922.1_2, AL645922.1_1@0@0@0@NA@NA@NA
A2463_31@63768@63773@duplication@6@31994761@31996309@6@chr6:31994761-31996309@9.12@221@329@1.49@CNVR2843.6, CNVR2843.5@C4B_20, C4B_21, C4B_22, C4B_23, C4B_24, C4B_25@0@0@0@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
A2463_31@63953@63958@deletion@6@32485517@32498001@6@chr6:32485517-32498001@32.4@336@132@0.393@CNVR2845.21, CNVR2845.25, CNVR2845.30, CNVR2845.43, CNVR2845.6@HLA-DRB5_6, HLA-DRB5_5, HLA-DRB5_4, HLA-DRB5_3, HLA-DRB5_2, HLA-DRB5_1@0@0@0@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
A2463_31@63953@63960@duplication@2@32485517@32548047@6@chr6:32485517-32548047@-40.7@479@345@0.72@CNVR2845.21, CNVR2845.25, CNVR2845.24@HLA-DRB5_6, HLA-DRB5_5, HLA-DRB5_4, HLA-DRB5_3, HLA-DRB5_2, HLA-DRB5_1, HLA-DRB1_6, HLA-DRB1_5@0@0@0@:major histocompatibility complex, class II, DR beta 5:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
A2463_31@70816@70817@deletion@2@161054786@161056336@6@chr6:161054786-161056336@19.7@234@96@0.41@CNVR3133.1@LPA_9, LPA_8@0@0@0@:lipoprotein, Lp(a)@:blood circulation;endopeptidase inhibitor activity;catalytic activity;lipoprotein metabolic process;proteolysis;heparin binding;receptor-mediated endocytosis;fibronectin binding;small molecule metabolic process;apolipoprotein binding;lipid metabolic process;negative regulation of endopeptidase activity;extracellular region;plasma lipoprotein particle;lipid transport;serine-type endopeptidase activity@: APOLIPOPROTEIN(a); LPA
A2463_31@71030@71030@deletion@1@167790035@167790192@6@chr6:167790035-167790192@10.2@60@9@0.15@NA@TCP10_5@0@0@0@:t-complex 10@:cytosol@NA
A2463_31@71763@71763@duplication@1@5978354@5978460@7@chr7:5978354-5978460@4.62@13@44@3.38@NA@RSPH10B_15@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
A2463_31@71775@71776@deletion@2@6005269@6006747@7@chr7:6005269-6006747@5.69@141@81@0.574@NA@RSPH10B_3, RSPH10B_2@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
A2463_31@74707@74709@duplication@3@75511148@75517667@7@chr7:75511148-75517667@9.33@245@360@1.47@NA@RHBDD2_2, RHBDD2_3, RHBDD2_4@0@0@0@:rhomboid domain containing 2@:integral to membrane;serine-type endopeptidase activity@NA
A2463_31@76743@76752@duplication@10@102194807@102212968@7@chr7:102194807-102212968@15.8@587@835@1.42@CNVR3518.1@SPDYE2_3, SPDYE2_4, SPDYE2_5, SPDYE2_6, SPDYE2_7, SPDYE2_8, POLR2J3_4, POLR2J3_3, POLR2J3_2, POLR2J3_1@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:speedy homolog E2 (Xenopus laevis)@:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
A2463_31@76765@76766@duplication@2@102235753@102236231@7@chr7:102235753-102236231@7.99@50@110@2.2@CNVR3518.1@RASA4_11, RASA4_10@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity@NA
A2463_31@76792@76793@deletion@2@102309363@102312048@7@chr7:102309363-102312048@14.3@66@1@0.0152@CNVR3518.1@POLR2J2_2, POLR2J2_2, POLR2J2_1, POLR2J2_1@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
A2463_31@79310@79311@duplication@2@143884023@143929936@7@chr7:143884023-143929936@11.5@318@481@1.51@CNVR3598.4, CNVR3598.3, CNVR3598.7@ARHGEF35_2, OR2A42_1@0@0@0@:Rho guanine nucleotide exchange factor (GEF) 35:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_31@79313@79313@duplication@1@143964011@143966343@7@chr7:143964011-143966343@7.35@306@438@1.43@CNVR3598.4@CTAGE8_1@0@0@0@:Rho guanine nucleotide exchange factor (GEF) 35:CTAGE family, member 6, pseudogene;CTAGE family, member 15, pseudogene@:integral to membrane@NA
A2463_31@79315@79315@duplication@1@144059764@144062916@7@chr7:144059764-144062916@6.84@899@1201@1.34@CNVR3598.4, CNVR3598.5@ARHGEF5_2@0@0@0@:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
A2463_31@79323@79327@duplication@5@144070289@144075959@7@chr7:144070289-144075959@8.31@150@236@1.57@CNVR3598.4, CNVR3598.5, CNVR3598.11@ARHGEF5_10, ARHGEF5_11, ARHGEF5_12, ARHGEF5_13, ARHGEF5_14@0@0@0@:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
A2463_31@80141@80143@duplication@3@116087@150533@8@chr8:116087-150533@20.8@103@266@2.58@CNVR3684.5, CNVR3684.11@OR4F21_1, RP11-585F1.10_2, RP11-585F1.10_1@0@0@0@:olfactory receptor, family 4, subfamily F, member 21:F-box only protein 25-like;putative uncharacterized protein C20orf69-like@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_31@80388@80388@duplication@1@7637545@7637611@8@chr8:7637545-7637611@5.99@14@54@3.86@CNVR3772.4, CNVR3772.6, CNVR3772.2, CNVR3772.8, CNVR3772.10@AC084121.16_3@0@0@0@:uncharacterized LOC100133251@NA@NA
A2463_31@80564@80565@duplication@2@11970084@11996269@8@chr8:11970084-11996269@35.2@1696@2791@1.65@CNVR3785.8, CNVR3785.5, CNVR3785.6@ZNF705D_6, USP17L2_1@0@0@0@:zinc finger protein 705D:ubiquitin specific peptidase 17-like family member 1, pseudogene;ubiquitin specific peptidase 17-like family member 2;ubiquitin specific peptidase 17-like family member 4;ubiquitin specific peptidase 17-like family member 7;ubiquitin specific peptidase 17-like family member 8;ubiquitin specific peptidase 17-like family member 3@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:protein deubiquitination;ubiquitin-specific protease activity;mitotic cell cycle G1/S transition checkpoint;nucleus;G2/M transition checkpoint;apoptotic process;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
A2463_31@80738@80738@deletion@1@17581182@17581342@8@chr8:17581182-17581342@9.18@113@48@0.425@CNVR3804.1@MTUS1_4@0@0@0@:microtubule associated tumor suppressor 1@:oxidation-reduction process;mitochondrion;Golgi apparatus;microtubule organizing center;oxidoreductase activity;cellular response to peptide hormone stimulus;nucleus;plasma membrane;microtubule;transition metal ion binding;spindle@: HEPATOCELLULAR CARCINOMA
A2463_31@83673@83673@duplication@1@86573700@86575726@8@chr8:86573700-86575726@11.6@375@571@1.52@CNVR3955.1@REXO1L1_1@0@0@0@:exonuclease GOR-like;REX1, RNA exonuclease 1 homolog (S. cerevisiae)-like 1@:intracellular;nucleus;exonuclease activity;nucleic acid binding;cytoplasm@NA
A2463_31@88492@88494@duplication@3@39078688@39086846@9@chr9:39078688-39086846@6.5@311@423@1.36@NA@CNTNAP3_22, CNTNAP3_21, CNTNAP3_20@0@0@0@:contactin associated protein-like 3@:binding;signal transduction;protein binding;integral to membrane;extracellular region;cell adhesion;plasma membrane;cell recognition;receptor binding@NA
A2463_31@88511@88513@duplication@3@39238991@39288061@9@chr9:39238991-39288061@7.69@8@56@7@CNVR4262.1@CNTNAP3_3, CNTNAP3_2, CNTNAP3_1@0@0@0@:contactin associated protein-like 3@:binding;signal transduction;protein binding;integral to membrane;extracellular region;cell adhesion;plasma membrane;cell recognition;receptor binding@NA
A2463_31@88528@88529@deletion@2@40702653@40716325@9@chr9:40702653-40716325@14.1@1072@708@0.66@NA@SPATA31A3_4, FAM74A3_1@0@0@0@:SPATA31 subfamily A, member 3@:integral to membrane@NA
A2463_31@88534@88534@deletion@1@41306194@41306209@9@chr9:41306194-41306209@12.6@57@0@0@CNVR4278.2@FAM74A2_2@0@0@0@@:integral to membrane@NA
A2463_31@88536@88536@duplication@1@41321261@41324995@9@chr9:41321261-41324995@7.05@25@74@2.96@CNVR4278.2@SPATA31A4_4@0@0@0@:SPATA31 subfamily A, member 4@:integral to membrane@NA
A2463_31@88633@88633@deletion@1@65508137@65508193@9@chr9:65508137-65508193@8.95@72@21@0.292@CNVR4312.5@SPATA31A7_2@0@0@0@:SPATA31 subfamily A, member 7@:integral to membrane@NA
A2463_31@88639@88641@deletion@3@67926874@67930837@9@chr9:67926874-67930837@15.6@77@4@0.0519@NA@ANKRD20A1_1, ANKRD20A1_2, ANKRD20A1_3@0@0@0@:ankyrin repeat domain 20 family, member A1@:protein binding;plasma membrane@NA
A2463_31@88643@88643@deletion@1@67935876@67936012@9@chr9:67935876-67936012@7.53@34@0@0@NA@ANKRD20A1_5@0@0@0@:ankyrin repeat domain 20 family, member A1@:protein binding;plasma membrane@NA
A2463_31@88648@88657@deletion@10@67954723@67987998@9@chr9:67954723-67987998@38.2@946@548@0.579@NA@ANKRD20A1_10, ANKRD20A1_11, ANKRD20A1_12, ANKRD20A1_13, ANKRD20A1_14, ANKRD20A1_15, RP11-195B21.3_3, RP11-195B21.3_4, RP11-195B21.3_5, RP11-195B21.3_6@0@0@0@:ankyrin repeat domain 20 family, member A1:coiled-coil domain-containing protein 29-like;uncharacterized LOC644249@:protein binding;plasma membrane@NA
A2463_31@88677@88678@deletion@2@69385606@69386055@9@chr9:69385606-69386055@7.96@36@0@0@NA@ANKRD20A4_2, ANKRD20A4_3@0@0@0@:ankyrin repeat domain 20 family, member A4@:protein binding@NA
A2463_31@88688@88690@duplication@3@69420264@69424176@9@chr9:69420264-69424176@9.23@608@826@1.36@NA@ANKRD20A4_13, ANKRD20A4_14, ANKRD20A4_15@0@0@0@:ankyrin repeat domain 20 family, member A4@:protein binding@NA
A2463_31@88706@88708@deletion@3@70484376@70490068@9@chr9:70484376-70490068@11.8@179@87@0.486@NA@CBWD5_3, CBWD5_2, CBWD5_1@0@0@0@:COBW domain-containing protein 5-like;COBW domain containing 7;COBW domain containing 5@:ATP binding@NA
A2463_31@88718@88718@duplication@1@70881137@70881222@9@chr9:70881137-70881222@5.07@32@71@2.22@NA@CBWD3_8@0@0@0@:COBW domain-containing protein 5-like;COBW domain-containing protein 1-like;COBW domain containing 3@:ATP binding@NA
A2463_31@95352@95354@deletion@3@17875675@17887435@10@chr10:17875675-17887435@9.07@96@39@0.406@NA@MRC1L1_4, MRC1L1_5, MRC1L1_6@0@0@0@:macrophage mannose receptor 1-like@:carbohydrate binding@NA
A2463_31@95377@95380@deletion@4@17951323@18060364@10@chr10:17951323-18060364@6.58@29@0@0@NA@MRC1L1_29, MRC1L1_30, TMEM236_1, TMEM236_2@0@0@0@:macrophage mannose receptor 1-like:transmembrane protein 236;transmembrane protein 236-like@:carbohydrate binding:integral to membrane@NA
A2463_31@95389@95393@deletion@5@18138509@18152611@10@chr10:18138509-18152611@6.7@38@6@0.158@NA@MRC1_7, MRC1_8, MRC1_9, MRC1_10, MRC1_11@0@0@0@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
A2463_31@96454@96461@deletion@8@46312644@46342795@10@chr10:46312644-46342795@32.9@227@44@0.194@NA@FAM25E_1, AGAP4_7, AGAP4_6, AGAP4_5, AGAP4_4, AGAP4_3, AGAP4_2, AGAP4_1@0@0@0@:ArfGAP with GTPase domain, ankyrin repeat and PH domain 4;arf-GAP with GTPase, ANK repeat and PH domain-containing protein 5-like@:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity@NA
A2463_31@96467@96470@deletion@4@46587345@46611811@10@chr10:46587345-46611811@10@56@8@0.143@CNVR4712.3@PTPN20A_5, PTPN20A_4, PTPN20A_3, PTPN20A_2@0@0@0@:protein tyrosine phosphatase, non-receptor type 20B;protein tyrosine phosphatase, non-receptor type 20A@:phosphatase activity;protein tyrosine phosphatase activity;microtubule;nucleus;dephosphorylation;protein dephosphorylation;microtubule organizing center@NA
A2463_31@96536@96565@deletion@30@47894573@48004056@10@chr10:47894573-48004056@112@744@167@0.224@CNVR4715.2@FAM21B_2, FAM21B_3, FAM21B_4, FAM21B_5, FAM21B_6, FAM21B_7, FAM21B_8, FAM21B_9, FAM21B_10, FAM21B_11, FAM21B_12, FAM21B_13, FAM21B_14, FAM21B_15, FAM21B_16, FAM21B_17, FAM21B_18, FAM21B_19, FAM21B_20, FAM21B_21, FAM21B_22, FAM21B_23, FAM21B_24, FAM21B_25, FAM21B_26, FAM21B_27, FAM21B_28, FAM21B_29, ASAH2C_18, ASAH2C_17@0@0@0@:family with sequence similarity 21, member B@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome:ceramidase activity;sphingolipid metabolic process@NA
A2463_31@96573@96577@deletion@5@48025301@48033105@10@chr10:48025301-48033105@8.32@346@222@0.642@CNVR4715.2@ASAH2C_9, ASAH2C_8, ASAH2C_7, ASAH2C_6, ASAH2C_5@0@0@0@@:ceramidase activity;sphingolipid metabolic process@NA
A2463_31@96605@96605@duplication@1@48277509@48277993@10@chr10:48277509-48277993@5.15@63@111@1.76@CNVR4716.14, CNVR4716.12, CNVR4716.6@AL591684.1_2@0@0@0@NA@NA@NA
A2463_31@96620@96620@deletion@1@48771316@48771405@10@chr10:48771316-48771405@17.1@85@4@0.0471@CNVR4716.10, CNVR4716.3@PTPN20B_6@0@0@0@:protein tyrosine phosphatase, non-receptor type 20B;protein tyrosine phosphatase, non-receptor type 20A@:phosphatase activity;protein tyrosine phosphatase activity;microtubule;nucleus;dephosphorylation;protein dephosphorylation;microtubule organizing center@NA
A2463_31@96851@96860@duplication@10@51371542@51472652@10@chr10:51371542-51472652@22.4@800@1158@1.45@NA@TIMM23B_1, TIMM23B_2, TIMM23B_3, TIMM23B_4, TIMM23B_5, TIMM23B_6, AGAP7_7, AGAP7_6, AGAP7_5, AGAP7_4@0@0@0@:translocase of inner mitochondrial membrane 23 homolog B (yeast):ArfGAP with GTPase domain, ankyrin repeat and PH domain 7@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity@NA
A2463_31@96883@96884@deletion@2@51620325@51623214@10@chr10:51620325-51623214@7.71@242@146@0.603@NA@TIMM23_2, TIMM23_1@0@0@0@:translocase of inner mitochondrial membrane 23 homolog B (yeast):translocase of inner mitochondrial membrane 23 homolog B (yeast);translocase of inner mitochondrial membrane 23 homolog (yeast)@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process:mitochondrion;mitochondrial inner membrane;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;mitochondrial intermembrane space;integral to mitochondrial inner membrane;intracellular protein transport;protein binding;integral to membrane;cellular protein metabolic process;protein targeting to mitochondrion@NA
A2463_31@96904@96937@duplication@34@51853029@51978390@10@chr10:51853029-51978390@50.7@966@1494@1.55@NA@FAM21A_12, FAM21A_13, FAM21A_14, FAM21A_15, FAM21A_16, FAM21A_17, FAM21A_18, FAM21A_19, FAM21A_20, FAM21A_21, FAM21A_22, FAM21A_23, FAM21A_24, FAM21A_25, FAM21A_26, FAM21A_27, FAM21A_28, FAM21A_29, FAM21A_30, FAM21A_31, ASAH2_20, ASAH2_19, ASAH2_18, ASAH2_17, ASAH2_16, ASAH2_15, ASAH2_14, ASAH2_13, ASAH2_12, ASAH2_11, ASAH2_10, ASAH2_9, ASAH2_8, ASAH2_7@0@0@0@:family with sequence similarity 21, member B;family with sequence similarity 21, member A:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
A2463_31@96952@96952@duplication@1@52504963@52505034@10@chr10:52504963-52505034@6.23@20@63@3.15@NA@ASAH2B_3@0@0@0@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2B@NA@NA
A2463_31@98334@98334@duplication@1@81272407@81272870@10@chr10:81272407-81272870@5.87@249@352@1.41@NA@EIF5AL1_1@0@0@0@:eukaryotic translation initiation factor 5A-like 1@:ribosome binding;translation elongation factor activity;positive regulation of translational termination;mRNA transport;RNA binding;protein transport;translational frameshifting;endoplasmic reticulum membrane;peptidyl-lysine modification to hypusine;nuclear pore;positive regulation of translational elongation@NA
A2463_31@98344@98350@duplication@7@81463367@81472241@10@chr10:81463367-81472241@22.1@676@1030@1.52@CNVR4815.2, CNVR4815.4@FAM22B_1, FAM22B_2, FAM22B_3, FAM22B_4, FAM22B_5, FAM22B_6, FAM22B_7@0@0@0@NA@NA@NA
A2463_31@98344@98357@deletion@7@81463367@81610362@10@chr10:81463367-81610362@-34.7@838@1032@1.23@CNVR4815.2@FAM22B_1, FAM22B_2, FAM22B_3, FAM22B_4, FAM22B_5, FAM22B_6, FAM22B_7, FAM22E_1, FAM22E_2, FAM22E_3, FAM22E_4, FAM22E_5, FAM22E_6, FAM22E_7@0@0@0@NA@NA@NA
A2463_31@98603@98606@deletion@4@89120239@89124960@10@chr10:89120239-89124960@12.7@94@25@0.266@CNVR4840.3@FAM22D_2, FAM22D_3, FAM22D_4, FAM22D_5@0@0@0@:family with sequence similarity 22, member D@NA@NA
A2463_31@103289@103290@deletion@2@5270599@5271034@11@chr11:5270599-5271034@18.7@105@12@0.114@NA@HBG1_2, HBG1_1@0@0@0@:hemoglobin, gamma A@:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex@NA
A2463_31@103292@103293@duplication@2@5275523@5275958@11@chr11:5275523-5275958@5.53@305@418@1.37@NA@HBG2_7, HBG2_6@0@0@0@:hemoglobin, gamma G@:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex@: CYANOSIS, TRANSIENT NEONATAL; TNCY
A2463_31@103342@103342@duplication@1@5798891@5799864@11@chr11:5798891-5799864@6.3@240@345@1.44@CNVR5049.1@OR52N5_1@0@0@0@:tripartite motif containing 5:olfactory receptor, family 52, subfamily N, member 5@:defense response to virus;Golgi apparatus;intracellular;protein trimerization;ligase activity;cytoplasm;protein binding;nucleus;protein homodimerization activity;identical protein binding;zinc ion binding;cytoplasmic mRNA processing body;protein ubiquitination;virus-host interaction:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_31@106046@106048@duplication@3@55370918@55419315@11@chr11:55370918-55419315@9.37@738@977@1.32@CNVR5179.1@OR4C11_1, OR4P4_1, OR4S2_1@0@0@0@:olfactory receptor, family 4, subfamily C, member 11:olfactory receptor, family 4, subfamily P, member 4:olfactory receptor, family 4, subfamily S, member 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_31@110121@110125@duplication@5@89768381@89773130@11@chr11:89768381-89773130@10.3@245@367@1.5@NA@TRIM49C_3, TRIM49C_4, TRIM49C_5, TRIM49C_6, TRIM49C_7@0@0@0@:tripartite motif containing 49D, pseudogene;tripartite motif containing 49-like 1;tripartite motif containing 49C;tripartite motif-containing protein 49-like protein 1-like@:protein binding;intracellular;DNA binding;zinc ion binding@NA
A2463_31@111509@111512@deletion@4@117077398@117079769@11@chr11:117077398-117079769@8.85@130@64@0.492@NA@PCSK7_16, PCSK7_15, PCSK7_14, PCSK7_13@0@0@0@:proprotein convertase subtilisin/kexin type 7@:proteolysis;integral to Golgi membrane;serine-type endopeptidase activity;peptide hormone processing@NA
A2463_31@114862@114876@duplication@15@19472956@19522721@12@chr12:19472956-19522721@70.1@2061@3021@1.47@NA@PLEKHA5_17, PLEKHA5_18, PLEKHA5_19, PLEKHA5_20, PLEKHA5_21, PLEKHA5_22, PLEKHA5_23, PLEKHA5_24, PLEKHA5_25, PLEKHA5_26, PLEKHA5_27, PLEKHA5_28, PLEKHA5_29, PLEKHA5_30, PLEKHA5_31@0@0@0@:pleckstrin homology domain containing, family A member 5@:phospholipid binding;protein binding;1-phosphatidylinositol binding;cellular_component;biological_process@NA
A2463_31@123374@123374@duplication@1@124496693@124497477@12@chr12:124496693-124497477@8.69@337@492@1.46@CNVR5712.1@ZNF664_6@0@0@0@:zinc finger protein 664@:intracellular;nucleus;DNA binding;molecular_function;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;biological_process@NA
A2463_31@127336@127340@deletion@5@19561995@19573144@14@chr14:19561995-19573144@33.6@695@369@0.531@CNVR6072.1@POTEG_4, POTEG_5, POTEG_6, POTEG_7, POTEG_8@0@0@0@:POTE ankyrin domain family, member G@:protein binding@NA
A2463_31@128899@128899@duplication@1@35779947@35780101@14@chr14:35779947-35780101@7.51@161@252@1.57@NA@PSMA6_4@0@0@0@:KIAA0391:proteasome (prosome, macropain) subunit, alpha type, 6@:tRNA processing;mitochondrion:nucleoplasm;S phase of mitotic cell cycle;mitochondrion;mitotic cell cycle;antigen processing and presentation of peptide antigen via MHC class I;regulation of inflammatory response;positive regulation of NF-kappaB transcription factor activity;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;mRNA metabolic process;myofibril;viral reproduction;nucleus;polysome;gene expression;cell cycle checkpoint;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;NF-kappaB binding;negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;cytosol;antigen processing and presentation of exogenous peptide antigen via MHC class I;proteolysis involved in cellular protein catabolic process;proteasome core complex, alpha-subunit complex;regulation of apoptotic process;cellular nitrogen compound metabolic process;proteasome core complex;endopeptidase activity;purine ribonucleoside triphosphate binding;RNA metabolic process;G1/S transition of mitotic cell cycle;nuclear matrix;regulation of cellular amino acid metabolic process;RNA binding;sarcomere;apoptotic process;regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;small molecule metabolic process;threonine-type endopeptidase activity;ubiquitin-dependent protein catabolic process;cytoplasm;M/G1 transition of mitotic cell cycle;protein binding;protein polyubiquitination@NA
A2463_31@133426@133427@duplication@2@106478111@106478539@14@chr14:106478111-106478539@7.08@147@227@1.54@CNVR6294.36, CNVR6294.48, CNVR6294.12, CNVR6294.24@IGHV4-4_2, IGHV4-4_1@0@0@0@@:protein binding@NA
A2463_31@133460@133462@duplication@3@106805210@106816026@14@chr14:106805210-106816026@24.1@153@352@2.3@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.41@IGHV4-31_2, IGHV4-31_1, IGHV3-33_2@0@0@0@@:protein binding:protein binding@NA
A2463_31@133470@133471@deletion@2@106877620@106878076@14@chr14:106877620-106878076@5.43@211@134@0.635@CNVR6294.26, CNVR6294.56, CNVR6294.2, CNVR6294.18@IGHV4-39_2, IGHV4-39_1@0@0@0@@:protein binding@NA
A2463_31@133532@133542@duplication@11@22062317@22383423@15@chr15:22062317-22383423@29.7@1143@1673@1.46@NA@POTEB_9, POTEB_8, POTEB_7, POTEB_6, POTEB_5, POTEB_4, POTEB_3, POTEB_2, POTEB_1, OR4M2_1, OR4N4_1@0@0@0@:POTE ankyrin domain family member B-like:olfactory receptor, family 4, subfamily M, member 2:olfactory receptor, family 4, subfamily N, member 4@:protein binding:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_31@133549@133552@duplication@4@22739724@22743598@15@chr15:22739724-22743598@31.6@956@1704@1.78@CNVR6298.5@GOLGA6L1_5, GOLGA6L1_6, GOLGA6L1_7, GOLGA6L1_8@0@0@0@:golgin A6 family-like 1;putative transmembrane protein FLJ36131-like;putative transmembrane protein ENSP00000320207-like;putative golgin subfamily A member 6-like@NA@NA
A2463_31@133622@133623@deletion@2@23259497@23259716@15@chr15:23259497-23259716@5.73@70@32@0.457@CNVR6300.4@GOLGA8I_6, GOLGA8I_7@0@0@0@:golgin A8 family, member I@:Golgi cisterna membrane@NA
A2463_31@133638@133641@deletion@4@23409198@23411062@15@chr15:23409198-23411062@7.3@150@84@0.56@CNVR6300.8@RP11-467N20.5_6, RP11-467N20.5_5, RP11-467N20.5_4, RP11-467N20.5_3@0@0@0@:putative golgin subfamily A member 6-like protein 6-like@NA@NA
A2463_31@133648@133651@duplication@4@23603620@23604356@15@chr15:23603620-23604356@5.57@88@140@1.59@CNVR6301.3@GOLGA8S_5, GOLGA8S_6, GOLGA8S_7, GOLGA8S_8@0@0@0@@:Golgi apparatus@NA
A2463_31@133909@133911@deletion@3@28951760@28953183@15@chr15:28951760-28953183@11.7@395@241@0.61@CNVR6331.1@GOLGA8M_9, GOLGA8M_8, GOLGA8M_7@0@0@0@:golgin A8 family, member M@:Golgi apparatus@NA
A2463_31@134009@134015@duplication@7@30659622@30675554@15@chr15:30659622-30675554@8.1@240@343@1.43@CNVR6337.1@CHRFAM7A_9, CHRFAM7A_8, CHRFAM7A_7, CHRFAM7A_6, CHRFAM7A_5, CHRFAM7A_4, CHRFAM7A_3@0@0@0@:CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:transport;integral to membrane;ion transport;postsynaptic membrane;membrane;extracellular ligand-gated ion channel activity@NA
A2463_31@134044@134047@duplication@4@30850148@30851494@15@chr15:30850148-30851494@6.16@74@127@1.72@NA@GOLGA8Q_10, GOLGA8Q_11, GOLGA8Q_12, GOLGA8Q_13@0@0@0@@:Golgi apparatus@NA
A2463_31@134158@134161@duplication@4@32684984@32685771@15@chr15:32684984-32685771@14.2@179@307@1.72@NA@GOLGA8K_19, GOLGA8K_18, GOLGA8K_17, GOLGA8K_16@0@0@0@:golgin A8 family, member J@:Golgi apparatus@NA
A2463_31@134171@134177@duplication@7@32691140@32695395@15@chr15:32691140-32695395@18.1@181@332@1.83@NA@GOLGA8K_6, GOLGA8K_5, GOLGA8K_4, GOLGA8K_3, GOLGA8K_2, AC139426.2_1, GOLGA8K_1@0@0@0@:golgin A8 family, member J@:Golgi apparatus@NA
A2463_31@134180@134191@deletion@12@32737820@32743539@15@chr15:32737820-32743539@21.4@219@84@0.384@CNVR6346.1@GOLGA8O_17, GOLGA8O_16, GOLGA8O_15, GOLGA8O_14, GOLGA8O_13, GOLGA8O_12, GOLGA8O_11, GOLGA8O_10, GOLGA8O_9, GOLGA8O_8, GOLGA8O_7, GOLGA8O_6@0@0@0@:golgin A8 family, member O@:Golgi apparatus@NA
A2463_31@134457@134460@deletion@4@34823677@34825163@15@chr15:34823677-34825163@6.98@75@31@0.413@CNVR6351.3@GOLGA8B_15, GOLGA8B_14, GOLGA8B_13, GOLGA8B_12@0@0@0@:golgin A8 family, member A:golgin A8 family, member A;golgin A8 family, member B@:Golgi cisterna membrane;Golgi apparatus:Golgi cisterna membrane;Golgi apparatus@NA
A2463_31@135680@135681@deletion@2@43873201@43873586@15@chr15:43873201-43873586@8.46@542@359@0.662@CNVR6365.1@PPIP5K1_10, PPIP5K1_9@0@0@0@:diphosphoinositol pentakisphosphate kinase 1@:inositol hexakisphosphate 3-kinase activity;inositol hexakisphosphate 1-kinase activity;inositol metabolic process;diphosphoinositol-pentakisphosphate kinase activity;ATP binding;acid phosphatase activity;cytoplasm;cytosol;inositol hexakisphosphate 5-kinase activity;nucleus;kinase activity;inositol-1,3,4,5,6-pentakisphosphate kinase activity@NA
A2463_31@135708@135721@duplication@14@43900062@43906674@15@chr15:43900062-43906674@12.8@526@721@1.37@CNVR6365.1@STRC_18, STRC_17, STRC_16, STRC_15, STRC_14, STRC_13, STRC_12, STRC_11, STRC_10, STRC_9, STRC_8, STRC_7, STRC_6, STRC_5@0@0@0@:diphosphoinositol pentakisphosphate kinase 1:stereocilin@:inositol hexakisphosphate 3-kinase activity;inositol hexakisphosphate 1-kinase activity;inositol metabolic process;diphosphoinositol-pentakisphosphate kinase activity;ATP binding;acid phosphatase activity;cytoplasm;cytosol;inositol hexakisphosphate 5-kinase activity;nucleus;kinase activity;inositol-1,3,4,5,6-pentakisphosphate kinase activity:detection of mechanical stimulus involved in sensory perception of sound;stereocilium bundle tip;stereocilium;cell surface;kinocilium;auditory receptor cell stereocilium organization@: DEAFNESS, AUTOSOMAL RECESSIVE 16; DFNB16; DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY
A2463_31@138281@138287@duplication@7@72953606@72957376@15@chr15:72953606-72957376@33.1@367@676@1.84@CNVR6443.1@GOLGA6B_8, GOLGA6B_9, GOLGA6B_10, GOLGA6B_11, GOLGA6B_12, GOLGA6B_13, GOLGA6B_14@0@0@0@:golgin A6 family, member B@:Golgi apparatus@NA
A2463_31@138632@138637@duplication@6@75555690@75557765@15@chr15:75555690-75557765@9.9@330@465@1.41@CNVR6452.1@GOLGA6C_4, GOLGA6C_5, GOLGA6C_6, GOLGA6C_7, GOLGA6C_8, GOLGA6C_9@0@0@0@:golgin A6 family, member C@:Golgi apparatus@NA
A2463_31@138652@138655@deletion@4@75580422@75582040@15@chr15:75580422-75582040@17.6@189@77@0.407@CNVR6452.1@GOLGA6D_6, GOLGA6D_7, GOLGA6D_8, GOLGA6D_9@0@0@0@:golgin A6 family, member D@:Golgi apparatus@NA
A2463_31@139295@139296@deletion@2@82933940@82935146@15@chr15:82933940-82935146@6.81@121@63@0.521@CNVR6477.6@RP13-996F3.5_7, RP13-996F3.5_6@0@0@0@NA@NA@NA
A2463_31@140476@140483@duplication@8@64382@67750@16@chr16:64382-67750@20.3@374@584@1.56@CNVR6565.1@WASH4P_10, WASH4P_9, WASH4P_8, WASH4P_7, WASH4P_6, WASH4P_5, WASH4P_4, WASH4P_3@0@0@0@@:intracellular membrane-bounded organelle;endosomal transport;recycling endosome;early endosome;Arp2/3 complex-mediated actin nucleation;actin binding;alpha-tubulin binding;retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;recycling endosome membrane@NA
A2463_31@142690@142690@duplication@1@15045473@15045882@16@chr16:15045473-15045882@6.91@173@263@1.52@NA@NPIP_8@0@0@0@:nuclear pore complex-interacting protein-like;nuclear pore complex interacting protein;nuclear pore complex-interacting protein-like 1-like@:nuclear membrane;protein transport;nuclear pore;mRNA transport@NA
A2463_31@142750@142750@deletion@1@15457517@15457926@16@chr16:15457517-15457926@4.78@289@191@0.661@CNVR6649.1@PKD1P1_8@0@0@0@:NPIP-like protein 1-like;nuclear pore complex-interacting protein-like 1-like@NA@NA
A2463_31@143481@143485@deletion@5@21763257@21771861@16@chr16:21763257-21771861@24.5@243@89@0.366@CNVR6668.5, CNVR6668.2, CNVR6668.7@OTOA_24, OTOA_25, OTOA_26, OTOA_27, OTOA_28@0@0@0@:otoancorin@:proteinaceous extracellular matrix;apical plasma membrane;sensory perception of sound;anchored to membrane@: DEAFNESS, AUTOSOMAL RECESSIVE 22; DFNB22
A2463_31@144047@144052@deletion@6@28467746@28478223@16@chr16:28467746-28478223@31.3@162@12@0.0741@NA@NPIPL1_7, NPIPL1_6, NPIPL1_5, NPIPL1_4, NPIPL1_3, NPIPL1_2@0@0@0@:ceroid-lipofuscinosis, neuronal 3@:membrane:negative regulation of apoptotic process;late endosome;mitochondrion;galactosylceramide metabolic process;neuromuscular process controlling balance;neuron projection;lysosomal lumen pH elevation;integral to endoplasmic reticulum membrane;cell death;plasma membrane;nucleus;lysosomal lumen acidification;negative regulation of catalytic activity;negative regulation of macroautophagy;unfolded protein binding;neurotransmitter metabolic process;endoplasmic reticulum;vesicle transport along microtubule;protein catabolic process;autophagic vacuole;early endosome;trans-Golgi network;cellular membrane organization;ceramide metabolic process;glucosylceramide metabolic process;negative regulation of neuron apoptotic process;membrane;globoside metabolic process;membrane raft;synaptic vesicle;vacuolar transport;protein processing;Golgi membrane;caveola;protein folding;ionotropic glutamate receptor signaling pathway;cytosolic calcium ion homeostasis;Golgi stack;integral to membrane;receptor-mediated endocytosis;arginine transport;lysosome;negative regulation of proteolysis;Golgi apparatus;lysosome organization;associative learning;sphingomyelin metabolic process;macroautophagy;lysosomal membrane;amyloid precursor protein catabolic process;cytoplasm;autophagic vacuole fusion;protein binding;regulation of action potential;cellular amino acid metabolic process@: CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3
A2463_31@144095@144104@deletion@10@28607105@28659638@16@chr16:28607105-28659638@60.3@767@338@0.441@NA@SULT1A2_2, SULT1A1_10, SULT1A1_9, SULT1A1_8, SULT1A1_7, SULT1A1_6, SULT1A1_5, SULT1A1_4, A-575C2.4_1, A-575C2.4_2@0@0@0@:sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2:sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1:nuclear pore complex-interacting protein-like 2-like;putative NPIP-like protein LOC613037-like@:steroid metabolic process;small molecule metabolic process;sulfation;aryl sulfotransferase activity;catecholamine metabolic process;cytosol;xenobiotic metabolic process;phenol-containing compound metabolic process;sulfotransferase activity;amine biosynthetic process;flavonol 3-sulfotransferase activity;3'-phosphoadenosine 5'-phosphosulfate metabolic process:small molecule metabolic process;sulfation;aryl sulfotransferase activity;amine metabolic process;catecholamine metabolic process;xenobiotic metabolic process;cytosol;steroid sulfotransferase activity;integral to membrane;sulfotransferase activity;flavonol 3-sulfotransferase activity;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process;estrogen metabolic process@NA
A2463_31@144130@144134@deletion@5@28763890@28777810@16@chr16:28763890-28777810@14.6@99@23@0.232@NA@A-575C2.4_1, A-575C2.4_2, A-575C2.4_3, A-575C2.4_4, A-575C2.4_5@0@0@0@NA@NA@NA
A2463_31@145012@145014@duplication@3@32063312@32266224@16@chr16:32063312-32266224@12.2@360@530@1.47@CNVR6701.6@AC142381.1_1, TP53TG3D_1@0@0@0@:TP53 target 3B;TP53 target 3;TP53-target gene 3 protein-like;TP53 target 3C@:protein binding:nucleus;cytoplasm@NA
A2463_31@147091@147091@deletion@1@69988238@69988476@16@chr16:69988238-69988476@11.2@77@17@0.221@CNVR6762.3, CNVR6762.1@CLEC18A_3@0@0@0@:C-type lectin domain family 18, member A@:carbohydrate binding;protein binding;extracellular region@NA
A2463_31@147100@147100@duplication@1@69997478@69997514@16@chr16:69997478-69997514@4.92@51@94@1.84@CNVR6762.3, CNVR6762.1@CLEC18A_12@0@0@0@:C-type lectin domain family 18, member A@:carbohydrate binding;protein binding;extracellular region@NA
A2463_31@147110@147124@duplication@15@70162688@70190782@16@chr16:70162688-70190782@52.3@1819@2606@1.43@CNVR6764.1, CNVR6764.3@PDPR_5, PDPR_6, PDPR_7, PDPR_8, PDPR_9, PDPR_10, PDPR_11, PDPR_12, PDPR_13, PDPR_14, PDPR_15, PDPR_16, PDPR_17, PDPR_18, PDPR_19@0@0@0@:pyruvate dehydrogenase phosphatase regulatory subunit@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix@NA
A2463_31@147110@147126@deletion@2@70162688@70208941@16@chr16:70162688-70208941@-196@1906@2608@1.37@CNVR6764.1, CNVR6764.3@PDPR_5, PDPR_6, PDPR_7, PDPR_8, PDPR_9, PDPR_10, PDPR_11, PDPR_12, PDPR_13, PDPR_14, PDPR_15, PDPR_16, PDPR_17, PDPR_18, PDPR_19, CLEC18C_1, CLEC18C_2@0@0@0@:pyruvate dehydrogenase phosphatase regulatory subunit:C-type lectin domain family 18, member C@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix:carbohydrate binding;protein binding;extracellular region@NA
A2463_31@147110@147127@duplication@1@70162688@70211383@16@chr16:70162688-70211383@40.8@2035@2812@1.38@CNVR6764.1, CNVR6764.3@PDPR_5, PDPR_6, PDPR_7, PDPR_8, PDPR_9, PDPR_10, PDPR_11, PDPR_12, PDPR_13, PDPR_14, PDPR_15, PDPR_16, PDPR_17, PDPR_18, PDPR_19, CLEC18C_1, CLEC18C_2, CLEC18C_3@0@0@0@:pyruvate dehydrogenase phosphatase regulatory subunit:C-type lectin domain family 18, member C@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix:carbohydrate binding;protein binding;extracellular region@NA
A2463_31@147497@147516@duplication@20@74415415@74486029@16@chr16:74415415-74486029@61.5@2701@3758@1.39@CNVR6778.2@NPIPL2_2, NPIPL2_3, NPIPL2_4, NPIPL2_5, NPIPL2_6, NPIPL2_7, CLEC18B_13, CLEC18B_12, CLEC18B_11, CLEC18B_10, CLEC18B_9, CLEC18B_8, CLEC18B_7, CLEC18B_6, CLEC18B_5, CLEC18B_4, CLEC18B_3, CLEC18B_2, CLEC18B_1, GLG1_27@0@0@0@:C-type lectin domain family 18, member B:golgi glycoprotein 1@:extracellular region:carbohydrate binding;protein binding;extracellular region:extracellular matrix;Golgi apparatus;negative regulation of protein processing;negative regulation of transforming growth factor beta receptor signaling pathway;bone morphogenesis;Golgi membrane;Golgi medial cisterna;regulation of chondrocyte differentiation;integral to membrane;membrane;receptor binding@NA
A2463_31@151876@151886@duplication@11@18387190@18430117@17@chr17:18387190-18430117@27.9@539@835@1.55@NA@LGALS9C_2, LGALS9C_3, LGALS9C_4, LGALS9C_5, LGALS9C_6, LGALS9C_7, LGALS9C_8, LGALS9C_9, LGALS9C_10, LGALS9C_11, FAM106A_1@0@0@0@:lectin, galactoside-binding, soluble, 9C:protein FAM106B-like@:carbohydrate binding@NA
A2463_31@152122@152129@deletion@8@20353287@20359984@17@chr17:20353287-20359984@22.3@176@53@0.301@CNVR7021.1, CNVR7021.3@LGALS9B_11, LGALS9B_10, LGALS9B_9, LGALS9B_8, LGALS9B_7, LGALS9B_6, LGALS9B_5, LGALS9B_4@0@0@0@:lectin, galactoside-binding, soluble, 9B@:carbohydrate binding@NA
A2463_31@153006@153007@duplication@2@30502982@30503232@17@chr17:30502982-30503232@5.64@208@293@1.41@NA@RHOT1_5, RHOT1_6@0@0@0@:ras homolog family member T1@:mitochondrion;mitochondrial outer membrane;protein transport;GTP binding;apoptotic process;plasma membrane;regulation of small GTPase mediated signal transduction;small GTPase mediated signal transduction;intracellular;GTPase activity;GTP catabolic process;cytosol;signal transduction;protein binding;mitochondrion transport along microtubule;cellular homeostasis;integral to mitochondrial outer membrane;molecular_function;membrane;calcium ion binding@NA
A2463_31@153376@153394@deletion@19@34522686@34590454@17@chr17:34522686-34590454@16.9@109@24@0.22@CNVR7077.1, CNVR7077.13, CNVR7077.19@CCL3L3_3, CCL3L3_2, CCL3L3_1, CCL4L1_1, CCL4L1_2, CCL4L1_3, TBC1D3C_14, TBC1D3C_13, TBC1D3C_12, TBC1D3C_11, TBC1D3C_10, TBC1D3C_9, TBC1D3C_8, TBC1D3C_7, TBC1D3C_6, TBC1D3C_5, TBC1D3C_4, TBC1D3C_3, TBC1D3C_2@0@0@0@:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1:TBC1 domain family, member 3C;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3H-like;TBC1 domain family, member 3H@:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_31@153414@153414@deletion@1@34797487@34798054@17@chr17:34797487-34798054@21.4@99@0@0@CNVR7078.2, CNVR7078.3@TBC1D3G_14@0@0@0@:TBC1 domain family member 3H-like;TBC1 domain family, member 3H:TBC1 domain family, member 3;TBC1 domain family, member 3G;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like;TBC1 domain family, member 3H@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_31@153650@153659@deletion@10@36351930@36375177@17@chr17:36351930-36375177@35.2@1668@1077@0.646@CNVR7083.3@RP11-1407O15.2_12, RP11-1407O15.2_11, RP11-1407O15.2_10, RP11-1407O15.2_9, RP11-1407O15.2_8, RP11-1407O15.2_7, RP11-1407O15.2_6, RP11-1407O15.2_5, RP11-1407O15.2_4, RP11-1407O15.2_3@0@0@0@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
A2463_31@155582@155582@duplication@1@44372501@44375108@17@chr17:44372501-44375108@11.4@91@191@2.1@CNVR7114.3, CNVR7114.2@LRRC37A_1@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
A2463_31@155584@155586@deletion@3@44380005@44383675@17@chr17:44380005-44383675@14.8@67@0@0@CNVR7114.3, CNVR7114.2@LRRC37A_3, LRRC37A_4, LRRC37A_5@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
A2463_31@155591@155591@duplication@1@44409919@44410022@17@chr17:44409919-44410022@10.2@130@233@1.79@CNVR7114.3, CNVR7114.2, CNVR7114.1, CNVR7114.7@LRRC37A_10@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
A2463_31@155591@155595@deletion@4@44409919@44415089@17@chr17:44409919-44415089@-1.31@231@236@1.02@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A_10, LRRC37A_11, LRRC37A_12, LRRC37A_13, LRRC37A_14@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
A2463_31@155599@155600@deletion@2@44590080@44594799@17@chr17:44590080-44594799@37.4@175@0@0@CNVR7114.2, CNVR7114.5@LRRC37A2_2, LRRC37A2_3@0@0@0@:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
A2463_31@155604@155612@duplication@9@44617543@44632945@17@chr17:44617543-44632945@64@2136@3236@1.51@CNVR7114.2, CNVR7114.5, CNVR7114.4@LRRC37A2_7, LRRC37A2_8, LRRC37A2_9, LRRC37A2_10, LRRC37A2_11, LRRC37A2_12, LRRC37A2_13, LRRC37A2_14, LRRC37A2_15@0@0@0@:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
A2463_31@155625@155628@duplication@4@44770270@44782220@17@chr17:44770270-44782220@5.69@279@380@1.36@CNVR7114.2, CNVR7114.4@NSF_10, NSF_11, NSF_12, NSF_13@0@0@0@:N-ethylmaleimide-sensitive factor@:PDZ domain binding;Rab GTPase binding;regulation of exocytosis;ATP binding;Golgi stack;protein transport;protein C-terminus binding;plasma membrane;dendritic shaft;potassium ion transport;nucleoside-triphosphatase activity;exocytosis;positive regulation of receptor recycling;nucleotide binding;plasma membrane fusion;cytoplasm;cytosol;protein binding;vesicle-mediated transport;ATPase activity, coupled;protein complex binding;synaptic transmission;syntaxin binding;metal ion binding@NA
A2463_31@157607@157607@duplication@1@62888648@62888718@17@chr17:62888648-62888718@5.97@125@195@1.56@CNVR7165.1@LRRC37A3_4@0@0@0@:leucine rich repeat containing 37, member A3@:protein binding;integral to membrane@NA
A2463_31@162017@162018@deletion@2@44542732@44550298@18@chr18:44542732-44550298@100@505@8@0.0158@CNVR7319.1, CNVR7319.2@TCEB3CL2_1, TCEB3CL_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2:transcription elongation factor B polypeptide 3C-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_31@162017@162019@duplication@1@44542732@44556213@18@chr18:44542732-44556213@-65.1@2990@4363@1.46@CNVR7319.1, CNVR7319.2@TCEB3CL2_1, TCEB3CL_1, TCEB3C_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2:transcription elongation factor B polypeptide 3C-like:transcription elongation factor B polypeptide 3C (elongin A3);RNA polymerase II transcription factor SIII subunit A3-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_31@164951@164953@deletion@3@7032325@7040155@19@chr19:7032325-7040155@9.2@62@15@0.242@CNVR7517.1@MBD3L5_2, MBD3L4_2, MBD3L4_1@0@0@0@:methyl-CpG binding domain protein 3-like 5:methyl-CpG binding domain protein 3-like 4@:regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_31@164956@164956@deletion@1@7056334@7056914@19@chr19:7056334-7056914@11.6@177@82@0.463@CNVR7517.1@MBD3L3_2@0@0@0@:methyl-CpG binding domain protein 3-like 3@:regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_31@168952@168952@deletion@1@35862263@35863302@19@chr19:35862263-35863302@13.6@120@37@0.308@CNVR7627.1@GPR42_2@0@0@0@@:integral to membrane;G-protein coupled receptor activity;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
A2463_31@169778@169778@duplication@1@39262470@39262670@19@chr19:39262470-39262670@4.6@42@80@1.9@NA@LGALS7_3@0@0@0@:lectin, galactoside-binding, soluble, 7;lectin, galactoside-binding, soluble, 7B@:carbohydrate binding;heterophilic cell-cell adhesion;extracellular space;nucleus;apoptotic process;cytoplasm@NA
A2463_31@170099@170100@duplication@2@40380120@40382826@19@chr19:40380120-40382826@15.2@133@262@1.97@CNVR7639.2@FCGBP_23, FCGBP_22@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_31@170109@170112@duplication@4@40399240@40406060@19@chr19:40399240-40406060@8.71@99@176@1.78@CNVR7639.2@FCGBP_13, FCGBP_12, FCGBP_11, FCGBP_10@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_31@172565@172567@duplication@3@50463395@50464338@19@chr19:50463395-50464338@11.2@246@380@1.54@NA@SIGLEC11_3, SIGLEC11_2, SIGLEC11_1@0@0@0@:sialic acid binding Ig-like lectin 11@:carbohydrate binding;protein binding;integral to membrane;cell adhesion@NA
A2463_31@173300@173304@deletion@5@54726816@54745003@19@chr19:54726816-54745003@11.3@390@244@0.626@CNVR7721.3, CNVR7721.4, CNVR7721.1@LILRB3_1, LILRA6_8, LILRA6_7, LILRA6_6, LILRA6_5@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
A2463_31@173336@173341@deletion@6@54801928@54804173@19@chr19:54801928-54804173@81.4@381@3@0.00787@CNVR7722.1@LILRA3_6, LILRA3_5, LILRA3_4, LILRA3_3, LILRA3_2, LILRA3_1@0@0@0@:leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3@:antigen binding;signal transduction;protein binding;extracellular region;plasma membrane;receptor activity;defense response@NA
A2463_31@173456@173506@deletion@51@55237520@55367367@19@chr19:55237520-55367367@456@2424@221@0.0912@CNVR7725.1@KIR3DL3_3, KIR3DL3_4, KIR3DL3_5, KIR3DL3_6, KIR3DL3_7, KIR3DL3_8, KIR2DL3_1, KIR2DL3_2, KIR2DL3_3, KIR2DL3_4, KIR2DL3_5, KIR2DL3_6, KIR2DL3_7, KIR2DL3_8, KIR2DL1_1, KIR2DL1_2, KIR2DL1_3, KIR2DL1_4, KIR2DL1_5, KIR2DL1_6, KIR2DL1_7, KIR2DL1_8, KIR2DL4_1, KIR2DL4_2, KIR2DL4_3, KIR2DL4_4, KIR2DL4_5, KIR2DL4_6, KIR2DL4_7, KIR3DL1_1, KIR3DL1_2, KIR3DL1_3, KIR3DL1_4, KIR3DL1_5, KIR3DL1_6, KIR3DL1_7, KIR3DL1_8, KIR3DL1_9, KIR2DS4_1, KIR2DS4_2, KIR2DS4_3, KIR2DS4_4, KIR2DS4_5, KIR2DS4_6, KIR2DS4_7, KIR2DS4_8, KIR3DL2_1, KIR3DL2_2, KIR3DL2_3, KIR3DL2_4, KIR3DL2_5@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2-like@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:integral to membrane;plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane:regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane@NA
A2463_31@173842@173842@deletion@1@56273168@56273452@19@chr19:56273168-56273452@5.64@69@30@0.435@CNVR7734.1@RFPL4A_2@0@0@0@:ret finger protein-like 4A;ret finger protein-like 4A-like@:protein binding;zinc ion binding@NA
A2463_31@173844@173845@duplication@2@56283172@56284545@19@chr19:56283172-56284545@13.2@428@627@1.46@CNVR7734.1@CTD-2611O12.2_2, CTD-2611O12.2_3@0@0@0@:ret finger protein-like 4A-like@:protein binding;zinc ion binding@NA
A2463_31@179011@179011@deletion@1@14982551@14983070@21@chr21:14982551-14983070@16.9@86@5@0.0581@CNVR7952.1@POTED_1@0@0@0@:POTE ankyrin domain family, member B;POTE ankyrin domain family, member C;POTE ankyrin domain family, member D@:protein binding;plasma membrane@NA
A2463_31@179016@179021@deletion@6@14995127@15013887@21@chr21:14995127-15013887@26.9@154@22@0.143@CNVR7952.1@POTED_6, POTED_7, POTED_8, POTED_9, POTED_10, POTED_11@0@0@0@:POTE ankyrin domain family, member B;POTE ankyrin domain family, member C;POTE ankyrin domain family, member D@:protein binding;plasma membrane@NA
A2463_31@180976@180976@deletion@1@16287255@16287885@22@chr22:16287255-16287885@12.1@324@178@0.549@CNVR8071.2, CNVR8071.3, CNVR8071.9@POTEH_1@0@0@0@:POTE ankyrin domain family, member H@:protein binding@NA
A2463_31@181129@181133@deletion@5@18727044@18739404@22@chr22:18727044-18739404@12.3@77@15@0.195@CNVR8087.5, CNVR8087.2, CNVR8087.11@AC008132.1_4, AC008132.1_5, AC008132.1_6, AC008132.1_7, AC008132.1_8@0@0@0@NA@NA@NA
A2463_31@181806@181806@deletion@1@23243157@23243475@22@chr22:23243157-23243475@22.8@112@4@0.0357@CNVR8103.2, CNVR8103.1, CNVR8103.6, CNVR8103.11@IGLC2_1@0@0@0@@:protein binding@NA
A2463_08@8507@8508@deletion@2@89476588@89477710@1@chr1:89476588-89477710@74.3@392@2@0.0051@CNVR244.1@GBP3_8, GBP3_7@0@0@0@:guanylate binding protein 3@:defense response to virus;GTP binding;GTPase activity;membrane;cytoplasm@NA
A2463_08@9365@9366@duplication@2@104202983@104203298@1@chr1:104202983-104203298@5.49@221@314@1.42@CNVR266.3, CNVR266.1@AMY1A_7, AMY1A_8@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
A2463_08@9373@9374@deletion@2@104233917@104234232@1@chr1:104233917-104234232@16.2@76@1@0.0132@CNVR266.3, CNVR266.5@AMY1B_8, AMY1B_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
A2463_08@9766@9773@deletion@8@110230497@110235917@1@chr1:110230497-110235917@63.2@308@8@0.026@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_1, GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
A2463_08@10793@10793@deletion@1@144339779@144340398@1@chr1:144339779-144340398@7.3@35@1@0.0286@CNVR334.4, CNVR334.2@AL592284.1_1@0@0@0@:uncharacterized LOC730256;uncharacterized LOC101060698;uncharacterized LOC642441@NA@NA
A2463_08@11353@11357@deletion@5@148021578@148025848@1@chr1:148021578-148025848@5.93@444@308@0.694@CNVR346.2, CNVR346.4@NBPF14_5, NBPF14_4, NBPF14_3, NBPF14_2, NBPF14_1@0@0@0@:neuroblastoma breakpoint family, member 14@:cytoplasm@NA
A2463_08@12117@12118@deletion@2@152573209@152586574@1@chr1:152573209-152586574@31.4@149@0@0@CNVR358.1@LCE3C_1, LCE3B_1@0@0@0@:late cornified envelope 3C:late cornified envelope 3B@:keratinization:keratinization@NA
A2463_08@12129@12129@deletion@1@152770272@152770615@1@chr1:152770272-152770615@6.67@91@39@0.429@CNVR360.1@LCE1D_2@0@0@0@:late cornified envelope 1D@:cytoplasmic part;cornified envelope;cellular response to calcium ion;keratinization;perinuclear region of cytoplasm;cytoplasm@NA
A2463_08@14053@14055@deletion@3@161565346@161596192@1@chr1:161565346-161596192@20@357@170@0.476@CNVR383.1@FCGR2C_1, FCGR3B_5, FCGR3B_4@0@0@0@:Fc fragment of IgG, low affinity IIIa, receptor (CD16a):Fc fragment of IgG, low affinity IIb, receptor (CD32):Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene):Fc fragment of IgG, low affinity IIIb, receptor (CD16b)@:IgG binding;protein binding;regulation of immune response;extracellular region;integral to membrane;immune response;plasma membrane;external side of plasma membrane:IgG binding;protein binding;signal transduction;regulation of immune response;integral to membrane;immune response;plasma membrane;virus-host interaction:IgG binding;protein binding;extracellular region;immune response;plasma membrane;anchored to membrane@: MALARIA, SUSCEPTIBILITY TO; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
A2463_08@16029@16040@duplication@12@196744018@196801129@1@chr1:196744018-196801129@47.9@2086@3017@1.45@CNVR459.1@CFHR3_1, CFHR3_2, CFHR3_3, CFHR3_4, CFHR3_5, CFHR3_6, CFHR1_1, CFHR1_2, CFHR1_3, CFHR1_4, CFHR1_5, CFHR1_6@0@0@0@:complement factor H-related 3:complement factor H-related 1:complement factor H-related 2@:extracellular space:extracellular space;complement activation:extracellular region@NA
A2463_08@19774@19775@duplication@2@248737103@248757069@1@chr1:248737103-248757069@5.36@470@629@1.34@CNVR600.1@OR2T34_1, OR2T10_1@0@0@0@:olfactory receptor, family 2, subfamily T, member 34:olfactory receptor, family 2, subfamily T, member 10@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_08@25006@25007@deletion@2@90198717@90199190@2@chr2:90198717-90199190@8.92@185@93@0.503@CNVR867.10, CNVR867.5, CNVR867.3, CNVR867.9, CNVR867.15, CNVR867.2@IGKV1D-12_1, IGKV1D-12_2@0@0@0@@:protein binding@NA
A2463_08@25383@25386@deletion@4@97867940@97870000@2@chr2:97867940-97870000@8.21@651@439@0.674@CNVR886.1@ANKRD36_47, ANKRD36_48, ANKRD36_49, ANKRD36_50@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_08@25402@25404@deletion@3@97884912@97899608@2@chr2:97884912-97899608@6.99@381@256@0.672@NA@ANKRD36_66, ANKRD36_67, ANKRD36_68@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_08@26008@26011@deletion@4@108454714@108460186@2@chr2:108454714-108460186@8.99@133@61@0.459@NA@RGPD4_3, RGPD4_4, RGPD4_5, RGPD4_6@0@0@0@:RANBP2-like and GRIP domain containing 4@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_08@26021@26022@deletion@2@108479139@108479488@2@chr2:108479139-108479488@5.61@315@205@0.651@NA@RGPD4_16, RGPD4_17@0@0@0@:RANBP2-like and GRIP domain containing 4@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_08@27163@27163@deletion@1@130843388@130843568@2@chr2:130843388-130843568@9.11@42@0@0@NA@POTEF_13@0@0@0@:POTE ankyrin domain family, member F@:cell cortex;protein binding;ATP binding@NA
A2463_08@27172@27172@deletion@1@130869569@130869674@2@chr2:130869569-130869674@6.56@67@24@0.358@NA@POTEF_4@0@0@0@:POTE ankyrin domain family, member F@:cell cortex;protein binding;ATP binding@NA
A2463_08@27279@27281@deletion@3@131381638@131389026@2@chr2:131381638-131389026@5.59@150@86@0.573@NA@POTEJ_6, POTEJ_7, POTEJ_8@0@0@0@:POTE ankyrin domain family, member J@:protein binding;ATP binding@NA
A2463_08@27285@27288@deletion@4@131403311@131415450@2@chr2:131403311-131415450@9.31@740@471@0.636@NA@POTEJ_12, POTEJ_13, POTEJ_14, POTEJ_15@0@0@0@:POTE ankyrin domain family, member J@:protein binding;ATP binding@NA
A2463_08@27326@27326@deletion@1@132010100@132010143@2@chr2:132010100-132010143@5.03@23@0@0@NA@POTEE_12@0@0@0@:pleckstrin homology domain containing, family B (evectins) member 2:POTE ankyrin domain family, member E@:phospholipid binding;protein binding;recycling endosome membrane:protein binding;ATP binding@NA
A2463_08@27334@27334@deletion@1@132237643@132238322@2@chr2:132237643-132238322@12.5@166@63@0.38@NA@TUBA3D_4@0@0@0@:microRNA 4784;mitotic spindle organizing protein 2A:tubulin, alpha 3c;tubulin, alpha 3d@:gamma-tubulin ring complex;centrosome;spindle:microtubule-based process;structural constituent of cytoskeleton;protein folding;protein polymerization;cytoplasmic microtubule;GTP binding;microtubule cytoskeleton organization;GTPase activity;GTP catabolic process;protein complex;cytoplasm;microtubule cytoskeleton;protein binding;'de novo' posttranslational protein folding;cellular protein metabolic process;microtubule-based movement;structural molecule activity;microtubule;protein domain specific binding@NA
A2463_08@27342@27342@deletion@1@132289238@132289375@2@chr2:132289238-132289375@5.4@86@41@0.477@NA@CCDC74A_4@0@0@0@:coiled-coil domain containing 74A@NA@NA
A2463_08@27987@27987@duplication@1@152450522@152450832@2@chr2:152450522-152450832@6.77@51@112@2.2@CNVR1026.1@NEB_93@0@0@0@:nebulin@:Z disc;muscle filament sliding;oxidation-reduction process;contractile fiber part;actin cytoskeleton;regulation of actin filament length;structural constituent of muscle;cytosol;actin binding;protein binding;myofibril;somatic muscle development;muscle organ development@: NEMALINE MYOPATHY 2; NEM2
A2463_08@27995@27997@deletion@3@152461075@152464122@2@chr2:152461075-152464122@23.6@112@1@0.00893@CNVR1026.1@NEB_85, NEB_84, NEB_83@0@0@0@:nebulin@:Z disc;muscle filament sliding;oxidation-reduction process;contractile fiber part;actin cytoskeleton;regulation of actin filament length;structural constituent of muscle;cytosol;actin binding;protein binding;myofibril;somatic muscle development;muscle organ development@: NEMALINE MYOPATHY 2; NEM2
A2463_08@34150@34186@duplication@37@241631332@241709123@2@chr2:241631332-241709123@72.5@1823@2746@1.51@NA@AQP12A_1, AQP12A_2, AQP12A_3, AQP12A_4, KIF1A_49, KIF1A_48, KIF1A_47, KIF1A_46, KIF1A_45, KIF1A_44, KIF1A_43, KIF1A_42, KIF1A_41, KIF1A_40, KIF1A_39, KIF1A_38, KIF1A_37, KIF1A_36, KIF1A_35, KIF1A_34, KIF1A_33, KIF1A_32, KIF1A_31, KIF1A_30, KIF1A_29, KIF1A_28, KIF1A_27, KIF1A_26, KIF1A_25, KIF1A_24, KIF1A_23, KIF1A_22, KIF1A_21, KIF1A_20, KIF1A_19, KIF1A_18, KIF1A_17, KIF1A_16@0@0@0@:aquaporin 12A:kinesin family member 1A@:transport;integral to membrane;transporter activity;membrane:phospholipid binding;microtubule motor activity;microtubule associated complex;anterograde axon cargo transport;ATP binding;cytoplasm;motor activity;protein binding;microtubule-based movement;cell death;nucleus;microtubule@: NEUROPATHY, HEREDITARY SENSORY, TYPE IIC; HSN2C; MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9; SPASTIC PARAPLEGIA 30, AUTOSOMAL RECESSIVE; SPG30
A2463_08@34945@34945@deletion@1@10091059@10091189@3@chr3:10091059-10091189@5.9@172@96@0.558@NA@FANCD2_17@0@0@0@:Fanconi anemia, complementation group D2@:nucleoplasm;synapsis;binding;response to DNA damage stimulus;gamete generation;DNA repair;condensed chromosome;protein binding;response to gamma radiation@: FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2
A2463_08@37525@37526@deletion@2@48612498@48612675@3@chr3:48612498-48612675@5.92@188@114@0.606@NA@COL7A1_75, COL7A1_74@0@0@0@:collagen, type VII, alpha 1@:extracellular matrix;extracellular matrix organization;endoplasmic reticulum lumen;serine-type endopeptidase inhibitor activity;protein binding;extracellular region;cell adhesion;basement membrane;collagen type VII;epidermis development@: NAIL DISORDER, NONSYNDROMIC CONGENITAL, 8; NDNC8; EPIDERMOLYSIS BULLOSA DYSTROPHICA, PRETIBIAL; EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL DOMINANT; DDEB; EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE; RDEB; EPIDERMOLYSIS BULLOSA WITH CONGENITAL LOCALIZED ABSENCE OF SKIN AND; EPIDERMOLYSIS BULLOSA PRURIGINOSA; TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN; TBDN
A2463_08@37549@37550@deletion@2@48618694@48618916@3@chr3:48618694-48618916@4.98@154@93@0.604@NA@COL7A1_51, COL7A1_50@0@0@0@:collagen, type VII, alpha 1@:extracellular matrix;extracellular matrix organization;endoplasmic reticulum lumen;serine-type endopeptidase inhibitor activity;protein binding;extracellular region;cell adhesion;basement membrane;collagen type VII;epidermis development@: NAIL DISORDER, NONSYNDROMIC CONGENITAL, 8; NDNC8; EPIDERMOLYSIS BULLOSA DYSTROPHICA, PRETIBIAL; EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL DOMINANT; DDEB; EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE; RDEB; EPIDERMOLYSIS BULLOSA WITH CONGENITAL LOCALIZED ABSENCE OF SKIN AND; EPIDERMOLYSIS BULLOSA PRURIGINOSA; TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN; TBDN
A2463_08@39892@39894@duplication@3@75786030@75790887@3@chr3:75786030-75790887@13.2@214@358@1.67@CNVR1432.5, CNVR1432.9, CNVR1432.4@ZNF717_5, ZNF717_4, ZNF717_3@0@0@0@:zinc finger protein 717;zinc finger protein 717-like@:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_08@45437@45438@duplication@2@195474048@195475935@3@chr3:195474048-195475935@9.32@257@393@1.53@CNVR1703.1, CNVR1703.2, CNVR1703.5, CNVR1703.4@MUC4_25, MUC4_24@0@0@0@:mucin 4, cell surface associated@:ErbB-2 class receptor binding;Golgi lumen;cell-matrix adhesion;post-translational protein modification;extracellular matrix structural constituent;protein binding;O-glycan processing;cellular protein metabolic process;proteinaceous extracellular matrix;integral to plasma membrane;membrane;extracellular matrix constituent, lubricant activity;biological_process@NA
A2463_08@46667@46676@deletion@10@9174900@9247197@4@chr4:9174900-9247197@23.9@169@40@0.237@NA@FAM90A26P_4, FAM90A26P_5, FAM90A26P_6, FAM90A26P_7, USP17L13_1, USP17L10_1, USP17L11_1, USP17L12_1, USP17L13_2, USP17L15_1, USP17L17_1@0@0@0@:ubiquitin specific peptidase 17-like family member 10:ubiquitin specific peptidase 17-like family member 13:ubiquitin specific peptidase 17-like family member 11:ubiquitin specific peptidase 17-like family member 12:ubiquitin specific peptidase 17-like family member 15:ubiquitin specific peptidase 17-like family member 17@:zinc ion binding;nucleic acid binding:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
A2463_08@53189@53195@deletion@7@190947540@191003541@4@chr4:190947540-191003541@8.97@99@38@0.384@CNVR2258.3@FRG2_3, FRG2_2, FRG2_1, DUX4L7_1, DUX4L6_1, DUX4L5_1, DUX4L4_1@0@0@0@:FSHD region gene 2-like;FSHD region gene 2:double homeobox protein 4-like;double homeobox 4 like 6;double homeobox 4 like 7;double homeobox 4 like 2;double homeobox 4 like 3;double homeobox 4;double homeobox 4 like 5;double homeobox 2:double homeobox protein 4-like;double homeobox 4 like 6;double homeobox 4 like 7;double homeobox 4 like 2;double homeobox 4 like 3;double homeobox 4;double homeobox 4 like 5;double homeobox 2:double homeobox protein 4-like;double homeobox 4 like 6;double homeobox 4 like 7;double homeobox 4 like 2;double homeobox 4 like 3;double homeobox 4;double homeobox 4 like 5;double homeobox 2:double homeobox 4 like 4@:nucleus:transcription regulatory region sequence-specific DNA binding;sequence-specific DNA binding;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;sequence-specific DNA binding transcription factor activity:transcription regulatory region sequence-specific DNA binding;sequence-specific DNA binding;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;sequence-specific DNA binding transcription factor activity:transcription regulatory region sequence-specific DNA binding;sequence-specific DNA binding;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;sequence-specific DNA binding transcription factor activity:transcription regulatory region sequence-specific DNA binding;sequence-specific DNA binding;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;sequence-specific DNA binding transcription factor activity@NA
A2463_08@53306@53310@deletion@5@741710@755214@5@chr5:741710-755214@16.1@200@91@0.455@CNVR2280.3@ZDHHC11B_7, ZDHHC11B_6, ZDHHC11B_5, ZDHHC11B_4, ZDHHC11B_3@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
A2463_08@53313@53320@duplication@8@801223@840765@5@chr5:801223-840765@24.1@616@933@1.51@CNVR2280.3@ZDHHC11_12, ZDHHC11_11, ZDHHC11_10, ZDHHC11_9, ZDHHC11_8, ZDHHC11_7, ZDHHC11_6, ZDHHC11_5@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
A2463_08@54849@54849@duplication@1@42629141@42629205@5@chr5:42629141-42629205@5.08@121@190@1.57@CNVR2445.1@GHR_3@0@0@0@:growth hormone receptor@:neuronal cell body;mitochondrion;proline-rich region binding;JAK-STAT cascade;growth factor binding;nucleus;succinate metabolic process;positive regulation of JAK-STAT cascade;JAK-STAT cascade involved in growth hormone signaling pathway;response to morphine;activation of MAPK activity;peptide hormone binding;response to estradiol stimulus;2-oxoglutarate metabolic process;valine metabolic process;response to cytokine stimulus;hormone-mediated signaling pathway;response to food;SH2 domain binding;oxaloacetate metabolic process;growth hormone receptor signaling pathway;allantoin metabolic process;integral to membrane;response to hormone stimulus;cartilage development involved in endochondral bone morphogenesis;positive regulation of peptidyl-tyrosine phosphorylation;receptor internalization;cytoplasm;cellular response to hormone stimulus;extracellular region;growth hormone receptor complex;positive regulation of tyrosine phosphorylation of Stat5 protein;regulation of multicellular organism growth;growth hormone receptor activity;positive regulation of tyrosine phosphorylation of Stat3 protein;response to peptide hormone stimulus;fatty acid metabolic process;creatinine metabolic process;plasma membrane;positive regulation of multicellular organism growth;receptor complex;protein phosphatase binding;protein kinase binding;creatine metabolic process;response to interleukin-1;response to cycloheximide;extracellular space;positive regulation of cell differentiation;activation of Janus kinase activity;taurine metabolic process;cellular response to insulin stimulus;integral to plasma membrane;protein homodimerization activity;negative regulation of neuron death;citrate metabolic process;endocytosis;isoleucine metabolic process;activation of JAK2 kinase activity;extrinsic to membrane;response to glucocorticoid stimulus;protein binding;insulin-like growth factor receptor signaling pathway;multicellular organismal metabolic process;cell surface@: HYPERCHOLESTEROLEMIA, FAMILIAL; LARON SYNDROME; SHORT STATURE, IDIOPATHIC, AUTOSOMAL
A2463_08@59488@59488@deletion@1@147553798@147553933@5@chr5:147553798-147553933@5.87@26@0@0@CNVR2637.2, CNVR2637.1@SPINK14_3@0@0@0@:serine peptidase inhibitor, Kazal type 14 (putative)@:serine-type endopeptidase inhibitor activity;protein binding;extracellular region@NA
A2463_08@60884@60885@deletion@2@175517374@175520277@5@chr5:175517374-175520277@11.8@84@18@0.214@NA@FAM153B_3, FAM153B_4@0@0@0@:uncharacterized LOC100507387;family with sequence similarity 153, member B@NA@NA
A2463_08@63730@63730@duplication@1@31963497@31963571@6@chr6:31963497-31963571@7.14@116@203@1.75@CNVR2843.6, CNVR2843.3@C4A_25@0@0@0@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
A2463_08@63734@63735@deletion@2@31964607@31965088@6@chr6:31964607-31965088@4.97@24@1@0.0417@CNVR2843.6, CNVR2843.3@C4A_29, C4A_30@0@0@0@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
A2463_08@63769@63773@deletion@5@31995014@31996309@6@chr6:31995014-31996309@21.5@131@20@0.153@CNVR2843.6, CNVR2843.5@C4B_21, C4B_22, C4B_23, C4B_24, C4B_25@0@0@0@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
A2463_08@63953@63957@deletion@5@32485517@32489951@6@chr6:32485517-32489951@27.6@204@50@0.245@CNVR2845.21, CNVR2845.25, CNVR2845.30@HLA-DRB5_6, HLA-DRB5_5, HLA-DRB5_4, HLA-DRB5_3, HLA-DRB5_2@0@0@0@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
A2463_08@63962@63962@deletion@1@32549335@32549615@6@chr6:32549335-32549615@5.15@205@123@0.6@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.5, CNVR2845.11, CNVR2845.54@HLA-DRB1_3@0@0@0@:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1@:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
A2463_08@63966@63969@duplication@4@32609088@32628026@6@chr6:32609088-32628026@21.3@616@978@1.59@CNVR2845.21, CNVR2845.25, CNVR2845.27, CNVR2845.22, CNVR2845.39, CNVR2845.20@HLA-DQA1_2, HLA-DQA1_3, HLA-DQA1_4, HLA-DQB1_6@0@0@0@:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@NA
A2463_08@70816@70817@duplication@2@161054786@161056336@6@chr6:161054786-161056336@17.1@204@411@2.01@CNVR3133.1@LPA_9, LPA_8@0@0@0@:lipoprotein, Lp(a)@:blood circulation;endopeptidase inhibitor activity;catalytic activity;lipoprotein metabolic process;proteolysis;heparin binding;receptor-mediated endocytosis;fibronectin binding;small molecule metabolic process;apolipoprotein binding;lipid metabolic process;negative regulation of endopeptidase activity;extracellular region;plasma lipoprotein particle;lipid transport;serine-type endopeptidase activity@: APOLIPOPROTEIN(a); LPA
A2463_08@71028@71028@deletion@1@167787840@167787939@6@chr6:167787840-167787939@9@53@7@0.132@NA@TCP10_7@0@0@0@:t-complex 10@:cytosol@NA
A2463_08@71753@71763@deletion@11@5958499@5978460@7@chr7:5958499-5978460@16.1@583@378@0.648@NA@CCZ1_11, CCZ1_12, CCZ1_13, CCZ1_14, CCZ1_15, RSPH10B_20, RSPH10B_19, RSPH10B_18, RSPH10B_17, RSPH10B_16, RSPH10B_15@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae):radial spoke head 10 homolog B (Chlamydomonas)@:lysosomal membrane@NA
A2463_08@71771@71772@deletion@2@5997539@5998709@7@chr7:5997539-5998709@6.3@39@7@0.179@NA@RSPH10B_7, RSPH10B_6@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
A2463_08@71933@71934@duplication@2@6820441@6821107@7@chr7:6820441-6821107@5.02@168@243@1.45@NA@RSPH10B2_13, RSPH10B2_14@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
A2463_08@71939@71944@duplication@6@6836200@6844686@7@chr7:6836200-6844686@22@230@435@1.89@NA@RSPH10B2_19, RSPH10B2_20, CCZ1B_15, CCZ1B_14, CCZ1B_13, CCZ1B_12@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
A2463_08@74566@74582@deletion@17@74159098@74193503@7@chr7:74159098-74193503@19.4@746@467@0.626@NA@GTF2I_21, GTF2I_22, GTF2I_23, GTF2I_24, GTF2I_25, GTF2I_26, GTF2I_27, GTF2I_28, GTF2I_29, GTF2I_30, GTF2I_31, GTF2I_32, GTF2I_33, GTF2I_34, NCF1_1, NCF1_2, NCF1_3@0@0@0@:general transcription factor IIi:neutrophil cytosolic factor 1@:neuronal cell body;transcription initiation from RNA polymerase II promoter;mitogen-activated protein kinase binding;negative regulation of angiogenesis;DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;cytoplasm;transcription from RNA polymerase II promoter;protein binding;signal transduction;nucleus;cell projection;reduction of cytosolic calcium ion concentration:inflammatory response;antigen processing and presentation of peptide antigen via MHC class I;phagosome maturation;NADPH oxidase complex;neutrophil mediated killing of gram-positive bacterium;cell communication;interaction with host;leukotriene metabolic process;response to yeast;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;respiratory burst;GTPase activity;negative regulation of smooth muscle contraction;GTP catabolic process;cytosol;defense response to fungus;defense response to bacterium;antigen processing and presentation of exogenous peptide antigen via MHC class I;leukocyte mediated cytotoxicity;neutrophil mediated killing of fungus;phosphatidylinositol binding;defense response to Gram-positive bacterium;GTP binding;respiratory burst involved in defense response;superoxide-generating NADPH oxidase activity;hydrogen peroxide biosynthetic process;protein targeting to membrane;electron carrier activity;superoxide metabolic process;innate immune response;phagolysosome;cytoplasm;cell proliferation;superoxide anion generation;protein binding;SH3 domain binding;cellular defense response;response to bacterium@: GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE,
A2463_08@74597@74598@deletion@2@74225431@74227349@7@chr7:74225431-74227349@8.07@44@5@0.114@NA@GTF2IRD2_10, GTF2IRD2_9@0@0@0@:GTF2I repeat domain containing 2@:nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_08@74781@74783@deletion@3@76121471@76129837@7@chr7:76121471-76129837@9.01@74@22@0.297@CNVR3462.1@DTX2_6, DTX2_7, DTX2_8@0@0@0@:deltex homolog 2 (Drosophila)@:ligase activity;cytoplasm;nuclear membrane;Notch signaling pathway;protein binding;nucleus;zinc ion binding;protein ubiquitination@NA
A2463_08@76726@76744@deletion@19@102133564@102196577@7@chr7:102133564-102196577@13.3@353@207@0.586@CNVR3518.1@RASA4B_16, RASA4B_15, RASA4B_14, RASA4B_13, RASA4B_12, RASA4B_11, RASA4B_10, RASA4B_9, RASA4B_8, RASA4B_7, RASA4B_6, RASA4B_5, RASA4B_4, RASA4B_3, RASA4B_2, RASA4B_1, SPDYE2_2, SPDYE2_3, SPDYE2_4@0@0@0@:RAS p21 protein activator 4B:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:speedy homolog E2 (Xenopus laevis)@:phospholipid binding;intracellular;GTPase activator activity;cytosol;signal transduction;protein binding;plasma membrane;regulation of small GTPase mediated signal transduction;metal ion binding;intracellular signal transduction:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
A2463_08@76792@76793@deletion@2@102309363@102312048@7@chr7:102309363-102312048@17.5@84@2@0.0238@CNVR3518.1@POLR2J2_2, POLR2J2_2, POLR2J2_1, POLR2J2_1@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
A2463_08@79309@79311@deletion@3@143880598@143929936@7@chr7:143880598-143929936@59.4@693@255@0.368@CNVR3598.4, CNVR3598.3, CNVR3598.7@CTAGE4_1, ARHGEF35_2, OR2A42_1@0@0@0@:CTAGE family, member 4:Rho guanine nucleotide exchange factor (GEF) 35:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1@:integral to membrane;nucleotide binding;cellular_component;biological_process:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_08@79313@79313@deletion@1@143964011@143966343@7@chr7:143964011-143966343@12.4@273@127@0.465@CNVR3598.4@CTAGE8_1@0@0@0@:Rho guanine nucleotide exchange factor (GEF) 35:CTAGE family, member 6, pseudogene;CTAGE family, member 15, pseudogene@:integral to membrane@NA
A2463_08@79315@79315@deletion@1@144059764@144062916@7@chr7:144059764-144062916@59.1@843@149@0.177@CNVR3598.4, CNVR3598.5@ARHGEF5_2@0@0@0@:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
A2463_08@80141@80142@deletion@2@116087@142298@8@chr8:116087-142298@6.11@96@47@0.49@CNVR3684.8, CNVR3684.5@OR4F21_1, RP11-585F1.10_2@0@0@0@:olfactory receptor, family 4, subfamily F, member 21:F-box only protein 25-like;putative uncharacterized protein C20orf69-like@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_08@80367@80379@deletion@13@7272484@7345699@8@chr8:7272484-7345699@10.5@524@358@0.683@CNVR3771.8, CNVR3771.10, CNVR3771.4@DEFB4B_2, DEFB4B_1, DEFB103B_2, DEFB103B_1, SPAG11B_3, SPAG11B_2, SPAG11B_1, DEFB104B_2, DEFB104B_1, DEFB106B_2, DEFB106B_1, DEFB105B_1, DEFB105B_2@0@0@0@:defensin, beta 4B;defensin, beta 4A:defensin, beta 103B;defensin, beta 103A:sperm associated antigen 11B:defensin, beta 104A;defensin, beta 104B:defensin, beta 106B;defensin, beta 106A:defensin, beta 105B;defensin, beta 105A@:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response:extracellular region;defense response to bacterium;Golgi lumen;positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria;defense response;innate immune response:spermatogenesis;defense response to bacterium;extracellular region;molecular_function;defense response:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium@NA
A2463_08@80564@80568@deletion@5@11970084@12044126@8@chr8:11970084-12044126@60.7@1766@693@0.392@CNVR3785.8, CNVR3785.5, CNVR3785.2, CNVR3785.3@ZNF705D_6, USP17L2_1, FAM86B1_8, FAM86B1_7, FAM86B1_6@0@0@0@:zinc finger protein 705D:ubiquitin specific peptidase 17-like family member 1, pseudogene;ubiquitin specific peptidase 17-like family member 2;ubiquitin specific peptidase 17-like family member 4;ubiquitin specific peptidase 17-like family member 7;ubiquitin specific peptidase 17-like family member 8;ubiquitin specific peptidase 17-like family member 3:family with sequence similarity 86, member B2;family with sequence similarity 86, member B1@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:protein deubiquitination;ubiquitin-specific protease activity;mitotic cell cycle G1/S transition checkpoint;nucleus;G2/M transition checkpoint;apoptotic process;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
A2463_08@80577@80578@duplication@2@12285167@12286407@8@chr8:12285167-12286407@7.94@88@162@1.84@CNVR3786.4, CNVR3786.16@FAM86B2_7, FAM86B2_6@0@0@0@:family with sequence similarity 86, member B2@NA@NA
A2463_08@83673@83673@duplication@1@86573700@86575726@8@chr8:86573700-86575726@10.8@385@627@1.63@CNVR3955.1@REXO1L1_1@0@0@0@:exonuclease GOR-like;REX1, RNA exonuclease 1 homolog (S. cerevisiae)-like 1@:intracellular;nucleus;exonuclease activity;nucleic acid binding;cytoplasm@NA
A2463_08@88534@88534@duplication@1@41306194@41306209@9@chr9:41306194-41306209@8.89@58@139@2.4@CNVR4278.2@FAM74A2_2@0@0@0@@:integral to membrane@NA
A2463_08@88623@88623@duplication@1@46386623@46387002@9@chr9:46386623-46387002@6.11@36@86@2.39@CNVR4307.4, CNVR4307.2, CNVR4307.3@FAM27E1_1@0@0@0@:family with sequence similarity 27, member E3@NA@NA
A2463_08@88631@88633@duplication@3@65503517@65508193@9@chr9:65503517-65508193@10.9@283@436@1.54@CNVR4312.5@SPATA31A7_4, SPATA31A7_3, SPATA31A7_2@0@0@0@:SPATA31 subfamily A, member 7@:integral to membrane@NA
A2463_08@88639@88641@deletion@3@67926874@67930837@9@chr9:67926874-67930837@13.4@64@2@0.0312@NA@ANKRD20A1_1, ANKRD20A1_2, ANKRD20A1_3@0@0@0@:ankyrin repeat domain 20 family, member A1@:protein binding;plasma membrane@NA
A2463_08@95346@95377@deletion@32@17813309@17951363@10@chr10:17813309-17951363@40.7@435@176@0.405@NA@TMEM236_2, TMEM236_3, TMEM236_4, MRC1L1_1, MRC1L1_2, MRC1L1_3, MRC1L1_4, MRC1L1_5, MRC1L1_6, MRC1L1_7, MRC1L1_8, MRC1L1_9, MRC1L1_10, MRC1L1_11, MRC1L1_12, MRC1L1_13, MRC1L1_14, MRC1L1_15, MRC1L1_16, MRC1L1_17, MRC1L1_18, MRC1L1_19, MRC1L1_20, MRC1L1_21, MRC1L1_22, MRC1L1_23, MRC1L1_24, MRC1L1_25, MRC1L1_26, MRC1L1_27, MRC1L1_28, MRC1L1_29@0@0@0@:transmembrane protein 236;transmembrane protein 236-like:macrophage mannose receptor 1-like@:integral to membrane:carbohydrate binding@NA
A2463_08@95380@95393@duplication@14@18060293@18152611@10@chr10:18060293-18152611@20.8@195@369@1.89@NA@TMEM236_2, TMEM236_3, TMEM236_4, MRC1_1, MRC1_2, MRC1_3, MRC1_4, MRC1_5, MRC1_6, MRC1_7, MRC1_8, MRC1_9, MRC1_10, MRC1_11@0@0@0@:transmembrane protein 236;transmembrane protein 236-like:mannose receptor, C type 1;macrophage mannose receptor 1-like@:integral to membrane:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
A2463_08@96529@96534@deletion@6@47756640@47769665@10@chr10:47756640-47769665@7.09@190@114@0.6@CNVR4714.1@ANXA8L2_8, ANXA8L2_9, ANXA8L2_10, ANXA8L2_11, ANXA8L2_12, AL603965.1_2@0@0@0@:annexin A8-like 2:uncharacterized LOC101060462;uncharacterized LOC100996760@:calcium-dependent phospholipid binding;calcium ion binding@NA
A2463_08@96550@96550@deletion@1@47919943@47920043@10@chr10:47919943-47920043@6.29@30@1@0.0333@CNVR4715.2@FAM21B_16@0@0@0@:family with sequence similarity 21, member B@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_08@96631@96635@deletion@5@49376639@49383982@10@chr10:49376639-49383982@11.5@129@54@0.419@CNVR4717.2@FRMPD2_27, FRMPD2_26, FRMPD2_25, FRMPD2_24, FRMPD2_23@0@0@0@:FERM and PDZ domain containing 2@:basolateral plasma membrane;transferase activity, transferring phosphorus-containing groups;cytoplasm;tight junction;protein binding;cytoskeleton;1-phosphatidylinositol binding;tight junction assembly@NA
A2463_08@96860@96860@deletion@1@51472553@51472652@10@chr10:51472553-51472652@8.25@38@0@0@CNVR4729.1@AGAP7_4@0@0@0@:translocase of inner mitochondrial membrane 23 homolog B (yeast):ArfGAP with GTPase domain, ankyrin repeat and PH domain 7@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity@NA
A2463_08@96906@96907@deletion@2@51854909@51855538@10@chr10:51854909-51855538@8.32@87@35@0.402@NA@FAM21A_14, FAM21A_15@0@0@0@:family with sequence similarity 21, member B;family with sequence similarity 21, member A@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_08@96920@96939@deletion@20@51887344@51994312@10@chr10:51887344-51994312@28.4@474@242@0.511@NA@FAM21A_28, FAM21A_29, FAM21A_30, FAM21A_31, ASAH2_20, ASAH2_19, ASAH2_18, ASAH2_17, ASAH2_16, ASAH2_15, ASAH2_14, ASAH2_13, ASAH2_12, ASAH2_11, ASAH2_10, ASAH2_9, ASAH2_8, ASAH2_7, ASAH2_6, ASAH2_5@0@0@0@:family with sequence similarity 21, member B;family with sequence similarity 21, member A:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
A2463_08@98344@98350@deletion@7@81463367@81472241@10@chr10:81463367-81472241@56.7@665@204@0.307@CNVR4815.2, CNVR4815.4@FAM22B_1, FAM22B_2, FAM22B_3, FAM22B_4, FAM22B_5, FAM22B_6, FAM22B_7@0@0@0@NA@NA@NA
A2463_08@98355@98356@deletion@2@81608270@81609243@10@chr10:81608270-81609243@5.52@30@4@0.133@NA@FAM22E_5, FAM22E_6@0@0@0@NA@NA@NA
A2463_08@98595@98595@duplication@1@88985589@88985969@10@chr10:88985589-88985969@15.6@14@135@9.64@CNVR4840.3, CNVR4840.5@FAM22A_1@0@0@0@:family with sequence similarity 22, member A@NA@NA
A2463_08@98602@98602@deletion@1@89118024@89118188@10@chr10:89118024-89118188@13.7@344@162@0.471@CNVR4840.3@FAM22D_1@0@0@0@:family with sequence similarity 22, member D@NA@NA
A2463_08@103269@103269@duplication@1@4976003@4976943@11@chr11:4976003-4976943@7.5@356@535@1.5@CNVR5040.1@OR51A2_1@0@0@0@:matrix metallopeptidase 26:olfactory receptor, family 51, subfamily A, member 2@:metallopeptidase activity;extracellular matrix;proteolysis;proteinaceous extracellular matrix;collagen catabolic process;metalloendopeptidase activity;zinc ion binding;metabolic process:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_08@103289@103290@deletion@2@5270599@5271034@11@chr11:5270599-5271034@11.1@88@22@0.25@NA@HBG1_2, HBG1_1@0@0@0@:hemoglobin, gamma A@:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex@NA
A2463_08@103342@103342@duplication@1@5798891@5799864@11@chr11:5798891-5799864@9.48@222@375@1.69@CNVR5049.1@OR52N5_1@0@0@0@:tripartite motif containing 5:olfactory receptor, family 52, subfamily N, member 5@:defense response to virus;Golgi apparatus;intracellular;protein trimerization;ligase activity;cytoplasm;protein binding;nucleus;protein homodimerization activity;identical protein binding;zinc ion binding;cytoplasmic mRNA processing body;protein ubiquitination;virus-host interaction:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_08@110109@110111@deletion@3@89531299@89534156@11@chr11:89531299-89534156@9.3@283@158@0.558@NA@TRIM49_8, TRIM49_7, TRIM49_6@0@0@0@:tripartite motif containing 49@:protein binding;intracellular;DNA binding;zinc ion binding@NA
A2463_08@110126@110126@duplication@1@89774220@89774718@11@chr11:89774220-89774718@5.05@211@309@1.46@NA@TRIM49C_8@0@0@0@:tripartite motif containing 49D, pseudogene;tripartite motif containing 49-like 1;tripartite motif containing 49C;tripartite motif-containing protein 49-like protein 1-like@:protein binding;intracellular;DNA binding;zinc ion binding@NA
A2463_08@114080@114080@deletion@1@7945547@7945808@12@chr12:7945547-7945808@5.51@87@41@0.471@NA@NANOG_2@0@0@0@:NECAP endocytosis associated 1:Nanog homeobox@:coated pit;protein binding;endocytosis;protein transport;clathrin vesicle coat;plasma membrane;membrane:cell differentiation;regulation of cell differentiation;somatic stem cell maintenance;sequence-specific DNA binding;transcription corepressor activity;embryo development;DNA binding;sequence-specific DNA binding transcription factor activity;nucleus;positive regulation of transcription from RNA polymerase II promoter;regulation of gene expression;regulation of transcription, DNA-dependent;cell proliferation;endodermal cell fate specification;nucleolus;transcription, DNA-dependent@NA
A2463_08@114095@114095@deletion@1@8051132@8051499@12@chr12:8051132-8051499@4.62@79@39@0.494@CNVR5421.1@NANOGP1_4@0@0@0@:NECAP endocytosis associated 1@:coated pit;protein binding;endocytosis;protein transport;clathrin vesicle coat;plasma membrane;membrane:sequence-specific DNA binding;nucleus;DNA binding;regulation of transcription, DNA-dependent;sequence-specific DNA binding transcription factor activity@NA
A2463_08@114136@114138@deletion@3@8374419@8376811@12@chr12:8374419-8376811@21.5@1539@926@0.602@CNVR5422.3, CNVR5422.5, CNVR5422.6, CNVR5422.1@FAM90A1_7, FAM90A1_6, FAM90A1_5@0@0@0@:family with sequence similarity 90, member A1@:zinc ion binding;nucleic acid binding@NA
A2463_08@114483@114483@duplication@1@11243900@11244828@12@chr12:11243900-11244828@14.4@311@579@1.86@CNVR5434.1@TAS2R43_1@0@0@0@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):taste receptor, type 2, member 14:taste receptor, type 2, member 43@:extracellular space;visual perception:bitter taste receptor activity;taste receptor activity;integral to membrane;sensory perception of taste;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of bitter taste:G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;motile cilium;taste receptor activity;bitter taste receptor activity;integral to membrane;sensory perception of taste;detection of chemical stimulus involved in sensory perception of bitter taste;cilium membrane@NA
A2463_08@117171@117172@deletion@2@52865851@52867521@12@chr12:52865851-52867521@27@383@154@0.402@NA@KRT6C_2, KRT6C_1@0@0@0@:keratin 6C@:intermediate filament;structural molecule activity;keratin filament;cytoskeleton organization@NA
A2463_08@127333@127336@deletion@4@19553418@19562100@14@chr14:19553418-19562100@43.8@722@343@0.475@CNVR6072.1@POTEG_1, POTEG_2, POTEG_3, POTEG_4@0@0@0@:POTE ankyrin domain family, member G@:protein binding@NA
A2463_08@127339@127341@deletion@3@19571349@19574352@14@chr14:19571349-19574352@14.7@273@140@0.513@CNVR6072.1@POTEG_7, POTEG_8, POTEG_9@0@0@0@:POTE ankyrin domain family, member G@:protein binding@NA
A2463_08@127347@127352@deletion@6@20007563@20020220@14@chr14:20007563-20020220@23@354@164@0.463@CNVR6072.6, CNVR6072.12@POTEM_6, POTEM_5, POTEM_4, POTEM_3, POTEM_2, POTEM_1@0@0@0@:POTE ankyrin domain family, member M@:protein binding@NA
A2463_08@131032@131034@duplication@3@74004127@74010359@14@chr14:74004127-74010359@13@423@630@1.49@CNVR6188.1, CNVR6188.4@ACOT1_1, ACOT1_2, ACOT1_3@0@0@0@:HEAT repeat containing 4:acyl-CoA thioesterase 1@:protein binding;binding:hydrolase activity;mitochondrion;acyl-CoA metabolic process;very long-chain fatty acid metabolic process;thiolester hydrolase activity;acyl-CoA hydrolase activity;cytosol;palmitoyl-CoA hydrolase activity;long-chain fatty acid metabolic process;carboxylesterase activity@NA
A2463_08@133399@133399@deletion@1@106359401@106359419@14@chr14:106359401-106359419@5.58@33@5@0.152@CNVR6294.11, CNVR6294.27, CNVR6294.52, CNVR6294.39, CNVR6294.36, CNVR6294.48, CNVR6294.55@IGHD5-18_1@0@0@0@NA@NA@NA
A2463_08@133426@133426@deletion@1@106478111@106478411@14@chr14:106478111-106478411@8.67@78@24@0.308@CNVR6294.36, CNVR6294.48, CNVR6294.12, CNVR6294.24@IGHV4-4_2@0@0@0@@:protein binding@NA
A2463_08@133432@133435@duplication@4@106539080@106552729@14@chr14:106539080-106552729@21.9@150@338@2.25@CNVR6294.36, CNVR6294.48, CNVR6294.24, CNVR6294.10, CNVR6294.34@IGHV1-8_2, IGHV1-8_1, IGHV3-9_2, IGHV3-9_1@0@0@0@@:protein binding:protein binding@NA
A2463_08@133462@133463@deletion@2@106815723@106816173@14@chr14:106815723-106816173@5.02@90@46@0.511@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.56, CNVR6294.51@IGHV3-33_2, IGHV3-33_1@0@0@0@@:protein binding@NA
A2463_08@133552@133552@deletion@1@22742397@22743598@15@chr15:22742397-22743598@26.6@913@373@0.409@CNVR6298.5@GOLGA6L1_8@0@0@0@:golgin A6 family-like 1;putative transmembrane protein FLJ36131-like;putative transmembrane protein ENSP00000320207-like;putative golgin subfamily A member 6-like@NA@NA
A2463_08@133636@133642@deletion@7@23406272@23412276@15@chr15:23406272-23412276@19.9@630@355@0.563@CNVR6300.8@RP11-467N20.5_8, RP11-467N20.5_7, RP11-467N20.5_6, RP11-467N20.5_5, RP11-467N20.5_4, RP11-467N20.5_3, RP11-467N20.5_2@0@0@0@:putative golgin subfamily A member 6-like protein 6-like@NA@NA
A2463_08@133662@133662@deletion@1@23610107@23610281@15@chr15:23610107-23610281@5.35@89@43@0.483@NA@GOLGA8S_19@0@0@0@@:Golgi apparatus@NA
A2463_08@133869@133873@deletion@5@28629294@28630863@15@chr15:28629294-28630863@14.3@139@51@0.367@CNVR6329.4@GOLGA8F_9, GOLGA8F_10, GOLGA8F_11, GOLGA8F_12, GOLGA8F_13@0@0@0@@:Golgi apparatus@NA
A2463_08@134015@134015@deletion@1@30675523@30675554@15@chr15:30675523-30675554@4.51@41@14@0.341@CNVR6337.1, CNVR6337.3@CHRFAM7A_3@0@0@0@:CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:transport;integral to membrane;ion transport;postsynaptic membrane;membrane;extracellular ligand-gated ion channel activity@NA
A2463_08@134036@134039@deletion@4@30845996@30848215@15@chr15:30845996-30848215@12@82@19@0.232@NA@GOLGA8Q_2, GOLGA8Q_3, GOLGA8Q_4, GOLGA8Q_5@0@0@0@@:Golgi apparatus@NA
A2463_08@134044@134054@deletion@11@30850148@30896376@15@chr15:30850148-30896376@27.8@164@25@0.152@CNVR6339.2, CNVR6339.3, CNVR6339.1@GOLGA8Q_10, GOLGA8Q_11, GOLGA8Q_12, GOLGA8Q_13, GOLGA8Q_14, GOLGA8Q_15, GOLGA8Q_16, GOLGA8Q_17, GOLGA8Q_18, GOLGA8Q_19, GOLGA8H_1@0@0@0@:golgin A8 family, member H@:Golgi apparatus:Golgi apparatus@NA
A2463_08@134158@134161@duplication@4@32684984@32685771@15@chr15:32684984-32685771@7.91@169@258@1.53@NA@GOLGA8K_19, GOLGA8K_18, GOLGA8K_17, GOLGA8K_16@0@0@0@:golgin A8 family, member J@:Golgi apparatus@NA
A2463_08@134173@134177@duplication@5@32692342@32695395@15@chr15:32692342-32695395@6.54@113@180@1.59@NA@GOLGA8K_4, GOLGA8K_3, GOLGA8K_2, AC139426.2_1, GOLGA8K_1@0@0@0@:golgin A8 family, member J@:Golgi apparatus@NA
A2463_08@134180@134181@deletion@2@32737820@32738099@15@chr15:32737820-32738099@5.01@22@0@0@CNVR6346.1@GOLGA8O_17, GOLGA8O_16@0@0@0@:golgin A8 family, member O@:Golgi apparatus@NA
A2463_08@134189@134191@deletion@3@32743115@32743539@15@chr15:32743115-32743539@12.3@66@7@0.106@CNVR6346.1@GOLGA8O_8, GOLGA8O_7, GOLGA8O_6@0@0@0@:golgin A8 family, member O@:Golgi apparatus@NA
A2463_08@135680@135680@deletion@1@43873201@43873321@15@chr15:43873201-43873321@5.28@145@81@0.559@CNVR6365.1@PPIP5K1_10@0@0@0@:diphosphoinositol pentakisphosphate kinase 1@:inositol hexakisphosphate 3-kinase activity;inositol hexakisphosphate 1-kinase activity;inositol metabolic process;diphosphoinositol-pentakisphosphate kinase activity;ATP binding;acid phosphatase activity;cytoplasm;cytosol;inositol hexakisphosphate 5-kinase activity;nucleus;kinase activity;inositol-1,3,4,5,6-pentakisphosphate kinase activity@NA
A2463_08@135714@135721@deletion@8@43903698@43906674@15@chr15:43903698-43906674@6.96@71@27@0.38@CNVR6365.1@STRC_12, STRC_11, STRC_10, STRC_9, STRC_8, STRC_7, STRC_6, STRC_5@0@0@0@:diphosphoinositol pentakisphosphate kinase 1:stereocilin@:inositol hexakisphosphate 3-kinase activity;inositol hexakisphosphate 1-kinase activity;inositol metabolic process;diphosphoinositol-pentakisphosphate kinase activity;ATP binding;acid phosphatase activity;cytoplasm;cytosol;inositol hexakisphosphate 5-kinase activity;nucleus;kinase activity;inositol-1,3,4,5,6-pentakisphosphate kinase activity:detection of mechanical stimulus involved in sensory perception of sound;stereocilium bundle tip;stereocilium;cell surface;kinocilium;auditory receptor cell stereocilium organization@: DEAFNESS, AUTOSOMAL RECESSIVE 16; DFNB16; DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY
A2463_08@138632@138635@deletion@4@75555690@75556424@15@chr15:75555690-75556424@14.7@147@53@0.361@CNVR6452.1@GOLGA6C_4, GOLGA6C_5, GOLGA6C_6, GOLGA6C_7@0@0@0@:golgin A6 family, member C@:Golgi apparatus@NA
A2463_08@139273@139274@deletion@2@82636944@82638127@15@chr15:82636944-82638127@5.9@33@4@0.121@CNVR6475.4, CNVR6475.2@GOLGA6L10_6, GOLGA6L10_5@0@0@0@:golgin A6 family-like 3;golgin A6 family-like 10@NA@NA
A2463_08@139305@139308@deletion@4@83013228@83015609@15@chr15:83013228-83015609@6.75@33@2@0.0606@CNVR6477.6, CNVR6477.2@RP13-996F3.4_6, RP13-996F3.4_5, RP13-996F3.4_4, RP13-996F3.4_3@0@0@0@NA@NA@NA
A2463_08@142690@142690@duplication@1@15045473@15045882@16@chr16:15045473-15045882@4.7@167@247@1.48@NA@NPIP_8@0@0@0@:nuclear pore complex-interacting protein-like;nuclear pore complex interacting protein;nuclear pore complex-interacting protein-like 1-like@:nuclear membrane;protein transport;nuclear pore;mRNA transport@NA
A2463_08@143481@143485@deletion@5@21763257@21771861@16@chr16:21763257-21771861@14.9@221@106@0.48@CNVR6668.5, CNVR6668.2, CNVR6668.7@OTOA_24, OTOA_25, OTOA_26, OTOA_27, OTOA_28@0@0@0@:otoancorin@:proteinaceous extracellular matrix;apical plasma membrane;sensory perception of sound;anchored to membrane@: DEAFNESS, AUTOSOMAL RECESSIVE 22; DFNB22
A2463_08@147101@147101@duplication@1@70010292@70010635@16@chr16:70010292-70010635@5.78@183@279@1.52@CNVR6762.3, CNVR6762.2@RP11-419C5.2_7@0@0@0@NA@NA@NA
A2463_08@147110@147124@deletion@15@70162688@70190782@16@chr16:70162688-70190782@40@1719@1078@0.627@CNVR6764.1, CNVR6764.3@PDPR_5, PDPR_6, PDPR_7, PDPR_8, PDPR_9, PDPR_10, PDPR_11, PDPR_12, PDPR_13, PDPR_14, PDPR_15, PDPR_16, PDPR_17, PDPR_18, PDPR_19@0@0@0@:pyruvate dehydrogenase phosphatase regulatory subunit@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix@NA
A2463_08@147496@147512@deletion@17@74411873@74447574@16@chr16:74411873-74447574@111@2449@1176@0.48@CNVR6778.2, CNVR6778.4@NPIPL2_1, NPIPL2_2, NPIPL2_3, NPIPL2_4, NPIPL2_5, NPIPL2_6, NPIPL2_7, CLEC18B_13, CLEC18B_12, CLEC18B_11, CLEC18B_10, CLEC18B_9, CLEC18B_8, CLEC18B_7, CLEC18B_6, CLEC18B_5, CLEC18B_4@0@0@0@:C-type lectin domain family 18, member B@:extracellular region:carbohydrate binding;protein binding;extracellular region@NA
A2463_08@151876@151886@deletion@11@18387190@18430117@17@chr17:18387190-18430117@25.2@516@285@0.552@NA@LGALS9C_2, LGALS9C_3, LGALS9C_4, LGALS9C_5, LGALS9C_6, LGALS9C_7, LGALS9C_8, LGALS9C_9, LGALS9C_10, LGALS9C_11, FAM106A_1@0@0@0@:lectin, galactoside-binding, soluble, 9C:protein FAM106B-like@:carbohydrate binding@NA
A2463_08@153363@153373@deletion@11@34493376@34500806@17@chr17:34493376-34500806@41.7@305@67@0.22@CNVR7077.1, CNVR7077.3, CNVR7077.11, CNVR7077.16@TBC1D3B_14, TBC1D3B_13, TBC1D3B_12, TBC1D3B_11, TBC1D3B_10, TBC1D3B_9, TBC1D3B_8, TBC1D3B_7, TBC1D3B_6, TBC1D3B_5, TBC1D3B_4@0@0@0@:TBC1 domain family, member 3B@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_08@153376@153381@duplication@6@34522686@34539971@17@chr17:34522686-34539971@20.9@47@206@4.38@CNVR7077.1, CNVR7077.3, CNVR7077.6@CCL3L3_3, CCL3L3_2, CCL3L3_1, CCL4L1_1, CCL4L1_2, CCL4L1_3@0@0@0@:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
A2463_08@153394@153394@duplication@1@34590384@34590454@17@chr17:34590384-34590454@7.5@30@88@2.93@CNVR7077.1, CNVR7077.13, CNVR7077.19, CNVR7077.10, CNVR7077.2@TBC1D3C_2@0@0@0@:TBC1 domain family, member 3C;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3H-like;TBC1 domain family, member 3H@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_08@153394@153401@deletion@7@34590384@34747002@17@chr17:34590384-34747002@23.3@216@100@0.463@CNVR7077.1, CNVR7077.2@TBC1D3C_2, CCL3L1_3, CCL3L1_2, CCL3L1_1, CCL4L2_1, CCL4L2_2, CCL4L2_3, TBC1D3H_14@0@0@0@:TBC1 domain family, member 3C;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3H-like;TBC1 domain family, member 3H:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1:TBC1 domain family, member 3;TBC1 domain family, member 3G;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like;TBC1 domain family, member 3H@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_08@153414@153414@duplication@1@34797487@34798054@17@chr17:34797487-34798054@12.5@97@230@2.37@CNVR7078.2, CNVR7078.3@TBC1D3G_14@0@0@0@:TBC1 domain family member 3H-like;TBC1 domain family, member 3H:TBC1 domain family, member 3;TBC1 domain family, member 3G;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like;TBC1 domain family, member 3H@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_08@154317@154317@duplication@1@39150054@39150349@17@chr17:39150054-39150349@5.3@90@151@1.68@NA@KRTAP3-3_1@0@0@0@:keratin associated protein 3-3@:structural molecule activity;keratin filament@NA
A2463_08@154317@154318@deletion@1@39150054@39156105@17@chr17:39150054-39156105@-6.37@160@180@1.12@NA@KRTAP3-3_1, KRTAP3-2_1@0@0@0@:keratin associated protein 3-3:keratin associated protein 3-2@:structural molecule activity;keratin filament:structural molecule activity;keratin filament@NA
A2463_08@154346@154346@deletion@1@39421631@39422112@17@chr17:39421631-39422112@9.55@68@15@0.221@CNVR7096.1@KRTAP9-6_1@0@0@0@:keratin associated protein 9-6@:keratin filament@NA
A2463_08@155581@155612@deletion@32@44248222@44632945@17@chr17:44248222-44632945@172@3412@1583@0.464@CNVR7114.2@KANSL1_2, LRRC37A_1, LRRC37A_2, LRRC37A_3, LRRC37A_4, LRRC37A_5, LRRC37A_6, LRRC37A_7, LRRC37A_8, LRRC37A_9, LRRC37A_10, LRRC37A_11, LRRC37A_12, LRRC37A_13, LRRC37A_14, ARL17B_4, ARL17B_3, ARL17B_2, LRRC37A2_2, LRRC37A2_3, LRRC37A2_4, LRRC37A2_5, LRRC37A2_6, LRRC37A2_7, LRRC37A2_8, LRRC37A2_9, LRRC37A2_10, LRRC37A2_11, LRRC37A2_12, LRRC37A2_13, LRRC37A2_14, LRRC37A2_15@0@0@0@:KAT8 regulatory NSL complex subunit 1:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:histone acetyltransferase activity (H4-K8 specific);histone acetyltransferase activity (H4-K16 specific);histone acetyltransferase activity (H4-K5 specific);histone acetyltransferase complex;histone H4-K5 acetylation;MLL1 complex;histone H4-K16 acetylation;protein binding;histone H4-K8 acetylation;nucleus:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
A2463_08@157441@157454@deletion@14@61949487@61973871@17@chr17:61949487-61973871@66.7@1292@631@0.488@NA@CSH2_5, CSH2_4, CSH2_3, CSH2_2, CSH2_1, GH2_4, GH2_3, GH2_2, GH2_1, CSH1_5, CSH1_4, CSH1_3, CSH1_2, CSH1_1@0@0@0@:chorionic somatomammotropin hormone 2:growth hormone 2:chorionic somatomammotropin hormone 1 (placental lactogen);chorionic somatomammotropin hormone-like 1@:JAK-STAT cascade involved in growth hormone signaling pathway;signal transduction;female pregnancy;hormone activity;extracellular region;metal ion binding:JAK-STAT cascade involved in growth hormone signaling pathway;hormone activity;extracellular region:JAK-STAT cascade involved in growth hormone signaling pathway;signal transduction;hormone activity;extracellular region;female pregnancy;metal ion binding@NA
A2463_08@162017@162018@deletion@2@44542732@44550298@18@chr18:44542732-44550298@75.4@422@13@0.0308@CNVR7319.1, CNVR7319.2@TCEB3CL2_1, TCEB3CL_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2:transcription elongation factor B polypeptide 3C-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_08@164950@164956@deletion@7@7030624@7056914@19@chr19:7030624-7056914@20.2@362@187@0.517@CNVR7517.1@MBD3L5_1, MBD3L5_2, MBD3L4_2, MBD3L4_1, MBD3L2_1, MBD3L2_2, MBD3L3_2@0@0@0@:methyl-CpG binding domain protein 3-like 5:methyl-CpG binding domain protein 3-like 4:methyl-CpG-binding domain protein 3-like 2-like;methyl-CpG binding domain protein 3-like 2:methyl-CpG binding domain protein 3-like 3@:regulation of transcription, DNA-dependent;transcription, DNA-dependent:regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_08@168952@168952@deletion@1@35862263@35863302@19@chr19:35862263-35863302@16.5@107@16@0.15@CNVR7627.1@GPR42_2@0@0@0@@:integral to membrane;G-protein coupled receptor activity;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
A2463_08@170096@170100@deletion@5@40373946@40382826@19@chr19:40373946-40382826@44.3@419@150@0.358@CNVR7639.2@FCGBP_26, FCGBP_25, FCGBP_24, FCGBP_23, FCGBP_22@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_08@170104@170112@duplication@9@40389653@40406060@19@chr19:40389653-40406060@15.1@707@994@1.41@CNVR7639.2, CNVR7639.3@FCGBP_18, FCGBP_17, FCGBP_16, FCGBP_15, FCGBP_14, FCGBP_13, FCGBP_12, FCGBP_11, FCGBP_10@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_08@172987@172987@deletion@1@52133087@52133469@19@chr19:52133087-52133469@8.51@44@3@0.0682@CNVR7702.1@SIGLEC5_2, SIGLEC5_2@0@0@0@:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 5@:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion@NA
A2463_08@173305@173308@deletion@4@54745453@54746600@19@chr19:54745453-54746600@7.05@395@270@0.684@CNVR7721.3, CNVR7721.6@LILRA6_4, LILRA6_3, LILRA6_2, LILRA6_1@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
A2463_08@173456@173457@duplication@2@55237520@55239376@19@chr19:55237520-55239376@6.72@17@64@3.76@NA@KIR3DL3_3, KIR3DL3_4@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:integral to membrane;plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane@NA
A2463_08@173470@173473@deletion@4@55281304@55286910@19@chr19:55281304-55286910@8.42@207@120@0.58@CNVR7725.2, CNVR7725.1, CNVR7725.7@KIR2DL1_1, KIR2DL1_2, KIR2DL1_3, KIR2DL1_4@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane@NA
A2463_08@173476@173477@deletion@2@55294939@55295265@19@chr19:55294939-55295265@7.97@77@28@0.364@CNVR7725.2, CNVR7725.1@KIR2DL1_7, KIR2DL1_8@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane@NA
A2463_08@173479@173502@duplication@24@55315347@55361964@19@chr19:55315347-55361964@31.8@1098@1562@1.42@CNVR7725.1, CNVR7725.6@KIR2DL4_2, KIR2DL4_3, KIR2DL4_4, KIR2DL4_5, KIR2DL4_6, KIR2DL4_7, KIR3DL1_1, KIR3DL1_2, KIR3DL1_3, KIR3DL1_4, KIR3DL1_5, KIR3DL1_6, KIR3DL1_7, KIR3DL1_8, KIR3DL1_9, KIR2DS4_1, KIR2DS4_2, KIR2DS4_3, KIR2DS4_4, KIR2DS4_5, KIR2DS4_6, KIR2DS4_7, KIR2DS4_8, KIR3DL2_1@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2-like@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane@NA
A2463_08@173844@173845@deletion@2@56283172@56284545@19@chr19:56283172-56284545@13.8@398@218@0.548@CNVR7734.1@CTD-2611O12.2_2, CTD-2611O12.2_3@0@0@0@:ret finger protein-like 4A-like@:protein binding;zinc ion binding@NA
A2463_08@175731@175732@deletion@2@25667028@25755948@20@chr20:25667028-25755948@15.4@186@68@0.366@NA@ZNF337_1, FAM182B_3@0@0@0@:zinc finger protein 337:family with sequence similarity 27, member B;family with sequence similarity 27, member A;family with sequence similarity 27, member C;family with sequence similarity 182, member B@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_08@175736@175737@duplication@2@26061801@26063616@20@chr20:26061801-26063616@18@175@363@2.07@CNVR7823.4, CNVR7823.3, CNVR7823.5, CNVR7823.1@FAM182A_4, FAM182A_5@0@0@0@NA@NA@NA
A2463_08@180979@180979@duplication@1@17264510@17265299@22@chr22:17264510-17265299@8.12@70@149@2.13@NA@XKR3_4@0@0@0@:XK, Kell blood group complex subunit-related family, member 3@:integral to membrane;plasma membrane@NA
A2463_08@181131@181133@deletion@3@18734088@18739404@22@chr22:18734088-18739404@6.53@42@9@0.214@CNVR8087.5, CNVR8087.2, CNVR8087.11@AC008132.1_6, AC008132.1_7, AC008132.1_8@0@0@0@NA@NA@NA
A2463_08@181417@181420@deletion@4@20366369@20367356@22@chr22:20366369-20367356@7.63@36@1@0.0278@CNVR8094.9, CNVR8094.4, CNVR8094.3@GGTLC3_5, GGTLC3_4, GGTLC3_3, GGTLC3_2@0@0@0@@:leukotriene biosynthetic process;glutathione metabolic process;gamma-glutamyltransferase activity;anchored to external side of plasma membrane@NA
A2463_08@181806@181807@deletion@2@23243157@23247205@22@chr22:23243157-23247205@11.9@188@87@0.463@CNVR8103.2, CNVR8103.1, CNVR8103.6, CNVR8103.11, CNVR8103.35@IGLC2_1, IGLJ3_1@0@0@0@@:protein binding@NA
A2463_08@181850@181850@deletion@1@23652512@23652620@22@chr22:23652512-23652620@10.2@60@8@0.133@CNVR8107.2, CNVR8107.3@BCR_18@0@0@0@:breakpoint cluster region@:phospholipid binding;protein autophosphorylation;protein tyrosine kinase activity;GTPase activator activity;neuromuscular process controlling balance;ATP binding;actin cytoskeleton organization;negative regulation of cell migration;plasma membrane;inner ear morphogenesis;positive regulation of Rac GTPase activity;positive regulation of phagocytosis;regulation of small GTPase mediated signal transduction;response to lipopolysaccharide;intracellular signal transduction;Rac GTPase activator activity;regulation of cell cycle;platelet-derived growth factor receptor signaling pathway;protein serine/threonine kinase activity;intracellular;small GTPase mediated signal transduction;regulation of Rho protein signal transduction;protein phosphorylation;negative regulation of inflammatory response;enzyme binding;Rho guanyl-nucleotide exchange factor activity;cytoplasm;cytosol;protein binding;signal transduction;brain development;kinase activity;negative regulation of neutrophil degranulation@: LEUKEMIA, CHRONIC MYELOID; CML
A2463_08@181951@181955@duplication@5@24376424@24384231@22@chr22:24376424-24384231@12.5@123@229@1.86@CNVR8114.13, CNVR8114.1, CNVR8114.7@GSTT1_5, GSTT1_4, GSTT1_3, GSTT1_2, GSTT1_1@0@0@0@:glutathione S-transferase theta 1@:glutathione peroxidase activity;response to drug;transferase activity;cytosol;protein binding;glutathione transferase activity;glutathione metabolic process;response to organic cyclic compound@NA
A2463_08@184153@184154@deletion@2@42536567@42537296@22@chr22:42536567-42537296@6.37@242@148@0.612@CNVR8168.1, CNVR8168.3, CNVR8168.4@CYP2D7P1_4, CYP2D7P1_3@0@0@0@@:oxidation-reduction process;electron carrier activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;monooxygenase activity;iron ion binding;heme binding@NA
A2463_08@9340@9352@deletion@13@104114226@104161730@1@chr1:104114226-104161730@23.8@2006@1360@0.678@CNVR266.8, CNVR266.3@AMY2B_3, AMY2B_4, AMY2B_5, AMY2B_6, AMY2B_7, AMY2B_8, AMY2B_9, AMY2B_10, AMY2B_11, AMY2B_12, AMY2A_1, AMY2A_2, AMY2A_3@0@0@0@:actin, gamma 1 pseudogene 4;amylase, alpha 2B (pancreatic):amylase, alpha 2A (pancreatic)@:extracellular region;cation binding;digestion;carbohydrate metabolic process;catalytic activity;alpha-amylase activity;metal ion binding:chloride ion binding;cation binding;small molecule metabolic process;carbohydrate metabolic process;catalytic activity;extracellular space;polysaccharide digestion;extracellular region;carbohydrate catabolic process;alpha-amylase activity;calcium ion binding@NA
A2463_08@10890@10893@duplication@4@145325953@145328432@1@chr1:145325953-145328432@5.82@52@101@1.94@CNVR341.2, CNVR341.3@NBPF10_30, NBPF10_31, NBPF10_32, NBPF10_33@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family, member 10@NA@NA
A2463_08@14051@14058@deletion@8@161518802@161600992@1@chr1:161518802-161600992@26.2@605@322@0.532@CNVR383.1@FCGR3A_2, FCGR3A_1, FCGR2C_1, FCGR3B_5, FCGR3B_4, FCGR3B_3, FCGR3B_2, FCGR3B_1@0@0@0@:Fc fragment of IgG, low affinity IIIa, receptor (CD16a):Fc fragment of IgG, low affinity IIb, receptor (CD32):Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene):Fc fragment of IgG, low affinity IIIb, receptor (CD16b)@:IgG binding;protein binding;regulation of immune response;extracellular region;integral to membrane;immune response;plasma membrane;external side of plasma membrane:IgG binding;protein binding;signal transduction;regulation of immune response;integral to membrane;immune response;plasma membrane;virus-host interaction:IgG binding;protein binding;extracellular region;immune response;plasma membrane;anchored to membrane@: MALARIA, SUSCEPTIBILITY TO; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
A2463_08@16038@16038@duplication@1@196797201@196797376@1@chr1:196797201-196797376@7.89@121@227@1.88@CNVR459.1@CFHR1_4@0@0@0@:complement factor H-related 1:complement factor H-related 2@:extracellular space;complement activation:extracellular region@NA
A2463_08@24993@24993@deletion@1@90060701@90060995@2@chr2:90060701-90060995@4.91@93@46@0.495@CNVR867.10, CNVR867.1, CNVR867.6, CNVR867.5, CNVR867.12@IGKV6D-21_2@0@0@0@@:protein binding@NA
A2463_08@25375@25386@deletion@12@97860464@97870000@2@chr2:97860464-97870000@25.6@1777@1181@0.665@CNVR886.1@ANKRD36_39, ANKRD36_40, ANKRD36_41, ANKRD36_42, ANKRD36_43, ANKRD36_44, ANKRD36_45, ANKRD36_46, ANKRD36_47, ANKRD36_48, ANKRD36_49, ANKRD36_50@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_08@25391@25411@deletion@21@97875419@97915904@2@chr2:97875419-97915904@28.8@2256@1523@0.675@NA@ANKRD36_55, ANKRD36_56, ANKRD36_57, ANKRD36_58, ANKRD36_59, ANKRD36_60, ANKRD36_61, ANKRD36_62, ANKRD36_63, ANKRD36_64, ANKRD36_65, ANKRD36_66, ANKRD36_67, ANKRD36_68, ANKRD36_69, ANKRD36_70, ANKRD36_71, ANKRD36_72, ANKRD36_73, ANKRD36_74, ANKRD36_75@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_08@26412@26414@duplication@3@113127756@113138540@2@chr2:113127756-113138540@5.88@185@274@1.48@NA@RGPD8_23, RGPD8_22, RGPD8_21@0@0@0@:RANBP2-like and GRIP domain containing 8@:protein binding;intracellular;intracellular transport;nuclear pore;protein targeting to Golgi;Ran GTPase binding;biological_process@NA
A2463_08@27162@27163@deletion@2@130834655@130843568@2@chr2:130834655-130843568@10.3@49@1@0.0204@NA@POTEF_14, POTEF_13@0@0@0@:POTE ankyrin domain family, member F@:cell cortex;protein binding;ATP binding@NA
A2463_08@27171@27172@deletion@2@130868117@130869674@2@chr2:130868117-130869674@12.6@93@21@0.226@NA@POTEF_5, POTEF_4@0@0@0@:POTE ankyrin domain family, member F@:cell cortex;protein binding;ATP binding@NA
A2463_08@27272@27288@deletion@17@131356484@131415450@2@chr2:131356484-131415450@33@1185@666@0.562@NA@CFC1_2, CFC1_1, POTEJ_1, POTEJ_2, POTEJ_3, POTEJ_4, POTEJ_5, POTEJ_6, POTEJ_7, POTEJ_8, POTEJ_9, POTEJ_10, POTEJ_11, POTEJ_12, POTEJ_13, POTEJ_14, POTEJ_15@0@0@0@:cripto, FRL-1, cryptic family 1:POTE ankyrin domain family, member J@:gastrulation;nodal signaling pathway;protein binding;extracellular region;nodal binding;plasma membrane;molecular_function;determination of left/right symmetry;cellular_component;anchored to membrane:protein binding;ATP binding@: TRANSPOSITION OF THE GREAT ARTERIES, DEXTRO-LOOPED 2; DTGA2; CONOTRUNCAL HEART MALFORMATIONS; CTHM; HETEROTAXY, VISCERAL, 2, AUTOSOMAL; HTX2
A2463_08@39893@39894@duplication@2@75790428@75790887@3@chr3:75790428-75790887@9.97@24@99@4.12@CNVR1432.5, CNVR1432.9, CNVR1432.4@ZNF717_4, ZNF717_3@0@0@0@:zinc finger protein 717;zinc finger protein 717-like@:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_08@45433@45438@duplication@6@195447880@195475935@3@chr3:195447880-195475935@19.1@769@1140@1.48@CNVR1703.1, CNVR1703.2, CNVR1703.5, CNVR1703.3@MUC20_1, MUC20_2, MUC20_3, MUC20_4, MUC4_25, MUC4_24@0@0@0@:mucin 20, cell surface associated:mucin 4, cell surface associated@:microvillus membrane;apical plasma membrane;activation of MAPK activity;Golgi lumen;post-translational protein modification;protein binding;O-glycan processing;hepatocyte growth factor receptor signaling pathway;cellular protein metabolic process;extracellular region;protein homooligomerization;basal plasma membrane:ErbB-2 class receptor binding;Golgi lumen;cell-matrix adhesion;post-translational protein modification;extracellular matrix structural constituent;protein binding;O-glycan processing;cellular protein metabolic process;proteinaceous extracellular matrix;integral to plasma membrane;membrane;extracellular matrix constituent, lubricant activity;biological_process@NA
A2463_08@53306@53308@deletion@3@741710@748674@5@chr5:741710-748674@13.5@166@74@0.446@CNVR2280.3@ZDHHC11B_7, ZDHHC11B_6, ZDHHC11B_5@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
A2463_08@55785@55787@duplication@3@68863555@68868377@5@chr5:68863555-68868377@8.02@120@209@1.74@CNVR2494.7, CNVR2494.46@GTF2H2C_6, GTF2H2C_7, GTF2H2C_8@0@0@0@:general transcription factor IIH, polypeptide 2C;general transcription factor IIH, polypeptide 2D@:regulation of transcription, DNA-dependent;nucleotide-excision repair;DNA repair;core TFIIH complex;protein binding;nucleus;transcription, DNA-dependent;zinc ion binding@NA
A2463_08@55837@55838@duplication@2@70343834@70344676@5@chr5:70343834-70344676@5.54@90@150@1.67@CNVR2494.41, CNVR2494.14, CNVR2494.20, CNVR2494.62, CNVR2494.8@GTF2H2_12, GTF2H2_11@0@0@0@:general transcription factor IIH, polypeptide 2, 44kDa@:nucleoplasm;nucleotide-excision repair, DNA damage removal;transcription from RNA polymerase I promoter;DNA repair;RNA polymerase II carboxy-terminal domain kinase activity;nucleus;viral reproduction;translation;gene expression;transcription elongation from RNA polymerase I promoter;response to UV;holo TFIIH complex;protein kinase activity;nucleotide-excision repair;transcription from RNA polymerase II promoter;transcription-coupled nucleotide-excision repair;transcription, DNA-dependent;zinc ion binding;transcription elongation from RNA polymerase II promoter;termination of RNA polymerase I transcription;sequence-specific DNA binding transcription factor activity;G-protein coupled receptor internalization;DNA-dependent ATPase activity;protein N-terminus binding;transcription initiation from RNA polymerase I promoter;7-methylguanosine mRNA capping;transcription initiation from RNA polymerase II promoter;protein phosphorylation;translation factor activity, nucleic acid binding;regulation of transcription, DNA-dependent;core TFIIH complex;protein binding;positive regulation of viral transcription;nucleic acid binding@NA
A2463_08@60882@60885@deletion@4@175487236@175520277@5@chr5:175487236-175520277@13.4@100@22@0.22@NA@RP11-826N14.2_2, FAM153B_3, FAM153B_4@0@0@0@:uncharacterized LOC100507387;family with sequence similarity 153, member B@NA@NA
A2463_08@63768@63773@deletion@6@31994761@31996309@6@chr6:31994761-31996309@18.9@189@68@0.36@CNVR2843.6, CNVR2843.5@C4B_20, C4B_21, C4B_22, C4B_23, C4B_24, C4B_25@0@0@0@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
A2463_08@63966@63967@duplication@2@32609088@32610030@6@chr6:32609088-32610030@9.14@477@698@1.46@CNVR2845.21, CNVR2845.25, CNVR2845.37, CNVR2845.27, CNVR2845.22, CNVR2845.39, CNVR2845.20@HLA-DQA1_2, HLA-DQA1_3@0@0@0@:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
A2463_08@64602@64606@duplication@5@35754776@35765065@6@chr6:35754776-35765065@9.05@464@660@1.42@CNVR2861.1@CLPSL1_2, CLPSL1_3, CLPS_3, CLPS_2, CLPS_1@0@0@0@:colipase-like 1:colipase, pancreatic@:extracellular region;enzyme activator activity;digestion;lipid catabolic process:steroid metabolic process;post-embryonic development;small molecule metabolic process;retinoid metabolic process;lipid metabolic process;extracellular region;enzyme activator activity;digestion;lipid catabolic process;lipid digestion;response to food@NA
A2463_08@71744@71745@duplication@2@5939916@5940197@7@chr7:5939916-5940197@7.32@172@272@1.58@NA@CCZ1_2, CCZ1_3@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
A2463_08@71754@71758@deletion@5@5959481@5966179@7@chr7:5959481-5966179@12.6@280@151@0.539@NA@CCZ1_12, CCZ1_13, CCZ1_14, CCZ1_15, RSPH10B_20@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae):radial spoke head 10 homolog B (Chlamydomonas)@:lysosomal membrane@NA
A2463_08@71760@71763@deletion@4@5972414@5978460@7@chr7:5972414-5978460@10.7@52@2@0.0385@NA@RSPH10B_18, RSPH10B_17, RSPH10B_16, RSPH10B_15@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
A2463_08@71772@71772@deletion@1@5998625@5998709@7@chr7:5998625-5998709@4.88@35@8@0.229@NA@RSPH10B_6@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
A2463_08@71932@71934@duplication@3@6819242@6821107@7@chr7:6819242-6821107@6.28@183@273@1.49@NA@RSPH10B2_12, RSPH10B2_13, RSPH10B2_14@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
A2463_08@71940@71944@duplication@5@6837995@6844686@7@chr7:6837995-6844686@14.4@145@278@1.92@NA@RSPH10B2_20, CCZ1B_15, CCZ1B_14, CCZ1B_13, CCZ1B_12@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
A2463_08@73262@73263@deletion@2@38393317@38393784@7@chr7:38393317-38393784@7.76@118@53@0.449@CNVR3354.3, CNVR3354.1@TRGV4_2, TRGV4_1@0@0@0@@:protein binding@NA
A2463_08@74597@74599@deletion@3@74225431@74234127@7@chr7:74225431-74234127@9.58@54@6@0.111@NA@GTF2IRD2_10, GTF2IRD2_9, GTF2IRD2_8@0@0@0@:GTF2I repeat domain containing 2@:nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_08@76727@76727@deletion@1@102134273@102134416@7@chr7:102134273-102134416@4.65@21@0@0@CNVR3518.1@RASA4B_15@0@0@0@:RAS p21 protein activator 4B@:phospholipid binding;intracellular;GTPase activator activity;cytosol;signal transduction;protein binding;plasma membrane;regulation of small GTPase mediated signal transduction;metal ion binding;intracellular signal transduction@NA
A2463_08@76743@76744@deletion@2@102194807@102196577@7@chr7:102194807-102196577@5.38@173@98@0.566@CNVR3518.1@SPDYE2_3, SPDYE2_4@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:speedy homolog E2 (Xenopus laevis)@:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
A2463_08@80564@80569@deletion@6@11970084@12044342@8@chr8:11970084-12044342@37@1480@695@0.47@CNVR3785.8, CNVR3785.5, CNVR3785.2, CNVR3785.3@ZNF705D_6, USP17L2_1, FAM86B1_8, FAM86B1_7, FAM86B1_6, FAM86B1_5@0@0@0@:zinc finger protein 705D:ubiquitin specific peptidase 17-like family member 1, pseudogene;ubiquitin specific peptidase 17-like family member 2;ubiquitin specific peptidase 17-like family member 4;ubiquitin specific peptidase 17-like family member 7;ubiquitin specific peptidase 17-like family member 8;ubiquitin specific peptidase 17-like family member 3:family with sequence similarity 86, member B2;family with sequence similarity 86, member B1@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:protein deubiquitination;ubiquitin-specific protease activity;mitotic cell cycle G1/S transition checkpoint;nucleus;G2/M transition checkpoint;apoptotic process;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
A2463_08@88535@88539@deletion@5@41311441@41327364@9@chr9:41311441-41327364@6.21@47@13@0.277@CNVR4278.2@FAM74A2_1, SPATA31A4_4, SPATA31A4_3, SPATA31A4_2, SPATA31A4_1@0@0@0@:SPATA31 subfamily A, member 4@:integral to membrane:integral to membrane@NA
A2463_08@88639@88644@deletion@6@67926874@67938658@9@chr9:67926874-67938658@15.2@293@156@0.532@NA@ANKRD20A1_1, ANKRD20A1_2, ANKRD20A1_3, ANKRD20A1_4, ANKRD20A1_5, ANKRD20A1_6@0@0@0@:ankyrin repeat domain 20 family, member A1@:protein binding;plasma membrane@NA
A2463_08@95346@95357@deletion@12@17813309@17898362@10@chr10:17813309-17898362@28.1@298@118@0.396@NA@TMEM236_2, TMEM236_3, TMEM236_4, MRC1L1_1, MRC1L1_2, MRC1L1_3, MRC1L1_4, MRC1L1_5, MRC1L1_6, MRC1L1_7, MRC1L1_8, MRC1L1_9@0@0@0@:transmembrane protein 236;transmembrane protein 236-like:macrophage mannose receptor 1-like@:integral to membrane:carbohydrate binding@NA
A2463_08@95380@95394@duplication@15@18060293@18155690@10@chr10:18060293-18155690@25.5@175@383@2.19@NA@TMEM236_2, TMEM236_3, TMEM236_4, MRC1_1, MRC1_2, MRC1_3, MRC1_4, MRC1_5, MRC1_6, MRC1_7, MRC1_8, MRC1_9, MRC1_10, MRC1_11, MRC1_12@0@0@0@:transmembrane protein 236;transmembrane protein 236-like:mannose receptor, C type 1;macrophage mannose receptor 1-like@:integral to membrane:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
A2463_08@95717@95719@deletion@3@26355905@26359144@10@chr10:26355905-26359144@5.57@544@370@0.68@CNVR4661.2@MYO3A_11, MYO3A_12, MYO3A_13@0@0@0@:myosin IIIA@:ADP binding;filamentous actin;inner ear development;protein autophosphorylation;protein tyrosine kinase activity;peptidyl-serine phosphorylation;calmodulin binding;stereocilium bundle tip;myosin complex;transferase activity, transferring phosphorus-containing groups;ATP binding;motor activity;filopodium tip;microfilament motor activity;protein serine/threonine kinase activity;plus-end directed microfilament motor activity;protein phosphorylation;photoreceptor inner segment;protein kinase activity;sensory perception of sound;positive regulation of filopodium assembly;cytoplasm;actin-dependent ATPase activity;filopodium;actin binding;protein binding;response to stimulus;actin filament binding;visual perception;peptidyl-threonine phosphorylation@: DEAFNESS, AUTOSOMAL RECESSIVE 30; DFNB30
A2463_08@96544@96547@duplication@4@47909171@47911679@10@chr10:47909171-47911679@6.73@166@251@1.51@CNVR4715.2@FAM21B_10, FAM21B_11, FAM21B_12, FAM21B_13@0@0@0@:family with sequence similarity 21, member B@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_08@96631@96636@deletion@6@49376639@49386194@10@chr10:49376639-49386194@19.1@228@101@0.443@CNVR4717.2@FRMPD2_27, FRMPD2_26, FRMPD2_25, FRMPD2_24, FRMPD2_23, FRMPD2_22@0@0@0@:FERM and PDZ domain containing 2@:basolateral plasma membrane;transferase activity, transferring phosphorus-containing groups;cytoplasm;tight junction;protein binding;cytoskeleton;1-phosphatidylinositol binding;tight junction assembly@NA
A2463_08@96860@96861@deletion@2@51472553@51480527@10@chr10:51472553-51480527@8.55@105@48@0.457@CNVR4729.1@AGAP7_4, AGAP7_3@0@0@0@:translocase of inner mitochondrial membrane 23 homolog B (yeast):ArfGAP with GTPase domain, ankyrin repeat and PH domain 7@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity@NA
A2463_08@96900@96908@deletion@9@51847036@51857562@10@chr10:51847036-51857562@10.7@149@74@0.497@NA@FAM21A_8, FAM21A_9, FAM21A_10, FAM21A_11, FAM21A_12, FAM21A_13, FAM21A_14, FAM21A_15, FAM21A_16@0@0@0@:family with sequence similarity 21, member B;family with sequence similarity 21, member A@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_08@96922@96939@deletion@18@51890662@51994312@10@chr10:51890662-51994312@24.4@332@152@0.458@NA@FAM21A_30, FAM21A_31, ASAH2_20, ASAH2_19, ASAH2_18, ASAH2_17, ASAH2_16, ASAH2_15, ASAH2_14, ASAH2_13, ASAH2_12, ASAH2_11, ASAH2_10, ASAH2_9, ASAH2_8, ASAH2_7, ASAH2_6, ASAH2_5@0@0@0@:family with sequence similarity 21, member B;family with sequence similarity 21, member A:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
A2463_08@103288@103290@deletion@3@5269590@5271034@11@chr11:5269590-5271034@10.1@228@127@0.557@NA@HBG1_3, HBG1_2, HBG1_1@0@0@0@:hemoglobin, gamma A@:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex@NA
A2463_08@103606@103607@deletion@2@7716802@7717257@11@chr11:7716802-7717257@6.8@145@77@0.531@NA@OVCH2_12, OVCH2_11@0@0@0@:ovochymase 2 (gene/pseudogene)@:proteolysis;extracellular region;catalytic activity;serine-type endopeptidase activity;metal ion binding@NA
A2463_08@106044@106048@deletion@5@55321784@55419315@11@chr11:55321784-55419315@27.7@1400@843@0.602@CNVR5179.1@OR4C15_1, OR4C16_1, OR4C11_1, OR4P4_1, OR4S2_1@0@0@0@:olfactory receptor, family 4, subfamily C, member 15:olfactory receptor, family 4, subfamily C, member 16:olfactory receptor, family 4, subfamily C, member 11:olfactory receptor, family 4, subfamily P, member 4:olfactory receptor, family 4, subfamily S, member 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_08@106056@106062@deletion@7@55652906@55682058@11@chr11:55652906-55682058@8.83@1416@991@0.7@NA@TRIM51_2, TRIM51_3, TRIM51_4, TRIM51_5, TRIM51_6, TRIM51_7, OR5W2_1@0@0@0@:tripartite motif-containing 51G, pseudogene;tripartite motif-containing 51:olfactory receptor, family 5, subfamily W, member 2@:protein binding;intracellular;zinc ion binding:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_08@110121@110122@deletion@2@89768381@89769151@11@chr11:89768381-89769151@5.57@171@96@0.561@NA@TRIM49C_3, TRIM49C_4@0@0@0@:tripartite motif containing 49D, pseudogene;tripartite motif containing 49-like 1;tripartite motif containing 49C;tripartite motif-containing protein 49-like protein 1-like@:protein binding;intracellular;DNA binding;zinc ion binding@NA
A2463_08@114136@114139@deletion@4@8374419@8377428@12@chr12:8374419-8377428@15.1@1547@967@0.625@CNVR5422.3, CNVR5422.5, CNVR5422.6, CNVR5422.1@FAM90A1_7, FAM90A1_6, FAM90A1_5, FAM90A1_4@0@0@0@:family with sequence similarity 90, member A1@:zinc ion binding;nucleic acid binding@NA
A2463_08@117169@117172@deletion@4@52865206@52867521@12@chr12:52865206-52867521@18.5@709@429@0.605@NA@KRT6C_4, KRT6C_3, KRT6C_2, KRT6C_1@0@0@0@:keratin 6C@:intermediate filament;structural molecule activity;keratin filament;cytoskeleton organization@NA
A2463_08@131032@131033@duplication@2@74004127@74008399@14@chr14:74004127-74008399@17.9@222@452@2.04@CNVR6188.1, CNVR6188.4@ACOT1_1, ACOT1_2@0@0@0@:HEAT repeat containing 4:acyl-CoA thioesterase 1@:protein binding;binding:hydrolase activity;mitochondrion;acyl-CoA metabolic process;very long-chain fatty acid metabolic process;thiolester hydrolase activity;acyl-CoA hydrolase activity;cytosol;palmitoyl-CoA hydrolase activity;long-chain fatty acid metabolic process;carboxylesterase activity@NA
A2463_08@133426@133427@deletion@2@106478111@106478539@14@chr14:106478111-106478539@10.6@135@56@0.415@CNVR6294.36, CNVR6294.48, CNVR6294.12, CNVR6294.24@IGHV4-4_2, IGHV4-4_1@0@0@0@@:protein binding@NA
A2463_08@133460@133463@deletion@4@106805210@106816173@14@chr14:106805210-106816173@8.99@175@88@0.503@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.41@IGHV4-31_2, IGHV4-31_1, IGHV3-33_2, IGHV3-33_1@0@0@0@@:protein binding:protein binding@NA
A2463_08@133532@133541@deletion@10@22062317@22369517@15@chr15:22062317-22369517@12.3@583@363@0.623@NA@POTEB_9, POTEB_8, POTEB_7, POTEB_6, POTEB_5, POTEB_4, POTEB_3, POTEB_2, POTEB_1, OR4M2_1@0@0@0@:POTE ankyrin domain family member B-like:olfactory receptor, family 4, subfamily M, member 2@:protein binding:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_08@133622@133623@deletion@2@23259497@23259716@15@chr15:23259497-23259716@8.37@59@14@0.237@CNVR6300.4@GOLGA8I_6, GOLGA8I_7@0@0@0@:golgin A8 family, member I@:Golgi cisterna membrane@NA
A2463_08@133826@133826@deletion@1@28467175@28467361@15@chr15:28467175-28467361@10.6@73@13@0.178@CNVR6328.1@HERC2_36@0@0@0@:putative HERC2-like protein 3-like;HECT and RLD domain containing E3 ubiquitin protein ligase 2@:mitochondrial inner membrane;protein ubiquitination involved in ubiquitin-dependent protein catabolic process;guanyl-nucleotide exchange factor activity;SUMO binding;DNA repair;intracellular protein transport;spermatogenesis;cellular protein modification process;nucleus;ubiquitin protein ligase binding;ubiquitin-protein ligase activity;centriole;intracellular;response to DNA damage stimulus;heme binding;cytoplasm;protein binding;zinc ion binding;protein ubiquitination;metal ion binding@: SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1; SHEP1
A2463_08@134036@134041@deletion@6@30845996@30848698@15@chr15:30845996-30848698@17.3@95@11@0.116@NA@GOLGA8Q_2, GOLGA8Q_3, GOLGA8Q_4, GOLGA8Q_5, GOLGA8Q_6, GOLGA8Q_7@0@0@0@@:Golgi apparatus@NA
A2463_08@134061@134061@deletion@1@30900851@30900959@15@chr15:30900851-30900959@5.67@103@49@0.476@CNVR6339.2, CNVR6339.3@GOLGA8H_8@0@0@0@:golgin A8 family, member H@:Golgi apparatus@NA
A2463_08@138643@138646@deletion@4@75561795@75562540@15@chr15:75561795-75562540@5.62@92@48@0.522@CNVR6452.1@GOLGA6C_15, GOLGA6C_16, GOLGA6C_17, GOLGA6C_18@0@0@0@:golgin A6 family, member C@:Golgi apparatus@NA
A2463_08@142750@142754@deletion@5@15457517@15463713@16@chr16:15457517-15463713@5.87@314@196@0.624@CNVR6649.1@PKD1P1_8, PKD1P1_7, PKD1P1_6, PKD1P1_5, PKD1P1_4@0@0@0@:NPIP-like protein 1-like;nuclear pore complex-interacting protein-like 1-like@NA@NA
A2463_08@143487@143488@duplication@2@21846953@21849065@16@chr16:21846953-21849065@6.47@180@286@1.59@CNVR6668.5, CNVR6668.7@NPIPL3_8, NPIPL3_7@0@0@0@:nuclear pore complex interacting protein-like 3;nuclear pore complex interacting protein-like;nuclear pore complex-interacting protein-like 3-like@NA@NA
A2463_08@147110@147120@deletion@11@70162688@70178436@16@chr16:70162688-70178436@27@1277@795@0.623@CNVR6764.1, CNVR6764.3@PDPR_5, PDPR_6, PDPR_7, PDPR_8, PDPR_9, PDPR_10, PDPR_11, PDPR_12, PDPR_13, PDPR_14, PDPR_15@0@0@0@:pyruvate dehydrogenase phosphatase regulatory subunit@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix@NA
A2463_08@147123@147124@deletion@2@70187295@70190782@16@chr16:70187295-70190782@5.31@304@196@0.645@CNVR6764.1, CNVR6764.3@PDPR_18, PDPR_19@0@0@0@:pyruvate dehydrogenase phosphatase regulatory subunit@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix@NA
A2463_08@153376@153391@deletion@10@34522686@34588329@17@chr17:34522686-34588329@-10.9@111@192@1.73@CNVR7077.1, CNVR7077.13, CNVR7077.19@CCL3L3_3, CCL3L3_2, CCL3L3_1, CCL4L1_1, CCL4L1_2, CCL4L1_3, TBC1D3C_14, TBC1D3C_13, TBC1D3C_12, TBC1D3C_11, TBC1D3C_10, TBC1D3C_9, TBC1D3C_8, TBC1D3C_7, TBC1D3C_6, TBC1D3C_5@0@0@0@:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1:TBC1 domain family, member 3C;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3H-like;TBC1 domain family, member 3H@:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_08@154318@154318@deletion@1@39155810@39156105@17@chr17:39155810-39156105@7.5@71@22@0.31@CNVR7091.1@KRTAP3-2_1@0@0@0@:keratin associated protein 3-2@:structural molecule activity;keratin filament@NA
A2463_08@170104@170108@duplication@5@40389653@40398510@19@chr19:40389653-40398510@16.4@553@838@1.52@CNVR7639.2, CNVR7639.3@FCGBP_18, FCGBP_17, FCGBP_16, FCGBP_15, FCGBP_14@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_08@173301@173305@deletion@5@54742830@54745754@19@chr19:54742830-54745754@7.44@410@278@0.678@CNVR7721.3, CNVR7721.6@LILRA6_8, LILRA6_7, LILRA6_6, LILRA6_5, LILRA6_4@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
A2463_08@173466@173477@deletion@12@55258788@55295265@19@chr19:55258788-55295265@22.7@621@371@0.597@CNVR7725.2, CNVR7725.1@KIR2DL3_5, KIR2DL3_6, KIR2DL3_7, KIR2DL3_8, KIR2DL1_1, KIR2DL1_2, KIR2DL1_3, KIR2DL1_4, KIR2DL1_5, KIR2DL1_6, KIR2DL1_7, KIR2DL1_8@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane@NA
A2463_08@175732@175732@deletion@1@25755498@25755948@20@chr20:25755498-25755948@10.5@159@62@0.39@CNVR7821.2, CNVR7821.4@FAM182B_3@0@0@0@:family with sequence similarity 27, member B;family with sequence similarity 27, member A;family with sequence similarity 27, member C;family with sequence similarity 182, member B@NA@NA
A2463_08@181622@181622@deletion@1@21480538@21481925@22@chr22:21480538-21481925@4.36@102@54@0.529@CNVR8100.6, CNVR8100.12@POM121L7_1@0@0@0@:putative POM121-like protein 1-like@NA@NA
A2463_09@4135@4141@deletion@7@32154463@32157113@1@chr1:32154463-32157113@7.31@225@72@0.32@NA@COL16A1_25, COL16A1_24, COL16A1_23, COL16A1_22, COL16A1_21, COL16A1_20, COL16A1_19@0@0@0@:collagen, type XVI, alpha 1@:integrin binding;cellular response to amino acid stimulus;extracellular matrix organization;endoplasmic reticulum lumen;protein binding;female pregnancy;extracellular region;cell adhesion;collagen type XVI;integrin-mediated signaling pathway@NA
A2463_09@8321@8342@deletion@22@86249180@86361748@1@chr1:86249180-86361748@12.4@1304@643@0.493@NA@COL24A1_51, COL24A1_50, COL24A1_49, COL24A1_48, COL24A1_47, COL24A1_46, COL24A1_45, COL24A1_44, COL24A1_43, COL24A1_42, COL24A1_41, COL24A1_40, COL24A1_39, COL24A1_38, COL24A1_37, COL24A1_36, COL24A1_35, COL24A1_34, COL24A1_33, COL24A1_32, COL24A1_31, COL24A1_30@0@0@0@:collagen, type XXIV, alpha 1@:extracellular matrix structural constituent;collagen;extracellular region;extracellular matrix organization;endoplasmic reticulum lumen@NA
A2463_09@9766@9773@deletion@8@110230497@110235917@1@chr1:110230497-110235917@12@95@5@0.0526@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_1, GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
A2463_09@11341@11346@deletion@6@148008574@148012675@1@chr1:148008574-148012675@7.6@802@311@0.388@CNVR346.2, CNVR346.4@NBPF14_17, NBPF14_16, NBPF14_15, NBPF14_14, NBPF14_13, NBPF14_12@0@0@0@:neuroblastoma breakpoint family, member 14@:cytoplasm@NA
A2463_09@24980@25012@deletion@33@89952882@90248974@2@chr2:89952882-90248974@27.9@1971@845@0.429@CNVR867.10, CNVR867.5@IGKV1D-33_1, IGKV1D-33_2, IGKV2D-30_1, IGKV2D-30_2, IGKV2D-29_1, IGKV2D-29_2, IGKV2D-28_1, IGKV2D-28_2, IGKV2D-26_1, IGKV2D-26_2, IGKV2D-24_1, IGKV2D-24_2, IGKV6D-21_1, IGKV6D-21_2, IGKV3D-20_1, IGKV3D-20_2, IGKV6D-41_1, IGKV6D-41_2, IGKV1D-17_1, IGKV1D-17_2, IGKV1D-16_1, IGKV1D-16_2, IGKV3D-15_1, IGKV3D-15_2, IGKV1D-13_1, IGKV1D-13_2, IGKV1D-12_1, IGKV1D-12_2, IGKV3D-11_1, IGKV3D-11_2, IGKV1D-42_1, IGKV1D-42_2, IGKV1D-43_1@0@0@0@@:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding@NA
A2463_09@33013@33036@deletion@24@228134627@228169799@2@chr2:228134627-228169799@14.5@2756@1208@0.438@NA@COL4A3_24, COL4A3_25, COL4A3_26, COL4A3_27, COL4A3_28, COL4A3_29, COL4A3_30, COL4A3_31, COL4A3_32, COL4A3_33, COL4A3_34, COL4A3_35, COL4A3_36, COL4A3_37, COL4A3_38, COL4A3_39, COL4A3_40, COL4A3_41, COL4A3_42, COL4A3_43, COL4A3_44, COL4A3_45, COL4A3_46, COL4A3_47@0@0@0@:collagen, type IV, alpha 3 (Goodpasture antigen)@:integrin binding;blood circulation;negative regulation of cell proliferation;negative regulation of angiogenesis;induction of apoptosis;activation of cysteine-type endopeptidase activity involved in apoptotic process;basement membrane;collagen type IV;cell surface receptor signaling pathway;metalloendopeptidase inhibitor activity;glomerular basement membrane development;sensory perception of sound;extracellular matrix organization;endoplasmic reticulum lumen;axon guidance;response to glucose stimulus;extracellular matrix structural constituent;cell proliferation;collagen;protein binding;extracellular region;structural molecule activity;cell adhesion@: ALPORT SYNDROME, AUTOSOMAL DOMINANT; HEMATURIA, BENIGN FAMILIAL; BFH; ALPORT SYNDROME, AUTOSOMAL RECESSIVE
A2463_09@37525@37535@deletion@11@48612498@48614460@3@chr3:48612498-48614460@8.23@747@314@0.42@NA@COL7A1_75, COL7A1_74, COL7A1_73, COL7A1_72, COL7A1_71, COL7A1_70, COL7A1_69, COL7A1_68, COL7A1_67, COL7A1_66, COL7A1_65@0@0@0@:collagen, type VII, alpha 1@:extracellular matrix;extracellular matrix organization;endoplasmic reticulum lumen;serine-type endopeptidase inhibitor activity;protein binding;extracellular region;cell adhesion;basement membrane;collagen type VII;epidermis development@: NAIL DISORDER, NONSYNDROMIC CONGENITAL, 8; NDNC8; EPIDERMOLYSIS BULLOSA DYSTROPHICA, PRETIBIAL; EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL DOMINANT; DDEB; EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE; RDEB; EPIDERMOLYSIS BULLOSA WITH CONGENITAL LOCALIZED ABSENCE OF SKIN AND; EPIDERMOLYSIS BULLOSA PRURIGINOSA; TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN; TBDN
A2463_09@37548@37570@deletion@23@48618556@48623167@3@chr3:48618556-48623167@12.5@1376@648@0.471@NA@COL7A1_52, COL7A1_51, COL7A1_50, COL7A1_49, COL7A1_48, COL7A1_47, COL7A1_46, COL7A1_45, COL7A1_44, COL7A1_43, COL7A1_42, COL7A1_41, COL7A1_40, COL7A1_39, COL7A1_38, COL7A1_37, COL7A1_36, COL7A1_35, COL7A1_34, COL7A1_33, COL7A1_32, COL7A1_31, COL7A1_30@0@0@0@:collagen, type VII, alpha 1@:extracellular matrix;extracellular matrix organization;endoplasmic reticulum lumen;serine-type endopeptidase inhibitor activity;protein binding;extracellular region;cell adhesion;basement membrane;collagen type VII;epidermis development@: NAIL DISORDER, NONSYNDROMIC CONGENITAL, 8; NDNC8; EPIDERMOLYSIS BULLOSA DYSTROPHICA, PRETIBIAL; EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL DOMINANT; DDEB; EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE; RDEB; EPIDERMOLYSIS BULLOSA WITH CONGENITAL LOCALIZED ABSENCE OF SKIN AND; EPIDERMOLYSIS BULLOSA PRURIGINOSA; TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN; TBDN
A2463_09@55835@55842@deletion@8@70338009@70355997@5@chr5:70338009-70355997@9.58@174@36@0.207@CNVR2494.41, CNVR2494.14, CNVR2494.20, CNVR2494.62, CNVR2494.8@GTF2H2_14, GTF2H2_13, GTF2H2_12, GTF2H2_11, GTF2H2_10, GTF2H2_9, GTF2H2_8, GTF2H2_7@0@0@0@:general transcription factor IIH, polypeptide 2, 44kDa@:nucleoplasm;nucleotide-excision repair, DNA damage removal;transcription from RNA polymerase I promoter;DNA repair;RNA polymerase II carboxy-terminal domain kinase activity;nucleus;viral reproduction;translation;gene expression;transcription elongation from RNA polymerase I promoter;response to UV;holo TFIIH complex;protein kinase activity;nucleotide-excision repair;transcription from RNA polymerase II promoter;transcription-coupled nucleotide-excision repair;transcription, DNA-dependent;zinc ion binding;transcription elongation from RNA polymerase II promoter;termination of RNA polymerase I transcription;sequence-specific DNA binding transcription factor activity;G-protein coupled receptor internalization;DNA-dependent ATPase activity;protein N-terminus binding;transcription initiation from RNA polymerase I promoter;7-methylguanosine mRNA capping;transcription initiation from RNA polymerase II promoter;protein phosphorylation;translation factor activity, nucleic acid binding;regulation of transcription, DNA-dependent;core TFIIH complex;protein binding;positive regulation of viral transcription;nucleic acid binding@NA
A2463_09@61262@61275@deletion@14@177158571@177175644@5@chr5:177158571-177175644@12.5@370@175@0.473@NA@FAM153A_15, FAM153A_14, FAM153A_13, FAM153A_12, FAM153A_11, FAM153A_10, FAM153A_9, FAM153A_8, FAM153A_7, FAM153A_6, FAM153A_5, FAM153A_4, FAM153A_3, FAM153A_2@0@0@0@:family with sequence similarity 153, member A@NA@NA
A2463_09@66645@66661@deletion@17@70745797@70859937@6@chr6:70745797-70859937@11.6@988@439@0.444@NA@COL19A1_14, COL19A1_15, COL19A1_16, COL19A1_17, COL19A1_18, COL19A1_19, COL19A1_20, COL19A1_21, COL19A1_22, COL19A1_23, COL19A1_24, COL19A1_25, COL19A1_26, COL19A1_27, COL19A1_28, COL19A1_29, COL19A1_30@0@0@0@:collagen, type XIX, alpha 1@:cell differentiation;cell-cell adhesion;protein binding, bridging;extracellular matrix organization;endoplasmic reticulum lumen;extracellular matrix structural constituent;collagen;extracellular region;proteinaceous extracellular matrix;cell adhesion;skeletal muscle tissue development;skeletal system development@NA
A2463_09@73259@73267@deletion@9@38370381@38402929@7@chr7:38370381-38402929@18.9@481@158@0.328@NA@TRGV8_1, TRGV5_2, TRGV5_1, TRGV4_2, TRGV4_1, TRGV3_2, TRGV3_1, TRGV2_2, TRGV2_1@0@0@0@@:protein binding:protein binding:protein binding:protein binding;immune response;peptide antigen binding;plasma membrane;MHC protein binding:protein binding@NA
A2463_09@80409@80412@deletion@4@7806652@7809913@8@chr8:7806652-7809913@9.17@140@10@0.0714@CNVR3772.4, CNVR3772.6, CNVR3772.10, CNVR3772.13@ZNF705B_3, ZNF705B_4, ZNF705B_5, ZNF705B_6@0@0@0@:zinc finger protein 705B@:intracellular;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_09@80564@80579@deletion@16@11970084@12286623@8@chr8:11970084-12286623@17.9@1090@884@0.811@NA@ZNF705D_6, USP17L2_1, FAM86B1_8, FAM86B1_7, FAM86B1_6, FAM86B1_5, FAM86B1_4, FAM86B1_3, FAM86B1_2, FAM86B1_1, DEFB130_2, DEFB130_1, FAM86B2_8, FAM86B2_7, FAM86B2_6, FAM86B2_5@0@0@0@:zinc finger protein 705D:ubiquitin specific peptidase 17-like family member 1, pseudogene;ubiquitin specific peptidase 17-like family member 2;ubiquitin specific peptidase 17-like family member 4;ubiquitin specific peptidase 17-like family member 7;ubiquitin specific peptidase 17-like family member 8;ubiquitin specific peptidase 17-like family member 3:family with sequence similarity 86, member B2;family with sequence similarity 86, member B1:defensin, beta 130-like;defensin, beta 130:family with sequence similarity 86, member B2@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:protein deubiquitination;ubiquitin-specific protease activity;mitotic cell cycle G1/S transition checkpoint;nucleus;G2/M transition checkpoint;apoptotic process;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:extracellular region;defense response to bacterium;defense response@NA
A2463_09@85653@85677@deletion@25@139601497@139688878@8@chr8:139601497-139688878@16@1159@606@0.523@NA@COL22A1_65, COL22A1_64, COL22A1_63, COL22A1_62, COL22A1_61, COL22A1_60, COL22A1_59, COL22A1_58, COL22A1_57, COL22A1_56, COL22A1_55, COL22A1_54, COL22A1_53, COL22A1_52, COL22A1_51, COL22A1_50, COL22A1_49, COL22A1_48, COL22A1_47, COL22A1_46, COL22A1_45, COL22A1_44, COL22A1_43, COL22A1_42, COL22A1_41@0@0@0@:collagen, type XXII, alpha 1@:collagen;protein binding;extracellular region;extracellular matrix organization;endoplasmic reticulum lumen@NA
A2463_09@88643@88656@deletion@14@67935876@67985922@9@chr9:67935876-67985922@10.1@766@453@0.591@NA@ANKRD20A1_5, ANKRD20A1_6, ANKRD20A1_7, ANKRD20A1_8, ANKRD20A1_9, ANKRD20A1_10, ANKRD20A1_11, ANKRD20A1_12, ANKRD20A1_13, ANKRD20A1_14, ANKRD20A1_15, RP11-195B21.3_3, RP11-195B21.3_4, RP11-195B21.3_5@0@0@0@:ankyrin repeat domain 20 family, member A1:coiled-coil domain-containing protein 29-like;uncharacterized LOC644249@:protein binding;plasma membrane@NA
A2463_09@96900@96937@deletion@38@51847036@51978390@10@chr10:51847036-51978390@34.7@553@111@0.201@NA@FAM21A_8, FAM21A_9, FAM21A_10, FAM21A_11, FAM21A_12, FAM21A_13, FAM21A_14, FAM21A_15, FAM21A_16, FAM21A_17, FAM21A_18, FAM21A_19, FAM21A_20, FAM21A_21, FAM21A_22, FAM21A_23, FAM21A_24, FAM21A_25, FAM21A_26, FAM21A_27, FAM21A_28, FAM21A_29, FAM21A_30, FAM21A_31, ASAH2_20, ASAH2_19, ASAH2_18, ASAH2_17, ASAH2_16, ASAH2_15, ASAH2_14, ASAH2_13, ASAH2_12, ASAH2_11, ASAH2_10, ASAH2_9, ASAH2_8, ASAH2_7@0@0@0@:family with sequence similarity 21, member B;family with sequence similarity 21, member A:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
A2463_09@101596@101599@deletion@4@124329679@124333278@10@chr10:124329679-124333278@5.82@176@41@0.233@CNVR4912.4, CNVR4912.6@DMBT1_3, DMBT1_4, DMBT1_5, DMBT1_6@0@0@0@:deleted in malignant brain tumors 1@:defense response to virus;calcium-dependent protein binding;pattern recognition receptor signaling pathway;blastocyst development;response to estrogen stimulus;tissue regeneration;proteinaceous extracellular matrix;protein transport;Gram-negative bacterial cell surface binding;positive regulation of epithelial cell differentiation;virus-host interaction;epithelial cell differentiation;induction of bacterial agglutination;phagocytic vesicle membrane;intracellular;Gram-positive bacterial cell surface binding;zymogen binding;innate immune response;cytoplasm;extrinsic to membrane;protein binding;zymogen granule membrane;extracellular region;scavenger receptor activity;pattern recognition receptor activity;inner cell mass cell proliferation;membrane@: GLIOMA SUSCEPTIBILITY 1; GLM1
A2463_09@126879@126887@deletion@9@110826794@110831383@13@chr13:110826794-110831383@7.6@1188@444@0.374@NA@COL4A1_39, COL4A1_38, COL4A1_37, COL4A1_36, COL4A1_35, COL4A1_34, COL4A1_33, COL4A1_32, COL4A1_31@0@0@0@:collagen, type IV, alpha 1@:platelet-derived growth factor binding;neuromuscular junction development;extracellular matrix;angiogenesis;cellular response to amino acid stimulus;extracellular matrix organization;endoplasmic reticulum lumen;axon guidance;extracellular matrix structural constituent;collagen;protein binding;extracellular region;basement membrane;collagen type IV;epithelial cell differentiation@: PORENCEPHALY 1; POREN1; ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS;; BRAIN SMALL VESSEL DISEASE WITH HEMORRHAGE
A2463_09@126944@126964@deletion@21@111117753@111156340@13@chr13:111117753-111156340@13.7@1035@625@0.604@NA@COL4A2_25, COL4A2_26, COL4A2_27, COL4A2-AS2_1, COL4A2_28, COL4A2_29, COL4A2_30, COL4A2_31, COL4A2_32, COL4A2_33, COL4A2_34, COL4A2_35, COL4A2_36, COL4A2_37, COL4A2_38, COL4A2_39, COL4A2_40, COL4A2_41, COL4A2_42, COL4A2_43, COL4A2_44@0@0@0@:collagen, type IV, alpha 2@:extracellular matrix;angiogenesis;negative regulation of angiogenesis;extracellular matrix organization;endoplasmic reticulum lumen;axon guidance;cellular response to transforming growth factor beta stimulus;extracellular matrix structural constituent;collagen;protein binding;extracellular region;basement membrane;collagen type IV;transcription, DNA-dependent@: HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO; ICH; PORENCEPHALY 2; POREN2
A2463_09@127334@127336@deletion@3@19558718@19562100@14@chr14:19558718-19562100@8.99@95@1@0.0105@CNVR6072.1@POTEG_2, POTEG_3, POTEG_4@0@0@0@:POTE ankyrin domain family, member G@:protein binding@NA
A2463_09@128445@128448@deletion@4@24707796@24709536@14@chr14:24707796-24709536@5.74@584@255@0.437@NA@GMPR2_9, TINF2_9, TINF2_8, TINF2_7@0@0@0@:guanosine monophosphate reductase 2:TERF1 (TRF1)-interacting nuclear factor 2@:oxidation-reduction process;nucleobase-containing small molecule metabolic process;purine nucleobase metabolic process;small molecule metabolic process;catalytic activity;nucleotide metabolic process;cytosol;oxidoreductase activity;purine-containing compound salvage;GMP reductase activity;metal ion binding:nucleoplasm;protein localization to chromosome;negative regulation of protein ADP-ribosylation;nuclear telomere cap complex;negative regulation of telomere maintenance via telomerase;telomere assembly;nuclear matrix;telomeric DNA binding;negative regulation of telomere maintenance;chromosome, telomeric region;positive regulation of telomere maintenance;telomere maintenance;negative regulation of epithelial cell proliferation;protein localization to chromosome, telomeric region;protein binding;telomere maintenance via telomere lengthening;perinucleolar chromocenter@: DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT, 3; DKCA3; REVESZ SYNDROME
A2463_09@134173@134177@deletion@5@32692342@32695395@15@chr15:32692342-32695395@6.35@51@4@0.0784@NA@GOLGA8K_4, GOLGA8K_3, GOLGA8K_2, AC139426.2_1, GOLGA8K_1@0@0@0@:golgin A8 family, member J@:Golgi apparatus@NA
A2463_09@134203@134205@deletion@3@32889954@32890378@15@chr15:32889954-32890378@5.29@66@6@0.0909@NA@GOLGA8N_6, GOLGA8N_7, GOLGA8N_8@0@0@0@:golgin A8 family, member R@:Golgi apparatus@NA
A2463_09@147500@147512@deletion@13@74423724@74447574@16@chr16:74423724-74447574@12.9@1336@629@0.471@CNVR6778.2, CNVR6778.3@NPIPL2_5, NPIPL2_6, NPIPL2_7, CLEC18B_13, CLEC18B_12, CLEC18B_11, CLEC18B_10, CLEC18B_9, CLEC18B_8, CLEC18B_7, CLEC18B_6, CLEC18B_5, CLEC18B_4@0@0@0@:C-type lectin domain family 18, member B@:extracellular region:carbohydrate binding;protein binding;extracellular region@NA
A2463_09@154324@154347@deletion@24@39203134@39432459@17@chr17:39203134-39432459@14.3@2120@1015@0.479@NA@KRTAP2-1_1, KRTAP2-2_1, KRTAP2-3_1, KRTAP2-4_1, KRTAP4-7_1, KRTAP4-8_1, KRTAP4-16P_1, KRTAP4-9_1, KRTAP4-11_1, KRTAP4-12_1, KRTAP4-6_1, KRTAP4-5_1, KRTAP4-4_1, KRTAP4-3_1, KRTAP4-2_1, KRTAP4-1_1, KRTAP9-1_1, KRTAP9-2_1, KRTAP9-3_1, KRTAP9-8_1, KRTAP9-4_1, KRTAP9-9_1, KRTAP9-6_1, KRTAP9-7_1@0@0@0@:keratin associated protein 2-1:keratin associated protein 2-2:keratin associated protein 2-3;keratin associated protein 2-4:keratin associated protein 2-3;keratin associated protein 2-4:keratin associated protein 4-7:keratin associated protein 4-8:keratin associated protein 4-9:keratin associated protein 4-11:keratin associated protein 4-12:keratin associated protein 4-6:keratin associated protein 4-5:keratin associated protein 4-4:keratin associated protein 4-3:keratin associated protein 4-2:keratin associated protein 4-1:keratin associated protein 9-1:keratin associated protein 9-2;keratin-associated protein 9-2-like:keratin associated protein 9-3:keratin associated protein 9-8:keratin associated protein 9-4:keratin associated protein 9-9:keratin associated protein 9-6:keratin associated protein 9-7@:keratin filament:keratin filament:keratin filament:keratin filament:keratin filament:keratin filament:keratin filament:keratin filament:keratin filament:keratin filament:keratin filament:keratin filament:keratin filament:keratin filament:keratin filament:keratin filament:keratin filament:keratin filament:keratin filament:keratin filament:keratin filament:keratin filament:keratin filament:keratin filament@NA
A2463_09@155592@155592@deletion@1@44412912@44412960@17@chr17:44412912-44412960@5.38@6@71@11.8@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A_11@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
A2463_09@156150@156173@deletion@24@48269342@48275566@17@chr17:48269342-48275566@14.3@1549@778@0.502@NA@COL1A1_30, COL1A1_29, COL1A1_28, COL1A1_27, COL1A1_26, COL1A1_25, COL1A1_24, COL1A1_23, COL1A1_22, COL1A1_21, COL1A1_20, COL1A1_19, COL1A1_18, COL1A1_17, COL1A1_16, COL1A1_15, COL1A1_14, COL1A1_13, COL1A1_12, COL1A1_11, COL1A1_10, COL1A1_9, COL1A1_8, COL1A1_7@0@0@0@:collagen, type I, alpha 1@:embryonic skeletal system development;cellular response to transforming growth factor beta stimulus;cellular response to mechanical stimulus;protein heterotrimerization;response to peptide hormone stimulus;proteinaceous extracellular matrix;response to mechanical stimulus;response to inorganic substance;negative regulation of cell-substrate adhesion;protein transport;identical protein binding;blood vessel development;receptor binding;skin development;tooth mineralization;platelet activation;response to cAMP;sensory perception of sound;endoplasmic reticulum lumen;extracellular matrix structural constituent;collagen;positive regulation of transcription, DNA-dependent;response to hydrogen peroxide;visual perception;collagen type I;response to corticosteroid stimulus;positive regulation of canonical Wnt receptor signaling pathway;skin morphogenesis;skeletal system development;extracellular matrix;protein localization to nucleus;wound healing;positive regulation of epithelial to mesenchymal transition;cellular response to amino acid stimulus;collagen fibril organization;extracellular space;positive regulation of cell migration;blood coagulation;cartilage development involved in endochondral bone morphogenesis;cellular response to growth factor stimulus;response to nutrient;bone trabecula formation;ossification;platelet-derived growth factor binding;skeletal system morphogenesis;cellular response to retinoic acid;endochondral ossification;osteoblast differentiation;extracellular matrix organization;axon guidance;face morphogenesis;cytoplasm;collagen biosynthetic process;protein binding;signal transduction;extracellular region;intramembranous ossification;leukocyte migration@: DERMATOFIBROSARCOMA PROTUBERANS; DFSP; CAFFEY DISEASE; OSTEOGENESIS IMPERFECTA, TYPE I; OSTEOGENESIS IMPERFECTA, TYPE IV; OSTEOGENESIS IMPERFECTA, TYPE II; EHLERS-DANLOS SYNDROME, TYPE I; OSTEOPOROSIS; EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL DOMINANT; OSTEOGENESIS IMPERFECTA, TYPE III
A2463_09@164949@164957@deletion@9@7011818@7058616@19@chr19:7011818-7058616@8.5@260@81@0.312@CNVR7517.1@AC025278.1_1, MBD3L5_1, MBD3L5_2, MBD3L4_2, MBD3L4_1, MBD3L2_1, MBD3L2_2, MBD3L3_2, MBD3L3_1@0@0@0@:methyl-CpG binding domain protein 3-like 5:methyl-CpG binding domain protein 3-like 4:methyl-CpG-binding domain protein 3-like 2-like;methyl-CpG binding domain protein 3-like 2:methyl-CpG binding domain protein 3-like 3@:regulation of transcription, DNA-dependent;transcription, DNA-dependent:regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_09@168441@168444@deletion@4@22939008@22941882@19@chr19:22939008-22941882@5.95@897@176@0.196@NA@ZNF99_8, ZNF99_7, ZNF99_6, ZNF99_5@0@0@0@:zinc finger protein 99@:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_09@418@418@deletion@1@1607504@1607638@1@chr1:1607504-1607638@10.5@48@0@0@CNVR17.1@SLC35E2B_4@0@0@0@:solute carrier family 35, member E2B@:integral to membrane;membrane;transmembrane transport@NA
A2463_09@1849@1849@deletion@1@13474690@13475262@1@chr1:13474690-13475262@5.09@57@22@0.386@CNVR74.8, CNVR74.12@PRAMEF18_3@0@0@0@:PRAME family member 18@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_09@3333@3342@duplication@10@25599040@25655415@1@chr1:25599040-25655415@74.9@724@1569@2.17@CNVR116.1, CNVR116.2@RHD_1, RHD_2, RHD_3, RHD_4, RHD_5, RHD_6, RHD_7, RHD_8, RHD_9, RHD_10@0@0@0@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
A2463_09@3351@3351@duplication@1@25701841@25701919@1@chr1:25701841-25701919@4.9@158@243@1.54@CNVR117.1@RHCE_8@0@0@0@:Rh blood group, CcEe antigens@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@: BLOOD GROUP--RHESUS SYSTEM E POLYPEPTIDE; RHE; RHESUS BLOOD GROUP, CcEe ANTIGENS; RHCE
A2463_09@3357@3357@deletion@1@25735175@25735360@1@chr1:25735175-25735360@21.5@107@1@0.00935@CNVR117.1@RHCE_2@0@0@0@:Rh blood group, CcEe antigens@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@: BLOOD GROUP--RHESUS SYSTEM E POLYPEPTIDE; RHE; RHESUS BLOOD GROUP, CcEe ANTIGENS; RHCE
A2463_09@9460@9460@deletion@1@109007811@109008046@1@chr1:109007811-109008046@11.5@63@5@0.0794@CNVR294.4@NBPF6_13@0@0@0@:neuroblastoma breakpoint family, member 6@:cytoplasm@NA
A2463_09@10868@10868@deletion@1@145302655@145302868@1@chr1:145302655-145302868@5.94@81@34@0.42@CNVR341.2, CNVR341.3, CNVR341.4@NBPF10_8@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family, member 10@:protein binding;calcium ion binding@NA
A2463_09@10890@10893@deletion@4@145325953@145328432@1@chr1:145325953-145328432@7.99@40@3@0.075@CNVR341.2, CNVR341.3@NBPF10_30, NBPF10_31, NBPF10_32, NBPF10_33@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family, member 10@NA@NA
A2463_09@11341@11343@deletion@3@148008574@148010164@1@chr1:148008574-148010164@22.6@533@269@0.505@CNVR346.2, CNVR346.4@NBPF14_17, NBPF14_16, NBPF14_15@0@0@0@:neuroblastoma breakpoint family, member 14@:cytoplasm@NA
A2463_09@11346@11346@deletion@1@148012504@148012675@1@chr1:148012504-148012675@8.07@39@1@0.0256@CNVR346.2, CNVR346.4@NBPF14_12@0@0@0@:neuroblastoma breakpoint family, member 14@:cytoplasm@NA
A2463_09@12117@12118@duplication@2@152573209@152586574@1@chr1:152573209-152586574@16.3@108@267@2.47@CNVR358.1@LCE3C_1, LCE3B_1@0@0@0@:late cornified envelope 3C:late cornified envelope 3B@:keratinization:keratinization@NA
A2463_09@16038@16038@duplication@1@196797201@196797376@1@chr1:196797201-196797376@6.46@123@212@1.72@CNVR459.1@CFHR1_4@0@0@0@:complement factor H-related 1:complement factor H-related 2@:extracellular space;complement activation:extracellular region@NA
A2463_09@17286@17291@deletion@6@207718654@207726196@1@chr1:207718654-207726196@6.96@60@19@0.317@CNVR485.1@CR1_14, CR1_15, CR1_16, CR1_17, CR1_18, CR1_19@0@0@0@:complement component (3b/4b) receptor 1 (Knops blood group)@:complement component C4b receptor activity;complement activation, classical pathway;negative regulation of complement activation, alternative pathway;innate immune response;negative regulation of serine-type endopeptidase activity;complement component C3b binding;negative regulation of complement activation, classical pathway;plasma membrane;integral to plasma membrane;complement component C3b receptor activity;complement component C4b binding;cell surface;regulation of complement activation;positive regulation of serine-type endopeptidase activity@: MALARIA, SUSCEPTIBILITY TO; KNOPS BLOOD GROUP SYSTEM; KN
A2463_09@19756@19756@deletion@1@248223985@248224922@1@chr1:248223985-248224922@4.57@303@190@0.627@NA@OR2L3_1@0@0@0@:olfactory receptor, family 2, subfamily L, member 13:olfactory receptor, family 2, subfamily L, member 3@:protein binding;integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity;biological_process:integral to membrane;G-protein coupled receptor activity;plasma membrane;molecular_function;G-protein coupled receptor signaling pathway;olfactory receptor activity;biological_process@NA
A2463_09@24862@24863@deletion@2@88094928@88095367@2@chr2:88094928-88095367@5.78@28@1@0.0357@NA@RGPD2_11, RGPD2_10@0@0@0@:RANBP2-like and GRIP domain containing 2@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_09@24974@25015@deletion@42@89890602@90260248@2@chr2:89890602-90260248@212@2734@1094@0.4@CNVR867.10@IGKV2D-40_2, IGKV1D-39_1, IGKV1D-39_2, IGKV1D-37_1, IGKV1D-37_2, IGKV1D-33_1, IGKV1D-33_2, IGKV2D-30_1, IGKV2D-30_2, IGKV2D-29_1, IGKV2D-29_2, IGKV2D-28_1, IGKV2D-28_2, IGKV2D-26_1, IGKV2D-26_2, IGKV2D-24_1, IGKV2D-24_2, IGKV6D-21_1, IGKV6D-21_2, IGKV3D-20_1, IGKV3D-20_2, IGKV6D-41_1, IGKV6D-41_2, IGKV1D-17_1, IGKV1D-17_2, IGKV1D-16_1, IGKV1D-16_2, IGKV3D-15_1, IGKV3D-15_2, IGKV1D-13_1, IGKV1D-13_2, IGKV1D-12_1, IGKV1D-12_2, IGKV3D-11_1, IGKV3D-11_2, IGKV1D-42_1, IGKV1D-42_2, IGKV1D-43_1, IGKV1D-43_2, IGKV1D-8_1, IGKV1D-8_2@0@0@0@@:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding@NA
A2463_09@25369@25370@deletion@2@97854825@97855027@2@chr2:97854825-97855027@22.8@126@11@0.0873@CNVR886.2, CNVR886.3@ANKRD36_33, ANKRD36_34@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_09@25385@25386@duplication@2@97869806@97870000@2@chr2:97869806-97870000@8.28@311@462@1.49@CNVR886.1@ANKRD36_49, ANKRD36_50@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_09@25391@25394@duplication@4@97875419@97877478@2@chr2:97875419-97877478@6.17@529@703@1.33@CNVR886.1@ANKRD36_55, ANKRD36_56, ANKRD36_57, ANKRD36_58@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_09@26008@26011@deletion@4@108454714@108460186@2@chr2:108454714-108460186@5.96@108@55@0.509@NA@RGPD4_3, RGPD4_4, RGPD4_5, RGPD4_6@0@0@0@:RANBP2-like and GRIP domain containing 4@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_09@26021@26024@deletion@4@108479139@108486433@2@chr2:108479139-108486433@9.59@295@171@0.58@NA@RGPD4_16, RGPD4_17, RGPD4_18, RGPD4_19@0@0@0@:RANBP2-like and GRIP domain containing 4@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_09@26414@26414@deletion@1@113138402@113138540@2@chr2:113138402-113138540@10@60@8@0.133@NA@RGPD8_21@0@0@0@:RANBP2-like and GRIP domain containing 8@:protein binding;intracellular;intracellular transport;nuclear pore;protein targeting to Golgi;Ran GTPase binding;biological_process@NA
A2463_09@27247@27250@deletion@4@131245606@131254195@2@chr2:131245606-131254195@13.3@132@39@0.295@NA@POTEI_9, POTEI_8, POTEI_7, POTEI_6@0@0@0@:POTE ankyrin domain family, member I@:protein binding;ATP binding@NA
A2463_09@39892@39894@duplication@3@75786030@75790887@3@chr3:75786030-75790887@13.6@224@395@1.76@CNVR1432.5, CNVR1432.9, CNVR1432.4@ZNF717_5, ZNF717_4, ZNF717_3@0@0@0@:zinc finger protein 717;zinc finger protein 717-like@:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_09@46314@46314@deletion@1@3589634@3589777@4@chr4:3589634-3589777@4.89@48@17@0.354@NA@RP3-368B9.1_2@0@0@0@NA@NA@NA
A2463_09@46667@46677@deletion@11@9174900@9251948@4@chr4:9174900-9251948@17.9@383@197@0.514@NA@FAM90A26P_4, FAM90A26P_5, FAM90A26P_6, FAM90A26P_7, USP17L13_1, USP17L10_1, USP17L11_1, USP17L12_1, USP17L13_2, USP17L15_1, USP17L17_1, USP17L18_1@0@0@0@:ubiquitin specific peptidase 17-like family member 10:ubiquitin specific peptidase 17-like family member 13:ubiquitin specific peptidase 17-like family member 11:ubiquitin specific peptidase 17-like family member 12:ubiquitin specific peptidase 17-like family member 15:ubiquitin specific peptidase 17-like family member 17:ubiquitin specific peptidase 17-like family member 18@:zinc ion binding;nucleic acid binding:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
A2463_09@48556@48561@duplication@6@69403344@69434202@4@chr4:69403344-69434202@19@477@754@1.58@CNVR1953.1@UGT2B17_6, UGT2B17_5, UGT2B17_4, UGT2B17_3, UGT2B17_2, UGT2B17_1@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B17@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;membrane@: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
A2463_09@48968@48969@deletion@2@75314765@75316249@4@chr4:75314765-75316249@4.95@81@40@0.494@NA@AREG_3, AREG_4@0@0@0@:amphiregulin;amphiregulin B@:growth factor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;cell proliferation;epidermal growth factor receptor signaling pathway;extracellular space;protein binding;integral to membrane;cytokine activity;cell surface;positive regulation of DNA replication@NA
A2463_09@53303@53312@duplication@10@716924@767067@5@chr5:716924-767067@22.7@473@754@1.59@CNVR2280.3@ZDHHC11B_10, ZDHHC11B_9, ZDHHC11B_8, ZDHHC11B_7, ZDHHC11B_6, ZDHHC11B_5, ZDHHC11B_4, ZDHHC11B_3, ZDHHC11B_2, ZDHHC11B_1@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
A2463_09@55787@55787@duplication@1@68868273@68868377@5@chr5:68868273-68868377@4.58@50@95@1.9@CNVR2494.7, CNVR2494.46@GTF2H2C_8@0@0@0@:general transcription factor IIH, polypeptide 2C;general transcription factor IIH, polypeptide 2D@:regulation of transcription, DNA-dependent;nucleotide-excision repair;DNA repair;core TFIIH complex;protein binding;nucleus;transcription, DNA-dependent;zinc ion binding@NA
A2463_09@59046@59047@deletion@2@140228082@140238021@5@chr5:140228082-140238021@20.8@1545@862@0.558@CNVR2622.1@PCDHA9_1, PCDHA10_1@0@0@0@:protocadherin alpha 1:protocadherin alpha 2:protocadherin alpha 3:protocadherin alpha 4:protocadherin alpha 5:protocadherin alpha 6:protocadherin alpha 7:protocadherin alpha 8:protocadherin alpha 9:protocadherin alpha 10@:extracellular region;cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:integral to membrane;cell adhesion;homophilic cell adhesion;plasma membrane;integral to plasma membrane;membrane;nervous system development;calcium ion binding:cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:extracellular region;cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:integral to membrane;homophilic cell adhesion;plasma membrane;membrane;calcium ion binding:extracellular region;cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development@NA
A2463_09@59065@59065@deletion@1@140557617@140560021@5@chr5:140557617-140560021@5.26@2158@1444@0.669@CNVR2624.1@PCDHB8_1@0@0@0@:protocadherin beta 8@:integral to membrane;homophilic cell adhesion;plasma membrane;membrane;calcium ion binding@NA
A2463_09@60884@60885@deletion@2@175517374@175520277@5@chr5:175517374-175520277@5.8@59@21@0.356@NA@FAM153B_3, FAM153B_4@0@0@0@:uncharacterized LOC100507387;family with sequence similarity 153, member B@NA@NA
A2463_09@61260@61264@deletion@5@177156025@177161405@5@chr5:177156025-177161405@7.59@102@46@0.451@NA@FAM153A_17, FAM153A_16, FAM153A_15, FAM153A_14, FAM153A_13@0@0@0@:family with sequence similarity 153, member A@NA@NA
A2463_09@61266@61267@deletion@2@177163581@177164113@5@chr5:177163581-177164113@12.6@108@33@0.306@NA@FAM153A_11, FAM153A_10@0@0@0@:family with sequence similarity 153, member A@NA@NA
A2463_09@61269@61271@deletion@3@177166602@177168333@5@chr5:177166602-177168333@10.1@46@0@0@NA@FAM153A_8, FAM153A_7, FAM153A_6@0@0@0@:family with sequence similarity 153, member A@NA@NA
A2463_09@61638@61645@deletion@8@180375356@180429785@5@chr5:180375356-180429785@17.4@705@415@0.589@CNVR2719.1@BTNL8_5, BTNL8_6, BTNL8_7, BTNL8_8, BTNL3_1, BTNL3_2, BTNL3_3, BTNL3_4@0@0@0@:butyrophilin-like 8:butyrophilin-like 3@:protein binding;integral to membrane:protein binding;integral to membrane;molecular_function;cellular_component;biological_process@NA
A2463_09@61690@61697@deletion@8@292541@350868@6@chr6:292541-350868@13.8@561@351@0.626@CNVR2728.1@DUSP22_1, DUSP22_2, DUSP22_3, DUSP22_4, DUSP22_5, DUSP22_6, DUSP22_7, DUSP22_8@0@0@0@:dual specificity phosphatase 22;dual specificity protein phosphatase 22-like@:protein dephosphorylation;transforming growth factor beta receptor signaling pathway;positive regulation of JNK cascade;protein tyrosine/serine/threonine phosphatase activity;nucleus;apoptotic process;multicellular organismal development;phosphatase activity;protein tyrosine phosphatase activity;regulation of cell proliferation;cytoplasm;cell proliferation;inactivation of MAPK activity;protein binding;negative regulation of transcription from RNA polymerase II promoter;dephosphorylation@NA
A2463_09@63731@63735@duplication@5@31963733@31965088@6@chr6:31963733-31965088@9.93@535@751@1.4@CNVR2843.6, CNVR2843.3@C4A_26, C4A_27, C4A_28, C4A_29, C4A_30@0@0@0@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
A2463_09@63953@63957@duplication@5@32485517@32489951@6@chr6:32485517-32489951@25.4@161@388@2.41@CNVR2845.21, CNVR2845.25, CNVR2845.30@HLA-DRB5_6, HLA-DRB5_5, HLA-DRB5_4, HLA-DRB5_3, HLA-DRB5_2@0@0@0@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
A2463_09@66668@66670@deletion@3@70875834@70878107@6@chr6:70875834-70878107@5.26@239@153@0.64@NA@COL19A1_37, COL19A1_38, COL19A1_39@0@0@0@:collagen, type XIX, alpha 1@:cell differentiation;cell-cell adhesion;protein binding, bridging;extracellular matrix organization;endoplasmic reticulum lumen;extracellular matrix structural constituent;collagen;extracellular region;proteinaceous extracellular matrix;cell adhesion;skeletal muscle tissue development;skeletal system development@NA
A2463_09@71745@71749@deletion@5@5940105@5944900@7@chr7:5940105-5944900@10.9@509@313@0.615@NA@CCZ1_3, CCZ1_4, CCZ1_5, CCZ1_6, CCZ1_7@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
A2463_09@71777@71779@duplication@3@6013031@6018327@7@chr7:6013031-6018327@10.1@498@714@1.43@NA@PMS2_15, PMS2_14, PMS2_13@0@0@0@:PMS2 postmeiotic segregation increased 2 (S. cerevisiae)@:response to drug;DNA binding;MutSalpha complex binding;ATP binding;mismatch repair;DNA repair;mismatched DNA binding;ATPase activity;nucleus;mismatch repair complex;reciprocal meiotic recombination;ATP catabolic process;single-stranded DNA binding;response to DNA damage stimulus;single base insertion or deletion binding;protein binding;somatic hypermutation of immunoglobulin genes;somatic recombination of immunoglobulin gene segments;MutLalpha complex;endonuclease activity@: COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 4; HNPCC4; MISMATCH REPAIR CANCER SYNDROME
A2463_09@73260@73263@deletion@4@38388957@38393784@7@chr7:38388957-38393784@35.4@188@13@0.0691@CNVR3354.3, CNVR3354.1@TRGV5_2, TRGV5_1, TRGV4_2, TRGV4_1@0@0@0@@:protein binding:protein binding@NA
A2463_09@76427@76432@duplication@6@100331793@100336236@7@chr7:100331793-100336236@17@242@416@1.72@CNVR3509.1@ZAN_1, ZAN_2, ZAN_3, ZAN_4, ZAN_5, ZAN_6@0@0@0@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
A2463_09@76743@76752@duplication@10@102194807@102212968@7@chr7:102194807-102212968@9.5@467@665@1.42@CNVR3518.1@SPDYE2_3, SPDYE2_4, SPDYE2_5, SPDYE2_6, SPDYE2_7, SPDYE2_8, POLR2J3_4, POLR2J3_3, POLR2J3_2, POLR2J3_1@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:speedy homolog E2 (Xenopus laevis)@:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
A2463_09@76765@76779@duplication@15@102235753@102279646@7@chr7:102235753-102279646@14.1@330@514@1.56@CNVR3518.1@RASA4_11, RASA4_10, RASA4_9, RASA4_8, RASA4_7, RASA4_6, RASA4_5, RASA4_4, RASA4_3, RASA4_2, UPK3BL_7, RASA4_1, UPK3BL_6, UPK3BL_6, UPK3BL_5, UPK3BL_5, UPK3BL_4, UPK3BL_4@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4:uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity:integral to membrane:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
A2463_09@76792@76792@deletion@1@102309363@102309451@7@chr7:102309363-102309451@4.97@22@0@0@CNVR3518.1@POLR2J2_2, POLR2J2_2@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
A2463_09@76794@76795@duplication@2@102313398@102319303@7@chr7:102313398-102319303@5.35@193@289@1.5@CNVR3518.1@AC105052.1_3, AC105052.1_2, AC105052.1_1@0@0@0@NA@NA@NA
A2463_09@79309@79309@deletion@1@143880598@143882930@7@chr7:143880598-143882930@5.05@320@198@0.619@CNVR3598.4, CNVR3598.3@CTAGE4_1@0@0@0@:CTAGE family, member 4@:integral to membrane;nucleotide binding;cellular_component;biological_process@NA
A2463_09@79313@79313@duplication@1@143964011@143966343@7@chr7:143964011-143966343@5.16@214@321@1.5@CNVR3598.4@CTAGE8_1@0@0@0@:Rho guanine nucleotide exchange factor (GEF) 35:CTAGE family, member 6, pseudogene;CTAGE family, member 15, pseudogene@:integral to membrane@NA
A2463_09@79313@79314@deletion@1@143964011@144016150@7@chr7:143964011-144016150@-6.65@392@421@1.07@CNVR3598.4@CTAGE8_1, OR2A1_1@0@0@0@:Rho guanine nucleotide exchange factor (GEF) 35:CTAGE family, member 6, pseudogene;CTAGE family, member 15, pseudogene:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1@:integral to membrane:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_09@80141@80143@deletion@3@116087@150533@8@chr8:116087-150533@7.49@84@35@0.417@CNVR3684.5, CNVR3684.11@OR4F21_1, RP11-585F1.10_2, RP11-585F1.10_1@0@0@0@:olfactory receptor, family 4, subfamily F, member 21:F-box only protein 25-like;putative uncharacterized protein C20orf69-like@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_09@80362@80365@duplication@4@7215499@7218758@8@chr8:7215499-7218758@15.8@859@1231@1.43@CNVR3771.8, CNVR3771.10, CNVR3771.4@ZNF705G_7, ZNF705G_6, ZNF705G_5, ZNF705G_4@0@0@0@:zinc finger protein 705G@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_09@80371@80376@deletion@6@7308236@7340274@8@chr8:7308236-7340274@13.1@305@173@0.567@CNVR3771.8, CNVR3771.10, CNVR3771.4@SPAG11B_3, SPAG11B_2, SPAG11B_1, DEFB104B_2, DEFB104B_1, DEFB106B_2@0@0@0@:sperm associated antigen 11B:defensin, beta 104A;defensin, beta 104B:defensin, beta 106B;defensin, beta 106A@:spermatogenesis;defense response to bacterium;extracellular region;molecular_function;defense response:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium@NA
A2463_09@80564@80564@deletion@1@11970084@11970667@8@chr8:11970084-11970667@20.4@102@1@0.0098@CNVR3785.8, CNVR3785.5@ZNF705D_6@0@0@0@:zinc finger protein 705D@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_09@80567@80567@deletion@1@12042886@12043034@8@chr8:12042886-12043034@5.62@29@2@0.069@CNVR3785.5, CNVR3785.3@FAM86B1_7@0@0@0@:family with sequence similarity 86, member B2;family with sequence similarity 86, member B1@NA@NA
A2463_09@80570@80572@deletion@3@12045582@12049350@8@chr8:12045582-12049350@12.8@74@9@0.122@CNVR3785.5, CNVR3785.3@FAM86B1_4, FAM86B1_3, FAM86B1_2@0@0@0@:family with sequence similarity 86, member B2;family with sequence similarity 86, member B1@NA@NA
A2463_09@80576@80578@deletion@3@12283399@12286407@8@chr8:12283399-12286407@14@75@7@0.0933@CNVR3786.4, CNVR3786.16@FAM86B2_8, FAM86B2_7, FAM86B2_6@0@0@0@:family with sequence similarity 86, member B2@NA@NA
A2463_09@86891@86892@deletion@2@5304371@5335597@9@chr9:5304371-5335597@9.78@270@148@0.548@NA@RLN2_1, RLN1_2@0@0@0@:relaxin 2:relaxin 1@:hormone activity;extracellular region;female pregnancy:signal transduction;hormone activity;extracellular region;female pregnancy@NA
A2463_09@88517@88517@deletion@1@39358072@39361806@9@chr9:39358072-39361806@9.91@145@58@0.4@NA@SPATA31A1_4@0@0@0@:SPATA31 subfamily A, member 1@:integral to membrane@NA
A2463_09@88527@88528@deletion@2@40702337@40706387@9@chr9:40702337-40706387@10.4@487@267@0.548@NA@SPATA31A3_3, SPATA31A3_4@0@0@0@:SPATA31 subfamily A, member 3@:integral to membrane@NA
A2463_09@88584@88598@deletion@15@43624656@43849851@9@chr9:43624656-43849851@44.9@2386@1338@0.561@CNVR4294.1@SPATA31A6_4, SPATA31A6_3, SPATA31A6_2, SPATA31A6_1, CNTNAP3B_1, CNTNAP3B_2, CNTNAP3B_3, CNTNAP3B_4, CNTNAP3B_5, CNTNAP3B_6, CNTNAP3B_7, CNTNAP3B_8, CNTNAP3B_9, CNTNAP3B_10, CNTNAP3B_11@0@0@0@:SPATA31 subfamily A, member 6:contactin associated protein-like 3B;contactin associated protein-like 3@:integral to membrane:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
A2463_09@88643@88643@deletion@1@67935876@67936012@9@chr9:67935876-67936012@4.9@22@0@0@NA@ANKRD20A1_5@0@0@0@:ankyrin repeat domain 20 family, member A1@:protein binding;plasma membrane@NA
A2463_09@88647@88656@deletion@10@67951933@67985922@9@chr9:67951933-67985922@25.1@822@509@0.619@NA@ANKRD20A1_9, ANKRD20A1_10, ANKRD20A1_11, ANKRD20A1_12, ANKRD20A1_13, ANKRD20A1_14, ANKRD20A1_15, RP11-195B21.3_3, RP11-195B21.3_4, RP11-195B21.3_5@0@0@0@:ankyrin repeat domain 20 family, member A1:coiled-coil domain-containing protein 29-like;uncharacterized LOC644249@:protein binding;plasma membrane@NA
A2463_09@93566@93566@deletion@1@138441155@138441176@9@chr9:138441155-138441176@4.62@21@0@0@CNVR4529.1@OBP2A_6@0@0@0@:odorant binding protein 2A@:odorant binding;sensory perception of chemical stimulus;response to stimulus;transport;extracellular region;sensory perception of smell;cellular_component@NA
A2463_09@95377@95386@deletion@10@17951323@18122792@10@chr10:17951323-18122792@13.5@101@28@0.277@NA@MRC1L1_29, MRC1L1_30, TMEM236_1, TMEM236_2, TMEM236_3, TMEM236_4, MRC1_1, MRC1_2, MRC1_3, MRC1_4@0@0@0@:macrophage mannose receptor 1-like:transmembrane protein 236;transmembrane protein 236-like:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding:integral to membrane:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
A2463_09@96468@96470@deletion@3@46605764@46611811@10@chr10:46605764-46611811@6.55@30@0@0@CNVR4712.3@PTPN20A_4, PTPN20A_3, PTPN20A_2@0@0@0@:protein tyrosine phosphatase, non-receptor type 20B;protein tyrosine phosphatase, non-receptor type 20A@:phosphatase activity;protein tyrosine phosphatase activity;microtubule;nucleus;dephosphorylation;protein dephosphorylation;microtubule organizing center@NA
A2463_09@96543@96563@duplication@21@47908065@47948853@10@chr10:47908065-47948853@87.8@447@1193@2.67@CNVR4715.2, CNVR4715.1@FAM21B_9, FAM21B_10, FAM21B_11, FAM21B_12, FAM21B_13, FAM21B_14, FAM21B_15, FAM21B_16, FAM21B_17, FAM21B_18, FAM21B_19, FAM21B_20, FAM21B_21, FAM21B_22, FAM21B_23, FAM21B_24, FAM21B_25, FAM21B_26, FAM21B_27, FAM21B_28, FAM21B_29@0@0@0@:family with sequence similarity 21, member B@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_09@96620@96620@deletion@1@48771316@48771405@10@chr10:48771316-48771405@10.7@50@0@0@CNVR4716.10, CNVR4716.3@PTPN20B_6@0@0@0@:protein tyrosine phosphatase, non-receptor type 20B;protein tyrosine phosphatase, non-receptor type 20A@:phosphatase activity;protein tyrosine phosphatase activity;microtubule;nucleus;dephosphorylation;protein dephosphorylation;microtubule organizing center@NA
A2463_09@96631@96633@duplication@3@49376639@49381136@10@chr10:49376639-49381136@12.9@63@166@2.63@CNVR4717.2@FRMPD2_27, FRMPD2_26, FRMPD2_25@0@0@0@:FERM and PDZ domain containing 2@:basolateral plasma membrane;transferase activity, transferring phosphorus-containing groups;cytoplasm;tight junction;protein binding;cytoskeleton;1-phosphatidylinositol binding;tight junction assembly@NA
A2463_09@96900@96939@deletion@40@51847036@51994312@10@chr10:51847036-51994312@123@848@176@0.208@NA@FAM21A_8, FAM21A_9, FAM21A_10, FAM21A_11, FAM21A_12, FAM21A_13, FAM21A_14, FAM21A_15, FAM21A_16, FAM21A_17, FAM21A_18, FAM21A_19, FAM21A_20, FAM21A_21, FAM21A_22, FAM21A_23, FAM21A_24, FAM21A_25, FAM21A_26, FAM21A_27, FAM21A_28, FAM21A_29, FAM21A_30, FAM21A_31, ASAH2_20, ASAH2_19, ASAH2_18, ASAH2_17, ASAH2_16, ASAH2_15, ASAH2_14, ASAH2_13, ASAH2_12, ASAH2_11, ASAH2_10, ASAH2_9, ASAH2_8, ASAH2_7, ASAH2_6, ASAH2_5@0@0@0@:family with sequence similarity 21, member B;family with sequence similarity 21, member A:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
A2463_09@98005@98005@deletion@1@75436478@75436528@10@chr10:75436478-75436528@4.75@37@10@0.27@CNVR4799.1@AGAP5_7@0@0@0@:ankyrin repeat and GTPase domain Arf GTPase activating protein 11;ArfGAP with GTPase domain, ankyrin repeat and PH domain 5;ArfGAP with GTPase domain, ankyrin repeat and PH domain 10;arf-GAP with GTPase, ANK repeat and PH domain-containing protein 5-like@:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity@NA
A2463_09@98355@98356@duplication@2@81608270@81609243@10@chr10:81608270-81609243@6.09@24@68@2.83@NA@FAM22E_5, FAM22E_6@0@0@0@NA@NA@NA
A2463_09@98595@98595@deletion@1@88985589@88985969@10@chr10:88985589-88985969@4.63@21@0@0@CNVR4840.3, CNVR4840.5@FAM22A_1@0@0@0@:family with sequence similarity 22, member A@NA@NA
A2463_09@98603@98606@deletion@4@89120239@89124960@10@chr10:89120239-89124960@9.8@71@17@0.239@CNVR4840.3@FAM22D_2, FAM22D_3, FAM22D_4, FAM22D_5@0@0@0@:family with sequence similarity 22, member D@NA@NA
A2463_09@101608@101615@deletion@8@124344788@124354044@10@chr10:124344788-124354044@25.5@498@255@0.512@CNVR4912.4, CNVR4912.3, CNVR4912.2@DMBT1_15, DMBT1_16, DMBT1_17, DMBT1_18, DMBT1_19, DMBT1_20, DMBT1_21, DMBT1_22@0@0@0@:deleted in malignant brain tumors 1@:defense response to virus;calcium-dependent protein binding;pattern recognition receptor signaling pathway;blastocyst development;response to estrogen stimulus;tissue regeneration;proteinaceous extracellular matrix;protein transport;Gram-negative bacterial cell surface binding;positive regulation of epithelial cell differentiation;virus-host interaction;epithelial cell differentiation;induction of bacterial agglutination;phagocytic vesicle membrane;intracellular;Gram-positive bacterial cell surface binding;zymogen binding;innate immune response;cytoplasm;extrinsic to membrane;protein binding;zymogen granule membrane;extracellular region;scavenger receptor activity;pattern recognition receptor activity;inner cell mass cell proliferation;membrane@: GLIOMA SUSCEPTIBILITY 1; GLM1
A2463_09@104444@104444@duplication@1@18288436@18288525@11@chr11:18288436-18288525@5.61@66@125@1.89@NA@SAA1_2@0@0@0@:serum amyloid A1@:regulation of protein secretion;platelet activation;neutrophil chemotaxis;negative regulation of inflammatory response;positive regulation of cytokine secretion;macrophage chemotaxis;positive regulation of cell adhesion;positive regulation of interleukin-1 secretion;extracellular region;lymphocyte chemotaxis;high-density lipoprotein particle;elevation of cytosolic calcium ion concentration;acute-phase response;G-protein coupled receptor binding@NA
A2463_09@106571@106578@duplication@8@60971038@60978907@11@chr11:60971038-60978907@7.95@111@188@1.69@CNVR5194.1@PGA3_1, PGA3_2, PGA3_3, PGA3_4, PGA3_5, PGA3_6, PGA3_7, PGA3_8@0@0@0@:pepsinogen 3, group I (pepsinogen A)@:proteolysis;extracellular region;digestion;aspartic-type endopeptidase activity@NA
A2463_09@110110@110114@deletion@5@89532885@89537637@11@chr11:89532885-89537637@8.54@277@170@0.614@NA@TRIM49_7, TRIM49_6, TRIM49_5, TRIM49_4, TRIM49_3@0@0@0@:tripartite motif containing 49@:protein binding;intracellular;DNA binding;zinc ion binding@NA
A2463_09@114218@114218@deletion@1@9085160@9085946@12@chr12:9085160-9085946@5.04@95@47@0.495@NA@PHC1_8@0@0@0@:polyhomeotic homolog 1 (Drosophila)@:multicellular organismal development;cellular response to retinoic acid;sex chromatin;nuclear body;DNA binding;chromatin binding;protein binding;nucleus;PcG protein complex;zinc ion binding;PRC1 complex@NA
A2463_09@114483@114483@deletion@1@11243900@11244828@12@chr12:11243900-11244828@12.2@289@130@0.45@CNVR5434.1@TAS2R43_1@0@0@0@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):taste receptor, type 2, member 14:taste receptor, type 2, member 43@:extracellular space;visual perception:bitter taste receptor activity;taste receptor activity;integral to membrane;sensory perception of taste;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of bitter taste:G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;motile cilium;taste receptor activity;bitter taste receptor activity;integral to membrane;sensory perception of taste;detection of chemical stimulus involved in sensory perception of bitter taste;cilium membrane@NA
A2463_09@115344@115345@deletion@2@27648614@27655054@12@chr12:27648614-27655054@4.87@94@50@0.532@CNVR5465.1@C12orf70_8, C12orf70_9@0@0@0@:chromosome 12 open reading frame 70@:integral to membrane@NA
A2463_09@127333@127358@deletion@26@19553418@20404761@14@chr14:19553418-20404761@71.9@3582@2256@0.63@CNVR6072.12@POTEG_1, POTEG_2, POTEG_3, POTEG_4, POTEG_5, POTEG_9, POTEG_10, POTEM_10, POTEM_9, POTEM_5, POTEM_4, POTEM_3, POTEM_2, POTEM_1, OR4Q3_1, OR4M1_1, OR4N2_1, OR4K2_1, OR4K5_1, OR4K1_1@0@0@0@:POTE ankyrin domain family, member G:POTE ankyrin domain family, member M:olfactory receptor, family 4, subfamily N, member 2:olfactory receptor, family 4, subfamily Q, member 3:olfactory receptor, family 4, subfamily M, member 1:olfactory receptor, family 4, subfamily K, member 2:olfactory receptor, family 4, subfamily K, member 5:olfactory receptor, family 4, subfamily K, member 1@:protein binding:protein binding:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_09@133432@133435@duplication@4@106539080@106552729@14@chr14:106539080-106552729@14.1@137@266@1.94@CNVR6294.36, CNVR6294.48, CNVR6294.24, CNVR6294.10, CNVR6294.34@IGHV1-8_2, IGHV1-8_1, IGHV3-9_2, IGHV3-9_1@0@0@0@@:protein binding:protein binding@NA
A2463_09@133499@133500@deletion@2@107178821@107179262@14@chr14:107178821-107179262@5.48@101@51@0.505@CNVR6294.6, CNVR6294.92@IGHV2-70_2, IGHV2-70_1@0@0@0@@:protein binding@NA
A2463_09@133541@133542@deletion@2@22368577@22383423@15@chr15:22368577-22383423@6.63@748@502@0.671@CNVR6297.4, CNVR6297.17, CNVR6297.2@OR4M2_1, OR4N4_1@0@0@0@:olfactory receptor, family 4, subfamily M, member 2:olfactory receptor, family 4, subfamily N, member 4@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_09@133622@133623@duplication@2@23259497@23259716@15@chr15:23259497-23259716@6.38@49@102@2.08@CNVR6300.4@GOLGA8I_6, GOLGA8I_7@0@0@0@:golgin A8 family, member I@:Golgi cisterna membrane@NA
A2463_09@133815@133817@deletion@3@28447260@28451528@15@chr15:28447260-28451528@6.74@107@52@0.486@CNVR6328.1@HERC2_47, HERC2_46, HERC2_45@0@0@0@:putative HERC2-like protein 3-like;HECT and RLD domain containing E3 ubiquitin protein ligase 2@:mitochondrial inner membrane;protein ubiquitination involved in ubiquitin-dependent protein catabolic process;guanyl-nucleotide exchange factor activity;SUMO binding;DNA repair;intracellular protein transport;spermatogenesis;cellular protein modification process;nucleus;ubiquitin protein ligase binding;ubiquitin-protein ligase activity;centriole;intracellular;response to DNA damage stimulus;heme binding;cytoplasm;protein binding;zinc ion binding;protein ubiquitination;metal ion binding@: SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1; SHEP1
A2463_09@133900@133912@deletion@13@28947361@28953319@15@chr15:28947361-28953319@18.8@921@597@0.648@CNVR6331.1@GOLGA8M_18, GOLGA8M_17, GOLGA8M_16, GOLGA8M_15, GOLGA8M_14, GOLGA8M_13, GOLGA8M_12, GOLGA8M_11, GOLGA8M_10, GOLGA8M_9, GOLGA8M_8, GOLGA8M_7, GOLGA8M_6@0@0@0@:golgin A8 family, member M@:Golgi apparatus@NA
A2463_09@134004@134006@duplication@3@30436983@30437510@15@chr15:30436983-30437510@7.04@135@215@1.59@NA@GOLGA8T_16, GOLGA8T_17, GOLGA8T_18@0@0@0@:golgin A8 family, member J;golgin A8 family, member K@:Golgi apparatus@NA
A2463_09@134158@134161@deletion@4@32684984@32685771@15@chr15:32684984-32685771@13.2@142@57@0.401@NA@GOLGA8K_19, GOLGA8K_18, GOLGA8K_17, GOLGA8K_16@0@0@0@:golgin A8 family, member J@:Golgi apparatus@NA
A2463_09@134180@134181@duplication@2@32737820@32738099@15@chr15:32737820-32738099@5.42@23@62@2.7@CNVR6346.1@GOLGA8O_17, GOLGA8O_16@0@0@0@:golgin A8 family, member O@:Golgi apparatus@NA
A2463_09@134189@134193@duplication@5@32743115@32744772@15@chr15:32743115-32744772@11.4@153@266@1.74@CNVR6346.1@GOLGA8O_8, GOLGA8O_7, GOLGA8O_6, GOLGA8O_5, GOLGA8O_4@0@0@0@:golgin A8 family, member O@:Golgi apparatus@NA
A2463_09@134204@134205@deletion@2@32890090@32890378@15@chr15:32890090-32890378@13.8@72@5@0.0694@NA@GOLGA8N_7, GOLGA8N_8@0@0@0@:golgin A8 family, member R@:Golgi apparatus@NA
A2463_09@138636@138637@deletion@2@75557464@75557765@15@chr15:75557464-75557765@10.1@159@73@0.459@CNVR6452.1@GOLGA6C_8, GOLGA6C_9@0@0@0@:golgin A6 family, member C@:Golgi apparatus@NA
A2463_09@138645@138655@duplication@11@75562174@75582040@15@chr15:75562174-75582040@9.69@224@341@1.52@CNVR6452.1@GOLGA6C_17, GOLGA6C_18, GOLGA6D_1, GOLGA6D_2, GOLGA6D_3, GOLGA6D_4, GOLGA6D_5, GOLGA6D_6, GOLGA6D_7, GOLGA6D_8, GOLGA6D_9@0@0@0@:golgin A6 family, member C:golgin A6 family, member D@:Golgi apparatus:Golgi apparatus@NA
A2463_09@142673@142674@duplication@2@14970522@14972691@16@chr16:14970522-14972691@6.19@167@253@1.51@NA@NOMO1_22, NOMO1_23@0@0@0@:NODAL modulator 1;nodal modulator 1-like@:carbohydrate binding;integral to membrane;carboxypeptidase activity;molecular_function;cellular_component;biological_process@NA
A2463_09@142750@142750@duplication@1@15457517@15457926@16@chr16:15457517-15457926@9.71@203@367@1.81@CNVR6649.1@PKD1P1_8@0@0@0@:NPIP-like protein 1-like;nuclear pore complex-interacting protein-like 1-like@NA@NA
A2463_09@142927@142928@deletion@2@16367547@16367932@16@chr16:16367547-16367932@5.24@89@44@0.494@NA@NOMO3_19, NOMO3_20@0@0@0@:NODAL modulator 3@:carbohydrate binding;integral to membrane;carboxypeptidase activity@NA
A2463_09@143444@143444@deletion@1@21415429@21416614@16@chr16:21415429-21416614@5.64@102@49@0.48@CNVR6668.3@NPIPL3_10, NPIPL3_9, NPIPL3_8, NPIPL3_7@0@0@0@@:integral to membrane;molecular_function;cellular_component;biological_process@NA
A2463_09@144096@144099@deletion@4@28617143@28618398@16@chr16:28617143-28618398@6.64@254@158@0.622@CNVR6685.1, CNVR6685.2@SULT1A1_10, SULT1A1_9, SULT1A1_8, SULT1A1_7@0@0@0@:sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1@:small molecule metabolic process;sulfation;aryl sulfotransferase activity;amine metabolic process;catecholamine metabolic process;xenobiotic metabolic process;cytosol;steroid sulfotransferase activity;integral to membrane;sulfotransferase activity;flavonol 3-sulfotransferase activity;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process;estrogen metabolic process@NA
A2463_09@144104@144104@duplication@1@28659457@28659638@16@chr16:28659457-28659638@4.93@10@45@4.5@NA@A-575C2.4_2@0@0@0@:nuclear pore complex-interacting protein-like 2-like;putative NPIP-like protein LOC613037-like@NA@NA
A2463_09@147109@147120@deletion@12@70161164@70178436@16@chr16:70161164-70178436@39.3@1184@682@0.576@CNVR6764.1, CNVR6764.3@PDPR_4, PDPR_5, PDPR_6, PDPR_7, PDPR_8, PDPR_9, PDPR_10, PDPR_11, PDPR_12, PDPR_13, PDPR_14, PDPR_15@0@0@0@:pyruvate dehydrogenase phosphatase regulatory subunit@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix@NA
A2463_09@147419@147419@deletion@1@72091292@72091365@16@chr16:72091292-72091365@7.74@35@0@0@CNVR6769.1, CNVR6769.2@HP_4@0@0@0@:thioredoxin-like 4B:haptoglobin:haptoglobin-related protein@:mitosis;mRNA processing;RNA splicing;spliceosomal complex;cell redox homeostasis:cellular iron ion homeostasis;negative regulation of oxidoreductase activity;catalytic activity;negative regulation of hydrogen peroxide catabolic process;positive regulation of cell death;haptoglobin-hemoglobin complex;extracellular space;proteolysis;response to hydrogen peroxide;extracellular region;hemoglobin binding;defense response;serine-type endopeptidase activity:spherical high-density lipoprotein particle;proteolysis;extracellular region;hemoglobin binding;catalytic activity;serine-type endopeptidase activity@: ANHAPTOGLOBINEMIA; AHP
A2463_09@147496@147503@deletion@8@74411873@74442941@16@chr16:74411873-74442941@35@1418@790@0.557@CNVR6778.2, CNVR6778.4@NPIPL2_1, NPIPL2_2, NPIPL2_3, NPIPL2_4, NPIPL2_5, NPIPL2_6, NPIPL2_7, CLEC18B_13@0@0@0@:C-type lectin domain family 18, member B@:extracellular region:carbohydrate binding;protein binding;extracellular region@NA
A2463_09@147508@147512@deletion@5@74445568@74447574@16@chr16:74445568-74447574@21.2@445@228@0.512@CNVR6778.2, CNVR6778.3, CNVR6778.5@CLEC18B_8, CLEC18B_7, CLEC18B_6, CLEC18B_5, CLEC18B_4@0@0@0@:C-type lectin domain family 18, member B@:carbohydrate binding;protein binding;extracellular region@NA
A2463_09@151877@151886@deletion@10@18389249@18430117@17@chr17:18389249-18430117@16.1@382@216@0.565@NA@LGALS9C_3, LGALS9C_4, LGALS9C_5, LGALS9C_6, LGALS9C_7, LGALS9C_8, LGALS9C_9, LGALS9C_10, LGALS9C_11, FAM106A_1@0@0@0@:lectin, galactoside-binding, soluble, 9C:protein FAM106B-like@:carbohydrate binding@NA
A2463_09@151958@151959@deletion@2@18996506@18997166@17@chr17:18996506-18997166@8.15@250@139@0.556@CNVR7018.4, CNVR7018.2, CNVR7018.6@AC007952.5_1, AC007952.5_2@0@0@0@NA@NA@NA
A2463_09@153380@153382@duplication@3@34539179@34581968@17@chr17:34539179-34581968@6.14@44@94@2.14@CNVR7077.1, CNVR7077.13, CNVR7077.19@CCL4L1_2, CCL4L1_3, TBC1D3C_14@0@0@0@:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1:TBC1 domain family, member 3C;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3H-like;TBC1 domain family, member 3H@:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_09@154346@154346@deletion@1@39421631@39422112@17@chr17:39421631-39422112@5.23@52@18@0.346@CNVR7096.1@KRTAP9-6_1@0@0@0@:keratin associated protein 9-6@:keratin filament@NA
A2463_09@155582@155582@deletion@1@44372501@44375108@17@chr17:44372501-44375108@4.57@75@36@0.48@CNVR7114.3, CNVR7114.2@LRRC37A_1@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
A2463_09@155584@155590@duplication@7@44380005@44409347@17@chr17:44380005-44409347@25.8@288@575@2@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A_3, LRRC37A_4, LRRC37A_5, LRRC37A_6, LRRC37A_7, LRRC37A_8, LRRC37A_9@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
A2463_09@155592@155600@duplication@9@44412912@44594799@17@chr17:44412912-44594799@54.7@197@768@3.9@CNVR7114.2, CNVR7114.1@LRRC37A_11, LRRC37A_12, LRRC37A_13, LRRC37A_14, ARL17B_4, ARL17B_3, ARL17B_2, LRRC37A2_2, LRRC37A2_3@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
A2463_09@156882@156882@deletion@1@57676737@57676844@17@chr17:57676737-57676844@7.66@122@53@0.434@NA@DHX40_14@0@0@0@:DEAH (Asp-Glu-Ala-His) box polypeptide 40@:transport;helicase activity;intracellular;ATP-dependent helicase activity;nucleic acid binding;ATP binding@NA
A2463_09@162017@162018@duplication@2@44542732@44550298@18@chr18:44542732-44550298@31.5@370@895@2.42@CNVR7319.1, CNVR7319.2@TCEB3CL2_1, TCEB3CL_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2:transcription elongation factor B polypeptide 3C-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_09@162017@162019@deletion@1@44542732@44556213@18@chr18:44542732-44556213@-18@2525@2182@0.864@CNVR7319.1, CNVR7319.2@TCEB3CL2_1, TCEB3CL_1, TCEB3C_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2:transcription elongation factor B polypeptide 3C-like:transcription elongation factor B polypeptide 3C (elongin A3);RNA polymerase II transcription factor SIII subunit A3-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_09@164950@164957@deletion@8@7030624@7058616@19@chr19:7030624-7058616@20.5@302@143@0.474@CNVR7517.1@MBD3L5_1, MBD3L5_2, MBD3L4_2, MBD3L4_1, MBD3L2_1, MBD3L2_2, MBD3L3_2, MBD3L3_1@0@0@0@:methyl-CpG binding domain protein 3-like 5:methyl-CpG binding domain protein 3-like 4:methyl-CpG-binding domain protein 3-like 2-like;methyl-CpG binding domain protein 3-like 2:methyl-CpG binding domain protein 3-like 3@:regulation of transcription, DNA-dependent;transcription, DNA-dependent:regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_09@167047@167047@duplication@1@14877791@14877921@19@chr19:14877791-14877921@5.71@58@115@1.98@NA@EMR2_6@0@0@0@:egf-like module containing, mucin-like, hormone receptor-like 2@:transmembrane signaling receptor activity;inflammatory response;G-protein coupled receptor activity;ruffle membrane;integral to membrane;plasma membrane;cell surface receptor signaling pathway;neuropeptide signaling pathway;granulocyte chemotaxis;cell migration;leading edge membrane;G-protein coupled receptor signaling pathway;protein binding;cell adhesion;membrane;calcium ion binding;chondroitin sulfate binding@NA
A2463_09@168952@168952@duplication@1@35862263@35863302@19@chr19:35862263-35863302@6.13@83@153@1.84@CNVR7627.1@GPR42_2@0@0@0@@:integral to membrane;G-protein coupled receptor activity;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
A2463_09@169778@169778@deletion@1@39262470@39262670@19@chr19:39262470-39262670@5.79@29@2@0.069@NA@LGALS7_3@0@0@0@:lectin, galactoside-binding, soluble, 7;lectin, galactoside-binding, soluble, 7B@:carbohydrate binding;heterophilic cell-cell adhesion;extracellular space;nucleus;apoptotic process;cytoplasm@NA
A2463_09@170098@170101@duplication@4@40376632@40384167@19@chr19:40376632-40384167@11.2@305@459@1.5@CNVR7639.2@FCGBP_24, FCGBP_23, FCGBP_22, FCGBP_21@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_09@170107@170109@deletion@3@40395805@40399855@19@chr19:40395805-40399855@12.5@360@212@0.589@CNVR7639.2, CNVR7639.3@FCGBP_15, FCGBP_14, FCGBP_13@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_09@173301@173308@duplication@8@54742830@54746600@19@chr19:54742830-54746600@16.6@614@882@1.44@CNVR7721.3, CNVR7721.6@LILRA6_8, LILRA6_7, LILRA6_6, LILRA6_5, LILRA6_4, LILRA6_3, LILRA6_2, LILRA6_1@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
A2463_09@173336@173341@duplication@6@54801928@54804173@19@chr19:54801928-54804173@7.29@266@378@1.42@CNVR7722.1@LILRA3_6, LILRA3_5, LILRA3_4, LILRA3_3, LILRA3_2, LILRA3_1@0@0@0@:leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3@:antigen binding;signal transduction;protein binding;extracellular region;plasma membrane;receptor activity;defense response@NA
A2463_09@173460@173482@duplication@23@55247288@55320338@19@chr19:55247288-55320338@60.1@867@1497@1.73@CNVR7725.2, CNVR7725.1@KIR3DL3_7, KIR3DL3_8, KIR2DL3_1, KIR2DL3_2, KIR2DL3_3, KIR2DL3_4, KIR2DL3_5, KIR2DL3_6, KIR2DL3_7, KIR2DL3_8, KIR2DL1_1, KIR2DL1_2, KIR2DL1_3, KIR2DL1_4, KIR2DL1_5, KIR2DL1_6, KIR2DL1_7, KIR2DL1_8, KIR2DL4_1, KIR2DL4_2, KIR2DL4_3, KIR2DL4_4, KIR2DL4_5@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:integral to membrane;plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane@NA
A2463_09@173487@173503@duplication@17@55329771@55362710@19@chr19:55329771-55362710@37.6@750@1182@1.58@CNVR7725.1, CNVR7725.6@KIR3DL1_3, KIR3DL1_4, KIR3DL1_5, KIR3DL1_6, KIR3DL1_7, KIR3DL1_8, KIR3DL1_9, KIR2DS4_1, KIR2DS4_2, KIR2DS4_3, KIR2DS4_4, KIR2DS4_5, KIR2DS4_6, KIR2DS4_7, KIR2DS4_8, KIR3DL2_1, KIR3DL2_2@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2-like@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane@NA
A2463_09@175742@175743@deletion@2@29631539@29632721@20@chr20:29631539-29632721@5.72@191@112@0.586@CNVR7827.3, CNVR7827.1@FRG1B_7, FRG1B_8@0@0@0@:protein FRG1-like@NA@NA
A2463_09@178985@179000@deletion@16@10862623@10944787@21@chr21:10862623-10944787@29.5@3112@2136@0.686@CNVR7947.10, CNVR7947.6, CNVR7947.11@IGHV1OR21-1_1, IGHV1OR21-1_2, TPTE_24, TPTE_23, TPTE_22, TPTE_21, TPTE_20, TPTE_19, TPTE_18, TPTE_17, TPTE_16, TPTE_15, TPTE_14, TPTE_13, TPTE_12, TPTE_11@0@0@0@:transmembrane phosphatase with tensin homology@:protein binding;extracellular region:phosphatase activity;ion channel activity;protein tyrosine phosphatase activity;ion transport;protein dephosphorylation;transmembrane transport;protein binding;signal transduction;integral to membrane;protein tyrosine/serine/threonine phosphatase activity;dephosphorylation;membrane;peptidyl-tyrosine dephosphorylation@NA
A2463_09@179011@179021@duplication@11@14982551@15013887@21@chr21:14982551-15013887@21.1@186@386@2.08@CNVR7952.1@POTED_1, POTED_2, POTED_3, POTED_4, POTED_5, POTED_6, POTED_7, POTED_8, POTED_9, POTED_10, POTED_11@0@0@0@:POTE ankyrin domain family, member B;POTE ankyrin domain family, member C;POTE ankyrin domain family, member D@:protein binding;plasma membrane@NA
A2463_09@180976@180977@deletion@2@16287255@16449804@22@chr22:16287255-16449804@12.4@556@333@0.599@CNVR8071.2, CNVR8071.3@POTEH_1, OR11H1_1@0@0@0@:POTE ankyrin domain family, member H:olfactory receptor, family 11, subfamily H, member 1;olfactory receptor, family 11, subfamily H, member 2@:protein binding:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_09@181127@181133@deletion@7@18723546@18739404@22@chr22:18723546-18739404@7.88@57@15@0.263@CNVR8087.5, CNVR8087.2, CNVR8087.11@AC008132.1_2, AC008132.1_3, AC008132.1_4, AC008132.1_5, AC008132.1_6, AC008132.1_7, AC008132.1_8@0@0@0@NA@NA@NA
A2463_09@181624@181634@deletion@11@21562879@21579843@22@chr22:21562879-21579843@15.6@218@103@0.472@CNVR8100.4, CNVR8100.10, CNVR8100.7@GGT2_14, GGT2_13, GGT2_12, GGT2_11, GGT2_10, GGT2_9, GGT2_8, GGT2_7, GGT2_6, GGT2_5, GGT2_4@0@0@0@:gamma-glutamyltransferase 2;gamma-glutamyltranspeptidase 2-like@:hydrolase activity;small molecule metabolic process;leukotriene biosynthetic process;anchored to external side of plasma membrane;glutathione biosynthetic process;xenobiotic metabolic process;integral to membrane;glutathione metabolic process;plasma membrane;gamma-glutamyltransferase activity;cellular_component@NA
A2463_02@425@443@deletion@19@1635663@1670996@1@chr1:1635663-1670996@48.9@795@404@0.508@CNVR17.1@CDK11A_15, CDK11A_14, CDK11A_13, CDK11A_12, CDK11A_11, CDK11A_10, CDK11A_9, CDK11A_8, CDK11A_7, CDK11A_6, CDK11A_5, CDK11A_4, CDK11A_3, CDK11A_2, SLC35E2_6, SLC35E2_5, SLC35E2_4, SLC35E2_3, SLC35E2_2@0@0@0@:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A:solute carrier family 35, member E2@:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division:integral to membrane;membrane@NA
A2463_02@1806@1807@deletion@2@12853378@12854642@1@chr1:12853378-12854642@6.63@428@288@0.673@CNVR72.3, CNVR72.10@PRAMEF1_2, PRAMEF1_3@0@0@0@:PRAME family member 1@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_02@1809@1811@deletion@3@12884801@12888523@1@chr1:12884801-12888523@33.7@573@258@0.45@CNVR72.3, CNVR72.10, CNVR72.11, CNVR72.4@PRAMEF11_4, PRAMEF11_3, PRAMEF11_2@0@0@0@:PRAME family member 11@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_02@1816@1824@deletion@9@12939366@12980233@1@chr1:12939366-12980233@40.1@1010@570@0.564@CNVR72.3, CNVR72.4, CNVR72.2@PRAMEF4_4, PRAMEF4_3, PRAMEF4_2, PRAMEF10_4, PRAMEF10_3, PRAMEF10_2, PRAMEF7_2, PRAMEF7_3, PRAMEF7_4@0@0@0@:PRAME family member 4:PRAME family member 10:PRAME family member 7@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_02@1835@1839@deletion@5@13330415@13368733@1@chr1:13330415-13368733@8.72@44@3@0.0682@CNVR74.8, CNVR74.4@PRAMEF3_2, PRAMEF3_1, PRAMEF5_2, PRAMEF5_3, PRAMEF5_4@0@0@0@:PRAME family member 3:PRAME family member 5@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_02@1853@1855@duplication@3@13495968@13522259@1@chr1:13495968-13522259@8.57@49@113@2.31@NA@PRAMEF16_2, PRAMEF16_3, PRAMEF21_2@0@0@0@:PRAME family member 16:PRAME family member 21;PRAME family member 20@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_02@1869@1870@deletion@2@13718405@13743098@1@chr1:13718405-13743098@13.9@108@30@0.278@NA@PRAMEF17_3, PRAMEF20_2@0@0@0@:PRAME family member 17:PRAME family member 21;PRAME family member 20@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_02@3333@3342@deletion@10@25599040@25655415@1@chr1:25599040-25655415@156@801@45@0.0562@CNVR116.1, CNVR116.2@RHD_1, RHD_2, RHD_3, RHD_4, RHD_5, RHD_6, RHD_7, RHD_8, RHD_9, RHD_10@0@0@0@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
A2463_02@3357@3357@duplication@1@25735175@25735360@1@chr1:25735175-25735360@4.76@92@147@1.6@CNVR117.1@RHCE_2@0@0@0@:Rh blood group, CcEe antigens@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@: BLOOD GROUP--RHESUS SYSTEM E POLYPEPTIDE; RHE; RHESUS BLOOD GROUP, CcEe ANTIGENS; RHCE
A2463_02@8507@8508@deletion@2@89476588@89477710@1@chr1:89476588-89477710@71.6@365@4@0.011@CNVR244.1@GBP3_8, GBP3_7@0@0@0@:guanylate binding protein 3@:defense response to virus;GTP binding;GTPase activity;membrane;cytoplasm@NA
A2463_02@9354@9374@deletion@21@104163174@104234232@1@chr1:104163174-104234232@36.7@607@311@0.512@CNVR266.3, CNVR266.1@AMY2A_5, AMY2A_6, AMY2A_7, AMY2A_8, AMY2A_9, AMY2A_10, AMY1A_2, AMY1A_3, AMY1A_4, AMY1A_5, AMY1A_6, AMY1A_7, AMY1A_8, AMY1A_9, AMY1A_10, AMY1A_11, AMY1B_11, AMY1B_10, AMY1B_9, AMY1B_8, AMY1B_7@0@0@0@:amylase, alpha 2A (pancreatic):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:chloride ion binding;cation binding;small molecule metabolic process;carbohydrate metabolic process;catalytic activity;extracellular space;polysaccharide digestion;extracellular region;carbohydrate catabolic process;alpha-amylase activity;calcium ion binding:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
A2463_02@9766@9773@deletion@8@110230497@110235917@1@chr1:110230497-110235917@52.8@251@5@0.0199@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_1, GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
A2463_02@10788@10788@duplication@1@144220788@144220959@1@chr1:144220788-144220959@8.67@57@131@2.3@CNVR333.1, CNVR333.3@RP3-377D14.1_87@0@0@0@NA@NA@NA
A2463_02@10793@10793@deletion@1@144339779@144340398@1@chr1:144339779-144340398@4.57@23@2@0.087@CNVR334.4, CNVR334.2@AL592284.1_1@0@0@0@:uncharacterized LOC730256;uncharacterized LOC101060698;uncharacterized LOC642441@NA@NA
A2463_02@10890@10893@deletion@4@145325953@145328432@1@chr1:145325953-145328432@9.35@47@3@0.0638@CNVR341.2, CNVR341.3@NBPF10_30, NBPF10_31, NBPF10_32, NBPF10_33@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family, member 10@NA@NA
A2463_02@11143@11157@deletion@15@146227744@146244717@1@chr1:146227744-146244717@13.2@61@1@0.0164@NA@NBPF12_22, NBPF12_21, NBPF12_20, NBPF12_19, NBPF12_18, NBPF12_17, NBPF12_16, NBPF12_15, NBPF12_14, NBPF12_13, NBPF12_12, NBPF12_11, NBPF12_10, NBPF12_9, NBPF12_8@0@0@0@:neuroblastoma breakpoint family member 21-like@NA@NA
A2463_02@11161@11164@deletion@4@146248917@146253110@1@chr1:146248917-146253110@14.8@144@56@0.389@NA@NBPF12_4, NBPF12_3, NBPF12_2, NBPF12_1@0@0@0@:neuroblastoma breakpoint family member 21-like@NA@NA
A2463_02@11169@11173@duplication@5@146400092@146405926@1@chr1:146400092-146405926@11.7@94@191@2.03@NA@NBPF12_9, NBPF12_10, NBPF12_11, NBPF12_12, NBPF12_13@0@0@0@:neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family member 14-like;neuroblastoma breakpoint family, member 12@:cytoplasm@NA
A2463_02@11353@11355@deletion@3@148021578@148023669@1@chr1:148021578-148023669@11.1@219@115@0.525@CNVR346.2, CNVR346.4@NBPF14_5, NBPF14_4, NBPF14_3@0@0@0@:neuroblastoma breakpoint family, member 14@:cytoplasm@NA
A2463_02@12117@12118@deletion@2@152573209@152586574@1@chr1:152573209-152586574@23.9@111@0@0@CNVR358.1@LCE3C_1, LCE3B_1@0@0@0@:late cornified envelope 3C:late cornified envelope 3B@:keratinization:keratinization@NA
A2463_02@14046@14053@duplication@8@161487766@161565521@1@chr1:161487766-161565521@20.8@1187@1641@1.38@CNVR383.3, CNVR383.1@FCGR2A_7, HSPA6_1, FCGR3A_5, FCGR3A_4, FCGR3A_3, FCGR3A_2, FCGR3A_1, FCGR2C_1@0@0@0@:Fc fragment of IgG, low affinity IIa, receptor (CD32):heat shock 70kDa protein 6 (HSP70B'):Fc fragment of IgG, low affinity IIIa, receptor (CD16a):Fc fragment of IgG, low affinity IIb, receptor (CD32):Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene)@:IgG binding;protein binding;integral to membrane;plasma membrane:signalosome;cell morphogenesis;response to unfolded protein;ATP binding:IgG binding;protein binding;regulation of immune response;extracellular region;integral to membrane;immune response;plasma membrane;external side of plasma membrane:IgG binding;protein binding;signal transduction;regulation of immune response;integral to membrane;immune response;plasma membrane;virus-host interaction@: MALARIA, SUSCEPTIBILITY TO; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
A2463_02@16026@16026@duplication@1@196712583@196712758@1@chr1:196712583-196712758@5.04@238@339@1.42@CNVR459.1@CFH_20@0@0@0@:complement factor H@:complement activation, alternative pathway;extracellular space;complement activation;extracellular region;regulation of complement activation;innate immune response@: HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1; AHUS1; MACULAR DEGENERATION, AGE-RELATED, 4; ARMD4; COMPLEMENT FACTOR H DEFICIENCY; CFHD; BASAL LAMINAR DRUSEN
A2463_02@16038@16038@deletion@1@196797201@196797376@1@chr1:196797201-196797376@9.29@124@52@0.419@CNVR459.1@CFHR1_4@0@0@0@:complement factor H-related 1:complement factor H-related 2@:extracellular space;complement activation:extracellular region@NA
A2463_02@19774@19778@deletion@5@248737103@248814185@1@chr1:248737103-248814185@27.5@927@547@0.59@CNVR600.1@OR2T34_1, OR2T10_1, OR2T11_1, OR2T35_1, OR2T27_1@0@0@0@:olfactory receptor, family 2, subfamily T, member 34:olfactory receptor, family 2, subfamily T, member 10:olfactory receptor, family 2, subfamily T, member 11:olfactory receptor, family 2, subfamily T, member 35:olfactory receptor, family 2, subfamily T, member 27@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_02@24822@24822@duplication@1@87178420@87178483@2@chr2:87178420-87178483@6.77@20@68@3.4@NA@RGPD1_2@0@0@0@:RANBP2-like and GRIP domain containing 1@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_02@24851@24851@deletion@1@88071689@88071883@2@chr2:88071689-88071883@5.37@36@8@0.222@NA@RGPD2_22@0@0@0@:RANBP2-like and GRIP domain containing 2@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_02@24862@24871@deletion@10@88094928@88118142@2@chr2:88094928-88118142@14.3@103@24@0.233@NA@RGPD2_11, RGPD2_10, RGPD2_9, RGPD2_8, RGPD2_7, RGPD2_6, RGPD2_5, RGPD2_4, RGPD2_3, RGPD2_2@0@0@0@:RANBP2-like and GRIP domain containing 2@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_02@25004@25005@duplication@2@90192949@90193424@2@chr2:90192949-90193424@6.83@176@265@1.51@CNVR867.10, CNVR867.5, CNVR867.3, CNVR867.9, CNVR867.15@IGKV1D-13_1, IGKV1D-13_2@0@0@0@@:protein binding@NA
A2463_02@25089@25091@deletion@3@96259773@96262180@2@chr2:96259773-96262180@18.9@343@169@0.493@NA@TRIM43_2, TRIM43_3, TRIM43_4@0@0@0@:tripartite motif containing 43B;tripartite motif containing 43@:protein binding;intracellular;zinc ion binding@NA
A2463_02@25369@25370@duplication@2@97854825@97855027@2@chr2:97854825-97855027@21.9@106@287@2.71@CNVR886.2, CNVR886.3@ANKRD36_33, ANKRD36_34@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_02@25383@25386@deletion@4@97867940@97870000@2@chr2:97867940-97870000@20.6@584@335@0.574@CNVR886.1@ANKRD36_47, ANKRD36_48, ANKRD36_49, ANKRD36_50@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_02@26008@26011@deletion@4@108454714@108460186@2@chr2:108454714-108460186@12@121@43@0.355@NA@RGPD4_3, RGPD4_4, RGPD4_5, RGPD4_6@0@0@0@:RANBP2-like and GRIP domain containing 4@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_02@26021@26021@deletion@1@108479139@108479317@2@chr2:108479139-108479317@4.83@145@85@0.586@NA@RGPD4_16@0@0@0@:RANBP2-like and GRIP domain containing 4@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_02@27163@27163@deletion@1@130843388@130843568@2@chr2:130843388-130843568@8.85@40@0@0@NA@POTEF_13@0@0@0@:POTE ankyrin domain family, member F@:cell cortex;protein binding;ATP binding@NA
A2463_02@27171@27173@deletion@3@130868117@130872627@2@chr2:130868117-130872627@10.5@112@44@0.393@NA@POTEF_5, POTEF_4, POTEF_3@0@0@0@:POTE ankyrin domain family, member F@:cell cortex;protein binding;ATP binding@NA
A2463_02@27279@27288@deletion@10@131381638@131415450@2@chr2:131381638-131415450@16.2@834@533@0.639@NA@POTEJ_6, POTEJ_7, POTEJ_8, POTEJ_9, POTEJ_10, POTEJ_11, POTEJ_12, POTEJ_13, POTEJ_14, POTEJ_15@0@0@0@:POTE ankyrin domain family, member J@:protein binding;ATP binding@NA
A2463_02@27318@27319@duplication@2@131984397@131985954@2@chr2:131984397-131985954@4.97@197@277@1.41@NA@POTEE_4, POTEE_5@0@0@0@:pleckstrin homology domain containing, family B (evectins) member 2:POTE ankyrin domain family, member E@:phospholipid binding;protein binding;recycling endosome membrane:protein binding;ATP binding@NA
A2463_02@27996@27997@duplication@2@152463121@152464122@2@chr2:152463121-152464122@6.83@88@155@1.76@CNVR1026.1@NEB_84, NEB_83@0@0@0@:nebulin@:Z disc;muscle filament sliding;oxidation-reduction process;contractile fiber part;actin cytoskeleton;regulation of actin filament length;structural constituent of muscle;cytosol;actin binding;protein binding;myofibril;somatic muscle development;muscle organ development@: NEMALINE MYOPATHY 2; NEM2
A2463_02@39892@39894@deletion@3@75786030@75790887@3@chr3:75786030-75790887@9.91@206@113@0.549@CNVR1432.5, CNVR1432.9, CNVR1432.4@ZNF717_5, ZNF717_4, ZNF717_3@0@0@0@:zinc finger protein 717;zinc finger protein 717-like@:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_02@41721@41722@deletion@2@126142169@126142487@3@chr3:126142169-126142487@6.28@62@23@0.371@NA@CCDC37_12, CCDC37_13@0@0@0@:coiled-coil domain containing 37@:pathogenesis;extracellular region@NA
A2463_02@46667@46675@deletion@9@9174900@9237700@4@chr4:9174900-9237700@24.1@124@9@0.0726@NA@FAM90A26P_4, FAM90A26P_5, FAM90A26P_6, FAM90A26P_7, USP17L13_1, USP17L10_1, USP17L11_1, USP17L12_1, USP17L13_2, USP17L15_1@0@0@0@:ubiquitin specific peptidase 17-like family member 10:ubiquitin specific peptidase 17-like family member 13:ubiquitin specific peptidase 17-like family member 11:ubiquitin specific peptidase 17-like family member 12:ubiquitin specific peptidase 17-like family member 15@:zinc ion binding;nucleic acid binding:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
A2463_02@46677@46677@deletion@1@9250357@9251948@4@chr4:9250357-9251948@10.9@292@154@0.527@NA@USP17L18_1@0@0@0@:ubiquitin specific peptidase 17-like family member 18@:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
A2463_02@48556@48561@deletion@6@69403344@69434202@4@chr4:69403344-69434202@84.6@483@51@0.106@CNVR1953.1@UGT2B17_6, UGT2B17_5, UGT2B17_4, UGT2B17_3, UGT2B17_2, UGT2B17_1@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B17@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;membrane@: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
A2463_02@48592@48597@deletion@6@70146220@70160527@4@chr4:70146220-70160527@13.3@660@432@0.655@CNVR1957.2, CNVR1957.1@UGT2B28_1, UGT2B28_2, UGT2B28_3, UGT2B28_4, UGT2B28_5, UGT2B28_6@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B28@:carbohydrate binding;transferase activity, transferring hexosyl groups;endoplasmic reticulum;glucuronosyltransferase activity;carbohydrate metabolic process;xenobiotic metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process@NA
A2463_02@55835@55837@deletion@3@70338009@70343940@5@chr5:70338009-70343940@11.7@103@37@0.359@CNVR2494.41, CNVR2494.14, CNVR2494.20, CNVR2494.62, CNVR2494.8@GTF2H2_14, GTF2H2_13, GTF2H2_12@0@0@0@:general transcription factor IIH, polypeptide 2, 44kDa@:nucleoplasm;nucleotide-excision repair, DNA damage removal;transcription from RNA polymerase I promoter;DNA repair;RNA polymerase II carboxy-terminal domain kinase activity;nucleus;viral reproduction;translation;gene expression;transcription elongation from RNA polymerase I promoter;response to UV;holo TFIIH complex;protein kinase activity;nucleotide-excision repair;transcription from RNA polymerase II promoter;transcription-coupled nucleotide-excision repair;transcription, DNA-dependent;zinc ion binding;transcription elongation from RNA polymerase II promoter;termination of RNA polymerase I transcription;sequence-specific DNA binding transcription factor activity;G-protein coupled receptor internalization;DNA-dependent ATPase activity;protein N-terminus binding;transcription initiation from RNA polymerase I promoter;7-methylguanosine mRNA capping;transcription initiation from RNA polymerase II promoter;protein phosphorylation;translation factor activity, nucleic acid binding;regulation of transcription, DNA-dependent;core TFIIH complex;protein binding;positive regulation of viral transcription;nucleic acid binding@NA
A2463_02@59046@59047@deletion@2@140228082@140238021@5@chr5:140228082-140238021@23.4@1521@904@0.594@CNVR2622.1@PCDHA9_1, PCDHA10_1@0@0@0@:protocadherin alpha 1:protocadherin alpha 2:protocadherin alpha 3:protocadherin alpha 4:protocadherin alpha 5:protocadherin alpha 6:protocadherin alpha 7:protocadherin alpha 8:protocadherin alpha 9:protocadherin alpha 10@:extracellular region;cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:integral to membrane;cell adhesion;homophilic cell adhesion;plasma membrane;integral to plasma membrane;membrane;nervous system development;calcium ion binding:cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:extracellular region;cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:integral to membrane;homophilic cell adhesion;plasma membrane;membrane;calcium ion binding:extracellular region;cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development@NA
A2463_02@59065@59065@deletion@1@140557617@140560021@5@chr5:140557617-140560021@23.3@2107@1106@0.525@CNVR2624.1@PCDHB8_1@0@0@0@:protocadherin beta 8@:integral to membrane;homophilic cell adhesion;plasma membrane;membrane;calcium ion binding@NA
A2463_02@59488@59488@deletion@1@147553798@147553933@5@chr5:147553798-147553933@6.64@30@0@0@CNVR2637.2, CNVR2637.1@SPINK14_3@0@0@0@:serine peptidase inhibitor, Kazal type 14 (putative)@:serine-type endopeptidase inhibitor activity;protein binding;extracellular region@NA
A2463_02@60882@60887@deletion@6@175487236@175523903@5@chr5:175487236-175523903@13.8@125@41@0.328@NA@RP11-826N14.2_2, FAM153B_3, FAM153B_4, FAM153B_5, FAM153B_6@0@0@0@:uncharacterized LOC100507387;family with sequence similarity 153, member B@NA@NA
A2463_02@61454@61455@duplication@2@179071801@179078353@5@chr5:179071801-179078353@5.3@153@226@1.48@NA@C5orf60_1, AC136604.1_1@0@0@0@:chromosome 5 open reading frame 60@:integral to membrane@NA
A2463_02@61640@61647@deletion@8@180376240@180431443@5@chr5:180376240-180431443@29.4@716@394@0.55@CNVR2719.1@BTNL8_7, BTNL8_8, BTNL3_1, BTNL3_2, BTNL3_3, BTNL3_4, BTNL3_5, BTNL3_6@0@0@0@:butyrophilin-like 8:butyrophilin-like 3@:protein binding;integral to membrane:protein binding;integral to membrane;molecular_function;cellular_component;biological_process@NA
A2463_02@63773@63777@duplication@5@31996235@31997575@6@chr6:31996235-31997575@6.85@579@759@1.31@CNVR2843.6, CNVR2843.5@C4B_25, C4B_26, C4B_27, C4B_28, C4B_29@0@0@0@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
A2463_02@63953@63955@deletion@3@32485517@32486443@6@chr6:32485517-32486443@5.92@35@6@0.171@CNVR2845.21, CNVR2845.25, CNVR2845.30@HLA-DRB5_6, HLA-DRB5_5, HLA-DRB5_4@0@0@0@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
A2463_02@65214@65215@deletion@2@42023270@42023752@6@chr6:42023270-42023752@5.06@84@43@0.512@NA@TAF8_3, TAF8_4@0@0@0@:TAF8 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 43kDa@:cell differentiation;protein heterodimerization activity;transcription factor TFIID complex;perinuclear region of cytoplasm;maintenance of protein location in nucleus;protein binding;positive regulation of transcription, DNA-dependent;regulation of fat cell differentiation;nucleus;transcription, DNA-dependent;inner cell mass cell proliferation@NA
A2463_02@70808@70817@deletion@10@161032595@161056336@6@chr6:161032595-161056336@21.9@236@91@0.386@CNVR3133.1@LPA_17, LPA_16, LPA_15, LPA_14, LPA_13, LPA_12, LPA_11, LPA_10, LPA_9, LPA_8@0@0@0@:lipoprotein, Lp(a)@:blood circulation;endopeptidase inhibitor activity;catalytic activity;lipoprotein metabolic process;proteolysis;heparin binding;receptor-mediated endocytosis;fibronectin binding;small molecule metabolic process;apolipoprotein binding;lipid metabolic process;negative regulation of endopeptidase activity;extracellular region;plasma lipoprotein particle;lipid transport;serine-type endopeptidase activity@: APOLIPOPROTEIN(a); LPA
A2463_02@71011@71011@duplication@1@167590486@167590622@6@chr6:167590486-167590622@4.74@76@126@1.66@NA@TCP10L2_4@0@0@0@:t-complex 10;t-complex 10-like 2@NA@NA
A2463_02@71030@71032@deletion@3@167790035@167794824@6@chr6:167790035-167794824@16.2@130@38@0.292@NA@TCP10_5, TCP10_4, TCP10_3@0@0@0@:t-complex 10@:cytosol@NA
A2463_02@71746@71758@duplication@13@5940487@5966179@7@chr7:5940487-5966179@33.8@893@1341@1.5@NA@CCZ1_4, CCZ1_5, CCZ1_6, CCZ1_7, CCZ1_8, CCZ1_9, CCZ1_10, CCZ1_11, CCZ1_12, CCZ1_13, CCZ1_14, CCZ1_15, RSPH10B_20@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae):radial spoke head 10 homolog B (Chlamydomonas)@:lysosomal membrane@NA
A2463_02@71772@71776@duplication@5@5998625@6006747@7@chr7:5998625-6006747@8.64@153@248@1.62@NA@RSPH10B_6, RSPH10B_5, RSPH10B_4, RSPH10B_3, RSPH10B_2@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
A2463_02@71922@71927@deletion@6@6797310@6806508@7@chr7:6797310-6806508@18.7@272@125@0.46@NA@RSPH10B2_2, RSPH10B2_3, RSPH10B2_4, RSPH10B2_5, RSPH10B2_6, RSPH10B2_7@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
A2463_02@71939@71953@deletion@15@6836200@6864179@7@chr7:6836200-6864179@60.3@1067@548@0.514@NA@RSPH10B2_19, RSPH10B2_20, CCZ1B_15, CCZ1B_14, CCZ1B_13, CCZ1B_12, CCZ1B_11, CCZ1B_10, CCZ1B_9, CCZ1B_8, CCZ1B_7, CCZ1B_6, CCZ1B_5, CCZ1B_4, CCZ1B_3@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
A2463_02@73260@73263@duplication@4@38388957@38393784@7@chr7:38388957-38393784@9.67@211@325@1.54@CNVR3354.3, CNVR3354.1@TRGV5_2, TRGV5_1, TRGV4_2, TRGV4_1@0@0@0@@:protein binding:protein binding@NA
A2463_02@74573@74573@duplication@1@74166423@74166502@7@chr7:74166423-74166502@6.86@66@129@1.95@NA@GTF2I_28@0@0@0@:general transcription factor IIi@:neuronal cell body;transcription initiation from RNA polymerase II promoter;mitogen-activated protein kinase binding;negative regulation of angiogenesis;DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;cytoplasm;transcription from RNA polymerase II promoter;protein binding;signal transduction;nucleus;cell projection;reduction of cytosolic calcium ion concentration@NA
A2463_02@74597@74598@duplication@2@74225431@74227349@7@chr7:74225431-74227349@9.42@45@115@2.56@NA@GTF2IRD2_10, GTF2IRD2_9@0@0@0@:GTF2I repeat domain containing 2@:nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_02@74634@74635@deletion@2@74550812@74552657@7@chr7:74550812-74552657@6.04@121@64@0.529@NA@GTF2IRD2B_10, GTF2IRD2B_11@0@0@0@:GTF2I repeat domain containing 2B@:nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_02@76779@76793@deletion@15@102279571@102312048@7@chr7:102279571-102312048@17.5@170@61@0.359@CNVR3518.1@UPK3BL_4, UPK3BL_4, UPK3BL_3, UPK3BL_3, UPK3BL_2, UPK3BL_2, UPK3BL_1, UPK3BL_1, SPDYE2L_2, SPDYE2L_3, SPDYE2L_4, SPDYE2L_5, SPDYE2L_6, SPDYE2L_7, SPDYE2L_8, POLR2J2_4, POLR2J2_4, POLR2J2_3, POLR2J2_3, POLR2J2_2, POLR2J2_2, POLR2J2_1, POLR2J2_1@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4:uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J2:WBSCR19-like protein 3;speedy homolog E6 (Xenopus laevis)@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity:integral to membrane:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
A2463_02@77407@77407@deletion@1@111958238@111958328@7@chr7:111958238-111958328@6.11@72@30@0.417@NA@ZNF277_5@0@0@0@:zinc finger protein 277@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;sequence-specific DNA binding transcription factor activity;nucleic acid binding@NA
A2463_02@79287@79288@duplication@2@143400089@143417767@7@chr7:143400089-143417767@8.3@113@193@1.71@CNVR3594.2, CNVR3594.1@FAM115C_2, FAM115C_3@0@0@0@:family with sequence similarity 115, member C;protein FAM115C-like@NA@NA
A2463_02@80364@80366@deletion@3@7217760@7220468@8@chr8:7217760-7220468@5.86@333@221@0.664@CNVR3771.8, CNVR3771.10, CNVR3771.4@ZNF705G_5, ZNF705G_4, ZNF705G_3@0@0@0@:zinc finger protein 705G@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_02@80387@80388@duplication@2@7636684@7637611@8@chr8:7636684-7637611@5.08@14@49@3.5@CNVR3772.4, CNVR3772.6, CNVR3772.2, CNVR3772.8, CNVR3772.10@AC084121.16_4, AC084121.16_3@0@0@0@:uncharacterized LOC100133251@NA@NA
A2463_02@80565@80565@duplication@1@11994678@11996269@8@chr8:11994678-11996269@5.42@1137@1521@1.34@CNVR3785.8, CNVR3785.5, CNVR3785.6, CNVR3785.2, CNVR3785.1, CNVR3785.3@USP17L2_1@0@0@0@:ubiquitin specific peptidase 17-like family member 1, pseudogene;ubiquitin specific peptidase 17-like family member 2;ubiquitin specific peptidase 17-like family member 4;ubiquitin specific peptidase 17-like family member 7;ubiquitin specific peptidase 17-like family member 8;ubiquitin specific peptidase 17-like family member 3@:protein deubiquitination;ubiquitin-specific protease activity;mitotic cell cycle G1/S transition checkpoint;nucleus;G2/M transition checkpoint;apoptotic process;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
A2463_02@88596@88596@deletion@1@43828079@43828221@9@chr9:43828079-43828221@7.63@50@10@0.2@CNVR4294.1@CNTNAP3B_9@0@0@0@:contactin associated protein-like 3B;contactin associated protein-like 3@:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
A2463_02@88610@88611@deletion@2@43915827@43920370@9@chr9:43915827-43920370@8.41@71@22@0.31@NA@CNTNAP3B_23, CNTNAP3B_24@0@0@0@:contactin associated protein-like 3B;contactin associated protein-like 3@:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
A2463_02@88620@88622@duplication@3@45727245@45733965@9@chr9:45727245-45733965@10.3@149@254@1.7@CNVR4305.1@FAM27A_1, AL953889.1_2, AL953889.1_1, FAM27A_2, FAM27E2_1@0@0@0@NA@NA@NA
A2463_02@88631@88632@duplication@2@65503517@65507567@9@chr9:65503517-65507567@12.3@201@341@1.7@CNVR4312.5@SPATA31A7_4, SPATA31A7_3@0@0@0@:SPATA31 subfamily A, member 7@:integral to membrane@NA
A2463_02@88643@88643@deletion@1@67935876@67936012@9@chr9:67935876-67936012@5.68@25@0@0@NA@ANKRD20A1_5@0@0@0@:ankyrin repeat domain 20 family, member A1@:protein binding;plasma membrane@NA
A2463_02@88647@88657@deletion@11@67951933@67987998@9@chr9:67951933-67987998@31.5@838@507@0.605@NA@ANKRD20A1_9, ANKRD20A1_10, ANKRD20A1_11, ANKRD20A1_12, ANKRD20A1_13, ANKRD20A1_14, ANKRD20A1_15, RP11-195B21.3_3, RP11-195B21.3_4, RP11-195B21.3_5, RP11-195B21.3_6@0@0@0@:ankyrin repeat domain 20 family, member A1:coiled-coil domain-containing protein 29-like;uncharacterized LOC644249@:protein binding;plasma membrane@NA
A2463_02@88681@88690@duplication@10@69393823@69424176@9@chr9:69393823-69424176@39.6@674@1181@1.75@NA@ANKRD20A4_6, ANKRD20A4_7, ANKRD20A4_8, ANKRD20A4_9, ANKRD20A4_10, ANKRD20A4_11, ANKRD20A4_12, ANKRD20A4_13, ANKRD20A4_14, ANKRD20A4_15@0@0@0@:ankyrin repeat domain 20 family, member A4@:protein binding@NA
A2463_02@91242@91246@duplication@5@117085415@117087432@9@chr9:117085415-117087432@27.1@338@635@1.88@CNVR4448.1@ORM1_1, ORM1_2, ORM1_3, ORM1_4, ORM1_5@0@0@0@:orosomucoid 1@:protein binding;extracellular space;regulation of immune system process;transport;inflammatory response;extracellular region;acute-phase response@NA
A2463_02@91249@91249@deletion@1@117092715@117092856@9@chr9:117092715-117092856@11.8@146@57@0.39@CNVR4448.1@ORM2_2@0@0@0@:orosomucoid 2@:extracellular space;regulation of immune system process;transport;acute-phase response@NA
A2463_02@95350@95352@duplication@3@17865074@17875838@10@chr10:17865074-17875838@7.05@117@190@1.62@NA@MRC1L1_2, MRC1L1_3, MRC1L1_4@0@0@0@:macrophage mannose receptor 1-like@:carbohydrate binding@NA
A2463_02@95384@95386@deletion@3@18112045@18122792@10@chr10:18112045-18122792@11.3@71@14@0.197@NA@MRC1_2, MRC1_3, MRC1_4@0@0@0@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
A2463_02@96467@96470@deletion@4@46587345@46611811@10@chr10:46587345-46611811@8.57@44@4@0.0909@CNVR4712.3@PTPN20A_5, PTPN20A_4, PTPN20A_3, PTPN20A_2@0@0@0@:protein tyrosine phosphatase, non-receptor type 20B;protein tyrosine phosphatase, non-receptor type 20A@:phosphatase activity;protein tyrosine phosphatase activity;microtubule;nucleus;dephosphorylation;protein dephosphorylation;microtubule organizing center@NA
A2463_02@96480@96481@duplication@2@46998882@47087911@10@chr10:46998882-47087911@5.63@640@844@1.32@CNVR4712.9, CNVR4712.2, CNVR4712.7, CNVR4712.4@GPRIN2_1, PPYR1_3@0@0@0@:G protein regulated inducer of neurite outgrowth 2:pancreatic polypeptide receptor 1;neuropeptide Y receptor type 4-like@:blood circulation;peptide YY receptor activity;peptide binding;pancreatic polypeptide receptor activity;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;integral to membrane;digestion;plasma membrane;integral to plasma membrane;feeding behavior@NA
A2463_02@96499@96499@deletion@1@47207813@47207846@10@chr10:47207813-47207846@6.06@45@12@0.267@CNVR4712.9@AGAP10_6@0@0@0@:ArfGAP with GTPase domain, ankyrin repeat and PH domain 9@:phospholipid binding;protein binding;ARF GTPase activator activity;GTP binding;GTPase activity;zinc ion binding;regulation of ARF GTPase activity@NA
A2463_02@96538@96577@deletion@40@47899952@48033105@10@chr10:47899952-48033105@113@980@331@0.338@CNVR4715.2@FAM21B_4, FAM21B_5, FAM21B_6, FAM21B_7, FAM21B_8, FAM21B_9, FAM21B_10, FAM21B_11, FAM21B_12, FAM21B_13, FAM21B_14, FAM21B_15, FAM21B_16, FAM21B_17, FAM21B_18, FAM21B_19, FAM21B_20, FAM21B_21, FAM21B_22, FAM21B_23, FAM21B_24, FAM21B_25, FAM21B_26, FAM21B_27, FAM21B_28, FAM21B_29, ASAH2C_18, ASAH2C_17, ASAH2C_16, ASAH2C_15, ASAH2C_14, ASAH2C_13, ASAH2C_12, ASAH2C_11, ASAH2C_10, ASAH2C_9, ASAH2C_8, ASAH2C_7, ASAH2C_6, ASAH2C_5@0@0@0@:family with sequence similarity 21, member B@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome:ceramidase activity;sphingolipid metabolic process@NA
A2463_02@96620@96620@deletion@1@48771316@48771405@10@chr10:48771316-48771405@13.3@63@1@0.0159@CNVR4716.10, CNVR4716.3@PTPN20B_6@0@0@0@:protein tyrosine phosphatase, non-receptor type 20B;protein tyrosine phosphatase, non-receptor type 20A@:phosphatase activity;protein tyrosine phosphatase activity;microtubule;nucleus;dephosphorylation;protein dephosphorylation;microtubule organizing center@NA
A2463_02@96898@96922@duplication@25@51843833@51890838@10@chr10:51843833-51890838@29.4@655@996@1.52@CNVR4734.2@FAM21A_6, FAM21A_7, FAM21A_8, FAM21A_9, FAM21A_10, FAM21A_11, FAM21A_12, FAM21A_13, FAM21A_14, FAM21A_15, FAM21A_16, FAM21A_17, FAM21A_18, FAM21A_19, FAM21A_20, FAM21A_21, FAM21A_22, FAM21A_23, FAM21A_24, FAM21A_25, FAM21A_26, FAM21A_27, FAM21A_28, FAM21A_29, FAM21A_30@0@0@0@:family with sequence similarity 21, member B;family with sequence similarity 21, member A@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_02@96932@96937@duplication@6@51965743@51978390@10@chr10:51965743-51978390@13.3@75@173@2.31@NA@ASAH2_12, ASAH2_11, ASAH2_10, ASAH2_9, ASAH2_8, ASAH2_7@0@0@0@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
A2463_02@96952@96952@duplication@1@52504963@52505034@10@chr10:52504963-52505034@5.06@17@53@3.12@NA@ASAH2B_3@0@0@0@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2B@NA@NA
A2463_02@98348@98350@duplication@3@81470139@81472241@10@chr10:81470139-81472241@5.8@477@637@1.34@CNVR4815.2, CNVR4815.4@FAM22B_5, FAM22B_6, FAM22B_7@0@0@0@NA@NA@NA
A2463_02@98353@98357@deletion@5@81606587@81610362@10@chr10:81606587-81610362@18.3@105@13@0.124@NA@FAM22E_3, FAM22E_4, FAM22E_5, FAM22E_6, FAM22E_7@0@0@0@NA@NA@NA
A2463_02@98599@98599@deletion@1@88992361@88992742@10@chr10:88992361-88992742@5.73@39@9@0.231@CNVR4840.3, CNVR4840.5, CNVR4840.6@FAM22A_5@0@0@0@:family with sequence similarity 22, member A@NA@NA
A2463_02@101622@101622@deletion@1@124361314@124361636@10@chr10:124361314-124361636@8.92@45@3@0.0667@CNVR4912.1@DMBT1_29@0@0@0@:deleted in malignant brain tumors 1@:defense response to virus;calcium-dependent protein binding;pattern recognition receptor signaling pathway;blastocyst development;response to estrogen stimulus;tissue regeneration;proteinaceous extracellular matrix;protein transport;Gram-negative bacterial cell surface binding;positive regulation of epithelial cell differentiation;virus-host interaction;epithelial cell differentiation;induction of bacterial agglutination;phagocytic vesicle membrane;intracellular;Gram-positive bacterial cell surface binding;zymogen binding;innate immune response;cytoplasm;extrinsic to membrane;protein binding;zymogen granule membrane;extracellular region;scavenger receptor activity;pattern recognition receptor activity;inner cell mass cell proliferation;membrane@: GLIOMA SUSCEPTIBILITY 1; GLM1
A2463_02@103289@103290@deletion@2@5270599@5271034@11@chr11:5270599-5271034@14.3@79@8@0.101@NA@HBG1_2, HBG1_1@0@0@0@:hemoglobin, gamma A@:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex@NA
A2463_02@106571@106578@deletion@8@60971038@60978907@11@chr11:60971038-60978907@15.1@109@28@0.257@CNVR5194.1@PGA3_1, PGA3_2, PGA3_3, PGA3_4, PGA3_5, PGA3_6, PGA3_7, PGA3_8@0@0@0@:pepsinogen 3, group I (pepsinogen A)@:proteolysis;extracellular region;digestion;aspartic-type endopeptidase activity@NA
A2463_02@114424@114429@deletion@6@10583717@10588585@12@chr12:10583717-10588585@27.4@659@373@0.566@CNVR5430.1@KLRC2_6, KLRC2_5, KLRC2_4, KLRC2_3, NKG2-E_3, KLRC2_2, NKG2-E_2, KLRC2_1, NKG2-E_1@0@0@0@:killer cell lectin-like receptor subfamily C, member 2@:carbohydrate binding:transmembrane signaling receptor activity;carbohydrate binding;protein binding;signal transduction;cellular defense response;integral to plasma membrane@NA
A2463_02@114483@114483@duplication@1@11243900@11244828@12@chr12:11243900-11244828@15.5@233@447@1.92@CNVR5434.1@TAS2R43_1@0@0@0@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):taste receptor, type 2, member 14:taste receptor, type 2, member 43@:extracellular space;visual perception:bitter taste receptor activity;taste receptor activity;integral to membrane;sensory perception of taste;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of bitter taste:G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;motile cilium;taste receptor activity;bitter taste receptor activity;integral to membrane;sensory perception of taste;detection of chemical stimulus involved in sensory perception of bitter taste;cilium membrane@NA
A2463_02@124178@124178@deletion@1@24468279@24468340@13@chr13:24468279-24468340@5.85@35@6@0.171@NA@C1QTNF9B_2@0@0@0@:C1q and tumor necrosis factor related protein 9B@:collagen;protein binding@NA
A2463_02@127333@127336@deletion@4@19553418@19562100@14@chr14:19553418-19562100@11.8@635@426@0.671@CNVR6072.1@POTEG_1, POTEG_2, POTEG_3, POTEG_4@0@0@0@:POTE ankyrin domain family, member G@:protein binding@NA
A2463_02@127339@127340@deletion@2@19571349@19573144@14@chr14:19571349-19573144@13.4@218@103@0.472@CNVR6072.1@POTEG_7, POTEG_8@0@0@0@:POTE ankyrin domain family, member G@:protein binding@NA
A2463_02@127352@127352@duplication@1@20019701@20020220@14@chr14:20019701-20020220@4.44@171@246@1.44@CNVR6072.6, CNVR6072.12@POTEM_1@0@0@0@:POTE ankyrin domain family, member M@:protein binding@NA
A2463_02@130410@130412@duplication@3@65016717@65019579@14@chr14:65016717-65019579@8.9@175@273@1.56@CNVR6172.1@PPP1R36_1, PPP1R36_2, PPP1R36_3@0@0@0@:protein phosphatase 1, regulatory subunit 36@:phosphatase binding;protein phosphatase inhibitor activity;negative regulation of phosphatase activity@NA
A2463_02@133317@133320@duplication@4@105933045@105936552@14@chr14:105933045-105936552@7.15@179@264@1.47@NA@MTA1_18, MTA1_19, MTA1_20, MTA1_21@0@0@0@:metastasis associated 1@:intracellular membrane-bounded organelle;endoplasmic reticulum;sequence-specific DNA binding;enzyme binding;DNA binding;regulation of transcription, DNA-dependent;sequence-specific DNA binding transcription factor activity;cytoplasm;NuRD complex;protein binding;chromatin binding;signal transduction;secretory granule organization;nucleus;zinc ion binding@NA
A2463_02@133349@133351@duplication@3@106090814@106091716@14@chr14:106090814-106091716@10@324@477@1.47@CNVR6294.46, CNVR6294.20, CNVR6294.54, CNVR6294.43, CNVR6294.50, CNVR6294.61@IGHG4_4, IGHG4_3, IGHG4_2@0@0@0@@:antigen binding;protein binding;complement activation;extracellular region;immune response;membrane;complement activation, classical pathway;innate immune response@NA
A2463_02@133426@133426@deletion@1@106478111@106478411@14@chr14:106478111-106478411@5.45@62@25@0.403@CNVR6294.36, CNVR6294.48, CNVR6294.12, CNVR6294.24@IGHV4-4_2@0@0@0@@:protein binding@NA
A2463_02@133432@133435@duplication@4@106539080@106552729@14@chr14:106539080-106552729@7.07@103@170@1.65@CNVR6294.36, CNVR6294.48, CNVR6294.24, CNVR6294.10, CNVR6294.34@IGHV1-8_2, IGHV1-8_1, IGHV3-9_2, IGHV3-9_1@0@0@0@@:protein binding:protein binding@NA
A2463_02@133460@133463@duplication@4@106805210@106816173@14@chr14:106805210-106816173@15.1@130@264@2.03@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.41@IGHV4-31_2, IGHV4-31_1, IGHV3-33_2, IGHV3-33_1@0@0@0@@:protein binding:protein binding@NA
A2463_02@133552@133552@duplication@1@22742397@22743598@15@chr15:22742397-22743598@4.76@756@1010@1.34@CNVR6298.5@GOLGA6L1_8@0@0@0@:golgin A6 family-like 1;putative transmembrane protein FLJ36131-like;putative transmembrane protein ENSP00000320207-like;putative golgin subfamily A member 6-like@NA@NA
A2463_02@133636@133641@deletion@6@23406272@23411062@15@chr15:23406272-23411062@7.05@501@342@0.683@CNVR6300.8@RP11-467N20.5_8, RP11-467N20.5_7, RP11-467N20.5_6, RP11-467N20.5_5, RP11-467N20.5_4, RP11-467N20.5_3@0@0@0@:putative golgin subfamily A member 6-like protein 6-like@NA@NA
A2463_02@133869@133870@deletion@2@28629294@28629596@15@chr15:28629294-28629596@5.56@25@0@0@CNVR6329.4@GOLGA8F_9, GOLGA8F_10@0@0@0@@:Golgi apparatus@NA
A2463_02@134036@134040@deletion@5@30845996@30848525@15@chr15:30845996-30848525@13.8@81@13@0.16@NA@GOLGA8Q_2, GOLGA8Q_3, GOLGA8Q_4, GOLGA8Q_5, GOLGA8Q_6@0@0@0@@:Golgi apparatus@NA
A2463_02@134044@134054@deletion@11@30850148@30896376@15@chr15:30850148-30896376@28.2@152@16@0.105@CNVR6339.2, CNVR6339.3, CNVR6339.1@GOLGA8Q_10, GOLGA8Q_11, GOLGA8Q_12, GOLGA8Q_13, GOLGA8Q_14, GOLGA8Q_15, GOLGA8Q_16, GOLGA8Q_17, GOLGA8Q_18, GOLGA8Q_19, GOLGA8H_1@0@0@0@:golgin A8 family, member H@:Golgi apparatus:Golgi apparatus@NA
A2463_02@134158@134162@duplication@5@32684984@32686434@15@chr15:32684984-32686434@16.3@163@303@1.86@NA@GOLGA8K_19, GOLGA8K_18, GOLGA8K_17, GOLGA8K_16, GOLGA8K_15@0@0@0@:golgin A8 family, member J@:Golgi apparatus@NA
A2463_02@134174@134177@duplication@4@32692604@32695395@15@chr15:32692604-32695395@9.79@73@151@2.07@NA@GOLGA8K_3, GOLGA8K_2, AC139426.2_1, GOLGA8K_1@0@0@0@:golgin A8 family, member J@:Golgi apparatus@NA
A2463_02@134180@134190@deletion@11@32737820@32743403@15@chr15:32737820-32743403@8.09@186@112@0.602@CNVR6346.1@GOLGA8O_17, GOLGA8O_16, GOLGA8O_15, GOLGA8O_14, GOLGA8O_13, GOLGA8O_12, GOLGA8O_11, GOLGA8O_10, GOLGA8O_9, GOLGA8O_8, GOLGA8O_7@0@0@0@:golgin A8 family, member O@:Golgi apparatus@NA
A2463_02@135680@135681@deletion@2@43873201@43873586@15@chr15:43873201-43873586@13.5@429@248@0.578@CNVR6365.1@PPIP5K1_10, PPIP5K1_9@0@0@0@:diphosphoinositol pentakisphosphate kinase 1@:inositol hexakisphosphate 3-kinase activity;inositol hexakisphosphate 1-kinase activity;inositol metabolic process;diphosphoinositol-pentakisphosphate kinase activity;ATP binding;acid phosphatase activity;cytoplasm;cytosol;inositol hexakisphosphate 5-kinase activity;nucleus;kinase activity;inositol-1,3,4,5,6-pentakisphosphate kinase activity@NA
A2463_02@138284@138287@duplication@4@72954594@72957376@15@chr15:72954594-72957376@14.9@148@279@1.89@CNVR6443.1@GOLGA6B_11, GOLGA6B_12, GOLGA6B_13, GOLGA6B_14@0@0@0@:golgin A6 family, member B@:Golgi apparatus@NA
A2463_02@138416@138416@deletion@1@74364560@74364650@15@chr15:74364560-74364650@4.83@111@61@0.55@CNVR6448.1@GOLGA6A_14@0@0@0@:golgin A6 family, member C;golgin A6 family, member A;golgin A6 family, member D;golgin A6 family, member B@:Golgi apparatus@NA
A2463_02@138421@138422@deletion@2@74368025@74368326@15@chr15:74368025-74368326@5.88@112@59@0.527@CNVR6448.1@GOLGA6A_9, GOLGA6A_8@0@0@0@:golgin A6 family, member C;golgin A6 family, member A;golgin A6 family, member D;golgin A6 family, member B@:Golgi apparatus@NA
A2463_02@138632@138637@duplication@6@75555690@75557765@15@chr15:75555690-75557765@7.37@266@372@1.4@CNVR6452.1@GOLGA6C_4, GOLGA6C_5, GOLGA6C_6, GOLGA6C_7, GOLGA6C_8, GOLGA6C_9@0@0@0@:golgin A6 family, member C@:Golgi apparatus@NA
A2463_02@143607@143607@deletion@1@22544948@22547706@16@chr16:22544948-22547706@7.91@357@214@0.599@CNVR6669.2@NPIPL3_7@0@0@0@:nuclear pore complex interacting protein pseudogene;nuclear pore complex interacting protein related gene;nuclear pore complex interacting protein-like@:integral to membrane@NA
A2463_02@144288@144290@deletion@3@29468954@29469445@16@chr16:29468954-29469445@7.48@34@0@0@CNVR6690.2, CNVR6690.3, CNVR6690.4@SLX1B_4, SLX1B_5, SLX1B_6@0@0@0@:structure-specific endonuclease subunit SLX1-like;SLX1 structure-specific endonuclease subunit homolog B (S. cerevisiae);SLX1 structure-specific endonuclease subunit homolog A (S. cerevisiae):sulfotransferase family, cytosolic, 1A, phenol-preferring, member 4;sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3;sulfotransferase 1A3/1A4-like@:Slx1-Slx4 complex;5'-flap endonuclease activity;DNA repair;protein binding;DNA double-strand break processing involved in repair via single-strand annealing;double-strand break repair via homologous recombination;metal ion binding;crossover junction endodeoxyribonuclease activity:steroid metabolic process;small molecule metabolic process;sulfation;aryl sulfotransferase activity;cytoplasm;catecholamine metabolic process;cytosol;endoplasmic reticulum unfolded protein response;xenobiotic metabolic process;sulfotransferase activity;activation of signaling protein activity involved in unfolded protein response;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process@NA
A2463_02@144303@144303@duplication@1@29495011@29497154@16@chr16:29495011-29497154@4.76@74@124@1.68@CNVR6690.2, CNVR6690.4@NPIPL3_3@0@0@0@NA@NA@NA
A2463_02@147125@147125@deletion@1@70208183@70208305@16@chr16:70208183-70208305@4.9@23@1@0.0435@CNVR6764.1@CLEC18C_1@0@0@0@:C-type lectin domain family 18, member C@:carbohydrate binding;protein binding;extracellular region@NA
A2463_02@147421@147421@deletion@1@72093014@72093087@16@chr16:72093014-72093087@5.36@64@27@0.422@CNVR6769.1, CNVR6769.2@HP_6@0@0@0@:thioredoxin-like 4B:haptoglobin:haptoglobin-related protein@:mitosis;mRNA processing;RNA splicing;spliceosomal complex;cell redox homeostasis:cellular iron ion homeostasis;negative regulation of oxidoreductase activity;catalytic activity;negative regulation of hydrogen peroxide catabolic process;positive regulation of cell death;haptoglobin-hemoglobin complex;extracellular space;proteolysis;response to hydrogen peroxide;extracellular region;hemoglobin binding;defense response;serine-type endopeptidase activity:spherical high-density lipoprotein particle;proteolysis;extracellular region;hemoglobin binding;catalytic activity;serine-type endopeptidase activity@: ANHAPTOGLOBINEMIA; AHP
A2463_02@147513@147515@duplication@3@74451958@74455168@16@chr16:74451958-74455168@9.13@123@213@1.73@CNVR6778.2, CNVR6778.3@CLEC18B_3, CLEC18B_2, CLEC18B_1@0@0@0@:C-type lectin domain family 18, member B@:carbohydrate binding;protein binding;extracellular region@NA
A2463_02@152122@152129@deletion@8@20353287@20359984@17@chr17:20353287-20359984@15.8@138@49@0.355@CNVR7021.1, CNVR7021.3@LGALS9B_11, LGALS9B_10, LGALS9B_9, LGALS9B_8, LGALS9B_7, LGALS9B_6, LGALS9B_5, LGALS9B_4@0@0@0@:lectin, galactoside-binding, soluble, 9B@:carbohydrate binding@NA
A2463_02@153380@153382@deletion@3@34539179@34581968@17@chr17:34539179-34581968@7.61@37@2@0.0541@CNVR7077.1, CNVR7077.13, CNVR7077.19@CCL4L1_2, CCL4L1_3, TBC1D3C_14@0@0@0@:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1:TBC1 domain family, member 3C;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3H-like;TBC1 domain family, member 3H@:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_02@153394@153394@deletion@1@34590384@34590454@17@chr17:34590384-34590454@4.69@21@0@0@CNVR7077.1, CNVR7077.13, CNVR7077.19, CNVR7077.10, CNVR7077.2@TBC1D3C_2@0@0@0@:TBC1 domain family, member 3C;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3H-like;TBC1 domain family, member 3H@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_02@153414@153414@deletion@1@34797487@34798054@17@chr17:34797487-34798054@18@84@0@0@CNVR7078.2, CNVR7078.3@TBC1D3G_14@0@0@0@:TBC1 domain family member 3H-like;TBC1 domain family, member 3H:TBC1 domain family, member 3;TBC1 domain family, member 3G;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like;TBC1 domain family, member 3H@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_02@153643@153643@duplication@1@36342585@36342632@17@chr17:36342585-36342632@6.07@24@68@2.83@CNVR7083.3@TBC1D3_12@0@0@0@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
A2463_02@154346@154346@deletion@1@39421631@39422112@17@chr17:39421631-39422112@5.78@53@18@0.34@CNVR7096.1@KRTAP9-6_1@0@0@0@:keratin associated protein 9-6@:keratin filament@NA
A2463_02@155584@155588@deletion@5@44380005@44400393@17@chr17:44380005-44400393@10.2@94@34@0.362@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A_3, LRRC37A_4, LRRC37A_5, LRRC37A_6, LRRC37A_7@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
A2463_02@155592@155600@deletion@9@44412912@44594799@17@chr17:44412912-44594799@38.6@218@28@0.128@CNVR7114.2, CNVR7114.1@LRRC37A_11, LRRC37A_12, LRRC37A_13, LRRC37A_14, ARL17B_4, ARL17B_3, ARL17B_2, LRRC37A2_2, LRRC37A2_3@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
A2463_02@157443@157445@deletion@3@61950196@61950974@17@chr17:61950196-61950974@5.23@167@102@0.611@NA@CSH2_3, CSH2_2, CSH2_1@0@0@0@:chorionic somatomammotropin hormone 2@:JAK-STAT cascade involved in growth hormone signaling pathway;signal transduction;female pregnancy;hormone activity;extracellular region;metal ion binding@NA
A2463_02@157452@157454@duplication@3@61973092@61973871@17@chr17:61973092-61973871@8.76@55@124@2.25@NA@CSH1_3, CSH1_2, CSH1_1@0@0@0@:chorionic somatomammotropin hormone 1 (placental lactogen);chorionic somatomammotropin hormone-like 1@:JAK-STAT cascade involved in growth hormone signaling pathway;signal transduction;hormone activity;extracellular region;female pregnancy;metal ion binding@NA
A2463_02@160150@160153@duplication@4@47391@49557@18@chr18:47391-49557@6.79@571@754@1.32@CNVR7228.2@RP11-683L23.1_4, RP11-683L23.1_3, RP11-683L23.1_2, RP11-683L23.1_1@0@0@0@@:GTPase activity;protein complex;GTP catabolic process;cytoplasm;microtubule cytoskeleton;protein polymerization;microtubule-based movement;structural molecule activity;microtubule;GTP binding;plasma membrane@NA
A2463_02@162017@162018@deletion@2@44542732@44550298@18@chr18:44542732-44550298@84.7@440@6@0.0136@CNVR7319.1, CNVR7319.2@TCEB3CL2_1, TCEB3CL_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2:transcription elongation factor B polypeptide 3C-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_02@162017@162019@duplication@1@44542732@44556213@18@chr18:44542732-44556213@-59@2237@3399@1.52@CNVR7319.1, CNVR7319.2@TCEB3CL2_1, TCEB3CL_1, TCEB3C_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2:transcription elongation factor B polypeptide 3C-like:transcription elongation factor B polypeptide 3C (elongin A3);RNA polymerase II transcription factor SIII subunit A3-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_02@164950@164955@deletion@6@7030624@7051633@19@chr19:7030624-7051633@10.6@167@86@0.515@CNVR7517.1@MBD3L5_1, MBD3L5_2, MBD3L4_2, MBD3L4_1, MBD3L2_1, MBD3L2_2@0@0@0@:methyl-CpG binding domain protein 3-like 5:methyl-CpG binding domain protein 3-like 4:methyl-CpG-binding domain protein 3-like 2-like;methyl-CpG binding domain protein 3-like 2@:regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_02@167457@167460@duplication@4@17014513@17017927@19@chr19:17014513-17017927@5.88@155@226@1.46@NA@CPAMD8_33, CPAMD8_32, CPAMD8_31, CPAMD8_30@0@0@0@:C3 and PZP-like, alpha-2-macroglobulin domain containing 8@:serine-type endopeptidase inhibitor activity;protein binding;extracellular space;extracellular region;endopeptidase inhibitor activity;plasma membrane@NA
A2463_02@168952@168952@deletion@1@35862263@35863302@19@chr19:35862263-35863302@11.2@103@32@0.311@CNVR7627.1@GPR42_2@0@0@0@@:integral to membrane;G-protein coupled receptor activity;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
A2463_02@170096@170101@deletion@6@40373946@40384167@19@chr19:40373946-40384167@53.5@387@94@0.243@CNVR7639.2@FCGBP_26, FCGBP_25, FCGBP_24, FCGBP_23, FCGBP_22, FCGBP_21@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_02@170104@170112@duplication@9@40389653@40406060@19@chr19:40389653-40406060@32.1@642@1015@1.58@CNVR7639.2, CNVR7639.3@FCGBP_18, FCGBP_17, FCGBP_16, FCGBP_15, FCGBP_14, FCGBP_13, FCGBP_12, FCGBP_11, FCGBP_10@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_02@173336@173341@deletion@6@54801928@54804173@19@chr19:54801928-54804173@60.6@289@5@0.0173@CNVR7722.1@LILRA3_6, LILRA3_5, LILRA3_4, LILRA3_3, LILRA3_2, LILRA3_1@0@0@0@:leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3@:antigen binding;signal transduction;protein binding;extracellular region;plasma membrane;receptor activity;defense response@NA
A2463_02@173486@173501@deletion@16@55328990@55359398@19@chr19:55328990-55359398@15.7@768@512@0.667@CNVR7725.1, CNVR7725.6@KIR3DL1_2, KIR3DL1_3, KIR3DL1_4, KIR3DL1_5, KIR3DL1_6, KIR3DL1_7, KIR3DL1_8, KIR3DL1_9, KIR2DS4_1, KIR2DS4_2, KIR2DS4_3, KIR2DS4_4, KIR2DS4_5, KIR2DS4_6, KIR2DS4_7, KIR2DS4_8@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
A2463_02@180807@180807@duplication@1@47612392@47613088@21@chr21:47612392-47613088@5.16@137@208@1.52@NA@AP001468.1_3, AP001468.1_2@0@0@0@:lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase):uncharacterized LOC101060037@:steroid metabolic process;lanosterol synthase activity;small molecule metabolic process;lipid particle;cholesterol biosynthetic process;endoplasmic reticulum membrane;catalytic activity;intramolecular transferase activity:protein binding@NA
A2463_02@181129@181134@deletion@6@18727044@18835833@22@chr22:18727044-18835833@31.7@252@60@0.238@CNVR8087.5, CNVR8087.2, CNVR8087.7@AC008132.1_4, AC008132.1_5, AC008132.1_6, AC008132.1_7, AC008132.1_8, AC008132.13_1@0@0@0@NA@NA@NA
A2463_02@181628@181633@deletion@6@21567355@21576503@22@chr22:21567355-21576503@18.1@136@37@0.272@CNVR8100.4, CNVR8100.10, CNVR8100.7@GGT2_10, GGT2_9, GGT2_8, GGT2_7, GGT2_6, GGT2_5@0@0@0@:gamma-glutamyltransferase 2;gamma-glutamyltranspeptidase 2-like@:hydrolase activity;small molecule metabolic process;leukotriene biosynthetic process;anchored to external side of plasma membrane;glutathione biosynthetic process;xenobiotic metabolic process;integral to membrane;glutathione metabolic process;plasma membrane;gamma-glutamyltransferase activity;cellular_component@NA
A2463_02@181806@181807@deletion@2@23243157@23247205@22@chr22:23243157-23247205@20.1@156@44@0.282@CNVR8103.2, CNVR8103.1, CNVR8103.6, CNVR8103.11, CNVR8103.35@IGLC2_1, IGLJ3_1@0@0@0@@:protein binding@NA
A2463_02@181850@181850@deletion@1@23652512@23652620@22@chr22:23652512-23652620@5.28@42@12@0.286@CNVR8107.2, CNVR8107.3@BCR_18@0@0@0@:breakpoint cluster region@:phospholipid binding;protein autophosphorylation;protein tyrosine kinase activity;GTPase activator activity;neuromuscular process controlling balance;ATP binding;actin cytoskeleton organization;negative regulation of cell migration;plasma membrane;inner ear morphogenesis;positive regulation of Rac GTPase activity;positive regulation of phagocytosis;regulation of small GTPase mediated signal transduction;response to lipopolysaccharide;intracellular signal transduction;Rac GTPase activator activity;regulation of cell cycle;platelet-derived growth factor receptor signaling pathway;protein serine/threonine kinase activity;intracellular;small GTPase mediated signal transduction;regulation of Rho protein signal transduction;protein phosphorylation;negative regulation of inflammatory response;enzyme binding;Rho guanyl-nucleotide exchange factor activity;cytoplasm;cytosol;protein binding;signal transduction;brain development;kinase activity;negative regulation of neutrophil degranulation@: LEUKEMIA, CHRONIC MYELOID; CML
A2463_02@181936@181938@duplication@3@24300473@24302568@22@chr22:24300473-24302568@7.22@37@89@2.41@CNVR8114.6, CNVR8114.12, CNVR8114.13, CNVR8114.8@GSTT2B_4, GSTT2B_3, GSTT2B_2@0@0@0@:glutathione S-transferase theta 2B (gene/pseudogene);glutathione S-transferase theta 2@:protein binding;glutathione transferase activity;nucleus;transferase activity;cytoplasm@NA
A2463_02@181949@181950@duplication@2@24325063@24325797@22@chr22:24325063-24325797@5@11@45@4.09@CNVR8114.6, CNVR8114.13, CNVR8114.8, CNVR8114.14@GSTT2_4, GSTT2_5@0@0@0@@:protein binding;glutathione transferase activity;nucleus;cytoplasm@NA
A2463_02@184165@184167@duplication@3@42908917@42910785@22@chr22:42908917-42910785@5.52@162@234@1.44@CNVR8171.2, CNVR8171.3@RRP7A_7, RRP7A_6, RRP7A_5@0@0@0@:ribosomal RNA processing 7 homolog A (S. cerevisiae)@:RNA binding;nucleotide binding@NA
A2463_02@423@440@deletion@18@1635264@1666274@1@chr1:1635264-1666274@52.4@790@363@0.459@CNVR17.1@CDK11A_17, CDK11A_16, CDK11A_15, CDK11A_14, CDK11A_13, CDK11A_12, CDK11A_11, CDK11A_10, CDK11A_9, CDK11A_8, CDK11A_7, CDK11A_6, CDK11A_5, CDK11A_4, CDK11A_3, CDK11A_2, SLC35E2_6, SLC35E2_5@0@0@0@:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A:solute carrier family 35, member E2@:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division:integral to membrane;membrane@NA
A2463_02@1806@1811@deletion@6@12853378@12888523@1@chr1:12853378-12888523@34.1@1229@683@0.556@CNVR72.3, CNVR72.10@PRAMEF1_2, PRAMEF1_3, PRAMEF1_4, PRAMEF11_4, PRAMEF11_3, PRAMEF11_2@0@0@0@:PRAME family member 1:PRAME family member 11@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_02@1868@1870@deletion@3@13716802@13743098@1@chr1:13716802-13743098@14@132@43@0.326@NA@PRAMEF17_2, PRAMEF17_3, PRAMEF20_2@0@0@0@:PRAME family member 17:PRAME family member 21;PRAME family member 20@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_02@6287@6290@deletion@4@47398434@47400038@1@chr1:47398434-47400038@5.96@139@78@0.561@NA@CYP4A11_11, CYP4A11_10, CYP4A11_9, CYP4A11_8@0@0@0@:cytochrome P450, family 4, subfamily A, polypeptide 11@:pressure natriuresis;oxidation-reduction process;arachidonic acid metabolic process;sodium ion homeostasis;renal water homeostasis;arachidonic acid epoxygenase activity;fatty acid metabolic process;leukotriene B4 catabolic process;leukotriene metabolic process;endoplasmic reticulum membrane;epoxygenase P450 pathway;arachidonic acid omega-hydroxylase activity;electron carrier activity;intracellular membrane-bounded organelle;alkane 1-monooxygenase activity;small molecule metabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;apical plasma membrane;cellular lipid metabolic process;heme binding;cytoplasm;xenobiotic metabolic process;leukotriene-B4 20-monooxygenase activity;positive regulation of icosanoid secretion;monooxygenase activity;long-chain fatty acid metabolic process;iron ion binding@NA
A2463_02@8506@8508@deletion@3@89475076@89477710@1@chr1:89475076-89477710@64.3@513@103@0.201@NA@GBP3_9, GBP3_8, GBP3_7@0@0@0@:guanylate binding protein 3@:defense response to virus;GTP binding;GTPase activity;membrane;cytoplasm@NA
A2463_02@9340@9386@deletion@47@104114226@104297436@1@chr1:104114226-104297436@76.9@3037@1840@0.606@CNVR266.3@AMY2B_3, AMY2B_4, AMY2B_5, AMY2B_6, AMY2B_7, AMY2B_8, AMY2B_9, AMY2B_10, AMY2B_11, AMY2B_12, AMY2A_1, AMY2A_2, AMY2A_3, AMY2A_4, AMY2A_5, AMY2A_6, AMY2A_7, AMY2A_8, AMY2A_9, AMY2A_10, AMY1A_2, AMY1A_3, AMY1A_4, AMY1A_5, AMY1A_6, AMY1A_7, AMY1A_8, AMY1A_9, AMY1A_10, AMY1A_11, AMY1B_11, AMY1B_10, AMY1B_9, AMY1B_8, AMY1B_7, AMY1B_6, AMY1B_5, AMY1B_4, AMY1B_3, AMY1B_2, AMY1C_1, AMY1C_2, AMY1C_3, AMY1C_4, AMY1C_5, AMY1C_6, AMY1C_7@0@0@0@:actin, gamma 1 pseudogene 4;amylase, alpha 2B (pancreatic):amylase, alpha 2A (pancreatic):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:extracellular region;cation binding;digestion;carbohydrate metabolic process;catalytic activity;alpha-amylase activity;metal ion binding:chloride ion binding;cation binding;small molecule metabolic process;carbohydrate metabolic process;catalytic activity;extracellular space;polysaccharide digestion;extracellular region;carbohydrate catabolic process;alpha-amylase activity;calcium ion binding:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
A2463_02@10793@10796@deletion@4@144339779@144811957@1@chr1:144339779-144811957@13.5@276@145@0.525@NA@AL592284.1_1, PPIAL4B_1, AL592284.1_2, NBPF9_1@0@0@0@:uncharacterized LOC730256;uncharacterized LOC101060698;uncharacterized LOC642441:peptidylprolyl isomerase A (cyclophilin A)-like 4C;peptidyl-prolyl cis-trans isomerase A-like 4A/B/C-like;peptidylprolyl isomerase A (cyclophilin A)-like 4B;peptidylprolyl isomerase A (cyclophilin A)-like 4A:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 24@:protein folding;peptidyl-prolyl cis-trans isomerase activity;cytoplasm@NA
A2463_02@10842@10850@duplication@9@144916571@144946742@1@chr1:144916571-144946742@13.5@1370@1820@1.33@NA@PDE4DIP_13, PDE4DIP_12, PDE4DIP_11, PDE4DIP_10, PDE4DIP_9, PDE4DIP_8, PDE4DIP_7, PDE4DIP_6, PDE4DIP_5@0@0@0@:phosphodiesterase 4D interacting protein;uncharacterized LOC101060344;myomegalin-like@:Golgi apparatus;binding;centrosome;enzyme binding;cytoplasm;protein binding;myofibril;cellular protein complex assembly;nucleus@NA
A2463_02@11143@11164@deletion@22@146227744@146253110@1@chr1:146227744-146253110@26.2@358@179@0.5@NA@NBPF12_22, NBPF12_21, NBPF12_20, NBPF12_19, NBPF12_18, NBPF12_17, NBPF12_16, NBPF12_15, NBPF12_14, NBPF12_13, NBPF12_12, NBPF12_11, NBPF12_10, NBPF12_9, NBPF12_8, NBPF12_7, NBPF12_6, NBPF12_5, NBPF12_4, NBPF12_3, NBPF12_2, NBPF12_1@0@0@0@:neuroblastoma breakpoint family member 21-like@NA@NA
A2463_02@11169@11170@duplication@2@146400092@146401880@1@chr1:146400092-146401880@9.27@72@158@2.19@NA@NBPF12_9, NBPF12_10@0@0@0@:neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family member 14-like;neuroblastoma breakpoint family, member 12@:cytoplasm@NA
A2463_02@11353@11357@deletion@5@148021578@148025848@1@chr1:148021578-148025848@11.9@388@227@0.585@CNVR346.2, CNVR346.4@NBPF14_5, NBPF14_4, NBPF14_3, NBPF14_2, NBPF14_1@0@0@0@:neuroblastoma breakpoint family, member 14@:cytoplasm@NA
A2463_02@24945@24951@deletion@7@89326669@89399647@2@chr2:89326669-89399647@9.52@716@484@0.676@CNVR866.7, CNVR866.10, CNVR866.11@IGKV3-11_2, IGKV3-11_1, IGKV1-12_2, IGKV1-12_1, IGKV3-15_2, IGKV3-15_1, IGKV1-16_2@0@0@0@@:regulation of immune response;complement activation;immune response;complement activation, classical pathway;innate immune response;antigen binding;protein binding;extracellular region;plasma membrane:protein binding:protein binding:protein binding@NA
A2463_02@25385@25386@deletion@2@97869806@97870000@2@chr2:97869806-97870000@8.43@335@193@0.576@CNVR886.1@ANKRD36_49, ANKRD36_50@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_02@27163@27164@deletion@2@130843388@130843960@2@chr2:130843388-130843960@8.93@90@35@0.389@NA@POTEF_13, POTEF_12@0@0@0@:POTE ankyrin domain family, member F@:cell cortex;protein binding;ATP binding@NA
A2463_02@27171@27172@deletion@2@130868117@130869674@2@chr2:130868117-130869674@8.79@84@27@0.321@NA@POTEF_5, POTEF_4@0@0@0@:POTE ankyrin domain family, member F@:cell cortex;protein binding;ATP binding@NA
A2463_02@27209@27211@deletion@3@130952653@130955933@2@chr2:130952653-130955933@8.9@117@53@0.453@NA@TUBA3E_3, TUBA3E_2, TUBA3E_1@0@0@0@:tubulin, alpha 3e@:GTPase activity;structural constituent of cytoskeleton;protein complex;GTP catabolic process;cytoplasm;microtubule cytoskeleton;protein polymerization;microtubule-based movement;structural molecule activity;cytoplasmic microtubule;GTP binding;microtubule;microtubule cytoskeleton organization;protein domain specific binding@NA
A2463_02@27272@27288@deletion@17@131356484@131415450@2@chr2:131356484-131415450@31.1@1055@586@0.555@NA@CFC1_2, CFC1_1, POTEJ_1, POTEJ_2, POTEJ_3, POTEJ_4, POTEJ_5, POTEJ_6, POTEJ_7, POTEJ_8, POTEJ_9, POTEJ_10, POTEJ_11, POTEJ_12, POTEJ_13, POTEJ_14, POTEJ_15@0@0@0@:cripto, FRL-1, cryptic family 1:POTE ankyrin domain family, member J@:gastrulation;nodal signaling pathway;protein binding;extracellular region;nodal binding;plasma membrane;molecular_function;determination of left/right symmetry;cellular_component;anchored to membrane:protein binding;ATP binding@: TRANSPOSITION OF THE GREAT ARTERIES, DEXTRO-LOOPED 2; DTGA2; CONOTRUNCAL HEART MALFORMATIONS; CTHM; HETEROTAXY, VISCERAL, 2, AUTOSOMAL; HTX2
A2463_02@27995@27997@duplication@3@152461075@152464122@2@chr2:152461075-152464122@9.58@73@167@2.29@CNVR1026.1@NEB_85, NEB_84, NEB_83@0@0@0@:nebulin@:Z disc;muscle filament sliding;oxidation-reduction process;contractile fiber part;actin cytoskeleton;regulation of actin filament length;structural constituent of muscle;cytosol;actin binding;protein binding;myofibril;somatic muscle development;muscle organ development@: NEMALINE MYOPATHY 2; NEM2
A2463_02@60882@60885@deletion@4@175487236@175520277@5@chr5:175487236-175520277@11.5@81@16@0.198@NA@RP11-826N14.2_2, FAM153B_3, FAM153B_4@0@0@0@:uncharacterized LOC100507387;family with sequence similarity 153, member B@NA@NA
A2463_02@61638@61647@deletion@10@180375356@180431443@5@chr5:180375356-180431443@23@788@456@0.579@CNVR2719.1@BTNL8_5, BTNL8_6, BTNL8_7, BTNL8_8, BTNL3_1, BTNL3_2, BTNL3_3, BTNL3_4, BTNL3_5, BTNL3_6@0@0@0@:butyrophilin-like 8:butyrophilin-like 3@:protein binding;integral to membrane:protein binding;integral to membrane;molecular_function;cellular_component;biological_process@NA
A2463_02@62510@62510@deletion@1@24551663@24551753@6@chr6:24551663-24551753@4.8@69@30@0.435@NA@KIAA0319_20@0@0@0@:KIAA0319@:protein binding;integral to membrane;plasma membrane;neuron migration;negative regulation of dendrite development;early endosome membrane;early endosome@: DYSLEXIA, SUSCEPTIBILITY TO, 2; DYX2
A2463_02@62955@62957@deletion@3@29912278@29913058@6@chr6:29912278-29913058@5.62@85@41@0.482@CNVR2829.7, CNVR2829.2, CNVR2829.3@HLA-A_7, HLA-A_8, HLA-A_9@0@0@0@:major histocompatibility complex, class I, A@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;MHC class I receptor activity;membrane@: SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO
A2463_02@63959@63962@deletion@4@32546869@32549615@6@chr6:32546869-32549615@6.88@412@273@0.663@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.5, CNVR2845.4@HLA-DRB1_6, HLA-DRB1_5, HLA-DRB1_4, HLA-DRB1_3@0@0@0@:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1@:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
A2463_02@70816@70817@deletion@2@161054786@161056336@6@chr6:161054786-161056336@17.3@162@44@0.272@CNVR3133.1@LPA_9, LPA_8@0@0@0@:lipoprotein, Lp(a)@:blood circulation;endopeptidase inhibitor activity;catalytic activity;lipoprotein metabolic process;proteolysis;heparin binding;receptor-mediated endocytosis;fibronectin binding;small molecule metabolic process;apolipoprotein binding;lipid metabolic process;negative regulation of endopeptidase activity;extracellular region;plasma lipoprotein particle;lipid transport;serine-type endopeptidase activity@: APOLIPOPROTEIN(a); LPA
A2463_02@71746@71756@duplication@11@5940487@5963593@7@chr7:5940487-5963593@33.5@756@1269@1.68@NA@CCZ1_4, CCZ1_5, CCZ1_6, CCZ1_7, CCZ1_8, CCZ1_9, CCZ1_10, CCZ1_11, CCZ1_12, CCZ1_13, CCZ1_14@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
A2463_02@71778@71779@duplication@2@6017220@6018327@7@chr7:6017220-6018327@6.74@457@650@1.42@NA@PMS2_14, PMS2_13@0@0@0@:PMS2 postmeiotic segregation increased 2 (S. cerevisiae)@:response to drug;DNA binding;MutSalpha complex binding;ATP binding;mismatch repair;DNA repair;mismatched DNA binding;ATPase activity;nucleus;mismatch repair complex;reciprocal meiotic recombination;ATP catabolic process;single-stranded DNA binding;response to DNA damage stimulus;single base insertion or deletion binding;protein binding;somatic hypermutation of immunoglobulin genes;somatic recombination of immunoglobulin gene segments;MutLalpha complex;endonuclease activity@: COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 4; HNPCC4; MISMATCH REPAIR CANCER SYNDROME
A2463_02@71922@71934@deletion@13@6797310@6821107@7@chr7:6797310-6821107@12.7@448@281@0.627@NA@RSPH10B2_2, RSPH10B2_3, RSPH10B2_4, RSPH10B2_5, RSPH10B2_6, RSPH10B2_7, RSPH10B2_8, RSPH10B2_9, RSPH10B2_10, RSPH10B2_11, RSPH10B2_12, RSPH10B2_13, RSPH10B2_14@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
A2463_02@71940@71952@deletion@13@6837995@6863797@7@chr7:6837995-6863797@65.6@961@391@0.407@NA@RSPH10B2_20, CCZ1B_15, CCZ1B_14, CCZ1B_13, CCZ1B_12, CCZ1B_11, CCZ1B_10, CCZ1B_9, CCZ1B_8, CCZ1B_7, CCZ1B_6, CCZ1B_5, CCZ1B_4@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
A2463_02@74793@74793@deletion@1@76241040@76241130@7@chr7:76241040-76241130@5.55@35@6@0.171@CNVR3463.10@POMZP3_5@0@0@0@:uroplakin 3B:POM121 and ZP3 fusion@:negative regulation of gene expression;integral to membrane;plasma membrane:molecular_function;cellular_component;biological_process@NA
A2463_02@76792@76793@deletion@2@102309363@102312048@7@chr7:102309363-102312048@16.5@77@0@0@CNVR3518.1@POLR2J2_2, POLR2J2_2, POLR2J2_1, POLR2J2_1@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
A2463_02@79311@79312@deletion@2@143929005@143956721@7@chr7:143929005-143956721@7.9@327@182@0.557@CNVR3598.4, CNVR3598.7@OR2A42_1, OR2A7_1@0@0@0@:Rho guanine nucleotide exchange factor (GEF) 35:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1:olfactory receptor, family 2, subfamily A, member 7@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_02@80362@80368@deletion@7@7215499@7274349@8@chr8:7215499-7274349@8.2@1025@717@0.7@CNVR3771.8, CNVR3771.10, CNVR3771.4@ZNF705G_7, ZNF705G_6, ZNF705G_5, ZNF705G_4, ZNF705G_3, DEFB4B_2, DEFB4B_1@0@0@0@:zinc finger protein 705G:defensin, beta 4B;defensin, beta 4A@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response@NA
A2463_02@80388@80388@duplication@1@7637545@7637611@8@chr8:7637545-7637611@6.03@10@54@5.4@CNVR3772.4, CNVR3772.6, CNVR3772.2, CNVR3772.8, CNVR3772.10@AC084121.16_3@0@0@0@:uncharacterized LOC100133251@NA@NA
A2463_02@80564@80565@duplication@2@11970084@11996269@8@chr8:11970084-11996269@7.07@1077@1572@1.46@CNVR3785.8, CNVR3785.5, CNVR3785.6@ZNF705D_6, USP17L2_1@0@0@0@:zinc finger protein 705D:ubiquitin specific peptidase 17-like family member 1, pseudogene;ubiquitin specific peptidase 17-like family member 2;ubiquitin specific peptidase 17-like family member 4;ubiquitin specific peptidase 17-like family member 7;ubiquitin specific peptidase 17-like family member 8;ubiquitin specific peptidase 17-like family member 3@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:protein deubiquitination;ubiquitin-specific protease activity;mitotic cell cycle G1/S transition checkpoint;nucleus;G2/M transition checkpoint;apoptotic process;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
A2463_02@88544@88549@deletion@6@42368416@42380206@9@chr9:42368416-42380206@8.04@128@59@0.461@NA@ANKRD20A2_1, ANKRD20A2_2, ANKRD20A2_3, ANKRD20A2_4, ANKRD20A2_5, ANKRD20A2_6@0@0@0@:ankyrin repeat domain 20 family, member A2@:protein binding@NA
A2463_02@88596@88611@deletion@16@43828079@43920370@9@chr9:43828079-43920370@26@469@250@0.533@NA@CNTNAP3B_9, CNTNAP3B_10, CNTNAP3B_11, CNTNAP3B_12, CNTNAP3B_13, CNTNAP3B_14, CNTNAP3B_15, CNTNAP3B_16, CNTNAP3B_17, CNTNAP3B_18, CNTNAP3B_19, CNTNAP3B_20, CNTNAP3B_21, CNTNAP3B_22, CNTNAP3B_23, CNTNAP3B_24@0@0@0@:contactin associated protein-like 3B;contactin associated protein-like 3@:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
A2463_02@88613@88613@deletion@1@44401891@44402255@9@chr9:44401891-44402255@4.33@116@62@0.534@CNVR4297.3@BX088651.1_1@0@0@0@NA@NA@NA
A2463_02@88623@88624@deletion@2@46386623@46390900@9@chr9:46386623-46390900@6.13@38@6@0.158@CNVR4307.4, CNVR4307.3@FAM27E1_1, FAM27D1_1@0@0@0@:family with sequence similarity 27, member E3:protein FAM27E2-like;protein FAM27D1-like@NA@NA
A2463_02@88642@88657@deletion@16@67934724@67987998@9@chr9:67934724-67987998@56.3@1298@670@0.516@NA@ANKRD20A1_4, ANKRD20A1_5, ANKRD20A1_6, ANKRD20A1_7, ANKRD20A1_8, ANKRD20A1_9, ANKRD20A1_10, ANKRD20A1_11, ANKRD20A1_12, ANKRD20A1_13, ANKRD20A1_14, ANKRD20A1_15, RP11-195B21.3_3, RP11-195B21.3_4, RP11-195B21.3_5, RP11-195B21.3_6@0@0@0@:ankyrin repeat domain 20 family, member A1:coiled-coil domain-containing protein 29-like;uncharacterized LOC644249@:protein binding;plasma membrane@NA
A2463_02@88694@88694@deletion@1@70176734@70177983@9@chr9:70176734-70177983@4.71@272@162@0.596@NA@FOXD4L5_1@0@0@0@:forkhead box D4-like 5@:positive regulation of BMP signaling pathway;positive regulation of kidney development;axon extension involved in axon guidance;lateral line nerve glial cell development;DNA binding, bending;sequence-specific DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;regulation of sequence-specific DNA binding transcription factor activity;transcription factor complex;nucleus;dichotomous subdivision of terminal units involved in ureteric bud branching;sympathetic nervous system development;melanocyte differentiation;enteric nervous system development;positive regulation of transcription from RNA polymerase II promoter;regulation of transcription, DNA-dependent;neural crest cell migration;peripheral nervous system development;double-stranded DNA binding;RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity;iridophore differentiation;transcription factor binding;cartilage development;pattern specification process@NA
A2463_02@88720@88723@deletion@4@70889799@70912733@9@chr9:70889799-70912733@7.83@158@85@0.538@NA@CBWD3_10, CBWD3_11, CBWD3_12, CBWD3_13@0@0@0@:COBW domain-containing protein 5-like;COBW domain-containing protein 1-like;COBW domain containing 3@:ATP binding@NA
A2463_02@96442@96442@deletion@1@46264898@46265066@10@chr10:46264898-46265066@4.8@110@56@0.509@CNVR4711.1@FAM21C_20@0@0@0@:family with sequence similarity 21, member C@:endosome;protein binding;plasma membrane;retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_02@96468@96470@deletion@3@46605764@46611811@10@chr10:46605764-46611811@7.52@34@0@0@CNVR4712.3@PTPN20A_4, PTPN20A_3, PTPN20A_2@0@0@0@:protein tyrosine phosphatase, non-receptor type 20B;protein tyrosine phosphatase, non-receptor type 20A@:phosphatase activity;protein tyrosine phosphatase activity;microtubule;nucleus;dephosphorylation;protein dephosphorylation;microtubule organizing center@NA
A2463_02@96538@96565@deletion@28@47899952@48004056@10@chr10:47899952-48004056@102@622@100@0.161@CNVR4715.2@FAM21B_4, FAM21B_5, FAM21B_6, FAM21B_7, FAM21B_8, FAM21B_9, FAM21B_10, FAM21B_11, FAM21B_12, FAM21B_13, FAM21B_14, FAM21B_15, FAM21B_16, FAM21B_17, FAM21B_18, FAM21B_19, FAM21B_20, FAM21B_21, FAM21B_22, FAM21B_23, FAM21B_24, FAM21B_25, FAM21B_26, FAM21B_27, FAM21B_28, FAM21B_29, ASAH2C_18, ASAH2C_17@0@0@0@:family with sequence similarity 21, member B@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome:ceramidase activity;sphingolipid metabolic process@NA
A2463_02@96907@96937@duplication@31@51855360@51978390@10@chr10:51855360-51978390@36.1@720@1158@1.61@NA@FAM21A_15, FAM21A_16, FAM21A_17, FAM21A_18, FAM21A_19, FAM21A_20, FAM21A_21, FAM21A_22, FAM21A_23, FAM21A_24, FAM21A_25, FAM21A_26, FAM21A_27, FAM21A_28, FAM21A_29, FAM21A_30, FAM21A_31, ASAH2_20, ASAH2_19, ASAH2_18, ASAH2_17, ASAH2_16, ASAH2_15, ASAH2_14, ASAH2_13, ASAH2_12, ASAH2_11, ASAH2_10, ASAH2_9, ASAH2_8, ASAH2_7@0@0@0@:family with sequence similarity 21, member B;family with sequence similarity 21, member A:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
A2463_02@96952@96953@duplication@2@52504963@52509162@10@chr10:52504963-52509162@6.19@16@63@3.94@NA@ASAH2B_3, ASAH2B_4@0@0@0@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2B@NA@NA
A2463_02@98351@98357@deletion@7@81601498@81610362@10@chr10:81601498-81610362@12.1@93@23@0.247@NA@FAM22E_1, FAM22E_2, FAM22E_3, FAM22E_4, FAM22E_5, FAM22E_6, FAM22E_7@0@0@0@NA@NA@NA
A2463_02@98595@98595@deletion@1@88985589@88985969@10@chr10:88985589-88985969@5.03@23@0@0@CNVR4840.3, CNVR4840.5@FAM22A_1@0@0@0@:family with sequence similarity 22, member A@NA@NA
A2463_02@98603@98606@deletion@4@89120239@89124960@10@chr10:89120239-89124960@5.95@68@28@0.412@CNVR4840.3@FAM22D_2, FAM22D_3, FAM22D_4, FAM22D_5@0@0@0@:family with sequence similarity 22, member D@NA@NA
A2463_02@103269@103269@deletion@1@4976003@4976943@11@chr11:4976003-4976943@10.7@342@158@0.462@CNVR5040.1@OR51A2_1@0@0@0@:matrix metallopeptidase 26:olfactory receptor, family 51, subfamily A, member 2@:metallopeptidase activity;extracellular matrix;proteolysis;proteinaceous extracellular matrix;collagen catabolic process;metalloendopeptidase activity;zinc ion binding;metabolic process:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_02@106046@106048@deletion@3@55370918@55419315@11@chr11:55370918-55419315@25.7@657@304@0.463@CNVR5179.1@OR4C11_1, OR4P4_1, OR4S2_1@0@0@0@:olfactory receptor, family 4, subfamily C, member 11:olfactory receptor, family 4, subfamily P, member 4:olfactory receptor, family 4, subfamily S, member 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_02@106062@106073@deletion@12@55681127@56000661@11@chr11:55681127-56000661@12.3@3512@2536@0.722@NA@OR5W2_1, OR5I1_1, OR10AG1_1, OR5F1_1, OR5AS1_1, OR8I2_1, OR8H2_1, OR8H3_1, OR8J3_1, OR8K5_1, OR5J2_1, OR5T2_1@0@0@0@:olfactory receptor, family 5, subfamily W, member 2:olfactory receptor, family 5, subfamily I, member 1:olfactory receptor, family 10, subfamily AG, member 1:olfactory receptor, family 5, subfamily F, member 1:olfactory receptor, family 5, subfamily AS, member 1:olfactory receptor, family 8, subfamily I, member 2:olfactory receptor, family 8, subfamily H, member 2:olfactory receptor, family 8, subfamily H, member 3:olfactory receptor, family 8, subfamily J, member 3:olfactory receptor, family 8, subfamily K, member 5:olfactory receptor, family 5, subfamily J, member 2:olfactory receptor, family 5, subfamily T, member 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:signal transduction;integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;sensory perception of smell;G-protein coupled receptor activity;plasma membrane;detection of chemical stimulus involved in sensory perception of smell;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_02@118020@118023@duplication@4@56580972@56601533@12@chr12:56580972-56601533@5.78@212@302@1.42@NA@SMARCC2_2, SMARCC2_1, RNF41_7, RNF41_6@0@0@0@:SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 2:ring finger protein 41@:SWI/SNF complex;npBAF complex;negative regulation of transcription, DNA-dependent;DNA binding;transcription coactivator activity;nucleus;chromatin remodeling;nucleosome disassembly;regulation of transcription from RNA polymerase II promoter;positive regulation of transcription, DNA-dependent;chromatin binding;protein binding;transcription, DNA-dependent;transcriptional repressor complex;nBAF complex;nervous system development:erythropoietin receptor binding;negative regulation of cell proliferation;ubiquitin ligase complex;regulation of reactive oxygen species metabolic process;induction of apoptosis;negative regulation of cell migration;apoptotic process;regulation of protein kinase B signaling cascade;regulation of lymphocyte differentiation;ubiquitin-protein ligase activity;regulation of myeloid cell differentiation;protein tag;cytosol;protein binding;interleukin-3 receptor binding;regulation of MAPK cascade;protein polyubiquitination;zinc ion binding;acid-amino acid ligase activity;protein ubiquitination@NA
A2463_02@127333@127340@deletion@8@19553418@19573144@14@chr14:19553418-19573144@30.9@1050@612@0.583@CNVR6072.1@POTEG_1, POTEG_2, POTEG_3, POTEG_4, POTEG_5, POTEG_6, POTEG_7, POTEG_8@0@0@0@:POTE ankyrin domain family, member G@:protein binding@NA
A2463_02@133342@133342@deletion@1@106053275@106053668@14@chr14:106053275-106053668@5.49@79@33@0.418@CNVR6294.46@IGHA2_3@0@0@0@@:protein binding@NA
A2463_02@133458@133459@deletion@2@106791006@106791456@14@chr14:106791006-106791456@7.93@204@101@0.495@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.53@IGHV3-30_2, IGHV3-30_1@0@0@0@@:protein binding@NA
A2463_02@133462@133462@duplication@1@106815723@106816026@14@chr14:106815723-106816026@5.32@73@137@1.88@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.56, CNVR6294.51@IGHV3-33_2@0@0@0@@:protein binding@NA
A2463_02@133470@133472@deletion@3@106877620@106926495@14@chr14:106877620-106926495@11.3@269@143@0.532@CNVR6294.26, CNVR6294.56, CNVR6294.18@IGHV4-39_2, IGHV4-39_1, IGHV3-43_2@0@0@0@@:protein binding:protein binding@NA
A2463_02@133622@133624@deletion@3@23259497@23259921@15@chr15:23259497-23259921@8.41@115@51@0.443@CNVR6300.4@GOLGA8I_6, GOLGA8I_7, GOLGA8I_8@0@0@0@:golgin A8 family, member I@:Golgi cisterna membrane@NA
A2463_02@133826@133826@deletion@1@28467175@28467361@15@chr15:28467175-28467361@4.71@66@28@0.424@CNVR6328.1@HERC2_36@0@0@0@:putative HERC2-like protein 3-like;HECT and RLD domain containing E3 ubiquitin protein ligase 2@:mitochondrial inner membrane;protein ubiquitination involved in ubiquitin-dependent protein catabolic process;guanyl-nucleotide exchange factor activity;SUMO binding;DNA repair;intracellular protein transport;spermatogenesis;cellular protein modification process;nucleus;ubiquitin protein ligase binding;ubiquitin-protein ligase activity;centriole;intracellular;response to DNA damage stimulus;heme binding;cytoplasm;protein binding;zinc ion binding;protein ubiquitination;metal ion binding@: SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1; SHEP1
A2463_02@134036@134054@deletion@19@30845996@30896376@15@chr15:30845996-30896376@41.3@354@116@0.328@CNVR6339.2, CNVR6339.3, CNVR6339.1@GOLGA8Q_2, GOLGA8Q_3, GOLGA8Q_4, GOLGA8Q_5, GOLGA8Q_6, GOLGA8Q_7, GOLGA8Q_8, GOLGA8Q_9, GOLGA8Q_10, GOLGA8Q_11, GOLGA8Q_12, GOLGA8Q_13, GOLGA8Q_14, GOLGA8Q_15, GOLGA8Q_16, GOLGA8Q_17, GOLGA8Q_18, GOLGA8Q_19, GOLGA8H_1@0@0@0@:golgin A8 family, member H@:Golgi apparatus:Golgi apparatus@NA
A2463_02@134060@134061@deletion@2@30900671@30900959@15@chr15:30900671-30900959@6.9@242@146@0.603@CNVR6339.2, CNVR6339.3@GOLGA8H_7, GOLGA8H_8@0@0@0@:golgin A8 family, member H@:Golgi apparatus@NA
A2463_02@134158@134161@duplication@4@32684984@32685771@15@chr15:32684984-32685771@8.15@120@207@1.72@NA@GOLGA8K_19, GOLGA8K_18, GOLGA8K_17, GOLGA8K_16@0@0@0@:golgin A8 family, member J@:Golgi apparatus@NA
A2463_02@134173@134177@duplication@5@32692342@32695395@15@chr15:32692342-32695395@8.65@73@147@2.01@NA@GOLGA8K_4, GOLGA8K_3, GOLGA8K_2, AC139426.2_1, GOLGA8K_1@0@0@0@:golgin A8 family, member J@:Golgi apparatus@NA
A2463_02@134180@134181@deletion@2@32737820@32738099@15@chr15:32737820-32738099@5.5@25@0@0@CNVR6346.1@GOLGA8O_17, GOLGA8O_16@0@0@0@:golgin A8 family, member O@:Golgi apparatus@NA
A2463_02@134459@134460@deletion@2@34824163@34825163@15@chr15:34824163-34825163@6.12@46@11@0.239@CNVR6351.3@GOLGA8B_13, GOLGA8B_12@0@0@0@:golgin A8 family, member A:golgin A8 family, member A;golgin A8 family, member B@:Golgi cisterna membrane;Golgi apparatus:Golgi cisterna membrane;Golgi apparatus@NA
A2463_02@135050@135054@duplication@5@41860416@41862897@15@chr15:41860416-41862897@7.38@214@315@1.47@NA@TYRO3_8, TYRO3_9, TYRO3_10, TYRO3_11, TYRO3_12@0@0@0@:TYRO3 protein tyrosine kinase@:protein tyrosine kinase activity;platelet aggregation;negative regulation of toll-like receptor signaling pathway;ATP binding;vagina development;substrate adhesion-dependent cell spreading;nucleus;negative regulation of lymphocyte activation;endoplasmic reticulum membrane;phosphatidylinositol 3-kinase cascade;nuclear envelope;platelet activation;protein kinase activity;protein kinase B signaling cascade;neuron homeostasis;negative regulation of neuron apoptotic process;negative regulation of innate immune response;protein autophosphorylation;transmembrane receptor protein tyrosine kinase activity;apoptotic cell clearance;transferase activity, transferring phosphorus-containing groups;spermatogenesis;forebrain cell migration;integral to membrane;integral to plasma membrane;ovulation cycle;natural killer cell differentiation;phosphatidylinositol 3-kinase binding;negative regulation of inflammatory response;protein phosphorylation;receptor signaling protein tyrosine kinase activity;protein heterodimerization activity;secretion by cell;protein binding;signal transduction;cell adhesion;signal transduction by phosphorylation@NA
A2463_02@142651@142651@deletion@1@14858861@14859270@16@chr16:14858861-14859270@4.66@69@30@0.435@CNVR6644.1@RP11-719K4.2_8@0@0@0@:nuclear pore complex-interacting protein-like 1-like@NA@NA
A2463_02@144095@144104@deletion@10@28607105@28659638@16@chr16:28607105-28659638@15.1@647@406@0.628@NA@SULT1A2_2, SULT1A1_10, SULT1A1_9, SULT1A1_8, SULT1A1_7, SULT1A1_6, SULT1A1_5, SULT1A1_4, A-575C2.4_1, A-575C2.4_2@0@0@0@:sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2:sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1:nuclear pore complex-interacting protein-like 2-like;putative NPIP-like protein LOC613037-like@:steroid metabolic process;small molecule metabolic process;sulfation;aryl sulfotransferase activity;catecholamine metabolic process;cytosol;xenobiotic metabolic process;phenol-containing compound metabolic process;sulfotransferase activity;amine biosynthetic process;flavonol 3-sulfotransferase activity;3'-phosphoadenosine 5'-phosphosulfate metabolic process:small molecule metabolic process;sulfation;aryl sulfotransferase activity;amine metabolic process;catecholamine metabolic process;xenobiotic metabolic process;cytosol;steroid sulfotransferase activity;integral to membrane;sulfotransferase activity;flavonol 3-sulfotransferase activity;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process;estrogen metabolic process@NA
A2463_02@144286@144290@deletion@5@29466720@29469445@16@chr16:29466720-29469445@7.82@35@0@0@CNVR6690.2, CNVR6690.3, CNVR6690.4@SLX1B_2, SLX1B_3, SLX1B_4, SLX1B_5, SLX1B_6@0@0@0@:structure-specific endonuclease subunit SLX1-like;SLX1 structure-specific endonuclease subunit homolog B (S. cerevisiae);SLX1 structure-specific endonuclease subunit homolog A (S. cerevisiae):sulfotransferase family, cytosolic, 1A, phenol-preferring, member 4;sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3;sulfotransferase 1A3/1A4-like@:Slx1-Slx4 complex;5'-flap endonuclease activity;DNA repair;protein binding;DNA double-strand break processing involved in repair via single-strand annealing;double-strand break repair via homologous recombination;metal ion binding;crossover junction endodeoxyribonuclease activity:steroid metabolic process;small molecule metabolic process;sulfation;aryl sulfotransferase activity;cytoplasm;catecholamine metabolic process;cytosol;endoplasmic reticulum unfolded protein response;xenobiotic metabolic process;sulfotransferase activity;activation of signaling protein activity involved in unfolded protein response;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process@NA
A2463_02@144499@144502@duplication@4@30206062@30208678@16@chr16:30206062-30208678@6.43@102@170@1.67@CNVR6694.1, CNVR6694.2, CNVR6694.3@SLX1A_2, SLX1A_3, SLX1A_4, SLX1A_5@0@0@0@:structure-specific endonuclease subunit SLX1-like;SLX1 structure-specific endonuclease subunit homolog B (S. cerevisiae);SLX1 structure-specific endonuclease subunit homolog A (S. cerevisiae):sulfotransferase family, cytosolic, 1A, phenol-preferring, member 4;sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3;sulfotransferase 1A3/1A4-like@:Slx1-Slx4 complex;5'-flap endonuclease activity;DNA repair;protein binding;DNA double-strand break processing involved in repair via single-strand annealing;double-strand break repair via homologous recombination;metal ion binding;crossover junction endodeoxyribonuclease activity:steroid metabolic process;small molecule metabolic process;sulfation;aryl sulfotransferase activity;cytoplasm;catecholamine metabolic process;cytosol;endoplasmic reticulum unfolded protein response;xenobiotic metabolic process;sulfotransferase activity;activation of signaling protein activity involved in unfolded protein response;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process@NA
A2463_02@147125@147127@deletion@3@70208183@70211383@16@chr16:70208183-70211383@7.68@181@103@0.569@CNVR6764.1@CLEC18C_1, CLEC18C_2, CLEC18C_3@0@0@0@:C-type lectin domain family 18, member C@:carbohydrate binding;protein binding;extracellular region@NA
A2463_02@147420@147421@deletion@2@72092154@72093087@16@chr16:72092154-72093087@8.16@97@36@0.371@CNVR6769.1, CNVR6769.2@HP_5, HP_6@0@0@0@:thioredoxin-like 4B:haptoglobin:haptoglobin-related protein@:mitosis;mRNA processing;RNA splicing;spliceosomal complex;cell redox homeostasis:cellular iron ion homeostasis;negative regulation of oxidoreductase activity;catalytic activity;negative regulation of hydrogen peroxide catabolic process;positive regulation of cell death;haptoglobin-hemoglobin complex;extracellular space;proteolysis;response to hydrogen peroxide;extracellular region;hemoglobin binding;defense response;serine-type endopeptidase activity:spherical high-density lipoprotein particle;proteolysis;extracellular region;hemoglobin binding;catalytic activity;serine-type endopeptidase activity@: ANHAPTOGLOBINEMIA; AHP
A2463_02@147513@147513@duplication@1@74451958@74452196@16@chr16:74451958-74452196@5.05@48@99@2.06@CNVR6778.2, CNVR6778.3@CLEC18B_3@0@0@0@:C-type lectin domain family 18, member B@:carbohydrate binding;protein binding;extracellular region@NA
A2463_02@148453@148453@deletion@1@89016666@89017768@16@chr16:89016666-89017768@5.82@391@229@0.586@NA@RP11-830F9.6_2@0@0@0@:core-binding factor, runt domain, alpha subunit 2; translocated to, 3@:nucleoplasm;intracellular;granulocyte differentiation;regulation of transcription, DNA-dependent;sequence-specific DNA binding transcription factor activity;Golgi membrane;cell proliferation;chromatin binding;protein binding;nucleolus;transcription, DNA-dependent;zinc ion binding;positive regulation of transcription from RNA polymerase II promoter@NA
A2463_02@153376@153394@deletion@19@34522686@34590454@17@chr17:34522686-34590454@21.6@117@13@0.111@CNVR7077.1, CNVR7077.13, CNVR7077.19@CCL3L3_3, CCL3L3_2, CCL3L3_1, CCL4L1_1, CCL4L1_2, CCL4L1_3, TBC1D3C_14, TBC1D3C_13, TBC1D3C_12, TBC1D3C_11, TBC1D3C_10, TBC1D3C_9, TBC1D3C_8, TBC1D3C_7, TBC1D3C_6, TBC1D3C_5, TBC1D3C_4, TBC1D3C_3, TBC1D3C_2@0@0@0@:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1:TBC1 domain family, member 3C;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3H-like;TBC1 domain family, member 3H@:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_02@153654@153655@deletion@2@36358126@36358395@17@chr17:36358126-36358395@5.19@136@78@0.574@CNVR7083.3@RP11-1407O15.2_8, RP11-1407O15.2_7@0@0@0@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
A2463_02@155584@155590@deletion@7@44380005@44409347@17@chr17:44380005-44409347@19.4@353@190@0.538@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A_3, LRRC37A_4, LRRC37A_5, LRRC37A_6, LRRC37A_7, LRRC37A_8, LRRC37A_9@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
A2463_02@157453@157453@duplication@1@61973436@61973595@17@chr17:61973436-61973595@7.14@18@76@4.22@NA@CSH1_2@0@0@0@:chorionic somatomammotropin hormone 1 (placental lactogen);chorionic somatomammotropin hormone-like 1@:JAK-STAT cascade involved in growth hormone signaling pathway;signal transduction;hormone activity;extracellular region;female pregnancy;metal ion binding@NA
A2463_02@160151@160153@duplication@3@48941@49557@18@chr18:48941-49557@6.81@94@161@1.71@CNVR7228.2@RP11-683L23.1_3, RP11-683L23.1_2, RP11-683L23.1_1@0@0@0@@:GTPase activity;protein complex;GTP catabolic process;cytoplasm;microtubule cytoskeleton;protein polymerization;microtubule-based movement;structural molecule activity;microtubule;GTP binding;plasma membrane@NA
A2463_02@164951@164955@deletion@5@7032325@7051633@19@chr19:7032325-7051633@6.63@154@85@0.552@CNVR7517.1@MBD3L5_2, MBD3L4_2, MBD3L4_1, MBD3L2_1, MBD3L2_2@0@0@0@:methyl-CpG binding domain protein 3-like 5:methyl-CpG binding domain protein 3-like 4:methyl-CpG-binding domain protein 3-like 2-like;methyl-CpG binding domain protein 3-like 2@:regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_02@170096@170100@deletion@5@40373946@40382826@19@chr19:40373946-40382826@52.8@352@57@0.162@CNVR7639.2@FCGBP_26, FCGBP_25, FCGBP_24, FCGBP_23, FCGBP_22@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_02@170106@170109@duplication@4@40392317@40399855@19@chr19:40392317-40399855@21.9@429@735@1.71@CNVR7639.2, CNVR7639.3@FCGBP_16, FCGBP_15, FCGBP_14, FCGBP_13@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_02@173479@173482@deletion@4@55315347@55320338@19@chr19:55315347-55320338@5.76@66@28@0.424@CNVR7725.1, CNVR7725.3@KIR2DL4_2, KIR2DL4_3, KIR2DL4_4, KIR2DL4_5@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane@NA
A2463_02@179001@179007@deletion@7@10951267@10973733@21@chr21:10951267-10973733@17.5@828@517@0.624@CNVR7947.11, CNVR7947.12@TPTE_10, TPTE_9, TPTE_8, TPTE_7, TPTE_6, TPTE_5, TPTE_4@0@0@0@:transmembrane phosphatase with tensin homology@:phosphatase activity;ion channel activity;protein tyrosine phosphatase activity;ion transport;protein dephosphorylation;transmembrane transport;protein binding;signal transduction;integral to membrane;protein tyrosine/serine/threonine phosphatase activity;dephosphorylation;membrane;peptidyl-tyrosine dephosphorylation@NA
A2463_02@181417@181420@deletion@4@20366369@20367356@22@chr22:20366369-20367356@7.52@44@7@0.159@CNVR8094.9, CNVR8094.4, CNVR8094.3@GGTLC3_5, GGTLC3_4, GGTLC3_3, GGTLC3_2@0@0@0@@:leukotriene biosynthetic process;glutathione metabolic process;gamma-glutamyltransferase activity;anchored to external side of plasma membrane@NA
A2463_02@181805@181807@deletion@3@23241695@23247205@22@chr22:23241695-23247205@18@191@73@0.382@CNVR8103.2, CNVR8103.1, CNVR8103.6, CNVR8103.11@IGLJ2_1, IGLC2_1, IGLJ3_1@0@0@0@@:protein binding@NA
A2463_02@181937@181938@duplication@2@24300739@24302568@22@chr22:24300739-24302568@5.73@12@54@4.5@CNVR8114.6, CNVR8114.12, CNVR8114.13, CNVR8114.8@GSTT2B_3, GSTT2B_2@0@0@0@:glutathione S-transferase theta 2B (gene/pseudogene);glutathione S-transferase theta 2@:protein binding;glutathione transferase activity;nucleus;transferase activity;cytoplasm@NA
A2463_20@422@441@deletion@20@1634916@1669887@1@chr1:1634916-1669887@63.5@990@476@0.481@CNVR17.1@CDK11A_18, CDK11A_17, CDK11A_16, CDK11A_15, CDK11A_14, CDK11A_13, CDK11A_12, CDK11A_11, CDK11A_10, CDK11A_9, CDK11A_8, CDK11A_7, CDK11A_6, CDK11A_5, CDK11A_4, CDK11A_3, CDK11A_2, SLC35E2_6, SLC35E2_5, SLC35E2_4@0@0@0@:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A:solute carrier family 35, member E2@:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division:integral to membrane;membrane@NA
A2463_20@1806@1807@deletion@2@12853378@12854642@1@chr1:12853378-12854642@10.7@558@353@0.633@CNVR72.3, CNVR72.10@PRAMEF1_2, PRAMEF1_3@0@0@0@:PRAME family member 1@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_20@1809@1811@deletion@3@12884801@12888523@1@chr1:12884801-12888523@30.6@757@367@0.485@CNVR72.3, CNVR72.10, CNVR72.11, CNVR72.4@PRAMEF11_4, PRAMEF11_3, PRAMEF11_2@0@0@0@:PRAME family member 11@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_20@1815@1826@deletion@12@12921077@13001395@1@chr1:12921077-13001395@44.2@1660@979@0.59@CNVR72.3, CNVR72.4, CNVR72.2@PRAMEF2_4, PRAMEF4_4, PRAMEF4_3, PRAMEF4_2, PRAMEF10_4, PRAMEF10_3, PRAMEF10_2, PRAMEF7_2, PRAMEF7_3, PRAMEF7_4, PRAMEF6_4, PRAMEF6_3@0@0@0@:PRAME family member 2:PRAME family member 4:PRAME family member 10:PRAME family member 7:PRAME family member 6;PRAME family member 23;PRAME family member 9/15-like;PRAME family member 5@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_20@1835@1838@deletion@4@13330415@13366425@1@chr1:13330415-13366425@9.66@55@7@0.127@CNVR74.8, CNVR74.4@PRAMEF3_2, PRAMEF3_1, PRAMEF5_2, PRAMEF5_3@0@0@0@:PRAME family member 3:PRAME family member 5@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_20@1861@1861@deletion@1@13668906@13669463@1@chr1:13668906-13669463@5.11@84@40@0.476@CNVR76.2, CNVR76.5@PRAMEF14_4@0@0@0@:PRAME family member 14@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_20@1869@1869@deletion@1@13718405@13718962@1@chr1:13718405-13718962@4.82@66@29@0.439@CNVR76.2@PRAMEF17_3@0@0@0@:PRAME family member 17@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_20@3333@3342@deletion@10@25599040@25655415@1@chr1:25599040-25655415@193@1047@64@0.0611@CNVR116.1, CNVR116.2@RHD_1, RHD_2, RHD_3, RHD_4, RHD_5, RHD_6, RHD_7, RHD_8, RHD_9, RHD_10@0@0@0@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
A2463_20@5149@5149@duplication@1@39987049@39987242@1@chr1:39987049-39987242@5.93@24@70@2.92@NA@BMP8A_4@0@0@0@:bone morphogenetic protein 8a@:cell differentiation;growth factor activity;extracellular space;growth;cytokine activity;cartilage development;ossification@NA
A2463_20@8175@8175@deletion@1@84610046@84610231@1@chr1:84610046-84610231@4.85@149@85@0.57@NA@PRKACB_1@0@0@0@:protein kinase, cAMP-dependent, catalytic, beta@:nucleoplasm;fibroblast growth factor receptor signaling pathway;negative regulation of meiotic cell cycle;protein tyrosine kinase activity;energy reserve metabolic process;ATP binding;transmembrane transport;cAMP-dependent protein kinase activity;activation of protein kinase A activity;cAMP-dependent protein kinase complex;plasma membrane;glucose metabolic process;water transport;ubiquitin protein ligase binding;activation of phospholipase C activity;protein kinase activity;perinuclear region of cytoplasm;lipid metabolic process;cytosol;regulation of insulin secretion;epidermal growth factor receptor signaling pathway;gluconeogenesis;nerve growth factor receptor signaling pathway;synaptic transmission;cellular response to glucagon stimulus;intracellular protein kinase cascade;response to clozapine;magnesium ion binding;transferase activity, transferring phosphorus-containing groups;blood coagulation;triglyceride catabolic process;adenylate cyclase-modulating G-protein coupled receptor signaling pathway;small molecule metabolic process;protein serine/threonine kinase activity;protein phosphorylation;centrosome;carbohydrate metabolic process;cytoplasm;signal transduction;protein binding@NA
A2463_20@8507@8508@deletion@2@89476588@89477710@1@chr1:89476588-89477710@81.5@453@4@0.00883@CNVR244.1@GBP3_8, GBP3_7@0@0@0@:guanylate binding protein 3@:defense response to virus;GTP binding;GTPase activity;membrane;cytoplasm@NA
A2463_20@9373@9374@duplication@2@104233917@104234232@1@chr1:104233917-104234232@12.2@76@179@2.36@CNVR266.3, CNVR266.5@AMY1B_8, AMY1B_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
A2463_20@9436@9448@deletion@13@108769302@108786383@1@chr1:108769302-108786383@14.4@263@139@0.529@CNVR294.4@NBPF4_14, NBPF4_13, NBPF4_12, NBPF4_11, NBPF4_10, NBPF4_9, NBPF4_8, NBPF4_7, NBPF4_6, NBPF4_5, NBPF4_4, NBPF4_3, NBPF4_2@0@0@0@:neuroblastoma breakpoint family, member 4@:cytoplasm@NA
A2463_20@9766@9773@deletion@8@110230497@110235917@1@chr1:110230497-110235917@69.3@364@22@0.0604@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_1, GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
A2463_20@10694@10696@deletion@3@120934382@120935894@1@chr1:120934382-120935894@4.93@239@155@0.649@CNVR320.1@FCGR1B_3, FCGR1B_2, FCGR1B_1@0@0@0@:Fc fragment of IgG, high affinity Ib, receptor (CD64);Fc fragment of IgG, high affinity Ic, receptor (CD64), pseudogene@:IgG binding;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;antigen processing and presentation of peptide antigen via MHC class I;immune response;immunoglobulin receptor activity;clathrin-coated endocytic vesicle membrane;protein binding;interferon-gamma-mediated signaling pathway;integral to membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I;plasma membrane;Fc receptor signaling pathway;cytokine-mediated signaling pathway;early endosome membrane@NA
A2463_20@10788@10788@duplication@1@144220788@144220959@1@chr1:144220788-144220959@11.1@85@200@2.35@CNVR333.1, CNVR333.3@RP3-377D14.1_87@0@0@0@NA@NA@NA
A2463_20@10793@10795@deletion@3@144339779@144520832@1@chr1:144339779-144520832@20.3@115@12@0.104@NA@AL592284.1_1, PPIAL4B_1, AL592284.1_2@0@0@0@:uncharacterized LOC730256;uncharacterized LOC101060698;uncharacterized LOC642441:peptidylprolyl isomerase A (cyclophilin A)-like 4C;peptidyl-prolyl cis-trans isomerase A-like 4A/B/C-like;peptidylprolyl isomerase A (cyclophilin A)-like 4B;peptidylprolyl isomerase A (cyclophilin A)-like 4A@:protein folding;peptidyl-prolyl cis-trans isomerase activity;cytoplasm@NA
A2463_20@10868@10869@duplication@2@145302655@145303982@1@chr1:145302655-145303982@6.69@267@383@1.43@CNVR341.2, CNVR341.3@NBPF10_8, NBPF10_9@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family, member 10@:protein binding;calcium ion binding@NA
A2463_20@11143@11157@deletion@15@146227744@146244717@1@chr1:146227744-146244717@20.9@100@3@0.03@NA@NBPF12_22, NBPF12_21, NBPF12_20, NBPF12_19, NBPF12_18, NBPF12_17, NBPF12_16, NBPF12_15, NBPF12_14, NBPF12_13, NBPF12_12, NBPF12_11, NBPF12_10, NBPF12_9, NBPF12_8@0@0@0@:neuroblastoma breakpoint family member 21-like@NA@NA
A2463_20@11161@11164@deletion@4@146248917@146253110@1@chr1:146248917-146253110@22.4@214@79@0.369@NA@NBPF12_4, NBPF12_3, NBPF12_2, NBPF12_1@0@0@0@:neuroblastoma breakpoint family member 21-like@NA@NA
A2463_20@11169@11173@duplication@5@146400092@146405926@1@chr1:146400092-146405926@17.9@103@256@2.49@NA@NBPF12_9, NBPF12_10, NBPF12_11, NBPF12_12, NBPF12_13@0@0@0@:neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family member 14-like;neuroblastoma breakpoint family, member 12@:cytoplasm@NA
A2463_20@11184@11184@duplication@1@146420020@146420191@1@chr1:146420020-146420191@5.23@58@110@1.9@NA@NBPF12_24@0@0@0@:neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family member 14-like;neuroblastoma breakpoint family, member 12@:cytoplasm@NA
A2463_20@11341@11352@duplication@12@148008574@148017665@1@chr1:148008574-148017665@60.3@1601@2665@1.66@CNVR346.2, CNVR346.4@NBPF14_17, NBPF14_16, NBPF14_15, NBPF14_14, NBPF14_13, NBPF14_12, NBPF14_11, NBPF14_10, NBPF14_9, NBPF14_8, NBPF14_7, NBPF14_6@0@0@0@:neuroblastoma breakpoint family, member 14@:cytoplasm@NA
A2463_20@11503@11503@deletion@1@149754301@149754330@1@chr1:149754301-149754330@6.87@60@18@0.3@CNVR351.3, CNVR351.5@FCGR1A_1@0@0@0@:Fc fragment of IgG, high affinity Ib, receptor (CD64);Fc fragment of IgG, high affinity Ia, receptor (CD64):histone cluster 2, H2bf@:IgG receptor activity;phagocytosis, recognition;antibody-dependent cellular cytotoxicity;regulation of immune response;phagocytosis, engulfment;antigen processing and presentation of peptide antigen via MHC class I;immune response;clathrin-coated endocytic vesicle membrane;interferon-gamma-mediated signaling pathway;integral to membrane;Fc-gamma receptor signaling pathway;positive regulation of type III hypersensitivity;plasma membrane;receptor-mediated endocytosis;positive regulation of phagocytosis;cytokine-mediated signaling pathway;early endosome membrane;cell surface receptor signaling pathway;IgG binding;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;positive regulation of type IIa hypersensitivity;antigen processing and presentation of exogenous antigen;external side of plasma membrane;signal transduction;protein binding;defense response to bacterium;antigen processing and presentation of exogenous peptide antigen via MHC class I;receptor signaling protein activity;response to bacterium:sequence-specific DNA binding;intracellular;nucleus;protein heterodimerization activity;DNA binding;nucleosome assembly;nucleosome@NA
A2463_20@12117@12118@deletion@2@152573209@152586574@1@chr1:152573209-152586574@32.8@159@1@0.00629@CNVR358.1@LCE3C_1, LCE3B_1@0@0@0@:late cornified envelope 3C:late cornified envelope 3B@:keratinization:keratinization@NA
A2463_20@14046@14053@duplication@8@161487766@161565521@1@chr1:161487766-161565521@12.3@1544@1998@1.29@CNVR383.3, CNVR383.1@FCGR2A_7, HSPA6_1, FCGR3A_5, FCGR3A_4, FCGR3A_3, FCGR3A_2, FCGR3A_1, FCGR2C_1@0@0@0@:Fc fragment of IgG, low affinity IIa, receptor (CD32):heat shock 70kDa protein 6 (HSP70B'):Fc fragment of IgG, low affinity IIIa, receptor (CD16a):Fc fragment of IgG, low affinity IIb, receptor (CD32):Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene)@:IgG binding;protein binding;integral to membrane;plasma membrane:signalosome;cell morphogenesis;response to unfolded protein;ATP binding:IgG binding;protein binding;regulation of immune response;extracellular region;integral to membrane;immune response;plasma membrane;external side of plasma membrane:IgG binding;protein binding;signal transduction;regulation of immune response;integral to membrane;immune response;plasma membrane;virus-host interaction@: MALARIA, SUSCEPTIBILITY TO; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
A2463_20@16033@16034@duplication@2@196759176@196762643@1@chr1:196759176-196762643@11.2@374@564@1.51@CNVR459.1@CFHR3_5, CFHR3_6@0@0@0@:complement factor H-related 3@:extracellular space@NA
A2463_20@16038@16038@deletion@1@196797201@196797376@1@chr1:196797201-196797376@11.2@151@58@0.384@CNVR459.1@CFHR1_4@0@0@0@:complement factor H-related 1:complement factor H-related 2@:extracellular space;complement activation:extracellular region@NA
A2463_20@19773@19777@deletion@5@248721846@248802559@1@chr1:248721846-248802559@22.8@998@601@0.602@CNVR600.1@OR2T29_1, OR2T34_1, OR2T10_1, OR2T11_1, OR2T35_1@0@0@0@:olfactory receptor, family 2, subfamily T, member 29:olfactory receptor, family 2, subfamily T, member 34:olfactory receptor, family 2, subfamily T, member 10:olfactory receptor, family 2, subfamily T, member 11:olfactory receptor, family 2, subfamily T, member 35@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_20@25369@25370@duplication@2@97854825@97855027@2@chr2:97854825-97855027@17.9@154@335@2.18@CNVR886.2, CNVR886.3@ANKRD36_33, ANKRD36_34@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_20@25375@25386@deletion@12@97860464@97870000@2@chr2:97860464-97870000@23.4@2037@1391@0.683@CNVR886.1@ANKRD36_39, ANKRD36_40, ANKRD36_41, ANKRD36_42, ANKRD36_43, ANKRD36_44, ANKRD36_45, ANKRD36_46, ANKRD36_47, ANKRD36_48, ANKRD36_49, ANKRD36_50@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_20@25390@25403@deletion@14@97873672@97890616@2@chr2:97873672-97890616@45.2@2340@1512@0.646@NA@ANKRD36_54, ANKRD36_55, ANKRD36_56, ANKRD36_57, ANKRD36_58, ANKRD36_59, ANKRD36_60, ANKRD36_61, ANKRD36_62, ANKRD36_63, ANKRD36_64, ANKRD36_65, ANKRD36_66, ANKRD36_67@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_20@26008@26011@deletion@4@108454714@108460186@2@chr2:108454714-108460186@6.93@148@81@0.547@NA@RGPD4_3, RGPD4_4, RGPD4_5, RGPD4_6@0@0@0@:RANBP2-like and GRIP domain containing 4@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_20@26021@26022@deletion@2@108479139@108479488@2@chr2:108479139-108479488@7@356@225@0.632@NA@RGPD4_16, RGPD4_17@0@0@0@:RANBP2-like and GRIP domain containing 4@:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
A2463_20@27163@27163@deletion@1@130843388@130843568@2@chr2:130843388-130843568@10.8@50@0@0@NA@POTEF_13@0@0@0@:POTE ankyrin domain family, member F@:cell cortex;protein binding;ATP binding@NA
A2463_20@27172@27173@deletion@2@130869569@130872627@2@chr2:130869569-130872627@12.9@109@32@0.294@NA@POTEF_4, POTEF_3@0@0@0@:POTE ankyrin domain family, member F@:cell cortex;protein binding;ATP binding@NA
A2463_20@27211@27211@deletion@1@130955932@130955933@2@chr2:130955932-130955933@4.63@21@0@0@CNVR985.1@TUBA3E_1@0@0@0@:tubulin, alpha 3e@:GTPase activity;structural constituent of cytoskeleton;protein complex;GTP catabolic process;cytoplasm;microtubule cytoskeleton;protein polymerization;microtubule-based movement;structural molecule activity;cytoplasmic microtubule;GTP binding;microtubule;microtubule cytoskeleton organization;protein domain specific binding@NA
A2463_20@27996@27996@duplication@1@152463121@152463227@2@chr2:152463121-152463227@4.81@93@152@1.63@CNVR1026.1@NEB_84@0@0@0@:nebulin@:Z disc;muscle filament sliding;oxidation-reduction process;contractile fiber part;actin cytoskeleton;regulation of actin filament length;structural constituent of muscle;cytosol;actin binding;protein binding;myofibril;somatic muscle development;muscle organ development@: NEMALINE MYOPATHY 2; NEM2
A2463_20@39893@39894@deletion@2@75790428@75790887@3@chr3:75790428-75790887@6.09@27@0@0@CNVR1432.5, CNVR1432.9, CNVR1432.4@ZNF717_4, ZNF717_3@0@0@0@:zinc finger protein 717;zinc finger protein 717-like@:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_20@45435@45438@deletion@4@195456520@195475935@3@chr3:195456520-195475935@7.15@384@254@0.661@CNVR1703.1, CNVR1703.2, CNVR1703.5, CNVR1703.3@MUC20_3, MUC20_4, MUC4_25, MUC4_24@0@0@0@:mucin 20, cell surface associated:mucin 4, cell surface associated@:microvillus membrane;apical plasma membrane;activation of MAPK activity;Golgi lumen;post-translational protein modification;protein binding;O-glycan processing;hepatocyte growth factor receptor signaling pathway;cellular protein metabolic process;extracellular region;protein homooligomerization;basal plasma membrane:ErbB-2 class receptor binding;Golgi lumen;cell-matrix adhesion;post-translational protein modification;extracellular matrix structural constituent;protein binding;O-glycan processing;cellular protein metabolic process;proteinaceous extracellular matrix;integral to plasma membrane;membrane;extracellular matrix constituent, lubricant activity;biological_process@NA
A2463_20@46667@46671@deletion@5@9174900@9213975@4@chr4:9174900-9213975@20.2@115@14@0.122@NA@FAM90A26P_4, FAM90A26P_5, FAM90A26P_6, FAM90A26P_7, USP17L13_1, USP17L10_1@0@0@0@:ubiquitin specific peptidase 17-like family member 10:ubiquitin specific peptidase 17-like family member 13@:zinc ion binding;nucleic acid binding:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
A2463_20@46677@46677@duplication@1@9250357@9251948@4@chr4:9250357-9251948@5.43@428@607@1.42@NA@USP17L18_1@0@0@0@:ubiquitin specific peptidase 17-like family member 18@:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
A2463_20@51422@51422@deletion@1@135121063@135122348@4@chr4:135121063-135122348@16@1497@794@0.53@NA@PABPC4L_2@0@0@0@:poly(A) binding protein, cytoplasmic 4-like@:RNA binding;nucleotide binding;nucleic acid binding@NA
A2463_20@51672@51673@deletion@2@145041644@145061788@4@chr4:145041644-145061788@5.08@258@165@0.64@NA@GYPA_2, GYPA_1@0@0@0@:glycophorin B (MNS blood group):glycophorin A (MNS blood group)@:integral to membrane;plasma membrane;integral to plasma membrane:external side of plasma membrane;integral to membrane;cytoskeletal anchoring at plasma membrane;plasma membrane;molecular_function;protein homodimerization activity;integral to plasma membrane;cellular_component;identical protein binding;membrane;biological_process;regulation of response to osmotic stress;virus-host interaction@: BLOOD GROUP--Ss LOCUS; Ss: MALARIA, SUSCEPTIBILITY TO; BLOOD GROUP--MN LOCUS; MN
A2463_20@53051@53051@deletion@1@186382204@186382313@4@chr4:186382204-186382313@5.24@160@91@0.569@NA@CCDC110_5@0@0@0@:coiled-coil domain containing 110@:intracellular membrane-bounded organelle;Golgi apparatus;nucleolus;plasma membrane;nucleus;cytoplasm@NA
A2463_20@53308@53308@duplication@1@748520@748674@5@chr5:748520-748674@4.72@55@102@1.85@CNVR2280.3@ZDHHC11B_5@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
A2463_20@59488@59488@deletion@1@147553798@147553933@5@chr5:147553798-147553933@6.22@28@0@0@CNVR2637.2, CNVR2637.1@SPINK14_3@0@0@0@:serine peptidase inhibitor, Kazal type 14 (putative)@:serine-type endopeptidase inhibitor activity;protein binding;extracellular region@NA
A2463_20@60884@60885@deletion@2@175517374@175520277@5@chr5:175517374-175520277@13@100@23@0.23@NA@FAM153B_3, FAM153B_4@0@0@0@:uncharacterized LOC100507387;family with sequence similarity 153, member B@NA@NA
A2463_20@63291@63292@duplication@2@31324466@31324935@6@chr6:31324466-31324935@8.6@231@357@1.55@CNVR2841.12, CNVR2841.14, CNVR2841.8@HLA-B_2, HLA-B_1@0@0@0@:major histocompatibility complex, class I, B@:MHC class I protein complex;regulation of immune response;regulation of interleukin-12 production;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;regulation of T cell anergy;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;receptor binding;early endosome membrane;virus-host interaction;regulation of interleukin-6 production;regulation of dendritic cell differentiation;phagocytic vesicle membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;MHC class I receptor activity;membrane@: SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO; SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1; SPDA1
A2463_20@63734@63735@duplication@2@31964607@31965088@6@chr6:31964607-31965088@5.93@25@68@2.72@CNVR2843.6, CNVR2843.3@C4A_29, C4A_30@0@0@0@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
A2463_20@63768@63775@duplication@8@31994761@31996838@6@chr6:31994761-31996838@8.44@507@686@1.35@CNVR2843.6, CNVR2843.5@C4B_20, C4B_21, C4B_22, C4B_23, C4B_24, C4B_25, C4B_26, C4B_27@0@0@0@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
A2463_20@63953@63957@duplication@5@32485517@32489951@6@chr6:32485517-32489951@17.9@227@398@1.75@CNVR2845.21, CNVR2845.25, CNVR2845.30@HLA-DRB5_6, HLA-DRB5_5, HLA-DRB5_4, HLA-DRB5_3, HLA-DRB5_2@0@0@0@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
A2463_20@63961@63962@deletion@2@32548524@32549615@6@chr6:32548524-32549615@12@360@203@0.564@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.5, CNVR2845.11, CNVR2845.54@HLA-DRB1_4, HLA-DRB1_3@0@0@0@:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1@:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
A2463_20@63966@63969@duplication@4@32609088@32628026@6@chr6:32609088-32628026@13.2@705@1004@1.42@CNVR2845.21, CNVR2845.25, CNVR2845.27, CNVR2845.22, CNVR2845.39, CNVR2845.20@HLA-DQA1_2, HLA-DQA1_3, HLA-DQA1_4, HLA-DQB1_6@0@0@0@:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@NA
A2463_20@64602@64606@duplication@5@35754776@35765065@6@chr6:35754776-35765065@8.06@533@730@1.37@CNVR2861.1@CLPSL1_2, CLPSL1_3, CLPS_3, CLPS_2, CLPS_1@0@0@0@:colipase-like 1:colipase, pancreatic@:extracellular region;enzyme activator activity;digestion;lipid catabolic process:steroid metabolic process;post-embryonic development;small molecule metabolic process;retinoid metabolic process;lipid metabolic process;extracellular region;enzyme activator activity;digestion;lipid catabolic process;lipid digestion;response to food@NA
A2463_20@70816@70819@deletion@4@161054786@161061880@6@chr6:161054786-161061880@18.5@228@86@0.377@CNVR3133.1@LPA_9, LPA_8, LPA_7, LPA_6@0@0@0@:lipoprotein, Lp(a)@:blood circulation;endopeptidase inhibitor activity;catalytic activity;lipoprotein metabolic process;proteolysis;heparin binding;receptor-mediated endocytosis;fibronectin binding;small molecule metabolic process;apolipoprotein binding;lipid metabolic process;negative regulation of endopeptidase activity;extracellular region;plasma lipoprotein particle;lipid transport;serine-type endopeptidase activity@: APOLIPOPROTEIN(a); LPA
A2463_20@71030@71032@deletion@3@167790035@167794824@6@chr6:167790035-167794824@20.7@182@56@0.308@NA@TCP10_5, TCP10_4, TCP10_3@0@0@0@:t-complex 10@:cytosol@NA
A2463_20@71748@71749@duplication@2@5942293@5944900@7@chr7:5942293-5944900@10.1@380@579@1.52@NA@CCZ1_6, CCZ1_7@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
A2463_20@74573@74573@duplication@1@74166423@74166502@7@chr7:74166423-74166502@10.4@77@182@2.36@NA@GTF2I_28@0@0@0@:general transcription factor IIi@:neuronal cell body;transcription initiation from RNA polymerase II promoter;mitogen-activated protein kinase binding;negative regulation of angiogenesis;DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;cytoplasm;transcription from RNA polymerase II promoter;protein binding;signal transduction;nucleus;cell projection;reduction of cytosolic calcium ion concentration@NA
A2463_20@74597@74598@duplication@2@74225431@74227349@7@chr7:74225431-74227349@11.7@47@139@2.96@NA@GTF2IRD2_10, GTF2IRD2_9@0@0@0@:GTF2I repeat domain containing 2@:nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_20@74633@74634@deletion@2@74548944@74550867@7@chr7:74548944-74550867@6.92@168@90@0.536@NA@GTF2IRD2B_9, GTF2IRD2B_10@0@0@0@:GTF2I repeat domain containing 2B@:nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_20@74781@74783@deletion@3@76121471@76129837@7@chr7:76121471-76129837@5.42@77@38@0.494@CNVR3462.1@DTX2_6, DTX2_7, DTX2_8@0@0@0@:deltex homolog 2 (Drosophila)@:ligase activity;cytoplasm;nuclear membrane;Notch signaling pathway;protein binding;nucleus;zinc ion binding;protein ubiquitination@NA
A2463_20@74792@74793@deletion@2@76240783@76241130@7@chr7:76240783-76241130@6.52@86@40@0.465@CNVR3463.10@POMZP3_6, POMZP3_5@0@0@0@:uroplakin 3B:POM121 and ZP3 fusion@:negative regulation of gene expression;integral to membrane;plasma membrane:molecular_function;cellular_component;biological_process@NA
A2463_20@76427@76432@duplication@6@100331793@100336236@7@chr7:100331793-100336236@19.5@307@515@1.68@CNVR3509.1@ZAN_1, ZAN_2, ZAN_3, ZAN_4, ZAN_5, ZAN_6@0@0@0@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
A2463_20@76792@76792@duplication@1@102309363@102309451@7@chr7:102309363-102309451@15.6@42@183@4.36@CNVR3518.1@POLR2J2_2, POLR2J2_2@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
A2463_20@79287@79288@duplication@2@143400089@143417767@7@chr7:143400089-143417767@7.18@140@222@1.59@CNVR3594.2, CNVR3594.1@FAM115C_2, FAM115C_3@0@0@0@:family with sequence similarity 115, member C;protein FAM115C-like@NA@NA
A2463_20@79310@79310@duplication@1@143884023@143885476@7@chr7:143884023-143885476@4.77@228@331@1.45@CNVR3598.4, CNVR3598.3, CNVR3598.7@ARHGEF35_2@0@0@0@:Rho guanine nucleotide exchange factor (GEF) 35@NA@NA
A2463_20@79310@79313@deletion@3@143884023@143966343@7@chr7:143884023-143966343@-5.83@970@840@0.866@CNVR3598.4, CNVR3598.7@ARHGEF35_2, OR2A42_1, OR2A7_1, CTAGE8_1@0@0@0@:Rho guanine nucleotide exchange factor (GEF) 35:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1:olfactory receptor, family 2, subfamily A, member 7:CTAGE family, member 6, pseudogene;CTAGE family, member 15, pseudogene@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane@NA
A2463_20@80388@80388@duplication@1@7637545@7637611@8@chr8:7637545-7637611@7.71@15@70@4.67@CNVR3772.4, CNVR3772.6, CNVR3772.2, CNVR3772.8, CNVR3772.10@AC084121.16_3@0@0@0@:uncharacterized LOC100133251@NA@NA
A2463_20@80565@80565@duplication@1@11994678@11996269@8@chr8:11994678-11996269@7.37@1415@2009@1.42@CNVR3785.8, CNVR3785.5, CNVR3785.6, CNVR3785.2, CNVR3785.1, CNVR3785.3@USP17L2_1@0@0@0@:ubiquitin specific peptidase 17-like family member 1, pseudogene;ubiquitin specific peptidase 17-like family member 2;ubiquitin specific peptidase 17-like family member 4;ubiquitin specific peptidase 17-like family member 7;ubiquitin specific peptidase 17-like family member 8;ubiquitin specific peptidase 17-like family member 3@:protein deubiquitination;ubiquitin-specific protease activity;mitotic cell cycle G1/S transition checkpoint;nucleus;G2/M transition checkpoint;apoptotic process;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
A2463_20@80738@80738@deletion@1@17581182@17581342@8@chr8:17581182-17581342@5.36@117@61@0.521@CNVR3804.1@MTUS1_4@0@0@0@:microtubule associated tumor suppressor 1@:oxidation-reduction process;mitochondrion;Golgi apparatus;microtubule organizing center;oxidoreductase activity;cellular response to peptide hormone stimulus;nucleus;plasma membrane;microtubule;transition metal ion binding;spindle@: HEPATOCELLULAR CARCINOMA
A2463_20@83673@83673@duplication@1@86573700@86575726@8@chr8:86573700-86575726@15.9@379@731@1.93@CNVR3955.1@REXO1L1_1@0@0@0@:exonuclease GOR-like;REX1, RNA exonuclease 1 homolog (S. cerevisiae)-like 1@:intracellular;nucleus;exonuclease activity;nucleic acid binding;cytoplasm@NA
A2463_20@85273@85274@deletion@2@125551267@125551528@8@chr8:125551267-125551528@5.23@260@167@0.642@NA@TATDN1_1, NDUFB9_1@0@0@0@:TatD DNase domain containing 1:NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9, 22kDa@:endodeoxyribonuclease activity, producing 5'-phosphomonoesters;nucleus;metal ion binding:mitochondrion;small molecule metabolic process;mitochondrial inner membrane;sensory perception of sound;respiratory electron transport chain;mitochondrial electron transport, NADH to ubiquinone;mitochondrial respiratory chain complex I;NADH dehydrogenase (ubiquinone) activity@NA
A2463_20@86646@86646@duplication@1@178817@178969@9@chr9:178817-178969@5.05@76@132@1.74@CNVR4135.1@CBWD1_1@0@0@0@:COBW domain containing 1;COBW domain-containing protein 1-like;COBW domain containing 5@:ATP binding@NA
A2463_20@88511@88513@duplication@3@39238991@39288061@9@chr9:39238991-39288061@6.16@9@49@5.44@CNVR4262.1@CNTNAP3_3, CNTNAP3_2, CNTNAP3_1@0@0@0@:contactin associated protein-like 3@:binding;signal transduction;protein binding;integral to membrane;extracellular region;cell adhesion;plasma membrane;cell recognition;receptor binding@NA
A2463_20@88528@88528@deletion@1@40702653@40706387@9@chr9:40702653-40706387@11.5@674@373@0.553@NA@SPATA31A3_4@0@0@0@:SPATA31 subfamily A, member 3@:integral to membrane@NA
A2463_20@88544@88545@duplication@2@42368416@42372039@9@chr9:42368416-42372039@5.25@136@211@1.55@NA@ANKRD20A2_1, ANKRD20A2_2@0@0@0@:ankyrin repeat domain 20 family, member A2@:protein binding@NA
A2463_20@88558@88558@duplication@1@42409510@42410483@9@chr9:42409510-42410483@7.48@103@190@1.84@NA@ANKRD20A2_15, RP11-146D12.2_1@0@0@0@:ankyrin repeat domain 20 family, member A2@:protein binding@NA
A2463_20@88584@88585@duplication@2@43624656@43628694@9@chr9:43624656-43628694@9.74@1660@2197@1.32@NA@SPATA31A6_4, SPATA31A6_3@0@0@0@:SPATA31 subfamily A, member 6@:integral to membrane@NA
A2463_20@88596@88596@duplication@1@43828079@43828221@9@chr9:43828079-43828221@4.69@81@136@1.68@CNVR4294.1@CNTNAP3B_9@0@0@0@:contactin associated protein-like 3B;contactin associated protein-like 3@:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
A2463_20@88631@88633@deletion@3@65503517@65508193@9@chr9:65503517-65508193@61.1@308@3@0.00974@CNVR4312.5@SPATA31A7_4, SPATA31A7_3, SPATA31A7_2@0@0@0@:SPATA31 subfamily A, member 7@:integral to membrane@NA
A2463_20@88639@88643@deletion@5@67926874@67936012@9@chr9:67926874-67936012@24.9@161@33@0.205@NA@ANKRD20A1_1, ANKRD20A1_2, ANKRD20A1_3, ANKRD20A1_4, ANKRD20A1_5@0@0@0@:ankyrin repeat domain 20 family, member A1@:protein binding;plasma membrane@NA
A2463_20@88648@88657@deletion@10@67954723@67987998@9@chr9:67954723-67987998@34.5@1016@614@0.604@NA@ANKRD20A1_10, ANKRD20A1_11, ANKRD20A1_12, ANKRD20A1_13, ANKRD20A1_14, ANKRD20A1_15, RP11-195B21.3_3, RP11-195B21.3_4, RP11-195B21.3_5, RP11-195B21.3_6@0@0@0@:ankyrin repeat domain 20 family, member A1:coiled-coil domain-containing protein 29-like;uncharacterized LOC644249@:protein binding;plasma membrane@NA
A2463_20@88676@88678@deletion@3@69382094@69386055@9@chr9:69382094-69386055@13.8@64@1@0.0156@NA@ANKRD20A4_1, ANKRD20A4_2, ANKRD20A4_3@0@0@0@:ankyrin repeat domain 20 family, member A4@:protein binding@NA
A2463_20@88681@88683@deletion@3@69393823@69403204@9@chr9:69393823-69403204@16.6@121@27@0.223@NA@ANKRD20A4_6, ANKRD20A4_7, ANKRD20A4_8@0@0@0@:ankyrin repeat domain 20 family, member A4@:protein binding@NA
A2463_20@88705@88708@deletion@4@70483189@70490068@9@chr9:70483189-70490068@16.2@191@75@0.393@NA@CBWD5_4, CBWD5_3, CBWD5_2, CBWD5_1@0@0@0@:COBW domain-containing protein 5-like;COBW domain containing 7;COBW domain containing 5@:ATP binding@NA
A2463_20@89218@89218@deletion@1@80863679@80863789@9@chr9:80863679-80863789@5.09@183@107@0.585@NA@CEP78_8@0@0@0@:centrosomal protein 78kDa@:cytosol;G2/M transition of mitotic cell cycle;mitotic cell cycle;centrosome@NA
A2463_20@93192@93192@deletion@1@135944444@135944646@9@chr9:135944444-135944646@4.78@85@42@0.494@CNVR4502.1@CEL_9@0@0@0@:carboxyl ester lipase (bile salt-stimulated lipase)@:intestinal lipid catabolic process;pancreatic juice secretion;catalytic activity;extracellular space;heparin binding;sterol esterase activity;carboxylesterase activity;metabolic process;ceramide catabolic process;hydrolase activity;small molecule metabolic process;acylglycerol lipase activity;lipid metabolic process;cytoplasm;protein esterification;cytosol;retinyl-palmitate esterase activity;fatty acid catabolic process;extracellular region;triglyceride lipase activity;lipid digestion;triglyceride metabolic process;cholesterol catabolic process;intestinal cholesterol absorption@: MATURITY-ONSET DIABETES OF THE YOUNG; MODY; MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 8, WITH EXOCRINE DYSFUNCTION;
A2463_20@95353@95357@deletion@5@17882693@17898362@10@chr10:17882693-17898362@9.01@111@49@0.441@NA@MRC1L1_5, MRC1L1_6, MRC1L1_7, MRC1L1_8, MRC1L1_9@0@0@0@:macrophage mannose receptor 1-like@:carbohydrate binding@NA
A2463_20@95386@95389@duplication@4@18122629@18138693@10@chr10:18122629-18138693@8.58@103@182@1.77@NA@MRC1_4, MRC1_5, MRC1_6, MRC1_7@0@0@0@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
A2463_20@96435@96435@duplication@1@46248629@46248685@10@chr10:46248629-46248685@4.67@56@102@1.82@NA@FAM21C_13@0@0@0@:family with sequence similarity 21, member C@:endosome;protein binding;plasma membrane;retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_20@96466@96470@deletion@5@46584433@46611811@10@chr10:46584433-46611811@13.9@78@10@0.128@CNVR4712.3@PTPN20A_6, PTPN20A_5, PTPN20A_4, PTPN20A_3, PTPN20A_2@0@0@0@:protein tyrosine phosphatase, non-receptor type 20B;protein tyrosine phosphatase, non-receptor type 20A@:phosphatase activity;protein tyrosine phosphatase activity;microtubule;nucleus;dephosphorylation;protein dephosphorylation;microtubule organizing center@NA
A2463_20@96472@96482@duplication@11@46961971@47158896@10@chr10:46961971-47158896@38.3@1572@2342@1.49@CNVR4712.9, CNVR4712.2, CNVR4712.4, CNVR4712.6@SYT15_8, SYT15_7, SYT15_6, SYT15_5, SYT15_4, SYT15_3, SYT15_2, GPRIN2_1, PPYR1_3, ANXA8L1_12@0@0@0@:synaptotagmin XV:G protein regulated inducer of neurite outgrowth 2:pancreatic polypeptide receptor 1;neuropeptide Y receptor type 4-like:uncharacterized LOC101060462;uncharacterized LOC100996760:annexin A8-like 1;annexin A8@:protein binding;synaptic vesicle;integral to membrane;transporter activity;plasma membrane;membrane;extrinsic to membrane:blood circulation;peptide YY receptor activity;peptide binding;pancreatic polypeptide receptor activity;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;integral to membrane;digestion;plasma membrane;integral to plasma membrane;feeding behavior:calcium-dependent phospholipid binding;calcium ion binding@NA
A2463_20@96505@96531@duplication@27@47658500@47758904@10@chr10:47658500-47758904@135@1690@3164@1.87@NA@ANTXRL_1, ANTXRL_2, ANTXRL_3, ANTXRL_4, ANTXRL_5, ANTXRL_6, ANTXRL_7, ANTXRL_8, ANTXRL_9, ANTXRL_10, ANTXRL_11, ANTXRL_12, ANTXRL_13, ANTXRL_14, ANTXRL_15, ANTXRL_16, ANTXRL_17, ANXA8L2_1, ANXA8L2_2, ANXA8L2_3, ANXA8L2_4, ANXA8L2_5, ANXA8L2_6, ANXA8L2_7, ANXA8L2_8, ANXA8L2_9, ANXA8L2_10@0@0@0@:annexin A8-like 2:uncharacterized LOC101060462;uncharacterized LOC100996760@:protein binding;integral to membrane;receptor activity;metal ion binding:calcium-dependent phospholipid binding;calcium ion binding@NA
A2463_20@96550@96563@duplication@14@47919943@47948853@10@chr10:47919943-47948853@12@447@630@1.41@CNVR4715.2, CNVR4715.1@FAM21B_16, FAM21B_17, FAM21B_18, FAM21B_19, FAM21B_20, FAM21B_21, FAM21B_22, FAM21B_23, FAM21B_24, FAM21B_25, FAM21B_26, FAM21B_27, FAM21B_28, FAM21B_29@0@0@0@:family with sequence similarity 21, member B@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_20@96572@96581@deletion@10@48020451@48055018@10@chr10:48020451-48055018@13.3@386@234@0.606@CNVR4715.2@ASAH2C_10, ASAH2C_9, ASAH2C_8, ASAH2C_7, ASAH2C_6, ASAH2C_5, ASAH2C_4, ASAH2C_3, ASAH2C_2, ASAH2C_1@0@0@0@@:ceramidase activity;sphingolipid metabolic process@NA
A2463_20@96620@96620@deletion@1@48771316@48771405@10@chr10:48771316-48771405@19@93@1@0.0108@CNVR4716.10, CNVR4716.3@PTPN20B_6@0@0@0@:protein tyrosine phosphatase, non-receptor type 20B;protein tyrosine phosphatase, non-receptor type 20A@:phosphatase activity;protein tyrosine phosphatase activity;microtubule;nucleus;dephosphorylation;protein dephosphorylation;microtubule organizing center@NA
A2463_20@96631@96633@deletion@3@49376639@49381136@10@chr10:49376639-49381136@10@75@20@0.267@CNVR4717.2@FRMPD2_27, FRMPD2_26, FRMPD2_25@0@0@0@:FERM and PDZ domain containing 2@:basolateral plasma membrane;transferase activity, transferring phosphorus-containing groups;cytoplasm;tight junction;protein binding;cytoskeleton;1-phosphatidylinositol binding;tight junction assembly@NA
A2463_20@96933@96937@duplication@5@51970584@51978390@10@chr10:51970584-51978390@14.8@116@240@2.07@NA@ASAH2_11, ASAH2_10, ASAH2_9, ASAH2_8, ASAH2_7@0@0@0@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
A2463_20@98005@98005@deletion@1@75436478@75436528@10@chr10:75436478-75436528@6.13@51@15@0.294@CNVR4799.1@AGAP5_7@0@0@0@:ankyrin repeat and GTPase domain Arf GTPase activating protein 11;ArfGAP with GTPase domain, ankyrin repeat and PH domain 5;ArfGAP with GTPase domain, ankyrin repeat and PH domain 10;arf-GAP with GTPase, ANK repeat and PH domain-containing protein 5-like@:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity@NA
A2463_20@98344@98350@duplication@7@81463367@81472241@10@chr10:81463367-81472241@22.7@662@1079@1.63@CNVR4815.2, CNVR4815.4@FAM22B_1, FAM22B_2, FAM22B_3, FAM22B_4, FAM22B_5, FAM22B_6, FAM22B_7@0@0@0@NA@NA@NA
A2463_20@98344@98357@deletion@7@81463367@81610362@10@chr10:81463367-81610362@-12.6@839@1079@1.29@CNVR4815.2@FAM22B_1, FAM22B_2, FAM22B_3, FAM22B_4, FAM22B_5, FAM22B_6, FAM22B_7, FAM22E_1, FAM22E_2, FAM22E_3, FAM22E_4, FAM22E_5, FAM22E_6, FAM22E_7@0@0@0@NA@NA@NA
A2463_20@103269@103269@deletion@1@4976003@4976943@11@chr11:4976003-4976943@4.74@413@268@0.649@CNVR5040.1@OR51A2_1@0@0@0@:matrix metallopeptidase 26:olfactory receptor, family 51, subfamily A, member 2@:metallopeptidase activity;extracellular matrix;proteolysis;proteinaceous extracellular matrix;collagen catabolic process;metalloendopeptidase activity;zinc ion binding;metabolic process:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_20@103289@103290@deletion@2@5270599@5271034@11@chr11:5270599-5271034@20.2@98@1@0.0102@NA@HBG1_2, HBG1_1@0@0@0@:hemoglobin, gamma A@:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex@NA
A2463_20@114424@114430@deletion@7@10583717@10599261@12@chr12:10583717-10599261@24@1037@644@0.621@CNVR5430.1@KLRC2_6, KLRC2_5, KLRC2_4, KLRC2_3, NKG2-E_3, KLRC2_2, NKG2-E_2, KLRC2_1, NKG2-E_1, KLRC1_8@0@0@0@:killer cell lectin-like receptor subfamily C, member 2:killer cell lectin-like receptor subfamily C, member 1@:carbohydrate binding:transmembrane signaling receptor activity;carbohydrate binding;protein binding;signal transduction;cellular defense response;integral to plasma membrane:transmembrane signaling receptor activity;carbohydrate binding;regulation of immune response;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway@NA
A2463_20@114483@114483@duplication@1@11243900@11244828@12@chr12:11243900-11244828@12.5@351@616@1.75@CNVR5434.1@TAS2R43_1@0@0@0@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):taste receptor, type 2, member 14:taste receptor, type 2, member 43@:extracellular space;visual perception:bitter taste receptor activity;taste receptor activity;integral to membrane;sensory perception of taste;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of bitter taste:G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;motile cilium;taste receptor activity;bitter taste receptor activity;integral to membrane;sensory perception of taste;detection of chemical stimulus involved in sensory perception of bitter taste;cilium membrane@NA
A2463_20@114863@114874@duplication@12@19473497@19514640@12@chr12:19473497-19514640@34.8@1714@2421@1.41@NA@PLEKHA5_18, PLEKHA5_19, PLEKHA5_20, PLEKHA5_21, PLEKHA5_22, PLEKHA5_23, PLEKHA5_24, PLEKHA5_25, PLEKHA5_26, PLEKHA5_27, PLEKHA5_28, PLEKHA5_29@0@0@0@:pleckstrin homology domain containing, family A member 5@:phospholipid binding;protein binding;1-phosphatidylinositol binding;cellular_component;biological_process@NA
A2463_20@127336@127337@deletion@2@19561995@19563541@14@chr14:19561995-19563541@7.75@110@52@0.473@CNVR6072.1@POTEG_4, POTEG_5@0@0@0@:POTE ankyrin domain family, member G@:protein binding@NA
A2463_20@127348@127349@duplication@2@20010104@20011657@14@chr14:20010104-20011657@6.41@67@126@1.88@CNVR6072.6, CNVR6072.12@POTEM_5, POTEM_4@0@0@0@:POTE ankyrin domain family, member M@:protein binding@NA
A2463_20@127353@127358@deletion@6@20215588@20404761@14@chr14:20215588-20404761@16.2@2916@2040@0.7@CNVR6072.12, CNVR6072.4, CNVR6072.5@OR4Q3_1, OR4M1_1, OR4N2_1, OR4K2_1, OR4K5_1, OR4K1_1@0@0@0@:olfactory receptor, family 4, subfamily N, member 2:olfactory receptor, family 4, subfamily Q, member 3:olfactory receptor, family 4, subfamily M, member 1:olfactory receptor, family 4, subfamily K, member 2:olfactory receptor, family 4, subfamily K, member 5:olfactory receptor, family 4, subfamily K, member 1@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_20@127878@127878@deletion@1@23235732@23235973@14@chr14:23235732-23235973@5.59@151@83@0.55@NA@OXA1L_1@0@0@0@:oxidase (cytochrome c) assembly 1-like@:oxidation-reduction process;integral to mitochondrial membrane;mitochondrion;mitochondrial ribosome binding;mitochondrial inner membrane;mitochondrial proton-transporting ATP synthase complex assembly;mitochondrial respiratory chain;protein tetramerization;protein insertion into membrane;integral to membrane;mitochondrial membrane;protein homodimerization activity;mitochondrial respiratory chain complex I biogenesis;negative regulation of oxidoreductase activity;protein complex assembly;protein complex;aerobic respiration;mitochondrial respiratory chain complex I assembly;protein binding;negative regulation of ATPase activity@NA
A2463_20@133491@133492@deletion@2@107095127@107095561@14@chr14:107095127-107095561@16.1@100@16@0.16@CNVR6294.56, CNVR6294.16, CNVR6294.91@IGHV4-61_2, IGHV4-61_1@0@0@0@@:protein binding@NA
A2463_20@133509@133509@duplication@1@20739498@20740969@15@chr15:20739498-20740969@6.7@419@614@1.47@CNVR6296.13@GOLGA6L6_8@0@0@0@:putative transmembrane protein FLJ36131-like;putative transmembrane protein ENSP00000320207-like;golgin A6 family-like 6@NA@NA
A2463_20@133523@133525@deletion@3@21059387@21063546@15@chr15:21059387-21063546@5.96@31@3@0.0968@NA@POTEB_6, POTEB_5, POTEB_4@0@0@0@:POTE ankyrin domain family member B-like@:protein binding@NA
A2463_20@133622@133622@duplication@1@23259497@23259543@15@chr15:23259497-23259543@4.63@36@76@2.11@CNVR6300.4@GOLGA8I_6@0@0@0@:golgin A8 family, member I@:Golgi cisterna membrane@NA
A2463_20@133642@133642@deletion@1@23412149@23412276@15@chr15:23412149-23412276@5.05@76@35@0.461@CNVR6300.8@RP11-467N20.5_2@0@0@0@:putative golgin subfamily A member 6-like protein 6-like@NA@NA
A2463_20@133869@133872@deletion@4@28629294@28630527@15@chr15:28629294-28630527@13.1@143@59@0.413@CNVR6329.4@GOLGA8F_9, GOLGA8F_10, GOLGA8F_11, GOLGA8F_12@0@0@0@@:Golgi apparatus@NA
A2463_20@133884@133887@duplication@4@28769090@28771657@15@chr15:28769090-28771657@7@64@125@1.95@CNVR6330.3@GOLGA8G_15, GOLGA8G_14, GOLGA8G_13, GOLGA8G_12@0@0@0@:golgin A8 family, member G;golgin A8 family, member F@:Golgi apparatus@NA
A2463_20@133977@133980@duplication@4@30379779@30381526@15@chr15:30379779-30381526@9.08@127@218@1.72@NA@GOLGA8J_8, GOLGA8J_9, GOLGA8J_10, GOLGA8J_11@0@0@0@:golgin A8 family, member J@:Golgi apparatus@NA
A2463_20@133997@134001@duplication@5@30433046@30434585@15@chr15:30433046-30434585@7.5@258@368@1.43@NA@GOLGA8T_9, GOLGA8T_10, GOLGA8T_11, GOLGA8T_12, GOLGA8T_13@0@0@0@:golgin A8 family, member J;golgin A8 family, member K@:Golgi apparatus@NA
A2463_20@134024@134030@duplication@7@30700112@30702470@15@chr15:30700112-30702470@9.69@221@345@1.56@NA@GOLGA8R_11, GOLGA8R_10, GOLGA8R_9, GOLGA8R_8, GOLGA8R_7, GOLGA8R_6, GOLGA8R_5@0@0@0@@:Golgi apparatus@NA
A2463_20@134036@134041@deletion@6@30845996@30848698@15@chr15:30845996-30848698@17.3@103@17@0.165@NA@GOLGA8Q_2, GOLGA8Q_3, GOLGA8Q_4, GOLGA8Q_5, GOLGA8Q_6, GOLGA8Q_7@0@0@0@@:Golgi apparatus@NA
A2463_20@134044@134054@deletion@11@30850148@30896376@15@chr15:30850148-30896376@30@172@23@0.134@CNVR6339.2, CNVR6339.3, CNVR6339.1@GOLGA8Q_10, GOLGA8Q_11, GOLGA8Q_12, GOLGA8Q_13, GOLGA8Q_14, GOLGA8Q_15, GOLGA8Q_16, GOLGA8Q_17, GOLGA8Q_18, GOLGA8Q_19, GOLGA8H_1@0@0@0@:golgin A8 family, member H@:Golgi apparatus:Golgi apparatus@NA
A2463_20@134158@134162@duplication@5@32684984@32686434@15@chr15:32684984-32686434@10.5@210@333@1.59@NA@GOLGA8K_19, GOLGA8K_18, GOLGA8K_17, GOLGA8K_16, GOLGA8K_15@0@0@0@:golgin A8 family, member J@:Golgi apparatus@NA
A2463_20@134173@134177@duplication@5@32692342@32695395@15@chr15:32692342-32695395@14.8@115@239@2.08@NA@GOLGA8K_4, GOLGA8K_3, GOLGA8K_2, AC139426.2_1, GOLGA8K_1@0@0@0@:golgin A8 family, member J@:Golgi apparatus@NA
A2463_20@134180@134181@deletion@2@32737820@32738099@15@chr15:32737820-32738099@5.88@26@0@0@CNVR6346.1@GOLGA8O_17, GOLGA8O_16@0@0@0@:golgin A8 family, member O@:Golgi apparatus@NA
A2463_20@134444@134447@duplication@4@34678827@34820035@15@chr15:34678827-34820035@9.88@154@266@1.73@CNVR6351.3@GOLGA8A_11, GOLGA8A_10, GOLGA8A_9, GOLGA8B_25@0@0@0@:golgin A8 family, member A:golgin A8 family, member A;golgin A8 family, member B@:Golgi cisterna membrane;Golgi apparatus:Golgi cisterna membrane;Golgi apparatus@NA
A2463_20@135680@135681@deletion@2@43873201@43873586@15@chr15:43873201-43873586@6.09@528@364@0.689@CNVR6365.1@PPIP5K1_10, PPIP5K1_9@0@0@0@:diphosphoinositol pentakisphosphate kinase 1@:inositol hexakisphosphate 3-kinase activity;inositol hexakisphosphate 1-kinase activity;inositol metabolic process;diphosphoinositol-pentakisphosphate kinase activity;ATP binding;acid phosphatase activity;cytoplasm;cytosol;inositol hexakisphosphate 5-kinase activity;nucleus;kinase activity;inositol-1,3,4,5,6-pentakisphosphate kinase activity@NA
A2463_20@135708@135711@duplication@4@43900062@43902635@15@chr15:43900062-43902635@6.53@348@476@1.37@CNVR6365.1@STRC_18, STRC_17, STRC_16, STRC_15@0@0@0@:diphosphoinositol pentakisphosphate kinase 1:stereocilin@:inositol hexakisphosphate 3-kinase activity;inositol hexakisphosphate 1-kinase activity;inositol metabolic process;diphosphoinositol-pentakisphosphate kinase activity;ATP binding;acid phosphatase activity;cytoplasm;cytosol;inositol hexakisphosphate 5-kinase activity;nucleus;kinase activity;inositol-1,3,4,5,6-pentakisphosphate kinase activity:detection of mechanical stimulus involved in sensory perception of sound;stereocilium bundle tip;stereocilium;cell surface;kinocilium;auditory receptor cell stereocilium organization@: DEAFNESS, AUTOSOMAL RECESSIVE 16; DFNB16; DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY
A2463_20@138281@138287@duplication@7@72953606@72957376@15@chr15:72953606-72957376@9.64@370@530@1.43@CNVR6443.1@GOLGA6B_8, GOLGA6B_9, GOLGA6B_10, GOLGA6B_11, GOLGA6B_12, GOLGA6B_13, GOLGA6B_14@0@0@0@:golgin A6 family, member B@:Golgi apparatus@NA
A2463_20@138632@138637@duplication@6@75555690@75557765@15@chr15:75555690-75557765@23.4@343@596@1.74@CNVR6452.1@GOLGA6C_4, GOLGA6C_5, GOLGA6C_6, GOLGA6C_7, GOLGA6C_8, GOLGA6C_9@0@0@0@:golgin A6 family, member C@:Golgi apparatus@NA
A2463_20@138651@138655@deletion@5@75580271@75582040@15@chr15:75580271-75582040@7.28@207@123@0.594@CNVR6452.1@GOLGA6D_5, GOLGA6D_6, GOLGA6D_7, GOLGA6D_8, GOLGA6D_9@0@0@0@:golgin A6 family, member D@:Golgi apparatus@NA
A2463_20@138661@138664@deletion@4@75586071@75586816@15@chr15:75586071-75586816@15.7@177@68@0.384@CNVR6452.1@GOLGA6D_15, GOLGA6D_16, GOLGA6D_17, GOLGA6D_18@0@0@0@:golgin A6 family, member D@:Golgi apparatus@NA
A2463_20@139294@139296@deletion@3@82932797@82935146@15@chr15:82932797-82935146@5.77@133@73@0.549@CNVR6477.6@RP13-996F3.5_8, RP13-996F3.5_7, RP13-996F3.5_6@0@0@0@NA@NA@NA
A2463_20@139474@139479@deletion@6@84904588@84909534@15@chr15:84904588-84909534@10.2@262@143@0.546@CNVR6486.2@GOLGA6L4_1, GOLGA6L4_2, GOLGA6L4_3, GOLGA6L4_4, GOLGA6L4_5, GOLGA6L4_6@0@0@0@@:Golgi apparatus@NA
A2463_20@140476@140484@duplication@9@64382@68068@16@chr16:64382-68068@24@415@678@1.63@CNVR6565.1@WASH4P_10, WASH4P_9, WASH4P_8, WASH4P_7, WASH4P_6, WASH4P_5, WASH4P_4, WASH4P_3, WASH4P_2@0@0@0@@:intracellular membrane-bounded organelle;endosomal transport;recycling endosome;early endosome;Arp2/3 complex-mediated actin nucleation;actin binding;alpha-tubulin binding;retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;recycling endosome membrane@NA
A2463_20@142690@142690@duplication@1@15045473@15045882@16@chr16:15045473-15045882@6.92@181@291@1.61@NA@NPIP_8@0@0@0@:nuclear pore complex-interacting protein-like;nuclear pore complex interacting protein;nuclear pore complex-interacting protein-like 1-like@:nuclear membrane;protein transport;nuclear pore;mRNA transport@NA
A2463_20@142750@142750@deletion@1@15457517@15457926@16@chr16:15457517-15457926@6.41@297@176@0.593@CNVR6649.1@PKD1P1_8@0@0@0@:NPIP-like protein 1-like;nuclear pore complex-interacting protein-like 1-like@NA@NA
A2463_20@142919@142928@duplication@10@16349866@16367932@16@chr16:16349866-16367932@10.5@481@665@1.38@NA@NOMO3_11, NOMO3_12, NOMO3_13, NOMO3_14, NOMO3_15, NOMO3_16, NOMO3_17, NOMO3_18, NOMO3_19, NOMO3_20@0@0@0@:NODAL modulator 3@:carbohydrate binding;integral to membrane;carboxypeptidase activity@NA
A2463_20@143483@143483@deletion@1@21764349@21764445@16@chr16:21764349-21764445@5.76@89@41@0.461@CNVR6668.5, CNVR6668.2, CNVR6668.7@OTOA_26@0@0@0@:otoancorin@:proteinaceous extracellular matrix;apical plasma membrane;sensory perception of sound;anchored to membrane@: DEAFNESS, AUTOSOMAL RECESSIVE 22; DFNB22
A2463_20@144047@144052@deletion@6@28467746@28478223@16@chr16:28467746-28478223@29.5@169@17@0.101@NA@NPIPL1_7, NPIPL1_6, NPIPL1_5, NPIPL1_4, NPIPL1_3, NPIPL1_2@0@0@0@:ceroid-lipofuscinosis, neuronal 3@:membrane:negative regulation of apoptotic process;late endosome;mitochondrion;galactosylceramide metabolic process;neuromuscular process controlling balance;neuron projection;lysosomal lumen pH elevation;integral to endoplasmic reticulum membrane;cell death;plasma membrane;nucleus;lysosomal lumen acidification;negative regulation of catalytic activity;negative regulation of macroautophagy;unfolded protein binding;neurotransmitter metabolic process;endoplasmic reticulum;vesicle transport along microtubule;protein catabolic process;autophagic vacuole;early endosome;trans-Golgi network;cellular membrane organization;ceramide metabolic process;glucosylceramide metabolic process;negative regulation of neuron apoptotic process;membrane;globoside metabolic process;membrane raft;synaptic vesicle;vacuolar transport;protein processing;Golgi membrane;caveola;protein folding;ionotropic glutamate receptor signaling pathway;cytosolic calcium ion homeostasis;Golgi stack;integral to membrane;receptor-mediated endocytosis;arginine transport;lysosome;negative regulation of proteolysis;Golgi apparatus;lysosome organization;associative learning;sphingomyelin metabolic process;macroautophagy;lysosomal membrane;amyloid precursor protein catabolic process;cytoplasm;autophagic vacuole fusion;protein binding;regulation of action potential;cellular amino acid metabolic process@: CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3
A2463_20@144095@144101@deletion@7@28607105@28619924@16@chr16:28607105-28619924@15.1@616@380@0.617@CNVR6685.1@SULT1A2_2, SULT1A1_10, SULT1A1_9, SULT1A1_8, SULT1A1_7, SULT1A1_6, SULT1A1_5@0@0@0@:sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2:sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1@:steroid metabolic process;small molecule metabolic process;sulfation;aryl sulfotransferase activity;catecholamine metabolic process;cytosol;xenobiotic metabolic process;phenol-containing compound metabolic process;sulfotransferase activity;amine biosynthetic process;flavonol 3-sulfotransferase activity;3'-phosphoadenosine 5'-phosphosulfate metabolic process:small molecule metabolic process;sulfation;aryl sulfotransferase activity;amine metabolic process;catecholamine metabolic process;xenobiotic metabolic process;cytosol;steroid sulfotransferase activity;integral to membrane;sulfotransferase activity;flavonol 3-sulfotransferase activity;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process;estrogen metabolic process@NA
A2463_20@144130@144134@deletion@5@28763890@28777810@16@chr16:28763890-28777810@13.2@102@29@0.284@NA@A-575C2.4_1, A-575C2.4_2, A-575C2.4_3, A-575C2.4_4, A-575C2.4_5@0@0@0@NA@NA@NA
A2463_20@147090@147091@deletion@2@69985939@69988476@16@chr16:69985939-69988476@12.5@84@15@0.179@CNVR6762.3, CNVR6762.1@CLEC18A_2, CLEC18A_3@0@0@0@:C-type lectin domain family 18, member A@:carbohydrate binding;protein binding;extracellular region@NA
A2463_20@147100@147101@duplication@2@69997478@70010635@16@chr16:69997478-70010635@5.13@245@339@1.38@CNVR6762.3, CNVR6762.1@CLEC18A_12, RP11-419C5.2_7@0@0@0@:C-type lectin domain family 18, member A@:carbohydrate binding;protein binding;extracellular region@NA
A2463_20@147125@147126@deletion@2@70208183@70208941@16@chr16:70208183-70208941@19.1@88@0@0@CNVR6764.1@CLEC18C_1, CLEC18C_2@0@0@0@:C-type lectin domain family 18, member C@:carbohydrate binding;protein binding;extracellular region@NA
A2463_20@147423@147423@deletion@1@72097156@72097159@16@chr16:72097156-72097159@7.01@79@30@0.38@CNVR6769.1@HPR_1@0@0@0@:thioredoxin-like 4B:haptoglobin-related protein@:mitosis;mRNA processing;RNA splicing;spliceosomal complex;cell redox homeostasis:spherical high-density lipoprotein particle;proteolysis;extracellular region;hemoglobin binding;catalytic activity;serine-type endopeptidase activity@NA
A2463_20@147504@147508@duplication@5@74443449@74445673@16@chr16:74443449-74445673@6.83@426@572@1.34@CNVR6778.2, CNVR6778.3, CNVR6778.5@CLEC18B_12, CLEC18B_11, CLEC18B_10, CLEC18B_9, CLEC18B_8@0@0@0@:C-type lectin domain family 18, member B@:carbohydrate binding;protein binding;extracellular region@NA
A2463_20@147513@147513@duplication@1@74451958@74452196@16@chr16:74451958-74452196@5.57@70@128@1.83@CNVR6778.2, CNVR6778.3@CLEC18B_3@0@0@0@:C-type lectin domain family 18, member B@:carbohydrate binding;protein binding;extracellular region@NA
A2463_20@153363@153372@duplication@10@34493376@34500284@17@chr17:34493376-34500284@9.36@329@472@1.43@CNVR7077.1, CNVR7077.3, CNVR7077.11, CNVR7077.16@TBC1D3B_14, TBC1D3B_13, TBC1D3B_12, TBC1D3B_11, TBC1D3B_10, TBC1D3B_9, TBC1D3B_8, TBC1D3B_7, TBC1D3B_6, TBC1D3B_5@0@0@0@:TBC1 domain family, member 3B@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_20@153376@153394@deletion@19@34522686@34590454@17@chr17:34522686-34590454@21.5@135@28@0.207@CNVR7077.1, CNVR7077.13, CNVR7077.19@CCL3L3_3, CCL3L3_2, CCL3L3_1, CCL4L1_1, CCL4L1_2, CCL4L1_3, TBC1D3C_14, TBC1D3C_13, TBC1D3C_12, TBC1D3C_11, TBC1D3C_10, TBC1D3C_9, TBC1D3C_8, TBC1D3C_7, TBC1D3C_6, TBC1D3C_5, TBC1D3C_4, TBC1D3C_3, TBC1D3C_2@0@0@0@:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1:TBC1 domain family, member 3C;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3H-like;TBC1 domain family, member 3H@:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_20@153414@153414@deletion@1@34797487@34798054@17@chr17:34797487-34798054@21.6@104@0@0@CNVR7078.2, CNVR7078.3@TBC1D3G_14@0@0@0@:TBC1 domain family member 3H-like;TBC1 domain family, member 3H:TBC1 domain family, member 3;TBC1 domain family, member 3G;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like;TBC1 domain family, member 3H@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
A2463_20@153643@153643@duplication@1@36342585@36342632@17@chr17:36342585-36342632@6.52@32@85@2.66@CNVR7083.3@TBC1D3_12@0@0@0@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
A2463_20@155584@155590@deletion@7@44380005@44409347@17@chr17:44380005-44409347@19.6@397@221@0.557@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A_3, LRRC37A_4, LRRC37A_5, LRRC37A_6, LRRC37A_7, LRRC37A_8, LRRC37A_9@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
A2463_20@155592@155600@deletion@9@44412912@44594799@17@chr17:44412912-44594799@61.6@333@25@0.0751@CNVR7114.2, CNVR7114.1@LRRC37A_11, LRRC37A_12, LRRC37A_13, LRRC37A_14, ARL17B_4, ARL17B_3, ARL17B_2, LRRC37A2_2, LRRC37A2_3@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
A2463_20@162017@162018@deletion@2@44542732@44550298@18@chr18:44542732-44550298@103@599@6@0.01@CNVR7319.1, CNVR7319.2@TCEB3CL2_1, TCEB3CL_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2:transcription elongation factor B polypeptide 3C-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_20@162017@162019@duplication@1@44542732@44556213@18@chr18:44542732-44556213@-102@3063@3484@1.14@CNVR7319.1, CNVR7319.2@TCEB3CL2_1, TCEB3CL_1, TCEB3C_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2:transcription elongation factor B polypeptide 3C-like:transcription elongation factor B polypeptide 3C (elongin A3);RNA polymerase II transcription factor SIII subunit A3-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_20@163962@163965@duplication@4@3027828@3028902@19@chr19:3027828-3028902@5.58@223@312@1.4@NA@TLE2_4, TLE2_3, TLE2_2, TLE2_1@0@0@0@:transducin-like enhancer of split 2 (E(sp1) homolog, Drosophila)@:nucleoplasm;negative regulation of canonical Wnt receptor signaling pathway;regulation of transcription, DNA-dependent;transcription corepressor activity;negative regulation of transcription, DNA-dependent;signal transduction;Notch signaling pathway;protein binding;nucleus;transcription, DNA-dependent;Wnt receptor signaling pathway;organ morphogenesis@NA
A2463_20@164951@164951@duplication@1@7032325@7032905@19@chr19:7032325-7032905@8.82@35@107@3.06@CNVR7517.1@MBD3L5_2@0@0@0@:methyl-CpG binding domain protein 3-like 5@NA@NA
A2463_20@168952@168952@deletion@1@35862263@35863302@19@chr19:35862263-35863302@19.2@136@22@0.162@CNVR7627.1@GPR42_2@0@0@0@@:integral to membrane;G-protein coupled receptor activity;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
A2463_20@170096@170100@duplication@5@40373946@40382826@19@chr19:40373946-40382826@44.6@458@969@2.12@CNVR7639.2@FCGBP_26, FCGBP_25, FCGBP_24, FCGBP_23, FCGBP_22@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_20@170104@170104@deletion@1@40389653@40389793@19@chr19:40389653-40389793@10.4@50@1@0.02@CNVR7639.2, CNVR7639.3@FCGBP_18@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_20@170106@170109@deletion@4@40392317@40399855@19@chr19:40392317-40399855@88.9@588@85@0.145@CNVR7639.2, CNVR7639.3@FCGBP_16, FCGBP_15, FCGBP_14, FCGBP_13@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_20@172987@172987@deletion@1@52133087@52133469@19@chr19:52133087-52133469@9.06@46@3@0.0652@CNVR7702.1@SIGLEC5_2, SIGLEC5_2@0@0@0@:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 5@:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion@NA
A2463_20@173297@173300@deletion@4@54725701@54726848@19@chr19:54725701-54726848@10.1@91@31@0.341@CNVR7721.3, CNVR7721.4@LILRB3_4, LILRB3_3, LILRB3_2, LILRB3_1@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
A2463_20@173336@173341@deletion@6@54801928@54804173@19@chr19:54801928-54804173@83.7@408@2@0.0049@CNVR7722.1@LILRA3_6, LILRA3_5, LILRA3_4, LILRA3_3, LILRA3_2, LILRA3_1@0@0@0@:leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3@:antigen binding;signal transduction;protein binding;extracellular region;plasma membrane;receptor activity;defense response@NA
A2463_20@173478@173482@deletion@5@55315108@55320338@19@chr19:55315108-55320338@6.54@83@39@0.47@CNVR7725.1, CNVR7725.3@KIR2DL4_1, KIR2DL4_2, KIR2DL4_3, KIR2DL4_4, KIR2DL4_5@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane@NA
A2463_20@173488@173501@deletion@14@55331169@55359398@19@chr19:55331169-55359398@35.3@971@566@0.583@CNVR7725.1, CNVR7725.6@KIR3DL1_4, KIR3DL1_5, KIR3DL1_6, KIR3DL1_7, KIR3DL1_8, KIR3DL1_9, KIR2DS4_1, KIR2DS4_2, KIR2DS4_3, KIR2DS4_4, KIR2DS4_5, KIR2DS4_6, KIR2DS4_7, KIR2DS4_8@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
A2463_20@178327@178327@deletion@1@58559695@58559860@20@chr20:58559695-58559860@6.96@99@43@0.434@NA@CDH26_6@0@0@0@:cadherin 26@:integral to membrane;homophilic cell adhesion;plasma membrane;membrane;calcium ion binding@NA
A2463_20@179011@179021@deletion@11@14982551@15013887@21@chr21:14982551-15013887@42@263@48@0.183@CNVR7952.1@POTED_1, POTED_2, POTED_3, POTED_4, POTED_5, POTED_6, POTED_7, POTED_8, POTED_9, POTED_10, POTED_11@0@0@0@:POTE ankyrin domain family, member B;POTE ankyrin domain family, member C;POTE ankyrin domain family, member D@:protein binding;plasma membrane@NA
A2463_20@180966@180970@deletion@5@16157307@16269943@22@chr22:16157307-16269943@6.92@445@302@0.679@CNVR8071.2, CNVR8071.5@AP000525.1_1, POTEH_10, POTEH_9, POTEH_8, POTEH_7@0@0@0@:uncharacterized LOC101060615:POTE ankyrin domain family, member H@:protein binding@NA
A2463_20@180976@180976@deletion@1@16287255@16287885@22@chr22:16287255-16287885@5.47@304@187@0.615@CNVR8071.2, CNVR8071.3, CNVR8071.9@POTEH_1@0@0@0@:POTE ankyrin domain family, member H@:protein binding@NA
A2463_20@180979@180979@duplication@1@17264510@17265299@22@chr22:17264510-17265299@11.4@75@189@2.52@NA@XKR3_4@0@0@0@:XK, Kell blood group complex subunit-related family, member 3@:integral to membrane;plasma membrane@NA
A2463_20@181127@181133@deletion@7@18723546@18739404@22@chr22:18723546-18739404@14.6@78@8@0.103@CNVR8087.5, CNVR8087.2, CNVR8087.11@AC008132.1_2, AC008132.1_3, AC008132.1_4, AC008132.1_5, AC008132.1_6, AC008132.1_7, AC008132.1_8@0@0@0@NA@NA@NA
A2463_20@181487@181489@deletion@3@21065630@21067085@22@chr22:21065630-21067085@11@157@74@0.471@CNVR8099.6, CNVR8099.2@PI4KA_51, PI4KA_50, PI4KA_49@0@0@0@:phosphatidylinositol 4-kinase, catalytic, alpha@:phospholipid metabolic process;1-phosphatidylinositol 4-kinase activity;small molecule metabolic process;phosphatidylinositol phosphorylation;binding;transferase activity, transferring phosphorus-containing groups;phosphotransferase activity, alcohol group as acceptor;ATP binding;Golgi-associated vesicle;phosphatidylinositol biosynthetic process;cytosol;protein binding;signal transduction;synaptic transmission;kinase activity;phosphatidylinositol-mediated signaling@NA
A2463_20@181806@181806@deletion@1@23243157@23243475@22@chr22:23243157-23243475@5.03@122@66@0.541@CNVR8103.2, CNVR8103.1, CNVR8103.6, CNVR8103.11@IGLC2_1@0@0@0@@:protein binding@NA
A2463_20@181850@181850@duplication@1@23652512@23652620@22@chr22:23652512-23652620@5.6@59@114@1.93@CNVR8107.2, CNVR8107.3@BCR_18@0@0@0@:breakpoint cluster region@:phospholipid binding;protein autophosphorylation;protein tyrosine kinase activity;GTPase activator activity;neuromuscular process controlling balance;ATP binding;actin cytoskeleton organization;negative regulation of cell migration;plasma membrane;inner ear morphogenesis;positive regulation of Rac GTPase activity;positive regulation of phagocytosis;regulation of small GTPase mediated signal transduction;response to lipopolysaccharide;intracellular signal transduction;Rac GTPase activator activity;regulation of cell cycle;platelet-derived growth factor receptor signaling pathway;protein serine/threonine kinase activity;intracellular;small GTPase mediated signal transduction;regulation of Rho protein signal transduction;protein phosphorylation;negative regulation of inflammatory response;enzyme binding;Rho guanyl-nucleotide exchange factor activity;cytoplasm;cytosol;protein binding;signal transduction;brain development;kinase activity;negative regulation of neutrophil degranulation@: LEUKEMIA, CHRONIC MYELOID; CML
A2463_20@417@441@deletion@25@1606903@1669887@1@chr1:1606903-1669887@55.6@772@352@0.456@CNVR17.1@SLC35E2B_5, SLC35E2B_4, SLC35E2B_3, CDK11A_20, CDK11A_19, CDK11A_18, CDK11A_17, CDK11A_16, CDK11A_15, CDK11A_14, CDK11A_13, CDK11A_12, CDK11A_11, CDK11A_10, CDK11A_9, CDK11A_8, CDK11A_7, CDK11A_6, CDK11A_5, CDK11A_4, CDK11A_3, CDK11A_2, SLC35E2_6, SLC35E2_5, SLC35E2_4@0@0@0@:solute carrier family 35, member E2B:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A:solute carrier family 35, member E2@:integral to membrane;membrane;transmembrane transport:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division:integral to membrane;membrane@NA
A2463_20@1815@1838@deletion@24@12921077@13366425@1@chr1:12921077-13366425@73@1389@661@0.476@NA@PRAMEF2_4, PRAMEF4_4, PRAMEF4_3, PRAMEF4_2, PRAMEF10_4, PRAMEF10_3, PRAMEF10_2, PRAMEF7_2, PRAMEF7_3, PRAMEF7_4, PRAMEF6_4, PRAMEF6_3, PRAMEF6_2, PRAMEF22_1, PRAMEF22_2, PRAMEF22_3, WI2-3308P17.2_1, WI2-2994D6.2_2, WI2-2994D6.2_1, PRAMEF3_3, PRAMEF3_2, PRAMEF3_1, PRAMEF5_2, PRAMEF5_3@0@0@0@:PRAME family member 2:PRAME family member 4:PRAME family member 10:PRAME family member 7:PRAME family member 6;PRAME family member 23;PRAME family member 9/15-like;PRAME family member 5:PRAME family member 22:PRAME family member:PRAME family member 3:PRAME family member 5@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
A2463_20@2170@2179@deletion@10@17248515@17264232@1@chr1:17248515-17264232@10.4@421@271@0.644@CNVR94.4, CNVR94.5, CNVR94.6@CROCC_1, CROCC_2, CROCC_3, CROCC_4, CROCC_5, CROCC_6, CROCC_7, CROCC_8, CROCC_9, CROCC_10@0@0@0@:ciliary rootlet coiled-coil, rootletin@:centriole;centrosome organization;centrosome;kinesin binding;actin cytoskeleton;cytoplasm;protein binding;vesicle-mediated transport;structural molecule activity;ciliary rootlet;protein localization;plasma membrane;cell cycle;cell projection organization;membrane@NA
A2463_20@3358@3358@deletion@1@25747131@25747277@1@chr1:25747131-25747277@5.33@51@17@0.333@CNVR117.1@RHCE_1@0@0@0@:Rh blood group, CcEe antigens@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@: BLOOD GROUP--RHESUS SYSTEM E POLYPEPTIDE; RHE; RHESUS BLOOD GROUP, CcEe ANTIGENS; RHCE
A2463_20@9340@9350@deletion@11@104114226@104160230@1@chr1:104114226-104160230@15.9@1446@1016@0.703@CNVR266.8, CNVR266.3@AMY2B_3, AMY2B_4, AMY2B_5, AMY2B_6, AMY2B_7, AMY2B_8, AMY2B_9, AMY2B_10, AMY2B_11, AMY2B_12, AMY2A_1@0@0@0@:actin, gamma 1 pseudogene 4;amylase, alpha 2B (pancreatic):amylase, alpha 2A (pancreatic)@:extracellular region;cation binding;digestion;carbohydrate metabolic process;catalytic activity;alpha-amylase activity;metal ion binding:chloride ion binding;cation binding;small molecule metabolic process;carbohydrate metabolic process;catalytic activity;extracellular space;polysaccharide digestion;extracellular region;carbohydrate catabolic process;alpha-amylase activity;calcium ion binding@NA
A2463_20@9385@9386@deletion@2@104297122@104297436@1@chr1:104297122-104297436@6.29@317@199@0.628@CNVR266.3, CNVR266.5@AMY1C_6, AMY1C_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
A2463_20@9436@9436@deletion@1@108769302@108769515@1@chr1:108769302-108769515@5.37@24@0@0@CNVR294.4@NBPF4_14@0@0@0@:neuroblastoma breakpoint family, member 4@:cytoplasm@NA
A2463_20@9766@9774@deletion@9@110230497@110254970@1@chr1:110230497-110254970@61.9@338@28@0.0828@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_1, GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8, GSTM5_1@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1:glutathione S-transferase mu 5@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process:xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process;glutathione metabolic process;endoplasmic reticulum membrane@NA
A2463_20@10793@10796@deletion@4@144339779@144811957@1@chr1:144339779-144811957@23.7@234@78@0.333@NA@AL592284.1_1, PPIAL4B_1, AL592284.1_2, NBPF9_1@0@0@0@:uncharacterized LOC730256;uncharacterized LOC101060698;uncharacterized LOC642441:peptidylprolyl isomerase A (cyclophilin A)-like 4C;peptidyl-prolyl cis-trans isomerase A-like 4A/B/C-like;peptidylprolyl isomerase A (cyclophilin A)-like 4B;peptidylprolyl isomerase A (cyclophilin A)-like 4A:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 24@:protein folding;peptidyl-prolyl cis-trans isomerase activity;cytoplasm@NA
A2463_20@10865@10866@deletion@2@145298156@145299939@1@chr1:145298156-145299939@8.86@526@341@0.648@CNVR341.2, CNVR341.3, CNVR341.4@NBPF10_5, NBPF10_6@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family, member 10@:protein binding;calcium ion binding@NA
A2463_20@11143@11164@deletion@22@146227744@146253110@1@chr1:146227744-146253110@33.8@322@118@0.366@NA@NBPF12_22, NBPF12_21, NBPF12_20, NBPF12_19, NBPF12_18, NBPF12_17, NBPF12_16, NBPF12_15, NBPF12_14, NBPF12_13, NBPF12_12, NBPF12_11, NBPF12_10, NBPF12_9, NBPF12_8, NBPF12_7, NBPF12_6, NBPF12_5, NBPF12_4, NBPF12_3, NBPF12_2, NBPF12_1@0@0@0@:neuroblastoma breakpoint family member 21-like@NA@NA
A2463_20@11169@11170@duplication@2@146400092@146401880@1@chr1:146400092-146401880@9.09@59@135@2.29@NA@NBPF12_9, NBPF12_10@0@0@0@:neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family member 14-like;neuroblastoma breakpoint family, member 12@:cytoplasm@NA
A2463_20@11341@11342@duplication@2@148008574@148009516@1@chr1:148008574-148009516@7.14@451@628@1.39@CNVR346.2, CNVR346.4@NBPF14_17, NBPF14_16@0@0@0@:neuroblastoma breakpoint family, member 14@:cytoplasm@NA
A2463_20@11345@11346@duplication@2@148011681@148012675@1@chr1:148011681-148012675@10.5@250@402@1.61@CNVR346.2, CNVR346.4@NBPF14_13, NBPF14_12@0@0@0@:neuroblastoma breakpoint family, member 14@:cytoplasm@NA
A2463_20@11503@11504@deletion@2@149754301@149754816@1@chr1:149754301-149754816@6.18@38@6@0.158@CNVR351.3, CNVR351.5@FCGR1A_1, FCGR1A_2, HIST2H2BF_2@0@0@0@:Fc fragment of IgG, high affinity Ib, receptor (CD64);Fc fragment of IgG, high affinity Ia, receptor (CD64):histone cluster 2, H2bf@:IgG receptor activity;phagocytosis, recognition;antibody-dependent cellular cytotoxicity;regulation of immune response;phagocytosis, engulfment;antigen processing and presentation of peptide antigen via MHC class I;immune response;clathrin-coated endocytic vesicle membrane;interferon-gamma-mediated signaling pathway;integral to membrane;Fc-gamma receptor signaling pathway;positive regulation of type III hypersensitivity;plasma membrane;receptor-mediated endocytosis;positive regulation of phagocytosis;cytokine-mediated signaling pathway;early endosome membrane;cell surface receptor signaling pathway;IgG binding;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;positive regulation of type IIa hypersensitivity;antigen processing and presentation of exogenous antigen;external side of plasma membrane;signal transduction;protein binding;defense response to bacterium;antigen processing and presentation of exogenous peptide antigen via MHC class I;receptor signaling protein activity;response to bacterium:sequence-specific DNA binding;intracellular;nucleus;protein heterodimerization activity;DNA binding;nucleosome assembly;nucleosome@NA
A2463_20@14047@14053@duplication@7@161494450@161565521@1@chr1:161494450-161565521@13.7@931@1263@1.36@CNVR383.3, CNVR383.1@HSPA6_1, FCGR3A_5, FCGR3A_4, FCGR3A_3, FCGR3A_2, FCGR3A_1, FCGR2C_1@0@0@0@:heat shock 70kDa protein 6 (HSP70B'):Fc fragment of IgG, low affinity IIIa, receptor (CD16a):Fc fragment of IgG, low affinity IIb, receptor (CD32):Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene)@:signalosome;cell morphogenesis;response to unfolded protein;ATP binding:IgG binding;protein binding;regulation of immune response;extracellular region;integral to membrane;immune response;plasma membrane;external side of plasma membrane:IgG binding;protein binding;signal transduction;regulation of immune response;integral to membrane;immune response;plasma membrane;virus-host interaction@: MALARIA, SUSCEPTIBILITY TO; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
A2463_20@14061@14062@deletion@2@161641183@161643019@1@chr1:161641183-161643019@6.9@156@89@0.571@CNVR383.1@FCGR2B_3, FCGR2B_4@0@0@0@:Fc fragment of IgG, low affinity IIb, receptor (CD32)@:IgG binding;protein binding;signal transduction;regulation of immune response;integral to membrane;immune response;plasma membrane;virus-host interaction@: MALARIA, SUSCEPTIBILITY TO; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
A2463_20@16030@16037@duplication@8@196748293@196796135@1@chr1:196748293-196796135@15.6@1024@1409@1.38@CNVR459.1@CFHR3_2, CFHR3_3, CFHR3_4, CFHR3_5, CFHR3_6, CFHR1_1, CFHR1_2, CFHR1_3@0@0@0@:complement factor H-related 3:complement factor H-related 1:complement factor H-related 2@:extracellular space:extracellular space;complement activation:extracellular region@NA
A2463_20@19750@19750@deletion@1@248084321@248085258@1@chr1:248084321-248085258@6.05@66@24@0.364@NA@OR2T8_1@0@0@0@:olfactory receptor, family 2, subfamily T, member 8@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_20@24998@25006@deletion@9@90121659@90198770@2@chr2:90121659-90198770@10.8@584@388@0.664@CNVR867.10, CNVR867.5, CNVR867.3, CNVR867.9@IGKV1D-17_1, IGKV1D-17_2, IGKV1D-16_1, IGKV1D-16_2, IGKV3D-15_1, IGKV3D-15_2, IGKV1D-13_1, IGKV1D-13_2, IGKV1D-12_1@0@0@0@@:protein binding:protein binding:protein binding:protein binding:protein binding@NA
A2463_20@25115@25116@deletion@2@96652500@96652954@2@chr2:96652500-96652954@4.92@67@31@0.463@NA@ANKRD36C_3, ANKRD36C_2@0@0@0@:ankyrin repeat domain-containing protein 36A-like@:ion channel inhibitor activity;protein binding@NA
A2463_20@25390@25404@deletion@15@97873672@97899608@2@chr2:97873672-97899608@58.8@1665@931@0.559@NA@ANKRD36_54, ANKRD36_55, ANKRD36_56, ANKRD36_57, ANKRD36_58, ANKRD36_59, ANKRD36_60, ANKRD36_61, ANKRD36_62, ANKRD36_63, ANKRD36_64, ANKRD36_65, ANKRD36_66, ANKRD36_67, ANKRD36_68@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_20@25407@25411@deletion@5@97910895@97915904@2@chr2:97910895-97915904@10.6@227@110@0.485@CNVR887.1@ANKRD36_71, ANKRD36_72, ANKRD36_73, ANKRD36_74, ANKRD36_75@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
A2463_20@26304@26305@deletion@2@112539947@112541541@2@chr2:112539947-112541541@6.79@153@88@0.575@CNVR928.1@ANAPC1_43, ANAPC1_42@0@0@0@:anaphase-promoting complex subunit 1-like;anaphase promoting complex subunit 1@:nucleoplasm;regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle;anaphase-promoting complex;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle spindle assembly checkpoint;cytosol;protein K11-linked ubiquitination;protein binding;mitosis;nucleus;cell cycle checkpoint;cell division;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle@NA
A2463_20@27171@27172@deletion@2@130868117@130869674@2@chr2:130868117-130869674@8.92@71@19@0.268@NA@POTEF_5, POTEF_4@0@0@0@:POTE ankyrin domain family, member F@:cell cortex;protein binding;ATP binding@NA
A2463_20@27281@27286@deletion@6@131388983@131403883@2@chr2:131388983-131403883@6.4@96@48@0.5@NA@POTEJ_8, POTEJ_9, POTEJ_10, POTEJ_11, POTEJ_12, POTEJ_13@0@0@0@:POTE ankyrin domain family, member J@:protein binding;ATP binding@NA
A2463_20@27326@27327@duplication@2@132010100@132010672@2@chr2:132010100-132010672@5.15@112@177@1.58@NA@POTEE_12, POTEE_13@0@0@0@:pleckstrin homology domain containing, family B (evectins) member 2:POTE ankyrin domain family, member E@:phospholipid binding;protein binding;recycling endosome membrane:protein binding;ATP binding@NA
A2463_20@48972@48973@deletion@2@75482007@75484724@4@chr4:75482007-75484724@5.01@32@7@0.219@NA@AREGB_2, AREGB_3@0@0@0@:amphiregulin;amphiregulin B@:growth factor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;cell proliferation;epidermal growth factor receptor signaling pathway;extracellular space;protein binding;integral to membrane;cytokine activity;cell surface;positive regulation of DNA replication@NA
A2463_20@55777@55778@deletion@2@68840732@68843928@5@chr5:68840732-68843928@6.54@103@48@0.466@CNVR2494.7, CNVR2494.4, CNVR2494.46@OCLN_6, OCLN_7@0@0@0@:occludin@:S-adenosylmethionine metabolic process;cell-cell junction organization;cellular component disassembly involved in execution phase of apoptosis;response to testosterone stimulus;tight junction;integral to membrane;cell junction;plasma membrane;apoptotic process;thiopurine S-methyltransferase activity;S-adenosylhomocysteine metabolic process;apical plasma membrane;protein complex assembly;cytosol;cell-cell junction;protein binding;structural molecule activity;response to organic cyclic compound;apicolateral plasma membrane@: BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA;
A2463_20@55806@55806@duplication@1@69372349@69372398@5@chr5:69372349-69372398@4.37@100@161@1.61@CNVR2494.48, CNVR2494.39, CNVR2494.15, CNVR2494.18, CNVR2494.26, CNVR2494.43, CNVR2494.52, CNVR2494.28, CNVR2494.2, CNVR2494.36@SMN2_8@0@0@0@:survival of motor neuron 2, centromeric;survival of motor neuron 1, telomeric@:nucleoplasm;ncRNA metabolic process;Cajal body;RNA metabolic process;spliceosomal complex;cytoplasm;cytosol;protein binding;cell death;spliceosomal complex assembly;RNA binding;mRNA processing;nucleus;gene expression;spliceosomal snRNP assembly@: SPINAL MUSCULAR ATROPHY, TYPE II; SMA2; SPINAL MUSCULAR ATROPHY, TYPE I; SMA1; SPINAL MUSCULAR ATROPHY, TYPE IV; SMA4; SPINAL MUSCULAR ATROPHY, TYPE III; SMA3
A2463_20@60882@60888@deletion@7@175487236@175524382@5@chr5:175487236-175524382@14.5@120@36@0.3@NA@RP11-826N14.2_2, FAM153B_3, FAM153B_4, FAM153B_5, FAM153B_6, FAM153B_7@0@0@0@:uncharacterized LOC100507387;family with sequence similarity 153, member B@NA@NA
A2463_20@62955@62957@deletion@3@29912278@29913058@6@chr6:29912278-29913058@6.19@69@29@0.42@CNVR2829.7, CNVR2829.2, CNVR2829.3@HLA-A_7, HLA-A_8, HLA-A_9@0@0@0@:major histocompatibility complex, class I, A@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;MHC class I receptor activity;membrane@: SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO
A2463_20@63725@63732@deletion@8@31962023@31964100@6@chr6:31962023-31964100@9.06@585@390@0.667@CNVR2843.6, CNVR2843.3@C4A_20, C4A_21, C4A_22, C4A_23, C4A_24, C4A_25, C4A_26, C4A_27@0@0@0@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
A2463_20@63797@63799@deletion@3@32008184@32008911@6@chr6:32008184-32008911@13.9@398@227@0.57@CNVR2843.6, CNVR2843.5@CYP21A2_8, CYP21A2_9, CYP21A2_10@0@0@0@:cytochrome P450, family 21, subfamily A, polypeptide 2@:oxidation-reduction process;electron carrier activity;response to antibiotic;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;steroid 21-monooxygenase activity;C21-steroid hormone biosynthetic process;heme binding;mineralocorticoid biosynthetic process;progesterone metabolic process;monooxygenase activity;cellular response to peptide hormone stimulus;iron ion binding@: ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY
A2463_20@63810@63812@deletion@3@32011785@32012996@6@chr6:32011785-32012996@5.07@203@123@0.606@CNVR2843.6, CNVR2843.5@TNXB_3, TNXB_2, TNXB_1@0@0@0@:tenascin-X-like;tenascin XB@:integrin binding;extracellular matrix;cell-cell adhesion;elastic fiber assembly;collagen fibril organization;fibrillar collagen;actin cytoskeleton organization;extracellular space;heparin binding;proteinaceous extracellular matrix;fatty acid metabolic process;regulation of JUN kinase activity;receptor binding;intracellular;cell-matrix adhesion;extracellular matrix organization;lipid metabolic process;protein binding;signal transduction;extracellular region;collagen binding;cell adhesion;triglyceride metabolic process;fibril organization;collagen metabolic process@: EHLERS-DANLOS-LIKE SYNDROME DUE TO TENASCIN-X DEFICIENCY; EHLERS-DANLOS SYNDROME, TYPE III
A2463_20@70816@70817@deletion@2@161054786@161056336@6@chr6:161054786-161056336@19.2@141@28@0.199@CNVR3133.1@LPA_9, LPA_8@0@0@0@:lipoprotein, Lp(a)@:blood circulation;endopeptidase inhibitor activity;catalytic activity;lipoprotein metabolic process;proteolysis;heparin binding;receptor-mediated endocytosis;fibronectin binding;small molecule metabolic process;apolipoprotein binding;lipid metabolic process;negative regulation of endopeptidase activity;extracellular region;plasma lipoprotein particle;lipid transport;serine-type endopeptidase activity@: APOLIPOPROTEIN(a); LPA
A2463_20@71030@71033@deletion@4@167790035@167796361@6@chr6:167790035-167796361@11.7@143@62@0.434@NA@TCP10_5, TCP10_4, TCP10_3, TCP10_2@0@0@0@:t-complex 10@:cytosol@NA
A2463_20@71747@71748@duplication@2@5941289@5942375@7@chr7:5941289-5942375@7.85@217@357@1.65@NA@CCZ1_5, CCZ1_6@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
A2463_20@74576@74582@deletion@7@74169842@74193503@7@chr7:74169842-74193503@7.91@235@145@0.617@NA@GTF2I_31, GTF2I_32, GTF2I_33, GTF2I_34, NCF1_1, NCF1_2, NCF1_3@0@0@0@:general transcription factor IIi:neutrophil cytosolic factor 1@:neuronal cell body;transcription initiation from RNA polymerase II promoter;mitogen-activated protein kinase binding;negative regulation of angiogenesis;DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;cytoplasm;transcription from RNA polymerase II promoter;protein binding;signal transduction;nucleus;cell projection;reduction of cytosolic calcium ion concentration:inflammatory response;antigen processing and presentation of peptide antigen via MHC class I;phagosome maturation;NADPH oxidase complex;neutrophil mediated killing of gram-positive bacterium;cell communication;interaction with host;leukotriene metabolic process;response to yeast;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;respiratory burst;GTPase activity;negative regulation of smooth muscle contraction;GTP catabolic process;cytosol;defense response to fungus;defense response to bacterium;antigen processing and presentation of exogenous peptide antigen via MHC class I;leukocyte mediated cytotoxicity;neutrophil mediated killing of fungus;phosphatidylinositol binding;defense response to Gram-positive bacterium;GTP binding;respiratory burst involved in defense response;superoxide-generating NADPH oxidase activity;hydrogen peroxide biosynthetic process;protein targeting to membrane;electron carrier activity;superoxide metabolic process;innate immune response;phagolysosome;cytoplasm;cell proliferation;superoxide anion generation;protein binding;SH3 domain binding;cellular defense response;response to bacterium@: GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE,
A2463_20@74587@74591@deletion@5@74199529@74212604@7@chr7:74199529-74212604@5.94@587@408@0.695@NA@NCF1_8, NCF1_9, NCF1_10, NCF1_11, GTF2IRD2_16@0@0@0@:neutrophil cytosolic factor 1:GTF2I repeat domain containing 2@:inflammatory response;antigen processing and presentation of peptide antigen via MHC class I;phagosome maturation;NADPH oxidase complex;neutrophil mediated killing of gram-positive bacterium;cell communication;interaction with host;leukotriene metabolic process;response to yeast;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;respiratory burst;GTPase activity;negative regulation of smooth muscle contraction;GTP catabolic process;cytosol;defense response to fungus;defense response to bacterium;antigen processing and presentation of exogenous peptide antigen via MHC class I;leukocyte mediated cytotoxicity;neutrophil mediated killing of fungus;phosphatidylinositol binding;defense response to Gram-positive bacterium;GTP binding;respiratory burst involved in defense response;superoxide-generating NADPH oxidase activity;hydrogen peroxide biosynthetic process;protein targeting to membrane;electron carrier activity;superoxide metabolic process;innate immune response;phagolysosome;cytoplasm;cell proliferation;superoxide anion generation;protein binding;SH3 domain binding;cellular defense response;response to bacterium:nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@: GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE,
A2463_20@74628@74635@deletion@8@74536693@74552657@7@chr7:74536693-74552657@8.71@137@64@0.467@NA@GTF2IRD2B_4, GTF2IRD2B_5, GTF2IRD2B_6, GTF2IRD2B_7, GTF2IRD2B_8, GTF2IRD2B_9, GTF2IRD2B_10, GTF2IRD2B_11@0@0@0@:GTF2I repeat domain containing 2B@:nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
A2463_20@74793@74793@deletion@1@76241040@76241130@7@chr7:76241040-76241130@5.45@29@3@0.103@CNVR3463.10@POMZP3_5@0@0@0@:uroplakin 3B:POM121 and ZP3 fusion@:negative regulation of gene expression;integral to membrane;plasma membrane:molecular_function;cellular_component;biological_process@NA
A2463_20@76426@76432@duplication@7@100320602@100336236@7@chr7:100320602-100336236@12@274@421@1.54@CNVR3509.1@EPO_5, ZAN_1, ZAN_2, ZAN_3, ZAN_4, ZAN_5, ZAN_6@0@0@0@:erythropoietin:zonadhesin@:negative regulation of apoptotic process;peptidyl-serine phosphorylation;embryo implantation;response to estrogen stimulus;eukaryotic cell surface binding;response to electrical stimulus;response to lipopolysaccharide;hemoglobin biosynthetic process;response to hyperoxia;negative regulation of sodium ion transport;response to salt stress;positive regulation of transcription, DNA-dependent;cellular response to hypoxia;positive regulation of DNA replication;erythropoietin receptor binding;protein kinase activator activity;cellular response to stress;blood circulation;hormone activity;aging;erythrocyte maturation;response to testosterone stimulus;response to axon injury;response to interleukin-1;extracellular space;response to vitamin A;regulation of transcription from RNA polymerase II promoter in response to hypoxia;erythrocyte differentiation;positive regulation of cell proliferation;apoptotic process;response to nutrient;negative regulation of ion transmembrane transporter activity;response to hypoxia;positive regulation of Ras protein signal transduction;regulation of transcription from RNA polymerase II promoter;positive regulation of protein kinase activity;protein binding;positive regulation of neuron differentiation;signal transduction;extracellular region;cellular hyperosmotic response;negative regulation of myeloid cell apoptotic process;positive regulation of tyrosine phosphorylation of Stat5 protein:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@: MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 2; MVCD2
A2463_20@76751@76751@deletion@1@102210283@102210371@7@chr7:102210283-102210371@6.25@99@44@0.444@CNVR3518.1@POLR2J3_2@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
A2463_20@79311@79323@deletion@13@143929005@144070377@7@chr7:143929005-144070377@25.8@1412@901@0.638@CNVR3598.4@OR2A42_1, OR2A7_1, CTAGE8_1, OR2A1_1, ARHGEF5_2, ARHGEF5_3, ARHGEF5_4, ARHGEF5_5, ARHGEF5_6, ARHGEF5_7, ARHGEF5_8, ARHGEF5_9, ARHGEF5_10@0@0@0@:Rho guanine nucleotide exchange factor (GEF) 35:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1:olfactory receptor, family 2, subfamily A, member 7:CTAGE family, member 6, pseudogene;CTAGE family, member 15, pseudogene:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
A2463_20@80362@80367@deletion@6@7215499@7272619@8@chr8:7215499-7272619@21.4@896@535@0.597@CNVR3771.8, CNVR3771.10, CNVR3771.4@ZNF705G_7, ZNF705G_6, ZNF705G_5, ZNF705G_4, ZNF705G_3, DEFB4B_2@0@0@0@:zinc finger protein 705G:defensin, beta 4B;defensin, beta 4A@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response@NA
A2463_20@80577@80577@duplication@1@12285167@12285315@8@chr8:12285167-12285315@4.64@12@46@3.83@CNVR3786.4, CNVR3786.16@FAM86B2_7@0@0@0@:family with sequence similarity 86, member B2@NA@NA
A2463_20@86633@86635@deletion@3@121962@123454@9@chr9:121962-123454@8.46@138@68@0.493@CNVR4135.1@CBWD1_14, CBWD1_13, CBWD1_12@0@0@0@:COBW domain containing 1;COBW domain-containing protein 1-like;COBW domain containing 5@:ATP binding@NA
A2463_20@88535@88539@deletion@5@41311441@41327364@9@chr9:41311441-41327364@7.01@43@8@0.186@CNVR4278.2@FAM74A2_1, SPATA31A4_4, SPATA31A4_3, SPATA31A4_2, SPATA31A4_1@0@0@0@:SPATA31 subfamily A, member 4@:integral to membrane:integral to membrane@NA
A2463_20@88577@88583@deletion@7@43121641@43135514@9@chr9:43121641-43135514@6.37@54@17@0.315@NA@ANKRD20A3_6, ANKRD20A3_5, ANKRD20A3_4, ANKRD20A3_3, ANKRD20A3_2, ANKRD20A3_1, AL513478.1_1@0@0@0@:coiled-coil domain-containing protein 29-like;ankyrin repeat domain 20 family, member A3@:protein binding@NA
A2463_20@88645@88657@deletion@13@67945207@67987998@9@chr9:67945207-67987998@24.3@903@609@0.674@NA@ANKRD20A1_7, ANKRD20A1_8, ANKRD20A1_9, ANKRD20A1_10, ANKRD20A1_11, ANKRD20A1_12, ANKRD20A1_13, ANKRD20A1_14, ANKRD20A1_15, RP11-195B21.3_3, RP11-195B21.3_4, RP11-195B21.3_5, RP11-195B21.3_6@0@0@0@:ankyrin repeat domain 20 family, member A1:coiled-coil domain-containing protein 29-like;uncharacterized LOC644249@:protein binding;plasma membrane@NA
A2463_20@88676@88687@deletion@12@69382094@69416205@9@chr9:69382094-69416205@19.6@296@153@0.517@NA@ANKRD20A4_1, ANKRD20A4_2, ANKRD20A4_3, ANKRD20A4_4, ANKRD20A4_5, ANKRD20A4_6, ANKRD20A4_7, ANKRD20A4_8, ANKRD20A4_9, ANKRD20A4_10, ANKRD20A4_11, ANKRD20A4_12@0@0@0@:ankyrin repeat domain 20 family, member A4@:protein binding@NA
A2463_20@88721@88725@deletion@5@70900906@70914503@9@chr9:70900906-70914503@10@154@76@0.494@NA@CBWD3_11, CBWD3_12, CBWD3_13, CBWD3_14, CBWD3_15@0@0@0@:COBW domain-containing protein 5-like;COBW domain-containing protein 1-like;COBW domain containing 3@:ATP binding@NA
A2463_20@91244@91247@deletion@4@117086299@117088637@9@chr9:117086299-117088637@6.52@145@81@0.559@CNVR4448.1@ORM1_3, ORM1_4, ORM1_5, ORM1_6@0@0@0@:orosomucoid 1@:protein binding;extracellular space;regulation of immune system process;transport;inflammatory response;extracellular region;acute-phase response@NA
A2463_20@94609@94610@deletion@2@5019893@5032230@10@chr10:5019893-5032230@7.35@89@37@0.416@NA@AKR1C1_9, AKR1C2_9@0@0@0@:aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase):aldo-keto reductase family 1, member C2 (dihydrodiol dehydrogenase 2; bile acid binding protein; 3-alpha hydroxysteroid dehydrogenase, type III);aldo-keto reductase family 1 member C2-like@:trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity;bile acid and bile salt transport;oxidation-reduction process;phenanthrene 9,10-monooxygenase activity;indanol dehydrogenase activity;daunorubicin metabolic process;carboxylic acid binding;retinal metabolic process;response to organophosphorus;cholesterol homeostasis;ketosteroid monooxygenase activity;progesterone metabolic process;oxidoreductase activity;17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity;aldo-keto reductase (NADP) activity;digestion;androsterone dehydrogenase (B-specific) activity;doxorubicin metabolic process;alditol:NADP+ 1-oxidoreductase activity;bile acid binding;oxidoreductase activity, acting on NADH or NADPH, quinone or similar compound as acceptor;bile acid metabolic process;xenobiotic metabolic process;cytosol;protein homooligomerization;intestinal cholesterol absorption;cellular response to jasmonic acid stimulus:trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity;steroid metabolic process;oxidation-reduction process;phenanthrene 9,10-monooxygenase activity;prostaglandin F receptor activity;daunorubicin metabolic process;carboxylic acid binding;ketosteroid monooxygenase activity;progesterone metabolic process;oxidoreductase activity;digestion;positive regulation of cell proliferation;prostaglandin metabolic process;doxorubicin metabolic process;response to prostaglandin stimulus;positive regulation of protein kinase B signaling cascade;alditol:NADP+ 1-oxidoreductase activity;androsterone dehydrogenase (A-specific) activity;bile acid binding;G-protein coupled receptor signaling pathway;oxidoreductase activity, acting on NADH or NADPH, quinone or similar compound as acceptor;cytoplasm;cellular response to jasmonic acid stimulus@: 46,XY SEX REVERSAL 8; SRXY8
A2463_20@95352@95357@deletion@6@17875675@17898362@10@chr10:17875675-17898362@17@139@40@0.288@NA@MRC1L1_4, MRC1L1_5, MRC1L1_6, MRC1L1_7, MRC1L1_8, MRC1L1_9@0@0@0@:macrophage mannose receptor 1-like@:carbohydrate binding@NA
A2463_20@96438@96440@deletion@3@46252461@46258937@10@chr10:46252461-46258937@6.13@96@48@0.5@NA@FAM21C_16, FAM21C_17, FAM21C_18@0@0@0@:family with sequence similarity 21, member C@:endosome;protein binding;plasma membrane;retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
A2463_20@96463@96470@deletion@8@46552470@46611811@10@chr10:46552470-46611811@12@59@3@0.0508@CNVR4712.3@PTPN20A_9, PTPN20A_8, PTPN20A_7, PTPN20A_6, PTPN20A_5, PTPN20A_4, PTPN20A_3, PTPN20A_2@0@0@0@:protein tyrosine phosphatase, non-receptor type 20B;protein tyrosine phosphatase, non-receptor type 20A@:phosphatase activity;protein tyrosine phosphatase activity;microtubule;nucleus;dephosphorylation;protein dephosphorylation;microtubule organizing center@NA
A2463_20@98004@98006@deletion@3@75434358@75439864@10@chr10:75434358-75439864@8.79@417@264@0.633@CNVR4799.1@AGAP5_8, AGAP5_7, AGAP5_6@0@0@0@:ankyrin repeat and GTPase domain Arf GTPase activating protein 11;ArfGAP with GTPase domain, ankyrin repeat and PH domain 5;ArfGAP with GTPase domain, ankyrin repeat and PH domain 10;arf-GAP with GTPase, ANK repeat and PH domain-containing protein 5-like@:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity@NA
A2463_20@98350@98350@duplication@1@81471457@81472241@10@chr10:81471457-81472241@5.03@201@304@1.51@CNVR4815.2, CNVR4815.4@FAM22B_7@0@0@0@NA@NA@NA
A2463_20@98350@98357@deletion@7@81471457@81610362@10@chr10:81471457-81610362@11.2@305@304@0.997@CNVR4815.2@FAM22B_7, FAM22E_1, FAM22E_2, FAM22E_3, FAM22E_4, FAM22E_5, FAM22E_6, FAM22E_7@0@0@0@NA@NA@NA
A2463_20@103289@103289@deletion@1@5270599@5270820@11@chr11:5270599-5270820@10.4@48@0@0@NA@HBG1_2@0@0@0@:hemoglobin, gamma A@:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex@NA
A2463_20@104444@104445@deletion@2@18288436@18290880@11@chr11:18288436-18290880@5.65@91@45@0.495@NA@SAA1_2, SAA1_3@0@0@0@:serum amyloid A1@:regulation of protein secretion;platelet activation;neutrophil chemotaxis;negative regulation of inflammatory response;positive regulation of cytokine secretion;macrophage chemotaxis;positive regulation of cell adhesion;positive regulation of interleukin-1 secretion;extracellular region;lymphocyte chemotaxis;high-density lipoprotein particle;elevation of cytosolic calcium ion concentration;acute-phase response;G-protein coupled receptor binding@NA
A2463_20@106046@106048@deletion@3@55370918@55419315@11@chr11:55370918-55419315@13.6@578@343@0.593@CNVR5179.1@OR4C11_1, OR4P4_1, OR4S2_1@0@0@0@:olfactory receptor, family 4, subfamily C, member 11:olfactory receptor, family 4, subfamily P, member 4:olfactory receptor, family 4, subfamily S, member 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
A2463_20@114424@114426@deletion@3@10583717@10586541@12@chr12:10583717-10586541@5.45@268@174@0.649@CNVR5430.1@KLRC2_6, KLRC2_5, KLRC2_4@0@0@0@:killer cell lectin-like receptor subfamily C, member 2@:carbohydrate binding:transmembrane signaling receptor activity;carbohydrate binding;protein binding;signal transduction;cellular defense response;integral to plasma membrane@NA
A2463_20@114862@114875@duplication@14@19472956@19519043@12@chr12:19472956-19519043@33@1601@2262@1.41@NA@PLEKHA5_17, PLEKHA5_18, PLEKHA5_19, PLEKHA5_20, PLEKHA5_21, PLEKHA5_22, PLEKHA5_23, PLEKHA5_24, PLEKHA5_25, PLEKHA5_26, PLEKHA5_27, PLEKHA5_28, PLEKHA5_29, PLEKHA5_30@0@0@0@:pleckstrin homology domain containing, family A member 5@:phospholipid binding;protein binding;1-phosphatidylinositol binding;cellular_component;biological_process@NA
A2463_20@114916@114916@deletion@1@20968674@20968756@12@chr12:20968674-20968756@4.6@100@52@0.52@CNVR5450.1@SLCO1B3_1, SLCO1B3_3@0@0@0@:solute carrier organic anion transporter family, member 1B3:solute carrier organic anion transporter family, member 1B7 (non-functional)@:bile acid and bile salt transport;transport;basolateral plasma membrane;small molecule metabolic process;transporter activity;organic anion transport;cytoplasm;bile acid metabolic process;transmembrane transport;organic anion transmembrane transporter activity;sodium-independent organic anion transport;integral to membrane;plasma membrane;integral to plasma membrane;membrane:transport;integral to membrane;transporter activity;membrane;transmembrane transport:transport;integral to membrane;transmembrane transporter activity;transporter activity;plasma membrane;membrane;transmembrane transport@: HYPERBILIRUBINEMIA, ROTOR TYPE; HBLRR
A2463_20@117170@117172@deletion@3@52865457@52867521@12@chr12:52865457-52867521@6.98@394@256@0.65@NA@KRT6C_3, KRT6C_2, KRT6C_1@0@0@0@:keratin 6C@:intermediate filament;structural molecule activity;keratin filament;cytoskeleton organization@NA
A2463_20@124178@124179@deletion@2@24468279@24471125@13@chr13:24468279-24471125@4.96@69@32@0.464@NA@C1QTNF9B_2, C1QTNF9B_1@0@0@0@:C1q and tumor necrosis factor related protein 9B@:collagen;protein binding@NA
A2463_20@125548@125549@duplication@2@48954190@48954377@13@chr13:48954190-48954377@6.93@401@568@1.42@NA@RB1_15, RB1_16@0@0@0@:retinoblastoma 1@:nucleoplasm;regulation of mitotic cell cycle;negative regulation of cell proliferation;regulation of centromere complex assembly;G1 phase of mitotic cell cycle;neuron projection development;mitotic cell cycle;Ras protein signal transduction;negative regulation of transcription, DNA-dependent;transcription coactivator activity;kinase binding;neuron apoptotic process;PML body;nucleus;androgen receptor binding;cell division;spindle;negative regulation of transcription involved in G1/S phase of mitotic cell cycle;negative regulation of smoothened signaling pathway;enzyme binding;positive regulation of transcription, DNA-dependent;cell morphogenesis involved in neuron differentiation;transcription, DNA-dependent;cellular_component;regulation of transcription involved in G1/S phase of mitotic cell cycle;digestive tract development;chromatin;negative regulation of cell growth;cell cycle arrest;androgen receptor signaling pathway;M phase;positive regulation of transcription from RNA polymerase II promoter;negative regulation of S phase of mitotic cell cycle;regulation of cell cycle;core promoter binding;sister chromatid biorientation;negative regulation of transcription from RNA polymerase II promoter;S phase of mitotic cell cycle;mitotic cell cycle G1/S transition checkpoint;positive regulation of mitotic metaphase/anaphase transition;striated muscle cell differentiation;enucleate erythrocyte differentiation;neuron differentiation;cell cycle checkpoint;negative regulation of epithelial cell proliferation;ubiquitin protein ligase binding;biological_process;regulation of cohesin localization to chromatin;negative regulation of cell cycle;protein localization to chromosome, centromeric region;transcription factor binding;SWI/SNF complex;G1 phase;phosphoprotein binding;DNA binding;G1/S transition of mitotic cell cycle;regulation of S phase of mitotic cell cycle;sequence-specific DNA binding transcription factor activity;negative regulation of protein kinase activity;myoblast differentiation;transcription factor complex;negative regulation of sequence-specific DNA binding transcription factor activity;chromatin remodeling;neuron maturation;virus-host interaction;RNA polymerase II activating transcription factor binding;positive regulation of macrophage differentiation;Rb-E2F complex;regulation of lipid kinase activity;protein binding;maintenance of mitotic sister chromatid cohesion;molecular_function@: OSTEOGENIC SARCOMA; RETINOBLASTOMA; RB1; BLADDER CANCER
A2463_20@127334@127337@deletion@4@19558718@19563541@14@chr14:19558718-19563541@5.56@127@76@0.598@CNVR6072.1@POTEG_2, POTEG_3, POTEG_4, POTEG_5@0@0@0@:POTE ankyrin domain family, member G@:protein binding@NA
A2463_20@128128@128128@deletion@1@23889055@23889443@14@chr14:23889055-23889443@5.48@117@59@0.504@NA@MYH7_27@0@0@0@:myosin, heavy chain 7, cardiac muscle, beta@:Z disc;muscle filament sliding;response to reactive oxygen species;ventricular cardiac muscle tissue morphogenesis;calmodulin binding;myosin complex;myosin filament;regulation of heart rate;ATP binding;motor activity;myofibril;stress fiber;ATPase activity;sarcomere;focal adhesion;nucleus;protein homodimerization activity;muscle myosin complex;ATP catabolic process;microfilament motor activity;protein heterodimerization activity;adult heart development;cytoplasm;actin-dependent ATPase activity;structural constituent of muscle;actin binding;protein binding;nucleolus;muscle contraction@: CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1; CMH1; CARDIOMYOPATHY, DILATED, 1S; CMD1S; SCAPULOPERONEAL MYOPATHY, MYH7-RELATED; SPMM; MYOPATHY, MYOSIN STORAGE; MYOPATHY, DISTAL, 1; MPD1
A2463_20@131037@131037@deletion@1@74041613@74042217@14@chr14:74041613-74042217@6.24@61@20@0.328@CNVR6188.1, CNVR6188.6@ACOT2_3@0@0@0@:acyl-CoA thioesterase 2@:acyl-CoA metabolic process;mitochondrion;very long-chain fatty acid metabolic process;thiolester hydrolase activity;acyl-CoA hydrolase activity;palmitoyl-CoA hydrolase activity;long-chain fatty acid metabolic process;carboxylesterase activity;receptor binding@NA
A2463_20@133457@133459@deletion@3@106780901@106791456@14@chr14:106780901-106791456@6.57@183@105@0.574@CNVR6294.48, CNVR6294.24, CNVR6294.40, CNVR6294.38, CNVR6294.17, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.53@IGHV4-28_1, IGHV3-30_2, IGHV3-30_1@0@0@0@:uncharacterized LOC100653243;uncharacterized LOC642131@:protein binding:protein binding@NA
A2463_20@133552@133552@deletion@1@22742397@22743598@15@chr15:22742397-22743598@8.01@578@332@0.574@CNVR6298.5@GOLGA6L1_8@0@0@0@:golgin A6 family-like 1;putative transmembrane protein FLJ36131-like;putative transmembrane protein ENSP00000320207-like;putative golgin subfamily A member 6-like@NA@NA
A2463_20@133636@133653@deletion@18@23406272@23605679@15@chr15:23406272-23605679@15.8@562@341@0.607@CNVR6300.8@RP11-467N20.5_8, RP11-467N20.5_7, RP11-467N20.5_6, RP11-467N20.5_5, RP11-467N20.5_4, RP11-467N20.5_3, RP11-467N20.5_2, RP11-467N20.5_1, GOLGA8S_1, GOLGA8S_2, GOLGA8S_3, GOLGA8S_4, GOLGA8S_5, GOLGA8S_6, GOLGA8S_7, GOLGA8S_8, GOLGA8S_9, GOLGA8S_10@0@0@0@:putative golgin subfamily A member 6-like protein 6-like@:Golgi apparatus@NA
A2463_20@133826@133826@deletion@1@28467175@28467361@15@chr15:28467175-28467361@6.84@61@18@0.295@CNVR6328.1@HERC2_36@0@0@0@:putative HERC2-like protein 3-like;HECT and RLD domain containing E3 ubiquitin protein ligase 2@:mitochondrial inner membrane;protein ubiquitination involved in ubiquitin-dependent protein catabolic process;guanyl-nucleotide exchange factor activity;SUMO binding;DNA repair;intracellular protein transport;spermatogenesis;cellular protein modification process;nucleus;ubiquitin protein ligase binding;ubiquitin-protein ligase activity;centriole;intracellular;response to DNA damage stimulus;heme binding;cytoplasm;protein binding;zinc ion binding;protein ubiquitination;metal ion binding@: SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1; SHEP1
A2463_20@134036@134054@deletion@19@30845996@30896376@15@chr15:30845996-30896376@42.6@317@92@0.29@CNVR6339.2, CNVR6339.3, CNVR6339.1@GOLGA8Q_2, GOLGA8Q_3, GOLGA8Q_4, GOLGA8Q_5, GOLGA8Q_6, GOLGA8Q_7, GOLGA8Q_8, GOLGA8Q_9, GOLGA8Q_10, GOLGA8Q_11, GOLGA8Q_12, GOLGA8Q_13, GOLGA8Q_14, GOLGA8Q_15, GOLGA8Q_16, GOLGA8Q_17, GOLGA8Q_18, GOLGA8Q_19, GOLGA8H_1@0@0@0@:golgin A8 family, member H@:Golgi apparatus:Golgi apparatus@NA
A2463_20@134061@134068@deletion@8@30900851@30905398@15@chr15:30900851-30905398@13.9@270@150@0.556@CNVR6339.2, CNVR6339.3@GOLGA8H_8, GOLGA8H_9, GOLGA8H_10, GOLGA8H_11, GOLGA8H_12, GOLGA8H_13, GOLGA8H_14, GOLGA8H_15@0@0@0@:golgin A8 family, member H@:Golgi apparatus@NA
A2463_20@134457@134460@deletion@4@34823677@34825163@15@chr15:34823677-34825163@5.65@50@17@0.34@CNVR6351.3@GOLGA8B_15, GOLGA8B_14, GOLGA8B_13, GOLGA8B_12@0@0@0@:golgin A8 family, member A:golgin A8 family, member A;golgin A8 family, member B@:Golgi cisterna membrane;Golgi apparatus:Golgi cisterna membrane;Golgi apparatus@NA
A2463_20@135046@135061@duplication@16@41854747@41870474@15@chr15:41854747-41870474@18.4@616@876@1.42@NA@TYRO3_4, TYRO3_5, TYRO3_6, TYRO3_7, TYRO3_8, TYRO3_9, TYRO3_10, TYRO3_11, TYRO3_12, TYRO3_13, TYRO3_14, TYRO3_15, TYRO3_16, TYRO3_17, TYRO3_18, TYRO3_19@0@0@0@:TYRO3 protein tyrosine kinase@:protein tyrosine kinase activity;platelet aggregation;negative regulation of toll-like receptor signaling pathway;ATP binding;vagina development;substrate adhesion-dependent cell spreading;nucleus;negative regulation of lymphocyte activation;endoplasmic reticulum membrane;phosphatidylinositol 3-kinase cascade;nuclear envelope;platelet activation;protein kinase activity;protein kinase B signaling cascade;neuron homeostasis;negative regulation of neuron apoptotic process;negative regulation of innate immune response;protein autophosphorylation;transmembrane receptor protein tyrosine kinase activity;apoptotic cell clearance;transferase activity, transferring phosphorus-containing groups;spermatogenesis;forebrain cell migration;integral to membrane;integral to plasma membrane;ovulation cycle;natural killer cell differentiation;phosphatidylinositol 3-kinase binding;negative regulation of inflammatory response;protein phosphorylation;receptor signaling protein tyrosine kinase activity;protein heterodimerization activity;secretion by cell;protein binding;signal transduction;cell adhesion;signal transduction by phosphorylation@NA
A2463_20@138651@138664@deletion@14@75580271@75586816@15@chr15:75580271-75586816@21.3@232@92@0.397@CNVR6452.1@GOLGA6D_5, GOLGA6D_6, GOLGA6D_7, GOLGA6D_8, GOLGA6D_9, GOLGA6D_10, GOLGA6D_11, GOLGA6D_12, GOLGA6D_13, GOLGA6D_14, GOLGA6D_15, GOLGA6D_16, GOLGA6D_17, GOLGA6D_18@0@0@0@:golgin A6 family, member D@:Golgi apparatus@NA
A2463_20@139294@139299@deletion@6@82932797@82936608@15@chr15:82932797-82936608@13.6@107@25@0.234@CNVR6477.6@RP13-996F3.5_8, RP13-996F3.5_7, RP13-996F3.5_6, RP13-996F3.5_5, RP13-996F3.5_4, RP13-996F3.5_3@0@0@0@NA@NA@NA
A2463_20@139472@139482@deletion@11@84842761@84911344@15@chr15:84842761-84911344@21.6@360@172@0.478@CNVR6486.2@RP11-182J1.16_2, RP11-182J1.16_3, GOLGA6L4_1, GOLGA6L4_2, GOLGA6L4_3, GOLGA6L4_4, GOLGA6L4_5, GOLGA6L4_6, GOLGA6L4_7, GOLGA6L4_8, GOLGA6L4_9@0@0@0@:uncharacterized LOC100505679@:Golgi apparatus@NA
A2463_20@141416@141416@deletion@1@2152063@2152257@16@chr16:2152063-2152257@4.84@65@28@0.431@CNVR6597.1@PKD1_26@0@0@0@:polycystin-1-like;polycystic kidney disease 1 (autosomal dominant)@:peptidyl-serine phosphorylation;kidney development;placenta blood vessel development;JAK-STAT cascade;metanephric distal tubule morphogenesis;homophilic cell adhesion;nucleus;metanephric ascending thin limb development;skin development;protein export from nucleus;lung epithelium development;spinal cord development;cilium;in utero embryonic development;detection of mechanical stimulus;heart development;cation channel activity;membrane;protein domain specific binding;motile primary cilium;carbohydrate binding;anatomical structure morphogenesis;mesonephric tubule development;basolateral plasma membrane;protein kinase binding;digestive tract development;calcium ion transport;calcium-independent cell-matrix adhesion;integral to membrane;embryonic placenta development;metanephric proximal tubule development;cell cycle arrest;integral to plasma membrane;branching morphogenesis of a tube;genitalia development;positive regulation of transcription from RNA polymerase II promoter;neuropeptide signaling pathway;mesonephric duct development;cell-matrix adhesion;cytoplasmic sequestering of transcription factor;cytoplasm;positive regulation of protein binding;protein binding;metanephric collecting duct development;positive regulation of cyclin-dependent protein kinase activity involved in G1/S;ion channel binding;polycystin complex;neural tube development;cartilage condensation;cartilage development@: POLYCYSTIC KIDNEY DISEASE 1; PKD1
A2463_20@142750@142754@deletion@5@15457517@15463713@16@chr16:15457517-15463713@11@227@108@0.476@CNVR6649.1@PKD1P1_8, PKD1P1_7, PKD1P1_6, PKD1P1_5, PKD1P1_4@0@0@0@:NPIP-like protein 1-like;nuclear pore complex-interacting protein-like 1-like@NA@NA
A2463_20@143487@143491@duplication@5@21846953@21854902@16@chr16:21846953-21854902@6.25@295@411@1.39@CNVR6668.5, CNVR6668.7@NPIPL3_8, NPIPL3_7, NPIPL3_6, NPIPL3_5, NPIPL3_4@0@0@0@:nuclear pore complex interacting protein-like 3;nuclear pore complex interacting protein-like;nuclear pore complex-interacting protein-like 3-like@NA@NA
A2463_20@143607@143607@deletion@1@22544948@22547706@16@chr16:22544948-22547706@7.17@305@169@0.554@CNVR6669.2@NPIPL3_7@0@0@0@:nuclear pore complex interacting protein pseudogene;nuclear pore complex interacting protein related gene;nuclear pore complex interacting protein-like@:integral to membrane@NA
A2463_20@144095@144104@deletion@10@28607105@28659638@16@chr16:28607105-28659638@38.3@535@236@0.441@NA@SULT1A2_2, SULT1A1_10, SULT1A1_9, SULT1A1_8, SULT1A1_7, SULT1A1_6, SULT1A1_5, SULT1A1_4, A-575C2.4_1, A-575C2.4_2@0@0@0@:sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2:sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1:nuclear pore complex-interacting protein-like 2-like;putative NPIP-like protein LOC613037-like@:steroid metabolic process;small molecule metabolic process;sulfation;aryl sulfotransferase activity;catecholamine metabolic process;cytosol;xenobiotic metabolic process;phenol-containing compound metabolic process;sulfotransferase activity;amine biosynthetic process;flavonol 3-sulfotransferase activity;3'-phosphoadenosine 5'-phosphosulfate metabolic process:small molecule metabolic process;sulfation;aryl sulfotransferase activity;amine metabolic process;catecholamine metabolic process;xenobiotic metabolic process;cytosol;steroid sulfotransferase activity;integral to membrane;sulfotransferase activity;flavonol 3-sulfotransferase activity;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process;estrogen metabolic process@NA
A2463_20@147091@147091@deletion@1@69988238@69988476@16@chr16:69988238-69988476@6.7@62@19@0.306@CNVR6762.3, CNVR6762.1@CLEC18A_3@0@0@0@:C-type lectin domain family 18, member A@:carbohydrate binding;protein binding;extracellular region@NA
A2463_20@147125@147127@deletion@3@70208183@70211383@16@chr16:70208183-70211383@11.8@145@67@0.462@CNVR6764.1@CLEC18C_1, CLEC18C_2, CLEC18C_3@0@0@0@:C-type lectin domain family 18, member C@:carbohydrate binding;protein binding;extracellular region@NA
A2463_20@147418@147423@deletion@6@72090430@72097159@16@chr16:72090430-72097159@11.5@479@348@0.727@CNVR6769.1, CNVR6769.2@HP_3, HP_4, HP_5, HP_6, HP_7, HPR_1@0@0@0@:thioredoxin-like 4B:haptoglobin:haptoglobin-related protein@:mitosis;mRNA processing;RNA splicing;spliceosomal complex;cell redox homeostasis:cellular iron ion homeostasis;negative regulation of oxidoreductase activity;catalytic activity;negative regulation of hydrogen peroxide catabolic process;positive regulation of cell death;haptoglobin-hemoglobin complex;extracellular space;proteolysis;response to hydrogen peroxide;extracellular region;hemoglobin binding;defense response;serine-type endopeptidase activity:spherical high-density lipoprotein particle;proteolysis;extracellular region;hemoglobin binding;catalytic activity;serine-type endopeptidase activity@: ANHAPTOGLOBINEMIA; AHP
A2463_20@147508@147510@deletion@3@74445568@74446778@16@chr16:74445568-74446778@5.56@170@100@0.588@CNVR6778.2, CNVR6778.3, CNVR6778.5@CLEC18B_8, CLEC18B_7, CLEC18B_6@0@0@0@:C-type lectin domain family 18, member B@:carbohydrate binding;protein binding;extracellular region@NA
A2463_20@151544@151546@deletion@3@16593716@16608713@17@chr17:16593716-16608713@6.55@126@67@0.532@NA@CCDC144A_1, CCDC144A_1, CCDC144A_2, CCDC144A_2, CCDC144A_3, CCDC144A_3@0@0@0@:coiled-coil domain containing 144A@NA@NA
A2463_20@151556@151558@deletion@3@16664740@16667489@17@chr17:16664740-16667489@5.32@562@391@0.696@NA@CCDC144A_13, CCDC144A_13, CCDC144A_14, CCDC144A_14, CCDC144A_15, CCDC144A_15@0@0@0@:coiled-coil domain containing 144A@NA@NA
A2463_20@152992@152992@deletion@1@30357676@30357746@17@chr17:30357676-30357746@5.94@98@45@0.459@NA@LRRC37B_4@0@0@0@:leucine rich repeat containing 37B@:protein binding;integral to membrane;cytoplasm@NA
A2463_20@153376@153395@deletion@20@34522686@34624349@17@chr17:34522686-34624349@24.2@132@16@0.121@CNVR7077.1, CNVR7077.13, CNVR7077.19, CNVR7077.2@CCL3L3_3, CCL3L3_2, CCL3L3_1, CCL4L1_1, CCL4L1_2, CCL4L1_3, TBC1D3C_14, TBC1D3C_13, TBC1D3C_12, TBC1D3C_11, TBC1D3C_10, TBC1D3C_9, TBC1D3C_8, TBC1D3C_7, TBC1D3C_6, TBC1D3C_5, TBC1D3C_4, TBC1D3C_3, TBC1D3C_2, CCL3L1_3@0@0@0@:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1:TBC1 domain family, member 3C;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3H-like;TBC1 domain family, member 3H:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3@:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity@NA
A2463_20@164952@164957@deletion@6@7037873@7058616@19@chr19:7037873-7058616@6.52@214@132@0.617@CNVR7517.1@MBD3L4_2, MBD3L4_1, MBD3L2_1, MBD3L2_2, MBD3L3_2, MBD3L3_1@0@0@0@:methyl-CpG binding domain protein 3-like 4:methyl-CpG-binding domain protein 3-like 2-like;methyl-CpG binding domain protein 3-like 2:methyl-CpG binding domain protein 3-like 3@:regulation of transcription, DNA-dependent;transcription, DNA-dependent:regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
A2463_20@167241@167246@deletion@6@15769538@15791329@19@chr19:15769538-15791329@6.32@139@79@0.568@CNVR7553.1@CYP4F3_12, CYP4F3_13, CYP4F12_2, CYP4F12_3, CYP4F12_4, CYP4F12_5@0@0@0@:cytochrome P450, family 4, subfamily F, polypeptide 3:cytochrome P450, family 4, subfamily F, polypeptide 12@:oxidation-reduction process;electron carrier activity;small molecule metabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;heme binding;xenobiotic metabolic process;icosanoid metabolic process;integral to membrane;leukotriene-B4 20-monooxygenase activity;monooxygenase activity;leukotriene metabolic process;endoplasmic reticulum membrane;iron ion binding;alpha-tocopherol omega-hydroxylase activity:pressure natriuresis;negative regulation of blood coagulation;oxidation-reduction process;very long-chain fatty acid metabolic process;arachidonic acid metabolic process;aromatase activity;sodium ion homeostasis;renal water homeostasis;arachidonic acid epoxygenase activity;integral to membrane;leukotriene B4 catabolic process;endoplasmic reticulum membrane;epoxygenase P450 pathway;electron carrier activity;intracellular membrane-bounded organelle;drug metabolic process;alkane 1-monooxygenase activity;small molecule metabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;apical plasma membrane;heme binding;vitamin E metabolic process;cytoplasm;vitamin-K-epoxide reductase (warfarin-sensitive) activity;xenobiotic metabolic process;vitamin K biosynthetic process;leukotriene-B4 20-monooxygenase activity;long-chain fatty acid metabolic process;iron ion binding@NA
A2463_20@170098@170100@duplication@3@40376632@40382826@19@chr19:40376632-40382826@11.7@264@419@1.59@CNVR7639.2@FCGBP_24, FCGBP_23, FCGBP_22@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_20@170104@170109@deletion@6@40389653@40399855@19@chr19:40389653-40399855@45.3@341@87@0.255@CNVR7639.2, CNVR7639.3@FCGBP_18, FCGBP_17, FCGBP_16, FCGBP_15, FCGBP_14, FCGBP_13@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
A2463_20@172128@172129@deletion@2@49547468@49548001@19@chr19:49547468-49548001@5.14@32@6@0.188@CNVR7684.1@CGB5_1, CGB5_2@0@0@0@:chorionic gonadotropin, beta polypeptide 1:chorionic gonadotropin, beta polypeptide 8;chorionic gonadotropin, beta polypeptide;chorionic gonadotropin, beta polypeptide 5@:hormone activity;extracellular region:hormone activity;small molecule metabolic process;female gamete generation;cell-cell signaling;signal transduction;extracellular region;apoptotic process;cellular nitrogen compound metabolic process;peptide hormone processing@NA
A2463_20@173474@173482@deletion@9@55290065@55320338@19@chr19:55290065-55320338@9.42@139@70@0.504@CNVR7725.1, CNVR7725.3@KIR2DL1_5, KIR2DL1_6, KIR2DL1_7, KIR2DL1_8, KIR2DL4_1, KIR2DL4_2, KIR2DL4_3, KIR2DL4_4, KIR2DL4_5@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane@NA
A2463_20@181417@181420@deletion@4@20366369@20367356@22@chr22:20366369-20367356@6.96@42@8@0.19@CNVR8094.9, CNVR8094.4, CNVR8094.3@GGTLC3_5, GGTLC3_4, GGTLC3_3, GGTLC3_2@0@0@0@@:leukotriene biosynthetic process;glutathione metabolic process;gamma-glutamyltransferase activity;anchored to external side of plasma membrane@NA
A2463_20@181429@181429@deletion@1@20706373@20706405@22@chr22:20706373-20706405@5.08@91@44@0.484@CNVR8095.6, CNVR8095.5, CNVR8095.7, CNVR8095.3@FAM230A_7@0@0@0@:putative uncharacterized protein ENSP00000383309-like:ubiquitin specific peptidase 41@:transferase activity, transferring phosphorus-containing groups:cysteine-type peptidase activity;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
A2463_20@181622@181622@deletion@1@21480538@21481925@22@chr22:21480538-21481925@7.1@79@28@0.354@CNVR8100.6, CNVR8100.12@POM121L7_1@0@0@0@:putative POM121-like protein 1-like@NA@NA
